PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Halade, GV; Kain, V; Serhan, CN				Halade, Ganesh V.; Kain, Vasundhara; Serhan, Charles N.			Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure	FASEB JOURNAL			English	Article						leukocytes; inflammation resolution; neutrophil clearance; miRNA storm	ACUTE KIDNEY INJURY; ACUTE-INFLAMMATION; MACROPHAGE ACTIVATION; LIPID MEDIATORS; RESOLUTION; MICRORNAS; MICE; DYSFUNCTION; MECHANISMS; PATHOLOGY	Resolvins are innate, immune responsive, bioactive mediators generated after myocardial infarction (MI) to resolve inflammation. The MI-induced bidirectional interaction between progressive left ventricle (LV) remodeling and kidney dysfunction is known to advance cardiorenal syndrome (CRS). Whether resolvins limit MI-induced cardiorenal inflammation is unclear. Thus, to define the role of exogenous resolvin D (RvD)-1 in post-MI CRS, we subjected 8- to 12-wk-old male C57BL/6 mice to coronary artery ligation. RvD1 was injected 3 h after MI. MI mice with no treatment served as MI controls (d 1 and 5). Mice with no surgery served as naive controls. In the injected mice, RvD1 promoted neutrophil (CD11b(+)/Ly6G(+)) egress from the infarcted LV, compared with the MI control group at d 5, indicative of neutrophil clearance and thereby resolved inflammation. Further, RvD1-injected mice showed higher reparative macrophages (F4/80(+)/Ly6C(low)/CD206(+)) in the infarcted LV than did MI control mice at d 5 after MI. RvD1 suppressed the miRNA storm at d 1 and limited the MI-induced edematous milieu in a remote area of the LV compared with the MI control at d 5 after MI. Also, RvD1 preserved the nephrin expression that was diffuse in the glomerular membrane at d 5 and 28 in MI controls, indicating renal injury. RvD1 attenuated MI-induced renal inflammation, decreasing neutrophil gelatinase-associated lipocalin and proinflammatory cytokines and chemokines in the kidney compared with the MI control. In summary, RvD1 clears MI-induced inflammation by increasing resolving leukocytes and facilitates renoprotective mechanisms to limit CRS in acute and chronic heart failure.Halade, G. V., Kain, V., Serhan, C. N. Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure.	[Halade, Ganesh V.; Kain, Vasundhara] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, 703 19th St South,MC 7755, Birmingham, AL 35294 USA; [Serhan, Charles N.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA USA; [Serhan, Charles N.] Harvard Med Sch, Boston, MA USA	University of Alabama System; University of Alabama Birmingham; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Halade, GV (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, 703 19th St South,MC 7755, Birmingham, AL 35294 USA.	ganeshhalade@uabmc.edu	Kain, Vasundhara/AAL-7371-2021		U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health Grant [AT006704]; NIH National Heart, Lung and Blood Institute [HL132989]; University of Alabama at Birmingham (UAB) Pittman Scholar Award; American Heart Association Postdoctoral Fellowship [POST31000008]; NIH National Institute of General Medical Sciences [P01-GM095467, GM038765-32]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K99AT006704] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R00AT006704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467, R01GM038765, R37GM038765] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health Grant; NIH National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Alabama at Birmingham (UAB) Pittman Scholar Award; American Heart Association Postdoctoral Fellowship(American Heart Association); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health Grant AT006704; NIH National Heart, Lung and Blood Institute Grant HL132989; The University of Alabama at Birmingham (UAB) Pittman Scholar Award (to G.V.H.); American Heart Association Postdoctoral Fellowship Grant POST31000008 (to V.K.); and NIH National Institute of General Medical Sciences Grants P01-GM095467 and GM038765-32 (to C.N.S.) The authors declare no conflicts of interest.	Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Chistiakov DA, 2016, J MOL CELL CARDIOL, V94, P107, DOI 10.1016/j.yjmcc.2016.03.015; Coletta AP, 2002, EUR J HEART FAIL, V4, P559, DOI 10.1016/S1388-9842(02)00121-6; Damman K, 2015, EUR HEART J, V36, P1437, DOI 10.1093/eurheartj/ehv010; Fox CS, 2012, CIRCULATION, V125, P497, DOI 10.1161/CIRCULATIONAHA.111.039909; Halade GV, 2018, AM J PHYSIOL-HEART C, V314, pH255, DOI 10.1152/ajpheart.00528.2017; Halade GV, 2016, AGING-US, V8, P2611, DOI 10.18632/aging.101077; Halade GV, 2013, AM J PHYSIOL-HEART C, V305, pH1830, DOI 10.1152/ajpheart.00224.2013; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Ingle KA, 2015, AM J PHYSIOL-HEART C, V309, pH1827, DOI 10.1152/ajpheart.00608.2015; Kain V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10441-8; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Kain V, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0444-7; Knier B, 2011, J HYPERTENS, V29, P1602, DOI 10.1097/HJH.0b013e32834840e8; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kyne L, 2000, AM HEART J, V139, P94, DOI 10.1016/S0002-8703(00)90314-4; Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011; Lopez EF, 2015, AM J PHYSIOL-HEART C, V308, pH269, DOI 10.1152/ajpheart.00604.2014; Ma YG, 2013, CIRC RES, V112, P675, DOI 10.1161/CIRCRESAHA.111.300502; Maisel AS, 2011, NEPHROL DIAL TRANSPL, V26, P62, DOI 10.1093/ndt/gfq647; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Mohamed JS, 2015, J BIOL CHEM, V290, P24986, DOI 10.1074/jbc.M115.659375; Muller WA, 2015, CARDIOVASC RES, V107, P310, DOI 10.1093/cvr/cvv145; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Olson EN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009008; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Recchiuti A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00298; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Roy AK, 2013, CARDIORENAL MED, V3, P26, DOI 10.1159/000347037; SEKULIC M., 2013, PATHOL RES INT, V2013; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Silva MT, 2011, J LEUKOCYTE BIOL, V89, P675, DOI 10.1189/jlb.0910536; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tourki B, 2017, FASEB J, V31, P4226, DOI 10.1096/fj.201700109R; Wei YY, 2013, CIRCULATION, V127, P1609, DOI 10.1161/CIRCULATIONAHA.112.000736; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	42	40	41	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3717	3729		10.1096/fj.201701173RR	http://dx.doi.org/10.1096/fj.201701173RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29455574	Green Published			2022-12-26	WOS:000435104500020
J	Senchenkova, EY; Russell, J; Vital, SA; Yildirim, A; Orr, AW; Granger, DN; Gavins, FNE				Senchenkova, Elena Y.; Russell, Janice; Vital, Shantel A.; Yildirim, Alper; Orr, A. Wayne; Granger, D. Neil; Gavins, Felicity N. E.			A critical role for both CD40 and VLA5 in angiotensin II-mediated thrombosis and inflammation	FASEB JOURNAL			English	Article						sCD40L thrombosis; leukocytes; platelets; endothelium; hypertension	ALPHA-5-BETA-1 INTEGRIN; MICROVASCULAR RESPONSES; GLYCOPROTEIN IIB/IIIA; SOLUBLE CD40L; LIGAND; LEUKOCYTE; PLATELETS; TRIGGERS; BINDING; HYPERTENSION	Angiotensin II (Ang-II)-induced hypertension is associated with accelerated thrombus formation in arterioles and leukocyte recruitment in venules. The mechanisms that underlie the prothrombotic and proinflammatory responses to chronic Ang-II administration remain poorly understood. We evaluated the role of CD40/CD40 ligand (CD40L) signaling in Ang-Il-mediated microvascular responses and assessed whether and how soluble CD40L (sCD40L) contributes to this response. Intravital video microscopy was performed to analyze leukocyte recruitment and dihydrorhodamine-123 oxidation in postcapillary venules. Thrombus formation in cremaster muscle arterioles was induced by using the light/dye endothelial cell injury model. Wild-type (WT), CD40, and CD40L(-/-) mice received Ang-II for 14 d via osmotic minipumps. Some mice were treated with either recombinant sCD40L or the VLA5 (very late antigen 5; alpha 5 beta 1) antagonist, ATN-161. Our results demonstrate that CD40(-/-), CD40L(-/-), and WT mice that were treated with ATN-161 were protected against the thrombotic and inflammatory effects of Ang-II infusion. Infusion of sCD40L into CD40(-/-) or CD40L(-/-) mice restored the prothrombotic effect of Ang-II infusion. Mice that were treated with ATN-161 and infused with sCD40L were protected against accelerated thrombosis. Collectively, these novel findings suggest that the mechanisms that underlie Ang-Il-dependent thrombotic and inflammatory responses link to the signaling of CD40L via both CD40 and VLA5.	[Senchenkova, Elena Y.; Russell, Janice; Vital, Shantel A.; Yildirim, Alper; Granger, D. Neil; Gavins, Felicity N. E.] Louisiana State Univ, Dept Mol & Cellular Physiol, Hlth Sci Ctr Shreveport, 1501 Kings Highway, Shreveport, LA 71103 USA; [Orr, A. Wayne] Louisiana State Univ, Dept Pathol & Translat Pathobiol, Hlth Sci Ctr Shreveport, Shreveport, LA 71103 USA; [Gavins, Felicity N. E.] Louisiana State Univ, Dept Neurol, Hlth Sci Ctr Shreveport, Shreveport, LA 71103 USA; [Senchenkova, Elena Y.] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia; [Yildirim, Alper] Marmara Univ, Dept Physiol, Sch Med, Istanbul, Turkey	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Marmara University	Gavins, FNE (corresponding author), Louisiana State Univ, Dept Mol & Cellular Physiol, Hlth Sci Ctr Shreveport, 1501 Kings Highway, Shreveport, LA 71103 USA.	fgavin@lsuhsc.edu	Yildirim, Alper/I-2330-2014; Gavins, Felicity N. E./AAU-6010-2020; Orr, Anthony/P-8927-2015	Yildirim, Alper/0000-0002-3328-1692; Gavins, Felicity N. E./0000-0001-7008-5423; Orr, Anthony/0000-0002-2377-213X				Alexander RW, 2006, ARTERIOSCL THROM VAS, V26, P240, DOI 10.1161/01.ATV.0000199680.42737.ca; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Bachsais M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158987; Celi A, 2010, EXPERT REV CARDIOVAS, V8, P1723, DOI 10.1586/ERC.10.161; El Fakhry Y, 2012, J BIOL CHEM, V287, P18055, DOI 10.1074/jbc.M111.333989; Ferroni Patrizia, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P194, DOI 10.2174/187152908785849125; Freedman JE, 2003, CIRC RES, V92, P944, DOI 10.1161/01.RES.0000074030.98009.FF; Fullard JF, 2004, CURR PHARM DESIGN, V10, P1567, DOI 10.2174/1381612043384682; Gavins FNE, 2011, J THROMB HAEMOST, V9, P574, DOI 10.1111/j.1538-7836.2010.04176.x; Granger DN, 2010, MICROCIRCULATION, V17, P192, DOI 10.1111/j.1549-8719.2009.00015.x; HALL J E, 1991, Comprehensive Therapy, V17, P8; Hausding M, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0386-5; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Kuijpers MJE, 2015, ARTERIOSCL THROM VAS, V35, P1374, DOI 10.1161/ATVBAHA.114.305127; Leveille C, 2007, J BIOL CHEM, V282, P5143, DOI 10.1074/jbc.M608342200; Li HM, 2007, J BIOL CHEM, V282, P5991, DOI 10.1074/jbc.M608482200; Matthies KMG, 2006, CELL IMMUNOL, V241, P47, DOI 10.1016/j.cellimm.2006.08.001; May AE, 2002, CIRCULATION, V106, P2111, DOI 10.1161/01.CIR.0000033597.45947.0F; Pamukcu B, 2011, ANN MED, V43, P331, DOI 10.3109/07853890.2010.546362; Prandoni P, 2007, J INTERN MED, V262, P341, DOI 10.1111/j.1365-2796.2007.01815.x; Safar ME, 2008, J HUM HYPERTENS, V22, P590, DOI 10.1038/jhh.2008.43; Senchenkova EY, 2014, MICROCIRCULATION, V21, P401, DOI 10.1111/micc.12120; Senchenkova EY, 2011, HYPERTENSION, V58, P959, DOI 10.1161/HYPERTENSIONAHA.111.173856; Senchenkova EY, 2010, HYPERTENSION, V56, P1089, DOI 10.1161/HYPERTENSIONAHA.110.158220; Souza HP, 2009, CLIN SCI, V116, P423, DOI 10.1042/CS20080155; Stokes KY, 2009, AM J PHYSIOL-HEART C, V296, pH689, DOI 10.1152/ajpheart.00962.2008; Touyz RM, 2001, J HYPERTENS, V19, P1245, DOI 10.1097/00004872-200107000-00009; Ueland T, 2005, EUR HEART J, V26, P1101, DOI 10.1093/eurheartj/ehi132; Varo N, 2003, CIRCULATION, V108, P1049, DOI 10.1161/01.CIR.0000088521.04017.13; Vital SA, 2010, MICROCIRCULATION, V17, P641, DOI 10.1111/j.1549-8719.2010.00060.x; Vowinkel T, 2007, GASTROENTEROLOGY, V132, P955, DOI 10.1053/j.gastro.2006.12.027; Wolf D, 2011, CIRC RES, V109, P1269, DOI 10.1161/CIRCRESAHA.111.247684; Yan JC, 2005, CLIN CHIM ACTA, V355, P191, DOI 10.1016/j.cccn.2005.01.009; Yildirim A, 2012, HYPERTENSION, V60, P1503, DOI 10.1161/HYPERTENSIONAHA.112.198465	35	13	14	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3448	3456		10.1096/fj.201701068R	http://dx.doi.org/10.1096/fj.201701068R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29452567	Green Published			2022-12-26	WOS:000432546000044
J	Wang, H; Bei, L; Shah, CA; Huang, WQ; Platanias, LC; Eklund, EA				Wang, Hao; Bei, Ling; Shah, Chirag A.; Huang, Weiqi; Platanias, Leonidas C.; Eklund, Elizabeth A.			The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia	ONCOGENE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; BONE-MARROW-CELLS; GENE-EXPRESSION; ACTIVATES TRANSCRIPTION; ENCODING GP91(PHOX); PROGENITOR CELLS; HOX EXPRESSION; DNA-BINDING; IN-VITRO; DIFFERENTIATION	Chromosomal translocations involving the MLL1 gene characterize a poor prognosis subset of acute myeloid leukemia (AML), referred to as 11q23-AML. Transcription of the HOXA9 and HOXA10 genes is enhanced in hematopoietic stem and progenitor cells in these leukemias. We previously found the ARIH2 gene was repressed by HoxA9 in myeloid progenitors, but activated by HoxA10 during granulopoiesis. ARIH2 encodes the Triad1 protein, an anti-proliferative E3 ubiquitin ligase. In the current study, we investigate the role of Triad1 in leukemogenesis induced by an MLL1 fusion protein (Mll-Ell). We found Mll-Ell increased expression of HoxA9, HoxA10, and Triad1 because HoxA9 represses only one of two ARIH2 cis elements that are activated by HoxA10. Although Triad1 antagonized the generally pro-proliferative effects of the Mll-Ell oncoprotein, we found blocking HoxA9 and HoxA10 phosphorylation shifted the balance to ARIH2 repression in Mll-Ell(+) cells. We investigated the significance of these in vitro results in a murine bone marrow transplant model. We found Triad1 knockdown significantly shortened the latency to development of AML in mice transplanted with Mll-Ell-transduced bone marrow. And, Triad1 expression fell during the prolonged AML latency period in mice transplanted with bone marrow expressing Mll-Ell alone. Our studies identify Triad1 as a leukemia suppressor in 11q23-AML. This suggests defining relevant Triad1 substrates may indicate novel therapeutic targets in this disease.	[Wang, Hao; Bei, Ling; Shah, Chirag A.; Huang, Weiqi; Platanias, Leonidas C.; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Bei, Ling; Shah, Chirag A.; Platanias, Leonidas C.; Eklund, Elizabeth A.] Jesse Brown Vet Adm Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.; Eklund, EA (corresponding author), Jesse Brown Vet Adm Med Ctr, Chicago, IL 60612 USA.	e-eklund@northwestern.edu		Wang, Hao/0000-0003-2131-0377	NIH [HL87717]; Robert H. Lurie Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA195642] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER; Veterans Affairs [I01BX004635] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert H. Lurie Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	NIH grant HL87717, a VA Merit Review, the Mander Foundation, and the Director's Research Fund of the Robert H. Lurie Comprehensive Cancer Center (to EAE).	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bei L, 2005, J BIOL CHEM, V280, P12359, DOI 10.1074/jbc.M408138200; Bei L, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.49; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bei L, 2011, J BIOL CHEM, V286, P19047, DOI 10.1074/jbc.M110.213983; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; Compendia Biosciences, ONC 4 4; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Eklund E. A., 2011, Critical Reviews in Oncogenesis, V16, P65; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Eklund EA, 2000, J BIOL CHEM, V39, P36878; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Li ZJ, 2009, CANCER RES, V69, P1109, DOI 10.1158/0008-5472.CAN-08-3381; Lin AE, 2013, NAT IMMUNOL, V14, P27, DOI 10.1038/ni.2478; Lindsey S, 2005, J IMMUNOL, V175, P5269, DOI 10.4049/jimmunol.175.8.5269; Lindsey S, 2007, J BIOL CHEM, V282, P2237, DOI 10.1074/jbc.M608642200; Marteijn JAF, 2005, BLOOD, V106, P4114, DOI 10.1182/blood-2005-04-1450; Nabinger SC, 2013, LEUKEMIA, V27, P398, DOI 10.1038/leu.2012.308; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Roche J, 2004, LEUKEMIA, V18, P1059, DOI 10.1038/sj.leu.2403366; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Shah CA, 2013, J BIOL CHEM, V288, P32490, DOI 10.1074/jbc.M113.496109; Shah CA, 2012, J BIOL CHEM, V287, P18230, DOI 10.1074/jbc.M111.328401; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Van der Reijden BA, 1999, PROTEIN SCI, V8, P1557, DOI 10.1110/ps.8.7.1557; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wang H, 2015, J IMMUNOL, V194, P5375, DOI 10.4049/jimmunol.1401909; Wang H, 2011, J BIOL CHEM, V286, P16832, DOI 10.1074/jbc.M110.213975; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894	38	13	13	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	19					2532	2544		10.1038/s41388-018-0131-5	http://dx.doi.org/10.1038/s41388-018-0131-5			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GF3RN	29459712	Green Published, hybrid			2022-12-26	WOS:000431873400006
J	Benedetto, S; Caldato, C; Bazzan, E; Greenwood, DC; Pensabene, V; Actis, P				Benedetto, Simone; Caldato, Christian; Bazzan, Elia; Greenwood, Darren C.; Pensabene, Virginia; Actis, Paolo			Assessment of the Fitbit Charge 2 for monitoring heart rate	PLOS ONE			English	Article							VALIDATION; ACCURACY; EXERCISE; AGREEMENT; DISEASE	Fitness trackers are devices or applications for monitoring and tracking fitness-related metrics such as distance walked or run, calorie consumption, quality of sleep and heart rate. Since accurate heart rate monitoring is essential in fitness training, the objective of this study was to assess the accuracy and precision of the Fitbit Charge 2 for measuring heart rate with respect to a gold standard electrocardiograph. Fifteen healthy participants were asked to ride a stationary bike for 10 minutes and their heart rate was simultaneously recorded from each device. Results showed that the Fitbit Charge 2 underestimates the heart rate. Although the mean bias in measuring heart rate was a modest -5.9 bpm (95% CI: -6.1 to -5.6 bpm), the limits of agreement, which indicate the precision of individual measurements, between the Fitbit Charge 2 and criterion measure were wide (+16.8 to -28.5 bpm) indicating that an individual heart rate measure could plausibly be underestimated by almost 30 bpm.	[Benedetto, Simone; Caldato, Christian; Bazzan, Elia] TSW XP Lab, Treviso, Italy; [Greenwood, Darren C.] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England; [Greenwood, Darren C.] Univ Leeds, Leeds Inst Data Analyt, Leeds, W Yorkshire, England; [Pensabene, Virginia; Actis, Paolo] Univ Leeds, Sch Elect & Elect Engn, Leeds, W Yorkshire, England; [Pensabene, Virginia] Univ Leeds, Leeds Inst Biomed & Clin Sci, Sch Med, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; University of Leeds	Benedetto, S (corresponding author), TSW XP Lab, Treviso, Italy.	simone.benedetto@tsw.it		Benedetto, Simone/0000-0002-6053-1052; Pensabene, Virginia/0000-0002-3352-8202	TSW XP Lab	TSW XP Lab	This work was supported by TSW XP Lab, which only provided financial support in the form of authors' salaries [SB, CC, EB] and/or research materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.	Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Allen J., 2007, PHYSL MEASUREMENT, V28; Alnaeb ME, 2007, CURR VASC PHARMACOL, V5, P53, DOI 10.2174/157016107779317242; [Anonymous], FITB CHARG HR PROD M; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Cadmus-Bertram L, 2017, ANN INTERN MED, V166, P610, DOI 10.7326/L16-0353; de Zambotti M, 2016, PHYSIOL BEHAV, V158, P143, DOI 10.1016/j.physbeh.2016.03.006; Gao W, 2016, NATURE, V529, P509, DOI 10.1038/nature16521; Gillinov S, 2017, MED SCI SPORT EXER, V49, P1697, DOI 10.1249/MSS.0000000000001284; Jin H, 2016, NANO LETT, V16, P4194, DOI 10.1021/acs.nanolett.6b01066; Jo E, 2016, J SPORT SCI MED, V15, P540; Lee JMM, 2016, MED SCI SPORT EXER, V48, P786, DOI 10.1249/01.mss.0000487361.48518.aa; Murthy V, 2001 C P 23 ANN INT, DOI [10.1109/iembs.2001.1017209, DOI 10.1109/IEMBS.2001.1017209]; Nazari G, 2017, J STRENGTH CONDITION, V1; Parak J, 2014, IEEE ENG MED BIO, P3670, DOI 10.1109/EMBC.2014.6944419; Powierza CS, 2017, PM&R, V9, P1077, DOI 10.1016/j.pmrj.2017.03.012; Reisner A, 2008, ANESTHESIOLOGY, V108, P950, DOI 10.1097/ALN.0b013e31816c89e1; Shcherbina A, 2017, ACCURACY WRISTWORN S, V7; Spierer David K., 2015, Journal of Medical Engineering & Technology, V39, P264, DOI 10.3109/03091902.2015.1047536; Stahl Sarah E, 2016, BMJ Open Sport Exerc Med, V2, pe000106; Takacs J, 2014, J SCI MED SPORT, V17, P496, DOI 10.1016/j.jsams.2013.10.241; Wallen MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154420; Wang R, 2017, JAMA CARDIOL, V2, P104, DOI 10.1001/jamacardio.2016.3340; Wright SP, 2017, AM J PHYSL REGULATOR, V312	25	72	72	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192691	10.1371/journal.pone.0192691	http://dx.doi.org/10.1371/journal.pone.0192691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489850	Green Submitted, Green Published, gold			2022-12-26	WOS:000426276000038
J	Hwang, SB; Choi, JG; Wei, S; Park, BJ; Chelliah, R; Oh, DH				Hwang, Su-Bin; Choi, Jung-gu; Wei, Shuai; Park, Byung-Jae; Chelliah, Ramachandran; Oh, Deog-Hwan			In vivo screening platform for shiga toxinproducing Escherichia coli (STEC) using Caenorhabditis elegans as a model	PLOS ONE			English	Article							VIRULENCE GENES; INFECTION; PATHOGENICITY; ACTIVATION; LONGEVITY; BACTERIA; REVEALS; FOOD	Shiga toxin-producing Escherichia coli (STEC) strains are the main cause of bacillary dysentery, although STEC strains generally induce milder disease symptoms compared to Shigella species. This study aimed to determine the virulence of STEC using the nematode Caenorhabditis elegans as a model host. Worm killing, fertility and bacterial colonisation assays were performed to examine the potential difference in the virulence of STEC strains compared to that of the control E. coli OP50 strains on which worms were fed. A statistically significant difference in the survival rates of C. elegans was observed in that the STEC strains caused death in 8 +/- 10 days and the E. coli OP50 strains caused death in 15 days. STEC strains severely reduced the fertility of the worms. The intestinal load of bacteria in the adult stage nematodes harbouring the E. coli OP50 strains was found to be 3.5 log CFU mL(-1). In contrast, the STEC strains E15, E18 and E22 harboured 4.1, 4.2 and 4.7 log CFU ml(-1) per nematode, respectively. The heat-killed STEC strains significantly increased the longevity of the worms compared to the non-heated STEC strains. In addition, PCR-based genomic profiling of shiga toxin genes, viz., stx1 and stx2, identified in selected STEC strains revealed that these toxins may be associated with the virulence of the STEC strains. This study demonstrated that C. elegans is an effective model to examine and compare the pathogenicity and virulence variation of STEC strains to that of E. coli OP50 strains.	[Hwang, Su-Bin; Choi, Jung-gu; Wei, Shuai; Park, Byung-Jae; Chelliah, Ramachandran; Oh, Deog-Hwan] Kangwon Natl Univ, Coll Agr & Life Sci, Dept Food Sci & Biotechnol, Chunchon, South Korea	Kangwon National University	Oh, DH (corresponding author), Kangwon Natl Univ, Coll Agr & Life Sci, Dept Food Sci & Biotechnol, Chunchon, South Korea.	deoghwa@kangwon.ac.kr	wei, shuai/GUS-6394-2022	DeogHwan, Oh/0000-0002-7472-0436; Chelliah, Ramachandran/0000-0003-2060-9297	Ministry of Agriculture, Food and Drug Safety [14162MFDS085]; Kangwon National University [14162MFDS085]; Ministry of Agriculture, Food and Drug Safety	Ministry of Agriculture, Food and Drug Safety; Kangwon National University; Ministry of Agriculture, Food and Drug Safety	This research work was carried out with the support of research grant (14162MFDS085) to DHO from Ministry of Agriculture, Food and Drug Safety and Kangwon National University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Caenorhabdtis Genetics Center (CGC), Jinn Lee, and Young-hoon Kim for providing the C. elegans strains, and Mr. Park-Yong IK and Ms. Lee Hyun Ah of Kangwon National University, Central laboratory, for training and technical support for con focal analysis. This work was supported by a grant from the Ministry of Agriculture, Food and Drug Safety and Kangwon National University 14162MFDS085.	Abada EAE, 2007, KOREAN J GENETIC, V29, P275; Akiyama Y, 2017, JPN J INFECT DIS, V70, P181, DOI 10.7883/yoken.JJID.2016.100; Anyanful A, 2005, MOL MICROBIOL, V57, P988, DOI 10.1111/j.1365-2958.2005.04739.x; Bae WK, 2006, YONSEI MED J, V47, P437, DOI 10.3349/ymj.2006.47.3.437; Bommarius B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054456; Cheung Man Kit, 2011, BMC Res Notes, V4, P533, DOI 10.1186/1756-0500-4-533; Chou TC, 2013, CELL MICROBIOL, V15, P82, DOI 10.1111/cmi.12030; Cypser JR, 2013, MECH AGEING DEV, V134, P291, DOI 10.1016/j.mad.2013.02.003; Dallman TJ, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000029; Diaz SA, 2015, ECOL EVOL, V5, P1343, DOI 10.1002/ece3.1436; Dunne KA, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000106; Essebe CN, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00077; Ewbank JJ, 2016, CURR OPIN IMMUNOL, V38, P1, DOI 10.1016/j.coi.2015.09.005; Franz E, 2014, INT J FOOD MICROBIOL, V187, P57, DOI 10.1016/j.ijfoodmicro.2014.07.002; Fruth A, 2015, INT J MED MICROBIOL, V305, P697, DOI 10.1016/j.ijmm.2015.08.020; Fung CC, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu045; George DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106085; Golan L, 2011, DIS MODEL MECH, V4, P86, DOI 10.1242/dmm.005777; Greaney AJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00570; He YH, 2014, J PATHOL, V233, P269, DOI 10.1002/path.4350; Huang XW, 2005, RES MICROBIOL, V156, P719, DOI 10.1016/j.resmic.2005.02.006; Hwang AB, 2014, P NATL ACAD SCI USA, V111, pE4458, DOI 10.1073/pnas.1411199111; Ikeda T, 2007, APPL ENVIRON MICROB, V73, P6404, DOI 10.1128/AEM.00704-07; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kang D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01707; Kulshreshtha G, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00421; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Lan R, 2004, INFECT IMMUN, V72, P5080, DOI 10.1128/IAI.72.9.5080-5088.2004; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lee JH, 2017, ENVIRON MICROBIOL, V19, P1776, DOI 10.1111/1462-2920.13649; Losada L, 2016, PLASMID, V83, P8, DOI 10.1016/j.plasmid.2015.12.001; Martin N, 2017, G3-GENES GENOM GENET, V7, P1137, DOI 10.1534/g3.117.039057; Merkx-Jacques A, 2013, APPL ENVIRON MICROB, V79, P2435, DOI 10.1128/AEM.03501-12; Michelacci V, 2017, FOOD MICROBIOL FOOD, P109, DOI 10.1007/978-3-319-43751-4_7; Miko A, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00078; Mohawk KL, 2011, BIOMED RES INT; Neuhaus K, 2017, ARCH MICROBIOL, V199, P203, DOI 10.1007/s00203-016-1291-8; Njamkepo E, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.27, 10.1038/nmicrobiol.2016.27]; Paauw A, 2015, INT J MED MICROBIOL, V305, P446, DOI 10.1016/j.ijmm.2015.04.001; Panda A, 2010, COMPARATIVE MED, V60, P31; Rivas M., 2016, Escherichia coli in the Americas, P97; Sanchez-Diener I, 2017, ANTIMICROBIAL AGENTS; Sarabhai S, 2014, MOL MECH TERMINALIAC; Sastalla I, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00300; Shen JL, 2015, FOOD MICROBIOL, V50, P20, DOI 10.1016/j.fm.2015.02.007; Shimizu T, 2011, GENE, V478, P1, DOI 10.1016/j.gene.2011.01.006; Singh P, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00029; Smati M, 2017, INT J MED MICROBIOL, V307, P44, DOI 10.1016/j.ijmm.2016.11.004; So SH, 2011, MECH AGEING DEV, V132, P210, DOI 10.1016/j.mad.2011.02.005; Stiernagle T, 2006, MAINTENANCE C ELEGAN; Taylor EV, 2013, J FOOD PROTECT, V76, P939, DOI 10.4315/0362-028X.JFP-12-503; Thompson TA, 2017, INT J INFECT DIS, V54, P72, DOI 10.1016/j.ijid.2016.11.411; Topalcengiz Z, 2017, FOOD CONTROL, V72, P73, DOI 10.1016/j.foodcont.2016.07.014; Utari PD, 2013, TRENDS MICROBIOL, V21, P315, DOI 10.1016/j.tim.2013.04.006; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wu DQ, 2006, EXP GERONTOL, V41, P261, DOI 10.1016/j.exger.2006.01.003; Yang WT, 2016, ZOOLOGY, V119, P244, DOI 10.1016/j.zool.2016.05.013; Yun EJ, 2017, PROCESS BIOCHEM, V53, P36, DOI 10.1016/j.procbio.2016.12.001; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	59	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193277	10.1371/journal.pone.0193277	http://dx.doi.org/10.1371/journal.pone.0193277			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489863	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000060
J	Baillieul, S; Wuyam, B; Pepin, JL; Marillier, M; Tamisier, R; Perennou, D; Verges, S				Baillieul, Sebastien; Wuyam, Bernard; Pepin, Jean-Louis; Marillier, Mathieu; Tamisier, Renaud; Perennou, Dominic; Verges, Samuel			Continuous positive airway pressure improves gait control in severe obstructive sleep apnoea: A prospective study	PLOS ONE			English	Article							NEUROCOGNITIVE FUNCTION; DAYTIME SLEEPINESS; WALKING SPEED; MATTER VOLUME; OLDER-ADULTS; VARIABILITY; ATTENTION; BRAIN; PARAMETERS; DISORDERS	Study aim Severe obstructive sleep apnoea (OSA) can lead to neurocognitive alterations, including gait impairments. The beneficial effects of continuous positive airway pressure (CPAP) on improving excessive daytime sleepiness and daily functioning have been documented. However, a demonstration of CPAP treatment efficacy on gait control is still lacking. This study aims to test the hypothesis that CPAP improves gait control in severe OSA patients. Material and methods In this prospective controlled study, twelve severe OSA patients (age = 57.2 +/- 8.9 years, body mass index = 27.4 +/- 3.1 kg.m(-2), apnoea-hypopnoea index = 46.3 +/- 11.7 events.h (-1)) and 10 healthy matched subjects were included. Overground gait parameters were recorded at spontaneous speed and stride time variability, a clinical marker of gait control, was calculated. To assess the role of executive functions in gait and postural control, a dual-task paradigm was applied using a Stroop test as secondary cognitive task. All assessments were performed before and after 8 weeks of CPAP treatment. Results Before CPAP treatment, OSA patients had significantly larger stride time variability (3.1 +/- 1.1% vs 2.1 +/- 0.5%) and lower cognitive performances under dual task compared to controls. After CPAP treatment, stride time variability was significantly improved and no longer different compared to controls. Cognitive performance under dual task also improved after CPAP treatment. Conclusion Eight weeks of CPAP treatment improves gait control of severe OSA patients, suggesting morphological and functional cerebral improvements. Our data provide a rationale for further mechanistic studies and the use of gait as a biomarker of OSA brain consequences.	[Baillieul, Sebastien; Wuyam, Bernard; Pepin, Jean-Louis; Marillier, Mathieu; Tamisier, Renaud; Verges, Samuel] Grenoble Alpes Univ, Lab HP2, Grenoble, France; [Baillieul, Sebastien; Wuyam, Bernard; Pepin, Jean-Louis; Marillier, Mathieu; Tamisier, Renaud; Verges, Samuel] INSERM, U1042, Grenoble, France; [Baillieul, Sebastien; Wuyam, Bernard; Pepin, Jean-Louis; Tamisier, Renaud] Grenoble Alpes Univ Hosp, Pole Thorax & Vaisseaux, Grenoble, France; [Perennou, Dominic] Grenoble Alpes Univ, LPNC Lab, UMPR CNRS 5105, Grenoble, France; [Perennou, Dominic] Grenoble Alpes Univ Hosp, MPR Dept, Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Baillieul, S (corresponding author), Grenoble Alpes Univ, Lab HP2, Grenoble, France.; Baillieul, S (corresponding author), INSERM, U1042, Grenoble, France.; Baillieul, S (corresponding author), Grenoble Alpes Univ Hosp, Pole Thorax & Vaisseaux, Grenoble, France.	sbaillieul@chu-grenoble.fr	Tamisier, Renaud/M-6858-2014; Sébastien, BAILLIEUL/M-7143-2015; Verges, Samuel/M-7040-2014; wuyam, bernard MF/M-7438-2014	Tamisier, Renaud/0000-0003-1128-6529; Sébastien, BAILLIEUL/0000-0002-2348-6918; Verges, Samuel/0000-0002-0831-9222; MARILLIER, Mathieu/0000-0003-2272-7633; Pepin, Jean Louis/0000-0003-3832-2358				Allali G, 2014, RESP PHYSIOL NEUROBI, V201, P31, DOI 10.1016/j.resp.2014.06.012; Allali G, 2016, J NEURAL TRANSM VIEN; Beauchet O, 2013, J NUTR HEALTH AGING, V17, P235, DOI 10.1007/s12603-012-0394-4; Beauchet O, 2014, BRAIN TOPOGR, V27, P293, DOI 10.1007/s10548-013-0293-y; Beauchet O, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-12; Bucks RS, 2013, RESPIROLOGY, V18, P61, DOI 10.1111/j.1440-1843.2012.02255.x; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Caron O, 2000, J APPL BIOMECH, V16, P234, DOI 10.1123/jab.16.3.234; Castronovo V, 2014, SLEEP, V37, P1465, DOI 10.5665/sleep.3994; Celle S, 2016, SLEEP MED REV, V25, P112, DOI 10.1016/j.smrv.2015.03.001; Celle S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-140; Chen G, 2005, GAIT POSTURE, V22, P51, DOI 10.1016/j.gaitpost.2004.06.009; Clark DJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00246; Cohen J.E., 1988, STAT POWER ANAL BEHA; Degache F, 2016, THORAX, V71, P543, DOI 10.1136/thoraxjnl-2015-207490; Diomedi M, 1998, NEUROLOGY, V51, P1051, DOI 10.1212/WNL.51.4.1051; Donker SF, 2005, J MOTOR BEHAV, V37, P217, DOI 10.3200/JMBR.37.3.217-230; Ferini-Strambi L, 2013, INT J PSYCHOPHYSIOL, V89, P203, DOI 10.1016/j.ijpsycho.2013.03.022; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Galna B, 2013, GAIT POSTURE, V37, P580, DOI 10.1016/j.gaitpost.2012.09.025; Hall CD, 2011, PHYS THER, V91, P1039, DOI 10.2522/ptj.20100114; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Innes CRH, 2015, SLEEP, V38, P699, DOI 10.5665/sleep.4658; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Joyeux-Faure M, 2016, SLEEP MED, V23, P44, DOI 10.1016/j.sleep.2016.06.023; Kerner NA, 2016, AM J GERIAT PSYCHIAT, V24, P496, DOI 10.1016/j.jagp.2016.01.134; Konig N, 2014, GAIT POSTURE, V39, P615, DOI 10.1016/j.gaitpost.2013.06.014; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Levy P, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.15; Lienhard K, 2013, MED ENG PHYS, V35, P500, DOI 10.1016/j.medengphy.2012.06.015; Lord S, 2011, J NEUROL, V258, P566, DOI 10.1007/s00415-010-5789-8; Marshall NS, 2006, THORAX, V61, P430, DOI 10.1136/thx.2005.050583; Mazza S, 2005, EUR RESPIR J, V25, P75, DOI 10.1183/09031936.04.00011204; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Naegele B, 1998, SLEEP, V21, P392, DOI 10.1093/sleep/21.4.392; Naegele B, 2006, SLEEP, V29, P533, DOI 10.1093/sleep/29.4.533; Osofundiya O, 2016, CLIN BIOMECH, V35, P42, DOI 10.1016/j.clinbiomech.2016.03.011; Prilipko O, 2014, SLEEP MED, V15, P892, DOI 10.1016/j.sleep.2014.04.004; Rankin BL, 2014, J NEUROPHYSIOL, V112, P374, DOI 10.1152/jn.00138.2014; Rosenzweig I, 2015, LANCET RESP MED, V3, P404, DOI 10.1016/S2213-2600(15)00090-9; Schrager MA, 2008, GAIT POSTURE, V28, P466, DOI 10.1016/j.gaitpost.2008.02.009; Schwab RJ, 2013, AM J RESP CRIT CARE, V188, P613, DOI 10.1164/rccm.201307-1282ST; Schwarz EI, 2015, RESPIROLOGY, V20, P889, DOI 10.1111/resp.12573; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Van de Putte M, 2006, BIO-MED MATER ENG, V16, P43; Verghese J, 2006, J AM GERIATR SOC, V54, P255, DOI 10.1111/j.1532-5415.2005.00580.x; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Yogev-Seligmann G, 2012, MOVEMENT DISORD, V27, P765, DOI 10.1002/mds.24963	49	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192442	10.1371/journal.pone.0192442	http://dx.doi.org/10.1371/journal.pone.0192442			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX4LV	29474363	gold, Green Published, Green Submitted			2022-12-26	WOS:000426049500019
J	Eid, BG; Gurney, AM				Eid, Basma G.; Gurney, Alison M.			Zinc pyrithione activates K+ channels and hyperpolarizes the membrane of rat pulmonary artery smooth muscle cells	PLOS ONE			English	Article							KCNQ POTASSIUM CHANNELS; KV7 CHANNELS; CURRENTS; PAXILLINE; CIRCULATION; SELECTIVITY; MODULATION; INHIBITION; SUBUNITS; MYOCYTES	The membrane potential helps determine pulmonary artery smooth muscle cell (PASMC) contraction. The Kv7 channel activators, retigabine and flupirtine, are thought to dilate pulmonary arteries by hyperpolarising PASMC. Zinc pyrithione activates Kv7 channels by a mechanism distinct from retigabine and with different Kv7 subunit selectivity. This study aimed to determine if zinc pyrithione selectively activates Kv7 channels in rat PASMC to evoke pulmonary artery dilation. Zinc pyrithione relaxed pulmonary arteries with half-maximal effect at 4.3 mu M. At 10 mu M it activated pronounced voltage-dependent K+ current and hyperpolarized PASMCs by around 10mV. Tetraethylammonium ions (TEA, 10mM) and paxilline (1 mu M) abolished both the current and hyperpolarisation. XE991 (10 mu M) blocked the hyperpolarization and reduced the current by 30%. Iberiotoxin (50nM) had no effect on the hyperpolarisation, but reduced the current by 40%. The XE991-sensitive current activated with an exponential time course (time constant 17ms), whereas the iberiotoxin-sensitive current followed a bi-exponential time course (time constants 6 and 57ms), suggesting that the drugs blocked different components of the zinc pyrithione-induced current. Zinc pyrithione therefore appears to activate at least two types of K+ channel in PASMC; an XE991, TEA and paxilline-sensitive Kv7 channel and a TEA, paxilline and iberiotoxin-sensitive BKCa channel. Both could contribute to the relaxing effect of zinc pyrithione on pulmonary artery.	[Eid, Basma G.; Gurney, Alison M.] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Eid, Basma G.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah, Saudi Arabia	University of Manchester; King Abdulaziz University	Gurney, AM (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.	Alison.gurney@manchester.ac.uk			British Heart Foundation [PG/14/22/30714]; King Abdul-Aziz University; Saudi Arabia Ministry of Higher Education	British Heart Foundation(British Heart Foundation); King Abdul-Aziz University; Saudi Arabia Ministry of Higher Education	Funded by a British Heart Foundation project grant to AMG (PG/14/22/30714: www.bhf. org.uk) and a PhD studentship awarded to BGE by King Abdul-Aziz University and the Saudi Arabia Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBARWANI S, 1995, BIOCHEM BIOPH RES CO, V208, P183, DOI 10.1006/bbrc.1995.1321; Archer SL, 1996, CIRC RES, V78, P431, DOI 10.1161/01.RES.78.3.431; Bal M, 2008, J BIOL CHEM, V283, P30668, DOI 10.1074/jbc.M805216200; Bilmen JG, 2002, ARCH BIOCHEM BIOPHYS, V406, P55, DOI 10.1016/S0003-9861(02)00240-0; Brueggemann LI, 2014, AM J PHYSIOL-LUNG C, V306, pL476, DOI 10.1152/ajplung.00253.2013; Brueggemann LI, 2014, J BIOL CHEM, V289, P2099, DOI 10.1074/jbc.M113.527820; Chadha PS, 2014, ARTERIOSCL THROM VAS, V34, P887, DOI 10.1161/ATVBAHA.114.303405; Chadha PS, 2012, BRIT J PHARMACOL, V166, P1377, DOI 10.1111/j.1476-5381.2012.01863.x; CLAPP LH, 1991, EXP PHYSIOL, V76, P677, DOI 10.1113/expphysiol.1991.sp003535; CLAPP LH, 1993, AM J PHYSIOL, V264, pH1907, DOI 10.1152/ajpheart.1993.264.6.H1907; CLAPP LH, 1992, AM J PHYSIOL, V262, pH916, DOI 10.1152/ajpheart.1992.262.3.H916; Evans AM, 1996, J PHYSIOL-LONDON, V496, P407, DOI 10.1113/jphysiol.1996.sp021694; Gao YD, 2003, PROTEINS, V52, P146, DOI 10.1002/prot.10341; Gao ZB, 2008, J BIOL CHEM, V283, P22649, DOI 10.1074/jbc.M802426200; Gurney AM, 2010, ADV EXP MED BIOL, V661, P405, DOI 10.1007/978-1-60761-500-2_26; Gurney AM, 2002, CLIN EXP PHARMACOL P, V29, P330, DOI 10.1046/j.1440-1681.2002.03653.x; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; Joshi S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-31; Joshi S, 2009, J PHARMACOL EXP THER, V329, P368, DOI 10.1124/jpet.108.147785; Kang YJ, 2011, EXP MOL MED, V43, P24, DOI 10.3858/emm.2011.43.1.003; KNAUS HG, 1994, BIOCHEMISTRY-US, V33, P5819, DOI 10.1021/bi00185a021; Leitner MG, 2012, BRIT J PHARMACOL, V165, P2244, DOI 10.1111/j.1476-5381.2011.01697.x; Linley JE, 2012, J PHYSIOL-LONDON, V590, P793, DOI 10.1113/jphysiol.2011.223404; Longland CL, 2000, EUR J PHARMACOL, V408, P219, DOI 10.1016/S0014-2999(00)00775-5; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; McCulloch KM, 2000, EXP PHYSIOL, V85, P487, DOI 10.1017/S0958067000020807; Morecroft I, 2009, BRIT J PHARMACOL, V157, P1241, DOI 10.1111/j.1476-5381.2009.00283.x; Osipenko ON, 1997, BRIT J PHARMACOL, V120, P1461, DOI 10.1038/sj.bjp.0701075; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Sedivy V, 2015, AM J PHYSIOL-LUNG C, V308, pL48, DOI 10.1152/ajplung.00362.2013; Smirnov SV, 2002, J PHYSIOL-LONDON, V538, P867, DOI 10.1113/jphysiol.2001.013003; Sones WR, 2009, BRIT J PHARMACOL, V158, P521, DOI 10.1111/j.1476-5381.2009.00332.x; Stott JB, 2014, DRUG DISCOV TODAY, V19, P413, DOI 10.1016/j.drudis.2013.12.003; Tang ZL, 2001, AM J PHYSIOL-LUNG C, V281, pL243, DOI 10.1152/ajplung.2001.281.1.L243; Xiong QJ, 2008, P NATL ACAD SCI USA, V105, P3128, DOI 10.1073/pnas.0712256105; Xiong QJ, 2007, NAT CHEM BIOL, V3, P287, DOI 10.1038/nchembio874; Zhou PZ, 2013, P NATL ACAD SCI USA, V110, P8726, DOI 10.1073/pnas.1302167110	37	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192699	10.1371/journal.pone.0192699	http://dx.doi.org/10.1371/journal.pone.0192699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474372	Green Published, gold, Green Submitted			2022-12-26	WOS:000426049500028
J	Ahmadi, F; Noorian, F; Novakovic, D; van Schaik, A				Ahmadi, Farzaneh; Noorian, Farzad; Novakovic, Daniel; van Schaik, Andre			A pneumatic Bionic Voice prosthesis-Pre-clinical trials of controlling the voice onset and offset	PLOS ONE			English	Article							PHONATION THRESHOLD PRESSURE; ARTIFICIAL LARYNX; PERCEPTUAL CHARACTERISTICS; ELECTROMYOGRAPHIC ACTIVITY; ELECTROLARYNGEAL SPEECH; FUNDAMENTAL-FREQUENCY; PATTERN-RECOGNITION; TOTAL LARYNGECTOMY; ALARYNGEAL SPEECH; AIR-PRESSURE	Despite emergent progress in many fields of bionics, a functional Bionic Voice prosthesis for laryngectomy patients (larynx amputees) has not yet been achieved, leading to a lifetime of vocal disability for these patients. This study introduces a novel framework of Pneumatic Bionic Voice Prostheses as an electronic adaptation of the Pneumatic Artificial Larynx (PAL) device. The PAL is a non-invasive mechanical voice source, driven exclusively by respiration with an exceptionally high voice quality, comparable to the existing gold standard of Tracheoesophageal (TE) voice prosthesis. Following PAL design closely as the reference, Pneumatic Bionic Voice Prostheses seem to have a strong potential to substitute the existing gold standard by generating a similar voice quality while remaining non-invasive and non-surgical. This paper designs the first Pneumatic Bionic Voice prosthesis and evaluates its onset and offset control against the PAL device through pre-clinical trials on one laryngectomy patient. The evaluation on a database of more than five hours of continuous/isolated speech recordings shows a close match between the onset/offset control of the Pneumatic Bionic Voice and the PAL with an accuracy of 98.45 +/- 0.54%. When implemented in real-time, the Pneumatic Bionic Voice prosthesis controller has an average onset/offset delay of 10 milliseconds compared to the PAL. Hence it addresses a major disadvantage of previous electronic voice prostheses, including myoelectric Bionic Voice, in meeting the short time-frames of controlling the onset/offset of the voice in continuous speech.	[Ahmadi, Farzaneh; van Schaik, Andre] Western Sydney Univ, MARCS Inst Brain Behaviour & Dev, Sydney, NSW, Australia; [Noorian, Farzad] Univ Sydney, Sch Elect & Informat Engn, Sydney, NSW, Australia; [Novakovic, Daniel] Univ Sydney, Cent Clin Sch, Fac Med, Sydney, NSW, Australia	Western Sydney University; University of Sydney; University of Sydney	Ahmadi, F (corresponding author), Western Sydney Univ, MARCS Inst Brain Behaviour & Dev, Sydney, NSW, Australia.	farzaneh.ahmadi@westernsydney.edu.au		van Schaik, Andre/0000-0001-6140-017X; Ahmadi, Farzaneh/0000-0002-0076-0304	Garnett Pass and Rodney Williams Memorial Foundation; MARCS Institute of Brain and Behaviour - Western Sydney University	Garnett Pass and Rodney Williams Memorial Foundation; MARCS Institute of Brain and Behaviour - Western Sydney University	This study is funded by The Garnett Pass and Rodney Williams Memorial Foundation (https://gprwmf.org.au/) research fellowship awards for Dr. Farzaneh Ahmadi (2015-2019), Dr Liang Voice Program at University of Sydney (https://sydney.edu.au/health-sciences/research/hang-voice-program.shtml), and the MARCS Institute of Brain and Behaviour - Western Sydney University (https://www.westemsydney.edu.au./marcs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi F, 2014, BIOM CIRC SYST C BIO; Almeida A, 2002, INT S MUS AC; Amon C., 2014, THESIS; Audet C, 2003, SIAM J OPTIMIZ, V13, P889, DOI 10.1137/S1052623400378742; Avanzini F., 2001, THESIS; Barjau A, 1997, J ACOUST SOC AM, V102, P3023, DOI 10.1121/1.420357; BENNETT S, 1973, J SPEECH HEAR RES, V16, P608, DOI 10.1044/jshr.1604.608; Berry DA, 1996, J VOICE, V10, P129, DOI 10.1016/S0892-1997(96)80039-7; Blom E. D., 1978, ARTIFICIAL LARYNX HD, P57; Chan RW, 2006, J ACOUST SOC AM, V119, P2351, DOI 10.1121/1.2173516; Chan RW, 1996, J ACOUST SOC AM, V99, P2471; CHING TYC, 1994, J SPEECH HEAR RES, V37, P557, DOI 10.1044/jshr.3703.557; CHRISTENSEN JM, 1990, J COMMUN DISORD, V23, P445, DOI 10.1016/0021-9924(90)90030-3; Clements KS, 1997, ARCH OTOLARYNGOL, V123, P493; COLE RA, 1975, J ACOUST SOC AM, V58, P1280, DOI 10.1121/1.380810; De Armas W, 2014, SPEECH COMMUN, V63-64, P15, DOI 10.1016/j.specom.2014.04.004; Fairbanks G, 1960, VOICE ARTICULATION D; Farrell TR, 2007, IEEE T NEUR SYS REH, V15, P111, DOI 10.1109/TNSRE.2007.891391; Farrell TR, 2011, J REHABIL RES DEV, V48, pXXI, DOI 10.1682/JRRD.2011.03.0055; Finnegan EM, 2000, J SPEECH LANG HEAR R, V43, P934, DOI 10.1044/jslhr.4304.934; FLETCHER NH, 1993, J ACOUST SOC AM, V93, P2172, DOI 10.1121/1.406857; Fuchs AK, 2015, BIOS INT C BIOINSP S; Fuchs AK, 2016, IEEE J-STSP, V10, P952, DOI 10.1109/JSTSP.2016.2535970; Goldstein EA, 2004, IEEE T BIO-MED ENG, V51, P325, DOI 10.1109/TBME.2003.820373; Goldstein EA, 2003, THESIS; Goldstein EA, 2007, J SPEECH LANG HEAR R, V50, P335, DOI 10.1044/1092-4388(2007/024); GOODE RL, 1975, LARYNGOSCOPE, V85, P677, DOI 10.1288/00005537-197504000-00011; Guillemain P, 2005, J ACOUST SOC AM, V118, P483, DOI 10.1121/1.1937507; Hage SR, 2010, HBK BEHAV NEUROSCI, V19, P339, DOI 10.1016/B978-0-12-374593-4.00032-2; Heaton JT, 2004, ANN OTO RHINOL LARYN, V113, P754, DOI 10.1177/000348940411300915; Hillman R E, 1998, Ann Otol Rhinol Laryngol Suppl, V172, P1; HOLLEY SC, 1983, J COMMUN DISORD, V16, P143, DOI 10.1016/0021-9924(83)90045-X; Klammer H., 2015, THESIS; KLATT DH, 1975, J SPEECH HEAR RES, V18, P686, DOI 10.1044/jshr.1804.686; Kubert HL, 2009, J COMMUN DISORD, V42, P211, DOI 10.1016/j.jcomdis.2008.12.002; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Laje R, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.056201; Law IKY, 2009, ARCH OTOLARYNGOL, V135, P704, DOI 10.1001/archoto.2009.71; LIEBERMAN P, 1969, J ACOUST SOC AM, V45, P1537, DOI 10.1121/1.1911635; LISKER L, 1964, WORD, V20, P384, DOI 10.1080/00437956.1964.11659830; Lucero JC, 2005, COMMUN MATH SCI, V3, P517; Lucero JC, 1999, J ACOUST SOC AM, V105, P423, DOI 10.1121/1.424572; Lucero JC, 2011, J ACOUST SOC AM, V129, P1568, DOI 10.1121/1.3531805; MacLarnon AM, 1999, AM J PHYS ANTHROPOL, V109, P341, DOI 10.1002/(SICI)1096-8644(199907)109:3<341::AID-AJPA5>3.0.CO;2-2; Meltzner GS, 2005, J SPEECH LANG HEAR R, V48, P766, DOI 10.1044/1092-4388(2005/053); Meltzner GS, 2003, THESIS; Millot L, 2007, ACTA ACUST UNITED AC, V93, P122; Mohammadi SH, 2017, SPEECH COMMUN; MOON JB, 1993, J ACOUST SOC AM, V94, P54, DOI 10.1121/1.407067; Ng ML, 1997, J VOICE, V11, P338, DOI 10.1016/S0892-1997(97)80013-6; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pou AM, 2004, OTOLARYNG CLIN N AM, V37, P531, DOI 10.1016/j.otc.2004.01.009; Regner MF, 2008, LARYNGOSCOPE, V118, P1313, DOI 10.1097/MLG.0b013e31816e2ec7; Rothenberg M, 1981, VOCAL FOLD PHYSL, P305; Ruty N, 2007, J ACOUST SOC AM, V121, P479, DOI 10.1121/1.2384846; Scheme E, 2011, J REHABIL RES DEV, V48, P643, DOI 10.1682/JRRD.2010.09.0177; Schmidt-Nielsen A., 1992, DTIC DOCUMENT; SCHULTZCOULON HJ, 1978, ACTA OTO-LARYNGOL, V86, P142, DOI 10.3109/00016487809124731; Simonyan K, 2011, NEUROSCIENTIST, V17, P197, DOI 10.1177/1073858410386727; Singer  S., 2012, HEAD NECK-J SCI SPEC, P1; Smith LH, 2011, IEEE T NEUR SYS REH, V19, P186, DOI 10.1109/TNSRE.2010.2100828; Stepp CE, 2010, J SPEECH LANG HEAR R, V53, P1220, DOI 10.1044/1092-4388(2010/09-0234); Stepp CE, 2009, IEEE T NEUR SYS REH, V17, P146, DOI 10.1109/TNSRE.2009.2017805; Takahashi H, 2008, J VOICE, V22, P420, DOI 10.1016/j.jvoice.2006.10.004; Tarnopolsky AZ, 2000, J ACOUST SOC AM, V108, P400, DOI 10.1121/1.429473; TITZE IR, 1995, J ACOUST SOC AM, V97, P3080, DOI 10.1121/1.411870; TITZE IR, 1992, J ACOUST SOC AM, V91, P2926, DOI 10.1121/1.402928; Toda T, 2007, IEEE T AUDIO SPEECH, V15, P2222, DOI 10.1109/TASL.2007.907344; Voiers WD, 1973, RES DIAGNOSTIC EVALU; WEINBERG B, 1973, J SPEECH HEAR DISORD, V38, P383, DOI 10.1044/jshd.3803.383; WEISS MS, 1979, J ACOUST SOC AM, V65, P1298, DOI 10.1121/1.382697; WEISS MS, 1985, J SPEECH HEAR RES, V28, P294, DOI 10.1044/jshr.2802.294; WILLIAMS SE, 1987, LARYNGOSCOPE, V97, P737; WILSON TA, 1974, J ACOUST SOC AM, V56, P653, DOI 10.1121/1.1903304; Wolfe J, 2009, HFSP J, V3, P6, DOI 10.2976/1.2998482; Wong F., 1996, ATLAS HEAD NECK SURG; Xu JJ, 2009, OTOLARYNG HEAD NECK, V141, P776, DOI 10.1016/j.otohns.2009.09.008; ZLATIN MA, 1974, J ACOUST SOC AM, V56, P981, DOI 10.1121/1.1903359	79	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192257	10.1371/journal.pone.0192257	http://dx.doi.org/10.1371/journal.pone.0192257			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	29466455	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300042
J	Laursen, SB; Finsen, S; Marcussen, N; Quaggin, SE; Hansen, PBL; Dimke, H				Laursen, Sidsel B.; Finsen, Stine; Marcussen, Niels; Quaggin, Susan E.; Hansen, Pernille B. L.; Dimke, Henrik			Endothelial mineralocorticoid receptor ablation does not alter blood pressure, kidney function or renal vessel contractility	PLOS ONE			English	Article							SELECTIVE ALDOSTERONE BLOCKER; VASCULAR REACTIVITY; DYSFUNCTION; ARTERIOLES; VASOCONSTRICTION; INSUFFICIENCY; EPLERENONE; ACTIVATION; DISEASE; DAMAGE	Aldosterone blockade confers substantial cardiovascular and renal protection. The effects of aldosterone on mineralocorticoid receptors (MR) expressed in endothelial cells (EC) within the renal vasculature have not been delineated. We hypothesized that lack of MR in EC may be protective in renal vasculature and examined this by ablating the Nr3c2 gene in endothelial cells (EC-MR) in mice. Blood pressure, heart rate and PAH clearance were measured using indwelling catheters in conscious mice. The role of the MR in EC on contraction and relaxation was investigated in the renal artery and in perfused afferent arterioles. Urinary sodium excretion was determined by use of metabolic cages. EC-MR transgenics had markedly decreased MR expression in isolated aortic endothelial cells as compared to litter-mates (WT). Blood pressure and effective renal plasma flow at baseline and following AngII infusion was similar between groups. No differences in contraction and relaxation were observed between WT and EC-MR KO in isolated renal arteries during baseline or following 2 or 4 weeks of AngII infusion. The constriction or dilatations of afferent arterioles between genotypes were not different. No changes were found between the groups with respect to urinary excretion of sodium after 4 weeks of AngII infusion, or in urinary albumin excretion and kidney morphology. In conclusion, deletion of the EC-MR does not confer protection towards the development of hypertension, endothelial dysfunction of renal arteries or renal function following prolonged AngII-infusion.	[Laursen, Sidsel B.; Finsen, Stine; Hansen, Pernille B. L.; Dimke, Henrik] Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense, Denmark; [Marcussen, Niels] Odense Univ Hosp, Dept Clin Pathol, Odense, Denmark; [Quaggin, Susan E.] Northwestern Univ, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Quaggin, Susan E.] Northwestern Univ, Div Nephrol & Hypertens, Chicago, IL 60611 USA; [Hansen, Pernille B. L.] AstraZeneca, IMED Biotech Unit, Cardiovasc & Metab Dis, Gothenburg, Sweden	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Northwestern University; Northwestern University; AstraZeneca	Dimke, H (corresponding author), Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense, Denmark.	hdimke@health.sdu.dk	Dimke, Henrik/M-3319-2019; Dimke, Henrik/G-7970-2011	Finsen, Stine/0000-0002-7294-0697; Dimke, Henrik/0000-0002-9170-2168	CIHR [M0P62931, M0P77756]; E-Rare Joint Translational Call (JTC) for European Research Projects on Rare Diseases; TF grant [016002]; Danish Heart Association [13-04-1294-A4646-22776]; Novo Nordisk Foundation [13273]; Danish Council for Independent Research [DFF-1331-00086]; Fabrikant Vilhelm Pedersen og Hustrus Mindelegat (on recommendation from the Novo Nordisk Foundation); Novo Nordisk Foundation; Carlsberg Foundation; A.P. Moller Foundation; Beckett Foundation; Helen AMP; Ejnar Bjornows Foundation; Lundbeck Foundation; Astra Zeneca; NATIONAL EYE INSTITUTE [R01EY025799] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); E-Rare Joint Translational Call (JTC) for European Research Projects on Rare Diseases; TF grant; Danish Heart Association; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Fabrikant Vilhelm Pedersen og Hustrus Mindelegat (on recommendation from the Novo Nordisk Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); A.P. Moller Foundation; Beckett Foundation; Helen AMP; Ejnar Bjornows Foundation; Lundbeck Foundation(Lundbeckfonden); Astra Zeneca(AstraZeneca); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	S.E. Quaggin is funded by CIHR grants M0P62931 and M0P77756, E-Rare Joint Translational Call (JTC 2011) for European Research Projects on Rare Diseases and TF grant 016002. The laboratory of P. B. L. Hansen is funded by The Danish Heart Association (13-04-1294-A4646-22776), the Novo Nordisk Foundation (13273) and the Danish Council for Independent Research (DFF-1331-00086). The laboratory of H. Dimke is funded by Fabrikant Vilhelm Pedersen og Hustrus Mindelegat (on recommendation from the Novo Nordisk Foundation), the Novo Nordisk Foundation, the Carlsberg Foundation, the A.P. Moller Foundation, the Beckett Foundation, Helen & Ejnar Bjornows Foundation, and the Lundbeck Foundation. None of the funders have been involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Astra Zeneca have provided salary support for P.B.L.H., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.r The authors would like to thank Kenneth Andersen, Kristoffer Rosenstand, Vivi Monrad, Lene Bundgaard Andersen, Inger Nissen, and Mie Rytz Hansen at the University of Southern Denmark for expert technical assistance. Jane Stubbe is thanked for fruitful discussions on the topic. Moreover, Professors Stefan Berger and Gunther Schutz (German Cancer Research Center, Heidelberg, Germany) is thanked for generously providing floxed Nr3c2 mice and Professor Rong Wang (University of California, San Francisco, US) is thanked for generously sharing the Tie2-Cre mice. S.E. Quaggin is funded by CIHR grants M0P62931 and M0P77756, E-Rare Joint Translational Call (JTC 2011) for European Research Projects on Rare Diseases and TF grant 016002. The laboratory of P. B. L. Hansen is funded by The Danish Heart Association (13-04-1294-A4646-22776), the Novo Nordisk Foundation (13273) and the Danish Council for Independent Research (DFF-1331-00086). The laboratory of H. Dimke is funded by Fabrikant Vilhelm Pedersen og Hustrus Mindelegat (on recommendation from the Novo Nordisk Foundation), the Novo Nordisk Foundation, the Carlsberg Foundation, the A.P. Moller Foundation, the Beckett Foundation, Helen & Ejnar Bjornows Foundation, and the Lundbeck Foundation. None of the funders have been involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Astra Zeneca have provided salary support for P.B.L.H., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Mashhadi RH, 2009, KIDNEY INT, V75, P793, DOI 10.1038/ki.2008.684; Alexander RT, 2015, AM J PHYSIOL-RENAL, V309, pF604, DOI 10.1152/ajprenal.00651.2014; Andersen H, 2011, ACTA PHYSIOL, V203, P197, DOI 10.1111/j.1748-1716.2010.02218.x; Arima S, 2003, J AM SOC NEPHROL, V14, P2255, DOI 10.1097/01.ASN.0000083982.74108.54; Arima S, 2004, HYPERTENSION, V43, P352, DOI 10.1161/01.HYP.0000111138.78714.1a; Barrera-Chimal J, 2017, J AM SOC NEPHROL, V28, P1216, DOI 10.1681/ASN.2016040477; Belteki G, 2005, NUCLEIC ACIDS RES, V33, P2765, DOI 10.1093/nar/gki559; Berger S, 2006, P NATL ACAD SCI USA, V103, P195, DOI 10.1073/pnas.0503878102; Bianchi S, 2006, KIDNEY INT, V70, P2116, DOI 10.1038/sj.ki.5001854; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Caprio M, 2008, CIRC RES, V102, P1359, DOI 10.1161/CIRCRESAHA.108.174235; Nguyen D, 2010, FASEB J, V24; Del Vecchio L, 2007, NAT CLIN PRACT NEPHR, V3, P42, DOI 10.1038/ncpneph0362; DEMEY JG, 1982, CIRC RES, V51, P439, DOI 10.1161/01.RES.51.4.439; Hansen PB, 2010, ACTA PHYSIOL, V200, P171, DOI 10.1111/j.1748-1716.2010.02135.x; Heylen E, 2009, J CARDIOVASC PHARM, V54, P535, DOI 10.1097/FJC.0b013e3181bfb00d; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; KATUSIC ZS, 1988, STROKE, V19, P476, DOI 10.1161/01.STR.19.4.476; KATUSIC ZS, 1984, CIRC RES, V55, P575, DOI 10.1161/01.RES.55.5.575; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Liu SL, 2003, CIRCULATION, V108, P2400, DOI 10.1161/01.CIR.0000093188.53554.44; Lother A, 2016, HYPERTENSION, V67, P130, DOI 10.1161/HYPERTENSIONAHA.115.06530; Lyngso KS, 2016, J CARDIOVASC PHARM, V68, P1, DOI 10.1097/FJC.0000000000000345; Casare FAM, 2016, AM J PHYSIOL-RENAL, V310, pF1295, DOI 10.1152/ajprenal.00471.2015; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; Mueller KB, 2015, HYPERTENSION, V66, P988, DOI 10.1161/HYPERTENSIONAHA.115.06172; Perticone F, 2004, CIRCULATION, V110, P821, DOI 10.1161/01.CIR.0000138745.21879.27; Rickard AJ, 2014, HYPERTENSION, V63, P1033, DOI 10.1161/HYPERTENSIONAHA.113.01803; Rossi GP, 2006, HYPERTENSION, V48, P232, DOI 10.1161/01.HYP.0000230444.01215.6a; Schafer N, 2013, EUR HEART J, V34, P3515, DOI 10.1093/eurheartj/eht095; Schjerning J, 2013, AM J PHYSIOL-HEART C, V304, pH1094, DOI 10.1152/ajpheart.00524.2012; Stam F, 2006, J AM SOC NEPHROL, V17, P537, DOI 10.1681/ASN.2005080834; Svenningsen P, 2014, PFLUG ARCH EUR J PHY, V466, P2205, DOI 10.1007/s00424-014-1492-4; Thuesen AD, 2014, AM J PHYSIOL-RENAL, V307, pF445, DOI 10.1152/ajprenal.00016.2014; Toda N, 2013, BRIT J PHARMACOL, V168, P519, DOI 10.1111/j.1476-5381.2012.02194.x; Uhrenholt TR, 2004, ACTA PHYSIOL SCAND, V181, P415, DOI 10.1111/j.1365-201X.2004.01313.x; Uhrenholt TR, 2004, HYPERTENSION, V43, pE30, DOI 10.1161/01.HYP.0000122805.14695.97; Uhrenholt TR, 2003, CIRC RES, V93, P1258, DOI 10.1161/01.RES.0000106135.02935.E1; VALLANCE P, 1992, LANCET, V339, P572; Weinberger MH, 2002, AM J HYPERTENS, V15, P709, DOI 10.1016/S0895-7061(02)02957-6; White WB, 2003, HYPERTENSION, V41, P1021, DOI 10.1161/01.HYP.0000067463.13172.EA	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193032	10.1371/journal.pone.0193032	http://dx.doi.org/10.1371/journal.pone.0193032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466427	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300079
J	Veltrop, M; van Vliet, L; Hulsker, M; Claassens, J; Brouwers, C; Breukel, C; van der Kaa, J; Linssen, MM; den Dunnen, JT; Verbeek, S; Aartsma-Rus, A; van Putten, M				Veltrop, Marcel; van Vliet, Laura; Hulsker, Margriet; Claassens, Jill; Brouwers, Conny; Breukel, Cor; van der Kaa, Jos; Linssen, Margot M.; den Dunnen, Johan T.; Verbeek, Sjef; Aartsma-Rus, Annemieke; van Putten, Maaike			A dystrophic Duchenne mouse model for testing human antisense oligonucleotides	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; MUSCLE PATHOLOGY; MESSENGER-RNA; EXONS 45-55; GENE; MDX; MICE; DEFICIENT	Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disease generally caused by reading frame disrupting mutations in the DMD gene resulting in loss of functional dystrophin protein. The reading frame can be restored by antisense oligonucleotide (AON)-mediated exon skipping, allowing production of internally deleted, but partially functional dystrophin proteins as found in the less severe Becker muscular dystrophy. Due to genetic variation between species, mouse models with mutations in the murine genes are of limited use to test and further optimize human specific AONs in vivo. To address this we have generated the del52hDMD/mdx mouse. This model carries both murine and human DMD genes. However, mouse dystrophin expression is abolished due to a stop mutation in exon 23, while the expression of human dystrophin is abolished due to a deletion of exon 52. The del52hDMD/mdx model, like mdx, shows signs of muscle dystrophy on a histological level and phenotypically mild functional impairment. Local administration of human specific vivo morpholinos induces exon skipping and dystrophin restoration in these mice. Depending on the number of mismatches, occasional skipping of the murine Dmd gene, albeit at low levels, could be observed. Unlike previous models, the del52hDMD/mdx model enables the in vivo analysis of human specific AONs targeting exon 51 or exon 53 on RNA and protein level and muscle quality and function. Therefore, it will be a valuable tool for optimizinghuman specific AONs and genome editing approaches for DMD.	[Veltrop, Marcel; van Vliet, Laura; Hulsker, Margriet; den Dunnen, Johan T.; Verbeek, Sjef; Aartsma-Rus, Annemieke; van Putten, Maaike] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, RC, Netherlands; [Claassens, Jill; Brouwers, Conny; Breukel, Cor; van der Kaa, Jos; Linssen, Margot M.; Verbeek, Sjef] Leiden Univ, Med Ctr, Transgen Facil, Leiden, RC, Netherlands; [den Dunnen, Johan T.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, RC, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Aartsma-Rus, A (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, RC, Netherlands.	a.m.rus@lumc.nl	dunnen, johan den/ABH-4228-2020	dunnen, johan den/0000-0002-6304-1710; Brouwers, Conny/0000-0002-5595-8887; Aartsma-Rus, Annemieke/0000-0003-1565-654X; van Putten, Maaike/0000-0002-0683-8897; Linssen, Margot/0000-0002-9157-1073	Duchenne Parent Project (the Netherlands)	Duchenne Parent Project (the Netherlands)(Netherlands Government)	The authors report receiving funding from the Duchenne Parent Project (the Netherlands) to cover part of the experiments reported in this study.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Aartsma-Rus A, 2017, NUCLEIC ACID THER, V27, P67, DOI 10.1089/nat.2017.0665; Aartsma-Rus A, 2014, JOVE-J VIS EXP, DOI 10.3791/51303; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Aoki Y, 2012, P NATL ACAD SCI USA, V109, P13763, DOI 10.1073/pnas.1204638109; Aoki Y, 2010, MOL THER, V18, P1995, DOI 10.1038/mt.2010.186; Araki E, 1997, BIOCHEM BIOPH RES CO, V238, P492, DOI 10.1006/bbrc.1997.7328; BEGGS AH, 1991, AM J HUM GENET, V49, P54; Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chamberlain J.S., 1990, PCR PROTOCOLS GUIDE, P272; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Connolly AM, 2001, NEUROMUSCULAR DISORD, V11, P703, DOI 10.1016/S0960-8966(01)00232-2; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Draper J S, 2007, Handb Exp Pharmacol, P107; Dunckley MG, 1998, HUM MOL GENET, V7, P1083, DOI 10.1093/hmg/7.7.1083; Echigoya Y, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2014.76; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; Hulsker M, 2016, J NEUROMUSCULAR DIS, P1; Kharraz Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965631; Marden FA, 2005, SKELETAL RADIOL, V34, P140, DOI 10.1007/s00256-004-0825-3; Mendell JR, 2013, MUSCLE NERVE, V48, P21, DOI 10.1002/mus.23810; Moat SJ, 2013, EUR J HUM GENET, V21, P1049, DOI 10.1038/ejhg.2012.301; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Spitali P, 2010, LAB INVEST, V90, P1396, DOI [10.1038/labinvest.2010.98, 10.1038/labinvest.labinvest201098]; Syed YY, 2016, DRUGS, V76, P1699, DOI 10.1007/s40265-016-0657-1; 't Hoen PAC, 2008, J BIOL CHEM, V283, P5899, DOI 10.1074/jbc.M709410200; van den Bergen J.C., 2013, J NEUROL NEUROSURG P; van Putten M, 2013, FASEB J, V27, P2484, DOI 10.1096/fj.12-224170; van Putten M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031937; van Putten M, 2012, NEUROMUSCULAR DISORD, V22, P406, DOI 10.1016/j.nmd.2011.10.011; Veltrop M, 2013, PLOS CURR, V5; Wefers B, 2016, METHODS MOL BIOL, V1338, P229, DOI 10.1007/978-1-4939-2932-0_17; Wilton SD, 1999, NEUROMUSCULAR DISORD, V9, P330, DOI 10.1016/S0960-8966(99)00010-3; Young Courtney S, 2017, J Neuromuscul Dis, V4, P139, DOI 10.3233/JND-170218; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhou L, 2010, J NEUROPATH EXP NEUR, V69, P771, DOI 10.1097/NEN.0b013e3181e9a34b	43	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193289	10.1371/journal.pone.0193289	http://dx.doi.org/10.1371/journal.pone.0193289			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466448	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300111
J	Yadav, S; Frazer, J; Banga, A; Pruitt, K; Harsh, S; Jaenike, J; Eleftherianos, I				Yadav, Shruti; Frazer, Joanna; Banga, Ashima; Pruitt, Katherine; Harsh, Sneh; Jaenike, John; Eleftherianos, Ioannis			Endosymbiont-based immunity in Drosophila melanogaster against parasitic nematode infection	PLOS ONE			English	Article							ENTOMOPATHOGENIC NEMATODES; STEINERNEMA-CARPOCAPSAE; DEFENSIVE SYMBIONT; WOLBACHIA; BACTERIA; SPIROPLASMA; XENORHABDUS; SUSCEPTIBILITY; FILARIAL; ASSOCIATION	Associations between endosymbiotic bacteria and their hosts represent a complex ecosystem within organisms ranging from humans to protozoa. Drosophila species are known to naturally harbor Wolbachia and Spiroplasma endosymbionts, which play a protective role against certain microbial infections. Here, we investigated whether the presence or absence of endosymbionts affects the immune response of Drosophila melanogaster larvae to infection by Steinernema carpocapsae nematodes carrying or lacking their mutualistic Gramnegative bacteria Xenorhabdus nematophila (symbiotic or axenic nematodes, respectively). We find that the presence of Wolbachia alone or together with Spiroplasma promotes the survival of larvae in response to infection with S. carpocapsae symbiotic nematodes, but not against axenic nematodes. We also find that Wolbachia numbers are reduced in Spiroplasma- free larvae infected with axenic compared to symbiotic nematodes, and they are also reduced in Spiroplasma-containing compared to Spiroplasma-free larvae infected with axenic nematodes. We further show that S. carpocapsae axenic nematode infection induces the Toll pathway in the absence of Wolbachia, and that symbiotic nematode infection leads to increased phenoloxidase activity in D. melanogaster larvae devoid of endosymbionts. Finally, infection with either type of nematode alters the metabolic status and the fat body lipid droplet size in D. melanogaster larvae containing only Wolbachia or both endosymbionts. Our results suggest an interaction between Wolbachia endosymbionts with the immune response of D. melanogaster against infection with the entomopathogenic nematodes S. carpocapsae. Results from this study indicate a complex interplay between insect hosts, endosymbiotic microbes and pathogenic organisms.	[Yadav, Shruti; Frazer, Joanna; Banga, Ashima; Pruitt, Katherine; Harsh, Sneh; Eleftherianos, Ioannis] George Washington Univ, Dept Biol Sci, Infect & Innate Immun Lab, Washington, DC 20052 USA; [Banga, Ashima; Pruitt, Katherine] Thomas Jefferson High Sch Sci & Technol, Alexandria, VA USA; [Jaenike, John] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	George Washington University; University of Rochester	Eleftherianos, I (corresponding author), George Washington Univ, Dept Biol Sci, Infect & Innate Immun Lab, Washington, DC 20052 USA.	ioannise@gwu.edu	HARSH, SNEH/AAE-7485-2022	yadav, Shruti/0000-0002-0958-9304; Pruitt, Katherine/0000-0001-9596-3165; Eleftherianos, Ioannis/0000-0002-4822-3110; HARSH, SNEH/0000-0002-3224-9586				AKHURST RJ, 1982, J GEN MICROBIOL, V128, P3061; Anand P, 2012, ELIFE, V1, DOI 10.7554/eLife.00003; Arefin B, 2014, J INNATE IMMUN, V6, P192, DOI 10.1159/000353734; Bidla G, 2005, DEV COMP IMMUNOL, V29, P669, DOI 10.1016/j.dci.2004.11.007; Bier E, 2012, DIS MODEL MECH, V5, P48, DOI 10.1242/dmm.000406; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Brun S, 2006, GENES CELLS, V11, P397, DOI 10.1111/j.1365-2443.2006.00953.x; Castillo JC, 2013, J INSECT PHYSIOL, V59, P179, DOI 10.1016/j.jinsphys.2012.08.003; Castillo JC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1690-2; Castillo JC, 2011, TRENDS PARASITOL, V27, P537, DOI 10.1016/j.pt.2011.09.001; Cooper DE, 2016, ROUTLEDGE ENCYCLOPAEDIA OF EDUCATIONAL THINKERS, P5; Dillman AR, 2012, CURR BIOL, V22, pR430, DOI 10.1016/j.cub.2012.03.047; Dionne MS, 2008, DIS MODEL MECH, V1, P43, DOI 10.1242/dmm.000307; Dutton TJ, 2005, MED VET ENTOMOL, V19, P60, DOI 10.1111/j.0269-283X.2005.00557.x; Duvic B, 2002, CURR BIOL, V12, P1923, DOI 10.1016/S0960-9822(02)01297-6; Ebrahimi L., 2011, J INSECT SCI, V75, P11; Eleftherianos I, 2017, TRENDS PARASITOL; Eleftherianos I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00046; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Erickson SM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000529; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Goodrich-Blair H, 2007, CURR OPIN MICROBIOL, V10, P225, DOI 10.1016/j.mib.2007.05.006; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Hamilton PT, 2016, P NATL ACAD SCI USA, V113, P350, DOI 10.1073/pnas.1518648113; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Herren JK, 2014, ELIFE, V3, DOI 10.7554/eLife.02964; Herren JK, 2011, CELL MICROBIOL, V13, P1385, DOI 10.1111/j.1462-5822.2011.01627.x; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Jaenike J, 2012, TRENDS ECOL EVOL, V27, P226, DOI 10.1016/j.tree.2011.10.005; Jaenike J, 2011, ECOL LETT, V14, P150, DOI 10.1111/j.1461-0248.2010.01564.x; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Jaenike J, 2010, MOL ECOL, V19, P414, DOI 10.1111/j.1365-294X.2009.04448.x; Kaneko T, 2005, CELL MICROBIOL, V7, P461, DOI 10.1111/j.1462-5822.2005.00504.x; Kikuchi Y, 2009, MICROBES ENVIRON, V24, P195, DOI 10.1264/jsme2.ME09140S; Klager SL, 2002, PARASITOLOGY, V125, P359, DOI 10.1017/S0031182002002159; Krautz R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00342; Kremer N, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S7; Maizels RM, 2001, INT J PARASITOL, V31, P889, DOI 10.1016/S0020-7519(01)00213-2; Martens EC, 2003, J BACTERIOL, V185, P3147, DOI 10.1128/JB.185.10.3147-3154.2003; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Montenegro H, 2006, GENETICA, V127, P207, DOI 10.1007/s10709-005-3766-4; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Panteleev D Iu, 2007, Genetika, V43, P1277; Pena JM, 2015, INFECT IMMUN, V83, P1130, DOI 10.1128/IAI.02740-14; Ponton F, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2029; Ramet M, 2012, ACTA PAEDIATR, V101, P900, DOI 10.1111/j.1651-2227.2012.02740.x; Rottschaefer SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040500; Schmid-Hempel P, 2009, PHILOS T R SOC B, V364, P85, DOI 10.1098/rstb.2008.0157; Shokal U, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0634-6; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Tennessen JM, 2014, METHODS, V68, P105, DOI 10.1016/j.ymeth.2014.02.034; Thomas P, 2011, DEV COMP IMMUNOL, V35, P360, DOI 10.1016/j.dci.2010.11.007; Toubarro D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075691; Toubarro D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069161; Toubarro D, 2010, J BIOL CHEM, V285, P30666, DOI 10.1074/jbc.M110.129346; Voronin D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153812; Wong ACN, 2016, DIS MODEL MECH, V9, P271, DOI 10.1242/dmm.023408; Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430; Yadav S, 2017, G3-GENES GENOM GENET, V7, P1955, DOI 10.1534/g3.117.041004; Yadav Shruti, 2015, BMC Research Notes, V8, P461, DOI 10.1186/s13104-015-1443-y; Zele F, 2012, J EVOLUTION BIOL, V25, P1243, DOI 10.1111/j.1420-9101.2012.02519.x	66	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192183	10.1371/journal.pone.0192183	http://dx.doi.org/10.1371/journal.pone.0192183			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466376	gold, Green Published, Green Submitted			2022-12-26	WOS:000425604300034
J	Bucholc, M; O'Kane, M; Ashe, S; Wong-Lin, K				Bucholc, Magda; O'Kane, Maurice; Ashe, Siobhan; Wong-Lin, KongFatt			Prescriptive variability of drugs by general practitioners	PLOS ONE			English	Article							PRESCRIBING RATES; DEPRIVATION; POPULATIONS; OUTCOMES; QUALITY; COSTS; CARE	Prescription drug spending is growing faster than any other sector of healthcare. However, very little is known about patterns of prescribing and cost of prescribing between general practices. In this study, we examined variation in prescription rates and prescription costs through time for 55 GP surgeries in Northern Ireland Western Health and Social Care Trust. Temporal changes in variability of prescribing rates and costs were assessed using the Mann-Kendall test. Outlier practices contributing to between practice variation in prescribing rates were identified with the interquartile range outlier detection method. The relationship between rates and cost of prescribing was explored with Spearman's statistics. The differences in variability and mean number of prescribing rates associated with the practice setting and socioeconomic deprivation were tested using t-test and F-test respectively. The largest between-practice difference in prescribing rates was observed for Apr-Jun 2015, with the number of prescriptions ranging from 3.34 to 8.36 per patient. We showed that practices with outlier prescribing rates greatly contributed to between-practice variability. The largest difference in prescribing costs was reported for Apr-Jun 2014, with the prescription cost per patient ranging from 26.4 pound to 64.5 pound. In addition, the temporal changes in variability of prescribing rates and costs were shown to undergo an upward trend. We demonstrated that practice setting and socio-economic deprivation accounted for some of the between-practice variation in prescribing. Rural practices had higher between practice variability than urban practices at all time points. Practices situated in more deprived areas had higher prescribing rates but lower variability than those located in less deprived areas. Further analysis is recommended to assess if variation in prescribing can be explained by demographic characteristics of patient population and practice features. Identification of other factors contributing to prescribing variability can help us better address potential inappropriateness of prescribing.	[Bucholc, Magda; Wong-Lin, KongFatt] Univ Ulster, Intelligent Syst Res Ctr, Magee Campus, Londonderry, North Ireland; [O'Kane, Maurice; Ashe, Siobhan] Altnagelvin Hosp, Western Hlth & Social Care Trust, Glenshane Rd, Londonderry, North Ireland	Ulster University	Bucholc, M (corresponding author), Univ Ulster, Intelligent Syst Res Ctr, Magee Campus, Londonderry, North Ireland.	bucholc-m@email.ulster.ac.uk	Bucholc, Magda/ABF-9272-2020	Bucholc, Magda/0000-0002-8417-1602; Wong-Lin, KongFatt/0000-0001-8724-4398	Invest NI through Northern Ireland Science Park (Catalyst Inc)	Invest NI through Northern Ireland Science Park (Catalyst Inc)	This work was performed under the Northern Ireland International Health Analytics Centre (IHAC) collaborative network project funded by Invest NI through Northern Ireland Science Park (Catalyst Inc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderwick H, 2015, BETTER VALUE NHS ROL; [Anonymous], [No title captured]; [Anonymous], 2016, PRESCR DISP COMM STA; [Anonymous], 2016, PRESCR COSTS HOSP CO; [Anonymous], 2013, PAYING PRIC PRESCR C; Ashworth M, 2007, J PUBLIC HEALTH-UK, V29, P40, DOI 10.1093/pubmed/fdl068; Backer C., 2016, MED STAT GP PRESCRIB; Baker K., 2016, MED STAT GP PRESCRIB; Burton JH, 2016, WEST J EMERG MED, V17, P258, DOI 10.5811/westjem.2016.3.29692; Cahir C, 2010, BRIT J CLIN PHARMACO, V69, P543, DOI 10.1111/j.1365-2125.2010.03628.x; Covvey JR, 2014, J ANTIMICROB CHEMOTH, V69, P835, DOI 10.1093/jac/dkt439; Duerden M, 2011, QUALITY GP PRESCRIBI; Favato G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000592; Fischer SH, 2013, J GEN INTERN MED, V28, P513, DOI 10.1007/s11606-012-2271-6; FORSTER DP, 1991, BRIT J GEN PRACT, V41, P67; Haastrup PF, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0460-9; Hallsworth M, 2016, LANCET, V387, P1743, DOI 10.1016/S0140-6736(16)00215-4; Hann M, 2004, J CLIN PHARM THER, V29, P537, DOI 10.1111/j.1365-2710.2004.00604.x; Holm M, 1988, Scand J Prim Health Care, V6, P169, DOI 10.3109/02813438809009311; HSC Business Services Organisation, PRESCR GP PRACT; Hull SA, 2005, FAM PRACT, V22, P37, DOI 10.1093/fampra/cmh712; Kvam PH, 2007, NONPARAMETRIC STATISTICS WITH APPLICATIONS TO SCIENCE AND ENGINEERING, P1, DOI 10.1002/9780470168707; LASH S, 1995, J MANAGE CARE PHARM, V1, P193; Mackenzie IF, 1999, BRIT J GEN PRACT, V49, P884; Majeed A, 1998, BRIT MED J, V316, P748, DOI 10.1136/bmj.316.7133.748; MCLEOD AI, 1991, ENVIRONMETRICS, V2, P169, DOI 10.1002/env.3770020205; Meals DW, 2011, TECH NOTES US EPA; Moon JC, 2010, BMJ-BRIT MED J, P341; Morrison J, 2009, BRIT J GEN PRACT, V59, P88, DOI 10.3399/bjgp09X395076; Northern Ireland Statistics and Research Agency, 2015, REV STAT CLASS DEL S; Northern Ireland Statistics and Research Agency, 2010, NO IR MULT DEPR MEAS; OFORIASENSO R, 2016, PHARMACY, V4, P61295, DOI [DOI 10.3390/pharmacy4040035, DOI 10.3390/PHARMACY4040035]; PECK R, 2015, INTRO STAT DATA ANAL; PHAROAH PDP, 1995, BRIT J GEN PRACT, V45, P595; PURVES IN, 1993, BRIT MED J, V306, P496, DOI 10.1136/bmj.306.6876.496; SLEATOR DJD, 1993, BRIT J GEN PRACT, V43, P102; Srivastava, 2012, REGRESSION ANAL THEO; Szczepura A, 2005, POSTGRAD MED J, V81, P141, DOI 10.1136/pgmj.2004.026237; Thompson J, 2015, PRIMARY CARE PRESCRI; Thompson M, 2016, LANCET, V387, P2270, DOI 10.1016/S0140-6736(16)00743-1; Ventola C Lee, 2015, P T, V40, P277; Wagner Andrew C., 2010, Pharmacy Pract (Granada), V8, P193; Wise J., 2005, BMJ-BRIT MED J, P351; Wu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067611	44	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0189599	10.1371/journal.pone.0189599	http://dx.doi.org/10.1371/journal.pone.0189599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462143	gold, Green Submitted, Green Published			2022-12-26	WOS:000425554200002
J	Lu, QC; Shan, S; Li, YY; Zhu, DY; Jin, WJ; Ren, T				Lu, Qingchun; Shan, Shan; Li, Yanyan; Zhu, Dongyi; Jin, Wenjing; Ren, Tao			Long noncoding RNA SNHG1 promotes non-small cell lung cancer progression by up-regulating MTDH via sponging miR-145-5p	FASEB JOURNAL			English	Article						competing endogenous RNA; NSCLC; long noncoding RNAs; SNHG1	LNCRNA SNHG1; HEPATOCELLULAR-CARCINOMA; TARGETING METADHERIN; SIGNALING PATHWAY; PROSTATE-CANCER; BREAST-CANCER; METASTASIS; EXPRESSION; INVASION; PROLIFERATION	Long noncoding RNAs participate in the progression and initiation of non-small cell lung cancer (NSCLC), although the mechanism remains unknown. The lncRNA identified as small nucleolar RNA host gene 1 (SNHG1) is a novel lncRNA that is increased in multiple human cancers; however, the regulatory mechanism requires further investigation. In this study, we discovered that SNHG1 was markedly up-regulated in NSCLC tissues and cells and that SNHG1 silencing decreased tumor volumes. Moreover, we explored its regulatory mechanism and found that SNHG1 directly bound to microRNA (miRNA)-145-5p, isolating miR-145-5p from its target gene MTDH. Inhibition of SNHG1 suppressed NSCLC cell viability, proliferation, migration, and invasion in vitro, but its effect was rescued by miR-145-5p inhibition. These results demonstrate that SNHG1 contributes to NSCLC progression by modulating the miR-145-5p/MTDH axis, and it could potentially be a therapeutic target as well as a diagnostic marker.Lu, Q., Shan, S., Li, Y., Zhu, D., Jin, W., Ren, T. Long noncoding RNA SNHG1 promotes non-small cell lung cancer progression by up-regulating MTDHvia sponging miR-145-5p.	[Lu, Qingchun; Zhu, Dongyi] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Resp Med, Shanghai, Peoples R China; [Shan, Shan; Ren, Tao] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Resp Med, Shanghai, Peoples R China; [Li, Yanyan] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China; [Jin, Wenjing] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Jin, Wenjing] Fudan Univ, Pudong Med Ctr, Shanghai Pudong Hosp, Intens Care Unit, Shanghai, Peoples R China	Tongji University; Shanghai Jiao Tong University; Fudan University; Fudan University; Fudan University	Ren, T (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Resp Med, Xuhui Area, 600 Yishan Rd, Shanghai 200233, Peoples R China.	rentaosh@126.com	Lu, Qingchun/K-8250-2019		National Natural Science Foundation of China [81673014, 81372347, 81602075]; Outstanding Academic Leaders Plan of Shanghai Municipal Science and Technology Committee [16XD1403100]; National Key Research and Development Plan [2017YFA0104600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Academic Leaders Plan of Shanghai Municipal Science and Technology Committee; National Key Research and Development Plan	This work was supported by the National Natural Science Foundation of China (Grants 81673014, 81372347, and 81602075), the Outstanding Academic Leaders Plan of Shanghai Municipal Science and Technology Committee (Grant 16XD1403100), and the National Key Research and Development Plan (Grant 2017YFA0104600). The authors declare no conflicts of interest.	Adams BD, 2017, J CLIN INVEST, V127, P761, DOI 10.1172/JCI84424; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Cui Y, 2017, ONCOTARGET, V8, P17785, DOI 10.18632/oncotarget.14854; Dong RF, 2014, ONCOTARGET, V5, P10816, DOI 10.18632/oncotarget.2522; Du Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10982; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Emdad L, 2016, ADV CANCER RES, V131, P97, DOI 10.1016/bs.acr.2016.05.002; Hou JP, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00193; Hu HB, 2016, LUNG CANCER, V97, P87, DOI 10.1016/j.lungcan.2016.04.017; Jen JY, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0674-z; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kartha RV, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00008; Li J, 2017, HORMONE METABOLISM AND SIGNALING IN PLANTS, P1; Liang YJ, 2015, CANCER RES, V75, P3672, DOI 10.1158/0008-5472.CAN-15-0930; Ma MZ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.541; Mataki H, 2016, ONCOTARGET, V7, P72084, DOI 10.18632/oncotarget.12290; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Peng WX, 2017, ONCOGENE, V36, P5661, DOI 10.1038/onc.2017.184; Shen Y, 2017, EMBO REP, V18, P536, DOI 10.15252/embr.201643139; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; Subramanian M, 2015, METHODS MOL BIOL, V1206, P29, DOI 10.1007/978-1-4939-1369-5_3; Suh SO, 2011, CARCINOGENESIS, V32, P772, DOI 10.1093/carcin/bgr036; Sun SJ, 2017, EUR REV MED PHARMACO, V21, P504; Wang MZ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0344-6; Wang Q, 2017, BIOMED PHARMACOTHER, V91, P906, DOI 10.1016/j.biopha.2017.05.014; Wang YH, 2015, CANCER BIOL THER, V16, P1308, DOI 10.1080/15384047.2015.1056413; Wu T, 2015, J CANCER RES THER, V11, pC7, DOI 10.4103/0973-1482.163831; Xie Y, 2016, EXCLI J, V15, P745, DOI 10.17179/excli2016-694; Yan Y, 2017, ONCOTARGET, V8, P35750, DOI 10.18632/oncotarget.16189; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; You J, 2014, INDIAN J CANCER, V51, P99, DOI 10.4103/0019-509X.154092; Yu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129190; Yu J, 2016, ONCOTARGET, V7, P38612, DOI 10.18632/oncotarget.9572; Zhang HY, 2017, BIOMED PHARMACOTHER, V90, P650, DOI 10.1016/j.biopha.2017.03.104; Zhang M, 2017, ONCOL REP, V37, P1772, DOI 10.3892/or.2017.5401; Zhang X, 2017, ONCOTARGET, V8, P51058, DOI 10.18632/oncotarget.16918; Zhu GC, 2017, ONCOL REP, V38, P2893, DOI 10.3892/or.2017.5949	38	112	116	0	50	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3957	3967		10.1096/fj.201701237RR	http://dx.doi.org/10.1096/fj.201701237RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29466052	Bronze			2022-12-26	WOS:000435104500040
J	Zhang, XP; Li, KR; Yu, Q; Yao, MD; Ge, HM; Li, XM; Jiang, Q; Yao, J; Cao, C				Zhang, Xiao-Pei; Li, Ke-Ran; Yu, Qing; Yao, Mu-Di; Ge, Hui-Min; Li, Xiu-Miao; Jiang, Qin; Yao, Jin; Cao, Cong			Ginsenoside Rh2 inhibits vascular endothelial growth factor-induced corneal neovascularization	FASEB JOURNAL			English	Article						VEGF; Gab1; inflammation; traditional Chinese medicine	NF-KAPPA-B; LONG NONCODING RNAS; ACTIVATION; EXPRESSION; VEGF; GAB1; CELLS; PROLIFERATION; ANGIOGENESIS; MIGRATION	VEGF-induced neovascularization plays a pivotal role in corneal neovascularization (CoNV). The current study investigated the potential effect of ginsenoside Rh2 (GRh2) on neovascularization. In HUVECs, pretreatment with GRh2 largely attenuated VEGF-induced cell proliferation, migration, and vessel-like tube formation in vitro. At the molecular level, GRh2 disrupted VEGF-induced VEGF receptor 2 (VEGFR2)-Grb-2-associated binder 1 (Gab1) association in HUVECs, causing inactivation of downstream AKT and ERK signaling. Gab1 knockdown (by targeted short hairpin RNA) similarly inhibited HUVEC proliferation and migration. Notably, GRh2 was ineffective against VEGF in Gab1-silenced HUVECs. In a mouse cornea alkali burn model, GRh2 eyedrops inhibited alkali-induced neovascularization and inflammatory cell infiltrations in the cornea. Furthermore, alkali-induced corneal expression of mRNAs/long noncoding RNAs in cornea were largely attenuated by GRh2. Overall, GRh2 inhibits VEGF-induced angiogenic effect via inhibiting VEGFR2-Gab1 signaling in vitro. It also alleviates angiogenic and inflammatory responses in alkali burn-treated mouse corneas.Zhang, X.-P., Li, K.-R., Yu, Q., Yao, M.-D., Ge, H.-M., Li, X.-M., Jiang, Q., Yao, J., Cao, C. Ginsenoside Rh2 inhibits vascular endothelial growth factor-induced corneal neovascularization.	[Zhang, Xiao-Pei; Li, Ke-Ran; Yu, Qing; Yao, Mu-Di; Ge, Hui-Min; Li, Xiu-Miao; Jiang, Qin; Yao, Jin; Cao, Cong] Nanjing Med Univ, Affiliated Eye Hosp, Sch Clin Med 4, Nanjing, Jiangsu, Peoples R China; [Cao, Cong] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis Res, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Cao, Cong] Soochow Univ, Inst Neurosci, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Cao, Cong] Municipal Hosp Suzhou, Suzhou, Peoples R China	Nanjing Medical University; Soochow University - China; Soochow University - China	Cao, C (corresponding author), Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis Res, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China.; Cao, C (corresponding author), Soochow Univ, Inst Neurosci, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China.; Jiang, Q (corresponding author), Nanjing Med Univ, Affiliated Eye Hosp, 138 Han Zhong Rd, Nanjing 210029, Jiangsu, Peoples R China.	jqin710@vip.sina.com; caocong@suda.edu.cn			National Natural Science Foundation of China [81302195, 31371139, 81571282, 81771457, 81700859, 81371055, 81570859, 81670878]; Medical Science and Technology Development Project Fund of Nanjing [YKK16271, YKK15241, YKK16270]; Jiangsu Province Six-Talent Peaks; Natural Science Foundation [BK2016022104, BK20170060, BK20171065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science and Technology Development Project Fund of Nanjing; Jiangsu Province Six-Talent Peaks; Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was generously supported by the National Natural Science Foundation of China (Grants 81302195, 31371139, 81571282, 81771457, 81700859, 81371055, 81570859, 81670878), the Medical Science and Technology Development Project Fund of Nanjing (Grants YKK16271, YKK15241, YKK16270), grants from Jiangsu Province Six-Talent Peaks (to C.C.) and Natural Science Foundation (BK2016022104, BK20170060, BK20171065). The authors declare no conflicts of interest.	Abdelfattah NS, 2015, INT J OPHTHALMOL-CHI, V8, P182, DOI 10.3980/j.issn.2222-3959.2015.01.32; Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18; Aurora AB, 2010, BLOOD, V116, P475, DOI 10.1182/blood-2009-07-232132; Bi WY, 2012, INFLAMMATION, V35, P1659, DOI 10.1007/s10753-012-9482-1; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; Caron C, 2009, CELL SIGNAL, V21, P943, DOI 10.1016/j.cellsig.2009.02.004; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; Choi K, 2007, NEUROSCI LETT, V421, P37, DOI 10.1016/j.neulet.2007.05.017; Christensen LP, 2009, ADV FOOD NUTR RES, V55, P1, DOI 10.1016/S1043-4526(08)00401-4; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.2.10; Ferrari G, 2015, EYE CONTACT LENS, V41, P72, DOI 10.1097/ICL.0000000000000071; Gong YQ, 2016, ONCOTARGET, V7, P60123, DOI 10.18632/oncotarget.11164; Guo XX, 2014, PROTEIN CELL, V5, P224, DOI 10.1007/s13238-014-0027-2; He L, 2012, BONE, V50, P1207, DOI 10.1016/j.bone.2012.03.022; Huang J, 2015, CORNEA, V34, P580, DOI 10.1097/ICO.0000000000000389; Huang JJ, 2016, ACTA BIOCH BIOPH SIN, V48, P750, DOI 10.1093/abbs/gmw049; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Li KR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25525; Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068157, 10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057, 10.1371/journal.pone.0067018, 10.1371/journal.pone.0063139]; Lian LH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/646728; Lu Y, 2011, P NATL ACAD SCI USA, V108, P2957, DOI 10.1073/pnas.1009395108; Lv Y, 2017, ONCOTARGET, V8, P52699, DOI 10.18632/oncotarget.17084; Nakata H, 1998, JPN J CANCER RES, V89, P733, DOI 10.1111/j.1349-7006.1998.tb03278.x; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park EK, 2004, BIOL PHARM BULL, V27, P433, DOI 10.1248/bpb.27.433; Park EK, 2003, BIOL PHARM BULL, V26, P1581, DOI 10.1248/bpb.26.1581; Park JA, 1997, CANCER LETT, V121, P73, DOI 10.1016/S0304-3835(97)00333-9; Poon MW, 2015, INVEST OPHTH VIS SCI, V56, P711, DOI 10.1167/iovs.14-15268; Saika S, 2005, AM J PATHOL, V166, P1405, DOI 10.1016/S0002-9440(10)62358-9; Shakiba Y, 2009, RECENT PATENTS INFLA, V3, P221, DOI 10.2174/187221309789257450; Wang M, 2017, ONCOL LETT, V13, P681, DOI 10.3892/ol.2016.5490; Wang W, 2007, CANCER CHEMOTH PHARM, V59, P589, DOI 10.1007/s00280-006-0300-z; Wu CH, 2012, NANO LETT, V12, P5475, DOI 10.1021/nl301865c; Yan B, 2014, INVEST OPHTH VIS SCI, V55, P941, DOI 10.1167/iovs.13-13221; Yang ZQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19383; Zhang H, 2014, FREE RADICAL BIO MED, V69, P219, DOI 10.1016/j.freeradbiomed.2014.01.025; Zhang Y, 2015, INT REV SPAT PLAN SU, V3, P1, DOI 10.14246/irspsd.3.2_1	42	18	19	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3782	3791		10.1096/fj.201701074RR	http://dx.doi.org/10.1096/fj.201701074RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29465315				2022-12-26	WOS:000435104500025
J	Abdul-Aziz, AM; Shafat, MS; Sun, Y; Marlein, CR; Piddock, RE; Robinson, SD; Edwards, DR; Zhou, ZG; Collins, A; Bowles, KM; Rushworth, SA				Abdul-Aziz, Amina M.; Shafat, Manar S.; Sun, Yu; Marlein, Christopher R.; Piddock, Rachel E.; Robinson, Stephen D.; Edwards, Dylan R.; Zhou, Zhigang; Collins, Angela; Bowles, Kristian M.; Rushworth, Stuart A.			HIF1 alpha drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia	ONCOGENE			English	Article							MIGRATION INHIBITORY FACTOR; HYPOXIA-INDUCIBLE FACTORS; HEMATOPOIETIC STEM-CELLS; TARGET GENES; HIF-1-ALPHA; EXPRESSION; CANCER; AML; CHEMORESISTANCE; MAINTENANCE	Approximately 80% of patients diagnosed with acute myeloid leukemia (AML) die as a consequence of failure to eradicate the tumor from the bone marrow microenvironment. We have recently shown that stroma-derived interleukin-8 (IL-8) promotes AML growth and survival in the bone marrow in response to AML-derived macrophage migration inhibitory factor (MIF). In the present study we show that high constitutive expression of MIF in AML blasts in the bone marrow is hypoxia-driven and, through knockdown of MIF, HIF1 alpha and HIF2 alpha, establish that hypoxia supports AML tumor proliferation through HIF1 alpha signaling. In vivo targeting of leukemic cell HIF1 alpha inhibits AML proliferation in the tumor microenvironment through transcriptional regulation of MIF, but inhibition of HIF2 alpha had no measurable effect on AML blast survival. Functionally, targeted inhibition of MIF in vivo improves survival in models of AML. Here we present a mechanism linking HIF1 alpha to a pro-tumoral chemokine factor signaling pathway and in doing so, we establish a potential strategy to target AML.	[Abdul-Aziz, Amina M.; Shafat, Manar S.; Sun, Yu; Marlein, Christopher R.; Piddock, Rachel E.; Edwards, Dylan R.; Zhou, Zhigang; Bowles, Kristian M.; Rushworth, Stuart A.] Univ East Anglia, Norwich Med Sch, Norwich Res Pk, Norwich NR4 7UQ, Norfolk, England; [Robinson, Stephen D.] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Collins, Angela; Bowles, Kristian M.] Norfolk & Norwich Univ Hosp NHS Trust, Dept Haematol, Colney Lane, Norwich NR4 7UY, Norfolk, England	University of East Anglia; University of East Anglia; Norfolk & Norwich University Hospitals NHS Foundation Trust	Rushworth, SA (corresponding author), Univ East Anglia, Norwich Med Sch, Norwich Res Pk, Norwich NR4 7UQ, Norfolk, England.	s.rushworth@uea.ac.uk	Edwards, Dylan R/B-4734-2009	Edwards, Dylan R/0000-0002-3292-2064; Bowles, Kristian/0000-0003-1334-4526; Rushworth, Stuart/0000-0002-3711-7558; Shafat, Manar/0000-0002-3493-9089; Robinson, Stephen/0000-0002-6606-7588; Piddock, Rachel E./0000-0002-5831-004X	Ministry of Higher Education and Scientific Research of the State of Libya; Big C cancer charity (Norfolk, UK); National Institute for Health Research (UK); Rosetrees Trust [M499] Funding Source: researchfish	Ministry of Higher Education and Scientific Research of the State of Libya; Big C cancer charity (Norfolk, UK); National Institute for Health Research (UK)(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust)	The authors wish to thank the Ministry of Higher Education and Scientific Research of the State of Libya, The Big C cancer charity (Norfolk, UK) and the National Institute for Health Research (UK) for funding and Professor Richard Ball, Dr Mark Wilkinson and Mr Iain Sheriffs, Norwich Biorepository (UK), for help with sample collection and storage. pCDH-luciferase-T2A-mCherry was kindly gifted from Prof. Dr. med. Irmela Jeremias, (Helmholtz Zentrum Munchen, Munich, Germany).	Abdul-Aziz AM, 2017, CANCER RES, V77, P303, DOI 10.1158/0008-5472.CAN-16-1095; Ammirante M, 2014, P NATL ACAD SCI USA, V111, P14776, DOI 10.1073/pnas.1416498111; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Deeb G, 2011, LEUKEMIA RES, V35, P579, DOI 10.1016/j.leukres.2010.10.020; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Fiegl M, 2009, BLOOD, V113, P1504, DOI 10.1182/blood-2008-06-161539; Forristal CE, 2015, LEUKEMIA, V29, P2075, DOI 10.1038/leu.2015.102; Fu H, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-66; Gaber T, 2011, J IMMUNOL, V186, P764, DOI 10.4049/jimmunol.0903421; Gilkes DM, 2013, FUTURE ONCOL, V9, P1623, DOI [10.2217/fon.13.92, 10.2217/FON.13.92]; GRANT WC, 1947, FED PROC, V6, P114; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu X, 2015, DEV PHASE 1B 2A PROO; Luo JC, 2001, ONCOGENE, V20, P1435, DOI 10.1038/sj.onc.1204228; MacRae T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072884; Mahalingam D, 2016, 1 IN HUMAN PHASE 1 S; Miharada K, 2012, ANN NY ACAD SCI, V1266, P55, DOI 10.1111/j.1749-6632.2012.06564.x; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Pillinger G, 2015, SCI REP-UK, V5, DOI 10.1038/srep12949; Piya S, 2017, AUTOPHAGY, V13, P214, DOI 10.1080/15548627.2016.1245263; Rapin N, 2014, BLOOD, V123, P894, DOI 10.1182/blood-2013-02-485771; Rouault-Pierre K, 2013, CELL STEM CELL, V13, P549, DOI 10.1016/j.stem.2013.08.011; Rowe JM, 2010, BLOOD, V116, P3147, DOI 10.1182/blood-2010-05-260117; Rushworth SA, 2012, BLOOD, V120, P5188, DOI 10.1182/blood-2012-04-422121; Schepers K, 2015, CELL STEM CELL, V16, P254, DOI 10.1016/j.stem.2015.02.014; Selvendiran K, 2009, INT J CANCER, V125, P2198, DOI 10.1002/ijc.24601; Shachar I, 2012, FEBS LETT, V586, P2906, DOI 10.1016/j.febslet.2012.07.016; Shafat MS, 2017, BLOOD, V129, P1320, DOI 10.1182/blood-2016-08-734798; Simons D, 2011, J CELL MOL MED, V15, P668, DOI 10.1111/j.1582-4934.2010.01041.x; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Velasco-Hernandez T, 2015, LEUKEMIA, V29, P2366, DOI 10.1038/leu.2015.156; Velasco-Hernandez T, 2014, BLOOD, V124, P3597, DOI 10.1182/blood-2014-04-567065; Vick B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120925; Vukovic M, 2015, J EXP MED, V212, P2223, DOI 10.1084/jem.20150452; Vyas P, 2014, BLOOD, V124, P3510, DOI 10.1182/blood-2014-10-605055; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wierenga ATJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093494; Yonekura S, 2013, ANTICANCER RES, V33, P3099; Zaitseva L, 2014, ONCOTARGET, V5, P9930, DOI 10.18632/oncotarget.2479	44	14	14	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	20					2676	2686		10.1038/s41388-018-0151-1	http://dx.doi.org/10.1038/s41388-018-0151-1			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG2TH	29487418	Green Accepted			2022-12-26	WOS:000432545100005
J	Madacki, J; Laval, F; Grzegorzewicz, A; Lemassu, A; Zahorszka, M; Arand, M; McNeil, M; Daffe, M; Jackson, M; Laneelle, MA; Kordulakova, J				Madacki, Jan; Laval, Francoise; Grzegorzewicz, Anna; Lemassu, Anne; Zahorszka, Monika; Arand, Michael; McNeil, Michael; Daffe, Mamadou; Jackson, Mary; Laneelle, Marie-Antoinette; Kordulakova, Jana			Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mycobacteria; cell wall; fatty acid metabolism; lipid; mass spectrometry (MS); bacterial cell envelope; epoxide hydrolase; epoxymycolic acid; mycolic acids	MOLECULAR-MASS DETERMINATION; COMMON MECHANISM; TUBERCULOSIS; BIOSYNTHESIS; CYCLOPROPANATION; PHOSPHORYLATION; PURIFICATION; INHIBITION; EXPRESSION; TRANSPORT	nd H-1 NMR spectroscopy of mycolic acids and lipids isolated from EphD-overproducing M. smegmatis, we identified new oxygenated mycolic acid species that accumulated during epoxymycolate depletion. Disruption of the ephD gene in M. tuberculosis specifically impaired the synthesis of ketomycolates and caused accumulation of their precursor, hydroxymycolate, indicating either direct or indirect involvement of EphD in ketomycolate biosynthesis. Our results clearly indicate that EphD plays a role in met Mycolic acids are the hallmark of the cell envelope in mycobacteria, which include the important human pathogens Mycobacterium tuberculosis and Mycobacterium leprae. Mycolic acids are very long C60-C90 -alkyl -hydroxy fatty acids having a variety of functional groups on their hydrocarbon chain that define several mycolate types. Mycobacteria also produce an unusually large number of putative epoxide hydrolases, but the physiological functions of these enzymes are still unclear. Here, we report that the mycobacterial epoxide hydrolase EphD is involved in mycolic acid metabolism. We found that orthologs of EphD from M. tuberculosis and M. smegmatis are functional epoxide hydrolases, cleaving a lipophilic substrate, 9,10-cis-epoxystearic acid, in vitro and forming a vicinal diol. The results of EphD overproduction in M. smegmatis and M. bovis BCG hma strains producing epoxymycolic acids indicated that EphD is involved in the metabolism of these forms of mycolates in both fast- and slow-growing mycobacteria. Moreover, using MALDI-TOF-MS aabolism of oxygenated mycolic acids in mycobacteria.	[Madacki, Jan; Zahorszka, Monika; Kordulakova, Jana] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia; [Laval, Francoise; Lemassu, Anne; Daffe, Mamadou; Laneelle, Marie-Antoinette] CNRS, Inst Pharmacol & Biol Struct, TB & Infect Biol Dept, F-31077 Toulouse, France; [Grzegorzewicz, Anna; McNeil, Michael; Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Arand, Michael] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	Comenius University Bratislava; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Colorado State University; University of Zurich	Kordulakova, J (corresponding author), Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia.	jana.kordulakova@uniba.sk	LAUZERAL-VIZCAINO, Françoise/W-8898-2019; Arand, Michael/J-3926-2014; Kordulakova, Jana/I-3887-2014; McNeil, Michael/G-3325-2019; Jackson, Mary/D-5345-2017	LAUZERAL-VIZCAINO, Françoise/0000-0002-9741-3252; Arand, Michael/0000-0003-2413-3177; Kordulakova, Jana/0000-0003-2834-0165; Jackson, Mary/0000-0002-9212-0258; Madacki, Jan/0000-0001-6534-4240; Lemassu, Anne/0000-0002-9323-2497	Slovak Research and Development Agency [APVV-0441-10]; Slovak Grant Agency VEGA Grant [1/0284/15]; Research and Development Operational Programe funded by European Regional Development Fund [ITMS 26240120027]; NIAID, National Institutes of Health [AI063054]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063054] Funding Source: NIH RePORTER	Slovak Research and Development Agency(Slovak Research and Development Agency); Slovak Grant Agency VEGA Grant; Research and Development Operational Programe funded by European Regional Development Fund; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Slovak Research and Development Agency Grant APVV-0441-10 (to J. K.), Slovak Grant Agency VEGA Grant 1/0284/15 (to J. K.), the project supported by the Research and Development Operational Programe funded by European Regional Development Fund Contract ITMS 26240120027 (to J. K.), and NIAID, National Institutes of Health Grant AI063054 (to M. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhter Y, 2008, GENE, V407, P148, DOI 10.1016/j.gene.2007.10.017; Alibaud L, 2010, J BIOL CHEM, V285, P21698, DOI 10.1074/jbc.M110.125724; Arand M, 2005, METHOD ENZYMOL, V400, P569, DOI 10.1016/S0076-6879(05)00032-7; BABA T, 1989, J BIOCHEM-TOKYO, V106, P81, DOI 10.1093/oxfordjournals.jbchem.a122825; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barkan D, 2012, INFECT IMMUN, V80, P1958, DOI 10.1128/IAI.00021-12; Barkan D, 2009, CHEM BIOL, V16, P499, DOI 10.1016/j.chembiol.2009.04.001; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Biswal BK, 2006, ACTA CRYSTALLOGR F, V62, P136, DOI 10.1107/S1744309106000637; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Brown AC, 2006, PLASMID, V55, P81, DOI 10.1016/j.plasmid.2005.06.005; Cantaloube S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029564; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; Derrick SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032959; Dhiman RK, 2004, J LIPID RES, V45, P1140, DOI 10.1194/jlr.M400047-JLR200; Dinadayala P, 2003, J BIOL CHEM, V278, P7310, DOI 10.1074/jbc.M210501200; Dubnau E, 1997, MOL MICROBIOL, V23, P313, DOI 10.1046/j.1365-2958.1997.2301589.x; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujita Y, 2005, MICROBIOL-SGM, V151, P1443, DOI 10.1099/mic.0.27791-0; Gavalda S, 2014, CHEM BIOL, V21, P1660, DOI 10.1016/j.chembiol.2014.10.011; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Grzegorzewicz AE, 2012, J BIOL CHEM, V287, P38434, DOI 10.1074/jbc.M112.400994; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Jang J, 2010, MICROBIOL-SGM, V156, P1619, DOI 10.1099/mic.0.038133-0; Johansson P, 2005, J MOL BIOL, V351, P1048, DOI 10.1016/j.jmb.2005.06.055; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; LANEELLE MA, 1970, EUR J BIOCHEM, V12, P296, DOI 10.1111/j.1432-1033.1970.tb00850.x; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Laval F, 2008, J BIOL CHEM, V283, P1419, DOI 10.1074/jbc.M708859200; LEVYFREBAULT V, 1986, ANN INST PASTEUR MIC, V137A, P143, DOI 10.1016/S0769-2609(86)80019-9; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; MINNIKIN DE, 1985, ZBL BAKT-INT J MED M, V259, P446; MINNIKIN DE, 1984, ARCH MICROBIOL, V139, P225, DOI 10.1007/BF00402005; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Morisseau C, 2013, BIOCHIMIE, V95, P91, DOI 10.1016/j.biochi.2012.06.011; Muller F, 1997, EUR J BIOCHEM, V245, P490, DOI 10.1111/j.1432-1033.1997.00490.x; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Phetsuksiri B, 1999, ANTIMICROB AGENTS CH, V43, P1042, DOI 10.1128/AAC.43.5.1042; Purwantini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081985; Quemard A, 2016, TRENDS MICROBIOL, V24, P725, DOI 10.1016/j.tim.2016.04.009; Rodriguez-Rivera FP, 2017, J AM CHEM SOC, V139, P3488, DOI 10.1021/jacs.6b12541; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Slama N, 2016, MOL MICROBIOL, V99, P794, DOI 10.1111/mmi.13266; Slama N, 2011, BIOCHEM BIOPH RES CO, V412, P401, DOI 10.1016/j.bbrc.2011.07.051; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; TORIYAMA S, 1978, FEBS LETT, V95, P111, DOI 10.1016/0014-5793(78)80063-5; TORIYAMA S, 1982, BIOCHIM BIOPHYS ACTA, V712, P427, DOI 10.1016/0005-2760(82)90363-0; Tortoli E, 2014, CLIN MICROBIOL REV, V27, P727, DOI 10.1128/CMR.00035-14; Triccas JA, 1998, FEMS MICROBIOL LETT, V167, P151, DOI 10.1111/j.1574-6968.1998.tb13221.x; van der Werf MJ, 1999, APPL ENVIRON MICROB, V65, P2092; van Loo B, 2006, APPL ENVIRON MICROB, V72, P2905, DOI 10.1128/AEM.72.4.2905-2917.2006; Veyron-Churlet R, 2005, J MOL BIOL, V353, P847, DOI 10.1016/j.jmb.2005.09.016; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Watanabe M, 2001, MICROBIOL-SGM, V147, P1825, DOI 10.1099/00221287-147-7-1825; Yamaryo-Botte Y, 2015, ACS CHEM BIOL, V10, P734, DOI 10.1021/cb5007689; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828	61	12	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5172	5184		10.1074/jbc.RA117.000246	http://dx.doi.org/10.1074/jbc.RA117.000246			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29472294	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000429409300022
J	Zamarian, L; Scherfler, C; Kremser, C; Pertl, MT; Gizewski, E; Benke, T; Delazer, M				Zamarian, Laura; Scherfler, Christoph; Kremser, Christian; Pertl, Marie-Theres; Gizewski, Elke; Benke, Thomas; Delazer, Margarete			Arithmetic learning in advanced age	PLOS ONE			English	Article							SKILL ACQUISITION; STRATEGY EXECUTION; ANGULAR GYRUS; OLDER-ADULTS; NUMBER; BRAIN; MULTIPLICATION; AUTOMATICITY; REGISTRATION; KNOWLEDGE	Acquisition of numerical knowledge and understanding of numerical information are crucial for coping with the changing demands of our digital society. In this study, we assessed arithmetic learning in older and younger individuals in a training experiment including brain imaging. In particular, we assessed age-related effects of training intensity, prior arithmetic competence, and neuropsychological variables on the acquisition of new arithmetic knowledge and on the transfer to new, unknown problems. Effects were assessed immediately after training and after 3 months. Behavioural results showed higher training effects for younger individuals than for older individuals and significantly better performance after 90 problem repetitions than after 30 repetitions in both age groups. A correlation analysis indicated that older adults with lower memory and executive functions at baseline could profit more from intensive training. Similarly, training effects in the younger group were higher for those individuals who had lower arithmetic competence and executive functions prior to intervention. In younger adults, successful transfer was associated with higher executive functions. Memory and set-shifting emerged as significant predictors of training effects in the older group. For the younger group, prior arithmetic competence was a significant predictor of training effects, while cognitive flexibility was a predictor of transfer effects. After training, a subgroup of participants underwent an MRI assessment. A voxel-based morphometry analysis showed a significant interaction between training effects and grey matter volume of the right middle temporal gyrus extending to the angular gyrus for the younger group relative to the older group. The reverse contrast (older group vs. younger group) did not yield any significant results. These results suggest that improvements in arithmetic competence are supported by temporo-parietal areas in the right hemisphere in younger participants, while learning in older people might be more widespread. Overall, our study indicates that arithmetic learning depends on the training intensity as well as on person-related factors including individual age, arithmetic competence before training, memory, and executive functions. In conclusion, we suggest that major progress can be also achieved by older participants, but that interventions have to take into account individual variables in order to provide maximal benefit.	[Zamarian, Laura; Scherfler, Christoph; Pertl, Marie-Theres; Benke, Thomas; Delazer, Margarete] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Scherfler, Christoph; Gizewski, Elke] Med Univ Innsbruck, Neuroimaging Res Core Facil, Innsbruck, Austria; [Kremser, Christian] Med Univ Innsbruck, Dept Radiol, Innsbruck, Austria; [Gizewski, Elke] Med Univ Innsbruck, Dept Neuroradiol, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Zamarian, L (corresponding author), Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria.	laura.zamarian@i-med.ac.at	Zamarian, Laura/J-9575-2018	Zamarian, Laura/0000-0002-1640-4179; Gizewski, Elke Ruth/0000-0001-6859-8377; Delazer, Margarete/0000-0001-6482-4445; Scherfler, Christoph/0000-0002-4885-5265	Tiroler Wissenschaftsfonds [TWF-2010-1-993]	Tiroler Wissenschaftsfonds	This research was entirely supported by Tiroler Wissenschaftsfonds (TWF-2010-1-993) to L.Z. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional internal or external funding received for this study.	ALLEN PA, 1992, PSYCHOL AGING, V7, P536, DOI 10.1037/0882-7974.7.4.536; ANDERSON JR, 1992, AM J PSYCHOL, V105, P165, DOI 10.2307/1423026; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; ASHCRAFT MH, 1992, COGNITION, V44, P75, DOI 10.1016/0010-0277(92)90051-I; Barrouillet P, 1998, MEM COGNITION, V26, P355, DOI 10.3758/BF03201146; Bloechle J, 2016, HUM BRAIN MAPP, V37, P3061, DOI 10.1002/hbm.23226; Butterworth B, 2005, J CHILD PSYCHOL PSYC, V46, P3, DOI 10.1111/j.1469-7610.2004.00374.x; Butterworth B, 2011, SCIENCE, V332, P1049, DOI 10.1126/science.1201536; Cappelletti M, 2014, COGNITIVE PSYCHOL, V69, P25, DOI 10.1016/j.cogpsych.2013.11.004; Claros-Salinas D, 2014, RESTOR NEUROL NEUROS, V32, P463, DOI 10.3233/RNN-130342; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Delazer M, 2005, NEUROIMAGE, V25, P838, DOI 10.1016/j.neuroimage.2004.12.009; Delazer M, 2003, COGNITIVE BRAIN RES, V18, P76, DOI 10.1016/j.cogbrainres.2003.09.005; Delazer M, 2003, CLIN NEUROPSYCHOL, V17, P331, DOI 10.1076/clin.17.3.331.18092; Delazer M, 2003, STUD MATH TH LEARN, P385; Delazer M, 2013, AGING NEUROPSYCHOL C, V20, P639, DOI 10.1080/13825585.2012.750261; Dennis NA., 2011, HDB AGING COGN; Duverne S, 2005, CAN J EXP PSYCHOL, V59, P262, DOI 10.1037/h0087479; Duverne S, 2008, PSYCHOL RES-PSYCH FO, V72, P27, DOI 10.1007/s00426-006-0071-5; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Glisky E.L., 2007, BRAIN AGING MODELS M; Grabner RH, 2009, HUM BRAIN MAPP, V30, P2936, DOI 10.1002/hbm.20720; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Howell DC., 1997, STAT METHODS PSYCHOL, V4th ed; Ischebeck A, 2007, NEUROIMAGE, V36, P993, DOI 10.1016/j.neuroimage.2007.03.051; Ischebeck A, 2006, NEUROIMAGE, V30, P1365, DOI 10.1016/j.neuroimage.2005.11.016; Ischebeck A, 2009, NEUROIMAGE, V44, P1103, DOI 10.1016/j.neuroimage.2008.10.025; KLAPP ST, 1991, J EXP PSYCHOL LEARN, V17, P196, DOI 10.1037/0278-7393.17.2.196; LeFevre J-O, 2015, OXF HDB NUMER COGN, P895; LEMAIRE P, 1995, J EXP PSYCHOL GEN, V124, P83, DOI 10.1037/0096-3445.124.1.83; Lemaire P, 2008, AM J PSYCHOL, V121, P1, DOI 10.2307/20445440; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; LOGAN GD, 1991, J EXP PSYCHOL LEARN, V17, P179, DOI 10.1037/0278-7393.17.2.179; Park D C, 2001, Dialogues Clin Neurosci, V3, P151; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Rickard TC, 1997, J EXP PSYCHOL GEN, V126, P288, DOI 10.1037/0096-3445.126.3.288; Rickard TC, 2004, J EXP PSYCHOL LEARN, V30, P65, DOI 10.1037/0278-7393.30.1.65; SALTHOUSE TA, 1994, J EXP PSYCHOL LEARN, V20, P1172, DOI 10.1037/0278-7393.20.5.1172; Schmidt R, 2003, LANCET, V361, P2046, DOI 10.1016/S0140-6736(03)13616-1; Semenza C, 2017, PHILOS T R SOC LON B, P373; SIEGLER RS, 1988, J EXP PSYCHOL GEN, V117, P258, DOI 10.1037/0096-3445.117.3.258; Sliwinski M, 1997, PSYCHOL AGING, V12, P38, DOI 10.1037/0882-7974.12.1.38; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023175; Touron DR, 2015, CURR DIR PSYCHOL SCI, V24, P170, DOI 10.1177/0963721414563730; Touron DR, 2011, J GERONTOL B-PSYCHOL, V66, P151, DOI 10.1093/geronb/gbq076; Touron DR, 2009, PSYCHOL AGING, V24, P574, DOI 10.1037/a0015966; Touron DR, 2004, PSYCHOL AGING, V19, P565, DOI 10.1037/0882-7974.19.4.565; Touron DR, 2001, PSYCHOL AGING, V16, P555, DOI 10.1037//0882-7974.16.4.555; Tronsky LN, 2005, MEM COGNITION, V33, P927, DOI 10.3758/BF03193086; Uittenhove K, 2015, OXF HDB NUMER COGN, P895; Willmes Klaus, 2008, Handb Clin Neurol, V88, P339, DOI 10.1016/S0072-9752(07)88017-1; Zamarian L, 2007, NEUROPSYCHOLOGIA, V45, P1511, DOI 10.1016/j.neuropsychologia.2006.11.012; Zamarian L, 2009, NEUROSCI BIOBEHAV R, V33, P909, DOI 10.1016/j.neubiorev.2009.03.005; Zamarian L., 2015, OXFORDHANDBOOK NUMER, P837, DOI [10.1093/oxfordhb/9780199642342.013.007, DOI 10.1093/OXFORDHB/9780199642342.013.007]	55	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193529	10.1371/journal.pone.0193529	http://dx.doi.org/10.1371/journal.pone.0193529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489905	gold, Green Submitted, Green Published			2022-12-26	WOS:000426276000085
J	David, M; Lecorche, P; Masse, M; Faucon, A; Abouzid, K; Gaudin, N; Varini, K; Gassiot, F; Ferracci, G; Jacquot, G; Vlieghe, P; Khrestchatisky, M				David, Marion; Lecorche, Pascaline; Masse, Maxime; Faucon, Aude; Abouzid, Karima; Gaudin, Nicolas; Varini, Karine; Gassiot, Fanny; Ferracci, Geraldine; Jacquot, Guillaume; Vlieghe, Patrick; Khrestchatisky, Michel			Identification and characterization of highly versatile peptide-vectors that bind non-competitively to the low-density lipoprotein receptor for in vivo targeting and delivery of small molecules and protein cargos	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; LDL RECEPTOR; DRUG-DELIVERY; ANTISENSE OLIGONUCLEOTIDES; LYSOSOMAL-ENZYME; NERVOUS-SYSTEM; OPTIMIZATION; TRANSCYTOSIS; CHOLESTEROL; CELLS	Insufficient membrane penetration of drugs, in particular biotherapeutics and/or low target specificity remain a major drawback in their efficacy. We propose here the rational characterization and optimization of peptides to be developed as vectors that target cells expressing specific receptors involved in endocytosis or transcytosis. Among receptors involved in receptor-mediated transport is the LDL receptor. Screening complex phage-displayed peptide libraries on the human LDLR (hLDLR) stably expressed in cell lines led to the characterization of a family of cyclic and linear peptides that specifically bind the hLDLR. The VH41 1 lead cyclic peptide allowed endocytosis of payloads such as the S-Tag peptide or antibodies into cells expressing the hLDLR. Size reduction and chemical optimization of this lead peptide-vector led to improved receptor affinity. The optimized peptide-vectors were successfully conjugated to cargos of different nature and size including small organic molecules, siRNAs, peptides or a protein moiety such as an Fc fragment. We show that in all cases, the peptide-vectors retain their binding affinity to the hLDLR and potential for endocytosis. Following i.v. administration in wild type or Idlr-!-mice, an Fc fragment chemically conjugated or fused in C-terminal to peptide-vectors showed significant biodistribution in LDLR-enriched organs. We have thus developed highly versatile peptide-vectors endowed with good affinity for the LDLR as a target receptor. These peptide-vectors have the potential to be further developed for efficient transport of therapeutic or imaging agents into cells-including pathological cells-or organs that express the LDLR.	[David, Marion; Lecorche, Pascaline; Masse, Maxime; Faucon, Aude; Abouzid, Karima; Varini, Karine; Gassiot, Fanny; Jacquot, Guillaume; Vlieghe, Patrick] VECT HORUS SAS, Marseille, France; [Gaudin, Nicolas; Varini, Karine; Khrestchatisky, Michel] Aix Marseille Univ, CNRS, NICN, Marseille, France; [Ferracci, Geraldine] Aix Marseille Univ, CNRS, CRN2M, Marseille, France; [Ferracci, Geraldine; Khrestchatisky, Michel] Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France; [Vlieghe, Patrick] SATT Sud Est, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite	Khrestchatisky, M (corresponding author), Aix Marseille Univ, CNRS, NICN, Marseille, France.; Khrestchatisky, M (corresponding author), Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.	michel.khrestchatisky@univ-amu.fr			CNRS; Aix-Marseille Universite; Direction Generale de la Competitivite, de lIndustrie et des Services (DGCIS); Fonds Unique Interministeriel (FUI/); French National Agency for Research (ANR) - A*MIDEX [UMR7259]; ANRT; Direction Generale de la Competitivite, de l'Industrie et des Services (DGCIS); French National Agency for Research (ANR) - A*MIDEX	CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Direction Generale de la Competitivite, de lIndustrie et des Services (DGCIS); Fonds Unique Interministeriel (FUI/); French National Agency for Research (ANR) - A*MIDEX(French National Research Agency (ANR)); ANRT(French National Research Agency (ANR)); Direction Generale de la Competitivite, de l'Industrie et des Services (DGCIS); French National Agency for Research (ANR) - A*MIDEX(French National Research Agency (ANR))	The UMR7259 and UMR7286 laboratories acknowledge financial support from the CNRS and from Aix-Marseille Universite. Financial support to VECT-HORUS is acknowledged from the Direction Generale de la Competitivite, de lIndustrie et des Services (DGCIS) and Fonds Unique Interministeriel (FUI/) for the MEDUL project followingqualification by the Pole de Competitivite Eurobiomed. Financial support to the UMR7259 and VECT-HORUScollaborative research programs is acknowledged from the French National Agency for Research (ANR) for theDHUNE project supported by A*MIDEX, and for the following ANR projects: VECtoBrain to PV and MK, VEC2Brain to MK and NANOVECTOR to MK. KV was supported in part by a CIFRE doctoral fellowship from the ANRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The NICN and CRN2M laboratories acknowledge financial support from the CNRS and from Aix-Marseille Universite. Financial support to VECT-HORUS is acknowledged from the Direction Generale de la Competitivite, de l'Industrie et des Services (DGCIS) and Fonds Unique Interministeriel (FUI/) for the MEDUL project following qualification by the Pole de Competitivite Eurobiomed. Financial support to NICN and VECT-HORUS collaborative research programs is acknowledged from the French National Agency for Research (ANR) for the DHUNE project supported by A*MIDEX, and for the following ANR projects: VECtoBrain to PV and MK, VEC2Brain to MK and NANOVECTOR to MK." KV was supported in part by a CIFRE doctoral fellowship from the ANRT.	Abbott NJ, 1996, MOL MED TODAY, V2, P106, DOI 10.1016/1357-4310(96)88720-X; Aggarwal S, 2006, CANCER RES, V66, P9171, DOI 10.1158/0008-5472.CAN-06-1520; Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Bockenhoff A, 2014, J NEUROSCI, V34, P3122, DOI 10.1523/JNEUROSCI.4785-13.2014; Brasnjevic I, 2009, PROG NEUROBIOL, V87, P212, DOI 10.1016/j.pneurobio.2008.12.002; BROWN MS, 1979, P NATL ACAD SCI USA, V76, P3330, DOI 10.1073/pnas.76.7.3330; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Chen Z, 2017, MOL PHARM, V20; Clayton D, 1999, PROTEIN SCI, V8, P1797, DOI 10.1110/ps.8.9.1797; Crooke ST, 2017, NAT BIOTECHNOL, V35, P230, DOI 10.1038/nbt.3779; Cwirla SE, 1997, SCIENCE, V276, P1696, DOI 10.1126/science.276.5319.1696; Dehouck B, 1997, J CELL BIOL, V138, P877, DOI 10.1083/jcb.138.4.877; DEHOUCK B, 1994, J CELL BIOL, V126, P465, DOI 10.1083/jcb.126.2.465; Demeule M, 2008, J PHARMACOL EXP THER, V324, P1064, DOI 10.1124/jpet.107.131318; Demeule M, 2008, J NEUROCHEM, V106, P1534, DOI 10.1111/j.1471-4159.2008.05492.x; Dower W J, 1998, Stem Cells, V16 Suppl 2, P21; Firer MA, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-70; FIRESTONE RA, 1994, BIOCONJUGATE CHEM, V5, P105, DOI 10.1021/bc00026a002; FONG LG, 1989, J CLIN INVEST, V84, P847, DOI 10.1172/JCI114245; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Guillaumond F, 2015, P NATL ACAD SCI USA, V112, P2473, DOI 10.1073/pnas.1421601112; Harisa GI, 2014, SAUDI PHARM J, V22, P504, DOI 10.1016/j.jsps.2013.12.015; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Jacquot G, 2016, MOL PHARMACEUT, V13, P4094, DOI 10.1021/acs.molpharmaceut.6b00687; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Kawamoto M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-359; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8; Lalatsa A, 2014, MOL PHARMACEUT, V11, P1081, DOI 10.1021/mp400680d; Laude AJ, 2004, MOL MEMBR BIOL, V21, P193, DOI 10.1080/09687680410001700517; Lee JH, 2001, EUR J BIOCHEM, V268, P2004, DOI 10.1046/j.1432-1327.2001.02073.x; Li YH, 2001, MOL NEUROBIOL, V23, P53; Liu ZF, 2009, EUR J NUCL MED MOL I, V36, P947, DOI 10.1007/s00259-008-1045-1; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Luegmayr E, 2004, CELL DEATH DIFFER, V11, pS108, DOI 10.1038/sj.cdd.4401399; Malcor JD, 2012, J MED CHEM, V55, P2227, DOI 10.1021/jm2014919; Martinez-Olivan J, 2014, FEBS J, V281, P1534, DOI 10.1111/febs.12721; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; MERESSE S, 1989, J NEUROCHEM, V53, P340, DOI 10.1111/j.1471-4159.1989.tb07340.x; Molino Y, 2017, FASEB J OFFICIAL PUB, V20; Muro S, 2012, J CONTROL RELEASE, V164, P125, DOI 10.1016/j.jconrel.2012.05.052; Nair JK, 2014, J AM CHEM SOC, V136, P16958, DOI 10.1021/ja505986a; Pardridge WM, 2005, MOL BIOTECHNOL, V30, P57, DOI 10.1385/MB:30:1:057; Prakash TP, 2014, NUCLEIC ACIDS RES, V42, P8796, DOI 10.1093/nar/gku531; Sorrentino NC, 2013, EMBO MOL MED, V5, P675, DOI 10.1002/emmm.201202083; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Spencer B, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00114; Spencer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016575; Spencer BJ, 2007, P NATL ACAD SCI USA, V104, P7594, DOI 10.1073/pnas.0702170104; Tserentsoodol N, 2006, MOL VIS, V12, P1306; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Vlieghe P, 2013, MED RES REV, V33, P457, DOI 10.1002/med.21252; Wang DR, 2013, P NATL ACAD SCI USA, V110, P2999, DOI 10.1073/pnas.1222742110; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Wu CH, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0223-x; Zhang B, 2013, BIOMATERIALS, V34, P9171, DOI 10.1016/j.biomaterials.2013.08.039	58	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0191052	10.1371/journal.pone.0191052	http://dx.doi.org/10.1371/journal.pone.0191052			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29485998	Green Published, Green Submitted, gold			2022-12-26	WOS:000426242400002
J	Rajpal, S; Kumar, A; Joe, W				Rajpal, Sunil; Kumar, Abhishek; Joe, William			Economic burden of cancer in India: Evidence from cross-sectional nationally representative household survey, 2014	PLOS ONE			English	Article							HEALTH-CARE; DESCRIPTIVE EPIDEMIOLOGY; CERVICAL-CANCER; BREAST-CANCER; AGE; EXPENDITURE; POPULATION; NUTRITION; DIAGNOSIS; PAYMENTS	With the ongoing demographic and epidemiological transition, cancer is emerging as a major public health concern in India. This paper uses nationally representative household survey to examine the overall prevalence and economic burden of cancer in India. The age-standardized prevalence of cancer is estimated to be 97 per 100,000 persons with greater prevalence in urban areas. The evidence suggests that cancer prevalence is highest among the elderly and also among females in the reproductive age groups. Cancer displays a significant socioeconomic gradient even after adjusting for age-sex specifics and clustering in a multilevel regression framework. We find that out of pocket expenditure on cancer treatment is among the highest for any ailment. The average out of pocket spending on inpatient care in private facilities is about three-times that of public facilities. Furthermore, treatment for about 40 percent of cancer hospitalization cases is financed mainly through borrowings, sale of assets and contributions from friends and relatives. Also, over 60 percent of the households who seek care from the private sector incur out of pocket expenditure in excess of 20 percent of their annual per capita household expenditure. Given the catastrophic implications, this study calls for a disease-based approach towards financing such high-cost ailment. It is suggested that universal cancer care insurance should be envisaged and combined with existing accident and life insurance policies for the poorer sections in India. In concluding, we call for policies to improve cancer survivorship through effective prevention and early detection. In particular, greater public health investments in infrastructure, human resources and quality of care deserve priority attention.	[Rajpal, Sunil; Kumar, Abhishek; Joe, William] Delhi Univ Enclave, Inst Econ Growth, North Campus, Delhi, India	University of Delhi	Rajpal, S (corresponding author), Delhi Univ Enclave, Inst Econ Growth, North Campus, Delhi, India.	sunilrajpa127@gmail.com		Rajpal, Sunil/0000-0001-8607-1878				[Anonymous], 2017, MIN HLTH FAM WELF GO; BATTISTA RN, 1988, ANNU REV PUBL HEALTH, V9, P21; Berer M, 2008, REPROD HEALTH MATTER, V16, P4, DOI 10.1016/S0968-8080(08)32429-X; Berki S, 1998, HEALTHAFFAIRS, V5, P138; Bloom DE, 2014, EC NONCOMMUNICABLE D; Brown ML, 2001, ANNU REV PUBL HEALTH, V22, P91, DOI 10.1146/annurev.publhealth.22.1.91; BURCH PRJ, 1985, BRIT MED J, V290, P710, DOI 10.1136/bmj.290.6469.710-a; Chakravarthi I, 2013, ECON POLIT WEEKLY, V48, P20; Colditz GA, 2012, ANNU REV PUBL HEALTH, V33, P137, DOI 10.1146/annurev-publhealth-031811-124627; Confortini CC, 2015, HEALTH POLICY PLANN, V30, P1350, DOI 10.1093/heapol/czu134; Dale W, 2012, JNCI-J NATL CANCER I, V104, P581, DOI 10.1093/jnci/djs145; Dame P, 1977, ECON POLIT WEEKLY, P1844; Dinshaw K A, 2010, HLTH ADM, V17, P10; Erreygers G, 2009, J HEALTH ECON, V28, P504, DOI 10.1016/j.jhealeco.2008.02.003; Gajalakshmi CK, 1996, CANCER CAUSE CONTROL, V7, P520, DOI 10.1007/BF00051884; Gajalakshmi CK, 1998, CANCER CAUSE CONTROL, V9, P131, DOI 10.1023/A:1008822008788; Gajalakshmi V, 2012, CANCER CAUSE CONTROL, V23, P91, DOI 10.1007/s10552-012-9905-1; Gallus S, 2009, CANCER CAUSE CONTROL, V20, P1303, DOI 10.1007/s10552-009-9350-y; Gonzalez JM, 2005, J COMMUNITY PSYCHOL, V33, P611, DOI 10.1002/jcop.20071; Heck JE, 2008, CANCER CAUSE CONTROL, V19, P1329, DOI 10.1007/s10552-008-9204-z; Hiatt RA, 2004, EUR J EPIDEMIOL, V19, P821; Joe W, 2015, HEALTH POLICY PLANN, V30, P728, DOI 10.1093/heapol/czu050; Joseph F, 1982, ANNU REV PUBL HEALTH, V3, P80; Kaarthigeyan K, 2012, INDIAN J MED PAEDIAT, V33, P7, DOI 10.4103/0971-5851.96961; Kirkova J, 2012, AM J HOSP PALLIAT ME, V29, P139, DOI 10.1177/1049909111410965; Krieger N, 2005, CANCER CAUSE CONTROL, V16, P5, DOI 10.1007/s10552-004-1251-5; Kruk ME, 2009, HEALTH AFFAIR, V28, P1056, DOI 10.1377/hlthaff.28.4.1056; Leckie G, 2011, 17 STAT US GROUP M L; Leckie G, 2013, J STAT SOFTW, V52, P1; Li CI, 2000, CANCER CAUSE CONTROL, V11, P805, DOI 10.1023/A:1008942616092; Long ER., 1928, HIST PATHOLOGY; Madison T, 2004, AM J PUBLIC HEALTH, V94, P2104, DOI 10.2105/AJPH.94.12.2104; Mahal A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071853; Mallath MK, 2014, LANCET ONCOL, V15, pE205, DOI 10.1016/S1470-2045(14)70115-9; Marshall JR, 1996, CANCER CAUSE CONTROL, V7, P101, DOI 10.1007/BF00115642; Mathew A, 2008, BRIT J CANCER, V99, P207, DOI 10.1038/sj.bjc.6604423; McNeil C, 2013, JNCI-J NATL CANCER I, V105, P585, DOI 10.1093/jnci/djt104; Modugu HR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1048; Mohanti BK, 2011, ECON POLIT WEEKLY, V46, P112; Nagulapalli S, 2014, ECON POLIT WEEKLY, V49, P64; Nandakumar A, 1996, CANCER CAUSE CONTROL, V7, P405, DOI 10.1007/BF00052665; National Cancer Registry Program, 2016, INC DISR RENDS INC R; National Sample Survey Organisation, 2015, KEY IND SOC CONS IND; O'Donnell O, 2008, J HEALTH ECON, V27, P460, DOI 10.1016/j.jhealeco.2007.08.005; Okonkwo OL, 2008, JNCI-J NATL CANCER I, V18, P1290; Pfizer Facts, 2008, BURD CANC AS; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Rajkumar R, 2000, CANCER CAUSE CONTROL, V11, P433, DOI 10.1023/A:1008900425151; Ramadas K, 2008, CANCER DETECT PREV, V32, P109, DOI 10.1016/j.cdp.2008.02.008; Rock CL, 2000, ANNU REV PUBL HEALTH, V21, P47, DOI 10.1146/annurev.publhealth.21.1.47; Schlotterbeck ME, 1949, AM J NURS, V49, P300, DOI 10.1097/00000446-194905000-00025; Schottenfeld D, 2005, ANNU REV PUBL HEALTH, V26, P37, DOI 10.1146/annurev.publhealth.26.021304.144402; Sinha G, 2006, J NATL CANCER I, V98, P1516, DOI 10.1093/jnci/djj458; Sreedevi A, 2015, INT J WOMENS HEALTH, V7, P405, DOI 10.2147/IJWH.S50001; StataCorp, 2013, STAT STAT SOFTW REL; Swaminathan R, 2009, CANCER EPIDEMIOL, V33, P89, DOI 10.1016/j.canep.2009.06.012; Takiar R, 2010, ASIAN PAC J CANCER P, V11, P1045; Trichopoulos D, 1996, SCI AM, V275, P80, DOI 10.1038/scientificamerican0996-80; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Wagstaff A., 2008, MEASURING FINANCIAL; Weinberg AD, 2010, CANCER CAUSE CONTROL, V21, P2015, DOI 10.1007/s10552-010-9649-8; WHO, 2011, NCD COUNTR PROF; WHO, 2006, CANC CONTR KNOWL ACT; World Health Organization, 2010, NMH FACT SHEET JAN 2; World Health Organization, 2014, WORLD STAT REP; World Health Organization, 2015, WORLD STAT REP; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yeole BB, 2003, CANCER CAUSE CONTROL, V14, P945, DOI 10.1023/B:CACO.0000007965.61579.b2; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007	71	64	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0193320	10.1371/journal.pone.0193320	http://dx.doi.org/10.1371/journal.pone.0193320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX6NQ	29481563	Green Published, Green Submitted, gold			2022-12-26	WOS:000426202700010
J	Ferguson, L; Nicholson, A; Henry, I; Saha, A; Sellers, T; Gruskin, S				Ferguson, Laura; Nicholson, Alexandra; Henry, Ian; Saha, Amitrajit; Sellers, Tilly; Gruskin, Sofia			Assessing changes in HIV-related legal and policy environments: Lessons learned from a multi-country evaluation	PLOS ONE			English	Article								Introduction There is growing recognition in the health community that the legal environment-including laws, policies, and related procedures D impacts vulnerability to HIV and access to HIV-related services both positively and negatively. Assessing changes in the legal environment and how these affect HIV-related outcomes, however, is challenging, and understanding of appropriate methodologies nascent. Methods We conducted an evaluation of a UNDP project designed to strengthen legal environments to support the human rights of key populations, in particular LGBT populations, women and girls, affected by HIV in sub-Saharan Africa. We analyzed data on activities designed to improve legal environments through a systematic document review and 53 qualitative interviews. Results The project made substantial strides towards legal change in many places, and examples provide broader lessons for work in this area. Two core pillars appear fundamental: a government- led participatory assessment of the legal environment, and building the capacity of those impacted by and engaged in this work. Systematic attention to human rights is vital: it can help open new spaces for dialogue among diverse stakeholders, foster new collaborations, and ensure local ownership, nuanced understanding of the political landscape, attention to marginalized populations, and accountability for (in) action. Entry points for effecting legal change go beyond "HIV laws" to also include other laws, national policies and strategies. Conclusion Conducting legal environment assessments, multi-stakeholder dialogues, action planning and related activities, alongside capacity building, can contribute to changes in knowledge and attitudes directly relevant to reforming laws that are found to be harmful. Shorter-term goals along the causal pathway to legal change (e.g. changes in policy) can constitute interim markers of success, and recognition of these can maintain momentum. Increasing understanding of progress towards changes in the legal environment that can positively affect HIV-related outcomes is important in working to improve the health and lives of people living with HIV.	[Ferguson, Laura; Nicholson, Alexandra; Henry, Ian; Gruskin, Sofia] Univ Southern Calif, Inst Global Hlth, Program Global Hlth & Human Rights, Los Angeles, CA 90007 USA; [Saha, Amitrajit] Istanbul Reg Hub, United Nations Dev Program, HIV Hlth & Dev Team, Istanbul, Turkey; [Sellers, Tilly] Reg Ctr Africa, United Nations Dev Program, Hlth & Dev Team, Addis Ababa, Ethiopia	University of Southern California	Ferguson, L (corresponding author), Univ Southern Calif, Inst Global Hlth, Program Global Hlth & Human Rights, Los Angeles, CA 90007 USA.	laura.ferguson@med.usc.edu	Ferguson, Laura/AAO-9694-2021	Ferguson, Laura/0000-0002-1340-793X	United Nations Development Programme	United Nations Development Programme	The evaluated project was launched by UNDP Regional Centre for Africa with the assistance of the Governments of Norway and Sweden, and funding for this work was received from the United Nations Development Programme.; The authors would like to acknowledge Keith Antonio Jones for his significant work to finalize the manuscript. The evaluated project was launched by UNDP Regional Centre for Africa with the assistance of the Governments of Norway and Sweden, and funding for this work was received from the United Nations Development Programme.	[Anonymous], LAW AND HLTH; [Anonymous], 2015, ANONYMOUS KEY INFORM; [Anonymous], 2015, KEY INFORMANT; Clayton M, 2013, SEYCHELLES LEGAL ENV; Csete J, 2016, LANCET, V387, P1427, DOI 10.1016/S0140-6736(16)00619-X; Gruskin S, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18000, 10.7448/IAS.16.3.18726]; Johns Hopkins University and the Center for Development of People, 2014, PREL REP UN JOINT TE; Kalala MM, 2013, REV CADRE JURIDIQUE; Levine J., 2012, GLOBAL COMMISSION HI; Matlho L., 2014, LESOTHO ASSESSMENT L; Nyako A., 2013, NATL POLICY DIALOGUE; Program on Global Health and Human Rights Institute for Global Health University of Southern California, 2015, MIDT EV UNDP RSC AFR; Stackpool-Moore L, 2014, LEGAL ENV ASSESSMENT; The Global Fund, GLOB FUND STRAT 2012, P17; The Global Fund, 2022, BMJ, DOI DOI 10.1136/BMJ.O2320; The Global Fund Strategy, GLOB FUND FIGHT AIDS; UNAIDS, 2013, GLOBAL REPORT UNAIDS; UNAIDS, KEY POP ATL; United Nations Development Programme, 2014, RSCARFP201405 UN DEV; United Nations Development Programme, 2014, TERMS REF MIDT EV ST; Wirtz AL, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-20; World Health Organization; United Nations Office on Drugs and Crime; UNAIDS, 2004, PROV STER INJ EQ RED	22	4	4	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192765	10.1371/journal.pone.0192765	http://dx.doi.org/10.1371/journal.pone.0192765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474486	gold, Green Published			2022-12-26	WOS:000426049500037
J	Kulling, PM; Olson, KC; Hamele, CE; Toro, MF; Tan, SF; Feith, DJ; Jr, TP				Kulling, Paige M.; Olson, Kristine C.; Hamele, Cait E.; Toro, Mariella F.; Tan, Su-Fern; Feith, David J.; Loughran, Thomas P., Jr.			Dysregulation of the IFN-gamma-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia	PLOS ONE			English	Article							IFN-GAMMA RECEPTOR; T-CELL; GENE-EXPRESSION; DOWN-REGULATION; OPPOSING ROLES; LGL LEUKEMIA; NK CELLS; STAT3; ACTIVATION; PROLIFERATION	T cell large granular lymphocyte leukemia (T-LGLL) is a rare incurable disease that is characterized by defective apoptosis of cytotoxic CD8+ T cells. Chronic activation of the Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) pathway is a hallmark of T-LGLL. One manifestation is the constitutive phosphorylation of tyrosine 701 of STAT1 (p-STAT1). T-LGLL patients also exhibit elevated serum levels of the STAT1 activator, interferon-gamma (IFN-gamma), thus contributing to an inflammatory environment. In normal cells, IFN-gamma production is tightly controlled through induction of IFN-gamma negative regulators. However, in T-LGLL, IFN-gamma signaling lacks this negative feedback mechanism as evidenced by excessive IFN-gamma production and decreased levels of suppressors of cytokine signaling 1 (SOCS1), a negative regulator of IFN-gamma. Here we characterize the IFN-gamma-STAT1 pathway in TL-1 cells, a cell line model of T-LGLL. TL-1 cells exhibited lower IFN-gamma receptor protein and mRNA expression compared to an IFN-gamma responsive cell line. Furthermore, IFN-gamma treatment did not induce JAK2 or STAT1 activation or transcription of IFN-gamma-inducible gene targets. However, IFN-8 induced p-STAT1 and subsequent STAT1 gene transcription, demonstrating a specific IFN-gamma signaling defect in TL-1 cells. We utilized siRNA targeting of STAT1, STAT3, and STAT5b to probe their role in IL-2-mediated IFN-gamma regulation. These studies identified STAT5b as a positive regulator of IFN-gamma production. We also characterized the relationship between STAT1, STAT3, and STAT5b proteins. Surprisingly, p-STAT1 was positively correlated with STAT3 levels while STAT5b suppressed the activation of both STAT1 and STAT3. Taken together, these results suggest that the dysregulation of the IFN-gamma-STAT1 signaling pathway in TL-1 cells likely results from low levels of the IFN-gamma receptor. The resulting inability to induce negative feedback regulators explains the observed elevated IL-2 driven IFN-gamma production. Future work will elucidate the best way to target this pathway, with the ultimate goal to find a better therapeutic for T-LGLL.	[Kulling, Paige M.; Olson, Kristine C.; Hamele, Cait E.; Toro, Mariella F.; Tan, Su-Fern; Feith, David J.; Loughran, Thomas P., Jr.] Univ Virginia, Canc Ctr, Charlottesville, VA 22908 USA; [Kulling, Paige M.; Olson, Kristine C.; Hamele, Cait E.; Toro, Mariella F.; Tan, Su-Fern; Feith, David J.; Loughran, Thomas P., Jr.] Univ Virginia, Dept Med, Div Hematol Oncol, Charlottesville, VA 22903 USA; [Kulling, Paige M.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia; University of Virginia	Jr, TP (corresponding author), Univ Virginia, Canc Ctr, Charlottesville, VA 22908 USA.; Jr, TP (corresponding author), Univ Virginia, Dept Med, Div Hematol Oncol, Charlottesville, VA 22903 USA.	tl7cs@virginia.edu		Larkin, Paige/0000-0002-8371-584X; Hamele, Cait/0000-0003-0077-7840	National Cancer Institute of the National Institute of Health [R01CA098472, R01CA178393]; Bess Family Charitable Fund; LGL Leukemia Foundation; Immunology Training Grant [T32AI007496]; UVA Wagner Fellowship; University of Virginia Cancer Center National Cancer Institute [P30-CA044579]; NATIONAL CANCER INSTITUTE [R01CA178393, R01CA098472, P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496] Funding Source: NIH RePORTER	National Cancer Institute of the National Institute of Health; Bess Family Charitable Fund; LGL Leukemia Foundation; Immunology Training Grant; UVA Wagner Fellowship; University of Virginia Cancer Center National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Cancer Institute of the National Institute of Health under award numbers R01CA098472 and R01CA178393, the Bess Family Charitable Fund (to TPL), a generous anonymous donor (to TPL), the LGL Leukemia Foundation (to TPL), Immunology Training Grant T32AI007496 (to PMK), UVA Wagner Fellowship (to PMK), and the University of Virginia Cancer Center National Cancer Institute P30-CA044579. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko K, 2015, BRIT J CANCER, V112, P1501, DOI 10.1038/bjc.2015.101; Andersson EI, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.65; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Bernabei P, 2001, J LEUKOCYTE BIOL, V70, P950; Bian Guanglin, 2016, J Immunol Res Ther, V1, P15; Bream JH, 2004, J BIOL CHEM, V279, P41249, DOI 10.1074/jbc.M401168200; Chandra PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108616; Chapman RS, 2000, ADV EXP MED BIOL, V480, P129; CHOMARAT P, 1993, J EXP MED, V177, P523, DOI 10.1084/jem.177.2.523; de Araujo-Souza PS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/849573; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; Gonsky R, 2004, J IMMUNOL, V173, P6241, DOI 10.4049/jimmunol.173.10.6241; Han W, 2013, MOL CARCINOGEN, V52, P959, DOI 10.1002/mc.21936; Harris DP, 2005, J IMMUNOL, V174, P6781, DOI 10.4049/jimmunol.174.11.6781; Hedrich CM, 2014, P NATL ACAD SCI USA, V111, P13457, DOI 10.1073/pnas.1408023111; Herr F, 2014, J IMMUNOL, V192, P5660, DOI 10.4049/jimmunol.1300422; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Kooy AJW, 1998, J PATHOL, V184, P169; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Krause CD, 2006, CELL RES, V16, P113, DOI 10.1038/sj.cr.7310015; Krause CD, 2006, CELL RES, V16, P55, DOI 10.1038/sj.cr.7310008; Kulling PM, 2017, J STEROID BIOCH MOL; Lamy T, 2017, BLOOD, V129, P1082, DOI 10.1182/blood-2016-08-692590; Lamy T, 2011, BLOOD, V117, P2764, DOI 10.1182/blood-2010-07-296962; Lasfar A, 2014, IMMUNOLOGY, V142, P442, DOI 10.1111/imm.12273; Lee M, 2017, IMMUNE NETW, V17, P214, DOI 10.4110/in.2017.17.4.214; Li QL, 2007, J VIROL, V81, P2117, DOI 10.1128/JVI.01961-06; Liu Y, 2015, EUR J PHARMACOL, V761, P36, DOI 10.1016/j.ejphar.2015.04.033; Loughran TP, 2015, LEUKEMIA, V29, P886, DOI 10.1038/leu.2014.298; Novelli F, 1996, J IMMUNOL, V157, P1935; NOVELLI F, 1994, J IMMUNOL, V152, P496; Olson KC, 2017, CANCER BIOL THER, V18, P290, DOI 10.1080/15384047.2016.1235669; PERNIS A, 1995, SCIENCE, V269, P245, DOI 10.1126/science.7618088; Rajala HLM, 2014, ANN MED, V46, P114, DOI 10.3109/07853890.2014.882105; Ramana CV, 2015, AM J PHYSIOL-LUNG C, V308, pL650, DOI 10.1152/ajplung.00360.2014; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Ren T, 2013, LEUKEMIA RES, V37, P1737, DOI 10.1016/j.leukres.2013.10.002; SAKATSUME M, 1995, J BIOL CHEM, V270, P17528, DOI 10.1074/jbc.270.29.17528; Skrenta H, 2000, J IMMUNOL, V164, P3506, DOI 10.4049/jimmunol.164.7.3506; Solerte SB, 2000, ANN NY ACAD SCI, V917, P331; Sporri B, 2001, BLOOD, V97, P221, DOI 10.1182/blood.V97.1.221; Stancato LF, 1996, J BIOL CHEM, V271, P4134; Strengell M, 2003, J IMMUNOL, V170, P5464, DOI 10.4049/jimmunol.170.11.5464; Tabellini G, 2017, J ALLERGY CLIN IMMUN, V140, P553, DOI 10.1016/j.jaci.2016.10.051; Teramo A, 2013, BLOOD, V121, P3843, DOI 10.1182/blood-2012-07-441378; Thornton S, 2001, EUR J IMMUNOL, V31, P3355, DOI 10.1002/1521-4141(200111)31:11<3355::AID-IMMU3355>3.0.CO;2-D; VILCEK J, 1985, J IMMUNOL, V135, P1851; Walker SR, 2013, MOL CELL BIOL, V33, P2879, DOI 10.1128/MCB.01620-12; Walker SR, 2009, MOL CANCER RES, V7, P966, DOI 10.1158/1541-7786.MCR-08-0238; Wan CK, 2015, P NATL ACAD SCI USA, V112, P9394, DOI 10.1073/pnas.1511711112; Weiss JM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8953; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995	56	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193429	10.1371/journal.pone.0193429	http://dx.doi.org/10.1371/journal.pone.0193429			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474442	Green Published, gold, Green Submitted			2022-12-26	WOS:000426049500108
J	Beyene, TJ; Mourits, MCM; Kidane, AH; Hogeveen, H				Beyene, Tariku Jibat; Mourits, Monique C. M.; Kidane, Abraham Haile; Hogeveen, Henk			Estimating the burden of rabies in Ethiopia by tracing dog bite victims	PLOS ONE			English	Article							POSTEXPOSURE PROPHYLAXIS; COST-EFFECTIVENESS; TANZANIA; VACCINE	In developing countries where financial resources are limited and numerous interests compete, there is a need for quantitative data on the public health burden and costs of diseases to support intervention prioritization. This study aimed at estimating the health burden and post-exposure treatment (PET) costs of canine rabies in Ethiopia by an investigation of exposed human cases. Data on registered animal bite victims during the period of one year were collected from health centers in three districts, i.e. Bishoftu, Lemuna-bilbilo and Yabelo, to account for variation in urban highland and lowland areas. This data collection was followed by an extensive case search for unregistered victims in the same districts as the registered cases. Victims were visited and questioned on their use of PET, incurred treatment costs and the behavioral manifestations of the animal that had bitten them. Based on the collected data PET costs were evaluated by financial accounting and the health burden was estimated in Disability-Adjusted Life Years (DALYs). In total 655 animal bite cases were traced of which 96.5% was caused by dog bites. 73.6% of the biting dogs were suspected to be potentially rabid dog. Annual suspected rabid dog exposures were estimated per evaluated urban, rural highland and rural lowland district at, respectively, 135, 101 and 86 bites, which led, respectively, to about 1, 4 and 3 deaths per 100,000 population. In the same district order average costs per completed PET equaled to 23, 31 and 40 USD, which was significantly higher in rural districts. Extrapolation of the district results to the national level indicated an annual estimate of approximately 3,000 human deaths resulting in about 194,000 DALYs per year and 97,000 exposed persons requiring on average 2 million USD treatment costs per year countrywide. These estimations of the burden of rabies to the Ethiopian society provide decision makers insights into the potential benefits of implementing effective interventions.	[Beyene, Tariku Jibat; Mourits, Monique C. M.; Hogeveen, Henk] Wageningen Univ, Business Econ Grp, Wageningen, Netherlands; [Beyene, Tariku Jibat] Addis Ababa Univ, Coll Vet Med & Agr, Debre Zeit, Ethiopia; [Beyene, Tariku Jibat] Kansas State Univ, Coll Vet Med, Ctr Outcomes Res & Epidemiol, Manhattan, KS 66506 USA; [Kidane, Abraham Haile] Ethiopian Publ Hlth Inst, Zoonosis Res Unit, Addis Ababa, Ethiopia; [Hogeveen, Henk] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	Wageningen University & Research; Addis Ababa University; Kansas State University; Utrecht University	Beyene, TJ (corresponding author), Wageningen Univ, Business Econ Grp, Wageningen, Netherlands.; Beyene, TJ (corresponding author), Addis Ababa Univ, Coll Vet Med & Agr, Debre Zeit, Ethiopia.; Beyene, TJ (corresponding author), Kansas State Univ, Coll Vet Med, Ctr Outcomes Res & Epidemiol, Manhattan, KS 66506 USA.	jibattariku@gmail.com	Beyene, Tariku J/A-6875-2017	Beyene, Tariku J/0000-0002-7474-1966; Hogeveen, Henk/0000-0002-9443-1412; Mourits, Monique/0000-0001-5213-2927	NUFFIC/Netherlands Organisation for International Cooperation in Higher Education	NUFFIC/Netherlands Organisation for International Cooperation in Higher Education	This work was supported by NUFFIC/Netherlands Organisation for International Cooperation in Higher Education.	Abraham Ali, 2010, Ethiopian Veterinary Journal, V14, P91; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P77; [Anonymous], 2016, VET REC, V178, P86, DOI 10.1136/vr.i51; [Anonymous], 2001, NATL BURDEN DIS STUD; [Anonymous], [No title captured]; Ayele W, 2001, ETHIOPIAN MED J, V39, P313; Bilinski AM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1211; Cleaveland S, 2002, B WORLD HEALTH ORGAN, V80, P304; Coetzer A, 2016, ANTIVIR RES, V135, P74, DOI 10.1016/j.antiviral.2016.09.011; CSA, 2013, POPULATION PROJECTIO; CSA, 2012, HOUS CONS EXP HCE SU, P47; Deressa A, 2010, ETHIOPIAN J HLTH DEV, V24; Deressa A, 2013, 11 SEARG M DAR SAL 1; Deribe K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-240; EHNRI, 2012, P NAT WORKSH RAB PRE; Eshetu Yimer, 2002, Ethiopian Journal of Health Development, V16, P105; Fitzpatrick MC, 2014, ANN INTERN MED, V160, P91, DOI 10.7326/M13-0542; Hampson K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000339; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hossain M, 2012, EPIDEMIOL INFECT, V140, P1964, DOI 10.1017/S095026881100272X; Hotez P J, 2009, PLOS NEGLECT TROP D, V3; Hurisa B, 2013, PROCEDIA VACCINOL, V7, P2, DOI 10.1016/j.provac.2013.06.002; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Kahn Laura H, 2007, Vet Ital, V43, P5; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lea RA, 1993, WORLD DEV REPORT 199; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; Ly S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000511; Moges N, 2015, ACAD J ANIMAL DIS, V4, P74; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Murray CJL, 1996, GLOBAL BURDEN DIS IN, V1; NBE, 2014, EXCH RAT USD ETH BIR; Pieracci EG, 2016, ONE HEALTH, V2, P131, DOI 10.1016/j.onehlt.2016.09.001; Piyasirisilp S, 1999, J NEUROIMMUNOL, V98, P96, DOI 10.1016/S0165-5728(99)00065-X; Pruss-ustun A., 2003, INTRO METHODS ASSESS, V1; R Core Team, 2000, R LANG DEF; Rupprecht CE, 2010, USE REDUCED 4 DOSE V; Sambo M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002510; Shim E, 2009, VACCINE, V27, P7167, DOI 10.1016/j.vaccine.2009.09.027; Switzerland World Health Organization, 2010, Weekly Epidemiological Record, V85, P309; Taylor LH, 2015, ZOONOSES PUBLIC HLTH, V62, P543, DOI 10.1111/zph.12183; Teklu GG, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005271; Tenzin, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001391; Tepsumethanon Veera, 2005, Journal of the Medical Association of Thailand, V88, P419; Teshome E, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-189; WHO, 2017, GLOBAL HLTH ESTIMATE; WHO, 2015, WHO DALY CALC; *WHO, 2002, CURR WHO GUID RAB PR; World Bank, 2015, GDP CAP ETH; Wunner W. H., 2010, RABIES SCI BASIS DIS; Yibrah M, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/2049-9957-4-3	53	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192313	10.1371/journal.pone.0192313	http://dx.doi.org/10.1371/journal.pone.0192313			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466403	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300047
J	Davis, MI; Crittenden, JR; Feng, AY; Kupferschmidt, DA; Naydenov, A; Stella, N; Graybiel, AM; Lovinger, DM				Davis, Margaret I.; Crittenden, Jill R.; Feng, Austin Y.; Kupferschmidt, David A.; Naydenov, Alipi; Stella, Nephi; Graybiel, Ann M.; Lovinger, David M.			The cannabinoid-1 receptor is abundantly expressed in striatal striosomes and striosome-dendron bouquets of the substantia nigra	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; MEDIUM SPINY NEURONS; MATRIX COMPARTMENTS; CB1 RECEPTOR; RAT-BRAIN; BASAL GANGLIA; DOPAMINE-D2 RECEPTORS; TYPE-1 RECEPTORS; GENE-EXPRESSION; MOUSE STRIATUM	Presynaptic cannabinoid-1 receptors (CB1-R) bind endogenous and exogenous cannabinoids to modulate neurotransmitter release. CB1-Rs are expressed throughout the basal ganglia, including striatum and substantia nigra, where they play a role in learning and control of motivated actions. However, the pattern of CB1-R expression across different striatal compartments, microcircuits and efferent targets, and the contribution of different CB1-R-expressing neurons to this pattern, are unclear. We use a combination of conventional techniques and novel genetic models to evaluate CB1-R expression in striosome (patch) and matrix compartments of the striatum, and in nigral targets of striatal medium spiny projection neurons (MSNs). CB1-R protein and mRNA follow a descending dorsolateral-to-ventromedial intensity gradient in the caudal striatum, with elevated expression in striosomes relative to the surrounding matrix. The lateral predominance of striosome CB1-Rs contrasts with that of the classical striosomal marker, the mu opioid receptor (MOR), which is expressed most prominently in rostromedial striosomes. The dorsolateral-to-ventromedial CB1-R gradient is similar to Drd2 dopamine receptor immunoreactivity and opposite to Substance P. This topology of CB1-R expression is maintained downstream in the globus pallidus and substantia nigra. Dense CB1-R-expressing striatonigral fibers extend dorsally within the substantia nigra pars reticulata, and colocalize with bundles of ventrally extending, striosome-targeted, dendrites of dopamine-containing neurons in the substantia nigra pars compacta (striosome- dendron bouquets). Within striatum, CB1-Rs colocalize with fluorescently labeled MSN collaterals within the striosomes. Cre recombinase-mediated deletion of CB1-Rs from cortical projection neurons or MSNs, and MSN-selective reintroduction of CB1-Rs in knockout mice, demonstrate that the principal source of CB1-Rs in dorsolateral striosomes is local MSN collaterals. These data suggest a role for CB1-Rs in caudal dorsolateral striosome collaterals and striosome-dendron bouquet projections to lateral substantia nigra, where they are anatomically poised to mediate presynaptic disinhibition of both striosomal MSNs and midbrain dopamine neurons in response to endocannabinoids and cannabinomimetics.	[Davis, Margaret I.; Feng, Austin Y.; Kupferschmidt, David A.; Lovinger, David M.] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA; [Crittenden, Jill R.; Graybiel, Ann M.] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Naydenov, Alipi; Stella, Nephi] Univ Washington, Sch Med, Lab Brain Immunol, Seattle, WA USA; [Feng, Austin Y.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; Stanford University	Davis, MI (corresponding author), NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA.	midavis@mail.nih.gov	Crittenden, Jill/V-5490-2019	Crittenden, Jill/0000-0002-1981-1917; Graybiel, Ann/0000-0002-4326-7720; Davis, Margaret/0000-0002-0489-8351	Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health; CHDI Foundation [A5552]; Saks-Kavanaugh Foundation; National Institute of Mental Health [R01 MH060379]; William N. and Bernice E. Bumpus Foundation Innovation Award [2017.1.1]; Rapid Response Discovery Award RRDA Pilot [2013.1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000407] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD012210] Funding Source: NIH RePORTER	Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health; CHDI Foundation; Saks-Kavanaugh Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); William N. and Bernice E. Bumpus Foundation Innovation Award; Rapid Response Discovery Award RRDA Pilot; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health; CHDI Foundation Grant #A5552 http://chdifoundation.org/; Saks-Kavanaugh Foundation; National Institute of Mental Health R01 MH060379 Dr. Ann M. Graybiel; William N. and Bernice E. Bumpus Foundation Innovation Award 2017.1.1 Dr. Jill R. Crittenden; William N. and Bernice E. Bumpus Foundation Innovation Award 2017.1.1 Dr. Ann M. Graybiel; Rapid Response Discovery Award RRDA Pilot:2013.1 Dr. Ann M. Graybiel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade KK, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00032; Adermark L, 2009, EUR J NEUROSCI, V29, P32, DOI 10.1111/j.1460-9568.2008.06551.x; Amemori KI, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00047; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Banghart MR, 2015, NEURON, V88, P1227, DOI 10.1016/j.neuron.2015.11.010; Biezonski DK, 2015, J COMP NEUROL, V523, P1175, DOI 10.1002/cne.23730; Blume LC, 2013, J NEUROCHEM, V124, P808, DOI 10.1111/jnc.12139; Brimblecombe KR, 2015, J NEUROSCI, V35, P9017, DOI 10.1523/JNEUROSCI.0870-15.2015; Bubser M, 2002, EUR J NEUROSCI, V15, P713, DOI 10.1046/j.1460-9568.2002.01903.x; Canales JJ, 2000, ANN NEUROL, V47, pS53; Cazorla M, 2014, NEURON, V81, P153, DOI 10.1016/j.neuron.2013.10.041; CHARUCHINDA C, 1987, J NEUROSCI, V7, P1352; Corbille AG, 2007, J NEUROSCI, V27, P6937, DOI 10.1523/JNEUROSCI.3936-06.2007; Covey DP, 2017, NEUROPHARMACOLOGY, V124, P52, DOI 10.1016/j.neuropharm.2017.04.033; Crittenden JR, 2016, P NATL ACAD SCI USA, V113, P11318, DOI 10.1073/pnas.1613337113; Crittenden JR, 2017, HDB BASAL GANGLIA ST, P783; Cui YJ, 2014, NAT NEUROSCI, V17, P254, DOI 10.1038/nn.3622; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Davis MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027434; EBLEN F, 1995, J NEUROSCI, V15, P5999; Friedman A, 2017, CELL, V171, P1191, DOI 10.1016/j.cell.2017.10.017; Friedman A, 2015, CELL, V161, P1320, DOI 10.1016/j.cell.2015.04.049; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00124; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00022; GERFEN CR, 1985, J COMP NEUROL, V236, P454, DOI 10.1002/cne.902360404; GERFEN CR, 1984, NATURE, V311, P461, DOI 10.1038/311461a0; Gokce O, 2016, CELL REP, V16, P1126, DOI 10.1016/j.celrep.2016.06.059; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gonzalez B, 2009, J PHARMACOL EXP THER, V328, P822, DOI 10.1124/jpet.108.145425; Gorski JA, 2002, J NEUROSCI, V22, P6309; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Gremel CM, 2016, NEURON, V90, P1312, DOI 10.1016/j.neuron.2016.04.043; Grimsey NL, 2008, J NEUROSCI METH, V171, P78, DOI 10.1016/j.jneumeth.2008.02.014; Gutierrez-Rodriguez A, 2017, J COMP NEUROL, V525, P302, DOI 10.1002/cne.24066; HABER SN, 1985, J COMP NEUROL, V235, P322, DOI 10.1002/cne.902350304; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Hoffman A.F., 2013, COLD SPRING HARB PER, V3, DOI [10.1101/cshperspect.a012237, DOI 10.1101/CSHPERSPECT.A012237]; Hohmann AG, 2000, SYNAPSE, V37, P71, DOI 10.1002/(SICI)1098-2396(200007)37:1<71::AID-SYN8>3.3.CO;2-B; Horne EA, 2013, EUR J NEUROSCI, V37, P429, DOI 10.1111/ejn.12045; Houchi H, 2005, NEUROPSYCHOPHARMACOL, V30, P339, DOI 10.1038/sj.npp.1300568; Hu SSJ, 2015, HANDB EXP PHARMACOL, V231, P59, DOI 10.1007/978-3-319-20825-1_3; Jedynak JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034227; Julian MD, 2003, NEUROSCIENCE, V119, P309, DOI 10.1016/S0306-4522(03)00070-8; Kearn CS, 2005, MOL PHARMACOL, V67, P1697, DOI 10.1124/mol.104.006882; KENNEDY RT, 1992, J NEUROCHEM, V59, P449, DOI 10.1111/j.1471-4159.1992.tb09391.x; Kincaid AE, 1996, J COMP NEUROL, V374, P578; Kupferschmidt DA, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00006; Lalchandani RR, 2013, J NEUROSCI, V33, P14075, DOI 10.1523/JNEUROSCI.0692-13.2013; LANGER LF, 1989, BRAIN RES, V498, P344, DOI 10.1016/0006-8993(89)91114-1; Lee CR, 2009, J NEURAL TRANSM-SUPP, P71, DOI 10.1007/978-3-211-92660-4_6; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Lovinger DM, 2010, HBK BEHAV NEUROSCI, V20, P167; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Martin AB, 2008, NEUROPSYCHOPHARMACOL, V33, P1667, DOI 10.1038/sj.npp.1301558; Mateo Y, 2017, NEURON, V95, P1; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Matyas F, 2006, NEUROSCIENCE, V137, P337, DOI 10.1016/j.neuroscience.2005.09.005; Miura M, 2008, MOL NEUROBIOL, V37, P104, DOI 10.1007/s12035-008-8023-2; Morozov YM, 2013, EUR J NEUROSCI, V38, P2341, DOI 10.1111/ejn.12237; Mulder J, 2008, P NATL ACAD SCI USA, V105, P8760, DOI 10.1073/pnas.0803545105; Munoz-Arenas G, 2015, SYNAPSE, V69, P103, DOI 10.1002/syn.21796; Murray RC, 2014, BRAIN STRUCT FUNCT, V219, P1213, DOI 10.1007/s00429-013-0559-x; Naydenov AV, 2014, NEUROBIOL DIS, V71, P140, DOI 10.1016/j.nbd.2014.08.009; Ophuis RJAO, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00014; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Prensa L, 2001, J NEUROSCI, V21, P7247, DOI 10.1523/JNEUROSCI.21-18-07247.2001; Saka E, 2004, J NEUROSCI, V24, P7557, DOI 10.1523/JNEUROSCI.1072-04.2004; Sales-Carbonell C, 2013, P NATL ACAD SCI USA, V110, P719, DOI 10.1073/pnas.1217144110; Salinas AG, 2016, NEUROPHARMACOLOGY, V108, P275, DOI 10.1016/j.neuropharm.2016.03.049; Sgobio C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05598-1; Smith JB, 2016, NEURON, V91, P1069, DOI 10.1016/j.neuron.2016.07.046; Tajima K, 2013, NEUROSCIENCE, V241, P215, DOI 10.1016/j.neuroscience.2013.03.012; Taverna S, 2008, J NEUROSCI, V28, P5504, DOI 10.1523/JNEUROSCI.5493-07.2008; Thanos PK, 2011, ALCOHOL CLIN EXP RES, V35, P19, DOI 10.1111/j.1530-0277.2010.01318.x; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Valjent E, 2001, EUR J NEUROSCI, V14, P342, DOI 10.1046/j.0953-816x.2001.01652.x; Van Waes V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00021; VANDERWEIDE J, 1987, NEUROSCI LETT, V83, P259, DOI 10.1016/0304-3940(87)90096-6; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Winters BD, 2012, P NATL ACAD SCI USA, V109, pE2717, DOI 10.1073/pnas.1206303109; Wouterlood FG, 2012, J COMP NEUROL, V520, P2123, DOI 10.1002/cne.23031; Wu CS, 2010, EUR J NEUROSCI, V32, P693, DOI 10.1111/j.1460-9568.2010.07337.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	89	41	41	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0191436	10.1371/journal.pone.0191436	http://dx.doi.org/10.1371/journal.pone.0191436			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466446	Green Submitted, gold, Green Published			2022-12-26	WOS:000425604300010
J	Howard, BH; Hirai, TH; Russanova, VR				Howard, Bruce H.; Hirai, Tazuko H.; Russanova, Valya R.			Epigenome comparisons reveal linkage between gene expression and postnatal remodeling of chromatin domain topology	PLOS ONE			English	Article							AGE-RELATED-CHANGES; DNA-METHYLATION; STEM-CELLS; EPIGENETIC REGULATION; SENESCENCE; GENOME; RNA; ORGANIZATION; LANDSCAPE; A/C	Substantial evidence has accumulated linking epigenome change to alterations in stem cell function during postnatal development and aging. Yet much remains to be learned about causal relationships, and large gaps remain in our understanding of epigenome-transcriptome interactions. Here we investigate structural features of large histone H3K27me3-enriched regions in human stem cell-like monocytes and their dendritic cell derivatives, where the H3K27me3 modification is considered to demarcate Polycomb (PcG) domains. Both differentiation-and postnatal development-related change are explored, initially by confirming expected reciprocal relationships between transcript abundance and span of PcG domains overlapping transcribed regions. PcG-associated postnatal transcriptome change specific to the stem cell-like monocytes is found to be incompletely explained by conventional measures of PcG region structure. To address this, we introduce algorithms that quantify local nucleosome-scale conservation of PcG-region topology. It is shown that topology-based comparisons can reveal broad statistical linkage between postnatal gene down-regulation and epigenome remodeling; further, such comparisons provide access to a previously unexplored dimension of epigenome architecture.	[Howard, Bruce H.; Hirai, Tazuko H.; Russanova, Valya R.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Dev Biol, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Howard, BH (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Dev Biol, NIH, Bethesda, MD USA.	howard@helix.nih.gov			Intramural Research Program, Eunice Kennedy Shriver National Institute for Child Health and Human Development, National Institutes of Health	Intramural Research Program, Eunice Kennedy Shriver National Institute for Child Health and Human Development, National Institutes of Health	This work was supported by the Intramural Research Program, Eunice Kennedy Shriver National Institute for Child Health and Human Development, National Institutes of Health.	Alvarado S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00088; Barbier E, 2015, J NEUROSCI, V35, P6153, DOI 10.1523/JNEUROSCI.4571-14.2015; Bauer M, 2016, CHROMOSOMA, V125, P471, DOI 10.1007/s00412-015-0539-4; Beerman I, 2015, CELL STEM CELL, V16, P613, DOI 10.1016/j.stem.2015.05.009; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Beltran M, 2016, GENOME RES, V26, P896, DOI 10.1101/gr.197632.115; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Booth LN, 2016, MOL CELL, V62, P728, DOI 10.1016/j.molcel.2016.05.013; Criscione SW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500882; Dekker J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019356; Denker A, 2016, GENE DEV, V30, P1357, DOI 10.1101/gad.281964.116; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fernandez AF, 2015, GENOME RES, V25, P27, DOI 10.1101/gr.169011.113; Finkielstain GP, 2009, ENDOCRINOLOGY, V150, P1791, DOI 10.1210/en.2008-0868; Goodell MA, 2015, SCIENCE, V350, P1199, DOI 10.1126/science.aab3388; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Howard BH, 1996, EXP GERONTOL, V31, P281, DOI 10.1016/0531-5565(95)00022-4; Isoda T, 2017, CELL, V171, P103, DOI 10.1016/j.cell.2017.09.001; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lui JLC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086957; MACIEIRACOELHO A, 1991, MUTAT RES, V256, P81, DOI 10.1016/0921-8734(91)90003-T; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Marullo F, 2016, NUCLEUS-PHILA, V7, P103, DOI 10.1080/19491034.2016.1157675; McCord RP, 2013, GENOME RES, V23, P260, DOI 10.1101/gr.138032.112; Pollina EA, 2011, ONCOGENE, V30, P3105, DOI 10.1038/onc.2011.45; Porras A, 2008, MOL IMMUNOL, V46, P27, DOI 10.1016/j.molimm.2008.06.030; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Ray MK, 2016, J BIOL CHEM, V291, P19558, DOI 10.1074/jbc.M116.730853; Salpea P, 2012, NUCLEIC ACIDS RES, V40, P6477, DOI 10.1093/nar/gks312; Schmitt AM, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026492; Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Simpkin AJ, 2015, HUM MOL GENET, V24, P3752, DOI 10.1093/hmg/ddv119; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Teschendorff AE, 2013, HUM MOL GENET, V22, pR7, DOI 10.1093/hmg/ddt375; Vierstra J, 2016, NAT METHODS, V13, P213, DOI 10.1038/nmeth.3768; Wang XY, 2017, MOL CELL, V65, P1056, DOI 10.1016/j.molcel.2017.02.003; Yasuhara JC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040016; Yu B, 2015, ONCOTARGET, V6, P3627, DOI 10.18632/oncotarget.2875	45	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0191033	10.1371/journal.pone.0191033	http://dx.doi.org/10.1371/journal.pone.0191033			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466355	Green Submitted, Green Published, gold			2022-12-26	WOS:000425604300007
J	Russell, MP; Gibbs, VK; Duwan, E				Russell, Michael P.; Gibbs, Victoria K.; Duwan, Emily			Bioerosion by pit-forming, temperate-reef sea urchins: History, rates and broader implications	PLOS ONE			English	Article							STRONGYLOCENTROTUS-PURPURATUS; EASTERN CANADA; WEST-COAST; MOVEMENT; DROEBACHIENSIS; SIZE; OTTERS	Sea urchins are dominant members of rocky temperate reefs around the world. They often occur in cavities within the rock, and fit so tightly, it is natural to assume they sculpted these "pits." However, there are no experimental data demonstrating they bore pits. If they do, what are the rates and consequences of bioerosion to nearshore systems? We sampled purple sea urchins, Strongylocentrotus purpuratus, from sites with four rock types, three sedimentary (two sandstones and one mudstone) and one metamorphic (granite). A yearlong experiment showed urchins excavated depressions on sedimentary rocks in just months. The rate of pit formation varied with rock type and ranged from <5 yr for medium-grain sandstone to >100 yr for granite. In the field, there were differences in pit size and shapes of the urchins (height: diameter ratio). The pits were shallow and urchins flatter at the granite site, and the pits were deeper and urchins taller at the sedimentary sites. Although overall pit sizes were larger on mudstone than on sandstone, urchin size accounted for this difference. A second, short-term experiment, showed the primary mechanism for bioerosion was ingestion of the substratum. This experiment eliminated potential confounding factors of the year-long experiment and yielded higher bioerosion rates. Given the high densities of urchins, large amounts of rock can be converted to sediment over short time periods. Urchins on sandstone can excavate as much as 11.4 kg m(-2) yr(-1). On a broader geographic scale, sediment production can exceed 100 t ha(-1) yr(-1), and across their range, their combined bioerosion is comparable to the sediment load of many rivers. The phase shift between urchin barrens and kelp bed habitats in the North Pacific is controlled by the trophic cascade of sea otters. By limiting urchin populations, these apex predators also may indirectly control a substantial component of coastal rates of bioerosion.	[Russell, Michael P.; Gibbs, Victoria K.; Duwan, Emily] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Gibbs, Victoria K.] Birmingham Southern Coll, Dept Biol, Birmingham, AL USA; [Duwan, Emily] Northeastern Univ, Univ Marine Sci Ctr, Nahant, MA USA	Villanova University; Northeastern University	Russell, MP (corresponding author), Villanova Univ, Dept Biol, Villanova, PA 19085 USA.	michael.russell@villanova.edu			MPR - Villanova University; National Science Foundation [NSF OCE-0623934]; US Department of Agriculture [USDA/NRI 2003-35206-12844]; VKG - Villanova University; Villanova; US National Science Foundation (NSF); US Department of Agriculture (USDA)	MPR - Villanova University; National Science Foundation(National Science Foundation (NSF)); US Department of Agriculture(United States Department of Agriculture (USDA)); VKG - Villanova University; Villanova; US National Science Foundation (NSF)(National Science Foundation (NSF)); US Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	This work received support from the following sources: MPR - Villanova University; National Science Foundation (NSF OCE-0623934); US Department of Agriculture (USDA/NRI 2003-35206-12844), www.villanova.edu, www.nsf.gov, www.usda.gov; VKG - Villanova University, www.villanova.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Villanova supported this work through a postdoctoral fellowship for VKG. Students in the MPR lab assisted with maintenance of the experiment and data collection; JC Russell assisted in the field. D. Barber provided interpretations of site geology and descriptions of rock samples, M. Damian provided the MATLAB code for Delaunay triangulation, D. Miller assisted with R-code, R. Bowles furnished library assistance, K. Scott provided access to the muffle furnace, E. Wagner helped with GIS calculations and V. Pearse coined the term "legacy pits." Gougeon Brothers Inc. discounted the cost of epoxy resin, and costs of some lab and field supplies were offset by grants from the US National Science Foundation (NSF) and US Department of Agriculture (USDA). T. A. Ebert, J. C. Hernandez, and J Sones assisted with size and urchin counts from the SI Table. A. Langley, J. Pawlik, and P. Petraitis provided critical comments on an earlier version of the manuscript.	[Anonymous], 2013, MATLAB DEL TRI; BELLWOOD DR, 1995, MAR BIOL, V121, P419, DOI 10.1007/BF00349451; Bennett ET, 1827, T LINNEAN  SOC NEW Y, V15, P74; Bruggemann JH, 1996, MAR ECOL PROG SER, V134, P59, DOI 10.3354/meps134059; Cailliaud F., 1856, REV MAG ZOOL, V82, P158; Cailliaud F., 1857, REV MAG ZOOL, V9, P391; Clark JC, 1997, 97456 US GEOL SURV; Clemente S, 2013, MAR BIOL, V160, P579, DOI 10.1007/s00227-012-2114-3; Davidson TM, 2015, MAR ECOL-EVOL PERSP, V36, P185, DOI 10.1111/maec.12134; Deshayes GP, 1855, B SOC GEOL FR 2, V13, P46; DUGGINS DO, 1980, ECOLOGY, V61, P447, DOI 10.2307/1937405; Dumont C, 2004, MAR ECOL PROG SER, V276, P93, DOI 10.3354/meps276093; Dumont CP, 2006, MAR ECOL PROG SER, V317, P87, DOI 10.3354/meps317087; Ebert TA, 2012, MAR ECOL PROG SER, V467, P147, DOI 10.3354/meps09960; Ebert T.A., 2013, ECOLOGY, V94, P2109, DOI [10.1890/13-0127.1, DOI 10.1890/13-0127.1]; EBERT TA, 1988, LIMNOL OCEANOGR, V33, P286, DOI 10.4319/lo.1988.33.2.0286; Ebert TA, 2010, MAR ECOL PROG SER, V406, P105, DOI 10.3354/meps08547; Elliott LF, 2013, ECHINODERMS IN A CHANGING WORLD, P105; Estes J.A., 2016, SERENDIPITY ECOLOGIS; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Estes JA, 1998, SCIENCE; Fewkes J. W., 1890, AM NAT, V24, P1; FRANK PW, 1981, AM NAT, V118, P288, DOI 10.1086/283821; Gravem SA, 2012, MAR BIOL, V159, P2839, DOI 10.1007/s00227-012-2045-z; Harding APC, 2015, J EXP MAR BIOL ECOL, V466, P59, DOI 10.1016/j.jembe.2015.02.005; Harrold C., 1987, Echinoderm Studies, V2, P137; Hernandez JC, 2010, J EXP BIOL, V213, P520, DOI 10.1242/jeb.029959; Hesse M., 1867, ANN SCI NAT PARIS, V3, P257; HIMMELMAN JH, 1983, OECOLOGIA, V59, P27, DOI 10.1007/BF00388068; HOLLAND ND, 1965, J EXP ZOOL, V158, P275, DOI 10.1002/jez.1401580304; Hoseinie SH, 2012, ARAB J SCI ENG, V37, P1451, DOI 10.1007/s13369-012-0247-9; Jacinto D, 2012, ZOOSYMPOSIA, V7, P231, DOI 10.11646/zoosymposia.7.1.21; John G., 1889, ARCH NATURGESCH, V55, P268; Jurgens LJ, 2015, PLOS ONE, V10; Kawamata S, 1998, J EXP MAR BIOL ECOL, V224, P31, DOI 10.1016/S0022-0981(97)00165-2; Killian CE, 2011, ADV FUNCT MATER, V21, P682, DOI 10.1002/adfm.201001546; Lauzon-Guay JS, 2006, J MAR BIOL ASSOC UK, V86, P167, DOI 10.1017/S0025315406012999; Lawrence J.M., 1975, Oceanography mar Biol, V13, P213; Lowe DR, 1979, USGS FIELD TRIP GUID; MATTISON JE, 1977, MAR BIOL, V39, P25, DOI 10.1007/BF00395589; Milliman J.D., 2011, RIVER DISCHARGE COAS, DOI 10.1017/CBO9780511781247; NOAA, 2015, HIER HIGH RES GEOGR; Ogden J., 1977, STUDIES GEOLOGY, V4, P281; Otter GW, 1932, BIOL REV BIOL P CAMB, V7, P89; PAINE RT, 1980, J ANIM ECOL, V49, P667; Pearse J. E., 2007, LIGHT SMITH MANUAL I, P914; R Core Team, 2013, LANG ENV STAT COMP; Ricketts EF, 1939, PACIFIC TIDES, P320; Robert VE, 1854, CR HEBD ACAD SCI, V34, P639; Romanes J, 1912, P CAMB PHILOS SOC, V16, P121; ROSS DC, 1983, GEOL SOC AM MEM, V159, P255; SCOFFIN TP, 1980, B MAR SCI, V30, P475; Steneck RS, 2013, DEV AQUAC FISH SCI, V38, P195, DOI 10.1016/B978-0-12-396491-5.00014-9; Stock SR, 2014, CONNECT TISSUE RES, V55, P41, DOI 10.3109/03008207.2013.867338; Trevelyan WC, 1849, EDINGBURGH NEW PHIL, V46, P386; Valenciennes M., 1854, ACAD SCI PARIS, V39, P640; Zhao C, 2013, MAR FRESHW BEHAV PHY, V45, P357, DOI 10.1080/10236244.2013.763456	57	13	13	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0191278	10.1371/journal.pone.0191278	http://dx.doi.org/10.1371/journal.pone.0191278			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466357	gold, Green Published, Green Submitted			2022-12-26	WOS:000425604300008
J	Starace, F; Mungai, F; Barbui, C				Starace, Fabrizio; Mungai, Francesco; Barbui, Corrado			Does mental health staffing level affect antipsychotic prescribing? Analysis of Italian national statistics	PLOS ONE			English	Article								Introduction In mental healthcare, one area of major concern identified by health information systems is variability in antipsychotic prescribing. While most studies have investigated patient-and prescriber-related factors as possible reasons for such variability, no studies have investigated facility-level characteristics. The present study ascertained whether staffing level is associated with antipsychotic prescribing in community mental healthcare. Methods A cross-sectional analysis of data extracted from the Italian national mental health information system was carried out. For each Italian region, it collects data on the availability and use of mental health facilities. The rate of individuals exposed to antipsychotic drugs was tested for evidence of association with the rate of mental health staff availability by means of univariate and multivariate analyses. Results In Italy there were on average nearly 60 mental health professionals per 100,000 inhabitants, with wide regional variations (range 21 to 100). The average rate of individuals prescribed antipsychotic drugs was 2.33%, with wide regional variations (1.04% to 4.01%). Univariate analysis showed that the rate of individuals prescribed antipsychotic drugs was inversely associated with the rate of mental health professionals available in Italian regions (Kendall's tau -0.438, p = 0.006), with lower rates of antipsychotic prescriptions in regions with higher rates of mental health professionals. After adjustment for possible confounders, the total availability of mental health professionals was still inversely associated with the rate of individuals exposed to antipsychotic drugs. Discussion The evidence that staffing level was inversely associated with antipsychotic prescribing indicates that any actions aimed at decreasing variability in antipsychotic prescribing need to take into account aspects related to the organization of the mental health system.	[Starace, Fabrizio; Mungai, Francesco] AUSL Modena, Dept Mental Hlth & Drug Abuse, Modena, Italy; [Barbui, Corrado] Univ Verona, Dept Neurosci Biomed & Movement Sci, WHO Collaborating Ctr Res & Training Mental Hlth, Sect Psychiat, Verona, Italy	University of Verona	Barbui, C (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, WHO Collaborating Ctr Res & Training Mental Hlth, Sect Psychiat, Verona, Italy.	corrado.barbui@univr.it		barbui, corrado/0000-0003-1073-9282				Barbui C, 2017, EPIDEMIOL P IN PRESS; Cioltan H, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0428-1; Drake R, 2008, AM J PSYCHIAT, V165, P1385, DOI 10.1176/appi.ajp.2008.08030334; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Horvitz-Lennon M, 2009, HEALTH AFFAIR, V28, P701, DOI 10.1377/hlthaff.28.3.701; Lora A, 2017, EPIDEMIOL P IN PRESS; Lora A, 2017, EPIDEMIOL PSYCHIAT S, V26, P481; Mattingly TJ, 2015, NEUROL THER, V4, P169, DOI 10.1007/s40120-015-0032-2; Ministero della Salute, 2015, RAPP SAL MENT ANN 20; WHO, 2011, COUNTR HLTH INF SYST; World Health Organization CGF, 2017, IMPR ACC APPR US MED	11	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193216	10.1371/journal.pone.0193216	http://dx.doi.org/10.1371/journal.pone.0193216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	29466422	gold, Green Submitted, Green Published			2022-12-26	WOS:000425604300097
J	Zhang, DZ; Wang, X; Li, SY; Ni, N; Zhang, Z				Zhang, Dezhi; Wang, Xin; Li, Shuangyan; Ni, Nan; Zhang, Zhuo			Joint optimization of green vehicle scheduling and routing problem with time-varying speeds	PLOS ONE			English	Article							LARGE-NEIGHBORHOOD SEARCH; CO2 EMISSIONS; TRAVEL-TIMES; LOGISTICS; ALGORITHM; NETWORK; WINDOWS; PATH	Based on an analysis of the congestion effect and changes in the speed of vehicle flow during morning and evening peaks in a large-or medium-sized city, the piecewise function is used to capture the rules of the time-varying speed of vehicles, which are very important in modelling their fuel consumption and CO2 emission. A joint optimization model of the green vehicle scheduling and routing problem with time-varying speeds is presented in this study. Extra wages during nonworking periods and soft time-window constraints are considered. A heuristic algorithm based on the adaptive large neighborhood search algorithm is also presented. Finally, a numerical simulation example is provided to illustrate the optimization model and its algorithm. Results show that, (1) the shortest route is not necessarily the route that consumes the least energy, (2) the departure time influences the vehicle fuel consumption and CO2 emissions and the optimal departure time saves on fuel consumption and reduces CO2 emissions by up to 5.4%, and (3) extra driver wages have significant effects on routing and departure time slot decisions.	[Zhang, Dezhi; Wang, Xin; Ni, Nan; Zhang, Zhuo] Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China; [Zhang, Dezhi] Natl & Local Joint Engn Res Ctr Safety Technol Ra, Changsha, Hunan, Peoples R China; [Wang, Xin] Cent S Univ, Minist Educ, Key Lab Traff Safety Track, Changsha, Hunan, Peoples R China; [Li, Shuangyan] Cent South Univ Forestry & Technol, Sch Logist & Transportat, Changsha, Hunan, Peoples R China; [Ni, Nan] Joint Int Res Lab Key Technol Rail Traff Safety, Changsha, Hunan, Peoples R China; [Zhang, Zhuo] Smart Transport Key Lab Hunan Prov, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University of Forestry & Technology	Li, SY (corresponding author), Cent South Univ Forestry & Technol, Sch Logist & Transportat, Changsha, Hunan, Peoples R China.	lishuangyan585@163.com			Central South University Teacher Research Fund [2015JSJJ001]; Hunan Province Science and Technology Development Funds [2015RS4045]; Hunan Provincial Department of Education [15B261]; National Natural Science Foundation of China [71672193]	Central South University Teacher Research Fund; Hunan Province Science and Technology Development Funds; Hunan Provincial Department of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work that is described in this paper was supported by Central South University Teacher Research Fund (NO. 2015JSJJ001, DZZ receives funding), Hunan Province Science and Technology Development Funds (NO. 2015RS4045, SYL receives funding), Excellent youth project of Hunan Provincial Department of Education (NO.15B261, SYL receives funding) and National Natural Science Foundation of China (NO. 71672193, DZZ receives funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work that is described in this paper was supported by Central South University Teacher Research Fund (NO. 2015JSJJ001, DZZ receives funding), Hunan Province Science and Technology Development Funds (NO. 2015RS4045, SYL receives funding), Excellent youth project of Hunan Provincial Department of Education (NO.15B261, SYL receives funding) and National Natural Science Foundation of China (NO. 71672193, DZZ receives funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank of China (BOC), 2017, BANK CHIN EXCH RAT; Barth M, 2008, TRANSPORT RES REC, P163, DOI 10.3141/2058-20; Bektas T, 2011, TRANSPORT RES B-METH, V45, P1232, DOI 10.1016/j.trb.2011.02.004; Breunig U, 2016, COMPUT OPER RES, V76, P208, DOI 10.1016/j.cor.2016.06.014; Carling K, 2017, TRANSPORT RES A-POL, V97, P47, DOI 10.1016/j.tra.2017.01.010; Chen ZM, 2015, APPL ENERG, V156, P16, DOI 10.1016/j.apenergy.2015.06.066; China Federation of Logistics & Purchasing, 2014, WHY IS LOG COST CHIN; DANTZIG GB, 1959, MANAGE SCI, V6, P80, DOI 10.1287/mnsc.6.1.80; Dayarian I, 2016, TRANSPORT RES E-LOG, V95, P95, DOI 10.1016/j.tre.2016.09.004; Dekker R, 2012, EUR J OPER RES, V219, P671, DOI 10.1016/j.ejor.2011.11.010; Demir E, 2012, EUR J OPER RES, V223, P346, DOI 10.1016/j.ejor.2012.06.044; Department of Traffic of Changsha, 2014, ANN REP CHANGSH TRAF; Department of Traffic of Changsha, 2013, ANN REP CHANGSH TRAF; Dernir E, 2014, EUR J OPER RES, V237, P775, DOI 10.1016/j.ejor.2013.12.033; Drexl Michael, 2012, Logistics Research, V5, P47, DOI 10.1007/s12159-012-0080-2; Eglese R, 2006, COMPUT OPER RES, V33, P3508, DOI 10.1016/j.cor.2005.03.029; Ehmke JF, 2016, EUR J OPER RES, V251, P478, DOI 10.1016/j.ejor.2015.11.034; Figliozzi MA, 2012, TRANSPORT RES E-LOG, V48, P616, DOI 10.1016/j.tre.2011.11.006; Figliozzi MA, 2011, TRANSPORT RES C-EMER, V19, P766, DOI 10.1016/j.trc.2010.11.002; Franceschetti A, 2013, TRANSPORT RES B-METH, V56, P265, DOI 10.1016/j.trb.2013.08.008; Grangier P, 2016, EUR J OPER RES, V254, P80, DOI 10.1016/j.ejor.2016.03.040; Huang YX, 2017, TRANSPORT RES B-METH, V95, P169, DOI 10.1016/j.trb.2016.10.013; Ichoua S, 2003, EUR J OPER RES, V144, P379, DOI 10.1016/S0377-2217(02)00147-9; Jabali O, 2012, PROD OPER MANAG, V21, P1060, DOI 10.1111/j.1937-5956.2012.01338.x; Kara BY, 2007, ENERGY MINIMIZING VE; Kwon YJ, 2013, TRANSPORT RES D-TR E, V23, P81, DOI 10.1016/j.trd.2013.04.001; Lorini S, 2011, COMPUT OPER RES, V38, P1086, DOI 10.1016/j.cor.2010.10.019; Luo ZX, 2016, TRANSPORT RES E-LOG, V85, P69, DOI 10.1016/j.tre.2015.11.004; Lysgaard J, 2014, EUR J OPER RES, V236, P800, DOI 10.1016/j.ejor.2013.08.032; Maden W, 2010, J OPER RES SOC, V61, P515, DOI 10.1057/jors.2009.116; McKinnon A, 2010, LOGFORUM, V6; Palmer A., 2007, DEV INTEGRATED ROUTI, P1; Pisinger D, 2007, COMPUT OPER RES, V34, P2403, DOI 10.1016/j.cor.2005.09.012; Pradenas L, 2013, EXPERT SYST APPL, V40, P2985, DOI 10.1016/j.eswa.2012.12.014; Qian J, 2016, EUR J OPER RES, V248, P840, DOI 10.1016/j.ejor.2015.09.009; Ropke S, 2006, TRANSPORT SCI, V40, P455, DOI 10.1287/trsc.1050.0135; Sahin B, 2009, EUR J OPER RES, V193, P1, DOI 10.1016/j.ejor.2007.10.030; Sze JF, 2017, TRANSPORT RES B-METH, V101, P162, DOI 10.1016/j.trb.2017.04.003; Tas D, 2014, TRANSPORT RES C-EMER, V48, P66, DOI 10.1016/j.trc.2014.08.007; Van Woensel T, 2008, EUR J OPER RES, V186, P990, DOI 10.1016/j.ejor.2007.03.012; Wang Y, 2017, APPL SOFT COMPUT, V56, P143, DOI 10.1016/j.asoc.2017.02.025; Wang Y, 2014, EXPERT SYST APPL, V41, P521, DOI 10.1016/j.eswa.2013.07.078; Wen L, 2015, COMPUT OPER RES, V56, P41, DOI 10.1016/j.cor.2014.10.007; Wen L, 2014, EUR J OPER RES, V236, P915, DOI 10.1016/j.ejor.2013.10.044; Xiao YY, 2017, J CLEAN PROD, V167, P1450, DOI 10.1016/j.jclepro.2016.11.115; Xiao YY, 2016, TRANSPORT RES E-LOG, V88, P146, DOI 10.1016/j.tre.2016.01.011; Zare-Reisabadi E, 2015, COMPUT IND ENG, V90, P177, DOI 10.1016/j.cie.2015.09.002; Zhang DZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185001; Zhang DZ, 2017, J ADV TRANSPORT, DOI 10.1155/2017/6350562; Zhu XY, 2014, J CLEAN PROD, V85, P331, DOI 10.1016/j.jclepro.2013.10.036	50	30	30	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192000	10.1371/journal.pone.0192000	http://dx.doi.org/10.1371/journal.pone.0192000			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	29466370	gold, Green Published, Green Submitted			2022-12-26	WOS:000425604300023
J	Hassan, F; Lossie, SL; Kasik, EP; Channon, AM; Ni, SS; Kennedy, MA				Hassan, Faizule; Lossie, Sarah L.; Kasik, Ellen P.; Channon, Audrey M.; Ni, Shuisong; Kennedy, Michael A.			A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy	PLOS ONE			English	Article							GENE-THERAPY; IMMUNE-RESPONSES; LIVER TOXICITY; TPA STEPS; VECTORS; EXPRESSION; PROTEINS; MOBILITY; GEMCITABINE; ACTIVATION	The HGMA1 architectural transcription factor is highly overexpressed in many human cancers. Because HMGA1 is a hub for regulation of many oncogenes, its overexpression in cancer plays a central role in cancer progression and therefore HMGA1 is gaining increasing attention as a target for development of therapeutic approaches to suppress either its expression or action in cancer cells. We have developed the strategy of introducing decoy hyper binding sites for HMGA1 into the nucleus of cancer cells with the goal of competetively sequestering overexpressed HMGA1 and thus suppressing its oncogenic action. Towards achieving this goal, we have introduced an HMGA1 decoy hyper binding site composed of six copies of a high affinity HMGA1 binding site into the genome of the replication defective adenovirus serotype 5 genome and shown that the engineered virus effectively reduces the viability of human pancreatic and cancer cells. Here we report the first pre-clinical measures of toxicity and biodistribution of the engineered virus in C57BL/6J Black 6 mice. The immune response to exposure of the engineered virus was determined by assaying the serum levels of key cytokines, IL-6 and TNF-alpha. Toxicity due to exposure to the virus was determined by measuring the serum levels of the liver enzymes aspartate aminotransferase and alanine aminotransferase. Biodistribution was measured following direct injection into the pancreas or liver by quantifying viral loads in the pancreas, liver, spleen and brain.	[Hassan, Faizule; Lossie, Sarah L.; Kasik, Ellen P.; Channon, Audrey M.; Ni, Shuisong; Kennedy, Michael A.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA	University System of Ohio; Miami University	Kennedy, MA (corresponding author), Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA.	kennedm4@miamioh.edu	Kennedy, Michael/ABE-6002-2021; Kennedy, Michael/M-2578-2019	Kennedy, Michael/0000-0001-6462-665X	Miami University	Miami University	This work was supported by internal funding from Miami University including awards to multiple undergraduate students from the Undergraduate Research Award Program and from the Undergraduate Summer Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by internal funding from Miami University including awards to multiple undergraduate students from the Undergraduate Research Award Program and from the Undergraduate Summer Scholars Program. The authors would like to thank Tafadzwa Chihanga, Miami University for providing technical support during animal surgery and sample collection.	Benihoud K, 1999, CURR OPIN BIOTECH, V10, P440, DOI 10.1016/S0958-1669(99)00007-5; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Chen J, 2005, GENE THER, V12, P1079, DOI 10.1038/sj.gt.3302494; Chiappetta G, 1996, ONCOGENE, V13, P2439; Crosby CM, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020079; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Giancotti V, 2016, J MOD HUMAN PHYSL, V1, P899; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; GINSBERG HS, 1991, P NATL ACAD SCI USA, V88, P1651, DOI 10.1073/pnas.88.5.1651; GOODING LR, 1994, INFECT AGENT DIS, V3, P106; Hassan F, 2018, MOL THER ON IN PRESS; Hsich G, 2002, HUM GENE THER, V13, P579, DOI 10.1089/10430340252837198; Hu ZW, 2000, P NATL ACAD SCI USA, V97, P9221, DOI 10.1073/pnas.97.16.9221; Huang D, 2008, GENE THER, V15, P298, DOI 10.1038/sj.gt.3303085; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; JAIN R, 1997, IEEE MULTIMEDIA, V4, P1; KENNEDY MA, 1993, BIOCHEMISTRY-US, V32, P8022, DOI 10.1021/bi00082a025; Koizumi N, 2007, J IMMUNOL, V178, P1767, DOI 10.4049/jimmunol.178.3.1767; Liau SS, 2008, CLIN CANCER RES, V14, P1470, DOI 10.1158/1078-0432.CCR-07-1450; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; Lingbeck J, 1996, BIOCHEMISTRY-US, V35, P719, DOI 10.1021/bi951364k; Liu Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03852-0; McAteer K, 2004, BIOPOLYMERS, V75, P497, DOI 10.1002/bip.20168; McAteer K, 2000, J BIOMOL STRUCT DYN, V17, P1001, DOI 10.1080/07391102.2000.10506588; Michou AI, 1997, GENE THER, V4, P473, DOI 10.1038/sj.gt.3300412; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Pearson S, 2004, NAT BIOTECHNOL, V22, P3, DOI 10.1038/nbt0104-3; Puca F, 2014, ONCOTARGET, V5, P3234, DOI 10.18632/oncotarget.1914; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; SOLOMON MJ, 1986, P NATL ACAD SCI USA, V83, P1276, DOI 10.1073/pnas.83.5.1276; Tang Y, 2007, GENE THER, V14, P523, DOI 10.1038/sj.gt.3302888; Tripathy SK, 1996, NAT MED, V2, P545, DOI 10.1038/nm0596-545; Varnavski AN, 2005, GENE THER, V12, P427, DOI 10.1038/sj.gt.3302347; Wang Y, 2003, MOL CANCER THER, V2, P1233; Watanabe Miki, 2013, Open Biochem J, V7, P73, DOI 10.2174/1874091X01307010073; Watanabe M, 2012, CANCER LETT, V315, P18, DOI 10.1016/j.canlet.2011.10.005; Wold WSM, 2013, CURR GENE THER, V13, P421; Yang YP, 1996, HUM MOL GENET, V5, P1703, DOI 10.1093/hmg/5.11.1703; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; Zhang HG, 2002, J VIROL, V76, P5692, DOI 10.1128/JVI.76.11.5692-5700.2002; Zhang Y, 2001, MOL THER, V3, P697, DOI 10.1006/mthe.2001.0329; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06; Zsengeller Z, 2000, J VIROL, V74, P9655, DOI 10.1128/JVI.74.20.9655-9667.2000	44	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192882	10.1371/journal.pone.0192882	http://dx.doi.org/10.1371/journal.pone.0192882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462157	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200029
J	Vondracek, D; Fuchsova, A; Ahrens, D; Kral, D; Sipek, P				Vondracek, Dominik; Fuchsova, Aneta; Ahrens, Dirk; Kral, David; Sipek, Petr			Phylogeography and DNA-based species delimitation provide insight into the taxonomy of the polymorphic rose chafer Protaetia (Potosia) cuprea species complex (Coleoptera: Scarabaeidae: Cetoniinae) in the Western Palearctic	PLOS ONE			English	Article							COLOR POLYMORPHISM; BEETLE; MORPHOLOGY; BIOLOGY; CHRYSOMELIDAE; SCARABAEOIDEA; TEMPERATURE; IRIDESCENT; EUDICELLA; FABRICIUS	The development of modern methods of species delimitation, unified under the "integrated taxonomy" approach, allows a critical examination and re-evaluation of complex taxonomic groups. The rose chafer Protaetia (Potosia) cuprea is a highly polymorphic species group with a large distribution range. Despite its overall commonness, its taxonomy is unclear and subject to conflicting hypotheses, most of which largely fail to account for its evolutionary history. Based on the sequences of two mitochondrial markers from 65 individuals collected across the species range, and a detailed analysis of morphological characters including a geometric morphometry approach, we infer the evolutionary history and phylogeography of the P. cuprea species complex. Our results demonstrate the existence of three separate lineages in the Western Palearctic region, presumably with a species status. However, these lineages are in conflict with current taxonomic concepts. None of the 29 analyzed morphological characters commonly used in the taxonomy of this group proved to be unambiguously species- or subspecies- specific. The geometric morphometry analysis reveals a large overlap in the shape of the analyzed structures (pronotum, meso-metaventral projection, elytra and aedeagus), failing to identify either the genetically detected clades or the classical species entities. Our results question the monophyly of P. cuprea in regard to P. cuprina, as well as the species status of P. metallica. On the other hand, we found support for the species status of the Sicilian P. hypocrita. Collectively, our findings provide a new and original insight into the taxonomy and phylogeny of the P. cuprea species complex. At the same time, the results represent the first attempt to elucidate the phylogeography of these polymorphic beetles.	[Vondracek, Dominik; Fuchsova, Aneta; Kral, David; Sipek, Petr] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Ahrens, Dirk] Zool Forsch Museum Alexander Koenig, Dept Orthopoda, Bonn, Germany	Charles University Prague; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Vondracek, D (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	dominik.vondracek@gmail.com	Ahrens, Dirk/AAR-1310-2021; Šípek, Petr/M-6920-2017; Král, David/Q-7732-2019	Šípek, Petr/0000-0002-2769-2217; Vondracek, Dominik/0000-0002-3699-9245	Charles University grant [SW 260 434/2017]; Charles University Research Centre program [204069]; Faculty of Science, Charles University	Charles University grant; Charles University Research Centre program; Faculty of Science, Charles University	DV was supported by Charles University grant (SW 260 434/2017), while PS has been supported by Charles University Research Centre program No. 204069. PS and DK were supported by the institutional resource of Faculty of Science, Charles University as well.; We are very thankful to Conrad Gillet, Michael Hadjiconstantis, Jiri Hajek, Oldfich Jahn, Stanislav Jakl, Jean-Philippe Legrand, Petr Malec, Olivier Montreuil, Matthias Seidel, Yann Vasseur and other collectors or breeders for the important material, which was used in this study, and for the possibility to discuss our results with them. Stanislav Jakl also kindly revised the identification of all samples and Aleg Bezdek discussed chosen nomenclatorial problems and supplied inaccessible literature. Robert Angus (Royal Holloway, University of London, United Kingdom) and Marek Romagek kindly revised and corrected the English version of the MS. DV was supported by Charles University grant (SVV 260 434/2017), while PS has been supported by Charles University Research Centre program No. 204069. PS and DK were supported by the institutional resource of Faculty of Science, Charles University as well.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Ahrens D, 2007, MOL PHYLOGENET EVOL, V44, P436, DOI 10.1016/j.ympev.2007.02.024; Ahrens D, 2016, SYST BIOL, V65, P478, DOI 10.1093/sysbio/syw002; Ahrens D, 2013, MOL PHYLOGENET EVOL, V69, P83, DOI 10.1016/j.ympev.2013.05.016; Alexis R., 2001, Cetoniimania, V1, P21; Alexis R., 2000, Cetoniimania, V1, P3; Anonymous, 1973, Proceedings Trans Br ent nat Hist Soc, V6, P43; [Anonymous], 2014, TRACER V1 6; Arrow GJ, 1951, HORNED BEETLES STUDY; Audisio P, 2009, J ZOOL SYST EVOL RES, V47, P88, DOI 10.1111/j.1439-0469.2008.00475.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Balthasar V, 1956, FAUNA CSR; Baraud J., 1992, FAUNE FRANCE, V78, P1, DOI DOI 10.3406/LINLY.1992.11007; Baraud J, 1985, COLEOPTERES SCARABAE; Barraclough TG, 1999, P ROY SOC B-BIOL SCI, V266, P1061, DOI 10.1098/rspb.1999.0744; Bezdek A., 2016, CATALOGUE PALAEARCTI, V3, P367; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Brady P, 2010, AM NAT, V175, P614, DOI 10.1086/651593; BRAKEFIELD PM, 1985, BIOL J LINN SOC, V26, P243, DOI 10.1111/j.1095-8312.1985.tb01635.x; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Compte-Sart A, 2012, B SOC HIST NATURAL B, V56, P59; Cox K, 2013, ZOOKEYS, P105, DOI 10.3897/zookeys.365.5526; Crowson RA, 1981, BIOL COLEOPTERA; Davis ALV, 2008, ECOL ENTOMOL, V33, P771, DOI 10.1111/j.1365-2311.2008.01033.x; Decaens T, 2013, APPL SOIL ECOL, V65, P35, DOI 10.1016/j.apsoil.2013.01.001; Decobert O, 2013, SCARABS, V72, P7; Decobert O, 2011, SCARABS, V61, P1; Di Gennaro Cyril, 2014, Entomologia Africana, V19, P47; Dubey A, 2016, J THERM BIOL, V58, P35, DOI 10.1016/j.jtherbio.2016.03.011; Dutrillaux AM, 2012, CYTOGENET GENOME RES, V136, P208, DOI 10.1159/000336694; Dutrillaux AM, 2008, ANN SOC ENTOMOL FR, V44, P443, DOI 10.1080/00379271.2008.10697579; Favila ME, 2000, COLEOPTS BULL, V54, P541, DOI 10.1649/0010-065X(2000)054[0541:IOARCC]2.0.CO;2; Ghrejyan T, 2017, ZOOTAXA, V4231, P100, DOI 10.11646/zootaxa.4231.1.6; Gotoh H, 2014, COLEOPTS BULL, V68, P209, DOI 10.1649/0010-065X-68.2.209; Gross J, 2004, ENVIRON ENTOMOL, V33, P799, DOI 10.1603/0046-225X-33.4.799; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HENROTTE JG, 1984, CR ACAD SCI III-VIE, V299, P339; Huang JP, 2017, HERCULES BEETLES SUB, V206, P1; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jacobs CT, 2015, ZOOTAXA, V4057, P135, DOI 10.11646/zootaxa.4057.1.9; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kleisner K, 2012, EVOL ECOL, V26, P1025, DOI 10.1007/s10682-011-9537-z; Krajcik M, 1998, CETONIIDAE WORLD C 1; Krajcik M, 2012, ANIMMA 10, V5, P1; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lee GE, 2015, ZOOKEYS, P63, DOI 10.3897/zookeys.501.8658; Leonard P, 2014, ENTOMOLOGIA AFRICANA, V19, P19; Leonard Philippe, 2014, Lambillionea, V114, P211; Maddison WP, 2019, MESQUITE MODULAR SYS; Medvedev SI, 1964, FAUNA SSSR; Michie LJ, 2010, J EVOLUTION BIOL, V23, P1699, DOI 10.1111/j.1420-9101.2010.02043.x; Mico E, 2003, EUR J ENTOMOL, V100, P131, DOI 10.14411/eje.2003.023; Miksic R, 1987, MONOGRAPHIE CETONIIN; Miller SE, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0339; Miraldo A, 2014, SYST ENTOMOL, V39, P531, DOI 10.1111/syen.12079; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nikolajev GV, 1987, SCARABAEOIDEA COLEOP; Papadopoulou A, 2013, ZOOL J LINN SOC-LOND, V168, P473, DOI 10.1111/zoj.12039; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Philips KT, 2016, PSYCHE; Pivotti Igor, 2011, Bulletin of the Entomological Society of Malta, V4, P85; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rataj K, 1998, ZLATOHLAVKOVITI CETO; Richtsmeier JT, 2002, YEARB PHYS ANTHROPOL, V45, P63, DOI 10.1002/ajpa.10174; Rohlf F.J., 1993, CONTRIBUTIONS MORPHO, P131; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1990, SPECIAL PUBLICATION, V2, P167; Rohlf FJ, 2010, TPSRELW VERSION 1 49, P11794; Rohlf FJ, 2009, PSUTIL VERSION 1 44; Rossner Eckehard, 2010, Entomologische Zeitschrift, V120, P147; Seidel M, 2016, ZOOTAXA, V4137, P535, DOI 10.11646/zootaxa.4137.4.5; Sfenthourakis S, 2017, J NAT HIST, V51, P1; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Smetana A., 2006, CATALOGUE PALAEARCTI, V3, P283; Sparacio I, 2009, GIORNALE SCI NATURAL, V33, P157; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tauzin P., 2012, COL OPTERISTE SUPPL, V15, P1; Tauzin Pierre-Hubert, 2015, Lambillionea, V115, P99; Thomas Donald B., 2007, American Entomologist, V53, P224; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; Trizzino M, 2013, SYST ENTOMOL, V38, P192, DOI 10.1111/j.1365-3113.2012.00654.x; VOGLER AP, 1994, MOL BIOL EVOL, V11, P393; Vulinec K, 1997, FLA ENTOMOL, V80, P132, DOI 10.2307/3495550; Wesener T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162284; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Zauli A, 2016, J ZOOL SYST EVOL RES, V54, P206, DOI 10.1111/jzs.12127; Zelditch ML, 2004, GEOMETRIC MORPHOMETR; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	96	15	16	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192349	10.1371/journal.pone.0192349	http://dx.doi.org/10.1371/journal.pone.0192349			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462164	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200014
J	Fayolle, D; Fiore, M; Stano, P; Strazewski, P				Fayolle, Dimitri; Fiore, Michele; Stano, Pasquale; Strazewski, Peter			Rapid purification of giant lipid vesicles by microfiltration	PLOS ONE			English	Article							SMALL UNILAMELLAR VESICLES; SELF-REPRODUCTION; INVERTED EMULSION; LIPOSOMES; MODEL	Giant lipid vesicles (GVs) are emerging models for investigating the properties and reactivity of cell-like microcompartments, providing useful information about plausible protocellular structures in primitive times, as well as for the modern synthetic biology goal of constructing the first artificial cell from its reconstituted and partly modified components. Here we explore a novel methodology of GV purification by microfiltration under reduced pressure, operated by a simple apparatus. The method has been characterized in terms of flow rate, amount of lipid loss, quality of recovered GVs, and size distribution. A case study is reported to show the practicability of GV microfiltration. A clickable fluorescent probe was encapsulated inside GVs; more than 99.9% of the non-entrapped probe was easily and rapidly removed by multiple microfiltrations. This novel methodology is briefly discussed as a future tool for selection experiments on GV populations.	[Fayolle, Dimitri; Fiore, Michele; Strazewski, Peter] Claude Bernard Lyon 1, Univ Lyon, Inst Chim & Biochim Mol & Supramol, Villeurbanne, France; [Stano, Pasquale] Roma Tre Univ, Dept Sci, Rome, Italy; [Stano, Pasquale] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lecce, Italy	Institut National des Sciences Appliquees de Lyon - INSA Lyon; Italfarmaco; Roma Tre University; University of Salento	Strazewski, P (corresponding author), Claude Bernard Lyon 1, Univ Lyon, Inst Chim & Biochim Mol & Supramol, Villeurbanne, France.; Stano, P (corresponding author), Roma Tre Univ, Dept Sci, Rome, Italy.; Stano, P (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lecce, Italy.	pasquale.stano@unisalento.it; strazewski@univ-lyon1.fr	Stano, Pasquale/ABH-1195-2020; Fiore, Michele/X-5049-2019; Stano, Pasquale/AGG-8333-2022	Fiore, Michele/0000-0001-8176-9249; Stano, Pasquale/0000-0002-2228-2825; Fayolle, Dimitri/0000-0002-1543-136X	European COST Action [CM1304, COST-STSM-CM1304-34406]; Volkswagen Foundation [92 850]	European COST Action; Volkswagen Foundation(Volkswagen)	This work was carried out and developed within and thanks to the European COST Action CM1304 "Emergence and Evolution of Complex Chemical Systems" (COST-STSM-CM1304-34406). Co-funding from the Volkswagen Foundation (grant no. 92 850) is gratefully acknowledged.; This work was carried out and developed within and thanks to the European COST Action CM1304 Emergence and Evolution of Complex Chemical Systems (COST-STSM-CM1304-34406). Co-funding from the Volkswagen Foundation (grant no. 92 850) is gratefully acknowledged.	Adamala K, 2015, NAT PROTOC, V10, P927, DOI 10.1038/nprot.2015.054; Akashi K, 1996, BIOPHYS J, V71, P3242, DOI 10.1016/S0006-3495(96)79517-6; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bhatia T, 2015, BBA-BIOMEMBRANES, V1848, P3175, DOI 10.1016/j.bbamem.2015.09.020; Carrara P, 2012, CHEMBIOCHEM, V13, P1497, DOI 10.1002/cbic.201200133; de Souza TP, 2017, PHYS CHEM CHEM PHYS, V19, P20082, DOI 10.1039/c7cp03751a; Dimova R, 2006, J PHYS-CONDENS MAT, V18, pS1151, DOI 10.1088/0953-8984/18/28/S04; Fanti A, 2018, INTEGR BIOL-UK, V10, P6, DOI 10.1039/c7ib00138j; Fayolle D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18053-y; Horger KS, 2009, J AM CHEM SOC, V131, P1810, DOI 10.1021/ja805625u; Isaad AL, 2014, ORG BIOMOL CHEM, V12, P6363, DOI 10.1039/c4ob00721b; Kurihara K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9352; Kurihara K, 2011, NAT CHEM, V3, P775, DOI [10.1038/NCHEM.1127, 10.1038/nchem.1127]; Lohse B, 2008, J AM CHEM SOC, V130, P14372, DOI 10.1021/ja805030w; Luisi PL, 1999, PERSPECTIVES SUPRAMO, P1; MAGIN R L, 1987, Biotechnology Techniques, V1, P185; Menger FM, 1998, ACCOUNTS CHEM RES, V31, P789, DOI 10.1021/ar970103v; Nishimura K, 2012, J COLLOID INTERF SCI, V376, P119, DOI 10.1016/j.jcis.2012.02.029; Nishimura K, 2012, LANGMUIR, V28, P8426, DOI 10.1021/la3001703; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Nomura S, 2003, CHEMBIOCHEM, V4, P1172, DOI 10.1002/cbic.200300630; Pautot S, 2003, LANGMUIR, V19, P2870, DOI 10.1021/la026100v; REEVES JP, 1969, J CELL PHYSIOL, V73, P49, DOI 10.1002/jcp.1040730108; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stano P, 2015, MECH ADV MATER STRUC, V22, P748, DOI 10.1080/15376494.2013.857743; Stano P, 2011, J MATER CHEM, V21, P18887, DOI 10.1039/c1jm12298c; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Strazewski P, 2015, ISR J CHEM, V55, P851, DOI 10.1002/ijch.201400175; Walde P, 2010, CHEMBIOCHEM, V11, P848, DOI 10.1002/cbic.201000010; WICK R, 1995, J AM CHEM SOC, V117, P1435, DOI 10.1021/ja00109a031; Zhu TF, 2009, J AM CHEM SOC, V131, P5705, DOI 10.1021/ja900919c; Zhu TF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005009	32	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192975	10.1371/journal.pone.0192975	http://dx.doi.org/10.1371/journal.pone.0192975			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451909	Green Published, gold, Green Submitted			2022-12-26	WOS:000425369800030
J	Hou, DY; Shi, LC; Yang, MM; Li, J; Zhou, S; Zhang, HX; Xu, HW				Hou, Dian-Yun; Shi, Lin-Chun; Yang, Meng-Meng; Li, Jiong; Zhou, Shuang; Zhang, Hong-Xiao; Xu, Hua-Wei			De novo transcriptomic analysis of leaf and fruit tissue of Cornus officinalis using Illumina platform	PLOS ONE			English	Article							RNA-SEQ DATA; IDENTIFICATION; BIOSYNTHESIS; ANNOTATION; EXPRESSION; DISCOVERY; GLYCOSIDE; SEQUENCE; REVEALS; LOGANIN	Cornus officinalis is one of the most widely used medicinal plants in China and other East Asian countries to cure diseases such as liver, kidney, cardiovascular diseases and frequent urination for thousands of years. It is a Level 3 protected species, and is one of the 42 national key protected wild species of animals and plants in China. However, the genetics and molecular biology of C. officinalis are poorly understood, which has hindered research on the molecular mechanism of its metabolism and utilization. Hence, enriching its genomic data and information is very important. In recent years, the fast-growing technology of next generation sequencing has provided an effective path to gain genomic information from nonmodel species. This study is the first to explore the leaf and fruit tissue transcriptome of C. officinalis using the Illumina HiSeq 4000 platform. A total of 57,954,134 and 60,971,652 clean reads from leaf and fruit were acquired, respectively (GenBank number SRP115440). The pooled reads from all two libraries were assembled into 56,392 unigenes with an average length 856 bp. Among these, 41,146 unigenes matched with sequences in the NCBI nonredundant protein database. The Gene Ontology database assigned 24,336 unigenes with biological process (83.26%), cellular components (53.58%), and molecular function (83.93%). In addition, 10,808 unigenes were assigned a KOG functional classification by the KOG database. Searching against the KEGG pathway database indicated that 18,435 unigenes were mapped to 371 KEGG pathways. Moreover, the edgeR database identified 4,585 significant differentially expressed genes (DEGs), of which 1,392 were up-regulated and 3,193 were down-regulated in fruit tissue compared with leaf tissue. Finally, we explored 581 transcription factors with 50 transcription factor gene families. Most DEGs and transcription factors were related to terpene biosynthesis and secondary metabolic regulation. This study not only represented the first de novo transcriptomic analysis of C. officinalis but also provided fundamental information on its genes and biosynthetic pathway. These findings will help us explore the molecular metabolism mechanism of terpene biosynthesis in C. officinalis.	[Hou, Dian-Yun; Yang, Meng-Meng; Zhou, Shuang; Zhang, Hong-Xiao; Xu, Hua-Wei] Henan Univ Sci & Technol, Agr Coll, Luoyang, Henan, Peoples R China; [Hou, Dian-Yun; Yang, Meng-Meng; Zhou, Shuang; Zhang, Hong-Xiao; Xu, Hua-Wei] Luoyang Engn Res Ctr Breeding & Utilizat Dao Di H, Luoyang, Henan, Peoples R China; [Shi, Lin-Chun] Chinese Acad Med Sci, Inst Med Plant Dev IMPLAD, Beijing, Peoples R China; [Shi, Lin-Chun] Peking Union Med Coll, Beijing, Peoples R China; [Li, Jiong] Chinese Med Mat Prod Technol Serv Ctr, Dept Agr Henan Prov, Zhengzhou, Henan, Peoples R China	Henan University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Hou, DY (corresponding author), Henan Univ Sci & Technol, Agr Coll, Luoyang, Henan, Peoples R China.; Hou, DY (corresponding author), Luoyang Engn Res Ctr Breeding & Utilizat Dao Di H, Luoyang, Henan, Peoples R China.	dianyun518@163.com	dianyun518, dianyun518/AGK-1633-2022		National Natural Science Foundation of China by Natural Science Foundation of China [U1404829]	National Natural Science Foundation of China by Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (U1404829) by Natural Science Foundation of China. Dianyun Hou is the project director. The funding can support this research. The URL is http://www.nsfc.gov.cn/.	Akhtar MQ, 2017, PHYSIOL PLANTARUM, V160, P128, DOI 10.1111/ppl.12550; An YA, 2015, TOX RESEARCH, V31, P165, DOI 10.5487/TR.2015.31.2.165; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chen S.L., 2006, INTRO SUSTAINABLE UT; Chen SL, 2010, REGIONAL SUITABILITY; Chen SL, 2016, HERB GENOMICS; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Es Haghi M, 2014, Indian J Nephrol, V24, P291, DOI 10.4103/0971-4065.133000; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Gagne SJ, 2012, P NATL ACAD SCI USA, V109, P12811, DOI 10.1073/pnas.1200330109; Goettel W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086153; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guitton Y, 2010, PHYSIOL PLANTARUM, V138, P150, DOI 10.1111/j.1399-3054.2009.01315.x; Han Y, 2014, AM J CHINESE MED, V42, P1169, DOI 10.1142/S0192415X14500736; He J, 2017, FITOTERAPIA, V120, P136, DOI 10.1016/j.fitote.2017.06.003; He K, 2016, PHYTOTHER RES, V30, P283, DOI 10.1002/ptr.5529; Hou DY, 2013, CHIN J NAT MEDICINES, V11, P121, DOI [10.1016/S1875-5364(13)60038-2, 10.3724/SP.J.1009.2013.00121]; Hu LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129822; Hwang KA, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1172-3; Jang SE, 2014, J AGR FOOD CHEM, V62, P9711, DOI 10.1021/jf501487v; Jeena GS, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3865-5; Jeong EJ, 2012, PHYTOMEDICINE, V19, P317, DOI 10.1016/j.phymed.2011.08.068; Jiang WL, 2011, PHYTOMEDICINE, V18, P266, DOI 10.1016/j.phymed.2010.07.009; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lee J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0424-6; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-245; Liu CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179219; Liu DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098855; Long Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1111; Lu JG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-246; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; National Pharmacopoeia Committee, 2015, PHARM PEOPL REP CH 1; Niu J, 2015, GENE, V559, P22, DOI 10.1016/j.gene.2015.01.002; Pandey A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34464; Park JY, 2016, NAT PROD RES, V30, P1504, DOI 10.1080/14786419.2015.1115996; Piskol R, 2013, AM J HUM GENET, V93, P641, DOI 10.1016/j.ajhg.2013.08.008; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ramilowski JA, 2013, PLANT CELL PHYSIOL, V54, P697, DOI 10.1093/pcp/pct057; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; Sozanski T, 2014, PHYTOMEDICINE, V21, P1774, DOI 10.1016/j.phymed.2014.09.005; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Tabata S, 2000, NATURE, V408, P823, DOI 10.1038/35048507; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Wei SH, 2013, NAT PROD RES, V27, P911, DOI 10.1080/14786419.2012.668687; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Youn K, 2013, NAT PROD RES, V27, P1471, DOI 10.1080/14786419.2012.718774; Zhang QC, 2013, PHYTOTHER RES, V27, P1894, DOI 10.1002/ptr.4934; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zheng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142542; Zhu YY, 2015, GENE, V555, P362, DOI 10.1016/j.gene.2014.11.032	59	10	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192610	10.1371/journal.pone.0192610	http://dx.doi.org/10.1371/journal.pone.0192610			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451882	gold, Green Published, Green Submitted			2022-12-26	WOS:000425369800018
J	Wilson, HV; Johnson, MI; Francis, P				Wilson, Hannah V.; Johnson, Mark I.; Francis, Peter			Repeated stimulation, inter-stimulus interval and inter-electrode distance alters muscle contractile properties as measured by Tensiomyography	PLOS ONE			English	Article							GASTROCNEMIUS MEDIALIS MUSCLE; POSTACTIVATION POTENTIATION; NONINVASIVE ESTIMATION; RADIAL DISPLACEMENT; TWITCH POTENTIATION; SKELETAL-MUSCLE; SINGLE FIBERS; PARAMETERS; RELIABILITY; VOLUNTARY	Context The influence of methodological parameters on the measurement of muscle contractile properties using Tensiomyography (TMG) has not been published. Objective To investigate the; (1) reliability of stimulus amplitude needed to elicit maximum muscle displacement (Dm), (2) effect of changing inter-stimulus interval on Dm (using a fixed stimulus amplitude) and contraction time (T-c), (3) the effect of changing inter-electrode distance on Dm and T-c. Design Within subject, repeated measures. Participants 10 participants for each objective. Main outcome measures Dm and T-c of the rectus femoris, measured using TMG. Results The coefficient of variance (CV) and the intra-class correlation (ICC) of stimulus amplitude needed to elicit maximum Dm was 5.7% and 0.92 respectively. Dm was higher when using an inter-electrode distance of 7cm compared to 5cm [P = 0.03] and when using an interstimulus interval of 10s compared to 30s [P = 0.017]. Further analysis of inter-stimulus interval data, found that during 10 repeated stimuli T-c became faster after the 5th measure when compared to the second measure [P<0.05]. The 30s inter-stimulus interval produced the most stable T-c over 10 measures compared to 10s and 5s respectively. Conclusion Our data suggest that the stimulus amplitude producing maximum Dm of the rectus femoris is reliable. Inter-electrode distance and inter-stimulus interval can significantly influence Dm and/or T-c. Our results support the use of a 30s inter-stimulus interval over 10s or 5s. Future studies should determine the influence of methodological parameters on muscle contractile properties in a range of muscles.	[Wilson, Hannah V.; Francis, Peter] Leeds Beckett Univ, Sch Clin & Appl Sci, Musculoskeletal Hlth Res Grp, Leeds, W Yorkshire, England; [Wilson, Hannah V.; Johnson, Mark I.] Leeds Beckett Univ, Sch Clin & Appl Sci, Ctr Pain Res, Leeds, W Yorkshire, England	Leeds Beckett University; Leeds Beckett University	Wilson, HV (corresponding author), Leeds Beckett Univ, Sch Clin & Appl Sci, Musculoskeletal Hlth Res Grp, Leeds, W Yorkshire, England.; Wilson, HV (corresponding author), Leeds Beckett Univ, Sch Clin & Appl Sci, Ctr Pain Res, Leeds, W Yorkshire, England.	H.Wilson@Student.Leedsbeckett.ac.uk			Leeds Beckett University	Leeds Beckett University	The authors received no specific funding for this work. Funding for this work was attached to a PhD studentship financed by Leeds Beckett University.	Abian Vicen J, 2016, IMPACT HYDRATION MUS; Baudry S, 2004, MUSCLE NERVE, V30, P328, DOI 10.1002/mus.20101; Bergman BC, 2001, J STRENGTH COND RES, V15, P1; BROOKS M E, 1990, Journal of Orthopaedic and Sports Physical Therapy, V11, P530; Carrasco L, 2011, EUR J APPL PHYSIOL, V111, P2271, DOI 10.1007/s00421-011-1848-9; Dahmane R, 2005, J BIOMECH, V38, P2451, DOI 10.1016/j.jbiomech.2004.10.020; Dahmane R, 2001, MED BIOL ENG COMPUT, V39, P51, DOI 10.1007/BF02345266; De Hoyo M, 2013, EUR J SPORT SCI, V13, P666, DOI 10.1080/17461391.2013.774052; de Hoyo M, 2013, J SPORT REHABIL, V22, P53, DOI 10.1123/jsr.22.1.53; de Paula Simola R. A., 2015, SPORTS TECHNOL, V8, P58; Ditroilo M, 2013, J ELECTROMYOGR KINES, V23, P558, DOI 10.1016/j.jelekin.2013.01.014; Ditroilo M, 2011, PHYSIOL MEAS, V32, P1315, DOI 10.1088/0967-3334/32/8/020; Garcia-Garcia O, 2015, J STRENGTH COND RES, V29, P844, DOI 10.1519/JSC.0000000000000702; Gasparini M, 2012, EUR J VASC ENDOVASC, V44, P170, DOI 10.1016/j.ejvs.2012.04.024; Hamada T, 2000, J APPL PHYSIOL, V88, P2131, DOI 10.1152/jappl.2000.88.6.2131; Hunter AM, 2012, J ELECTROMYOGR KINES, V22, P334, DOI 10.1016/j.jelekin.2012.01.009; Kersevan K, 2002, CELL MOL BIOL LETT, V7, P367; KNAFLITZ M, 1990, J APPL PHYSIOL, V68, P1657, DOI 10.1152/jappl.1990.68.4.1657; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Koren K, 2015, KINESIOLOGY, V47, P19; Krizaj D, 2008, J ELECTROMYOGR KINES, V18, P645, DOI 10.1016/j.jelekin.2007.01.008; Loturco I, 2015, J STRENGTH COND RES, V29, P1723, DOI 10.1519/JSC.0000000000000803; Macgregor LJ, 2016, J SPORT REHABIL, V25, P241, DOI [10-1123/jsr.2014-0325, 10.1123/jsr.2014-0325]; Garcia-Manso JM, 2012, J ELECTROMYOGR KINES, V22, P612, DOI 10.1016/j.jelekin.2012.01.005; Garcia-Manso JM, 2011, J SPORT SCI, V29, P619, DOI 10.1080/02640414.2010.548822; Miyamoto N, 2012, MUSCLE NERVE, V45, P110, DOI 10.1002/mus.22259; Mortimer J.T., 2004, NEUROPROSTHETICS THE, P638, DOI DOI 10.1142/4987; Murray AM, 2016, INT J SPORTS PHYS TH, V11, P765; PETRELLA RJ, 1989, EUR J APPL PHYSIOL O, V58, P395, DOI 10.1007/BF00643515; Pisot R, 2008, EUR J APPL PHYSIOL, V104, P409, DOI 10.1007/s00421-008-0698-6; Plastaras CT, 2008, AM J PHYS MED REHAB, V87, P183, DOI 10.1097/PHM.0b013e318164aa04; Rey E, 2012, J ELECTROMYOGR KINES, V22, P866, DOI 10.1016/j.jelekin.2012.06.003; Ruiz DR, 2012, REV BRAS MED ESPORTE, V18, P95; Rodriguez-Matoso D., 2010, REV ANDAL DERECHO DE, V3, P81; Rodriguez-Ruiz D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/239708; Rusu LD, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-67; Simunic B, 2012, J ELECTROMYOGR KINES, V22, P527, DOI 10.1016/j.jelekin.2012.04.003; SWEENEY HL, 1990, P NATL ACAD SCI USA, V87, P414, DOI 10.1073/pnas.87.1.414; Tous-Fajardo J, 2010, J ELECTROMYOGR KINES, V20, P761, DOI 10.1016/j.jelekin.2010.02.008; Valencic V, 1997, ARTIF ORGANS, V21, P240, DOI 10.1111/j.1525-1594.1997.tb04658.x; WESTERBLAD H, 1993, J PHYSIOL-LONDON, V468, P729, DOI 10.1113/jphysiol.1993.sp019797; WESTERBLAD H, 1993, J APPL PHYSIOL, V75, P382, DOI 10.1152/jappl.1993.75.1.382; WESTERBLAD H, 1991, AM J PHYSIOL, V261, pC195, DOI 10.1152/ajpcell.1991.261.2.C195	43	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0191965	10.1371/journal.pone.0191965	http://dx.doi.org/10.1371/journal.pone.0191965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451885	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000425369800008
J	Winge, DR				Winge, Dennis R.			Filling the mitochondrial copper pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						copper; cytochrome c oxidase (Complex IV); superoxide dismutase (SOD); metal; metal homeostasis	OXIDASE; MATRIX; FAMILY	A host of critical metalloproteins reside in mitochondria, where metallation occurs within the organelle after protein import. Although the pathways by which proteins are imported into the mitochondria are well known, the mechanisms by which their metal partners are imported are more obscure. A new study by Boulet et al. demonstrates that the mammalian SLC25A3 inner membrane transporter, previously known as a phosphate carrier, is also a functional Cu(I) importer, clarifying the source of mitochondrial copper and raising new questions about cellular copper homeostasis.	[Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT 84132 USA; [Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT 84132 USA.; Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA.	Dennis.winge@hsc.utah.edu			NIDDK NIH HHS [U54 DK110858] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK110858] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baker ZN, 2017, HUM MOL GENET, V26, P4617, DOI 10.1093/hmg/ddx344; Boulet A, 2018, J BIOL CHEM, V293, P1887, DOI 10.1074/jbc.RA117.000265; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Moore M. J., 2018, BIOCHEMISTRY-US, DOI [10. 1021/acs. biochem. 7b01034 29228768, DOI 10.1021/ACS.BIOCHEM.7B01034]; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Troadec MB, 2011, BLOOD, V117, P5494, DOI 10.1182/blood-2010-11-319483; Vest KE, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150223; Vest KE, 2013, J BIOL CHEM, V288, P23884, DOI 10.1074/jbc.M113.470674; Yoon H, 2011, BIOCHEM J, V440, P137, DOI 10.1042/BJ20111036	10	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1897	1898		10.1074/jbc.H118.001457	http://dx.doi.org/10.1074/jbc.H118.001457			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29462794	Green Published, hybrid			2022-12-26	WOS:000424948000004
J	Kim, D; Cho, S; Woo, JA; Liggett, SB				Kim, Donghwa; Cho, Soomin; Woo, Jung A.; Liggett, Stephen B.			A CREB-mediated increase in miRNA let-7f during prolonged -agonist exposure: a novel mechanism of (2)-adrenergic receptor down-regulation in airway smooth muscle	FASEB JOURNAL			English	Article						G protein; tachyphylaxis; asthma; microRNA	BITTER TASTE RECEPTORS; BETA(2)-ADRENERGIC RECEPTORS; BETA-2-ADRENERGIC RECEPTOR; EXPRESSION; ASTHMA; PHOSPHORYLATION; SUBSENSITIVITY; SALMETEROL; CELLS; DESENSITIZATION	(2)-Adrenergic receptors ((2)ARs) desensitize during continuous agonist activation, which manifests clinically as tachyphylaxis. -Agonist desensitization of (2)ARs in human airway smooth muscle (HASM) cells is recognized in the treatment of asthma and may be related to poor outcomes. Rapid events in desensitization include receptor phosphorylation and internalization, but mechanisms responsible for the decrease in receptor protein after prolonged agonist exposure (down-regulation) are ill defined. The microRNA (miRNA) let-7f regulates (2)AR expression by translational repression. In cultured HASM cells from nonasthmatic and asthmatic lungs, 18 h of -agonist exposure increased let-7f by 2-3-fold, concomitant with a approximate to 90% decrease in (2)ARs. Inhibition of let-7f attenuated this down-regulation response by approximate to 50%. The let-7f increase was found to be cAMP/PKA-dependent. The mechanism of the let-7f increase was found by chromatin immunoprecipitation to be from activated cAMP response element-binding protein (CREB) binding to the let-7f promoter, thereby increasing let-7f expression. Knockdown of CREB attenuated agonist-promoted (2)AR down-regulation by approximate to 50%. Thus, (2)AR down-regulation occurs as a result of not only internalized receptor degradation but also a novel cAMP/PKA/CREB-mediated increase in let-7f, which causes enhanced repression of the (2)AR gene, adrenoreceptor (2) (ADRB2) translation and represents approximate to 50% of the net loss of receptors observed after prolonged agonist exposure. This mechanism is apparent in asthmatic HASM cells, indicating relevance in a disease model.Kim, D., Cho, S., Woo, J. A., Liggett, S. B. A CREB-mediated increase in miRNA let-7f during prolonged -agonist exposure: a novel mechanism of (2)-adrenergic receptor down-regulation in airway smooth muscle.	[Kim, Donghwa; Cho, Soomin] Univ S Florida, Ctr Personalized Med, Morsani Coll Med, Tampa, FL 33635 USA; [Woo, Jung A.; Liggett, Stephen B.] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33635 USA; [Liggett, Stephen B.] Univ S Florida, Dept Internal Med, Morsani Coll Med, Tampa, FL 33635 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Liggett, SB (corresponding author), Univ S Florida, 12901 Bruce B Downs Blvd,MDC 2, Tampa, FL 33635 USA.	sliggett@health.usf.edu	Kim, Donghwa/AAJ-8148-2021	Kim, Donghwa/0000-0002-8994-8513; Liggett, Stephen B./0000-0002-0128-3669; Woo, Jung A/0000-0002-9194-1361	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL045967, HL114471]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL045967, R37HL045967, P01HL114471, R01HL045967] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Ashley Goss, Maria Castano, and Tara Rosin for technical assistance, and Lisa Steward for manuscript preparation and editing (all from the University of South Florida). This work was funded by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL045967 and HL114471. The authors declare no conflicts of interest.	Aisenberg WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep38231; An SS, 2016, J ALLERGY CLIN IMMUN, V138, P294, DOI 10.1016/j.jaci.2015.12.1315; Barnes NA, 2012, J IMMUNOL, V189, P253, DOI 10.4049/jimmunol.1101563; BHAGAT R, 1995, CHEST, V108, P1235, DOI 10.1378/chest.108.5.1235; Booth H, 1996, THORAX, V51, P1100, DOI 10.1136/thx.51.11.1100; BOUVIER M, 1989, J BIOL CHEM, V264, P16786; CAMPBELL PT, 1991, MOL PHARMACOL, V39, P192; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; GRAINGER J, 1991, THORAX, V46, P105, DOI 10.1136/thx.46.2.105; GROVE A, 1995, LANCET, V346, P201, DOI 10.1016/S0140-6736(95)91265-7; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; HARVEY JE, 1982, THORAX, V37, P280, DOI 10.1136/thx.37.4.280; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Kalra S, 1996, CHEST, V109, P953, DOI 10.1378/chest.109.4.953; Kim DW, 2017, AM J RESP CELL MOL, V56, P762, DOI 10.1165/rcmb.2016-0373OC; Kim D, 2016, J BIOL CHEM, V291, P17616, DOI 10.1074/jbc.M116.722736; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; LIGGETT SB, 1989, MOL PHARMACOL, V36, P641; LIGGETT SB, 1991, PHARMACOL RES, V24, P29, DOI 10.1016/1043-6618(91)90119-I; Liggett SB, 2013, EXPERT OPIN THER TAR, V17, P721, DOI 10.1517/14728222.2013.782395; Liggett SB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002331; Lipworth BJ, 1997, DRUG SAFETY, V16, P295, DOI 10.2165/00002018-199716050-00002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; McGraw DW, 2001, AM J PHYSIOL-LUNG C, V281, pL895, DOI 10.1152/ajplung.2001.281.4.L895; Mizuta K, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-89; Moore RH, 1999, J CELL SCI, V112, P329; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; NEWNHAM DM, 1995, THORAX, V50, P497, DOI 10.1136/thx.50.5.497; Panebra A, 2008, AM J PHYSIOL-LUNG C, V294, pL190, DOI 10.1152/ajplung.00277.2007; Panebra A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011819; Perez JM, 2003, NAT MED, V9, P1300, DOI 10.1038/nm930; Qiu ZJ, 2009, J BIOL CHEM, V284, P13099, DOI 10.1074/jbc.M807307200; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sears MR, 1998, LUNG BIOL HEALTH DIS, V115, P457; Swift SM, 2007, AM J RESP CELL MOL, V36, P236, DOI 10.1165/rcmb.2006-0257OC; Wang WCH, 2011, P NATL ACAD SCI USA, V108, P6246, DOI 10.1073/pnas.1101439108; Xue H, 2016, ONCOL REP, V35, P1771, DOI 10.3892/or.2016.4548	43	9	11	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3680	3688		10.1096/fj.201701278R	http://dx.doi.org/10.1096/fj.201701278R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29455573	Green Published			2022-12-26	WOS:000435104500016
J	Li, X; Ma, HG; Li, L; Chen, YF; Sun, X; Dong, ZZ; Liu, JY; Zhu, WM; Zhang, JT				Li, Xia; Ma, Hongguang; Li, Lin; Chen, Yifan; Sun, Xiao; Dong, Zizheng; Liu, Jing-Yuan; Zhu, Weiming; Zhang, Jian-Ting			Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth	ONCOGENE			English	Article							EPITHELIAL-CELLS; CANCER; PHOSPHORYLATION; PATHOGENESIS; EXPRESSION; PATHWAY	Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in malignant tumors and plays important roles in multiple aspects of cancer aggressiveness. Thus, targeting STAT3 promises to be an attractive strategy for the treatment of advanced metastatic tumors. Bisindolylmaleimide alkaloid (BMA) has been shown to have anticancer activities and was thought to suppress tumor cell growth by inhibiting protein kinase C. In this study, we show that a newly synthesized BMA analog, BMA097, is effective in suppressing tumor cell and xenograft growth and in inducing spontaneous apoptosis. We also provide evidence that BMA097 binds directly to the SH2 domain of STAT3 and inhibits STAT3 phosphorylation and activation, leading to reduced expression of STAT3 downstream target genes. Structure activity relationship analysis revealed that the hydroxymethyl group in the 2,5-dihydropyrrole-2,5-dione prohibits STAT3 inhibitory activity of BMA analogs. Altogether, we conclude that the synthetic BMA analogs may be developed as anti-cancer drugs by targeting and binding to the SH2 domain of STAT3 and inhibiting the STAT3 signaling pathway.	[Li, Xia; Chen, Yifan; Dong, Zizheng; Liu, Jing-Yuan; Zhang, Jian-Ting] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Li, Xia; Li, Lin; Sun, Xiao] Shandong Univ, Sch Ocean, Weihai, Peoples R China; [Ma, Hongguang; Zhu, Weiming] Ocean Univ China, Sch Med & Pharm, Key Lab Marine Drugs, Minist Educ China, Qingdao, Peoples R China; [Liu, Jing-Yuan] Indiana Univ Purdue Univ, Dept Comp & Informat Sci, Indianapolis, IN 46202 USA; [Zhang, Jian-Ting] Indiana Univ Sch Med, IU Simon Canc Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Shandong University; Ministry of Education, China; Ocean University of China; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Li, X; Liu, JY; Zhang, JT (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.; Zhu, WM (corresponding author), Ocean Univ China, Sch Med & Pharm, Key Lab Marine Drugs, Minist Educ China, Qingdao, Peoples R China.; Liu, JY (corresponding author), Indiana Univ Purdue Univ, Dept Comp & Informat Sci, Indianapolis, IN 46202 USA.; Zhang, JT (corresponding author), Indiana Univ Sch Med, IU Simon Canc Ctr, Indianapolis, IN 46202 USA.	xiali@sdu.edu.cn; jliu2@iu.edu; weimingzhu@ouc.edu.cn; jianzhan@iu.edu	li, xia/HHZ-7468-2022	Zhang, Jian-Ting/0000-0002-2803-9914	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT_17R68]; National Natural Science Foundation of China [81273532, U1501221]; National Institute of Health [R01 CA211904]; NATIONAL CANCER INSTITUTE [R01CA211904] Funding Source: NIH RePORTER	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank IU Big Red supercomputers for the CPU time. This work was supported in part by grants from the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, No IRT_17R68), the National Natural Science Foundation of China (Nos. 81273532 & U1501221) and by National Institute of Health Grant R01 CA211904.	Bhatnagar I, 2010, MAR DRUGS, V8, P2673, DOI 10.3390/md8102673; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen Q, 2006, J BIOL CHEM, V281, P31152, DOI 10.1074/jbc.M603529200; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Gartsbein M, 2006, J CELL SCI, V119, P470, DOI 10.1242/jcs.02744; Huang W, 2016, ONCOGENE, V35, P783, DOI 10.1038/onc.2015.215; Huang W, 2014, ACS CHEM BIOL, V9, P1188, DOI 10.1021/cb500071v; Li Y, 2007, CANCER RES, V67, P8494, DOI 10.1158/0008-5472.CAN-07-0647; Liu JY, 2011, J CHEM INF MODEL, V51, P2612, DOI 10.1021/ci200212y; Liu SS, 2013, ACTA PHARMACOL SIN, V34, P271, DOI 10.1038/aps.2012.137; Ma HG, 2016, CHINESE J ORG CHEM, V36, P1839, DOI 10.6023/cjoc201602035; Mantel C, 2012, BLOOD, V120, P2589, DOI 10.1182/blood-2012-01-404004; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Mukohara T, 2003, LUNG CANCER, V41, P123, DOI 10.1016/S0169-5002(03)00225-3; Pajak B, 2008, ADV MED SCI-POLAND, V53, P21, DOI 10.2478/v10039-008-0028-6; Pereira ER, 1996, J MED CHEM, V39, P4471; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer M, 2009, BRIT J CANCER, V100, P1949, DOI 10.1038/sj.bjc.6605068; Qian L, 2006, BIOCHEM BIOPH RES CO, V345, P660, DOI 10.1016/j.bbrc.2006.04.153; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	28	17	18	3	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	18					2469	2480		10.1038/s41388-017-0076-0	http://dx.doi.org/10.1038/s41388-017-0076-0			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE7BW	29456240	Green Submitted, Green Accepted			2022-12-26	WOS:000431386000010
J	Cao, S; Anishkin, A; Zinkevich, NS; Nishijima, Y; Korishettar, A; Wang, ZH; Fang, J; Wilcox, DA; Zhang, DX				Cao, Sheng; Anishkin, Andriy; Zinkevich, Natalya S.; Nishijima, Yoshinori; Korishettar, Ankush; Wang, Zhihao; Fang, Juan; Wilcox, David A.; Zhang, David X.			Transient receptor potential vanilloid 4 (TRPV4) activation by arachidonic acid requires protein kinase A-mediated phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arachidonic acid (AA) (ARA); endothelial cell; hydrogen peroxide; protein kinase A (PKA); protein phosphorylation; signal transduction; transient receptor potential channels (TRP channels)	CATION CHANNEL TRPV4; HEAT-EVOKED ACTIVATION; INDUCED VASODILATATION; CARDIOVASCULAR-SYSTEM; MOLECULAR-DYNAMICS; SCORING FUNCTION; S4-S5 LINKER; CA2+ SIGNALS; SHEAR-STRESS; ION-CHANNEL	Transient receptor potential vanilloid 4 (TRPV4) is a Ca2+-permeable channel of the transient receptor potential (TRP) superfamily activated by diverse stimuli, including warm temperature, mechanical forces, and lipid mediators such as arachidonic acid (AA) and its metabolites. This activation is tightly regulated by protein phosphorylation carried out by various serine/threonine or tyrosine kinases. It remains poorly understood how phosphorylation differentially regulates TRPV4 activation in response to different stimuli. We investigated how TRPV4 activation by AA, an important signaling process in the dilation of coronary arterioles, is affected by protein kinase A (PKA)-mediated phosphorylation at Ser-824. Wildtype and mutant TRPV4 channels were expressed in human coronary artery endothelial cells (HCAECs). AA-induced TRPV4 activation was blunted in the S824A mutant but was enhanced in the phosphomimetic S824E mutant, whereas the channel activation by the synthetic agonist GSK1016790A was not affected. The low level of basal phosphorylation at Ser-824 was robustly increased by the redox signaling molecule hydrogen peroxide (H2O2). The H2O2-induced phosphorylation was accompanied by an enhanced channel activation by AA, and this enhanced response was largely abolished by PKA inhibition or S824A mutation. We further identified a potential structural context dependence of Ser-824 phosphorylation-mediated TRPV4 regulation involving an interplay between AA binding and the possible phosphorylation-induced rearrangements of the C-terminal helix bearing Ser-824. These results provide insight into how phosphorylation specifically regulates TRPV4 activation. Redox-mediated TRPV4 phosphorylation may contribute to pathologies associated with enhanced TRPV4 activity in endothelial and other systems.	[Cao, Sheng; Zinkevich, Natalya S.; Nishijima, Yoshinori; Korishettar, Ankush; Wang, Zhihao; Zhang, David X.] Med Coll Wisconsin, Dept Med, Cardiovasc Ctr, Milwaukee, WI 53226 USA; [Fang, Juan; Wilcox, David A.] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Anishkin, Andriy] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Zinkevich, Natalya S.] Carroll Univ, Dept Hlth & Med, Waukesha, WI 53186 USA; [Fang, Juan; Wilcox, David A.] Childrens Hosp Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; University System of Maryland; University of Maryland College Park; Children's Hospital of Wisconsin	Zhang, DX (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	xfzhang@mcw.edu		, Yoshinori/0000-0002-5547-4508	National Institute of Health [HL096647]; Biology Department, University of Maryland, College Park; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096647] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biology Department, University of Maryland, College Park; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health Grant HL096647 (to D. X. Z.) and by the Biology Department, University of Maryland, College Park (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adapala RK, 2013, J MOL CELL CARDIOL, V54, P45, DOI 10.1016/j.yjmcc.2012.10.016; Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Andreucci E, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-37; Berna-Erro A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11274-1; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bubolz AH, 2012, AM J PHYSIOL-HEART C, V302, pH634, DOI 10.1152/ajpheart.00717.2011; Burgoyne JR, 2013, ANTIOXID REDOX SIGN, V18, P1042, DOI 10.1089/ars.2012.4817; Dalsgaard T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33841; de Groot T, 2011, MOL CELL BIOL, V31, P2845, DOI 10.1128/MCB.01319-10; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Fang J, 2005, BLOOD, V106, P2671, DOI 10.1182/blood-2004-12-4619; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Garcia-Elias A, 2014, HANDB EXP PHARMACOL, V222, P293, DOI 10.1007/978-3-642-54215-2_12; Gauthier KM, 2002, CIRC RES, V90, P1028, DOI 10.1161/01.RES.0000018162.87285.F8; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guler AD, 2002, J NEUROSCI, V22, P6408; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Ho WSV, 2015, BRIT J PHARMACOL, V172, P5251, DOI 10.1111/bph.13312; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kallberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; Kusudo T, 2012, J APPL PHYSIOL, V112, P1223, DOI 10.1152/japplphysiol.01070.2011; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Loot AE, 2008, CARDIOVASC RES, V80, P445, DOI 10.1093/cvr/cvn207; Loukin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019533; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; Loukin SH, 2015, P NATL ACAD SCI USA, V112, P9400, DOI 10.1073/pnas.1510602112; McGuffin LJ, 2015, NUCLEIC ACIDS RES, V43, pW169, DOI 10.1093/nar/gkv236; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2013, EMBO REP, V14, P152, DOI 10.1038/embor.2012.219; Nishijima Y, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.199; Peng HQ, 2010, BIOCHEM BIOPH RES CO, V391, P1721, DOI 10.1016/j.bbrc.2009.12.140; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poole DP, 2013, J BIOL CHEM, V288, P5790, DOI 10.1074/jbc.M112.438184; Rahaman SO, 2014, J CLIN INVEST, V124, P5225, DOI 10.1172/JCI75331; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Randhawa PK, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0512-7; Rykunov Dmitry, 2009, Journal of Structural and Functional Genomics, V10, P95, DOI 10.1007/s10969-008-9044-9; Servin-Vences MR, 2017, ELIFE, V6, DOI 10.7554/eLife.21074; Shuttleworth TJ, 2009, CELL CALCIUM, V45, P602, DOI 10.1016/j.ceca.2009.02.001; Sies H, 2014, J BIOL CHEM, V289, P8735, DOI 10.1074/jbc.R113.544635; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Strotmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010580; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Teng JF, 2016, P NATL ACAD SCI USA, V113, P11847, DOI 10.1073/pnas.1613523113; Teng JF, 2015, P NATL ACAD SCI USA, V112, P3386, DOI 10.1073/pnas.1502366112; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Wegierski T, 2009, J BIOL CHEM, V284, P2923, DOI 10.1074/jbc.M805357200; White JPM, 2016, PHYSIOL REV, V96, P911, DOI 10.1152/physrev.00016.2015; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Zhang DX, 2011, J CARDIOVASC PHARM, V57, P133, DOI 10.1097/FJC.0b013e3181fd35d1; Zhang XM, 2006, J GEN PHYSIOL, V128, P491, DOI 10.1085/jgp.200609676; Zhao PS, 2015, J BIOL CHEM, V290, P13875, DOI 10.1074/jbc.M115.642736; Zheng XD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000080; Zuccolo E, 2016, VASC PHARMACOL, V87, P159, DOI 10.1016/j.vph.2016.09.005	75	30	31	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5307	5322		10.1074/jbc.M117.811075	http://dx.doi.org/10.1074/jbc.M117.811075			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29462784	Green Published, hybrid			2022-12-26	WOS:000429409300034
J	Li, XL; Liu, LS; Li, R; Wu, AL; Lu, JQ; Wu, QZ; Jia, JL; Zhao, MJ; Song, H				Li, Xiaoling; Liu, Liansheng; Li, Ran; Wu, Ailing; Lu, Jinqiu; Wu, Qingzhe; Jia, Junling; Zhao, Mujun; Song, Hai			Hepatic loss of Lissencephaly 1 (Lis1) induces fatty liver and accelerates liver tumorigenesis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); Golgi; liver metabolism; liver cancer; hepatocyte; mouse genetics; Lis1; nonalcoholic fatty liver disease; ploidy; steatosis	ENDOPLASMIC-RETICULUM STRESS; HEMATOPOIETIC STEM-CELLS; MILLER-DIEKER-SYNDROME; NONALCOHOLIC STEATOHEPATITIS; MICROTUBULE ORGANIZATION; HEPATOCELLULAR-CARCINOMA; GLUCOSE-HOMEOSTASIS; METABOLIC DISEASE; INITIATION-FACTOR; MOUSE MODEL	The liver is a major organ in lipid metabolism, and its malfunction leads to various diseases. Nonalcoholic fatty liver disease, the most common chronic liver disorder in developed countries, is characterized by the abnormal retention of excess lipid within hepatocytes and predisposes individuals to liver cancer. We previously reported that the levels of Lissencephaly 1 (LIS1, also known as PAFAH1B1) are down-regulated in human hepatocellular carcinoma. Following up on this observation, we found that genetic deletion of Lis1 in the mouse liver increases lipid accumulation and inflammation in this organ. Further analysis revealed that loss of Lis1 triggers endoplasmic reticulum (ER) stress and reduces triglyceride secretion. Attenuation of ER stress by addition of tauroursodeoxycholic acid (TUDCA) diminished lipid accumulation in the Lis1-deficient hepatocytes. Moreover, the Golgi stacks were disorganized in Lis1-deficient liver cells. Of note, the Lis1 liver-knockout mice exhibited increased hepatocyte ploidy and accelerated development of liver cancer after exposure to the liver carcinogen diethylnitrosamine (DEN). Taken together, these findings suggest that reduced Lis1 levels can spur the development of liver diseases from steatosis to liver cancer and provide a useful model for delineating the molecular pathways that lead to these diseases.	[Li, Xiaoling; Liu, Liansheng; Li, Ran; Wu, Ailing; Lu, Jinqiu; Wu, Qingzhe; Jia, Junling; Song, Hai] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Xiaoling; Liu, Liansheng; Li, Ran; Wu, Ailing; Lu, Jinqiu; Wu, Qingzhe; Jia, Junling; Song, Hai] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Zhao, Mujun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, H (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Song, H (corresponding author), Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China.	haisong@zju.edu.cn		Li, Xiaoling/0000-0002-1554-1569	National Natural Science Foundation of China [31471368]; Zhejiang Provincial Natural Science Foundation of China [LR16C120001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported in part by the National Natural Science Foundation of China Grant 31471368 and Zhejiang Provincial Natural Science Foundation of China Grant LR16C120001 (to H. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Argo CK, 2009, CLIN LIVER DIS, V13, P511, DOI 10.1016/j.cld.2009.07.005; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Chen XF, 2014, CELL RES, V24, P1013, DOI 10.1038/cr.2014.69; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Czuchlewski DR, 2008, J PEDIAT HEMATOL ONC, V30, P865, DOI 10.1097/MPH.0b013e31818a958a; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; DEHANDT HA, 1966, NATURE, V212, P827, DOI 10.1038/212827a0; Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Jaarsma D, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00397; Kammoun HL, 2009, CURR OPIN CLIN NUTR, V12, P575, DOI 10.1097/MCO.0b013e32833189db; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Koliaki C, 2013, MOL CELL ENDOCRINOL, V379, P35, DOI 10.1016/j.mce.2013.06.002; Kondratova AA, 2005, CELL CYCLE, V4, P1403, DOI 10.4161/cc.4.10.2041; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Rehberg M, 2005, MOL BIOL CELL, V16, P2759, DOI 10.1091/mbc.E05-01-0069; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reiner O, 2013, CURR OPIN NEUROBIOL, V23, P951, DOI 10.1016/j.conb.2013.08.001; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Sipe CW, 2013, DEVELOPMENT, V140, P1785, DOI 10.1242/dev.089763; Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016; Sonoda H, 2007, J BIOL CHEM, V282, P34085, DOI 10.1074/jbc.M705593200; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Sumigray KD, 2011, J CELL BIOL, V194, P631, DOI 10.1083/jcb.201104009; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Ueda S, 2006, ACTA PAEDIATR, V95, P113, DOI 10.1080/08035250510046731; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; VANDENBERGHE G, 1991, J INHERIT METAB DIS, V14, P407, DOI 10.1007/BF01797914; Xing Z, 2011, BIOCHEM BIOPH RES CO, V409, P193, DOI 10.1016/j.bbrc.2011.04.117; Yamada M, 2009, NAT MED, V15, P1202, DOI 10.1038/nm.2023; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zimdahl B, 2014, NAT GENET, V46, P245, DOI 10.1038/ng.2889	53	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5160	5171		10.1074/jbc.RA117.001474	http://dx.doi.org/10.1074/jbc.RA117.001474			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29475944	hybrid, Green Published			2022-12-26	WOS:000429409300021
J	Donovan, TM; Katz, JE				Donovan, Therese M.; Katz, Jonathan E.			AM Models: An R package for storing models, data, and metadata to facilitate adaptive management	PLOS ONE			English	Article								Agencies are increasingly called upon to implement their natural resource management programs within an adaptive management (AM) framework. This article provides the background and motivation for the R package, AMModels. AMModels was developed under R version 3.2.2. The overall goal of AMModels is simple: To codify knowledge in the form of models and to store it, along with models generated from numerous analyses and datasets that may come our way, so that it can be used or recalled in the future. AMModels facilitates this process by storing all models and datasets in a single object that can be saved to an-RData file and routinely augmented to track changes in knowledge through time. Through this process, AMModels allows the capture, development, sharing, and use of knowledge that may help organizations achieve their mission. While AMModels was designed to facilitate adaptive management, its utility is far more general. Many R packages exist for creating and summarizing models, but to our knowledge, AMModels is the only package dedicated not to the mechanics of analysis but to organizing analysis inputs, analysis outputs, and preserving descriptive metadata. We anticipate that this package will assist users hoping to preserve the key elements of an analysis so they may be more confidently revisited at a later date.	[Donovan, Therese M.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Vermont Cooperat Fish & Wildlife Res Unit, US Geol Survey, Burlington, VT 05405 USA; [Katz, Jonathan E.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Vermont Cooperat Fish & Wildlife Res Unit, Burlington, VT USA	United States Department of the Interior; United States Geological Survey; University of Vermont; University of Vermont	Donovan, TM (corresponding author), Univ Vermont, Rubenstein Sch Environm & Nat Resources, Vermont Cooperat Fish & Wildlife Res Unit, US Geol Survey, Burlington, VT 05405 USA.	tdonovan@uvm.edu		Donovan, Therese/0000-0001-8124-9251	U. S. Bureau of Land Management	U. S. Bureau of Land Management	This work was supported by the U. S. Bureau of Land Management.	Allen CR, 2015, ADAPTIVE MANAGEMENT; [Anonymous], 2021, LANG ENV STAT COMP; Balantic C, AMMONITOR REMO UNPUB; Bolker B, 2008, ECOLOGICAL MODELS DA; Burnetas AN, 1997, MATH OPER RES, V22, P222, DOI 10.1287/moor.22.1.222; Burnham K. P., 1998, MODEL SELECTION INFE; Conroy M. J., 2013, DECISION MAKING NATU; DAVENPORT TH, 1994, HARVARD BUS REV, V72, P119; Fischman RL, 2016, CONSERV BIOL, V30, P268, DOI 10.1111/cobi.12616; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fontaine JJ, 2011, J ENVIRON MANAGE, V92, P1403, DOI 10.1016/j.jenvman.2010.10.015; Fuller AK, 2014, J WILDLIFE MANAGE, V78, P175, DOI 10.1002/jwmg.629; Goodwin P., 2014, DECISION ANAL MANAGE, V5th ed.; Gregory R, 2006, ECOL APPL, V16, P2411, DOI 10.1890/1051-0761(2006)016[2411:DAMCFA]2.0.CO;2; Greig LA, 2013, ECOL SOC, V18, DOI 10.5751/ES-05686-180324; Hallgren L, 2015, WILDLIFE BIOL, V21, P165, DOI 10.2981/wlb.00005; Hobbs N.T., 2015, BAYESIAN MODELS; Holling CS, 1978, ADAPTIVE ENV ASSESSM, pxviii; Jaksch T, 2010, J MACH LEARN RES, V11, P1563; Katz J, AMEXPERT DERIV UNPUB; Katz J, 2017, AMMODELS ADAPTIVE MA; Lee K., 1993, COMPASS GYROSCOPE IN, P255; MacKenzie D, 2002, OCCUPANCY ESTIMATION; Merali Z, 2010, NATURE, V467, P775, DOI 10.1038/467775a; Miller G, 2006, SCIENCE, V314, P1856, DOI 10.1126/science.314.5807.1856; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Plummer M., 2016, RJAGS BAYESIAN GRAPH; Rehme SE, 2011, J ENVIRON MANAGE, V92, P1360, DOI 10.1016/j.jenvman.2010.10.012; Rist L, 2013, ECOL SOC, V18, DOI 10.5751/ES-06183-180463; Royle JA, 2016, APPL HIERARCHICAL MO; Runge MC, 2011, J FISH WILDL MANAG, V2, P220, DOI 10.3996/082011-JFWM-045; Susskind L, 2012, J APPL ECOL, V49, P47, DOI 10.1111/j.1365-2664.2011.02070.x; Walters C.J., 1986, ADAPTIVE MANAGEMENT, P374; Weir LA, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P307; Westgate MJ, 2013, BIOL CONSERV, V158, P128, DOI 10.1016/j.biocon.2012.08.016; Williams B.K., 2012, ADAPTIVE MANAGEMENT; Williams BK, 2016, BIOL CONSERV, V195, P255, DOI 10.1016/j.biocon.2016.01.012; Williams BK, 2011, J ENVIRON MANAGE, V92, P1346, DOI 10.1016/j.jenvman.2010.10.041	38	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0188966	10.1371/journal.pone.0188966	http://dx.doi.org/10.1371/journal.pone.0188966			57	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489825	Green Submitted, Green Published, gold			2022-12-26	WOS:000426276000003
J	Ko, SY; Ro, YS; Shin, SD; Song, KJ; Hong, KJ; Kong, SY				Ko, Seo Young; Ro, Young Sun; Shin, Sang Do; Song, Kyoung Jun; Hong, Ki Jeong; Kong, So Yeon			Effect of a first responder on survival outcomes after out-of-hospital cardiac arrest occurs during a period of exercise in a public place	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION; SUDDEN-DEATH; ASSOCIATION; BYSTANDER; INTERVENTION; DISEASE; YOUNG	Introduction The deployment of first responders in a public place is one of the interventions that is used for increasing bystander cardiopulmonary resuscitation (CPR) of out-of-hospital cardiac arrests (OHCA). We studied the association between the presence of a first responder and the survival of OHCA that occurred during a period of exercise in a public place. Methods All of the adult OHCAs of a presumed cardiac etiology that occurred during a period of exercise in a public place and that were witnessed by a bystander between 2013 and 2015 were analyzed. The main exposure of interest was the characteristics of the bystander (first responder vs. layperson). The endpoints were the provision of bystander CPR and good neurological recovery. Multivariable logistic regression analysis, adjusting for patient-environment and prehospital factors, was performed. Results A total of 870 patients had a cardiac arrest during a period of exercise in a public place, and 58 (6.7%) patients were witnessed by the first responder. The OHCAs witnessed by first responders were more likely to result in bystander CPR than those witnessed by laypersons (89.7% vs. 75.4%, p=0.01, adjusted OR (95% CI): 3.51 (1.44-8.55)). In terms of good neurological recovery, the OHCAs witnessed by first responders had a higher likelihood than the patients witnessed by laypersons (37.9% vs, 24.0%, p = 0.02, adjusted OR (95% CI): 2.92 (1.33-6.40)). Conclusion The OHCAs occurred during a period of exercise in a public place and whom first responders witnessed were more likely to receive bystander CPR and to have a neurologically intact survival.	[Ko, Seo Young; Shin, Sang Do; Song, Kyoung Jun] Seoul Natl Univ, Coll Med, Dept Emergency Med, Seoul, South Korea; [Ko, Seo Young; Ro, Young Sun; Shin, Sang Do; Song, Kyoung Jun; Hong, Ki Jeong; Kong, So Yeon] Seoul Natl Univ Hosp, Biomed Res Inst, Lab Emergency Med Serv, Seoul, South Korea; [Hong, Ki Jeong] Seoul Natl Univ Seoul, Boramae Med Ctr, Dept Emergency Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Ro, YS (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Lab Emergency Med Serv, Seoul, South Korea.	Ro.youngsun@gmail.com	Lee, Jae Hyuk/W-5616-2018	Lee, Jae Hyuk/0000-0003-2429-4085	National Emergency Management Agency of Korea; Korea Centers for Disease Control and Prevention (CDC; Korea CDC [2013-E33015-00, 2014-E33011-00, 2016-E33012-00]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare, Korea [H113C1964]	National Emergency Management Agency of Korea; Korea Centers for Disease Control and Prevention (CDC; Korea CDC; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare, Korea	This study was supported by the National Emergency Management Agency of Korea and the Korea Centers for Disease Control and Prevention (CDC). The study was funded by the Korea CDC (2013-2016) (Grant No.: 2013-E33015-00; 2014-E33011-00; 2016-E33012-00) to SDS. This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Korea (Grant No.: H113C1964) to YSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902; Berdowski J, 2013, EUR HEART J, V34, P3616, DOI 10.1093/eurheartj/eht401; Callaham M, 1996, ANN EMERG MED, V27, P638, DOI 10.1016/S0196-0644(96)70169-5; Chan PS, 2014, CIRCULATION, V130, P1876, DOI 10.1161/CIRCULATIONAHA.114.009711; Chang I, 2017, RESUSCITATION, V111, P26, DOI 10.1016/j.resuscitation.2016.11.007; Daya MR, 2015, RESUSCITATION, V91, P108, DOI 10.1016/j.resuscitation.2015.02.003; Edwards MJ, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2015-000281; Fishbein MC, 2010, CARDIOVASC PATHOL, V19, P326, DOI 10.1016/j.carpath.2009.06.005; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Hansen CM, 2015, JAMA-J AM MED ASSOC, V314, P255, DOI 10.1001/jama.2015.7938; MacDonald Russell D, 2002, Prehosp Emerg Care, V6, P1; Marijon E, 2011, CIRCULATION, V124, P672, DOI 10.1161/CIRCULATIONAHA.110.008979; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Myerburg RJ, 2002, CIRCULATION, V106, P1058, DOI 10.1161/01.CIR.0000028147.92190.A7; Park GJ, 2017, AM J EMERG MED, V35, P1049, DOI 10.1016/j.ajem.2017.02.033; Park YM, 2017, RESUSCITATION, V118, P55, DOI 10.1016/j.resuscitation.2017.06.024; Perkins GD, 2014, CIRCULATION; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1177/2047487316653709, 10.1016/j.atherosclerosis.2016.05.037]; Ro YS, 2017, RESUSCITATION, V115, P44, DOI 10.1016/j.resuscitation.2017.03.041; Ro YS, 2017, ANN EMERG MED, V69, P52, DOI 10.1016/j.annemergmed.2016.07.028; Ro YS, 2016, RESUSCITATION, V102, P17, DOI 10.1016/j.resuscitation.2016.02.004; Soholm H, 2014, RESUSCITATION, V85, P1612, DOI 10.1016/j.resuscitation.2014.06.033; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; van Alem AP, 2003, BMJ-BRIT MED J, V327, P1312, DOI 10.1136/bmj.327.7427.1312; Wissenberg M, 2013, JAMA-J AM MED ASSOC, V310, P1377, DOI 10.1001/jama.2013.278483	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193361	10.1371/journal.pone.0193361	http://dx.doi.org/10.1371/journal.pone.0193361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489877	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000067
J	Aguilar-Palacio, I; Malo, S; Feja, C; Lallana, MJ; Leon-Latre, M; Casasnovas, JA; Rabanaque, MJ; Guallar, E				Aguilar-Palacio, Isabel; Malo, Sara; Feja, Cristina; Jesus Lallana, Ma; Leon-Latre, Montserrat; Antonio Casasnovas, Jose; Jose Rabanaque, Ma; Guallar, Eliseo			Risk factors control for primary prevention of cardiovascular disease in men: Evidence from the Aragon Workers Health Study (AWHS)	PLOS ONE			English	Article							METAANALYSIS; POPULATION; ADHERENCE; ACHIEVEMENT; PREVALENCE; THERAPY; EUROPE; IMPACT; SPAIN; GOALS	Benefits of cardiovascular disease (CVD) risk factors control are well known, but goals achievement remains low. The objective of this study is to evaluate the prevalence of CVD risk factors among men ina worker's cohort with no previous CVD, to study control variations across time and the factors associated with poor control. To this end, we conducted a cohort reexamination (2010-2014) within the context of the Aragon Workers Health Study (AWHS). Data from working characteristics, analytical values and pharmacological prescription were included in the analysis. Prevalences of risk factor diagnosis and control were calculated, as well as factors associated with poor control. The prevalence of CVD risk factors was high. In 2014dyslipidaemia was the most prevalent (85.2%) followed by Hypertension (HT) (42.0%). People under treatment increased for the period analysed (p < 0.001). The proportion of people treated varied from 72.2% in Diabetes Mellitus to 31.1% in dyslipidaemia in 2014. 46.2% of the workers with HT were controlled, decreasing to 21.9% in Diabetes and 11.0% in dyslipidaemia (2014). Working in a turn different to central shift was associated with poor control, especially for those working at night with HT (Odds Ratio in 2010: 3.6; Confidence Interval 95% 1.8-7.4) and dyslipidaemia (Odds Ratio 2010: 4.7; Confidence Interval 95% 1.3-16.4). We conclude that, although CVD control has increased significantly for the period studied, there are still many people that do not receive any treatment, and control goals are normally not achieved.	[Aguilar-Palacio, Isabel; Malo, Sara; Feja, Cristina; Jose Rabanaque, Ma] Zaragoza Univ, Prevent Med & Publ Hlth Dept, Zaragoza, Spain; [Aguilar-Palacio, Isabel; Malo, Sara; Feja, Cristina; Jesus Lallana, Ma; Antonio Casasnovas, Jose; Jose Rabanaque, Ma] IIS Aragon, Aragon Inst Hlth Res, Zaragoza, Spain; [Jesus Lallana, Ma; Leon-Latre, Montserrat] Serv Aragones Salud, Primary Hlth Care, Zaragoza, Spain; [Antonio Casasnovas, Jose] Zaragoza Univ, Med Psychiat & Dermatol Dept, Zaragoza, Spain; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Epidemiol Dept, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Aguilar-Palacio, I (corresponding author), Zaragoza Univ, Prevent Med & Publ Hlth Dept, Zaragoza, Spain.; Aguilar-Palacio, I (corresponding author), IIS Aragon, Aragon Inst Hlth Res, Zaragoza, Spain.	iaguilar@unizar.es	Malo, S/J-8824-2019; Lenguas, José Antonio Casasnovas/F-4038-2010; Aguilar-Palacio, Isabel/H-6816-2017	Malo, S/0000-0002-7194-8275; Lenguas, José Antonio Casasnovas/0000-0002-9887-2629; Aguilar-Palacio, Isabel/0000-0001-7293-701X; Feja Solana, Cristina/0000-0002-2712-6709	Fondo de Investigacion Sanitaria [PI13/01668]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by the Fondo de Investigacion Sanitaria, PI13/01668 (http://www.isciii.es). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ATCC DDD IND 2016; Banegas JR, 2012, HYPERTENSION, V60, P898, DOI 10.1161/HYPERTENSIONAHA.112.193078; Banegas JR, 2011, EUR HEART J, V32, P2143, DOI 10.1093/eurheartj/ehr080; Boggild H, 1999, SCAND J WORK ENV HEA, V25, P85, DOI 10.5271/sjweh.410; Bouchard MH, 2007, BRIT J CLIN PHARMACO, V63, P698, DOI 10.1111/j.1365-2125.2006.02828.x; Casasnovas JA, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-45; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chowdhury R, 2013, EUR HEART J, V34, P2940, DOI 10.1093/eurheartj/eht295; Dallongeville J, 2012, EUR J PREV CARDIOL, V19, P541, DOI 10.1177/1741826711407705; Fores R, 2017, MED CLIN-BARCELONA, V148, P107, DOI 10.1016/j.medcli.2016.09.043; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Gabriel R, 2008, REV ESP CARDIOL, V61, P1030, DOI 10.1016/S1885-5857(09)60006-2; Godin G, 2008, HEALTH PSYCHOL, V27, P179, DOI 10.1037/0278-6133.27.2.179; Grau M, 2011, REV ESP CARDIOL, V64, P295, DOI [10.1016/j.rec.2010.11.005, 10.1016/j.recesp.2010.11.005]; Guallar E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-704; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Mazzaglia G, 2009, CIRCULATION, V120, P1598, DOI 10.1161/CIRCULATIONAHA.108.830299; Baena-Diez JM, 2011, REV ESP CARDIOL, V64, P766, DOI 10.1016/j.recesp.2011.04.019; Naderi SH, 2012, AM J MED, V125, P882, DOI 10.1016/j.amjmed.2011.12.013; Navarro-Vidal B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061549; Neil-Sztramko SE, 2014, SCAND J WORK ENV HEA, V40, P543, DOI 10.5271/sjweh.3445; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1177/2047487316653709, 10.1016/j.atherosclerosis.2016.05.037]; Quick A, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2016-7; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Schmieder RE, 2012, VASC HEALTH RISK MAN, V8, P177, DOI 10.2147/VHRM.S29915; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Townsend N, 2015, EUR HEART J, V36, P2673; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193541	10.1371/journal.pone.0193541	http://dx.doi.org/10.1371/journal.pone.0193541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474499	Green Published, gold			2022-12-26	WOS:000426049500128
J	Kawasaki, T; Iwasaki, T; Yamada, M; Yoshida, T; Watanabe, T				Kawasaki, Takeshi; Iwasaki, Tomohito; Yamada, Michi; Yoshida, Takashi; Watanabe, Takafumi			Rapid growth rate results in remarkably hardened breast in broilers during the middle stage of rearing: A biochemical and histopathological study	PLOS ONE			English	Article							PECTORALIS-MAJOR MUSCLE; PERIPHERAL ARTERY-DISEASE; QUALITY TRAITS; WOODEN BREAST; GASTROCNEMIUS; HISTOLOGY; CHICKENS; BIRDS	The high incidence of meat of impaired quality poses a serious problem in the poultry industry. In recent years, the incidence of the pectoralis major muscle that appeared pale colored, remarkably hardened, and exudative, called "wooden breast" or "woody breast" has increased in slaughter houses. In the present study, 19-day-old Ross 308 broiler chickens affected (n = 10) and unaffected (n = 10) with remarkably hardened breast were selected from a commercial broiler farm, and reared to 55 days of age under a controlled environment. Among the affected birds, 5 of 10 birds appeared exhausted with markedly suppressed weight gain and 4 of 10 birds died during the rearing period. In contrast, all unaffected birds survived and most gained weight. Four of 10 unaffected birds lost the ability of back-to-back wing contact by the late stage of rearing. The biochemical analysis of blood plasma samples of 20-day-old birds revealed that creatine kinase and L-aspartate amino-transferase values in most affected birds were higher than those in unaffected birds; however, these values in unaffected birds increased rapidly with lost wing contactability and increasing age. Postmortem examinations revealed that the mean diameter of myofibers in affected birds was smaller than that in unaffected birds. Moreover, symptoms of degenerative and regenerative muscles were observed in most birds in both groups. Among them, a decrease in, or defect of, the characteristic polygonal shape of myofibers was the most common change within the pectoralis major muscles in both groups. The present study demonstrated that broilers affected with remarkably hardened breast during the middle stage of rearing would have suppressed physical status and weight gain, or would die. It was suggested that rapid growth in broilers might be a cause of remarkably hardened breast.	[Kawasaki, Takeshi; Iwasaki, Tomohito] Rakuno Gakuen Univ, Dept Food Sci & Human Wellness, Ebetsu, Hokkaido, Japan; [Kawasaki, Takeshi] Res Off Hlth Humans & Birds, Abashiri, Hokkaido, Japan; [Kawasaki, Takeshi; Yoshida, Takashi] Kitami Inst Technol, Grad Sch Engn, Med Engn Course, Kitami, Hokkaido, Japan; [Yamada, Michi] Rakuno Gakuen Univ, Dept Sustainable Agr, Ebetsu, Hokkaido, Japan; [Watanabe, Takafumi] Shinshu Univ, Fac Agr, Nagano, Japan	Rakuno Gakuen University; Kitami Institute of Technology; Rakuno Gakuen University; Shinshu University	Watanabe, T (corresponding author), Shinshu Univ, Fac Agr, Nagano, Japan.	yosenabe@shinshu-u.ac.jp		Kawasaki, Takeshi/0000-0002-2173-1801	Rakuno Gakuen Univ [17-2]; Grants-in-Aid for Scientific Research [15K05617] Funding Source: KAKEN	Rakuno Gakuen Univ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Rakuno Gakuen Univ. Research Fund No.17-2 (http//en.rakuno.ac.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153750; Abdul-Aziz T, 2016, AM ASS AVIAN PATHOLO, P423; Burchell A, 1998, BAILLIERE CLIN GASTR, V12, P337, DOI 10.1016/S0950-3528(98)90138-5; Crespo R, 2008, CLIN BIOCH DOMESTIC, P1233; Hoffmann WE, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P351, DOI 10.1016/B978-0-12-370491-7.00012-X; Jennette JC, 2005, RUBINS PATHOLOGY CLI, P826; Kawasaki T, 2016, J POULT SCI, V53, P291, DOI 10.2141/jpsa.0160036; Koutakis P, 2015, J HISTOCHEM CYTOCHEM, V63, P256, DOI 10.1369/0022155415569348; Koutakis P, 2014, REDOX BIOL, V2, P921, DOI 10.1016/j.redox.2014.07.002; Kuttappan VA, 2013, POULTRY SCI, V92, P339, DOI 10.3382/ps.2012-02647; Mazzoni M, 2015, POULTRY SCI, V94, P123, DOI 10.3382/ps/peu043; Radaelli G, 2017, POULTRY SCI, V96, P309, DOI 10.3382/ps/pew270; Sihvo HK, 2014, VET PATHOL, V51, P619, DOI 10.1177/0300985813497488; SILLER WG, 1978, AVIAN PATHOL, V7, P583, DOI 10.1080/03079457808418313; Soglia F, 2016, POULTRY SCI, V95, P651, DOI 10.3382/ps/pev353; Velleman SG, 2015, AVIAN DIS, V59, P410, DOI 10.1637/11097-042015-Reg.1; Weinstein DA, 2006, MOL GENET METAB, V87, P284, DOI 10.1016/j.ymgme.2005.10.006	17	25	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193307	10.1371/journal.pone.0193307	http://dx.doi.org/10.1371/journal.pone.0193307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474396	Green Published, gold			2022-12-26	WOS:000426049500080
J	Nowacka-Woszuk, J; Szczerbal, I; Malinowska, AM; Chmurzynska, A				Nowacka-Woszuk, Joanna; Szczerbal, Izabela; Malinowska, Anna M.; Chmurzynska, Agata			Transgenerational effects of prenatal restricted diet on gene expression and histone modifications in the rat	PLOS ONE			English	Article							DNA METHYLATION; S-ADENOSYLHOMOCYSTEINE; PROTEIN RESTRICTION; MOUSE-LIVER; ADULT; INTRAUTERINE; HYPERTENSION; ACETYLATION; DEFICIENCY; METABOLISM	Dietary triggers acting on a developing fetus can affect the functioning of the body in later life; this can be observed on various levels, including epigenetic modifications and gene expression. Early-life programmed changes may be transmitted to successive generations. In this study, the impact of prenatal restricted diet was studied in four generations of rats. We hypothesized that this diet can induce changes in the expression of major genes involved in two epigenetic mechanisms: DNA methylation and histone modifications. The transcript level of six genes involved in these processes (Dnmtl, Dnmt3a, Dnmt3b, Mecp2, Hdacl, and Sin3a) was therefore determined in three tissues (liver, adipose, and muscle). This diet was found to have no effect on the F0 pregnant females. In the F1 progeny (fetuses at day 19 of pregnancy and 4-week-old rats) significant differences in the expression of the genes were observed mostly in the liver; in subsequent generations, we therefore studied only this tissue. Among the genes encoding DNA methyltransferases, significant changes were observed for Dnmtl in the F1 animals from the restricted group, but these were no longer evident in F2 and F3. The Dnmt3a and Dnmt3b genes showed no differences in mRNA level in F1 fetuses. Concerning the transcript level of the Mecp2 gene only in F1 generation significant changes were found. For the histone modification genes, an increase in the expression of Hdacl in fetus liver was found in F1 and F2, while its level decreased in F3. The abundance of the Sin3a transcript varied in all generations. It was also found that the mRNA levels of the studied genes correlated highly positive with each other, but only in fetuses from the F1 restricted group. The DNA methylation cell potential, defined as the ratio of SAM (S-adenosylmethionine) to SAH (S-adenosylhomocysteine), was measured in the liver, with no alterations being found in the restricted groups. Evaluation of global histone H3 acetylation showed that it underwent a significant increase in the fetal livers of F1, while during aging (four-week old animals) this difference was no longer maintained. A tendency of increased H3 acetylation in fetuses was also detected in F2 generation. In F1 fetuses from restricted group the increased H3 acetylation positively correlated with transcriptional status of the studied genes. Our results indicate that the prenatal restriction diet can affect the activity of genes involved in epigenetic mechanisms in the liver across generations. Moreover, this feeding type influenced the global histone H3 acetylation in fetal liver.	[Nowacka-Woszuk, Joanna; Szczerbal, Izabela] Poznan Univ Life Sci, Dept Genet & Anim Breeding, Wolynska 33, Poznan, Poland; [Malinowska, Anna M.; Chmurzynska, Agata] Poznan Univ Life Sci, Inst Human Nutr & Dietet, Wojska Polskiego 31, Poznan, Poland	Poznan University of Life Sciences; Poznan University of Life Sciences	Nowacka-Woszuk, J (corresponding author), Poznan Univ Life Sci, Dept Genet & Anim Breeding, Wolynska 33, Poznan, Poland.	jnowacka@up.poznan.pl	Malinowska, Anna/Q-6042-2019; Szczerbal, Izabela/AFM-9268-2022	Malinowska, Anna/0000-0002-7402-1328; Szczerbal, Izabela/0000-0002-4238-0414; Nowacka-Woszuk, Joanna/0000-0002-1041-3576; Chmurzynska, Agata/0000-0002-2045-0709	National Science Centre (Poland) [2013/ 09/D/NZ2/02006]	National Science Centre (Poland)	All the analyses were funded by the National Science Centre (Poland) project no. 2013/ 09/D/NZ2/02006 to JN-W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CE, 2014, HUM REPROD UPDATE, V20, P63, DOI 10.1093/humupd/dmt043; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chmurzynska A, 2010, NUTR REV, V68, P87, DOI 10.1111/j.1753-4887.2009.00265.x; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Ding YB, 2012, REPRODUCTION, V144, P91, DOI 10.1530/REP-12-0006; Freije WA, 2015, J CELL BIOCHEM, V116, P566, DOI 10.1002/jcb.25008; Friso S, 2017, MOL ASPECTS MED, V54, P28, DOI 10.1016/j.mam.2016.11.007; Ganguly A, 2014, J NUTR BIOCHEM, V25, P259, DOI 10.1016/j.jnutbio.2013.10.015; Garg M, 2013, ENDOCRINOLOGY, V154, P102, DOI 10.1210/en.2012-1640; Harrison M, 2009, BRIT J NUTR, V101, P1020, DOI 10.1017/S0007114508057607; Hermes M, 2005, CELL PHYSIOL BIOCHEM, V15, P233, DOI 10.1159/000086410; Hoile SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021668; Ishii D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105750; Jang Hyeran, 2014, Clin Nutr Res, V3, P1, DOI 10.7762/cnr.2014.3.1.1; Kawakami K, 2012, BIOCHEM BIOPH RES CO, V418, P836, DOI 10.1016/j.bbrc.2012.01.120; 김지희, 2008, [Journal of Korea Spatial Information System Society, 한국공간정보시스템학회 논문지], V10, P1; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Li YY, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-98; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupu DS, 2012, AGING DIS, V3, P444; Mattocks DAL, 2017, EXP GERONTOL, V88, P1, DOI 10.1016/j.exger.2016.12.003; Nakamura A, 2013, GERONTOLOGY, V59, P542, DOI 10.1159/000354087; Nilsson EE, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.134817; Nohara K, 2011, ARCH TOXICOL, V85, P653, DOI 10.1007/s00204-010-0611-z; Nowacka-Woszuk J, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0544-0; Ogawa T, 2014, CONGENIT ANOM, V54, P195, DOI [10.1111/cga.12089, 10.1111/cga.12062]; Palou M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-69; Ponzio BF, 2012, LIFE SCI, V90, P571, DOI 10.1016/j.lfs.2012.01.017; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SHE QB, 1994, BIOCHEM BIOPH RES CO, V205, P1748, DOI 10.1006/bbrc.1994.2871; Wang W, 2001, J CHROMATOGR B, V762, P59, DOI 10.1016/S0378-4347(01)00341-3; Xia L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118101; Zhang HY, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0121-y	37	17	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193464	10.1371/journal.pone.0193464	http://dx.doi.org/10.1371/journal.pone.0193464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474484	Green Published, gold, Green Submitted			2022-12-26	WOS:000426049500113
J	Risoy, AJ; Kjome, RLS; Sandberg, S; Solvik, UO				Risoy, Aslaug Johanne; Kjome, Reidun Lisbet Skeide; Sandberg, Sverre; Solvik, Una Orvim			Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study	PLOS ONE			English	Article							CARDIOVASCULAR MORBIDITY; HEALTH; CARE; SCORE; DIAGNOSIS; EUROQOL; QUESTIONNAIRE; POPULATION; VALIDATION	Objectives Determine the feasibility of using a diabetes risk assessment tool followed by HbA1c-measurement in a community-pharmacy setting in Norway. Methods In this longitudinal study two pharmacists in each of three community pharmacies were trained to perform risk assessments, HbA1c-measurements and counselling. Pharmacy customers who were > 18 years old and could understand and speak Norwegian or English were recruited in the pharmacies during a two-months-period. Information about the service was presented in local newspapers, social media, leaflets and posters at the pharmacy. Customers wishing to participate contacted the pharmacy staff. Participants completed a validated diabetes risk test and a background questionnaire including a validated instrument for self-rated health. A HbA1c measurement was performed for individuals with a moderate to high risk of developing diabetes. If HbA1c >= 6.5% they were recommended to visit their general practitioner for follow-up. The pharmacies performed internal and external quality control of the HbA1c instrument. Results Of the 211 included participants 97 (46%) were > 50 years old. HbA1c was measured for the 47 participants (22%) with high risk. Thirty-two (15%) had HbA1c values < 5.7%, twelve (5.4%) had values between 5.7%-6.4%, and three (1.4%) had an HbA1c >= 6.5%. Two participants with HbA1 >= 6.5% were diagnosed with diabetes by their general practitioner. The third was lost to follow-up. Results from internal and external quality control for HbA1c were within set limits. Conclusion The pharmacists were able to perform the risk assessment and measurement of HbA1c, and pharmacy customers were willing to participate. The HbA1c measurements fulfilled the requirements for analytical quality. Thus, it is feasible to implement this service in community pharmacies in Norway. In a large-scale study the inclusion criteria should be increased to 45 years in accordance with the population the risk test has been validated for.	[Risoy, Aslaug Johanne; Kjome, Reidun Lisbet Skeide; Sandberg, Sverre; Solvik, Una Orvim] Univ Bergen, Fac Med, Dept Global Hlth & Primary Care, Bergen, Norway; [Risoy, Aslaug Johanne; Kjome, Reidun Lisbet Skeide] Univ Bergen, Fac Med, Ctr Pharm, Bergen, Norway; [Sandberg, Sverre] Haraldsplass Deaconess Hosp, Norwegian Qual Improvement Lab Examinat Noklus, Bergen, Norway; [Sandberg, Sverre] Haukeland Hosp, Lab Clin Biochem, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Risoy, AJ (corresponding author), Univ Bergen, Fac Med, Dept Global Hlth & Primary Care, Bergen, Norway.; Risoy, AJ (corresponding author), Univ Bergen, Fac Med, Ctr Pharm, Bergen, Norway.	aslaug.risoy@uib.no	Sandberg, Sverre/T-9304-2019	Sandberg, Sverre/0000-0001-9521-5087; Solvik, Una Orvim/0000-0003-4186-6620; Kjome, Reidun Lisbet/0000-0002-9454-5188	Norwegian Community Pharmacy Foundation; University of Bergen	Norwegian Community Pharmacy Foundation; University of Bergen	The study was financed by The Norwegian Community Pharmacy Foundation (https://www.proff.no/selskap/stiftelsen-til-fremme-av-norskapotekfarmasi/oslo/fondlegat/IG9KD0M10NC/) and the University of Bergen (http://www.uib.no). The purpose of the Norwegian Community Pharmacy Foundation is to help promote the development of Norwegian pharmacy. Siemens (https://www.siemens.com/no/no/home.html) lent the DCA Vantage Analyzer instruments to the pharmacies and provided training free of charge. The participating pharmacy chain, Apotek 1, covered expenses of the course day and paid the membership fee in Noklus. The Norwegian Community Pharmacy Foundation had no influence on how the study was conducted, the analysis or the results. Apotek 1, University of Bergen, Siemens and The Norwegian Community Pharmacy Foundation had no influence on the analysis or the results, but Apotek 1 have been given valuable input to the protocol and procedures.; We thank all the participants, the pharmacists and pharmacy who participated, as well as the Pharmacy chain Apotek 1, Noklus and Siemens that lent out DCA Vantage. This project was supported by The Norwegian Community Pharmacy Foundation and the University of Bergen.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Apotekforeningen, 2016, 3 1 APOTEKKUNDER RES; AS SH, 2017, DCA VANT AN SIEM HEA; Clarke PM, 2009, MED CARE, V47, P61, DOI 10.1097/MLR.0b013e3181844855; Collins RE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-603; Craig P, 2013, INT J NURS STUD, V50, P585, DOI 10.1016/j.ijnurstu.2012.09.009; Diabetesforbundet Helsedirektoraret., 2015, SJEKK DIN DIAB DIAB; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Echouffo-Tcheugui JB, 2015, ANN FAM MED, V13, P149, DOI 10.1370/afm.1737; Fikri-Benbrahim N, 2015, DIABETES RES CLIN PR, V108, pE49, DOI 10.1016/j.diabres.2015.03.006; Gray LJ, 2010, DIABETIC MED, V27, P887, DOI 10.1111/j.1464-5491.2010.03037.x; Hassell K, 2000, HEALTH SOC CARE COMM, V8, P40, DOI 10.1046/j.1365-2524.2000.00222.x; HealthKnowledge, 2011, DIFF SCREEN DIAG TES; Helsedirektoraret, 2016, NASJ FAGL RETN DIAB; Herman WH, 2015, DIABETES CARE, V38, P1449, DOI 10.2337/dc14-2459; Hersberger KE, 2006, PHARM WORLD SCI, V28, P171, DOI 10.1007/s11096-006-9034-6; ISO, 2006, POINT OF CAR TEST PO; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; Kowall B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171152; Krass I, 2007, DIABETES RES CLIN PR, V75, P339, DOI 10.1016/j.diabres.2006.06.022; Kulkarni M, 2017, DIABETES OBESITY MET; Larsson Elin C., 2008, Pharmacy Pract (Granada), V6, P74; Lee WJ, 2012, J KOREAN MED SCI, V27, P255, DOI 10.3346/jkms.2012.27.3.255; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Najafi Behzad, 2016, Med J Islam Repub Iran, V30, P326; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; NORD E, 1991, HEALTH POLICY, V18, P25, DOI 10.1016/0168-8510(91)90141-J; Norris SL, 2008, ANN INTERN MED, V148, P855, DOI 10.7326/0003-4819-148-11-200806030-00008; Papastergiou J, 2016, INT J PHARM PRACT, V24, P189, DOI 10.1111/ijpp.12228; Papastergiou John, 2012, Can Pharm J (Ott), V145, P165, DOI 10.3821/145.4.cpj165; Pavlish CL, 2010, SOC SCI MED, V71, P353, DOI 10.1016/j.socscimed.2010.04.010; Porta M, 2014, DIABETES CARE, V37, P1668, DOI 10.2337/dc13-2101; Rahman M, 2012, DIABETOLOGIA, V55, P1651, DOI 10.1007/s00125-011-2441-9; Sherifali D., 2013, OPEN DIABETES J, V6, P1; Solvik UO, 2013, CLIN CHEM, V59, P1790, DOI 10.1373/clinchem.2013.210781; Soriguer F, 2012, MED CLIN-BARCELONA, V138, P371, DOI 10.1016/j.medcli.2011.05.025; Stene L, 2017, DIABETES NORWAY; Stiglic G, 2016, DIABETES RES CLIN PR, V120, P194, DOI 10.1016/j.diabres.2016.08.010; Suphanchaimat R, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1065-z; Thoopputra Thitaporn, 2016, Value Health Reg Issues, V9, P1, DOI 10.1016/j.vhri.2015.03.022; Waynes P, 2010, QUALITY MANAGEMENT A; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Willis A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091157; World Health Organization, 2003, SCREEN TYP 2 DIAB; Wu YL, 2014, INT J MED SCI, V11, P1185, DOI 10.7150/ijms.10001	47	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0191316	10.1371/journal.pone.0191316	http://dx.doi.org/10.1371/journal.pone.0191316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474501	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500007
J	McLean, N; van der Jeugd, HP; van de Pol, M				McLean, Nina; van der Jeugd, Henk P.; van de Pol, Martijn			High intra-specific variation in avian body condition responses to climate limits generalisation across species	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; POPULATION-DYNAMICS; INTRASPECIFIC VARIATION; PHENOLOGY; SIZE; TEMPERATURE; BIRDS; GREAT; MASS; DIVERSITY	It is generally assumed that populations of a species will have similar responses to climate change, and thereby that a single value of sensitivity will reflect species-specific responses. However, this assumption is rarely systematically tested. High intraspecific variation will have consequences for identifying species-or population-level traits that can predict differences in sensitivity, which in turn can affect the reliability of projections of future climate change impacts. We investigate avian body condition responses to changes in six climatic variables and how consistent and generalisable these responses are both across and within species, using 21 years of data from 46 common passerines across 80 Dutch sites. We show that body condition decreases with warmer spring/early summer temperatures and increases with higher humidity, but other climate variables do not show consistent trends across species. In the future, body condition is projected to decrease by 2050, mainly driven by temperature effects. Strikingly, populations of the same species generally responded just as differently as populations of different species implying that a single species signal is not meaningful. Consequently, species-level traits did not explain interspecific differences in sensitivities, rather population-level traits were more important. The absence of a clear species signal in body condition responses implies that generalisation and identifying species for conservation prioritisation is problematic, which sharply contrasts conclusions of previous studies on the climate sensitivity of phenology.	[McLean, Nina; van de Pol, Martijn] Australian Natl Univ, Div Evolut Ecol & Genet, Res Sch Biol, Canberra, ACT, Australia; [van der Jeugd, Henk P.; van de Pol, Martijn] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [van der Jeugd, Henk P.] Netherlands Inst Ecol NIOO KNAW, Vogeltrekstat Dutch Ctr Avian Migrat & Demog, Wageningen, Netherlands	Australian National University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	McLean, N (corresponding author), Australian Natl Univ, Div Evolut Ecol & Genet, Res Sch Biol, Canberra, ACT, Australia.	nina.m.mclean@gmail.com	van der Jeugd, Henk P/F-4891-2010; van der Jeugd, Henk/S-3159-2019; KNAW, NIOO-KNAW/A-4320-2012	van der Jeugd, Henk P/0000-0002-5332-9526; van der Jeugd, Henk/0000-0002-5332-9526; van de Pol, Martijn/0000-0003-4102-4079; KNAW, NIOO-KNAW/0000-0002-3835-159X	Australian Government Research Training Program (RTP) Scholarship; Australian Research Council Future Fellowship [FT120100204]	Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council Future Fellowship(Australian Research Council)	NM is supported by an Australian Government Research Training Program (RTP) Scholarship and MvdP by the Australian Research Council Future Fellowship (FT120100204).	Abbott RE, 2017, ECOLOGY, V98, P1071, DOI 10.1002/ecy.1738; Ambrosini R, 2016, J ANIM ECOL, V85, P749, DOI 10.1111/1365-2656.12497; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Aubry LM, 2013, GLOBAL CHANGE BIOL, V19, P149, DOI 10.1111/gcb.12013; Bailey LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167980; BAKKEN GS, 1991, J THERM BIOL, V16, P121, DOI 10.1016/0306-4565(91)90009-Q; Balbontin J, 2012, BIOL J LINN SOC, V105, P420, DOI 10.1111/j.1095-8312.2011.01800.x; Bardsen BJ, 2011, OIKOS, V120, P245, DOI 10.1111/j.1600-0706.2010.18597.x; Barton K., 2013, PACKAGE MUMIN MODEL; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; Berteaux D, 2006, CLIM RES, V32, P151, DOI 10.3354/cr032151; BIRKHEAD TR, 1976, BRIT BIRDS, V69, P490; Blanck A, 2007, J BIOGEOGR, V34, P862, DOI 10.1111/j.1365-2699.2006.01654.x; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Both C, 2004, P ROY SOC B-BIOL SCI, V271, P1657, DOI 10.1098/rspb.2004.2770; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Briga M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16600; Buckley LB, 2014, J ANIM ECOL, V83, P41, DOI 10.1111/1365-2656.12083; Buckley LB, 2012, ANNU REV ECOL EVOL S, V43, P205, DOI 10.1146/annurev-ecolsys-110411-160516; Carr JM, 2014, OECOLOGIA, V174, P713, DOI 10.1007/s00442-013-2804-7; Collins MD, 2017, J ORNITHOL, V158, P39, DOI 10.1007/s10336-016-1391-x; Cormont A, 2011, CLIM RES, V49, P59, DOI 10.3354/cr01007; Diamond SE, 2011, ECOLOGY, V92, P1005, DOI 10.1890/i0012-9658-92-5-1005; du Plessis KL, 2012, GLOBAL CHANGE BIOL, V18, P3063, DOI 10.1111/j.1365-2486.2012.02778.x; Dunn PO, 2014, J ANIM ECOL, V83, P729, DOI 10.1111/1365-2656.12162; Foden W, 2009, WILDLIFE CHANGING WO, P77; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Freckleton RP, 2011, BEHAV ECOL SOCIOBIOL, V65, P91, DOI 10.1007/s00265-010-1045-6; Gamfeldt L, 2005, ECOLOGY, V86, P3219, DOI 10.1890/05-0377; Garant D, 2004, AM NAT, V164, pE115, DOI 10.1086/424764; Gardner JL, 2016, ECOLOGY, V97, P786, DOI 10.1890/15-0642.1; Gardner JL, 2014, GLOBAL CHANGE BIOL, V20, P2062, DOI 10.1111/gcb.12507; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gardner JL., 2016, CLIMATE CHANGE RESPO, V3, P1, DOI 10.118/s40665-016-0026-z; Gerson AR, 2011, SCIENCE, V333, P1434, DOI 10.1126/science.1210449; Goodman RE, 2012, GLOBAL CHANGE BIOL, V18, P63, DOI 10.1111/j.1365-2486.2011.02538.x; Gosler AG, 1998, BIRD STUDY, V45, P92, DOI 10.1080/00063659809461082; Grotan V, 2008, GLOBAL CHANGE BIOL, V14, P218, DOI 10.1111/j.1365-2486.2007.01484.x; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jiguet F, 2010, P ROYAL SOC B; Kampichler C, 2011, ARDEA, V99, P129, DOI 10.5253/078.099.0202; Kanuscak P, 2004, OECOLOGIA, V141, P158, DOI 10.1007/s00442-004-1646-8; Klein Tank A, 2009, KNMI 06 SCENARIOS S; KNMI, 2015, KNMI 14 KLIM NED LEI; KONARZEWSKI M, 1989, ORNIS SCAND, V20, P112, DOI 10.2307/3676877; Krause JS, 2016, GEN COMP ENDOCR, V237, P10, DOI 10.1016/j.ygcen.2016.07.015; Kruuk LEB, 2015, GLOBAL CHANGE BIOL, V21, P2929, DOI 10.1111/gcb.12926; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Malyshev AV, 2016, GLOBAL CHANGE BIOL, V22, P449, DOI 10.1111/gcb.13114; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McLean N, 2016, ECOL LETT, V19, P595, DOI 10.1111/ele.12599; Medina I, 2016, AM NAT, V187, P351, DOI 10.1086/684627; Moller AP, 2002, J ANIM ECOL, V71, P201, DOI 10.1046/j.1365-2656.2002.00589.x; Mullarney K, 2000, COMPLETE GUIDE BIRDS; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Oney B, 2013, ECOL EVOL, V3, P437, DOI 10.1002/ece3.426; Oswald SA, 2008, J AVIAN BIOL, V39, P163, DOI 10.1111/j.2008.0908-8857.04187.x; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; Paquette SR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0649; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Pendlebury CJ, 2004, J EXP BIOL, V207, P2065, DOI 10.1242/jeb.00999; Petchey OL, 2015, ECOL LETT, V18, P597, DOI 10.1111/ele.12443; Phillimore AB, 2010, P NATL ACAD SCI USA, V107, P8292, DOI 10.1073/pnas.0913792107; Quillfeldt P, 2006, POLAR BIOL, V29, P372, DOI 10.1007/s00300-005-0066-5; Rahmstorf S, 2012, ENVIRON RES LETT, V7, DOI [10.1088/1748-9326/7/4/044035, 10.1088/1748-9326/7/2/021001]; Reed TE, 2013, J ANIM ECOL, V82, P131, DOI 10.1111/j.1365-2656.2012.02020.x; Robinson Robert A., 2009, Ringing & Migration, V24, P199; Rogers CM, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00317.1; Rubolini D, 2007, CLIM RES, V35, P135, DOI 10.3354/cr00720; Saether BE, 2003, P ROY SOC B-BIOL SCI, V270, P2397, DOI 10.1098/rspb.2003.2499; Salewski V, 2010, OECOLOGIA, V162, P247, DOI 10.1007/s00442-009-1446-2; Sandvik H, 2012, MAR ECOL PROG SER, V454, P273, DOI 10.3354/meps09558; Sanz JJ, 2002, GLOBAL CHANGE BIOL, V8, P409, DOI 10.1046/j.1365-2486.2002.00496.x; Seebacher F, 2012, FUNCT ECOL, V26, P1418, DOI 10.1111/j.1365-2435.2012.02052.x; Senar JC, 2002, BEHAV ECOL, V13, P725, DOI 10.1093/beheco/13.6.725; SNIJDERS TAB, 2011, INT ENCY STAT SCI, P879, DOI DOI 10.1007/978-3-642-04898-2_387; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; STEEN I, 1965, ACTA PHYSIOL SCAND, V63, P285, DOI 10.1111/j.1748-1716.1965.tb04067.x; Stephens PA, 2016, SCIENCE, V352, P84, DOI 10.1126/science.aac4858; Stevens VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011123; Svensson L., 1992, IDENTIFICATION GUIDE; Thackeray SJ, 2016, NATURE, V535, P241, DOI 10.1038/nature18608; Usui T, 2017, J ANIM ECOL, V86, P250, DOI 10.1111/1365-2656.12612; Van Buskirk J, 2010, OIKOS, V119, P1047, DOI 10.1111/j.1600-0706.2009.18349.x; van de Pol M, 2016, METHODS ECOL EVOL, V7, P1246, DOI 10.1111/2041-210X.12590; Visser ME, 2003, P ROY SOC B-BIOL SCI, V270, P367, DOI 10.1098/rspb.2002.2244; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Yom-Tov Y, 2006, OIKOS, V112, P91, DOI 10.1111/j.0030-1299.2006.14183.x	95	19	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192401	10.1371/journal.pone.0192401	http://dx.doi.org/10.1371/journal.pone.0192401			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466460	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000425604300056
J	Purkayastha, GD; Mangar, P; Saha, A; Saha, D				Purkayastha, Gargee Dhar; Mangar, Preeti; Saha, Aniruddha; Saha, Dipanwita			Evaluation of the biocontrol efficacy of a Serratia marcescens strain indigenous to tea rhizosphere for the management of root rot disease in tea	PLOS ONE			English	Article							PLANT-GROWTH; BIOLOGICAL-CONTROL; ANTIFUNGAL ACTIVITY; BIOFILM FORMATION; PSEUDOMONAS-FLUORESCENS; SYSTEMIC RESISTANCE; BACILLUS-SUBTILIS; BROAD-SPECTRUM; PLYMUTHICA; BIOSYNTHESIS	The aim of the present study is to evaluate plant growth promoting and biocontrol efficacy of a Serratia marcescens strain ETR17 isolated from tea rhizosphere for the effective management of root rot disease in tea. Isolated bacterial culture ETR17 showed significant level of in vitro antagonism against nine different foliar and root pathogens of tea. The phenotypic and molecular characterization of ETR17 revealed the identity of the bacterium as Serratia marcescens. The bacterium was found to produce several hydrolytic enzymes like chitinase, protease, lipase, cellulase and plant growth promoting metabolites like IAA and siderophore. Scanning electron microscopic studies on the interaction zone between pathogen and antagonistic bacterial isolate revealed severe deformities in the fungal mycelia. Spectral analyses (LC-ESI-MS, UV-VIS spectrophotometry and HPLC) and TLC indicated the presence of the antibiotics pyrrolnitrin and prodigiosin in the extracellular bacterial culture extracts. Biofilm formation by ETR17 on polystyrene surface was also observed. In vivo application of talc-based formulations prepared with the isolate ETR17 in tea plantlets under green house conditions revealed effective reduction of root-rot disease as well as plant growth promotion to a considerable extent. Viability studies with the ETR17 talc formulation showed the survivability of the isolate up to six months at room temperature. The sustenance of ETR17 (concentration of 8-9x10(8) cfu g(-1)) in the soil after the application of talc formulation was recorded by ELISA. Safety studies revealed that ETR17 did not produce hemolysin as observed in pathogenic Serratia strains. The biocontrol strain reported in this study can be used for field application in order to minimize the use of chemical fungicides for disease control in tea gardens.	[Purkayastha, Gargee Dhar; Saha, Dipanwita] Univ North Bengal, Dept Biotechnol, Siliguri, W Bengal, India; [Mangar, Preeti; Saha, Aniruddha] Univ North Bengal, Dept Bot, Siliguri, W Bengal, India	University of North Bengal; University of North Bengal	Saha, D (corresponding author), Univ North Bengal, Dept Biotechnol, Siliguri, W Bengal, India.	dsahanbu@yahoo.com			Council of Scientific & Industrial Research (CSIR), India [9/285(0064)/2013]; University Grants Commission (UGC), India [F.25-1/2014-15(BSR)/7-132/2007(BSR)]	Council of Scientific & Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC), India(University Grants Commission, India)	This work was supported by: 1. Council of Scientific & Industrial Research (CSIR), India (www.csirhrdg.res.in/) Grant No. 9/285(0064)/2013, EMR I dated 14.03.2013; 2. University Grants Commission (UGC), India (www.ugc.ac.in/) Grant No. F.25-1/2014-15(BSR)/7-132/2007(BSR) dated 07.10.2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aneja KR, 2003, EXPT MICROBIOLOGY PL, V4; Arnow LE, 1937, J BIOL CHEM, V118, P531; Baakza A, 2004, J EXP MAR BIOL ECOL, V311, P1, DOI 10.1016/j.jembe.2003.12.028; Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; BAKKER AW, 1987, SOIL BIOL BIOCHEM, V19, P451, DOI 10.1016/0038-0717(87)90037-X; Bargabus RL, 2002, PHYSIOL MOL PLANT P, V61, P289, DOI 10.1006/pmpp.2003.0443; Barrow G.I., 1993, COWAN STEELS MANUAL, V3rd; Bashan Y., 2016, SUPERIOR POLYM FORMU, P15; Berg G, 2005, APPL ENVIRON MICROB, V71, P4203, DOI 10.1128/AEM.71.8.4203-4213.2005; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Cattelan AJ, 1999, SOIL SCI SOC AM J, V63, P1670, DOI 10.2136/sssaj1999.6361670x; Chakraborty U, 2010, J PLANT INTERACT, V5, P261, DOI 10.1080/17429140903551738; Chakraborty U, 2009, J APPL MICROBIOL, V107, P625, DOI 10.1111/j.1365-2672.2009.04242.x; Chandramouli B., 1999, GLOBAL ADV TEA SCI, P647; Chen YW, 2015, GENOM DATA, V4, P33, DOI 10.1016/j.gdata.2015.01.006; Chernin L, 1996, CURR MICROBIOL, V32, P208, DOI 10.1007/s002849900037; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Costa R, 2009, ENVIRON MICROBIOL, V11, P159, DOI 10.1111/j.1462-2920.2008.01750.x; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Dasgupta S, 2005, J APPL MICROBIOL, V98, P1084, DOI 10.1111/j.1365-2672.2005.02538.x; De La Fuente L, 2004, EUR J PLANT PATHOL, V110, P671, DOI 10.1023/B:EJPP.0000041569.35143.22; Dias M.C., 2012, J BOT, P135479, DOI [10.1155/2012/135479, DOI 10.1155/2012/135479]; Duffy B, 2004, APPL ENVIRON MICROB, V70, P1836, DOI 10.1128/AEM.70.3.1836-1842.2004; ELDER BL, 1982, J CLIN MICROBIOL, V16, P141, DOI 10.1128/JCM.16.1.141-144.1982; Soares ACF, 2007, SCI AGR, V64, P641, DOI 10.1590/S0103-90162007000600013; Frankowski J, 2001, ARCH MICROBIOL, V176, P421, DOI 10.1007/s002030100347; Ge YH, 2007, CURR MICROBIOL, V54, P277, DOI 10.1007/s00284-006-0317-x; George P, 2013, WORLD J MICROB BIOT, V29, P109, DOI 10.1007/s11274-012-1163-6; Gerbore J, 2014, ENVIRON SCI POLLUT R, V21, P4847, DOI 10.1007/s11356-013-1807-6; Gomes L.H., 2000, SCI AGR, V57, P553, DOI DOI 10.1590/S0103-90162000000300028; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Gyaneshwar P, 2001, J BACTERIOL, V183, P2634, DOI 10.1128/JB.183.8.2634-2645.2001; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hammer PE, 1997, APPL ENVIRON MICROB, V63, P2147, DOI 10.1128/AEM.63.6.2147-2154.1997; Harvey J, 2007, FOOD MICROBIOL, V24, P380, DOI 10.1016/j.fm.2006.06.006; Hofte M, 2010, RES MICROBIOL, V161, P464, DOI 10.1016/j.resmic.2010.04.007; INBAR J, 1995, MICROBIOL-SGM, V141, P2823, DOI 10.1099/13500872-141-11-2823; Gutierrez-Roman MI, 2015, BIOCONTROL, V60, P565, DOI 10.1007/s10526-015-9655-6; Gutierrez-Roman MI, 2014, WORLD J MICROB BIOT, V30, P33, DOI 10.1007/s11274-013-1421-2; Jaiganesh V., 2007, Notulae Botanicae, Horti Agrobotanici, Cluj-Napoca, V35, P48; Kamensky M, 2003, SOIL BIOL BIOCHEM, V35, P323, DOI 10.1016/S0038-0717(02)00283-3; Kim PI, 2004, FEMS MICROBIOL LETT, V234, P177, DOI 10.1111/j.1574-6968.2004.tb09530.x; Kim YC, 2011, APPL ENVIRON MICROB, V77, P1548, DOI 10.1128/AEM.01867-10; Kirner S, 1996, MICROBIOL-UK, V142, P2129, DOI 10.1099/13500872-142-8-2129; Kobayashi DY, 2002, APPL ENVIRON MICROB, V68, P1047, DOI 10.1128/AEM.68.3.1047-1054.2002; Kobriger KM, 1998, ANAL SNAP BEAN ROOT; KONIG W, 1987, INFECT IMMUN, V55, P2554; Kumar RS, 2005, J APPL MICROBIOL, V98, P145, DOI 10.1111/j.1365-2672.2004.02435.x; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Latz E, 2015, FUNCT ECOL, V29, P1225, DOI 10.1111/1365-2435.12417; LEVITCH ME, 1964, ARCH BIOCHEM BIOPHYS, V106, P194, DOI 10.1016/0003-9861(64)90175-4; LIM HS, 1991, APPL ENVIRON MICROB, V57, P510, DOI 10.1128/AEM.57.2.510-516.1991; Liu XG, 2007, FEMS MICROBIOL LETT, V270, P299, DOI 10.1111/j.1574-6968.2007.00681.x; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mandal P, 2006, INDIAN PHYTOPATHOL, V59, P384; Mehmood MA, 2009, WORLD J MICROB BIOT, V25, P1955, DOI 10.1007/s11274-009-0094-3; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Meziane H, 2006, POSTHARVEST BIOL TEC, V39, P125, DOI 10.1016/j.postharvbio.2005.10.007; Miller JH, 1974, EXPT MOL GENETICS; Muller H, 2009, FEMS MICROBIOL ECOL, V67, P468, DOI 10.1111/j.1574-6941.2008.00635.x; Murray R. G. E., 1994, P21; Nandakumar R, 2001, BIOCONTROL, V46, P493, DOI 10.1023/A:1014131131808; Neupane S, 2015, ENV MICROBIOL REP, V7, P123, DOI 10.1111/1758-2229.12203; ORDENTLICH A, 1988, PHYTOPATHOLOGY, V78, P84; Ovadis M, 2004, J BACTERIOL, V186, P4986, DOI 10.1128/JB.186.15.4986-4993.2004; Pal KK, 2006, PLANT HLTH INSTRUCTO, V2, P1117, DOI [DOI 10.1094/PHI-A-2006-1117-02, 10.1094/PHI-A-2006-1117-02]; Pang YD, 2009, EUR J PLANT PATHOL, V124, P261, DOI 10.1007/s10658-008-9411-1; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Petersen LM, 2013, CAN J MICROBIOL, V59, P627, DOI 10.1139/cjm-2013-0343; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; PIKOVSKAIA R. I., 1948, Mikrobiologiya, V17, P362; Press CM, 2001, PHYTOPATHOLOGY, V91, P593, DOI 10.1094/PHYTO.2001.91.6.593; Purkayastha G. Dhar, 2010, Journal of Mycology and Plant Pathology, V40, P27; Raaijmakers JM, 2002, ANTON LEEUW INT J G, V81, P537, DOI 10.1023/A:1020501420831; Ray S. K., 2012, International Journal of Agriculture Sciences, V4, P325; Saha A, 2008, J ENVIRON BIOL, V29, P407; Saha A., 2001, Environment and Ecology, V19, P846; Saha D, 2005, PHARM BIOL, V43, P87, DOI 10.1080/13880200590903426; Saha D, 2012, J PLANT PATHOL, V94, P109; Saha D, 2012, FRONT REC DEV PLANT, V1, P99; Saha D, 2012, IND CROP PROD, V37, P376, DOI 10.1016/j.indcrop.2011.12.030; Sahu G. K., 2011, Research Journal of Microbiology, V6, P735, DOI 10.3923/jm.2011.735.749; Sakai M, 1991, ASIAN FISH SCI, V4, P23; Samain E, 2017, BIOL CONTROL, V114, P87, DOI 10.1016/j.biocontrol.2017.07.012; Sarmah K. C., 1960, 26 IND TEA ASS TOCKL; Sayyed R. Z., 2005, Indian Journal of Biotechnology, V4, P484; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Selim S, 2009, J PLANT PATHOL, V91, P391; Selim S, 2010, APPL ENVIRON MICROB, V76, P7420, DOI 10.1128/AEM.00171-10; SHANAHAN P, 1992, APPL ENVIRON MICROB, V58, P353, DOI 10.1128/AEM.58.1.353-358.1992; Shanmugam V, 2011, FOLIA MICROBIOL, V56, P170, DOI 10.1007/s12223-011-0031-3; Singh ID, 2005, PLANTERS GUIDE TEA C; Smibert Robert M., 1994, P607; Someya N, 2005, BIOCONTROL SCI TECHN, V15, P105, DOI 10.1080/09583150400016092; Someya N, 2000, PLANT DIS, V84, P334, DOI 10.1094/PDIS.2000.84.3.334; Someya Nobutaka, 2001, Journal of General Plant Pathology, V67, P312, DOI 10.1007/PL00013038; Someya N, 2009, NATURWISSENSCHAFTEN, V96, P743, DOI 10.1007/s00114-009-0524-y; Tan DW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131780; Thomson NR, 2000, MOL MICROBIOL, V36, P539, DOI 10.1046/j.1365-2958.2000.01872.x; Timmusk S, 2005, APPL ENVIRON MICROB, V71, P7292, DOI 10.1128/AEM.71.11.7292-7300.2005; TSUCHIYA K, 1991, Annals of the Phytopathological Society of Japan, V57, P196, DOI 10.3186/jjphytopath.57.196; de Queiroz BPV, 2006, BRAZ J MICROBIOL, V37, P448, DOI 10.1590/S1517-83822006000400008; Wang K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/397142; Whipps JM, 2001, J EXP BOT, V52, P487, DOI 10.1093/jexbot/52.suppl_1.487; Zachow C, 2009, EUR J PLANT PATHOL, V125, P367, DOI 10.1007/s10658-009-9486-3; Zaheer A, 2016, RES MICROBIOL, V167, P510, DOI 10.1016/j.resmic.2016.04.001	107	42	45	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0191761	10.1371/journal.pone.0191761	http://dx.doi.org/10.1371/journal.pone.0191761			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466418	Green Submitted, gold, Green Published			2022-12-26	WOS:000425604300016
J	Trachsel, LD; Ryffel, CP; De Marchi, S; Seiler, C; Brugger, N; Eser, P; Wilhelm, M				Trachsel, Lukas D.; Ryffel, Christoph P.; De Marchi, Stefano; Seiler, Christian; Brugger, Nicolas; Eser, Prisca; Wilhelm, Matthias			Exercise-induced cardiac remodeling in none-lite endurance athletes: Comparison of 2-tiered and 4-tiered classification of left ventricular hypertrophy	PLOS ONE			English	Article							HEART; RISK; MASS; GUIDELINES; MANAGEMENT; GEOMETRY	Background Long-term endurance sport practice leads to eccentric left ventricular hypertrophy (LVH). We aimed to compare the new 4-tiered classification (4TC) for LVH with the established 2-tiered classification (2TC) in a cohort of normotensive non-elite endurance athletes. Methods Male participants of a 10-mile race were recruited and included when blood pressure (BP) was normal (< 140/90 mmHg). Phenotypic characterization of LVH was based on relative wall thickness (2TC), and on LV concentricity 2/3 (LV mass/end-diastolic volume [LVM/ EDV] 2/3) plus LVEDV index (4TC). Parameters of LV geometry, BP, cumulative training hours, and race time were compared between 2TC and 4TC by analysis of variance, and post-hoc analysis. Results Of 198 athletes recruited, 174 were included. Mean age was 41.6 +/- 7.5 years. Forty-two (24%) athletes had LVH. Allocation in the 2TC was: 32 (76%) eccentric LVH and 10 (24%) concentric LVH. Using the 4TC 12 were reclassified to concentric LVH, and 2 to eccentric LVH, resulting in 22 (52%) eccentric LVH (7 non-dilated, 15 dilated), and 20 (48%) concentric LVH (all non-dilated). Based on the 2TC, markers of endurance training did not differ between eccentric and concentric LVH. Based on the 4TC, athletes with eccentric LVH had more cumulative training hours and faster race times, with highest values thereof in athletes with eccentric dilated LVH. Conclusions In our cohort of normotensive endurance athletes, the new 4TC demonstrated a superior discrimination of exercise-induced LVH patterns, compared to the established 2TC, most likely because it takes three-dimensional information of the ventricular geometry into account.	[Trachsel, Lukas D.; Ryffel, Christoph P.; De Marchi, Stefano; Seiler, Christian; Brugger, Nicolas; Eser, Prisca; Wilhelm, Matthias] Univ Bern, Bern Univ Hosp, Inselspital, Prevent Cardiol & Sports Med,Univ Clin Cardiol, Bern, Switzerland	University of Bern; University Hospital of Bern	Wilhelm, M (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Prevent Cardiol & Sports Med,Univ Clin Cardiol, Bern, Switzerland.	matthias.wilhelm@insel.ch	Eser, Prisca/AAE-3758-2021; Wilhelm, Matthias/AAS-9456-2020	Wilhelm, Matthias/0000-0003-4541-3995; Ryffel, Christoph/0000-0002-5861-5599	Inselspital, University Hospital Bern, Switzerland	Inselspital, University Hospital Bern, Switzerland	The study was funded by an internal grant of the Inselspital, University Hospital Bern, Switzerland.	Arbab-Zadeh A, 2014, CIRCULATION, V130, P2152, DOI 10.1161/CIRCULATIONAHA.114.010775; Bang CN, 2014, CIRC-CARDIOVASC IMAG, V7, P422, DOI 10.1161/CIRCIMAGING.113.001275; Brugger N, 2014, INT J CARDIOL, V170, P419, DOI 10.1016/j.ijcard.2013.11.032; Drazner MH, 2004, J AM COLL CARDIOL, V43, P2207, DOI 10.1016/j.jacc.2003.11.064; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Finocchiaro G, 2016, JACC CARDIOVASC IMAG; Garg S, 2015, JACC-CARDIOVASC IMAG, V8, P1034, DOI 10.1016/j.jcmg.2015.06.007; Khouri MG, 2010, CIRC-CARDIOVASC IMAG, V3, P164, DOI 10.1161/CIRCIMAGING.109.883652; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; Pelliccia A, 2010, J AM COLL CARDIOL, V55, P1619, DOI 10.1016/j.jacc.2009.10.068; Schiros CG, 2013, AM J CARDIOL, V111, P1067, DOI 10.1016/j.amjcard.2012.12.027; Trachsel LD, 2015, J HYPERTENS, V33, P1276, DOI 10.1097/HJH.0000000000000558; Utomi V, 2013, HEART, V99, P1727, DOI 10.1136/heartjnl-2012-303465; Weiner RB, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.003651; Wilhelm M, 2011, AM J CARDIOL, V108, P580, DOI 10.1016/j.amjcard.2011.03.086	20	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0193203	10.1371/journal.pone.0193203	http://dx.doi.org/10.1371/journal.pone.0193203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462182	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200056
J	Liu, GT; Kung, HN; Chen, CK; Huang, C; Wang, YL; Yu, CP; Lee, CP				Liu, Guan-Ting; Kung, Hsiu-Ni; Chen, Chung-Kuan; Huang, Cheng; Wang, Yung-Li; Yu, Cheng-Pu; Lee, Chung-Pei			Improving nuclear envelope dynamics by EBV BFRF1 facilitates intranuclear component clearance through autophagy	FASEB JOURNAL			English	Article						autophagic proteolysis; Epstein-Barr virus; vesicular nucleocytoplasmic transport; nuclear component catabolism	EPSTEIN-BARR-VIRUS; PROTEIN-QUALITY-CONTROL; MEMBRANE-FILTER ASSAY; EGRESS COMPLEX; SELECTIVE AUTOPHAGY; HUNTINGTONS-DISEASE; VIRAL REPLICATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MAMMALIAN-CELLS	Although a vesicular nucleocytoplasmic transport system is believed to exist in eukaryotic cells, the features of this pathway are mostly unknown. Here, we report that the BFRF1 protein of the Epstein-Barr virus improves vesicular transport of nuclear envelope (NE) to facilitate the translocation and clearance of nuclear components. BFRF1 expression induces vesicles that selectively transport nuclear components to the cytoplasm. With the use of aggregation-prone proteins as tools, we found that aggregated nuclear proteins are dispersed when these BFRF1-induced vesicles are formed. BFRF1-containing vesicles engulf the NE-associated aggregates, exit through from the NE, and putatively fuse with autophagic vacuoles. Chemical treatment and genetic ablation of autophagy-related factors indicate that autophagosome formation and autophagy-linked FYVE protein-mediated autophagic proteolysis are involved in this selective clearance of nuclear proteins. Remarkably, vesicular transport, elicited by BFRF1, also attenuated nuclear aggregates accumulated in neuroblastoma cells. Accordingly, induction of NE-derived vesicles by BFRF1 facilitates nuclear protein translocation and clearance, suggesting that autophagy-coupled transport of nucleus-derived vesicles can be elicited for nuclear component catabolism in mammalian cells.Liu, G.-T., Kung, H.-N., Chen, C.-K., Huang, C., Wang, Y.-L., Yu, C.-P., Lee, C.-P. Improving nuclear envelope dynamics by EBV BFRF1 facilitates intranuclear component clearance through autophagy.	[Liu, Guan-Ting; Chen, Chung-Kuan; Wang, Yung-Li; Yu, Cheng-Pu; Lee, Chung-Pei] Natl Taipei Univ Nursing & Hlth Sci, Sch Nursing, Taipei, Taiwan; [Kung, Hsiu-Ni] Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei, Taiwan; [Huang, Cheng] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei, Taiwan	National Taipei University of Nursing & Health Science (NTUNHS); National Taiwan University; National Yang Ming Chiao Tung University	Lee, CP (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, S214 Room,365 Min Te Rd, Taipei 11219, Taiwan.	chungpei@ntunhs.edu.tw	Kung, Hsiu-Ni/B-4832-2009	KUNG, HSIU-NI/0000-0001-6979-8346; Chen, Chung-Kuan/0000-0002-6973-2563	Ministry of Science and Technology, Taipei, Taiwan [MOST102-2320-B-227-002, MOST103-2320-B-227-001-MY3, MOST106-2320-B-227-001-MY3]	Ministry of Science and Technology, Taipei, Taiwan	For material support, the authors thank Dr. Elizabeth Sztul (University of Alabama at Birmingham, Birmingham, AL, USA) for plasmids expressing GFP170*; Drs. Pang-Hsien Tu and Wen-Chuan Shen (Academia Sinica, Taipai, Taiwan) for plasmids expressing Htt25Q-NLS and Htt81Q-NLS; Dr. Noboru Mizushima (Tokyo Medical and Dental University, Tokyo, Japan) for ATG5 WT and null MEF cells; Dr. Ching-wa Tsai (National Taiwan University College of Medicine) for NA and Akata cells; and the National RNAi Core Facility (Taipei, Taiwan) for short hairpin RNA-containing lentiviral reagents. For technical support, the authors are grateful to Yun-Yu Sun (Image Core Lab at National Taiwan University Hospital); Hua-Man Hsu and Dr. Cheng-Yen Huang [First Core Facility at National Taiwan University College of Medicine, and the Imaging Core Facility of Nanotechnology of the University System of Taiwan-National Yang-Ming University (UST-YMU)] for the technical assistance on confocal and live-cell imaging; Horng-Tzer Shy (National Taiwan University College of Medicine) for EM sample preparation; and Drs. Mei-Ru Chen and Mei-Tzu Su (National Taiwan University College of Medicine) for equipment and cell line supports. Finally, the authors thank Drs. Anne Simonsen and Alf Hakon Lystad (Institute of Basic Medical Sciences, Oslo, Norway); Drs. Y. Henry Sun, Yijuang Chern, and Steve S.-L. Chen (Academia Sinica); and Dr. Yao Chang (National Health Research Institutes, Taipei, Taiwan) for experimental suggestions. This study was supported by Grants MOST102-2320-B-227-002, MOST103-2320-B-227-001-MY3, and MOST106-2320-B-227-001-MY3 from the Ministry of Science and Technology, Taipei, Taiwan). The authors declare no conflicts of interest.	Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bigalke JM, 2015, J VIROL, V89, P9150, DOI 10.1128/JVI.02530-14; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Boban M, 2016, NUCLEUS-PHILA, V7, P41, DOI 10.1080/19491034.2016.1139273; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cautain B, 2015, FEBS J, V282, P445, DOI 10.1111/febs.13163; Chang E, 2008, ANAL BIOCHEM, V373, P330, DOI 10.1016/j.ab.2007.09.015; Chang Y, 1999, J VIROL, V73, P8857, DOI 10.1128/JVI.73.10.8857-8866.1999; Chow KH, 2012, NAT REV CANCER, V12, P196, DOI 10.1038/nrc3219; Chun WJ, 2001, NEUROBIOL DIS, V8, P391, DOI 10.1006/nbdi.2001.0390; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548; Eenjes E, 2016, J CELL SCI, V129, P1260, DOI 10.1242/jcs.179978; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; English L, 2009, AUTOPHAGY, V5, P1026, DOI 10.4161/auto.5.7.9163; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Fukuda M, 2008, AUTOPHAGY, V4, P824, DOI 10.4161/auto.6542; Gonnella R, 2005, J VIROL, V79, P3713, DOI 10.1128/JVI.79.6.3713-3727.2005; Granato M, 2014, J VIROL, V88, P12715, DOI 10.1128/JVI.02199-14; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Hagen C, 2015, CELL, V163, P1692, DOI 10.1016/j.cell.2015.11.029; Hellberg T, 2016, ADV VIRUS RES, V94, P81, DOI 10.1016/bs.aivir.2015.10.002; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Isakson P, 2013, CELL DEATH DIFFER, V20, P12, DOI 10.1038/cdd.2012.66; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Jokhi V, 2013, CELL REP, V3, P988, DOI 10.1016/j.celrep.2013.03.015; Kaufmann A, 2014, CELL, V156, P469, DOI 10.1016/j.cell.2013.12.022; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Lee CP, 2016, J VIROL, V90, P8994, DOI 10.1128/JVI.01235-16; Lee CP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002904; Lee JY, 2010, AUTOPHAGY, V6, P555, DOI 10.4161/auto.6.4.11812; Leigh KE, 2015, P NATL ACAD SCI USA, V112, P9010, DOI 10.1073/pnas.1511140112; Lye MF, 2015, EMBO J, V34, P2937, DOI 10.15252/embj.201592651; Lystad AH, 2014, EMBO REP, V15, P557, DOI 10.1002/embr.201338003; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Matunis MJ, 2006, METHODS, V39, P277, DOI 10.1016/j.ymeth.2006.06.003; MCKEON FD, 1986, NATURE, V319, P463, DOI 10.1038/319463a0; Mijaljica D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040013; Mijaljica D, 2010, NUCLEUS-PHILA, V1, P213, DOI 10.4161/nucl.1.3.11738; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Nowag H, 2014, EBIOMEDICINE, V1, P116, DOI 10.1016/j.ebiom.2014.11.007; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Rose A, 2012, TRENDS CELL BIOL, V22, P509, DOI 10.1016/j.tcb.2012.07.003; Sarisky RT, 1996, J VIROL, V70, P8340, DOI 10.1128/JVI.70.12.8340-8347.1996; SEIGNEURIN JM, 1977, J VIROL, V24, P836, DOI 10.1128/JVI.24.3.836-845.1977; Shen WC, 2015, AUTOPHAGY, V11, P685, DOI 10.4161/auto.36098; Slobodkin MR, 2013, ESSAYS BIOCHEM, V55, P51, DOI [10.1042/bse0550051, 10.1042/BSE0550051]; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Walzer SA, 2015, J BIOL CHEM, V290, P27452, DOI 10.1074/jbc.C115.686527; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Zeev-Ben-Mordehai T, 2015, CELL REP, V13, P2645, DOI 10.1016/j.celrep.2015.11.008	61	9	9	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3968	3983		10.1096/fj.201701253R	http://dx.doi.org/10.1096/fj.201701253R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29481305				2022-12-26	WOS:000435104500041
J	Huang, F; Shao, W; Fujinaga, K; Peterlin, BM				Huang, Fang; Shao, Wei; Fujinaga, Koh; Peterlin, B. Matija			Bromodomain-containing protein 4-independent transcriptional activation by autoimmune regulator (AIRE) and NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene transcription; NF-kB transcription factor; transcription factor; chromatin; transcription promoter; gene expression; bromodomain-containing protein 4; epigenetic regulation	RNA-POLYMERASE-II; SMALL NUCLEAR RIBONUCLEOPROTEIN; P-TEFB; GENE-EXPRESSION; EUKARYOTIC TRANSCRIPTION; ACETYLATED CHROMATIN; SUPER-ENHANCERS; TARGET GENES; ELONGATION; BRD4	Autoimmune regulator (AIRE) and nuclear factor-B (NF-B) are transcription factors (TFs) that direct the expression of individual genes and gene clusters. Bromodomain-containing protein 4 (BRD4) is an epigenetic regulator that recognizes and binds to acetylated histones. BRD4 also has been reported to promote interactions between the positive transcription elongation factor b (P-TEFb) and AIRE or P-TEFb and NF-B subunit p65. Here, we report that AIRE and p65 bind to P-TEFb independently of BRD4. JQ1, a compound that disrupts interactions between BRD4 and acetylated proteins, does not decrease transcriptional activities of AIRE or p65. Moreover, siRNA-mediated inactivation of BRD4 alone or in combination with JQ1 had no effects on AIRE- and NF-B-targeted genes on plasmids and in chromatin and on interactions between P-TEFb and AIRE or NF-B. Finally, ChIP experiments revealed that recruitment of P-TEFb to AIRE or p65 to transcription complexes was independent of BRD4. We conclude that direct interactions between AIRE, NF-B, and P-TEFb result in efficient transcription of their target genes.	[Peterlin, B. Matija] Univ Calif San Francisco, Dept Med, U432,Box 0703,533 Parnassus Ave, San Francisco, CA 94143 USA; [Peterlin, B. Matija] Univ Calif San Francisco, Dept Microbiol, U432,Box 0703,533 Parnassus Ave, San Francisco, CA 94143 USA; [Peterlin, B. Matija] Univ Calif San Francisco, Dept Immunol, U432,Box 0703,533 Parnassus Ave, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med, U432,Box 0703,533 Parnassus Ave, San Francisco, CA 94143 USA.; Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Microbiol, U432,Box 0703,533 Parnassus Ave, San Francisco, CA 94143 USA.; Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Immunol, U432,Box 0703,533 Parnassus Ave, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu		HUANG, FANG/0000-0002-0511-2568	Nora Eccles Treadwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125104] Funding Source: NIH RePORTER	Nora Eccles Treadwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Nora Eccles Treadwell Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Bansal K, 2017, NAT IMMUNOL, V18, P263, DOI 10.1038/ni.3675; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Bi HL, 2014, MOL BIOL CELL, V25, P2499, DOI 10.1091/mbc.E13-12-0733; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Diamant G, 2013, BBA-GENE REGUL MECH, V1829, P937, DOI 10.1016/j.bbagrm.2013.04.007; Ebmeier CC, 2017, CELL REP, V20, P1173, DOI 10.1016/j.celrep.2017.07.021; Fujinaga K, 2012, NUCLEIC ACIDS RES, V40, P9160, DOI 10.1093/nar/gks682; Gressel S, 2017, ELIFE, V6, DOI 10.7554/eLife.29736; Herrmann H, 2012, ONCOTARGET, V3, P1588, DOI 10.18632/oncotarget.733; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Krishnamurthy S, 2009, CURR BIOL, V19, pR153, DOI 10.1016/j.cub.2008.11.052; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Lin X, 2002, J BIOL CHEM, V277, P16873, DOI 10.1074/jbc.M200117200; Liu PY, 2014, J BIOL CHEM, V289, P9918, DOI 10.1074/jbc.M113.539015; Liu Y, 2008, BIOCHEMISTRY-US, V47, P6403, DOI 10.1021/bi8001659; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Patel MC, 2013, MOL CELL BIOL, V33, P2497, DOI 10.1128/MCB.01180-12; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Saenz DT, 2017, LEUKEMIA, V31, P1951, DOI 10.1038/leu.2016.393; Shao W, 2016, J BIOL CHEM, V291, P17953, DOI 10.1074/jbc.M116.724401; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; Wang RR, 2012, J BIOL CHEM, V287, P10738, DOI 10.1074/jbc.M111.323493; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Winter GE, 2017, MOL CELL, V67, P5, DOI 10.1016/j.molcel.2017.06.004; Yoshida H, 2015, P NATL ACAD SCI USA, V112, pE4448, DOI 10.1073/pnas.1512081112; Zumer K, 2013, J IMMUNOL, V190, P2479, DOI 10.4049/jimmunol.1203210; Zumer K, 2012, MOL CELL BIOL, V32, P1354, DOI 10.1128/MCB.06359-11; Zumer K, 2011, NUCLEIC ACIDS RES, V39, P7908, DOI 10.1093/nar/gkr527	42	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					4993	5004		10.1074/jbc.RA117.001518	http://dx.doi.org/10.1074/jbc.RA117.001518			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29463681	hybrid, Green Published			2022-12-26	WOS:000429409300004
J	Fife, D; Cepeda, MS; Baseman, A; Richards, H; Hu, P; Starr, HL; Sena, AG				Fife, Daniel; Cepeda, M. Soledad; Baseman, Alan; Richards, Henry; Hu, Peter; Starr, H. Lynn; Sena, Anthony G.			Medication changes after switching from CONCERTA (R) brand methylphenidate HCI to a generic long-acting formulation: A retrospective database study	PLOS ONE			English	Article							REGRESSION SHRINKAGE; SWITCHBACK RATES; SUBSTITUTION; SELECTION; IMPACT	Background Observational studies of switching from branded to generic formulations of the same drug substance often lack appropriate comparators for the subjects who switched. Three generic formulations were deemed equivalent to Concerta: an authorized generic (AG) identical except for external packaging, and two other generics (EG). Objective Compare the incidence of a combined endpoint (switching back to Concerta, changing the use of immediate release methylphenidate (MPH), stopping all long-acting methylphenidate, or starting a new medication) among people switched from Concerta to the AG versus the EG. Methods Cohort study from the Truven CCAE database of people aged 6 to 65 diagnosed with ADHD, treated with Concerta, and switched to the EG or to the AG formulation. Results In the EG arm 24.6% and in the AG arm 19.7% of subjects switched back to Concerta. The proportion of subjects meeting the combined endpoint was 39.5% in the EG arm, 32.9% in the AG arm, a crude risk ratio of 1.20 (95% CI 0.94, 1.54). After adjustment by propensity score stratification, the adjusted odds ratio (OR) was 1.23 (95% CI 0.90, 1.70). In an unplanned analysis using a different method of adjustment, the adjusted OR was 1.00 (95% CI 0.69, 1.44). Discussion This study did not detect a difference between the proportion of people who met the study endpoint in the two study arms, i.e. between those who switched to a generic formulation that was identical to Concerta except for external packaging and those who switched to the comparison generics. The high incidence of the combined endpoint in the AG arm demonstrates the need for an appropriate comparator in studies of this type.	[Fife, Daniel; Cepeda, M. Soledad; Sena, Anthony G.] Janssen Res & Dev LLC, Epidemiol, Titusville, NJ 08560 USA; [Baseman, Alan] Janssen Res & Dev LLC, Global Med Safety, Horsham, PA USA; [Richards, Henry] Janssen Res & Dev LLC, Established Prod, Titusville, NJ USA; [Hu, Peter] Janssen Res & Dev LLC, Clin Biostat, Raritan, NJ USA; [Starr, H. Lynn] Janssen Sci Affairs LLC, Titusville, NJ USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Janssen Pharmaceuticals	Fife, D (corresponding author), Janssen Res & Dev LLC, Epidemiol, Titusville, NJ 08560 USA.	DFife@jnj.com			Janssen Research & Development, LLC	Janssen Research & Development, LLC	This study was supported by Janssen Research & Development, LLC, who provided financial support for the work in the form of salaries for all the authors, and its commitment to pay the associated publishing fees. Janssen Research & Development, LLC's Standard Operating Procedures require publication of studies that, like this one, concern its products and were intended for publication when they were begun. For the present study, that intention is documented by its registration with ClinicalTrails.gov. The funding organization's Standard Operating Procedures also require that the study undergo a standard internal company review before it is submitted for publication. Internal company review is limited to roles not responsible for sales or marketing functions. Janssen Research & Development, LLC. did not have any additional role in the study design, data collection, analysis, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Andermann F, 2007, EPILEPSIA, V48, P464, DOI 10.1111/j.1528-1167.2007.01007.x; ARNOLD P, 1990, Journal of Clinical Research and Pharmacoepidemiology, V4, P139; Banaschewski T, 2016, Z KINDER JUG-PSYCH, V44, P307, DOI 10.1024/1422-4917/a000433; Cheetham TC, 2005, AM J MANAG CARE, V11, P546; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Duh MS, 2009, NEUROLOGY, V72, P2122, DOI 10.1212/WNL.0b013e3181aa5300; Erickson SC, 2011, EPILEPSIA, V52, P1365, DOI 10.1111/j.1528-1167.2011.03130.x; Halkin H, 2007, ANN PHARMACOTHER, V41, P29, DOI 10.1345/aph.1H218; Hansen RA, 2017, PHARMACOTHERAPY, V37, P429, DOI 10.1002/phar.1908; Helin-Salmivaara A, 2012, J CLIN PHARM THER, V37, P58, DOI 10.1111/j.1365-2710.2011.01250.x; Kam-Hansen S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006175; Kaptchuk TJ, 2015, NEW ENGL J MED, V373, P8, DOI 10.1056/NEJMp1504023; Lally MD, 2015, CLIN PEDIAT; LeLorier J, 2008, NEUROLOGY, V70, P2179, DOI 10.1212/01.wnl.0000313154.55518.25; Qian J, 2016, CLIN PHARM THER; Schuemie MJ, 2014, STAT MED, V33, P209, DOI 10.1002/sim.5925; Storebo OJ, 2016, Z KINDER JUG-PSYCH, V44, P334, DOI 10.1024/1422-4917/a000472; Storebo OJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009885.pub2; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Wu EQ, 2011, ANN PHARMACOTHER, V45, P441, DOI 10.1345/aph.1P482	21	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193453	10.1371/journal.pone.0193453	http://dx.doi.org/10.1371/journal.pone.0193453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489906	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000078
J	Ma, NL; Lah, WAC; Kadir, NA; Mustaqim, M; Rahmat, Z; Ahmad, A; Lam, SD; Ismail, MR				Ma, Nyuk Ling; Lah, Wan Afifudeen Che; Kadir, Nisrin Abd; Mustaqim, Mohamad; Rahmat, Zaidah; Ahmad, Aziz; Lam, Su Datt; Ismail, Mohd Razi			Susceptibility and tolerance of rice crop to salt threat: Physiological and metabolic inspections	PLOS ONE			English	Article							ORYZA-SATIVA L.; ANTIOXIDANT RESPONSES; ION HOMEOSTASIS; STRESS-RESPONSE; SALINITY; PLANTS; ACCUMULATION; PHOSPHATIDYLCHOLINE; GLYCINEBETAINE; POLYAMINES	Salinity threat is estimated to reduce global rice production by 50%. Comprehensive analysis of the physiological and metabolite changes in rice plants from salinity stress (i.e. tolerant versus susceptible plants) is important to combat higher salinity conditions. In this study, we screened a total of 92 genotypes and selected the most salinity tolerant line (SS1-14) and most susceptible line (SS2-18) to conduct comparative physiological and metabolome inspections. We demonstrated that the tolerant line managed to maintain their water and chlorophyll content with lower incidence of sodium ion accumulation. We also examined the antioxidant activities of these lines: production of ascorbate peroxidase (APX) and catalase (CAT) were significantly higher in the sensitive line while superoxide dismutase (SOD) was higher in the tolerant line. Partial least squares discriminant analysis (PLS-DA) score plots show significantly different response for both lines after the exposure to salinity stress. In the tolerant line, there was an upregulation of non-polar metabolites and production of sucrose, GABA and acetic acid, suggesting an important role in salinity adaptation. In contrast, glutamine and putrescine were noticeably high in the susceptible rice. Coordination of different strategies in tolerant and susceptible lines show that they responded differently after exposure to salt stress. These findings can assist crop development in terms of developing tolerance mechanisms for rice crops.	[Ma, Nyuk Ling; Lah, Wan Afifudeen Che; Kadir, Nisrin Abd; Mustaqim, Mohamad; Ahmad, Aziz] Univ Malaysia Terengganu, Sch Fundamental Sci, Kuala Terengganu, Terengganu, Malaysia; [Rahmat, Zaidah] Univ Technol Malaysia, Dept Biotechnol & Med Engn, Skudai, Johor, Malaysia; [Lam, Su Datt] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi, Selangor, Malaysia; [Lam, Su Datt] UCL, Div Biosci, Inst Struct & Mol Biol, Gower St, London, England; [Ismail, Mohd Razi] Univ Putra Malaysia, Inst Trop Agr, Serdang, Selangor, Malaysia	Universiti Malaysia Terengganu; Universiti Teknologi Malaysia; Universiti Kebangsaan Malaysia; University of London; Birkbeck University London; University College London; Universiti Putra Malaysia	Ma, NL (corresponding author), Univ Malaysia Terengganu, Sch Fundamental Sci, Kuala Terengganu, Terengganu, Malaysia.	nyukling@umt.edu.my	Ling, Nyuk/Q-1474-2018; Lam, Su Datt/A-9933-2018; Ahmad, Aziz/AAF-8909-2020; Rahmat, Zaidah/AAE-1953-2020; Che Lah, Wan Afifudeen/AAZ-9785-2021; Lam, Su Datt/AAN-2116-2020; Ahmad, Aziz/M-4919-2016	Ling, Nyuk/0000-0002-1301-4730; Lam, Su Datt/0000-0003-4772-7656; Ahmad, Aziz/0000-0002-2270-5197; Che Lah, Wan Afifudeen/0000-0002-5478-3800; Lam, Su Datt/0000-0003-4772-7656; Ahmad, Aziz/0000-0002-2270-5197; Ismail, M.R./0000-0001-5670-9279	Fundamental Research Grant Scheme (FRGS) [59342]; Long Term Research Grant Scheme (LRGS) under Abotic breeding of Rice Varieties	Fundamental Research Grant Scheme (FRGS); Long Term Research Grant Scheme (LRGS) under Abotic breeding of Rice Varieties	The works were supported by Fundamental Research Grant Scheme (FRGS) (VOT 59342) - project leader Nyuk Ling Ma; and Long Term Research Grant Scheme (LRGS) under Abotic breeding of Rice Varieties - Project leader Mohd Razi Ismail.	Afzal F, 2014, OXIDATIVE DAMAGE TO PLANTS: ANTIOXIDANT NETWORKS AND SIGNALING, P397, DOI 10.1016/B978-0-12-799963-0.00013-7; Ahmad I, 2016, J EXP BOT, V67, P2689, DOI 10.1093/jxb/erw103; Akcay N, 2012, J PLANT PHYSIOL, V169, P452, DOI 10.1016/j.jplph.2011.11.006; Amirjani MR., 2010, EUR J BIOL SCI, V3, P6; Anjula Chaudhary, 2015, Plant Archives, V15, P7; Bandeoglu E, 2004, PLANT GROWTH REGUL, V42, P69, DOI 10.1023/B:GROW.0000014891.35427.7b; Bartwal A, 2013, J PLANT GROWTH REGUL, V32, P216, DOI 10.1007/s00344-012-9272-x; Basu S, 2010, PLANT GROWTH REGUL, V60, P51, DOI 10.1007/s10725-009-9418-4; Bhoomika K, 2013, PLANT GROWTH REGUL, V71, P235, DOI 10.1007/s10725-013-9824-5; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; CLARE DA, 1984, ANAL BIOCHEM, V140, P532, DOI 10.1016/0003-2697(84)90204-5; Darwish E, 2009, PLANT CELL PHYSIOL, V50, P986, DOI 10.1093/pcp/pcp051; Demidchik V, 2007, NEW PHYTOL, V175, P387, DOI 10.1111/j.1469-8137.2007.02128.x; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Felle HH, 2005, PROTOPLASMA, V227, P17, DOI 10.1007/s00709-005-0131-5; Galvan-Ampudia CS, 2011, CURR OPIN PLANT BIOL, V14, P296, DOI 10.1016/j.pbi.2011.03.019; Gill SS, 2010, PLANT SIGNAL BEHAV, V5, P26, DOI 10.4161/psb.5.1.10291; Groppa MD, 2008, AMINO ACIDS, V34, P35, DOI 10.1007/s00726-007-0501-8; Gupta AK, 2005, J BIOSCIENCES, V30, P761, DOI 10.1007/BF02703574; Hossain M. A., 2013, Australian Journal of Crop Science, V7, P1801; Jenks M.A, 2007, ADV MOL BREEDING DRO; Kakkar RK, 2000, BIOL PLANTARUM, V43, P419, DOI 10.1023/A:1026715032115; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Kishitani S, 2000, PLANT CELL ENVIRON, V23, P107, DOI 10.1046/j.1365-3040.2000.00527.x; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kronzucker HJ, 2013, PLANT SOIL, V369, P1, DOI 10.1007/s11104-013-1801-2; Krugman T, 2010, FUNCT INTEGR GENOMIC, V10, P167, DOI 10.1007/s10142-010-0166-3; Ludwig C, 2012, METABOLOMICS, V8, P8, DOI 10.1007/s11306-011-0347-7; Ma NL, 2013, INT J MOL SCI, V14, P7515, DOI 10.3390/ijms14047515; Maathuis FJM, 2014, J EXP BOT, V65, P849, DOI 10.1093/jxb/ert326; Maiale S, 2004, J PLANT PHYSIOL, V161, P35, DOI 10.1078/0176-1617-01167; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mishra P, 2013, PROTOPLASMA, V250, P3, DOI 10.1007/s00709-011-0365-3; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nahar K, 2016, FRONT PLANT SCI, V7; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Pattanagul W, 2008, INDIAN J EXP BIOL, V46, P736; Pical C, 1999, J BIOL CHEM, V274, P38232, DOI 10.1074/jbc.274.53.38232; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012571; PORRA RJ, 1990, BIOCHIM BIOPHYS ACTA, V1015, P493, DOI 10.1016/0005-2728(90)90083-G; Ramesh SA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8879; Renault H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-20; Sarkar RK, 2013, ACTA PHYSIOL PLANT, V35, P2915, DOI 10.1007/s11738-013-1322-x; Shirasawa K, 2006, ANN BOT-LONDON, V98, P565, DOI 10.1093/aob/mcl126; Silvente S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038554; Singh J, 2014, J FOOD SCI TECH MYS, V51, P67, DOI 10.1007/s13197-011-0479-9; Siringam K, 2011, AFR J BIOTECHNOL, V10, P1340; Tananuwong K, 2010, LWT-FOOD SCI TECHNOL, V43, P476, DOI 10.1016/j.lwt.2009.09.014; Tasseva G, 2004, FEBS LETT, V566, P115, DOI 10.1016/j.febslet.2004.04.015; Taylor Nicolas L, 2007, Methods Mol Biol, V372, P389, DOI 10.1007/978-1-59745-365-3_28; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xiong HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092913; Yeo AR, 1999, PLANT CELL ENVIRON, V22, P559, DOI 10.1046/j.1365-3040.1999.00418.x; Zhao JL, 2015, PHYSIOL PLANTARUM, V154, P381, DOI 10.1111/ppl.12291; Zhao X.-M., 2014, PLOS ONE, V9; Zuraida A R, 2012, J TROP AGR FD SC, V39, P167	59	49	55	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192732	10.1371/journal.pone.0192732	http://dx.doi.org/10.1371/journal.pone.0192732			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489838	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000040
J	Navarro, JM; Widdows, J; Chaparro, OR; Ortiz, A; Mellado, C; Villanueva, PA				Navarro, Jorge M.; Widdows, John; Chaparro, Oscar R.; Ortiz, Alejandro; Mellado, Carla; Villanueva, Paola A.			Pre-ingestive selection capacity and endoscopic analysis in the sympatric bivalves Mulinia edulis and Mytilus chilensis exposed to diets containing toxic and non-toxic dinoflagellates	PLOS ONE			English	Article							SUSPENSION-FEEDING BIVALVES; PARALYTIC SHELLFISH TOXINS; OYSTER CRASSOSTREA-VIRGINICA; ALEXANDRIUM-CATENELLA; PARTICLE SELECTION; CERASTODERMA-EDULE; ENERGY-BALANCE; WIDE-RANGE; MUSSEL; SESTON	This study investigates the effects of toxic and non-toxic dinoflatellates on two sympatric bivalves, the clam Mulinia edulis and the mussel Mytilus chilensis. Groups of bivalves were fed one of three diets: (i) the toxic paralytic shellfish producing (PSP) Alexandrium catenella + Isochrysis galbana; (ii) the non-toxic Alexandrium affine + Isochrysis galbana and (iii) the control diet of Isochrysis galbana. Several physiological traits were measured, such as, clearance rate, pre-ingestive selection efficiency and particle transport velocity in the gill. The clearance rates of both M. chilensis and M. edulis showed a significant reduction when fed a mixed toxic diet of 50% Alexandrium catenella: 50% Isochrysis galbana. Similarly, when both species of bivalves were fed with the non-toxic diet (50% A. affine: 50% I. galbana), clearance rate was significantly lower compared with a diet of 100% I. galbana. Under all the experimental diets, M. chilensis showed higher clearance rate values, slightly more than double that of M. edulis. M. edulis and M. chilensis have the ability to select particles at the pre-ingestive level, thus eliminating a larger proportion of the toxic dinoflagellate A. catenella as well as the non-toxic A. affine in the form of pseudofaeces. Higher values of selection efficiency were registered in M. edulis than in M. chilensis when exposed to the toxic diet. Similar results were observed when these two species were exposed to the diet containing the non-toxic dinoflagellate, explained by the fact that the infaunal Mulinia edulis is adapted to dealing with larger particle sizes and higher particle densities (Navarro et al., 1993). The lower transport particle velocity observed in the present work for both species, is related to the reduced clearance rate, the higher particle concentration, and the presence of larger, toxic dinoflagellates. In addition, the species differ in their feeding responses to diets, with and without A. catenella or A. affine, largely reflecting their adaptations to different environmental conditions. The results suggest that the presence of a dinoflagellate bloom, whether toxic or non-toxic spp in Yaldad Bay, is likely to have a greater impact on the Mytilus chilensis than the infaunal Mulinia edulis, based on the combined effects on clearance rate, selection efficiency and particle transport velocity.	[Navarro, Jorge M.; Chaparro, Oscar R.; Ortiz, Alejandro; Mellado, Carla; Villanueva, Paola A.] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Navarro, Jorge M.; Ortiz, Alejandro] Ctr FONDAP Invest Dinam Ecosistemas Marino Altas, Valdivia, Chile; [Widdows, John] Plymouth Marine Lab, Prospect Pl, Plymouth, Devon, England	Universidad Austral de Chile; Plymouth Marine Laboratory	Navarro, JM (corresponding author), Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile.; Navarro, JM (corresponding author), Ctr FONDAP Invest Dinam Ecosistemas Marino Altas, Valdivia, Chile.	jnavarro@uach.cl	Chaparro, Oscar R/A-5070-2009; Navarro, Jorge M./B-7928-2008	Navarro, Jorge M./0000-0001-9920-190X	Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT) [1161420, 15150003]	Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Study funded by the Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT), through the research grants to JMN: FONDECYT 1161420 and FONDAP IDEAL, grant No 15150003.	Anderson D.M., 1989, P11; ANDERSON DM, 1994, MAR BIOL, V120, P467, DOI 10.1007/BF00680222; Bacon GS, 1998, J EXP MAR BIOL ECOL, V219, P105, DOI 10.1016/S0022-0981(97)00177-9; BARDOUIL M, 1993, J SHELLFISH RES, V12, P417; Barille L, 1993, MODELING JAPANESE OY, P12; Bayne B.L., 1983, P407; BAYNE BL, 1989, MAR ECOL PROG SER, V55, P47, DOI 10.3354/meps055047; BAYNE BL, 1993, J MAR BIOL ASSOC UK, V73, P813, DOI 10.1017/S0025315400034743; BAYNE BL, 1990, COMP PHYSIOL, V5, P70; Bricelj V, 1996, HARMFUL TOXIC ALGAL, P405; Bricelj VM, 2005, NATURE, V434, P763, DOI 10.1038/nature03415; BRICELJ VM, 1990, MAR ECOL PROG SER, V63, P177, DOI 10.3354/meps063177; Colin SP, 2007, HARMFUL ALGAE, V6, P875, DOI 10.1016/j.hal.2007.05.003; COUGHLAN J, 1969, MAR BIOL, V2, P356, DOI 10.1007/BF00355716; Cranford PJ, 1998, J EXP MAR BIOL ECOL, V219, P45, DOI 10.1016/S0022-0981(97)00174-3; Dam HG., 2012, ANNU REV MAR SCI, V5; Espinosa EP, 2008, ESTUAR COAST SHELF S, V79, P1, DOI 10.1016/j.ecss.2008.02.022; Espinosa EP, 2010, BIOL BULL-US, V218, P75, DOI 10.1086/BBLv218n1p75; Espinosa EP, 2009, BIOL BULL-US, V217, P130, DOI 10.1086/BBLv217n2p130; Fernandez-Reiriz MJ, 2008, AQUAT TOXICOL, V87, P245, DOI 10.1016/j.aquatox.2008.02.011; GAINEY L F JR, 1988, Journal of Shellfish Research, V7, P623; Haberkorn H, 2010, HARMFUL ALGAE, V9, P427, DOI 10.1016/j.hal.2010.01.003; Hawkins AJS, 1996, MAR ECOL PROG SER, V131, P179, DOI 10.3354/meps131179; Fernandez-Reiriz MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148245; KIORBOE T, 1981, MAR ECOL PROG SER, V5, P291, DOI 10.3354/meps005291; Lassus P, 2004, AQUAT LIVING RESOUR, V17, P207, DOI 10.1051/alr:2004012; Le Goic N, 2013, AQUAT LIVING RESOUR, V26, P221, DOI 10.1051/alr/2013047; Li SC, 2002, MAR ENVIRON RES, V53, P145, DOI 10.1016/S0141-1136(01)00117-9; MARSDEN ID, 1992, NEW ZEAL J MAR FRESH, V26, P371, DOI 10.1080/00288330.1992.9516530; NAVARRO JM, 1982, MAR BIOL, V67, P255, DOI 10.1007/BF00397666; Navarro JM, 1997, MAR ECOL PROG SER, V152, P175, DOI 10.3354/meps152175; Navarro JM, 2008, REV CHIL HIST NAT, V81, P41; Navarro JM, 2016, ESTUAR COAST, V39, P1133, DOI 10.1007/s12237-015-0061-1; Navarro JM, 2011, AQUAT LIVING RESOUR, V24, P93, DOI 10.1051/alr/2011105; Navarro JM, 2010, MAR BIOL, V157, P1967, DOI 10.1007/s00227-010-1465-x; Ortiz A, 2013, RESPUESTA FISIOLOGIC; Riisgard HU, 2001, MAR ECOL PROG SER, V211, P275, DOI 10.3354/meps211275; Rosa M, 2013, J EXP MAR BIO ECOL, V446; Shumway S.E., 1985, P389; SHUMWAY SE, 1987, AQUAT TOXICOL, V10, P9, DOI 10.1016/0166-445X(87)90024-5; Tran D, 2015, AQUAT TOXICOL, V158, P41, DOI 10.1016/j.aquatox.2014.10.023; Underwood A. J., 1997, EXPT ECOLOGY THEIR L, P1, DOI DOI 10.1016/J.PORGCOAT.2011.04.008; Urrutia MB, 1996, J MAR BIOL ASSOC UK, V76, P431, DOI 10.1017/S0025315400030654; Velasco LA, 2005, MAR ECOL PROG SER, V291, P115, DOI 10.3354/meps291115; Velasco LA, 2002, MAR ECOL PROG SER, V240, P143, DOI 10.3354/meps240143; Velez P, 2001, TOXICON, V39, P929, DOI 10.1016/S0041-0101(00)00230-0; Villanueva PA, 2016, MAR FRESHW BEHAV PHY, V49, P291, DOI 10.1080/10236244.2016.1193952; Ward JE, 1998, MAR BIOL, V131, P283, DOI 10.1007/s002270050321; WIDDOWS J, 1979, J MAR BIOL ASSOC UK, V59, P522, DOI 10.1017/S0025315400042843; Zemlys P, 2003, ECOL MODEL, V166, P67, DOI 10.1016/S0304-3800(03)00099-1	50	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193370	10.1371/journal.pone.0193370	http://dx.doi.org/10.1371/journal.pone.0193370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474467	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000426049500097
J	Niu, SX; Ma, X; Zhang, Y; Liu, YN; Chen, XF; Gong, HJ; Yao, YX; Liu, K; Zhang, X				Niu, Shaoxi; Ma, Xin; Zhang, Yu; Liu, Yen-Nien; Chen, Xufeng; Gong, Huijie; Yao, Yuanxin; Liu, Kan; Zhang, Xu			MicroRNA-19a and microRNA-19b promote the malignancy of clear cell renal cell carcinoma through targeting the tumor suppressor RhoB	PLOS ONE			English	Article							FARNESYLTRANSFERASE INHIBITORS; CANCER CELLS; INVASION; REVEALS; OVEREXPRESSION; TRANSFORMATION; PROLIFERATION; METASTASIS; PHENOTYPE; CLUSTER	Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma, which shows high aggressiveness and lacks biomarkers. RhoB acts as a tumor suppressor that inhibits the progression of ccRCC. In the present study, we examined the effects of oncogenic microRNAs, miR-19a and miR-19b, on RhoB expression in ccRCC cells. The results showed that both miR-19a and miR-19b could directly target the 30untranslated region (3'UTR) of RhoB, resulting in the reduced expression of RhoB. With RT-PCR analysis, we detected the increased expression of miR-19a and miR-19b in ccRCC tissues compared to adjacent non-tumor renal tissues. These data also demonstrated an exclusive negative correlation between miR-19a/19b and RhoB expression in ccRCC specimens and cell lines. In addition, the knockdown of RhoB or overexpression of miR-19a and miR-19b in ccRCC cells could promote cell proliferation, migration and invasion. These data demonstrate the direct roles of miR-19a and miR-19b on the repression of RhoB and its consequences on tumorigenesis, cancer cell proliferation and invasiveness. These results suggest the potential clinical impact of miR-19a and miR-19b as molecular targets for ccRCC.	[Niu, Shaoxi; Ma, Xin; Zhang, Yu; Gong, Huijie; Yao, Yuanxin; Liu, Kan; Zhang, Xu] Chinese PLA Med Acad, Chinese PLA Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Beijing, Peoples R China; [Niu, Shaoxi; Liu, Yen-Nien; Chen, Xufeng] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Liu, Yen-Nien] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Gong, Huijie] Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Urol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Duke University; Taipei Medical University; Beijing University of Chinese Medicine	Zhang, X (corresponding author), Chinese PLA Med Acad, Chinese PLA Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Beijing, Peoples R China.	xzhang@tjh.tjmu.edu.cn	Liu, Yen-Nien/AAW-4698-2021		National High Technology Research and Development Program of China [2014AA020607]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (2014AA020607).	Al-Ali BM, 2012, ANTICANCER RES, V32, P3727; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen W, 2014, ONCOL LETT; Chen WH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157599; Connolly EC, 2010, MOL CANCER RES, V8, P691, DOI 10.1158/1541-7786.MCR-09-0465; Eades G, 2011, J BIOL CHEM, V286, P40725, DOI 10.1074/jbc.M111.275495; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huang M, 2006, HISTOL HISTOPATHOL, V21, P213, DOI 10.14670/HH-21.213; Huang QB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067294; Jia ZF, 2013, PATHOL ONCOL RES, V19, P847, DOI 10.1007/s12253-013-9653-x; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Le XF, 2010, CANCER MICROENVIRON, V3, P137, DOI 10.1007/s12307-010-0037-4; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu AX, 2000, MOL CELL BIOL, V20, P6105, DOI 10.1128/MCB.20.16.6105-6113.2000; Liu M, 2011, FEBS LETT, V585, P2998, DOI 10.1016/j.febslet.2011.08.014; Ma X, 2014, UROL ONCOL, V32, pe49; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Ouyang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096228; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Qin S, 2013, ASIAN PAC J CANCER P, V14, P835, DOI 10.7314/APJCP.2013.14.2.835; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Santarpia L, 2010, ENDOCR-RELAT CANCER, V17, pF51, DOI 10.1677/ERC-09-0222; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; White NMA, 2011, BRIT J CANCER, V105, P1741, DOI 10.1038/bjc.2011.401; Xu XM, 2012, CANCER LETT, V322, P148, DOI 10.1016/j.canlet.2012.02.038; Zeng PY, 2003, ONCOGENE, V22, P1124, DOI 10.1038/sj.onc.1206181; Zhou JT, 2011, INT J CANCER, V128, P1057, DOI 10.1002/ijc.25445	31	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192790	10.1371/journal.pone.0192790	http://dx.doi.org/10.1371/journal.pone.0192790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474434	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500040
J	Palmeiro-Silva, YK; Orellana, P; Venegas, P; Monteiro, L; Varas-Godoy, M; Norwitz, E; Rice, G; Osorio, E; Illanes, SE				Palmeiro-Silva, Yasna K.; Orellana, Pelusa; Venegas, Pia; Monteiro, Lara; Varas-Godoy, Manuel; Norwitz, Errol; Rice, Gregory; Osorio, Eduardo; Illanes, Sebastian E.			Effects of earthquake on perinatal outcomes: A Chilean register-based study	PLOS ONE			English	Article							FETOMATERNAL GLUCOCORTICOID METABOLISM; MATERNAL PRENATAL ANXIETY; SPONTANEOUS PRETERM BIRTH; 2008 WENCHUAN EARTHQUAKE; PLACENTAL 11-BETA-HSD2; EXPRESSION PATTERNS; STRESS; HEALTH; EXPOSURE; DISASTERS	Background Natural disasters increase the level population stress, including pregnant women, who can experience prenatal maternal stress, affecting the fetus and triggering perinatal complications, such as low birth weight, smaller head circumference, etc. However, little is known about effects of earthquake on perinatal outcomes. Objective To evaluate the effect of earthquake occurred on February 27, 2010 and perinatal outcomes of Chilean pregnant women, and to examine these effects by timing of exposure during pregnancy and newborn gender. Methods A register-based study was performed using data collected from women who had a vaginal delivery in a large private health center in Santiago, Chile, during 2009 and 2010. The study population was categorized according to exposure to earthquake and timing during gestation. Primary perinatal outcomes were gestational age at birth, birth weight, length and head circumference. Analyses adjusted for gender, gestational age at exposure, parity, maternal age and income. Results A total of 1,966 eligible vaginal deliveries occurred during 2009 and 2,110 in 2010. Birth weight was not affected by the trimester of exposure; however, length, head circumference and gestational age at birth were significantly different according to trimester of exposure and gender of newborn. In multivariable analysis, newborns were shorter by 2 mm, 5 mm and 4.5 mm, if they were exposed during their first, second and third trimester, respectively. Furthermore, newborns had a smaller head circumference by 1.2 mm and 1.5 mm if they were exposed during first and second trimester of gestation. Conclusion In this cohort, exposure to the February 2010 earthquake resulted in earlier delivery and reduced length and head circumference in the offspring. This association varied according to trimester of exposure and fetal gender. Health workers should include exposed to high levels of stress associated with natural disasters when assessing pregnancy risk factors.	[Palmeiro-Silva, Yasna K.] Univ Los Andes, Sch Nursing, Santiago, Chile; [Orellana, Pelusa] Univ Los Andes, Sch Educ, Santiago, Chile; [Venegas, Pia; Monteiro, Lara; Varas-Godoy, Manuel; Illanes, Sebastian E.] Univ Los Andes, Fac Med, Santiago, Chile; [Norwitz, Errol] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Rice, Gregory] Univ Queensland, Fac Med, Ctr Clin Res, Brisbane, Qld, Australia; [Osorio, Eduardo; Illanes, Sebastian E.] Clin Davila, Dept Obstet & Gynecol, Santiago, Chile	Universidad de los Andes - Chile; Universidad de los Andes - Chile; Universidad de los Andes - Chile; Tufts University; University of Queensland; Clinica Davila	Illanes, SE (corresponding author), Univ Los Andes, Fac Med, Santiago, Chile.; Illanes, SE (corresponding author), Clin Davila, Dept Obstet & Gynecol, Santiago, Chile.	sillanes@uandes.cl	Monteiro, Lara J/AAU-8518-2020; RICE, GREGORY/F-2412-2010	Varas-Godoy, Manuel/0000-0001-5857-4793; Palmeiro-Silva, Yasna K/0000-0001-6664-1079; Illanes, Sebastian/0000-0001-5433-9315; RICE, GREGORY/0000-0001-7177-0246; , Pelusa/0000-0003-3851-8780	Fundacion Banmedica	Fundacion Banmedica	The authors wish to acknowledge Fundacion Banmedica for its support and Clinica Davila.	Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Billack B, 2012, J PHARMACOL TOX MET, V66, P221, DOI 10.1016/j.vascn.2012.08.169; Borzsonyi B, 2012, EUR J OBSTET GYN R B, V161, P12, DOI 10.1016/j.ejogrb.2011.12.013; Cai DG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168747; Cao-Lei L., 2016, CURR MOL BIO REP, V2, P16, DOI DOI 10.1007/S40610-016-0030-X; Chang HL, 2002, PSYCHIAT CLIN NEUROS, V56, P139, DOI 10.1046/j.1440-1819.2002.00948.x; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Dancause KN, 2011, EARLY HUM DEV, V87, P813, DOI 10.1016/j.earlhumdev.2011.06.007; Dayan J, 2006, PSYCHOSOM MED, V68, P938, DOI 10.1097/01.psy.0000244025.20549.bd; Demendi C, 2012, EUR J OBSTET GYN R B, V165, P210, DOI 10.1016/j.ejogrb.2012.08.009; Departamento de Estadisticas e Informacion en Salud, 2013, IND BAS SALUD CHIL 2; Eriksson JG, 2005, MATERN CHILD NUTR, V1, P149, DOI 10.1111/j.1740-8709.2005.00017.x; Franzek EJ, 2008, ADDICTION, V103, P433, DOI 10.1111/j.1360-0443.2007.02084.x; Harville E, 2010, OBSTET GYNECOL SURV, V65, P713, DOI 10.1097/OGX.0b013e31820eddbe; Harville EW, 2016, DISASTER MED PUBLIC, V10, P59, DOI 10.1017/dmp.2015.69; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Hobel CJ, 2004, CLIN OBSTET GYNECOL, V47, P856, DOI 10.1097/01.grf.0000142512.38733.8c; Kajantie E, 2006, PEDIATR RES, V59, P575, DOI 10.1203/01.pdr.0000203106.59832.7a; King S, 2000, Sante Ment Que, V25, P163; King S, 2012, BIRTH DEFECTS RES C, V96, P273, DOI 10.1002/bdrc.21026; Kramer MS, 2009, AM J EPIDEMIOL, V169, P1319, DOI 10.1093/aje/kwp061; Lau Y, 2011, JOGNN-J OBST GYN NEO, V40, P62, DOI 10.1111/j.1552-6909.2010.01208.x; Lazinski M, 2008, ARCH WOMEN MENT HLTH, V11, P363, DOI 10.1007/s00737-008-0035-4; Liu SJ, 2010, INT J GYNECOL OBSTET, V108, P161, DOI 10.1016/j.ijgo.2009.08.030; LOU HC, 1994, DEV MED CHILD NEUROL, V36, P826; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Malaspina D, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-71; Mancuso RA, 2004, PSYCHOSOM MED, V66, P762, DOI 10.1097/01.psy.0000138284.70670.d5; Moehle J., 2010, EARTHQUAKE ENG; Nieuwenhuizen AG, 2008, PHYSIOL BEHAV, V94, P169, DOI 10.1016/j.physbeh.2007.12.011; O'Donnell KJ, 2012, PSYCHONEUROENDOCRINO, V37, P818, DOI 10.1016/j.psyneuen.2011.09.014; Oyarzo C, 2012, J MATERN-FETAL NEO M, V25, P1868, DOI 10.3109/14767058.2012.678437; Perera F, 2011, REPROD TOXICOL, V31, P363, DOI 10.1016/j.reprotox.2010.12.055; Salaria S, 2006, NEUROBIOL DIS, V23, P630, DOI 10.1016/j.nbd.2006.05.003; SANDMAN CA, 1994, ANN NY ACAD SCI, V739, P198, DOI 10.1111/j.1749-6632.1994.tb19822.x; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; SEREMI de Desarrollo Social Metropolitana, 2014, IND COM ENC CASEN 20; Suzuki K, 2016, J EPIDEMIOL, V26, P76, DOI 10.2188/jea.JE20150055; Tan CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008200; Tegethoff M, 2010, PSYCHOSOM MED, V72, P419, DOI 10.1097/PSY.0b013e3181d2f0b0; Torche F, 2012, HUM REPROD, V27; Torche F, 2011, DEMOGRAPHY, V48, P1473, DOI 10.1007/s13524-011-0054-z; Wang R, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00208; Xiong X, 2008, AM J MED SCI, V336, P111, DOI 10.1097/MAJ.0b013e318180f21c	44	14	14	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0191340	10.1371/journal.pone.0191340	http://dx.doi.org/10.1371/journal.pone.0191340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474413	gold, Green Published, Green Submitted			2022-12-26	WOS:000426049500008
J	Cruz, E; Kumar, S; Yuan, L; Arikkath, J; Batra, SK				Cruz, Eric; Kumar, Sushil; Yuan, Li; Arikkath, Jyothi; Batra, Surinder K.			Intracellular amyloid beta expression leads to dysregulation of the mitogen-activated protein kinase and bone morphogenetic protein-2 signaling axis	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ALZHEIMERS-DISEASE; A-BETA; HIPPOCAMPAL ATROPHY; TRANSPORT DEFICITS; NEURAL PRECURSORS; TRANSGENIC MICE; NEURONS; NEURODEGENERATION; DEGENERATION	Alzheimer's disease (AD) is a neurodegenerative syndrome classically depicted by the parenchymal accumulation of extracellular amyloid beta plaques. However, recent findings suggest intraneuronal amyloid beta (iA beta(1-42)) accumulation precedes extracellular deposition. Furthermore, the pathologic increase in iA beta(1-42) has been implicated in dysregulation of cellular mechanisms critically important in axonal transport. Owing to neuronal cell polarity, retrograde and anterograde axonal transport are essential trafficking mechanism necessary to convey membrane bound neurotransmitters, neurotrophins, and endosomes between soma and synaptic interfaces. Although iA beta(1-42) disruption of axonal transport has been implicated in dysregulation of neuronal synaptic transmission, the role of iA beta(1-42) and its influence on signal transduction involving the mitogen-activated protein kinase (MAPK) and morphogenetic signaling axis are unknown. Our biochemical characterization of intracellular amyloid beta accumulation on MAPK and morphogenetic signaling have revealed increased iA beta(1-42) expression leads to significant reduction in ERK 1/2 phosphorylation and increased bone morphogenetic protein 2 dependent Smad 1/5/8 phosphorylation. Furthermore, rescue of iA beta(1-42) mediated attenuation of MAPK signaling can be accomplished with the small molecule PLX4032 as a downstream enhancer of the MAPK pathway. Consequently, our observations regarding the dysregulation of these gatekeepers of neuronal viability may have important implications in understanding the iA beta(1-42) mediated effects observed in AD.	[Cruz, Eric; Kumar, Sushil; Batra, Surinder K.] Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Dept Biochem & Mol Biol, Omaha, NE 68182 USA; [Yuan, Li; Arikkath, Jyothi] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68182 USA; [Arikkath, Jyothi] Univ Nebraska, Med Ctr, Munroe Meyer Inst, Dev Neurosci, Omaha, NE 68178 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Kumar, S; Batra, SK (corresponding author), Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Dept Biochem & Mol Biol, Omaha, NE 68182 USA.	skumar@unmc.edu; sbatra@unmc.edu		Batra, Surinder K./0000-0001-9470-9317	NIH [T32CA009476, U01 CA185148, R01 CA183459, 5P20GM103471]; Alzheimer's Association and Brain and Behavior Research Foundation [R03MH110726]; UNMC graduate fellowship program; NATIONAL CANCER INSTITUTE [T32CA009476, R01CA183459, U01CA185148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103471, P30GM110768] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association and Brain and Behavior Research Foundation; UNMC graduate fellowship program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors on this manuscript were, in part, supported by the NIH grants [T32CA009476 Cancer Biology Training Program (E.C.); U01 CA185148 and R01 CA183459 (S.K.B.); NIH COBRE (5P20GM103471)] (J.A.), Alzheimer's Association and Brain and Behavior Research Foundation, Startup funds, R03MH110726 (J.A.) and the UNMC graduate fellowship program (L.Y.) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Arbor Sage C., 2016, Yale Journal of Biology and Medicine, V89, P5; Ascano M, 2012, TRENDS CELL BIOL, V22, P266, DOI 10.1016/j.tcb.2012.02.005; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Capsoni S, 2002, P NATL ACAD SCI USA, V99, P12432, DOI 10.1073/pnas.192442999; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Deinhardt K, 2014, NEUROPHARMACOLOGY, V76, P603, DOI 10.1016/j.neuropharm.2013.04.054; Dekkers MPJ, 2013, J CELL BIOL, V203, P385, DOI 10.1083/jcb.201306136; Eisen A, 2001, MUSCLE NERVE, V24, P564, DOI 10.1002/mus.1042; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Finelli MJ, 2013, CELL REP, V3, P1592, DOI 10.1016/j.celrep.2013.04.011; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gambaro K, 2006, CELL DEATH DIFFER, V13, P1075, DOI 10.1038/sj.cdd.4401799; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Henneman WJP, 2009, NEUROLOGY, V72, P999, DOI 10.1212/01.wnl.0000344568.09360.31; HEUMANN R, 1984, J NEUROSCI, V4, P3039; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Piacentini R, 2015, SCI REP-UK, V5, DOI 10.1038/srep15444; Pisano JM, 2000, DEV BIOL, V227, P1, DOI 10.1006/dbio.2000.9876; Reinke AA, 2011, CHEM BIOL DRUG DES, V77, P399, DOI 10.1111/j.1747-0285.2011.01110.x; Ripoli C, 2014, J NEUROSCI, V34, P12893, DOI 10.1523/JNEUROSCI.1201-14.2014; Schinder AF, 2000, NEURON, V25, P151, DOI 10.1016/S0896-6273(00)80879-X; Segal RA, 2014, COLD SPRING HARB PER, V6; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; van De Pol LA, 2006, J NEUROL NEUROSUR PS, V77, P439, DOI 10.1136/jnnp.2005.075341; Yuen EC, 1996, BRAIN DEV-JPN, V18, P362, DOI 10.1016/0387-7604(96)00051-4; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738	42	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0191696	10.1371/journal.pone.0191696	http://dx.doi.org/10.1371/journal.pone.0191696			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470488	gold, Green Submitted, Green Published			2022-12-26	WOS:000425831000004
J	Lin, JT; Gao, J; Lai, KF; Zhou, X; He, B; Zhou, JY; Wang, CZ				Lin, Jiangtao; Gao, Jie; Lai, Kefang; Zhou, Xin; He, Bei; Zhou, Jianying; Wang, Changzheng			The characteristic of asthma control among nasal diseases population: Results from a cross-sectional study	PLOS ONE			English	Article							CONCOMITANT ALLERGIC RHINITIS; TO-CONTROL ASTHMA; CHRONIC RHINOSINUSITIS; MEDICATION ADHERENCE; IMPACT; LINK; COEXISTENCE; SINUSITIS; SEVERITY; OUTCOMES	Asthma affects a large number of patients in China, but comprehensive evaluation of risks associated with poor asthma control in asthmatic patients with nasal diseases was still limited. We conducted this study to provide a comprehensive estimate of asthma control in Chinese asthma patients with combined nasal diseases, to explore the effect of kinds of nasal diseases on the asthma control, and to identify risk factors associated with uncontrolled asthmatic patients with combined nasal diseases. 1756 asthma patients concomitant with nasal diseases aged >= 17 years and representing all regions of mainland China were surveyed. Multivariate logistic regression model with all related demographic characteristics and disease characteristics factors entered was used to identify risk factors associated with uncontrolled asthma. 56.4% of asthmatic patients with combined allergic rhinitis or rhinosinusitis or rhinopolyp remained uncontrolled. Concomitant without allergic rhinitis, younger age, better treatment adherence and higher education level might positively impact asthma control among asthmatic patients with combined nasal diseases. Perennial allergic rhinitis (OR = 1.5, P = 0.021), moderate-severe allergic rhinitis (OR = 2.2, P = 0.001) were all found to significantly increase the risk of uncontrolled asthma among asthma patients with combined allergic rhinitis. The high prevalence of uncontrolled asthma indicates that asthma management among adult Chinese asthmatic patients comorbid with nasal disease is still a challenge. Efforts should be made to raise the awareness of asthma management and to provide sufficient treatment will greatly contribute to improved quality of asthma management. It is possible to minimize the influence of allergic rhinitis on asthma control by improving nasal function, especially for more severe allergic rhinitis and perennial allergic rhinitis.	[Lin, Jiangtao] China Japan Friendship Hosp, Beijing, Peoples R China; [Gao, Jie] MSD China, Dept Outcomes Res, Shanghai, Peoples R China; [Lai, Kefang] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Zhou, Xin] Shanghai Gen Hosp, Shanghai, Peoples R China; [He, Bei] Peking Univ, Beijing 3, Beijing, Peoples R China; [Zhou, Jianying] Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China; [Wang, Changzheng] Third Mil Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China	China-Japan Friendship Hospital; Guangzhou Medical University; Peking University; Zhejiang University; Army Medical University	Lin, JT (corresponding author), China Japan Friendship Hosp, Beijing, Peoples R China.	jiangtao_l@263.net			Merck Sharp Dohme (China)	Merck Sharp Dohme (China)	The study and this subgroup data analysis were fully sponsored by Merck Sharp & Dohme (China). Merck Sharp & Dohme (China) also played a role in study design and making decision to publish. The specific role of the author from Merck Sharp & Dohme (China) is articulated in the author contributions section.	Ahmedani BK, 2013, ANN ALLERG ASTHMA IM, V110, P75, DOI 10.1016/j.anai.2012.11.006; [Anonymous], GLOB STRAT ASTHM MAN; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Cope SF, 2008, PEDIATR PULM, V43, P745, DOI 10.1002/ppul.20847; Davidsen JR, 2012, DAN MED J, V59; Dixon AE, 2009, CURR OPIN PULM MED, V15, P19, DOI 10.1097/MCP.0b013e32831da87e; Dursun AB, 2006, ALLERGY ASTHMA PROC, V27, P510, DOI 10.2500/aap.2006.27.2914; Feng CH, 2012, AM J RHINOL ALLERGY, V26, P187, DOI 10.2500/ajra.2012.26.3762; Gaugris S, 2006, J ASTHMA, V43, P1, DOI 10.1080/02770900500446823; Global Initiative for Asthma Executive Committee, 2015, POCK GUID ASTHM MAN; Greiner AN, 2011, LANCET, V378, P2112, DOI 10.1016/S0140-6736(11)60130-X; Gu Z., 2006, PRACTICAL J CLIN MED, V3, P8; Health Standard of the People's Republic of China, 2013, 4282013 WST HLTH STA; Hojo M, 2015, ALLERGOL INT, V64, P150, DOI 10.1016/j.alit.2014.10.002; Kandane-Rathnayake RK, 2009, THORAX, V64, P1025, DOI 10.1136/thx.2009.118430; Lin DC, 2011, AM J RHINOL ALLERGY, V25, P205, DOI 10.2500/ajra.2011.25.3613; Lin JT, 2014, J ASTHMA, V51, P34, DOI 10.3109/02770903.2013.840789; Makela MJ, 2013, RESP MED, V107, P1481, DOI 10.1016/j.rmed.2013.04.005; Murphy AC, 2012, THORAX, V67, P751, DOI 10.1136/thoraxjnl-2011-201096; Navarro A, 2008, J INVEST ALLERG CLIN, V18, P233; Pearlman AN, 2009, AM J RHINOL ALLERGY, V23, P145, DOI 10.2500/ajra.2009.23.3284; Pinart M, 2014, LANCET RESP MED, V2, P131, DOI 10.1016/S2213-2600(13)70277-7; Price D, 2005, CLIN EXP ALLERGY, V35, P282, DOI 10.1111/j.1365-2222.2005.02182.x; Senior BA, 1996, ANN ALLERG ASTHMA IM, V77, P6, DOI 10.1016/S1081-1206(10)63473-4; SETTIPANE GA, 1977, J ALLERGY CLIN IMMUN, V59, P17, DOI 10.1016/0091-6749(77)90171-3; Sheehan WJ, 2015, CURR OPIN ALLERGY CL, V15, P397, DOI 10.1097/ACI.0000000000000195; Slavin RG, 2008, ALLERGY ASTHMA PROC, V29, P553, DOI 10.2500/aap.2008.29.3169; Su Nan, 2014, Zhonghua Nei Ke Za Zhi, V53, P601; Takemura M, 2016, RESPIR INVESTIG, V54, P320, DOI 10.1016/j.resinv.2016.05.006; US Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute, 3 US DEP HLTH HUM SE; Nguyen VN, 2012, PRIM CARE RESP J, V21, P85, DOI 10.4104/pcrj.2011.00093; Wang DX, 2013, RESPIROLOGY, V18, P313, DOI 10.1111/resp.12005; World Health Organization, 2017, ASTHM FACT SHEET; Yawn BP, 1999, J ALLERGY CLIN IMMUN, V103, P54, DOI 10.1016/S0091-6749(99)70525-7; Zhou X, 2009, CHEST, V135, P904, DOI 10.1378/chest.08-0967	36	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0191543	10.1371/journal.pone.0191543	http://dx.doi.org/10.1371/journal.pone.0191543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470484	gold, Green Published, Green Submitted			2022-12-26	WOS:000425831000003
J	Revathikumar, P; Estelius, J; Karmakar, U; Le Maitre, E; Korotkova, M; Jakobsson, PJ; Lampa, J				Revathikumar, Priya; Estelius, Johanna; Karmakar, Utsa; Le Maitre, Erwan; Korotkova, Marina; Jakobsson, Per-Johan; Lampa, Jon			Microsomal prostaglandin E synthase-1 gene deletion impairs neuro-immune circuitry of the cholinergic anti-inflammatory pathway in endotoxaemic mouse spleen	PLOS ONE			English	Article							VAGUS NERVE-STIMULATION; CYTOKINE PRODUCTION; ALPHA RELEASE; T-CELLS; RECEPTOR; INFLAMMATION; RESPONSES; MACROPHAGES; MODULATION; EXPRESSION	The cholinergic anti-inflammatory pathway (CAP) is an innate neural reflex where parasympathetic and sympathetic nerves work jointly to control inflammation. Activation of CAP by vagus nerve stimulation (VNS) has paved way for novel therapeutic strategies in treating inflammatory diseases. Recently, we discovered that VNS mediated splenic acetylcholine (ACh) release and subsequent immunosuppression in response to LPS associated inflammation is impaired in mice lacking microsomal prostaglandin E synthase-1 (mPGES-1) expression, a key enzyme responsible for prostaglandin E2 synthesis. Here, we have further investigated the consequences of mPGES-1 deficiency on various molecular/cellular events in the spleen which is critical for the optimal functioning of VNS in endotoxaemic mice. First, VNS induced splenic norepinephrine (NE) release in both mPGES-1 (+/+) and (-/-) mice. Compared to mPGES-1 (+/+), immunomodulatory effects of NE on cytokines were strongly compromised in mPGES-1 (-/-) splenocytes. Interestingly, while LPS increased choline acetyltransferase (ChAT) protein level in mPGES-1 (+/+) splenocytes, it failed to exert similar effects in mPGES-1 (-/-) splenocytes despite unaltered beta(2) AR protein expression. In addition, nicotine inhibited TNF alpha release by LPS activated mPGES-1 (+/+) splenocytes in vitro. However, such immunosuppressive effects of nicotine were reversed both in mPGES-1 (-/-) mouse splenocytes and human PBMC treated with mPGES-1 inhibitor. In summary, our data implicate PGE2 as an important mediator of ACh synthesis and noradrenergic/cholinergic molecular events in the spleen that constitute a crucial part of the CAP immune regulation. Our results suggest a possible link between cholinergic and PG system of CAP that may be of clinical significance in VNS treatment.	[Revathikumar, Priya; Estelius, Johanna; Karmakar, Utsa; Le Maitre, Erwan; Korotkova, Marina; Jakobsson, Per-Johan; Lampa, Jon] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Lampa, J (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden.	jon.lampa@ki.se	Jakobsson, Per-Johan/ABC-5594-2021		Swedish Research Council [2013-09306]; Marianne and Marcus Wallenberg Foundation [MMW 2013.0120]; Stockholm County Council ALF [20150893]; Swedish Rheumatism Association [R-663421]; King Gustaf V's 80-year foundation; Crafoord Foundation [FOA13Craf-008]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Marianne and Marcus Wallenberg Foundation; Stockholm County Council ALF(Stockholm County Council); Swedish Rheumatism Association; King Gustaf V's 80-year foundation; Crafoord Foundation	This study used funding received by JL from the following sources: The Swedish Research Council (https://www.vr.se, grant no: 2013-09306), Marianne and Marcus Wallenberg Foundation (https://www.wallenberg.com/mmw/, grant no: MMW 2013.0120), Stockholm County Council ALF (https://forskningsstod.vmi.se/Ansokan/start.asp, grant no: 20150893) and The Swedish Rheumatism Association (https://www.reumatikerforbundet.org, grant no: R-663421), as well as funding received by EL from King Gustaf Vs 80-year foundation (http://www.kungahuset.se/monarkinhovstaterna/kungligastiftelser/forskning/konunggustafvs80arsfond.4.11deaee4147afe3f46050da.html, grant no: n/a) and The Crafoord Foundation (http://www.crafoord.se/, grant no: FOA13Craf-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Arimura T, J CARDIAC FAILURE, V20, pS150; Barnes PJ, 1999, J ALLERGY CLIN IMMUN, V104, pS10, DOI 10.1016/S0091-6749(99)70269-1; Bissonnette EY, 1997, J ALLERGY CLIN IMMUN, V100, P825, DOI 10.1016/S0091-6749(97)70280-X; Bonaz B, 2016, NEUROGASTROENT MOTIL, V28, P948, DOI 10.1111/nmo.12792; Borovikova LV, 2000, NATURE, P405; Cheon H, 2006, J IMMUNOL, V177, P1092, DOI 10.4049/jimmunol.177.2.1092; Dawson J, 2016, STROKE, V47, P143, DOI 10.1161/STROKEAHA.115.010477; de Lartigue G, 2016, J PHYSIOL-LONDON, V594, P5791, DOI 10.1113/JP271538; Dooper MMBW, 2002, IMMUNOLOGY, V107, P152, DOI 10.1046/j.1365-2567.2002.01474.x; Egea J, 2015, BIOCHEM PHARMACOL, P97; Ek M, ACTIVATION VAGAL AFF; Engblom D, 2002, J MOL MED, V80, P5, DOI 10.1007/s00109-001-0289-z; Fujii T, 2017, J PHARMACOL SCI, V134, P1, DOI 10.1016/j.jphs.2017.05.002; Furuyashiki T, 2011, NAT REV ENDOCRINOL, V7, P163, DOI 10.1038/nrendo.2010.194; Grailer JJ, 2014, J INNATE IMMUN, V6, P607, DOI 10.1159/000358524; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Izeboud CA, 1999, J RECEPT SIGNAL TR R, V19, P191, DOI 10.3109/10799899909036645; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kohm AP, 2001, PHARMACOL REV, V53, P487; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Le Maitre E, 2015, PROSTAG OTH LIPID M, V121, P155, DOI 10.1016/j.prostaglandins.2015.05.006; Leclerc P, 2013, PROSTAG OTH LIPID M, V107, P26, DOI 10.1016/j.prostaglandins.2013.09.001; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; MacNeil BJ, 1997, AM J PHYSIOL-REG I, V273, pR609, DOI 10.1152/ajpregu.1997.273.2.R609; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Meyers EE, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12718; Noubade R, 2014, NATURE, V509, P235, DOI 10.1038/nature13152; Olofsson PS, 2012, MOL MED, V18, P539, DOI 10.2119/molmed.2011.00405; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Revathikumar P, 2016, J NEUROINFLAMM, V13, P1; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Simone R, 2005, J NEUROINFLAMMATION, V2; SPATAFORA M, 1991, PHARMACOL RES, V23, P247, DOI 10.1016/S1043-6618(05)80084-2; Suberville S, 1996, EUR J IMMUNOL, V26, P2601, DOI 10.1002/eji.1830261110; Suenaga A, 2004, VASC PHARMACOL, V41, P51, DOI 10.1016/j.vph.2004.03.006; Takahashi HK, 2006, J LEUKOCYTE BIOL, V80, P1388, DOI 10.1189/jlb.0406236; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Vida G, 2011, FASEB J, V25, P4476, DOI 10.1096/fj.11-191007; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Vijayaraghavan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065936; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Zhang ZH, 2011, AM J PHYSIOL-HEART C, V301, pH1559, DOI 10.1152/ajpheart.00262.2011	50	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193210	10.1371/journal.pone.0193210	http://dx.doi.org/10.1371/journal.pone.0193210			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470537	Green Published, Green Submitted, gold			2022-12-26	WOS:000425831000042
J	Zuloaga, FO; Salariato, DL; Scataglini, A				Omar Zuloaga, Fernando; Leonel Salariato, Diego; Scataglini, Amalia			Molecular phylogeny of Panicum s. str. (Poaceae, Panicoideae, Paniceae) and insights into its biogeography and evolution	PLOS ONE			English	Article							C-4 PHOTOSYNTHESIS; TAXONOMIC POSITION; CLADE POACEAE; GENUS; GRASSES; ORIGINS; CLIMATE; CLASSIFICATION; DELIMITATION; SPECIATION	Panicum sensu stricto is a genus of grasses (Poaceae) with nearly, according to this study, 163 species distributed worldwide. This genus is included in the subtribe Panicinae together with Louisiella, the latter with 2 species. Panicum and subtribe Panicinae are characterized by including annual or perennial taxa with open and lax panicles, and spikelets with the lower glume reduced; all taxa also share a basic chromosome number of x = 9 and a Kranz leaf blade anatomy typical of the NAD-me subtype photosynthetic pathway. Nevertheless, the phylogenetic placements of many Panicum species, and the circumscription of the genus, remained untested. Therefore, phylogenetic analyses were conducted using sequence data from the ndhF plastid region, in an extensive worldwide sampling of Panicum and related genera, in order to infer evolutionary relationships and to provide a phylogenetic framework to review the classification of the genus. Diversification times, historical biogeography and evolutionary patterns of the life history (annual vs. perennial) in the subtribe and Panicum were also studied. Results obtained provide strong support for a monophyletic Panicum including 71 species and 7 sections, of which sections Arthragrostis and Yakirra are new in the genus; 7 new combinations are made here. Furthermore, 32 species traditionally assigned to Panicum were excluded from the genus, and discussed in other subtribes of Paniceae. Our study suggested that early diversification in subtribe Panicinae and Panicum occurred through the Early-Mid Miocene in the Neotropics, while the subsequent diversification of its sections mainly occurred in the Late Miocene-Pleistocene, involving multiple dispersals to all continents. Our analyses also showed that transition rates and changes between annual and perennial life history in Panicum were quite frequent, suggesting considerable lability of this trait. Changes of the life history, together with C-4 photosynthesis, and the multiple dispersal events since the Mid Miocene, seem to have facilitated a widespread distribution of the genus. All these findings contribute to a better understanding of the systematics and evolution of Panicum.	[Omar Zuloaga, Fernando; Leonel Salariato, Diego; Scataglini, Amalia] Inst Bot Darwin, Buenos Aires, DF, Argentina		Zuloaga, FO; Salariato, DL (corresponding author), Inst Bot Darwin, Buenos Aires, DF, Argentina.	fzuloaga@darwin.edu.ar; dsalariato@darwin.edu.ar		Zuloaga, Fernando/0000-0003-2794-539X; Salariato, Diego/0000-0002-3253-3755	ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnica, Argentina) [1220-2013]; CONICET [0207]; National Geographic Society [8862-10, 3938-13]	ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnica, Argentina)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Geographic Society(National Geographic Society)	This study was supported in part by ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnica, Argentina), grant 1220-2013 to Fernando Omar Zuloaga and by CONICET, grant 0207 to Fernando Omar Zuloaga and by the National Geographic Society, grants 8862-10 and 3938-13 to Fernando Omar Zuloaga. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagesen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151075; Acosta JM, 2014, PLANT SYST EVOL, V300, P2155, DOI 10.1007/s00606-014-1034-8; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Aliscioni SS, 2003, AM J BOT, V90, P796, DOI 10.3732/ajb.90.5.796; Scataglini MA, 2014, SYST BOT, V39, P1108, DOI 10.1600/036364414X683886; Scataglini MA, 2014, PHYTOTAXA, V163, P1; Scataglini MA, 2013, SYST BOT, V38, P1076, DOI 10.1600/036364413X674823; [Anonymous], 2021, LANG ENV STAT COMP; BARBIER P, 1991, THEOR APPL GENET, V81, P693, DOI 10.1007/BF00226739; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; BERG RY, 1985, AUST J BOT, V33, P579, DOI 10.1071/BT9850579; Bess EC, 2006, SYST BOT, V31, P656, DOI 10.1600/036364406779695898; BROWN W V, 1977, Memoirs of the Torrey Botanical Club, V23, P1; Buerki S, 2011, J BIOGEOGR, V38, P531, DOI 10.1111/j.1365-2699.2010.02432.x; Burke SV, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0823-3; Christin PA, 2008, CURR BIOL, V18, P37, DOI 10.1016/j.cub.2007.11.058; Christin PA, 2015, MOL BIOL EVOL, V32, P846, DOI 10.1093/molbev/msu410; Christin PA, 2014, SYST BIOL, V63, P153, DOI 10.1093/sysbio/syt072; Christin PA, 2013, P NATL ACAD SCI USA, V110, P1381, DOI 10.1073/pnas.1216777110; Christin PA, 2009, PLANT PHYSIOL, V149, P82, DOI 10.1104/pp.108.128553; Clayton W. D., 1986, Kew Bulletin Additional Series, V13; Clayton WD, GRASSBASE ONLINE WOR; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dupin J, 2017, J BIOGEOGR, V44, P887, DOI 10.1111/jbi.12898; Duvall MR, 2003, INT J PLANT SCI, V164, P949, DOI 10.1086/378657; Duvall MR, 2001, AM J BOT, V88, P1988, DOI 10.2307/3558426; Ellis R.P., 1988, MONOGRAPHS SYSTEMATI, V25, P129; Evans MEK, 2005, EVOLUTION, V59, P1914, DOI 10.1111/j.0014-3820.2005.tb01061.x; Friedman J, 2015, AM J BOT, V102, P497, DOI 10.3732/ajb.1500062; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Gadgil M., 1975, ECOLOGY EVOLUTION CO, P142; Giussani LM, 2001, AM J BOT, V88, P1993, DOI 10.2307/3558427; Gomez-Martinez R., 2000, Grasses: systematics and evolution., P136; Grande-Allende JR, 2014, PHYTONEURON, V22, P1; Hackel J, 2018, J BIOGEOGR, V45, P750, DOI 10.1111/jbi.13147; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hitchcock A.S., 1910, CONTRIB US NAT HERB, V15, P1, DOI [10.5962/bhl.title.45885, DOI 10.5962/BHL.TITLE.45885]; Hitchcock AS., 1915, CONTRIB U S NATL HER, V17, P459; Honda M., 1930, J FS U TOKYO 3, V3, P43; Hubbard C.E, 1952, Bulletin du Jardin botanique de l'Etat a Bruxelles. Brussels, V22, P312; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; Hughes DK, 1923, B MISC INFORM KEW, V1923, P244; Karl R, 2013, ANN BOT-LONDON, V112, P983, DOI 10.1093/aob/mct165; Kellogg E.A., 2015, FAMILIES GENERA VASC, V13, P1; Lanfear R., 2016, MOL BIOL EVOL; LAZARIDES M, 1978, Brunonia, V1, P69, DOI 10.1071/BRU9780069; LAZARIDES M, 1984, Nuytsia, V5, P273; Lazarides M., 1984, BRUNONIA, V7, P289, DOI [10.1071/BRU9840289, DOI 10.1071/BRU9840289]; Li WP, 2012, ANN BOT-LONDON, V109, P1341, DOI 10.1093/aob/mcs054; Luckow M, 2005, TAXON, V54, P513, DOI 10.2307/25065385; Matzke N.J., 2012, FRONTIERS BIOGEOGRAP, V4, P210; Matzke N.J., 2013, PACKAGE BIOGEOBEARS; Matzke NJ, 2014, SYST BIOL, V63, P951, DOI 10.1093/sysbio/syu056; Miller JT, 2014, TAXON, V63, P653, DOI 10.12705/633.2; Miller M.A., 2010, P GAT COMP ENV WORKS; Morrone O, 2008, SYST BOT, V33, P66, DOI 10.1600/036364408783887393; Morrone O, 2007, TAXON, V56, P521, DOI 10.1002/tax.562023; Morrone O, 2012, CLADISTICS, V28, P333, DOI 10.1111/j.1096-0031.2011.00384.x; Morrone Osvaldo, 1993, Darwiniana (San Isidro), V32, P59; Nesom Guy L., 1994, Phytologia, V77, P141; Nicola MV, 2015, PLANT SYST EVOL, V301, P2247, DOI 10.1007/s00606-015-1227-9; Ogburn RM, 2015, MOL PHYLOGENET EVOL, V92, P181, DOI 10.1016/j.ympev.2015.06.006; Ogburn RM, 2009, AM J BOT, V96, P391, DOI 10.3732/ajb.0800142; Orme D., 2018, R PACKAGE VERSION, V5, P1; Osborne CP, 2004, P NATL ACAD SCI USA, V101, P10360, DOI 10.1073/pnas.0402787101; Pagel M., 2016, BAYESTRAITS VERSION; Pelser PB, 2007, TAXON, V56, P1077, DOI 10.2307/25065905; Pessoa M, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3904-2; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Prasad V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1482; Rambaut A, 2013, TRACER VERSION 1 6 C; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Salariato DL, 2010, MOL PHYLOGENET EVOL, V56, P355, DOI 10.1016/j.ympev.2010.02.009; Sanchez-Ken JG, 2007, SYST BOT, V32, P71, DOI 10.1600/036364407780360102; Sede SM, 2008, SYST BOT, V33, P284, DOI 10.1600/036364408784571626; Sede SM, 2009, SYST BOT, V34, P684, DOI 10.1600/036364409790139655; Silva C, 2015, MOL PHYLOGENET EVOL, V93, P212, DOI 10.1016/j.ympev.2015.07.015; SIMON B K, 1990, Austrobaileya, V3, P239; Simon BK, GRASSWORLD; Simon Bryan K., 2003, Austrobaileya, V6, P571; Soreng RJ, 2017, J SYST EVOL, V55, P259, DOI 10.1111/jse.12262; Soreng RJ, 2015, J SYST EVOL, V53, P117, DOI 10.1111/jse.12150; Soreng Robert J., 2010, Journal of the Botanical Research Institute of Texas, V4, P691; Stadler T, 2009, J THEOR BIOL, V261, P58, DOI 10.1016/j.jtbi.2009.07.018; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stapf O., 1920, FLORA TROPICAL AFRIC, V9, P638; Thiers B., INDEX HERBARIORUM GL; Triplett JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038702; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Vorontsova MS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2262; Vorontsova MS, 2012, TAXON, V61, P735, DOI 10.1002/tax.614003; Watson L., 1992, GRASS GENERA WORLD D; Wills KE, 2000, AUST SYST BOT, V13, P437, DOI 10.1071/SB99007; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zimmermann T, 2013, J PLANT RES, V126, P363, DOI 10.1007/s10265-012-0538-y; ZULOAGA F O, 1981, Darwiniana (San Isidro), V23, P233; Zuloaga FO, 2007, TAXON, V56, P145, DOI 10.2307/25065745; Zuloaga FO, 2006, SYST BOT, V31, P497, DOI 10.1600/036364406778388548; Zuloaga FO, 2015, PLANT SYST EVOL, V301, P1693, DOI 10.1007/s00606-014-1186-6; Zuloaga FO, 2011, SYST BOTANY MONOGR, V94, P1; Zuloaga FO, 2010, TAXON, V59, P1535, DOI 10.1002/tax.595017; ZULOAGA FO, 1987, ANN MO BOT GARD, V74, P463, DOI 10.2307/2399313; Zuloaga FO, 1998, ANN MO BOT GARD, V85, P631, DOI 10.2307/2992019; Zuloaga FO, 1985, SMITHSONIAN CONTRIBU, V59, P1, DOI DOI 10.5479/SI.0081024X.59; Zuloaga FO., 1987, GRASS SYSTEMATICS EV, P287	108	19	22	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0191529	10.1371/journal.pone.0191529	http://dx.doi.org/10.1371/journal.pone.0191529			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466405	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300012
J	Bao, H; Chen, YX; Huang, K; Zhuang, F; Bao, M; Han, Y; Chen, XH; Shi, Q; Yao, QP; Qi, YX				Bao, Han; Chen, Yuan-Xiu; Huang, Kai; Zhuang, Fei; Bao, Min; Han, Yue; Chen, Xiao-Hu; Shi, Qian; Yao, Qing-Ping; Qi, Ying-Xin			Platelet-derived microparticles promote endothelial cell proliferation in hypertension via miR-142-3p	FASEB JOURNAL			English	Article						intercellular communication; microRNA; vascular homeostasis; BCLAF1	CIRCULATING MICROPARTICLES; SHEAR-STRESS; DYSFUNCTION; APOPTOSIS; PROTEIN; CANCER; BCLAF1; RAT; PATHOPHYSIOLOGY; TRANSCRIPTION	Endothelial cells (ECs) are located at the interface between flowing blood and the vessel wall, and abnormal EC proliferation induced by pathologic environments plays an important role in vascular remodeling in hypertensive conditions. Exchanges of information between blood components and ECs are important for EC function. Hence, the present study sought to determine how platelets induce EC dysfunction under hypertensive conditions. EC proliferation was increased in renal hypertensive rats established by abdominal aortic coarctation compared with control rats and that elevated thrombin in plasma promoted platelet activation, which may induce the release of platelet-derived microparticles (PMPs). MicroRNA (MiR) array and qPCR revealed a higher level of miR-142-3p in platelets and PMPs. In vitro, PMPs delivered miR-142-3p into ECs and enhanced their proliferation via Bcl-2-associated transcription factor (BCLAF)1 and its downstream genes. These results indicate that PMPs deliver miR-142-3p from activated platelets into ECs and that miR-142-3p may play important roles in EC dysfunction in hypertensive conditions and may be a novel therapeutic target for maintaining EC homeostasis in hypertension.Bao, H., Chen, Y.-X., Huang, K., Zhuang, F., Bao, M., Han, Y., Chen, X.-H., Shi, Q., Yao, Q.-P., Qi, Y.-X. Platelet-derived microparticles promote endothelial cell proliferation in hypertension via miR-142-3p.	[Bao, Han; Chen, Yuan-Xiu; Huang, Kai; Zhuang, Fei; Bao, Min; Han, Yue; Chen, Xiao-Hu; Shi, Qian; Yao, Qing-Ping; Qi, Ying-Xin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Inst Mechanobiol & Med Engn, 800 Dongchuan Rd,POB 888, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University	Yao, QP; Qi, YX (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Inst Mechanobiol & Med Engn, 800 Dongchuan Rd,POB 888, Shanghai 200240, Peoples R China.	qpyao@sjtu.edu.cn; qiyx@sjtu.edu.cn			National Natural Science Foundation of China [11222223, 11625209, 11572199]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China Grants 11625209, 11572199, and 11222223 (all to Y.-X.Q.). The authors declare no conflicts of interest.	Aissa KA, 2015, ARTERIOSCL THROM VAS, V35, P930, DOI 10.1161/ATVBAHA.115.305377; Barton CH, 2001, KIDNEY INT, V60, P1083, DOI 10.1046/j.1523-1755.2001.0600031083.x; Bautista LE, 2001, J HYPERTENS, V19, P857, DOI 10.1097/00004872-200105000-00004; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Cines DB, 1998, BLOOD, V91, P3527; Condorelli G, 1999, CIRCULATION, V99, P3071, DOI 10.1161/01.CIR.99.23.3071; Dai L, 2009, ELECTROPHORESIS, V30, P1119, DOI 10.1002/elps.200800505; Dewi IS, 2017, CARDIOVASC RES, V113, P440, DOI 10.1093/cvr/cvw244; Duarte D, 2013, ALLERGY, V68, P1073, DOI 10.1111/all.12190; Efrati S, 2007, J HYPERTENS, V25, P1041, DOI 10.1097/HJH.0b013e32807fb09c; Goubran H, 2015, TRANSFUS APHER SCI, V53, P168, DOI 10.1016/j.transci.2015.10.014; Han Y, 2015, BBA-MOL CELL RES, V1853, P1165, DOI 10.1016/j.bbamcr.2015.02.013; Ishida K, 2016, ACTA PHYSIOL, V216, P211, DOI 10.1111/apha.12561; Ismail EAR, 2013, CLIN APPL THROMB-HEM, V19, P424, DOI 10.1177/1076029612456733; Jiang P, 2015, EXP BIOL MED, V240, P876, DOI 10.1177/1535370214565076; Jones R, 2014, ULTRASTRUCT PATHOL, V38, P93, DOI 10.3109/01913123.2013.846450; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Kong SY, 2011, J BIOL CHEM, V286, P16967, DOI 10.1074/jbc.M111.218206; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Lee YY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.76; Li Q, 2015, J HYPERTENS, V33, P1128, DOI 10.1097/HJH.0000000000000587; Liu H, 2007, MOL CELL BIOL, V27, P8480, DOI 10.1128/MCB.01126-07; Lovren F, 2013, CLIN CHEM, V59, P1166, DOI 10.1373/clinchem.2012.199711; Mause SF, 2005, ARTERIOSCL THROM VAS, V25, P1512, DOI 10.1161/01.ATV.0000170133.43608.37; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Naqvi AR, 2016, SCI REP-UK, V6, DOI 10.1038/srep32925; Nishimura K, 2006, AM J PHYSIOL-CELL PH, V290, pC812, DOI 10.1152/ajpcell.00347.2005; Orieux G, 2014, J NEUROSCI, V34, P1530, DOI 10.1523/JNEUROSCI.3227-13.2014; Preston RA, 2003, HYPERTENSION, V41, P211, DOI 10.1161/01.HYP.0000049760.15764.2D; Renert AF, 2009, J PROTEOME RES, V8, P4810, DOI 10.1021/pr9005316; Rojas E, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0463-7; Schock SC, 2014, BIOCHEM BIOPH RES CO, V450, P912, DOI 10.1016/j.bbrc.2014.06.096; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; SCHWARTZ SM, 1977, CIRC RES, V41, P248, DOI 10.1161/01.RES.41.2.248; SCHWARTZ SM, 1984, PROG CARDIOVASC DIS, V26, P355, DOI 10.1016/0033-0620(84)90010-0; Shen B, 2016, TUMOR BIOL, V37, P7371, DOI 10.1007/s13277-015-4410-2; Sheu JJ, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0381-8; Tual-Chalot S, 2010, AM J RESP CRIT CARE, V182, P261, DOI 10.1164/rccm.200909-1347OC; van Balkom BWM, 2013, BLOOD, V121, P3997, DOI 10.1182/blood-2013-02-478925; Vaziri ND, 1995, AM J PHYSIOL-RENAL, V269, pF838, DOI 10.1152/ajprenal.1995.269.6.F838; Wang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep41058; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x; Xiong Y, 2013, CELL RES, V23, P820, DOI 10.1038/cr.2013.56; Yeh JJ, 2010, BLOOD, V115, P4247, DOI 10.1182/blood-2009-09-241166; Zhou J, 2013, CIRC RES, V113, P40, DOI 10.1161/CIRCRESAHA.113.280883	45	44	47	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3912	3923		10.1096/fj.201701073R	http://dx.doi.org/10.1096/fj.201701073R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29481306				2022-12-26	WOS:000435104500036
J	Nakayama, S; Yumimoto, K; Kawamura, A; Nakayama, KI				Nakayama, Shogo; Yumimoto, Kanae; Kawamura, Atsuki; Nakayama, Keiichi I.			Degradation of the endoplasmic reticulum-anchored transcription factor MyRF by the ubiquitin ligase SCFFbxw7 in a manner dependent on the kinase GSK-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEIN; GENE REGULATORY FACTOR; TUMOR-SUPPRESSOR; CYCLIN-E; C-MYC; CAENORHABDITIS-ELEGANS; PHOSPHODEGRON MOTIFS; FBW7; PHOSPHORYLATION; CANCER	The ubiquitin-proteasome system regulates the abundance of many cellular proteins by mediating their targeted degradation. We previously developed a method-differential proteomics-based identification of ubiquitylation substrates (DiPIUS)-for the comprehensive identification of substrates for a given F-box protein subunit of SCF-type ubiquitin ligases. We have now applied DiPIUS to the F-box protein Fbxw7 in three cell lines (mHepa, Neuro2A, and C2C12) and thereby identified myelin regulatory factor (MyRF), an endoplasmic reticulum-anchored transcription factor that is essential for myelination of nerves in the central nervous system, as a candidate substrate of Fbxw7 specifically in mHepa cells. Co-immunoprecipitation analysis confirmed that the NH2-terminal cytoplasmic domain of MyRF interacted with Fbxw7 in these cells. Furthermore, an in vitro ubiquitylation assay revealed that MyRF undergoes polyubiquitylation in the presence of purified recombinant SCFFbxw7. In addition, the stability of MyRF in mHepa cells was increased by mutation of a putative phosphodegron sequence or by exposure of the cells to an inhibitor of glycogen synthase kinase-3 (GSK-3). We found that MyRF mRNA is not restricted to the central nervous system but is instead distributed widely among mouse tissues. Furthermore, with the use of RNA sequencing in mHepa cells overexpressing or depleted of MyRF, we identified many novel potential target genes of MyRF. Our results thus suggest that Fbxw7 controls the transcription of MyRF target genes in various tissues through regulation of MyRF protein stability in a manner dependent on MyRF phosphorylation by GSK-3.	[Nakayama, Shogo; Yumimoto, Kanae; Kawamura, Atsuki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan	Kyushu University	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [25221303, 17H06301, 15H01186]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 25221303 and 17H06301 (to K. I. N.) and 15H01186 (to K. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Bengoechea-Alonso MT, 2010, P NATL ACAD SCI USA, V107, P11817, DOI 10.1073/pnas.0913367107; Bujalka H, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001625; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Crawford LA, 2009, MOL ENDOCRINOL, V23, P324, DOI 10.1210/me.2008-0045; Emery Ben, 2013, Cold Spring Harb Protoc, V2013, P854, DOI 10.1101/pdb.prot073973; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hall-Glenn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030562; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Kanazawa K, 2003, J BONE MINER RES, V18, P443, DOI 10.1359/jbmr.2003.18.3.443; Katayama Y, 2016, NATURE, V537, P675, DOI 10.1038/nature19357; Kearns CA, 2015, J NEUROSCI, V35, P14861, DOI 10.1523/JNEUROSCI.4968-14.2015; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Koenning M, 2012, J NEUROSCI, V32, P12528, DOI 10.1523/JNEUROSCI.1069-12.2012; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kumadaki S, 2011, J BIOL CHEM, V286, P40835, DOI 10.1074/jbc.M111.235283; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Matsumoto A, 2011, J BIOL CHEM, V286, P13754, DOI 10.1074/jbc.M110.194936; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Okuda S, 2017, NUCLEIC ACIDS RES, V45, pD1107, DOI 10.1093/nar/gkw1080; Onoyama I, 2011, J CLIN INVEST, V121, P342, DOI 10.1172/JCI40725; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Shi L, 2010, NEURON, V65, P204, DOI 10.1016/j.neuron.2010.01.012; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; SUNDARAM M, 1993, GENETICS, V135, P765; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Yokobori T, 2009, CANCER RES, V69, P3788, DOI 10.1158/0008-5472.CAN-08-2846; Yumimoto K, 2013, J BIOL CHEM, V288, P28488, DOI 10.1074/jbc.M113.465179; Yumimoto K, 2012, J PROTEOME RES, V11, P3175, DOI 10.1021/pr201216u; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040	51	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5705	5714		10.1074/jbc.RA117.000741	http://dx.doi.org/10.1074/jbc.RA117.000741			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29472293	Green Published, hybrid			2022-12-26	WOS:000430044100030
J	Jamalabadi, MYA; Daqiqshirazi, M; Nasiri, H; Safaei, MR; Nguyen, TK				Jamalabadi, Mohammad Yaghoub Abdollahzadeh; Daqiqshirazi, Mohammadreza; Nasiri, Hossein; Safaei, Mohammad Reza; Truong Khang Nguyen			Modeling and analysis of biomagnetic blood Carreau fluid flow through a stenosis artery with magnetic heat transfer: A transient study	PLOS ONE			English	Article							NON-NEWTONIAN BLOOD; NUMERICAL-SIMULATION; ENDOTHELIAL-CELLS; MICROPOLAR FLUID; DISTURBED FLOW; DRUG-DELIVERY; FIELD; BIFURCATION; RADIATION; DYNAMICS	We present a numerical investigation of tapered arteries that addresses the transient simulation of non-Newtonian bio-magnetic fluid dynamics (BFD) of blood through a stenosis artery in the presence of a transverse magnetic field. The current model is consistent with ferro-hydrodynamic (FHD) and magneto-hydrodynamic (MHD) principles. In the present work, blood in small arteries is analyzed using the Carreau-Yasuda model. The arterial wall is assumed to be fixed with cosine geometry for the stenosis. A parametric study was conducted to reveal the effects of the stenosis intensity and the Hartman number on a wide range of flow parameters, such as the flow velocity, temperature, and wall shear stress. Current findings are in a good agreement with recent findings in previous research studies. The results show that wall temperature control can keep the blood in its ideal blood temperature range (below 40 degrees C) and that a severe pressure drop occurs for blockages of more than 60 percent. Additionally, with an increase in the Ha number, a velocity drop in the blood vessel is experienced.	[Jamalabadi, Mohammad Yaghoub Abdollahzadeh] Dongguk Univ, Dept Mech Robot & Energy Engn, Seoul, South Korea; [Daqiqshirazi, Mohammadreza] Univ Tehran, Coll Engn, Sch Mech Engn, Tehran, Iran; [Nasiri, Hossein] Daneshpajoohan Higher Educ Inst, Dept Mech Engn, Esfahan, Iran; [Safaei, Mohammad Reza; Truong Khang Nguyen] Ton Duc Thang Univ, Inst Computat Sci, Div Computat Phys, Ho Chi Minh City, Vietnam; [Safaei, Mohammad Reza; Truong Khang Nguyen] Ton Duc Thang Univ, Fac Elect & Elect Engn, Ho Chi Minh City, Vietnam	Dongguk University; University of Tehran; Ton Duc Thang University; Ton Duc Thang University	Safaei, MR (corresponding author), Ton Duc Thang Univ, Inst Computat Sci, Div Computat Phys, Ho Chi Minh City, Vietnam.; Safaei, MR (corresponding author), Ton Duc Thang Univ, Fac Elect & Elect Engn, Ho Chi Minh City, Vietnam.	cfd_safaei@tdt.edu.vn	Jamalabadi, Mohammad Yaghoub Abdollahzadeh/M-5838-2015; Nguyen, Truong Khang/G-4686-2015; Daqiqshirazi, Mohammadreza/P-2843-2015; NASIRI, Hossein/AAD-8260-2021; Safaei, Mohammad Reza/E-1111-2013	Jamalabadi, Mohammad Yaghoub Abdollahzadeh/0000-0002-4423-1025; Nguyen, Truong Khang/0000-0001-9654-4392; Daqiqshirazi, Mohammadreza/0000-0002-9292-7668; Safaei, Mohammad Reza/0000-0001-7301-2561				Akbar NS, 2015, PHYSICA E, V72, P70, DOI 10.1016/j.physe.2015.04.017; Akbar NS, 2014, AIN SHAMS ENG J, V5, P1307, DOI 10.1016/j.asej.2014.05.010; Akbar NS, 2015, ENTROPY-SWITZ, V17, P1411, DOI 10.3390/e17031411; Ali F, 2017, J MAGN MAGN MATER, V423, P327, DOI 10.1016/j.jmmm.2016.09.125; Alimohamadi H, 2015, INT J FLUID MECH RES, V42, P149, DOI 10.1615/InterJFluidMechRes.v42.i2.50; Alimohamadi H, 2014, INT J COMPUT METH EN, V15, P522, DOI 10.1080/15502287.2014.952848; Alimohamadi H, 2014, INT J COMPUT METH EN, V15, P390, DOI 10.1080/15502287.2014.915253; Amornsamankul S., 2006, INT J BIOL MED SCI, V1, P42; [Anonymous], 2008, INT J NUMERICAL METH; ARIMAN T, 1974, J APPL MECH-T ASME, V41, P1, DOI 10.1115/1.3423224; Behnia S, 2015, CHAOS SOLITON FRACT, V78, P194, DOI 10.1016/j.chaos.2015.07.029; Behnia S, 2013, NONLINEAR DYNAM, V74, P559, DOI 10.1007/s11071-013-0988-3; Berger SA, 2000, ANNU REV FLUID MECH, V32, P347, DOI 10.1146/annurev.fluid.32.1.347; Brenn G., 2016, ANAL SOLUTIONS TRANS; Caballero AD, 2015, COMPUT METHOD BIOMEC, V18, P1200, DOI 10.1080/10255842.2014.887698; Cebral JR, 2002, ACAD RADIOL, V9, P1286, DOI 10.1016/S1076-6332(03)80562-7; Chhabra RP, 1999, NONNEWTONIAN FLOW PR, DOI 10.1016/b978-075063770-1/50009-9; Chien S, 2008, ANN BIOMED ENG, V36, P554, DOI 10.1007/s10439-007-9426-3; Chiu JJ, 1998, J BIOMECH ENG-T ASME, V120, P2, DOI 10.1115/1.2834303; den Harder AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171138; Ellahi R, 2014, APPL MATH INFORM SCI, V8, P1567, DOI 10.12785/amis/080410; Haghighi AR, 2015, INT J BIOMATH, V8, DOI 10.1142/S1793524515500564; HALDAR K, 1985, B MATH BIOL, V47, P545, DOI 10.1007/BF02460013; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145525; HIGASHI T, 1993, BLOOD, V82, P1328; Houpt JC, 1996, SPINE, V21, P1808, DOI 10.1097/00007632-199608010-00018; Ikbal MA, 2009, J COMPUT APPL MATH, V230, P243, DOI 10.1016/j.cam.2008.11.010; Jamalabadi MYA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167393; Jamalabadi MYA, 2015, CHEM ENG RES DES, V102, P407, DOI 10.1016/j.cherd.2015.07.015; Jamalabadi MYA, 2015, ENTROPY-SWITZ, V17, P866, DOI 10.3390/e17020866; Jamalabadi MYA, 2015, J HYDRODYNAMICS, V14; Kalra N, 2016, INDIAN J PHYSIOTHERA, V10, P15; Karimipour A, 2017, PHYSICA E, V86, P146, DOI 10.1016/j.physe.2016.10.015; Kim D, 2000, J COMPUT PHYS, V162, P411, DOI 10.1006/jcph.2000.6546; Kim SO, 2001, KOREAN J WOMENS HLTH, V7, P610; Kischinhevsky M, BRIEF REV SIMPLE FIN; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; Liu GY, 2015, COMPUT BIOL MED, V64, P117, DOI 10.1016/j.compbiomed.2015.06.009; Liu XM, 2016, J MECH MED BIOL, V16, DOI 10.1142/S0219519416500342; LOU Z, 1993, J BIOMECH, V26, P37, DOI 10.1016/0021-9290(93)90611-H; Lukacova-Medvidova M, 2008, INT J NUMER METH FL, V56, P1409, DOI 10.1002/fld.1676; Mabood F, 2016, INT J HEAT MASS TRAN, V93, P674, DOI 10.1016/j.ijheatmasstransfer.2015.10.014; Mandal PK, 2007, INT J COMPUT MATH, V84, P1059, DOI 10.1080/00207160701288881; Mandal PK, 2005, INT J NONLIN MECH, V40, P151, DOI 10.1016/j.ijnonlinmec.2004.07.007; Medhavi A, 2015, 2 PHASE ARTERIAL BLO; Mohammadpour A, 2014, J CLIN NURS, V23, P3460, DOI 10.1111/jocn.12595; Morris L, 2005, J BIOMECH ENG-T ASME, V127, P767, DOI 10.1115/1.1992521; Mosayebidorcheh S, 2015, J BRAZILIAN SOC MECH; Mousavi SM, 2016, APPL MATH MODEL, V40, P7336, DOI 10.1016/j.apm.2016.03.012; Patankar S.V., 2018, NUMERICAL HEAT TRANS; Pereira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113769; PESKIN CS, 1977, J COMPUT PHYS, V25, P220, DOI 10.1016/0021-9991(77)90100-0; Pontrelli G, 2001, P I MECH ENG H, V215, P1, DOI 10.1243/0954411011533445; Sankar DS, 2011, J MECH SCI TECHNOL, V25, P2573, DOI 10.1007/s12206-011-0728-x; Sarifuddin, 2008, Journal of Medical Engineering & Technology, V32, P385, DOI 10.1080/03091900601164820; Schenck JF, 2000, J MAGN RESON IMAGING, V12, P2, DOI 10.1002/1522-2586(200007)12:1<2::AID-JMRI2>3.0.CO;2-V; Seta B, 2017, IFMBE PROC, V62, P259, DOI 10.1007/978-981-10-4166-2_39; Shadloo MS, 2011, P I MECH ENG C-J MEC, V225, P347, DOI 10.1243/09544062JMES2334; Shahidian A, 2009, IEEE T MAGN, V45, P2667, DOI 10.1109/TMAG.2009.2018954; Srivastava V.P., 2015, J SCI TECHNOL, V4, P5; SRIVASTAVA VP, 1995, RHEOL ACTA, V34, P406, DOI 10.1007/BF00367155; Tabatabaei SN, 2015, J CONTROL RELEASE, V206, P49, DOI 10.1016/j.jconrel.2015.02.027; Tanwar V K, 2012, APPL MATH SCI, V6, P5959; TRAUTMAN ED, 1983, IEEE T BIO-MED ENG, V30, P141, DOI 10.1109/TBME.1983.325098; Truskey G. A., 2004, TRANSPORT PHENOMENA; Tzirtzilakis EE, 2008, PHYSICA D, V237, P66, DOI 10.1016/j.physd.2007.08.006; Tzirtzilakis EE, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1978807; Vaalma S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168902; Varshney G., 2010, INT J ENG SCI TECHNO, P967; Villa CH, 2016, ADV DRUG DELIVERY RE; Wang DN, 2009, COMPUT MATH APPL, V58, P1030, DOI 10.1016/j.camwa.2009.02.020; White F. M., 2006, VISCOUS FLUID FLOW; Xenos M., 2013, ADV DYN SYST APPL, V8, P427	73	34	34	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192138	10.1371/journal.pone.0192138	http://dx.doi.org/10.1371/journal.pone.0192138			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489852	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000017
J	Fan, CJ; Graff, P; Vihlborg, P; Bryngelsson, IL; Andersson, L				Fan, Chenjing; Graff, Pal; Vihlborg, Per; Bryngelsson, Ing-Liss; Andersson, Lena			Silica exposure increases the risk of stroke but not myocardial infarction-A retrospective cohort study	PLOS ONE			English	Article							SWEDISH IRON FOUNDRIES; QUARTZ EXPOSURE; MORTALITY; DISEASES; CANCER; NOISE	Introduction Work-related exposure to silica is a global health hazard that causes diseases such as silicosis. Some studies have also reported that silica exposure is linked to elevated cardiovascular disease mortality. However, these diagnoses have not been investigated in detail and there have been few studies on morbidity. The aim of this study is to examine morbidity and mortality from different cardiovascular diseases among silica-exposed Swedish foundry workers. Methods Historical and contemporary measurements (1968 +/- 2006) of respiratory silica exposure were matched to job categories, individual foundries, and 4 time periods (1968 +/- 1979, 1980 +/- 1989, 1990 +/- 1999, 2000 +/- 2006) using a mixed model. Morbidity and mortality data for the studied cohorts were matched against the General Population Registry. Statistical analyses were performed with SPSS and STATA, and the data were stratified by age, gender, and year. Results Mortality from cardiovascular disease (SMR 1.3; 95% CI 1.2 +/- 1.4) and stroke (SMR 1.6, 95% CI 1.2 +/- 2.1) was significantly elevated among the studied population. The cohort also exhibited significantly elevated morbidity from stroke (SIR 1.34; 95% CI 1.2 +/- 1.5) but not myocardial infarction. The mean age at the time of first morbidity from stroke was 64 years, with 36% of the cases occurring before the age of 60. Conclusions Swedish foundry workers exposed to respirable silica exhibit elevated morbidity and mortality from stroke, but not from myocardial infarction. Our results also suggest a relationship between silica exposure and morbidity from stroke at a younger age than the general population.	[Fan, Chenjing; Graff, Pal; Vihlborg, Per; Bryngelsson, Ing-Liss; Andersson, Lena] Orebro Univ, Fac Med & Hlth, Dept Occupat & Environm Med, Orebro, Sweden; [Graff, Pal] Natl Inst Occupat Hlth STAMI, Oslo, Norway	Orebro University	Graff, P (corresponding author), Orebro Univ, Fac Med & Hlth, Dept Occupat & Environm Med, Orebro, Sweden.; Graff, P (corresponding author), Natl Inst Occupat Hlth STAMI, Oslo, Norway.	pal.graff@stami.no	Graff, PÃl/E-1881-2017	Graff, PÃl/0000-0003-4928-617X				Andersson L, 2012, ANN OCCUP HYG, V56, P362, DOI 10.1093/annhyg/mer106; Andersson L, 2012, J OCCUP ENVIRON HYG, V9, P110, DOI 10.1080/15459624.2011.645397; Andersson L, 2009, J OCCUP ENVIRON HYG, V6, P9, DOI 10.1080/15459620802523943; ARRIGHI HM, 1994, EPIDEMIOLOGY, V5, P189, DOI 10.1097/00001648-199403000-00009; Babisch W, 2014, NOISE HEALTH, V16, P1, DOI 10.4103/1463-1741.127847; Chang TY, 2013, AM J EPIDEMIOL, V177, P818, DOI 10.1093/aje/kws300; CHEN JQ, 1992, J OCCUP ENVIRON MED, V34, P311, DOI 10.1097/00043764-199203000-00017; Chen W, 2005, AM J IND MED, V48, P1, DOI 10.1002/ajim.20174; Chen WG, 2012, J NANOMATER, V2012, DOI 10.1155/2012/612420; Duan JC, 2016, NANOTOXICOLOGY, V10, P575, DOI 10.3109/17435390.2015.1102981; Duan JC, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0050-8; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; KOSKELA RS, 1994, SCAND J WORK ENV HEA, V20, P286, DOI 10.5271/sjweh.1396; Liu Y, 2014, EPIDEMIOLOGY, V25, P689; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Moroni B, 2014, J EXPO SCI ENV EPID, V24, P42, DOI 10.1038/jes.2013.3; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; Pollard KM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00097; Reid PJ, 1996, OCCUP ENVIRON MED, V53, P11, DOI 10.1136/oem.53.1.11; Steenland K, 2001, AM J EPIDEMIOL, V153, P695, DOI 10.1093/aje/153.7.695; 't Mannetje A, 2002, OCCUP ENVIRON MED, V59, P723, DOI 10.1136/oem.59.11.723; Toren K, 2007, OCCUP ENVIRON MED, V64, P515, DOI 10.1136/oem.2006.029488; Wang W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16900; Weiner J, 2007, AM J IND MED, V50, P403, DOI 10.1002/ajim.20466; Westberg H, 2013, INT ARCH OCC ENV HEA, V86, P499, DOI 10.1007/s00420-012-0782-4; WYNDHAM CH, 1986, BRIT J IND MED, V43, P677	26	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0192840	10.1371/journal.pone.0192840	http://dx.doi.org/10.1371/journal.pone.0192840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481578	Green Submitted, Green Published, gold			2022-12-26	WOS:000426202700006
J	Bhattacharya, S; Huddar, V; Rajan, V; Reddy, CK				Bhattacharya, Sakyajit; Huddar, Vijay; Rajan, Vaibhav; Reddy, Chandan K.			A dual boundary classifier for predicting acute hypotensive episodes in critical care	PLOS ONE			English	Article							BLOOD-PRESSURE; SEPSIS; MORTALITY; ICU	An Acute Hypotensive Episode (AHE) is the sudden onset of a sustained period of low blood pressure and is one among the most critical conditions in Intensive Care Units (ICU). Without timely medical care, it can lead to an irreversible organ damage and death. By identifying patients at risk for AHE early, adequate medical intervention can save lives and improve patient outcomes. In this paper, we design a novel dual-boundary classification based approach for identifying patients at risk for AHE. Our algorithm uses only simple summary statistics of past Blood Pressure measurements and can be used in an online environment facilitating real-time updates and prediction. We perform extensive experiments with more than 4,500 patient records and demonstrate that our method outperforms the previous best approaches of AHE prediction. Our method can identify AHE patients two hours in advance of the onset, giving sufficient time for appropriate clinical intervention with nearly 80% sensitivity and at 95% specificity, thus having very few false positives.	[Bhattacharya, Sakyajit] TCS Innovat Labs, Kolkata, India; [Huddar, Vijay] Amazon, Bangalore, Karnataka, India; [Rajan, Vaibhav] Natl Univ Singapore, Sch Comp, Singapore, Singapore; [Reddy, Chandan K.] Virginia Tech, Dept Comp Sci, Arlington, VA USA	Amazon.com; National University of Singapore; Virginia Polytechnic Institute & State University	Rajan, V (corresponding author), Natl Univ Singapore, Sch Comp, Singapore, Singapore.	vaibhav.rajan@nus.edu.sg		Rajan, Vaibhav/0000-0002-6748-6864; Reddy, Chandan/0000-0003-2839-3662	US National Science Foundation [IIS-1646881, IIS-1527827]; Xerox Research Center India	US National Science Foundation(National Science Foundation (NSF)); Xerox Research Center India	This work was supported by the US National Science Foundation grants IIS-1646881 and IIS-1527827 (CR) and Xerox Research Center India (VR).	Anderson RJ, 2011, CRIT CARE MED, V39, P2196, DOI 10.1097/CCM.0b013e3182217465; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Awad HH, 2012, AM HEART J, V163, P963, DOI 10.1016/j.ahj.2012.03.003; Bhattacharya Sakyajit, 2014, P 5 ACM C BIOINF COM, P43; Chen X, 2009, COMPUT CARDIOL, V36, P545; Crespo C, 2002, BIOSIG BRNO, P206; Donald R., 2012, EARLY WARNING EUSIG; FEDULLO AJ, 1991, CHEST, V99, P1220, DOI 10.1378/chest.99.5.1220; Ghaffari A, 2010, CARDIOVASC ENG, V10, P12, DOI 10.1007/s10558-009-9088-x; Ghassemi M, 2011, THESIS, P541; Ghosh S, 2015, IEEE J BIOMEDICAL HL; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Heidenreich PA, 1996, CRIT CARE MED, V24, P1835, DOI 10.1097/00003246-199611000-00013; Henriques JH, 2009, COMPUT CARDIOL, V36, P549; Huddar V, 2016, IEEE ACCESS, V4, P7988, DOI 10.1109/ACCESS.2016.2618775; Kilgannon JH, 2008, RESUSCITATION, V79, P410, DOI 10.1016/j.resuscitation.2008.07.019; Klabunde R. E., CARDIOVASCULAR PHYSL; Knuth Donald E, 1981, ART PROGRAMMING, V2; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lee J, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-62; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Lehman LH, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P653, DOI 10.1109/CIC.2008.4749126; Mao Y., 2012, P 18 ACM SIGKDD INT, P1140; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayaud L, 2013, CRIT CARE MED, V41, P954, DOI 10.1097/CCM.0b013e3182772adb; Mneimneh MA, 2009, COMPUT CARDIOL, V36, P557; Moody GB, 2009, COMPUT CARDIOL, V36, P541; Reddy C.K., 2015, HEALTHCARE DATA ANAL; Rocha T, 2011, COMPUT BIOL MED, V41, P881, DOI 10.1016/j.compbiomed.2011.07.006; Saeed M, 2002, COMPUT CARDIOL, V29, P641, DOI 10.1109/CIC.2002.1166854; SCHAEFER JH, 1991, INTENS CARE MED, V17, P19, DOI 10.1007/BF01708404; Shibao C, 2013, J CLIN HYPERTENS, V15, P147, DOI 10.1111/jch.12062; Singh A, 2010, INT CONF ACOUST SPEE, P550, DOI 10.1109/ICASSP.2010.5495603; Stell A, 2009, PHILOS T R SOC A, V367, P2679, DOI 10.1098/rsta.2009.0042; Sun HJ, 2013, INT SYM COMPUT INTEL, P99, DOI 10.1109/ISCID.2013.32; Takala J, 2010, CRIT CARE MED, V38, pS613, DOI 10.1097/CCM.0b013e3181f2430c; Yuan Zhou, 2013, Journal of Software, V8, P1923, DOI 10.4304/jsw.8.8.1923-1931	37	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193259	10.1371/journal.pone.0193259	http://dx.doi.org/10.1371/journal.pone.0193259			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474481	gold, Green Published, Green Submitted			2022-12-26	WOS:000426049500073
J	Crouch, NMA; Mason-Gamer, RJ				Crouch, Nicholas M. A.; Mason-Gamer, Roberta J.			Structural equation modeling as a tool to investigate correlates of extra-pair paternity in birds	PLOS ONE			English	Article							PARENTAL CARE; BREEDING SYNCHRONY; SPERM COMPETITION; GENETIC MONOGAMY; MATING SYSTEMS; RANGE SIZE; EVOLUTION; ECOLOGY; PROMISCUITY; COPULATIONS	Identifying relationships between variables in ecological systems is challenging due to the large number of interacting factors. One system studied in detail is avian reproduction, where molecular analyses have revealed dramatic variation in rates of extra-pair paternity the frequency with which broods contain individuals sired by different males. Despite the attention the topic has received, identification of ecological predictors of the observed variation remains elusive. In this study we evaluate how structural equation modeling which allows for simultaneous estimation of covariation between all variables in a model can help identify significant relationships between ecological variables and extra-pair paternity. We estimated the correlation of eight different variables using data from 36 species of passerines by including them in six different models of varying complexity. We recover strong support for species with lower rates of male care having higher rates of extra-pair paternity. Our results also suggest that testes size, range size, and longevity all potentially have a relationship with rates of extra-pair paternity; however, interpretation of this result is more challenging. More generally, these results demonstrate the utility of applying structural equation modeling to understanding correlations among interacting variables in complex biological systems.	[Crouch, Nicholas M. A.; Mason-Gamer, Roberta J.] Univ Illinois, Dept Biol Sci, 840 West Taylor St,MC066, Chicago, IL 60607 USA; [Crouch, Nicholas M. A.] Field Museum, Dept Zool, 1400 S Lake Shore Dr, Chicago, IL 60605 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Field Museum of Natural History (Chicago)	Crouch, NMA (corresponding author), Univ Illinois, Dept Biol Sci, 840 West Taylor St,MC066, Chicago, IL 60607 USA.; Crouch, NMA (corresponding author), Field Museum, Dept Zool, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.	nick.crouch@utexas.edu	Crouch, Nick/L-2012-2019	Crouch, Nicholas/0000-0002-3504-8245				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akcay E, 2007, EVOL ECOL RES, V9, P855; Araya-Salas M, 2017, METHODS ECOL EVOL, V8, P184, DOI 10.1111/2041-210X.12624; Arnold KE, 2004, P ROY SOC LOND B BIO, V269, P1263; Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; Audacity Team, 2014, AUD R FREE AUD ED RE; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Ball AD, 2017, IBIS, V159, P449, DOI 10.1111/ibi.12446; Benedict L, 2008, BEHAV ECOL SOCIOBIOL, V62, P983, DOI 10.1007/s00265-007-0524-x; BirdLife International and NatureServe, 2012, BIRD SPEC DISTR MAPS; BOCK CE, 1983, AM NAT, V122, P295, DOI 10.1086/284136; Bonier F, 2014, AM NAT, V183, P54, DOI 10.1086/674130; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Charmantier A, 2004, J AVIAN BIOL, V35, P524, DOI 10.1111/j.0908-8857.2004.03296.x; Cornwallis CK, 2010, NATURE, V466, P969, DOI 10.1038/nature09335; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; DIXON A, 1994, NATURE, V371, P698, DOI 10.1038/371698a0; Double M, 2000, P ROY SOC B-BIOL SCI, V267, P465, DOI 10.1098/rspb.2000.1023; Du B, 2015, ANIM BEHAV, V110, P61, DOI 10.1016/j.anbehav.2015.09.023; DunningJr J. B., 2007, CRC HDB AVIAN BODY M, VSecond; Eliassen S, 2008, BEHAV ECOL SOCIOBIOL, V62, P1795, DOI 10.1007/s00265-008-0608-2; Elliott A, 2008, HDB BIRDS WORLD, V6, P15; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Forstmeier W, 2002, P ROY SOC B-BIOL SCI, V269, P1479, DOI 10.1098/rspb.2002.2039; Freeman-Gallant CR, 2006, BEHAV ECOL, V17, P952, DOI 10.1093/beheco/arl031; Garamszegi LZ, 2004, BEHAV ECOL, V15, P508, DOI 10.1093/beheco/arh041; Garcia-Vigon E, 2009, ANIM BEHAV, V78, P1335, DOI 10.1016/j.anbehav.2009.08.017; Gaston KJ, 1997, ECOGRAPHY, V20, P569, DOI 10.1111/j.1600-0587.1997.tb00425.x; Gohli J, 2013, EVOLUTION, V67, P1406, DOI 10.1111/evo.12045; Gomez JM, 2012, SYST BIOL, V61, P567, DOI 10.1093/sysbio/syr127; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Haggerty TM, 2001, AUK, V118, P215, DOI 10.1642/0004-8038(2001)118[0215:GMICWT]2.0.CO;2; Healy K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0298; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Houston AI, 1995, ANIM BEHAV, V50, P1635, DOI 10.1016/0003-3472(95)80017-4; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jonsson M, 2010, BIOL LETTERS, V6, P116, DOI 10.1098/rsbl.2009.0613; Kempenaers B, 1996, ANIM BEHAV, V51, P1165, DOI 10.1006/anbe.1996.0118; Laube I, 2013, GLOBAL ECOL BIOGEOGR, V22, P233, DOI 10.1111/j.1466-8238.2012.00798.x; Lesku JA, 2006, AM NAT, V168, P441, DOI 10.1086/506973; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Matysiokova B, 2013, J EVOLUTION BIOL, V26, P155, DOI 10.1111/jeb.12039; McGhee KE, 2013, AM NAT, V182, P704, DOI 10.1086/673526; MITCHELL RJ, 1992, FUNCT ECOL, V6, P123, DOI 10.2307/2389745; Mobley KB, 2009, MOL ECOL, V18, P1476, DOI 10.1111/j.1365-294X.2009.04104.x; MOLLER AP, 1991, BEHAVIOUR, V118, P170, DOI 10.1163/156853991X00274; MOLLER AP, 1993, AM NAT, V142, P118, DOI 10.1086/285531; MOLLER AP, 1995, BEHAV ECOL SOCIOBIOL, V36, P357, DOI 10.1007/BF00167797; MOLLER AP, 1994, EVOLUTION, V48, P1089, DOI 10.1111/j.1558-5646.1994.tb05296.x; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Moller AP, 1999, BEHAV ECOLOGY, V11, P472; Morton ES, 1998, BEHAV ECOL, V9, P515, DOI 10.1093/beheco/9.5.515; Neudorf DLH, 2004, AUK, V121, P302; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perlut NG, 2012, NORTHEAST NAT, V19, P335, DOI 10.1656/045.019.0214; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Phillimore AB, 2006, AM NAT, V168, P220, DOI 10.1086/505763; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; R Core Team, 2021, R LANGUAGE ENV STAT; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Riehl C, 2015, BEHAV ECOL SOCIOBIOL, V69, P1293, DOI 10.1007/s00265-015-1942-9; Sardell RJ, 2012, AM NAT, V179, P779, DOI 10.1086/665665; Sheldon BC, 2002, PHILOS T R SOC B, V357, P341, DOI 10.1098/rstb.2001.0931; STUTCHBURY BJ, 1995, BEHAVIOUR, V132, P675, DOI 10.1163/156853995X00081; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Tarka P, 2017, QUALITY QUANTITY; Thusius KJ, 2001, BEHAV ECOL, V12, P633, DOI 10.1093/beheco/12.5.633; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vidgen B, 2016, FRONT PHYS, V4, DOI 10.3389/fphy.2016.00006; Wagner RH, 1996, BEHAV ECOL SOCIOBIOL, V38, P379, DOI 10.1007/s002650050255; Wang IJ, 2013, ECOL LETT, V16, P175, DOI 10.1111/ele.12025; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Webster MS, 1995, EVOLUTION, V49, P1147, DOI [10.2307/2410439, 10.1111/j.1558-5646.1995.tb04441.x]; Westneat D.F., 1990, Current Ornithology, V7, P331; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381	79	8	8	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193365	10.1371/journal.pone.0193365	http://dx.doi.org/10.1371/journal.pone.0193365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474449	gold, Green Submitted, Green Published			2022-12-26	WOS:000426049500095
J	Golenia, L; Schoemaker, MM; Otten, E; Mouton, LJ; Bongers, RM				Golenia, Laura; Schoemaker, Marina M.; Otten, Egbert; Mouton, Leonora J.; Bongers, Raoul M.			Development of reaching during mid-childhood from a Developmental Systems perspective	PLOS ONE			English	Article							ONLINE CONTROL; VISUOMOTOR REPRESENTATIONS; CHILDREN; COORDINATION; MOVEMENTS; VARIABILITY; FEEDBACK; ADAPTATION; TRANSITION; KINEMATICS	Inspired by the Developmental Systems perspective, we studied the development of reaching during mid-childhood (5-10 years of age) not just at the performance level (i.e., endpoint movements), as commonly done in earlier studies, but also at the joint angle level. Because the endpoint position (i.e., the tip of the index finger) at the reaching target can be achieved with multiple joint angle combinations, we partitioned variability in joint angles over trials into variability that does not (goal-equivalent variability, GEV) and that does (non-goal-equivalent variability, NGEV) influence the endpoint position, using the Uncontrolled Manifold method. Quantifying this structure in joint angle variability allowed us to examine whether and how spatial variability of the endpoint at the reaching target is related to variability in joint angles and how this changes over development. 6-, 8- and 10-year-old children and young adults performed reaching movements to a target with the index finger. Polynomial trend analysis revealed a linear and a quadratic decreasing trend for the variable error. Linear decreasing and cubic trends were found for joint angle standard deviations at movement end. GEV and NGEV decreased gradually with age, but interestingly, the decrease of GEV was steeper than the decrease of NGEV, showing that the different parts of the joint angle variability changed differently over age. We interpreted these changes in the structure of variability as indicating changes over age in exploration for synergies (a family of task solutions), a concept that links the performance level with the joint angle level. Our results suggest changes in the search for synergies during mid-childhood development.	[Golenia, Laura; Schoemaker, Marina M.; Otten, Egbert; Mouton, Leonora J.; Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Groningen	Golenia, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	l.golenia@umcg.nl	Bongers, Raoul/C-1094-2012	Bongers, Raoul/0000-0002-3518-7464				Abe MO, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00225; Adolph K. E., 2015, HDB INTRAINDIVIDUAL, P59; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; BARD C, 1990, J EXP CHILD PSYCHOL, V50, P102, DOI 10.1016/0022-0965(90)90034-6; Bernstein N, 1967, COORDINATION REGULAT; Blanchard CCV, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00374; CHICOINE AJ, 1992, DEV NEUROPSYCHOL, V8, P381, DOI 10.1080/87565649209540533; Cohen J.E., 1988, STAT POWER ANAL BEHA; Contreras-Vidal J, 2005, EXP BRAIN RES, V162, P155, DOI 10.1007/s00221-004-2123-7; Corbetta D., 2009, UNIFIED THEORY DEV C, P51, DOI DOI 10.1093/ACPROF:0S0/9780195300598.003.0003; Corbetta D, 2009, INFANT BEHAV DEV, V32, P44, DOI 10.1016/j.infbeh.2008.10.004; de Freitas SMSF, 2007, NEUROSCI LETT, V417, P66, DOI 10.1016/j.neulet.2007.02.037; Deutsch KM, 2004, J EXP CHILD PSYCHOL, V88, P319, DOI 10.1016/j.jecp.2004.04.003; Domkin D, 2005, EXP BRAIN RES, V163, P44, DOI 10.1007/s00221-004-2137-1; Endedijk HM, 2015, DEV PSYCHOL, V51, P714, DOI 10.1037/a0038980; FAYT C, 1993, PERCEPT MOTOR SKILL, V77, P659, DOI 10.2466/pms.1993.77.2.659; FAYT C, 1992, PERCEPT MOTOR SKILL, V75, P375, DOI 10.2466/PMS.75.5.375-384; Ferrel C, 2001, EXP BRAIN RES, V138, P313, DOI 10.1007/s002210100697; Fuelscher I, 2015, J EXP CHILD PSYCHOL, V140, P74, DOI 10.1016/j.jecp.2015.06.013; Gerver WJM., 2001, PAEDIAT MORPHOMETRIC; Golenia L, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01774; Hadders-Algra M, 2010, PHYS THER, V90, P1823, DOI 10.2522/ptj.20100006; HAY L, 1991, ACTA PSYCHOL, V77, P203, DOI 10.1016/0001-6918(91)90035-X; HAY L, 1979, J MOTOR BEHAV, V11, P189, DOI 10.1080/00222895.1979.10735187; Henderson S. E., 2007, MOVEMENT ABC MOVEMEN, Vsecond; Hyde CE, 2013, DEV NEUROPSYCHOL, V38, P81, DOI 10.1080/87565641.2012.718820; Klimkeit EI, 2004, CHILD NEUROPSYCHOL, V10, P201, DOI 10.1080/713657846; Kuhtz-Buschbeck JP, 1998, BEHAV BRAIN RES, V93, P131, DOI 10.1016/S0166-4328(97)00147-2; Latash M, 2000, MOTOR CONTROL, V4, P259, DOI 10.1123/mcj.4.3.259; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Latash ML, 2012, EXP BRAIN RES, V217, P1, DOI 10.1007/s00221-012-3000-4; Lee MH, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12614; Mah VK, 2012, PAED CHILD HEALT-CAN, V17, P81, DOI 10.1093/pch/17.2.81; Malina RM, 2004, GROWTH MATURATION PH; Molenaar P. C. M., 2014, HDB DEV SYSTEMS THEO; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; Newell KM, 2009, PSYCHOL AGING, V24, P809, DOI 10.1037/a0017911; Newell KM, 2003, INFANT BEHAV DEV, V26, P449, DOI 10.1016/j.infbeh.2003.08.003; Olivier I, 2003, NEUROSCI LETT, V338, P169, DOI 10.1016/S0304-3940(02)01382-4; Olivier I, 2000, J EXP CHILD PSYCHOL, V77, P155, DOI 10.1006/jecp.1999.2558; Pacheco MM, 2015, HUM MOVEMENT SCI, V44, P258, DOI 10.1016/j.humov.2015.09.009; Pellizzer G, 1996, BRAIN COGNITION, V30, P175, DOI 10.1006/brcg.1996.0011; Ruddock S, 2016, BRAIN COGNITION, V109, P84, DOI 10.1016/j.bandc.2016.08.001; Schneiberg S, 2002, EXP BRAIN RES, V146, P142, DOI 10.1007/s00221-002-1156-z; Scholz JP, 2000, EXP BRAIN RES, V135, P382, DOI 10.1007/s002210000540; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schoner G, 1995, ECOL PSYCHOL, V7, P291, DOI 10.1207/s15326969eco0704_5; Takahashi CD, 2003, J NEUROPHYSIOL, V90, P703, DOI 10.1152/jn.01173.2002; Thelen E, 2001, BEHAV BRAIN SCI, V24, P1, DOI 10.1017/S0140525X01003910; THELEN E, 1993, CHILD DEV, V64, P1058, DOI 10.2307/1131327; Thelen E, 1996, J EXP PSYCHOL HUMAN, V22, P1059, DOI 10.1037/0096-1523.22.5.1059; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Thomas JR, 2000, J EXP CHILD PSYCHOL, V75, P228, DOI 10.1006/jecp.1999.2535; TURVEY MT, 1993, CHILD DEV, V64, P1175, DOI 10.2307/1131333; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; van Andel CJ, 2008, GAIT POSTURE, V27, P120, DOI 10.1016/j.gaitpost.2007.03.002; Van Braeckel K, 2007, HUM MOVEMENT SCI, V26, P927, DOI 10.1016/j.humov.2007.07.010; van der Heide JC, 2003, EXP BRAIN RES, V151, P32, DOI 10.1007/s00221-003-1451-3; Vereijken B, 2010, PHYS THER, V90, P1850, DOI 10.2522/ptj.20100019; Verrel J, 2011, J NEUROSCI METH, V200, P199, DOI 10.1016/j.jneumeth.2011.04.006; Verrel J, 2010, J NEUROSCI METH, V191, P166, DOI 10.1016/j.jneumeth.2010.06.016; von Hofsten C, 1993, CHILD DEV, V75, P377; Wilson PH, 2013, HUM MOVEMENT SCI, V32, P1138, DOI 10.1016/j.humov.2013.02.008; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Yang JF, 2007, EXP BRAIN RES, V176, P54, DOI 10.1007/s00221-006-0602-8	65	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193463	10.1371/journal.pone.0193463	http://dx.doi.org/10.1371/journal.pone.0193463			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX4LV	29474421	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500112
J	Alexander, J; Teague, AM; Chen, J; Aston, CE; Leung, YK; Chernausek, S; Simmons, RA; Pinney, SE				Alexander, Jacqueline; Teague, April M.; Chen, Jing; Aston, Christopher E.; Leung, Yuet-Kin; Chernausek, Steven; Simmons, Rebecca A.; Pinney, Sara E.			Offspring sex impacts DNA methylation and gene expression in placentae from women with diabetes during pregnancy	PLOS ONE			English	Article							INTRAUTERINE EXPOSURE; VILLOUS CAPILLARIES; GLUCOSE-METABOLISM; HUMAN GENOME; MELLITUS; PROTEINS; TRANSCRIPTOME; THIOREDOXIN; EPIGENOME; MARKERS	Aims/Hypothesis We hypothesized that diabetes during pregnancy (DDP) alters genome-wide DNA methylation in placenta resulting in differentially methylated loci of metabolically relevant genes and downstream changes in RNA and protein expression. Methods We mapped genome-wide DNA methylation with the Infinium 450K Human Methylation Bead Chip in term fetal placentae from Native American and Hispanic women with DDP using a nested case-control design (n = 17 pairs). RNA expression and protein levels were assayed via RNA-Seq and Western Blot. Results Genome-wide DNA methylation analysis revealed 465 CpG sites with significant changes for male offspring, 247 for female offspring, and 277 for offspring of both sexes (p<0.001). Placentae from female offspring were 40% more likely to have significant gains in DNA methylation compared with placentae from male offspring exposed to DDP (p<0.001). Changes in DNA methylation corresponded to changes in RNA and protein levels for 6 genes: PIWIL3, CYBA, GSTM1, GSTM5, KCNE1 and NXN. Differential DNA methylation was detected at loci related to mitochondrial function, DNA repair, inflammation, oxidative stress. Conclusions/Interpretation These findings begin to explain mechanisms responsible for the increased risk for obesity and type 2 diabetes in offspring of mothers with DDP.	[Alexander, Jacqueline; Pinney, Sara E.] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA; [Teague, April M.; Aston, Christopher E.; Chernausek, Steven] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, CMRI Metab Res Program, Oklahoma City, OK USA; [Teague, April M.; Chernausek, Steven] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Oklahoma City, OK USA; [Chen, Jing; Leung, Yuet-Kin] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH USA; [Simmons, Rebecca A.] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Simmons, Rebecca A.; Pinney, Sara E.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Pinney, SE (corresponding author), Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA.; Pinney, SE (corresponding author), Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.	pinneys@email.chop.edu	Leung, Ricky/H-5958-2019; Pinney, Sara/E-1938-2015	Leung, Ricky/0000-0003-2063-277X; Chen, Jing/0000-0002-6227-7393; Pinney, Sara/0000-0001-7824-2999; Teague, April/0000-0001-9004-1671; Simmons, Rebecca/0000-0002-2901-8904; , steven/0000-0003-4538-8793	NIH [R01 DK089034-03, K08 DK0903-02 9]; American Diabetes Association [1-10-CT-09]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089034, K08DK090302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, P30ES013508] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Work presented was funded by grants from the NIH (R01 DK089034-03 (SC), K08 DK0903-02 9 (SEP)), and the American Diabetes Association (1-10-CT-09 (SC)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, DIABETES CARE S1, V26, pS103, DOI DOI 10.2337/DIACARE.26.2007.S103; Anteby EY, 2005, PLACENTA, V26, P476, DOI 10.1016/j.placenta.2004.08.008; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Binder AM, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0116-y; Bouchard L, 2013, DIABETES, V62, P1026, DOI 10.2337/db12-1763; Bouchard L, 2010, DIABETES CARE, V33, P2436, DOI 10.2337/dc10-1024; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Chen Xinhua, 2005, Curr Diab Rep, V5, P282, DOI 10.1007/s11892-005-0024-1; Das UN, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-35; Davids M, 2015, J MED GENETICS; El Hajj N, 2013, DIABETES, V62, P1320, DOI 10.2337/db12-0289; Ericsson A, 2005, HUM REPROD, V20, P521, DOI 10.1093/humrep/deh596; Finer S, 2015, HUM MOL GENET, V24, P3021, DOI 10.1093/hmg/ddv013; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Funato Y, 2013, BIOCHEM BIOPH RES CO, V440, P737, DOI 10.1016/j.bbrc.2013.09.138; Gauster M, 2011, DIABETES, V60, P2457, DOI 10.2337/db10-1434; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Groth M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11640; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jansson T, 2002, DIABETES, V51, P2214, DOI 10.2337/diabetes.51.7.2214; Jirkovska M, 2002, J VASC RES, V39, P268, DOI 10.1159/000063692; Jirkovska M, 2016, PLACENTA, V40, P1, DOI 10.1016/j.placenta.2016.02.003; Krishnaveni GV, 2010, DIABETES CARE, V33, P402, DOI 10.2337/dc09-1393; Kurooka H, 1997, GENOMICS, V39, P331, DOI 10.1006/geno.1996.4493; Landon MB, 2015, DIABETES CARE, V38, P445, DOI 10.2337/dc14-2159; LINDSAY S, 1985, ANN HUM GENET, V49, P115, DOI 10.1111/j.1469-1809.1985.tb01683.x; Magnusson AL, 2004, J CLIN ENDOCR METAB, V89, P4607, DOI 10.1210/jc.2003-032234; Mordwinkin NM, 2013, J MATERN-FETAL NEO M, V26, P507, DOI 10.3109/14767058.2012.736564; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Ng BG, 2015, HUM MOL GENET; PETTITT DJ, 1983, NEW ENGL J MED, V308, P242, DOI 10.1056/NEJM198302033080502; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Rong C, 2015, EXP CLIN ENDOCR DIAB, V123, P282, DOI 10.1055/s-0034-1398666; Roovers EF, 2015, CELL REP, V10, P2069, DOI 10.1016/j.celrep.2015.02.062; Ruchat SM, 2013, EPIGENETICS-US, V8, P935, DOI 10.4161/epi.25578; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Sgarbosa F, 2006, DIABETES RES CLIN PR, V73, P143, DOI 10.1016/j.diabres.2005.12.014; Short KR, 2015, J PEDIATR-US, V166, P884, DOI 10.1016/j.jpeds.2014.12.036; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Stasia MJ, 2016, GENE, V586, P27, DOI 10.1016/j.gene.2016.03.050; Su EJ, 2015, J CLIN ENDOCR METAB, V100, pE30, DOI 10.1210/jc.2014-2385; Su RN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148399; Teague AM, 2015, REPROD BIOL ENDOCRIN, V13, P1, DOI 10.1186/s12958-015-0061-9; Trifonova EA, 2014, ACTA NATURAE, V6, P71, DOI 10.32607/20758251-2014-6-2-71-83; Wu M, 2013, PFLUGERS ARCH EUROPE, V466, P937; Zhang WY, 2016, CLIN CHEM, V62, P208, DOI 10.1373/clinchem.2015.243279; Zhao XD, 2008, J GENET GENOMICS, V35, P403, DOI 10.1016/S1673-8527(08)60058-2	52	24	24	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0190698	10.1371/journal.pone.0190698	http://dx.doi.org/10.1371/journal.pone.0190698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470513	Green Published, Green Submitted, gold			2022-12-26	WOS:000425831000001
J	He, XX; Liu, GW; Xia, DY; Feng, X; Lv, Y; Cheng, HY; Wang, YH; Lu, HY; Jiang, Y				He, Xiaoxia; Liu, Guowu; Xia, Dongyan; Feng, Xia; Lv, Yi; Cheng, Huanyi; Wang, Yuehua; Lu, Hongyan; Jiang, Yan			An innovative HIV testing service using the internet: Anonymous urine delivery testing service at drugstores in Beijing, China	PLOS ONE			English	Article							MSM; MEN; SEX	Innovative human immunodeficiency virus (HIV) testing services will be needed to achieve the first 90 (90% of HIV-positive persons aware of their infection status) of the 90-90-90 target in China. Here, we describe an internet-based urine delivery testing service delivered through three pilot drugstores in Beijing that send specimens to a designated laboratory for HIV. From May 2016 to January 2017, we provided 500 HIV urine-testing service packs for display at the drugstores, and a total of 430 (86.0%) urine specimens were mailed back. All of the 430 urine specimens were of good quality and were tested. 70 urine specimens were HIV positive, showing a 16.3% (70/430) positivity rate. A total of 94.3% (66/70) of the HIV-positive participants obtained their test results through the internet, and 69.7% (46/66) of these participants received follow-up care. A total of 40 out of 46 (87.0%) participants agreed to have their results confirmed by a blood test, and 39 out of 40 (97.5%) participants were confirmed as HIV-1 positive, including two individuals that were previously diagnosed. Lastly, 28 out of 37 (75.7%) of the study participants were referred to the hospital and provided free antiviral treatment. Our data indicate that this innovative HIV testing service is effective and play an important role in HIV testing and surveillance.	[He, Xiaoxia; Lv, Yi; Cheng, Huanyi; Wang, Yuehua; Jiang, Yan] China CDC, Natl Ctr AIDS STD Control & Prevent, Natl HIV HCV Reference Lab, Beijing, Peoples R China; [Liu, Guowu; Xia, Dongyan; Lu, Hongyan] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Liu, Guowu; Xia, Dongyan; Lu, Hongyan] Beijing Res Ctr Prevent Med, Beijing, Peoples R China; [Feng, Xia] Capital Med Univ, Beijing Youan Hosp, Dept Clin Lab, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University	Lu, HY (corresponding author), Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China.; Lu, HY (corresponding author), Beijing Res Ctr Prevent Med, Beijing, Peoples R China.	hongyan_lu@sina.com; jiangyan03@263.net		xiaoxia, he/0000-0002-7951-5407	Bill & Melinda Gates Foundation's Program [OPP1120190]; 12th Five-Year Plan [2013ZX10001001-001-007]	Bill & Melinda Gates Foundation's Program; 12th Five-Year Plan(Chinese Academy of Sciences)	This study was supported by the Bill & Melinda Gates Foundations Program to Establish and Implement Community-based Organizations (CBO) Participation Mechanism in HIV/AIDS Control (OPP1120190) and the 12th Five-Year Plan (2013ZX10001001-001-007). The funder had no role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	[Anonymous], 2004, MMWR-MORBID MORTAL W, V53, P129; [Anonymous], HOM US TESTS HUM IMM; [Anonymous], 2017, 13 5 YEAR ACT PLAN C; Blas MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010448; Bolding G, 2007, AIDS BEHAV, V11, P522, DOI 10.1007/s10461-007-9224-9; Carpenter KM, 2010, AIDS BEHAV, V14, P549, DOI 10.1007/s10461-009-9578-2; CONNELL JA, 1990, LANCET, V335, P1366, DOI 10.1016/0140-6736(90)91245-6; CONSTANTINE NT, 1994, AM J CLIN PATHOL, V101, P157, DOI 10.1093/ajcp/101.2.157; Dai Jianping, 2003, CHIN J AIDS STD, V5, P278, DOI DOI 10.3969/J.ISSN.1672-5662.2003.05.009; Feng Xia, 2016, CHIN J AIDS STD, V4, P16; Fernandez MI, 2004, AIDS CARE, V16, P953, DOI 10.1080/09540120412331292480; Ibitoye M, 2014, AIDS BEHAV, V18, P933, DOI 10.1007/s10461-013-0668-9; Jiang Y, 2010, INT J EPIDEMIOL, V39, pII72, DOI 10.1093/ije/dyq224; Li Youfang, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P72, DOI 10.3760/cma.j.issn.0254-6450.2016.01.015; Rhodes SD, 2011, HEALTH EDUC BEHAV, V38, P311, DOI 10.1177/1090198110379572; Sahni A K, 2014, Med J Armed Forces India, V70, P211, DOI 10.1016/j.mjafi.2013.10.011; [田雨 Tian Yu], 2017, [中国艾滋病性病, Chinese JOurnal of Aids & STD], V23, P20; UNAIDS, 2014, 90 90 90 AMB TREATM; World Health Organization, 2011, UN ACC SCAL PRIOR HI; [吴尊友 Wu Zunyou], 2016, [中华疾病控制杂志, Chinese Journal of Disease Control & Prevention], V20, P1187; Wu Zunyou, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P1329; Yoshihara N, 1995, Rinsho Byori, V43, P249; ZHANG GL, 2016, CHIN J AIDS STD, V10, P810, DOI DOI 10.1186/1752-4458-4-1; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zou HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051919; Zou HC, 2012, AIDS BEHAV, V16, P1717, DOI 10.1007/s10461-012-0225-y	26	5	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192255	10.1371/journal.pone.0192255	http://dx.doi.org/10.1371/journal.pone.0192255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX1SB	29470485	gold, Green Published, Green Submitted			2022-12-26	WOS:000425831000008
J	Mus, LM; Denecker, G; Speleman, F; Roman, BI				Mus, Liselot M.; Denecker, Geertrui; Speleman, Frank; Roman, Bart I.			Vehicle development, pharmacokinetics and toxicity of the anti-invasive agent 4-fluoro-3',4',5'-trimethoxychalcone in rodents	PLOS ONE			English	Article							METASTASIS; CHALCONES; DIMETHYLSULFOXIDE	Effective inhibitors of invasion and metastasis represent a serious unmet clinical need. We have recently identified 4-fluoro-3',4',5'-trimethoxychalcone or C-16 as a potent anti-invasive molecule. In this paper, we report on the development of an optimized vehicle for oral administration of C16. We also explore its pharmacokinetic and toxicity profile in rodents as a prelude to a broad-scope evaluation as a pharmacological tool in animal models of disease. C16 showed suboptimal pharmacokinetics with limited oral bioavailability and whole blood stability. Rapid metabolism with elimination via glutathione conjugation was observed. An oral dosing routine using medicated gels was developed to overcome bioavailability issues and yielded sustained whole blood levels above the half maximal effective concentration (EC50) in a 7-day study. The compound proved well-tolerated in acute and chronic experiments at 300 mg/kg PO dosing. The medicated gel formulation is highly suitable for evaluation of C16 in animal models of disease.	[Mus, Liselot M.; Denecker, Geertrui; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Mus, Liselot M.; Denecker, Geertrui; Speleman, Frank; Roman, Bart I.] CRIG, Ghent, Belgium; [Roman, Bart I.] Univ Ghent, Fac Biosci Engn, Dept Green Chem & Technol, SynBioC Res Grp, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University	Roman, BI (corresponding author), CRIG, Ghent, Belgium.; Roman, BI (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Green Chem & Technol, SynBioC Res Grp, Ghent, Belgium.	bart1.roman@ugent.be	speleman, frank/AAR-5184-2020; Roman, Bart/AAY-7301-2020; Mus, Liselot/FCB-1557-2022	speleman, frank/0000-0002-6628-8559; Roman, Bart/0000-0002-9407-6721; Mus, Liselot/0000-0001-5738-0639; Denecker, Geertrui/0000-0002-2515-2911	Fund for Scientific Research - Flanders (FWO-Vlaanderen), BIR [F2013/IOF-Advanced/686, 00000000116000000150]	Fund for Scientific Research - Flanders (FWO-Vlaanderen), BIR	This work received support from the Fund for Scientific Research - Flanders (FWO-Vlaanderen), BIR, Postdoctoral Research Grant, http://www.fwo.be/, Industrial Research Fund - Ghent University (IOF-UGent), BIR, Grant Number F2013/IOF-Advanced/686, https://www.ugent.be/techtransfer/en/support-for-academics/iof, and Kom op Tegen Kanker, LMM, Grant Number 00000000116000000150, http://www.komoptegenkanker.be/gesteunde-onderzoeksprojecten. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AWASTHI YC, 1983, BRIT J HAEMATOL, V55, P419, DOI 10.1111/j.1365-2141.1983.tb02156.x; Bevan CD, 2000, ANAL CHEM, V72, P1781, DOI 10.1021/ac9912247; Bracke ME, 2015, JOVE-J VIS EXP, DOI 10.3791/52792; BRAYTON CF, 1986, CORNELL VET, V76, P61; Carlier C, 2016, ONCOTARGET, V7, P59322, DOI 10.18632/oncotarget.11163; CAUJOLLE FM, 1967, ANN NY ACAD SCI, V141, P110, DOI 10.1111/j.1749-6632.1967.tb34871.x; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Christy AC, 2014, J AM ASSOC LAB ANIM, V53, P180; Cruz-Munoz W, 2008, CANCER RES, V68, P4500, DOI 10.1158/0008-5472.CAN-08-0041; Duffus JH, 2009, CONCEPTS IN TOXICOLOGY, P1; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Gandalovicova A, 2017, TRENDS CANCER, V3, P391, DOI 10.1016/j.trecan.2017.04.008; Gutteridge CE, 2011, PHARMACOLOGY, V87, P96, DOI 10.1159/000322532; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jaiswal S, 2017, DRUG TEST ANAL, V9, P1124, DOI 10.1002/dta.2128; National Research Council, 2011, GUIDE CARE USE LAB A; O'Connell KE, 2015, COMPARATIVE MED, V65, P96; Roman BI, 2013, CURR MED CHEM, V20, P186, DOI 10.2174/092986713804806630; Roman BI, 2015, EUR J MED CHEM, V101, P627, DOI 10.1016/j.ejmech.2015.06.029; Roman BI, 2015, BIOORG MED CHEM LETT, V25, P1021, DOI 10.1016/j.bmcl.2015.01.027; Roman BI, 2013, BIOORGAN MED CHEM, V21, P5054, DOI 10.1016/j.bmc.2013.06.048; Roman BI, 2012, BIOORGAN MED CHEM, V20, P4812, DOI 10.1016/j.bmc.2012.05.069; RUBIN LF, 1975, ANN NY ACAD SCI, V243, P98, DOI 10.1111/j.1749-6632.1975.tb25348.x; SMITH ER, 1967, ANN NY ACAD SCI, V141, P386, DOI 10.1111/j.1749-6632.1967.tb34901.x; Tadigoppula N, 2013, J MED CHEM, V56, P31, DOI 10.1021/jm300588j; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Weber GF, 2013, CANCER LETT, V328, P207, DOI 10.1016/j.canlet.2012.09.025; WILLHITE CC, 1984, J APPL TOXICOL, V4, P155, DOI 10.1002/jat.2550040308; Zhuang CL, 2017, CHEM REV, V117, P7762, DOI 10.1021/acs.chemrev.7b00020	29	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192548	10.1371/journal.pone.0192548	http://dx.doi.org/10.1371/journal.pone.0192548			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470507	Green Published, Green Submitted, gold			2022-12-26	WOS:000425831000013
J	Xiao, SY; Zhang, W; Manley, NR				Xiao, Shiyun; Zhang, Wen; Manley, Nancy R.			Thymic epithelial cell-derived signals control B progenitor formation and proliferation in the thymus by regulating Let-7 and Arid3a	PLOS ONE			English	Article							GAMMA-DELTA CELLS; BONE-MARROW; VITAMIN-D; HEMATOPOIETIC PROGENITORS; RETINOIC ACID; SELF-ANTIGENS; IMMUNE-SYSTEM; FEEDBACK LOOP; STEM-CELLS; MOUSE	The postnatal thymus is an efficient microenvironment for T cell specification and differentiation. B cells are also present in the thymus and have been recently shown to impact T cell selection, however, the mechanisms controlling B cell development in the thymus are largely unknown. In Foxn1(lacZ) mutant mice, down-regulation of Foxn1 expression in thymic epithelial cells beginning 1 week after birth caused a dramatic reduction of T progenitors and an increase of B cell progenitors. This time point is coincident with the switch from fetal to adult-type hematopoietic stem cells (HSCs), which is regulated by the Lin28-Let7 system. We hypothesize that the thymic environment might regulate this process to suppress fetal-type B cell development in the thymus. In this study we show that in the Foxn1(lacZ) thymus, although the down-regulation of Lin28 in thymocytes was normal, up-regulation of Let-7 was impaired. The failure to up-regulate Let-7 caused a transient increase of Arid3a in B precursors, which is known to promote fetal-type B cell fate. Over-expression of Lin28a in HSCs also reduced Let-7 and promoted Arid3a expression in BM and thymic B progenitors, increasing B cell production in the thymus. The level of Let-7 in thymic B progenitors was up regulated by in vitro co-culture with IL15, Vitamin-D3, and retinoic acid, thus down-regulating Arid3a to promote B cell differentiation. All of these signals were produced in thymic epithelial cells (TECs) related to Let-7 expression in thymic B progenitors, and down-regulated in Foxn1(lacZ) mutants. Our data show that signals provided by TEC control thymic B cell development by up-regulating Let-7, suppressing Arid3a expression in intrathymic progenitor B cells to limit their proliferation during the neonatal to adult transition.	[Xiao, Shiyun; Zhang, Wen; Manley, Nancy R.] Univ Georgia, Dept Genet, Paul D Coverdell Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Xiao, SY (corresponding author), Univ Georgia, Dept Genet, Paul D Coverdell Ctr, Athens, GA 30602 USA.	Shiyun@uga.edu		Xiao, Shiyun/0000-0003-0196-287X	National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) [R01 AI082127]	National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grant # R01 AI082127 to NRM from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, J IMMUNOL, V164, P5221, DOI 10.4049/jimmunol.164.10.5221; Aranow C, 2011, J INVEST MED, V59, P881, DOI 10.2310/JIM.0b013e31821b8755; Ballow M, 1996, CLIN IMMUNOL IMMUNOP, V80, pS73, DOI 10.1006/clin.1996.0144; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Ceredig R, 2007, EUR J IMMUNOL, V37, P830, DOI 10.1002/eji.200636728; Chen LG, 2008, BLOOD, V111, P2685, DOI 10.1182/blood-2006-12-062265; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; CHONG PJ, 1989, J AUTOIMMUN, V2, P861, DOI 10.1016/0896-8411(89)90012-7; Crompton T, 1998, EUR J IMMUNOL, V28, P1859, DOI 10.1002/(SICI)1521-4141(199806)28:06<1859::AID-IMMU1859>3.0.CO;2-A; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Goldschneider I, 2006, IMMUNOL REV, V209, P58, DOI 10.1111/j.0105-2896.2006.00354.x; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hart G, 2008, BLOOD, V111, P50, DOI 10.1182/blood-2007-07-099598; IKUTA K, 1992, ANNU REV IMMUNOL, V10, P759; Indrevaer RL, 2013, J IMMUNOL, V191, P3624, DOI 10.4049/jimmunol.1300213; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kincade PW, 2002, IMMUNOL REV, V187, P116, DOI 10.1034/j.1600-065X.2002.18710.x; Laky K, 2003, J IMMUNOL, V170, P4087, DOI 10.4049/jimmunol.170.8.4087; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; McAleer J, 2005, IMMUNOLOGY, V114, P171, DOI 10.1111/j.1365-2567.2004.02101.x; MIYAMAINABA M, 1988, J EXP MED, V168, P811, DOI 10.1084/jem.168.2.811; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mori S, 1997, J IMMUNOL, V158, P4193; Nakajima S, 2008, BIOCHEM BIOPH RES CO, V369, P1139, DOI 10.1016/j.bbrc.2008.03.004; Ohmura K, 1999, J IMMUNOL, V163, P4788; Perera J, 2013, P NATL ACAD SCI USA, V110, P17011, DOI 10.1073/pnas.1313001110; Pobezinsky LA, 2015, NAT IMMUNOL, V16, P517, DOI 10.1038/ni.3146; Ratliff ML, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00113; Rolf L, 2014, ANN NY ACAD SCI, V1317, P84, DOI 10.1111/nyas.12440; Rowe RG, 2016, J EXP MED, V213, P1497, DOI 10.1084/jem.20151912; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; WEBB CF, 1989, J IMMUNOL, V143, P3934; Yamano T, 2015, IMMUNITY, V42, P1048, DOI 10.1016/j.immuni.2015.05.013; Yang M, 2015, DEVELOPMENT, V142, P1616, DOI 10.1242/dev.120543; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zhou Y., 2015, REGION CITY, V3, P28	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0193188	10.1371/journal.pone.0193188	http://dx.doi.org/10.1371/journal.pone.0193188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462197	Green Published, gold, Green Submitted			2022-12-26	WOS:000425554200054
J	Fan, R; Cockerton, HM; Armitage, AD; Bates, H; Cascant-Lopez, E; Antanaviciute, L; Xu, XM; Hu, XP; Harrison, RJ				Fan, Rong; Cockerton, Helen M.; Armitage, Andrew D.; Bates, Helen; Cascant-Lopez, Emma; Antanaviciute, Laima; Xu, Xiangming; Hu, Xiaoping; Harrison, Richard J.			Vegetative compatibility groups partition variation in the virulence of Verticillium dahliae on strawberry	PLOS ONE			English	Article							RACE 2; INFECTING ARTICHOKE; WILT FUNGUS; RESISTANCE; GENOME; TOMATO; PATHOGEN; GENE; LETTUCE; RECOGNITION	Verticillium dahliae infection of strawberry (Fragaria x ananassa) is a major cause of disease-induced wilting in soil-grown strawberries across the world. To understand what components of the pathogen are affecting disease expression, the presence of the known effector VdAve1 was screened in a sample of Verticillium dahliae isolates. Isolates from strawberry were found to contain VdAve1 and were divided into two major clades, based upon their vegetative compatibility groups (VCG); no UK strawberry isolates contained VdAve1. VC clade was strongly related to their virulence levels. VdAve1-containing isolates pathogenic on strawberry were found in both clades, in contrast to some recently published findings. On strawberry, VdAve1-containing isolates had significantly higher virulence during early infection, which diminished in significance as the infection progressed. Transformation of a virulent non-VdAve1 containing isolate, with VdAve1 was found neither to increase nor decrease virulence when inoculated on a susceptible strawberry cultivar. There are therefore virulence factors that are epistatic to VdAve1 and potentially multiple independent routes to high virulence on strawberry in V. dahliae lineages. Genome sequencing a subset of isolates across the two VCGs revealed that isolates were differentiated at the whole genome level and contained multiple changes in putative effector content, indicating that different clonal VCGs may have evolved different strategies for infecting strawberry, leading to different virulence levels in pathogenicity tests. It is therefore important to consider both clonal lineage and effector complement as the adaptive potential of each lineage will differ, even if they contain the same race determining effector.	[Fan, Rong; Cockerton, Helen M.; Armitage, Andrew D.; Bates, Helen; Cascant-Lopez, Emma; Antanaviciute, Laima; Xu, Xiangming; Harrison, Richard J.] NIAB EMR, East Malling, Kent, England; [Fan, Rong; Xu, Xiangming; Hu, Xiaoping] Northwest A&F Univ, Dept Plant Pathol, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China; [Antanaviciute, Laima; Harrison, Richard J.] Univ Reading, Reading, Berks, England; [Fan, Rong] Guizhou Univ, Coll Agr, Guiyang, Guizhou, Peoples R China	Northwest A&F University - China; University of Reading; Guizhou University	Harrison, RJ (corresponding author), NIAB EMR, East Malling, Kent, England.; Harrison, RJ (corresponding author), Univ Reading, Reading, Berks, England.	richard.harrison@emr.ac.uk	Xu, Xiangming/I-3050-2014; Bates, Helen/ABE-7958-2020; Harrison, Richard/E-3169-2015	Xu, Xiangming/0000-0002-4567-7117; Bates, Helen/0000-0002-7978-9213; Harrison, Richard/0000-0002-3307-3519; Armitage, Andrew/0000-0002-0610-763X; , Emma/0000-0002-3824-7725; Cockerton, Helen Maria/0000-0002-7375-1804	China Scholarship Council [201506300012]; BBSRC [BB/K017071/1, BB/N006682/1]; innovate UK grant [101630]; AHDB [CP094]; BBSRC [BB/K017071/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N006682/1, BB/K017071/1, BB/K017071/2] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); innovate UK grant(UK Research & Innovation (UKRI)Innovate UK); AHDB; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RF gratefully acknowledges the financial assistance of the China Scholarship Council (grant number: 201506300012). RJH was funded by BBSRC grants BB/K017071/1, BB/N006682/1, AA by BB/K017071/1, HC by innovate UK grant 101630. LA was funded by AHDB grant CP094.	ALEXANDER LJ, 1962, PHYTOPATHOLOGY, V52, P998; Atallah ZK, 2011, PLANT DIS, V95, P784, DOI 10.1094/PDIS-01-11-0075; BAERGEN KD, 1993, HORTSCIENCE, V28, P833, DOI 10.21273/HORTSCI.28.8.833; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088; Bhat RG, 2003, PLANT DIS, V87, P789, DOI 10.1094/PDIS.2003.87.7.789; Bhat RG, 1999, PHYTOPATHOLOGY, V89, P1218, DOI 10.1094/PHYTO.1999.89.12.1218; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Brito N, 2006, MOL PLANT MICROBE IN, V19, P25, DOI 10.1094/MPMI-19-0025; Collado-Romero M, 2008, PHYTOPATHOLOGY, V98, P1019, DOI 10.1094/PHYTO-98-9-1019; Collado-Romero M, 2009, PLANT PATHOL, V58, P515, DOI 10.1111/j.1365-3059.2008.01981.x; de Jonge R, 2013, GENOME RES, V23, P1271, DOI 10.1101/gr.152660.112; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Dervis S, 2005, PHYTOPARASITICA, V33, P157, DOI 10.1007/BF03029975; Dervis S, 2010, EUR J PLANT PATHOL, V127, P287, DOI 10.1007/s10658-010-9595-z; Dervis S, 2009, PHYTOPARASITICA, V37, P467, DOI 10.1007/s12600-009-0061-4; DeWit PJGM, 1997, TRENDS PLANT SCI, V2, P452, DOI 10.1016/S1360-1385(97)01139-4; Dobinson KF, 2004, CURR GENET, V45, P104, DOI 10.1007/s00294-003-0464-6; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; European Food Safety Authority, 2011, EFSA Journal, V9, P2084; Faino L, 2016, GENOME RES, V26, P1091, DOI 10.1101/gr.204974.116; Faino L, 2015, MBIO, V6, DOI 10.1128/mBio.00936-15; FICK GN, 1974, CROP SCI, V14, P895, DOI 10.2135/cropsci1974.0011183X001400060037x; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; GLASS NL, 1992, ANNU REV PHYTOPATHOL, V30, P201, DOI 10.1146/annurev.py.30.090192.001221; Goud JC, 2002, EUR J PLANT PATHOL, V108, P771, DOI 10.1023/A:1020870632702; Govorova GF, 1997, ADV VERTICILLIUM RES, VVII, P58; Gui YJ, 2017, ENVIRON MICROBIOL, V19, P1914, DOI 10.1111/1462-2920.13695; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Haas Brian J, 2011, Mycology, V2, P118; Hayes RJ, 2011, THEOR APPL GENET, V123, P509, DOI 10.1007/s00122-011-1603-y; Hayes RJ, 2011, HORTSCIENCE, V46, P201, DOI 10.21273/HORTSCI.46.2.201; Hoff KJ, 2016, BIOINFORMATICS, V32, P767, DOI 10.1093/bioinformatics/btv661; Jimenez-Diaz RM, 2017, PLANT PATHOL, V66, P651, DOI 10.1111/ppa.12611; Jimenez-Diaz RM, 2006, PHYTOPATHOLOGY, V96, P288, DOI 10.1094/PHYTO-96-0288; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Koren S., 2016, BIORXIV; Kubicek CP, 2014, ANNU REV PHYTOPATHOL, V52, P427, DOI 10.1146/annurev-phyto-102313-045831; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Maruthachalam K, 2010, PHYTOPATHOLOGY, V100, P1222, DOI 10.1094/PHYTO-04-10-0122; Milgroom MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106740; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SCHAIBLE L, 1951, PHYTOPATHOLOGY, V41, P986; Seidl MF, 2014, BIOESSAYS, V36, P335, DOI 10.1002/bies.201300155; Shi X, 2017, BIORXIV; Short DPG, 2014, PHYTOPATHOLOGY, V104, P779, DOI 10.1094/PHYTO-09-13-0253-R; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smit A.F.A., 2015, REPEATMASKER OPEN 4; Song Y, 2017, MOL PLANT PATHOL, V18, P195, DOI 10.1111/mpp.12390; Sowik I, 2001, SCI HORTIC-AMSTERDAM, V88, P31, DOI 10.1016/S0304-4238(00)00195-3; Sperschneider J, 2016, NEW PHYTOL, V210, P743, DOI 10.1111/nph.13794; Surbanovski N, 2015, FRAGARIA HORTICULTUR, V2, P15009; Testa AC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1344-4; Tzima AK, 2011, MOL PLANT MICROBE IN, V24, P129, DOI 10.1094/MPMI-09-09-0217; Usami T, 2017, PLANT PATHOL, V66, P230, DOI 10.1111/ppa.12576; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; WILHELM S, 1955, PHYTOPATHOLOGY, V45, P180; Zhang Y, 2011, PLANT CELL REP, V30, P2085, DOI 10.1007/s00299-011-1115-x; Zhao ZT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-274	68	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0191824	10.1371/journal.pone.0191824	http://dx.doi.org/10.1371/journal.pone.0191824			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451893	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000425369800007
J	Heckl, M; Schmoeckel, E; Hertlein, L; Rottmann, M; Jeschke, U; Mayr, D				Heckl, Marlene; Schmoeckel, Elisa; Hertlein, Linda; Rottmann, Miriam; Jeschke, Udo; Mayr, Doris			The ARID1A, p53 and beta-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium	PLOS ONE			English	Article							REMODELING GENE ARID1A; TUMOR PROGRESSION; PROTEIN EXPRESSION; TP53 MUTATIONS; CANCER; PROGNOSIS; MARKER; CHEMORESISTANCE; P21(WAF1/CIP1); P16(INK4A)	Aim The objective of this study was to evaluate the prognostic value of ARID1A, p53, p21, p16 and beta-Catenin in endometrioid and clear cell ovarian and endometrial carcinomas. Materials and methods 97 tumors were available for analysis of ARID1A, p53, p21, p16 and beta-Catenin with the techniques of tissue microarray and immunohistochemistry. 32 were ovarian carcinomas and 65 were endometrial carcinomas. Results Endometrioid ovarian carcinomas showed negative staining for ARID1A (a) and p21 (b), aberrant expression of p53 (c) and p16 (d) and beta-Catenin positive nuclear expression (e) respectively in 19% (a), 100% (b), 28.6% (c), 52.4% (d) and 4.8% (e) of all cases. In the group of clear cell ovarian carcinomas it was 63.6% (a), 100% (b), 81.8% (c), 54.5% (d) and 0% (e). For endometrioid uterine carcinomas it was 75.7% (a), 94.9% (b), 30.5% (c), 52.1% (d) and 6.8% (e) and for clear cell uterine carcinomas it was 8.6% (a), 100% (b), 50% (c), 100% (d) and 0% (e). Survival analysis showed that negative expression of ARID1A, p53 aberrant expression and beta-Catenin nuclear positive staining are independent negative prognosticators in both, clear cell and endometrioid carcinoma, regardless of ovarian or uterine origin. Cox-Regression analysis showed them again as negative prognostic factors. Furthermore, we found a significant correlation between ARID1A and beta-Catenin expression in endometrioid uterine tumors. Conclusion The analyzed gynaecological carcinoma showed a distinct expression scheme of proteins that are associated with tumor suppression. We may conclude that ARID1A, p53 and beta-Catenin are the strongest prognostic factors by analyzing a subgroup of tumor suppressor genes in clear cell and endometrioid subtypes of ovarian and endometrial cancer and may be used along with traditional morphological and clinical characteristics for prognosis.	[Heckl, Marlene; Schmoeckel, Elisa; Mayr, Doris] Ludwig Maximilians Univ Munchen, Inst Pathol, Fac Med, Munich, Germany; [Hertlein, Linda; Jeschke, Udo] Ludwig Maximilians Univ LMU, Dept Gynaecol & Obstet, Munich, Germany; [Rottmann, Miriam] Ludwig Maximilians Univ LMU, Univ Hosp Munich, Inst Med Informat Proc Biometry & Epidemiol IBE, Munich Canc Registry MCR,Munich Tumour Ctr TZM, Munich, Germany	University of Munich; University of Munich; University of Munich	Schmoeckel, E (corresponding author), Ludwig Maximilians Univ Munchen, Inst Pathol, Fac Med, Munich, Germany.	Elisa.Schmoeckel@med.uni-muenchen.de	Jeschke, Udo/A-6643-2009	Jeschke, Udo/0000-0003-2623-3235; Heckl, Marlene/0000-0003-4295-3689	Heuer Stiftung fur medizinische Forschung	Heuer Stiftung fur medizinische Forschung	These studies were supported by a grant from Heuer Stiftung fur medizinische Forschung (https://www.heuer-stiftung.de/), no grant number was received. Dr. Linda Hertlein received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez T, 2012, AM J SURG PATHOL, V36, P753, DOI 10.1097/PAS.0b013e318247b7bb; Arai T, 2006, INT J GYNECOL CANCER, V16, P391, DOI 10.1111/j.1525-1438.2006.00494.x; Ayhan A, 2012, INT J GYNECOL CANCER, V22, P1310, DOI 10.1097/IGC.0b013e31826b5dcc; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Bodnar L, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-16; Buchynska L. G., 2006, Experimental Oncology, V28, P152; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Cho H, 2013, HUM PATHOL, V44, P1365, DOI 10.1016/j.humpath.2012.11.007; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; Deutsche Krebsgesellschaft DK AWMF, 2016, S3 LEITL DIAGN THER; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fadare O, 2012, J CANCER, V3, P129, DOI 10.7150/jca.4140; Faleiro-Rodrigues C, 2004, INT J GYNECOL PATHOL, V23, P337, DOI 10.1097/01.pgp.0000139711.22158.14; Felix AS, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00025; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; HALME J, 1984, OBSTET GYNECOL, V64, P151; Hoang LN, 2015, HISTOPATHOLOGY, V66, P664, DOI 10.1111/his.12581; Ichikawa Y, 1996, INT J CANCER, V69, P466, DOI 10.1002/(SICI)1097-0215(19961220)69:6<466::AID-IJC8>3.0.CO;2-2; Itamochi H, 2015, INT J CLIN ONCOL, V20, P967, DOI 10.1007/s10147-015-0811-x; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Katagiri A, 2012, MODERN PATHOL, V25, P282, DOI 10.1038/modpathol.2011.161; King CM, 2016, J PATHOL, V238, P185, DOI 10.1002/path.4657; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kurman RJ, 2014, WHO WHO CLASSIFICATI; Lai C-F, 2013, J FORMOS MED ASSOC, V2013, P1; Lee YH, 2011, INT J GYNECOL PATHOL, V30, P205, DOI 10.1097/PGP.0b013e3182063e71; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lichner Z, 2013, AM J PATHOL, V182, P1163, DOI 10.1016/j.ajpath.2013.01.007; Lowery WJ, 2012, INT J GYNECOL CANCER, V22, P9, DOI 10.1097/IGC.0b013e318231f140; Mao TL, 2013, AM J SURG PATHOL, V37, P1342, DOI 10.1097/PAS.0b013e3182889dc3; McCluggage WG, 2003, INT J GYNECOL PATHOL, V22, P231, DOI 10.1097/01.PGP.0000055172.04957.2F; MICHIELI P, 1994, CANCER RES, V54, P3391; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; Phillips V, 2009, INT J GYNECOL PATHOL, V28, P179, DOI 10.1097/PGP.0b013e318182c2d2; Piek JMJ, 2003, GYNECOL ONCOL, V90, P491, DOI 10.1016/S0090-8258(03)00365-2; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rechsteiner M, 2013, EXP MOL PATHOL, V95, P235, DOI 10.1016/j.yexmp.2013.08.004; Reid-Nicholson M, 2006, MODERN PATHOL, V19, P1091, DOI 10.1038/modpathol.3800620; REMMELE W, 1987, PATHOLOGE, V8, P138; Saegusa M, 2001, CANCER, V92, P1177, DOI 10.1002/1097-0142(20010901)92:5<1177::AID-CNCR1436>3.0.CO;2-5; Saso S, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3954; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHEPHERD JH, 1989, BRIT J OBSTET GYNAEC, V96, P889, DOI 10.1111/j.1471-0528.1989.tb03341.x; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Skirnisdottir I, 2013, CANCER GENOM PROTEOM, V10, P27; Skirnisdottir IA, 2011, INT J GYNECOL CANCER, V21, P236, DOI 10.1097/IGC.0b013e31820986e5; Steinbakk A, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.020; Vasileiou G, 2015, AM J HUM GENET, V97, P445, DOI 10.1016/j.ajhg.2015.08.002; Voeller HJ, 1998, CANCER RES, V58, P2520; Voutilainen KA, 2006, J CLIN PATHOL, V59, P460, DOI 10.1136/jcp.2005.029876; Wang DH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039920, 10.1371/journal.pone.0040364]; Wang H, 2014, INT J CLIN EXP PATHO, V7, P264; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; Werner HMJ, 2013, MODERN PATHOL, V26, P428, DOI 10.1038/modpathol.2012.174; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Yan HB, 2014, CARCINOGENESIS, V35, P867, DOI 10.1093/carcin/bgt398; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85; Yokoyama Y, 2014, J GYNECOL ONCOL, V25, P58, DOI 10.3802/jgo.2014.25.1.58; Yokoyama Y, 2011, PATHOBIOLOGY, V78, P253, DOI 10.1159/000328061; Zhang XY, 2013, PROC INT CONF DOC, P8, DOI 10.1109/ICDAR.2013.11	65	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192881	10.1371/journal.pone.0192881	http://dx.doi.org/10.1371/journal.pone.0192881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451900	Green Submitted, gold, Green Published			2022-12-26	WOS:000425369800022
J	Jung, MY; Kang, JH; Hernandez, DM; Yin, XQ; Andrianifahanana, M; Wang, YL; Gonzalez-Guerrico, A; Limper, AH; Lupu, R; Leof, EB				Jung, Mi-Yeon; Kang, Jeong-Han; Hernandez, Danielle M.; Yin, Xueqian; Andrianifahanana, Mahefatiana; Wang, Youli; Gonzalez-Guerrico, Anatilde; Limper, Andrew H.; Lupu, Ruth; Leof, Edward B.			Fatty acid synthase is required for profibrotic TGF- signaling	FASEB JOURNAL			English	Article						idiopathic pulmonary fibrosis; metabolism; fibrosis	IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; SREBP TRANSCRIPTION FACTORS; ELEMENT-BINDING PROTEINS; GENE-EXPRESSION; CANCER-CELLS; MAMMALIAN TARGET; OVARIAN-CANCER; MYOFIBROBLAST DIFFERENTIATION; MOLECULAR-MECHANISMS	Evidence is provided that the fibroproliferative actions of TGF- are dependent on a metabolic adaptation that sustains pathologic growth. Specifically, profibrotic TGF- signaling is shown to require fatty acid synthase (FASN), an essential anabolic enzyme responsible for the de novo synthesis of fatty acids. With the use of pharmacologic and genetic approaches, we show that TGF--stimulated FASN expression is independent of Smad2/3 and is mediated via mammalian target of rapamycin complex 1. In the absence of FASN activity or protein, TGF--driven fibrogenic processes are reduced with no apparent toxicity. Furthermore, as increased FASN expression was also observed to correlate with the degree of lung fibrosis in bleomycin-treated mice, inhibition of FASN was examined in a murine-treatment model of pulmonary fibrosis. Remarkably, inhibition of FASN not only decreased expression of profibrotic targets, but lung function was also stabilized/improved, as assessed by peripheral blood oxygenation.Jung, M.-Y., Kang, J.-H., Hernandez, D. M., Yin, X., Andrianifahanana, M., Wang, Y., Gonzalez-Guerrico, A., Limper, A. H., Lupu, R., Leof, E. B. Fatty acid synthase is required for profibrotic TGF- signaling.	[Jung, Mi-Yeon; Kang, Jeong-Han; Hernandez, Danielle M.; Yin, Xueqian; Andrianifahanana, Mahefatiana; Limper, Andrew H.; Leof, Edward B.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Thorac Dis Res Unit,Div Pulm & Crit Care Med, Rochester, MN 55905 USA; [Gonzalez-Guerrico, Anatilde; Lupu, Ruth] Mayo Clin, Coll Med, Dept Lab Med & Pathol, 2-12 Stabile,200 Second St SW, Rochester, MN 55905 USA; [Wang, Youli] Augusta Univ, Div Nephrol, Augusta, GA USA	Mayo Clinic; Mayo Clinic; University System of Georgia; Augusta University	Lupu, R (corresponding author), Mayo Clin, Coll Med, Dept Lab Med & Pathol, 2-12 Stabile,200 Second St SW, Rochester, MN 55905 USA.; Leof, EB (corresponding author), Mayo Clin, Coll Med, Thorac Dis Res Unit, 8-58 Stabile,200 Second St SW, Rochester, MN 55905 USA.	lupu.ruth@mayo.edu; leof.edward@mayo.edu	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696; Hernandez, Danielle M./0000-0003-0867-4950	Public Health Service from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [GM-55816, GM-54200]; Mayo Brain Specialized Programs of Research Excellence (SPORE) [CA-108961]; Caerus Foundation [91736058]; Mayo Foundation; Public Health Service Grant from the NIH National Cancer Institute [CA-116623]; NATIONAL CANCER INSTITUTE [P50CA108961, R01CA116623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055816, R01GM054200, R01GM055816] Funding Source: NIH RePORTER	Public Health Service from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; Mayo Brain Specialized Programs of Research Excellence (SPORE); Caerus Foundation; Mayo Foundation; Public Health Service Grant from the NIH National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service Grants GM-55816 and GM-54200 from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences, a pilot grant from the Mayo Brain Specialized Programs of Research Excellence (SPORE) (CA-108961), the Caerus Foundation (91736058), and the Mayo Foundation (to E.B.L.), as well as Public Health Service Grant CA-116623 from the NIH National Cancer Institute (to R.L.). The authors declare no conflicts of interest.	Agathocleous M, 2013, TRENDS CELL BIOL, V23, P484, DOI 10.1016/j.tcb.2013.05.004; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Alli PM, 2005, ONCOGENE, V24, P39, DOI 10.1038/sj.onc.1208174; Andrianifahanana M, 2016, FASEB J, V30, P3733, DOI 10.1096/fj.201600428R; Andrianifahanana M, 2013, FASEB J, V27, P4444, DOI 10.1096/fj.12-224907; Andrianifahanana M, 2010, CANCER RES, V70, P7421, DOI 10.1158/0008-5472.CAN-10-0232; Bengoechea-Alonso MT, 2006, CELL CYCLE, V5, P1708, DOI 10.4161/cc.5.15.3131; Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984; Beyer C, 2012, CURR OPIN RHEUMATOL, V24, P274, DOI 10.1097/BOR.0b013e3283524b9a; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Canestaro WJ, 2016, CHEST, V149, P756, DOI 10.1016/j.chest.2015.11.013; Chaudhary NI, 2006, AM J RESP CRIT CARE, V173, P769, DOI 10.1164/rccm.200505-717OC; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Flavin R, 2010, FUTURE ONCOL, V6, P551, DOI [10.2217/fon.10.11, 10.2217/FON.10.11]; Foskett AM, 2014, AM J PHYSIOL-LUNG C, V306, pL120, DOI 10.1152/ajplung.00240.2013; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Grunt TW, 2009, BIOCHEM BIOPH RES CO, V385, P454, DOI 10.1016/j.bbrc.2009.05.085; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Jo HE, 2016, DRUG AGING, V33, P321, DOI 10.1007/s40266-016-0366-1; Jones SF, 2015, CLIN CANCER RES, V21, P5434, DOI 10.1158/1078-0432.CCR-15-0126; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Kottmann RM, 2012, AM J RESP CRIT CARE, V186, P740, DOI 10.1164/rccm.201201-0084OC; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Kurotsu S, 2014, J PHARMACOL EXP THER, V350, P79, DOI 10.1124/jpet.114.213009; Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lewis CA, 2011, BIOCHEM SOC T, V39, P495, DOI 10.1042/BST0390495; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loomis-King H, 2013, CURR OPIN PHARMACOL, V13, P377, DOI 10.1016/j.coph.2013.03.015; Mattaini KR, 2016, J CELL BIOL, V214, P248, DOI 10.1083/jcb.201604085; Menendez JA, 2004, P NATL ACAD SCI USA, V101, P10715, DOI 10.1073/pnas.0403390101; Menendez JA, 2006, INT J MOL MED, V18, P1081; Menendez JA, 2017, EXPERT OPIN THER TAR, V21, P1001, DOI 10.1080/14728222.2017.1381087; MOSELEY PL, 1986, J CLIN INVEST, V78, P1150, DOI 10.1172/JCI112695; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Ohol YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144648; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Shao W, 2014, J BIOL CHEM, V289, P7547, DOI 10.1074/jbc.M113.545699; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Sime PJ, 2001, CLIN IMMUNOL, V99, P308, DOI 10.1006/clim.2001.5008; Sivakumar P, 2012, CURR OPIN PULM MED, V18, P462, DOI 10.1097/MCP.0b013e328356800f; Steele MP, 2013, ANNU REV MED, V64, P265, DOI 10.1146/annurev-med-042711-142004; Svensson RU, 2016, COLD SH Q B, V81, P93, DOI [10.1101/sqb.2016.81.030874, 10.1101/sqb.2016.81.030574]; Swinnen JV, 1997, P NATL ACAD SCI USA, V94, P12975, DOI 10.1073/pnas.94.24.12975; Todd NW, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-11; Tomek K, 2011, MOL CANCER RES, V9, P1767, DOI 10.1158/1541-7786.MCR-10-0467; Ventura R, 2015, EBIOMEDICINE, V2, P808, DOI 10.1016/j.ebiom.2015.06.020; Verhoeven D, 2009, VIROLOGY, V390, P151, DOI 10.1016/j.virol.2009.05.004; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; WARBURG O, 1956, SCIENCE, V124, P269; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC; Xie T, 2011, PHYSIOL GENOMICS, V43, P479, DOI 10.1152/physiolgenomics.00222.2010; Yang CS, 2015, ONCOGENE, V34, P3264, DOI 10.1038/onc.2014.271; Yang L, 2014, HEPATOLOGY, V59, P483, DOI 10.1002/hep.26698; Yuan MS, 2012, J BIOL CHEM, V287, P29579, DOI 10.1074/jbc.M112.386854; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012	76	33	33	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3803	3815		10.1096/fj.201701187R	http://dx.doi.org/10.1096/fj.201701187R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29475397	Green Published			2022-12-26	WOS:000435104500027
J	Cannataro, VL; Gaffney, SG; Stender, C; Zhao, ZM; Philips, M; Greenstein, AE; Townsend, JP				Cannataro, Vincent L.; Gaffney, Stephen G.; Stender, Carly; Zhao, Zi-Ming; Philips, Mark; Greenstein, Andrew E.; Townsend, Jeffrey P.			Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C	ONCOGENE			English	Article							EGFR T790M MUTATION; ACQUIRED-RESISTANCE; INTRATUMORAL HETEROGENEITY; POPULATION-GENETICS; LUNG CANCERS; RAS; INHIBITORS; THERAPY; MUTANT; GENES	Activating mutations in RAS genes are associated with approximately 20% of all human cancers. New targeted therapies show preclinical promise in inhibiting the KRAS G12C variant. However, concerns exist regarding the effectiveness of such therapies in vivo given the possibilities of existing intratumor heterogeneity or de novo mutation leading to treatment resistance. We performed deep sequencing of 27 KRAS G12-positive lung tumors to determine the prevalence of other oncogenic mutations within KRAS or within commonly mutated downstream genes that could confer resistance at the time of treatment. We also passaged patient-derived xenografts to assess the potential for novel KRAS mutation to arise during subsequent tumor evolution. Furthermore, we estimate the de novo mutation rate in KRAS position 12 and in genes downstream of KRAS. Finally, we present an approach for estimation of the selection intensity for these point mutations that explains their high prevalence in tumors. We find no evidence of heterogeneity that may compromise KRAS G12C targeted therapy within sequenced lung tumors or passaged xenografts. We find that mutations that confer resistance are even less likely to occur downstream of KRAS than to occur within KRAS. Our approach predicts that BRAF V600E would provide the highest fitness advantage for de novo-resistant subclones. Overall, our findings suggest that resistance to targeted therapy of KRAS G12C-positive tumors is unlikely to be present at the time of treatment and, among the de novo mutations likely to confer resistance, mutations in BRAF, a gene with targeted inhibitors presently available, result in subclones with the highest fitness advantage.	[Cannataro, Vincent L.; Gaffney, Stephen G.; Stender, Carly; Zhao, Zi-Ming; Townsend, Jeffrey P.] Yale Univ, Dept Biostat, New Haven, CT 06520 USA; [Philips, Mark] NYU, Sch Med, Dept Med, New York, NY USA; [Philips, Mark] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Philips, Mark] NYU, Sch Med, Dept Pharmacol, New York, NY USA; [Greenstein, Andrew E.] Gilead Sci, Foster City, CA USA; [Townsend, Jeffrey P.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Townsend, Jeffrey P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Yale University; New York University; New York University; New York University; Gilead Sciences; Yale University; Yale University	Townsend, JP (corresponding author), Yale Univ, Dept Biostat, New Haven, CT 06520 USA.; Townsend, JP (corresponding author), Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA.; Townsend, JP (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	jeffrey.townsend@yale.edu	Townsend, Jeffrey/H-2747-2019	Townsend, Jeffrey/0000-0002-9890-3907; Mark, Philips/0000-0002-1179-8156; Cannataro, Vincent/0000-0002-6364-7747; Gaffney, Stephen/0000-0002-5490-2945; Greenstein, Andrew/0000-0002-1470-1970	Gilead Sciences, Inc.; NATIONAL CANCER INSTITUTE [R01CA116034] Funding Source: NIH RePORTER	Gilead Sciences, Inc.(Gilead Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially funded by Gilead Sciences, Inc.	Al-Mulla F, 1998, J PATHOL, V185, P130, DOI 10.1002/(SICI)1096-9896(199806)185:2<130::AID-PATH85>3.0.CO;2-M; Alsdorf WH, 2013, EXP MOL PATHOL, V94, P155, DOI 10.1016/j.yexmp.2012.09.016; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Burrell RA, 2014, MOL ONCOL, V8, P1095, DOI 10.1016/j.molonc.2014.06.005; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Bustamante CD, 2005, STAT BIOL HEALTH, P63, DOI 10.1007/0-387-27733-1_4; Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu, 2017, Cancer Cell, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Cannataro VL, 2016, EVOL APPL, V9, P565, DOI 10.1111/eva.12361; CHANG EH, 1982, P NATL ACAD SCI-BIOL, V79, P4848, DOI 10.1073/pnas.79.16.4848; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cox AD, 2015, CLIN CANCER RES, V21, P1819, DOI 10.1158/1078-0432.CCR-14-3214; Cox Adrienne D, 2010, Small GTPases, V1, P2; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Fiala O, 2013, CANCER GENET-NY, V206, P26, DOI 10.1016/j.cancergen.2012.12.003; Fujita Y, 2012, J THORAC ONCOL, V7, P1640, DOI 10.1097/JTO.0b013e3182653d7f; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Greulich Heidi, 2010, Genes Cancer, V1, P1200, DOI 10.1177/1947601911407324; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashimoto D, 2016, PANCREAS, V45, P1111, DOI 10.1097/MPA.0000000000000624; Hobbs GA, 2016, CANCER CELL, V29, P251, DOI 10.1016/j.ccell.2016.02.015; Huang LH, 2015, ACTA PHARM SIN B, V5, P390, DOI 10.1016/j.apsb.2015.07.001; Hunter JC, 2014, P NATL ACAD SCI USA, V111, P8895, DOI 10.1073/pnas.1404639111; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Izar B, 2014, J THORAC ONCOL, V9, P1363, DOI 10.1097/JTO.0000000000000266; Kadara H, 2017, ANN ONCOL, V28, P75, DOI 10.1093/annonc/mdw436; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Lloyd MC, 2016, CANCER RES, V76, P3136, DOI 10.1158/0008-5472.CAN-15-2962; Mao CQ, 2014, MOL THER, V22, P964, DOI 10.1038/mt.2014.18; McCormick F, 2015, CLIN CANCER RES, V21, P1797, DOI 10.1158/1078-0432.CCR-14-2662; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Montalvo SK, 2017, FUTURE ONCOL, V13, P263, DOI 10.2217/fon-2016-0363; Moran P., 1958, MATH P CAMBRIDGE PHI, V54, P60, DOI DOI 10.1017/S0305004100033193; Mulloy R, 2007, CANCER RES, V67, P2325, DOI 10.1158/0008-5472.CAN-06-4293; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nadal E, 2014, J THORAC ONCOL, V9, P1513, DOI 10.1097/JTO.0000000000000305; Ohashi K, 2012, P NATL ACAD SCI USA, V109, pE2127, DOI 10.1073/pnas.1203530109; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Parsons TL, 2007, THEOR POPUL BIOL, V72, P121, DOI 10.1016/j.tpb.2006.11.004; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; Porta M, 2009, MUTAT RES-REV MUTAT, V682, P83, DOI 10.1016/j.mrrev.2009.07.003; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Roberts PJ, 2013, J CLIN ONCOL, V31, P1112, DOI 10.1200/JCO.2012.43.0454; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Rozhok AI, 2016, TRENDS CANCER, V2, P552, DOI 10.1016/j.trecan.2016.09.004; SAWYER SA, 1992, GENETICS, V132, P1161; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schildhaus HU, 2015, CLIN CANCER RES, V21, P907, DOI 10.1158/1078-0432.CCR-14-0450; Schmitt MW, 2016, NAT REV CLIN ONCOL, V13, P335, DOI 10.1038/nrclinonc.2015.175; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Singh H, 2015, J CLIN ONCOL, V33, P3650, DOI 10.1200/JCO.2015.62.1052; Stewart EL, 2015, TRANSL LUNG CANCER R, V4, P67, DOI 10.3978/j.issn.2218-6751.2014.11.06; Suda K, 2009, J THORAC ONCOL, V4, P1, DOI 10.1097/JTO.0b013e3181913c9f; Svaton M, 2016, ANTICANCER RES, V36, P1077; Tougeron D, 2013, ANN ONCOL, V24, P1267, DOI 10.1093/annonc/mds620; Vilarinho S, 2014, GASTROENTEROLOGY, V146, pS495; Visscher M, 2016, CURR OPIN CHEM BIOL, V30, P61, DOI 10.1016/j.cbpa.2015.11.004; Westover KD, 2016, CANCER DISCOV, V6, P233, DOI 10.1158/2159-8290.CD-16-0092; Wilson CY, 2016, DRUG DISCOV TODAY, V21, P1915, DOI 10.1016/j.drudis.2016.08.002; Xiong Y, 2017, ACS MED CHEM LETT, V8, P61, DOI 10.1021/acsmedchemlett.6b00373; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Yun C- H, 2016, P NATL ACAD SCI USA, V105, P2070; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232; Ziogas DE, 2016, BIOMARK MED, V10, P681, DOI 10.2217/bmm-2016-0044	73	21	21	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	18					2444	2455		10.1038/s41388-017-0105-z	http://dx.doi.org/10.1038/s41388-017-0105-z			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GE7BW	29453361	Green Submitted			2022-12-26	WOS:000431386000008
J	Forte, P; Marinho, DA; Morais, JE; Morouco, PG; Barbosa, TM				Forte, Pedro; Marinho, Daniel A.; Morais, Jorge E.; Morouco, Pedro G.; Barbosa, Tiago M.			The variations on the aerodynamics of a world-ranked wheelchair sprinter in the key-moments of the stroke cycle: A numerical simulation analysis	PLOS ONE			English	Article							ENERGY-COST; DRAG; PERFORMANCE; POSITION; FORCES; WIND	Biomechanics plays an important role helping Paralympic sprinters to excel, having the aerodynamic drag a significant impact on the athlete's performance. The aim of this study was to assess the aerodynamics in different key-moments of the stroke cycle by Computational Fluid Dynamics. A world-ranked wheelchair sprinter was scanned on the racing wheelchair wearing his competition gear and helmet. The sprinter was scanned in three different positions: (i) catch (hands in the 12h position on the hand-rim); (ii) the release (hands in the 18h position on the hand-rim) and; (iii) recovery phase (hands do not touch the handrim and are hyperextended backwards). The simulations were performed at 2.0, 3.5, 5.0 and 6.5 m/s. The mean viscous and pressure drag components, total drag force and effective area were retrieved after running the numerical simulations. The viscous drag ranged from 3.35 N to 2.94 N, pressure drag from 0.38 N to 5.51 N, total drag force from 0.72 N to 8.45 N and effective area from 0.24 to 0.41 m(2). The results pointed out that the sprinter was submitted to less drag in the recovery phase, and higher drag in the catch. These findings suggest the importance of keeping an adequate body alignment to avoid an increase in the drag force.	[Forte, Pedro; Marinho, Daniel A.] Univ Beira Interior, Dept Sport Sci, Covilha, Portugal; [Forte, Pedro; Marinho, Daniel A.; Morais, Jorge E.; Barbosa, Tiago M.] Res Ctr Sports Hlth & Human Dev, Covilha, Portugal; [Morais, Jorge E.; Barbosa, Tiago M.] Polytech Inst Braganca, Dept Sport Sci, Braganca, Portugal; [Morouco, Pedro G.] Polytech Inst Leiria, Dept Sport Sci, Leiria, Portugal; [Morouco, Pedro G.] Ctr Rapid & Sustainable Prod Dev, Leiria, Portugal; [Barbosa, Tiago M.] Nanyang Technol Univ, Natl Inst Educ, Singapore, Singapore	Universidade da Beira Interior; Instituto Politecnico de Braganca; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Forte, P (corresponding author), Univ Beira Interior, Dept Sport Sci, Covilha, Portugal.; Forte, P (corresponding author), Res Ctr Sports Hlth & Human Dev, Covilha, Portugal.	pedromiguelforte@gmail.com	Forte, Pedro/L-2858-2014; Barbosa, Tiago M./ABE-6789-2020; Morais, Jorge E./AAX-9541-2020; Morouço, Pedro/K-9545-2013; Barbosa, Tiago M./U-5335-2017	Forte, Pedro/0000-0003-0184-6780; Barbosa, Tiago M./0000-0001-7071-2116; Morais, Jorge E./0000-0002-6885-0648; Morouço, Pedro/0000-0002-5956-9790; Barbosa, Tiago M./0000-0001-7071-2116	National Funds through FCT - Portuguese Foundation for Science and Technology [UID/DTP/04045/2013]; European Fund for regional development (FEDER) by European Union through the COMPETE Programme [POCI-01-0145-FEDER-006969]; FCT Portuguese Foundation for Science and Technology [UID/DTP/04045/2013]; European Union European Fund for regional development (FEDER) under the COMPETE Programme [POCI-01-0145-FEDER-006969]	National Funds through FCT - Portuguese Foundation for Science and Technology; European Fund for regional development (FEDER) by European Union through the COMPETE Programme; FCT Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Union European Fund for regional development (FEDER) under the COMPETE Programme	This project was supported by the National Funds through FCT - Portuguese Foundation for Science and Technology (UID/DTP/04045/2013) - and the European Fund for regional development (FEDER) allocated by European Union through the COMPETE 2020 Programme (POCI-01-0145-FEDER-006969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the FCT Portuguese Foundation for Science and Technology (UID/DTP/04045/2013) and by European Union European Fund for regional development (FEDER) under the COMPETE 2020 Programme (POCI-01-0145-FEDER-006969).	ANSYS Inc, 2013, INTR US ANSYS FLUENT, P1; Barbosa TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177038; Barbosa TM, 2016, PROCEDIA ENGINEER, V147, P2, DOI 10.1016/j.proeng.2016.06.180; Barbosa TM, 2014, 1 INT C SPORTS SCI T, P749; Bixler B, 2007, SPORT BIOMECH, V6, P81, DOI 10.1080/14763140601058581; Blocken B, 2012, J BIOMECH, V43, P2281; Blocken B, 2013, COMPUT FLUIDS, V71, P435, DOI 10.1016/j.compfluid.2012.11.012; Bouillod A, 2016, 4 INT C SPORT SCI RE, P1; Candau RB, 1999, MED SCI SPORT EXER, V31, P1441, DOI 10.1097/00005768-199910000-00013; Chowdhury H., 2012, APPL AERODYNAMICS, P21; COOPER R A, 1990, Journal of Rehabilitation Research and Development, V27, P295, DOI 10.1682/JRRD.1990.07.0297; Cooper R. A., 1990, ADAPT PHYS ACT Q, V7, P74; Crouch TN, 2017, SPORTS ENG, V20, P81, DOI 10.1007/s12283-017-0234-1; Debraux P, 2011, SPORT BIOMECH, V10, P197, DOI 10.1080/14763141.2011.592209; Defraeye T, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4025792; Defraeye T, 2010, J BIOMECH, V43, P1262, DOI 10.1016/j.jbiomech.2010.01.025; DIPRAMPERO PE, 1986, INT J SPORTS MED, V7, P55, DOI 10.1055/s-2008-1025736; Edwards AG, 2007, MED SCI SPORT EXER, V39, P170, DOI 10.1249/01.mss.0000239400.85955.12; Faria EW, 2005, SPORTS MED, V35, P313, DOI 10.2165/00007256-200535040-00003; Forte P, 2017, AIP CONF PROC, V1863, DOI 10.1063/1.4992669; Forte P., 2015, NEW PERSPECTIVES FLU, P101; Fuss FK, 2009, SPORTS ENG, V12, P41, DOI 10.1007/s12283-009-0027-2; Gehlsen GM, 1990, ADAPTED PHYSICAL ACT, V7, P219; Grappe F, 1997, ERGONOMICS, V40, P1299, DOI 10.1080/001401397187388; Griffith MD, 2014, J FLUID ENG-T ASME, V136, DOI 10.1115/1.4027428; Hoffman MD, 2003, AM J PHYS MED REHAB, V82, P880, DOI 10.1097/01.PHM.0000091980.91666.58; Kennedy M. D., 2013, HDB ERGONOMICS SPORT, P115; Kulfan B, 2000, FLUIDS 2000 C EXH FL, P2; Kyle CR, 2013, HIGH TECH CYCLING, P1; Marinho DA, 2010, J APPL BIOMECH, V26, P87, DOI 10.1123/jab.26.1.87; Martin JC, 2006, MED SCI SPORT EXER, V38, P592, DOI 10.1249/01.mss.0000193560.34022.04; McLean B. D., 1994, Journal of Biomechanics, V27, P675, DOI 10.1016/0021-9290(94)91005-7; Millet GP, 2002, SCI SPORT, V17, P166, DOI 10.1016/S0765-1597(02)00139-9; Munson B.R., 1990, FUNDAMENTALS FLUID M; Paton C., 2006, SPORTSCIENCE, V10, P69; Pogni M, 2016, PROCEDIA ENGINEER, V147, P74, DOI 10.1016/j.proeng.2016.06.192; Ridgway M, 1988, ADAPTED PHYSICAL ACT, V5, P96; RYSCHON TW, 1991, MED SCI SPORT EXER, V23, P949; SANDERSON DJ, 1985, J BIOMECH, V18, P423, DOI 10.1016/0021-9290(85)90277-5; Schlichting H., 2017, BOUNDARY LAYER THEOR; Winkler A, 2010, PROCEDIA ENGINEER, V2, P2399, DOI 10.1016/j.proeng.2010.04.006	41	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193658	10.1371/journal.pone.0193658	http://dx.doi.org/10.1371/journal.pone.0193658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489904	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000100
J	Goudarzi, R; Reid, A; McDougall, JJ				Goudarzi, Ramin; Reid, Allison; McDougall, Jason J.			Evaluation of the novel avocado/soybean unsaponifiable Arthrocen to alter joint pain and inflammation in a rat model of osteoarthritis	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; DOUBLE-BLIND; GLUCOSAMINE SULFATE; 6-MONTH TREATMENT; GENE-EXPRESSION; CLINICAL-TRIAL; AVOCADO; PLACEBO; ASU; CHONDROCYTES	Background Avocado/soybean unsaponifiables such as Arthrocen have been reported to reduce cartilage catabolism and chondrocytic synthesis of inflammatory mediators associated with osteoarthritis (OA). While there is some clinical evidence that avocado/soybean unsaponifiables can reduce OA pain, no preclinical studies have corroborated this observation. The present study determined whether addition of an avocado/soybean unsaponifiable (Arthrocen) to the drinking water of OA rats reduced direct and referred joint pain. Methods OA was induced in male Wistar rats by intra-articular injection of sodium monoiodoacetate (MIA: 0.3mg) and animals were allowed to recover for 14 days. Arthrocen was added to the drinking water which was available to animals ad libitum. On day 30, joint pain was assessed by dynamic incapacitance while referred pain was determined by von Frey hair algesiometry. Results The joint damage induced by MIA injection was severe and was consistent with end-stage OA. Arthrocen consumption (approximately 35 mg/day) attenuated the joint oedema associated with MIA injection. Hindlimb weight bearing also significantly improved in Arthrocentreated rats (P<0.05); however, von Frey hair mechanosensitivity was unaffected by this treatment. Conclusions These data indicate that Arthrocen has the potential to reduce joint inflammation and pain associated with end-stage OA.	[Goudarzi, Ramin] Pharmin USA LLC, Div Res & Dev, San Jose, CA USA; [Reid, Allison; McDougall, Jason J.] Dalhousie Univ, Dept Pharmacol & Anaesthesia, Halifax, NS, Canada; [Reid, Allison; McDougall, Jason J.] Dalhousie Univ, Dept Pain Management & Perioperat Med, Halifax, NS, Canada	Dalhousie University; Dalhousie University	McDougall, JJ (corresponding author), Dalhousie Univ, Dept Pharmacol & Anaesthesia, Halifax, NS, Canada.; McDougall, JJ (corresponding author), Dalhousie Univ, Dept Pain Management & Perioperat Med, Halifax, NS, Canada.	jason.mcdougall@dal.ca	McDougall, Jason/AAK-2373-2020	Goudarzi, Ramin/0000-0003-0648-7588; McDougall, Jason/0000-0003-4529-3428	Pharmin USA LLC	Pharmin USA LLC	This work was funded by Pharmin USA LLC. R. Goudarzi was involved in the decision to publish and approved the final manuscript. The funder provided support in the form of salaries to AR and JJMcD, but did not have any additional role in study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the "Authors Contributions" section.	Appelboom T, 2001, SCAND J RHEUMATOL, V30, P242; Au RY, 2007, OSTEOARTHR CARTILAGE, V15, P1249, DOI 10.1016/j.joca.2007.07.009; Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)00163-8; Cake MA, 2000, OSTEOARTHR CARTILAGE, V8, P404, DOI 10.1053/joca.1999.0315; Catunda IS, 2016, INT J ORAL MAX SURG, V45, P1015, DOI 10.1016/j.ijom.2016.01.008; Chou MM, 2005, EXP BIOL MED, V230, P255; Christiansen BA, 2015, CARTILAGE, V6, P30, DOI 10.1177/1947603514554992; Gluszko Piotr, 2016, Reumatologia (Warsaw), V54, P217, DOI 10.5114/reum.2016.63661; Goudarzi R, 2017, FEBS OPEN BIO, V7, P187, DOI 10.1002/2211-5463.12176; Hochberg MC, 2016, ANN RHEUM DIS, V75, P37, DOI 10.1136/annrheumdis-2014-206792; Kawcak CE, 2007, AM J VET RES, V68, P598, DOI 10.2460/ajvr.68.6.598; Krustev E, 2015, CURR OSTEOPOROS REP, V13, P216, DOI 10.1007/s11914-015-0275-y; Maheu E, 1998, ARTHRITIS RHEUM-US, V41, P81, DOI 10.1002/1529-0131(199801)41:1<81::AID-ART11>3.3.CO;2-0; McDougall JJ, 2006, PAIN, V123, P98, DOI 10.1016/j.pain.2006.02.015; Ownby SL, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-8; Roman-Blas JA, 2017, ARTHRITIS RHEUMATOL, V69, P77, DOI 10.1002/art.39819	16	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191906	10.1371/journal.pone.0191906	http://dx.doi.org/10.1371/journal.pone.0191906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489828	Green Submitted, gold, Green Published			2022-12-26	WOS:000426276000012
J	Hou, L; Ji, ZB; Wang, GZ; Wang, J; Chao, TL; Wang, JM				Hou, Lei; Ji, Zhibin; Wang, Guizhi; Wang, Jin; Chao, Tianle; Wang, Jianmin			W Identification and characterization of microRNAs in the intestinal tissues of sheep (Ovis aries)	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; TAIL HAN SHEEP; MESSENGER-RNAS; KAZAKH SHEEP; BIOINFORMATICS; PATHWAY; DORSET; GENES; OVARY	Sheep are small ruminants, and their long intestines exhibit high digestive and absorptive capacity in many different rearing conditions; however, the genetic bases of this characteristic remains unclear. MicroRNAs (miRNAs) play a major role in maintaining both intestinal morphological structure as well as in regulating the physiological functions of this organ. However, no study has reported on the miRNA expression profile in the intestinal tissues of sheep. Here, we analyzed and identified the miRNA expression profile of three different intestinal tissues (i.e., duodenum, cecum, and colon) of sheep (Ovis aries) using high-throughput sequencing and bioinformatic methods. In total, 106 known miRNAs were identified, 458 conserved miRNAs were detected, 192 unannotated novel miRNAs were predicted, and 195 differentially expressed miRNAs were found between the different tissues. Additionally, 3,437 candidate target genes were predicted, and 17 non-redundant significantly enriched GO terms were identified using enrichment analysis. A total of 99 candidate target genes were found to significantly enriched in 4 KEGG biological pathways. A combined regulatory network was constructed based on 92 metabolism-related candidate target genes and 65 differentially expressed miRNAs, among which 7 miRNAs were identified as hub miRNAs. Via these mechanisms, miRNAs may play a role in maintaining intestinal homeostasis and metabolism. This study helps to further explain the mechanisms that underlie differences in tissue morphology and function in three intestinal segments of sheep.	[Hou, Lei; Ji, Zhibin; Wang, Guizhi; Wang, Jin; Chao, Tianle; Wang, Jianmin] Shandong Agr Univ, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China	Key Laboratory of Animal Biotechnology & Disease Control & Prevention of Shandong Province; Shandong Agricultural University	Chao, TL; Wang, JM (corresponding author), Shandong Agr Univ, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China.	2398901017@qq.com; wangjm@sdau.edu.cn	WANG, Jianmin/M-2002-2016	WANG, Jianmin/0000-0001-5678-8202; tianle, chao/0000-0001-9721-0634	Funds of Shandong "Double Tops" Program [SYL2017YSTD12]; Shandong Provincial Modern Agriculture Industry Technology System [SDAIT-0901101]; National Key Technology Support Program [2015BAD03B05]; Study on Super-high Reproductive New Breed and Supporting technological system of Small-Tailed Han Sheep [SDLZ2015131x]	Funds of Shandong "Double Tops" Program; Shandong Provincial Modern Agriculture Industry Technology System; National Key Technology Support Program(National Key Technology R&D Program); Study on Super-high Reproductive New Breed and Supporting technological system of Small-Tailed Han Sheep	This work was financially supported by the Funds of Shandong "Double Tops" Program (No. SYL2017YSTD12), Shandong Provincial Modern Agriculture Industry Technology System (no. SDAIT-0901101), National Key Technology Support Program (2015BAD03B05) and Study on Super-high Reproductive New Breed and Supporting technological system of Small-Tailed Han Sheep (no. SDLZ2015131x). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bai J W, 2016, EUROPEAN REV MED PHA, V20; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Carrigan C T, 2016, GROWTH HORM IGF RES, V32, P14; Chang WH, 2015, J VET MED SCI, V77, P1617, DOI 10.1292/jvms.15-0289; Consortium T G O, 2007, NUCL ACIDS RES S1, V36, P391; Coutinho LL, 2007, PHYSIOL GENOMICS, V29, P35, DOI 10.1152/physiolgenomics.00081.2006; DEGREGORIO RM, 1982, J ANIM SCI, V54, P855, DOI 10.2527/jas1982.544855x; FAICHNEY GJ, 1969, AUST J AGR RES, V20, P491, DOI 10.1071/AR9690491; Gao Y, 2011, NUCLEIC ACIDS RES, V39, P454, DOI 10.1093/nar/gkq782; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Jiang S, 2016, PARASITE, V23, DOI 10.1051/parasite/2016023; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kim H, 2017, ONCOTARGET, V8, P8484, DOI 10.18632/oncotarget.14298; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lagana A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143313; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LEWIS SM, 1985, APPL ENVIRON MICROB, V50, P356, DOI 10.1128/AEM.50.2.356-363.1985; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang GX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092592; Liao YL, 2013, GENES NUTR, V8, P69, DOI 10.1007/s12263-012-0297-3; Liu G, 2013, PLOS ONE, V8; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Meale SJ, 2014, J ANIM SCI, V92, P3328, DOI 10.2527/jas.2014-7710; Miao XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18470; Miao XY, 2015, GENE, V562, P188, DOI 10.1016/j.gene.2015.02.070; Miao XY, 2015, MOL CELL ENDOCRINOL, V402, P32, DOI 10.1016/j.mce.2014.12.023; Morozzi G, 2017, CELL DEATH DIFFERENT; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Qin YT, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007027; Runtsch MC, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00347; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharbati J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12681; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Sun HY, 2017, CELL BIOL INT, V41, P739, DOI 10.1002/cbin.10768; Sun ZW, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0178-y; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tang XiaoHui, 2012, Journal of Agricultural Biotechnology, V20, P1178; Tao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079343; Tsukerman P, 2012, CANCER RES, V72, P5463, DOI 10.1158/0008-5472.CAN-11-2671; Vienberg S., 2016, ACTA PHYSL; Wang CN, 2017, BIOL PHARM BULL, V40, P465, DOI 10.1248/bpb.b16-00898; Wang J., 2017, SCI REP, V7; Wang J, 2017, ASIAN AUSTRAL J ANIM, V30, P100, DOI 10.5713/ajas.16.0166; Wang L, 2014, N-S ARCH PHARMACOL, V387, P197, DOI 10.1007/s00210-013-0929-1; Wong LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08574-x; Yang H, 2016, ANIM REPROD SCI, V175, P18, DOI 10.1016/j.anireprosci.2016.10.004; Ye DM, 2011, GASTROENTEROLOGY, V141, P1323, DOI 10.1053/j.gastro.2011.07.005; Yu J, 2011, FUNCT INTEGR GENOMIC, V11, P203, DOI 10.1007/s10142-010-0198-8; Yuan TZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19413; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089817; Zhang S, 2013, J NANOMATER, V8, P2013, DOI DOI 10.1371/J0URNAL.P0NE.0071913; Zhou G, 2017, BIOMED RES INT, V2017	58	13	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193371	10.1371/journal.pone.0193371	http://dx.doi.org/10.1371/journal.pone.0193371			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489866	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000068
J	Khan, A; Mar, KF; Schilling, J; Brown, WA				Khan, Arif; Mar, Kaysee Fahl; Schilling, Joshua; Brown, Walter A.			Does the rising placebo response impact antihypertensive clinical trial outcomes? An analysis of data from the Food and Drug Administration 1990-2016	PLOS ONE			English	Article							BLOOD-PRESSURE; ANTIDEPRESSANT TRIALS; DOUBLE-BLIND; HYPERTENSION	Background Recent studies show that placebo response has grown significantly over time in clinical trials for antidepressants, ADHD medications, antiepileptics, and antidiabetics. Contrary to expectations, trial outcome measures and success rates have not been impacted. This study aimed to see if this trend of increasing placebo response and stable efficacy outcome measures is unique to the conditions previously studied or if it occurs in trials for conditions with physiologically-measured symptoms, such as hypertension. Method For this reason, we evaluated the efficacy data reported in the US Food and Drug Administration Medical and Statistical reviews for 23 antihypertensive programs (32,022 patients, 63 trials, 142 treatment arms). Placebo and medication response, effect sizes, and drug-placebo differences were calculated for each treatment arm and examined over time using meta-regression. We also explored the relationship of sample size, trial duration, baseline blood pressure, and number of treatment arms to placebo/drug response and efficacy outcome measures. Results Like trials of other conditions, placebo response has risen significantly over time (R-2 = 0.093, p = 0.018) and effect size (R-2 = 0.013, p = 0.187) drug-placebo difference (R-2 = 0.013, p = 0.182) and success rate (134/142, 94.4%) have remained unaffected, likely due to a significant compensatory increase in antihypertensive response (R-2 = 0.086, p< 0.001). Treatment arms are likely overpowered with sample sizes increasing over time (R-2 = 0.387, p< 0.0001) and stable, large effect sizes (0.78 +/- 0.37). The exploratory analysis of sample size, trial duration, baseline blood pressure, and number of treatment arms yielded mixed results unlikely to explain the pattern of placebo response and efficacy outcomes over time. The magnitude of placebo response had no relationship to effect size (p = 0.877), antihypertensive-placebo differences (p = 0.752), or p-values (p = 0.963) but was correlated with antihypertensive response (R-2 = 0.347, p< 0.0001). Conclusions As hypothesized, this study shows that placebo response is increasing in clinical trials for hypertension without any evidence of this increase impacting trial outcomes. Attempting to control placebo response in clinical trials for hypertension may not be necessary for successful efficacy outcomes. In exploratory analysis, we noted that despite finding significant relationships, none of the trial or patient characteristics we examined offered a clear explanation of the rise in placebo and stability in outcome measures over time. Collectively, these data suggest that the phenomenon of increasing placebo response and stable efficacy outcomes may be a general trend, occurring across trials for various psychiatric and medical conditions with physiological and non-physiological endpoints.	[Khan, Arif; Mar, Kaysee Fahl] Northwest Clin Res Ctr, Bellevue, WA USA; [Khan, Arif] Duke Univ, Dept Psychiat, Sch Med, Durham, NC 27706 USA; [Schilling, Joshua] Univ Massachusetts, Baystate Med Ctr, Dept Cardiol, Springfield, MA USA; [Brown, Walter A.] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA	Duke University; Baystate Medical Center; University of Massachusetts System; Brown University	Khan, A (corresponding author), Northwest Clin Res Ctr, Bellevue, WA USA.; Khan, A (corresponding author), Duke Univ, Dept Psychiat, Sch Med, Durham, NC 27706 USA.	akhan@nwcrc.net						Andrews G, 2001, BRIT J PSYCHIAT, V178, P192, DOI 10.1192/bjp.178.3.192; [Anonymous], 2016, FDA ACC DAT; ANTIVALLE M, 1990, J HUM HYPERTENS, V4, P633; Asmar R, 2001, AM J HYPERTENS, V14, P546, DOI 10.1016/S0895-7061(00)01286-3; Felmeden DC, 2000, BLOOD PRESSURE, V9, P335; Furukawa TA, 2016, LANCET PSYCHIAT, V3, P1059, DOI 10.1016/S2215-0366(16)30307-8; GOULD BA, 1981, LANCET, V2, P1377; Khan A, 2004, AM J PSYCHIAT, V161, P2045, DOI 10.1176/appi.ajp.161.11.2045; Khan A, 2003, J NERV MENT DIS, V191, P211, DOI 10.1097/00005053-200304000-00001; Khan A, 2018, CONT CLIN TRIALS; Khan A, 2018, DIABETES CARE, V41, P994, DOI 10.2337/dc17-1316; Khan A, 2017, J PSYCHIATR RES, V94, P202, DOI 10.1016/j.jpsychires.2017.07.018; Khan A, 2017, WORLD PSYCHIATRY, V16, P181, DOI 10.1002/wps.20421; Ntineri A, 2016, BLOOD PRESS MONIT, P353; Papakostas GI, 2009, EUR NEUROPSYCHOPHARM, V19, P34, DOI 10.1016/j.euroneuro.2008.08.009; PARAN E, 1993, J HUM HYPERTENS, V7, P567; Patel HC, 2015, HYPERTENSION, V65, P401, DOI 10.1161/HYPERTENSIONAHA.114.04640; Preston RA, 2000, ARCH INTERN MED, V160, P1449, DOI 10.1001/archinte.160.10.1449; Rutherford BR, 2013, AM J PSYCHIAT, V170, P723, DOI 10.1176/appi.ajp.2012.12040474; STAESSEN JA, 1994, J HYPERTENS, V12, P1035; Stergiou GS, 2002, AM J HYPERTENS, V15, P101, DOI 10.1016/S0895-7061(01)02324-X; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Walsh BT, 2001, JAMA-J AM MED ASSOC, V287, P1840; Wilhelm M, 2016, J AM SOC HYPERTENS, V10, P917, DOI 10.1016/j.jash.2016.10.009	24	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193043	10.1371/journal.pone.0193043	http://dx.doi.org/10.1371/journal.pone.0193043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489874	Green Submitted, Green Published, gold			2022-12-26	WOS:000426276000053
J	Misiuk, B; Lecours, V; Bell, T				Misiuk, Benjamin; Lecours, Vincent; Bell, Trevor			A multiscale approach to mapping seabed sediments	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; WATER GORGONIAN CORALS; HABITAT SUITABILITY; TEXTURE CLASSES; GRAIN-SIZE; SCALE; RESOLUTION; PREDICTION; ABUNDANCE; BACKSCATTER	Benthic habitat maps, including maps of seabed sediments, have become critical spatial-decision support tools for marine ecological management and conservation. Despite the increasing recognition that environmental variables should be considered at multiple spatial scales, variables used in habitat mapping are often implemented at a single scale. The objective of this study was to evaluate the potential for using environmental variables at multiple scales for modelling and mapping seabed sediments. Sixteen environmental variables were derived from multibeam echosounder data collected near Qikiqtarjuaq, Nunavut, Canada at eight spatial scales ranging from 5 to 275 m, and were tested as predictor variables for modelling seabed sediment distributions. Using grain size data obtained from grab samples, we tested which scales of each predictor variable contributed most to sediment models. Results showed that the default scale was often not the best. Out of 129 potential scale-dependent variables, 11 were selected to model the additive log-ratio of mud and sand at five different scales, and 15 were selected to model the additive log-ratio of gravel and sand, also at five different scales. Boosted Regression Tree models that explained between 46.4 and 56.3% of statistical deviance produced multiscale predictions of mud, sand, and gravel that were correlated with cross-validated test data ( Spearman's rho(mud) = 0.77, rho(sand) = 0.71, rho(gravel) = 0.58). Predictions of individual size fractions were classified to produce a map of seabed sediments that is useful for marine spatial planning. Based on the scale-dependence of variables in this study, we concluded that spatial scale consideration is at least as important as variable selection in seabed mapping.	[Misiuk, Benjamin; Bell, Trevor] Mem Univ Newfoundland, Dept Geog, St John, NF, Canada; [Lecours, Vincent] Univ Florida, Sch Forest Resources & Conservat, Dept Fisheries & Aquat Sci, Gainesville, FL USA	Memorial University Newfoundland; State University System of Florida; University of Florida	Misiuk, B (corresponding author), Mem Univ Newfoundland, Dept Geog, St John, NF, Canada.	bmisiuk@mun.ca	Lecours, Vincent/J-5514-2019	Lecours, Vincent/0000-0002-4777-3348; Misiuk, Benjamin/0000-0001-5822-4574	Government of Nunavut Department of Environment, Fisheries and Sealing Division; ArcticNet [268150-2011]	Government of Nunavut Department of Environment, Fisheries and Sealing Division; ArcticNet	TB received support for this work by way of funding from the Government of Nunavut Department of Environment, Fisheries and Sealing Division (http://www.gov.nu.ca/environment/information/fisheries-and-sealing), in addition to funding and ship time from ArcticNet (http://www.arcticnet.ulaval.ca/; grant no. 268150-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Albani M, 2004, INT J GEOGR INF SCI, V18, P577, DOI 10.1080/13658810410001701987; [Anonymous], 2009, BIOL LETT; Bradter U, 2013, METHODS ECOL EVOL, V4, P167, DOI 10.1111/j.2041-210x.2012.00253.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Brown CJ, 2012, J SEA RES, V72, P1, DOI 10.1016/j.seares.2012.04.009; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Bucas M, 2013, ICES J MAR SCI, V70, P1233, DOI 10.1093/icesjms/fst036; Calvert J, 2015, ICES J MAR SCI, V72, P1498, DOI 10.1093/icesjms/fsu223; Chow TE, 2009, INT J GEOGR INF SCI, V23, P1277, DOI 10.1080/13658810802344127; Coggan R, 2012, ESTUAR COAST SHELF S, V111, P118, DOI 10.1016/j.ecss.2012.06.017; Copeland A, 2013, J COAST CONSERV, V17, P225, DOI 10.1007/s11852-011-0172-1; Cowan B., 2015, THESIS; Diesing M, 2015, 569 JOINT NAT CONS C; Diesing M., 2015, C5818 CTR ENV FISH A; Diesing M, 2015, J SEA RES, V100, P62, DOI 10.1016/j.seares.2014.10.013; Diesing M, 2014, CONT SHELF RES, V84, P107, DOI 10.1016/j.csr.2014.05.004; Dixon B, 2009, HYDROL PROCESS, V23, P1714, DOI 10.1002/hyp.7306; Dolan MFJ, 2014, MAR GEOD, V37, P187, DOI 10.1080/01490419.2014.902888; Dolan MFJ., 2012, 2012041 GEOL SURV NO; Downie A.L., 2016, SEMIAUTOMATED MAPPIN; Dunn DC, 2009, MAR ECOL PROG SER, V377, P1, DOI 10.3354/meps07839; Eidens C, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00002; Eigenbrod F, 2008, BIOL CONSERV, V141, P35, DOI 10.1016/j.biocon.2007.08.025; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Evans JS, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P139, DOI 10.1007/978-1-4419-7390-0_8; FOLK RL, 1954, J GEOL, V62, P344, DOI 10.1086/626171; Franklin J, 2009, MAPPING SPECIES DIST; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Fulton R.J., 1995, GEOLOGICAL SURVEY CA; Galparsoro I, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00023; Gambi C, 2006, DEEP-SEA RES PT I, V53, P1117, DOI 10.1016/j.dsr.2006.05.003; Gilbert R, 1980, ENV STUDIES MAKTAK C; Giusti M, 2014, CONT SHELF RES, V81, P19, DOI 10.1016/j.csr.2014.03.011; Goff JA, 2000, GEO-MAR LETT, V20, P43, DOI 10.1007/s003670000032; Gottschalk TK, 2011, ECOL MODEL, V222, P3403, DOI 10.1016/j.ecolmodel.2011.07.008; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamil KAD, 2016, LANDSCAPE ECOL, V31, P7, DOI 10.1007/s10980-015-0288-z; Harris PT, 2012, ELSEV INSIGHT, P871, DOI 10.1016/B978-0-12-385140-6.00064-5; Harris PT, 2012, ELSEV INSIGHT, P3, DOI 10.1016/B978-0-12-385140-6.00001-3; Hopkins RL, 2009, LANDSCAPE ECOL, V24, P943, DOI 10.1007/s10980-009-9373-5; Lark RM, 2015, SEDIMENT GEOL, V328, P17, DOI 10.1016/j.sedgeo.2015.07.012; Lark RM, 2012, SEDIMENT GEOL, V281, P35, DOI 10.1016/j.sedgeo.2012.07.009; Lechner AM, 2012, ECOL COMPLEX, V11, P91, DOI 10.1016/j.ecocom.2012.04.002; Lecours V, 2017, REMOTE SENS ECO 0718; Lecours V., 2015, TERRAIN ATTRIBUTE SE, DOI [10.13140/RG.2.2.15014.52800, DOI 10.13140/RG.2.2.15014.52800]; Lecours V, 2017, IEEE T GEOSCI REMOTE, V55, P5391, DOI 10.1109/TGRS.2017.2707303; Lecours V, 2017, ENVIRON MODELL SOFTW, V89, P19, DOI 10.1016/j.envsoft.2016.11.027; Lecours V, 2016, HYDROL EARTH SYST SC, V20, P3207, DOI 10.5194/hess-20-3207-2016; Lecours V, 2015, MAR ECOL PROG SER, V535, P259, DOI 10.3354/meps11378; Long D, 2006, BGS DETAILED EXPLANA; Lundblad E., 2006, GEOD, V29, P89, DOI [10.1080/01490410600738021, DOI 10.1080/01490410600738021]; Margreth A, 2017, QUATERNARY SCI REV, V168, P79, DOI 10.1016/j.quascirev.2017.04.033; Martin-Fernandez JA, 2006, GEOL SOC SPEC PUBL, V264, P191, DOI 10.1144/GSL.SP.2006.264.01.14; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; Miyamoto M, 2017, MAR GEOD, V40, P205, DOI 10.1080/01490419.2017.1315543; Muggah J, 2015, 2014 MULTIBEAM SONAR; Muggah J., 2011, OMG ARCTIC METADATA; Muggah J, 2014, 2013 MULTIBEAM SONAR; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nielsen SE, 2005, ECOGRAPHY, V28, P197, DOI 10.1111/j.0906-7590.2005.04002.x; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Reiss H, 2015, ICES J MAR SCI, V72, P297, DOI 10.1093/icesjms/fsu107; Rengstorf AM, 2013, J BIOGEOGR, V40, P1702, DOI 10.1111/jbi.12123; Rengstorf AM, 2012, MAR GEOD, V35, P343, DOI 10.1080/01490419.2012.699020; Ridgeway G., 2015, GBM GEN BOOSTED REGR; Ross LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140061; Stephens D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142502; Stephens D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093950; Thurber AR, 2014, BIOGEOSCIENCES, V11, P3941, DOI 10.5194/bg-11-3941-2014; Tong RJ, 2016, CONT SHELF RES, V116, P13, DOI 10.1016/j.csr.2016.01.012; Tong RJ, 2013, ECOL INFORM, V13, P123, DOI 10.1016/j.ecoinf.2012.07.002; Tong RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043534; Wheeler J.O., 1996, 14 34 SVITAVY GEOLOG; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962; Wolff C, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00041; Wright D.J., 2012, ARCGIS BENTHIC TERRA; Ysebaert T, 2002, MAR ECOL PROG SER, V225, P79, DOI 10.3354/meps225079	84	34	35	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193647	10.1371/journal.pone.0193647	http://dx.doi.org/10.1371/journal.pone.0193647			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489899	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000426276000098
J	Paul, B; Annagiri, S				Paul, Bishwarup; Annagiri, Sumana			Tricks of the trade: Mechanism of brood theft in an ant	PLOS ONE			English	Article							SLAVE-MAKING ANTS; COLONY RELOCATION; GUARDING BEHAVIOR; NEST USURPATION; APIS-MELLIFERA; STINGLESS BEE; FIRE ANT; HYMENOPTERA; RECOGNITION; COEVOLUTION	Thievery is ubiquitous in the animal kingdom, social insects not being an exception. Brood is invaluable for the survival of social insect colonies and brood theft is well documented in ants. In many species the stolen brood act as slaves in the thief colony as they take up tasks related to foraging, defence and colony maintenance. Slave-making (dulotic) ants are at an advantage as they gain workforce without investing in rearing immature young, and several slave-making species have been recorded in temperate regions. In the current study we investigate brood theft in a primitively eusocial ponerine ant Diacamma indicum that inhabits the tropics. In the context of colony relocation we asked how thieves steal brood and what victim colonies do to prevent theft. While exposed nests increased colonies' vulnerability, the relocation process itself did not enhance the chances of theft. Various aggressive interactions, in particular immobilization of intruders helped in preventing theft. Thieves that acted quickly, stayed furtive and stole unguarded brood were found to be successful. This comprehensive study of behavioural mechanism of theft reveals that these are the 'tricks' adopted by thieves.	[Paul, Bishwarup; Annagiri, Sumana] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Behav & Ecol Lab, Mohanpur, W Bengal, India	Indian Institute of Science Education & Research (IISER) - Kolkata	Annagiri, S (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Behav & Ecol Lab, Mohanpur, W Bengal, India.	sumana@iiserkol.ac.in	Paul, Bishwarup/AAH-6897-2020	Paul, Bishwarup/0000-0003-3061-7418				[Anonymous], 1971, INSECT SOC; Baratte S, 2006, ANIM BEHAV, V72, P305, DOI 10.1016/j.anbehav.2005.10.025; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Blatrix R, 2003, MOL ECOL, V12, P2809, DOI 10.1046/j.1365-294X.2003.01947.x; BREED MD, 1990, OECOLOGIA, V84, P117, DOI 10.1007/BF00665604; BREED MD, 1990, BEHAV ECOL SOCIOBIOL, V27, P395, DOI 10.1007/BF00164065; Breed Michael D., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/484765; Buschinger A, 2009, MYRMECOL NEWS, V12, P219; BUTLER CG, 1952, BEHAVIOUR, V4, P262; Couvillon MJ, 2008, ANIM BEHAV, V76, P1653, DOI 10.1016/j.anbehav.2008.08.002; Cunningham JP, 2014, AM NAT, V184, P777, DOI 10.1086/678399; D'Ettorre Patrizia, 2001, Acta Ethologica, V3, P67, DOI 10.1007/s102110100038; De Carli P, 1998, ACT COLLOQ INSECT S, V11, P29; Downs SG, 2000, BEHAV ECOL, V11, P326, DOI 10.1093/beheco/11.3.326; Foitzik S, 2001, P ROY SOC B-BIOL SCI, V268, P1139, DOI 10.1098/rspb.2001.1627; Fuchikawa T, 2014, BEHAV ECOL SOCIOBIOL, V68, P1843, DOI 10.1007/s00265-014-1793-9; FUKUMOTO Y, 1989, Physiology and Ecology Japan, V26, P55; Gamboa GJ, 1996, ANIM BEHAV, V51, P625, DOI 10.1006/anbe.1996.0067; Gotwald WH, 1995, ARMY ANTS BIOL SOCIA; Holldobler B., 1990, pi; Iyengar EV, 2008, BIOL J LINN SOC, V93, P745, DOI 10.1111/j.1095-8312.2008.00954.x; Jeral JM, 1997, PHYSIOL ENTOMOL, V22, P207, DOI 10.1111/j.1365-3032.1997.tb01160.x; Kaspari M, 2003, EVOL ECOL RES, V5, P933; Kaur R., 2014, THESIS; Kaur R, 2012, ANIM BEHAV, V83, P1345, DOI 10.1016/j.anbehav.2012.02.022; Kolay S, 2015, SCI REP, P5; Kronauer DJC, 2003, P ROY SOC B-BIOL SCI, V270, P805, DOI 10.1098/rspb.2002.2288; LaPolla JS, 2002, INSECT SOC, V49, P251, DOI 10.1007/s00040-002-8310-2; LEFFELAAR D, 1985, WILSON BULL, V97, P221; LEMOLI F, 1993, INSECT SOC, V40, P433, DOI 10.1007/BF01253905; MAKINO S, 1989, INSECT SOC, V36, P116, DOI 10.1007/BF02225907; Paul B, 2016, SCI REP-UK, V6, DOI 10.1038/srep36166; PEETERS C, 1989, NATURWISSENSCHAFTEN, V76, P177, DOI 10.1007/BF00366404; Pohl S, 2011, ANIM BEHAV, V81, P61, DOI 10.1016/j.anbehav.2010.09.006; POLLOCK GB, 1989, AM NAT, V133, P61, DOI 10.1086/284901; R Core Team, 2021, R LANGUAGE ENV STAT; SAKAGAMI SF, 1993, SOCIOBIOLOGY, V21, P237; Slager DL, 2012, WILSON J ORNITHOL, V124, P812, DOI 10.1676/1559-4491-124.4.812; Sumana A, 2012, CURR SCI INDIA, V102, P1373; Tschinkel WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112981; TSCHINKEL WR, 1992, ECOL ENTOMOL, V17, P179, DOI 10.1111/j.1365-2311.1992.tb01176.x; TSCHINKEL WR, 1992, ANN ENTOMOL SOC AM, V85, P638, DOI 10.1093/aesa/85.5.638; van Zweden JS, 2011, BEHAV ECOL SOCIOBIOL, V65, P1277, DOI 10.1007/s00265-011-1141-2; Viginier B, 2004, MOL ECOL, V13, P2095, DOI 10.1111/j.1365-294X.2004.02201.x; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025	46	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192144	10.1371/journal.pone.0192144	http://dx.doi.org/10.1371/journal.pone.0192144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489858	gold, Green Published, Green Submitted			2022-12-26	WOS:000426276000019
J	Saarnio, E; Pekkinen, M; Itkonen, ST; Kemi, V; Karp, H; Ivaska, KK; Risteli, J; Koivula, MK; Karkkainen, M; Makitie, O; Sievanen, H; Lamberg-Allardt, C				Saarnio, Elisa; Pekkinen, Minna; Itkonen, Suvi T.; Kemi, Virpi; Karp, Heini; Ivaska, Kaisa K.; Risteli, Juha; Koivula, Marja-Kaisa; Karkkainen, Merja; Makitie, Outi; Sievanen, Harri; Lamberg-Allardt, Christel			Low free 25-hydroxyvitamin D and high vitamin D binding protein and parathyroid hormone in obese Caucasians. A complex association with bone?	PLOS ONE			English	Article							D DEFICIENCY; SERUM; MASS; WOMEN; SUPPLEMENTATION; 25(OH)D; ASSAYS; GC	Background Studies have shown altered vitamin D metabolism in obesity. We assessed differences between obese and normal-weight subjects in total, free, and bioavailable 25-hydroxyvitamin D (25(OH) D, 25(OH) D-Free, and 25(OH) D-Bio, respectively), vitamin D binding protein (DBP), parathyroid hormone (PTH) and bone traits. Methods 595 37-47-year-old healthy Finnish men and women stratified by BMI were examined in this cross-sectional study. Background characteristic and intakes of vitamin D and calcium were collected. The concentrations of 25(OH) D, PTH, DBP, albumin and bone turnover markers were determined from blood. 25(OH) D-Free and 25(OH) D-Bio were calculated. pQCT was performed at radius and tibia. Results Mean +/- SE (ANCOVA) 25(OH) D-Free (10.8 +/- 0.6 vs 12.9 +/- 0.4 nmol/L; P = 0.008) and 25(OH) DBio (4.1 +/- 0.3 vs 5.1 +/- 0.1 nmol/L; P = 0.003) were lower in obese than in normal-weight women. In men, 25(OH) D (48.0 +/- 2.4 vs 56.4 +/- 2.0 nmol/L, P = 0.003), 25(OH) D-Free (10.3 +/- 0.7 vs 12.5 +/- 0.6 pmol/L; P = 0.044) and 25(OH) D-Bio (4.2 +/- 0.3 vs 5.1 +/- 0.2 nmol/L; P = 0.032) were lower in obese. Similarly in all subjects, 25(OH) D, 25(OH) D-Free and 25(OH) D-Bio were lower in obese (P<0.001). DBP (399 +/- 12 vs 356 +/- 7mg/L, P = 0.008) and PTH (62.2 +/- 3.0 vs 53.3 +/- 1.9 ng/L; P = 0.045) were higher in obese than in normal-weight women. In all subjects, PTH and DBP were higher in obese (P = 0.047 and P = 0.004, respectively). In obese women, 25(OH) D was negatively associated with distal radius trabecular density (R-2 = 0.089, P = 0.009) and tibial shaft cortical strength index (CSI) (R-2 = 0.146, P = 0.004). 25(OH) D-Free was negatively associated with distal radius CSI (R-2 = 0.070, P = 0.049), radial shaft cortical density (CorD) (R-2 = 0.050, P = 0.045), and tibial shaft CSI (R-2 = 0.113, P = 0.012). 25(OH) D-Bio was negatively associated with distal radius CSI (R-2 = 0.072, P = 0.045), radial shaft CorD (R-2 = 0.059, P = 0.032), and tibial shaft CSI (R-2 = 0.093, P = 0.024). Conclusions The associations between BMI and 25(OH) D, 25(OH) D-Free, and 25(OH) D-Bio, DBP, and PTH suggest that obese subjects may differ from normal-weight subjects in vitamin D metabolism. BMI associated positively with trabecular bone traits and CSI in our study, and slightly negatively with cortical bone traits. Surprisingly, there was a negative association of free and bioavailable 25(OH) D and some of the bone traits in obese women.	[Saarnio, Elisa; Itkonen, Suvi T.; Kemi, Virpi; Karp, Heini; Karkkainen, Merja; Lamberg-Allardt, Christel] Univ Helsinki, Dept Food & Nutr, Calcium Res Unit, Helsinki, Finland; [Pekkinen, Minna; Makitie, Outi] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland; [Pekkinen, Minna; Makitie, Outi] Helsinki Univ Cent Hosp, Childrens Hosp, Helsinki, Finland; [Pekkinen, Minna; Makitie, Outi] Univ Helsinki, Helsinki, Finland; [Ivaska, Kaisa K.] Univ Turku, Inst Biomed, Dept Cell Biol & Anat, Turku, Finland; [Risteli, Juha; Koivula, Marja-Kaisa] Univ Oulu, Dept Clin Chem, Oulu, Finland; [Risteli, Juha; Koivula, Marja-Kaisa] Northern Finland Lab Ctr Nordlab, Oulu, Finland; [Risteli, Juha; Koivula, Marja-Kaisa] Med Res Ctr, Oulu, Finland; [Koivula, Marja-Kaisa] Hosp Dist Southwest Finland, Tykslab, Turku, Finland; [Koivula, Marja-Kaisa] Univ Hosp Turku, Dept Clin Chem, Turku, Finland; [Sievanen, Harri] UKK Inst Hlth Promot Res, Tampere, Finland	University of Helsinki; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Turku; University of Oulu; University of Turku; University of Turku; UKK Institute	Saarnio, E (corresponding author), Univ Helsinki, Dept Food & Nutr, Calcium Res Unit, Helsinki, Finland.		Saarnio, Elisa/L-2611-2019; Ivaska, Kaisa/G-1406-2012	Saarnio, Elisa/0000-0003-1227-567X; Ivaska, Kaisa/0000-0001-7482-7623; Lamberg-Allardt, Christel/0000-0001-7326-1904; Itkonen, Suvi/0000-0003-1635-8229	Academy of Finland [127536]; Doctoral school for Applied Biosciences, University of Helsinki Future Fund; Finnish Cultural Foundation; Medicinska Understodsforening Liv och Halsa; Alfred Kordelin Foundation	Academy of Finland(Academy of Finland); Doctoral school for Applied Biosciences, University of Helsinki Future Fund; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Medicinska Understodsforening Liv och Halsa; Alfred Kordelin Foundation	This work was supported by the Academy of Finland (127536), http://www.aka.fi/; Doctoral school for Applied Biosciences, University of Helsinki Future Fund, https://www.helsinki.fi/; Finnish Cultural Foundation, https://skr.fi/; Medicinska Understodsforening Liv och Halsa, http://www.livochhalsa.fi/ and Alfred Kordelin Foundation, https://kordelin.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almesri N, 2016, APPL PHYSIOL NUTR ME, V41, P345, DOI 10.1139/apnm-2015-0284; Arunabh S, 2003, J CLIN ENDOCR METAB, V88, P157, DOI 10.1210/jc.2002-020978; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; BELL NH, 1985, J CLIN INVEST, V76, P370, DOI 10.1172/JCI111971; Bikle D, 2017, J STEROID BIOCHEM, V173, P105, DOI 10.1016/j.jsbmb.2017.01.007; Bikle DD, 2017, ENDOCRIN METAB CLIN, V46, P901, DOI 10.1016/j.ecl.2017.07.013; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Bolland MJ, 2007, AM J CLIN NUTR, V86, P959, DOI 10.1093/ajcn/86.4.959; Botella-Carretero JI, 2007, CLIN NUTR, V26, P573, DOI 10.1016/j.clnu.2007.05.009; Bouillon R, 2014, NEW ENGL J MED, V370, P879, DOI 10.1056/NEJMc1315850; Bouillon R, 2013, J CLIN ENDOCR METAB, V98, pE1283, DOI 10.1210/jc.2013-1195; Denburg MR, 2016, J BONE MINER RES, V31, P1128, DOI 10.1002/jbmr.2829; Drincic A, 2013, J CLIN ENDOCR METAB, V98, P4845, DOI 10.1210/jc.2012-4103; Drincic AT, 2012, OBESITY, V20, P1444, DOI 10.1038/oby.2011.404; Gallagher JC, 2013, J STEROID BIOCHEM, V136, P195, DOI 10.1016/j.jsbmb.2012.12.003; GUHA C, 1995, HEPATOLOGY, V21, P1675; Holmlund-Suila E, 2016, CLIN ENDOCRINOL, V85, P378, DOI 10.1111/cen.13093; Itkonen ST, 2016, BRIT J NUTR, V115, P1100, DOI 10.1017/S0007114515005474; Itkonen ST, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-94; Jarvinen TL, 2003, J BONE MINER RES, V18, P1921, DOI 10.1359/jbmr.2003.18.11.1921; Johansson H, 2014, J BONE MINER RES, V29, P223, DOI 10.1002/jbmr.2017; Johnsen MS, 2014, SCAND J CLIN LAB INV, V74, P177, DOI 10.3109/00365513.2013.869701; Kakonen SM, 2000, CLIN CHEM, V46, P332; Karlsson T, 2014, EUR J NUTR, V53, P259, DOI 10.1007/s00394-013-0524-8; Konradsen S, 2008, EUR J NUTR, V47, P87, DOI 10.1007/s00394-008-0700-4; Laaksonen M.M.L., 2010, ARCH OSTEOPOROS, V5, P119, DOI [10.1007/s11657-010-0043-7, DOI 10.1007/S11657-010-0043-7]; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Macdonald HM, 2011, J CLIN ENDOCR METAB, V96, P1677, DOI 10.1210/jc.2010-2032; Malmstroem S, 2017, J AOAC INT, V100, P1323, DOI 10.5740/jaoacint.17-0085; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; Nordic Council of Ministers, 2013, NORD NUTR REC 2012 1; Paldanius PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063036; Popkin BM, 2010, AM J CLIN NUTR, V91, p284S, DOI 10.3945/ajcn.2009.28473C; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Saarnio E., 2016, BMC NUTR, V2, P46, DOI DOI 10.1186/S40795-016-0085-3; Sai AJ, 2011, J CLIN ENDOCR METAB, V96, pE436, DOI 10.1210/jc.2010-1886; Sievanen H, 2000, INVEST RADIOL, V35, P325, DOI 10.1097/00004424-200005000-00007; Sievanen H, 1998, J BONE MINER RES, V13, P871, DOI 10.1359/jbmr.1998.13.5.871; Taes YEC, 2006, BONE, V38, P701, DOI 10.1016/j.bone.2005.10.006; Uusi-Rasi K, 2012, OSTEOPOROSIS INT, V23, P1453, DOI 10.1007/s00198-011-1737-4; Uusi-Rasi K, 2010, J OSTEOPOROS, V2010, DOI 10.4061/2010/904806; Vanlint S, 2013, NUTRIENTS, V5, P949, DOI 10.3390/nu5030949; Walsh JS, 2016, AM J CLIN NUTR, V103, P1465, DOI 10.3945/ajcn.115.120139; Weeks BK, 2008, OSTEOPOROSIS INT, V19, P1567, DOI 10.1007/s00198-008-0606-2; Winters SJ, 2009, METABOLISM, V58, P438, DOI 10.1016/j.metabol.2008.10.017; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; YAMAMOTO N, 1993, J IMMUNOL, V151, P2794	49	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192596	10.1371/journal.pone.0192596	http://dx.doi.org/10.1371/journal.pone.0192596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489840	Green Submitted, Green Published, gold			2022-12-26	WOS:000426276000034
J	Li, YC; Qiu, RX; Jing, ST				Li, Yuancheng; Qiu, Rixuan; Jing, Sitong			Intrusion detection system using Online Sequence Extreme Learning Machine (OS-ELM) in advanced metering infrastructure of smart grid	PLOS ONE			English	Article							KEY MANAGEMENT SCHEME; SECURE COMMUNICATIONS; THEFT DETECTION; NETWORKS; ALGORITHM; ATTACK	Advanced Metering Infrastructure (AMI) realizes a two-way communication of electricity data through by interconnecting with a computer network as the core component of the smart grid. Meanwhile, it brings many new security threats and the traditional intrusion detection method can't satisfy the security requirements of AMI. In this paper, an intrusion detection system based on Online Sequence Extreme Learning Machine (OS-ELM) is established, which is used to detecting the attack in AMI and carrying out the comparative analysis with other algorithms. Simulation results show that, compared with other intrusion detection methods, intrusion detection method based on OS-ELM is more superior in detection speed and accuracy.	[Li, Yuancheng; Qiu, Rixuan; Jing, Sitong] North China Elect Power Univ, Dept Control & Comp Engn, Beijing, Peoples R China	North China Electric Power University	Qiu, RX (corresponding author), North China Elect Power Univ, Dept Control & Comp Engn, Beijing, Peoples R China.	rxqiu@ncepu.edu.cn						Akkaya K, 2015, IEEE T SMART GRID, V6, P2366, DOI 10.1109/TSG.2015.2390131; Allwood G, 2016, IEEE SENS J, V16, P5497, DOI 10.1109/JSEN.2016.2535465; Ambusaidi MA, 2016, IEEE T COMPUT, V65, P2986, DOI 10.1109/TC.2016.2519914; Amin S, 2015, IEEE CONTR SYST MAG, V35, P66, DOI 10.1109/MCS.2014.2364711; Bai X.-m, 2010, 2010 INT C POWER SYS, P1; Berthier R, 2010, INT CONF SMART GRID, P350, DOI 10.1109/SMARTGRID.2010.5622068; Buczak AL, 2016, IEEE COMMUN SURV TUT, V18, P1153, DOI 10.1109/COMST.2015.2494502; David G. H., 2008, POW EN SOC GEN M CON, P1932; Faisal MA, 2015, IEEE SYST J, V9, P31, DOI 10.1109/JSYST.2013.2294120; Gungor VC, 2013, IEEE T IND INFORM, V9, P28, DOI 10.1109/TII.2012.2218253; Gungor VC, 2011, IEEE T IND INFORM, V7, P529, DOI 10.1109/TII.2011.2166794; Ha T, 2016, IEEE NETWORK, V30, P22, DOI 10.1109/MNET.2016.1600106NM; Liang NY, 2006, IEEE T NEURAL NETWOR, V17, P1411, DOI 10.1109/TNN.2006.880583; Liu NA, 2013, IEEE T IND ELECTRON, V60, P4746, DOI 10.1109/TIE.2012.2216237; Liu XX, 2015, IEEE T SMART GRID, V6, P2435, DOI 10.1109/TSG.2015.2418280; Maharjan S, 2016, IEEE T SMART GRID, V7, P189, DOI 10.1109/TSG.2015.2431324; McLaughlin S, 2013, IEEE J SEL AREA COMM, V31, P1319, DOI 10.1109/JSAC.2013.130714; Miao X., 2012, EL DISTR CICED CHIN, V5, P10; Nicanfar Hasen, 2011, SMART GRID COMM SMAR; Ntalampiras S, 2016, EXPERT SYST APPL, V58, P164, DOI 10.1016/j.eswa.2016.04.006; Ntalampiras S, 2015, IEEE T IND INFORM, V11, P104, DOI 10.1109/TII.2014.2367322; Pan SY, 2015, IEEE T SMART GRID, V6, P3104, DOI 10.1109/TSG.2015.2409775; Ponomarev S, 2016, IEEE T DEPEND SECURE, V13, P252, DOI 10.1109/TDSC.2015.2443793; Quilumba-Gudino FL, 2014, USING ADV METERING I; Rahman MA, 2012, IEEE INFOCOM SER, P2255, DOI 10.1109/INFCOM.2012.6195611; Wang K, 2017, INT CON ADV INFO NET, P1, DOI [10.1109/AINA.2017.29, 10.1109/INTMAG.2017.8007837]; Wang XJ, 2016, CHINA COMMUN, V13, P24, DOI 10.1109/CC.2016.7559072; Weller-Fahy DJ, 2015, IEEE COMMUN SURV TUT, V17, P70, DOI 10.1109/COMST.2014.2336610; Yi P, 2014, IEEE ICC, P1029, DOI 10.1109/ICC.2014.6883456; Yu KP, 2015, IEEE T INSTRUM MEAS, V64, P2072, DOI 10.1109/TIM.2015.2444238; Zhang YC, 2011, IEEE T SMART GRID, V2, P796, DOI 10.1109/TSG.2011.2159818	31	16	17	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0192216	10.1371/journal.pone.0192216	http://dx.doi.org/10.1371/journal.pone.0192216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29485990	gold, Green Published, Green Submitted			2022-12-26	WOS:000426242400006
J	Zhang, Y; Warnock, GL; Ao, ZL; Park, YJ; Safikhan, N; Ghahary, A; Marzban, L				Zhang, Yun; Warnock, Garth L.; Ao, Ziliang; Park, Yoo Jin; Safikhan, Nooshin; Ghahary, Aziz; Marzban, Lucy			Amyloid formation reduces protein kinase B phosphorylation in primary islet beta-cells which is improved by blocking IL-1 beta signaling	PLOS ONE			English	Article							TRANSGENIC MICE; DIABETES-MELLITUS; INDUCED APOPTOSIS; TYPE-2; POLYPEPTIDE; INFLAMMATION; EXPRESSION; SURVIVAL; INSULIN; DEPOSITION	Amyloid formation in the pancreatic islets due to aggregation of human islet amyloid polypeptide (hIAPP) contributes to reduced beta-cell mass and function in type 2 diabetes (T2D) and islet transplantation. Protein kinase B (PKB) signaling plays a key role in the regulation of beta-cell survival, function and proliferation. In this study, we used human and hIAPP-expressing transgenic mouse islets in culture as two ex vivo models of human islet amyloid formation to: 1. Investigate the effects of amyloid formation on PKB phosphorylation in primary islet beta-cells; 2. Test if inhibition of amyloid formation and/or interleukin-1 beta (IL-1 beta) signaling in islets can restore the changes in beta-cell phospho-PKB levels mediated by amyloid formation. Human and hIAPP-expressing mouse islets were cultured in elevated glucose with an amyloid inhibitor (Congo red) or embedded within collagen matrix to prevent amyloid formation. To block the IL-1 beta signaling, human islets were treated with an IL-1 receptor antagonist (anakinra) or a glucagon-like peptide-1 agonist (exenatide). beta-cell phospho-PKB levels, proliferation, apoptosis, islet IL-1 beta levels and amyloid formation were assessed. Amyloid formation in both cultured human and hIAPP-expressing mouse islets reduced beta-cell phospho-PKB levels and increased islet IL-1 beta levels, both of which were restored by prevention of amyloid formation either by the amyloid inhibitor or embedding islets in collagen matrix, resulting in improved beta-cell survival. Furthermore, inhibition of IL-1 beta signaling by treatment with anakinra or exenatide increased beta-cell phospho-PKB levels, enhanced proliferation and reduced apoptosis in amyloid forming human islets during 7-day culture. These data suggest that amyloid formation leads to reduced PKB phosphorylation in beta-cells which is associated with elevated islet IL-1 beta levels. Inhibitors of amyloid or amyloid-induced IL-1 beta production may provide a new approach to restore phospho-PKB levels thereby enhance beta-cell survival and proliferation in conditions associated with islet amyloid formation such as T2D and clinical islet transplantation.	[Zhang, Yun; Warnock, Garth L.; Ao, Ziliang; Park, Yoo Jin; Safikhan, Nooshin; Ghahary, Aziz; Marzban, Lucy] Univ British Columbia, Fac Med, Dept Surg, Vancouver, BC, Canada	University of British Columbia	Marzban, L (corresponding author), Univ British Columbia, Fac Med, Dept Surg, Vancouver, BC, Canada.	lucy.marzban@ubc.ca	Safikhan, Nooshin/M-4994-2019	Safikhan, Nooshin/0000-0003-3062-9873	Canadian Institutes of Health Research (CIHR) [MOP-126204]; CIHR grant; CIHR Transplant Research Training Program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR grant(Canadian Institutes of Health Research (CIHR)); CIHR Transplant Research Training Program	This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) to LM (MOP-126204) and partially by a CIHR grant to AG. Also, YZ and YJP were recipients of scholarship from the CIHR Transplant Research Training Program.	Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Costes S, 2013, DIABETES, V62, P327, DOI 10.2337/db12-1326; Costes S, 2011, DIABETES, V60, P227, DOI 10.2337/db10-0522; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Gao D, 2014, AM J PHYSIOL-ENDOC M, V307, pE289, DOI 10.1152/ajpendo.00430.2013; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Marzban L, 2003, EXP GERONTOL, V38, P347, DOI 10.1016/S0531-5565(03)00004-4; Marzban L, 2008, DIABETES, V57, P3045, DOI 10.2337/db08-0485; Marzban L, 2006, DIABETES, V55, P2192, DOI 10.2337/db05-1566; Marzban L, 2015, DIABETES, V64, P1094, DOI 10.2337/db14-1903; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Meier DT, 2014, DIABETOLOGIA, V57, P1884, DOI 10.1007/s00125-014-3304-y; Park YJ, 2012, DIABETOLOGIA, V55, P1035, DOI 10.1007/s00125-012-2451-2; Park YJ, 2017, DIABETES OBES METAB, V19, P682, DOI 10.1111/dom.12873; Park YJ, 2014, DIABETOLOGIA, V57, P765, DOI 10.1007/s00125-013-3152-1; Potter KJ, 2010, P NATL ACAD SCI USA, V107, P4305, DOI 10.1073/pnas.0909024107; Potter KJ, 2014, DIABETES, V63, P12, DOI 10.2337/db12-0364; Ritzel RA, 2003, DIABETES, V52, P1701, DOI 10.2337/diabetes.52.7.1701; Rivera JF, 2011, CELL DEATH DIFFER, V18, P415, DOI 10.1038/cdd.2010.111; Rutti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035801; Sullivan BA, 2015, DIABETES, V64, P1698, DOI 10.2337/db14-1675; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Udayasankar J, 2009, DIABETOLOGIA, V52, P145, DOI 10.1007/s00125-008-1185-7; Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492; Visa M, 2015, FASEB J, V29, P2970, DOI 10.1096/fj.15-270553; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Westwell-Roper CY, 2015, DIABETOLOGIA, V58, P575, DOI 10.1007/s00125-014-3447-x; Westwell-Roper CY, 2014, DIABETES, V63, P1698, DOI 10.2337/db13-0863; Zhang Y, 2012, AM J PATHOL, V181, P1296, DOI 10.1016/j.ajpath.2012.06.032; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x	41	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193184	10.1371/journal.pone.0193184	http://dx.doi.org/10.1371/journal.pone.0193184			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474443	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500066
J	Liu, SL; Minaguchi, T; Lachkar, B; Zhang, S; Xu, CY; Tenjimbayashi, Y; Shikama, A; Tasaka, N; Akiyama, A; Sakurai, M; Nakao, S; Ochi, H; Onuki, M; Matsumoto, K; Yoshikawa, H; Satoh, T				Liu, Shuling; Minaguchi, Takeo; Lachkar, Bouchra; Zhang, Shuang; Xu, Chenyang; Tenjimbayashi, Yuri; Shikama, Ayumi; Tasaka, Nobutaka; Akiyama, Azusa; Sakurai, Manabu; Nakao, Sari; Ochi, Hiroyuki; Onuki, Mamiko; Matsumoto, Koji; Yoshikawa, Hiroyuki; Satoh, Toyomi			Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression	PLOS ONE			English	Article							LIQUID-BASED CYTOLOGY; CANCER; RISK; TRANSCRIPTS; CARCINOGENESIS; KERATINOCYTES; LESIONS	A few studies previously suggested that human papillomavirus (HPV) E6 messenger RNA (mRNA) may exist uniformly in all grades of cervical intraepithelial neoplasia (CIN), whereas the detection rate of E7 mRNA may increase with disease progression from low-grade CIN to invasive carcinoma. The aim of this study was to clarify the different roles of E6 and E7 mRNAs in cervical carcinogenesis. The presence of each E6 and E7 mRNA was analyzed in 171 patients with pathologically-diagnosed CIN or cervical carcinoma. We utilized a RTPCR assay based on consensus primers which could detect E6 mRNA (full-length E6/E7 transcript) and E7 mRNAs (spliced E6*/E7 transcripts) separately for various HPV types. E7 mRNAs were detected in 6% of CIN1, 12% of CIN2, 24% of CIN3, and 54% of cervical carcinoma. The presence of E7 mRNAs was significantly associated with progression from low-grade CIN to invasive carcinoma in contrast with E6 mRNA or high-risk HPV (HR-HPV) DNA (p = 0.00011, 0.80 and 0.54). The presence of both E6 and E7 mRNAs was significantly associated with HPV16/18 DNA but not with HR-HPV DNA (p = 0.0079 and 0.21), while the presence of E6 mRNA was significantly associated with HR-HPV DNA but not with HPV16/18 DNA (p = 0.036 and 0.089). The presence of both E6 and E7 mRNAs showed high specificity and low sensitivity (100% and 19%) for detecting CIN2+ by contrast with the positivity for HR-HPV DNA showing low specificity and high sensitivity (19% and 89%). The positive predictive value for detecting CIN2+ was even higher by the presence of both E6 and E7 mRNAs than by the positivity for HR-HPV DNA (100% vs. 91%). In 31 patients followed up for CIN1-2, the presence of both E6 and E7 mRNAs showed significant association with the occurrence of upgraded abnormal cytology in contrast with E6 mRNA, HR-HPV DNA, or HPV16/18 DNA (p = 0.034, 0.73, 0.53, and 0.72). Our findings support previous studies according to which E7 mRNA is more closely involved in cervical carcinogenesis than E6 mRNA. Moreover, the separate analysis of E6 and E7 mRNAs may be more useful than HR-HPV DNA test for detecting CIN2+ precisely and predicting disease progression. Further accumulation of evidence is warranted to validate our findings.	[Liu, Shuling; Lachkar, Bouchra; Zhang, Shuang; Xu, Chenyang] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Obstet & Gynecol, Tsukuba, Ibaraki, Japan; [Minaguchi, Takeo; Shikama, Ayumi; Tasaka, Nobutaka; Akiyama, Azusa; Sakurai, Manabu; Nakao, Sari; Ochi, Hiroyuki; Yoshikawa, Hiroyuki; Satoh, Toyomi] Univ Tsukuba, Dept Obstet & Gynecol, Fac Med, Tsukuba, Ibaraki, Japan; [Tenjimbayashi, Yuri; Onuki, Mamiko; Matsumoto, Koji] Showa Univ, Dept Obstet & Gynecol, Sch Med, Tokyo, Japan; [Yoshikawa, Hiroyuki] Ibaraki Cent Hosp, Kasama, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; Showa University	Minaguchi, T (corresponding author), Univ Tsukuba, Dept Obstet & Gynecol, Fac Med, Tsukuba, Ibaraki, Japan.	minaguchit@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan [25462585]	Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The Grant-in-Aid for Scientific Research (No. 25462585) from the Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan (KM). https://kaken.nii.ac.jp/grant/KAKENHI -PROJECT-25462585/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially supported by the Grant-in-Aid for Scientific Research (No. 25462585) from the Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan.	Broccolo F, 2013, J MED VIROL, V85, P1925, DOI 10.1002/jmv.23670; Coquillard G, 2011, GYNECOL ONCOL, V120, P89, DOI 10.1016/j.ygyno.2010.09.013; Cubie HA, 2014, J CLIN PATHOL, V67, P458, DOI 10.1136/jclinpath-2013-202014; DeFilippis RA, 2003, J VIROL, V77, P1551, DOI 10.1128/JVI.77.2.1551-1563.2003; Ferlay, 2016, CANC TODAY; Giorgi Rossi P., 2013, PLOS ONE, V8; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; Johansson H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124460; Kruse AJ, 2004, INT J GYNECOL PATHOL, V23, P100, DOI 10.1097/00004347-200404000-00003; MUNGER K, 1989, J VIROL, V63, P4417; Nakagawa S, 2000, J MED VIROL, V62, P251, DOI 10.1002/1096-9071(200010)62:2<251::AID-JMV18>3.0.CO;2-V; Persson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090023; Ratnam S, 2011, J CLIN MICROBIOL, V49, P557, DOI 10.1128/JCM.02147-10; Ratnam S, 2010, J CLIN MICROBIOL, V48, P2779, DOI 10.1128/JCM.00382-10; Reid JL, 2015, AM J CLIN PATHOL, V144, P473, DOI 10.1309/AJCPHVD7MIP3FYVV; Riley RR, 2003, CANCER RES, V63, P4862; Solomon D., 2004, BETHESDA SYSTEM REPO; Sotlar K, 2004, J MED VIROL, V74, P107, DOI 10.1002/jmv.20153; Steenbergen RDM, 2014, NAT REV CANCER, V14, P395, DOI 10.1038/nrc3728; Stoler MH, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.003; Takeda T, 2012, J OBSTET GYNAECOL RE, V38, P615, DOI 10.1111/j.1447-0756.2012.01858.x; Tang S, 2006, J VIROL, V80, P4249, DOI 10.1128/JVI.80.9.4249-4263.2006; Waldstrom M, 2012, CYTOPATHOLOGY, V23, P389, DOI 10.1111/j.1365-2303.2011.00923.x; Waldstrom M, 2013, CANCER CYTOPATHOL, V121, P136, DOI 10.1002/cncy.21233; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; Yugawa T, 2009, REV MED VIROL, V19, P97, DOI 10.1002/rmv.605; Zappacosta R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071480	27	9	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193061	10.1371/journal.pone.0193061	http://dx.doi.org/10.1371/journal.pone.0193061			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466435	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300082
J	Rattanavipapong, W; Anothaisintawee, T; Teerawattananon, Y				Rattanavipapong, Waranya; Anothaisintawee, Thunyarat; Teerawattananon, Yot			Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GENOTYPE 1 INFECTION; DACLATASVIR PLUS SOFOSBUVIR; RAPID VIROLOGICAL RESPONSE; TREATMENT-NAIVE PATIENTS; PEGINTERFERON ALPHA-2A; PEGYLATED INTERFERON; JAPANESE PATIENTS; RANDOMIZED-TRIAL; PHASE-III	Thailand is encountering challenges to introduce the high-cost sofosbuvir for chronic hepatitis C treatment as part of the Universal Health Care's benefit package. This study was conducted in respond to policy demand from the Thai government to assess the value for money and budget impact of introducing sofosbuvir-based regimens in the tax-based health insurance scheme. The Markov model was constructed to assess costs and benefits of the four treatment options that include: (i) current practice-peginterferon alfa (PEG) and ribavirin (RBV) for 24 weeks in genotype 3 and 48 weeks for other genotypes; (ii) Sofosbuvir plus peginterferon alfa and ribavirin (SOF+PEG-RBV) for 12 weeks; (iii) Sofosbuvir and daclatasvir (SOF+DCV) for 12 weeks; (iv) Sofosbuvir and ledipasvir (SOF+LDV) for 12 weeks for non-3 genotypes and SOF+PEG-RBV for 12 weeks for genotype 3 infection. Given that policy options (ii) and (iii) are for pan-genotypic infection, the cost of genotype testing was applied only for policy options (i) and (iv). Results reveal that all sofosbuvir-based regimens had greater quality adjusted life years (QALY) gains compared with the current treatment, therefore associated with lower lifetime costs and more favourable health outcomes. Additionally, among the three regimens of sofosbuvir, SOF+PEG-RBV for genotype 3 and SOF+LDV for non-3 genotype are the most cost-effective treatment option with the threshold of 160,000 THB per QALY gained. The results of this study had been used in policy discussion which resulted in the recent inclusion of SOF+PEG-RBV for genotype 3 and SOF+LDV for non-3 genotype in the Thailand's benefit package.	[Rattanavipapong, Waranya; Anothaisintawee, Thunyarat; Teerawattananon, Yot] Minist Publ Hlth, Dept Hlth, HITAP, Nonthaburi, Thailand; [Anothaisintawee, Thunyarat] Ramathibodi Hosp, Dept Family Med, Fac Med, Bangkok, Thailand	Ministry of Public Health - Thailand; Mahidol University	Rattanavipapong, W (corresponding author), Minist Publ Hlth, Dept Hlth, HITAP, Nonthaburi, Thailand.	waranya.r@hitap.net		Teerawattananon, Yot/0000-0003-2217-2930	Thailand Research Fund [RTA5980011]; Bureau of Health Policy and Strategy, Ministry of Public Health; international Decision Support Initiative - Bill & Melinda Gates Foundation; international Decision Support Initiative - Department for International Development, UK	Thailand Research Fund(Thailand Research Fund (TRF)); Bureau of Health Policy and Strategy, Ministry of Public Health; international Decision Support Initiative - Bill & Melinda Gates Foundation; international Decision Support Initiative - Department for International Development, UK	HITAP is funded by the Thailand Research Fund under the senior research scholar on Health Technology Assessment (RTA5980011) and the Bureau of Health Policy and Strategy, Ministry of Public Health. HITAP's international unit has been supported by the international Decision Support Initiative (funded by the Bill & Melinda Gates Foundation and the Department for International Development, UK), and the Rockefeller Foundation to provide technical assistance on health intervention and technology assessment for governments of low- and middle-income countries. The findings, interpretations and conclusions expressed in this article do not necessarily reflect the views of the aforementioned funding agencies. The authors would like to thank Ms. Thanthima Suwanthawornkul and Mr. Songyot Pilasant for their contribution to this project as co-investigators. They were both help doing budget impact analysis.; HITAP is funded by the Thailand Research Fund under the senior research scholar on Health Technology Assessment (RTA5980011) to WR and RT and the Bureau of Health Policy and Strategy, Ministry of Public Health. HITAP's international unit has been supported by the international Decision Support Initiative (funded by the Bill & Melinda Gates Foundation and the Department for International Development, UK), and the Rockefeller Foundation to provide technical assistance on health intervention and technology assessment for governments of low- and middle income countries. The findings, interpretations and conclusions expressed in this article do not necessarily reflect the views of the aforementioned funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Aggarwal R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176503; Andrieux-Meyer I, 2015, LANCET GLOB HEALTH, V3, pE676, DOI 10.1016/S2214-109X(15)00156-4; [Anonymous], 2015, REP CONS PRIC IND TH; Berger S., 2017, INFECT DIS THAILAND; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Chhatwal J, 2016, PHARMACOECONOMICS, V34, P551, DOI 10.1007/s40273-015-0373-9; Chittmittrapap S, 2015, EASL SP C END STAG L; Coward S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011821; Devine EB, 2007, CURR MED RES OPIN, V23, P1463, DOI 10.1185/030079907X188189; Foster GR, 2015, GASTROENTEROLOGY, V149, P1462, DOI 10.1053/j.gastro.2015.07.043; Fung J, 2008, J INFECT DIS, V198, P808, DOI 10.1086/591252; Gane EJ, 2015, GASTROENTEROLOGY, V149, P1454, DOI 10.1053/j.gastro.2015.07.063; Hayashi N, 2014, J HEPATOL, V61, P219, DOI 10.1016/j.jhep.2014.04.004; Hayashi N, 2014, J GASTROENTEROL, V49, P138, DOI 10.1007/s00535-013-0875-1; Health Intervention and Technology Assessment Program, 2016, CONST M RES RES PROJ; Health Intervention and Technology Assessment Program, 2016, CONS M PREL RES RES; International Monetary Fund, 2016, WORLD EC OUTL DAT; Kapol N, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0506-4; Kim Kyoung-Tae, 2008, Korean J Hepatol, V14, P36, DOI 10.3350/kjhep.2008.14.1.36; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Kuboki M, 2007, J GASTROEN HEPATOL, V22, P645, DOI 10.1111/j.1440-1746.2007.04834.x; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Lee Heon Ju, 2008, Korean J Hepatol, V14, P46, DOI 10.3350/kjhep.2008.14.1.46; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; Liu CJ, 2009, GASTROENTEROLOGY, V136, P496, DOI 10.1053/j.gastro.2008.10.049; Lynch SM, 2016, J CLIN TRANSL HEPATO, V4, P310, DOI 10.14218/JCTH.2016.00027; Matza LS, 2015, EUR J HEALTH ECON, V16, P1005, DOI 10.1007/s10198-014-0649-6; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Mizokami M, 2015, LANCET INFECT DIS, V15, P645, DOI 10.1016/S1473-3099(15)70099-X; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Permsuwan Unchalee, 2008, J Med Assoc Thai, V91 Suppl 2, pS53; Riewpaiboon, 2011, STANDARD COST LISTS; Rodriguez-Torres M, 2013, J HEPATOL, V58, P663, DOI 10.1016/j.jhep.2012.11.018; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Suwanthawornkul T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145953; Thai Association for the Study of the Liver, 2015, THAIL PRACT GUID MAN; The Health Economic Working Group, 2013, M HLTH EC WORK GROUP; The subcommittee for development of National List of Essential Medicines, 2015, RAT US PEG FER ALF 2; Thongsawat Satawat, 2014, Value Health Reg Issues, V3, P12, DOI 10.1016/j.vhri.2013.09.002; Wasitthankasem R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149362; Weerayingyong P., 2011, COST UTILIY ANAL BUD; World Health Organization, 2016, GLOB HLTH SECT STRAT; World Health Organization, 2015, 20 EXP COMM SEL US E; Yu JW, 2007, J GASTROEN HEPATOL, V22, P832, DOI 10.1111/j.1440-1746.2007.04904.x; Yu ML, 2008, HEPATOLOGY, V47, P1884, DOI 10.1002/hep.22319; Yu ML, 2006, LIVER INT, V26, P73, DOI 10.1111/j.1478-3231.2005.01196.x	49	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193112	10.1371/journal.pone.0193112	http://dx.doi.org/10.1371/journal.pone.0193112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466415	gold, Green Published, Green Submitted			2022-12-26	WOS:000425604300087
J	Valles, SM; Porter, SD; Calcaterra, LA				Valles, Steven M.; Porter, Sanford D.; Calcaterra, Luis A.			Prospecting for viral natural enemies of the fire ant Solenopsis invicta in Argentina	PLOS ONE			English	Article							STRAND RNA VIRUS; HYMENOPTERA-FORMICIDAE; HOST-SPECIFICITY; DISCOVERY; SEQUENCE; POPULATIONS; PATHOGEN	Metagenomics and next generation sequencing were employed to discover new virus natural enemies of the fire ant, Solenopsis invicta Buren in its native range (i.e., Formosa, Argentina) with the ultimate goal of testing and releasing new viral pathogens into U.S. S. invicta populations to provide natural, sustainable control of this ant. RNA was purified from worker ants from 182 S. invicta colonies, which was pooled into 4 groups according to location. A library was created from each group and sequenced using Illumina Miseq technology. After a series of winnowing methods to remove S. invicta genes, known S. invicta virus genes, and all other non-virus gene sequences, 61,944 unique singletons were identified with virus identity. These were assembled de novo yielding 171 contiguous sequences with significant identity to non-plant virus genes. Fifteen contiguous sequences exhibited very high expression rates and were detected in all four gene libraries. One contig (Contig_29) exhibited the highest expression level overall and across all four gene libraries. Random amplification of cDNA ends analyses expanded this contiguous sequence yielding a complete virus genome, which we have provisionally named Solenopsis invicta virus 5 (SINV-5). SINV-5 is a positive-sense, single-stranded RNA virus with genome characteristics consistent with insect-infecting viruses from the family Dicistroviridae. Moreover, the replicative genome strand of SINV-5 was detected in worker ants indicating that S. invicta serves as host for the virus. Many additional sequences were identified that are likely of viral origin. These sequences await further investigation to determine their origins and relationship with S. invicta. This study expands knowledge of the RNA virome diversity found within S. invicta populations.	[Valles, Steven M.; Porter, Sanford D.] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL 32608 USA; [Calcaterra, Luis A.] Fdn Estudio Especies Invasivas, B1686EFA, Buenos Aires, DF, Argentina	United States Department of Agriculture (USDA)	Valles, SM (corresponding author), ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL 32608 USA.	steven.valles@ars.usda.gov	Calcaterra, Luis/AAM-7370-2020	Porter, Sanford/0000-0001-5321-5898; valles, steven/0000-0001-6329-2942				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Briano Juan, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/198084; Calcaterra LA, 2008, OECOLOGIA, V156, P411, DOI 10.1007/s00442-008-0997-y; Caldera EJ, 2008, BIOL INVASIONS, V10, P1457, DOI 10.1007/s10530-008-9219-0; Callcott AMA, 1996, FLA ENTOMOL, V79, P240, DOI 10.2307/3495821; Callcott AMA, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0119; Chen YP, 2012, INSECT PATHOLOGY, 2ND EDITION, P133, DOI 10.1016/B978-0-12-384984-7.00005-1; Craggs JK, 2001, J VIROL METHODS, V94, P111, DOI 10.1016/S0166-0934(01)00281-6; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FUXA J. R., 1987, EPIZOOTIOLOGY INSECT; Gandon S, 1998, TRENDS ECOL EVOL, V13, P214, DOI 10.1016/S0169-5347(98)01358-5; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Johansson H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079777; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lacey LA, 2001, BIOL CONTROL, V21, P230, DOI 10.1006/bcon.2001.0938; LeBrun EG, 2007, ECOLOGY, V88, P63, DOI 10.1890/0012-9658(2007)88[63:AESOCB]2.0.CO;2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manfredini F, 2016, ECOL EVOL, V6, P233, DOI 10.1002/ece3.1843; Mukherjee S, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/1944-3277-10-18; Oi DH, 2012, FLA ENTOMOL, V95, P506, DOI 10.1653/024.095.0242; Oi David H., 2009, V6, P237; Olendraite I, J GEN VIROL IN PRESS; Pereira RM, 2003, J AGR URBAN ENTOMOL, V20, P123; Porter SD, 2015, FLA ENTOMOL, V98, P122, DOI 10.1653/024.098.0120; Porter SD, 2013, FLA ENTOMOL, V96, P1567, DOI 10.1653/024.096.0440; Porter SD, 2013, J INVERTEBR PATHOL, V114, P1, DOI 10.1016/j.jip.2013.04.013; Porter SD, 1997, ENVIRON ENTOMOL, V26, P373, DOI 10.1093/ee/26.2.373; PORTER SD, 1992, J ECON ENTOMOL, V85, P1155; Remnant EJ, 2017, J VIROLOGY IN PRESS; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmid-Hempel P., 1998, Parasites in social insects.; Tschinkel WR, 2006, FIRE ANTS; Valles SM, 2017, J GEN VIROL, V98, P355, DOI 10.1099/jgv.0.000756; Valles S. M., 2012, Psyche: A Journal of Entomology, V2012, P821591, DOI 10.1155/2012/821591; Valles SM, 2004, VIROLOGY, V328, P151, DOI 10.1016/j.virol.2004.07.016; Valles SM, 2008, J INVERTEBR PATHOL, V99, P74, DOI 10.1016/j.jip.2008.01.004; Valles SM, 2007, VIROLOGY, V365, P457, DOI 10.1016/j.virol.2007.03.043; Valles SM, 2007, J INVERTEBR PATHOL, V96, P18, DOI 10.1016/j.jip.2007.02.006; Valles SM, 2014, VIROLOGY, V460, P66, DOI 10.1016/j.virol.2014.04.026; Valles SM, 2013, BIOL CONTROL, V67, P431, DOI 10.1016/j.biocontrol.2013.09.015; Valles SM, 2013, J INVERTEBR PATHOL, V113, P198, DOI 10.1016/j.jip.2013.04.003; Valles SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031828; Valles SM, 2010, BIOL CONTROL, V54, P342, DOI 10.1016/j.biocontrol.2010.06.006; Valles SM, 2009, VIROLOGY, V388, P354, DOI 10.1016/j.virol.2009.03.028; Yang CC, 2010, BIOL INVASIONS, V12, P3307, DOI 10.1007/s10530-010-9724-9	45	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192377	10.1371/journal.pone.0192377	http://dx.doi.org/10.1371/journal.pone.0192377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466388	gold, Green Published, Green Submitted			2022-12-26	WOS:000425604300053
J	Winterfeld, G; Becher, H; Voshell, S; Hilu, K; Roser, M				Winterfeld, Grit; Becher, Hannes; Voshell, Stephanie; Hilu, Khidir; Roeser, Martin			Karyotype evolution in Phalaris (Poaceae): The role of reductional dysploidy, polyploidy and chromosome alteration in a wide-spread and diverse genus	PLOS ONE			English	Article							CANARY GRASSES PHALARIS; HELICTOTRICHON POACEAE; NUMBER REDUCTION; MOLECULAR PHYLOGENETICS; GENOME EVOLUTION; ARUNDINACEA L.; DNA AMOUNTS; HYBRIDIZATION; SPECIATION; NUCLEAR	Karyotype characteristics can provide valuable information on genome evolution and speciation, in particular in taxa with varying basic chromosome numbers and ploidy levels. Due to its worldwide distribution, remarkable variability in morphological traits and the fact that ploidy change plays a key role in its evolution, the canary grass genus Phalaris (Poaceae) is an excellent study system to investigate the role of chromosomal changes in species diversification and expansion. Phalaris comprises diploid species with two basic chromosome numbers of x = 6 and 7 as well as polyploids based on x = 7. To identify distinct karyotype structures and to trace chromosome evolution within the genus, we apply fluorescence in situ hybridisation (FISH) of 5S and 45S rDNA probes in four diploid and four tetraploid Phalaris species of both basic numbers. The data agree with a dysploid reduction from x = 7 to x = 6 as the result of reciprocal translocations between three chromosomes of an ancestor with a diploid chromosome complement of 2n = 14. We recognize three different genomes in the genus: (1) the exclusively Mediterranean genome A based on x = 6, (2) the cosmopolitan genome B based on x = 7 and (3) a genome C based on x = 7 and with a distribution in the Mediterranean and the Middle East. Both auto-and allopolyploidy of genomes B and C are suggested for the formation of tetraploids. The chromosomal divergence observed in Phalaris can be explained by the occurrence of dysploidy, the emergence of three different genomes, and the chromosome rearrangements accompanied by karyotype change and polyploidization. Mapping the recognized karyotypes on the existing phylogenetic tree suggests that genomes A and C are restricted to sections Phalaris and Bulbophalaris, respectively, while genome B occurs across all taxa with x = 7.	[Winterfeld, Grit; Roeser, Martin] Martin Luther Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany; [Becher, Hannes] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Voshell, Stephanie; Hilu, Khidir] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA	Martin Luther University Halle Wittenberg; University of Edinburgh; Virginia Polytechnic Institute & State University	Winterfeld, G (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany.	gwinterfeld@gmx.net	Becher, Hannes/AAQ-4878-2020	Becher, Hannes/0000-0003-3700-2942; Winterfeld, Grit/0000-0002-9866-335X	German Research Foundation (DFG) [RO 865/8-2]; Open Access Publication Fund of the Martin Luther University Halle-Wittenberg	German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of the Martin Luther University Halle-Wittenberg	Part of this research was supported by the German Research Foundation (DFG grant no. RO 865/8-2). We acknowledge the financial support of the Open Access Publication Fund of the Martin Luther University Halle-Wittenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Part of this research was supported by the German Research Foundation (DFG grant no. RO 865/8-2). We acknowledge the financial support of the Open Access Publication Fund of the Martin Luther University Halle-Wittenberg.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Ainouche ML, 2004, NEW PHYTOL, V161, P165, DOI 10.1046/j.1469-8137.2003.00926.x; AMBASTHA H. N. S., 1956, Genetica, V28, P64, DOI 10.1007/BF01694312; ANDERSON DENNIS E., 1961, IOWA STATE JOUR SCI, V36, P1; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Baldini Riccardo M., 1993, Webbia, V47, P1; Baldini Riccardo M., 1995, Webbia, V49, P265; Bennett MD, 1998, ANN BOT-LONDON, V82, P121, DOI 10.1006/anbo.1998.0785; BENNETT MD, 1987, NEW PHYTOL, V106, P177, DOI 10.1111/j.1469-8137.1987.tb04689.x; Bennett MD, 2012, PLANT DNA C VALUES D; BRETAGNOLLE F, 1995, NEW PHYTOL, V129, P1, DOI 10.1111/j.1469-8137.1995.tb03005.x; Cai XW, 2007, CURR GENOMICS, V8, P151, DOI 10.2174/138920207780833847; De Storme N, 2014, CURR PLANT BIOL, V1, P10, DOI 10.1016/j.cpb.2014.09.002; Doering Elke, 2007, Kew Bulletin, V62, P407; Escudero M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085266; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Ferreira V, 2002, CARYOLOGIA, V55, P151, DOI 10.1080/00087114.2002.10589271; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Gernand D, 2007, GENOME, V50, P435, DOI 10.1139/G07-023; Grant V., 1981, PLANT SPECIATION; Grzywacz B, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-48; Guerra M, 2008, CYTOGENET GENOME RES, V120, P339, DOI 10.1159/000121083; Hilu KW, 2004, AUST J BOT, V52, P13, DOI 10.1071/BT03103; Husband B. C., 2004, AM J BOT, V91, P621, DOI DOI 10.3732/AJB.91.4.621; Kellogg E.A., 2015, FAMILIES GENERA VASC, V13, P1; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Knight CA, 2002, ECOL LETT, V5, P66, DOI 10.1046/j.1461-0248.2002.00283.x; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Li XM, 1997, HEREDITAS, V126, P289, DOI 10.1111/j.1601-5223.1997.00289.x; Lim KY, 2006, PLANT J, V48, P907, DOI 10.1111/j.1365-313X.2006.02930.x; Luo MC, 2009, P NATL ACAD SCI USA, V106, P15780, DOI 10.1073/pnas.0908195106; Luo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035261; Lysak MA, 2006, P NATL ACAD SCI USA, V103, P5224, DOI 10.1073/pnas.0510791103; Madlung A, 2013, HEREDITY, V110, P99, DOI 10.1038/hdy.2012.79; Malinska H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-291; Merigliano MF, 1998, NAT AREA J, V18, P223; Moraes AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165960; Neffa VGS, 2000, GENET MOL BIOL, V23, P925, DOI 10.1590/S1415-47572000000400037; Parthasarathy N, 1939, ANN BOT-LONDON, V3, P43, DOI 10.1093/oxfordjournals.aob.a085057; Paszko B, 2006, PLANT SYST EVOL, V258, P39, DOI 10.1007/s00606-005-0389-2; Peruzzi L, 2017, PLANT BIOSYST, V151, P212, DOI 10.1080/11263504.2016.1149123; Peruzzi L, 2013, COMP CYTOGENET, V7, P1, DOI 10.3897/CompCytogen.v7i1.4431; Pikaard CS, 2000, TRENDS GENET, V16, P495, DOI 10.1016/S0168-9525(00)02113-2; Pimentel M, 2017, PEER J; Portal R, 2017, GENRE PHALARIS TRAVE; Quintanar A, 2007, AM J BOT, V94, P1554, DOI 10.3732/ajb.94.9.1554; Raskina O, 2008, CYTOGENET GENOME RES, V120, P351, DOI 10.1159/000121084; Ravi M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002121; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Roa F, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-225; Rockinger A, 2016, AM J BOT, V103, P1082, DOI 10.3732/ajb.1600134; Roser M, 2015, CYTOGENET GENOME RES, V147, P70, DOI 10.1159/000441677; Romermann C, 2005, OIKOS, V110, P219, DOI 10.1111/j.0030-1299.2005.13911.x; Roser M., 1995, Proceedings of the Kew chromosome conference IV, held at the Jodrell Laboratory, Royal Botanic Gardens, Kew, UK, 30 August-2 September 1994., P249; Roser M, 1998, FLORA, V193, P425; Roser M, 1996, PLANT SYST EVOL, V203, P181, DOI 10.1007/BF00983512; Roser M, 1997, BOT ACTA, V110, P79; Saarela JM, 2015, AOB PLANTS, V7, DOI [10.1093/aobpla/plv046, 10.10]; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; SCHIFINO MT, 1985, CYTOLOGIA, V50, P89, DOI 10.1508/cytologia.50.89; SCHUBERT I, 1985, CHROMOSOMA, V92, P143, DOI 10.1007/BF00328466; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; SCHWARZACHER T, 1980, PLANT SYST EVOL, V134, P293, DOI 10.1007/BF00986805; Shchapova AI, 2012, RUSSIAN J GENETICS A, V2, P252, DOI [DOI 10.1134/S2079059712030100, 10.1134/S2079059712030100]; Soltis DE, 2014, AM J BOT, V101, P1057, DOI 10.3732/ajb.1400178; Soreng RJ, 2017, J SYST EVOL, V55, P259, DOI 10.1111/jse.12262; Soreng RJ, 2015, J SYST EVOL, V53, P117, DOI 10.1111/jse.12150; Sousa dos Santos A, 2014, THESIS; Srinivasachary, 2007, THEOR APPL GENET, V115, P489, DOI 10.1007/s00122-007-0582-5; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Stebbins G. L., 1971, CHROMOSOMAL EVOLUTIO; Tackenberg O, 2006, BASIC APPL ECOL, V7, P45, DOI 10.1016/j.baae.2005.05.001; Tackholm G, 1922, ACTA HORTI BERGIANI, V7, P97, DOI DOI 10.5962/BHL.TITLE.15507; Theuri J, 2005, CYTOGENET GENOME RES, V110, P203, DOI 10.1159/000084953; VIINIKKA Y, 1993, CARYOLOGIA, V46, P47, DOI 10.1080/00087114.1993.10797245; Voshell SM, 2015, AUST SYST BOT, V28, P355, DOI 10.1071/SB15025; Voshell SM, 2014, MOL ECOL, V23, P212, DOI 10.1111/mec.12575; Voshell SM, 2011, TAXON, V60, P1306, DOI 10.1002/tax.605007; Watanabe K, 1999, J PLANT RES, V112, P145, DOI 10.1007/PL00013869; Weiss-Schneeweiss H, 2009, INT J PLANT SCI, V170, P1168, DOI 10.1086/605876; Winterfeld G, 2014, CYTOGENET GENOME RES, V142, P204, DOI 10.1159/000361002; Winterfeld G, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw039; Winterfeld G, 2015, AUST SYST BOT, V28, P145, DOI 10.1071/SB14029; Winterfeld G, 2012, INT J PLANT SCI, V173, P399, DOI 10.1086/664710; Winterfeld G, 2009, SYST BIODIVERS, V7, P277, DOI 10.1017/S1477200009003041; Wolk A, 2015, SYST BIODIVERS, V13, P326, DOI 10.1080/14772000.2015.1023867; Yakimowski SB, 2014, AM J BOT, V101, P1247, DOI 10.3732/ajb.1400201; Zhang YX, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1877-6	89	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192869	10.1371/journal.pone.0192869	http://dx.doi.org/10.1371/journal.pone.0192869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462207	gold, Green Published			2022-12-26	WOS:000425554200028
J	Wu, ST; Williams, CD; Grover, PA; Moore, LJ; Mukherjee, P				Wu, Shu-ta; Williams, Chandra D.; Grover, Priyanka A.; Moore, Laura J.; Mukherjee, Pinku			Early detection of pancreatic cancer in mouse models using a novel antibody, TAB004	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; DIABETES-MELLITUS; COMPUTED-TOMOGRAPHY; MAMMARY-GLAND; MUC1; CELLS; PROGRESSION; PREVALENCE; EXPRESSION; CARCINOMA	Pancreatic ductal adenocarcinoma (PDA) is the fourth-leading cause of cancer death in the United States with a 5-year overall survival rate of 8% for all stages combined. But this decreases to 3% for the majority of patients that present with stage IV PDA at time of diagnosis. The lack of distinct early symptoms for PDA is one of the primary reasons for the late diagnosis. Common symptoms like weight loss, abdominal and back pains, and jaundice are often mistaken for symptoms of other issues and do not appear until the cancer has progressed to a late stage. Thus the development of novel imaging platforms for PDA is crucial for the early detection of the disease. MUC1 is a tumor-associated antigen (tMUC1) expressed on 80% of PDA. The goal of this study was to determine the targeting and detection capabilities of a tMUC1 specific antibody, TAB004. TAB004 antibody conjugated to a near infrared fluorescent probe was injected intraperitoneally into immune competent orthotopic and spontaneous models of PDA. Results show that fluorophore conjugated TAB004 specifically targets a) 1 week old small tumor in the pancreas in an orthotopic PDA model and b) very early pre-neoplastic lesions (PanIN lesions) that develop in the spontaneous PDA model before progression to adenocarcinoma. Thus, TAB004 is a promising antibody to deliver imaging agents directly to the pancreatic tumor microenvironment, significantly affecting early detection of PDA.	[Wu, Shu-ta; Grover, Priyanka A.; Moore, Laura J.; Mukherjee, Pinku] Univ N Carolina, Dept Biol Sci, Charlotte, NC 28223 USA; [Williams, Chandra D.] Univ N Carolina, Dept Anim Lab Resources, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte	Mukherjee, P (corresponding author), Univ N Carolina, Dept Biol Sci, Charlotte, NC 28223 USA.	pmukherj@uncc.edu		Wu, Shuta/0000-0002-3351-277X	CPCP Levine UNCC Pancreatic Cancer Pilot Project; National Institutes of Health, National Cancer Institute (NIH-NIC grant) [R01 CA118944-01A1, RO1 CA118944-01A1]; UNC Charlotte Faculty Research Grant; Williams States Lee College of Engineering Center for Biomedical Engineering and Science IVIS Imaging System Award; UNC Charlotte; Williams States Lee College of Engineering, Center for Biomedical Engineering and Science IVIS Imaging System Award; NATIONAL CANCER INSTITUTE [R01CA118944] Funding Source: NIH RePORTER	CPCP Levine UNCC Pancreatic Cancer Pilot Project; National Institutes of Health, National Cancer Institute (NIH-NIC grant); UNC Charlotte Faculty Research Grant; Williams States Lee College of Engineering Center for Biomedical Engineering and Science IVIS Imaging System Award; UNC Charlotte; Williams States Lee College of Engineering, Center for Biomedical Engineering and Science IVIS Imaging System Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	OncoTAb Inc. only provided the antibody TAB004 for this study. OncoTAb did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and did not provide any financial support to any of the authors. All funding for this manuscript came from CPCP Levine UNCC Pancreatic Cancer Pilot Project, National Institutes of Health, National Cancer Institute (NIH-NIC grant R01 CA118944-01A1), UNC Charlotte Faculty Research Grant, and The Williams States Lee College of Engineering Center for Biomedical Engineering and Science IVIS Imaging System Award.; This work was supported by the CPCP Levine UNCC Pancreatic Cancer Pilot Project, National Institutes of Health, National Cancer Institute (NIH-NIC Grant RO1 CA11894401A1), UNC Charlotte Faculty Research Grant, and UNC Charlotte, The Williams States Lee College of Engineering, Center for Biomedical Engineering and Science IVIS Imaging System Award. The authors thank Laura J. Moore and the UNC Charlotte's Vivarium staff, A. Perez and H. Gordils, for their support in caring for the animals. We also thank OncoTAb, Inc., for supplying TABOO4 that was used in this research.	Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; Chari ST, 2005, GASTROENTEROLOGY, V129, P504, DOI 10.1053/j.gastro.2005.05.007; Chari ST, 2001, GASTROENTEROLOGY, V121, P640, DOI 10.1053/gast.2001.27210; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Condeelis J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003848; Curry JM, 2013, J SURG ONCOL, V107, P713, DOI 10.1002/jso.23316; Curry JM, 2013, J SURG ONCOLOGY, V107; Damiano J, 2004, DIABETES METAB, V30, P203, DOI 10.1016/S1262-3636(07)70111-8; do Carmo FS, 2017, INT J NANOMED, V12, P53, DOI 10.2147/IJN.S118482; Dreau D, 2016, J BIOMED NANOTECHNOL, V12, P2172, DOI 10.1166/jbn.2016.2318; Fokas E, 2015, BBA-REV CANCER, V1855, P61, DOI 10.1016/j.bbcan.2014.12.001; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Illes D, 2016, PANCREATOLOGY, V16, P266, DOI 10.1016/j.pan.2015.12.005; Katada T, 2017, PANCREAS, V46, P1196, DOI 10.1097/MPA.0000000000000915; Kraus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030716; Levin CS, 2005, EUR J NUCL MED MOL I, V32, pS325, DOI 10.1007/s00259-005-1973-y; Marshall Milton V, 2010, Open Surg Oncol J, V2, P12; Melisi D, 2012, CURR DRUG TARGETS, V13, P729, DOI 10.2174/138945012800564130; Moore LJ, 2016, TRANSL ONCOL, V9, P295, DOI 10.1016/j.tranon.2016.05.001; Nath S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.16; Ogawa Y, 2002, CANCER, V94, P2344, DOI 10.1002/cncr.10493.abs; Overdijk MB, 2012, J IMMUNOL, V189, P3430, DOI 10.4049/jimmunol.1200356; Pannala R, 2008, GASTROENTEROLOGY, V134, P981, DOI 10.1053/j.gastro.2008.01.039; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Park JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122100; Pascual L, 2017, NANOMEDICINE; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; Qu CF, 2004, BRIT J CANCER, V91, P2086, DOI 10.1038/sj.bjc.6602232; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Sahraei M, 2012, ONCOGENE, V31, P4935, DOI 10.1038/onc.2011.651; Schneider DW, 2009, J NUCL MED, V50, P435, DOI 10.2967/jnumed.108.055608; Shimizu Y, 2005, J GASTROEN HEPATOL, V20, P1591, DOI 10.1111/j.1440-1746.2005.03895.x; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tamburrino A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00056; Tantau Alina, 2014, Rom J Intern Med, V52, P18; Tinder TL, 2008, J IMMUNOL, V181, P3116, DOI 10.4049/jimmunol.181.5.3116; Tolmachev V, 2010, CURR MED CHEM, V17, P2636, DOI 10.2174/092986710791859397; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wallberg H, 2013, BIOTECHNOL APPL BIOC, V60, P365, DOI 10.1002/bab.1111; Yeh R, 2017, CLIN IMAG, V42, P203, DOI 10.1016/j.clinimag.2016.10.002; Yeo CJ, 1998, LANGENBECK ARCH SURG, V383, P129, DOI 10.1007/s004230050104; Yolken RH, J CLIN INVESTIGATION, V90, P1984; Zhou B, 2017, INT J CANCER, V141, P231, DOI 10.1002/ijc.30670; Zhou R, 2016, ONCOGENE, V35, P5608, DOI 10.1038/onc.2015.516; Zhou R, 2016, ONCOGENE	48	8	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0193260	10.1371/journal.pone.0193260	http://dx.doi.org/10.1371/journal.pone.0193260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462213	Green Submitted, gold, Green Published			2022-12-26	WOS:000425554200060
J	Zaman, RT; Tuerkcan, S; Mahmoudi, M; Saito, T; Yang, PC; Chin, FT; McConnell, MV; Xing, L				Zaman, Raiyan T.; Tuerkcan, Silvan; Mahmoudi, Morteza; Saito, Toshinobu; Yang, Phillip C.; Chin, Frederick T.; McConnell, Michael V.; Xing, Lei			Imaging cellular pharmacokinetics of F-18-FDG and 6-NBDG uptake by inflammatory and stem cells	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; INJURED MYOCARDIUM; VIABILITY; SURVIVAL; THERAPY; SALVAGE; HEART	Objectives Myocardial infarction (MI) causes significant loss of cardiomyocytes, myocardial tissue damage, and impairment of myocardial function. The inability of cardiomyocytes to proliferate prevents the heart from self-regeneration. The treatment for advanced heart failure following an MI is heart transplantation despite the limited availability of the organs. Thus, stem-cell-based cardiac therapies could ultimately prevent heart failure by repairing injured myocardium that reverses cardiomyocyte loss. However, stem-cell-based therapies lack understanding of the mechanisms behind a successful therapy, including difficulty tracking stem cells to provide information on cell migration, proliferation and differentiation. In this study, we have investigated the interaction between different types of stem and inflammatory cells and cell-targeted imaging molecules, F-18-FDG and 6-NBDG, to identify uptake patterns and pharmacokinetics in vitro. Methods Macrophages (both M1 and M2), human induced pluripotent stem cells (hiPSCs), and human amniotic mesenchymal stem cells (hAMSCs) were incubated with either F-18-FDG or 6-NBDG. Excess radiotracer and fluorescence were removed and a 100 mu m-thin CdWO4 scintillator plate was placed on top of the cells for radioluminescence microscopy imaging of F-18-FDG uptake, while no scintillator was needed for fluorescence imaging of 6-NBDG uptake. Light produced following beta decay was imaged with a highly sensitive inverted microscope (LV200, Olympus) and an Electron Multiplying Charge-Couple Device (EMCCD) camera. Custom-written software was developed in MATLAB for image processing. Results The average cellular activity of F-18-FDG in a single cell of hAMSCs (0.670 +/- 0.028 fCi/mu m(2), P = 0.001) was 20% and 36% higher compared to uptake in hiPSCs (0.540 +/- 0.026 fCi/mu m(2) P = 0.003) and macrophages (0.430 +/- 0.023 fCi/mu m(2), P = 0.002), respectively. hAMSCs exhibited the slowest influx (0.210 min(-1)) but the fastest efflux (0.327 min(-1)) rate compared to the other tested cell lines for F-18-FDG. This cell line also has the highest phosphorylation but exhibited the lowest rate of de-phosphorylation. The uptake pattern for 6-NBDG was very different in these three cell lines. The average cellular activity of 6-NBDG in a single cell of macrophages (0.570 +/- 0.230 fM/mu m(2), P = 0.004) was 38% and 14% higher compared to hiPSCs (0.350 +/- 0.160 fM/mu m(2), P = 0.001) and hAMSCs (0.490 +/- 0.028 fM/mu m(2), P = 0.006), respectively. The influx (0.276 min(-1)), efflux (0.612 min-1), phosphorylation (0.269 min(-1)), and de-phosphorylation (0.049 min(-1)) rates were also highest for macrophages compared to the other two tested cell lines. Conclusion hAMSCs were found to be 2-3x more sensitive to F-18-FDG molecule compared to hiPSCs/macrophages. However, macrophages exhibited the most sensitivity towards 6-NBDG. Based on this result, hAMSCs targeted with F-18-FDG could be more suitable for understanding the mechanisms behind successful therapy for treating MI patients by gathering information on cell migration, proliferation and differentiation.	[Zaman, Raiyan T.; Mahmoudi, Morteza; Saito, Toshinobu; Yang, Phillip C.; McConnell, Michael V.] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Zaman, Raiyan T.; Tuerkcan, Silvan; Xing, Lei] Stanford Univ, Sch Med, Dept Radiat Oncol, Div Med Phys, Stanford, CA 94305 USA; [Chin, Frederick T.] Stanford Univ, Sch Med, Dept Radiol, Mol Imaging Program, Stanford, CA USA	Stanford University; Stanford University; Stanford University	Zaman, RT (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA.; Zaman, RT (corresponding author), Stanford Univ, Sch Med, Dept Radiat Oncol, Div Med Phys, Stanford, CA 94305 USA.	rtzaman@stanford.edu	Mahmoudi, Morteza/F-3432-2011	Mahmoudi, Morteza/0000-0002-2575-9684; Xing, Lei/0000-0003-2536-5359; McConnell, Michael/0000-0001-8743-0932	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL130553] Funding Source: NIH RePORTER; NHLBI NIH HHS [K24 HL130553] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2005, TRACER KINETIC MODEL; Arai T, 2006, MAGN RESON MED, V55, P203, DOI 10.1002/mrm.20702; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Christoforou N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011536; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Edwards Leah B, 2002, Clin Transpl, P29; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hendry SL, 2008, J THORAC CARDIOV SUR, V136, P1028, DOI 10.1016/j.jtcvs.2007.12.053; Hong H, 2012, ACS NANO, V6, P2361, DOI 10.1021/nn204625e; Hung TC, 2008, CIRC-CARDIOVASC IMAG, V1, P6, DOI 10.1161/CIRCIMAGING.108.767343; Kim PJ, 2015, CIRC RES, V116, pE40, DOI 10.1161/CIRCRESAHA.116.304668; Kim PJ, 2012, REV RECENT CLIN TRIA, V7, P204, DOI 10.2174/157488712802281286; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Menasche P, 2009, MOL THER, V17, P758, DOI 10.1038/mt.2009.40; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Pratx G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046285; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1308, DOI 10.1152/ajpheart.01277.2006; Tachibana A, 2017, CIRC RES, V121, pE22, DOI 10.1161/CIRCRESAHA.117.310803; Tahara N, 2014, NAT MED, V20, P215, DOI 10.1038/nm.3437; Wang INE, 2014, SMALL, V10, P1479, DOI 10.1002/smll.201303133	24	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192662	10.1371/journal.pone.0192662	http://dx.doi.org/10.1371/journal.pone.0192662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462173	Green Submitted, Green Published, gold			2022-12-26	WOS:000425554200021
J	Haro, MM; Silveira, LCP; Wilby, A				Haro, Marcelo Mendes; Paterno Silveira, Luis Claudio; Wilby, Andrew			Stability lies in flowers: Plant diversification mediating shifts in arthropod food webs	PLOS ONE			English	Article							NATURAL ENEMIES; BIOLOGICAL-CONTROL; APPARENT COMPETITION; BIODIVERSITY LOSS; OMNIVORY; CONSEQUENCES; ABUNDANCE; PATTERNS; COMMUNITIES; ROBUSTNESS	Arthropod community composition in agricultural landscapes is dependent on habitat characteristics, such as plant composition, landscape homogeneity and the presence of key resources, which are usually absent in monocultures. Manipulating agroecosystems through the insertion of in-field floral resources is a useful technique to reduce the deleterious effects of habitat simplification. Food web analysis can clarify how the community reacts to the presence of floral resources which favour ecosystem services such as biological control of pest species. Here, we reported quantitative and qualitative alterations in arthropod food web complexity due to the presence of floral resources from the Mexican marigold (Tagetes erecta L.) in a field scale lettuce community network. The presence of marigold flowers in the field successfully increased richness, body size, and the numerical and biomass abundance of natural enemies in the lettuce arthropod community, which affected the number of links, vulnerability, generality, omnivory rate and food chain length in the community, which are key factors for the stability of relationships between species. Our results reinforce the notion that diversification through insertion of floral resources may assist in preventing pest outbreaks in agroecosystems. This community approach to arthropod interactions in agricultural landscapes can be used in the future to predict the effect of different management practices in the food web to contribute with a more sustainable management of arthropod pest species.	[Haro, Marcelo Mendes] Empresa Pesquisa Agr & Extensao Rural Santa Catar, Estacao Expt Itajai, Lab Entomol, Itajai, SC, Brazil; [Haro, Marcelo Mendes; Paterno Silveira, Luis Claudio] Univ Fed Lavras UFLA, Dept Entomol, Lavras, MG, Brazil; [Haro, Marcelo Mendes; Wilby, Andrew] Univ Lancaster, Lancaster Environm Ctr, Lancaster, Lancs, England	Universidade Federal de Lavras; Lancaster University	Haro, MM (corresponding author), Empresa Pesquisa Agr & Extensao Rural Santa Catar, Estacao Expt Itajai, Lab Entomol, Itajai, SC, Brazil.; Haro, MM (corresponding author), Univ Fed Lavras UFLA, Dept Entomol, Lavras, MG, Brazil.; Haro, MM (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, Lancs, England.	marceloharo@epagri.sc.gov.br	de Haro, Marcelo Mendes/AAK-6570-2021; SILVEIRA, LUÍS CLÁUDIO PATERNO/S-3414-2019; de Haro, Marcelo Mendes/V-5823-2017	SILVEIRA, LUÍS CLÁUDIO PATERNO/0000-0003-0391-3676; de Haro, Marcelo Mendes/0000-0001-7572-532X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [1122/31-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Grant No : 1122/31-2 (www.capes.gov.br/) to MMH and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (cnpq.br) to LCPS, MMH and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (www.fapemig.br) to LCPS, MMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosino MD, 2006, ENVIRON ENTOMOL, V35, P394, DOI 10.1603/0046-225X-35.2.394; Atlas WI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085830; Baggen LR, 1999, ENTOMOL EXP APPL, V91, P155, DOI 10.1023/A:1003627130449; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Bishop MJ, 2007, OIKOS, V116, P427, DOI 10.1111/j.2006.0030-1299.15557.x; Borrvall C, 2000, ECOL LETT, V3, P131, DOI 10.1046/j.1461-0248.2000.00130.x; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Chase JM, 1999, AM NAT, V154, P559, DOI 10.1086/303260; Clough Y, 2007, J APPL ECOL, V44, P22, DOI 10.1111/j.1365-2664.2006.01239.x; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; Cohen JE, 2009, P NATL ACAD SCI USA, V106, P22335, DOI 10.1073/pnas.0910582106; Coll M, 2002, ANNU REV ENTOMOL, V47, P267, DOI 10.1146/annurev.ento.47.091201.145209; Cullen R, 2008, BIOL CONTROL, V45, P272, DOI 10.1016/j.biocontrol.2008.01.016; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Emmerson M, 2004, WEAK INTERACTIONS OM; Estrada E, 2007, J THEOR BIOL, V244, P296, DOI 10.1016/j.jtbi.2006.08.002; Eveleigh ES, 2007, P NATL ACAD SCI USA, V104, P16976, DOI 10.1073/pnas.0704301104; Fagan WF, 1997, AM NAT, V150, P554, DOI 10.1086/286081; Griffiths GJK, 2008, BIOL CONTROL, V45, P200, DOI 10.1016/j.biocontrol.2007.09.002; Halpern BS, 2005, ECOL LETT, V8, P189, DOI 10.1111/j.1461-0248.2004.00712.x; Harper-Smith S, 2006, DYNAMIC FOOD WEBS, V3, P407; Heimpel George E., 2005, P267, DOI 10.1017/CBO9780511542220.010; Hickman JM, 1996, J ECON ENTOMOL, V89, P832, DOI 10.1093/jee/89.4.832; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Holyoak M, 1998, OECOLOGIA, V117, P413, DOI 10.1007/s004420050675; Ives AR, 2004, NATURE, V429, P174, DOI 10.1038/nature02515; Jonsson M, 2008, BIOL CONTROL, V45, P172, DOI 10.1016/j.biocontrol.2008.01.006; Kean J, 2003, ECOL LETT, V6, P604, DOI 10.1046/j.1461-0248.2003.00468.x; Kokkoris GD, 2002, J ANIM ECOL, V71, P362, DOI 10.1046/j.1365-2656.2002.00604.x; Koricheva J, 2006, CAN J FOREST RES, V36, P324, DOI 10.1139/x05-172; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Kremen C., 2012, ECOLOGY SOC, V17; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; LAWLER SP, 1993, AM NAT, V141, P675, DOI 10.1086/285499; LAWTON JH, 1988, TRENDS ECOL EVOL, V3, P242, DOI 10.1016/0169-5347(88)90167-X; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; Long ZT, 2011, J ANIM ECOL, V80, P586, DOI 10.1111/j.1365-2656.2010.01800.x; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann K, 2007, NATURE, V446, P29, DOI 10.1038/446029a; Melian CJ, 2004, ECOLOGY, V85, P352, DOI 10.1890/02-0638; Memmott J, 2006, SFI S SCI C, P325; Morris RJ, 2004, NATURE, V428, P310, DOI 10.1038/nature02394; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nicholls C. I., 2000, Agricultural and Forest Entomology, V2, P107, DOI 10.1046/j.1461-9563.2000.00054.x; O'Gorman EJ, 2010, ADV ECOL RES, V42, P301, DOI 10.1016/S0065-2504(10)42006-1; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; Silveira LCP, 2009, SCI AGR, V66, P780, DOI 10.1590/S0103-90162009000600009; Pauly D, 2001, CAN J FISH AQUAT SCI, V58, P51, DOI 10.1139/cjfas-58-1-51; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Perovic DJ, 2010, BIOL CONTROL, V52, P263, DOI 10.1016/j.biocontrol.2009.09.014; Petchey OL, 2004, OIKOS, V104, P467, DOI 10.1111/j.0030-1299.2004.13257.x; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; PIMM SL, 1987, OIKOS, V50, P302, DOI 10.2307/3565490; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rebek EJ, 2005, BIOL CONTROL, V33, P203, DOI 10.1016/j.biocontrol.2005.02.011; Rusch A, 2013, AGR ECOSYST ENVIRON, V166, P118, DOI 10.1016/j.agee.2011.05.004; Rusek J, 2001, EUR J SOIL BIOL, V37, P237, DOI 10.1016/S1164-5563(01)01090-1; Schmidt MH, 2008, J BIOGEOGR, V35, P157, DOI 10.1111/j.1365-2699.2007.01774.x; Schneider G, 2015, J APPL ECOL, V52, P1283, DOI 10.1111/1365-2664.12471; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Sousa JP, 2006, PEDOBIOLOGIA, V50, P147, DOI 10.1016/j.pedobi.2005.10.005; Stephan JG, 2016, BIOCONTROL, V61, P103, DOI 10.1007/s10526-015-9693-0; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Sunderland K, 2000, ENTOMOL EXP APPL, V95, P1, DOI 10.1023/A:1003986225443; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Wackers F. L., 2005, PLANT PROVIDED FOOD; Wackers FL, 2004, BIOL CONTROL, V29, P307, DOI 10.1016/j.biocontrol.2003.08.005; [No title captured]	72	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0193045	10.1371/journal.pone.0193045	http://dx.doi.org/10.1371/journal.pone.0193045			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451903	Green Submitted, Green Published, gold			2022-12-26	WOS:000425369800035
J	Marosi, K; Moehl, K; Navas-Enamorado, I; Mitchell, SJ; Zhang, YQ; Lehrmann, E; Aon, MA; Cortassa, S; Becker, KG; Mattson, MP				Marosi, Krisztina; Moehl, Keelin; Navas-Enamorado, Ignacio; Mitchell, Sarah J.; Zhang, Yongqing; Lehrmann, Elin; Aon, Miguel A.; Cortassa, Sonia; Becker, Kevin G.; Mattson, Mark P.			Metabolic and molecular framework for the enhancement of endurance by intermittent food deprivation	FASEB JOURNAL			English	Article						exercise; intermittent fasting; muscle; mitochondrial biogenesis; ketone	DISEASE RISK MARKERS; CHAIN AMINO-ACID; SKELETAL-MUSCLE; DIETARY RESTRICTION; UNCOUPLING PROTEIN-3; CALORIC RESTRICTION; ENERGY-INTAKE; WEIGHT-LOSS; OXIDATIVE CAPACITY; GLUCOSE-METABOLISM	Evolutionary considerations suggest that the body has been optimized to perform at a high level in the food-deprived state when fatty acids and their ketone metabolites are a major fuel source for muscle cells. Because controlled food deprivation in laboratory animals and intermittent energy restriction in humans is a potent physiologic stimulus for ketosis, we designed a study to determine the impact of intermittent food deprivation during endurance training on performance and to elucidate the underlying cellular and molecular mechanisms. Male mice were randomly assigned to either ad libitum feeding or alternate-day food deprivation (ADF) groups, and half of the mice in each diet group were trained daily on a treadmill for 1 mo. A run to exhaustion endurance test performed at the end of the training period revealed superior performance in the mice maintained on ADF during training compared to mice fed ad libitum during training. Maximal O-2 consumption was increased similarly by treadmill training in mice on ADF or ad libitum diets, whereas respiratory exchange ratio was reduced in ADF mice on food-deprivation days and during running. Analyses of gene expression in liver and soleus tissues, and metabolomics analysis of blood suggest that the metabolic switch invoked by ADF and potentiated by exercise strongly modulates molecular pathways involved in mitochondrial biogenesis, metabolism, and cellular plasticity. Our findings demonstrate that ADF engages metabolic and cellular signaling pathways that result in increased metabolic efficiency and endurance capacity.Marosi, K., Moehl, K., Navas-Enamorado, I., Mitchell, S. J., Zhang, Y., Lehrmann, E., Aon, M. A., Cortassa, S., Becker, K. G., Mattson, M. P. Metabolic and molecular framework for the enhancement of endurance by intermittent food deprivation.	[Marosi, Krisztina; Moehl, Keelin; Mattson, Mark P.] NIA, Lab Neurosci, Intramural Res Program, Baltimore, MD 21224 USA; [Navas-Enamorado, Ignacio] NIA, Translat Gerontol, Intramural Res Program, Baltimore, MD 21224 USA; [Zhang, Yongqing; Lehrmann, Elin; Becker, Kevin G.] NIA, Gene Express & Genom Unit Core Facil, Intramural Res Program, Baltimore, MD 21224 USA; [Aon, Miguel A.; Cortassa, Sonia] NIA, Lab Cardiovasc Sci, Intramural Res Program, Baltimore, MD 21224 USA; [Mitchell, Sarah J.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University	Mattson, MP (corresponding author), NIH, Biomed Res Ctr, 251 Bayview Blvd,Suite 100, Baltimore, MD 21224 USA.	mark.mattson@nih.gov	Moehl, Keelin/W-3227-2019; Cortassa, Sonia/AAO-1633-2020; Aon, Miguel Antonio/A-6564-2008	Moehl, Keelin/0000-0001-7720-3664; Cortassa, Sonia/0000-0001-7224-9858; Aon, Miguel Antonio/0000-0002-4355-5431; Lehrmann, Elin/0000-0002-9869-9475; Navas Enamorado, Ignacio/0000-0003-2197-2864	Intramural Research Program of the U.S. National Institutes of Health, National Institute of Aging; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER	Intramural Research Program of the U.S. National Institutes of Health, National Institute of Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the U.S. National Institutes of Health, National Institute of Aging. The authors declare no conflicts of interest.	Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Anton SD, 2018, OBESITY, V26, P254, DOI 10.1002/oby.22065; Arumugam TV, 2010, ANN NEUROL, V67, P41, DOI 10.1002/ana.21798; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Bhutani S, 2013, OBESITY, V21, P1370, DOI 10.1002/oby.20353; Blomstrand E, 2006, J NUTR, V136, p269S, DOI 10.1093/jn/136.1.269S; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Boutant M, 2014, MOL METAB, V3, P5, DOI 10.1016/j.molmet.2013.10.006; Burke LM, 2007, J SPORT SCI, V25, pS29, DOI 10.1080/02640410701607239; Burke LM, 2017, J PHYSIOL-LONDON, V595, P2785, DOI 10.1113/JP273230; Calbet JAL, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00483; Camandola S, 2017, EMBO J, V36, P1474, DOI 10.15252/embj.201695810; Catenacci VA, 2016, OBESITY, V24, P1874, DOI 10.1002/oby.21581; Cermak NM, 2013, SPORTS MED, V43, P1139, DOI 10.1007/s40279-013-0079-0; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Cheadle Chris, 2003, Appl Bioinformatics, V2, P209; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Conforto TL, 2015, MOL ENDOCRINOL, V29, P1286, DOI 10.1210/me.2015-1028; CONLEE RK, 1990, METABOLISM, V39, P289, DOI 10.1016/0026-0495(90)90049-I; Cox PJ, 2016, CELL METAB, V24, P256, DOI 10.1016/j.cmet.2016.07.010; Danno S, 1997, BIOCHEM BIOPH RES CO, V236, P804, DOI 10.1006/bbrc.1997.7059; Duan WZ, 2003, ENDOCRINOLOGY, V144, P2446, DOI 10.1210/en.2002-0113; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Ernst MC, 2012, ENDOCRINOLOGY, V153, P672, DOI 10.1210/en.2011-1490; Evans M, 2017, J PHYSIOL-LONDON, V595, P2857, DOI 10.1113/JP273185; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Franklin MP, 2017, DIABETES, V66, P2112, DOI 10.2337/db16-1519; Geisler JG, 2017, ALZHEIMERS DEMENT, V13, P582, DOI 10.1016/j.jalz.2016.08.001; Gibala MJ, 2013, NESTLE NUTR WORKS SE, V76, P51, DOI 10.1159/000350256; Godar RJ, 2015, AUTOPHAGY, V11, P1537, DOI 10.1080/15548627.2015.1063768; Gualano AB, 2011, J SPORT MED PHYS FIT, V51, P82; Harries LW, 2012, AGING CELL, V11, P262, DOI 10.1111/j.1474-9726.2011.00782.x; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Harvie M, 2013, BRIT J NUTR, V110, P1534, DOI 10.1017/S0007114513000792; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; HAWKES K, 1991, PHILOS T R SOC B, V334, P243, DOI 10.1098/rstb.1991.0113; Hirschfield GM, 2010, NAT GENET, V42, P655, DOI 10.1038/ng.631; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Kalinkovich A, 2017, AGEING RES REV, V35, P200, DOI 10.1016/j.arr.2016.09.008; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kephart WC, 2016, AMINO ACIDS, V48, P779, DOI 10.1007/s00726-015-2125-8; LAMBERT EV, 1994, EUR J APPL PHYSIOL O, V69, P287, DOI 10.1007/BF00392032; Leckey JJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00806; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Lyons CL, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050247; Mattson MP, 2018, NAT REV NEUROSCI, V19, P81, DOI 10.1038/nrn.2017.156; Mattson MP, 2017, AGEING RES REV, V39, P46, DOI 10.1016/j.arr.2016.10.005; Mattson MP, 2015, AGEING RES REV, V20, P37, DOI 10.1016/j.arr.2014.12.011; Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111; Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Miller BF, 2015, J APPL PHYSIOL, V118, P1502, DOI 10.1152/japplphysiol.00588.2014; Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027; Moro T, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1044-0; Mukherjee P, 2002, BRIT J CANCER, V86, P1615, DOI 10.1038/sj.bjc.6600298; Murray AJ, 2016, FASEB J, V30, P4021, DOI 10.1096/fj.201600773R; Nabben M, 2008, PHYSIOL BEHAV, V94, P259, DOI 10.1016/j.physbeh.2007.11.039; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Nelson AR, 2012, MED SCI SPORT EXER, V44, P57, DOI 10.1249/MSS.0b013e3182290371; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; Perez-Suarez I, 2017, J APPL PHYSIOL, V123, P1276, DOI 10.1152/japplphysiol.00454.2017; Pilegaard H, 2004, P NUTR SOC, V63, P221, DOI 10.1079/PNS2004345; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Ramalingam L, 2012, DIABETES, V61, P2424, DOI 10.2337/db11-1525; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; Seals DR, 2009, J PHYSIOL-LONDON, V587, P5541, DOI 10.1113/jphysiol.2009.178822; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; SIMONSON DC, 1990, AM J PHYSIOL, V258, pE399, DOI 10.1152/ajpendo.1990.258.3.E399; Smith CO, 2017, BIOCHEM J, V474, P2067, DOI 10.1042/BCJ20160623; STANFORD CB, 1994, AM J PHYS ANTHROPOL, V94, P213, DOI 10.1002/ajpa.1330940206; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; TARNOPOLSKY MA, 1995, J APPL PHYSIOL, V78, P1360, DOI 10.1152/jappl.1995.78.4.1360; Tinsley GM, 2017, EUR J SPORT SCI, V17, P200, DOI 10.1080/17461391.2016.1223173; VanZyl CG, 1996, J APPL PHYSIOL, V80, P2217, DOI 10.1152/jappl.1996.80.6.2217; Varady KA, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-146; Vijayakumar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044777; Volek JS, 2015, EUR J SPORT SCI, V15, P13, DOI 10.1080/17461391.2014.959564; Wan RQ, 2003, J NUTR, V133, P1921, DOI 10.1093/jn/133.6.1921; WERNIG A, 1990, J PHYSIOL-LONDON, V428, P639, DOI 10.1113/jphysiol.1990.sp018232; Wijngaarden MA, 2013, AM J PHYSIOL-ENDOC M, V304, pE1012, DOI 10.1152/ajpendo.00008.2013; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; Zhou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE622, DOI 10.1152/ajpendo.2000.279.3.E622	88	28	28	3	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3844	3858		10.1096/fj.201701378RR	http://dx.doi.org/10.1096/fj.201701378RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29485903	Green Published			2022-12-26	WOS:000435104500030
J	Wangsa, D; Quintanilla, I; Torabi, K; Vila-Casadesus, M; Ercilla, A; Klus, G; Yuce, Z; Galofre, C; Cuatrecasas, M; Lozano, JJ; Agell, N; Cimini, D; Castells, A; Ried, T; Camps, J				Wangsa, Darawalee; Quintanilla, Isabel; Torabi, Keyvan; Vila-Casadesus, Maria; Ercilla, Amaia; Klus, Gregory; Yuce, Zeynep; Galofre, Claudia; Cuatrecasas, Miriam; Jose Lozano, Juan; Agell, Neus; Cimini, Daniela; Castells, Antoni; Ried, Thomas; Camps, Jordi			Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness	FASEB JOURNAL			English	Article						genomic instability; aneuploidy; lagging chromosomes; invasive front; colorectal cancer	GENOMIC INSTABILITY; MITOTIC ERRORS; ANEUPLOIDY; EVOLUTION; CENTROSOMES; ATR; TUMORIGENESIS; CONSEQUENCES; POLYPLOIDY; TOLERANCE	A considerable proportion of tumors exhibit aneuploid karyotypes, likely resulting from the progressive loss of chromosomes after whole-genome duplication. Here, by using isogenic diploid and near-tetraploid (4N) single-cell-derived clones from the same parental cell lines, we aimed at exploring how polyploidization affects cellular functions and how tetraploidy generates chromosome instability. Gene expression profiling in 4N clones revealed a significant enrichment of transcripts involved in cell cycle and DNA replication. Increased levels of replication stress in 4N cells resulted in DNA damage, impaired proliferation caused by a cell cycle delay during S phase, and higher sensitivity to S phase checkpoint inhibitors. In fact, increased levels of replication stress were also observed in nontransformed, proliferative posttetraploid RPE1 cells. Additionally, replication stress promoted higher levels of intercellular genomic heterogeneity and ongoing genomic instability, which could be explained by high rates of mitotic defects, and was alleviated by the supplementation of exogenous nucleosides. Finally, our data found that 4N cancer cells displayed increased migratory and invasive capacity, both in vitro and in primary colorectal tumors, indicating that tetraploidy can promote aggressive cancer cell behavior.-Wangsa, D., Quintanilla, I., Torabi, K., Vila-Casadesus, M., Ercilla, A., Klus, G., Yuce, Z., Galofre, C., Cuatrecasas, M., Lozano, J. J., Agell, N., Cimini, D., Castells, A., Ried, T., Camps, J. Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness.	[Wangsa, Darawalee; Klus, Gregory; Yuce, Zeynep; Ried, Thomas] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Quintanilla, Isabel; Torabi, Keyvan; Vila-Casadesus, Maria; Galofre, Claudia; Castells, Antoni; Camps, Jordi] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Gastrointestinal & Pancreat Oncol Grp, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Cuatrecasas, Miriam] Hosp Clin Barcelona, CDB, Dept Pathol, Barcelona, Spain; [Torabi, Keyvan; Camps, Jordi] Univ Autonoma Barcelona, Fac Med, Dept Biol Cellular Fisiol & Immunol, Unitat Biol Cellular & Genet Med, Bellaterra, Spain; [Vila-Casadesus, Maria; Jose Lozano, Juan] CIBEREHD, Bioinformat Unit, Barcelona, Spain; [Ercilla, Amaia; Agell, Neus] Univ Barcelona, Fac Med, IDIBAPS, Dept Biol Cellular Immunol & Neurociencies, Barcelona, Spain; [Yuce, Zeynep] Dokuz Eylul Univ, Sch Med, Dept Med Biol & Genet, Izmir, Turkey; [Cimini, Daniela] Virginia Tech, Biocomplex Inst, Dept Biol Sci, Blacksburg, VA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Dokuz Eylul University; Virginia Polytechnic Institute & State University	Ried, T (corresponding author), NCI, Ctr Canc Res, 50 South Dr, Bethesda, MD 20802 USA.; Camps, J (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, Gastrointestinal & Pancreat Oncol Grp, Rossello 149-153,4th Floor, Barcelona 08036, Spain.	riedt@mail.nih.gov; jcamps@clinic.cat	Cuatrecasas, Miriam/C-9156-2019; Ercilla, Amaia/Y-1824-2019; Agell, Neus/E-9640-2016; Camps, Jordi/AAG-3080-2020; Cimini, Daniela/A-3039-2016; Castells, Antoni/ABC-1002-2021; Vila-Casadesus, Maria/J-8207-2016	Cuatrecasas, Miriam/0000-0003-3063-0110; Ercilla, Amaia/0000-0001-8999-7131; Agell, Neus/0000-0002-1205-6074; Camps, Jordi/0000-0002-3165-3640; Cimini, Daniela/0000-0002-4082-4894; Castells, Antoni/0000-0001-8431-2033; Vila-Casadesus, Maria/0000-0001-6597-7953; Lozano, Juan Jose/0000-0001-7613-3908; Quintanilla Leo, Isabel/0000-0002-6057-0342; Torabi, Keyvan/0000-0002-9067-0061	NIH; CIBEREHD Program; Instituto de Salud Carlos III; European Regional Development Fund (ERDF) [CP13/00160, PI14/00783]; European Commission MC-CIG (COLONGEVA); Spanish Association Against Cancer (AECC) [GCB13131592CAST]; Agencia de Gestio d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya [2014 SGR 135, 2014 SGR 903]; National Service Foundation (NSF) [MCB-1517506]; Ministerio de Educacion, Cultura y Deporte; Ministerio de Ciencia e Innovacion; Scientific and Technological Research Council of Turkey (TUBITAK) 2219 Program; NATIONAL CANCER INSTITUTE [ZIABC010833] Funding Source: NIH RePORTER; Direct For Biological Sciences [1517506] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIBEREHD Program; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission); European Commission MC-CIG (COLONGEVA)(European Commission); Spanish Association Against Cancer (AECC); Agencia de Gestio d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); National Service Foundation (NSF); Ministerio de Educacion, Cultura y Deporte(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Scientific and Technological Research Council of Turkey (TUBITAK) 2219 Program(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank Z. Storchova (Technische Universitat Kaiserslautern, Kaiserslauter, Germany) for kindly providing cell lines; A. Bosch and M. Calvo (University of Barcelona) for assessing the data analysis; and Z. Wong [U.S. National Institutes of Health (NIH)], R. Ebner (NIH), and S. D. Rutledge (Virginia Tech) for critical reading. The authors are also grateful to B. Chen (NIH) for editorial assistance. This work was supported by the Intramural Program of the NIH, the CIBEREHD Program, and grants to J.C. from Instituto de Salud Carlos III, and cofunded by the European Regional Development Fund (ERDF) (CP13/00160 and PI14/00783), the European Commission MC-CIG (COLONGEVA), the Spanish Association Against Cancer (AECC, GCB13131592CAST), and the Agencia de Gestio d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya (2014 SGR 135 and 2014 SGR 903). Further support was provided by National Service Foundation (NSF) Grant MCB-1517506 to D.C. I.Q., and M.V.-C. received a Formacion de Profesorado Universitario (FPU)-fellowship from Ministerio de Educacion, Cultura y Deporte; K.T. received a Personal Investigador en Formacio from the Universitat Autnonoma de Barcelona; A.E. received a Formacion de Personal Investigador (FPI) fellowship from Ministerio de Ciencia e Innovacion; and Z.Y. received a fellowship from the Scientific and Technological Research Council of Turkey (TUBITAK) 2219 Program. CIBEREHD is funded by the Instituto de Salud Carlos III. The authors declare no conflicts of interest.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Baia G, 2008, NEOPLASIA, V10, P604, DOI 10.1593/neo.08356; Bakhoum SF, 2014, CANCER DISCOV, V4, P1281, DOI 10.1158/2159-8290.CD-14-0403; Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Camps J, 2005, FASEB J, V19, P828, DOI 10.1096/fj.04-2276fje; Camps J, 2004, INT J CANCER, V110, P869, DOI 10.1002/ijc.20195; Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200; Cimini D, 2004, CURR BIOL, V14, P2149, DOI 10.1016/j.cub.2004.11.029; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Eykelenboom JK, 2013, CELL REP, V5, P1095, DOI 10.1016/j.celrep.2013.10.027; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Ichijima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008821; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuffer C, 2013, CHROMOSOMA, V122, P305, DOI 10.1007/s00412-013-0414-0; Kushner EJ, 2014, J CELL BIOL, V206, P257, DOI 10.1083/jcb.201311013; Kuznetsova AY, 2015, CELL CYCLE, V14, P2810, DOI 10.1080/15384101.2015.1068482; Lamm N, 2016, CELL STEM CELL, V18, P253, DOI 10.1016/j.stem.2015.11.003; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Mackay DR, 2015, MOL BIOL CELL, V26, P2217, DOI 10.1091/mbc.E14-11-1563; Nicholson JM, 2015, ELIFE, V4, DOI 10.7554/eLife.05068; Nicholson JM, 2011, ADV CANCER RES, V112, P43, DOI 10.1016/B978-0-12-387688-1.00003-X; Ogden A, 2013, CANCER METAST REV, V32, P269, DOI 10.1007/s10555-012-9413-5; Passerini V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10754; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Potapova TA, 2016, MOL BIOL CELL, V27, P3065, DOI 10.1091/mbc.E16-05-0268; Ried T, 2012, BBA-GENE REGUL MECH, V1819, P784, DOI 10.1016/j.bbagrm.2012.02.020; Ruiz S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9036; Rutledge SD, 2016, CURR OPIN CELL BIOL, V40, P41, DOI 10.1016/j.ceb.2016.02.003; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Selmecki AM, 2015, NATURE, V519, P349, DOI 10.1038/nature14187; Sheltzer JM, 2017, CANCER CELL, V31, P240, DOI 10.1016/j.ccell.2016.12.004; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Silkworth WT, 2012, MOL BIOL CELL, V23, P401, DOI 10.1091/mbc.E11-02-0095; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szilard RK, 2010, NAT STRUCT MOL BIOL, V17, P299, DOI 10.1038/nsmb.1754; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wilhelm T, 2014, P NATL ACAD SCI USA, V111, P763, DOI 10.1073/pnas.1311520111; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhu J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002719	60	32	32	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3502	3517		10.1096/fj.201700247RR	http://dx.doi.org/10.1096/fj.201700247RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29452566	Green Published			2022-12-26	WOS:000435104500003
J	Shi, SY; Lu, YW; Liu, Z; Stevens, J; Murawsky, CM; Wilson, V; Hu, ZH; Richards, WG; Michaels, ML; Zhang, J; Yan, W; Li, Y				Shi, Sally Yu; Lu, Ya-Wen; Liu, Zhi; Stevens, Jennitte; Murawsky, Christopher M.; Wilson, Vicki; Hu, Zhonghua; Richards, William G.; Michaels, Mark Leo; Zhang, Jun; Yan, Wei; Li, Yang			A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-KLOTHO; BISPECIFIC ANTIBODIES; METABOLIC-ACTIVITY; FGF21	Bispecific antibodies have become important formats for therapeutic discovery. They allow for potential synergy by simultaneously engaging two separate targets and enable new functions that are not possible to achieve by using a combination of two monospecific antibodies. Antagonistic antibodies dominate drug discovery today, but only a limited number of agonistic antibodies (i.e. those that activate receptor signaling) have been described. For receptors formed by two components, engaging both of these components simultaneously may be required for agonistic signaling. As such, bispecific antibodies may be particularly useful in activating multicomponent receptor complexes. Here, we describe a biparatopic (i.e. targeting two different epitopes on the same target) format that can activate the endocrine fibroblast growth factor (FGF) 21 receptor (FGFR) complex containing beta-Klotho and FGFR1c. This format was constructed by grafting two different antigen-specific VH domains onto the VH and VL positions of an IgG, yielding a tetravalent binder with two potential geometries, a close and a distant, between the two paratopes. Our results revealed that the biparatopic molecule provides activities that are not observed with each paratope alone. Our approach could help address the challenges with heterogeneity inherent in other bispecific formats and could provide the means to adjust intramolecular distances of the antibody domains to drive optimal activity in a bispecific format. In conclusion, this format is versatile, is easy to construct and produce, and opens a new avenue for agonistic antibody discovery and development.	[Shi, Sally Yu; Lu, Ya-Wen; Richards, William G.; Zhang, Jun; Li, Yang] Amgen Inc, San Francisco, CA 94080 USA; [Liu, Zhi; Stevens, Jennitte; Hu, Zhonghua; Michaels, Mark Leo; Yan, Wei] Amgen Inc, Thousand Oaks, CA 91320 USA; [Murawsky, Christopher M.; Wilson, Vicki] Amgen British Columbia Inc, Burnaby, BC V5A 1V7, Canada	Amgen; Amgen	Li, Y (corresponding author), Dept Cardiometab Disorders, 1120 Vet Blvd, San Francisco, CA 94080 USA.	yangln3101@gmail.com	Lu, Ya-Wen/A-7813-2016	Lu, Ya-Wen/0000-0003-0479-1471; Murawsky, Christopher/0000-0002-9698-052X				Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Brinkmann U, 2017, MABS-AUSTIN, V9, P182, DOI 10.1080/19420862.2016.1268307; Foltz IN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004690; Gimeno RE, 2014, TRENDS ENDOCRIN MET, V25, P303, DOI 10.1016/j.tem.2014.03.001; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Grujic O, 2017, BIOCHEM BIOPH RES CO, V486, P985, DOI 10.1016/j.bbrc.2017.03.145; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hecht R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049345; Janssens R, 2006, P NATL ACAD SCI USA, V103, P15130, DOI 10.1073/pnas.0601108103; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2014, MOL METAB, V3, P221, DOI 10.1016/j.molmet.2013.12.003; Kolumam G, 2015, EBIOMEDICINE, V2, P730, DOI 10.1016/j.ebiom.2015.05.028; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Moraga I, 2015, CELL, V160, P1196, DOI 10.1016/j.cell.2015.02.011; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Spiess C, 2015, MOL IMMUNOL, V67, P95, DOI 10.1016/j.molimm.2015.01.003; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Zhang J, 2014, DRUG DISCOV TODAY, V19, P579, DOI 10.1016/j.drudis.2013.10.021; Zhang J, 2015, GERIATR ORTHOP SURG, V6, P168, DOI 10.1177/2151458515583111	22	14	14	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5909	5919		10.1074/jbc.RA118.001752	http://dx.doi.org/10.1074/jbc.RA118.001752			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29483191	Green Published, hybrid			2022-12-26	WOS:000430497300013
J	Carroll, RG; Zaslona, Z; Galvan-Pena, S; Koppe, EL; Sevin, DC; Angiari, S; Triantafilou, M; Triantafilou, K; Modis, LK; O'Neill, LA				Carroll, Richard G.; Zaslona, Zbigniew; Galvan-Pena, Silvia; Koppe, Emma L.; Sevin, Daniel C.; Angiari, Stefano; Triantafilou, Martha; Triantafilou, Kathy; Modis, Louise K.; O'Neill, Luke A.			An unexpected link between fatty acid synthase and cholesterol synthesis in proinflammatory macrophage activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELL ACTIVATION; LIPID RAFTS; ALTERNATIVE ACTIVATION; FOAM CELL; METABOLISM; INHIBITOR; PROTEIN; SIGNAL; ACCUMULATION; INFLAMMATION	Different immune activation states require distinct metabolic features and activities in immune cells. For instance, inhibition of fatty acid synthase (FASN), which catalyzes the synthesis of long-chain fatty acids, prevents the proinflammatory response in macrophages; however, the precise role of this enzyme in this response remains poorly defined. Consistent with previous studies, we found here that FASN is essential for lipopolysaccha-ride-induced, Toll-like receptor (TLR)-mediated macrophage activation. Interestingly, only agents that block FASN upstream of acetoacetyl-CoA synthesis, including the well-characterized FASN inhibitor C75, inhibited TLR4 signaling, while those acting downstream had no effect. We found that acetoacetyl-CoA could overcome C75's inhibitory effect, whereas other FASN metabolites, including palmitate, did not prevent C75-mediated inhibition. This suggested an unexpected role for acetoacetyl-CoA in inflammation that is independent of its role in palmitate synthesis. Our evidence further suggested that acetoacetyl-CoA arising from FASN activity promotes cholesterol production, indicating a surprising link between fatty acid synthesis and cholesterol synthesis. We further demonstrate that this process is required for TLR4 to enter lipid rafts and facilitate TLR4 signaling. In conclusion, we have uncovered an unexpected link between FASN and cholesterol synthesis that appears to be required for TLR signal transduction and proinflammatory macrophage activation.	[Carroll, Richard G.; Zaslona, Zbigniew; Galvan-Pena, Silvia; Angiari, Stefano; O'Neill, Luke A.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Carroll, Richard G.; Galvan-Pena, Silvia; Koppe, Emma L.; Triantafilou, Martha; Triantafilou, Kathy; Modis, Louise K.; O'Neill, Luke A.] GlaxoSmithKline, Immunol Catalyst, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England; [Triantafilou, Martha; Triantafilou, Kathy] Cardiff Univ, Univ Hosp Wales, Inst Infect & Immun, Sch Med, Cardiff CF14 4XW, S Glam, Wales; [Sevin, Daniel C.] GlaxoSmithKline, Cellzome, Meyerhofstr 1, D-69117 Heidelberg, Germany	Trinity College Dublin; GlaxoSmithKline; Cardiff University; GlaxoSmithKline; Cellzome GmbH	O'Neill, LA (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie		Angiari, Stefano/0000-0003-4434-2224; Galvan-Pena, Silvia/0000-0003-1639-2048; Carroll, Richard/0000-0001-9917-3443; O'Neill, Luke/0000-0002-4333-2748; Zaslona, Zbigniew/0000-0003-3361-4140	Science Foundation Ireland (SFI) [SFI12/IA/1531]; Wellcome Trust [109443/Z/15/Z]	Science Foundation Ireland (SFI)(Science Foundation Ireland); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Science Foundation Ireland (SFI) Grant SFI12/IA/1531 and Wellcome Trust Grant 109443/Z/15/Z. The authors declare that they have no conflicts of interest with the contents of this article.	Carlisle-Moore L, 2005, J BIOL CHEM, V280, P42612, DOI 10.1074/jbc.M507082200; Chen C, 2014, J BIOL CHEM, V289, P17184, DOI 10.1074/jbc.M114.550806; Choi MS, 2016, J LIPID RES, V57, P607, DOI 10.1194/jlr.M065805; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gubern A, 2009, J BIOL CHEM, V284, P5697, DOI 10.1074/jbc.M806173200; Hardwicke MA, 2014, NAT CHEM BIOL, V10, P774, DOI [10.1038/NCHEMBIO.1603, 10.1038/nchembio.1603]; Hegyi L, 1996, J PATHOL, V180, P423, DOI 10.1002/(SICI)1096-9896(199612)180:4<423::AID-PATH677>3.0.CO;2-1; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Jin QR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2777; Joshi AK, 1997, BIOCHEMISTRY-US, V36, P2316, DOI 10.1021/bi9626968; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Kutchma AJ, 1999, J BACTERIOL, V181, P5498, DOI 10.1128/JB.181.17.5498-5504.1999; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Lehninger A. L., 1993, PRINCIPLES BIOCH; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; OMURA S, 1976, BACTERIOL REV, V40, P681, DOI 10.1128/MMBR.40.3.681-697.1976; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Ruysschaert JM, 2015, BBA-BIOMEMBRANES, V1848, P1860, DOI 10.1016/j.bbamem.2015.03.014; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Triantafilou M, 2002, J CELL SCI, V115, P2603; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wei XC, 2016, NATURE, V539, P294, DOI 10.1038/nature20117; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486	38	83	87	5	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5509	5521		10.1074/jbc.RA118.001921	http://dx.doi.org/10.1074/jbc.RA118.001921			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29463677	Green Published, hybrid			2022-12-26	WOS:000430044100014
J	Jentsch, JA; Kiburu, I; Pandey, K; Timme, M; Ramlall, T; Levkau, B; Wu, J; Eliezer, D; Boudker, O; Menon, AK				Jentsch, Julian-Alexander; Kiburu, Irene; Pandey, Kalpana; Timme, Michael; Ramlall, Trudy; Levkau, Bodo; Wu, Jin; Eliezer, David; Boudker, Olga; Menon, Anant K.			Structural basis of sterol binding and transport by a yeast StARkin domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE CONTACT SITES; LIPID TRANSFER PROTEINS; PLASMA-MEMBRANE; EVOLUTIONARY CONSERVATION; STRUCTURE REFINEMENT; LIGAND-BINDING; CHOLESTEROL; MECHANISM; STARD4; HOMEOSTASIS	The StARkin superfamily comprises proteins with steroidogenic acute regulatory protein-related lipid transfer (StART) domains that are implicated in intracellular, non-vesicular lipid transport. A new family of membrane-anchored StARkins was recently identified, including six members, Lam1-Lam6, in the yeast Saccharomyces cerevisiae. Lam1-Lam4 are anchored to the endoplasmic reticulum (ER) membrane at sites where the ER is tethered to the plasma membrane and proposed to be involved in sterol homeostasis in yeast. To better understand the biological roles of these proteins, we carried out a structure-function analysis of the second StARkin domain of Lam4, here termed Lam4S2. NMR experiments indicated that Lam4S2 undergoes specific conformational changes upon binding sterol, and fluorescence-based assays revealed that it catalyzes sterol transport between vesicle populations in vitro, exhibiting a preference for vesicles containing anionic lipids. Using such vesicles, we found that sterols are transported at a rate of similar to 50 molecules per Lam4S2 per minute. Crystal structures of Lam4S2, with and without bound sterol, revealed a largely hydrophobic but surprisingly accessible sterol-binding pocket with the 3-OH group of the sterol oriented toward its base. Single or multiple alanine or aspartic acid replacements of conserved lysine residues in a basic patch on the surface of Lam4S2 near the likely sterol entry/egress site strongly attenuated sterol transport. Our results suggest that Lam4S2 engages anionic membranes via a basic surface patch, enabling "head-first" entry of sterol into the binding pocket followed by partial closure of the entryway. Reversal of these steps enables sterol egress.	[Jentsch, Julian-Alexander; Pandey, Kalpana; Timme, Michael; Ramlall, Trudy; Wu, Jin; Eliezer, David; Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA; [Kiburu, Irene; Boudker, Olga] Weill Cornell Med Coll, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10065 USA; [Boudker, Olga] Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY 10065 USA; [Jentsch, Julian-Alexander; Levkau, Bodo] Univ Hosp Essen, Inst Pathophysiol, West German Heart & Vasc Ctr, D-45122 Essen, Germany	Cornell University; Cornell University; Cornell University; Howard Hughes Medical Institute; University of Duisburg Essen	Eliezer, D; Menon, AK (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.; Boudker, O (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10065 USA.	dae2005@med.cornell.edu; olb2003@med.cornell.edu; akm2003@med.cornell.edu	Pandey, Kalpana/GNW-5078-2022; Menon, Anant/AAN-8663-2021	Menon, Anant/0000-0001-6924-2698; Pandey, Kalpana/0000-0002-7048-0690	Deutsche Forschungsgemeinschaft; Qatar National Research Fund [NPRP 7-082-1-014]; National Institutes of Health [R01 GM117518, R37 AG019391, R37 NS085318]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS085318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG019391] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Qatar National Research Fund(Qatar National Research Fund (QNRF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Graduiertenkolleg 2098, Project 11, from the Deutsche Forschungsgemeinschaft (to J.-A.J., B.L., and A.K.M.); Qatar National Research Fund Grant NPRP 7-082-1-014 (to A.K.M.); and National Institutes of Health Grants R01 GM117518 (to D.E.), R37 AG019391 (to D.E.), and R37 NS085318 (to O.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Barbar E, 2009, MOL CELL ENDOCRINOL, V300, P89, DOI 10.1016/j.mce.2008.12.007; Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Beh CT, 2012, J BIOL CHEM, V287, P11481, DOI 10.1074/jbc.R111.338400; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dittman JS, 2017, TRENDS BIOCHEM SCI, V42, P90, DOI 10.1016/j.tibs.2016.11.004; Elbaz-Alon Y, 2015, CELL REP, V12, P7, DOI 10.1016/j.celrep.2015.06.022; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gatta AT, 2018, BIOCHEM BIOPH RES CO, V495, P2270, DOI 10.1016/j.bbrc.2017.12.109; Gatta AT, 2015, ELIFE, V4, DOI 10.7554/eLife.07253; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Iaea DB, 2015, BIOCHEMISTRY-US, V54, P4623, DOI 10.1021/acs.biochem.5b00618; Iaea DB, 2015, ESSAYS BIOCHEM, V57, P43, DOI [10.1042/BSE0570043, 10.1042/bse0570043]; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; John K, 2002, BIOPHYS J, V83, P1525, DOI 10.1016/S0006-3495(02)73922-2; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; Khafif M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-222; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Letourneau D, 2016, SCI REP-UK, V6, DOI 10.1038/srep28486; Letourneau D, 2013, BBA-MOL CELL BIOL L, V1831, P1589, DOI 10.1016/j.bbalip.2013.07.005; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCLEAN LR, 1981, BIOCHEMISTRY-US, V20, P2893, DOI 10.1021/bi00513a028; Mesmin B, 2011, MOL BIOL CELL, V22, P4004, DOI 10.1091/mbc.E11-04-0372; Murcia M, 2006, J LIPID RES, V47, P2614, DOI 10.1194/jlr.M600232-JLR200; Murley A, 2015, J CELL BIOL, V209, P539, DOI 10.1083/jcb.201502033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Reinisch KM, 2016, BBA-MOL CELL BIOL L, V1861, P924, DOI 10.1016/j.bbalip.2015.12.003; Romanowski MJ, 2002, P NATL ACAD SCI USA, V99, P6949, DOI 10.1073/pnas.052140699; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Saheki Y, 2016, NAT CELL BIOL, V18, P504, DOI 10.1038/ncb3339; Sullivan DP, 2009, EUKARYOT CELL, V8, P161, DOI 10.1128/EC.00135-08; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thorsell AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019521; Tong J, 2018, P NATL ACAD SCI USA, V115, pE856, DOI 10.1073/pnas.1719709115; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Wong LH, 2016, BIOCHEM SOC T, V44, P517, DOI 10.1042/BST20150275	48	24	24	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5522	5531		10.1074/jbc.RA118.001881	http://dx.doi.org/10.1074/jbc.RA118.001881			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29463678	Green Published, hybrid			2022-12-26	WOS:000430044100015
J	Michaud, K; de Tayrac, M; D'Astous, M; Paquet, C; Gould, PV; Saikali, S				Michaud, Karine; de Tayrac, Marie; D'Astous, Myreille; Paquet, Claudie; Gould, Peter Vincent; Saikali, Stephan			Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; PROGNOSTIC VALUE; MICROVASCULAR PROLIFERATION; CELL-PROLIFERATION; ASTROCYTIC TUMORS; ALPHA-INTERNEXIN; EXPRESSION; GLIOMAS; P16(INK4A); CANCER	Objective To study the presence of 9p deletion and p16, cyclin D1 and Myc expression and their respective diagnostic and prognostic interest in oligodendrogliomas. Methods We analyzed a retrospective series of 40 consecutive anaplastic oligodendrogliomas (OIII) from a single institution and compared them to a control series of 10 low grade oligodendrogliomas (OII). Automated FISH analysis of chromosome 9p status and immunohistochemistry for p16, cyclin D1 and Myc was performed for all cases and correlated with clinical and histological data, event free survival (EFS) and overall survival (OS). Results Chromosome 9p deletion was observed in 55% of OIII (22/40) but not in OII. Deletion was highly correlated to EFS (median = 29 versus 53 months, p<0.0001) and OS (median = 48 versus 83 months, p<0.0001) in both the total cohort and the OIII population. In 9p nondeleted oligodendrogliomas, p16 hyperexpression correlated with a shorter OS (p = 0.02 in OII and p = 0.0001 in OIII) whereas lack of p16 expression was correlated to a shorter EFS and OS in 9p deleted OIII (p = 0.001 and p = 0.0002 respectively). Expression of Cyclin D1 was significantly higher in OIII (median expression 45% versus 14% for OII, p = 0.0006) and was correlated with MIB-1 expression (p< 0.0001), vascular proliferation (p = 0.002), tumor necrosis (p = 0.04) and a shorter EFS in the total cohort (p = 0.05). Hyperexpression of Myc was correlated to grade (median expression 27% in OII versus 35% in OIII, p = 0.03), and to a shorter EFS in 9p non-deleted OIII (p = 0.01). Conclusion Chromosome 9p deletion identifies a subset of OIII with significantly worse prognosis. The combination of 9p status and p16 expression level identifies two distinct OIII populations with divergent prognosis. Hyperexpression of Bcl1 and Myc appears highly linked to anaplasia but the prognostic value is unclear and should be investigated further.	[Michaud, Karine; D'Astous, Myreille] CHU Quebec, Dept Neurosurg, Quebec City, PQ, Canada; [de Tayrac, Marie] CHU Rennes, Dept Genom & Mol Genet, Rennes, France; [Paquet, Claudie; Gould, Peter Vincent; Saikali, Stephan] CHU Quebec, Dept Pathol, Quebec City, PQ, Canada	Laval University; CHU Rennes; Laval University	Saikali, S (corresponding author), CHU Quebec, Dept Pathol, Quebec City, PQ, Canada.	stephan.saikali.cha@ssss.gouv.qc.ca	Michaud, Karine/AAM-3026-2020; de Tayrac, Marie/AAG-7800-2020	Saikali, Stephan/0000-0002-6966-7538	Fondation du CHU de Quebec [2885]	Fondation du CHU de Quebec	This work was supported by grants from Fondation du CHU de Quebec (grant #2885) to SS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldosari N, 2002, ARCH PATHOL LAB MED, V126, P540; Alentorn A, 2015, NEUROLOGY, V85, P1325, DOI 10.1212/WNL.0000000000002014; Bai H, 2016, NAT GENET, V48, P59, DOI 10.1038/ng.3457; Barker FG, 1997, J NEURO-ONCOL, V31, P17, DOI 10.1023/A:1005768910871; Bigner SH, 1999, AM J PATHOL, V155, P375, DOI 10.1016/S0002-9440(10)65134-6; Bortolotto S, 2000, INT J CANCER, V88, P554, DOI 10.1002/1097-0215(20001115)88:4<554::AID-IJC6>3.0.CO;2-Q; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Cavalla P, 1998, ACTA NEUROPATHOL, V95, P131, DOI 10.1007/s004010050776; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Dang CV, 2005, CANCER CELL, V8, P177, DOI 10.1016/j.ccr.2005.08.005; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Duval C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132125; Eide HA, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2104-9; Fallon KB, 2004, J NEUROPATH EXP NEUR, V63, P314, DOI 10.1093/jnen/63.4.314; Faria MH, 2008, ACTA NEUROPATHOL, V116, P87, DOI 10.1007/s00401-008-0368-0; Fiano V, 2003, NEUROSCI LETT, V347, P111, DOI 10.1016/S0304-3940(03)00615-3; Figarella-Branger D, 2014, NEURO-ONCOLOGY, V16, P1244, DOI 10.1093/neuonc/nou047; Gearhart J, 2007, NEW ENGL J MED, V357, P1469, DOI 10.1056/NEJMp078126; Giannini C, 2001, J NEUROPATH EXP NEUR, V60, P248, DOI 10.1093/jnen/60.3.248; Godraind C, 2003, NEUROPATH APPL NEURO, V29, P462, DOI 10.1046/j.1365-2990.2003.00484.x; Jenkins RB, 2012, NAT GENET, V44, P1122, DOI 10.1038/ng.2388; Jeon YK, 2007, NEUROPATHOLOGY, V27, P10, DOI 10.1111/j.1440-1789.2006.00735.x; Kamoun A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11263; Lebok P, 2016, ONCOTARGET, V7, P81322, DOI 10.18632/oncotarget.13227; Li JN, 2011, BIOCHEMISTRY-US, V50, P5566, DOI 10.1021/bi200642e; Louis, 2016, WHO CLASSIFICATION G; Louis DN, 2016, ACTA NEUROPATHOL, V5, P429; Matsumura N, 2015, BRAIN TUMOR PATHOL, V32, P261, DOI 10.1007/s10014-015-0228-2; Michaud K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168728; Miettinen H, 1999, J NEURO-ONCOL, V41, P205, DOI 10.1023/A:1006185220369; Mokhtari K, 2011, CANCER-AM CANCER SOC, V117, P3014, DOI 10.1002/cncr.25827; Odia Y, 2013, J NEURO-ONCOL, V115, P249, DOI 10.1007/s11060-013-1221-4; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Perry A, 1997, J NEUROPATH EXP NEUR, V56, P999, DOI 10.1097/00005072-199709000-00005; Preusser M, 2012, HISTOPATHOLOGY, V60, P885, DOI 10.1111/j.1365-2559.2011.04134.x; Qie S, 2016, J MOL MED, V94, P1313, DOI 10.1007/s00109-016-1475-3; Ranuncolo SM, 2004, J NEURO-ONCOL, V68, P113, DOI 10.1023/B:NEON.0000027741.19213.99; Reuss DE, 2015, ACTA NEUROPATHOL, V129, P133, DOI 10.1007/s00401-014-1370-3; Reyes-Botero G, 2014, NEURO-ONCOLOGY, V16, P662, DOI 10.1093/neuonc/not235; Sahm F, 2014, ACTA NEUROPATHOL, V128, P551, DOI 10.1007/s00401-014-1326-7; Sallinen SL, 1999, J PATHOL, V188, P289; SHIMIZU KT, 1993, RADIOLOGY, V186, P569, DOI 10.1148/radiology.186.2.8421767; Suh JH, 2013, J KOREAN MED SCI, V28, P593, DOI 10.3346/jkms.2013.28.4.593; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Swartling FJ, 2012, UPSALA J MED SCI, V117, P122, DOI 10.3109/03009734.2012.658975; Watanabe T, 2001, ACTA NEUROPATHOL, V101, P185; Wesseling P, 2015, ACTA NEUROPATHOL, V129, P809, DOI 10.1007/s00401-015-1424-1; Wiestler B, 2013, ACTA NEUROPATHOL, V126, P443, DOI 10.1007/s00401-013-1156-z; Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776; Wolter M, 2001, J NEUROPATH EXP NEUR, V60, P1170, DOI 10.1093/jnen/60.12.1170; Zhang X, 2005, J CLIN NEUROSCI, V12, P166, DOI 10.1016/j.jocn.2004.03.036; Zlatescu MC, 2001, CANCER RES, V61, P6713	54	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193213	10.1371/journal.pone.0193213	http://dx.doi.org/10.1371/journal.pone.0193213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489901	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000058
J	Zapata-Rios, G; Branch, LC				Zapata-Rios, Galo; Branch, Lyn C.			Mammalian carnivore occupancy is inversely related to presence of domestic dogs in the high Andes of Ecuador	PLOS ONE			English	Article							FREE-ROAMING DOGS; WEASEL MUSTELA; SCENT-MARKING; THRESHOLDS; LANDSCAPE; PATTERNS; FOREST; CONSERVATION; WILDLIFE; FRAGMENTATION	Although the Andes have long been occupied by people, habitat loss, fragmentation through deforestation, and other human activities such as introduction of invasive species have increased drastically during the past century. The Ecuadorian Andes are considered a biodiversity hotspot. However, the fauna and threats to the region are poorly studied, and understanding of factors that shape the distribution of species in habitats disturbed by human activities is needed to identify and mitigate region-wide threats to wildlife. We evaluated factors associated with patterns of occurrence of Andean carnivores in landscapes of the northern Ecuadorian Andes, particularly habitat loss, fragmentation, and occupancy of domestic dogs, and determined whether thresholds occurred for these factors beyond which carnivore occurrence declined markedly. Five study areas (each 20 x 20 km) were surveyed with a total effort of 2,800 camera trap nights. Occupancies of four of the eight carnivores known from the region were best predicted by occupancy of domestic dogs rather than measures of habitat loss and fragmentation [Andean fox (Pseudalopex culpaeus), puma (Puma concolor), striped hog-nosed skunk (Conepatus semistriatus), and Andean bear (Tremarctos ornatus)]. The two largest carnivores, puma and Andean bear, demonstrated significant threshold responses to the presence of domestic dogs at two sites. Four smaller carnivores were recorded too infrequently to model occupancy, and at least two of these species appear to be in decline. The magnitude of domestic dog impacts on native species in tropical areas like the Ecuadorian Andes currently are not recognized. Results of our study indicate that small and large carnivores are in urgent need of conservation and clearly point to dogs as a significant threat to a broad range of native species.	[Zapata-Rios, Galo; Branch, Lyn C.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Zapata-Rios, Galo] Ecuador Program, Wildlife Conservat Soc, Paris, Quito, Ecuador	State University System of Florida; University of Florida	Zapata-Rios, G (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.; Zapata-Rios, G (corresponding author), Ecuador Program, Wildlife Conservat Soc, Paris, Quito, Ecuador.	gzapata@wcs.org		Zapata-Rios, Galo/0000-0003-3508-5078	Compton Foundation through Program for Tropical Studies and Conservation, University of Florida; Proyecto Paramo Andino, CONDESAN; Tropical Conservation and Development Program, University of Florida; Amazon Conservation Leadership Initiative, University of Florida; Amazon Andes Conservation Program, Wildlife Conservation Society; SENESCYT Ecuador	Compton Foundation through Program for Tropical Studies and Conservation, University of Florida; Proyecto Paramo Andino, CONDESAN; Tropical Conservation and Development Program, University of Florida; Amazon Conservation Leadership Initiative, University of Florida; Amazon Andes Conservation Program, Wildlife Conservation Society; SENESCYT Ecuador	This work was supported by: Compton Foundation through Program for Tropical Studies and Conservation, University of Florida (GZR); Proyecto Paramo Andino, CONDESAN (GZR); Tropical Conservation and Development Program, University of Florida (GZR); Amazon Conservation Leadership Initiative, University of Florida (GZR); Amazon Andes Conservation Program, Wildlife Conservation Society (GZR); and SENESCYT Ecuador (GZR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Ausband D, 2009, ORYX, V43, P73, DOI 10.1017/S0030605308001622; Bailey LL, 2009, BIOL CONSERV, V142, P2983, DOI 10.1016/j.biocon.2009.07.028; Balaguera-Reina Sergio A., 2009, Small Carnivore Conservation, V41, P35; Baquero F, 2004, VEGETACION ANDES ECU; Barea-Azcon JM, 2007, BIODIVERS CONSERV, V16, P1213, DOI 10.1007/s10531-006-9114-x; Betts MG, 2007, CONSERV BIOL, V21, P1046, DOI 10.1111/j.1523-1739.2007.00723.x; Broquet T, 2006, MOL ECOL, V15, P1689, DOI 10.1111/j.1365-294X.2006.02878.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; Craft ME, 2017, ANIM CONSERV, V20, P193, DOI 10.1111/acv.12305; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cuesta Francisco, 2003, Ursus (Knoxville), V14, P198; Duellman WE, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P255; Elbroch M, 2009, REV CHIL HIST NAT, V82, P459; ERLINGE S, 1982, ANIM BEHAV, V30, P811, DOI 10.1016/S0003-3472(82)80154-1; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Gehring TM, 2004, J MAMMAL, V85, P79, DOI 10.1644/1545-1542(2004)085&lt;0079:HRAMOL&gt;2.0.CO;2; Gerber BD, 2012, POPUL ECOL, V54, P43, DOI 10.1007/s10144-011-0276-3; Goldstein I, 2006, URSUS, V17, P8, DOI 10.2192/1537-6176(2006)17[8:ABCAR]2.0.CO;2; Gompper ME, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P9; Guenette JS, 2005, CONSERV BIOL, V19, P1168, DOI 10.1111/j.1523-1739.2005.00085.x; HESS CG, 1990, MT RES DEV, V10, P333, DOI 10.2307/3673495; Hines J., 2006, PRESENCE2 SOFTWARE E; Hughes J, 2013, BIOL CONSERV, V157, P341, DOI 10.1016/j.biocon.2012.07.005; Hutchings MR, 2000, MAMMAL REV, V30, P157, DOI 10.1046/j.1365-2907.2000.00065.x; Instituto Ecuatoriano de Estadisticas y Censos (INEC), 2014, EC CIFR POBL DEM; IUCN, 2013, IUCN RED LIST THREAT; IZOR RJ, 1978, J MAMMAL, V59, P92, DOI 10.2307/1379878; Knapp S, 2002, BOT REV, V68, P22, DOI 10.1663/0006-8101(2002)068[0022:APOPEI]2.0.CO;2; Legendre P., 2012, NUMERICAL ECOLOGY; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Lindenmayer DB, 2005, BIOL CONSERV, V124, P311, DOI 10.1016/j.biocon.2005.01.038; Lindenmayer DB, 2005, BIOL CONSERV, V124, P351, DOI 10.1016/j.biocon.2005.01.041; Lucherini M, 2009, J MAMMAL, V90, P1404, DOI 10.1644/09-MAMM-A-002R.1; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manor R, 2004, BIOL CONSERV, V119, P231, DOI 10.1016/j.biocon.2003.11.005; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; Muntifering JR, 2006, ANIM CONSERV, V9, P103, DOI 10.1111/j.1469-1795.2005.00008.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Novaro Andres J., 1997, Mammalian Species, V0, P1; Parsons AW, 2016, BIOL CONSERV, V203, P75, DOI 10.1016/j.biocon.2016.09.001; Parsons J. J., 1982, Mountain Research and Development, V2, P253, DOI 10.2307/3673089; Peralvo MF, 2005, URSUS, V16, P222, DOI 10.2192/1537-6176(2005)016[0222:DPHAFT]2.0.CO;2; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; R Core Team, 2021, R LANGUAGE ENV STAT; Radford JQ, 2004, BIOL CONSERV, V117, P375, DOI 10.1016/j.biocon.2003.08.002; Rios-Uzeda B, 2006, J ZOOL, V268, P271, DOI 10.1111/j.1469-7998.2005.00013.x; RODRIGUEZ EA, 2010, AUSTRAL ECOLOGY, V35, P765; Saito J., 2009, ECOSISTEMAS ANDES NO; Sanchez F, 2008, CALDASIA, V30, P197; Sarmiento FO, 2002, GEOGR REV, V92, P213, DOI 10.2307/4140971; Sarmiento FO, 2000, AMBIO, V29, P423, DOI 10.1639/0044-7447(2000)029[0423:BMPEEO]2.0.CO;2; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Sheffield Steven R., 1997, Mammalian Species, V570, P1; Silva-Rodriguez EA, 2012, BIOL CONSERV, V150, P103, DOI 10.1016/j.biocon.2012.03.008; Silva-Rodriguez EA, 2011, CONSERV BIOL, V25, P808, DOI 10.1111/j.1523-1739.2011.01690.x; Silva-Rodriguez EA, 2010, ORYX, V44, P97, DOI 10.1017/S0030605309990445; Smith DA, 2008, BIOL CONSERV, V141, P925, DOI 10.1016/j.biocon.2007.12.021; Smith JNM, 2002, TRENDS ECOL EVOL, V17, P397, DOI 10.1016/S0169-5347(02)02576-4; STASINOPOULOS DM, 1992, COMPUT STAT DATA AN, V13, P461, DOI 10.1016/0167-9473(92)90119-Z; Sunquist ME, 2001, CONSERV BIOL SER, V5, P399; Swihart RK, 2003, J BIOGEOGR, V30, P1259, DOI 10.1046/j.1365-2699.2003.00925.x; Tabarelli M, 2004, BIODIVERS CONSERV, V13, P1419, DOI 10.1023/B:BIOC.0000019398.36045.1b; Tirira D., 2011, LIBRO ROJO MAMIFEROS; Tirira D., 2007, MAMIFEROS ECUADOR GU; Tirira Diego G., 2009, Small Carnivore Conservation, V41, P46; Torres PC, 2010, BRAZ J BIOL, V70, P987, DOI 10.1590/S1519-69842010000500010; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Vanak AT, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P69; Vanak AT, 2010, J APPL ECOL, V47, P1225, DOI 10.1111/j.1365-2664.2010.01870.x; Vanak AT, 2009, MAMMAL REV, V39, P265, DOI 10.1111/j.1365-2907.2009.00148.x; Villalba M. Lilian, 2012, Endangered Species Research, V16, P85, DOI 10.3354/esr00389; Winckell A, 1997, REGIONES PAISAJES EC; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; Wolf J., 2002, ECOTROPICOS, V15, P3; Wong DWS, 2005, STAT ANAL GEOGRAPHIC; Young JK, 2011, BIOSCIENCE, V61, P125, DOI 10.1525/bio.2011.61.2.7; Young KR, 1997, LANDSCAPE URBAN PLAN, V38, P137, DOI 10.1016/S0169-2046(97)00029-7; Zapata-Rios G, 2016, BIOL CONSERV, V193, P9, DOI 10.1016/j.biocon.2015.10.016; Zapata-Rios G, 2009, ORYX, V43, P375, DOI 10.1017/S0030605309001914; Zuckerberg B, 2010, BIOL CONSERV, V143, P952, DOI 10.1016/j.biocon.2010.01.004	88	22	27	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192346	10.1371/journal.pone.0192346	http://dx.doi.org/10.1371/journal.pone.0192346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489855	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000024
J	Bail, K; Draper, B; Berry, H; Karmel, R; Goss, J				Bail, Kasia; Draper, Brian; Berry, Helen; Karmel, Rosemary; Goss, John			Predicting excess cost for older inpatients with clinical complexity: A retrospective cohort study examining cognition, comorbidities and complications	PLOS ONE			English	Article							LENGTH-OF-STAY; HOSPITAL-ACQUIRED COMPLICATIONS; PATIENT SAFETY PROGRAMS; ADVERSE EVENTS; CONDITIONS INFORMATION; FUNCTIONAL DECLINE; ELDERLY-PATIENTS; AFTER-DISCHARGE; MARGINAL COSTS; HIP-FRACTURES	Background Hospital-acquired complications increase length of stay and contribute to poorer patient outcomes. Older adults are known to be at risk for four key hospital-acquired complications (pressure injuries, pneumonia, urinary tract infections and delirium). These complications have been identified as sensitive to nursing characteristics such as staffing levels and level of education. The cost of these complications compared to the cost of admission severity, dementia, other comorbidities or age has not been established. Method To investigate costs associated with nurse-sensitive hospital-acquired complications in an older patient population 157,178 overnight public hospital episodes for all patients over age 50 from one Australian state, 2006/07 were examined. A retrospective cohort study design with linear regression analysis provided modelling of length-of-stay costs. Explanatory variables included patient age, sex, comorbidities, admission severity, dementia status, surgical status and four complications. Extra costs were based on above-average length-of-stay for each patient's Diagnosis Related Group from hospital discharge data. Results For adults over 50 who have length of stay longer than average for their diagnostic condition, comorbid dementia predicts an extra cost of A$874, (US$1,247); any one of four key complications predicts A$812 (US$1,159); each increase in admission severity score predicts A $295 ($US421); each additional comorbidity predicts A$259 (US$370), and for each year of age above 50 predicts A$20 (US$29) (all estimates significant at p< 0.0001). Discussion Hospital-acquired complications and dementia cost more than other kinds of inpatient complexity, but admission severity is a better predictor of excess cost. Because complications are potentially preventable and dementia care in hospitals can be improved, risk-reduction strategies for common complications, particularly for patients with dementia could be cost effective. Conclusions Complications and dementia were found to cost more than other kinds of inpatient complexity.	[Bail, Kasia; Goss, John] Univ Canberra, Hlth Res Inst, Canberra, ACT, Australia; [Draper, Brian] Univ New South Wales, Prince Wales Hosp, Acad Dept Old Age Psychiat, Sch Psychiat, Sydney, NSW, Australia; [Berry, Helen] Univ Sydney, Sydney Med Sch, Sydney Sch Publ Hlth, Climate Change & Mental Hlth, Sydney, NSW, Australia; [Karmel, Rosemary] Australian Inst Hlth & Welf, Canberra, ACT, Australia	University of Canberra; University of New South Wales Sydney; University of Sydney	Bail, K (corresponding author), Univ Canberra, Hlth Res Inst, Canberra, ACT, Australia.	Kasia.Bail@canberra.edu.au	Bail, Kasia/AAN-7143-2020	Bail, Kasia/0000-0002-4797-0042	Dementia Collaborative Research Centre; National Health and Medical Research Council [465701]	Dementia Collaborative Research Centre; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	KB was sponsored by PhD Scholarship provided by Dementia Collaborative Research Centre. http://www.dementiaresearch.org.au. The PhD was nested in BD and RK's project that was supported by the National Health and Medical Research Council (grant number 465701). https://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackroyd-Stolarz Stacy, 2009, Healthc Manage Forum, V22, P32; Ackroyd-Stolarz Stacy, 2009, Healthc Q, V12 Spec No Patient, P34; Adams PD, 2014, AM J SURG, V208, P656, DOI 10.1016/j.amjsurg.2014.03.006; [Anonymous], AARHUS U DET JORDBRU; Arora V, 2007, J AM GERIATR SOC, V55, pS198; Australian Government, 2008, NAT HOSP COST DAT CO; Australian Institute of Health and Welfare, 2013, DEM CAR HOSP COSTS S; Australian Institute of Health and Welfare, 2013, HLTH EXP AUSTR 2011; Australian Institute of Health and Welfare, 2008, AUSTR HOSP STAT 2006; Australian Institute of Health and Welfare, 2001, EXP HLTH SERV AB TOR; Australian Institute of Health and Welfare, 2011, HOSP DEM SERV PROJ S; Australian Institute of Health and Welfare, 2013, AUSTR HOSP STAT 2011; Australian Institute of Health and Welfare, 2012, DER KEY PAT VAR TECH; Bail K, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0743-1; Bail K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002770; Bolbocean C, 2011, J HEALTH SERV RES PO, V16, P141; Bolbocean C, 2012, J HEALTH SERV RES PO, V17, P127, DOI 10.1258/jhsrp.2012.012007; Boltz M, 2012, GERIATR NURS, V33, P272, DOI 10.1016/j.gerinurse.2012.01.008; Borbasi S, 2006, GERIATR NURS, V27, P300, DOI 10.1016/j.gerinurse.2006.08.013; Briggs R, 2016, QJM-INT J MED, V109, P41, DOI 10.1093/qjmed/hcv085; Buurman BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029621; Calver J, 2006, MED J AUSTRALIA, V184, P393, DOI 10.5694/j.1326-5377.2006.tb00289.x; Chen LT, 2007, ANN ACAD MED SINGAP, V36, P784; Cho SH, 2003, NURS RES, V52, P71, DOI 10.1097/00006199-200303000-00003; Chuang KH, 2003, J AM GERIATR SOC, V51, P1729, DOI 10.1046/j.1532-5415.2003.51556.x; Dahl D, 2012, J HEALTHC MANAG, V57, P421, DOI 10.1097/00115514-201211000-00009; Dasgupta M, 2016, GERIATRICS, V1, P4; Dementia Australia, 2021, DEM AUSTR PREV EST 2; Diya L, 2012, J ADV NURS, V68, P1073, DOI 10.1111/j.1365-2648.2011.05812.x; Draper B, 2011, INT PSYCHOGERIATR, V23, P1649, DOI 10.1017/S1041610211001694; Duffield C, 2007, GLUEING IT TOGETHER; Ellidokuz H, 2003, ARCH GERONTOL GERIAT, V37, P259, DOI 10.1016/S0167-4943(03)00062-1; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Garcia AE, 2012, J ORTHOP TRAUMA, V26, P620, DOI 10.1097/BOT.0b013e3182695416; George J, 2013, J ROY SOC MED, V106, P355, DOI 10.1177/0141076813476497; Graves N, 2002, HEALTH ECON, V11, P735, DOI 10.1002/hec.683; Graves N, 2007, INFECT CONT HOSP EP, V28, P280, DOI 10.1086/512642; Graves N, 2007, INFECT CONT HOSP EP, V28, P178, DOI 10.1086/510787; Hickman L, 2007, J ADV NURS, V60, P113, DOI 10.1111/j.1365-2648.2007.04417.x; Hofmann W, 2013, Z GERONTOL GERIATR, V46, P198, DOI 10.1007/s00391-013-0485-9; Hu CJ, 2012, WORLD J SURG, V36, P2051, DOI 10.1007/s00268-012-1609-x; Ireland AW, 2015, BMC HEALTH SERV RES, P15; Jackson T, 2011, J HEALTH SERV RES PO, V16, P141, DOI 10.1258/jhsrp.2010.010050; Jackson TA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002247; Kalisch Beatrice J, 2012, Nurs Outlook, V60, pe32, DOI 10.1016/j.outlook.2012.04.006; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; Kay HF, 2014, J ORTHOP TRAUMA, V28, pE153, DOI 10.1097/01.bot.0000437568.84322.cd; Kuo YF, 2011, ANN INTERN MED, V155, P152, DOI 10.7326/0003-4819-155-3-201108020-00005; Long SJ, 2013, INT J QUAL HEALTH C, V25, P542, DOI 10.1093/intqhc/mzt056; Madden RH, 2015, INT J ENV RES PUB HE, V12, P5815, DOI 10.3390/ijerph120605815; Martin L, 2012, J CLIN NURS, V21, P2219, DOI 10.1111/j.1365-2702.2011.03862.x; Moerer O, 2007, CRIT CARE, V11, DOI 10.1186/cc5952; Mudge AM, 2008, J AM GERIATR SOC, V56, P630, DOI 10.1111/j.1532-5415.2007.01607.x; Naessens JM, 2012, AM J MED QUAL, V27, P48, DOI 10.1177/1062860611413456; Needleman J, 2001, NURSE STAFFING PATIE; Nikkel LE, 2012, J BONE JOINT SURG AM, V94A, P9, DOI [10.2106/JBJS.J.01077, 10.2106/JBJS.K.01214]; Olds DM, 2010, J SAFETY RES, V41, P153, DOI 10.1016/j.jsr.2010.02.002; Organisation for Economic Co-operation and Development, 2017, OECD HLTH STAT; Paddock S, 2006, TECHNICAL REPORT; Pappas SH, 2008, J NURS ADMIN, V38, P230, DOI 10.1097/01.NNA.0000312770.19481.ce; Parke B, 2010, J AGING STUD, V24, P115, DOI 10.1016/j.jaging.2008.09.003; Pitkaaho T, 2015, J ADV NURS, V71, P458, DOI 10.1111/jan.12550; Pugely AJ, 2014, CLIN ORTHOP RELAT R, V472, P3943, DOI 10.1007/s11999-014-3918-x; Rowell D, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.032235; Sari ABA, 2008, AGE AGEING, V37, P265, DOI 10.1093/ageing/afn043; Schneider MA, 2012, ORTHOP NURS, V31, P12, DOI 10.1097/NOR.0b013e3182419619; Schubert M, 2013, INT J NURS STUD, V50, P230, DOI 10.1016/j.ijnurstu.2012.09.016; Shah AN, 2004, J ARTHROPLASTY, V19, P700, DOI 10.1016/j.arth.2004.02.034; Stahl J. E., 2002, Infectious Diseases in Clinical Practice, V11, P46, DOI 10.1097/00019048-200202000-00002; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Taheri PA, 2000, J AM COLL SURGEONS, V191, P123, DOI 10.1016/S1072-7515(00)00352-5; Thornlow DK, 2014, RES GERONTOL NURS, V7, P66, DOI 10.3928/19404921-20131126-01; Trentino KM, 2013, MED J AUSTRALIA, V199, P543, DOI 10.5694/mja12.11640; Twigg D, 2015, J ADV NURSING, V71; van Oostveen CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098102; Vermeulen H, 2013, BMC HEALTH SERV RES, P13; Warshawsky N, 2013, J NURS MANAGE, V21, P725, DOI 10.1111/jonm.12101; Wilson M, 2014, ACAD EMERG MED, V21, P1101, DOI 10.1111/acem.12486; Wright CD, 2008, ANN THORAC SURG, V85, P1857, DOI 10.1016/j.athoracsur.2008.03.024; Zekry D, 2011, DEMENT GERIATR COGN, V32, P103, DOI 10.1159/000326950	80	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193319	10.1371/journal.pone.0193319	http://dx.doi.org/10.1371/journal.pone.0193319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX4LV	29474407	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500082
J	Wood, PL; Steinman, M; Erol, E; Carter, C; Christmann, U; Verma, A				Wood, Paul L.; Steinman, Margaret; Erol, Erdal; Carter, Craig; Christmann, Undine; Verma, Ashutosh			Lipidomic analysis of immune activation in equine leptospirosis and Leptospira-vaccinated horses	PLOS ONE			English	Article							CYCLIC PHOSPHATIDIC-ACID; KYNURENINE PATHWAY; MASS-SPECTROMETRY; INFECTION; INTERROGANS; INFLAMMATION; LIPOPROTEIN; METABOLISM; CYTOKINES; DISEASE	Currently available diagnostic assays for leptospirosis cannot differentiate vaccine from infection serum antibody. Several leptospiral proteins that are upregulated during infection have been described, but their utility as a diagnostic marker is still unclear. In this study, we undertook a lipidomics approach to determine if there are any differences in the serum lipid profiles of horses naturally infected with pathogenic Leptospira spp. and horses vaccinated against a commercially available bacterin. Utilizing a high-resolution mass spectrometry serum lipidomics analytical platform, we demonstrate that cyclic phosphatidic acids, diacylglycerols, and hydroperoxide oxidation products of choline plasmalogens are elevated in the serum of naturally infected as well as vaccinated horses. Other lipids of interest were triacylglycerols that were only elevated in the serum of infected horses and sphingomyelins that were increased only in the serum of vaccinated horses. This is the first report looking at the equine serum lipidome during leptospiral infection and vaccination.	[Wood, Paul L.] Lincoln Mem Univ, Coll Vet Med, Metab Unit, Harrogate, TN 37752 USA; [Steinman, Margaret; Erol, Erdal; Carter, Craig] Univ Kentucky, Vet Diagnost Lab, Lexington, KY USA; [Christmann, Undine; Verma, Ashutosh] Lincoln Mem Univ, Coll Vet Med, Ctr Infect Zoonot & Vector Borne Dis, Harrogate, TN 37752 USA	University of Kentucky	Wood, PL (corresponding author), Lincoln Mem Univ, Coll Vet Med, Metab Unit, Harrogate, TN 37752 USA.; Verma, A (corresponding author), Lincoln Mem Univ, Coll Vet Med, Ctr Infect Zoonot & Vector Borne Dis, Harrogate, TN 37752 USA.	paul.wood@lmunet.edu; ashutosh.verma@lmunet.edu		Christmann, Undine/0000-0001-9383-4968	LMU-College of Veterinary Medicine	LMU-College of Veterinary Medicine	Funds for this work were provided by LMU-College of Veterinary Medicine's internal grant program. The funders had no role in the study design or this manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Ait-Belkacem R, 2017, SLAS DISCOV, V22, P1182, DOI 10.1177/2472555217712659; Artiushin S, 2004, INFECT IMMUN, V72, P742, DOI 10.1128/IAI.72.2.742-749.2004; Avelino-Silva VI, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005219; Braidy N, 2017, NEURAL REGEN RES, V12, P39, DOI 10.4103/1673-5374.198971; Brown HA, 2017, NAT REV DRUG DISCOV, V16, P351, DOI 10.1038/nrd.2016.252; Carter CN, P 55 ANN AAVLD M, P51; Christmann U, 2016, 34 ANN S VET COMP RE; COLE JR, 1973, APPL MICROBIOL, V25, P976, DOI 10.1128/AEM.25.6.976-980.1973; Corte A, 2017, TRENDS PARASITOL; DONAHUE JM, 1995, J VET DIAGN INVEST, V7, P87, DOI 10.1177/104063879500700114; Fujiwara Y, 2008, BBA-MOL CELL BIOL L, V1781, P519, DOI 10.1016/j.bbalip.2008.05.002; Gazi IF, 2011, LIPIDS, V46, P953, DOI 10.1007/s11745-011-3580-y; Gomes STM, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2491-9; Gotoh M, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-52; GRUNFELD C, 1991, TRENDS ENDOCRIN MET, V2, P213, DOI 10.1016/1043-2760(91)90027-K; Jeewandara C, 2017, IMMUN INFLAMM DIS, V5, P7, DOI 10.1002/iid3.135; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Khovidhunkit W, 2000, J INFECT DIS, V181, pS462, DOI 10.1086/315611; Lamour SD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004200; Lau SKP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030307; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Liberopoulos EN, 2014, EUR J CLIN INVEST, V44, P719, DOI 10.1111/eci.12288; Losito I, 2015, J CHROMATOGR A, V1422, P194, DOI 10.1016/j.chroma.2015.10.023; Lucas EA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-270; Naiman BM, 2001, INFECT IMMUN, V69, P7550, DOI 10.1128/IAI.69.12.7550-7558.2001; Nakagawa K, 2015, J NUTR SCI VITAMINOL, V61, pS78, DOI 10.3177/jnsv.61.S78; Nemeth ZH, 2017, CUREUS, V9, DOI 10.7759/cureus.1177; Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002; Scarpelini B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161920; Schotthoefer AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179655; Spiri AM, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1056-x; Timoney JF, 2011, VET MICROBIOL, V150, P349, DOI 10.1016/j.vetmic.2011.02.049; To KKW, 2016, DIAGN MICR INFEC DIS, V85, P249, DOI 10.1016/j.diagmicrobio.2016.03.012; Tsukahara T, 2013, J LIPIDS, V2013, DOI 10.1155/2013/246597; Tsukahara T, 2014, INT J MED SCI, V11, P955, DOI 10.7150/ijms.9316; Tsukahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081139; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Velineni S, 2016, VET REC, V179, DOI 10.1136/vr.103686; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; Verma A, 2012, ZOONOSES PUBLIC HLTH, V59, P132, DOI 10.1111/j.1863-2378.2011.01445.x; Verma A, 2013, VET MICROBIOL, V167, P61, DOI 10.1016/j.vetmic.2013.04.012; Vernel-Pauillac F, 2006, INFECT IMMUN, V74, P4172, DOI 10.1128/IAI.00447-06; Vijay R, 2015, J EXP MED, V212, P1851, DOI 10.1084/jem.20150632; Vitenberga Z, 2017, BIOMED PAP, V161, P164, DOI 10.5507/bp.2017.029; Wood P, 2017, NEUROMETHODS, V125, P13, DOI 10.1007/978-1-4939-6946-3_2; Wood PL, 2016, THERIOGENOLOGY, V86, P1212, DOI 10.1016/j.theriogenology.2016.04.012; Wood PL, 2015, ACTA NEUROPSYCHIATR, V27, P270, DOI 10.1017/neu.2015.18; Wood PL, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt103; WOOD PL, 1994, LIFE SCI, V55, P661, DOI 10.1016/0024-3205(94)00672-5; Wood PL., NEUROINFLAMMATION ME, P1; Yamamoto S, 2014, EUR J PHARMACOL, V741, P17, DOI 10.1016/j.ejphar.2014.07.040; Zuerner RL, 2011, CLIN VACCINE IMMUNOL, V18, P684, DOI 10.1128/CVI.00288-10	53	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193424	10.1371/journal.pone.0193424	http://dx.doi.org/10.1371/journal.pone.0193424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474474	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500107
J	Saisawang, C; Kuadkitkan, A; Auewarakul, P; Smith, DR; Ketterman, AJ				Saisawang, Chonticha; Kuadkitkan, Atichat; Auewarakul, Prasert; Smith, Duncan R.; Ketterman, Albert J.			Glutathionylation of dengue and Zika NS5 proteins affects guanylyltransferase and RNA dependent RNA polymerase activities	PLOS ONE			English	Article							CAPPING ENZYME; VIRUS; DOMAIN; ENTRY; ASSAY	It has been estimated for dengue infection that the global population at risk is 3.5 billion people, which makes dengue an important public health problem. The causative agents of dengue are dengue viruses. For dengue virus replication, the dengue virus NS5 protein is of special importance as it has several enzyme activities important for viral replication. Previous reports of phosphorylation and SUMOylation of dengue NS5 have shown these protein modifications have important consequences for NS5 functions. In this report we identify glutathionylation, another reversible post translation modification that impacts on NS5 enzyme activity. Using dengue virus infected cells we employed specific antibodies and mass spectrometry to identify 3 cysteine residues of NS5 protein as being glutathionylated. Glutathionylation is a post translational protein modification where glutathione is covalently attached to a cysteine residue. We showed glutathionylation occurs on 3 conserved cysteine residues of dengue NS5. Then we generated two flavivirus recombinant full length proteins, dengue NS5 and Zika NS5, to characterize two of the NS5 enzyme activities, namely, guanylyltransferase and RNA-dependent RNA polymerase activities. We show glutathionylation of dengue and Zika NS5 affects enzyme activities of the two flavivirus proteins. The data suggests that glutathionylation is a general feature of the flavivirus NS5 protein and the modification has the potential to modulate several of the NS5 enzyme functions.	[Saisawang, Chonticha; Kuadkitkan, Atichat; Smith, Duncan R.; Ketterman, Albert J.] Mahidol Univ, Inst Mol Biosci, Salaya Campus, Salaya, Nakhon Pathom, Thailand; [Auewarakul, Prasert] Mahidol Univ, Fac Med, Dept Microbiol, Siriraj Hosp, Bangkok, Thailand	Mahidol University; Mahidol University	Ketterman, AJ (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya Campus, Salaya, Nakhon Pathom, Thailand.	albertketterman@yahoo.com	Smith, Duncan R/C-6891-2011	Smith, Duncan R/0000-0002-6592-9852	Thailand Research Fund [TRG5980012, IRG5780009]; Mahidol University; National Science and Technology Development Agency [P-16-50685]	Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; National Science and Technology Development Agency	This work was supported by the Thailand Research Fund (TRG5980012)(CS) and the Thailand Research Fund (IRG5780009)(AJK), and grants from Mahidol University (AJK, DRS) and The National Science and Technology Development Agency (P-16-50685)(DRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0; Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x; Anand SK, 2013, ADV VIROL, V2013, DOI 10.1155/2013/738794; Atasheva S, 2010, J VIROL, V84, P10004, DOI 10.1128/JVI.01151-10; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Cavrini F, 2009, J INFECT DEV COUNTR, V3, P744, DOI 10.3855/jidc.169; CONG PJ, 1993, J BIOL CHEM, V268, P7256; Geiss BJ, 2011, J BIOMOL SCREEN, V16, P852, DOI 10.1177/1087057111412183; Gonzalez-Dosal R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002250; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; Gullberg RC, 2015, VIROLOGY, V475, P219, DOI 10.1016/j.virol.2014.10.037; Hanh TDN, 2013, ANAL BIOCHEM, V434, P284, DOI 10.1016/j.ab.2012.11.019; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Alcaraz-Estrada SL, 2010, FUTURE VIROL, V5, P575, DOI 10.2217/FVL.10.49; Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012; Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666; Ramanathan A, 2016, NUCLEIC ACIDS RES, V44, P7511, DOI 10.1093/nar/gkw551; Russell P. K., 1980, CHEM ANTIGENIC STRUC; Su CI, 2016, J VIROL, V90, P4308, DOI 10.1128/JVI.00223-16; Suksanpaisan L, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-17; Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Weaver SC, 2005, ARCH VIROL, P33; Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Zhang J, 2014, ADV CANCER RES, V122, P143, DOI 10.1016/B978-0-12-420117-0.00004-9; Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193133	10.1371/journal.pone.0193133	http://dx.doi.org/10.1371/journal.pone.0193133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470500	Green Submitted, Green Published, gold			2022-12-26	WOS:000425831000037
J	Njuki, E; Bravo-Ureta, BE; O'Donnell, CJ				Njuki, Eric; Bravo-Ureta, Boris E.; O'Donnell, Christopher J.			A new look at the decomposition of agricultural productivity growth incorporating weather effects	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; US AGRICULTURE; PANEL-DATA; IMPACT; ADAPTATION; EFFICIENCY; MODELS; OUTPUT; TESTS	Random fluctuations in temperature and precipitation have substantial impacts on agricultural output. However, the contribution of these changing configurations in weather to total factor productivity (TFP) growth has not been addressed explicitly in econometric analyses. Thus, the key objective of this study is to quantify and to investigate the role of changing weather patterns in explaining yearly fluctuations in TFP. For this purpose, we define TFP to be a measure of total output divided by a measure of total input. We estimate a stochastic production frontier model using U.S. state-level agricultural data incorporating growing season temperature and precipitation, and intra-annual standard deviations of temperature and precipitation for the period 1960-2004. We use the estimated parameters of the model to compute a TFP index that has good axiomatic properties. We then decompose TFP growth in each state into weather effects, technological progress, technical efficiency, and scale-mix efficiency changes. This approach improves our understanding of the role of different components of TFP in agricultural productivity growth. We find that annual TFP growth averaged 1.56% between 1960 and 2004. Moreover, we observe substantial heterogeneity in weather effects across states and over time.	[Njuki, Eric; Bravo-Ureta, Boris E.] Univ Connecticut, Dept Agr & Resource Econ, Storrs, CT 06269 USA; [Bravo-Ureta, Boris E.] Univ Talca, Talca, Chile; [O'Donnell, Christopher J.] Univ Queensland, Sch Econ, St Lucia, Qld, Australia	University of Connecticut; Universidad de Talca; University of Queensland	Njuki, E (corresponding author), Univ Connecticut, Dept Agr & Resource Econ, Storrs, CT 06269 USA.	eric.njuki@uconn.edu		Njuki, Eric/0000-0002-1000-4609	National Institute of Food and Agriculture [2016-67012-24678, 2016-67024-24760]	National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This study was supported by the National Institute of Food and Agriculture, Grant # 2016-67012-24678 (EN) and Grant # 2016-67024-24760 (BBU). The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RM, 1989, AM J AGR ECON, V71, P1272, DOI 10.2307/1243120; ADAMS RM, 1995, CLIMATIC CHANGE, V30, P147, DOI 10.1007/BF01091839; ADAMS RM, 1988, W J AGR EC, V13, P348; Alston JM, 2010, NAT RES MANAG POLICY, V34, P1, DOI 10.1007/978-1-4419-0658-8; [Anonymous], 1995, MULTIOUTPUT PRODUCTI; Balk BM, 2001, J PROD ANAL, V15, P159, DOI 10.1023/A:1011117324278; Ball EV, 2016, APPL ECON PERSPECT P, V38, P30, DOI 10.1093/aepp/ppv031; Ball V. E., 2004, American Journal of Agricultural Economics, V86, P1315, DOI 10.1111/j.0002-9092.2004.00683.x; Ball VE, 2008, APPL ECON, V40, P1253, DOI 10.1080/00036840600771320; Ball VE, 1997, AM J AGR ECON, V79, P1045, DOI 10.2307/1244263; Barros VR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1133; Burke M, 2016, AM ECON J-ECON POLIC, V8, P106, DOI 10.1257/pol.20130025; CAVES DW, 1982, ECONOMETRICA, V50, P1393, DOI 10.2307/1913388; CLEVELAND WS, 1988, J ECONOMETRICS, V37, P87, DOI 10.1016/0304-4076(88)90077-2; Cline WR, 1996, AM ECON REV, V86, P1309; Darwin R, 1999, AM ECON REV, V89, P1049, DOI 10.1257/aer.89.4.1049; Dell M, 2014, J ECON LIT, V52, P740, DOI 10.1257/jel.52.3.740; Deschenes O, 2007, AM ECON REV, V97, P354, DOI 10.1257/aer.97.1.354; Fare R, 1998, INDEX NUMBERS: ESSAYS IN HONOUR OF STEN MALMQUIST, P127; FARE R, 1994, AM ECON REV, V84, P66; Greene W, 2005, J PROD ANAL, V23, P7, DOI 10.1007/s11123-004-8545-1; Greene W, 2005, J ECONOMETRICS, V126, P269, DOI 10.1016/j.jeconom.2004.05.003; Hatfield J., 2014, CLIMATE CHANGE IMPAC, P150, DOI DOI 10.7930/J02Z13FR; HUFFMAN WE, 1992, AM J AGR ECON, V74, P751, DOI 10.2307/1242589; Jackson T., 2011, 115 ABARES 115 ABARES; Jin Y, 2016, AGR ECON-BLACKWELL, V47, P15, DOI 10.1111/agec.12206; Kaminski J, 2013, AM J AGR ECON, V95, P70, DOI 10.1093/ajae/aas075; KAUFMAN R, 1994, ECOLOGICAL EC, V26, P113; Key N, 2014, AM J AGR ECON, V96, P1136, DOI 10.1093/ajae/aau002; Kneip A., 2012, EXPLORING RES FRONTI; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lovell CAK, 2003, J PROD ANAL, V20, P437, DOI 10.1023/A:1027312102834; Maddala GS, 1999, OXFORD B ECON STAT, V61, P631, DOI 10.1111/1468-0084.0610s1631; Malcolm S, 2012, 136 USDA EC RES SERV; Mendelsohn R, 2003, LAND ECON, V79, P328, DOI 10.2307/3147020; MENDELSOHN R, 1994, AM ECON REV, V84, P753; Mendelsohn R., 2004, IMPACT CLIMATE CHANG; Mukherjee D, 2013, AUST J AGR RESOUR EC, V57, P123, DOI 10.1111/j.1467-8489.2012.00603.x; Mutter RL, 2013, J PROD ANAL, V39, P101, DOI 10.1007/s11123-012-0277-z; Nelson GC, 2014, AGR ECON-BLACKWELL, V45, P85, DOI 10.1111/agec.12091; Njuki E, 2015, AM J AGR ECON, V97, P1087, DOI 10.1093/ajae/aav007; O'Donnell CJ, 2016, J ECONOMETRICS, V190, P328, DOI 10.1016/j.jeconom.2015.06.009; O'Donnell CJ, 2012, J PROD ANAL, V38, P255, DOI 10.1007/s11123-012-0275-1; O'Donnell CJ, 2012, AM J AGR ECON, V94, P873, DOI 10.1093/ajae/aas023; Orea L, 2002, J PROD ANAL, V18, P5, DOI 10.1023/A:1015793325292; Pardey P G, 2010, HDB EC TECHNICAL CHA, P804; Pedroni P, 2004, ECONOMET THEOR, V20, P597, DOI 10.1017/S0266466604203073; Plastina A, 2012, J PROD ANAL, V37, P95, DOI 10.1007/s11123-011-0252-0; Qi L, 2015, J DAIRY SCI, V98, P8664, DOI 10.3168/jds.2015-9536; Roberts MJ, 2013, AM J AGR ECON, V95, P236, DOI 10.1093/ajae/aas047; Schlenker W, 2006, REV ECON STAT, V88, P113, DOI 10.1162/rest.2006.88.1.113; Schlenker W, 2005, AM ECON REV, V95, P395, DOI 10.1257/0002828053828455; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Shee A, 2015, AM J AGR ECON, V97, P939, DOI 10.1093/ajae/aau083; Stiroh K, 2005, PRODUCTIVITY INFORM; Tran KC, 2013, ECON LETT, V118, P233, DOI 10.1016/j.econlet.2012.10.028; U. S. Department of Agriculture, 2017, AGR PROD US; U. S. Department of Agriculture, 2017, WORLD AGR SUPPL DEM; Verbeek M., 2008, GUIDE MODERN ECONOME, V3rd ed.	59	26	27	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192432	10.1371/journal.pone.0192432	http://dx.doi.org/10.1371/journal.pone.0192432			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	29466461	Green Submitted, Green Published, gold			2022-12-26	WOS:000425604300058
J	Pohlmeyer, CW; Laskey, SB; Beck, SE; Xu, DC; Capoferri, AA; Garliss, CC; May, ME; Livingston, A; Lichmira, W; Moore, RD; Leffell, MS; Butler, NJ; Thorne, JE; Flynn, JA; Siliciano, RF; Blankson, JN				Pohlmeyer, Christopher W.; Laskey, Sarah B.; Beck, Sarah E.; Xu, Daniel C.; Capoferri, Adam A.; Garliss, Caroline C.; May, Megan E.; Livingston, Alison; Lichmira, Walt; Moore, Richard D.; Leffell, M. Sue; Butler, Nicholas J.; Thorne, Jennifer E.; Flynn, John A.; Siliciano, Robert F.; Blankson, Joel N.			Cross-reactive microbial peptides can modulate HIV-specific CD8(+) T cell responses	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY; VIRUS TYPE-1; LYMPHOCYTE RESPONSE; INFECTION; ESCAPE; VIREMIA; IMMUNODOMINANT; EPITOPE; GAG; NONPROGRESSORS	Heterologous immunity is an important aspect of the adaptive immune response. We hypothesized that this process could modulate the HIV-1-specific CD8(+) T cell response, which has been shown to play an important role in HIV-1 immunity and control. We found that stimulation of peripheral blood mononuclear cells (PBMCs) from HIV-1-positive subjects with microbial peptides that were cross-reactive with immunodominant HIV-1 epitopes resulted in dramatic expansion of HIV-1-specific CD8(+) T cells. Interestingly, the TCR repertoire of HIV-1-specific CD8(+) T cells generated by ex vivo stimulation of PBMCs using HIV-1 peptide was different from that of cells stimulated with cross-reactive microbial peptides in some HIV-1-positive subjects. Despite these differences, CD8(+) T cells stimulated with either HIV-1 or cross-reactive peptides effectively suppressed HIV-1 replication in autologous CD4(+) T cells. These data suggest that exposure to cross-reactive microbial antigens can modulate HIV-1-specific immunity.	[Pohlmeyer, Christopher W.; Laskey, Sarah B.; Xu, Daniel C.; Capoferri, Adam A.; Garliss, Caroline C.; May, Megan E.; Livingston, Alison; Moore, Richard D.; Leffell, M. Sue; Flynn, John A.; Siliciano, Robert F.; Blankson, Joel N.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Beck, Sarah E.; Blankson, Joel N.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA; [Lichmira, Walt] Spondylitis Assoc Amer, Philadelphia, PA USA; [Butler, Nicholas J.; Thorne, Jennifer E.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Howard Hughes Med Inst, Baltimore, MD USA; [Pohlmeyer, Christopher W.] Gilead Sci, Foster City, CA USA; [Laskey, Sarah B.] 23andMe, Mountain View, CA USA; [Xu, Daniel C.] Univ Penn, Philadelphia, PA 19104 USA; [Butler, Nicholas J.] Harvard Med Sch, Dept Ophthalmol, Vet Affairs Boston Healthcare Syst, Boston, MA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Gilead Sciences; University of Pennsylvania; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Blankson, JN (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.; Blankson, JN (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA.	jblanks@jhmi.edu	Capoferri, Adam/AAM-9484-2021	Capoferri, Adam/0000-0002-6048-2115	National Institute of Health awards [P30A1094189, R56AI080328, R01AI120024, U01DA036935]; Johns Hopkins University innovation award; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, R01AI120024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD021323] Funding Source: NIH RePORTER	National Institute of Health awards; Johns Hopkins University innovation award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by National Institute of Health awards to the Johns Hopkins Center for AIDS Research(P30A1094189) and to JNB R56AI080328 and R01AI120024 and RDM (U01DA036935), a Johns Hopkins University innovation award (JNB), and the Howard Hughes Medical Institute (RFS).	Acierno Paula M, 2003, J Transl Med, V1, P3, DOI 10.1186/1479-5876-1-3; Ben Dror L, THE HLA, V62, P420; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brander C, 1998, J CLIN INVEST, V101, P2559, DOI 10.1172/JCI2405; Buckheit RW, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-68; Campion SL, 2014, J EXP MED, V211, P1273, DOI 10.1084/jem.20130555; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Christie NM, 2009, VIROLOGY, V388, P137, DOI 10.1016/j.virol.2009.03.003; Edwards CTT, 2005, J VIROL, V79, P9363, DOI 10.1128/JVI.79.14.9363-9366.2005; Goulder PJ, 1997, J EXP MED, V185; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Huckelhoven AG, 2015, JAIDS-J ACQ IMM DEF, V69, P528, DOI 10.1097/QAI.0000000000000657; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Ladell K, 2013, IMMUNITY, V38, P425, DOI 10.1016/j.immuni.2012.11.021; Lamas JR, 1999, ARTHRITIS RHEUM-US, V42, P1975, DOI 10.1002/1529-0131(199909)42:9<1975::AID-ANR25>3.0.CO;2-V; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; NIXON DF, 1988, NATURE, V336, P484, DOI 10.1038/336484a0; O'Connell KA, 2010, AIDS RES HUM RETROV, V26, P1307, DOI 10.1089/aid.2010.0135; Rolland M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017969; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Turnbull EL, 2006, J IMMUNOL, V176, P6130, DOI 10.4049/jimmunol.176.10.6130; Vali B, 2011, J VIROL, V85, P254, DOI 10.1128/JVI.01743-10	30	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192098	10.1371/journal.pone.0192098	http://dx.doi.org/10.1371/journal.pone.0192098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466365	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300028
J	Sadekuzzaman, M; Kim, Y				Sadekuzzaman, Md.; Kim, Yonggyun			Nitric oxide mediates antimicrobial peptide gene expression by activating eicosanoid signaling	PLOS ONE			English	Article							PLASMATOCYTE-SPREADING PEPTIDE; HUMORAL IMMUNE-RESPONSES; GENOME-WIDE ANALYSIS; BEET ARMYWORM; PHOSPHOLIPASE A(2); ENTOMOPATHOGENIC BACTERIUM; XENORHABDUS-NEMATOPHILA; DROSOPHILA-MELANOGASTER; ANOPHELES-STEPHENSI; SPODOPTERA-EXIGUA	Nitric oxide (NO) mediates both cellular and humoral immune responses in insects. Its mediation of cellular immune responses uses eicosanoids as a downstream signal. However, the cross-talk with two immune mediators was not known in humoral immune responses. This study focuses on cross-talk between two immune mediators in inducing gene expression of anti-microbial peptides (AMPs) of a lepidopteran insect, Spodoptera exigua. Up-regulation of eight AMPs was observed in S. exigua against bacterial challenge. However, the AMP induction was suppressed by injection of an NO synthase inhibitor, L-NAME, while little expressional change was observed on injecting its enantiomer, D-NAME. The functional association between NO biosynthesis and AMP gene expression was further supported by RNA interference (RNAi) against NO synthase (SeNOS), which suppressed AMP gene expression under the immune challenge. The AMP induction was also mimicked by NO alone because injecting an NO analog, SNAP, without bacterial challenge significantly induced the AMP gene expression. Interestingly, an eicosanoid biosynthesis inhibitor, dexamethasone (DEX), suppressed the NO induction of AMP expression. The inhibitory activity of DEX was reversed by the addition of arachidonic acid, a precursor of eicosanoid biosynthesis. AMP expression of S. exigua was also controlled by the Toll/IMD signal pathway. The RNAi of Toll receptors or Relish suppressed AMP gene expression by suppressing NO levels and subsequently reducing PLA2 enzyme activity. These results suggest that eicosanoids are a downstream signal of NO mediation of AMP expression against bacterial challenge.	[Sadekuzzaman, Md.; Kim, Yonggyun] Andong Natl Univ, Dept Plant Med, Andong, South Korea	Andong National University	Kim, Y (corresponding author), Andong Natl Univ, Dept Plant Med, Andong, South Korea.	hosanna@anu.ac.kr		Kim, Yonggyun/0000-0002-6840-2167	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2017R1A2133009815]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2017R1A2133009815). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa T, 2001, J BIOL CHEM, V276, P31813, DOI 10.1074/jbc.M105251200; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; BAINES D, 1994, ARCH INSECT BIOCHEM, V26, P249, DOI 10.1002/arch.940260402; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carton Y, 2002, J PARASITOL, V88, P405, DOI 10.1645/0022-3395(2002)088[0405:DIOTCI]2.0.CO;2; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Clark KD, 2004, J BIOL CHEM, V279, P33246, DOI 10.1074/jbc.M401157200; Clark KD, 1998, BIOCHEM BIOPH RES CO, V250, P479, DOI 10.1006/bbrc.1998.9145; Cooper D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00539; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; DiehlJones WL, 1996, J INSECT PHYSIOL, V42, P13, DOI 10.1016/0022-1910(95)00078-X; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; DUNPHY GB, 1994, J INSECT PHYSIOL, V40, P267, DOI 10.1016/0022-1910(94)90050-7; Eleftherianos I, 2009, J EXP BIOL, V212, P1840, DOI 10.1242/jeb.026278; Eleftherianos I, 2009, INSECT MOL BIOL, V18, P507, DOI 10.1111/j.1365-2583.2009.00899.x; Eleftherianos I, 2014, INFECT IMMUN, V82, P4169, DOI 10.1128/IAI.02318-14; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Foley E, 2003, GENE DEV, V17, P115, DOI 10.1101/gad.1018503; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; GOH H G, 1990, Korean Journal of Applied Entomology, V29, P180; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Hwang J, 2013, ARCH INSECT BIOCHEM, V83, P151, DOI 10.1002/arch.21103; Hyrsl P, 2011, J INNATE IMMUN, V3, P65, DOI 10.1159/000320634; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Ishii K, 2013, DEV COMP IMMUNOL, V39, P147, DOI 10.1016/j.dci.2012.10.014; Kim GS, 2010, J INSECT PHYSIOL, V56, P559, DOI 10.1016/j.jinsphys.2009.11.022; Kim GS, 2009, ARCH INSECT BIOCHEM, V70, P162, DOI 10.1002/arch.20286; Kim SF, 2011, NITRIC OXIDE-BIOL CH, V25, P255, DOI 10.1016/j.niox.2011.07.002; Kim Y, 2018, DEV COMP IM IN PRESS; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li QJ, 2017, DEV COMP IMMUNOL, V67, P293, DOI 10.1016/j.dci.2016.09.006; Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Merchant D, 2008, J INSECT PHYSIOL, V54, P215, DOI 10.1016/j.jinsphys.2007.09.004; MILLER JS, 1994, P NATL ACAD SCI USA, V91, P12418, DOI 10.1073/pnas.91.26.12418; Morishima I, 1997, FEBS LETT, V419, P83, DOI 10.1016/S0014-5793(97)01418-X; Nappi AJ, 2000, NITRIC OXIDE-BIOL CH, V4, P423, DOI 10.1006/niox.2000.0294; Park J, 2013, J INSECT PHYSIOL, V59, P682, DOI 10.1016/j.jinsphys.2013.04.012; Park Jiyeong, 2012, Korean Journal of Applied Entomology, V51, P349, DOI 10.5656/KSAE.2012.09.0.038; RADVANYI F, 1989, ANAL BIOCHEM, V177, P103, DOI 10.1016/0003-2697(89)90022-5; Rivero A, 2006, TRENDS PARASITOL, V22, P219, DOI 10.1016/j.pt.2006.02.014; Sadekuzzaman M, 2018, J INNATE IMMUN, V10, P70, DOI 10.1159/000481524; Sadekuzzaman M, 2017, DEV COMP IMMUNOL, V77, P210, DOI 10.1016/j.dci.2017.08.014; Salvemini D, 1996, METHOD ENZYMOL, V269, P12; SALVEMINI D, 1994, J CLIN INVEST, V93, P1940, DOI 10.1172/JCI117185; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; SAS Institute, 1989, SAS STAT US GUID; Shrestha S, 2007, J INVERTEBR PATHOL, V96, P64, DOI 10.1016/j.jip.2007.02.009; Shrestha S, 2010, DEV COMP IMMUNOL, V34, P530, DOI 10.1016/j.dci.2009.12.013; Shrestha S, 2009, BIOSCI BIOTECH BIOCH, V73, P2077, DOI 10.1271/bbb.90272; Stanley D., 2000, EICOSANOIDS INVERTEB; Stanley D, 2014, CRIT REV PLANT SCI, V33, P20, DOI 10.1080/07352689.2014.847631; Stanley DW, 2008, INSECT BIOCHEM MOLEC, V38, P275, DOI 10.1016/j.ibmb.2007.11.004; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Theopold U, 2014, DEV COMP IMMUNOL, V42, P42, DOI 10.1016/j.dci.2013.03.014; Vanha-aho LM, 2016, IMMUNOL LETT, V170, P42, DOI 10.1016/j.imlet.2015.12.005; Wang Y, 1999, INSECT BIOCHEM MOLEC, V29, P1075, DOI 10.1016/S0965-1748(99)00086-7; Yajima M, 2003, BIOCHEM J, V371, P205, DOI 10.1042/BJ20021603; Zhang CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121296; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	72	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193282	10.1371/journal.pone.0193282	http://dx.doi.org/10.1371/journal.pone.0193282			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466449	gold, Green Submitted, Green Published			2022-12-26	WOS:000425604300110
J	Torlasco, C; Cassinerio, E; Roghi, A; Faini, A; Capecchi, M; Abdel-Gadir, A; Giannattasio, C; Parati, G; Moon, JC; Cappellini, MD; Pedrotti, P				Torlasco, Camilla; Cassinerio, Elena; Roghi, Alberto; Faini, Andrea; Capecchi, Marco; Abdel-Gadir, Amna; Giannattasio, Cristina; Parati, Gianfranco; Moon, James C.; Cappellini, Maria D.; Pedrotti, Patrizia			Role of T1 mapping as a complementary tool to T2*for non-invasive cardiac iron overload assessment	PLOS ONE			English	Article							INVERSION-RECOVERY MOLLI; MAGNETIC-RESONANCE; THALASSEMIA MAJOR; T2	Background Iron overload-related heart failure is the principal cause of death in transfusion dependent patients, including those with Thalassemia Major. Linking cardiac siderosis measured by T2* to therapy improves outcomes. T1 mapping can also measure iron; preliminary data suggests it may have higher sensitivity for iron, particularly for early overload (the conventional cut-point for no iron by T2* is 20ms, but this is believed insensitive). We compared T1 mapping to T2* in cardiac iron overload. Methods In a prospectively large single centre study of 138 Thalassemia Major patients and 32 healthy controls, we compared T1 mapping to dark blood and bright blood T2* acquired at 1.5T. Linear regression analysis was used to assess the association of T2* and T1. A "moving window" approach was taken to understand the strength of the association at different levels of iron overload. Results The relationship between T2* (here dark blood) and T1 is described by a log-log linear regression, which can be split in three different slopes: 1) T2* low, <20ms, r2 = 0.92; 2) T2* = 20-30ms, r2 = 0.48; 3) T2*>30ms, weak relationship. All subjects with T2*<20ms had low T1; among those with T2*>20ms, 38% had low T1 with most of the subjects in the T2* range 20-30ms having a low T1. Conclusions In established cardiac iron overload, T1 and T2* are concordant. However, in the 20-30ms T2* range, T1 mapping appears to detect iron. These data support previous suggestions that T1 detects missed iron in 1 out of 3 subjects with normal T2*, and that T1 mapping is complementary to T2*. The clinical significance of a low T1 with normal T2* should be further investigated.	[Torlasco, Camilla; Faini, Andrea; Parati, Gianfranco] San Luca Hosp, Dept Cardiovasc Neural & Metab Sci, Ist Auxol Italiano, Milan, Italy; [Cassinerio, Elena; Capecchi, Marco; Cappellini, Maria D.] Ca Granda Fdn IRCCS, Dept Med & Med Special, Rare Dis Ctr, Milan, Italy; [Roghi, Alberto; Giannattasio, Cristina; Pedrotti, Patrizia] Osped Niguarda Ca Granda, Dept Cardiol & Cardiovasc Surg, Cardiol 4, Milan, Italy; [Abdel-Gadir, Amna; Moon, James C.] UCL, Inst Cardiovasc Sci, London, England; [Abdel-Gadir, Amna] St Bartholomews Hosp, Barts Heart Ctr, London, England; [Giannattasio, Cristina; Parati, Gianfranco] Univ Milano Bicocca, Dept Med & Surg, Milan, Italy; [Moon, James C.] Univ Coll London Hosp Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Cappellini, Maria D.] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy	IRCCS Istituto Auxologico Italiano; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of London; University College London; University of London; Queen Mary University London; University of Milano-Bicocca; University College London Hospitals NHS Foundation Trust; University of Milan	Pedrotti, P (corresponding author), Osped Niguarda Ca Granda, Dept Cardiol & Cardiovasc Surg, Cardiol 4, Milan, Italy.	patrizia.pedrotti@ospedaleniguarda.it	Faini, Andrea/E-1052-2018; Parati, Gianfranco/K-7151-2016; Moon, James/AAA-9905-2020; Capecchi, Marco/AAC-5206-2022; CAPPELLINI, MARIA DOMENICA/B-4475-2017	Faini, Andrea/0000-0002-8924-8234; Parati, Gianfranco/0000-0001-9402-7439; Moon, James/0000-0001-8071-1491; Capecchi, Marco/0000-0002-9223-145X; CAPPELLINI, MARIA DOMENICA/0000-0001-8676-6864; Torlasco, Camilla/0000-0003-2382-6721	Rosetrees Trust [M342] Funding Source: researchfish	Rosetrees Trust(Rosetrees Trust)		Abdel-Gadir A, 2016, CIRCULATION, V134, P432, DOI 10.1161/CIRCULATIONAHA.116.022803; Abdel-Gadir A, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0248-z; Alam MH, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0207-0; Alpendurada F, 2010, EUR HEART J, V31, P1648, DOI 10.1093/eurheartj/ehq106; Bellenger NG, 2000, J CARDIOV MAGN RESON, V2, P271, DOI 10.3109/10976640009148691; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Captur G, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0280-z; Carpenter JP, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0062-4; Carpenter JP, 2011, CIRCULATION, V123, P1519, DOI 10.1161/CIRCULATIONAHA.110.007641; COLLINS W, 1987, ANN CLIN BIOCHEM, V24, P483, DOI 10.1177/000456328702400510; He T, 2008, MAGN RESON MED, V60, P350, DOI 10.1002/mrm.21625; He TG, 2007, J MAGN RESON IMAGING, V25, P1205, DOI 10.1002/jmri.20929; Kellman P, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-014-0106-9; Kirk P, 2009, CIRCULATION, V120, P1961, DOI 10.1161/CIRCULATIONAHA.109.874487; Kramer C., HCM NOVEL MARKERS PR; Krittayaphong R, 2017, INT J CARDIOL, V248, P421, DOI 10.1016/j.ijcard.2017.06.100; Messroghli DR, 2007, J MAGN RESON IMAGING, V26, P1081, DOI 10.1002/jmri.21119; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Modell B, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-42; Pedersen SF, 2012, J CARDIOVASC MAGN R, P14; Pennell DJ, 2013, CIRCULATION, V128, P281, DOI 10.1161/CIR.0b013e31829b2be6; Piechnik SK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-69; Roghi A, 2015, J COMPUT ASSIST TOMO, V39, P128, DOI 10.1097/RCT.0000000000000159; Sado DM, 2015, J MAGN RESON IMAGING, V41, P1505, DOI 10.1002/jmri.24727; Smith GC, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-21; Wood JC, 2005, CIRCULATION, V112, P535, DOI 10.1161/CIRCULATIONAHA.104.504415	26	28	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192890	10.1371/journal.pone.0192890	http://dx.doi.org/10.1371/journal.pone.0192890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466447	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300073
J	Fujii, T; Oka, H; Katsuhira, J; Tonosu, J; Kasahara, S; Tanaka, S; Matsudaira, K				Fujii, Tomoko; Oka, Hiroyuki; Katsuhira, Junji; Tonosu, Juichi; Kasahara, Satoshi; Tanaka, Sakae; Matsudaira, Ko			Association between somatic symptom burden and health-related quality of life in people with chronic low back pain	PLOS ONE			English	Article							WIDESPREAD MUSCULOSKELETAL PAIN; PSYCHOMETRIC PROPERTIES; JAPANESE VERSION; CENTRAL SENSITIZATION; QUESTIONNAIRE; SOMATIZATION; DEPRESSION; POPULATION; DISORDERS; VALIDITY	Depression is a relevant risk factor for low back pain and is associated with the outcomes of low back pain. Depression also often overlaps with somatisation. As previous studies have suggested that somatisation or a higher somatic symptom burden has a role in the outcomes of low back pain, the aim of the present cross-sectional study was to examine whether somatic symptom burden was associated with health-related quality of life in individuals with chronic low back pain independent of depression. We analyzed internet survey data on physical and mental health in Japanese adults aged 20 +/- 64 years with chronic low back pain (n = 3,100). Health-related quality of life was assessed using the EuroQol five dimensions (EQ-5D) questionnaire. Somatic symptom burden and depression were assessed using the Somatic Symptom Scale-8 (SSS-8) and the Patient Health Questionnaire- 2 (PHQ-2), respectively. SSS-8 score was categorized as no to minimal (0 +/- 3), low (4 +/- 7), medium (8 +/- 11), high (12 +/- 15), and very high (16 +/- 32). The association between SSS-8 and EQ-5D was examined using linear regression models, adjusting for depression and other covariates, including age, sex, BMI, smoking, marital status, education, exercise, employment, and the number of comorbid diseases. A higher somatic symptom burden was significantly associated with a lower health-related quality of life independent of depression and the number of comorbid diseases (regression coefficient = 0.040 for SSS-8 high vs. very high and 0.218 for non to minimal vs. very high, p trend < 0.0001). In conclusion, somatic symptom burden might be important for the health-related quality of life of individuals with chronic low back pain.	[Fujii, Tomoko; Oka, Hiroyuki; Matsudaira, Ko] Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Dept Med Res & Management Musculoskeletal Pain, Tokyo, Japan; [Katsuhira, Junji] Niigata Univ Hlth & Welf, Fac Med Technol, Dept Prosthet & Orthot & Assist Technol, Niigata, Japan; [Tonosu, Juichi] Kanto Rosai Hosp, Dept Orthopaed Surg, Kawasaki, Kanagawa, Japan; [Kasahara, Satoshi] Univ Tokyo, Fac Med, Dept Pain & Palliat Med, Tokyo, Japan; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo, Japan	University of Tokyo; Niigata University; University of Tokyo; University of Tokyo	Fujii, T (corresponding author), Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Dept Med Res & Management Musculoskeletal Pain, Tokyo, Japan.	ort4771@gmail.com	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414	Eli Lilly Japan K.K.	Eli Lilly Japan K.K.(Eli Lilly)	This study was conducted as a collaborative research study between the University of Tokyo and Eli Lilly Japan (https://www.lilly.co.jp/). Eli Lilly Japan K.K. funded this study. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailliet L, 2016, MANUAL THER, V21, P170, DOI 10.1016/j.math.2015.07.007; Baumeister H, 2012, J PSYCHOSOM RES, V73, P79, DOI 10.1016/j.jpsychores.2012.05.008; Bourke JH, 2015, J PSYCHOSOM RES, V78, P228, DOI 10.1016/j.jpsychores.2015.01.003; Crombez G, 2009, PAIN, V145, P31, DOI 10.1016/j.pain.2009.04.006; Gierk B, 2014, JAMA INTERN MED, V174, P399, DOI 10.1001/jamainternmed.2013.12179; Gulec MY, 2012, COMPR PSYCHIAT, V53, P623, DOI 10.1016/j.comppsych.2011.08.002; Han C, 2009, PSYCHOSOMATICS, V50, P580, DOI 10.1176/appi.psy.50.6.580; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; HERR KA, 1993, CLIN J PAIN, V9, P104, DOI 10.1097/00002508-199306000-00005; Japanese EuroQol Translation Team, 1998, J HLTH CARE SOC, V8, P109, DOI DOI 10.4091/IKEN1991.8.1_109]; Kamaleri Y, 2008, PAIN, V138, P41, DOI 10.1016/j.pain.2007.11.002; Karekla M, 2012, COMPR PSYCHIAT, V53, P1217, DOI 10.1016/j.comppsych.2012.05.008; Kindler LL, 2011, PAIN MANAG NURS, V12, P15, DOI 10.1016/j.pmn.2009.10.003; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Lee S, 2011, J PSYCHOSOM RES, V71, P69, DOI 10.1016/j.jpsychores.2011.01.016; LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Matsudaira K., 2016, JPN PSYCHOSOM MED, V56, P931; Matsudaira K, 2017, GEN HOSP PSYCHIAT, V45, P7, DOI 10.1016/j.genhosppsych.2016.12.002; Matsudaira K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093924; Muramatsu K, 2007, PSYCHOL REP, V101, P952, DOI 10.2466/pr0.101.3.952-960; Narrow WE, 2013, AM J PSYCHIAT, V170, P71, DOI 10.1176/appi.ajp.2012.12071000; Natvig B, 2001, J REHABIL MED, V33, P21; Nickel R, 2002, J BONE JOINT SURG BR, V84B, P189, DOI 10.1302/0301-620X.84B2.12235; Nordin S, 2013, SCAND J PSYCHOL, V54, P112, DOI 10.1111/sjop.12029; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Pinheiro MB, 2015, ARTHRIT CARE RES, V67, P1591, DOI 10.1002/acr.22619; Montalban SR, 2010, ACTAS ESP PSIQUIATRI, V38, P345; Soer R, 2012, SPINE J, V12, P1035, DOI 10.1016/j.spinee.2012.10.030; Taylor JB, 2014, SPINE J, V14, P2299, DOI 10.1016/j.spinee.2014.01.026; Tomenson B, 2013, BRIT J PSYCHIAT, V203, P373, DOI 10.1192/bjp.bp.112.114405; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yamada K, 2014, MOD RHEUMATOL, V24, P343, DOI 10.3109/14397595.2013.854067; Yoshizawa K, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0438-2; Zijlema WL, 2013, J PSYCHOSOM RES, V74, P459, DOI 10.1016/j.jpsychores.2013.03.093	39	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0193208	10.1371/journal.pone.0193208	http://dx.doi.org/10.1371/journal.pone.0193208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8CI	29462181	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200057
J	Roh, JI; Kim, Y; Oh, J; Kim, Y; Lee, J; Lee, J; Chun, KH; Lee, HW				Roh, Jae-il; Kim, Yujin; Oh, Jahyun; Kim, Yunmi; Lee, Jeehyun; Lee, Jaehoon; Chun, Kyung-Hee; Lee, Han-Woong			Hexokinase 2 is a molecular bridge linking telomerase and autophagy	PLOS ONE			English	Article							DOUBLE-EDGED-SWORD; CANCER-CELLS; TARGET GENE; SURVIVAL; INHIBITION; ASSOCIATION; METABOLISM; DISEASE; HEALTH; KINASE	Autophagy is systematically regulated by upstream factors and nutrients. Recent studies reported that telomerase and hexokinase 2 [HK2) regulate autophagy through mTOR and that telomerase has the capacity to bind to the HK2 promoter. However, the molecular linkage among telomerase, HK2, and autophagy is not fully understood. Here, we show that HK2 connects telomerase to autophagy. HK2 inhibition in HepG2 cells suppressed TERT-induced autophagy activation and further enhancement by glucose deprivation. The HK2 downstream factor mTOR was responsible for the TERT-induced autophagy activation under glucose deprivation, implying that TERT promotes autophagy through an HK2-mTOR pathway. TERC played a role similar to that of TERT, and simultaneous expression of TERT and TERC synergistically enhanced HK2 expression and autophagy. At the gene level, TERT bound to the HK2 promoter at a specific region harboring the telomerase-responsive sequence 'TTGGG.' Mutagenesis of TERC and the TERT-responsive element in the HK2 promoter revealed that TERC is required for the binding of TERT to the HK2 promoter. We demonstrate the existence of a telomerase-HK2-mTOR-autophagy axis and suggest that inhibition of the interaction between telomerase and the HK2 promoter diminishes glucose starvation-induced autophagy.	[Roh, Jae-il; Kim, Yujin; Oh, Jahyun; Kim, Yunmi; Lee, Jeehyun; Lee, Jaehoon; Lee, Han-Woong] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul, South Korea; [Roh, Jae-il; Kim, Yujin; Oh, Jahyun; Kim, Yunmi; Lee, Jeehyun; Lee, Jaehoon; Lee, Han-Woong] Yonsei Univ, Anim Res Ctr, Yonsei Lab, Seoul, South Korea; [Chun, Kyung-Hee] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System	Lee, HW (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul, South Korea.; Lee, HW (corresponding author), Yonsei Univ, Anim Res Ctr, Yonsei Lab, Seoul, South Korea.	hwl@yonsei.ac.kr		Chun, Kyung-Hee/0000-0002-9867-7321	National Research Foundation of Korea (NRF) [2015R1A2A1A01003845, 2017R1A4A1015328]; Yonsei University Yonsei-SNU Collaborative Research Fund	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Yonsei University Yonsei-SNU Collaborative Research Fund	This work was supported by grants from the National Research Foundation of Korea (NRF; 2015R1A2A1A01003845, 2017R1A4A1015328) and The Yonsei University Yonsei-SNU Collaborative Research Fund of 2017 to HWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2016, BIOCH BIOPHYS RES CO; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Cheng HF, 2015, KIDNEY INT, V88, P85, DOI 10.1038/ki.2015.69; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dang C, 2013, COLD SPRING HARB PER, V3; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Devkota S, 2016, AUTOPHAGY; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harris RC, 2016, NEPHRON, V134, P145, DOI 10.1159/000446665; Heikkinen S, 1999, J BIOL CHEM, V274, P22517, DOI 10.1074/jbc.274.32.22517; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Koh CM, 2015, J CLIN INVEST, V125, P2109, DOI 10.1172/JCI79134; Kuhlow D, 2010, AGING-US, V2, P650, DOI 10.18632/aging.100200; Lee J, 2008, ONCOGENE, V27, P3754, DOI 10.1038/sj.onc.1211037; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Makino N, 2015, MOL CELL BIOCHEM, V403, P1, DOI 10.1007/s11010-015-2327-0; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Roberts DJ, 2015, CELL DEATH DIFFER, V22, P364, DOI 10.1038/cdd.2014.208; Roberts DJ, 2014, MOL CELL, V53, P521, DOI 10.1016/j.molcel.2013.12.019; Roh JI, 2014, CELL REP, V8, P991, DOI 10.1016/j.celrep.2014.07.027; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sundin T, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.1; Sung YH, 2013, J BIOL CHEM, V288, P31261, DOI 10.1074/jbc.M113.477570; Sung YH, 2010, CANCER RES, V70, P10454, DOI 10.1158/0008-5472.CAN-10-0031; TAANMAN JW, 1992, BIOCHIM BIOPHYS ACTA, V1139, P155, DOI 10.1016/0925-4439(92)90095-5; Taji F, 2017, MECH AGEING DEV, V163, P40, DOI 10.1016/j.mad.2016.12.011; Toh PPC, 2013, HUM MOL GENET, V22, P5237, DOI 10.1093/hmg/ddt381; Wardi L, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-60; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Xie JS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04927; Zhou JZ, 2014, AGING CELL, V13, P197, DOI 10.1111/acel.12161	47	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0193182	10.1371/journal.pone.0193182	http://dx.doi.org/10.1371/journal.pone.0193182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462198	Green Submitted, Green Published, gold			2022-12-26	WOS:000425554200053
J	Smith, HM; Smith, BP; Morales, NB; Moskwa, S; Clingeleffer, PR; Thomas, MR				Smith, Harley M.; Smith, Brady P.; Morales, Norma B.; Moskwa, Sam; Clingeleffer, Peter R.; Thomas, Mark R.			SNP markers tightly linked to root knot nematode resistance in grapevine (Vitis cinerea) identified by a genotyping-by-sequencing approach followed by Sequenom MassARRAY validation	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; DENSITY GENETIC-MAP; DOWNY MILDEW; MELOIDOGYNE-ARENARIA; MICROSATELLITE MARKERS; DISEASE-RESISTANCE; LINKAGE MAPS; LOCI; ROOTSTOCKS; ANALOGS	Plant parasitic nematodes, including root knot nematode Meloidogyne species, cause extensive damage to agriculture and horticultural crops. As Vitis vinifera cultivars are susceptible to root knot nematode parasitism, rootstocks resistant to these soil pests provide a sustainable approach to maintain grapevine production. Currently, most of the commercially available root knot nematode resistant rootstocks are highly vigorous and take up excess potassium, which reduces wine quality. As a result, there is a pressing need to breed new root knot nematode resistant rootstocks, which have no impact on wine quality. To develop molecular markers that predict root knot nematode resistance for marker assisted breeding, a genetic approach was employed to identify a root knot nematode resistance locus in grapevine. To this end, a Meloidogyne javanica resistant Vitis cinerea accession was crossed to a susceptible Vitis vinifera cultivar Riesling and results from screening the F-1 individuals support a model that root knot nematode resistance, is conferred by a single dominant allele, referred as MELOIDOGYNE JAVANICA RESISTANCE1 (MJR1). Further, MJR1 resistance appears to be mediated by a hypersensitive response that occurs in the root apical meristem. Single nucleotide polymorphisms (SNPs) were identified using geno-typing-by-sequencing and results from association and genetic mapping identified the MJR1 locus, which is located on chromosome 18 in the Vitis cinerea accession. Validation of the SNPs linked to the MJR1 locus using a Sequenom MassARRAY platform found that only 50% could be validated. The validated SNPs that flank and co-segregate with the MJR1 locus can be used for marker-assisted selection for Meloidogyne javanica resistance in grapevine.	[Smith, Harley M.; Smith, Brady P.; Morales, Norma B.; Clingeleffer, Peter R.; Thomas, Mark R.] CSIRO Agr & Food, Glen Osmond, SA, Australia; [Moskwa, Sam] CSIRO Informat Management & Technol, Clayton, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Smith, HM (corresponding author), CSIRO Agr & Food, Glen Osmond, SA, Australia.	harley.smith@csiro.au	Smith, Harley M/J-2649-2013; Thomas, Mark/A-3117-2010	Smith, Harley M/0000-0003-1304-9973; 	Wine Australia [CSP 1304]; CSIRO Agriculture and Food and Wine Australia (Australian Grape and Wine Authority) [CSP 1304]	Wine Australia(Australian Grape and Wine Authority); CSIRO Agriculture and Food and Wine Australia (Australian Grape and Wine Authority)	The authors received funding from Wine Australia (CSP 1304) for this research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We would like to acknowledge CSIRO Agriculture and Food and Wine Australia (Australian Grape and Wine Authority) for funding this research (CSP 1304). We thank Drs. Lars Kamphuis and Wolfgang Spielmeyer for critical reading of the manuscript as well as comments from the five reviewers. We also thank James Buller for maintaining grapevines the glasshouse and Adelle Craig for propagating plants in vitro. CSIRO Agriculture and Food is a partner of the Wine Innovation Cluster.	Anwar SA, 2002, J NEMATOL, V34, P28; Anwar SA, 2002, J NEMATOL, V34, P143; ANWAR SA, 1989, J NEMATOL, V21, P276; Anwar SA, 2000, NEMATROPICA, V30, P9; Anwar SA, 2000, J NEMATOL, V32, P265; Badenes ML, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00198; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barba P, 2014, THEOR APPL GENET, V127, P73, DOI 10.1007/s00122-013-2202-x; Bellin D, 2009, THEOR APPL GENET, V120, P163, DOI 10.1007/s00122-009-1167-2; Bowers JE, 1999, AM J ENOL VITICULT, V50, P243; Bowers JE, 1996, GENOME, V39, P628, DOI 10.1139/g96-080; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Bus A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-281; Cadle-Davidson L, 2016, PHYTOPATHOLOGY, V106, P1159, DOI 10.1094/PHYTO-02-16-0080-FI; CAIN DW, 1984, J NEMATOL, V16, P207; Canaguier A, 2017, GENOM DATA, V14, P56, DOI 10.1016/j.gdata.2017.09.002; Chen J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0428-2; Claverie M, 2011, PLANT PHYSIOL, V156, P779, DOI 10.1104/pp.111.176230; Cousins P, 2002, THEOR APPL GENET, V105, P802, DOI 10.1007/s00122-002-0977-2; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Davies LJ, 2015, NEMATOLOGY, V17, P249, DOI 10.1163/15685411-00002877; Di Gaspero G, 2007, THEOR APPL GENET, V114, P1249, DOI 10.1007/s00122-007-0516-2; Di Gaspero G, 2003, ACTA HORTIC, P419, DOI 10.17660/ActaHortic.2003.603.53; Di Gaspero G, 2002, THEOR APPL GENET, V106, P163, DOI 10.1007/s00122-002-1062-6; Di Gaspero G, 2012, THEOR APPL GENET, V124, P277, DOI 10.1007/s00122-011-1703-8; Diaz-Manzano FE, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00124; Donald TM, 2002, THEOR APPL GENET, V104, P610, DOI 10.1007/s00122-001-0768-1; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Esmenjaud D, 2009, SELECTION APPL RESIS; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; Feechan A, 2013, PLANT J, V76, P661, DOI 10.1111/tpj.12327; Ferris H, 2012, J NEMATOL, V44, P377; Franks T, 1998, MOL BREEDING, V4, P321, DOI 10.1023/A:1009673619456; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Garris A, 2009, AM J ENOL VITICULT, V60, P357; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; He JF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00484; Henning JA, 2016, EUPHYTICA, V208, P545, DOI 10.1007/s10681-015-1600-3; Hyma KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134880; Jablonska B, 2007, PLANT PHYSIOL, V143, P1044, DOI 10.1104/pp.106.089615; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jamann TM, 2011, PLANT FUNCTIONAL GEN, P257; Jo J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01606; Kim C, 2016, PLANT SCI, V242, P14, DOI 10.1016/j.plantsci.2015.04.016; Leggett RM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S4-S10; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIDER LA, 1954, P HELM SOC WASH, V21, P53; Mahanil S, 2012, THEOR APPL GENET, V124, P23, DOI 10.1007/s00122-011-1684-7; Margarido GRA, 2007, HEREDITAS, V144, P78, DOI 10.1111/j.2007.0018-0661.02000.x; McKenry MV, 2001, AM J ENOL VITICULT, V52, P304; Merdinoglu D, 2005, MOL BREEDING, V15, P349, DOI 10.1007/s11032-004-7651-0; Merdinoglu D, 2003, ACTA HORTIC, P451, DOI 10.17660/ActaHortic.2003.603.57; Milligan SB, 1998, PLANT CELL, V10, P1307, DOI 10.1105/tpc.10.8.1307; Mpelasoka BS, 2003, AUST J GRAPE WINE R, V9, P154, DOI 10.1111/j.1755-0238.2003.tb00265.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nelson JC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-352; Nicol J. M., 1999, Australian Journal of Grape and Wine Research, V5, P109, DOI 10.1111/j.1755-0238.1999.tb00295.x; Oeth P, 2009, METHODS MOL BIOL, V578, P307, DOI 10.1007/978-1-60327-411-1_20; Palomares-Rius JE, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01987; Peressotti E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-147; Pollard KS, 2005, STAT BIOL HEALTH, P249; Riaz S, 2011, THEOR APPL GENET, V122, P1059, DOI 10.1007/s00122-010-1511-6; Saucet SB, 2016, NEW PHYTOL, V211, P41, DOI 10.1111/nph.13933; Scaglione D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-3; Schwander F, 2012, THEOR APPL GENET, V124, P163, DOI 10.1007/s00122-011-1695-4; Sefc KM, 1999, GENOME, V42, P367, DOI 10.1139/gen-42-3-367; Smith BP, 2017, AUST J GRAPE WINE R, V23, P125, DOI 10.1111/ajgw.12242; Teh SL, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-016-0586-4; Tello J, 2016, THEOR APPL GENET, V129, P227, DOI 10.1007/s00122-015-2623-9; THOMAS MR, 1993, THEOR APPL GENET, V86, P985, DOI 10.1007/BF00211051; Torregrosa L, 2015, METHODS MOL BIOL, V1224, P177, DOI 10.1007/978-1-4939-1658-0_15; van Heerden CJ, 2014, EUPHYTICA, V200, P281, DOI 10.1007/s10681-014-1167-4; Walker GE, 2008, AUSTRALAS PLANT PATH, V37, P268, DOI 10.1071/AP08018; WALKER MA, 1994, PLANT DIS, V78, P1055, DOI 10.1094/PD-78-1055; Wang FP, 2015, VITIS, V54, P143; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Welter LJ, 2007, MOL BREEDING, V20, P359, DOI 10.1007/s11032-007-9097-7; Whiting J., 2004, RESOURCES, P167, DOI DOI 10.1073/PNAS.211312798; Williamson VM, 2006, TRENDS GENET, V22, P396, DOI 10.1016/j.tig.2006.05.003; Williamson VM, 2003, CURR OPIN PLANT BIOL, V6, P327, DOI 10.1016/S1369-5266(03)00059-1; Yang SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149560; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zyprian E, 2016, MOL GENET GENOMICS, V291, P1573, DOI 10.1007/s00438-016-1200-5	89	17	18	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0193121	10.1371/journal.pone.0193121	http://dx.doi.org/10.1371/journal.pone.0193121			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462210	gold, Green Submitted, Green Published			2022-12-26	WOS:000425554200049
J	Ciciliot, S; Albiero, M; Campanaro, S; Poncina, N; Tedesco, S; Scattolini, V; Dalla Costa, F; Cignarella, A; Vettore, M; Di Gangi, IM; Bogialli, S; Avogaro, A; Fadini, GP				Ciciliot, Stefano; Albiero, Mattia; Campanaro, Stefano; Poncina, Nicol; Tedesco, Serena; Scattolini, Valentina; Dalla Costa, Francesca; Cignarella, Andrea; Vettore, Monica; Di Gangi, Iole Maria; Bogialli, Sara; Avogaro, Angelo; Fadini, Gian Paolo			Interplay between gut microbiota and p66Shc affects obesity-associated insulin resistance	FASEB JOURNAL			English	Article						oxidative stress; inflammation; gut bacteria; microbiome; metabolic syndrome	HIGH-FAT DIET; OXIDATIVE STRESS; GLUCOSE-TOLERANCE; LIFE-SPAN; DELETION; HOST; MICE; PROMOTES; PROTECTS; GENE	The 66 kDa isoform of the mammalian Shc gene promotes adipogenesis, and p66Shc(-/-) mice accumulate less body weight than wild-type (WT) mice. As the metabolic consequences of the leaner phenotype of p66Shc(-/-) mice is debated, we hypothesized that gut microbiota may be involved. We confirmed that p66Shc(-/-) mice gained less weight than WT mice when on a high-fat diet (HFD), but they were not protected from insulin resistance and glucose intolerance. p66Shc deletion significantly modified the composition of gut microbiota and their modification after an HFD. This was associated with changes in gene expression of Il-1b and regenerating islet-derived protein 3 (Reg3g) in the gut and in systemic trimethylamine N-oxide and branched chain amino acid levels, despite there being no difference in intestinal structure and permeability. Depleting gut microbiota at the end of HFD rendered both strains more glucose tolerant but improved insulin sensitivity only in p66Shc(-/-) mice. Microbiota-depleted WT mice cohoused with microbiota-competent p66Shc(-/-) mice became significantly more insulin resistant than WT mice cohoused with WT mice, despite no difference in weight gain. These findings reconcile previous inconsistent observations on the metabolic phenotype of p66Shc(-/-) mice and illustrate the complex microbiome-host-genotype interplay under metabolic stress.Ciciliot, S., Albiero, M., Campanaro, S., Poncina, N., Tedesco, S., Scattolini, V., Dalla Costa, F., Cignarella, A., Vettore, M., Di Gangi, I. M., Bogialli, S., Avogaro, A., Fadini, G. P. Interplay between gut microbiota and p66Shc affects obesity-associated insulin resistance.	[Ciciliot, Stefano; Albiero, Mattia; Poncina, Nicol; Tedesco, Serena; Scattolini, Valentina; Dalla Costa, Francesca; Fadini, Gian Paolo] Venetian Inst Mol Med, Padua, Italy; [Campanaro, Stefano] Univ Padua, Dept Biol, Padua, Italy; [Scattolini, Valentina; Cignarella, Andrea; Vettore, Monica; Avogaro, Angelo; Fadini, Gian Paolo] Univ Padua, Dept Med, Padua, Italy; [Di Gangi, Iole Maria; Bogialli, Sara] Univ Padua, Dept Chem, Padua, Italy	Veneto Institute Molecular Medicine; University of Padua; University of Padua; University of Padua	Fadini, GP (corresponding author), Univ Padua, Med Sch, Dept Med, Via Giustiniani 2, I-35128 Padua, Italy.	gianpaolo.fadini@unipd.it	Avogaro, Angelo/S-3808-2016; Fadini, Gian Paolo/M-4575-2019; bogialli, sara/AAA-9818-2021; Campanaro, Stefano/I-5657-2019; Albiero, Mattia/AAG-4257-2019; Ciciliot, Stefano/L-3887-2019	Fadini, Gian Paolo/0000-0002-6510-2097; bogialli, sara/0000-0002-9152-3602; Albiero, Mattia/0000-0003-4142-9738; Ciciliot, Stefano/0000-0002-5833-6581; Cignarella, Andrea/0000-0002-4820-4876; Scattolini, Valentina/0000-0002-0855-9402; AVOGARO, ANGELO/0000-0002-1177-0516	Italian Ministry of University [PRIN 2015ZTT5KB]; Oviesse Co.	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Oviesse Co.	G.P.F. is the guarantor of this work, and as such, has full access to all the data in the study, and takes responsibility for the integrity of the data and its accuracy of the data analysis. This work was supported by grants from the Italian Ministry of University (PRIN 2015ZTT5KB to G.P.F.) and from the Oviesse Co. to the Venetian Institute of Molecular Medicine. The authors declare no conflicts of interest.	Albiero M, 2014, DIABETES, V63, P1353, DOI 10.2337/db13-0894; Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Ciciliot S, 2015, DIABETOLOGIA, V58, P2352, DOI 10.1007/s00125-015-3667-8; de Sablet T, 2016, CELL MICROBIOL, V18, P1871, DOI 10.1111/cmi.12632; Dumas ME, 2017, CELL REP, V20, P136, DOI 10.1016/j.celrep.2017.06.039; Fadini GP, 2010, DIABETES, V59, P2306, DOI 10.2337/db09-1727; Forman HJ, 2010, ANN NY ACAD SCI, V1203, P35, DOI 10.1111/j.1749-6632.2010.05551.x; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Giorgio M, 2016, AGING CELL, V15, P446, DOI 10.1111/acel.12448; Graiani G, 2005, HYPERTENSION, V46, P433, DOI 10.1161/01.HYP.0000174986.73346.ba; Iwakami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027401; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Suarez-Zamorano N, 2015, NAT MED, V21, P1497, DOI 10.1038/nm.3994; Tomilov AA, 2011, AGING CELL, V10, P55, DOI 10.1111/j.1474-9726.2010.00641.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Walker A, 2014, ISME J, V8, P2380, DOI 10.1038/ismej.2014.79; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112	29	9	10	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					4004	4015		10.1096/fj.201701409R	http://dx.doi.org/10.1096/fj.201701409R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29466053				2022-12-26	WOS:000435104500044
J	Oh, SM; Lim, YJ; Choi, JA; Lee, J; Cho, SN; Go, D; Kim, SH; Song, CH				Oh, Sung-Man; Lim, Yun-Ji; Choi, Ji-Ae; Lee, Junghwan; Cho, Soo-Na; Go, Dam; Kim, Seon-Hwa; Song, Chang-Hwa			TNF--mediated ER stress causes elimination of Mycobacterium fortuitum reservoirs by macrophage apoptosis	FASEB JOURNAL			English	Article						infection; nontuberculous mycobacteria; endoplasmic reticulum	ENDOPLASMIC-RETICULUM STRESS; CYTOKINE SECRETION; TUBERCULOSIS; ACTIVATION; DEFENSE; DISEASE; SNARES	Mycobacterium fortuitum (MF), a rapidly growing nontuberculosis mycobacterium, is recognized as an important human pathogen. We investigated whether the endoplasmic reticulum (ER) stress response is associated with the apoptosis of MF-infected macrophages. The expression of ER molecular chaperones was significantly induced by MF infection. We found that MF-induced reactive oxygen species (ROS) generation plays a critical role in the induction of ER stress-mediated apoptosis. Excess TNF- in the ER led to ER stress-mediated apoptosis during MF infection. The intracellular survival of MF was significantly increased by TNF- knockdown compared with the control. This is the first report of MF-induced TNF- as a cause of ER stress in macrophages. Furthermore, we found that TLR2-mediated ER stress response contributed to the elimination of intracellular MF in vivo. These results suggest that TNF--mediated ER stress during MF infection contributes to the suppression of intracellular survival of MF in macrophages. Our findings provide new insight into the importance of ER stress in mycobacterial infection.Oh, S.-M., Lim, Y.-J., Choi, J.-A., Lee, J., Cho, S.-N., Go, D., Kim, S.-H., Song, C.-H. TNF--mediated ER stress causes elimination of Mycobacterium fortuitum reservoirs by macrophage apoptosis.	[Oh, Sung-Man; Lim, Yun-Ji; Choi, Ji-Ae; Lee, Junghwan; Cho, Soo-Na; Go, Dam; Kim, Seon-Hwa; Song, Chang-Hwa] Chungnam Natl Univ, Coll Med, Dept Microbiol, 266 Munhwa Ro, Daejeon 35015, South Korea; [Oh, Sung-Man; Lim, Yun-Ji; Choi, Ji-Ae; Lee, Junghwan; Cho, Soo-Na; Go, Dam; Kim, Seon-Hwa; Song, Chang-Hwa] Chungnam Natl Univ, Coll Med, Dept Med Sci, Daejeon, South Korea; [Song, Chang-Hwa] Chungnam Natl Univ, Coll Med, Res Inst Med Sci, Daejeon, South Korea	Chungnam National University; Chungnam National University; Chungnam National University	Song, CH (corresponding author), Chungnam Natl Univ, Coll Med, Dept Microbiol, 266 Munhwa Ro, Daejeon 35015, South Korea.	songch@cnu.ac.kr	Song, Chang-Hwa/AAD-7917-2022	Song, Chang-Hwa/0000-0002-9490-0573	National Research Foundation of Korea (NRF) grant - Korean government (MEST) [NRF-2016R1A2B2008178]	National Research Foundation of Korea (NRF) grant - Korean government (MEST)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (NRF-2016R1A2B2008178). The authors declare no conflicts of interest.	Blair P, 2017, J INFECT CHEMOTHER, V23, P177, DOI 10.1016/j.jiac.2016.08.016; Butler RE, 2010, CELL MICROBIOL, V12, P1186, DOI 10.1111/j.1462-5822.2010.01463.x; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Celli J, 2015, NAT REV MICROBIOL, V13, P71, DOI 10.1038/nrmicro3393; Chan ED, 2010, AM J RESP CELL MOL, V43, P387, DOI 10.1165/rcmb.2009-0276TR; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Choi HH, 2010, FEBS LETT, V584, P2445, DOI 10.1016/j.febslet.2010.04.050; Choi J, 2013, IEEE ICCE, P7, DOI 10.1109/ICCE.2013.6486771; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cooper AM, 2000, INFECT IMMUN, V68, P1231, DOI 10.1128/IAI.68.3.1231-1234.2000; Han JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32079; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Johnson MM, 2014, J THORAC DIS, V6, P210, DOI 10.3978/j.issn.2072-1439.2013.12.24; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Kavoosi G, 2009, PARASITOLOGY, V136, P1193, DOI 10.1017/S0031182009990473; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Lim YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37211; Lim YJ, 2015, APOPTOSIS, V20, P358, DOI 10.1007/s10495-014-1080-2; Lim YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028531; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Morinaga N, 2008, CELL MICROBIOL, V10, P921, DOI 10.1111/j.1462-5822.2007.01094.x; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Murray RZ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00538; Porvaznik I, 2017, ADV EXP MED BIOL, V944, P19, DOI 10.1007/5584_2016_45; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	29	11	12	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3993	4003		10.1096/fj.201701407R	http://dx.doi.org/10.1096/fj.201701407R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29481309				2022-12-26	WOS:000435104500043
J	Wang, RZ; Fu, T; You, K; Li, SW; Zhao, N; Yang, JN; Zhuang, SM				Wang, Ruizhi; Fu, Tao; You, Kai; Li, Siwen; Zhao, Na; Yang, Jine; Zhuang, Shi-Mei			Identification of a TGF-beta-miR-195 positive feedback loop in hepatocytes and its deregulation in hepatoma cells	FASEB JOURNAL			English	Article						miR-195; noncoding RNA; TGF- signaling; HDAC1; hepatocellular carcinoma	HEPATOCELLULAR-CARCINOMA CELLS; TGF-BETA RECEPTOR; SUPPRESSES TUMORIGENICITY; LIVER FIBROSIS; LUNG-CANCER; EXPRESSION; PROMOTER; SP1; MICRORNA-195; REPRESSION	Resistance to TGF--induced growth repression is prevalent in various cancer cells, but the underlying mechanisms remain unclear. In this study, we showed that activation of TGF- signaling caused Sma- and Mad-related family (Smad) 2 and Smad3 to bind directly to the promoter region of miR-195, and then activated miR-195 transcription in normal hepatocytes. Conversely, miR-195 inhibited the expression of Smad7 by binding to its 3-UTR, thereby strengthening TGF--Smad signaling. These data identify a novel TGF--miR-195 positive regulatory circuitry in normal hepatocytes. Further investigation revealed that HDAC1, a histone deacetylase that was abnormally overexpressed in hepatocellular carcinoma, could bind to the miR-195 promoter via Smad3 and cause hypoacetylation in the histones associated with the miR-195 promoter in hepatoma cells. This resulted in transcriptional repression of miR-195 and, subsequently, disruption of the TGF--miR-195 regulatory loop and evasion of TGF--mediated growth inhibition. Moreover, silencing HDAC1 in hepatoma cells restored TGF--mediated growth suppression, but this effect was attenuated if miR-195 expression decreased. These findings suggest that HDAC1-induced miR-195 down-regulation is an important mechanism for tumor cells to resist the cytostatic activity of TGF-, and highlight the importance of TGF--Smad2/3-miR-195-Smad7 circuitry in preventing uncontrolled cell proliferation.Wang, R., Fu, T., You, K., Li, S., Zhao, N., Yang, J., Zhuang, S.-M. Identification of a TGF--miR-195 positive feedback loop in hepatocytes and its deregulation in hepatoma cells.	[Wang, Ruizhi; Fu, Tao; You, Kai; Li, Siwen; Zhao, Na; Yang, Jine; Zhuang, Shi-Mei] Sun Yat Sen Univ, Affiliated Hosp 1, Sch Life Sci,Minist Educ,State Key Lab Biocontrol, Collaborat Innovat Ctr Canc Med,Key Lab Gene Engn, Guangzhou, Guangdong, Peoples R China; [Wang, Ruizhi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Yang, JN; Zhuang, SM (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Xin Gang Xi Rd 135, Guangzhou 510275, Guangdong, Peoples R China.	lssyje@mail.sysu.edu.cn; zhuangshimei@163.com		Zhuang, Shi-Mei/0000-0002-2512-3942; Zhao, Na/0000-0002-8161-3380	National Key Research and Development Program of China [2017YFA0504400]; National Natural Science Foundation of China [91440205, 81572400, 81402421]; Natural Science Foundation of Guangdong Province [2014A030313119, 2017A030313107]; Fundamental Research Funds for the Central Universities [171gjc32, 17ykpy33]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors thank Wangjing Zhong (School of Life Sciences, Sun Yat-sen University) for technical assistance. This work was supported by National Key Research and Development Program of China Grant 2017YFA0504400, National Natural Science Foundation of China Grants 91440205, 81572400, and 81402421, Natural Science Foundation of Guangdong Province Grants 2014A030313119 and 2017A030313107, and the Fundamental Research Funds for the Central Universities (Grants 171gjc32 and 17ykpy33). The authors declare no conflicts of interest.	Bhattacharya A, 2013, ONCOGENE, V32, P3175, DOI 10.1038/onc.2012.324; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Colak S, 2017, TRENDS CANCER, V3, P56, DOI 10.1016/j.trecan.2016.11.008; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ding J, 2013, HEPATOLOGY, V58, P654, DOI 10.1002/hep.26378; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Kang SH, 1999, ONCOGENE, V18, P7280, DOI 10.1038/sj.onc.1203146; Kim HJ, 2011, BBA-GENE REGUL MECH, V1809, P184, DOI 10.1016/j.bbagrm.2011.01.004; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Osada H, 2001, CANCER RES, V61, P8331; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Roderburg C, 2013, J HEPATOL, V58, P736, DOI 10.1016/j.jhep.2012.11.022; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Wang JY, 2010, BIOCHEM BIOPH RES CO, V393, P291, DOI 10.1016/j.bbrc.2010.01.127; Wang RZ, 2013, HEPATOLOGY, V58, P642, DOI 10.1002/hep.26373; Ward SV, 2003, VIROLOGY, V313, P553, DOI 10.1016/S0042-6822(03)00347-7; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Zhang HT, 2004, CLIN CANCER RES, V10, P2359, DOI 10.1158/1078-0432.CCR-0959-3; Zhao N, 2016, BBA-GENE REGUL MECH, V1859, P933, DOI 10.1016/j.bbagrm.2016.05.006	26	7	7	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3936	3945		10.1096/fj.201701199R	http://dx.doi.org/10.1096/fj.201701199R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29465312				2022-12-26	WOS:000435104500038
J	Galan-Davila, AK; Ryu, J; Dong, K; Xiao, Y; Dai, Z; Zhang, DL; Li, Z; Dick, AM; Liu, KD; Kamat, A; Lu, M; Dong, QF; Liu, F; Dong, LQ				Galan-Davila, Amanda K.; Ryu, Jiyoon; Dong, Kun; Xiao, Yang; Dai, Zhe; Zhang, Deling; Li, Zhi; Dick, Amanda M.; Liu, Kevin D.; Kamat, Amrita; Lu, Min; Dong, Qunfeng; Liu, Feng; Dong, Lily Q.			Alternative splicing variant of the scaffold protein APPL1 suppresses hepatic adiponectin signaling and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-BETA; GLUCOSE-PRODUCTION; TARGET TISSUES; BAR-PH; INSULIN; RECEPTOR; AKT; PHOSPHORYLATION; HOMEOSTASIS; INHIBITION	Adiponectin is an adipocyte-derived hormone with antidiabetic activities that include increasing the sensitivity of cells to insulin. Adaptor protein containing pleckstrin homology domain, phosphotyrosine-binding domain, and leucine zipper motif (APPL1) stimulates adiponectin signaling and promotes adiponectin's insulin-sensitizing effects by binding to two adiponectin receptors, AdipoR1 and AdipoR2, and the insulin receptor. In this study, we report an alternative splicing variant of APPL1 (APPL1sv) that is highly expressed in mouse liver, pancreas, and spleen tissues. The expression levels of APPL1sv in liver tissues were enhanced in a mouse model of obesity and diabetic dyslipidemia (i.e. db/db mice) and reduced in calorie-restricted mice compared with ad libitum-fed mice. APPL1sv overexpression or suppression inhibited or enhanced, respectively, adiponectin-stimulated phosphorylation of AMP protein kinase (AMPK) in mouse hepatocytes. We also found that APPL1sv binds to AdipoR1 and AdipoR2 under basal conditions and that adiponectin treatment reduces this binding. Overexpression of APPL1sv blocked adiponectin-induced interactions of APPL1 with the adiponectin receptors. Moreover, adenovirus-mediated and short hairpin RNA-based suppression of APPL1sv greatly reduced high fat diet-induced insulin resistance and hepatic glucose production in mice. Our study identifies a key suppressor of hepatic adiponectin signaling and insulin sensitivity, a finding that may shed light on identifying effective therapeutic targets for treating insulin resistance and type 2 diabetes.	[Galan-Davila, Amanda K.; Ryu, Jiyoon; Dong, Kun; Xiao, Yang; Dai, Zhe; Zhang, Deling; Li, Zhi; Dick, Amanda M.; Liu, Kevin D.; Lu, Min; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cell Syst & Anat, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Kamat, Amrita] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Kamat, Amrita; Liu, Feng; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Ctr Longev & Aging Studies, San Antonio, TX 78229 USA; [Kamat, Amrita] South Texas Vet Hlth Care Syst, GRECC, San Antonio, TX 78229 USA; [Lu, Min] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lu, Min] Diabet Early Discovery, Merck Res Lab, Boston, MA 02115 USA; [Dong, Qunfeng] Loyola Univ, Chicago Stritch Sch Med, Ctr Biomed Informat, Dept Publ Hlth Sci, Maywood, IL 60153 USA; [Galan-Davila, Amanda K.] Univ Incarnate Word Sch Osteopath Med, Dept Clin & Appl Sci Educ, San Antonio, TX 78253 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of California System; University of California San Diego; Merck & Company; Loyola University Chicago	Dong, LQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cell Syst & Anat, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	DongQ@uthscsa.edu	Liu, Feng/CAG-8962-2022; Ryu, Jiyoon/M-8573-2019; Xiao, Yang/N-5021-2017	Ryu, Jiyoon/0000-0001-7365-0555; Xiao, Yang/0000-0003-3927-1839	NIDDK, National Institutes of Health Pre-Doctoral Fellowship [PA-11-112]; National Institutes of Health Grant [DK76902, DK102965, R01]; Veterans Affairs Merit Review Award [1I01BX001744-01]; American Heart Association Research Award [15GRNT23230053]; American Diabetes Association Grant [7-13-BS-043]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102965, R01DK076902] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001744] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health Pre-Doctoral Fellowship; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Award(US Department of Veterans Affairs); American Heart Association Research Award(American Heart Association); American Diabetes Association Grant(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by NIDDK, National Institutes of Health Pre-Doctoral Fellowship PA-11-112 (to A.K. G.-D.); National Institutes of Health R01 Grant DK76902 (to F.L.), Veterans Affairs Merit Review Award 1I01BX001744-01 (to A.K.); and American Heart Association Research Award 15GRNT23230053, American Diabetes Association Grant 7-13-BS-043, and National Institutes of Health R01 Grant DK102965 (to L.Q.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; CHALFANT CE, 1995, J BIOL CHEM, V270, P13326, DOI 10.1074/jbc.270.22.13326; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Cheng KKY, 2014, BEST PRACT RES CL EN, V28, P3, DOI 10.1016/j.beem.2013.06.006; Cheng KKY, 2009, CELL METAB, V9, P417, DOI 10.1016/j.cmet.2009.03.013; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; King GJ, 2012, J BIOL CHEM, V287, P40996, DOI 10.1074/jbc.M112.349803; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Liu ML, 2014, BEST PRACT RES CL EN, V28, P25, DOI 10.1016/j.beem.2013.06.003; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Patel NA, 2004, MOL ENDOCRINOL, V18, P899, DOI 10.1210/me.2003-0391; Prudente S, 2015, AM J HUM GENET, V97, P177, DOI 10.1016/j.ajhg.2015.05.011; Riojas RA, 2006, J BIOL CHEM, V281, P21588, DOI 10.1074/jbc.M600393200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruan H, 2016, J MOL CELL BIOL, V8, P101, DOI 10.1093/jmcb/mjw014; Ryu JY, 2014, CELL REP, V7, P1227, DOI 10.1016/j.celrep.2014.04.006; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Walsh CM, 2013, J BIOL CHEM, V288, P2816, DOI 10.1074/jbc.M112.410803; Wang CH, 2009, J BIOL CHEM, V284, P31608, DOI 10.1074/jbc.M109.010355; Wang C, 2013, DIABETOLOGIA, V56, P1999, DOI 10.1007/s00125-013-2971-4; Wang YJ, 2015, CIRCULATION, V131, P1392, DOI 10.1161/CIRCULATIONAHA.114.015248; Yadav A, 2013, CLIN CHIM ACTA, V417, P80, DOI 10.1016/j.cca.2012.12.007; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	35	10	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6064	6074		10.1074/jbc.RA118.002162	http://dx.doi.org/10.1074/jbc.RA118.002162			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29483192	Green Published, hybrid			2022-12-26	WOS:000430497300025
J	Bergmann, TJ; Fregno, I; Fumagalli, F; Rinaldi, A; Bertoni, F; Boersema, PJ; Picotti, P; Molinari, M				Bergmann, Timothy J.; Fregno, Ilaria; Fumagalli, Fiorenza; Rinaldi, Andrea; Bertoni, Francesco; Boersema, Paul J.; Picotti, Paola; Molinari, Maurizio			Chemical stresses fail to mimic the unfolded protein response resulting from luminal load with unfolded polypeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER-ASSOCIATED DEGRADATION; QUALITY-CONTROL; CELL-DEATH; COMPUTATIONAL PLATFORM; MISFOLDED PROTEINS; HUMAN-DISEASE; ATF6; PROTEOSTASIS; CHAPERONES	The stress sensors ATF6, IRE1, and PERK monitor deviations from homeostatic conditions in the endoplasmic reticulum (ER), a protein biogenesis compartment of eukaryotic cells. Their activation elicits unfolded protein responses (UPR) to re-establish proteostasis. UPR have been extensively investigated in cells exposed to chemicals that activate ER stress sensors by perturbing calcium, N-glycans, or redox homeostasis. Cell responses to variations in luminal load with unfolded proteins are, in contrast, poorly characterized. Here, we compared gene and protein expression profiles in HEK293 cells challenged with ER stress-inducing drugs or expressing model polypeptides. Drug titration to limit up-regulation of the endogenous ER stress reporters heat shock protein family A (Hsp70) member 5 (BiP/HSPA5) and homocysteine-inducible ER protein with ubiquitin-like domain 1 (HERP/HERPUD1) to levels comparable with luminal accumulation of unfolded proteins substantially reduced the amplitude of both transcriptional and translational responses. However, these drug-induced changes remained pleiotropic and failed to recapitulate responses to ER load with unfolded proteins. These required unfolded protein association with BiP and induced a much smaller subset of genes participating in a chap-erone complex that binds unfolded peptide chains. In conclusion, UPR resulting from ER load with unfolded proteins proceed via a well-defined and fine-tuned pathway, whereas even mild chemical stresses caused by compounds often used to stimulate UPR induce cellular responses largely unrelated to the UPR or ER-mediated protein secretion.	[Bergmann, Timothy J.; Fregno, Ilaria; Fumagalli, Fiorenza; Rinaldi, Andrea; Bertoni, Francesco; Molinari, Maurizio] Univ Svizzera Italiana, CH-6900 Lugano, Switzerland; [Bergmann, Timothy J.; Fregno, Ilaria; Fumagalli, Fiorenza; Molinari, Maurizio] Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Bergmann, Timothy J.; Fregno, Ilaria; Boersema, Paul J.; Picotti, Paola] Swiss Fed Inst Technol, Dept Biol, CH-8093 Zurich, Switzerland; [Fumagalli, Fiorenza] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3001 Bern, Switzerland; [Rinaldi, Andrea; Bertoni, Francesco] Ist Oncol Ric, CH-6500 Bellinzona, Switzerland; [Molinari, Maurizio] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland	Universita della Svizzera Italiana; Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Molinari, M (corresponding author), Via Vela 6, CH-6500 Bellinzona, Switzerland.	maurizio.molinari@irb.usi.ch	Bertoni, Francesco/G-6922-2014; Molinari, Maurizio/N-2587-2019	Bertoni, Francesco/0000-0001-5637-8983; Molinari, Maurizio/0000-0002-7636-5829; Picotti, Paola/0000-0002-4109-3552; Fregno, Ilaria/0000-0003-0546-8764	Signora Alessandra; Alpha-ONE Foundation; Foundation for Research on Neurodegenerative Diseases; Novartis Foundation; Swiss National Science Foundation (SNF); Comel Foundation; Gelu Foundation; Sinergia grant of the Swiss National Foundation	Signora Alessandra; Alpha-ONE Foundation; Foundation for Research on Neurodegenerative Diseases; Novartis Foundation(Novartis); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Comel Foundation; Gelu Foundation; Sinergia grant of the Swiss National Foundation	This work was supported in part by grants from Signora Alessandra, Alpha-ONE Foundation, Foundation for Research on Neurodegenerative Diseases, the Novartis Foundation, Swiss National Science Foundation (SNF), and Comel and Gelu Foundations (to M.M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Sinergia grant of the Swiss National Foundation.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bernasconi R, 2011, CURR OPIN CELL BIOL, V23, P176, DOI 10.1016/j.ceb.2010.10.002; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bonetti P, 2013, BLOOD, V122, P2233, DOI 10.1182/blood-2013-01-475772; Brown HC, 2011, J BIOL CHEM, V286, P24451, DOI 10.1074/jbc.M111.238758; Canova NK, 2007, CELL BIOL TOXICOL, V23, P337, DOI 10.1007/s10565-007-0185-6; Carrara M, 2015, ELIFE, V4, DOI 10.7554/eLife.03522; Chen KC, 2017, EMBO J, V36, P2296, DOI 10.15252/embj.201695616; Cleries R, 2012, COMPUT BIOL MED, V42, P438, DOI 10.1016/j.compbiomed.2011.12.012; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Fribley A, 2009, METHODS MOL BIOL, V559, P191, DOI 10.1007/978-1-60327-017-5_14; Fujimori T, 2017, GENES CELLS, V22, P684, DOI 10.1111/gtc.12506; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Hagiwara M, 2016, MOL CELL, V63, P753, DOI 10.1016/j.molcel.2016.07.014; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hartley CL, 2013, HUM MOL GENET, V22, P5262, DOI 10.1093/hmg/ddt383; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Karagoz GE, 2017, ELIFE, V6, DOI 10.7554/eLife.30700; Kopp MC, 2018, ELIFE, V7, DOI 10.7554/eLife.30257; Koritzinsky M, 2013, J CELL BIOL, V203, P615, DOI 10.1083/jcb.201307185; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Leitman J, 2014, MOL BIOL CELL, V25, P1050, DOI 10.1091/mbc.E13-06-0350; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Lynes EM, 2013, J CELL SCI, V126, P3893, DOI 10.1242/jcs.125856; Martinon F, 2015, NAT REV RHEUMATOL, V11, P11, DOI 10.1038/nrrheum.2014.158; Maurel M., 2014, TRENDS BIOCH SCI; Merulla J, 2015, MOL BIOL CELL, V26, P1532, DOI 10.1091/mbc.E14-12-1615; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Mori A, 2011, NEUROCHEM INT, V58, P344, DOI 10.1016/j.neuint.2010.12.010; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Oh YK, 2008, J NEUROCHEM, V104, P993, DOI 10.1111/j.1471-4159.2007.05053.x; Oikawa T, 2010, BIOCHEM BIOPH RES CO, V393, P253, DOI 10.1016/j.bbrc.2010.01.113; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Pisoni GB, 2016, TRAFFIC, V17, P341, DOI 10.1111/tra.12373; Preissler S, 2017, ELIFE, V6, DOI 10.7554/eLife.29428; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.12621; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Raina K, 2014, NAT CHEM BIOL, V10, P957, DOI [10.1038/NCHEMBIO.1638, 10.1038/nchembio.1638]; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Sou SN, 2012, BIOCHEM BIOPH RES CO, V420, P473, DOI 10.1016/j.bbrc.2012.03.030; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; Taylor RC, 2014, NAT REV MOL CELL BIO, V15, P211, DOI 10.1038/nrm3752; Thibault G, 2011, P NATL ACAD SCI USA, V108, P20597, DOI 10.1073/pnas.1117184109; TKACZ JS, 1975, BIOCHEM BIOPH RES CO, V65, P248, DOI 10.1016/S0006-291X(75)80086-6; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835	69	37	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5600	5612		10.1074/jbc.RA117.001484	http://dx.doi.org/10.1074/jbc.RA117.001484			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29453283	Green Published, hybrid			2022-12-26	WOS:000430044100021
J	Jin, ZC; Kitajima, T; Dong, WJ; Huang, YF; Ren, WW; Guan, F; Chiba, Y; Gao, XD; Fujita, M				Jin, Ze-Cheng; Kitajima, Toshihiko; Dong, Weijie; Huang, Yi-Fan; Ren, Wei-Wei; Guan, Feng; Chiba, Yasunori; Gao, Xiao-Dong; Fujita, Morihisa			Genetic disruption of multiple alpha 1,2-mannosidases generates mammalian cells producing recombinant proteins with high-mannose-type N-glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; FAMILY-47 ALPHA-MANNOSIDASES; LYSOSOMAL STORAGE DISEASES; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MOLECULAR-CLONING; TERMINATED GLUCOCEREBROSIDASE; ALPHA-1,2-LINKED MANNOSE; TRIMMING STEP; GOLGI	Recombinant therapeutic proteins are becoming very important pharmaceutical agents for treating intractable diseases. Most biopharmaceutical proteins are produced in mammalian cells because this ensures correct folding and glycosylation for protein stability and function. However, protein production in mammalian cells has several drawbacks, including heterogeneity of glycans attached to the produced protein. In this study, we established cell lines with high-mannose-type N-linked, low-complexity glycans. We first knocked out two genes encoding Golgi mannosidases (MAN1A1 and MAN1A2) in HEK293 cells. Single knockout (KO) cells did not exhibit changes in N-glycan structures, whereas double KO cells displayed increased high-mannose-type and decreased complex-type glycans. In our effort to eliminate the remaining complex-type glycans, we found that knocking out a gene encoding the endoplasmic reticulum mannosidase I (MAN1B1) in the double KO cells reduced most of the complex-type glycans. In triple KO (MAN1A1, MAN1A2, and MAN1B1) cells, Man9GlcNAc2 and Man8GlcNAc2 were the major N-glycan structures. Therefore, we expressed two lysosomal enzymes, alpha-galactosidase-A and lysosomal acid lipase, in the triple KO cells and found that the glycans on these enzymes were sensitive to endoglycosidase H treatment. The N-glycan structures on recombinant proteins expressed in triple KO cells were simplified and changed from complex types to high-mannose types at the protein level. Our results indicate that the triple KO HEK293 cells are suitable for producing recombinant proteins, including lysosomal enzymes with high-mannose-type N-glycans.	[Jin, Ze-Cheng; Kitajima, Toshihiko; Huang, Yi-Fan; Ren, Wei-Wei; Guan, Feng; Gao, Xiao-Dong; Fujita, Morihisa] Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi 214122, Jiangsu, Peoples R China; [Dong, Weijie] Dalian Med Univ, Coll Basic Med Sci, Dalian 116044, Liaoning, Peoples R China; [Chiba, Yasunori] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan	Jiangnan University; Dalian Medical University; National Institute of Advanced Industrial Science & Technology (AIST)	Gao, XD; Fujita, M (corresponding author), Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi 214122, Jiangsu, Peoples R China.	xdgao@jiangnan.edu.cn; fujita@jiangnan.edu.cn	Kitajima, Toshihiko/D-2463-2016; Fujita, Morihisa/AAM-4142-2020; Chiba, Yasunori/L-7993-2018	Kitajima, Toshihiko/0000-0001-9677-5086; Chiba, Yasunori/0000-0002-6401-5071	National Natural Science Foundation of China [31770853, 31400693]; Natural Science Foundation of Jiangsu Province [BK20140141]; Young 1000 Program; Fundamental Research Funds for the Central Universities [JUSRP11540]; 111 Program Grant [111-2-06]; International Joint Research Laboratory for Production of Therapeutic Glycoproteins at Jiangnan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Young 1000 Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Program Grant; International Joint Research Laboratory for Production of Therapeutic Glycoproteins at Jiangnan University	This work was supported by from the National Natural Science Foundation of China Grants-in-Aid 31770853 and 31400693, Natural Science Foundation of Jiangsu Province Grant BK20140141, the Young 1000 Program (to M.F.), Fundamental Research Funds for the Central Universities JUSRP11540 (to M.F.), 111 Program Grant (111-2-06), and the International Joint Research Laboratory for Production of Therapeutic Glycoproteins at Jiangnan University. The authors declare that they have no conflicts of interest with the contents of this article.	BAUSE E, 1993, EUR J BIOCHEM, V217, P535, DOI 10.1111/j.1432-1033.1993.tb18274.x; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Burrow Thomas A, 2011, Clin Investig (Lond), V1, P285; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COUSO R, 1986, J BIOL CHEM, V261, P6326; DELORME E, 1992, BIOCHEMISTRY-US, V31, P9871, DOI 10.1021/bi00156a003; DEREWENDA Z, 1989, EMBO J, V8, P2189, DOI 10.1002/j.1460-2075.1989.tb08341.x; Dicker M, 2015, EXPERT OPIN BIOL TH, V15, P1501, DOI 10.1517/14712598.2015.1069271; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Filocamo Mirella, 2011, Human Genomics, V5, P156; Fujita K, 2004, ARCH BIOCHEM BIOPHYS, V432, P41, DOI 10.1016/j.abb.2004.09.013; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; FURBISH FS, 1981, BIOCHIM BIOPHYS ACTA, V673, P425, DOI 10.1016/0304-4165(81)90474-8; Furukawa JI, 2008, ANAL CHEM, V80, P1094, DOI 10.1021/ac702124d; Gil GC, 2010, ANAL CHEM, V82, P6613, DOI 10.1021/ac1011377; Gonzalez DS, 1999, J BIOL CHEM, V274, P21375, DOI 10.1074/jbc.274.30.21375; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haas R, 1995, CYTOKINES MOL THER, V1, P249; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; HERSCOVICS A, 1994, J BIOL CHEM, V269, P9864; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Higel F, 2016, EUR J PHARM BIOPHARM, V100, P94, DOI 10.1016/j.ejpb.2016.01.005; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hirata T, 2015, MOL BIOL CELL, V26, P3071, DOI 10.1091/mbc.E14-11-1568; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Iannotti MJ, 2014, J BIOL CHEM, V289, P11844, DOI 10.1074/jbc.M114.552091; Kaneda Y, 2002, J BIOL CHEM, V277, P16928, DOI 10.1074/jbc.M112382200; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Kosloski MP, 2009, AAPS J, V11, P424, DOI 10.1208/s12248-009-9119-y; Lachmann RH, 2011, CURR OPIN PEDIATR, V23, P588, DOI 10.1097/MOP.0b013e32834c20d9; Lagasse H A Daniel, 2017, F1000Res, V6, P113, DOI 10.12688/f1000research.9970.1; Lal A, 1998, GLYCOBIOLOGY, V8, P981, DOI 10.1093/glycob/8.10.981; Lee GH, 2016, J CELL BIOL, V215, P705, DOI 10.1083/jcb.201605121; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mast SW, 2006, METHOD ENZYMOL, V415, P31, DOI 10.1016/S0076-6879(06)15003-X; Meuris L, 2014, NAT BIOTECHNOL, V32, P485, DOI 10.1038/nbt.2885; Murakami S, 2013, GLYCOBIOLOGY, V23, P736, DOI 10.1093/glycob/cwt012; MURRAY GJ, 1987, METHOD ENZYMOL, V149, P25; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Pan SJ, 2011, MOL BIOL CELL, V22, P2810, DOI 10.1091/mbc.E11-02-0118; Parenti G, 2015, ANNU REV MED, V66, P471, DOI 10.1146/annurev-med-122313-085916; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138553; Rymen D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003989; SATO Y, 1993, J CLIN INVEST, V91, P1909, DOI 10.1172/JCI116409; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Stepanenko AA, 2015, GENE, V569, P182, DOI 10.1016/j.gene.2015.05.065; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Tadevosyan A, 2017, CURR RES TRANSL MED, V65, P10, DOI 10.1016/j.retram.2016.09.001; TAKEGAWA K, 1989, APPL ENVIRON MICROB, V55, P3107, DOI 10.1128/AEM.55.12.3107-3112.1989; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Tremblay LO, 2000, J BIOL CHEM, V275, P31655, DOI 10.1074/jbc.M004935200; Tremblay LO, 1998, GLYCOBIOLOGY, V8, P585, DOI 10.1093/glycob/8.6.585; Umekawa M, 2010, BBA-GEN SUBJECTS, V1800, P1203, DOI 10.1016/j.bbagen.2010.07.003; Valayannopoulos V, 2017, MOL GENET METAB, V120, P62, DOI 10.1016/j.ymgme.2016.11.002; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Xiang Y, 2016, P NATL ACAD SCI USA, V113, pE7890, DOI 10.1073/pnas.1611213113; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; YAMAMOTO K, 1994, BIOSCI BIOTECH BIOCH, V58, P72, DOI 10.1271/bbb.58.72; YAMAMOTO KJ, 1994, BIOCHEM BIOPH RES CO, V203, P244, DOI 10.1006/bbrc.1994.2174; Yamane-Ohnuki N, 2009, MABS-AUSTIN, V1, P230, DOI 10.4161/mabs.1.3.8328; Yang GL, 2015, J PROTEOME RES, V14, P639, DOI 10.1021/pr5006026	69	16	18	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5572	5584		10.1074/jbc.M117.813030	http://dx.doi.org/10.1074/jbc.M117.813030			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475941	hybrid, Green Published			2022-12-26	WOS:000430044100019
J	Pleumeekers, MM; Nimeskern, L; Koevoet, JLM; Karperien, M; Stok, KS; van Osch, GJVM				Pleumeekers, M. M.; Nimeskern, L.; Koevoet, J. L. M.; Karperien, M.; Stok, K. S.; van Osch, G. J. V. M.			Trophic effects of adipose-tissue-derived and bone-marrow-derived mesenchymal stem cells enhance cartilage generation by chondrocytes in co-culture	PLOS ONE			English	Article							IN-VITRO CHONDROGENESIS; ARTICULAR CHONDROCYTES; FUNCTIONAL-PROPERTIES; ENGINEERED CARTILAGE; HUMAN EAR; DIFFERENTIATION; PROLIFERATION; HYPERTROPHY; EXPANSION; CAPACITY	Aims Combining mesenchymal stem cells (MSCs) and chondrocytes has great potential for cell based cartilage repair. However, there is much debate regarding the mechanisms behind this concept. We aimed to clarify the mechanisms that lead to chondrogenesis (chondrocyte driven MSC-differentiation versus MSC driven chondroinduction) and whether their effect was dependent on MSC-origin. Therefore, chondrogenesis of human adipose-tissue derived MSCs (hAMSCs) and bone-marrow-derived MSCs (hBMSCs) combined with bovine articular chondrocytes (bACs) was compared. Methods hAMSCs or hBMSCs were combined with bACs in alginate and cultured in vitro or implanted subcutaneously in mice. Cartilage formation was evaluated with biochemical, histological and biomechanical analyses. To further investigate the interactions between bACs and hMSCs, (1) co-culture, (2) pellet, (3) Transwell and (4) conditioned media studies were conducted. Results The presence of hMSCs either hAMSCs or hBMSCs increased chondrogenesis in culture; deposition of GAG was most evidently enhanced in hBMSC/bACs. This effect was similar when hMSCs and bAC were combined in pellet culture, in alginate culture or when conditioned media of hMSCs were used on bAC. Species-specific gene-expression analyses demonstrated that aggrecan was expressed by bACs only, indicating a predominantly trophic role for hMSCs. Collagen-10-gene expression of bACs was not affected by hBMSCs, but slightly enhanced by hAMSCs. After in-vivo implantation, hAMSC/bACs and hBMSC/bACs had similar cartilage matrix production, both appeared stable and did not calcify. Conclusions This study demonstrates that replacing 80% of bACs by either hAMSCs or hBMSCs does not influence cartilage matrix production or stability. The remaining chondrocytes produce more matrix due to trophic factors produced by hMSCs.	[Pleumeekers, M. M.; Koevoet, J. L. M.; van Osch, G. J. V. M.] Erasmus MC, Univ Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Rotterdam, Netherlands; [Nimeskern, L.; Stok, K. S.] ETH, Inst Biomech, Zurich, Switzerland; [Koevoet, J. L. M.; van Osch, G. J. V. M.] Erasmus MC, Univ Med Ctr, Dept Orthopaed, Rotterdam, Netherlands; [Karperien, M.] Univ Twente, Dept Tissue Regenerat, MIRA Inst Biomed Technol & Tech Med, Enschede, Netherlands	Erasmus University Rotterdam; Erasmus MC; Swiss Federal Institutes of Technology Domain; ETH Zurich; Erasmus University Rotterdam; Erasmus MC; University of Twente	van Osch, GJVM (corresponding author), Erasmus MC, Univ Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Rotterdam, Netherlands.; van Osch, GJVM (corresponding author), Erasmus MC, Univ Med Ctr, Dept Orthopaed, Rotterdam, Netherlands.	g.vanosch@erasmusmc.nl	Stok, Kathryn/AAA-2667-2021; Karperien, Marcel/R-3270-2018	Stok, Kathryn/0000-0002-0522-4180; Karperien, Marcel/0000-0003-0751-0604	SenterNovem	SenterNovem	The study was performed within the framework of EuroNanoMed (EAREG-406340-131009/1) and funded by SenterNovem.	Acharya C, 2012, J CELL PHYSIOL, V227, P88, DOI 10.1002/jcp.22706; Afizah H, 2007, TISSUE ENG, V13, P659, DOI 10.1089/ten.2006.0118; Ahmed Nazish, 2007, Cell Physiol Biochem, V20, P665, DOI 10.1159/000107728; Asawa Y, 2009, TISSUE ENG PT A, V15, P1109, DOI 10.1089/ten.tea.2007.0218; Aung A, 2011, ARTHRITIS RHEUM-US, V63, P148, DOI 10.1002/art.30086; Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]; Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198; Carlesimo M, 2009, EUR J DERMATOL, V19, P640, DOI 10.1684/ejd.2009.0774; Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586; Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]; Cooke ME, 2011, OSTEOARTHR CARTILAGE, V19, P1210, DOI 10.1016/j.joca.2011.07.005; de Windt TS, 2014, STEM CELL TRANSL MED, V3, P723, DOI 10.5966/sctm.2013-0207; Dmitrieva RI, 2012, CELL CYCLE, V11, P377, DOI 10.4161/cc.11.2.18858; El Sayed K, 2010, TISSUE ENG PART B-RE, V16, P603, DOI [10.1089/ten.teb.2010.0167, 10.1089/ten.TEB.2010.0167]; Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502; Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31; Farrell E, 2009, TISSUE ENG PART C-ME, V15, P285, DOI 10.1089/ten.tec.2008.0297; Farrell MJ, 2014, J BIOMECH, V47, P2173, DOI 10.1016/j.jbiomech.2013.10.030; Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565; Gharibi B, 2012, STEM CELL TRANSL MED, V1, P771, DOI 10.5966/sctm.2010-0031; HAUSELMANN HJ, 1992, MATRIX, V12, P116; Hellingman CA, 2011, CELL TRANSPLANT, V20, P925, DOI 10.3727/096368910X539119; Henderson JH, 2007, TISSUE ENG, V13, P843, DOI 10.1089/ten.2006.0256; Hendriks J, 2007, J TISSUE ENG REGEN M, V1, P170, DOI 10.1002/term.19; Hendriks JAA, 2010, SOFT MATTER, V6, P5080, DOI 10.1039/c0sm00266f; HIERCK BP, 1994, J HISTOCHEM CYTOCHEM, V42, P1499, DOI 10.1177/42.11.7930532; Hildner F, 2009, TISSUE ENG PT A, V15, P3961, DOI [10.1089/ten.tea.2009.0002, 10.1089/ten.TEA.2009.0002]; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Hubka KM, 2014, TISSUE ENG PART B-RE, V20, P641, DOI [10.1089/ten.teb.2014.0034, 10.1089/ten.TEB.2014.0034]; Hwang NS, 2007, J CELL PHYSIOL, V212, P281, DOI 10.1002/jcp.21052; Isogai N, 2006, TISSUE ENG, V12, P691, DOI 10.1089/ten.2006.12.691; Johnson TS, 2004, TISSUE ENG, V10, P1308, DOI 10.1089/1076327042500445; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Jork A, 2000, APPL MICROBIOL BIOT, V53, P224, DOI 10.1007/s002530050012; Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178; Karlsson C, 2007, J ORTHOP RES, V25, P152, DOI 10.1002/jor.20287; Kusuhara H, 2009, WOUND REPAIR REGEN, V17, P136, DOI 10.1111/j.1524-475X.2008.00451.x; Lee CSD, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt126; Lee JS, 2010, TISSUE ENG PT A, V16, P3569, DOI [10.1089/ten.tea.2010.0218, 10.1089/ten.TEA.2010.0218]; Lee J, 2007, BIOTECHNOL APPL BIOC, V48, P149, DOI 10.1042/BA20060233; Leijten JCH, 2013, TISSUE ENG PART B-RE, V19, P31, DOI [10.1089/ten.teb.2012.0273, 10.1089/ten.TEB.2012.0273]; Levorson EJ, 2014, ACTA BIOMATER, V10, P1824, DOI 10.1016/j.actbio.2013.12.026; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Liu X, 2010, BIOMATERIALS, V31, P9406, DOI 10.1016/j.biomaterials.2010.08.052; Lohan A, 2011, HISTOCHEM CELL BIOL, V136, P57, DOI 10.1007/s00418-011-0822-2; Lopa S, 2013, INT J IMMUNOPATH PH, V26, P23, DOI 10.1177/03946320130260S104; Malicev E, 2009, J ORTHOP RES, V27, P943, DOI 10.1002/jor.20833; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Maumus M, 2013, STEM CELL RES, V11, P834, DOI 10.1016/j.scr.2013.05.008; Meretoja VV, 2014, TISSUE ENG PART C-ME, V20, P514, DOI 10.1089/ten.tec.2013.0532; Meretoja VV, 2012, BIOMATERIALS, V33, P6362, DOI 10.1016/j.biomaterials.2012.05.042; Mo XT, 2009, BONE, V45, P42, DOI 10.1016/j.bone.2008.07.240; Naumann A, 2004, TISSUE ENG, V10, P1695, DOI 10.1089/ten.2004.10.1695; Panossian A, 2001, PLAST RECONSTR SURG, V108, P392, DOI 10.1097/00006534-200108000-00018; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Platas J, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/357014; Pleumeekers MM, 2014, EUR CELLS MATER, V27, P264, DOI 10.22203/eCM.v027a19; Pleumeekers MM, 2015, PLAST RECONSTR SURG, V136, p762E, DOI 10.1097/PRS.0000000000001812; Pleumeekers MM, 2014, EUR CELLS MATER, V27, P78; PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5; Scotti C, 2013, P NATL ACAD SCI USA, V110, P3997, DOI 10.1073/pnas.1220108110; Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572; Tsuchiya K, 2004, MAT SCI ENG C-BIO S, V24, P391, DOI 10.1016/j.msec.2003.12.014; van Osch GJVM, 2004, BIORHEOLOGY, V41, P411; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wang M., 2013, SHANDONG CHEM IND, V42, P9; Wu L., 2011, TISSUE ENG PART A, V17, P9; Wu L, 2012, TISSUE ENG PT A, V18, P1542, DOI [10.1089/ten.tea.2011.0715, 10.1089/ten.TEA.2011.0715]; Xu JW, 2004, PLAST RECONSTR SURG, V113, P1361, DOI 10.1097/01.PRS.0000111594.52661.29; Yang HN, 2009, BIOMATERIALS, V30, P6374, DOI 10.1016/j.biomaterials.2009.07.062; Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010; Zhang L, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045012; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Zuo Q, 2013, INT ORTHOP, V37, P747, DOI 10.1007/s00264-013-1782-z	76	32	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0190744	10.1371/journal.pone.0190744	http://dx.doi.org/10.1371/journal.pone.0190744			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489829	Green Published, gold, Green Accepted			2022-12-26	WOS:000426276000006
J	Zhang, MX; Wu, QQ; Chen, Y; Duan, MB; Tian, G; Deng, XB; Sun, YK; Zhou, T; Zhang, GH; Chen, WS; Chen, JX				Zhang, Mingxin; Wu, Qianqian; Chen, Yao; Duan, Mubing; Tian, Ge; Deng, Xianbo; Sun, Yankuo; Zhou, Tong; Zhang, Guihong; Chen, Weisan; Chen, Jianxin			Inhibition of proanthocyanidin A2 on porcine reproductive and respiratory syndrome virus replication in vitro	PLOS ONE			English	Article							LELYSTAD-VIRUS; ALVEOLAR MACROPHAGES; ANTIVIRAL ACTIVITY; NATURAL-PRODUCTS; UNITED-STATES; SYNDROME PRRS; IDENTIFICATION; MECHANISM; EXTRACT; RNA	Porcine reproductive and respiratory syndrome virus (PRRSV) is a widely prevalent and endemic swine pathogen that causes significant economic losses for the global pig industry annually. Currently, the most prevalent strategy for PRRSV control remains the prevention of virus transmission, with highly effective therapeutic agents and vaccines still lacking. Proanthocyanidin A2 (PA2) belongs to the family of tea polyphenols, which have been reported to exhibit a range of biological activities including anti-oxidative, cardio-protective, anti-tumoural, anti-bacterial, anti-viral, and anti-inflammatory effects in vitro as well as in vivo. Here, we demonstrate that PA2 exhibits potent anti-viral activity against PRRSV infection in Marc-145 cells. Similar inhibitory effects were also found in porcine alveolar macrophages, the primary target cell type of PRRSV infection in pigs in vivo. For traditional type II PRRSV CH-la strain and high pathogenic GD-XH strain and GD-HD strain, PA2 exhibited broad-spectrum and comparable inhibitory activities in vitro with EC50 ranging from 2.2 to 3.2 mu g/ml. Treatment of PRRSV-infected Marc-145 cells with PA2 significantly inhibited viral RNA synthesis, viral protein expression and progeny virus production in a dose-dependent manner. In addition, PA2 treatment reduced gene expressions of cytokines (TNF-alpha, IFN-alpha, IL-1(3 and IL-6) induced by PRRSV infection in PAMs. Mechanistically, PA2 inhibited PRRSV replication by targeting multiple pathways including blockade of viral entry and progeny virus release. Altogether, our findings suggest that PA2 has the potential to serve as a novel prophylactic and therapeutic strategies against PRRSV infection.	[Zhang, Mingxin; Wu, Qianqian; Tian, Ge; Deng, Xianbo; Zhou, Tong; Chen, Jianxin] South China Agr Univ, Coll Vet Med, Guangdong Prov Key Lab Vet Pharmaceut Dev & Safet, Guangzhou, Guangdong, Peoples R China; [Chen, Yao; Sun, Yankuo; Zhang, Guihong] South China Agr Univ, Coll Vet Med, Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou, Guangdong, Peoples R China; [Duan, Mubing; Chen, Weisan] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic, Australia	South China Agricultural University; South China Agricultural University; La Trobe University	Chen, JX (corresponding author), South China Agr Univ, Coll Vet Med, Guangdong Prov Key Lab Vet Pharmaceut Dev & Safet, Guangzhou, Guangdong, Peoples R China.; Zhang, GH (corresponding author), South China Agr Univ, Coll Vet Med, Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou, Guangdong, Peoples R China.; Chen, WS (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic, Australia.	guihongzh@scau.edu.cn; Weisan.Chen@latrobe.edu.au; jxchen@scau.edu.cn	Chen, Weisan/E-7828-2012	Chen, Weisan/0000-0002-5221-9771	National Natural Science Foundation of China [31572565, 30972217]; National Key Research and Development Program of China [2016YFD0501300, 2017YFD0501404]; Natural Science Foundation of Guangdong Province [2015A030313399]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (Grant No: 31572565, 30972217), the National Key Research and Development Program of China (Grant No: 2016YFD0501300, 2017YFD0501404) and the Natural Science Foundation of Guangdong Province (Grant No: 2015A030313399), all to JC.	Ahmad SF, 2014, INFLAMMATION, V37, P500, DOI 10.1007/s10753-013-9764-2; Ait-Ali T, 2007, VIRAL IMMUNOL, V20, P105, DOI 10.1089/vim.2006.0078; Bagchi DB, 2003, MUTAT RES-FUND MOL M, V523, P87, DOI 10.1016/S0027-5107(02)00324-X; Baum A, 2010, AMINO ACIDS, V38, P1283, DOI 10.1007/s00726-009-0374-0; Charerntantanakul Wasin, 2012, World J Virol, V1, P23, DOI 10.5501/wjv.v1.i1.23; Cheng Hua-Yew, 2002, Antivir Chem Chemother, V13, P223; Cheng HY, 2005, J SCI FOOD AGR, V85, P10, DOI 10.1002/jsfa.1958; CONZELMANN KK, 1993, VIROLOGY, V193, P329, DOI 10.1006/viro.1993.1129; Dea S, 1995, Adv Exp Med Biol, V380, P95; Duan EZ, 2015, ANTIVIR RES, V120, P122, DOI 10.1016/j.antiviral.2015.06.001; Duan X, 1997, VET MICROBIOL, V56, P9, DOI 10.1016/S0378-1135(96)01347-8; Fine A M, 2000, Altern Med Rev, V5, P144; Fink Ryan C., 2009, Antiviral Chemistry & Chemotherapy, V19, P243; Gallina L, 2011, ANTIVIR RES, V92, P447, DOI 10.1016/j.antiviral.2011.10.004; Gescher K, 2011, J ETHNOPHARMACOL, V134, P468, DOI 10.1016/j.jep.2010.12.038; GREIG A, 1975, ARCH VIROL, V47, P287, DOI 10.1007/BF01317816; Guo CH, 2017, VET MICROBIOL, V201, P231, DOI 10.1016/j.vetmic.2017.01.033; Hanada K, 2005, MOL BIOL EVOL, V22, P1024, DOI 10.1093/molbev/msi089; Iwasawa A, 2009, BIOCONTROL SCI, V14, P107, DOI 10.4265/bio.14.107; Jiang X, 2017, BRAIN RES BULL, V135, P40, DOI 10.1016/j.brainresbull.2017.09.010; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Khatun A, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0330-z; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; Kim WI, 2008, J CLIN MICROBIOL, V46, P1758, DOI 10.1128/JCM.01927-07; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Lee SM, 2005, VIROLOGY, V342, P47, DOI 10.1016/j.virol.2005.07.034; Li WG, 2001, ACTA PHARMACOL SIN, V22, P1117; Lunney JK, 2010, VIRUS RES, V154, P1, DOI 10.1016/j.virusres.2010.10.009; Luo R, 2011, ANTIVIR RES, V91, P99, DOI 10.1016/j.antiviral.2011.04.017; Ma SC, 2002, J ETHNOPHARMACOL, V79, P205, DOI 10.1016/S0378-8741(01)00389-0; Maldonado PD, 2005, J AGR FOOD CHEM, V53, P1996, DOI 10.1021/jf0483725; Mardassi H, 1996, VIROLOGY, V221, P98, DOI 10.1006/viro.1996.0356; MENG XJ, 1994, J GEN VIROL, V75, P1795, DOI 10.1099/0022-1317-75-7-1795; Meulenberg JJM, 1996, VIROLOGY, V225, P44, DOI 10.1006/viro.1996.0573; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; MEULENBERG JJM, 1993, J GEN VIROL, V74, P1697, DOI 10.1099/0022-1317-74-8-1697; Murtaugh MP, 2011, VACCINE, V29, P8192, DOI 10.1016/j.vaccine.2011.09.013; Murtaugh MP, 1996, VET IMMUNOL IMMUNOP, V54, P45, DOI 10.1016/S0165-2427(96)05698-X; Nauwynck HJ, 1999, J GEN VIROL, V80, P297, DOI 10.1099/0022-1317-80-2-297; NELSON EA, 1993, J CLIN MICROBIOL, V31, P3184, DOI 10.1128/JCM.31.12.3184-3189.1993; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Opriessnig T, 2011, ANTIVIR RES, V91, P36, DOI 10.1016/j.antiviral.2011.04.012; Qiao SL, 2011, VET MICROBIOL, V149, P213, DOI 10.1016/j.vetmic.2010.11.006; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh RP, 2004, INT J CANCER, V108, P733, DOI 10.1002/ijc.11620; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Song J, 2010, VIRUS GENES, V41, P241, DOI 10.1007/s11262-010-0507-2; Sun N, 2012, J ASIAN NAT PROD RES, V14, P721, DOI 10.1080/10286020.2012.685727; Sun Y, 2012, VIRUSES-BASEL, V4, P424, DOI 10.3390/v4040424; Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945; Wang LL, 2014, ANTIVIR RES, V105, P39, DOI 10.1016/j.antiviral.2014.02.010; Xie JX, 2013, MICROB PATHOGENESIS, V63, P30, DOI 10.1016/j.micpath.2013.05.013; Xu XY, 2010, J AGR FOOD CHEM, V58, P11667, DOI 10.1021/jf1033202; Xu Y, 2010, PHARMACOL BIOCHEM BE, V94, P447, DOI 10.1016/j.pbb.2009.10.007; YAMADA H, 1991, CURR OPIN BIOTECH, V2, P203, DOI 10.1016/0958-1669(91)90011-S; Yang Q, 2013, ANTIVIR RES, V97, P66, DOI 10.1016/j.antiviral.2012.11.004	57	17	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193309	10.1371/journal.pone.0193309	http://dx.doi.org/10.1371/journal.pone.0193309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489892	Green Submitted, Green Published, gold			2022-12-26	WOS:000426276000064
J	Bamberg, K; Johansson, U; Edman, K; William-Olsson, L; Myhre, S; Gunnarsson, A; Geschwindner, S; Aagaard, A; Granqvist, AB; Jaisser, F; Huang, YF; Granberg, KL; Jansson-Lofmark, R; Hartleib-Geschwindner, J				Bamberg, Krister; Johansson, Ulrika; Edman, Karl; William-Olsson, Lena; Myhre, Susanna; Gunnarsson, Anders; Geschwindner, Stefan; Aagaard, Anna; Granqvist, Anna Bjornson; Jaisser, Frederic; Huang, Yufeng; Granberg, Kenneth L.; Jansson-Lofmark, Rasmus; Hartleib-Geschwindner, Judith			Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEART-FAILURE; LIGAND-BINDING; DIABETIC-NEPHROPATHY; CARDIORENAL INJURY; HYPERTENSIVE-RATS; BAY 94-8862; ALDOSTERONE; ANTAGONIST; ACTIVATION	Excess mineralocorticoid receptor (MR) activation promotes target organ dysfunction, vascular injury and fibrosis. MR antagonists like eplerenone are used for treating heart failure, but their use is limited due to the compound class-inherent hyperkalemia risk. Here we present evidence that AZD9977, a first-in-class MR modulator shows cardio-renal protection despite a mechanism-based reduced liability to cause hyperkalemia. AZD9977 in vitro potency and binding mode to MR were characterized using reporter gene, binding, cofactor recruitment assays and X-ray crystallopgraphy. Organ protection was studied in uninephrectomised db/db mice and uni-nephrectomised rats administered aldosterone and high salt. Acute effects of single compound doses on urinary electrolyte excretion were tested in rats on a low salt diet. AZD9977 and eplerenone showed similar human MR in vitro potencies. Unlike eplerenone, AZD9977 is a partial MR antagonist due to its unique interaction pattern with MR, which results in a distinct recruitment of co-factor peptides when compared to eplerenone. AZD9977 dose dependently reduced albuminuria and improved kidney histopathology similar to eplerenone in db/db uni-nephrectomised mice and uninephrectomised rats. In acute testing, AZD9977 did not affect urinary Na+/K+ ratio, while eplerenone increased the Na+/K+ ratio dose dependently. AZD9977 is a selective MR modulator, retaining organ protection without acute effect on urinary electrolyte excretion. This predicts a reduced hyperkalemia risk and AZD9977 therefore has the potential to deliver a safe, efficacious treatment to patients prone to hyperkalemia.	[Bamberg, Krister; Johansson, Ulrika; William-Olsson, Lena; Myhre, Susanna; Granqvist, Anna Bjornson; Granberg, Kenneth L.; Jansson-Lofmark, Rasmus; Hartleib-Geschwindner, Judith] AstraZeneca, Innovat Med & Early Dev Biotech Unit, Cardiovasc Renal & Metab Dis, Gothenburg, Sweden; [Edman, Karl; Gunnarsson, Anders; Geschwindner, Stefan; Aagaard, Anna] AstraZeneca, Biotech Unit, Discovery Sci Innovat Med & Early Dev, Gothenburg, Sweden; [Jaisser, Frederic] INSERM U1138 Team 1, Ctr Rech Cordeliers, Paris, France; [Huang, Yufeng] Univ Utah, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Salt Lake City, UT USA	AstraZeneca; AstraZeneca; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Utah System of Higher Education; University of Utah	Bamberg, K (corresponding author), AstraZeneca, Innovat Med & Early Dev Biotech Unit, Cardiovasc Renal & Metab Dis, Gothenburg, Sweden.	krister.bamberg@astrazeneca.com	Jaisser, Frederic/P-4287-2017	Jaisser, Frederic/0000-0001-9051-1901; Jansson-Lofmark, Rasmus/0000-0003-1773-197X	AstraZeneca	AstraZeneca(AstraZeneca)	AstraZeneca provided the funding for this research. Authors KB, KJ, KE, LWO, SM, AG, SG, AA, ABG, KLG, RJL and JHG are employees of AstraZeneca. AstraZeneca provided support in the form of salaries for these authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Adams PD, 2016, STRUCTURE, V24, P502, DOI 10.1016/j.str.2016.02.017; AGARWAL R, 1994, GASTROENTEROLOGY, V107, P548, DOI 10.1016/0016-5085(94)90184-8; Arai K, 2015, EUR J PHARMACOL, V769, P266, DOI 10.1016/j.ejphar.2015.11.028; Barfacker L, 2012, CHEMMEDCHEM, V7, P1385, DOI 10.1002/cmdc.201200081; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertocchio JP, 2011, KIDNEY INT, V79, P1051, DOI 10.1038/ki.2011.48; Bianchi S, 2005, AM J KIDNEY DIS, V46, P45, DOI 10.1053/j.ajkd.2005.03.007; Bianchi S, 2006, KIDNEY INT, V70, P2116, DOI 10.1038/sj.ki.5001854; Blanco-Rivero J, 2005, HYPERTENSION, V46, P107, DOI 10.1161/01.HYP.0000171479.36880.17; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; Bricogne G., 2009, BUSTER; Briet M, 2013, J VASC RES, V50, P89, DOI 10.1159/000345243; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Carlsson P, 2005, MOL ENDOCRINOL, V19, P1960, DOI 10.1210/me.2004-0203; Casimiro-Garcia A, 2014, J MED CHEM, V57, P4273, DOI 10.1021/jm500206r; Colussi G, 2013, J HYPERTENS, V31, P3, DOI 10.1097/HJH.0b013e3283599b6a; Currie G, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0337-0; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; Eaton Dc PVC, 2013, VANDERS RENAL PHYSL, P284; Edman K, 2015, STRUCTURE, V23, P2280, DOI 10.1016/j.str.2015.09.012; Eudy RJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-180; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Funder JW, 2005, HEART FAIL REV, V10, P15, DOI 10.1007/s10741-005-2344-2; Gekle M, 2009, PFLUG ARCH EUR J PHY, V458, P231, DOI 10.1007/s00424-008-0616-0; Giannoukos G, 2001, MOL ENDOCRINOL, V15, P255, DOI 10.1210/me.15.2.255; Gomez-Sanchez EP, 2016, J CARDIOVASC PHARM, V67, P26, DOI 10.1097/FJC.0000000000000329; Huang Y, 2008, J AM SOC NEPHROL, V19, P329, DOI 10.1681/ASN.2007040510; Hultman ML, 2005, MOL ENDOCRINOL, V19, P1460, DOI 10.1210/me.2004-0537; Huyet J, 2007, MOL PHARMACOL, V72, P563, DOI 10.1124/mol.107.036459; Iqbal J, 2014, EUR J HEART FAIL, V16, P143, DOI 10.1111/ejhf.31; Ivanes F, 2012, EUR HEART J, V33, P191, DOI 10.1093/eurheartj/ehr176; Jia GH, 2017, BBA-MOL BASIS DIS, V1863, P2012, DOI 10.1016/j.bbadis.2016.10.025; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAGAWA CM, 1959, J PHARMACOL EXP THER, V126, P123; Kazmin D, 2006, MOL ENDOCRINOL, V20, P1201, DOI 10.1210/me.2005-0309; Kojetin DJ, 2013, MOL PHARMACOL, V83, P1, DOI 10.1124/mol.112.079285; Kolkhof P, 2014, J CARDIOVASC PHARM, V64, P69, DOI 10.1097/FJC.0000000000000091; Kolkhof P, 2012, MOL CELL ENDOCRINOL, V350, P310, DOI 10.1016/j.mce.2011.06.025; Lazich L, 2014, SEMIN NEPHROL, V34, P333, DOI 10.1016/j.semnephrol.2014.04.008; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Liu LCY, 2015, EXPERT OPIN INV DRUG, V24, P1123, DOI 10.1517/13543784.2015.1059819; Liu Z, 2002, P NATL ACAD SCI USA, V99, P7940, DOI 10.1073/pnas.122225699; LOMBES M, 1995, CIRCULATION, V92, P175, DOI 10.1161/01.CIR.92.2.175; Lu Y, 2010, CURR HYPERTENS REP, V12, P303, DOI 10.1007/s11906-010-0116-4; Matsumoto Y, 2014, J AM COLL CARDIOL, V63, P529, DOI 10.1016/j.jacc.2013.09.056; McCurley A, 2012, MOL CELL ENDOCRINOL, V350, P256, DOI 10.1016/j.mce.2011.06.014; Nariai T, 2011, J PHARMACOL SCI, V115, P346, DOI 10.1254/jphs.10285FP; Nielsen FT, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-42; Nishiyama A, 2005, HYPERTENSION, V45, P710, DOI 10.1161/01.HYP.0000154681.38944.9a; Nishizaka MK, 2004, CIRCULATION, V109, P2857, DOI 10.1161/01.CIR.0000129307.26791.8E; Palmer BF, 2004, NEW ENGL J MED, V351, P585, DOI 10.1056/NEJMra035279; Pearce D, 2003, VITAM HORM, V66, P29, DOI 10.1016/S0083-6729(03)01002-1; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pitt B, 2013, EUR HEART J, V34, P2453, DOI 10.1093/eurheartj/eht187; Regitz-Zagrosek V, 2007, CURR OPIN PHARMACOL, V7, P130, DOI 10.1016/j.coph.2006.10.009; Rossier MF, 2008, HYPERTENSION, V52, P721, DOI 10.1161/HYPERTENSIONAHA.108.114223; Sato A, 1996, ENDOCRINOLOGY, V137, P4145, DOI 10.1210/en.137.10.4145; Schrodinger LLC, 2015, JYMOL MOL GRAPH DEV; SCHULTZE RG, 1971, J CLIN INVEST, V50, P1061, DOI 10.1172/JCI106577; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shibata S, 2007, HYPERTENSION, V49, P355, DOI 10.1161/01.HYP.0000255636.11931.a2; SPITAL A, 1995, AM J NEPHROL, V15, P367, DOI 10.1159/000168868; Stahn C, 2007, MOL CELL ENDOCRINOL, V275, P71, DOI 10.1016/j.mce.2007.05.019; TAKEDA R, 1995, STEROIDS, V60, P120, DOI 10.1016/0039-128X(94)00026-9; Weikum ER, 2017, MOL PHARMACOL, V92, P12, DOI 10.1124/mol.117.108506; White WB, 2003, HYPERTENSION, V41, P1021, DOI 10.1161/01.HYP.0000067463.13172.EA; Wilson P, 2009, CLIN SCI, V116, P731, DOI 10.1042/CS20080247; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhou GY, 2016, AM J TRANSL RES, V8, P1339	71	32	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193380	10.1371/journal.pone.0193380	http://dx.doi.org/10.1371/journal.pone.0193380			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474466	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500100
J	Lindenmayer, DB; Blanchard, W; Blair, D; McBurney, L; Stein, J; Banks, SC				Lindenmayer, David B.; Blanchard, Wade; Blair, David; McBurney, Lachlan; Stein, John; Banks, Sam C.			Empirical relationships between tree fall and landscape-level amounts of logging and fire	PLOS ONE			English	Article							CARBON STOCKS; FOREST; FRAGMENTATION; PATTERNS; VICTORIA; CONSERVATION; MORTALITY; ABUNDANCE; COLLAPSE; REFUGES	Large old trees are critically important keystone structures in forest ecosystems globally. Populations of these trees are also in rapid decline in many forest ecosystems, making it important to quantify the factors that influence their dynamics at different spatial scales. Large old trees often occur in forest landscapes also subject to fire and logging. However, the effects on the risk of collapse of large old trees of the amount of logging and fire in the surrounding landscape are not well understood. Using an 18-year study in the Mountain Ash (Eucalyptus regnans) forests of the Central Highlands of Victoria, we quantify relationships between the probability of collapse of large old hollow-bearing trees at a site and the amount of logging and the amount of fire in the surrounding landscape. We found the probability of collapse increased with an increasing amount of logged forest in the surrounding landscape. It also increased with a greater amount of burned area in the surrounding landscape, particularly for trees in highly advanced stages of decay. The most likely explanation for elevated tree fall with an increasing amount of logged or burned areas in the surrounding landscape is change in wind movement patterns associated with cutblocks or burned areas. Previous studies show that large old hollow-bearing trees are already at high risk of collapse in our study area. New analyses presented here indicate that additional logging operations in the surrounding landscape will further elevate that risk. Current logging prescriptions require the protection of large old hollow-bearing trees on cutblocks. We suggest that efforts to reduce the probability of collapse of large old hollow-bearing trees on unlogged sites will demand careful landscape planning to limit the amount of timber harvesting in the surrounding landscape.	[Lindenmayer, David B.; Blanchard, Wade; Blair, David; McBurney, Lachlan; Stein, John; Banks, Sam C.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Lindenmayer, David B.; Blanchard, Wade; Blair, David; McBurney, Lachlan] Australian Natl Univ, Fenner Sch Environm & Soc, Natl Environm Sci Programme, Threated Species Recovery Hub, Canberra, ACT, Australia; [Lindenmayer, David B.; Blair, David; McBurney, Lachlan] Australian Natl Univ, Fenner Sch Environm & Soc, Long Term Ecol Res Network, Canberra, ACT, Australia	Australian National University; Australian National University; Australian National University	Lindenmayer, DB (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.; Lindenmayer, DB (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Natl Environm Sci Programme, Threated Species Recovery Hub, Canberra, ACT, Australia.; Lindenmayer, DB (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Long Term Ecol Res Network, Canberra, ACT, Australia.	david.lindenmayer@anu.edu.au	Lindenmayer, David B./P-7183-2017; /K-4907-2012	Lindenmayer, David B./0000-0002-4766-4088; /0000-0003-2415-0057	Australian Research Council Discovery Grant [DP1097170]; Victorian Government Department of Environment, land, water and Planning; Parks Victoria; Long Term Ecological Research Network; National Environmental Science Programme Threatened Species Recovery Hub; Australian Research Council; Government of Victoria; National Environmental Science Programme	Australian Research Council Discovery Grant(Australian Research Council); Victorian Government Department of Environment, land, water and Planning; Parks Victoria; Long Term Ecological Research Network; National Environmental Science Programme Threatened Species Recovery Hub; Australian Research Council(Australian Research Council); Government of Victoria; National Environmental Science Programme	This work was supported by an Australian Research Council Discovery Grant DP1097170 (DBL) http://www.arc.gov.au/; the Victorian Government Department of Environment, land, water and Planning (DBL) https://www2.delwp.vic.gov.au/; Parks Victoria (DBL) http://parkweb.vic.gov.au/ Long Term Ecological Research Network (DBL) http://www.ltern.org.au/; and National Environmental Science Programme Threatened Species Recovery Hub (DBL) http://www.nespthreatenedspecies.edu.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Australian Research Council, the Government of Victoria, the National Environmental Science Programme, and the Long Term Ecological Research Network for the funding that supported the data collection and analysis which underpinned this article. Comments by Mauricio Schneider significantly improved an earlier version of the paper. Claire Shepherd provide assistance in preparing the manuscript.	Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Berry LE, 2015, ECOL APPL, V25, P2337, DOI [10.1890/14-1699.1.sm, 10.1890/14-1699.1]; Berry LE, 2015, AUST MAMMAL, V37, P39, DOI 10.1071/AM14027; Briant G, 2010, BIOL CONSERV, V143, P2763, DOI 10.1016/j.biocon.2010.07.024; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Burns EL, 2015, AUSTRAL ECOL, V40, P386, DOI 10.1111/aec.12200; Chaplin-Kramer R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10158; Crowther TW, 2015, NATURE, V525, P201, DOI 10.1038/nature14967; Cruz MG, 2012, FOREST ECOL MANAG, V284, P269, DOI 10.1016/j.foreco.2012.02.035; DEWALLE DR, 1983, J FOREST, V81, P158; ENOKSSON B, 1995, LANDSCAPE ECOL, V10, P267, DOI 10.1007/BF00128994; ESSEEN PA, 1994, BIOL CONSERV, V68, P19, DOI 10.1016/0006-3207(94)90542-8; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Flint A., 2007, MOUNTAIN ASH VICTORI; Fragstats McGarigal K., 2015, FRAGSTATS VERSION 4; Franklin JE, 1987, LANDSCAPE ECOL, V1, P5, DOI 10.1007/BF02275261; Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2; Gibbons P, 2000, FOREST ECOL MANAG, V139, P51, DOI 10.1016/S0378-1127(99)00333-3; GRATKOWSKI H. J., 1956, FOREST SCI, V2, P60; Keith H., 2017, EXPT ECOSYSTEM ACCOU; Keith H, 2017, NAT ECOL EVOL, V1, P1683, DOI 10.1038/s41559-017-0309-1; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Laurance WF, 2000, TRENDS ECOL EVOL, V15, P134, DOI 10.1016/S0169-5347(00)01838-3; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Lindenmayer D, 2015, MOUNTAIN ASH: FIRE, LOGGING AND THE FUTURE OF VICTORIA'S GIANT FORESTS, P1; Lindenmayer D., 2016, CURR LANDS ECOL REP, V1, P10, DOI [10.1007/s40823-016-0002-0, DOI 10.1007/S40823-016-0002-0]; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lindenmayer DB, 2017, BIOL CONSERV, V211, P51, DOI 10.1016/j.biocon.2016.11.012; Lindenmayer DB, 2017, FOREST ECOL MANAG, V391, P221, DOI 10.1016/j.foreco.2017.02.014; Lindenmayer DB, 2017, BIOL REV, V92, P1434, DOI 10.1111/brv.12290; Lindenmayer DB, 2016, FOREST ECOL MANAG, V372, P226, DOI 10.1016/j.foreco.2016.04.017; Lindenmayer DB, 2012, SCIENCE, V338, P1305, DOI 10.1126/science.1231070; Lindenmayer DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041864; Lindenmayer DB, 2010, CAN J FOREST RES, V40, P48, DOI 10.1139/X09-185; Mackey B, 2015, CONSERV LETT, V8, P139, DOI 10.1111/conl.12120; Mackey B, 2012, ECOL APPL, V22, P1852, DOI 10.1890/11-1479.1; McGarigal K., 1994, FRAGSTATS SPATIAL AN; McKenzie D, 2011, ECOL STUD-ANAL SYNTH, V213, P3, DOI 10.1007/978-94-007-0301-8_1; MILLER DR, 1991, FOREST ECOL MANAG, V45, P79, DOI 10.1016/0378-1127(91)90208-D; OSSENBRUGGEN PJ, 1986, WOOD FIBER SCI, V18, P168; Parry BB, 1997, THESIS; R Core Team, 2013, R LANG ENV STAT COMP; Remm J, 2011, FOREST ECOL MANAG, V262, P579, DOI 10.1016/j.foreco.2011.04.028; Rose CL, 2001, WILDLIFE-HABITAT RELATIONSHIPS IN OREGON AND WASHINGTON, P580; Rosenberg N.J., 1983, MICROCLIMATE BIOL EN; Savill P.S., 1993, COMMONW FORESTRY ABS, V44, P473; Schwartz NB, 2017, ECOL APPL, V27, P1901, DOI 10.1002/eap.1576; Seidl R, 2014, NAT CLIM CHANGE, V4, P806, DOI [10.1038/NCLIMATE2318, 10.1038/nclimate2318]; Taylor C, 2014, CONSERV LETT, V7, P355, DOI 10.1111/conl.12122; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Torrenta R, 2017, J BIOGEOGR, V44, P1791, DOI 10.1111/jbi.13022; Whelan RJ., 1995, ECOLOGY FIRE; Zeng HC, 2004, FOREST ECOL MANAG, V203, P77, DOI 10.1016/j.foreco.2004.07.057	53	12	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193132	10.1371/journal.pone.0193132	http://dx.doi.org/10.1371/journal.pone.0193132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474487	Green Published, gold, Green Submitted			2022-12-26	WOS:000426049500058
J	Lycett, KA; Chung, JS; Pitula, JS				Lycett, Kristen A.; Chung, J. Sook; Pitula, Joseph S.			The relationship of blue crab (Callinectes sapidus) size class and molt stage to disease acquisition and intensity of Hematodinium perezi infections	PLOS ONE			English	Article							LOBSTER NEPHROPS-NORVEGICUS; PARASITIC DINOFLAGELLATE; SEASONAL PREVALENCE; CHIONOECETES-OPILIO; HYPERGLYCEMIC HORMONE; CONCEPTION BAY; BACULOVIRUS; CYCLE; SP.; NEWFOUNDLAND	In the blue crab, Callinectes sapidus, early studies suggested a relationship between smaller crabs, which molt more frequently, and higher rates of infection by the dinoflagellate parasite, Hematodinium perezi. In order to better explore the influence of size and molting on infections, blue crabs were collected from the Maryland coastal bays and screened for the presence of H. perezi in hemolymph samples using a quantitative PCR assay. Molt stage was determined by a radioimmunoassay which measured ecdysteroid concentrations in blue crab hemolymph. Differences were seen in infection prevalence between size classes, with the medium size class (crabs 61 to 90 mm carapace width) and juvenile crabs (>= 30 mm carapace width) having the highest infection prevalence at 47.2% and 46.7%, respectively. All size classes were susceptible to infection, although fall months favored disease acquisition by juveniles, whereas mid-sized animals (31-90 mm carapace width) acquired infection predominantly in summer. Disease intensity was also most pronounced in the summer, with blue crabs > 61 mm being primary sources of proliferation. Molt status appeared to be influenced by infection, with infected crabs having significantly lower concentrations of ecdysteroids than uninfected crabs in the spring and the fall. We hypothesize that infection by H. perezi may increase molt intervals, with a delay in the spring molt cycle as an evolutionary adaptation functioning to coincide with increased host metabolism, providing optimal conditions for H. perezi propagation. Regardless of season, postmolt crabs harbored significantly higher proportions of moderate and heavy infections, suggesting that the process of ecdysis, and the postmolt recovery period, has a positive effect on parasite proliferation.	[Lycett, Kristen A.; Pitula, Joseph S.] Univ Maryland Eastern Shore, Dept Nat Sci, Princess Anne, MD 21853 USA; [Chung, J. Sook] Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, Baltimore, MD 21201 USA; [Lycett, Kristen A.] Salisbury Univ, Dept Biol Sci, Salisbury, MD USA	University System of Maryland; University of Maryland Eastern Shore; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; University System of Maryland; Salisbury University	Pitula, JS (corresponding author), Univ Maryland Eastern Shore, Dept Nat Sci, Princess Anne, MD 21853 USA.	jspitula@umes.edu	Chung, J.Sook/D-3832-2012	Chung, J.Sook/0000-0002-9318-304X; Pitula, Joseph/0000-0001-5215-1976	National Science Foundation [1036586]; National Science Foundation CREST Award [1036586]	National Science Foundation(National Science Foundation (NSF)); National Science Foundation CREST Award	Funded by National Science Foundation 1036586. PI: Paulinus Chigbu. Co-PI: Joe Pitula. Co-PI: Sook Chung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this research was provided by National Science Foundation CREST Award number 1036586 awarded to Dr. Paulinus Chigbu (PI). We would like to thank the Maryland Department of Natural Resources, especially Steve Doctor, Gary Tyler, and Angel Wiley, for providing access to the Coastal Bays Fisheries Investigation surveys and database.	Chung JS, 2010, ARCH INSECT BIOCHEM, V73, P1, DOI 10.1002/arch.20327; Chung JS, 1999, P NATL ACAD SCI USA, V96, P13103, DOI 10.1073/pnas.96.23.13103; Cory JS, 2004, FUNCT ECOL, V18, P443, DOI 10.1111/j.0269-8463.2004.00853.x; EATON WD, 1991, J INVERTEBR PATHOL, V57, P426, DOI 10.1016/0022-2011(91)90147-I; Field RH, 1998, ICES J MAR SCI, V55, P846, DOI 10.1006/jmsc.1998.0357; Frischer ME, 2006, HARMFUL ALGAE, V5, P548, DOI 10.1016/j.hal.2005.11.002; Gandy R, 2015, DIS AQUAT ORGAN, V113, P235, DOI 10.3354/dao02841; Hamilton KM, 2009, ICES J MAR SCI, V66, P1837, DOI 10.1093/icesjms/fsp152; Hanif Ammar W, 2013, Aquat Biosyst, V9, P11, DOI 10.1186/2046-9063-9-11; Huang SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep14260; Huchin-Mian JP, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3185-y; Li CW, 2013, AQUACULTURE, V396, P59, DOI 10.1016/j.aquaculture.2013.02.022; Li CW, 2011, PARASITOLOGY, V138, P1924, DOI 10.1017/S0031182011001405; Li CW, 2010, HARMFUL ALGAE, V9, P515, DOI 10.1016/j.hal.2010.04.001; LOVE DC, 1993, DIS AQUAT ORGAN, V15, P1, DOI 10.3354/dao015001; Lund ED, 2007, COMP BIOCHEM PHYS A, V146, P141, DOI 10.1016/j.cbpa.2006.10.004; Lycett KA, 2017, DIS AQUAT ORGAN, V124, P169, DOI 10.3354/dao03112; McDonald J.H., 2014, HDB BIOL STAT; MESSICK GA, 1994, DIS AQUAT ORGAN, V19, P77, DOI 10.3354/dao019077; Messick GA, 1999, J SHELLFISH RES, V18, P657; Messick GA, 2000, DIS AQUAT ORGAN, V43, P139, DOI 10.3354/dao043139; MEYERS TR, 1987, DIS AQUAT ORGAN, V3, P195, DOI 10.3354/dao003195; Meyers TR, 1990, DISEASES MARINE ANIM, V3, P350; Nagle L, 2009, DIS AQUAT ORGAN, V84, P79, DOI 10.3354/dao02027; OREILLY DR, 1995, INSECT BIOCHEM MOLEC, V25, P541, DOI 10.1016/0965-1748(94)00105-Q; OREILLY DR, 1989, SCIENCE, V245, P1110, DOI 10.1126/science.2505387; Parmenter KJ, 2013, ESTUAR COAST, V36, P174, DOI 10.1007/s12237-012-9556-1; Pestal GP, 2003, DIS AQUAT ORGAN, V53, P67, DOI 10.3354/dao053067; Pitula Joseph S, 2012, Aquat Biosyst, V8, P16, DOI 10.1186/2046-9063-8-16; R Core Team, 2021, R LANGUAGE ENV STAT; Shields JD, 2005, DIS AQUAT ORGAN, V64, P253, DOI 10.3354/dao064253; Shields JD, 2003, B MAR SCI, V72, P519; Shields JD, 2000, FISH B-NOAA, V98, P139; Shields JD, 2007, DIS AQUAT ORGAN, V77, P61, DOI 10.3354/dao01825; Shields JD, 2015, J INVERTEBR PATHOL, V130, P124, DOI 10.1016/j.jip.2015.07.013; Smith AL, 2015, J SHELLFISH RES, V34, P511, DOI 10.2983/035.034.0236; Smith AL, 2015, PARASITOLOGY, V142, P428, DOI 10.1017/S0031182014001255; Smith S. W., 1997, SCI ENG GUIDE DIGITA; Smith SG., 2007, BLUE CRAB CALLINECTE, P197; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; SOUMOFF C, 1983, BIOL BULL, V165, P321, DOI 10.2307/1541372; Stentiford GD, 2000, DIS AQUAT ORGAN, V42, P133, DOI 10.3354/dao042133; Stentiford GD, 2005, DIS AQUAT ORGAN, V66, P47, DOI 10.3354/dao066047; Stentiford GD, 2002, J INVERTEBR PATHOL, V79, P179, DOI 10.1016/S0022-2011(02)00028-9; Stentiford GD, 2001, GEN COMP ENDOCR, V121, P13, DOI 10.1006/gcen.2000.7575; Stentiford GD, 2001, ICES J MAR SCI, V58, P814, DOI 10.1006/jmsc.2001.1072; Techa S, 2013, GENE, V527, P139, DOI 10.1016/j.gene.2013.05.035; Van ENGEL W. A., 1958, COMMERCIAL FISH REV, V20, P6; Wang JF, 2017, DIS AQUAT ORGAN, V124, P181, DOI 10.3354/dao03119; Xu Wei, 2007, Acta Hydrobiologica Sinica, V31, P67	50	4	4	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192237	10.1371/journal.pone.0192237	http://dx.doi.org/10.1371/journal.pone.0192237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474370	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500015
J	Huo, Y; Zhang, YH; Guo, HF; Liu, YJ; Fang, Q; Zhang, JX				Huo, Ying; Zhang, Yaohua; Guo, Huifen; Liu, Yingjuan; Fang, Qi; Zhang, Jianxu			Tph2(-/-) female mice restore socio-sexual recognition through upregulating ER alpha and OTR genes in the amygdala	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; ANXIETY-LIKE BEHAVIOR; MALE HAMSTERS; VOMERONASAL SYSTEM; SEXUAL EXPERIENCE; SOCIAL RECOGNITION; PARASITIZED MALES; BRAIN-SEROTONIN; KNOCKOUT MICE; MATE CHOICE	The central 5-hydroxytryptamine system impairs sociosexual behaviors and olfaction preferences in sexually naive mice. However, it remains unknown whether reproductive experiences impart an effect on the sexual olfactory preferences of female mice lacking central serotonin. Here, we aimed at examining such effects and the underlying mechanisms using Tph2 knockout female mice. Sexually naive Tph2(-/-)female mice failed to recognize olfactory cues regarding sex, genetic relatedness, and social hierarchy despite exhibiting normal olfactory discrimination. However, reproduction-experienced Tph2(-/-)female mice recovered sexual olfactory preferences, as did sexually naive Tph2(+/+) females. Meanwhile, both the estrogen receptor a and oxytocin receptor in the amygdala of reproduction-experienced Tph2(-/-)females presented upregulated expression at the mRNA level and an upward tendency at the protein level vs. sexually naive Tph2(-/-) females. Intracerebroventricular administration of a combination of estrogen receptor a and oxytocin receptor agonists, but not either agent alone, could restore the sexual olfactory preferences of sexually naive Tph2(-/-) female mice to some degree. We speculate that estrogen receptor a and oxytocin receptor activation in the amygdala after reproductive experiences restores sexual olfactory recognition in Tph2(-/-) female mice.	[Huo, Ying; Zhang, Yaohua; Guo, Huifen; Liu, Yingjuan; Fang, Qi; Zhang, Jianxu] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Zhang, JX (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	zhangjx@ioz.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDB11010400]; National Basic Research Program of China [973 Program] [2010CB833900]; China National Science Foundation [31272322]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China [973 Program](National Basic Research Program of China); China National Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences [XDB11010400], the National Basic Research Program of China [973 Program, no. 2010CB833900], and the China National Science Foundation [no. 31272322]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Amin Zenab, 2005, Behav Cogn Neurosci Rev, V4, P43, DOI 10.1177/1534582305277152; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Bethea CL, 2002, FRONT NEUROENDOCRIN, V23, P41, DOI 10.1006/frne.2001.0225; Bonthuis PJ, 2011, ENDOCRINOLOGY, V152, P3172, DOI 10.1210/en.2010-1001; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Byrnes EM, 2006, HORM BEHAV, V50, P70, DOI 10.1016/j.yhbeh.2006.01.006; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Choleris E, 2006, GENES BRAIN BEHAV, V5, P528, DOI 10.1111/j.1601-183X.2006.00203.x; Choleris E, 2003, P NATL ACAD SCI USA, V100, P6192, DOI 10.1073/pnas.0631699100; Choleris E, 2007, P NATL ACAD SCI USA, V104, P4670, DOI 10.1073/pnas.0700670104; CLANCY AN, 1984, J NEUROSCI, V4, P2222; CRAWFORD LL, 1994, J COMP PSYCHOL, V108, P252, DOI 10.1037/0735-7036.108.3.252; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Ehman KD, 2001, ANIM BEHAV, V62, P781, DOI 10.1006/anbe.2001.1805; FERON C, 1993, BEHAV NEURAL BIOL, V60, P280, DOI 10.1016/0163-1047(93)90561-U; Franklin K. B., 1997, MOUSE BRAIN STEREOTA; Freichel M, 2004, BIOCHEM BIOPH RES CO, V322, P1352, DOI 10.1016/j.bbrc.2004.08.041; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; HUCK UW, 1982, ANIM BEHAV, V30, P665, DOI 10.1016/S0003-3472(82)80136-X; HUCK UW, 1984, J COMP PSYCHOL, V98, P54, DOI 10.1037/0735-7036.98.1.54; Huo Y, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00116; Jouhanneau M, 2014, HORM BEHAV, V65, P128, DOI 10.1016/j.yhbeh.2013.12.006; Kane MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048975; Kavaliers M, 2005, ANIM BEHAV, V70, P693, DOI 10.1016/j.anbehav.2004.12.016; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; LANDAUER MR, 1978, ANIM BEHAV, V26, P611, DOI 10.1016/0003-3472(78)90073-8; Liu Y, 2011, NATURE, V472, P95, DOI 10.1038/nature09822; Liu YJ, 2010, J ETHOL, V28, P263, DOI 10.1007/s10164-009-0180-x; Macbeth AH, 2010, NEUROSCI BIOBEHAV R, V34, P452, DOI 10.1016/j.neubiorev.2009.08.011; Malkani S, 2004, LEARN MEMORY, V11, P617, DOI 10.1101/lm.73104; Moncho-Bogani J, 2002, PHYSIOL BEHAV, V77, P167, DOI 10.1016/S0031-9384(02)00842-9; Mosienko V, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.44; MURPHY MR, 1970, SCIENCE, V167, P302, DOI 10.1126/science.167.3916.302; Patris B, 1998, ANIM BEHAV, V56, P1465, DOI 10.1006/anbe.1998.0919; Pfaus JG, 2001, HORM BEHAV, V40, P291, DOI 10.1006/hbeh.2001.1686; PFEIFFER CA, 1994, PHYSIOL BEHAV, V55, P129, DOI 10.1016/0031-9384(94)90020-5; POWERS JB, 1979, PHYSIOL BEHAV, V22, P77; Sachs BD, 2013, INT J NEUROPSYCHOPH, V16, P2081, DOI 10.1017/S1461145713000321; TAYLOR SA, 1988, PHYSIOL BEHAV, V42, P379, DOI 10.1016/0031-9384(88)90280-6; Tennenhouse EM, 2014, ETHOLOGY, V120, P111, DOI 10.1111/eth.12187; THOMPSON ML, 1971, HORM BEHAV, V2, P299, DOI 10.1016/0018-506X(71)90004-3; THOR DH, 1977, PHYSIOL BEHAV, V19, P411, DOI 10.1016/0031-9384(77)90287-6; Wang HS, 2006, CRYOBIOLOGY, V53, P206, DOI 10.1016/j.cryobiol.2006.06.003; WINANS SS, 1977, BRAIN RES, V126, P325, DOI 10.1016/0006-8993(77)90729-6; Woodson JC, 2002, NEUROSCI BIOBEHAV R, V26, P69, DOI 10.1016/S0149-7634(01)00039-2; Xu HY, 2012, NEUROSCIENCE, V221, P21, DOI 10.1016/j.neuroscience.2012.06.056; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0; Zhang JX, 2008, J ETHOL, V26, P279, DOI 10.1007/s10164-007-0060-1; Zhang SS, 2013, P NATL ACAD SCI USA, V110, P9968, DOI 10.1073/pnas.1220712110; Zhang YH, 2011, CHEM SENSES, V36, P125, DOI 10.1093/chemse/bjq103	53	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193395	10.1371/journal.pone.0193395	http://dx.doi.org/10.1371/journal.pone.0193395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470551	Green Submitted, Green Published, gold			2022-12-26	WOS:000425831000052
J	Onufrieva, KS; Onufriev, AV				Onufrieva, Ksenia S.; Onufriev, Alexey V.			Linear relationship between peak and season-long abundances in insects	PLOS ONE			English	Article							GYPSY-MOTH LEPIDOPTERA; MATING DISRUPTION; CODLING MOTH; TRAP CATCH; PHEROMONE; SUCCESS; LYMANTRIIDAE; FORMULATION; TORTRICIDAE; POPULATION	An accurate quantitative relationship between key characteristics of an insect population, such as season-long and peak abundances, can be very useful in pest management programs. To the best of our knowledge, no such relationship has yet been established. Here we establish a predictive linear relationship between insect catch M-pw during the week of peak abundance, the length of seasonal flight period, F (number of weeks) and season-long cumulative catch (abundance) A = 0.41M(pw)F. The derivation of the equation is based on several general assumptions and does not involve fitting to experimental data, which implies generality of the result. A quantitative criterion for the validity of the model is presented. The equation was tested using extensive data collected on captures of male gypsy moths Lymantria dispar (L.) (Lepidoptera: Erebidae) in pheromone-baited traps during 15 years. The model was also tested using trap catch data for two species of mosquitoes, Culex pipiens (L.) (Diptera: Culicidae) and Aedes albopictus (Skuse) (Diptera: Culicidae), in Gravid and BG-sentinel mosquito traps, respectively. The simple, parameter-free equation approximates experimental data points with relative error of 13% and R-2 = 0.997, across all of the species tested. For gypsy moth, we also related season-long and weekly trap catches to the daily trap catches during peak flight. We describe several usage scenarios, in which the derived relationships are employed to help link results of small-scale field studies to the operational pest management programs.	[Onufrieva, Ksenia S.] Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA; [Onufriev, Alexey V.] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA; [Onufriev, Alexey V.] Virginia Tech, Dept Phys, Blacksburg, VA USA; [Onufriev, Alexey V.] Virginia Tech, Ctr High End Comp Syst, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Onufrieva, KS (corresponding author), Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA.	ksenia@vt.edu	Onufrieva, Ksenia S/A-4609-2008	Onufrieva, Ksenia S/0000-0002-8424-850X	Virginia Tech Open Access Subvention Fund	Virginia Tech Open Access Subvention Fund	Funding to cover publication fees was provided by Virginia Tech Open Access Subvention Fund.	Abell K, 2015, BIOL CONTROL EMERALD, P113; Casado D., 2014, IOBC/WPRS Bulletin, V99, P25; Contarini M, 2009, ENTOMOL EXP APPL, V133, P307, DOI 10.1111/j.1570-7458.2009.00930.x; El-Sayed AM, 2006, J ECON ENTOMOL, V99, P1550, DOI 10.1603/0022-0493-99.5.1550; Elkinton J.S., 1981, MANAGEMENT INSECT PE, P41; ELKINTON JS, 1987, J ECON ENTOMOL, V80, P754, DOI 10.1093/jee/80.4.754; Epstein DL, 2006, J ECON ENTOMOL, V99, P1327, DOI 10.1603/0022-0493-99.4.1327; HOKYO N, 1967, Researches on Population Ecology (Tokyo), V9, P130, DOI 10.1007/BF02514920; KIELER H, 1995, ULTRASOUND OBST GYN, V6, P353, DOI 10.1046/j.1469-0705.1995.06050353.x; Knight AL, 2015, ENVIRON ENTOMOL, V44, P252, DOI 10.1093/ee/nvv008; Larsson MC, 2016, J CHEM ECOL, V42, P853, DOI 10.1007/s10886-016-0753-4; LIEBHOLD AM, 1995, ENVIRON ENTOMOL, V24, P193, DOI 10.1093/ee/24.2.193; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017; Onufrieva K, 2016, ANN GYPSY MOTH REV; Onufrieva Ksenia S., 2013, Insects, V4, P104, DOI 10.3390/insects4010104; Onufrieva KS, 2010, ENTOMOL EXP APPL, V136, P109, DOI 10.1111/j.1570-7458.2010.01009.x; Onufrieva KS, 2008, J APPL ENTOMOL, V132, P461, DOI 10.1111/j.1439-0418.2007.01262.x; PFEIFFER DG, 1993, ENTOMOL EXP APPL, V67, P57, DOI 10.1007/BF02382717; Poland TM, 2006, J FOREST, V104, P118; REITER P, 1986, J AM MOSQUITO CONTR, V2, P209; Roberts E.A., 2007, SLOW SPREAD NATL PRO; Robinet C, 2007, OIKOS, V116, P1227, DOI 10.1111/j.0030-1299.2007.15891.x; Sharov AA, 2002, ENVIRON ENTOMOL, V31, P1119, DOI 10.1603/0046-225X-31.6.1119; SHAROV AA, 1995, ENVIRON ENTOMOL, V24, P1239, DOI 10.1093/ee/24.5.1239; Stelinski LL, 2007, J PEST SCI, V80, P109, DOI 10.1007/s10340-007-0162-0; Stelinski LL, 2010, J APPL ENTOMOL, V134, P512, DOI 10.1111/j.1439-0418.2009.01453.x; Stelinski LL, 2004, ENTOMOL EXP APPL, V113, P187, DOI 10.1111/j.0013-8703.2004.00219.x; Stelinski LL, 2013, ENVIRON ENTOMOL, V42, P158, DOI 10.1603/EN12257; Stork NE, 2018, ANNU REV ENTOMOL, V63, P31, DOI 10.1146/annurev-ento-020117-043348; Tcheslavskaia K, 2005, J APPL ENTOMOL, V129, P475, DOI 10.1111/j.1439-0418.2005.00997.x; Tcheslavskaia KS, 2005, ENTOMOL EXP APPL, V115, P355, DOI 10.1111/j.1570-7458.2005.00266.x; Thorpe K., 2006, REV USE MATING DISRU; Thorpe KW, 2007, ENTOMOL EXP APPL, V125, P223, DOI 10.1111/j.1570-7458.2007.00613.x; Thorpe KW, 1999, ENTOMOL EXP APPL, V90, P267, DOI 10.1023/A:1026420900250; THORPE KW, 1993, J ECON ENTOMOL, V86, P86, DOI 10.1093/jee/86.1.86; Tobin P. C., 2007, SLOW SPREAD NATL PRO, P47; Tobin Patrick C., 2004, American Entomologist, V50, P200; Tobin PC, 2013, ENTOMOL EXP APPL, V146, P103, DOI 10.1111/j.1570-7458.2012.01299.x; Tobin PC, 2009, ENVIRON ENTOMOL, V38, P1555, DOI 10.1603/022.038.0606; Tobin PC, 2007, NRS6 USDA FOR SERV; WALL C, 1987, ENTOMOL EXP APPL, V44, P5, DOI 10.1007/BF00361302; Webb RE, 1982, INSECT SUPPRESSION C, VII, P27; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Witzgall P, 2008, ANNU REV ENTOMOL, V53, P503, DOI 10.1146/annurev.ento.53.103106.093323; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y	46	6	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193110	10.1371/journal.pone.0193110	http://dx.doi.org/10.1371/journal.pone.0193110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470528	Green Published, Green Submitted, gold			2022-12-26	WOS:000425831000034
J	Sinnett, S; Maglinti, C; Kingstone, A				Sinnett, Scott; Maglinti, Cj; Kingstone, Alan			Grunting's competitive advantage: Considerations of force and distraction	PLOS ONE			English	Article							TENNIS; ENHANCEMENT; INTENSITY; IMPROVES; SERVE	Background Grunting is pervasive in many athletic contests, and empirical evidence suggests that it may result in one exerting more physical force. It may also distract one's opponent. That grunts can distract was supported by a study showing that it led to an opponent being slower and more error prone when viewing tennis shots. An alternative explanation was that grunting masks the sound of a ball being hit. The present study provides evidence against this alternative explanation by testing the effect of grunting in a sport-mixed martial arts-where distraction, rather than masking, is the most likely mechanism. Methodology/Principal findings We first confirmed that kicking force is increased when a grunt is performed (Experiment 1), and then adapted methodology used in the tennis study to mixed martial arts (Experiment 2). Lifting the foot to kick is a silent act, and therefore there is nothing for a grunt to mask, i.e., its effect on an opponent's response time and/or accuracy can likely be attributed to attentional distraction. Participants viewed videos of a trained mixed martial artist kicking that included, or did not include, a simulated grunt. The task was to determine as quickly as possible whether the kick was traveling upward or downward. Overall, and replicating the tennis finding, the present results indicate that a participant's response to a kick was delayed and more error prone when a simulated grunt was present. Conclusions/Significance The present findings indicate that simulated grunting may distract an opponent, leading to slower and more error prone responses. The implications for martial arts in particular, and the broader question of whether grunting should be perceived as 'cheating' in sports, are examined.	[Sinnett, Scott; Maglinti, Cj] Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA; [Kingstone, Alan] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of Hawaii System; University of Hawaii Manoa; University of British Columbia	Sinnett, S (corresponding author), Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA.	ssinnett@hawaii.edu			University Research Opportunities Program at the University of Hawaii at Manoa	University Research Opportunities Program at the University of Hawaii at Manoa	This research was partially supported by the University Research Opportunities Program at the University of Hawaii at Manoa awarded to CM. There was no additional external funding received for this study.	Alsius A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00727; Broadbent D. E., 1971, DECISION STRESS; Cohen EBO, 2006, BODY SOC, V12, P73, DOI 10.1177/1357034X06070885; Farhead N, 2015, PERCEPT MOTOR SKILL, V120, P722, DOI 10.2466/30.PMS.120v20x2; Fernandez J, 2006, BRIT J SPORT MED, V40, P387, DOI 10.1136/bjsm.2005.023168; IKAI M, 1961, J APPL PHYSIOL, V16, P157, DOI 10.1152/jappl.1961.16.1.157; Kingstone A, 2008, BRIT J PSYCHOL, V99, P317, DOI 10.1348/000712607X251243; Magnus JR, 1999, J ROY STAT SOC D-STA, V48, P247, DOI 10.1111/1467-9884.00186; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Morales Z, 1999, PERCEPT MOTOR SKILL, V89, P233, DOI 10.2466/PMS.89.5.233-234; Navratilova M., 2009, TIMES; O'Connell DG, 2016, J STRENGTH COND RES, V30, P430, DOI 10.1519/JSC.0000000000001120; O'Connell DG, 2014, J STRENGTH COND RES, V28, P3469, DOI 10.1519/JSC.0000000000000604; Ruz M., 2002, PSICOLOGICA, V23, P283, DOI DOI 10.1080/09084282.2010.547774; Santangelo V, 2008, CONSCIOUS COGN, V17, P989, DOI 10.1016/j.concog.2008.02.006; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shelton JT, 2009, J ENVIRON PSYCHOL, V29, P513, DOI 10.1016/j.jenvp.2009.03.001; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; Sinnett S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013148; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Strayer DL, 2007, CURR DIR PSYCHOL SCI, V16, P128, DOI 10.1111/j.1467-8721.2007.00489.x; Strayer DL, 2015, HUM FACTORS, V57, P1300, DOI 10.1177/0018720815575149; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Tandon K., 2017, WTA CEO WANTS MORE O; Tedeschi M., 2000, HAPKIDO TRADITIONS P, P188; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Welch AS, 2012, J APPL SPORT PSYCHOL, V24, P418, DOI 10.1080/10413200.2012.688787	27	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192939	10.1371/journal.pone.0192939	http://dx.doi.org/10.1371/journal.pone.0192939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX1SB	29470505	Green Published, Green Submitted, gold			2022-12-26	WOS:000425831000024
J	Singalavanija, T; Ausayakhun, S; Tangmonkongvoragul, C				Singalavanija, Tassapol; Ausayakhun, Somsanguan; Tangmonkongvoragul, Chulaluck			Anterior segment and external ocular disorders associated with HIV infections in the era of HAART in Chiang Mai University Hospital, a prospective descriptive cross sectional study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE RECOVERY UVEITIS; ACTIVE ANTIRETROVIRAL THERAPY; CYTOMEGALOVIRUS RETINITIS; AIDS; MANIFESTATIONS; RETINOPATHY; VITRITIS; INDIA; EYE	Human immunodeficiency virus (HIV) causes impairment to the human immune system which leads to immunocompromised conditions, including ocular complications. Several important HIV-associated disorders may involve the anterior segment, ocular surface, and adnexae organ such as dry eye, blepharitis which reduce quality of life of patients. In present, potent antiretroviral therapies HAART (highly active antiretroviral therapy) has improved the length and quality of life which may lead to an increased prevalence of anterior segment ocular disorders. Hence, this study has been undertaken to identify the prevalence and associated factors of anterior segment and external ocular disorder in HIV infected patients in the era of HAART. A prospective descriptive cross sectional study was carried out in HIV positive patients conducted at the Department of Ophthalmology, Chiang Mai University Hospital, from February 2014 to October 2015. Detail history and ocular examination was carried out to examine for anterior segment and external ocular disorders. A total number of 363 patients were included for this prospective cross-sectional study. From the total of 363 patients, 123 patients had an anterior segment and external ocular disorder which account as the prevalence of 33.9%. The most common anterior segment manifestations was dry eye seen in 36 patients (9.9%), followed by posterior blepharitis (Meibomian gland dysfunction) seen in 23 patients (6.3%) and anterior blepharitis seen in 12 patients (3.3%). Other ocular complications included microvasculopathy, immune recovery uveitis, conjunctivitis, papilloma, anterior uveitis, corneal ulcer, nevus, trichiasis, molluscum contangiosum, Kaposi sarcoma, interstitial keratitis, conjunctival lymphangiectasia, dacryocystitis, vernal keratoconjunctivitis and eyelid penicilosis. In this study, the prevalance of anterior segment disorders was higher than in the preHAART era. Dry eye, blepharitis and uveitis were the top three most common anterior segment disorders in the HAART era. The statistical analysis showed no association between age, sex, CD4 count, duration of infection or receiving HAART and anterior segment disorders. Anterior segment abnormalities reduce the quality of life of patients, so ophthalmologists have to be aware and complete ocular examination should be performed in all HIV infected patients.	[Singalavanija, Tassapol; Ausayakhun, Somsanguan; Tangmonkongvoragul, Chulaluck] Chiang Mai Univ Hosp, Dept Ophthalmol, Chiang Mai, Thailand	Chiang Mai University	Tangmonkongvoragul, C (corresponding author), Chiang Mai Univ Hosp, Dept Ophthalmol, Chiang Mai, Thailand.	oupae025@gmail.com		Tangmonkongvoragul, Chulaluck/0000-0003-2254-2532	Faculty of Medicine, Chiang Mai university, Thailand [073/2557]	Faculty of Medicine, Chiang Mai university, Thailand	This work was supported by Faculty of Medicine, Chiang Mai university, Thailand, grant number: 073/2557 (http://ros.med.ac.th/ Security/Signin.aspx). The funder has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya NR, 1998, INT OPHTHALMOL CLIN, V38, P161, DOI 10.1097/00004397-199803840-00015; [Anonymous], 2012, THAIL AIDS RESP PROG; Ausayakhun Somsanguan, 2003, J Med Assoc Thai, V86, P399; Bekele S., 2013, BMC OPHTHALMOL, V13, DOI DOI 10.1186/1471-2415-13-20; Biswas J, 2000, AM J OPHTHALMOL, V129, P9, DOI 10.1016/S0002-9394(99)00415-8; DeCarlo D K, 1995, J Am Optom Assoc, V66, P533; ENGSTROM RE, 1994, OPHTHALMOLOGY, V101, P1488; Forrest DM, 1998, CLIN INFECT DIS, V27, P1379, DOI 10.1086/515030; FRIEDLAENDER MH, 1980, ARCH OPHTHALMOL-CHIC, V98, P1211; Gharai S, 2008, OPHTHAL EPIDEMIOL, V15, P264, DOI 10.1080/09286580802077716; Goldberg DE, 2005, RETINA-J RET VIT DIS, V25, P633, DOI 10.1097/00006982-200507000-00015; Jeng BH, 2007, SURV OPHTHALMOL, V52, P329, DOI 10.1016/j.survophthal.2007.04.010; Karavellas MP, 1999, J INFECT DIS, V179, P697, DOI 10.1086/314639; Karavellas MP, 2000, AM J OPHTHALMOL, V130, P57, DOI 10.1016/S0002-9394(00)00528-6; Karavellas MP, 2001, RETINA-J RET VIT DIS, V21, P1, DOI 10.1097/00006982-200102000-00001; Kempen JH, 2006, OPHTHALMOLOGY, V113, P684, DOI 10.1016/j.ophtha.2005.10.067; Kim SH, 2012, J KOREAN MED SCI, V27, P1188, DOI 10.3346/jkms.2012.27.10.1188; Kim Young Shin, 2015, Korean J Ophthalmol, V29, P241, DOI 10.3341/kjo.2015.29.4.241; Lamichhane G, 2010, NEPAL J OPHTHALMOL, V2, P45; London Nikolas J S, 2010, Int Ophthalmol Clin, V50, P201, DOI 10.1097/IIO.0b013e3181d26fcf; LUCCA JA, 1990, OPHTHALMOLOGY, V97, P1008; Lucca John A., 1994, CLAO (Contact Lens Association of Ophthalmologists) Journal, V20, P49; Nguyen QD, 2000, AM J OPHTHALMOL, V129, P634, DOI 10.1016/S0002-9394(00)00356-1; PFLUGFELDER SC, 1986, OPHTHALMOLOGY, V93, P1513; Purushattam J, 2012, INT J CLIN MED, V3, P14, DOI [10.4236/ijcm.2012.31003, DOI 10.4236/IJCM.2012.31003]; Rajkumari V, 2013, INT J RES MED, V2, P34; Schein OD, 1997, AM J OPHTHALMOL, V124, P723, DOI 10.1016/S0002-9394(14)71688-5; Verma V, 2008, SURV OPHTHALMOL, V53, P312, DOI 10.1016/j.survophthal.2008.04.008	28	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193161	10.1371/journal.pone.0193161	http://dx.doi.org/10.1371/journal.pone.0193161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466424	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300092
J	Beyeza-Kashesya, J; Wanyenze, RK; Goggin, K; Finocchario-Kessler, S; Woldetsadik, MA; Mindry, D; Birungi, J; Wagner, GJ				Beyeza-Kashesya, Jolly; Wanyenze, Rhoda K.; Goggin, Kathy; Finocchario-Kessler, Sarah; Woldetsadik, Mahlet Atakilt; Mindry, Deborah; Birungi, Josephine; Wagner, Glenn J.			Stigma gets in my way: Factors affecting client-provider communication regarding childbearing among people living with HIV in Uganda	PLOS ONE			English	Article							SAFER CONCEPTION METHODS; SERODISCORDANT COUPLES; PREGNANCY INTENTIONS; DISCORDANT COUPLES; RELATIONSHIP POWER; PROSPECTIVE COHORT; FERTILITY DESIRES; CARE PROVIDERS; WOMEN; PREVENTION	Introduction Many HIV-affected couples living in sub-Saharan Africa desire to have children, but few quantitative studies have examined support for their childbearing needs. Our study explored client-provider communication about childbearing and safer conception among HIV clients in Uganda. Methods 400 Ugandan HIV clients in committed relationships and with intentions to conceive were surveyed. Knowledge, attitudes and practices related to childbearing, and use of safer conception methods were assessed, including communication with providers about childbearing needs, the correlates of which were examined with bivariate statistics and logistic multivariate analysis. Results 75% of the sample was female; 61% were on antiretroviral therapy; and 61% had HIV-negative or unknown status partners. Nearly all (98%) reported the desire to discuss childbearing intentions with their HIV provider; however, only 44% reported such discussions, the minority (28%) of which was initiated by the provider. Issues discussed with HIV providers included: HIV transmission risk to partner (30%), HIV transmission risk to child (30%), and how to prevent transmission to the child (27%); only 8% discussed safer conception methods. Regression analysis showed that those who had communicated with providers about childbearing were more likely to have been diagnosed with HIV for a longer period [OR (95% CI) = 1.09 (1.03, 1.15)], while greater internalized childbearing stigma was associated with lower odds of this communication [OR (95% CI) = 0.70 (0.49, 0.99)], after controlling for all bivariate correlates and basic demographics. Conclusions Communication between HIV clients and providers about childbearing needs is poor and associated with stigma. Innovations to mitigate stigma among clients as well as training to improve health worker communication and skills related to safer conception counseling is needed.	[Beyeza-Kashesya, Jolly] Makerere Univ, Coll Hlth Sci, Mulago Hosp, Dept Obstet & Gynaecol, Kampala, Uganda; [Wanyenze, Rhoda K.] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Goggin, Kathy] Univ Missouri, Sch Med, Childrens Mercy Hosp & Clin, Hlth Serv & Outcomes Res, Kansas City, MO 64108 USA; [Goggin, Kathy] Univ Missouri, Sch Pharm, Kansas City, MO 64110 USA; [Finocchario-Kessler, Sarah] Univ Kansas, Med Ctr, Dept Family Med, Kansas City, MO USA; [Woldetsadik, Mahlet Atakilt; Wagner, Glenn J.] RAND Corp, Santa Monica, CA USA; [Mindry, Deborah] Univ Calif Los Angeles, Ctr Culture & Hlth, Los Angeles, CA USA; [Birungi, Josephine] AIDS Support Org, Kampala, Uganda	Makerere University; Mulago National Referral Hospital; Makerere University; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Kansas; RAND Corporation; University of California System; University of California Los Angeles	Beyeza-Kashesya, J (corresponding author), Makerere Univ, Coll Hlth Sci, Mulago Hosp, Dept Obstet & Gynaecol, Kampala, Uganda.	jbeyeza@gmail.com		Woldetsadik, Mahlet A./0000-0001-7780-2915	Eunice Kennedy Shriver National Institute of Child Health & Human Development [R01 HD072633]	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the Eunice Kennedy Shriver National Institute of Child Health & Human Development; to The Rand Corporation, Grant R01 HD072633, Principal Investigator: Glenn Wagner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanian V, 2009, AIDS BEHAV, V13, pS103, DOI 10.1007/s10461-009-9535-0; Agbo S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4432-3; Barreiro P, 2006, JAIDS-J ACQ IMM DEF, V43, P324, DOI 10.1097/01.qai.0000243091.40490.fd; Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Beyeza-Kashesya J, 2009, AFR HEALTH SCI, V9, P2; Breitnauer BT, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19972; U.S. Public Health Service, 2001, MMWR Recomm Rep, V50, P1; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; Finocchario-Kessler S, 2014, HEALTH CARE WOMEN IN, V35, P896, DOI 10.1080/07399332.2014.924520; Finocchario-Kessler S, 2012, AIDS BEHAV, V16, P99, DOI 10.1007/s10461-011-9906-1; Finocchario-Kessler S, 2010, AIDS PATIENT CARE ST, V24, P317, DOI 10.1089/apc.2009.0293; Goggin K, 2015, AIDS PATIENT CARE ST, V29, P651, DOI 10.1089/apc.2015.0089; Goggin K, 2014, HEALTH CARE WOMEN IN, V35, P990, DOI 10.1080/07399332.2014.920023; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gruskin S, 2008, AM J PUBLIC HEALTH, V98, P1746, DOI 10.2105/AJPH.2008.137232; Kakaire O, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-27; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lampe MA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.026; Lyles CM, 2007, AM J PUBLIC HEALTH, V97, P133, DOI 10.2105/AJPH.2005.076182; Matovu JKB, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0272-3; Matthews LT, 2018, AIDS BEHAV, V22, P1713, DOI 10.1007/s10461-017-1777-7; Matthews LT, 2012, CURR OPIN HIV AIDS, V7, P569, DOI 10.1097/COH.0b013e328358bac9; Matthews LT, 2010, AIDS, V24, P1975, DOI 10.1097/QAD.0b013e32833bedeb; Matthews LT, 2009, AIDS BEHAV, V13, pS5, DOI 10.1007/s10461-009-9551-0; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Mindry D, 2013, MATERN CHILD HLTH J, V17, P593, DOI 10.1007/s10995-012-1035-6; Mmeje O, 2015, AIDS CARE, V27, P10, DOI 10.1080/09540121.2014.946385; Moodley J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-384; Myer L, 2006, AIDS CARE, V18, P772, DOI 10.1080/09540120500409283; Nair, 2010, HARV HUM RIGHTS J, V22, P223; Nduna M, 2009, AIDS BEHAV, V13, pS62, DOI 10.1007/s10461-009-9545-y; Pulerwitz J, 2002, AIDS CARE, V14, P789, DOI 10.1080/0954012021000031868; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Rujumba J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17429; Schwartz SR, 2012, AIDS BEHAV, V16, P69, DOI 10.1007/s10461-011-9981-3; Squires KE, 2011, AIDS PATIENT CARE ST, V25, P279, DOI 10.1089/apc.2010.0228; Steiner RJ, 2016, JAIDS-J ACQ IMM DEF, V72, P105, DOI 10.1097/QAI.0000000000000945; Steiner RJ, 2013, AM J PUBLIC HEALTH, V103, P1357, DOI 10.2105/AJPH.2013.301265; Strode Ann, 2012, Reprod Health Matters, V20, P61, DOI 10.1016/S0968-8080(12)39643-2; Turan JM, 2008, AIDS CARE, V20, P938, DOI 10.1080/09540120701767224; Turan JM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001295; Uganda MOH, 2012, NATL POLICY GUIDELIN; Wagner G, 2012, MATERN CHILD HLTH J, V16, P510, DOI 10.1007/s10995-011-0761-5; Wagner GJ, 2017, AIDS BEHAV, V21, P2479, DOI 10.1007/s10461-017-1732-7; Wanyenze RK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-98; Woldetsadik MA, 2016, AIDS BEHAV, V20, P1370, DOI 10.1007/s10461-015-1199-3	49	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192902	10.1371/journal.pone.0192902	http://dx.doi.org/10.1371/journal.pone.0192902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8CI	29462171	Green Submitted, Green Published, gold			2022-12-26	WOS:000425554200031
J	Lecamwasam, A; Sexton-Oates, A; Carmody, J; Ekinci, EI; Dwyer, KM; Saffery, R				Lecamwasam, Ashani; Sexton-Oates, Alexandra; Carmody, Jake; Ekinci, Elif I.; Dwyer, Karen M.; Saffery, Richard			DNA methylation profiling of genomic DNA isolated from urine in diabetic chronic kidney disease: A pilot study	PLOS ONE			English	Article							NEPHROPATHY; MELLITUS	Aim To characterise the genomic DNA (gDNA) yield from urine and quality of derived methylation data generated from the widely used Illuminia Infinium MethylationEPIC (HM850K) platform and compare this with buffy coat samples. Background DNA methylation is the most widely studied epigenetic mark and variations in DNA methylation profile have been implicated in diabetes which affects approximately 415 million people worldwide. Methods QIAamp Viral RNA Mini Kit and QIAamp DNA micro kit were used to extract DNA from frozen and fresh urine samples as well as increasing volumes of fresh urine. Matched buffy coats to the frozen urine were also obtained and DNA was extracted from the buffy coats using the QIAamp DNA Mini Kit. Genomic DNA of greater concentration than 20 mu g/ml were used for methylation analysis using the HM850K array. Results Irrespective of extraction technique or the use of fresh versus frozen urine samples, limited genomic DNA was obtained using a starting sample volume of 5ml (0-0.86 mu g/mL). In order to optimize the yield, we increased starting volumes to 50ml fresh urine, which yielded only 0-9.66 mu g/mL A different kit, QIAamp DNA Micro Kit, was trialled in six fresh urine samples and ten frozen urine samples with inadequate DNA yields from 0-17.7 mu g/mL and 0-1.6 mu g/mL respectively. Sufficient genomic DNA was obtained from only 4 of the initial 41 frozen urine samples (10%) for DNA methylation profiling. In comparison, all four buffy coat samples (100%) provided sufficient genomic DNA. Conclusion High quality data can be obtained provided a sufficient yield of genomic DNA is isolated. Despite optimizing various extraction methodologies, the modest amount of genomic DNA derived from urine, may limit the generalisability of this approach for the identification of DNA methylation biomarkers of chronic diabetic kidney disease.	[Lecamwasam, Ashani; Sexton-Oates, Alexandra; Carmody, Jake; Saffery, Richard] Murdoch Childrens Res Inst, Clin & Dis Epigenet Grp, Parkville, Vic, Australia; [Lecamwasam, Ashani; Ekinci, Elif I.] Austin Hlth, Dept Endocrinol, Heidelberg, Vic, Australia; [Lecamwasam, Ashani; Dwyer, Karen M.] Deakin Univ, Fac Hlth, Sch Med, Geelong, Vic, Australia; [Sexton-Oates, Alexandra; Carmody, Jake; Saffery, Richard] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Deakin University; University of Melbourne	Lecamwasam, A (corresponding author), Murdoch Childrens Res Inst, Clin & Dis Epigenet Grp, Parkville, Vic, Australia.; Lecamwasam, A (corresponding author), Austin Hlth, Dept Endocrinol, Heidelberg, Vic, Australia.; Lecamwasam, A (corresponding author), Deakin Univ, Fac Hlth, Sch Med, Geelong, Vic, Australia.	ashani.lecamwasam@mcri.edu.au	Saffery, Richard/GLS-1976-2022; Ekinci, Elif/H-2097-2017	Saffery, Richard/0000-0002-9510-4181; Lecamwasam, Ashani/0000-0002-1960-2242; Dwyer, Karen/0000-0002-4376-9720; Ekinci, Elif/0000-0003-2372-395X	Viertel Clinical Investigatorship; Royal Australasian College of Physicians (RACP) Fellowship; Sir Edward Weary Dunlop Medical Research Foundation; Stroke Foundation	Viertel Clinical Investigatorship; Royal Australasian College of Physicians (RACP) Fellowship; Sir Edward Weary Dunlop Medical Research Foundation; Stroke Foundation	Dr. Ekinci was supported by a Viertel Clinical Investigatorship, Royal Australasian College of Physicians (RACP) Fellowship, Sir Edward Weary Dunlop Medical Research Foundation and Stroke Foundation research grants. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. All the others authors had no financial/funding disclosures.	Baker IDI and Diabetes Australia, 2012, DIAB SIL PAND ITS IM; Bell CG, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-33; El Bali Latifa, 2014, J Biomol Tech, V25, P96, DOI 10.7171/jbt.14-2504-002; International Diabetes Federation, 2015, DIABETES ATLAS, V7th; Kavaler E, 1998, CANCER, V82, P708, DOI 10.1002/(SICI)1097-0142(19980215)82:4<708::AID-CNCR14>3.0.CO;2-1; MacFarlane AJ, 2009, MAMM GENOME, V20, P624, DOI 10.1007/s00335-009-9213-6; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Nilsson E, 2014, DIABETES, V63, P2962, DOI 10.2337/db13-1459; Sapienza C, 2011, EPIGENETICS-US, V6, P20, DOI 10.4161/epi.6.1.13362; US Renal Data System, 2008, US REN DAT SYST 2008; Valmadrid CT, 2000, ARCH INTERN MED, V160, P1093, DOI 10.1001/archinte.160.8.1093; Yokota M, 1998, J CLIN LAB ANAL, V12, P88, DOI 10.1002/(SICI)1098-2825(1998)12:2<88::AID-JCLA3>3.0.CO;2-F	12	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0190280	10.1371/journal.pone.0190280	http://dx.doi.org/10.1371/journal.pone.0190280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462136	Green Submitted, Green Published, gold			2022-12-26	WOS:000425554200005
J	Wagner, S; Brack, EK; Stutz-Grunder, E; Agyeman, P; Leibundgut, K; Teuffel, O; Ammann, RA				Wagner, Stephanie; Brack, Eva K.; Stutz-Grunder, Eveline; Agyeman, Philipp; Leibundgut, Kurt; Teuffel, Oliver; Ammann, Roland A.			The influence of different fever definitions on diagnostics and treatment after diagnosis of fever in chemotherapy-induced neutropenia in children with cancer	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; FEBRILE NEUTROPENIA; MANAGEMENT; GUIDELINE; UPDATE	Background There is no evidence-based definition of the temperature limit defining fever (TLDF) in children with neutropenia. Lowering the TLDF is known to increase the number of episodes of fever in neutropenia (FN). This study aimed to investigate the influence of a lower versus standard TLDF on diagnostics and therapy. Methods In a single pediatric cancer center using a high standard TLDF (39 degrees C tympanic-temperature) patients were observed prospectively (NCT01683370). The effect of applying lower TLDFs (range 37.5 degrees C to 38.9 degrees C) versus 39.0 degrees C on these measures was simulated in silicon. Results In reality, 45 FN episodes were diagnosed. Of 3391 temperatures measured, 193 were >= 39.0 degrees C, and 937 >= 38.0 degrees C. For persisting fever >= 24 hours, additional blood cultures were taken in 31 (69%) episodes in reality. This number decreased to 22 (49%) when applying 39.0 degrees C, and increased to 33 for 38.0 degrees C (73%; plus 11 episodes; plus 24%). For persisting fever >= 48 hours, i. v.-antibiotics were escalated in 25 (56%) episodes. This number decreased to 15 (33%) when applying >= 39.0 E C, and increased to 26 for >= 38.0 degrees C (58%; plus 11 episodes; plus 24%). For persisting fever >= 120 hours, i. v.-antifungals were added in 4 (9%) episodes. This number increased to 6 (13%) by virtually applying 39.0 degrees C, and to 11 for 38.0 degrees C (24%; plus 5 episodes; plus 11%). The median length of stay was 5.7 days (range, 0.8 to 43.4). In 43 episodes with hospital discharge beyond 24 hours, applying 38.0 degrees C led to discharge delay by >= 12 hours in 24 episodes (56%; 95% CI, 40 to 71), with a median delay of 13 hours, and a cumulative delay of 68 days. Conclusion Applying a low versus standard TLDF led to relevant increases of diagnostics, antimicrobial therapy, and length of stay. The differences between management in reality versus simply applying 39.0 degrees as TLDF reflect the important impact of clinical assessment.	[Wagner, Stephanie; Agyeman, Philipp; Leibundgut, Kurt; Ammann, Roland A.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Pediat, Bern, Switzerland; [Brack, Eva K.] Univ Zurich, Childrens Hosp Zurich, Dept Infect Dis & Canc Res, Zurich, Switzerland; [Stutz-Grunder, Eveline] Univ Zurich, Childrens Hosp Zurich, Dept Pediat Oncol, Zurich, Switzerland; [Teuffel, Oliver] Med Serv Statutory Hlth Insurance Baden Wurttembe, Div Oncol, Tubingen, Germany	University of Bern; University Hospital of Bern; University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich	Ammann, RA (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Pediat, Bern, Switzerland.	roland.ammann@insel.ch	Agyeman, Philipp/AAG-3510-2019; Ammann, Roland A/I-4716-2019	Ammann, Roland A/0000-0002-1902-2352; Agyeman, Philipp Kwame Abayie/0000-0002-8339-5444; Leibundgut, Kurt/0000-0003-2514-6041	Swiss Cancer League [KLS-2933-02-2012]	Swiss Cancer League	This work was supported by the Swiss Cancer League (Grant No. KLS-2933-02-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyeman P, 2014, PEDIATR INFECT DIS J, V33, pE219, DOI 10.1097/INF.0000000000000326; Agyeman P, 2011, PEDIATR INFECT DIS J, V30, pE114, DOI 10.1097/INF.0b013e318215a290; Altman D.G., 1991, PRACTICAL STATISTIC; Ammann RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117528; Ammann RA, 2012, CURR OPIN INFECT DIS, V25, P258, DOI 10.1097/QCO.0b013e328351d199; Ammann RA, 2010, J CLIN ONCOL, V28, P2008, DOI 10.1200/JCO.2009.25.8988; Binz P, 2013, PEDIATR BLOOD CANCER, V60, P799, DOI 10.1002/pbc.24380; Brack E, 2012, PEDIATR BLOOD CANCER, V59, P423, DOI 10.1002/pbc.24076; Charnas R, 1997, PEDIATR INFECT DIS J, V16, P346, DOI 10.1097/00006454-199704000-00003; Cheng S, 2011, BRIT J CANCER, V105, P606, DOI 10.1038/bjc.2011.213; Delebarre M, 2016, PEDIATR BLOOD CANCER, V63, P2167, DOI 10.1002/pbc.26121; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Gibson F, 2013, SUPPORT CARE CANCER, V21, P1241, DOI 10.1007/s00520-012-1653-y; Haeusler GM, 2015, PEDIATR BLOOD CANCER, V62, P483, DOI 10.1002/pbc.25335; Ichikawa M, 2011, PEDIATR BLOOD CANCER, V57, P1159, DOI 10.1002/pbc.23106; Kaz Europe SA, 2011, BRAUN THERM IRT 4520, P3; Lehrnbecher T, 2017, J CLIN ONCOL, V35, P2082, DOI 10.1200/JCO.2016.71.7017; Lehrnbecher T, 2012, J CLIN ONCOL, V30, P4427, DOI 10.1200/JCO.2012.42.7161; Phillips B, 2007, ARCH DIS CHILD, V92, P495, DOI 10.1136/adc.2006.102699; Teuffel O, 2011, PEDIATRICS, V127, pE279, DOI 10.1542/peds.2010-0734; Wicki S, 2008, PEDIATR BLOOD CANCER, V51, P778, DOI 10.1002/pbc.21726	21	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0193227	10.1371/journal.pone.0193227	http://dx.doi.org/10.1371/journal.pone.0193227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462193	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000425554200059
J	Galappaththi-Arachchige, HN; Holmen, S; Koukounari, A; Kleppa, E; Pillay, P; Sebitloane, M; Ndhlovu, P; van Lieshout, L; Vennervald, BJ; Gundersen, SG; Taylor, M; Kjetland, EF				Galappaththi-Arachchige, Hashini Nilushika; Holmen, Sigve; Koukounari, Artemis; Kleppa, Elisabeth; Pillay, Pavitra; Sebitloane, Motshedisi; Ndhlovu, Patricia; van Lieshout, Lisette; Vennervald, Birgitte Jyding; Gundersen, Svein Gunnar; Taylor, Myra; Kjetland, Eyrun Floerecke			Evaluating diagnostic indicators of urogenital Schistosoma haematobium infection in young women: A cross sectional study in rural South Africa	PLOS ONE			English	Article							FEMALE GENITAL SCHISTOSOMIASIS; ZIMBABWEAN WOMEN; IMAGE-ANALYSIS; URINE SAMPLES; TANZANIA; TRACT; HIV; ASSOCIATION; MORBIDITY; BLADDER	Background Urine microscopy is the standard diagnostic method for urogenital S. haematobium infection. However, this may lead to under-diagnosis of urogenital schistosomiasis, as the disease may present itself with genital symptoms in the absence of ova in the urine. Currently there is no single reliable and affordable diagnostic method to diagnose the full spectrum of urogenital S. haematobium infection. In this study we explore the classic indicators in the diagnosis of urogenital S. haematobium infection, with focus on young women. Methods In a cross-sectional study of 1237 sexually active young women in rural South Africa, we assessed four diagnostic indicators of urogenital S. haematobium infection: microscopy of urine, polymerase chain reaction (PCR) of cervicovaginal lavage (CVL), urogenital symptoms, and sandy patches detected clinically in combination with computerised image analysis of photocolposcopic images. We estimated the accuracy of these diagnostic indicators through the following analyses: 1) cross tabulation (assumed empirical gold standard) of the tests against the combined findings of sandy patches and/or computerized image analysis and 2) a latent class model of the four indicators without assuming any gold standard. Results The empirical approach showed that urine microscopy had a sensitivity of 34.7% and specificity of 75.2% while the latent class analysis approach (LCA) suggested a sensitivity of 81.0% and specificity of 85.6%. The empirical approach and LCA showed that Schistosoma PCR in CVL had low sensitivity (14.1% and 52.4%, respectively) and high specificity (93.0% and 98.0, respectively). Using LCA, the presence of sandy patches showed a sensitivity of 81.6 and specificity of 42.4%. The empirical approach and LCA showed that urogenital symptoms had a high sensitivity (89.4% and 100.0%, respectively), whereas specificity was low (10.6% and 12.3%, respectively). Conclusion All the diagnostic indicators used in the study had limited accuracy. Using urine microscopy or Schistosoma PCR in CVL would only confirm a fraction of the sandy patches found by colposcopic examination.	[Galappaththi-Arachchige, Hashini Nilushika; Holmen, Sigve; Kleppa, Elisabeth; Kjetland, Eyrun Floerecke] Oslo Univ Hosp, Dept Infect Dis Ullevaal, Norwegian Ctr Imported & Trop Dis, Oslo, Norway; [Galappaththi-Arachchige, Hashini Nilushika] Univ Oslo, Inst Clin Med, Oslo, Norway; [Koukounari, Artemis] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Pillay, Pavitra] Durban Univ Technol, Dept Biomed & Clin Technol, Kwa Zulu, South Africa; [Sebitloane, Motshedisi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Discipline Obstet & Gynaecol, Durban, South Africa; [Ndhlovu, Patricia] Imperial Coll London, Claybrook Ctr, London, England; [van Lieshout, Lisette] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands; [Vennervald, Birgitte Jyding] Univ Copenhagen, Fac Hlth & Med Sci, Sect Parasitol & Aquat Dis, Copenhagen, Denmark; [Gundersen, Svein Gunnar] Sorlandet Hosp, Res Unit, Kristiansand, Norway; [Gundersen, Svein Gunnar] Univ Agder, Dept Global Dev & Planning, Kristiansand, Norway; [Taylor, Myra; Kjetland, Eyrun Floerecke] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Coll Hlth Sci, Discipline Publ Hlth Med, Durban, South Africa	University of Oslo; University of Oslo; Liverpool School of Tropical Medicine; Durban University of Technology; University of Kwazulu Natal; Imperial College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Copenhagen; University of Agder; University of Kwazulu Natal	Galappaththi-Arachchige, HN (corresponding author), Oslo Univ Hosp, Dept Infect Dis Ullevaal, Norwegian Ctr Imported & Trop Dis, Oslo, Norway.; Galappaththi-Arachchige, HN (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	hashiniga@gmail.com		Kjetland, Eyrun Floerecke/0000-0002-5552-1095; Koukounari, Artemis/0000-0001-5574-3934; /0000-0001-9414-3384; Galappaththi-Arachchige, Hashini Nilushika/0000-0002-0273-3959; Vennervald, Birgitte/0000-0001-5721-3494	European Research Council under the European Union's Seventh Framework Programme [PIRSES-GA-2010-269245]; University of Copenhagen; Bill and Melinda Gates Foundation [OPPGH5344]; Norwegian Research Council [213702]; South-Eastern Regional Health Authority of Norway [2014065]; Oslo University Hospital, Norway; MRC [G0902130] Funding Source: UKRI; Medical Research Council [G0902130] Funding Source: researchfish	European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); University of Copenhagen; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Regional Health Authority of Norway; Oslo University Hospital, Norway; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results has been funded by the European Research Council under the European Union's Seventh Framework Programme (PIRSES-GA-2010-269245), University of Copenhagen with the support from the Bill and Melinda Gates Foundation (grant #OPPGH5344); the Norwegian Research Council (grant #213702), the South-Eastern Regional Health Authority of Norway (grant #2014065), and Oslo University Hospital, Norway. We would also like to thank Prof. Dr. P.C. Flu-Foundation for their payment of the consumables for the PCRs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell J, 1997, TROP MED INT HEALTH, V2, P1180, DOI 10.1046/j.1365-3156.1997.d01-209.x; Appleton CC, 1996, ANN TROP MED PARASIT, V90, P181, DOI 10.1080/00034983.1996.11813042; Botelho MC, 2011, VIRULENCE, V2, P267, DOI 10.4161/viru.2.4.16734; CHARLEWOOD GP, 1949, J OBSTET GYN BRIT EM, V56, P367; Colley DG, 2014, PARASITE IMMUNOL, V36, P347, DOI 10.1111/pim.12087; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Downs JA, 2013, TROP MED INT HEALTH, V18, P1090, DOI 10.1111/tmi.12154; Downs JA, 2012, AM J TROP MED HYG, V87, P868, DOI 10.4269/ajtmh.2012.12-0395; Etherington LJ, 1997, BRIT J OBSTET GYNAEC, V104, P1380, DOI 10.1111/j.1471-0528.1997.tb11007.x; Galappaththi-Arachchige HN, 2016, INT J ENV RES PUBLIC, V13; GELFAND M, 1971, AM J TROP MED HYG, V20, P846, DOI 10.4269/ajtmh.1971.20.846; Gray DJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2651; Hegertun IEA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002104; HellingGiese G, 1996, ACTA TROP, V62, P257, DOI 10.1016/S0001-706X(96)00027-7; Holmen SD, 2015, AM J TROP MED HYG, V93, P80, DOI 10.4269/ajtmh.15-0071; Holmen SD, 2015, MED ENG PHYS, V37, P309, DOI 10.1016/j.medengphy.2014.12.007; Ibironke O, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001464; Jourdan PM, 2013, INT J GYNECOL PATHOL, V32, P137, DOI 10.1097/PGP.0b013e31824fe327; Jourdan PM, 2011, AM J TROP MED HYG, V85, P1060, DOI 10.4269/ajtmh.2011.11-0135; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Kjetland EF, 2005, AM J TROP MED HYG, V72, P311, DOI 10.4269/ajtmh.2005.72.311; Kjetland EF, 2014, INT J GYNECOL OBSTET, V127, P227, DOI 10.1016/j.ijgo.2014.07.014; Kjetland EF, 2012, TRENDS PARASITOL, V28, P58, DOI 10.1016/j.pt.2011.10.008; Kjetland EF, 2009, AM J TROP MED HYG, V81, P1050, DOI 10.4269/ajtmh.2009.09-0081; Kjetland EF, 2008, TROP MED INT HEALTH, V13, P1509, DOI 10.1111/j.1365-3156.2008.02161.x; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Obeng BB, 2008, ANN TROP MED PARASIT, V102, P625, DOI 10.1179/136485908X337490; Organization WH, 2009, WHO WORK GROUP UR SC; Pillay P, 2016, CYTOJOURNAL, V13, DOI 10.4103/1742-6413.180784; Pillay P, 2014, AM J TROP MED HYG, V90, P546, DOI 10.4269/ajtmh.13-0406; Poggensee G, 1998, AM J TROP MED HYG, V59, P782, DOI 10.4269/ajtmh.1998.59.782; Poggensee G, 2000, J INFECT DIS, V181, P1210, DOI 10.1086/315345; SMITH JH, 1977, AM J TROP MED HYG, V26, P85, DOI 10.4269/ajtmh.1977.26.85; Utzinger J, 2015, CLIN MICROBIOL INFEC, V21, P529, DOI [10.1016/j.cmi.2015.02.016, 10.1016/j.cmi.2015.03.014]; Weerakoon KGAD, 2015, CLIN MICROBIOL REV, V28, P939, DOI 10.1128/CMR.00137-14; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0	36	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0191459	10.1371/journal.pone.0191459	http://dx.doi.org/10.1371/journal.pone.0191459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451887	Green Published, Green Accepted, gold			2022-12-26	WOS:000425369800004
J	Aran, G; Sanjurjo, L; Barcena, C; Simon-Coma, M; Tellez, E; Vazquez-Vitali, M; Garrido, M; Guerra, L; Diaz, E; Ojanguren, I; Elortza, F; Planas, R; Sala, M; Armengol, C; Sarrias, MR				Aran, Gemma; Sanjurjo, Lucia; Barcena, Cristina; Simon-Coma, Marina; Tellez, Erica; Vazquez-Vitali, Maria; Garrido, Marta; Guerra, Laura; Diaz, Esther; Ojanguren, Isabel; Elortza, Felix; Planas, Ramon; Sala, Margarita; Armengol, Carolina; Sarrias, Maria-Rosa			CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78)	FASEB JOURNAL			English	Article						soluble protein-; immunoglobulin protein; cirrhosis; hepatoblastoma	LARGE GENE LISTS; APOPTOSIS INHIBITOR; FATTY LIVER; HEPATITIS-C; PROTEIN; AIM; MACROPHAGE; MICE; CD36; METASTASIS	CD5-like (CD5L) is a soluble scavenger cysteine-rich protein that modulates inflammatory responses. We studied the involvement of CD5L in liver cancer. Immunohistochemistry (IHC) of CD5L in 60 hepatocellular carcinomas and 34 adjacent nontumor livers, showed that CD5L staining was higher in tumor than in nontumor tissue (Mann-Whitney test; P = 0.0039). High CD5L correlated with elevated proliferation (Ki67, linear regression; P < 0.0001) and lower patient event-free survival (log-rank; P = 0.0185). Accordingly, CD5L expression was detected in the liver cancer cell lines Huh7, HepG2, and SNU-398. In vitro technologies using these cell lines, including small interfering RNA (siRNA) and cDNA transfection, showed that CD5L promoted colony formation and cell proliferation and protected against cisplatin-induced apoptosis. To find a molecular explanation for these roles, novel CD5L-interacting protein ligands in liver cancer cells were identified by immunoprecipitation followed by mass spectrometry. Among these, the molecular chaperone of the unfolded protein response (UPR), heat shock protein (HSP)-A5, was selected for validation. The interaction was confirmed by confocal microscopy in the Huh7 and HepG2 cell lines. Furthermore, functional experiments revealed that CD5L activates the UPR and autophagy mechanisms in Huh7 cells, thereby providing a novel molecular link between the UPR and autophagy in liver cancer.Aran, G., Sanjurjo, L., Barcena, C., Simon-Coma, M., Tellez, E., Vazquez-Vitali, M., Garrido, M., Guerra, L., Diaz, E., Ojanguren, I., Elortza, F., Planas, R., Sala, M., Armengol, C., Sarrias, M.-R. CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78).	[Aran, Gemma; Sanjurjo, Lucia; Barcena, Cristina; Tellez, Erica; Sarrias, Maria-Rosa] Hlth Sci Res Inst Germans Trias & Pujol IGTP, Innate Immun Grp, Badalona, Spain; [Sanjurjo, Lucia] Network Biomed Res Diabet & Associated Metab Dis, Madrid, Spain; [Simon-Coma, Marina; Vazquez-Vitali, Maria; Armengol, Carolina] IGTP, Program Predict & Personalized Med Canc PMPCC, Childhood Liver Oncol Grp, Badalona, Spain; [Simon-Coma, Marina; Elortza, Felix; Planas, Ramon; Sala, Margarita; Armengol, Carolina; Sarrias, Maria-Rosa] Network Biomed Res Hepat & Digest Dis CIBEREHD, Madrid, Spain; [Garrido, Marta] Vall Hebron Hosp, Pathol Dept, Barcelona, Spain; [Guerra, Laura] Hosp Univ La Paz, Pathol Dept, Madrid, Spain; [Diaz, Esther] Josep Trueta Hosp, Pathol Dept, Girona, Spain; [Ojanguren, Isabel] Hosp Univ Germans Trias & Pujol Hosp HUGTiP, Pathol Dept, Badalona, Spain; [Planas, Ramon; Sala, Margarita] Hosp Univ Germans Trias & Pujol Hosp HUGTiP, Gastroenterol Dept, Badalona, Spain; [Elortza, Felix] Ctr Cooperat Res Biosci CIC BioGUNE, Prote Platform, Derio, Spain	Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitari Vall d'Hebron; Hospital Universitario La Paz; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; CIC bioGUNE	Sarrias, MR (corresponding author), Hlth Sci Res Inst Germans Trias & Pujol, Innate Immun Grp, Ctra Can Ruti,Caml Escoles S-N,Edifici Recerca, Badalona 08916, Spain.	mrsarrias@igtp.cat	Elortza, Felix/ABG-4183-2020; Sala, Margarita/AAP-6515-2020; Sanjurjo, Lucía/K-9221-2015; Aran, Gemma/L-4159-2015	Sanjurjo, Lucía/0000-0003-4006-8010; Barcena, Cristina/0000-0002-9640-5568; ARMENGOL, CAROLINA/0000-0002-4690-4027; Elortza, Felix/0000-0001-8839-5438; Aran, Gemma/0000-0003-2005-8843; G Pastrian, Laura/0000-0002-8478-8522	Fundacio la Marato de TV3 [MTV3 2013-3610]; Instituto de Salud Carlos III, ISCIII; ERDF [FIS IP10/01565, IP13/1906, IP16/0974, FIS IP13/02340]; AGAUR [2017-SGR-490]; IGTP; Ramon y Cajal [RYC-2010-07249]; Juan de la Cierva [FJCI-2014-20505];  [CPII14/00021]	Fundacio la Marato de TV3; Instituto de Salud Carlos III, ISCIII(Instituto de Salud Carlos IIIEuropean Commission); ERDF(European Commission); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); IGTP; Ramon y Cajal(Spanish Government); Juan de la Cierva(Instituto de Salud Carlos III); 	The authors thank Marco Fernandez, Gerard Requena, and Pilar Armengol [Innate Immunity Group, Health Sciences Research Institute Germans Trias i Pujol (IGTP)]; Marta Valeri [Vall d'Hebron Research Institute (VHIR)]; Montserrat Martin (Hospital Universitari Germans Trias i Pujol); and the following contributors of tissue samples and clinical databases: Isabel Serra (IGTP); Piotr Czauderna (Medical University of Gdansk, Gdansk, Poland); Rudolf Maibach (International Breast Cancer Study Group, Bern, Switzerland); Margaret Childs (University of Nottingham, Nottingham, United Kingdom); Francisco Hernandez (Hospital Universitario La Paz); Carlos Huertas (Josep Trueta Hospital); Susana Coll (Hospital del Mar, Barcelona, Spain); Maria Varela (Hospital Central de Asturias, Oviedo, Spain); Mireia Miquel (Consorci Hospital Parc Tauli, Sabadell, Spain): and Bruce Morland [Children's Hospital National Health Service (NHS) Foundation Trust, Birmingham, United Kingdom]. This work was supported by grants from the Fundacio la Marato de TV3 (MTV3 2013-3610) (to M.-R.S.); the Instituto de Salud Carlos III, ISCIII, and ERDFs (FIS IP10/01565, IP13/1906, IP16/0974, and FIS IP13/02340) (to M.-R.S. and C.A.); AGAUR 2017-SGR-490; a scholarship from the IGTP (to E.T.); grants from the Miguel Servet (CPII14/00021) (to M.R.S.), Ramon y Cajal (RYC-2010-07249) (to C.A.), and Juan de la Cierva (FJCI-2014-20505) (to C.B.). The IGTP is a member of the Centres de Recerca de Catalunya (CERCA) network of institutes. The authors declare no conflicts of interest.	Amezaga N, 2014, J LEUKOCYTE BIOL, V95, P509, DOI 10.1189/jlb.1212660; Anitua E, 2015, J TISSUE ENG REGEN M, V9, pE1, DOI 10.1002/term.1721; Arai S, 2016, NAT MED, V22, P183, DOI 10.1038/nm.4012; Arbelaiz A, 2017, HEPATOLOGY, V66, P1125, DOI 10.1002/hep.29291; Armengol C, 2011, INT J BIOCHEM CELL B, V43, P265, DOI 10.1016/j.biocel.2009.07.012; Armengol C, 2013, CRIT REV IMMUNOL, V33, P57; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Cairo S, 2008, CANCER CELL, V14, P471, DOI 10.1016/j.ccr.2008.11.002; Casas C, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00177; Chen JL, 2014, J LIPID RES, V55, P32, DOI 10.1194/jlr.M039453; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Gebe JA, 1997, J BIOL CHEM, V272, P6151, DOI 10.1074/jbc.272.10.6151; Gerdes MJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00366; Gray J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-271; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iannaccone A, 2017, EXP EYE RES, V155, P64, DOI 10.1016/j.exer.2016.12.006; Kojima J, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-30; Kurokawa J, 2011, P NATL ACAD SCI USA, V108, P12072, DOI 10.1073/pnas.1101841108; Kurokawa J, 2010, CELL METAB, V11, P479, DOI 10.1016/j.cmet.2010.04.013; Li Y, 2011, CANCER RES, V71, P5488, DOI 10.1158/0008-5472.CAN-10-4225; Lian XM, 2005, AM J PATHOL, V167, P813, DOI 10.1016/S0002-9440(10)62053-6; Luk JM, 2006, PROTEOMICS, V6, P1049, DOI 10.1002/pmic.200500306; Maehara N, 2014, CELL REP, V9, P61, DOI 10.1016/j.celrep.2014.08.058; Mera K, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-27; Meyers R. L., 2016, LANCET ONCOL, V2045, P1; Miyazaki T, 1999, J EXP MED, V189, P413, DOI 10.1084/jem.189.2.413; Nassir F, 2013, J LIPID RES, V54, P2988, DOI 10.1194/jlr.M037812; Sanjurjo L, 2015, J LEUKOCYTE BIOL, V98, P173, DOI 10.1189/jlb.3RU0215-074R; Sanjurjo L, 2015, AUTOPHAGY, V11, P487, DOI 10.1080/15548627.2015.1017183; Sanjurjo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079670; Sarvari J, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.8351; Severi T, 2010, ACTA PHARMACOL SIN, V31, P1409, DOI 10.1038/aps.2010.142; Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Su RJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-20; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055981; Wilson CG, 2016, ENDOCRINOLOGY, V157, P570, DOI 10.1210/en.2015-1866; Yamazaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109123; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Ye LY, 2016, CANCER RES, V76, P818, DOI 10.1158/0008-5472.CAN-15-0977; Yusa S, 1999, EUR J IMMUNOL, V29, P1086, DOI 10.1002/(SICI)1521-4141(199904)29:04<1086::AID-IMMU1086>3.3.CO;2-O; Zhao S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1401-z; Zimmermann A, 2005, EUR J CANCER, V41, P1503, DOI 10.1016/j.ejca.2005.02.035	51	22	22	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3878	3891		10.1096/fj.201700941RR	http://dx.doi.org/10.1096/fj.201700941RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29465313				2022-12-26	WOS:000435104500033
J	Aumailley, L; Dubois, MJ; Brennan, TA; Garand, C; Paquet, ER; Pignolo, RJ; Marette, A; Lebel, M				Aumailley, Lucie; Dubois, Marie Julie; Brennan, Tracy A.; Garand, Chantal; Paquet, Eric R.; Pignolo, Robert J.; Marette, Andre; Lebel, Michel			Serum vitamin C levels modulate the lifespan and endoplasmic reticulum stress response pathways in mice synthesizing a nonfunctional mutant WRN protein	FASEB JOURNAL			English	Article						Werner syndrome; ascorbate; metabolomic; gulonolactone oxidase; aging	WERNER-SYNDROME PROTEIN; COLONY-STIMULATING FACTOR; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASES; ASCORBIC-ACID; SYNDROME GENE; INFLAMMATION; COMPLEX; LACKING; LEPTIN	Werner syndrome (WS) is a premature aging disorder caused by mutations in a RecQ-family DNA helicase (WRN). Mice lacking part of the helicase domain of the WRN ortholog exhibit several phenotypic features of WS. In this study, we generated a Wrn mutant line that, like humans, relies entirely on dietary sources of vitamin C (ascorbate) to survive, by crossing them to mice that lack the gulonolactone oxidase enzyme required for ascorbate synthesis. In the presence of 0.01% ascorbate (w/v) in drinking water, double-mutant mice exhibited a severe reduction in lifespan, small size, sterility, osteopenia, and metabolic profiles different from wild-type (WT) mice. Although increasing the dose of ascorbate to 0.4% improved dramatically the phenotypes of double-mutant mice, the metabolic and cytokine profiles were different from age-matched WT mice. Finally, double-mutant mice treated with 0.01% ascorbate revealed a permanent activation of all the 3 branches of the ER stress response pathways due to a severe chronic oxidative stress in the ER compartment. In addition, markers associated with the ubiquitin-proteasome-dependent ER-associated degradation pathway were increased. Augmenting the dose of ascorbate reversed the activation of this pathway to WT levels rendering this pathway a potential therapeutic target in WS.Aumailley, L., Dubois, M. J., Brennan, T. A., Garand, C., Paquet, E. R., Pignolo, R. J., Marette, A., Lebel, M. Serum vitamin C levels modulate the lifespan and endoplasmic reticulum stress response pathways in mice synthesizing a nonfunctional mutant WRN protein.	[Aumailley, Lucie; Garand, Chantal; Lebel, Michel] Univ Laval, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada; [Dubois, Marie Julie; Marette, Andre] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Fac Med, Quebec City, PQ, Canada; [Brennan, Tracy A.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Paquet, Eric R.] Univ Laval, Ctr Rech Canc, Hop Hotel Dieu Quebec, Quebec City, PQ, Canada; [Pignolo, Robert J.] Mayo Clin, Coll Med, Dept Med, Rochester, MN USA	Laval University; Laval University; University of Pennsylvania; Pennsylvania Medicine; Laval University; Mayo Clinic	Lebel, M (corresponding author), Univ Laval, Ctr Rech, CHU Quebec, Ctr Hosp, 2705 Laurier Blvd,Local T-2-04, Quebec City, PQ G1V 4G2, Canada.	michel.lebel@crchudequebec.ulaval.ca		Paquet, Eric/0000-0001-9194-1655; Garand, Chantal/0000-0003-0716-6487; Marette, Andre/0000-0003-3950-5973	Canadian Institutes of Health Research; U.S. National Institutes of Health (NIH) National Institute on Aging [R01AG028873]; NATIONAL INSTITUTE ON AGING [R01AG028873] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health (NIH) National Institute on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funding from the Canadian Institutes of Health Research (to M.L. and A.M.), and by U.S. National Institutes of Health (NIH) National Institute on Aging Grant R01AG028873 (to R.J.P.). L.A. is a scholar from the Fondation du Centre Hospitalier Universitaire de Quebec. The authors declare no conflicts of interest.	Aumailley L, 2016, AGING-US, V8, P458, DOI 10.18632/aging.100902; Aumailley L, 2015, EXP GERONTOL, V72, P192, DOI 10.1016/j.exger.2015.10.012; Aumailley L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140292; Balajee AS, 1999, MOL BIOL CELL, V10, P2655, DOI 10.1091/mbc.10.8.2655; Banhegyi G, 2014, BBA-MOL CELL RES, V1843, P1909, DOI 10.1016/j.bbamcr.2014.05.016; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Carrero D, 2016, DIS MODEL MECH, V9, P719, DOI 10.1242/dmm.024711; Castro E, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-5; Cook DN, 1996, J LEUKOCYTE BIOL, V59, P61, DOI 10.1002/jlb.59.1.61; Cooper MP, 2000, GENE DEV, V14, P907; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; D'Amario D, 2018, PHARMACOL RES, V127, P67, DOI 10.1016/j.phrs.2017.06.001; D'Aniello C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/8936156; Deschenes F, 2005, HUM MOL GENET, V14, P3293, DOI 10.1093/hmg/ddi362; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Gieseg SP, 2009, FRONT BIOSCI-LANDMRK, V14, P1230, DOI 10.2741/3305; Gils A, 2004, THROMB HAEMOSTASIS, V91, P425, DOI 10.1160/TH03-12-0764; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Han J, 2013, DIABETOLOGIA, V56, P911, DOI 10.1007/s00125-012-2809-5; Harrison FE, 2010, BRAIN RES, V1349, P143, DOI 10.1016/j.brainres.2010.06.037; Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937; Hofer AC, 2005, J GERONTOL A-BIOL, V60, P10, DOI 10.1093/gerona/60.1.10; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Iwaki T, 2012, BRIT J HAEMATOL, V157, P291, DOI 10.1111/j.1365-2141.2012.09074.x; Jiang H, 2014, INT UROL NEPHROL, V46, P879, DOI 10.1007/s11255-013-0610-0; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Kompare M, 2008, SEMIN PEDIATR NEUROL, V15, P140, DOI 10.1016/j.spen.2008.05.008; Korovila I, 2017, REDOX BIOL, V13, P550, DOI 10.1016/j.redox.2017.07.008; Labbe A, 2011, J GERONTOL A-BIOL, V66, P264, DOI 10.1093/gerona/glq184; Labbe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-127; Lasic D, 2014, PSYCHIAT DANUB, V26, P214; Lebel M, 2003, AM J PATHOL, V162, P1559, DOI 10.1016/S0002-9440(10)64290-3; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lebel M, 2010, ANN NY ACAD SCI, V1197, P40, DOI 10.1111/j.1749-6632.2010.05189.x; Lemus Leticia, 2014, Cells, V3, P824, DOI 10.3390/cells3030824; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Martinez G, 2017, AGING CELL, V16, P615, DOI 10.1111/acel.12599; Mashima R, 2003, ANAL BIOCHEM, V313, P28, DOI 10.1016/S0003-2697(02)00537-7; Massip L, 2006, EXP GERONTOL, V41, P157, DOI 10.1016/j.exger.2005.10.011; Massip L, 2010, FASEB J, V24, P158, DOI 10.1096/fj.09-137133; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; Mori S, 2001, INT J OBESITY, V25, P292, DOI 10.1038/sj.ijo.0801529; Okumura M, 2015, FREE RADICAL BIO MED, V83, P314, DOI 10.1016/j.freeradbiomed.2015.02.010; Oshima J, 2017, AGEING RES REV, V33, P105, DOI 10.1016/j.arr.2016.03.002; Ozgenc A, 2005, MUTAT RES-FUND MOL M, V577, P237, DOI 10.1016/j.mrfmmm.2005.03.020; Pagano G, 2005, FREE RADICAL RES, V39, P529, DOI 10.1080/10715760500092683; Puskas F, 1998, FEBS LETT, V430, P293, DOI 10.1016/S0014-5793(98)00678-4; Quiroga C, 2013, BBA-MOL CELL RES, V1833, P3295, DOI 10.1016/j.bbamcr.2013.09.006; Rudyk O, 2014, REDOX BIOL, V2, P803, DOI 10.1016/j.redox.2014.06.005; Sadowski M, 2014, ATHEROSCLEROSIS, V237, P555, DOI 10.1016/j.atherosclerosis.2014.10.020; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SALK D, 1982, HUM GENET, V62, P1, DOI 10.1007/BF00295598; Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Shen JC, 2000, TRENDS GENET, V16, P213, DOI 10.1016/S0168-9525(99)01970-8; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Suzuki K, 2003, EXERC IMMUNOL REV, V9, P48; Szarka A, 2014, PROTOPLASMA, V251, P489, DOI 10.1007/s00709-013-0560-5; Takemoto M, 2013, GERIATR GERONTOL INT, V13, P475, DOI 10.1111/j.1447-0594.2012.00913.x; Trapeaux J, 2013, BRIT J PHARMACOL, V169, P1587, DOI 10.1111/bph.12236; Unterwurzacher I, 2008, CLIN CHEM LAB MED, V46, P1589, DOI 10.1515/CCLM.2008.323; Vincenz-Donnelly L, 2017, FREE RADICAL BIO MED, V108, P383, DOI 10.1016/j.freeradbiomed.2017.03.031; Yehuda S, 2002, NEUROBIOL AGING, V23, P843, DOI 10.1016/S0197-4580(02)00074-X; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010	76	3	3	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3623	3640		10.1096/fj.201701176R	http://dx.doi.org/10.1096/fj.201701176R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29452565	Green Published			2022-12-26	WOS:000435104500012
J	Basu, P; Sandhu, N; Bhatt, A; Singh, A; Balhana, R; Gobe, I; Crowhurst, NA; Mendum, TA; Gao, L; Ward, JL; Beale, MH; McFadden, J; Beste, DJV				Basu, Piyali; Sandhu, Noor; Bhatt, Apoorva; Singh, Albel; Balhana, Ricardo; Gobe, Irene; Crowhurst, Nicola A.; Mendum, Tom A.; Gao, Liang; Ward, Jane L.; Beale, Michael H.; McFadden, Johnjoe; Beste, Dany J. V.			The anaplerotic node is essential for the intracellular survival of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE; CORYNEBACTERIUM-GLUTAMICUM; CHOLESTEROL CATABOLISM; RESISTANT TUBERCULOSIS; THERAPEUTIC TARGET; METABOLISM; MECHANISMS; GROWTH; VIRULENCE; REQUIRES	Enzymes at the phosphoenolpyruvate (PEP)-pyruvate-oxaloacetate or anaplerotic (ANA) node control the metabolic flux to glycolysis, gluconeogenesis, and anaplerosis. Here we used genetic, biochemical, and C-13 isotopomer analysis to characterize the role of the enzymes at the ANA node in intracellular survival of the world's most successful bacterial pathogen, Mycobacterium tuberculosis (Mtb). We show that each of the four ANA enzymes, pyruvate carboxylase (PCA), PEP carboxykinase (PCK), malic enzyme (MEZ), and pyruvate phosphate dikinase (PPDK), performs a unique and essential metabolic function during the intracellular survival of Mtb. We show that in addition to PCK, intracellular Mtb requires PPDK as an alternative gateway into gluconeogenesis. Propionate and cholesterol detoxification was also identified as an essential function of PPDK revealing an unexpected role for the ANA node in the metabolism of these physiologically important intracellular substrates and highlighting this enzyme as a tuberculosis (TB)-specific drug target. We show that anaplerotic fixation of CO2 through the ANA node is essential for intracellular survival of Mtb and that Mtb possesses three enzymes (PCA, PCK, and MEZ) capable of fulfilling this function. In addition to providing a back-up role in anaplerosis we show that MEZ also has a role in lipid biosynthesis. MEZ knockout strains have an altered cell wall and were deficient in the initial entry into macrophages. This work reveals that the ANA node is a focal point for controlling the intracellular replication of Mtb, which goes beyond canonical gluconeogenesis and represents a promising target for designing novel anti-TB drugs.	[Basu, Piyali; Sandhu, Noor; Balhana, Ricardo; Gobe, Irene; Crowhurst, Nicola A.; Mendum, Tom A.; McFadden, Johnjoe; Beste, Dany J. V.] Univ Surrey, Fac Hlth & Med Sci, Dept Microbial & Cellular Sci, Guildford GU2 7XH, Surrey, England; [Bhatt, Apoorva; Singh, Albel] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Gao, Liang; Ward, Jane L.; Beale, Michael H.] Rothamsted Res, Dept Computat & Analyt Sci, Harpenden AL5 2JQ, Herts, England	University of Surrey; University of Birmingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Beste, DJV (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Dept Microbial & Cellular Sci, Guildford GU2 7XH, Surrey, England.	d.beste@surrey.ac.uk		Beste, Dany/0000-0001-6579-1366; McFadden, Johnjoe/0000-0003-2145-0046; Gao, Liang/0000-0003-3700-1069	Medical Research Council [MR/K01224X/1]; Biotechnology and Biological Sciences Research Council [BB/L022869/1]; BBSRC [BB/L022869/1] Funding Source: UKRI; MRC [MR/K01224X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant MR/K01224X/1 and Biotechnology and Biological Sciences Research Council Grant BB/L022869/1. The authors declare that they have no conflicts of interest with the contents of this article.	Abuhammad A, 2017, BRIT J PHARMACOL, V174, P2194, DOI 10.1111/bph.13694; Bar-Even A, 2010, P NATL ACAD SCI USA, V107, P8889, DOI 10.1073/pnas.0907176107; Beste DJV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r89; Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Beste DJV, 2005, J BACTERIOL, V187, P1677, DOI 10.1128/JB.187.5.1677-1684.2005; Brock M, 2004, EUR J BIOCHEM, V271, P3227, DOI 10.1111/j.1432-1033.2004.04255.x; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Dobson G., 1985, SYSTEMATIC ANAL COMP; Ganapathy U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8912; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hao GF, 2014, APPL ENVIRON MICROB, V80, P2672, DOI 10.1128/AEM.00140-14; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; Kappelmann J, 2016, BIOTECHNOL BIOENG, V113, P661, DOI 10.1002/bit.25833; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Machova I, 2014, J BIOL CHEM, V289, P13066, DOI 10.1074/jbc.M113.536748; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; MARUYAMA K, 1985, J BIOCHEM, V98, P819, DOI 10.1093/oxfordjournals.jbchem.a135340; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Petersen S, 2001, METAB ENG, V3, P344, DOI 10.1006/mben.2001.0198; Rhee KY, 2011, TRENDS MICROBIOL, V19, P307, DOI 10.1016/j.tim.2011.03.008; Rienksma RA, 2014, SEMIN IMMUNOL, V26, P610, DOI 10.1016/j.smim.2014.09.013; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Spaans SK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00742; Stewart GR, 2001, NAT MED, V7, P732, DOI 10.1038/89113; van Kessel JC, 2008, NAT REV MICROBIOL, V6, P851, DOI 10.1038/nrmicro2014; VanderVen BC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004679; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; WHO, 2016, GLOB TUB REP	37	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5695	5704		10.1074/jbc.RA118.001839	http://dx.doi.org/10.1074/jbc.RA118.001839			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475946	Green Published, hybrid			2022-12-26	WOS:000430044100029
J	Mund, T; Pelham, HR				Mund, Thomas; Pelham, Hugh R.			Substrate clustering potently regulates the activity of WW-HECT domain-containing ubiquitin ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin ligase; ubiquitin; protein degradation; protein folding; protein motif	E3 LIGASE; NEDD4 FAMILY; DEP DOMAIN; ITCH; ACTIVATION; MECHANISM; PROTEINS; INSIGHTS; COMPLEX; PHOSPHORYLATION	The Nedd4 family of HECT domain-containing E3 ligases ubiquitinate many transcription factors and signaling proteins, and their activity is tightly regulated. Normally, intramolecular interactions curb the catalytic activity of the HECT domain, but these can be broken by the binding of PY motifs, found on substrate molecules and adaptors, to the WW domains characteristic of this E3 ligase family. This raises the prospect of substrates automatically activating the ligases, frustrating the purpose of ligase regulation. Here we show that soluble protein substrates and adaptors such as arrestins, even with multiple PY elements, cannot activate ligase activity efficiently. However, we found that polymerization or membrane tethering of these substrates dramatically increases the ligase activity both in vivo and in vitro. Aggregation of luciferase-containing substrates upon heat shock had a similar effect and could also expose cryptic PY elements in the substrates. We inferred that ligase activation critically requires a substantial array of clustered PY motifs and that the formation of such arrays on membranes or in polymeric aggregates may be an essential step in this mode of ligase regulation. We conclude that recruitment of arrestins to membrane receptors and aggregation of unstable proteins after heat shock may be physiologically relevant mechanisms for triggering ubiquitination by Nedd4 family HECT domain-containing E3 ligases.	[Mund, Thomas; Pelham, Hugh R.] MRC, Mol Biol Lab, Cambridge Biomed Campus, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Pelham, HR (corresponding author), MRC, Mol Biol Lab, Cambridge Biomed Campus, Cambridge CB2 0QH, England.	hp@mrc-lmb.cam.ac.uk		Mund, Thomas/0000-0002-3957-1105	Medical Research Council [MC_U105178788]; MRC [MC_U105178788] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MC_U105178788). The authors declare that they have no conflicts of interest with the contents of this article.	Aki D, 2015, IMMUNOL REV, V266, P6, DOI 10.1111/imr.12301; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Broix L, 2016, NAT GENET, V48, P1349, DOI 10.1038/ng.3676; Buetow L, 2016, NAT REV MOL CELL BIO, V17, P626, DOI 10.1038/nrm.2016.91; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen Z, 2017, MOL CELL, V66, P345, DOI 10.1016/j.molcel.2017.03.020; Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908; Escobedo A, 2014, STRUCTURE, V22, P1446, DOI 10.1016/j.str.2014.08.016; Fang NN, 2014, NAT CELL BIOL, V16, P1227, DOI 10.1038/ncb3054; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; French ME, 2017, J BIOL CHEM, V292, P10398, DOI 10.1074/jbc.M117.789479; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gammons MV, 2016, J CELL SCI, V129, P3892, DOI 10.1242/jcs.195685; Gammons MV, 2016, MOL CELL, V64, P92, DOI 10.1016/j.molcel.2016.08.026; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lorenz S, 2018, BIOL CHEM, V399, P127, DOI 10.1515/hsz-2017-0184; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Mund T, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150185; Mund T, 2014, P NATL ACAD SCI USA, V111, P16736, DOI 10.1073/pnas.1412152111; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Persaud A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005290; Ramon HE, 2011, MUCOSAL IMMUNOL, V4, P314, DOI 10.1038/mi.2010.69; Riling C, 2015, J BIOL CHEM, V290, P23875, DOI 10.1074/jbc.M115.649269; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Rotin D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00212; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Shea FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050557; Todaro DR, 2017, J BIOL CHEM, V292, P19521, DOI 10.1074/jbc.M117.817882; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yoshida Y, 2015, P NATL ACAD SCI USA, V112, P4630, DOI 10.1073/pnas.1422313112; Zhu K, 2017, EMBO REP, V18, P1618, DOI 10.15252/embr.201744454; Zou X, 2015, BBA-REV CANCER, V1856, P91, DOI 10.1016/j.bbcan.2015.06.005	44	12	12	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5200	5209		10.1074/jbc.RA117.000934	http://dx.doi.org/10.1074/jbc.RA117.000934			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29463679	Green Published, hybrid			2022-12-26	WOS:000429409300024
J	Kamal, AM; Fessler, MB; Chowdhury, SM				Kamal, Abu Hena M.; Fessler, Michael B.; Chowdhury, Saiful M.			Comparative and network-based proteomic analysis of low dose ethanol- and lipopolysaccharide-induced macrophages	PLOS ONE			English	Article							IMMUNE-RESPONSE; LIVER; ALCOHOL; PROTEINS; LPS; CONSUMPTION; SEPSIS; CELLS; PHOSPHOGLUCOMUTASE; IDENTIFICATION	Macrophages are specialized phagocytes that play an essential role in inflammation, immunity, and tissue repair. Profiling the global proteomic response of macrophages to microbial molecules such as bacterial lipopolysaccharide is key to understanding fundamental mechanisms of inflammatory disease. Ethanol is a widely abused substance that has complex effects on inflammation. Reports have indicated that ethanol can activate or inhibit the lipopolysaccharide receptor, Toll-like Receptor 4, in different settings, with important consequences for liver and neurologic inflammation, but the underlying mechanisms are poorly understood. To profile the sequential effect of low dose ethanol and lipopolysaccharide on macrophages, a gel-free proteomic technique was applied to RAW 264.7 macrophages. Five hundred four differentially expressed proteins were identified and quantified with high confidence using >= 5 peptide spectral matches. Among these, 319 proteins were shared across all treatment conditions, and 69 proteins were exclusively identified in ethanol-treated or lipopolysaccharide-stimulated cells. The interactive impact of ethanol and lipopolysaccharide on the macrophage proteome was evaluated using bioinformatics tools, enabling identification of differentially responsive proteins, protein interaction networks, disease- and function-based networks, canonical pathways, and upstream regulators. Five candidate protein coding genes (PGM2, ISYNA1, PARP1, and PSAP) were further validated by qRT-PCR that mostly related to glucose metabolism and fatty acid synthesis pathways. Taken together, this study describes for the first time at a systems level the interaction between ethanol and lipopolysaccharide in the proteomic programming of macrophages, and offers new mechanistic insights into the biology that may underlie the impact of ethanol on infectious and inflammatory disease in humans.	[Kamal, Abu Hena M.; Chowdhury, Saiful M.] Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA; [Fessler, Michael B.] NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	University of Texas System; University of Texas Arlington; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Chowdhury, SM (corresponding author), Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA.	schowd@uta.edu	Fessler, Michael B/C-6323-2019	Fessler, Michael B/0000-0002-8262-8613; Kamal, Abu Hena Mostafa/0000-0001-6750-0729	NIGMS, NIH [1UA5GM113216-01]; UT Proteomics Core Facility Network; Intramural Research Program of the National Institute of Environmental Health Sciences, NIH [Z01 ES102005]; University of Texas at Arlington; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102005, ZIAES102005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [UA5GM113216] Funding Source: NIH RePORTER	NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UT Proteomics Core Facility Network; Intramural Research Program of the National Institute of Environmental Health Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of Texas at Arlington; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge funding from 1UA5GM113216-01, NIGMS, NIH, and also funding from the UT Proteomics Core Facility Network for a mass spectrometer. Dr. Michael Fessler is funded by the Intramural Research Program of the National Institute of Environmental Health Sciences, NIH (Z01 ES102005). We acknowledge start-up funding to Dr. Chowdhury from the University of Texas at Arlington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Ding, 2015, J IMMUNOL, V148, P2853; Alfonso-Loeches S, 2016, NEUROCHEM RES, V41, P193, DOI 10.1007/s11064-015-1760-5; Bala S, 2012, J LEUKOCYTE BIOL, V92, P611, DOI 10.1189/jlb.0112050; Barros FR, 2012, ALCOHOL ALCOHOLISM, V47, P677, DOI 10.1093/alcalc/ags081; Bhatty M, 2011, ALCOHOL, V45, P795, DOI 10.1016/j.alcohol.2011.07.003; Blanco AM, 2008, J NEUROCHEM, V106, P625, DOI 10.1111/j.1471-4159.2008.05425.x; Buchanan JT, 2005, INFECT IMMUN, V73, P6935, DOI 10.1128/IAI.73.10.6935-6944.2005; Chakrabarty JK, 2016, ANAL CHEM, V88, P10215, DOI 10.1021/acs.analchem.6b02886; Chakravortty D, 2000, BBA-MOL BASIS DIS, V1500, P125, DOI 10.1016/S0925-4439(99)00098-8; Chhetri DR, 2012, APPL BIOCHEM BIOTECH, V167, P2269, DOI 10.1007/s12010-012-9767-8; Chowdhury SM, 2015, MOL CELL PROTEOMICS, V14, P1859, DOI 10.1074/mcp.M114.045179; Dai Q, 2006, ALCOHOL CLIN EXP RES, V30, P1436, DOI 10.1111/j.1530-0277.2006.00172.x; Dolganiuc A, 2006, ALCOHOL CLIN EXP RES, V30, P76, DOI 10.1111/j.1530-0277.2006.00003.x; Dolganiuc A, 2009, WORLD J GASTROENTERO, V15, P1168, DOI 10.3748/wjg.15.1168; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Fernandez-Lizarbe S, 2008, MOL IMMUNOL, V45; Fernandez-Lizarbe S, 2013, J NEUROCHEM, V126, P261, DOI 10.1111/jnc.12276; Gadgil HS, 2003, PROTEOMICS, V3, P1767, DOI 10.1002/pmic.200300532; Gallego-Iradi MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142144; Gracie JA, 1999, J CLIN INVEST, V104, P1393, DOI 10.1172/JCI7317; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Gu S, 2008, PROTEOMICS, V8, P3061, DOI 10.1002/pmic.200700715; Guo MM, 2015, PROTEOMICS, V15, P3169, DOI 10.1002/pmic.201400431; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; HAYASHI E, 1974, BIOCHIM BIOPHYS ACTA, V360, P146, DOI 10.1016/0005-2760(74)90164-7; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Inokuchi S, 2011, ALCOHOL CLIN EXP RES, V35, P1509, DOI 10.1111/j.1530-0277.2011.01487.x; Jayashree B, 2014, MOL CELL BIOCHEM, V388, P203, DOI 10.1007/s11010-013-1911-4; Joseph RA, 2008, HEPATOLOGY, V47, P1745, DOI 10.1002/hep.22014; Kamal AM, 2015, J PROTEOME RES, V14, P2219, DOI 10.1021/acs.jproteome.5b00007; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Karinch AM, 2008, AM J PHYSIOL-ENDOC M, V295, pE3, DOI 10.1152/ajpendo.00026.2008; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lambert JC, 2003, J PHARMACOL EXP THER, V305, P880, DOI 10.1124/jpet.102.047852; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lin JH, 2017, NUCLEIC ACIDS RES, V45, P3707, DOI 10.1093/nar/gkw1285; Liu SJ, 2007, J CLIN INVEST, V117, P3296, DOI 10.1172/JCI32084; Massey VL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00193; MCDONOUGH KH, 1991, AM J PHYSIOL, V260, pH1857, DOI 10.1152/ajpheart.1991.260.6.H1857; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Meyer RC, 2014, BRAIN RES, V1585, P1, DOI 10.1016/j.brainres.2014.08.022; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; MICHAELSSON E, 1995, EUR J IMMUNOL, V25, P2234, DOI 10.1002/eji.1830250818; Nakayama Y, 2010, J BIOCHEM, V147, P471, DOI 10.1093/jb/mvp189; O'Neill LAJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001299; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Owens T, 2005, BRAIN RES REV, V48, P178, DOI 10.1016/j.brainresrev.2004.12.007; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Patel PC, 2009, MOL CELL PROTEOMICS, V8, P2500, DOI 10.1074/mcp.M900190-MCP200; Pruett SB, 2004, ALCOHOL, V33; Pruett SB, 2010, TOXICOL SCI, V117, P314, DOI 10.1093/toxsci/kfq215; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Sanchez RG, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-40; Sardiu ME, 2009, J PROTEOME RES, V8, P2944, DOI 10.1021/pr900073d; Schaffert CS, 2009, WORLD J GASTROENTERO, V15, P1209, DOI 10.3748/wjg.15.1209; SCHENKER S, 1995, ALCOHOL CLIN EXP RES, V19, P1364, DOI 10.1111/j.1530-0277.1995.tb01626.x; Seo JY, 2005, J PHARM PHARMACOL, V57, P911, DOI 10.1211/0022357056497; Shi L, 2009, INFECT IMMUN, V77, P3227, DOI 10.1128/IAI.00063-09; Shrestha N, 2012, J BIOL CHEM, V287, P28738, DOI 10.1074/jbc.M112.375915; Shukla SD, 2013, ALCOHOL CLIN EXP RES, V37, P550, DOI 10.1111/acer.12011; Stuhlmuller B, 2000, ARTHRITIS RHEUM, V43, P775, DOI 10.1002/1529-0131(200004)43:4<775::AID-ANR8>3.0.CO;2-7; Suh N, 1998, CANCER, P717; Swearingen KE, 2010, J PROTEOME RES, V9, P2412, DOI 10.1021/pr901124u; Szabo G, 2010, DIGEST DIS, V28, P737, DOI 10.1159/000324281; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang WX, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev046; Wiley DJ, 2009, J BIOL CHEM, V284, P24744, DOI 10.1074/jbc.M109.010140; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Woo SH, 2014, FISH SHELLFISH IMMUN, V41, P317, DOI 10.1016/j.fsi.2014.09.012; Yokoe T, 2010, ANN SURG ONCOL, V17, P821, DOI 10.1245/s10434-009-0795-8; Zhang AH, 2013, APPL BIOCHEM BIOTECH, V170, P774, DOI 10.1007/s12010-013-0238-7; Zhang XL, 2006, ELECTROPHORESIS, V27, P1659, DOI 10.1002/elps.200500736; Zhang YQ, 2016, AM J PATHOL, V186, P3117, DOI 10.1016/j.ajpath.2016.08.016; Zhou C, 2013, ALCOHOL, V47, P231, DOI 10.1016/j.alcohol.2013.01.003; Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014	81	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0193104	10.1371/journal.pone.0193104	http://dx.doi.org/10.1371/journal.pone.0193104			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481576	Green Published, Green Submitted, gold			2022-12-26	WOS:000426202700009
J	Chen, YY; Yu, HH; Cheng, YJ; Cheng, QQ; Li, DL				Chen, Yingyi; Yu, Huihui; Cheng, Yanjun; Cheng, Qianqian; Li, Daoliang			A hybrid intelligent method for three-dimensional short-term prediction of dissolved oxygen content in aquaculture	PLOS ONE			English	Article							SUPPORT VECTOR REGRESSION; RBF NEURAL-NETWORK; WATER-QUALITY; RIVER; ALGORITHM; OPTIMIZATION	A precise predictive model is important for obtaining a clear understanding of the changes in dissolved oxygen content in crab ponds. Highly accurate interval forecasting of dissolved oxygen content is fundamental to reduce risk, and three-dimensional prediction can provide more accurate results and overall guidance. In this study, a hybrid three-dimensional (3D) dissolved oxygen content prediction model based on a radial basis function (RBF) neural network, K-means and subtractive clustering was developed and named the subtractive clustering (SC)-K-means-RBF model. In this modeling process, K-means and subtractive clustering methods were employed to enhance the hyperparameters required in the RBF neural network model. The comparison of the predicted results of different traditional models validated the effectiveness and accuracy of the proposed hybrid SC-K-means-RBF model for three-dimensional prediction of dissolved oxygen content. Consequently, the proposed model can effectively display the three-dimensional distribution of dissolved oxygen content and serve as a guide for feeding and future studies.	[Chen, Yingyi; Yu, Huihui; Cheng, Yanjun; Cheng, Qianqian; Li, Daoliang] China Agr Univ, Coll Informat & Elect Engn, Beijing, Peoples R China; [Chen, Yingyi; Yu, Huihui; Cheng, Yanjun; Cheng, Qianqian; Li, Daoliang] Minist Agr, Key Lab Agr Informat Acquisit Technol, Beijing, Peoples R China; [Chen, Yingyi; Yu, Huihui; Cheng, Yanjun; Cheng, Qianqian; Li, Daoliang] Beijing Engn & Technol Res Ctr Internet Things Ag, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Chen, YY (corresponding author), China Agr Univ, Coll Informat & Elect Engn, Beijing, Peoples R China.; Chen, YY (corresponding author), Minist Agr, Key Lab Agr Informat Acquisit Technol, Beijing, Peoples R China.; Chen, YY (corresponding author), Beijing Engn & Technol Res Ctr Internet Things Ag, Beijing, Peoples R China.	chenyingyi@cau.edu.cn			EU cooperation project-"Innovative model & demonstration based water management for resource efficiency in integrated multitrophic aquaculture and horticulture systems" [619137]; Beijing Science and Technology Plan projects "Research and Demonstration of Intelligent Regulation Technology Equipments for Large - scale Freshwater Fish Health Breeding" [Z171100001517016]	EU cooperation project-"Innovative model & demonstration based water management for resource efficiency in integrated multitrophic aquaculture and horticulture systems"; Beijing Science and Technology Plan projects "Research and Demonstration of Intelligent Regulation Technology Equipments for Large - scale Freshwater Fish Health Breeding"	This paper was supported by the EU cooperation project-"Innovative model & demonstration based water management for resource efficiency in integrated multitrophic aquaculture and horticulture systems", No. 619137 and Beijing Science and Technology Plan projects "Research and Demonstration of Intelligent Regulation Technology Equipments for Large - scale Freshwater Fish Health Breeding", No. Z171100001517016.	Abdoos A, 2015, KNOWL-BASED SYST, V76, P139, DOI 10.1016/j.knosys.2014.12.008; Chai W, 2014, ENG APPL ARTIF INTEL, V28, P1, DOI 10.1016/j.engappai.2013.10.005; Chen MY, 2013, INFORM SCIENCES, V220, P180, DOI 10.1016/j.ins.2011.09.013; Chowdhury M, 2010, STOCH ENV RES RISK A, V24, P1, DOI 10.1007/s00477-008-0296-5; Cohen A, 2003, WATER SCI TECHNOL, V47, P57, DOI 10.2166/wst.2003.0628; Csabragi A, 2017, ECOL ENG, V100, P63, DOI 10.1016/j.ecoleng.2016.12.027; Dehghan M, 2015, ENG ANAL BOUND ELEM, V50, P412, DOI 10.1016/j.enganabound.2014.09.008; Deligiorgi D., 2013, P INT C PATT REC APP, P669; Ferreira NC, 2011, AQUACULTURE, V318, P425, DOI 10.1016/j.aquaculture.2011.05.045; Han HG, 2011, NEURAL NETWORKS, V24, P717, DOI 10.1016/j.neunet.2011.04.006; Hatvani IG, 2015, J HYDROL, V521, P460, DOI 10.1016/j.jhydrol.2014.11.078; Heddam S, 2017, ENVIRON SCI POLLUT R, V24, P16702, DOI 10.1007/s11356-017-9283-z; Heddam S, 2014, ENVIRON SCI POLLUT R, V21, P9212, DOI 10.1007/s11356-014-2842-7; Carbajal-Hernandez JJ, 2012, EXPERT SYST APPL, V39, P10571, DOI 10.1016/j.eswa.2012.02.141; Kim JS, 2015, APPL SOFT COMPUT, V29, P233, DOI 10.1016/j.asoc.2014.12.018; Kovacs J, 2015, J HYDROL, V520, P314, DOI 10.1016/j.jhydrol.2014.11.052; Kovacs J, 2014, ENVIRON MODELL SOFTW, V57, P52, DOI 10.1016/j.envsoft.2014.01.010; Likas A, 2003, PATTERN RECOGN, V36, P451, DOI 10.1016/S0031-3203(02)00060-2; Lin GF, 2004, J HYDROL, V288, P288, DOI 10.1016/j.jhydrol.2003.10.008; Liu SY, 2013, MATH COMPUT MODEL, V58, P458, DOI 10.1016/j.mcm.2011.11.021; Liu SY, 2013, COMPUT ELECTRON AGR, V95, P82, DOI 10.1016/j.compag.2013.03.009; Ma Z, 2014, AQUACULTURE, V433, P307, DOI 10.1016/j.aquaculture.2014.06.029; Masrur Ahmed A. A., 2017, Journal of King Saud University - Engineering Sciences, V29, P151, DOI 10.1016/j.jksues.2014.05.001; Monger SH, 2016, RENEW ENERG, V86, P602, DOI 10.1016/j.renene.2015.08.058; Nemati S, 2015, ENVIRON EARTH SCI, V74, P4065, DOI 10.1007/s12665-015-4450-3; Niros AD, 2012, FUZZY SET SYST, V193, P62, DOI 10.1016/j.fss.2011.08.011; Oliver MA, 2014, CATENA, V113, P56, DOI 10.1016/j.catena.2013.09.006; Olyaie E, 2017, GEOSCI FRONT, V8, P517, DOI 10.1016/j.gsf.2016.04.007; Qi JP, 2017, INT J DISTRIB SENS N, V13, DOI 10.1177/1550147717728627; Redmond SJ, 2007, PATTERN RECOGN LETT, V28, P965, DOI 10.1016/j.patrec.2007.01.001; Rota G C., 1973, ADV MATH, V24, P206; Shen W, 2011, KNOWL-BASED SYST, V24, P378, DOI 10.1016/j.knosys.2010.11.001; Sivapragasam C, 2010, METEOROL ATMOS PHYS, V109, P1, DOI 10.1007/s00703-010-0090-z; Tomenko V, 2007, ECOL MODEL, V205, P355, DOI 10.1016/j.ecolmodel.2007.02.030; Xu TS, 2017, IEEE T POWER DELIVER, V32, P609, DOI 10.1109/TPWRD.2015.2479941; Yu H., 2016, SCI REPORTS; Yu H., 2016, SENSORS, P1	37	12	13	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192456	10.1371/journal.pone.0192456	http://dx.doi.org/10.1371/journal.pone.0192456			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466394	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300061
J	Sun, HL; Qi, LT; Wang, SJ; Li, XW; Li, CD				Sun, Haolin; Qi, Longtao; Wang, Shijun; Li, Xuwen; Li, Chunde			Hydrogen sulfide is expressed in the human and the rat cultured nucleus pulposus cells and suppresses apoptosis induced by hypoxia	PLOS ONE			English	Article							INTERVERTEBRAL DISC; DEGENERATION; INHIBITION; PROTECTS; PATHWAY	Apoptosis plays pivotal role in the pathogenesis of degenerative disc diseases, which is the primary contributor to low back pain. Although the role of hydrogen sulfide (H2S) in cell apoptosis is well appreciated, the effects and mechanism that H2S regulates the program death of intervertebral disc cell are not yet elucidated. In this study, we utilized the nucleus pulposus (NP) from patients with lumbar disc herniation to investigate the relationship between endogenous H2S and NP cells apoptosis in human. Furthermore, we analyzed primary rat NP cells to study the effects of exogenous H2S on hypoxia induced cell apoptosis. Human NP samples were obtained from patients with lumbar disc herniation and were divided into uncontained and contained herniation groups. Using immunohistochemistry staining and sulphur-sensitive electrode, we detected the expression of cystathionine-beta-synthase (CBS) and cystathionine gamma-lyase (CSE), as well as the production of endogenous H2S in human NP. Tunel staining showed increased apoptosis in NP from herniated disc; and there was significant correlation between H2S generation and apoptosis in human NP. CoCl2 was then used to induce hypoxia in cultured primary rat NP cells. Annexin V staining indicated that exogenous NaHS attenuated hypoxia induced apoptosis in rat NP cells. Furthermore, hypoxia significantly increased the levels of multiple apoptosis associated proteins (Fas, Cytochromes C, Caspase 9 and cleaved-Caspase-3) in cells, which were eliminated by NaHS. Our study demonstrates the presence of endogenous H2S in human intervertebral disc; and the endogenous H2S generation rate is associated with NP apoptosis in herniated disc. In vitro study showes exogenous H2S donor attenuates hypoxia induced apoptosis in primary rat NP cells. Thus, our work provides insights that H2S may have beneficial effects in treating degenerative disc diseases.	[Sun, Haolin; Qi, Longtao; Wang, Shijun; Li, Xuwen; Li, Chunde] Peking Univ, Hosp 1, Dept Orthoped, Beijing, Peoples R China	Peking University	Li, CD (corresponding author), Peking Univ, Hosp 1, Dept Orthoped, Beijing, Peoples R China.	lichunde@medmail.com.cn	Sun, Haolin/GXH-3267-2022		National Natural Science Foundation of China [81071504, 81441058]; Natural Science Foundation of Beijing [7123231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (no. 81071504 to CL and no. 81441058 to HS) and Natural Science Foundation of Beijing (no. 7123231) to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminzadeh MA, 2012, NEPHROL DIAL TRANSPL, V27, P498, DOI 10.1093/ndt/gfr560; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; di Masi A, 2013, BIOFACTORS, V39, P186, DOI 10.1002/biof.1061; Farrugia G, 2014, GASTROENTEROLOGY, V147, P303, DOI 10.1053/j.gastro.2014.04.041; Gan JC, 2003, CLIN ORTHOP RELAT R, P315, DOI 10.1097/01.blo.0000063797.98363.d3; Ha KY, 2006, SPINE, V31, P1309, DOI 10.1097/01.brs.0000219493.76081.d6; He F, 2012, SPINE, V37, P459, DOI 10.1097/BRS.0b013e31821fcc64; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kida K, 2011, ANTIOXID REDOX SIGN, V15, P343, DOI 10.1089/ars.2010.3671; Kluba T, 2005, SPINE, V30, P2743, DOI 10.1097/01.brs.0000192204.89160.6d; Kohyama Kohzoh, 2000, Kobe Journal of Medical Sciences, V46, P283; Li W, 2011, ATHEROSCLEROSIS, V215, P323, DOI 10.1016/j.atherosclerosis.2010.12.037; Liu J, 2012, JOINT BONE SPINE, V79, P186, DOI 10.1016/j.jbspin.2011.04.011; Liu T, 2007, CELL DEATH DIFFER, V14, P411, DOI 10.1038/sj.cdd.4402022; Luo YG, 2012, BIOCHEM BIOPH RES CO, V425, P473, DOI 10.1016/j.bbrc.2012.07.131; Mikami Y, 2011, J BIOL CHEM, V286, P39379, DOI 10.1074/jbc.M111.298208; Niu CC, 2013, J ORTHOP RES, V31, P204, DOI 10.1002/jor.22209; Pan TT, 2006, J MOL CELL CARDIOL, V40, P119, DOI 10.1016/j.yjmcc.2005.10.003; Peter EA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000387; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Srilatha B, 2007, J SEX MED, V4, P1304, DOI 10.1111/j.1743-6109.2007.00561.x; Torii S, 2011, CELL DEATH DIFFER, V18, P1711, DOI 10.1038/cdd.2011.47; Tsai TT, 2007, SPINE, V32, P495, DOI 10.1097/01.brs.0000257341.88880.f1; Wang HQ, 2011, J PATHOL, V225, P232, DOI 10.1002/path.2931; Xu DL, 2017, PHARMACOL RES, V117, P357, DOI 10.1016/j.phrs.2017.01.005; Yang JY, 2015, J PEDIATR-US, V166, P965, DOI 10.1016/j.jpeds.2014.12.021; Yang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037020; Zhang CY, 2003, BIOCHEM BIOPH RES CO, V302, P810, DOI 10.1016/S0006-291X(03)00256-0; Zhang HJ, 2011, CHIN CONT DECIS CONF, P1, DOI 10.1109/CCDC.2011.5968131; Zhang Y, 2013, MOL CELL BIOL, V33, P1104, DOI 10.1128/MCB.01215-12; Zhu YZ, 2007, J APPL PHYSIOL, V102, P261, DOI 10.1152/japplphysiol.00096.2006	31	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192556	10.1371/journal.pone.0192556	http://dx.doi.org/10.1371/journal.pone.0192556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466396	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300065
J	Oberle, E				Oberle, Eva			Social-emotional competence and early adolescents' peer acceptance in school: Examining the role of afternoon cortisol	PLOS ONE			English	Article							SALIVARY CORTISOL; SELF-REGULATION; LONGITUDINAL ASSOCIATIONS; INDIVIDUAL-DIFFERENCES; PERSPECTIVE-TAKING; PROSOCIAL BEHAVIOR; MENTAL-HEALTH; AGGRESSION; CHILDREN; REJECTION	The present study investigated the role of afternoon cortisol in social-emotional competence and peer acceptance in early adolescence. To date, research on basal cortisol activity and social development in childhood and adolescence has predominately focused on understanding maladjustment and dysfunction in development. The degree to which basal cortisol is also involved in positive adjustment and social functioning remains largely unexplored. A total of 154 early adolescents (46% female; Mean age = 11.26; SD = .65) from diverse ethnic backgrounds provided self-reports of perspective taking, peer reports of acceptance by classmates, peer reports of prosocial behaviors, and saliva samples to assess basal cortisol. As expected and in alignment with previous research, afternoon cortisol, perspective taking, prosocial behaviors, and peer acceptance were all positively correlated. Path analyses followed by bootstrapping analyses revealed that the direct path from higher afternoon cortisol to higher levels of prosocial behavior was fully mediated by perspective taking skills. The direct path from higher afternoon cortisol to peer acceptance was fully mediated by perspective taking skills and prosocial behavior. The findings are discussed within the broader context of previous research on cortisol and social adjustment in childhood and early adolescence. The practical relevance of the findings is considered.	[Oberle, Eva] Univ British Columbia, Sch Populat & Publ Hlth, Human Early Learning Partnership, Vancouver, BC, Canada	University of British Columbia	Oberle, E (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Human Early Learning Partnership, Vancouver, BC, Canada.	eva.oberle@ubc.ca						Alink LRA, 2008, DEV PSYCHOBIOL, V50, P427, DOI 10.1002/dev.20300; Alink LRA, 2012, DEV PSYCHOL, V48, P224, DOI 10.1037/a0024892; BAGOZZI RP, 1992, SOC PSYCHOL QUART, V55, P178, DOI 10.2307/2786945; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; Bierman KL, 2011, HDB PEER INTERACTION, P603; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Catherine NLA, 2012, SCH MENT HEALTH, V4, P181, DOI 10.1007/s12310-012-9076-y; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Dodd JL, 2011, COMMUN DISORD Q, V33, P23, DOI 10.1177/1525740110395014; Durlak JA, 2011, CHILD DEV, V82, P405, DOI 10.1111/j.1467-8624.2010.01564.x; Eccles JS, 2013, HANDBOOK OF PSYCHOLO, V6, P321; Eisenberg N., 2009, HDB ADOLESCENT PSYCH; Eisenberg N, 2010, ANNU REV CLIN PSYCHO, V6, P495, DOI 10.1146/annurev.clinpsy.121208.131208; Elias M.J., 1997, PROMOTING SOCIAL EMO; Ettekal I, 2015, CHILD DEV, V86, P614, DOI 10.1111/cdev.12321; Evans SC, 2015, CHILD PSYCHIAT HUM D, V46, P903, DOI 10.1007/s10578-014-0530-y; Fink E, 2015, BRIT J DEV PSYCHOL, V33, P1, DOI 10.1111/bjdp.12060; Fite PJ, 2014, AGGRESSIVE BEHAV, V40, P69, DOI 10.1002/ab.21498; Geiser C., 2013, DATA ANAL MPLUS; Gilman R, 2003, SCHOOL PSYCHOL QUART, V18, P192, DOI 10.1521/scpq.18.2.192.21858; Greco LA, 2005, BEHAV THER, V36, P197, DOI 10.1016/S0005-7894(05)80068-1; Greenberg MT, 2006, ANN NY ACAD SCI, V1094, P139, DOI 10.1196/annals.1376.013; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Gunnar MR, 2001, DEV PSYCHOPATHOL, V13, P515, DOI 10.1017/S0954579401003066; Hart D, 2005, EUR J PERSONALITY, V19, P391, DOI 10.1002/per.547; Hawk ST, 2013, J PERS ASSESS, V95, P96, DOI 10.1080/00223891.2012.696080; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jahromi LB, 2008, MERRILL PALMER QUART, V54, P125, DOI 10.1353/mpq.2008.0007; Jessop DS, 2008, STRESS, V11, P1, DOI 10.1080/10253890701365527; KURDEK LA, 1978, MERRILL PALMER QUART, V24, P3; Ladd G.W., 2005, CHILDRENS PEER RELAT; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Layous K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051380; Lerner J. V., 2009, HDB ADOLESCENT PSYCH, V1, P524, DOI DOI 10.1002/9780470479193.ADLPSY001016; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; McBurnett K, 2000, ARCH GEN PSYCHIAT, V57, P38, DOI 10.1001/archpsyc.57.1.38; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Oberle E, 2017, DEV PSYCHOBIOL, V59, P688, DOI 10.1002/dev.21522; Oberle E, 2013, J APPL DEV PSYCHOL, V34, P45, DOI 10.1016/j.appdev.2012.09.003; Oberle E, 2010, J YOUTH ADOLESCENCE, V39, P1330, DOI 10.1007/s10964-009-9486-9; Oosterlaan J, 2005, PSYCHIAT RES, V134, P1, DOI 10.1016/j.psychres.2004.12.005; Pakaslahti L, 2002, INT J BEHAV DEV, V26, P137, DOI 10.1080/01650250042000681; PANAK WF, 1992, DEV PSYCHOPATHOL, V4, P145, DOI 10.1017/S0954579400005617; Payton JW, 2000, J SCHOOL HEALTH, V70, P179, DOI 10.1111/j.1746-1561.2000.tb06468.x; Pfeifer JH, 2008, NEUROIMAGE, V39, P2076, DOI 10.1016/j.neuroimage.2007.10.032; Raine A, 2002, J ABNORM CHILD PSYCH, V30, P311, DOI 10.1023/A:1015754122318; Roseth CJ, 2008, PSYCHOL BULL, V134, P223, DOI 10.1037/0033-2909.134.2.223; Schonert-Reichl KA, 2015, DEV PSYCHOL, V51, P52, DOI 10.1037/a0038454; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Shirtcliff EA, 2008, DEV PSYCHOBIOL, V50, P690, DOI 10.1002/dev.20336; Shoal GD, 2003, J AM ACAD CHILD PSY, V42, P1101, DOI 10.1097/01.CHI.0000070246.24125.6D; Slaughter V, 2015, CHILD DEV, V86, P1159, DOI 10.1111/cdev.12372; Stroud LR, 2009, DEV PSYCHOPATHOL, V21, P47, DOI 10.1017/S0954579409000042; Susman EJ, 2006, NEUROSCI BIOBEHAV R, V30, P376, DOI 10.1016/j.neubiorev.2005.08.002; Thomson KC, 2015, J HAPPINESS STUD, V16, P889, DOI 10.1007/s10902-014-9539-y; van Bokhoven I, 2005, J NEURAL TRANSM, V112, P1083, DOI 10.1007/s00702-004-0253-5; van Goozen SHM, 2007, PSYCHOL BULL, V133, P149, DOI 10.1037/0033-2909.133.1.149; Webster-Stratton C, 2004, INFANT YOUNG CHILD, V17, P96, DOI 10.1097/00001163-200404000-00002; Wentzel K.R., 2016, HDB SOCIAL INFLUENCE, DOI DOI 10.4324/9781315769929; WENTZEL KR, 1994, J EDUC PSYCHOL, V86, P173, DOI 10.1037/0022-0663.86.2.173; Wentzel KR, 2004, J EDUC PSYCHOL, V96, P195, DOI 10.1037/0022-0663.96.2.195; WENTZEL KR, 1993, DEV PSYCHOL, V29, P819, DOI 10.1037/0012-1649.29.5.819; Wolters N, 2014, J EARLY ADOLESCENCE, V34, P585, DOI 10.1177/0272431613510403; Zimmer-Gembeck MJ, 2005, J EARLY ADOLESCENCE, V25, P421, DOI 10.1177/0272431605279841	66	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192639	10.1371/journal.pone.0192639	http://dx.doi.org/10.1371/journal.pone.0192639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8CI	29462163	Green Published, gold, Green Submitted			2022-12-26	WOS:000425554200020
J	Xu, MJ; Ji, HB; Zhuang, SY				Xu, Mengjie; Ji, Haibao; Zhuang, Shunyao			Carbon stock of Moso bamboo (Phyllostachys pubescens) forests along a latitude gradient in the subtropical region of China	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; ALLOMETRIC EQUATIONS; BIOMASS; SEQUESTRATION; STORAGE; DIAMETER; TEMPERATE; CLIMATE	Latitude is an important factor that influences the carbon stock of Moso bamboo (Phyllostachys pubescens) forests. Accurate estimation of the carbon stock of Moso bamboo forest can contribute to sufficient evaluation of forests in carbon sequestration worldwide. Nevertheless, the effect of latitude on the carbon stock of Moso bamboo remains unclear. In this study, a field survey with 36 plots of Moso bamboo forests along a latitude gradient was conducted to investigate carbon stock. Results showed that the diameter at breast height (DBH) of Moso bamboo culms increased from 8.37 cm to 10.12 cm that well fitted by Weibull model, whereas the bamboo culm density decreased from 4722 culm ha(-1) to 3400 culm ha(-1) with increasing latitude. The bamboo biomass carbon decreased from 60.58 Mg C ha(-1) to 48.31 Mg C ha(-1) from north to south. The total carbon stock of Moso bamboo forests, which comprises soil and biomass carbon, ranged from 87.83 Mg C ha(-1) to 119.5 Mg C ha(-1) and linearly increased with latitude. As a fast-growing plant, Moso bamboo could be harvested amounts of 6.0 Mg C ha(-1) to 7.6 Mg C ha(-1) annually, which indicates a high potential of this species for carbon sequestration. Parameters obtained in this study can be used to accurately estimate the carbon stock of Moso bamboo forest to establish models of the global carbon balance.	[Xu, Mengjie] Nanjing Agr Univ, Coll Publ Adm, Nanjing, Jiangsu, Peoples R China; [Ji, Haibao] Zhejiang Acad Agr Sci, Inst Subtrop Crops, Wenzhou, Zhejiang, Peoples R China; [Ji, Haibao; Zhuang, Shunyao] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Zhejiang Academy of Agricultural Sciences; Chinese Academy of Sciences; Institute of Soil Science, CAS	Zhuang, SY (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	syzhuang@issas.ac.cn			National Forestry Public Welfare Industry Research Project [201504407]; National Natural Science Foundation of China [41671296]	National Forestry Public Welfare Industry Research Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors would like to thank the National Forestry Public Welfare Industry Research Project (201504407) and National Natural Science Foundation of China (41671296) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batjes NH, 1998, BIOL FERT SOILS, V27, P230, DOI 10.1007/s003740050425; Bernoux M, 2006, AGRON SUSTAIN DEV, V26, P1, DOI 10.1051/agro:2005055; BLAKE G. R., 1986, METHODS SOIL ANAL PH, P363, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C13; Bond-Lamberty B, 2002, CAN J FOREST RES, V32, P1441, DOI [10.1139/x02-063, 10.1139/X02-063]; BURKE IC, 1989, SOIL SCI SOC AM J, V53, P800, DOI 10.2136/sssaj1989.03615995005300030029x; Chen XG, 2009, FOREST ECOL MANAG, V258, P1489, DOI 10.1016/j.foreco.2009.06.051; Christanty L, 1996, FOREST ECOL MANAG, V87, P75, DOI 10.1016/S0378-1127(96)03834-0; Eggleston HS, 2006, 2006 IPCC GUID NAT G, V4; Fang Xi, 2002, Scientia Silvae Sinicae, V38, P14; Fu J., 2000, AM BAMBOO SOC MAG, V21, P12; Fukuda M, 2003, FOREST ECOL MANAG, V184, P1, DOI 10.1016/S0378-1127(03)00146-4; Ganuza A, 2003, BIOL FERT SOILS, V37, P154, DOI 10.1007/s00374-003-0579-4; Gifford R.M., 2000, 22 AUSTR GREENH OFF; Jackson ML, 1979, SOIL CHEM ANAL ADV C, P479; JENNY H, 1949, SOIL SCI, V68, P419, DOI 10.1097/00010694-194912000-00001; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Lal R, 1997, SOIL TILL RES, V43, P81, DOI 10.1016/S0167-1987(97)00036-6; Lal R, 2003, CRIT REV PLANT SCI, V22, P151, DOI 10.1080/713610854; Lamlom SH, 2006, TREE PHYSIOL, V26, P459, DOI 10.1093/treephys/26.4.459; Lemenih M, 2004, GEODERMA, V123, P177, DOI 10.1016/j.geoderma.2004.02.004; Losi CJ, 2003, FOREST ECOL MANAG, V184, P355, DOI 10.1016/S0378-1127(03)00160-9; Nath AJ, 2012, TROP ECOL, V53, P287; Nogueira EM, 2008, FOREST ECOL MANAG, V256, P1853, DOI 10.1016/j.foreco.2008.07.022; Ouimet R, 2008, CAN J FOREST RES, V38, P92, DOI 10.1139/X07-134; Percival HJ, 2000, SOIL SCI SOC AM J, V64, P1623, DOI 10.2136/sssaj2000.6451623x; Ruan H-H, 1997, CHINESE J ECOL, V16, P17; Scurlock JMO, 2000, BIOMASS BIOENERG, V19, P229, DOI 10.1016/S0961-9534(00)00038-6; SFAPRC (State Forestry Administration P. R. China), 2014, STAT FOR RES CHIN 20; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Song XZ, 2011, ENVIRON REV, V19, P418, DOI [10.1139/a11-015, 10.1139/A11-015]; Wang Bing, 2011, Guangxi Zhiwu / Guihaia, V31, P342; [王兵 Wang Bing], 2008, [生态环境, Ecology and Environment], V17, P1680; Xie ZB, 2007, GLOBAL CHANGE BIOL, V13, P1989, DOI 10.1111/j.1365-2486.2007.01409.x; Yen TM, 2011, FOREST ECOL MANAG, V261, P995, DOI 10.1016/j.foreco.2010.12.015; Yen TM, 2010, FOREST ECOL MANAG, V260, P339, DOI 10.1016/j.foreco.2010.04.021; Zhang HX, 2014, FORESTRY, V87, P674, DOI 10.1093/forestry/cpu028; Zhou GuoMo, 2004, Scientia Silvae Sinicae, V40, P20; Zhuang SY, 2015, TROP ECOL, V56, P383	38	16	19	8	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0193024	10.1371/journal.pone.0193024	http://dx.doi.org/10.1371/journal.pone.0193024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451911	Green Published, gold, Green Submitted			2022-12-26	WOS:000425369800034
J	Liu, Y; Leslie, PL; Jin, AW; Itahana, K; Graves, LM; Zhang, YP				Liu, Yong; Leslie, Patrick L.; Jin, Aiwen; Itahana, Koji; Graves, Lee M.; Zhang, Yanping			p32 regulates ER stress and lipid homeostasis by down-regulating GCS1 expression	FASEB JOURNAL			English	Article						lipid biosynthesis; obesity; glucosidase; fatty acids; endoplasmic reticulum	ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIA-ASSOCIATED MEMBRANES; UNFOLDED PROTEIN RESPONSE; ALPHA-GLUCOSIDASE-I; OXIDATIVE-PHOSPHORYLATION; RNA-BINDING; NUTRITIONAL REGULATION; HEPATIC LIPOGENESIS; GENE-EXPRESSION; CELL-SURFACE	Sustained endoplasmic reticulum (ER) stress plays a major role in the development of many metabolic diseases, including cardiovascular disease, nonalcoholic fatty liver disease, insulin resistance, obesity, and diabetes. p32 is a multicompartmental protein involved in the regulation of oxidative phosphorylation and glucose oxidation. p32 ablation is associated with resistance to age-associated and diet-induced obesity through a mechanism that remains largely unknown. Here, we show that p32 promotes lipid biosynthesis by modulating fatty acid-induced ER stress. We found that p32 interacts with endoplasmic reticulum-anchored enzyme mannosyl-oligosaccharide glucosidase I (GCS1), an ER lumen-anchored glucosidase that is essential for the processing of N-linked glycoproteins, and reduces GCS1 in a lysosome-dependent manner. We demonstrate that increased GCS1 expression alleviates fatty acid-induced ER stress and is critical for suppressing ER stress-associated lipogenic gene activation, as demonstrated by the down-regulation of Srebp1, Fasn, and Acc. Consistently, suppression of p32 leads to increased GCS1 expression and alleviates fatty acid-induced ER stress, resulting in reduced lipid accumulation. Thus, p32 and GCS1 are regulators of ER function and lipid homeostasis and are potential therapeutic targets for the treatment of obesity and diabetes.Liu, Y., Leslie, P. L., Jin, A., Itahana, K., Graves, L. M., Zhang, Y. p32 regulates ER stress and lipid homeostasis by down-regulating GCS1 expression.	[Liu, Yong; Leslie, Patrick L.; Jin, Aiwen; Itahana, Koji; Zhang, Yanping] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC USA; [Liu, Yong; Leslie, Patrick L.; Jin, Aiwen; Itahana, Koji; Zhang, Yanping] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Leslie, Patrick L.] Univ N Carolina, Sch Med, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Graves, Lee M.; Zhang, Yanping] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Liu, Yong; Zhang, Yanping] Xuzhou Med Coll, Canc Inst, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou, Jiangsu, Peoples R China; [Itahana, Koji] Duke NUS Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Xuzhou Medical University; National University of Singapore	Zhang, YP (corresponding author), Univ N Carolina, Campus Box 7295, Chapel Hill, NC 27599 USA.	ypzhang@med.unc.edu	Graves, Lee/AAG-5470-2021		U.S. National Institutes of Health, National Cancer Institute [CA127770, CA100302, CA167637, CA155235]; National Natural Science Foundation of China [81672618]; University of North Carolina Genetics and Molecular Biology Training Grant [5T32 GM007092]; National Natural Science Foundation of China (NSFC); Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy; Singapore Ministry of Education AcRF Tier 2 Fund [MOE2013-T2-1-123]; NATIONAL CANCER INSTITUTE [R01CA167637, R01CA127770, R01CA100302, R01CA155235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of North Carolina Genetics and Molecular Biology Training Grant; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy; Singapore Ministry of Education AcRF Tier 2 Fund(Ministry of Education, Singapore); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Derek Franklin (University of North Carolina, Chapel Hill) for helpful advice and technical assistance, Jenny P. Ting and Haitao Wen (University of North Carolina, Chapel Hill) for sharing reagents and for helpful discussions, and Pamela Stanley (Albert Einstein College of Medicine, Bronx, NY, USA) for the gift of WT and mutant GCS1 plasmid DNA. This research was supported by the U.S. National Institutes of Health, National Cancer Institute Grants CA127770, CA100302, CA167637, and CA155235 (to Y.Z.); by National Natural Science Foundation of China Grant 81672618 (to Y.L.); by University of North Carolina Genetics and Molecular Biology Training Grant 5T32 GM007092 (to P.L.L.); and by grants from the National Natural Science Foundation of China (NSFC) and Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy (to Y.Z.). K.I. received funding from the Singapore Ministry of Education AcRF Tier 2 Fund (Grant MOE2013-T2-1-123). Y.Z. is the guarantor of this work and, as such, had full access to all data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The authors declare no conflicts of interest.	Aras S, 2013, NUCLEIC ACIDS RES, V41, P2255, DOI 10.1093/nar/gks1454; Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; BAUSE E, 1989, EUR J BIOCHEM, V183, P661, DOI 10.1111/j.1432-1033.1989.tb21096.x; Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Filadi R, 2015, P NATL ACAD SCI USA, V112, pE2174, DOI 10.1073/pnas.1504880112; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Hong Y, 2004, J BIOL CHEM, V279, P49894, DOI 10.1074/jbc.M410121200; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Katoh T, 2013, GLYCOBIOLOGY, V23, P1142, DOI 10.1093/glycob/cwt051; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JS, 2012, AM J TRANSL RES, V4, P102; Liu Y, 2015, CELL DEATH DIFFER, V22, P1035, DOI 10.1038/cdd.2014.194; Liu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06209-9; Muta T, 1997, J BIOL CHEM, V272, P24363, DOI 10.1074/jbc.272.39.24363; NEVEROVA I, 1994, ANAL BIOCHEM, V222, P190, DOI 10.1006/abio.1994.1472; Ning J, 2011, ENDOCRINOLOGY, V152, P2247, DOI 10.1210/en.2010-1036; Oh SY, 2003, J BIOL CHEM, V278, P28410, DOI 10.1074/jbc.M300553200; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; PEARCE J, 1983, P NUTR SOC, V42, P263, DOI 10.1079/PNS19830031; Petersen-Mahrt SK, 1999, EMBO J, V18, P1014, DOI 10.1093/emboj/18.4.1014; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Quintens R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056719; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Sadat MA, 2014, NEW ENGL J MED, V370, P1615, DOI 10.1056/NEJMoa1302846; SAUL R, 1985, P NATL ACAD SCI USA, V82, P93, DOI 10.1073/pnas.82.1.93; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Sparks S.E., 1993, GENEREVIEWS R; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Theurey P, 2017, TRENDS ENDOCRIN MET, V28, P32, DOI 10.1016/j.tem.2016.09.002; van Leeuwen HC, 2001, J CELL SCI, V114, P2115; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wek RC, 2010, NAT MED, V16, P374, DOI 10.1038/nm0410-374; Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	51	9	9	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3892	3902		10.1096/fj.201701004RR	http://dx.doi.org/10.1096/fj.201701004RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29465311	Green Published			2022-12-26	WOS:000435104500034
J	Mohammed, SG; Arjona, FJ; Verschuren, EHJ; Bakey, Z; Alkema, W; van Hijum, S; Schmidts, M; Bindels, RJM; Hoenderop, JGJ				Mohammed, Sami G.; Arjona, Francisco J.; Verschuren, Eric H. J.; Bakey, Zeineb; Alkema, Wynand; van Hijum, Sacha; Schmidts, Miriam; Bindels, Rene J. M.; Hoenderop, Joost G. J.			Primary cilia-regulated transcriptome in the renal collecting duct	FASEB JOURNAL			English	Article						RNA-seq; fluid flow; electrolyte transport; iron uptake	EPITHELIAL NA+ CHANNELS; LARGE GENE LISTS; IRON-METABOLISM; SHEAR-STRESS; DEPENDENT REGULATION; KIDNEY-DISEASE; FLUID SHEAR; TRANSPORT; CELLS; FLOW	Renal tubular cells respond to mechanical stimuli generated by urinary flow to regulate the activity and transcript abundance of important genes for ion handling, cellular homeostasis, and proper renal development. The primary cilium, a mechanosensory organelle, is postulated to regulate this mRNA response. The aim of this study is to reveal the transcriptome changes of tubular epithelia in response to fluid flow and determine the role of primary cilia in this process. Inner-medullary collecting duct (CD) cells were subjected to either static or physiologically relevant fluid flow (approximate to 0.6 dyn/cm(2)). RNA-sequencing analysis of ciliated cells subjected to fluid flow showed up-regulation of 1379 genes and down-regulation of 1294 genes compared with static control cells. Strikingly, only 54 of these genes were identified as gene candidates sensitive to primary cilia sensing of fluid flow, of which 16 were linked to ion or water transport pathways in the CD. Validation by quantitative real-time PCR revealed that only the expression of transferrin receptor, which is involved in iron transport; and tribbles pseudokinase 3, which is involved in insulin signaling, were unequivocally regulated by primary cilia sensing of fluid flow. This study shows that the involvement of primary cilia in ion transport in the collecting duct is exceptionally specific.Mohammed, S. G., Arjona, F. J., Verschuren, E. H. J., Bakey, Z., Alkema, W., van Hijum, S., Schmidts, M., Bindels, R. J. M., Hoenderop, J. G. J. Primary cilia-regulated transcriptome in the renal collecting duct.	[Mohammed, Sami G.; Arjona, Francisco J.; Verschuren, Eric H. J.; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Physiol, Med, Nijmegen, Netherlands; [Bakey, Zeineb; Schmidts, Miriam] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Human Genet, Med Ctr, Nijmegen, Netherlands; [Alkema, Wynand; van Hijum, Sacha] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, Med Ctr, Nijmegen, Netherlands; [Schmidts, Miriam] Univ Freiburg, Med Fac, Ctr Pediat & Adolescent Med, Univ Hosp Freiburg, Freiburg, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Freiburg	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol 286, Geert Grootplein Zuid 28,POB 9101, NL-6500 HB Nijmegen, Netherlands.	joost.hoenderop@radboudumc.nl	Verschuren, Eric/AAG-9346-2020; Verschuren, Eric/G-4259-2016; Bindels, René JM/B-9824-2013; Verschuren, Eric H.J./AAX-6774-2020; Alkema, Wynand/G-5826-2018; Mohammed, Sami Gemal/F-3894-2016; van Hijum, Sacha/F-6445-2014; Schmidts, Miriam/A-3777-2012; Arjona, Francisco J/P-6059-2015; Hoenderop, Joost G.J./H-8047-2014	Verschuren, Eric/0000-0003-4046-4849; Bindels, René JM/0000-0003-1167-1339; Alkema, Wynand/0000-0002-5523-9217; Mohammed, Sami Gemal/0000-0002-0903-8131; Schmidts, Miriam/0000-0002-1714-6749; Arjona, Francisco J/0000-0002-2479-0735; Hoenderop, Joost G.J./0000-0002-1816-8544; van Hijum, Sacha/0000-0003-0741-2991	Radboud Institute for Molecular Life Sciences; Netherlands Organization for Scientific Research [NWO VICI 016.130.668]; Radboud University Medical Center; Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen (Excellence Fellowship); Deutsche Forschungsgemeinschaft (German Research Foundation) [DFG CRC1140 KIDGEM]; European Research Council (ERC StG TREATCilia) [716344]; Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen (Hypatia Tenure Track Grant)	Radboud Institute for Molecular Life Sciences; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Radboud University Medical Center; Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen (Excellence Fellowship); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); European Research Council (ERC StG TREATCilia); Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen (Hypatia Tenure Track Grant)	The authors thank the Microscope Imaging Centre (Nijmegen, The Netherlands) for providing the FV1000 confocal laser scanning microscope. The authors are grateful to the Department of Molecular Biology at Radboud University Medical Center for providing the next-generation sequencing facility. This work was supported by grants from the Radboud Institute for Molecular Life Sciences (to J.G.J.H.), and the Netherlands Organization for Scientific Research (NWO VICI 016.130.668 to J.G.J.H.). M.S. acknowledges funding from Radboud University Medical Center, the Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen (Excellence Fellowship and Hypatia Tenure Track Grant), the Deutsche Forschungsgemeinschaft (German Research Foundation; DFG CRC1140 KIDGEM), and the European Research Council (ERC StG TREATCilia; Grant 716344). The authors declare no conflicts of interest.	Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; ANDREWS PM, 1974, AM J ANAT, V140, P81, DOI 10.1002/aja.1001400107; Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Artunc F, 2016, NAT REV NEPHROL, V12, P721, DOI 10.1038/nrneph.2016.145; Baek JH, 2015, J CLIN INVEST, V125, P3198, DOI 10.1172/JCI81166; Baquero AF, 2011, AM J PHYSIOL-CELL PH, V300, pC860, DOI 10.1152/ajpcell.00318.2010; Bindels RJM, 2010, J AM SOC NEPHROL, V21, P1263, DOI 10.1681/ASN.2010010001; Blaine J, 2015, CLIN J AM SOC NEPHRO, V10, P1257, DOI 10.2215/CJN.09750913; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Carrisoza-Gaytan R, 2016, AM J PHYSIOL-CELL PH, V310, pC243, DOI 10.1152/ajpcell.00328.2015; Carrisoza-Gaytan R, 2014, AM J PHYSIOL-RENAL, V307, pF195, DOI 10.1152/ajprenal.00634.2013; Clement CA, 2013, CELL REP, V3, P1806, DOI 10.1016/j.celrep.2013.05.020; Corcoran CC, 2017, AM J PHYSIOL-RENAL, V312, pF533, DOI 10.1152/ajprenal.00601.2016; Delling M, 2016, NATURE, V531, P656, DOI 10.1038/nature17426; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Eaton AF, 2014, AM J PHYSIOL-LUNG C, V307, pL374, DOI 10.1152/ajplung.00040.2014; FITZGIBBONS JP, 1974, J CLIN INVEST, V54, P1428, DOI 10.1172/JCI107890; Flores D, 2012, AM J PHYSIOL-RENAL, V303, pF632, DOI 10.1152/ajprenal.00169.2012; Flores D, 2011, NEPHRON PHYSIOL, V117, P27, DOI 10.1159/000321640; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gillard A, 2006, AM J NEPHROL, V26, P34, DOI 10.1159/000091784; Hamada H, 2015, SEMIN CELL DEV BIOL, V47-48, P88, DOI 10.1016/j.semcdb.2015.10.011; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hoogewijs D, 2016, HYPOXIA, V4, P91, DOI 10.2147/HP.S97681; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ingraham SE, 2010, PEDIATR RES, V68, P500, DOI 10.1203/PDR.0b013e3181f82f15; Kopan R, 2014, PEDIATR NEPHROL, V29, P651, DOI 10.1007/s00467-013-2661-y; Kunnen SJ, 2017, CELL MOL LIFE SCI, V74, P2283, DOI 10.1007/s00018-017-2460-x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leroy V, 2009, J AM SOC NEPHROL, V20, P131, DOI 10.1681/ASN.2008020232; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu Y, 2014, AM J PHYSIOL-RENAL, V306, pF214, DOI 10.1152/ajprenal.00327.2013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HAJ, 2007, J BIOL CHEM, V282, P28721, DOI 10.1074/jbc.M611101200; Martines AMF, 2013, NAT REV NEPHROL, V9, P385, DOI 10.1038/nrneph.2013.98; Meneton P, 2004, AM J PHYSIOL-RENAL, V287, pF593, DOI 10.1152/ajprenal.00454.2003; MIGNON M, 1988, Revue du Praticien, V38, P203; MILLS JN, 1951, J PHYSIOL-LONDON, V113, P528, DOI 10.1113/jphysiol.1951.sp004593; Mohammed SG, 2017, FASEB J, V31, P1796, DOI 10.1096/fj.201600687RRR; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; Morla L, 2013, J BIOL CHEM, V288, P10124, DOI 10.1074/jbc.M112.446393; Orhon I, 2016, NAT CELL BIOL, V18, P657, DOI 10.1038/ncb3360; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Piedagnel R, 2006, J CELL PHYSIOL, V206, P394, DOI 10.1002/jcp.20485; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Raghavan V, 2014, P NATL ACAD SCI USA, V111, P8506, DOI 10.1073/pnas.1402195111; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roy A, 2015, CLIN J AM SOC NEPHRO, V10, P305, DOI 10.2215/CJN.08880914; Sakai Y, 2014, BIOL PHARM BULL, V37, P1068, DOI 10.1248/bpb.b14-00260; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Schmidts M, 2013, J MED GENET, V50, P309, DOI 10.1136/jmedgenet-2012-101284; Schmidts M, 2013, HUM MUTAT, V34, P714, DOI 10.1002/humu.22294; Schwartz EA, 1997, AM J PHYSIOL-RENAL, V272, pF132, DOI 10.1152/ajprenal.1997.272.1.F132; SIROTA JH, 1950, J CLIN INVEST, V29, P187, DOI 10.1172/JCI102245; Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010; Su Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep39701; Tiwari S, 2007, AM J PHYSIOL-RENAL, V293, pF178, DOI 10.1152/ajprenal.00447.2006; Tourneur E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003152; Uawithya P, 2008, PHYSIOL GENOMICS, V32, P229, DOI 10.1152/physiolgenomics.00201.2007; Veeramuthumari P, 2013, INT J CLIN MED, V2013, P200, DOI [10.4236/ijcm.2013.44035, DOI 10.4236/IJCM.2013.44035]; Wareing M, 2000, J PHYSIOL-LONDON, V524, P581, DOI 10.1111/j.1469-7793.2000.00581.x; Woda CB, 2001, AM J PHYSIOL-RENAL, V280, pF786, DOI 10.1152/ajprenal.2001.280.5.F786; Wong YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045725; Young JC, 2014, DIS MODEL MECH, V7, P319, DOI 10.1242/dmm.014001; Zhang DL, 2007, J AM SOC NEPHROL, V18, P401, DOI 10.1681/ASN.2006080908	68	9	9	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3653	3668		10.1096/fj.201701228R	http://dx.doi.org/10.1096/fj.201701228R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29452568				2022-12-26	WOS:000435104500014
J	de Souza, AF; Pieri, NCG; Roballo, KCS; Bressan, FF; Casals, JB; Ambrosio, CE; Perecin, F; Martins, DS				de Souza, Aline F.; Godoy Pieri, Naira C.; Roballo, Kelly C. S.; Bressan, Fabiana F.; Casals, Juliana B.; Ambrosio, Carlos E.; Perecin, Felipe; Martins, Daniele S.			Dynamics of male canine germ cell development	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DOGS; EXPRESSION; GENERATION; DERIVATION; MARKERS; EMBRYO; GENOME; OCT-4; SRY	Primordial germ cells (PGCs) are precursors of gametes that can generate new individuals throughout life in both males and females. Additionally, PGCs have been shown to differentiate into embryonic germ cells (EGCs) after in vitro culture. Most studies investigating germinative cells have been performed in rodents and humans but not dogs (Canis lupus familiaris). Here, we elucidated the dynamics of the expression of pluripotent (POU5F1 and NANOG), germline (DDX4, DAZL and DPPA3), and epigenetic (5mC, 5hmC, H3K27me3 and H3K9me2) markers that are important for the development of male canine germ cells during the early (22 +/- 30 days post-fertilization (dpf)), middle (35 +/- 40 dpf) and late (45 +/- 50 dpf) gestational periods. We performed sex genotype characterization, immunofluorescence, immunohistochemistry, and quantitative reverse transcriptase polymerase chain reaction (RT-qPCR) analyses. Furthermore, in a preliminary study, we evaluated the capacity of canine embryo PGCs (30 dpf) to differentiate into EGCs. To confirm the canine EGCs phenotype, we performed alkaline phosphatase detection, immunohistochemistry, electron and transmission scanning microscopy and RT-qPCR analyses. The PGCs were positive for POU5F1 and H3K27me3 during all assessed developmental periods, including all periods between the gonadal tissue stage and foetal testes development. The number of NANOG, DDX4, DAZL, DPPA3 and 5mC-positive cells increased along with the developing cords from 35 +/- 50 dpf. Moreover, our results demonstrate the feasibility of inducing canine PGCs into putative EGCs that present pluripotent markers, such as POU5F1 and the NANOG gene, and exhibit reduced expression of germinative genes and increased expression of H3K27me3. This study provides new insight into male germ cell development mechanisms in dogs.	[de Souza, Aline F.; Bressan, Fabiana F.; Casals, Juliana B.; Ambrosio, Carlos E.; Perecin, Felipe; Martins, Daniele S.] Univ Sao Paulo, Fac Vet Med & Anim Sci, Dept Surg, Sao Paulo, SP, Brazil; [de Souza, Aline F.; Roballo, Kelly C. S.; Bressan, Fabiana F.; Ambrosio, Carlos E.; Perecin, Felipe; Martins, Daniele S.] Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil; [Godoy Pieri, Naira C.] Univ Sao Paulo, Fac Vet Med, Dept Reprod, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Martins, DS (corresponding author), Univ Sao Paulo, Fac Vet Med & Anim Sci, Dept Surg, Sao Paulo, SP, Brazil.; Martins, DS (corresponding author), Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil.	daniele@usp.br	Bressan, Fabiana F./C-6679-2012; Ambrosio, Carlos Eduardo/F-3402-2010; Pieri, Naira/AAH-2843-2019; dos Santos Martins, Daniele/C-9004-2013; dos Santos Martins, Daniele/ABH-1262-2020; Perecin, Felipe/C-7268-2012; Roballo, Kelly C/I-6557-2015; De Souza, Aline Fernanda/F-8649-2017	Bressan, Fabiana F./0000-0001-9862-5874; Ambrosio, Carlos Eduardo/0000-0002-8224-5022; Pieri, Naira/0000-0002-6800-6025; dos Santos Martins, Daniele/0000-0002-6277-4664; dos Santos Martins, Daniele/0000-0002-6277-4664; Perecin, Felipe/0000-0003-2009-5863; Roballo, Kelly C/0000-0001-8420-9159; De Souza, Aline Fernanda/0000-0002-5702-1166	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/10542-5, 2012/05609-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was graciously funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant numbers, 2013/10542-5 and 2012/05609-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no competing interests to declare.; We acknowledge Dr. Andre Furugen Cesar de Andrade of the Laboratory of Swine Reproduction at the Faculty of Veterinary Medicine and Animal Sciences at the University of Sao Paulo for his technical support with the fluorescence microscopy. We also acknowledge Dra. Susana M. Chuva Sousa Lopes at the Department of Anatomy and Embryology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands, for her intellectual support. This study was graciously funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant numbers, 2013/10542-5 and 2012/05609-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no competing interests to declare.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Chastant-Maillard S, 2010, REPROD FERT DEVELOP, V22, P1049, DOI 10.1071/RD09270; Cinalli RM, 2008, CELL, V132, P559, DOI 10.1016/j.cell.2008.02.003; Cooke PS, 2015, ASIAN J ANDROL, V17, P441, DOI 10.4103/1008-682X.151401; De Felici M, 2000, INT J DEV BIOL, V44, P575; Durcova-Hills G, 2001, DIFFERENTIATION, V68, P220, DOI 10.1046/j.1432-0436.2001.680409.x; Durcova-Hills Gabriela, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01a03s5; FUJIMOTO T, 1977, ANAT REC, V188, P315, DOI 10.1002/ar.1091880305; Gaskell TL, 2004, BIOL REPROD, V71, P2012, DOI 10.1095/biolreprod.104.028381; Gier H. T., 1969, Biology of Reproduction Suppl, VNo. 1, P1, DOI 10.1095/biolreprod1.Supplement_1.1; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hatoya S, 2006, MOL REPROD DEV, V73, P298, DOI 10.1002/mrd.20392; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Hayashi Y, 2012, FERTIL STERIL, V97, P1250, DOI 10.1016/j.fertnstert.2012.04.037; Hayes B, 2008, STEM CELLS, V26, P465, DOI 10.1634/stemcells.2007-0640; Heeren AM, 2016, BIOL OPEN, V5, P185, DOI 10.1242/bio.013847; Heeren AM, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0054-0; Hendriks S, 2015, HUM REPROD UPDATE, P1; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kerr CL, 2008, STEM CELLS, V26, P412, DOI 10.1634/stemcells.2007-0605; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lee KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088497; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Lopes SMCD, 2010, DIFFERENTIATION, V79, P131, DOI 10.1016/j.diff.2009.11.003; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Mancanares CAF, 2015, THERIOGENOLOGY, P1; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Martins AA, 2016, REPROD DOMEST ANIM, V51, P804, DOI 10.1111/rda.12759; Martins DS, 2011, REPROD DOMEST ANIM, V46, pe62, DOI 10.1111/j.1439-0531.2010.01631.x; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Miglino MA, 2006, THERIOGENOLOGY, V66, P1699, DOI 10.1016/j.theriogenology.2006.02.027; Mollgard K, 2010, MOL HUM REPROD, V16, P621, DOI 10.1093/molehr/gaq052; Murakami K, 2016, NATURE, V529, P403, DOI 10.1038/nature16480; Nagamatsu G, 2013, METHODS MOL BIOL, V1052, P49, DOI 10.1007/7651_2013_24; Nakashima H, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105932; Nowacka J, 2005, J HERED, V96, P797, DOI 10.1093/jhered/esi106; Nowacka-Woszuk J, 2007, ANIM REPROD SCI, V98, P371, DOI 10.1016/j.anireprosci.2006.04.051; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Petkov SG, 2011, STEM CELL RES, V6, P226, DOI 10.1016/j.scr.2011.01.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piedrahita JA, 1998, BIOL REPROD, V58, P1321, DOI 10.1095/biolreprod58.5.1321; Pieri NCG, 2015, REPROD DOMEST ANIM, V50, P625, DOI 10.1111/rda.12539; Pieri NCG, 2016, REPROD DOMEST ANIM, V51, P1; RCore Team, 2020, R LANG ENV STAT COMP; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Shamblott MJ, 2001, P NATL ACAD SCI USA, V98, P113, DOI 10.1073/pnas.021537998; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Starkey Mike P., 2005, Briefings in Functional Genomics & Proteomics, V4, P112; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Tilgner K, 2008, STEM CELLS, V26, P3075, DOI 10.1634/stemcells.2008-0289; Turnpenny L, 2006, STEM CELLS, V24, P212, DOI 10.1634/stemcells.2005-0255; Whyte A, 2009, ANIM REPROD SCI, V115, P328, DOI 10.1016/j.anireprosci.2008.11.008; Wilhelm D, 2013, MAMMALIAN SEX DETERM	62	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193026	10.1371/journal.pone.0193026	http://dx.doi.org/10.1371/journal.pone.0193026			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489867	gold, Green Submitted, Green Published			2022-12-26	WOS:000426276000052
J	Monahan, WB; Theobald, DM				Monahan, William B.; Theobald, David M.			Climate change adaptation benefits of potential conservation partnerships	PLOS ONE			English	Article							PROTECTED AREAS; STRATEGIES; VULNERABILITY; CHALLENGES; PRIORITIES; RANGES; WORLDS; SHIFTS; LANDS	We evaluate the world terrestrial network of protected areas (PAs) for its partnership potential in responding to climate change. That is, if a PA engaged in collaborative, trans-boundary management of species, by investing in conservation partnerships with neighboring areas, what climate change adaptation benefits might accrue? We consider core tenets of conservation biology related to protecting large areas with high environmental heterogeneity and low climate change velocity and ask how a series of biodiversity adaptation indicators change across spatial scales encompassing potential PA and non-PA partners. Less than 1% of current world terrestrial PAs equal or exceed the size of established and successful conservation partnerships. Partnering at this scale would increase the biodiversity adaptation indicators by factors up to two orders of magnitude, compared to a null model in which each PA is isolated. Most partnership area surrounding PAs is comprised of non-PAs (70%), indicating the importance of looking beyond the current network of PAs when promoting climate change adaptation. Given monumental challenges with PA-based species conservation in the face of climate change, partnerships provide a logical and achievable strategy for helping areas adapt. Our findings identify where strategic partnering efforts in highly vulnerable areas of the world may prove critical in safeguarding biodiversity.	[Monahan, William B.] Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO 80525 USA; [Theobald, David M.] Conservat Sci Partners Inc, Ft Collins, CO USA; [Monahan, William B.] Forest Serv, USDA, Forest Hlth Protect, Ft Collins, CO 80526 USA	United States Department of the Interior; United States Department of Agriculture (USDA); United States Forest Service	Monahan, WB (corresponding author), Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO 80525 USA.; Monahan, WB (corresponding author), Forest Serv, USDA, Forest Hlth Protect, Ft Collins, CO 80526 USA.	wmonahan@fs.fed.us			NASA Applied Sciences program [10-BIOCLIM10-0034]	NASA Applied Sciences program(National Aeronautics & Space Administration (NASA))	This work was supported by the NASA Applied Sciences program through award number 10-BIOCLIM10-0034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagador D, 2014, J APPL ECOL, V51, P703, DOI 10.1111/1365-2664.12230; [Anonymous], 2014, CLIMATE CHANGE 2014, P1; [Anonymous], 2011, US GEOLOGICAL SURVEY; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Aycrigg JL, 2016, BIOSCIENCE, V66, P774, DOI 10.1093/biosci/biw090; Barr LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024707; Beever EA, 2014, CONSERV BIOL, V28, P302, DOI 10.1111/cobi.12233; Butchart S.H.M., 2015, CONSERV LETT; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Columbia Law School, 2015, CLIM CHANG LAWS WORL; Curtin C. G., 2015, SCI OPEN SPACES THEO; Dallimer M, 2015, TRENDS ECOL EVOL, V30, P132, DOI 10.1016/j.tree.2014.12.004; Gillingham PK, 2015, BIOL J LINN SOC, V115, P707, DOI 10.1111/bij.12506; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hannah L, 2002, GLOBAL ECOL BIOGEOGR, V11, P485, DOI 10.1046/j.1466-822X.2002.00306.x; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; International Union for Conservation of Nature, 2015, IUCN RED LIST THREAT; International Union for Conservation of Nature and United Nations Environment Programme-World Conservation Management Center, 2015, WORLD DAT PROT AR WD; Jenkins CN, 2015, P NATL ACAD SCI USA, V112, P5081, DOI 10.1073/pnas.1418034112; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004279; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; Krosby M, 2010, CONSERV BIOL, V24, P1686, DOI 10.1111/j.1523-1739.2010.01585.x; Lehner B, 2013, HYDROL PROCESS, V27, P2171, DOI 10.1002/hyp.9740; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Maciejewski K, 2015, ECOL APPL, V25, P11, DOI 10.1890/13-2240.1; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ordonez A, 2014, NAT CLIM CHANGE, V4, P811, DOI [10.1038/nclimate2337, 10.1038/NCLIMATE2337]; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Secretary of the Interior, 2009, 3289 SECR INT US DEP; Thomas CD, 2012, P NATL ACAD SCI USA, V109, P14063, DOI 10.1073/pnas.1210251109; Tingley MW, 2014, ANN NY ACAD SCI, V1322, P92, DOI 10.1111/nyas.12484; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; UNEP-WCMC, 2015, WORLD DAT PROT AR US; Urban MC, 2016, SCIENCE, V353, P1113, DOI 10.1126/science.aad8466; Venter O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12558; Watson JEM, 2013, NAT CLIM CHANGE, V3, P989, DOI [10.1038/NCLIMATE2007, 10.1038/nclimate2007]; Watson JEM, 2012, ADV CLIM CHANG RES, V3, P1, DOI 10.3724/SP.J.1248.2012.00001	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191468	10.1371/journal.pone.0191468	http://dx.doi.org/10.1371/journal.pone.0191468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489817	gold, Green Published, Green Submitted			2022-12-26	WOS:000426276000007
J	Thieme, S; Holzbaur, A; Wiedemuth, R; Binner, A; Navratiel, K; Anastassiadis, K; Brenner, S; Richter, C				Thieme, Sebastian; Holzbaur, Alexander; Wiedemuth, Ralf; Binner, Aline; Navratiel, Katrin; Anastassiadis, Konstantinos; Brenner, Sebastian; Richter, Cornelia			The Dox-pDC - A murine conditionally immortalized plasmacytoid dendritic cell line with native immune profile	PLOS ONE			English	Article							NAIVE T-CELLS; NK-CELLS; IN-VIVO; CPG-DNA; ACTIVATION; ANTIGEN; INTERFERON; TYPE-1; LIGAND; IL-10	Plasmacytoid dendritic cells (pDC) constitute a very rare blood cell population and play a significant role in immune response and immune-mediated disorders. Investigations on primary pDCs are hindered not only due to their rarity but also because they represent a heterogeneous cell population which is difficult to culture ex vivo. We generated a conditionally immortalized pDC line (Dox-pDC) from mice with Doxycycline-inducible SV40 Large T Antigen with a comparable immune profile to primary pDCs. The Dox-pDC secrete pro-and anti-inflammatory cytokines upon Toll-like receptor 9 stimulation and upregulate their MHCI, MHCII and costimulatory molecules. Further, the Dox-pDC activate and polarize naive T cells in vivo and in vitro in response to the model antigen Ovalbumin. Due to their long-term culture stability and their robust proliferation Dox-pDC represent a reliable alternative to primary mouse pDC.	[Thieme, Sebastian; Holzbaur, Alexander; Wiedemuth, Ralf; Binner, Aline; Navratiel, Katrin; Brenner, Sebastian; Richter, Cornelia] Univ Clin Carl Gustav Carus Dresden, Dept Pediat, Dresden, Germany; [Anastassiadis, Konstantinos] Tech Univ Dresden, Stem Cell Engn, BIOTEC, Dresden, Germany; [Brenner, Sebastian] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden	Brenner, S; Richter, C (corresponding author), Univ Clin Carl Gustav Carus Dresden, Dept Pediat, Dresden, Germany.; Brenner, S (corresponding author), Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany.	sebastian.brenner@uniklinikum-dresden.de; cornelia.richter@uniklinikum-dresden.de	Anastassiadis, Konstantinos/A-8944-2010	Anastassiadis, Konstantinos/0000-0002-9814-0559; Richter, Cornelia/0000-0003-4559-5696	Collaborative Research Grant (DFG) from the DFG-Center for Regenerative Therapies Dresden [SFB-655]; Saxon State Ministry for Higher Education, Research and the Arts; DFG-Center for Regenerative Therapies Dresden	Collaborative Research Grant (DFG) from the DFG-Center for Regenerative Therapies Dresden; Saxon State Ministry for Higher Education, Research and the Arts; DFG-Center for Regenerative Therapies Dresden	This work was supported by the Collaborative Research Grant SFB-655 (DFG, SFB-655 project B6 to SB, project B1 to KA; www.dfg.de), the seed grants from the DFG-Center for Regenerative Therapies Dresden (to S.B.; www.crt-dresden.de) and the Saxon State Ministry for Higher Education, Research and the Arts (to C.R. and S.T.; www.sachsen.de/en/1218.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Andras Nagy (Mount Sinai Hospital, Toronto, Canada) for providing the Rosa-rtTA mice. This work was supported by the Collaborative Research Grant SFB-655 (DFG, SFB-655 project B6 to SB, project B1 to KA), the seed grants from the DFG-Center for Regenerative Therapies Dresden (to S.B.) and the Saxon State Ministry for Higher Education, Research and the Arts (to C.R. and S.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis K, 2010, GENESIS, V48, P220, DOI 10.1002/dvg.20605; Bauer M, 2001, J IMMUNOL, V166, P5000, DOI 10.4049/jimmunol.166.8.5000; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Contractor N, 2007, J IMMUNOL, V179, P2690, DOI 10.4049/jimmunol.179.5.2690; Duramad O, 2003, BLOOD, V102, P4487, DOI 10.1182/blood-2003-07-2465; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Liu YC, 2010, J IMMUNOL, V184, P3367, DOI 10.4049/jimmunol.0903079; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Mach N, 2000, CANCER RES, V60, P3239; Maeda T, 2005, INT J HEMATOL, V81, P148, DOI 10.1532/IJH97.04116; Mouries J, 2008, BLOOD, V112, P3713, DOI 10.1182/blood-2008-03-146290; Narita M, 2009, LEUKEMIA RES, V33, P1224, DOI 10.1016/j.leukres.2009.03.047; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Richter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062621; Romagnani C, 2005, EUR J IMMUNOL, V35, P2452, DOI 10.1002/eji.200526069; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192437	10.1371/journal.pone.0192437	http://dx.doi.org/10.1371/journal.pone.0192437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489861	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000026
J	Murata, M; Ishii, A; Fujimoto, H; Nishimura, K; Kosaka, T; Mori, H; Yamada, M				Murata, Masayuki; Ishii, Ayana; Fujimoto, Hiroko; Nishimura, Kaori; Kosaka, Tomoyuki; Mori, Hirotada; Yamada, Mamoru			Update of thermotolerant genes essential for survival at a critical high temperature in Escherichia coil	PLOS ONE			English	Article							COLI	Previous screening of a single-gene knockout library consisting of 3,908 disrupted-mutant strains allowed us to identify 51 thermotolerant genes that are essential for survival at a critical high temperature (CHT) in Escherichia coli [Murata M, Fujimoto H, Nishimura K, Charoensuk K, Nagamitsu H, Raina S, Kosaka T, Oshima T, Ogasawara N, Yamada M (2011) PLoS ONE 6: e20063]. In this study, we identified another 21 thermotolerant genes. E. coli thus has 72 thermotolerant genes in total. The genes are classified into 8 groups: genes for energy metabolism, outer membrane organization, DNA double-strand break repair, tRNA modification, protein quality control, translation control, cell division and transporters. This classification and physiological analysis indicate the existence of fundamental strategies for survival at a CHT, which seems to exclude most of the heat shock responses.	[Murata, Masayuki; Ishii, Ayana; Fujimoto, Hiroko; Nishimura, Kaori; Kosaka, Tomoyuki; Yamada, Mamoru] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Life Sci, Ube, Yamaguchi, Japan; [Kosaka, Tomoyuki; Yamada, Mamoru] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi, Japan; [Kosaka, Tomoyuki; Yamada, Mamoru] Yamaguchi Univ, Res Ctr Thermotolerant Microbial Resources, Yamaguchi, Japan; [Mori, Hirotada] Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma, Nara, Japan	Yamaguchi University; Yamaguchi University; Yamaguchi University; Nara Institute of Science & Technology	Yamada, M (corresponding author), Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Life Sci, Ube, Yamaguchi, Japan.; Yamada, M (corresponding author), Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi, Japan.; Yamada, M (corresponding author), Yamaguchi Univ, Res Ctr Thermotolerant Microbial Resources, Yamaguchi, Japan.	m-yamada@yamaguchi-u.ac.jp		Yamada, Mamoru/0000-0003-4354-7324; Kosaka, Tomoyuki/0000-0002-8181-9127	Japan Society for the Promotion of Science, MEXT/JSPS Kakenhi [25250028]; Advanced Low Carbon Technology Research and Development Program, Japan Science and Technology Agency (JST); Scientific Cooperation Program; National Research Council of Thailand (NRCT)	Japan Society for the Promotion of Science, MEXT/JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Advanced Low Carbon Technology Research and Development Program, Japan Science and Technology Agency (JST); Scientific Cooperation Program; National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT))	This work was supported by the Japan Society for the Promotion of Science, MEXT/JSPS Kakenhi (25250028 to HM and MY) and the Advanced Low Carbon Technology Research and Development Program, Japan Science and Technology Agency (JST). This work was also partially performed as collaborative researches in the Asian Core Program and in the Core to Core Program, which was supported by the Scientific Cooperation Program agreed by the Japan Society for the Promotion of Science (JSPS), the National Research Council of Thailand (NRCT) and universities involved in the program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA H, 1981, J BIOL CHEM, V256, P1905; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barak R, 1998, J BACTERIOL, V180, P985, DOI 10.1128/JB.180.4.985-988.1998; Cassey B, 1998, FEMS MICROBIOL LETT, V159, P325; CHANG S, 1979, MOL GEN GENET, V168, P111, DOI 10.1007/BF00267940; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; HAYDON DJ, 1993, FEBS LETT, V336, P43, DOI 10.1016/0014-5793(93)81605-Y; LYNGSTADAAS A, 1995, MOL GEN GENET, V247, P546, DOI 10.1007/BF00290345; Murata M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020063; Noor R, 2009, J MOL MICROB BIOTECH, V17, P177, DOI 10.1159/000236029; Soemphol W, 2011, BIOSCI BIOTECH BIOCH, V75, P1921, DOI 10.1271/bbb.110310; Tsunedomi R, 2003, J BACTERIOL, V185, P1783, DOI 10.1128/JB.185.6.1783-1795.2003; Yamamoto Y, 1997, DNA Res, V4, P91, DOI 10.1093/dnares/4.2.91	13	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0189487	10.1371/journal.pone.0189487	http://dx.doi.org/10.1371/journal.pone.0189487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29485997	Green Submitted, gold, Green Published			2022-12-26	WOS:000426242400001
J	Mallhi, TH; Khan, AH; Adnan, AS; Sarriff, A; Khan, YH; Gan, SH				Mallhi, Tauqeer Hussain; Khan, Amer Hayat; Adnan, Azreen Syazril; Sarriff, Azmi; Khan, Yusra Habib; Gan, Siew Hua			Short-term renal outcomes following acute kidney injury among dengue patients: A follow-up analysis from large prospective cohort	PLOS ONE			English	Article							VIRAL-INFECTION; RECOVERY; EPIDEMIOLOGY; BIOMARKERS; IMPACT; RIFLE; AKI	Background Despite myriad improvements in the care of dengue patients, acute kidney injury (AKI) remained least appreciated intricacy of dengue infection. Exiting literature does not provide any information on renal outcomes among dengue patients surviving an episode of AKI. Methods Dengue patients who developed AKI were followed up for post-discharge period of three months and renal recovery was assessed by using recovery criteria based on different thresholds of serum creatinine (SCr) and estimated glomerular filtration rates (eGFR). Results Out of the 526 dengue participants, AKI was developed in 72 (13.7%) patients. Renal recovery was assessed among AKI survivors (n = 71). The use of less (+/- 50% recovery to baseline) to more (+/- 5% recovery to baseline) stringent definitions of renal recovery yielded recovery rates from 88.9% to 2.8% by SCr and 94.4% to 5.6% by eGFR, as renal function biomarkers. At the end of study, eight patients had AKI with AKIN-II (n = 7) and AKIN-III (n = 1). Approximately 50% patients (n = 36/71) with AKI had eGFR primitive to CKD stage 2, while 18.3% (n = 13/71) and 4.2% (n = 3/71) patients had eGFR corresponding to advanced stages of CKD (stage 3 & 4). Factors such as renal insufficiencies at hospital discharge, multiple organ involvements, advance age, female gender and diabetes mellitus were associated with poor renal outcomes. Conclusions We conclude that dengue patients with AKI portend unsatisfactory short-term renal outcomes and deserve a careful and longer follow-up, especially under nephrology care.	[Mallhi, Tauqeer Hussain] Govt Coll Univ Faisalabad, Fac Pharmaceut Sci, Dept Pharm Practice, Faisalabad, Pakistan; [Mallhi, Tauqeer Hussain; Khan, Amer Hayat; Sarriff, Azmi] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Adnan, Azreen Syazril] Univ Sains Malaysia, Sch Med Sci, Chron Kidney Dis Resource Ctr, Hlth Campus, Kubang Kerain, Kelantan, Malaysia; [Khan, Yusra Habib] Women Univ, Lahore Coll, Inst Pharmaceut Sci, Dept Pharm Practice, Lahore, Pakistan; [Gan, Siew Hua] Monash Univ Malaysia, Sch Pharm, Bandar Sunway, Malaysia	Government College University Faisalabad; Universiti Sains Malaysia; Universiti Sains Malaysia; Monash University; Monash University Sunway	Mallhi, TH (corresponding author), Govt Coll Univ Faisalabad, Fac Pharmaceut Sci, Dept Pharm Practice, Faisalabad, Pakistan.; Mallhi, TH; Khan, AH (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia.	tauqeer.hussain.mallhi@hotmali.com; dramer2006@gmail.com	Khan, Yusra Habib/AFK-9024-2022; Khan, Amer Hayat/O-5310-2018; gan, siew hua/A-6266-2011; Mallhi, Tauqeer Hussain/W-5155-2017	Khan, Yusra Habib/0000-0002-9479-6147; Khan, Amer Hayat/0000-0003-4802-6181; gan, siew hua/0000-0001-6470-3651; Mallhi, Tauqeer Hussain/0000-0001-9957-5362				Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Bagshaw SM, 2006, CURR OPIN CRIT CARE, V12, P544; Basu G, 2011, NEPHROL DIAL TRANSPL, V26, P524, DOI 10.1093/ndt/gfq477; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Goldstein SL, 2014, CRIT CARE, V18, DOI 10.1186/cc13180; Herath Nalaka J, 2014, BMC Res Notes, V7, P398, DOI 10.1186/1756-0500-7-398; Hoste EAJ, 2006, CURR OPIN CRIT CARE, V12, P531, DOI 10.1097/MCC.0b013e3280102af7; Kashani K, 2015, CURR OPIN NEPHROL HY, V24, P21, DOI 10.1097/MNH.0000000000000090; Khalil MAM, 2012, CLIN KIDNEY J, V5, P390, DOI 10.1093/ckj/sfs117; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kularatne S. A. M., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P686; Kumar V, 2015, RENAL INVOLVEMENT TR; Kuo MC, 2008, CLIN J AM SOC NEPHRO, V3, P1350, DOI 10.2215/CJN.00020108; Kute V B, 2012, Indian J Nephrol, V22, P33, DOI 10.4103/0971-4065.83737; Laoprasopwattana K, 2010, J PEDIATR-US, V157, P303, DOI 10.1016/j.jpeds.2010.02.008; Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149; Lee K., AM J TROP MED HYG, V80, P651; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Macedo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036388; Macedo E, 2008, CURR OPIN CRIT CARE, V14, P660, DOI 10.1097/MCC.0b013e328317ee6e; Magden K, 2013, HIPPOKRATIA, V17, P239; Mallhi TH, 2016, POSTGRAD MED J, V92, P78, DOI 10.1136/postgradmedj-2015-133582; Mallhi TH, 2015, JCPSP-J COLL PHYSICI, V25, P828, DOI 11.2015/JCPSP.828834; Mallhi TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138465; Mallhi TH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1141-3; Mehra N, 2012, TROP DOCT, V42, P160, DOI 10.1258/td.2012.120023; Nejat M, 2012, KIDNEY INT, V81, P1254, DOI 10.1038/ki.2012.23; Pannu N, 2013, CLIN J AM SOC NEPHRO, V8, P194, DOI 10.2215/CJN.06480612; Oliveira JFP, 2015, CLIN KIDNEY J, V8, P681, DOI 10.1093/ckj/sfv106; Pôncio Luana, 2015, Braz. J. Nephrol., V37, P115, DOI 10.5935/0101-2800.20150016; Sawhney S, 2015, BMJ OPEN, V5; Schetz M, 2015, INTENS CARE MED, V41, P1648, DOI 10.1007/s00134-015-3946-3; Schetz M, 2014, INTENS CARE MED, V40, P1709, DOI 10.1007/s00134-014-3487-1; Schortgen F, 2015, INTENS CARE MED, V41, P1993, DOI 10.1007/s00134-015-4033-5; Thomas ME, 2015, KIDNEY INT, V87, P62, DOI 10.1038/ki.2014.328; WHO/SEARO, 2011, COMPR GUID PREV CONT	36	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0192510	10.1371/journal.pone.0192510	http://dx.doi.org/10.1371/journal.pone.0192510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481564	Green Published, gold, Green Submitted			2022-12-26	WOS:000426202700004
J	Iribarren, PA; Di Marzio, LA; Berazategui, MA; De Gaudenzi, JG; Alvarez, VE				Ana Iribarren, Paula; Ayelen Di Marzio, Lucia; Agustina Berazategui, Maria; Gerardo De Gaudenzi, Javier; Eder Alvarez, Vanina			SUMO polymeric chains are involved in nuclear foci formation and chromatin organization in Trypanosoma brucei procyclic forms	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SYNAPTONEMAL COMPLEX; SUMOYLATION SITES; IDENTIFICATION; MOTIF; PROTEIN; CONJUGATION; PREDICTION; REVEALS; POLYSUMOYLATION	SUMOylation is a post-translational modification conserved in eukaryotic organisms that involves the covalent attachment of the small ubiquitin-like protein SUMO to internal lysine residues in target proteins. This tag usually alters the interaction surface of the modified protein and can be translated into changes in its biological activity, stability or subcellular localization, among other possible outputs. SUMO can be attached as a single moiety or as SUMO polymers in case there are internal acceptor sites in SUMO itself. These chains have been shown to be important for proteasomal degradation as well as for the formation of sub nuclear structures such as the synaptonemal complex in Saccharomyces cerevisiae or promyelocytic leukemia nuclear bodies in mammals. In this work, we have examined SUMO chain formation in the protozoan parasite Trypanosoma brucei. Using a recently developed bacterial strain engineered to produce SUMOylated proteins we confirmed the ability of TbSUMO to form polymers and determined the type of linkage using site-directed mutational analysis. By generating transgenic procyclic parasites unable to form chains we demonstrated that although not essential for normal growth, SUMO polymerization determines the localization of the modified proteins in the nucleus. In addition, FISH analysis of telomeres showed a differential positioning depending on the polySUMOylation abilities of the cells. Thus, our observations suggest that TbSUMO chains might play a role in establishing interaction platforms contributing to chromatin organization.	[Ana Iribarren, Paula; Ayelen Di Marzio, Lucia; Agustina Berazategui, Maria; Gerardo De Gaudenzi, Javier; Eder Alvarez, Vanina] Univ Nacl San Martin UNSAM, Inst Invest Biotecnol Dr Rodolfo A Ugalde, CONICET, Inst Tecnol Chascomus IIB INTECH, Campus Miguelete,Av 25 Mayo & Francia, San Martin, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	De Gaudenzi, JG; Alvarez, VE (corresponding author), Univ Nacl San Martin UNSAM, Inst Invest Biotecnol Dr Rodolfo A Ugalde, CONICET, Inst Tecnol Chascomus IIB INTECH, Campus Miguelete,Av 25 Mayo & Francia, San Martin, Buenos Aires, Argentina.	jdegaudenzi@iib.unsam.edu.ar; valvarez@iib.unsarn.edu.ar		Alvarez, Vanina/0000-0002-9890-6980	National Agency for Promotion of Scientific and Technological Research from Argentinian Ministry of Science and Technology (ANPCyT, MinCyT) [PICT 2011-1956, PICT-2016-0465]	National Agency for Promotion of Scientific and Technological Research from Argentinian Ministry of Science and Technology (ANPCyT, MinCyT)	This work was supported by the National Agency for Promotion of Scientific and Technological Research, from the Argentinian Ministry of Science and Technology (ANPCyT, MinCyT), grants PICT 2011-1956 to VEA and PICT-2016-0465 to VEA and JDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Iribarren PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134950; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bayona JC, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M110.007369-1, 10.1074/mcp.M110.007369]; Beauclair G, 2015, BIOINFORMATICS, V31, P3483, DOI 10.1093/bioinformatics/btv403; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; BRUN R, 1979, ACTA TROP, V36, P289; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Chen YJ, 2016, NUCLEIC ACIDS RES, V44, P2199, DOI 10.1093/nar/gkv1523; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; D'Ambrosio LM, 2014, CURR BIOL, V24, P361, DOI 10.1016/j.cub.2013.12.038; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; DuBois KN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001287; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Goos C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181884; Green J.R., 2006, PREDICTION PROTEIN S; He D, 2014, CURR BIOL, V24, P465, DOI 10.1016/j.cub.2014.01.036; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Horigome C, 2016, GENE DEV, V30, P931, DOI 10.1101/gad.277665.116; Iribarren PA, 2015, CELL MICROBIOL; Jones D, 2002, GENOME BIOL, V3; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Klein CA, 2013, PEERJ, V1, DOI 10.7717/peerj.180; de Jesus TCL, 2017, MOL CELL PROTEOMICS, V16, P23, DOI 10.1074/mcp.M116.061200; Leung WK, 2015, J CELL BIOL, V211, P785, DOI 10.1083/jcb.201506103; Liao SH, 2010, EXP CELL RES, V316, P704, DOI 10.1016/j.yexcr.2009.12.017; Lin FM, 2010, EMBO J, V29, P586, DOI 10.1038/emboj.2009.362; Lopez-Farfan D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004545; Maree JP, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0121-9; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Obado SO, 2011, NUCLEIC ACIDS RES, V39, P1023, DOI 10.1093/nar/gkq839; Perez-Morga D, 2001, J EUKARYOT MICROBIOL, V48, P221, DOI 10.1111/j.1550-7408.2001.tb00306.x; Picard N, 2012, MOL CELL BIOL, V32, P2709, DOI 10.1128/MCB.06624-11; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Srikumar T, 2013, J CELL BIOL, V201, P145, DOI 10.1083/jcb.201210019; Tammsalu T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005146; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Vertegaal ACO, 2010, BIOCHEM SOC T, V38, P46, DOI 10.1042/BST0380046; Watts FZ, 2011, BIOESSAYS, V33, P529, DOI 10.1002/bies.201100002; Xu HD, 2015, SCI REP-UK, V5, DOI 10.1038/srep10900; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383	56	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193528	10.1371/journal.pone.0193528	http://dx.doi.org/10.1371/journal.pone.0193528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474435	Green Published, gold, Green Submitted			2022-12-26	WOS:000426049500124
J	Bali, S; Robinson, BR; Sathuvalli, V; Bamberg, J; Goyer, A				Bali, Sapinder; Robinson, Bruce R.; Sathuvalli, Vidyasagar; Bamberg, John; Goyer, Aymeric			Single Nucleotide Polymorphism (SNP) markers associated with high folate content in wild potato species	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SOLANUM-TUBEROSUM L.; GAMMA-GLUTAMYL HYDROLASES; QUALITY TRAITS; PLANTS; POPULATION; MODEL; BIOSYNTHESIS; METABOLISM; RESISTANCE	Micronutrient deficiency, also known as the hidden hunger, affects over two billion people worldwide. Potato is the third most consumed food crops in the world, and is therefore a fundamental element of food security for millions of people. Increasing the amount of micronutrients in food crop could help alleviate worldwide micronutrient malnutrition. In the present study, we report on the identification of single nucleotide polymorphism (SNP) markers associated with folate, an essential micronutrient in the human diet. A high folate diploid clone Fol 1.6 from the wild potato relative Solanum boliviense (PI 597736) was crossed with a low/medium folate diploid S. tuberosum clone USW4self#3. The resulting F-1 progeny was intermated to generate an F-2 population, and tubers from 94 F-2 individuals were harvested for folate analysis and SNP genotyping using a SolCap 12K Potato SNP array. Folate content in the progeny ranged from 304 to 2,952 ng g(-1) dry weight. 6,759 high quality SNPs containing 4,174 (62%) polymorphic and 2,585 (38%) monomorphic SNPs were used to investigate marker-trait association. Association analysis was performed using two different approaches: survey SNP-trait association (SSTA) and SNP-trait association (STA). A total of 497 significant SNPs were identified, 489 by SSTA analysis and 43 by STA analysis. Markers identified by SSTA were located on all twelve chromosomes while those identified by STA were confined to chromosomes 2, 4, and 6. Eighteen of the significant SNPs were located within or in close proximity to folate metabolism-related genes. Forty two SNPs were identical between SSTA and STA analyses. These SNPs have potential to be used in marker-assisted selection for breeding high folate potato varieties.	[Bali, Sapinder; Robinson, Bruce R.; Sathuvalli, Vidyasagar; Goyer, Aymeric] Oregon State Univ, Hermiston Agr Res & Extens Ctr, Hermiston, OR 97838 USA; [Robinson, Bruce R.; Sathuvalli, Vidyasagar] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Bamberg, John] USDA ARS, US Potato Genebank, Sturgeon Bay, WI USA; [Goyer, Aymeric] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; United States Department of Agriculture (USDA); Oregon State University	Sathuvalli, V; Goyer, A (corresponding author), Oregon State Univ, Hermiston Agr Res & Extens Ctr, Hermiston, OR 97838 USA.; Sathuvalli, V (corresponding author), Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA.; Goyer, A (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	vidyasagar@oregonstate.edu; aymeric.goyer@oregonstate.edu	Goyer, Aymeric/AAW-2617-2021; Bali, Sapinder/AAR-7019-2021	Goyer, Aymeric/0000-0003-0714-6750; Sathuvalli, Vidyasagar/0000-0001-5727-9987	USDA, National Institute of Food and Agriculture [2012-04150]; USDA Western Sustainable Agriculture Research and Education Grant [GW15-034]; Oregon State University	USDA, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); USDA Western Sustainable Agriculture Research and Education Grant; Oregon State University	A National Needs Graduate Student Fellowship from the USDA, National Institute of Food and Agriculture (Grant# 2012-04150 https://nifa.usda.gov/funding-opportunity/food-and-agricultural-sciences-national-needs-graduate-and-postgraduate), and a Fellowship from the USDA Western Sustainable Agriculture Research and Education (Grant# GW15-034 https://www.westernsare.org/Grants/Types-of-Grants) supported Bruce Robinson. Dr. Sapinder Bali's postdoctoral research was supported by Start-up funds from Oregon State University awarded to Dr. Vidyasagar Sathuvalli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar TA, 2010, PLANT J, V64, P256, DOI 10.1111/j.1365-313X.2010.04330.x; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Araujo JR, 2015, AGEING RES REV, V22, P9, DOI 10.1016/j.arr.2015.04.005; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bailey LB, 2003, J NUTR, V133, p1961S, DOI 10.1093/jn/133.6.1961S; Bamberg J, 2015, AM J POTATO RES, V92, P276, DOI 10.1007/s12230-014-9428-2; Bamberg J, 2014, AM J POTATO RES, V91, P368, DOI 10.1007/s12230-013-9357-5; Bartholome J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165323; Bazzano LA, 2002, STROKE, V33, P1183, DOI 10.1161/01.STR.0000014607.90464.88; Beaudin Anna E., 2007, Birth Defects Research, V81, P183, DOI 10.1002/bdrc.20100; Berdugo-Cely J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173039; Bouis HE, 2002, J NUTR, V132, p491S, DOI 10.1093/jn/132.3.491S; Bradshaw JE, 2008, THEOR APPL GENET, V116, P193, DOI 10.1007/s00122-007-0659-1; Christian P, 2010, J NUTR, V140, p177S, DOI 10.3945/jn.109.111708; CIP, 2015, ANN REP 2014 CROSS C; Coppen A, 2005, J PSYCHOPHARMACOL, V19, P59, DOI 10.1177/0269881105048899; D'hoop BB, 2008, EUPHYTICA, V161, P47, DOI 10.1007/s10681-007-9565-5; D'hoop BB, 2010, THEOR APPL GENET, V121, P1151, DOI 10.1007/s00122-010-1379-5; Eudes A, 2008, J BIOL CHEM, V283, P15451, DOI 10.1074/jbc.M709591200; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Goyer A, 2005, J BIOL CHEM, V280, P26137, DOI 10.1074/jbc.M503106200; Goyer A, 2011, J AGR FOOD CHEM, V59, P13072, DOI 10.1021/jf203736e; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Hanson AD, 2011, ANNU REV PLANT BIOL, V62, P105, DOI 10.1146/annurev-arplant-042110-103819; Hirsch CN, 2013, G3-GENES GENOM GENET, V3, P1003, DOI 10.1534/g3.113.005595; Jansky SH, 2004, AM J POTATO RES, V81, P335, DOI 10.1007/BF02870179; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Manrique-Carpintero NC, 2013, G3-GENES GENOM GENET, V3, P1467, DOI 10.1534/g3.113.007146; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Orsomando G, 2005, J BIOL CHEM, V280, P28877, DOI 10.1074/jbc.M504306200; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Protection AaC, 1997, PREV MICR MALN GUID; Rebeille F, 2006, PHYSIOL PLANTARUM, V126, P330, DOI 10.1111/j.1399-3054.2006.00587.x; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Roberts SH, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-65; Robinson BR, 2015, GENES-BASEL, V6, P1300, DOI 10.3390/genes6041300; Rodriguez F, 2010, THEOR APPL GENET, V121, P1187, DOI 10.1007/s00122-010-1422-6; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Schonhals E, 2016, THEOR APPL GENET, V129, P767, DOI 10.1007/s00122-016-2665-7; Smith JG, 2009, METHODS MOL BIOL, V573, P231, DOI 10.1007/978-1-60761-247-6_14; SPOONER DM, 2006, HDB POTATO PRODUCTIO, P1, DOI DOI 10.1300/5776; Stich B, 2013, PLANT BREEDING, V132, P718, DOI 10.1111/pbr.12102; TANKSLEY SD, 1992, GENETICS, V132, P1141; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; Voutilainen S, 2001, CIRCULATION, V103, P2674, DOI 10.1161/01.CIR.103.22.2674; Youngblood ME, 2013, BIRTH DEFECTS RES A, V97, P658, DOI 10.1002/bdra.23166; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	49	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193415	10.1371/journal.pone.0193415	http://dx.doi.org/10.1371/journal.pone.0193415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474475	Green Published, gold, Green Submitted			2022-12-26	WOS:000426049500104
J	Choe, H; Thorne, JH; Huber, PR; Lee, D; Quinn, JF				Choe, Hyeyeong; Thorne, James H.; Huber, Patrick R.; Lee, Dongkun; Quinn, James F.			Assessing shortfalls and complementary conservation areas for national plant biodiversity in South Korea	PLOS ONE			English	Article							LAND-USE; PROTECTED AREAS; SPECIES DISTRIBUTIONS; GAP ANALYSIS; TRADE-OFFS; PREDICTION; PRIORITIZATION; MODELS; RANGE; WILL	Protected areas (PAs) are often considered the most important biodiversity conservation areas in national plans, but PAs often do not represent national-scale biodiversity. We evaluate the current conservation status of plant biodiversity within current existing PAs, and identify potential additional PAs for South Korea. We modeled species ranges for 2,297 plant species using Multivariate Adaptive Regression Splines and compared the level of mean range representation in South Korea's existing PAs, which comprise 5.7% of the country's mainland area, with an equal-area alternative PA strategy selected with the reserve algorithm Marxan. We also used Marxan to model two additional conservation scenarios that add lands to approach the Aichi Biodiversity Target objectives (17% of the country). Existing PAs in South Korea contain an average of 6.3% of each plant species' range, compared to 5.9% in the modeled equal-area alternative. However, existing PAs primarily represent a high percentage of the ranges for high-elevation and small range size species. The additional PAs scenario that adds lands to the existing PAs covers 14,587.55 km(2), and would improve overall plant range representation to a mean of 16.8% of every species' range. The other additional PAs scenario, which selects new PAs from all lands and covers 13,197.35 km(2), would improve overall plant range representation to a mean of 13.5%. Even though the additional PAs that includes existing PAs represents higher percentages of species' ranges, it is missing many biodiversity hotspots in non-mountainous areas and the additional PAs without locking in the existing PAs represent almost all species' ranges evenly, including low-elevation ones with larger ranges. Some priority conservation areas we identified are expansions of, or near, existing PAs, especially in northeastern and southern South Korea. However, lowland coastal areas and areas surrounding the capital city, Seoul, are also critical for biodiversity conservation in South Korea.	[Choe, Hyeyeong; Thorne, James H.; Huber, Patrick R.; Quinn, James F.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Lee, Dongkun] Seoul Natl Univ, Coll Agr Life Sci, Dept Landscape Architecture & Rural Syst Engn, Seoul, South Korea	University of California System; University of California Davis; Seoul National University (SNU)	Choe, H (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA.	hychoe@uodavis.edu		Choe, Hyeyeong/0000-0003-2130-1622; Thorne, James/0000-0002-9130-9921	UC Davis; South Korean government; Korea Environmental Industry and Technology Institute (KEITI) - Korean government [2014-001-310007]	UC Davis; South Korean government(Korean Government); Korea Environmental Industry and Technology Institute (KEITI) - Korean government	HC appreciates the UC Davis for the Provosts Dissertation Year Fellowship, and South Korean government for the government scholarship. This work was supported by the Korea Environmental Industry and Technology Institute (KEITI; http://www.keiti.re.kr/en/index.do) grant funded by the Korean government (ME) (No. 2014-001-310007) to DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bolliger J, 2007, LANDSCAPE ECOL, V22, P773, DOI 10.1007/s10980-007-9077-7; Booth TH, 2016, FOREST ECOL MANAG, V366, P175, DOI 10.1016/j.foreco.2016.02.009; Brost BM, 2012, ECOL APPL, V22, P87, DOI 10.1890/11-0213.1; Choe H, 2017, J APPL ECOL, V54, P1742, DOI 10.1111/1365-2664.12865; Choe H, 2017, FORESTS, V8, DOI 10.3390/f8090321; Choe H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149511; Chown SL, 2003, ECOL APPL, V13, P1233, DOI 10.1890/02-5105; Convention on Biological Diversity, 2010, STRAT PLAN BIOD 2011; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Das A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130566; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Esfandeh S., 2015, INT J ENG APPL SCI, V2, P6; Faith DP, 2002, J BIOSCIENCES, V27, P393, DOI 10.1007/BF02704968; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2009, MAPPING SPECIES DIST; Game ET, 2008, MARXAN USER MANUAL M; Groves CR, 2002, BIOSCIENCE, V52, P499, DOI 10.1641/0006-3568(2002)052[0499:PFBCPC]2.0.CO;2; Hall JM, 2012, LANDSCAPE ECOL, V27, P1135, DOI 10.1007/s10980-012-9755-y; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; Huber Patrick, 2015, Ecosystem Health and Sustainability, V1, P7, DOI 10.1890/EHS14-0008.1; Huggins A. E., 2005, MARXAN CONSERVATION; Joppa LN, 2016, SCIENCE, V352, P416, DOI 10.1126/science.aaf3565; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kumar HD, 1999, BIODIVERSITY SUSTAIN; Leathwick JR, 2005, FRESHWATER BIOL, V50, P2034, DOI 10.1111/j.1365-2427.2005.01448.x; Lessmann J, 2014, ECOL EVOL, V4, P2410, DOI 10.1002/ece3.1102; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Mateo RG, 2010, J VEG SCI, V21, P908, DOI 10.1111/j.1654-1103.2010.01198.x; McDonnell MD, 2002, ENVIRON MODEL ASSESS, V7, P107, DOI 10.1023/A:1015649716111; McKenney BA, 2010, ENVIRON MANAGE, V45, P165, DOI 10.1007/s00267-009-9396-3; Ministry of Environment, 2010, MAST PLANS PROT WILD; Ministry of Environment & National Institute of Environmental Research, 2006, 3 GUID NAT NAT ENV S; Naoe S, 2015, J NAT CONSERV, V24, P101, DOI 10.1016/j.jnc.2014.10.002; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Oldfield TEE, 2004, BIOL CONSERV, V120, P303, DOI 10.1016/j.biocon.2004.03.003; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; RAY GC, 1991, BIOSCIENCE, V41, P490, DOI 10.2307/1311807; Roberts DL, 2016, DIVERS DISTRIB, V22, P558, DOI 10.1111/ddi.12418; Scherer L, 2017, CONSERV BIOL, V31, P302, DOI 10.1111/cobi.12792; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Sekercioglu CH, 2010, CONSERVATION BIOLOGY FOR ALL, P45, DOI 10.1093/acprof:oso/9780199554232.003.0004; Sharafi SM, 2012, J ENVIRON MANAGE, V112, P240, DOI 10.1016/j.jenvman.2012.07.010; Smith RJ, 2010, BIOL CONSERV, V143, P2525, DOI 10.1016/j.biocon.2010.06.019; Statistics Korea, 2010, POP HOUS CENS; Torontow V, 2011, CAN J REMOTE SENS, V37, P387, DOI 10.5589/m11-047; van Proosdij A. S. J., 2015, ECOGRAPHY; Watson JEM, 2013, NAT CLIM CHANGE, V3, P989, DOI [10.1038/NCLIMATE2007, 10.1038/nclimate2007]; Weil G, 2015, ISR J ECOL EVOL, V61, P50, DOI 10.1080/15659801.2015.1035858; Wiens JA, 2011, BIOL CONSERV, V144, P2119, DOI 10.1016/j.biocon.2011.05.002; Yoshioka A, 2014, RESTOR ECOL, V22, P185, DOI 10.1111/rec.12075; Zhang MG, 2012, BIOL CONSERV, V153, P257, DOI 10.1016/j.biocon.2012.04.023	55	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0190754	10.1371/journal.pone.0190754	http://dx.doi.org/10.1371/journal.pone.0190754			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474355	Green Published, gold			2022-12-26	WOS:000426049500003
J	Wang, WX; Yue, ZN; Tian, ZP; Xie, YR; Zhang, JM; She, YP; Yang, B; Ye, Y; Yang, YH				Wang, Wanxue; Yue, Zhenni; Tian, Zhengping; Xie, Yiran; Zhang, Jiamiao; She, Yuanping; Yang, Bing; Ye, Yuan; Yang, Yihua			Expression of Yin Yang 1 in cervical cancer and its correlation with E-cadherin expression and HPV16 E6	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; TRANSCRIPTION; HPV-16; YY1; P53; ASSOCIATION; ONCOPROTEIN; PROGRESSION; INCREASES; PROTEIN	The molecular mechanisms of normal cervical squamous epithelium advancing to cervical intraepithelial neoplasia (CIN) and eventually to cervical squamous cell carcinoma (CSCC) are largely unknown. This study explored abnormal expression of Yin Yang 1 (YY1) in cervical cancer and its correlation with the expression of E-cadherin and human papillomavirus (HPV) 16 E6. YY1, E-cadherin and HPV16 E6 expression were detected by immunohistochemistry in 90 cervical tissue specimens collected from 30 patients with hysteromyoma, 15 patients with CIN I, 15 patients with CIN II-III, and 30 patients with CSCC. The H-score method was employed to measure the expression of YY1, E-cadherin and HPV16 E6. Increased expression of YY1 and HPV16 E6, and the decreased expression levels of E-cadherin were strongly associated with malignant transformation of the cervical epithelium and the histological progression of CSCC. The expression of YY1 in cervical tissues was inversely correlated with E-cadherin expression, and positively correlated with HPV16 E6 expression. Expression of YY1 in CSCC tissues was not significantly correlated with tumor differentiation, but was significantly correlated with an advanced clinical stage of CSCC. These results suggest that up-regulation of YY1 is closely associated with the progression of CSCC, and YY1 may play an important role in the pathogenesis of cervical cancer by modulating the expression of E-cadherin and HPV16 E6.	[Wang, Wanxue; Yang, Yihua] Guangxi Med Univ, Ctr Reprod Med, Affiliated Hosp 1, Nanning, Peoples R China; [Wang, Wanxue; Tian, Zhengping; Xie, Yiran; Zhang, Jiamiao] Guilin Med Coll, Affiliated Hosp, Ctr Reprod Med, Guilin, Peoples R China; [Yue, Zhenni; She, Yuanping; Yang, Bing; Ye, Yuan] Guilin Med Coll, Affiliated Hosp, Dept Obstet & Gynecol, Guilin, Peoples R China	Guangxi Medical University; Guilin Medical University; Guilin Medical University	Yang, YH (corresponding author), Guangxi Med Univ, Ctr Reprod Med, Affiliated Hosp 1, Nanning, Peoples R China.; Ye, Y (corresponding author), Guilin Med Coll, Affiliated Hosp, Dept Obstet & Gynecol, Guilin, Peoples R China.	glyy169@163.com; workyyh@163.com	Yang, Ye/GZM-4812-2022; Lang, Ming/HIK-0758-2022; yang, yang/HGT-7999-2022; Wang, Wanxue/M-6726-2019	Wang, Wanxue/0000-0003-0606-6628	National Natural Science Foundation of China [81360386, 81560245]; Natural Science Foundation of Guangxi Province [2015GXNSFAA139182]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi Province(National Natural Science Foundation of Guangxi Province)	These studies were supported by the National Natural Science Foundation of China (Grant No. 81360386 and No.81560245 to Yihua Yang) and the Natural Science Foundation of Guangxi Province (Grant No.2015GXNSFAA139182 to Yihua Yang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonavida B, 2015, PHARMACOL THERAPEUT, V150, P149, DOI 10.1016/j.pharmthera.2015.01.011; Bonavida Benjamin, 2011, Critical Reviews in Oncogenesis, V16, P211; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Cheng YW, 2008, CLIN CANCER RES, V14, P7173, DOI 10.1158/1078-0432.CCR-08-0850; D'Costa ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048954; Deng ZY, 2010, TRANSCR-AUSTIN, V1, P81, DOI 10.4161/trns.1.2.12375; DONG XP, 1994, INT J CANCER, V58, P803, DOI 10.1002/ijc.2910580609; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Gray E, 2010, CANCER RES, V70, P4081, DOI 10.1158/0008-5472.CAN-09-3335; Huang XQ, 2015, J HISTOCHEM CYTOCHEM, V63, P88, DOI 10.1369/0022155414561329; Jabbar S, 2010, VIROLOGY, V407, P60, DOI 10.1016/j.virol.2010.08.003; Kashyap Vaishali, 2014, Genes Cancer, V5, P71; Kaufhold S, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0359-2; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; LECHNER MS, 1994, J VIROL, V68, P4262, DOI 10.1128/JVI.68.7.4262-4273.1994; Li XY, 2015, INT J CLIN EXP MED, V8, P8363; OConnor MJ, 1996, J VIROL, V70, P6529, DOI 10.1128/JVI.70.10.6529-6539.1996; Olson B, 2016, INT J GYNECOL OBSTET, V134, P239, DOI 10.1016/j.ijgo.2016.03.011; Pastuszak-Lewandoska D, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0842-6; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Peng JF, 2016, FUTURE ONCOL, V12, P715, DOI 10.2217/fon.15.332; Pientong C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-30; Prieto-Garcia E, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-0980-8; Pyeon D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000318; Ramachandran B, 2017, ENDOCR-RELAT CANCER, V24, pR99, DOI 10.1530/ERC-16-0571; Roca F, 2006, J SURG ONCOL, V93, P151, DOI 10.1002/jso.20413; Shi JM, 2015, CURR CANCER DRUG TAR, V15, P145, DOI 10.2174/1568009615666150131124200; Small W, 2017, CANCER-AM CANCER SOC, V123, P2404, DOI 10.1002/cncr.30667; Sun LD, 2016, CELL MOL LIFE SCI, V73, P4493, DOI 10.1007/s00018-016-2303-1; TANG AM, 1993, NATURE, V361, P82, DOI 10.1038/361082a0; Thomas M, 1999, J GEN VIROL, V80, P1513, DOI 10.1099/0022-1317-80-6-1513; Tomao F, 2014, CURR DRUG TARGETS, V15, P1107, DOI 10.2174/1389450115666141010145547; Vega-Pena A, 2013, J CYTOL, V30, P226, DOI 10.4103/0970-9371.126644; Wallace NA, 2014, J VIROL, V88, P6112, DOI 10.1128/JVI.03808-13; Yang X, 2015, DRUG RES, V65, P70, DOI 10.1055/s-0034-1372614; Yang Y, 2012, ONCOGENE, V32, P3432; Yao RS, 2014, CANCER RES, V74, P5656, DOI 10.1158/0008-5472.CAN-14-0800; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001; Zhang QH, 2012, ADV DIFFER EQU-NY, DOI 10.1186/1687-1847-2012-136; Zhou Lei, 2015, Zhonghua Yi Xue Za Zhi, V95, P3050; Zhu WX, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/760730	41	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193340	10.1371/journal.pone.0193340	http://dx.doi.org/10.1371/journal.pone.0193340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470526	Green Submitted, Green Published, gold			2022-12-26	WOS:000425831000049
J	Wang, W; Xiao, CC; Yao, X; Yang, YM; Yan, H; Li, SY				Wang, Wei; Xiao, Chenchang; Yao, Xing; Yang, Yinmei; Yan, Hong; Li, Shiyue			Psychosocial health and suicidal ideation among people living with HIV/AIDS: A cross-sectional study in Nanjing, China	PLOS ONE			English	Article							PERCEIVED SOCIAL SUPPORT; HIV-POSITIVE PERSONS; QUALITY-OF-LIFE; MENTAL-HEALTH; ANTIRETROVIRAL THERAPY; RURAL CHINA; SELF-ESTEEM; PREVALENCE; DEPRESSION; STIGMA	Background Suicide is a serious cause of mortality worldwide and is considered as a psychiatric emergency. People living with HIV/AIDS (PLWHA) have higher rates of suicidal behavior than the general population. This study assessed the prevalence and verified the syndemic effect of psychosocial health conditions on suicidal ideation among PLWHA in China. Methods An institutional-based cross-sectional study was conducted from July to August 2016 in Nanjing, China, using a self-report questionnaire. Sociodemographic characteristics, infection status, psychosocial variables and suicide ideation reports of participants were collected. Logistic regressions were used to identify potential factors associated with suicidal ideation and to verify the syndemic effect of psychosocial factors. Additionally, odds ratios (ORs) with 95% confidence intervals (95% CI) were computed. Results In total, four hundred sixty-five PLWHA participated, 31.6% (n = 147) of whom had suicidal ideation. The results from univariate analysis showed that older age, low education level, being married, having children, and psychosocial variables (high perceived stigma, depression, low self-esteem, social support and resilience) were significantly associated with increased suicidal ideation. Multiple logistic regression models revealed that depression (OR = 2.70, 95% CI = 1.62-4.51), perceived stigma (OR = 1.97, 95% CI = 1.17-3.32), and low social support (OR = 1.85, 95% CI = 1.08-3.20) and self-esteem (OR = 4.11, 95% CI = 2.06-8.16) were statistically significant. PLWHA with at least two psychosocial health problems were nearly 5 times more likely (OR = 4.72, 95% CI 3.11-7.17) to have had suicidal ideation. Conclusions Suicidal ideation is frequent among PLWHA in China and is consistent with prevalence estimates from abroad. Psychosocial health problems were the determining factors associated with suicidal ideation, and a syndemic effect of psychosocial health conditions was confirmed in predicting suicidal ideation. Therefore, early screening of high-risk groups for suicidal ideation and more psychosocial health care among PLWHA are needed.	[Wang, Wei; Xiao, Chenchang; Yao, Xing; Yang, Yinmei; Yan, Hong; Li, Shiyue] Wuhan Univ, Sch Hlth Sci, Wuhan, Hubei, Peoples R China; [Wang, Wei] Univ Florida, Dept Epidemiol, Gainesville, FL USA; [Xiao, Chenchang] Wuhan Univ Sci & Technol, City Coll, Wuhan, Hubei, Peoples R China	Wuhan University; State University System of Florida; University of Florida; Wuhan University of Science & Technology	Li, SY (corresponding author), Wuhan Univ, Sch Hlth Sci, Wuhan, Hubei, Peoples R China.	lsywhu@sina.com			National Natural Science Foundation of China [81673196]; China Scholarship Council [201706270144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China [grant number 81673196] and China Scholarship Council [grant number 201706270144].	ABRAM HS, 1971, AM J PSYCHIAT, V127, P1199, DOI 10.1176/ajp.127.9.1199; Amiya RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090959; Badiee J, 2012, J AFFECT DISORDERS, V136, P993, DOI 10.1016/j.jad.2011.06.044; Baider L, 2003, J PSYCHOSOM RES, V55, P453, DOI 10.1016/S0022-3999(03)00502-6; Bekele T, 2013, AIDS CARE, V25, P337, DOI 10.1080/09540121.2012.701716; Bitew H, 2016, DEPRESS RES TREAT, V2016, DOI [https://doi.org/10.1155/2016/8913160, DOI 10.1155/2016/8913160]; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Brandt R, 2009, AJAR-AFR J AIDS RES, V8, P123, DOI 10.2989/AJAR.2009.8.2.1.853; Bunn JY, 2007, AIDS EDUC PREV, V19, P198, DOI 10.1521/aeap.2007.19.3.198; Carrico AW, 2007, AIDS, V21, P1199, DOI 10.1097/QAD.0b013e3281532c96; Carrico AW, 2010, JAIDS-J ACQ IMM DEF, V54, pE3, DOI 10.1097/QAI.0b013e3181da1270; Chander G, 2006, DRUGS, V66, P769, DOI 10.2165/00003495-200666060-00004; Charles B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-463; Chen HQ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1436-8; China & CDC, 2016, TOT NUMB AL PEOPL LI; Cho SE, 2016, J AFFECT DISORDERS, V190, P704, DOI 10.1016/j.jad.2015.11.008; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Cooperman NA, 2005, J BEHAV MED, V28, P149, DOI 10.1007/s10865-005-3664-3; Diaz RM, 2001, AM J PUBLIC HEALTH, V91, P927, DOI 10.2105/AJPH.91.6.927; Elenga N, 2014, INT J STD AIDS, V25, P559, DOI 10.1177/0956462413514954; Galvan FH, 2008, AIDS PATIENT CARE ST, V22, P423, DOI 10.1089/apc.2007.0169; Guadamuz TE, 2014, AIDS BEHAV, V18, P2089, DOI 10.1007/s10461-014-0826-8; Guimaraes PM, 2014, REV BRAS PSIQUIATR, V36, P131, DOI 10.1590/1516-4446-2013-1219; Horberg MA, 2008, JAIDS-J ACQ IMM DEF, V47, P384, DOI 10.1097/QAI.0b013e318160d53e; Jin H, 2006, J AFFECT DISORDERS, V94, P269, DOI 10.1016/j.jad.2006.04.013; Jin H, 2013, JAIDS-J ACQ IMM DEF, V62, P311, DOI 10.1097/QAI.0b013e31827ce513; Ke X, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-573; Kebede D, 1999, ACTA PSYCHIAT SCAND, V100, P35, DOI 10.1111/j.1600-0447.1999.tb10692.x; Keiser O, 2010, AM J PSYCHIAT, V167, P143, DOI 10.1176/appi.ajp.2009.09050651; Kelly B, 1998, PSYCHOSOMATICS, V39, P405, DOI 10.1016/S0033-3182(98)71299-X; Kim AY, 2013, J INFECT DIS, V207, pS1, DOI 10.1093/infdis/jis927; Kinyanda E, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-63; Komiti A, 2001, AUST NZ J PSYCHIAT, V35, P747, DOI 10.1046/j.1440-1614.2001.00943.x; Lau JTF, 2010, AIDS CARE, V22, P946, DOI 10.1080/09540120903511016; Lawrence ST, 2010, CLIN INFECT DIS, V50, P1165, DOI 10.1086/651420; Lehmann M, 2016, CRISIS, V37, P265, DOI 10.1027/0227-5910/a000399; Lemsalu L, 2016, AIDS BEHAV; Li L, 2009, AIDS CARE, V21, P1007, DOI 10.1080/09540120802614358; Li ZH, 2010, PSYCHIAT RES, V175, P227, DOI 10.1016/j.psychres.2009.03.007; Liu JX, 2006, AIDS BEHAV, V10, pS25, DOI 10.1007/s10461-006-9123-5; Ma X, 2009, AUST NZ J PSYCHIAT, V43, P158, DOI 10.1080/00048670802607170; Mars B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-606; MARZUK P M, 1991, International Review of Psychiatry, V3, P365, DOI 10.3109/09540269109072143; McAndrew S, 2004, J Psychiatr Ment Health Nurs, V11, P428, DOI 10.1111/j.1365-2850.2004.00739.x; Mcdowell TL, 2007, AIDS CARE, V19, P1223, DOI 10.1080/09540120701402830; Mustanski B, 2013, ARCH SEX BEHAV, V42, P437, DOI 10.1007/s10508-012-0013-9; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; ODOWD MA, 1990, GEN HOSP PSYCHIAT, V12, P50, DOI 10.1016/0163-8343(90)90038-E; ODOWD MA, 1993, PSYCHOSOMATICS, V34, P33; Operario D, 2010, JAIDS-J ACQ IMM DEF, V55, pS91, DOI 10.1097/QAI.0b013e3181fbc9ec; Polat B, 2015, EUR ARCH OTO-RHINO-L, V272, P3431, DOI 10.1007/s00405-014-3335-5; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Preau M, 2008, AIDS CARE, V20, P917, DOI 10.1080/09540120701777249; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Rukundo GZ, 2016, AIDS RES TREAT, V2016, DOI 10.1155/2016/3015468; Sarin E, 2013, SUBST ABUSE TREAT PR, V8, DOI 10.1186/1747-597X-8-2; Schlebusch L, 2015, DEPRESS RES TREAT, V2015; SCHNEIDER SG, 1991, J PERS SOC PSYCHOL, V61, P776, DOI 10.1037/0022-3514.61.5.776; Shang H, 2012, NATURE, V485, P576, DOI 10.1038/485576a; Sheng L, 2008, CHINESE MED J-PEKING, V121, P1230, DOI 10.1097/00029330-200807010-00016; Sherr L, 2008, AIDS, V22, P1651, DOI 10.1097/QAD.0b013e32830c4804; Simon M, 2013, ARCH GERONTOL GERIAT, V57, P250, DOI 10.1016/j.archger.2013.05.006; SINGER M, 1994, SOC SCI MED, V39, P931, DOI 10.1016/0277-9536(94)90205-4; Sivasubramanian M, 2011, PSYCHOL HEALTH MED, V16, P450, DOI 10.1080/13548506.2011.554645; Tezel A, 2011, J RES MED SCI, V16, P666; Wei W, 2016, AIDS CARE, V28, P99, DOI 10.1080/09540121.2016.1146217; Whetten K, 2008, PSYCHOSOM MED, V70, P531, DOI 10.1097/PSY.0b013e31817749dc; World Health Organization, 2014, PREV SUIC PREV SUIC; Wu Y., 2007, CHINESE J DIS CONTRO, V4, P342; Wu YL, 2015, INT J STD AIDS, V26, P496, DOI 10.1177/0956462414544722; Xiao S, 1999, CHINESE MENT HLTH J, V12, P127; Yang Y., 2004, THESIS	74	37	42	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192940	10.1371/journal.pone.0192940	http://dx.doi.org/10.1371/journal.pone.0192940			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX1SB	29470532	Green Published, gold, Green Submitted			2022-12-26	WOS:000425831000025
J	Wang, YJ; Jiang, L; Chen, JQ; Tao, L; An, YM; Cai, HS; Guo, CH				Wang, Youjing; Jiang, Lin; Chen, Jiaqi; Tao, Lei; An, Yimin; Cai, Hongsheng; Guo, Changhong			Overexpression of the alfalfa WRKY11 gene enhances salt tolerance in soybean	PLOS ONE			English	Article							STRESS-INDUCED CHANGES; TRANSCRIPTION FACTORS; REACTIVE OXYGEN; LOW-TEMPERATURE; SOLUBLE SUGARS; DROUGHT; EXPRESSION; RESPONSES; TOBACCO; ACID	The WRKY transcription factors play an important role in the regulation of transcriptional reprogramming associated with plant abiotic stress responses. In this study, the WRKY transcription factor MsWRKY11, containing the plant-specific WRKY zinc finger DNA-binding motif, was isolated from alfalfa. The MsWRKY11 gene was detected in all plant tissues ( root, stem, leaf, flower, and fruit), with high expression in root and leaf tissues. MsWRKY11 was upregulated in response to a variety of abiotic stresses, including salinity, alkalinity, cold, abscisic acid, and drought. Overexpression of MsWRKY11 in soybean enhanced the salt tolerance at the seedling stage. Transgenic soybean had a better salt-tolerant phenotype, and the hypocotyls were significantly longer than those of wild-type seeds after salt treatment. Furthermore, MsWRKY11 overexpression increased the contents of chlorophyll, proline, soluble sugar, superoxide dismutase, and catalase, but reduced the relative electrical conductivity and the contents of malonaldehyde, H2O2, and O-2(-). Plant height, pods per plant, seeds per plant, and 100-seed weight of transgenic MsWRKY11 soybean were higher than those of wild-type soybean, especially OX2. Results of the salt experiment showed that MsWRKY11 is involved in salt stress responses, and its overexpression improves salt tolerance in soybean.	[Wang, Youjing; Jiang, Lin; Chen, Jiaqi; Tao, Lei; An, Yimin; Cai, Hongsheng; Guo, Changhong] Harbin Normal Univ, Key Lab Mol Cytogenet & Genet Breeding Heilongjia, Coll Life Sci & Technol, Harbin, Heilongjiang, Peoples R China	Harbin Normal University	Guo, CH (corresponding author), Harbin Normal Univ, Key Lab Mol Cytogenet & Genet Breeding Heilongjia, Coll Life Sci & Technol, Harbin, Heilongjiang, Peoples R China.	kaku_2008@163.com		Cai, Hongsheng/0000-0002-9968-8719; An, Yi-Min/0000-0001-7266-121X	MOST 863 Project [2013AA102607-5]; Key Scientific and Technological Project of Heilongjiang Province of China [GA15B105-1]; Natural and Science Foundation of China [31470571]; National Major Project for Cultivation of Transgenic Crops [2016ZX08004-002-003]; National Key Research and Development Program of China [2017YFD0101303]	MOST 863 Project(National High Technology Research and Development Program of China); Key Scientific and Technological Project of Heilongjiang Province of China; Natural and Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Project for Cultivation of Transgenic Crops; National Key Research and Development Program of China	This work was supported by the MOST 863 Project (2013AA102607-5), the Key Scientific and Technological Project of Heilongjiang Province of China (GA15B105-1), the Natural and Science Foundation of China (No. 31470571), the National Major Project for Cultivation of Transgenic Crops (#2016ZX08004-002-003), and The National Key Research and Development Program of China (2017YFD0101303).	Agarwal P, 2016, FRONT PLANT SCI, V7; Machado RMA, 2017, HORTICULTURAE, V3, DOI 10.3390/horticulturae3020030; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Cai RH, 2014, PLANT CELL TISS ORG, V119, P565, DOI 10.1007/s11240-014-0556-7; Chi YJ, 2013, MOL PLANT, V6, P287, DOI 10.1093/mp/sst026; Du C, 2017, J PLANT PHYSIOL, V215, P48, DOI 10.1016/j.jplph.2017.05.002; EPSTEIN E, 1980, SCIENCE, V210, P399, DOI 10.1126/science.210.4468.399; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fath A, 2001, NEW PHYTOL, V151, P99, DOI 10.1046/j.1469-8137.2001.00153.x; Fu YJ, 2017, PLANT GROWTH REGUL, V83, P253, DOI 10.1007/s10725-017-0293-0; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hu YR, 2013, PLANT J, V74, P730, DOI 10.1111/tpj.12159; IRIGOYEN JJ, 1992, PHYSIOL PLANTARUM, V84, P55, DOI 10.1111/j.1399-3054.1992.tb08764.x; Ji XY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-151; Jia HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120646; Jiang JJ, 2017, J INTEGR PLANT BIOL, V59, P86, DOI 10.1111/jipb.12513; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Kim E, 2017, NUCLEIC ACIDS RES, V45, pD1082, DOI 10.1093/nar/gkw704; Kim HJ, 2016, PLANT BIOTECHNOL REP, V10, P257, DOI 10.1007/s11816-016-0402-y; Kim MiJin, 2017, Plant Breeding and Biotechnology, V5, P1, DOI [10.9787/PBB.2017.5.1.1, 10.9787/pbb.2017.5.1.001]; Ko KP, 2013, J EPIDEMIOL, V23, P337, DOI 10.2188/jea.JE20120232; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li SX, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00246; Liang QY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05170-x; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu F, 2010, J EXP MAR BIOL ECOL, V382, P82, DOI 10.1016/j.jembe.2009.11.005; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu QL, 2013, PLANT PHYSIOL BIOCH, V69, P27, DOI 10.1016/j.plaphy.2013.04.016; Lutts S, 1998, J PLANT PHYSIOL, V152, P92, DOI 10.1016/S0176-1617(98)80107-7; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; MUKHERJEE SP, 1983, PHYSIOL PLANTARUM, V58, P166, DOI 10.1111/j.1399-3054.1983.tb04162.x; Nino-Medina G, 2017, WASTE BIOMASS VALORI, V8, P1199, DOI 10.1007/s12649-016-9700-4; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; Peng YL, 2008, J INTEGR PLANT BIOL, V50, P29, DOI 10.1111/j.1744-7909.2007.00607.x; Phukan UJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00760; Qi DH, 2014, J TAIWAN INST CHEM E, V45, P504, DOI 10.1016/j.jtice.2013.06.021; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Rishi A, 2017, ANTIOXIDATIVE DEFENS; RoyChoudhury A, 2007, PLANT CELL REP, V26, P1839, DOI 10.1007/s00299-007-0371-2; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Schluttenhofer C, 2015, PLANT PHYSIOL, V167, P295, DOI 10.1104/pp.114.251769; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Shatters RG, 2008, SEED SCI RES, V4; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Suhas G.K., 2018, PLANT GENE, V13, P8, DOI [10.1016/j.plgene.2017.11.002, DOI 10.1016/J.PLGENE.2017.11.002]; Sulieman S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/687213; Wang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065120, 10.1371/journal.pone.0068807]; Wang F, 2012, MOL BIOL REP, V39, P4553, DOI 10.1007/s11033-011-1245-9; Wang FB, 2016, PLANT PHYSIOL BIOCH, V109, P248, DOI 10.1016/j.plaphy.2016.10.005; Wang YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166727; Wu GQ, 2013, ACTA PHYSIOL PLANT, V35, P2665, DOI 10.1007/s11738-013-1298-6; Xu XB, 2014, BIOLOGIA, V69, P994, DOI 10.2478/s11756-014-0398-0; Zhang LA, 2011, FEBS J, V278, P1367, DOI 10.1111/j.1742-4658.2011.08056.x; Zheng L, 2013, PLANT MOL BIOL, V82, P303, DOI 10.1007/s11103-013-0063-y; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zhu MK, 2014, J PLANT GROWTH REGUL, V33, P730, DOI 10.1007/s00344-014-9420-6	61	37	42	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192382	10.1371/journal.pone.0192382	http://dx.doi.org/10.1371/journal.pone.0192382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466387	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300055
J	von Born, P; Bernardo-Faura, M; Rubio-Somoza, I				von Born, Patrick; Bernardo-Faura, Marti; Rubio-Somoza, Ignacio			An artificial miRNA system reveals that relative contribution of translational inhibition to miRNA-mediated regulation depends on environmental and developmental factors in Arabidopsis thaliana	PLOS ONE			English	Article							MAMMALIAN MICRORNAS; AMBIENT-TEMPERATURE; ANTIVIRAL IMMUNITY; RNA INTERFERENCE; GENE-REGULATION; PLANT MIRNA; BIOGENESIS; PROTEIN; REPRESSION; HYL1	Development and fitness of any organism rely on properly controlled gene expression. This is especially true for plants, as their development is determined by both internal and external cues. MicroRNAs (miRNAs) are embedded in the genetic cascades that integrate and translate those cues into developmental programs. miRNAs negatively regulate their target genes mainly post-transcriptionally through two co-existing mechanisms; mRNA cleavage and translational inhibition. Despite our increasing knowledge about the genetic and biochemical processes involved in those concurrent mechanisms, little is known about their relative contributions to the overall miRNA-mediated regulation. Here we show that coexistence of cleavage and translational inhibition is dependent on growth temperature and developmental stage. We found that efficiency of an artificial miRNA-mediated (amiRNA) gene silencing declines with age during vegetative development in a temperature-dependent manner. That decline is mainly due to a reduction on the contribution from translational inhibition. Both, temperature and developmental stage were also found to affect mature amiRNA accumulation and the expression patterns of the core players involved in miRNA biogenesis and action. Therefore, that suggests that each miRNA family specifically regulates their respective targets, while temperature and growth might influence the performance of miRNA-dependent regulation in a more general way.	[von Born, Patrick; Rubio-Somoza, Ignacio] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Bernardo-Faura, Marti] Ctr Res Agr Genom, Barcelona, Spain; [Rubio-Somoza, Ignacio] Ctr Res Agr Genom, Mol Reprogramming & Evolut Lab, Barcelona, Spain; [Rubio-Somoza, Ignacio] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany	Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); Max Planck Society	Rubio-Somoza, I (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany.; Rubio-Somoza, I (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany.	ignacio.rubio@cragenomica.es	; Rubio Somoza, Ignacio/L-6139-2014	Bernardo-Faura, Marti/0000-0002-8023-3263; Rubio Somoza, Ignacio/0000-0003-0754-816X	Max Planck Society; DFG [SFB1101]; Spanish Ministry of Economy and Competitiveness [BFU2014-58361-JIN, RYC-2015-19154]; Severo Ochoa Programme for Centres of Excellence in RD [SEV-2015-0533]; CERCA programme from the Generalitat de Catalunya	Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG)); Spanish Ministry of Economy and Competitiveness(Spanish Government); Severo Ochoa Programme for Centres of Excellence in RD; CERCA programme from the Generalitat de Catalunya	Work at the Max Planck Institute in the Department of Molecular Biology was supported by the Max Planck Society and DFG SFB1101. I.R.-S. is supported by the Spanish Ministry of Economy and Competitiveness (BFU2014-58361-JIN, RYC-2015-19154) and through the "Severo Ochoa Programme for Centres of Excellence in R&D" 2016-2019 (SEV-2015-0533) and the CERCA programme from the Generalitat de Catalunya.	Achkar NP, 2016, TRENDS PLANT SCI, V21, P1034, DOI 10.1016/j.tplants.2016.09.003; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Box MS, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-7; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Capovilla G, 2015, J EXP BOT, V66, P59, DOI 10.1093/jxb/eru416; Cho SY, 2016, MOL CELLS, V39, P77, DOI 10.14348/molcells.2016.2350; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Eamens AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035933; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Field S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146534; Grant-Downton R, 2013, CURR BIOL, V23, pR599, DOI 10.1016/j.cub.2013.05.055; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Horman SR, 2013, MOL CELL, V50, P356, DOI 10.1016/j.molcel.2013.03.015; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Ji LZ, 2011, PURE APPL MATH Q, V7, P1, DOI 10.1371/journal.pgen.1001358; Jouannet V, 2012, EMBO J, V31, P1704, DOI 10.1038/emboj.2012.20; Karlsson P, 2015, P NATL ACAD SCI USA, V112, P14096, DOI 10.1073/pnas.1512865112; Kim W, 2016, J EXP BOT, V67, P4659, DOI 10.1093/jxb/erw248; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; Mallory AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000646; Manavella PA, 2012, CELL, V151, P859, DOI 10.1016/j.cell.2012.09.039; May P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3145; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pico S, 2015, PLANT PHYSIOL, V168, P1286, DOI 10.1104/pp.15.00073; Reis RS, 2015, TRENDS PLANT SCI, V20, P721, DOI 10.1016/j.tplants.2015.08.003; Reis RS, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.27, 10.1038/nplants.2014.27]; Rubio-Somoza I, 2014, CURR BIOL, V24, P2714, DOI 10.1016/j.cub.2014.09.058; Rubio-Somoza I, 2011, TRENDS PLANT SCI, V16, P258, DOI 10.1016/j.tplants.2011.03.001; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Szittya G, 2003, EMBO J, V22, P633, DOI 10.1093/emboj/cdg74; Szittya G, 2013, CURR TOP MICROBIOL, V371, P153, DOI 10.1007/978-3-642-37765-5_6; Tarver JE, 2015, NUCLEIC ACIDS RES, V43, P6384, DOI 10.1093/nar/gkv578; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xu ML, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006263; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x	48	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192984	10.1371/journal.pone.0192984	http://dx.doi.org/10.1371/journal.pone.0192984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451902	Green Published, Green Submitted, gold			2022-12-26	WOS:000425369800032
J	Wilson, JL; Samaranayake, VA; Limmer, MA; Burken, JG				Wilson, Jordan L.; Samaranayake, V. A.; Limmer, Matt A.; Burken, Joel G.			Phytoforensics: Trees as bioindicators of potential indoor exposure via vapor intrusion	PLOS ONE			English	Article							SOIL; PLUME; CONTAMINATION; VARIABILITY; GROUNDWATER; SORPTION; WOOD; PCE	Human exposure to volatile organic compounds (VOCs) via vapor intrusion (VI) is an emerging public health concern with notable detrimental impacts on public health. Phytoforensics, plant sampling to semi-quantitatively delineate subsurface contamination, provides a potential non-invasive screening approach to detect VI potential, and plant sampling is effective and also time-and cost-efficient. Existing VI assessment methods are time-and resource-intensive, invasive, and require access into residential and commercial buildings to drill holes through basement slabs to install sampling ports or require substantial equipment to install groundwater or soil vapor sampling outside the home. Tree-core samples collected in 2 days at the PCE Southeast Contamination Site in York, Nebraska were analyzed for tetrachloroethene (PCE) and results demonstrated positive correlations with groundwater, soil, soil-gas, sub-slab, and indoor-air samples collected over a 2-year period. Because tree-core samples were not collocated with other samples, interpolated surfaces of PCE concentrations were estimated so that comparisons could be made between pairs of data. Results indicate moderate to high correlation with average indoor-air and sub-slab PCE concentrations over long periods of time (months to years) to an interpolated tree-core PCE concentration surface, with Spearman's correlation coefficients (rho) ranging from 0.31 to 0.53 that are comparable to the pairwise correlation between sub-slab and indoor-air PCE concentrations (rho = 0.55, n = 89). Strong correlations between soil-gas, sub-slab, and indoor-air PCE concentrations and an interpolated tree-core PCE concentration surface indicate that trees are valid indicators of potential VI and human exposure to subsurface environment pollutants. The rapid and non-invasive nature of tree sampling are notable advantages: even with less than 60 trees in the vicinity of the source area, roughly 12 hours of tree-core sampling with minimal equipment at the PCE Southeast Contamination Site was sufficient to delineate vapor intrusion potential in the study area and offered comparable delineation to traditional sub-slab sampling performed at 140 properties over a period of approximately 2 years.	[Wilson, Jordan L.] US Geol Survey, Missouri Water Sci Ctr, Rolla, MO USA; [Wilson, Jordan L.; Burken, Joel G.] Missouri Univ Sci & Technol, Dept Civil Environm & Architectural Engn, Rolla, MO 65409 USA; [Samaranayake, V. A.] Missouri Univ Sci & Technol, Dept Math & Stat, Rolla, MO USA; [Limmer, Matt A.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA	United States Department of the Interior; United States Geological Survey; University of Missouri System; Missouri University of Science & Technology; University of Missouri System; Missouri University of Science & Technology; University of Delaware	Wilson, JL (corresponding author), US Geol Survey, Missouri Water Sci Ctr, Rolla, MO USA.; Wilson, JL (corresponding author), Missouri Univ Sci & Technol, Dept Civil Environm & Architectural Engn, Rolla, MO 65409 USA.	jlwilson@usgs.gov	Limmer, Matt A./J-1313-2019	Limmer, Matt A./0000-0001-8119-0229; Wilson, Jordan/0000-0003-0490-9062	USGS; National Science Foundation [1336877]	USGS(United States Geological Survey); National Science Foundation(National Science Foundation (NSF))	This work was funded by the USGS. This material is based upon work supported by the National Science Foundation under grant no. #1336877.	Algreen M, 2015, GROUND WATER MONIT R, V35, P57, DOI 10.1111/gwmr.12133; Algreen M, 2015, ENVIRON SCI POLLUT R, V22, P14673, DOI 10.1007/s11356-015-4649-6; Bennett DH, 2002, ENVIRON SCI TECHNOL, V36, p206A, DOI 10.1021/es0222770; BRIGGS GG, 1982, PESTIC SCI, V13, P495, DOI 10.1002/ps.2780130506; Burken JG, 1998, ENVIRON SCI TECHNOL, V32, P3379, DOI 10.1021/es9706817; DOBSON MC, 1995, WASTE MANAGE RES, V13, P579, DOI 10.1177/0734242X9501300607; Duncan CM, 2018, SCI TOTAL ENVIRON, V616, P875, DOI 10.1016/j.scitotenv.2017.10.235; FIELLER EC, 1957, BIOMETRIKA, V44, P470, DOI 10.2307/2332878; Fitzgerald J, 2009, GROUND WATER MONIT R, V29, P51, DOI 10.1111/j.1745-6592.2008.01213.x; JOHNSON PC, 1991, ENVIRON SCI TECHNOL, V25, P1445, DOI 10.1021/es00020a013; Larsen M, 2008, ENVIRON SCI TECHNOL, V42, P1711, DOI 10.1021/es0717055; Limmer MA, 2015, INT J PHYTOREMEDIAT, V17, P1115, DOI 10.1080/15226514.2015.1045127; Limmer MA, 2014, ENVIRON SCI TECHNOL, V48, P10634, DOI 10.1021/es502680p; Limmer MA, 2011, ENVIRON SCI TECHNOL, V45, P8276, DOI 10.1021/es201704v; Luo H, 2009, GROUND WATER MONIT R, V29, P81, DOI 10.1111/j.1745-6592.2008.01217.x; Ma XM, 2004, ENVIRON SCI TECHNOL, V38, P4580, DOI 10.1021/es035435b; Mackay AA, 2000, ENVIRON SCI TECHNOL, V34, P839, DOI 10.1021/es9900858; McAlary T., 2009, REV BEST PRACTICES K; Schumacher JG, 2004, US GEOLOGICAL SURVEY; Sibson R., 1981, BRIEF DESCRIPTION NA, P21, DOI DOI 10.1002/ADVS.201700552; Sorek A, 2008, ENVIRON SCI TECHNOL, V42, P536, DOI 10.1021/es072014b; Struckhoff GC, 2005, ENVIRON SCI TECHNOL, V39, P1563, DOI 10.1021/es049411w; Trapp S, 2001, ENVIRON SCI TECHNOL, V35, P1561, DOI 10.1021/es000204f; USEPA, 2015, OFF SOL WAST EM RESP, P267; Vroblesky D.A., 2008, USERS GUIDE COLLECTI; Wahyudi A, 2012, ENVIRON POLLUT, V162, P120, DOI 10.1016/j.envpol.2011.11.010; Watson D. F., 2013, CONTOURING GUIDE ANA; Wilson JL, 2017, ENVIRON SCI TECHNOL, V51, P14055, DOI 10.1021/acs.est.7b03466; Wilson JL, 2017, ENVIRON SCI TECHNOL, V51, P10369, DOI 10.1021/acs.est.7b02667	29	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0193247	10.1371/journal.pone.0193247	http://dx.doi.org/10.1371/journal.pone.0193247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451904	Green Published, gold, Green Submitted			2022-12-26	WOS:000425369800043
J	Jia, WW; Wu, WJ; Yang, D; Xiao, CX; Su, ZH; Huang, Z; Li, ZZ; Qin, M; Huang, MW; Liu, SY; Long, F; Mao, JC; Liu, XH; Zhu, YZ				Jia, Wanwan; Wu, Weijun; Yang, Di; Xiao, Chenxi; Su, Zhenghua; Huang, Zheng; Li, Zhongzheng; Qin, Ming; Huang, Mengwei; Liu, Siyu; Long, Fen; Mao, Jianchun; Liu, Xinhua; Zhu, Yi Zhun			Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis	FASEB JOURNAL			English	Article						platelet-derived growth factor; epigenetic alteration; proliferating cell nuclear antigen; GSK J4	CELL NUCLEAR ANTIGEN; NF-KAPPA-B; GROWTH-FACTOR; SYNOVIAL FIBROBLASTS; H3K27 DEMETHYLASE; INHIBITION; INFLAMMATION; EPIGENETICS; GENE; PCNA	Rheumatoid arthritis (RA) is an immune-mediated disease with the characteristics of progressive joint destruction, deformity, and disability. Epigenetic changes have been implicated in the development of some autoimmune disorders, resulting in an alteration of gene transcription. Here, we investigated how Jumonji C family of histone demethylases (JMJD3) regulated the proliferation and activation of fibroblast-like synoviocytes (FLSs), which are involved in RA joint destruction and pathologic process. The JMJD3 expression and proliferation markers in RA-FLS were higher than those in healthy-FLS and were upregulated in platelet-derived growth factor (PDGF)-induced FLS. Elevated JMJD3 promoted the proliferation and migration of FLS. Treatment with JMJD3 small interfering RNA or inhibitor glycogen synthase kinase (GSK) J4 led to decreased proliferation and migration of FLS. Interestingly, induction of proliferating cell nuclear antigen (PCNA), a major player of the cell-cycle regulation, was correlated with trimethylated lysine 27 in histone H3 loss around the gene promoters. The knockdown of JMJD3 abolished PCNA expression in PDGF-induced FLS and further inhibited cell proliferation and migration, suggesting that JMJD3/PCNA played a crucial role in aspects of FLS proliferation and migration. In vivo, the ability of GSK J4 to hinder collagen-induced arthritis (CIA) in DBA/1 mice was evaluated. We found that GSK J4 markedly attenuated the severity of arthritis in CIA mice. The therapeutic effects were associated with ameliorated joint swelling and reduced bone erosion and destruction. This study revealed how JMJD3 integrated with epigenetic processes to regulate RA-FLS proliferation and invasion. These data suggested that JMJD3 might contribute to rheumatoid synovial hyperplasia and have the potential as a novel therapeutic target for RA.Jia, W., Wu, W., Yang, D., Xiao, C., Su, Z., Huang, Z., Li, Z., Qin, M., Huang, M., Liu, S., Long, F., Mao, J., Liu, X., Zhu, Y. Z. Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis.	[Jia, Wanwan; Wu, Weijun; Yang, Di; Xiao, Chenxi; Su, Zhenghua; Qin, Ming; Huang, Mengwei; Liu, Siyu; Long, Fen; Liu, Xinhua; Zhu, Yi Zhun] Fudan Univ, Shanghai Key Lab Bioact Small Mol, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China; [Jia, Wanwan; Zhu, Yi Zhun] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Jia, Wanwan; Zhu, Yi Zhun] Macau Univ Sci & Technol, Sch Pharm, Macau, Peoples R China; [Huang, Zheng] Shanghai Univ Tradit Chinese Med, Guanghua Integrat Med Hosp, Shanghai Acad Chinese Med Sci, Inst Arthrit Res, Shanghai, Peoples R China; [Li, Zhongzheng] Ninth Hosp, Ningbo, Zhejiang, Peoples R China; [Mao, Jianchun] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Rheumatol, Shanghai, Peoples R China	Fudan University; Macau University of Science & Technology; Macau University of Science & Technology; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Zhu, YZ (corresponding author), Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China.; Zhu, YZ (corresponding author), Macau Univ Sci & Technol, Sch Pharm, Macau, Peoples R China.; Liu, XH (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, 826 Zhangheng Rd, Shanghai, Peoples R China.	liuxinhua@fudan.edu.cn; yzzhu@must.edu.mo	Zhu, Yi Zhun/ABG-8449-2021; Liu, Siyu/GYV-4856-2022	Zhu, Yi Zhun/0000-0001-7700-8041; 	National Natural Science Foundation of China [81673428, 81330080]; Key Laboratory Program of the Education Commission of Shanghai Municipality [ZDSYS14005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory Program of the Education Commission of Shanghai Municipality	This work was supported by grants from the National Natural Science Foundation of China (81673428; 81330080) and a Key Laboratory Program of the Education Commission of Shanghai Municipality (ZDSYS14005). The authors declare no conflicts of interest.	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bottini N, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0372-9; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Cheon H, 2004, SCAND J IMMUNOL, V60, P455, DOI 10.1111/j.0300-9475.2004.01505.x; Cheon H, 2002, CLIN EXP IMMUNOL, V127, P547, DOI 10.1046/j.1365-2249.2002.01785.x; Das ND, 2012, CELL BIOCHEM FUNCT, V30, P224, DOI 10.1002/cbf.1839; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; Greer JM, 2012, BIOL-TARGETS THER, V6, P307, DOI 10.2147/BTT.S24067; Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Juengel A, 2010, CURR OPIN RHEUMATOL, V22, P284, DOI 10.1097/BOR.0b013e3283389641; Keith MP, 2012, CLIN PHARMACOL THER, V92, P440, DOI 10.1038/clpt.2012.124; Koch MW, 2013, NAT REV NEUROL, V9, P35, DOI 10.1038/nrneurol.2012.226; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; LAFYATIS R, 1989, J CLIN INVEST, V83, P1267, DOI 10.1172/JCI114011; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee HY, 2014, MOL CELLS, V37, P43, DOI 10.14348/molcells.2014.2250; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mor A, 2005, CLIN IMMUNOL, V115, P118, DOI 10.1016/j.clim.2004.12.009; Morozov VM, 2017, ONCOTARGET, V8, P62131, DOI 10.18632/oncotarget.19100; Neidhart M, 2000, ARTHRITIS RHEUM, V43, P1719, DOI 10.1002/1529-0131(200008)43:8<1719::AID-ANR7>3.0.CO;2-4; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Pap T, 2005, ANN RHEUM DIS, V64, P52, DOI 10.1136/ard.2005.042424; Park WY, 2016, CANCER RES, V76, P161, DOI 10.1158/0008-5472.CAN-15-0536; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; REMMERS EF, 1991, SEMIN ARTHRITIS RHEU, V21, P191, DOI 10.1016/0049-0172(91)90009-O; SANO H, 1990, J CELL BIOL, V110, P1417, DOI 10.1083/jcb.110.4.1417; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shan JX, 2012, J BIOL CHEM, V287, P36393, DOI 10.1074/jbc.M112.399600; Strietholt S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2500; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; THORNTON SC, 1991, CLIN EXP IMMUNOL, V86, P79; Trenkmann M, 2010, CLIN REV ALLERG IMMU, V39, P10, DOI 10.1007/s12016-009-8166-6; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83	42	31	32	3	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					4031	4042		10.1096/fj.201701483R	http://dx.doi.org/10.1096/fj.201701483R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29481307				2022-12-26	WOS:000435104500046
J	Di Costanzo, A; Del Gaudio, N; Conte, L; Dell'Aversana, C; Vermeulen, M; de The, H; Migliaccio, A; Nebbioso, A; Altucci, L				Di Costanzo, Antonella; Del Gaudio, Nunzio; Conte, Lidio; Dell'Aversana, Carmela; Vermeulen, Michiel; de The, Hugues; Migliaccio, Antimo; Nebbioso, Angela; Altucci, Lucia			The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia	ONCOGENE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; POLYCOMB GROUP PROTEINS; HISTONE H3; SUMOYLATION; CANCER; CHROMODOMAIN; REPRESSION; TARGET; CELLS; TUMORIGENESIS	Polycomb group (PcG) proteins regulate transcription, playing a key role in stemness and differentiation. Deregulation of PcG members is known to be involved in cancer pathogenesis. Emerging evidence suggests that CBX2, a member of the PcG protein family, is overexpressed in several human tumors, correlating with lower overall survival. Unraveling the mechanisms regulating CBX2 expression may thus provide a promising new target for anticancer strategies. Here we show that the HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia. We identify CBX4 and RNF4 as the E3 SUMO and E3 ubiquitin ligase, respectively, and describe the specific molecular mechanism regulating CBX2 protein stability. Finally, we show that CBX2-depleted leukemic cells display impaired proliferation, underscoring its critical role in regulating leukemia cell tumorogenicity. Our results show that SAHA affects CBX2 stability, revealing a potential SAHA-mediated anti-leukemic activity though SUMO2/3 pathway.	[Di Costanzo, Antonella; Del Gaudio, Nunzio; Conte, Lidio; Dell'Aversana, Carmela; Migliaccio, Antimo; Nebbioso, Angela; Altucci, Lucia] Univ Campania Luigi Vanvitelli, Dept Biochem Biophys & Gen Pathol, Vico L De Crecchio 7, I-80138 Naples, Italy; [Vermeulen, Michiel] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [de The, Hugues] Hop St Louis, Inst Univ Hematol, INSERM Unite Mixte Rech 944, Equipe Labellisee Ligue Natl Canc, Paris 10, France	Universita della Campania Vanvitelli; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Di Costanzo, A; Altucci, L (corresponding author), Univ Campania Luigi Vanvitelli, Dept Biochem Biophys & Gen Pathol, Vico L De Crecchio 7, I-80138 Naples, Italy.	antonella.dicostanzo@unina.it; lucia.altucci@unicampania.it	NEBBIOSO, ANGELA/GVS-1294-2022; Dell'Aversana, Carmela/P-7829-2018; Vermeulen, Michiel/C-8883-2013; Altucci, Lucia/S-8031-2019; Migliaccio, Antimo/AAB-3376-2019	Dell'Aversana, Carmela/0000-0001-6588-698X; Vermeulen, Michiel/0000-0003-0836-6894; Migliaccio, Antimo/0000-0002-4197-2055; Conte, Lidio/0000-0002-9520-1344; altucci, lucia/0000-0002-7312-5387; Del Gaudio, Nunzio/0000-0003-3691-443X	Blueprint [282510]; EPIGEN (MIUR-CNR); MIUR [PRIN2012ZHN9YH, 20152TE5PK]; AIRC [17217]; COST EPICHEMBIO [CM1406]	Blueprint; EPIGEN (MIUR-CNR)(Consiglio Nazionale delle Ricerche (CNR)); MIUR(Ministry of Education, Universities and Research (MIUR)); AIRC(Fondazione AIRC per la ricerca sul cancro); COST EPICHEMBIO(European Cooperation in Science and Technology (COST))	Blueprint (282510), EPIGEN (MIUR-CNR); MIUR (PRIN2012ZHN9YH; 20152TE5PK), AIRC (17217); COST EPICHEMBIO CM1406.	Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Clermont PL, 2014, BRIT J CANCER, V111, P1663, DOI 10.1038/bjc.2014.474; Clermont PL, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0182-9; Dell'Aversana C, 2017, LEUKEMIA, V31, P2315, DOI 10.1038/leu.2017.64; Di Costanzo A, 2011, J CELL PHYSIOL, V226, P2189, DOI 10.1002/jcp.22553; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eifler K, 2015, TRENDS BIOCHEM SCI, V40, P779, DOI 10.1016/j.tibs.2015.09.006; Enserink JM, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0010-1; Forzati F, 2012, J CLIN INVEST, V122, P612, DOI 10.1172/JCI58620; Frank CL, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0065-5; Fujikawa D, 2016, BLOOD, V127, P1790, DOI 10.1182/blood-2015-08-662593; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hatano A, 2010, BIOCHEM BIOPH RES CO, V397, P93, DOI 10.1016/j.bbrc.2010.05.074; Ismail IH, 2012, NUCLEIC ACIDS RES, V40, P5497, DOI 10.1093/nar/gks222; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lee SH, 2013, CANCER LETT, V335, P397, DOI 10.1016/j.canlet.2013.02.051; Li B, 2007, BIOCHEM J, V405, P369, DOI 10.1042/BJ20061873; Li J, 2014, CANCER CELL, V25, P118, DOI 10.1016/j.ccr.2013.12.008; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Neff T, 2012, P NATL ACAD SCI USA, V109, P5028, DOI 10.1073/pnas.1202258109; Niessen HEC, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-10; Portanova P, 2008, INT J ONCOL, V33, P325, DOI 10.3892/ijo_00000012; Ren CY, 2015, CHEM BIOL, V22, P161, DOI 10.1016/j.chembiol.2014.11.021; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Simhadri C, 2014, J MED CHEM, V57, P2874, DOI 10.1021/jm401487x; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Stielow C, 2014, NUCLEIC ACIDS RES, V42, P3044, DOI 10.1093/nar/gkt1317; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van den Boom V, 2016, CELL REP, V14, P332, DOI 10.1016/j.celrep.2015.12.034; van den Boom V, 2013, BLOOD, V121, P2452, DOI 10.1182/blood-2012-08-451666; Wang W, 2015, MED RES REV, V35, P1220, DOI 10.1002/med.21358; Wu Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep09520; Zhang L, 2017, CELL DEATH DIFFER, V24, P1530, DOI 10.1038/cdd.2017.29; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	47	21	22	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	19					2559	2572		10.1038/s41388-018-0143-1	http://dx.doi.org/10.1038/s41388-018-0143-1			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GF3RN	29467492	Green Published, hybrid			2022-12-26	WOS:000431873400008
J	Wang, YC; Chuang, YH; Shao, Q; Chen, JF; Chen, SY				Wang, Yung-Chun; Chuang, Ya-Hui; Shao, Qiang; Chen, Jian-Fu; Chen, Shi-You			Brain cytoplasmic RNA 1 suppresses smooth muscle differentiation and vascular development in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG NONCODING RNA; DENDRITIC BC1 RNA; GROWTH-FACTOR; BC200 RNA; CELL DIFFERENTIATION; TGF-BETA; TRANSLATIONAL CONTROL; GENE; SMAD; PROTEINS	The cardiovascular system develops during the early stages of embryogenesis, and differentiation of smooth muscle cells (SMCs) is essential for that process. SMC differentiation is critically regulated by transforming growth factor (TGF)-beta/SMAD family member 3 (SMAD3) signaling, but other regulators may also play a role. For example, long noncoding RNAs (lncRNAs) regulate various cellular activities and events, such as proliferation, differentiation, and apoptosis. However, whether long noncoding RNAs also regulate SMC differentiation remains largely unknown. Here, using the murine cell line C3H10T1/2, we found that brain cytoplasmic RNA 1 (BC1) is an important regulator of SMC differentiation. BC1 overexpression suppressed, whereas BC1 knockdown promoted, TGF-beta-induced SMC differentiation, as indicated by altered cell morphology and expression of multiple SMC markers, including smooth muscle alpha-actin (alpha SMA), calponin, and smooth muscle 22 alpha (SM22 alpha). BC1 appeared to block SMAD3 activity and inhibit SMC marker gene transcription. Mechanistically, BC1 bound to SMAD3 via RNA SMAD-binding elements (rSBEs) and thus impeded TGF-beta-induced SMAD3 translocation to the nucleus. This prevented SMAD3 from binding to SBEs in SMC marker gene promoters, an essential event in SMC marker transcription. In vivo, BC1 overexpression in mouse embryos impaired vascular SMC differentiation, leading to structural defects in the artery wall, such as random breaks in the elastic lamina, abnormal collagen deposition on SM fibers, and disorganized extracellular matrix proteins in the media of the neonatal aorta. Our results suggest that BC1 is a suppressor of SMC differentiation during vascular development.	[Wang, Yung-Chun; Chuang, Ya-Hui; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA; [Chen, Shi-You] Hubei Univ Med, Renmin Hosp, Inst Clin Med, Shiyan 442000, Hubei, Peoples R China; [Chen, Shi-You] Hubei Univ Med, Renmin Hosp, Dept Cardiol, Shiyan 442000, Hubei, Peoples R China; [Shao, Qiang; Chen, Jian-Fu] Univ Southern Calif, Ostrow Sch Dent, Los Angeles, CA 90089 USA	University System of Georgia; University of Georgia; Hubei University of Medicine; Hubei University of Medicine; University of Southern California	Chen, SY (corresponding author), Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu	Shao, Eric Qiang/I-1359-2019	Shao, Eric Qiang/0000-0001-5307-8264; Wang, Yung-Chun/0000-0002-8775-3472	NHLBI, National Institutes of Health [HL119053, HL123302, HL135854]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119053, R01HL123302, R01HL135854] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grants HL119053, HL123302, and HL135854. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bell RD, 2014, ARTERIOSCL THROM VAS, V34, P1249, DOI 10.1161/ATVBAHA.114.303240; Brouillard P, 2003, CLIN GENET, V63, P340, DOI 10.1034/j.1399-0004.2003.00092.x; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Chen W, 1997, J PATHOL, V183, P345, DOI 10.1002/(SICI)1096-9896(199711)183:3<345::AID-PATH930>3.0.CO;2-8; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Eckersley-Maslin MA, 2014, DEV CELL, V28, P351, DOI 10.1016/j.devcel.2014.01.017; Eichmann A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006551; Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589; Gitai DLG, 2011, BRAIN RES, V1367, P114, DOI 10.1016/j.brainres.2010.10.069; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Guo Xia, 2012, World J Biol Chem, V3, P41, DOI 10.4331/wjbc.v3.i3.41; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Jakob P, 2012, CARDIOVASC RES, V93, P614, DOI 10.1093/cvr/cvr311; Jiao J, 2016, EBIOMEDICINE, V10, P282, DOI 10.1016/j.ebiom.2016.06.045; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Lewejohann L, 2004, BEHAV BRAIN RES, V154, P273, DOI 10.1016/j.bbr.2004.02.015; Li HX, 2010, J BIOL CHEM, V285, P17846, DOI 10.1074/jbc.M109.076992; Lin D, 2008, MOL CELL BIOL, V28, P3008, DOI 10.1128/MCB.01800-07; Liu D, 2007, BLOOD, V110, P1502, DOI 10.1182/blood-2006-11-058594; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; MARTIGNETTI JA, 1995, MOL CELL BIOL, V15, P1642; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; Mitchell M, 2000, GENE THER, V7, P1986, DOI 10.1038/sj.gt.3301332; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Muratoglu SC, 2013, ARTERIOSCL THROM VAS, V33, P2137, DOI 10.1161/ATVBAHA.113.301893; Mus E, 2007, P NATL ACAD SCI USA, V104, P10679, DOI 10.1073/pnas.0701532104; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Richards EJ, 2015, J BIOL CHEM, V290, P6857, DOI 10.1074/jbc.M114.610915; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; Singh R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.168; Skryabin BV, 2003, MOL CELL BIOL, V23, P6435, DOI 10.1128/MCB.23.18.6435-6441.2003; Song ZF, 2010, J CARDIOVASC TRANSL, V3, P246, DOI 10.1007/s12265-010-9163-0; Sosinska P, 2015, MUTAT RES-REV MUTAT, V766, P58, DOI 10.1016/j.mrrev.2015.08.002; Souchelnytskyi S, 2000, METH MOL B, V124, P107; Tang R, 2017, J BIOL CHEM, V292, P14270, DOI 10.1074/jbc.M117.790030; Taniue K, 2016, P NATL ACAD SCI USA, V113, P1273, DOI 10.1073/pnas.1500992113; Wang HD, 2005, J CELL BIOL, V171, P811, DOI 10.1083/jcb.200506006; Wang HD, 2002, J NEUROSCI, V22, P10232; Wang Q, 2012, IERI PROC, V3, P2, DOI 10.1016/j.ieri.2012.09.002; Xie CQ, 2011, ARTERIOSCL THROM VAS, V31, P1485, DOI 10.1161/ATVBAHA.110.221101; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhao JJ, 2016, ARTERIOSCL THROM VAS, V36, P2088, DOI 10.1161/ATVBAHA.116.307879	52	7	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5668	5678		10.1074/jbc.RA117.001578	http://dx.doi.org/10.1074/jbc.RA117.001578			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29467228	hybrid, Green Published			2022-12-26	WOS:000430044100027
J	Reyes-Valdes, MH; Burgueno, J; Singh, S; Martinez, O; Sansaloni, CP				Humberto Reyes-Valdes, M.; Burgueno, Juan; Singh, Sukhwinder; Martinez, Octavio; Paola Sansaloni, Carolina			An informational view of accession rarity and allele specificity in germplasm banks for management and conservation	PLOS ONE			English	Article							ALGORITHM; DIVERSITY	Germplasm banks are growing in their importance, number of accessions and amount of characterization data, with a large emphasis on molecular genetic markers. In this work, we offer an integrated view of accessions and marker data in an information theory framework. The basis of this development is the mutual information between accessions and allele frequencies for molecular marker loci, which can be decomposed in allele specificities, as well as in rarity and divergence of accessions. In this way, formulas are provided to calculate the specificity of the different marker alleles with reference to their distribution across accessions, accession rarity, defined as the weighted average of the specificity of its alleles, and divergence, defined by the Kullback-Leibler formula. Albeit being different measures, it is demonstrated that average rarity and divergence are equal for any collection. These parameters can contribute to the knowledge of the structure of a germplasm collection and to make decisions about the preservation of rare variants. The concepts herein developed served as the basis for a strategy for core subset selection called HCore, implemented in a publicly available R script. As a proof of concept, the mathematical view and tools developed in this research were applied to a large collection of Mexican wheat accessions, widely characterized by SNP markers. The most specific alleles were found to be private of a single accession, and the distribution of this parameter had its highest frequencies at low levels of specificity. Accession rarity and divergence had largely symmetrical distributions, and had a positive, albeit non-strictly linear relationship. Comparison of the HCore approach for core subset selection, with three state-of-the-art methods, showed it to be superior for average divergence and rarity, mean genetic distance and diversity. The proposed approach can be used for knowledge extraction and decision making in germplasm collections of diploid, inbred or outbred species.	[Humberto Reyes-Valdes, M.] Univ Autonoma Agr Antonio Narro, Dept Plant Breeding, Saltillo, Coahuila, Mexico; [Burgueno, Juan; Singh, Sukhwinder; Paola Sansaloni, Carolina] Int Maize & Wheat Improvement Ctr CIMMYT, Mexico City, DF, Mexico; [Martinez, Octavio] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Guanajuato, Mexico	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Reyes-Valdes, MH (corresponding author), Univ Autonoma Agr Antonio Narro, Dept Plant Breeding, Saltillo, Coahuila, Mexico.	mathgenome@gmail.com	Martinez, Octavio/F-3951-2014	Martinez, Octavio/0000-0002-7590-0041	MasAgro Biodiversidad [2016/003]	MasAgro Biodiversidad	This research was funded by MasAgro Biodiversidad (http://masagro.mx/index.php/es/componentes/masagro-biodiversidad) to MHRV, under the agreement MAB 2016/003. Additionally, MasAgro Biodiversidad provided data and technical support. Universidad Autonoma Agraria Antonio Narro (http://www.uaaan.mx/v3index.php) provided the salary for MHRV.	Ash R.B., 1965, INFORM THEORY; Baldi P, 2010, NEURAL NETWORKS, V23, P649, DOI 10.1016/j.neunet.2009.12.007; Brown A. H. D., 1991, Genetics and conservation of rare plants.., P99; Brown AHD, 2001, CORE COLLECTIONS PLA, P3; Cormen T., 2009, INTRO ALGORITHMS; De Beukelaer H, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-312; Franco J, 2005, CROP SCI, V45, P1035, DOI 10.2135/cropsci2004.0292; Frankel OH, 1984, GENETIC MANIPULATION, ppp161; GOODMAN MM, 1983, MAYDICA, V28, P169; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; Hartl D., 1989, PRINCIPLES POPULATIO; Hayano-Kanashiro C, 2017, ECOL EVOL, V7, P1680, DOI 10.1002/ece3.2754; Reyes-Valdes MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079936; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Martinez O, 2008, P NATL ACAD SCI USA, V105, P9709, DOI 10.1073/pnas.0803479105; Martinez O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010398; McCouch SR, 2012, AM J BOT, V99, P407, DOI 10.3732/ajb.1100385; Mobaied S, 2015, DATA BRIEF, V3, P165, DOI 10.1016/j.dib.2015.02.015; Pacheco A., 2016, BIO R BIODIVERSITY A; Papapanagiotou Matina, 2017, JCO Precis Oncol, V1, P1, DOI 10.1200/PO.16.00070; Pellegrini PA, 2016, BIODIVERS CONSERV, V25, P2753, DOI 10.1007/s10531-016-1201-z; R Development Core Team, 2017, R LANG ENV STAT COMP; Reyes-Valdes MH, 2005, GENET RES, V85, P81, DOI 10.1017/S0016672305007354; Reyes-Valdes MH, 2012, METHOD MOL BIOL, V1006, P259; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Singh S, 2014, DARTSEQ DERIVED SNPS; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Thachuk C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-243; Vikram P, 2016, SCI REP-UK, V6, DOI 10.1038/srep26216	29	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193346	10.1371/journal.pone.0193346	http://dx.doi.org/10.1371/journal.pone.0193346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489873	Green Submitted, Green Published, gold			2022-12-26	WOS:000426276000066
J	Tiwari, V; Kedia, S; Garg, SK; Rampal, R; Mouli, VP; Purwar, A; Mitra, DK; Das, P; Dattagupta, S; Makharia, G; Acharya, SK; Ahuja, V				Tiwari, Veena; Kedia, Saurabh; Garg, Sushil Kumar; Rampal, Ritika; Mouli, V. Pratap; Purwar, Anuja; Mitra, D. K.; Das, Prasenjit; Dattagupta, S.; Makharia, Govind; Acharya, S. K.; Ahuja, Vineet			CD4(+) CD25(+) FOXP3(+) T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn's disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; EXPRESSION; SITE	Background Distinguishing between Crohn's Disease (CD) and Intestinal Tuberculosis (ITB) has been a challenging task for clinicians due to their similar presentation. CD4(+)FOXP3(+) T regulatory cells (Tregs) have been reported to be increased in patients with pulmonary tuberculosis. However, there is no such data available in ITB. The aim of this study was to investigate the differential expression of FOXP3(+) T cells in patients with ITB and CD and its utility as a biomarker. Methods The study prospectively recruited 124 patients with CD, ITB and controls: ulcerative colitis (UC) and patients with only haemorrhoidal bleed. Frequency of CD4(+)CD25(+)FOXP3(+) Tregs in peripheral blood (flow cytometry), FOXP3 mRNA expression in blood and colonic mucosa (qPCR) and FOXP3(+) T cells in colonic mucosa (immunohistochemistry) were compared between controls, CD and ITB patients. Results Frequency of CD4(+)CD25(+)FOXP3(+) Treg cells in peripheral blood was significantly increased in ITB as compared to CD. Similarly, significant increase in FOXP3(+) T cells and FOXP3 mRNA expression was observed in colonic mucosa of ITB as compared to CD. ROC curve showed that a value of >32.5% for FOXP3(+) cells in peripheral blood could differentiate between CD and ITB with a sensitivity of 75% and a specificity of 90.6%. Conclusion Phenotypic enumeration of peripheral CD4(+)CD25(+)FOXP3(+) Treg cells can be used as a non-invasive biomarker in clinics with a high diagnostic accuracy to differentiate between ITB and CD in regions where TB is endemic.	[Tiwari, Veena; Kedia, Saurabh; Garg, Sushil Kumar; Rampal, Ritika; Mouli, V. Pratap; Purwar, Anuja; Makharia, Govind; Acharya, S. K.; Ahuja, Vineet] All India Inst Med Sci, Dept Gastroenterol & Human Nutr, New Delhi, India; [Mitra, D. K.] All India Inst Med Sci, Dept HLA & Transplant Immunol, New Delhi, India; [Das, Prasenjit; Dattagupta, S.] All India Inst Med Sci, Dept Pathol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Ahuja, V (corresponding author), All India Inst Med Sci, Dept Gastroenterol & Human Nutr, New Delhi, India.	vineet.aiims@gmail.com	Ahuja, Vineet/N-1705-2019; Kedia, Saurabh/AAD-7227-2020	Ahuja, Vineet/0000-0002-5474-9709; 	Indian council of Medical Research (ICMR)	Indian council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	The study has been funded by Indian council of Medical Research (ICMR) to VA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja V, 2016, GASTROENTEROL REP, V4, P59, DOI 10.1093/gastro/gov015; Ahuja V, 2012, INDIAN J GASTROENTER, V31, P294, DOI 10.1007/s12664-012-0272-3; Ahuja V, 2010, J DIGEST DIS, V11, P134, DOI 10.1111/j.1751-2980.2010.00429.x; Ban H, 2008, MOL MED REP, V1, P647, DOI 10.3892/mmr_00000006; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Dalziel TK, 1913, BRIT MED J, V1913, P1068; Das K, 2009, DIGEST DIS SCI, V54, P1099, DOI 10.1007/s10620-008-0469-6; Diaz A, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/985302; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Feruglio SL, 2015, CLIN EXP IMMUNOL, V179, P454, DOI 10.1111/cei.12468; He XY, 2010, EUR J CLIN MICROBIOL, V29, P643, DOI 10.1007/s10096-010-0908-0; Holmen N, 2006, INFLAMM BOWEL DIS, V12, P447, DOI 10.1097/00054725-200606000-00003; Kedia S, 2015, INDIAN J GASTROENTER, V34, P135, DOI 10.1007/s12664-015-0550-y; LOGAN VSC, 1969, P ROY SOC MED, V62, P1227, DOI 10.1177/003591576906201214; Makharia GK, 2010, AM J GASTROENTEROL, V105, P642, DOI 10.1038/ajg.2009.585; Makita S, 2007, J IMMUNOL, V178, P4937, DOI 10.4049/jimmunol.178.8.4937; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Mouli VP, 2017, ALIMENT PHARM THER, V45, P27, DOI 10.1111/apt.13840; Paustian FF, 1964, GASTROEN TEROLOGY, V11, P311; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Saruta M, 2007, CLIN IMMUNOL, V125, P281, DOI 10.1016/j.clim.2007.08.003; Sharma MP, 2009, TUBERCULOSIS COMPREH, P424; Sharma PK, 2009, AM J RESP CRIT CARE, V179, P1061, DOI 10.1164/rccm.200804-529OC; Singh B, 2015, INDIAN J GASTROENTER, V34, P43, DOI 10.1007/s12664-015-0538-7; Stange EF, 2008, J CROHNS COLITIS, V2, P1, DOI 10.1016/j.crohns.2007.11.001; Tandon R, 2013, INFLAMM BOWEL DIS, P41; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; Ueno A, 2013, INFLAMM BOWEL DIS, V19, P2522, DOI 10.1097/MIB.0b013e3182a85709; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Wang Y, 2011, J DIGEST DIS, V12, P286, DOI 10.1111/j.1751-2980.2011.00505.x; Xiao Li Feng, 2002, Curr Gastroenterol Rep, V4, P490, DOI 10.1007/s11894-002-0025-z; Yu QT, 2007, INFLAMM BOWEL DIS, V13, P191, DOI 10.1002/ibd.20053	33	16	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193433	10.1371/journal.pone.0193433	http://dx.doi.org/10.1371/journal.pone.0193433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489879	Green Submitted, Green Published, gold			2022-12-26	WOS:000426276000076
J	Arreguin-Rodriguez, GJ; Thomas, E; D'haenens, S; Speijer, RP; Alegret, L				Arreguin-Rodriguez, Gabriela J.; Thomas, Ellen; D'haenens, Simon; Speijer, Robert P.; Alegret, Laia			Early Eocene deep-sea benthic foraminiferal faunas: Recovery from the Paleocene Eocene Thermal Maximum extinction in a greenhouse world	PLOS ONE			English	Article							CLIMATIC OPTIMUM MECO; CRETACEOUS/PALEOGENE BOUNDARY; MIDDLE EOCENE; HYPERTHERMAL EVENTS; MASS EXTINCTION; PACIFIC-OCEAN; CARBON-CYCLE; ATLANTIC; PRODUCTIVITY; SECTION	The early Eocene greenhouse world was marked by multiple transient hyperthermal events. The most extreme was the Paleocene-Eocene Thermal Maximum (PETM, similar to 56 Ma), linked to the extinction of the globally recognised deep-sea benthic foraminiferal Velasco fauna, which led to the development of early Eocene assemblages. This turnover has been studied at high resolution, but faunal development into the later early Eocene is poorly documented. There is no widely accepted early Eocene equivalent of the Late Cretaceous-Paleocene Velasco fauna, mainly due to the use of different taxonomic concepts. We compiled Ypresian benthic foraminiferal data from 17 middle bathyal-lower abyssal ocean drilling sites in the Pacific, Atlantic and Indian Oceans, in order to characterise early Eocene deep-sea faunas by comparing assemblages across space, paleodepth and time. Nuttallides truempyi, Oridorsalis umbonatus, Bulimina trinitatensis, the Bulimina simplex group, the Anomalinoides spissiformis group, pleurostomellids, uniserial lagenids, stilostomellids and lenticulinids were ubiquitous during the early Eocene (lower-middle Ypresian). Aragonia aragonensis, the Globocassidulina subglobosa group, the Cibicidoides eocaenus group and polymorphinids became ubiquitous during the middle Ypresian. The most abundant early Ypresian taxa were tolerant to stressed or disturbed environments, either by opportunistic behavior (Quadrimorphina profunda, Tappanina selmensis, Siphogenerinoides brevispinosa) and/or the ability to calcify in carbonate-corrosive waters (N. truempyi). Nuttallides truempyi, T. selmensis and other buliminids (Bolivinoides cf. decoratus group, Bulimina virginiana) were markedly abundant during the middle Ypresian. Contrary to the long-lived, highly diverse and equitable Velasco fauna, common and abundant taxa reflect highly perturbed assemblages through the earliest Ypresian, with lower diversity and equitability following the PETM extinction. In contrast, the middle Ypresian assemblages may indicate a recovering fauna, though to some extent persistently disturbed by the lower-amplitude Eocene hyperthermals (e.g., Eocene Thermal Maximum 2 and 3). We propose the name 'Walvis Ridge fauna' for future reference to these Ypresian deep-sea benthic foraminiferal assemblages.	[Arreguin-Rodriguez, Gabriela J.; Alegret, Laia] Univ Zaragoza, Dept Ciencias Tierra, Zaragoza, Spain; [Thomas, Ellen; D'haenens, Simon] Yale Univ, Dept Geol & Geophys, New Haven, CT USA; [Thomas, Ellen] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT USA; [D'haenens, Simon; Speijer, Robert P.] Katholieke Univ Leuven, Dept Earth & Environm Sci, Leuven, Belgium; [Alegret, Laia] Univ Zaragoza, Inst Univ Ciencias Ambientales, Zaragoza, Spain	University of Zaragoza; Yale University; Wesleyan University; KU Leuven; University of Zaragoza	Arreguin-Rodriguez, GJ (corresponding author), Univ Zaragoza, Dept Ciencias Tierra, Zaragoza, Spain.	arreguin@unizar.es	de Jesús Arreguín Rodríguez, Gabriela/Y-8973-2019; D'haenens, Simon/K-5078-2012; Alegret, Laia/B-5420-2008; Thomas, Ellen/E-5573-2011	D'haenens, Simon/0000-0003-1248-3188; Alegret, Laia/0000-0002-8801-9544; Thomas, Ellen/0000-0002-7141-9904; Speijer, Robert/0000-0002-5873-7203; Arreguin-Rodriguez, Gabriela de Jesus/0000-0003-0662-6840	NSF; participating countries under the management of Joint Oceanographic Institutions (JOI); Spanish Ministry of Economy and Competitiveness [CGL2014-58794-P, CGL2017-84693-R]; FEDER funds [CGL2014-58794-P, CGL2017-84693-R]; Consolidated Group E05 (Government of Aragon/European Social Fund); Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico); NSF [OCE 1536611]; FWO [G.0422.10]	NSF(National Science Foundation (NSF)); participating countries under the management of Joint Oceanographic Institutions (JOI); Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER funds(European Commission); Consolidated Group E05 (Government of Aragon/European Social Fund); Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NSF(National Science Foundation (NSF)); FWO(FWO)	The samples used in this research were provided by the International Ocean Discovery Program (IODP). The ODP was sponsored by NSF and participating countries under the management of Joint Oceanographic Institutions (JOI). LA and GJAR were supported by projects CGL2014-58794-P and CGL2017-84693-R (Spanish Ministry of Economy and Competitiveness and FEDER funds), and from Consolidated Group E05 (Government of Aragon/European Social Fund). GJAR was also supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) through a predoctoral fellowship. ET recognizes funding by NSF award OCE 1536611. RPS and SD thank FWO support in G.0422.10.	Alegret L, 2005, PALAEOGEOGR PALAEOCL, V224, P53, DOI 10.1016/j.palaeo.2005.03.031; Alegret L, 2003, MAR MICROPALEONTOL, V48, P251, DOI 10.1016/S0377-8398(03)00022-7; Alegret L, 2009, MAR MICROPALEONTOL, V73, P105, DOI 10.1016/j.marmicro.2009.07.005; Alegret L, 2001, MICROPALEONTOLOGY, V47, P269, DOI 10.2113/47.4.269; Alegret L, 2009, PALAEOGEOGR PALAEOCL, V279, P186, DOI 10.1016/j.palaeo.2009.05.009; Alegret L, 2007, MAR MICROPALEONTOL, V64, P1, DOI 10.1016/j.marmicro.2006.12.003; Alegret L, 2006, MICROPALEONTOLOGY, V52, P433, DOI 10.2113/gsmicropal.52.5.433; Alegret L, 2013, MAR MICROPALEONTOL, V105, P40, DOI 10.1016/j.marmicro.2013.10.003; Alegret L, 2012, P NATL ACAD SCI USA, V109, P728, DOI 10.1073/pnas.1110601109; Alegret L, 2010, GEOL SOC AM BULL, V122, P1616, DOI 10.1130/B30055.1; Alegret L, 2009, PALAIOS, V24, P318, DOI 10.2110/palo.2008.p08-057r; Arndt S, 2013, EARTH-SCI REV, V123, P53, DOI 10.1016/j.earscirev.2013.02.008; Arreguin-Rodriguez GJ, 2016, PALAEOGEOGR PALAEOCL, V451, P62, DOI 10.1016/j.palaeo.2016.03.010; Arreguin-Rodriguez GJ, 2016, PALEOCEANOGRAPHY, V31, P346, DOI 10.1002/2015PA002837; Barker, 1988, P ODP INIT REPTS, V113, P183, DOI [10.2973/odp.proc.ir.113.107.1988, DOI 10.2973/ODP.PROC.IR.113.107.1988]; Barker P.F, 1988, PROC OCEAN DRILL INI, V113, P89; BECKMANN JP, 1960, INT GEOL C REP 21 SE, P57; Belford D. J., 1958, Contributions from the Cushman Foundation, V9, P93; Belford D. J., 1959, Contributions from the Cushman Foundation, V10, P20; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; Berggren WA, 2005, J FORAMIN RES, V35, P279, DOI 10.2113/35.4.279; BERGGREN WA, 1975, PALAEOGEOGR PALAEOCL, V18, P73, DOI 10.1016/0031-0182(75)90025-5; BERGGREN WA, 1989, MICROPALEONTOLOGY, V35, P308, DOI 10.2307/1485674; BERMUDEZ PEDRO JOAQUIN, 1949, CUSHMAN FOUND FORAMINIFERAL RES SPEC PUBL, V25, P1; Bignot G, 1998, P OCEAN DRILLING PRO, P433, DOI DOI 10.2973/0DP.PR0C.SR.159.017.1998; BOERSMA A, 1984, INITIAL REP DEEP SEA, V75, P1273; Bolli H. M., 1994, BENTHIC FORAMINIFERA; Brady H. B., 1881, Q J MICROSCOPICAL SC, V21, P31; BRALOWER TJ, 1995, PALEOCEANOGRAPHY, V10, P841, DOI 10.1029/95PA01143; Bralower TJ, 2002, P OC DRILL PROGR INT, P1, DOI DOI 10.2973/ODP.PROC.IR.198.105.2002; Brotzen F., 1940, FLINTRANNANS TRINDEL; Brotzen F., 1948, SWEDISH PALEOCENE IT; Brotzen F., 1936, FORAMINIFEREN SCHWED; Bukry D., 1975, Initial Rep Deep Sea Drilling Project, V32, P677, DOI 10.2973/dsdp.proc.32.124.1975; Bukry D, 1973, INITIAL REP DSDP, V15, P685; BUZAS MA, 1993, MAR MICROPALEONTOL, V20, P311, DOI 10.1016/0377-8398(93)90040-5; Chun COJ, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001861; Coccioni Rodolfo, 1995, Palaeopelagos, V4, P87; Cole WS, 1928, B AM PALEONTOL, V14, P199; CORLISS BH, 1985, NATURE, V314, P435, DOI 10.1038/314435a0; CORLISS BH, 1991, MAR MICROPALEONTOL, V17, P195, DOI 10.1016/0377-8398(91)90014-W; Cramer BS, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000909; Cushman J. A., 1936, Contributions from the Cushman Laboratory for Foraminiferal Research Sharon, V12, P71; Cushman J. A., 1935, Contributions from the Cushman Laboratory for Foraminiferal Research Sharon, V11, P96; CUSHMAN J. A., 1941, CONTR CUSHMAN LAB FORAMINIFERAL RES, V17, P1; Cushman J. A., 1926, Bulletin American Association of Petroleum Geologists, V10, P581; Cushman J. A., 1925, Contributions from the Cushman Laboratory for Foraminiferal Research, V1, P18; Cushman J. A., 1936, Contributions from the Cushman Laboratory for Foraminiferal Research Sharon, V12, P39; CUSHMAN J. A., 1945, CUSHMAN LAB FORAMINI, V14, P1; CUSHMAN JA, 1930, FLORIDA STATE GEOLOG, V4, P1; Cushman Joseph A., 1942, CONTR CUSHMAN LAB FORAMINIFERAL RES, V18, P1; CUSHMAN JOSEPH A., 1927, CONTR CUSHMAN LAB FORAMINIFERAL RES, V2, P77; CUSHMAN JOSEPH A., 1948, CONTR CUSHMAN LAB FORAMINIFERAL RES, V24, P85; CUSHMAN JOSEPH AUGUSTINE, 1933, CONTR CUSHMAN LAB FORAMINIFERAL RES, V9, P77; D'haenens S, 2014, PALEOCEANOGRAPHY, V29, P370, DOI 10.1002/2013PA002567; D'haenens S, 2012, MAR MICROPALEONTOL, V88-89, P15, DOI 10.1016/j.marmicro.2012.02.006; d'Orbigny A. D., 1839, VOYAGE AMERIQUE MERI; De Graciansky PC, 1985, INITIAL REP DEEP SEA, P251; Deprez A, 2017, MAR MICROPALEONTOL, V137, P31, DOI 10.1016/j.marmicro.2017.10.001; Deprez A, 2015, MAR MICROPALEONTOL, V115, P59, DOI 10.1016/j.marmicro.2014.11.003; Dickson AJ, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002346; Dickson AJ, 2012, GEOLOGY, V40, P639, DOI 10.1130/G32977.1; Diz P, 2016, J MICROPALAEONTOL, V35, P195, DOI 10.1144/jmpaleo2015-045; Dunkley Jones T, 2013, EARTH-SCI REV, V125, P123, DOI 10.1016/j.earscirev.2013.07.004; Earland A., 1936, DISCOVERY REP, V13, P1; Erbacher J, 2004, P OCEAN DRILL PROGRA, P1; Ernst SR, 2006, MAR MICROPALEONTOL, V60, P89, DOI 10.1016/j.marmicro.2006.03.002; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; Fontanier C, 2005, DEEP-SEA RES PT I, V52, P1189, DOI 10.1016/j.dsr.2005.01.006; Foster LC, 2013, P NATL ACAD SCI USA, V110, P9273, DOI 10.1073/pnas.1300579110; Frenzel P., 2000, BENTHISCHEN FORAMINI; Galazzo FB, 2013, PALAEOGEOGR PALAEOCL, V378, P22, DOI 10.1016/j.palaeo.2013.03.018; Galazzo FB, 2015, PALAEOGEOGR PALAEOCL, V417, P432, DOI 10.1016/j.palaeo.2014.10.004; Galeotti Simone, 2004, V8, P83; Galloway J. J., 1929, Bulletin of American Paleontology Ithaca, V15, P1; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Georgescu Marius Dan, 2011, Revista Espanola de Micropaleontologia, V43, P109; Giusberti L, 2016, CLIM PAST, V12, P213, DOI 10.5194/cp-12-213-2016; Giusberti L, 2009, MAR MICROPALEONTOL, V70, P102, DOI 10.1016/j.marmicro.2008.11.003; Glock N, 2013, BIOGEOSCIENCES, V10, P4767, DOI 10.5194/bg-10-4767-2013; Gooday AJ, 2003, ADV MAR BIOL, V46, P1, DOI 10.1016/S0065-2881(03)46002-1; GOODAY AJ, 1992, NATO ADV SCI I C-MAT, V360, P63; Gooday AJ, 1998, DEEP-SEA RES PT II, V45, P165, DOI 10.1016/S0967-0645(97)00041-6; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hay WW, 1999, GEOL S AM S, P1; Hayward B.W., 2012, LAST GLOBAL EXTINCTI, V43; Heinz P, 2004, MAR BIOL, V144, P985, DOI 10.1007/s00227-003-1257-7; Henson SA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004099; HERGUERA JC, 1991, GEOLOGY, V19, P1173, DOI 10.1130/0091-7613(1991)019<1173:PFBFAG>2.3.CO;2; Hofker J., 1951, FORAMINIFERA SIBOGA; Holbourn A., 2013, ATLAS BENTHIC FORAMI; Howe H. V., 1939, Geological Bulletin Department of Conservation Louisiana, V14, P1; Jennions SM, 2015, PALEOCEANOGRAPHY, V30, P1059, DOI 10.1002/2015PA002821; John EH, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0099; Jones RW, 1994, NATURAL HIST MUSEUM; Jorissen FJ, 1995, MAR MICROPALEONTOL, V26, P3, DOI 10.1016/0377-8398(95)00047-X; Jorissen FJ, 1999, MAR GEOL, V153, P91, DOI 10.1016/S0025-3227(98)00088-7; Jorissen FJ, 2007, DEV MARINE GEOL, V1, P263, DOI 10.1016/S1572-5480(07)01012-3; KAIHO K, 1994, GEOLOGY, V22, P719, DOI 10.1130/0091-7613(1994)022<0719:BFDOIA>2.3.CO;2; Katz M.E., 1991, Proceedings of the Ocean Drilling Program Scientific Results, V114, P481, DOI 10.2973/odp.proc.sr.114.147.1991; Katz ME, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000798; Katz ME, 2010, J FORAMIN RES, V40, P165, DOI 10.2113/gsjfr.40.2.165; Kender S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11970; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; Koutsoukos EAM, 2000, CRETACEOUS RES, V21, P381, DOI 10.1006/cres.1999.0206; Langlet D, 2014, BIOGEOSCIENCES, V11, P1775, DOI 10.5194/bg-11-1775-2014; Lauretano V, 2015, CLIM PAST, V11, P1313, DOI 10.5194/cp-11-1313-2015; Leon-Rodriguez L, 2010, PALAEOGEOGR PALAEOCL, V298, P409, DOI 10.1016/j.palaeo.2010.10.029; LeRoy L. W., 1953, BIOSTRATIGRAPHY MAQF; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Lipps J. H., 1965, Tulane Studies in Geology, V3, P117; Littler K, 2014, EARTH PLANET SC LETT, V401, P18, DOI 10.1016/j.epsl.2014.05.054; Loeblich A.R., 1987, FORAMINIFERA GENERA; LOEBLICH AR, 1961, J PALEONTOL, V35, P245; Lourens LJ, 2005, NATURE, V435, P1083, DOI 10.1038/nature03814; Lyle M.W., 2002, INITIAL REPORTS OCEA, V199, P1; Ma ZW, 2014, NAT GEOSCI, V7, P382, DOI [10.1038/ngeo2139, 10.1038/NGEO2139]; MARSSON TH, 1878, MITT NATURWISS VER N, V10, P115; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Martin LT, 1943, EOCENE FORAMINIFERA; Martini E, 1971, 2 P PLANKT C TECN RO, V2, P739; McInerney FA, 2011, ANNU REV EARTH PL SC, V39, P489, DOI 10.1146/annurev-earth-040610-133431; Miller Kenneth G., 1992, P67; Montadert L, 1979, INITIAL REPORTS DEEP, P71; MORROW A. L., 1934, JOUR PALEONTOL, V8, P186; MULLERMERZ E, 1991, PALAEOGEOGR PALAEOCL, V83, P117, DOI 10.1016/0031-0182(91)90078-6; Nardelli MP, 2014, BIOGEOSCIENCES, V11, P4029, DOI 10.5194/bg-11-4029-2014; Nguyen TMP, 2009, MAR MICROPALEONTOL, V73, P241, DOI 10.1016/j.marmicro.2009.10.005; Nicolo MJ, 2007, GEOLOGY, V35, P699, DOI 10.1130/G23648A.1; Nomura R, 1991, P OC DRILL PROGR SCI, V121, P3; NOMURA R., 2005, P OCEAN DRILLING PRO, V199, P1, DOI DOI 10.2973/ODP.PROC.SR.199.223.2005; Norris RD, 2013, SCIENCE, V341, P492, DOI 10.1126/science.1240543; Norvang A., 1968, P 23 INT GEOL C, P415; NUTTALL WINFRED LAURENCE FALK-INER, 1928, QUART JOUR GEOL SOC, V84, P57; Olshanetskiy DM, 2015, STRATIGR GEO CORREL+, V23, P661, DOI 10.1134/S0869593815070023; Olsson RK, 2002, GEOL SOC AM SPEC PAP, V356, P97; Ortiz S, 2006, MICROPALEONTOLOGY, V52, P97, DOI 10.2113/gsmicropal.52.2.97; Palike C, 2014, GEOCHEM GEOPHY GEOSY, V15, P1038, DOI 10.1002/2013GC005074; Pardo Alfonso, 1996, P139; PATTERSON RT, 1989, J PALEONTOL, V63, P245, DOI 10.1017/S0022336000019272; Payros A, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002300; Peirce J. W., 1989, P OCEAN DRILLING PRO, V121, P111; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; Plummer HJ, 1927, FORAMINIFERA MIDWAY; Post JE, 2016, AM MINERAL, V101, P407, DOI 10.2138/am-2016-5347; RATHBURN AE, 1994, PALEOCEANOGRAPHY, V9, P87, DOI 10.1029/93PA02327; Risgaard-Petersen N, 2006, NATURE, V443, P93, DOI 10.1038/nature05070; Rohl U, 2005, GEOLOGICAL SOC AM AB, V37; SAIDOVA KM, 1975, BENTHONIC FORAMINIFE; SCHNITKER D, 1980, Journal of Foraminiferal Research, V10, P235; Schnitker D., 1979, INITIAL REP DEEP SEA, P377; Self-Trail JM, 2017, PALEOCEANOGRAPHY, V32, P710, DOI 10.1002/2017PA003096; Shipboard Scientific Party, 2004, Proceedings of the Ocean Drilling Program Initial Reports, V208, P1; Shipboard Scientific Party, 1998, Proceedings of the Ocean Drilling Program Initial Reports, V171B, P171; Shipboard Scientific Party, 1993, Proceedings of the Ocean Drilling Program Initial Reports, V143, P111; SNIDER LJ, 1984, DEEP-SEA RES, V31, P1225, DOI 10.1016/0198-0149(84)90059-1; Speijer RP, 2008, GEOSPHERE, V4, P760, DOI 10.1130/GES00176.1; Speijer RP, 1998, PALAEOGEOGR PALAEOCL, V137, P79, DOI 10.1016/S0031-0182(97)00107-7; Speijer RP, 1994, THESIS; Sprong J, 2013, PALAEOGEOGR PALAEOCL, V379, P1, DOI 10.1016/j.palaeo.2013.01.018; Stap L, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003097; Stap L, 2010, GEOLOGY, V38, P607, DOI 10.1130/G30777.1; Stap L, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001655; Stassen P, 2015, MAR MICROPALEONTOL, V115, P1, DOI 10.1016/j.marmicro.2014.12.001; Stassen P, 2012, AUSTRIAN J EARTH SCI, V105, P154; Steineck PL, 1996, GEOLOGY, V24, P583; Takeda K, 2007, PALAEOGEOGR PALAEOCL, V251, P175, DOI 10.1016/j.palaeo.2007.02.026; Terquem O., 1882, MEMOIRES; THOMAS E, 1995, PALEOCEANOGRAPHY, V10, P545, DOI 10.1029/94PA03056; Thomas E, 2000, GFF, V122, P169, DOI 10.1080/11035890001221169; Thomas E., 1996, Geological Society Special Publication, V101, P401, DOI 10.1144/GSL.SP.1996.101.01.20; Thomas E, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P214; Thomas E., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P571, DOI 10.2973/odp.proc.sr.113.123.1990; Thomas E., 1989, Geological Society Special Publication, P283; THOMAS E, 1990, GEOL S AM S, V247, P481; Thomas E., 2003, SPEC PAP GEOL SOC AM, P319, DOI DOI 10.1130/0-8137-2369-8.319; Thomas E, 2007, GEOL SOC AM SPEC PAP, V424, P1, DOI 10.1130/2007.2424(01); Thomas Ellen, 2000, P132; Tjalsma R.C., 1983, MICROPALEONTOLOGY SP, V4, P1; Van Morkhoven F.P.C.M., 1986, B CTR RECHERCHE EXPL, V11; Vandenberghe N, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P855, DOI 10.1016/B978-0-444-59425-9.00028-7; Vasilenko VP, 1950, MIKROFAUNA SSSR, V4, P177; Verity PG, 2002, ENVIRON CONSERV, V29, P207, DOI 10.1017/S0376892902000139; Von Hillebrandt A., 1962, PALAOZAN SEINE FORAM; Westerhold T, 2009, CLIM PAST, V5, P309, DOI 10.5194/cp-5-309-2009; Westerhold T, 2017, CLIM PAST, V13, P1129, DOI 10.5194/cp-13-1129-2017; WHITE MAYNARD P., 1928, JOUR PALEONTOL, V2, P177; WHITE MAYNARD P., 1929, JOUR PALEONTOL, V3, P30; WHITE MAYNARD P., 1928, JOUR PALEONTOL, V2, P280; Widmark JGV, 1997, MAR MICROPALEONTOL, V31, P135, DOI 10.1016/S0377-8398(97)00008-X; Winguth AME, 2012, GEOLOGY, V40, P263, DOI 10.1130/G32529.1; WOOD KC, 1985, MICROPALEONTOLOGY, V31, P181, DOI 10.2307/1485485; Wright J., 1886, BELFAST NATURALISTS, V1, P330; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2010, EARTH PLANET SC LETT, V299, P242, DOI 10.1016/j.epsl.2010.09.004; Zeebe RE, 2012, ANNU REV EARTH PL SC, V40, P141, DOI 10.1146/annurev-earth-042711-105521; Zhou X, 2016, PALEOCEANOGRAPHY, V31, P1532, DOI 10.1002/2016PA003020; Zhou XL, 2014, PALEOCEANOGRAPHY, V29, P964, DOI 10.1002/2014PA002702	199	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193167	10.1371/journal.pone.0193167	http://dx.doi.org/10.1371/journal.pone.0193167			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474429	Green Accepted, gold, Green Published			2022-12-26	WOS:000426049500063
J	Faykoo-Martinez, M; Monks, DA; Zovkic, IB; Holmes, MM				Faykoo-Martinez, Mariela; Monks, D. Ashley; Zovkic, Iva B.; Holmes, Melissa M.			Sex- and brain region-specific patterns of gene expression associated with socially-mediated puberty in a eusocial mammal	PLOS ONE			English	Article							NAKED MOLE-RATS; GONADOTROPIN-RELEASING-HORMONE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MATERNAL DEXAMETHASONE EXPOSURE; PITUITARY-ADRENAL AXIS; HETEROCEPHALUS-GLABER; NEUROKININ B; ARCUATE NUCLEUS; FEMALE RATS; KISSPEPTIN NEURONS	The social environment can alter pubertal timing through neuroendocrine mechanisms that are not fully understood; it is thought that stress hormones (e.g., glucocorticoids or corticotropin-releasing hormone) influence the hypothalamic-pituitary-gonadal axis to inhibit puberty. Here, we use the eusocial naked mole-rat, a unique species in which social interactions in a colony (i.e. dominance of a breeding female) suppress puberty in subordinate animals. Removing subordinate naked mole-rats from this social context initiates puberty, allowing for experimental control of pubertal timing. The present study quantified gene expression for reproduction- and stress-relevant genes acting upstream of gonadotropin-releasing hormone in brain regions with reproductive and social functions in pre-pubertal, post-pubertal, and opposite sex-paired animals (which are in various stages of pubertal transition). Results indicate sex differences in patterns of neural gene expression. Known functions of genes in brain suggest stress as a key contributing factor in regulating male pubertal delay. Network analysis implicates neurokinin B (Tac3) in the arcuate nucleus of the hypothalamus as a key node in this pathway. Results also suggest an unappreciated role for the nucleus accumbens in regulating puberty.	[Faykoo-Martinez, Mariela; Monks, D. Ashley; Zovkic, Iva B.; Holmes, Melissa M.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Monks, D. Ashley; Zovkic, Iva B.; Holmes, Melissa M.] Univ Toronto, Dept Psychol, Mississauga, ON, Canada; [Holmes, Melissa M.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Mississauga; University of Toronto	Holmes, MM (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.; Holmes, MM (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON, Canada.; Holmes, MM (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	melissa.holmes@utoronto.ca		Holmes, Melissa/0000-0003-1979-1503; Zovkic, Iva/0000-0002-4497-6334; Faykoo-Martinez, Mariela/0000-0002-8885-657X	NSERC [402633, 312458, 498391]; Ontario Early Researcher Award; NSERC USRA; NSERC CGS M	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario); NSERC USRA(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CGS M(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a NSERC Discovery Grant (402633) and Ontario Early Researcher Award to MMH, a NSERC Discovery Grant (312458) to DAM, a NSERC Accelerator Grant (498391) to IBZ and a NSERC (http://nserc-crsng.gc.ca) USRA and CGS M to MFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn T, 2015, J NEUROENDOCRINOL, V27, P100, DOI 10.1111/jne.12244; Alicea B, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160496; Arim RG, 2011, J YOUTH ADOLESCENCE, V40, P1423, DOI 10.1007/s10964-011-9638-6; Azogu I, 2017, NEUROPHARMACOLOGY, V125, P129, DOI 10.1016/j.neuropharm.2017.07.008; Basso JC, 2015, BEHAV NEUROSCI, V129, P457, DOI 10.1037/bne0000070; Beery AK, 2016, J COMP NEUROL, V524, P228, DOI 10.1002/cne.23834; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; Brommer JE, 2002, ECOL LETT, V5, P802, DOI 10.1046/j.1461-0248.2002.00369.x; Bryant AS, 2016, J EXP BIOL; Carpenter RE, PLOS ONE; Cheng GL, 2010, ENDOCRINOLOGY, V151, P301, DOI 10.1210/en.2009-0541; Clarke FM, 1997, P ROY SOC B-BIOL SCI, V264, P993, DOI 10.1098/rspb.1997.0137; Clarke FM, 2001, ANIM BEHAV, V61, P311, DOI 10.1006/anbe.2000.1573; Clarke FM, 1998, P ROY SOC B-BIOL SCI, V265, P1391, DOI 10.1098/rspb.1998.0447; Clithero JA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00087; Day FR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11208; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Doremus-Fitzwater TL, 2009, PHYSIOL BEHAV, V97, P484, DOI 10.1016/j.physbeh.2009.03.025; Dungan HM, 2006, ENDOCRINOLOGY, V147, P1154, DOI 10.1210/en.2005-1282; Ellis BJ, 2000, CHILD DEV, V71, P485, DOI 10.1111/1467-8624.00159; Ernst M, 2005, NEUROIMAGE, V25, P1279, DOI 10.1016/j.neuroimage.2004.12.038; FAULKES CG, 1991, J REPROD FERTIL, V91, P593; FAULKES CG, 1990, J REPROD FERTIL, V89, P317; FAULKES CG, 1991, J REPROD FERTIL, V93, P427; Faulkes CG, PHYSL REPROD DICTATO; Flak JN, 2009, J COMP NEUROL, V517, P156, DOI 10.1002/cne.22142; Foilb AR, 2011, J ENDOCRINOL, V210, P391, DOI 10.1530/JOE-11-0206; GALLO RV, 1990, J NEUROENDOCRINOL, V2, P685, DOI 10.1111/j.1365-2826.1990.tb00465.x; Gill JC, 2012, ENDOCRINOLOGY, V153, P4883, DOI 10.1210/en.2012-1529; Goddings AL, 2014, NEUROIMAGE, V88, P242, DOI 10.1016/j.neuroimage.2013.09.073; Goff B, 2013, NEUROSCIENCE, V249, P129, DOI 10.1016/j.neuroscience.2012.12.010; Goodman RL, 2004, ENDOCRINOLOGY, V145, P2959, DOI 10.1210/en.2003-1305; Goodman RL, 2013, ENDOCRINOLOGY, V154, P4259, DOI 10.1210/en.2013-1331; Goubillon ML, 1999, NEUROENDOCRINOLOGY, V70, P228, DOI 10.1159/000054481; Grachev P, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12393; Grachev P, 2014, NEUROENDOCRINOLOGY, V99, P7, DOI 10.1159/000357734; Grachev P, 2014, ENDOCRINOLOGY, V155, P2589, DOI 10.1210/en.2013-2038; Green MR, 2016, GEN COMP ENDOCR, V234, P110, DOI 10.1016/j.ygcen.2016.02.004; Gunnar MR, 2009, DEV PSYCHOPATHOL, V21, P69, DOI 10.1017/S0954579409000054; Han XH, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0254-5; Handa RJ, 2014, FRONT NEUROENDOCRIN, V35, P197, DOI 10.1016/j.yfrne.2013.11.001; Harrell F.E., 2017, HMISC HARRELL MISCEL; Hathaway GA, 2016, HORM BEHAV, V79, P1, DOI 10.1016/j.yhbeh.2015.12.001; Henry EC, 2007, J EXP BIOL, V210, P261, DOI 10.1242/jeb.02631; Holmes MM, 2008, HORM BEHAV, V54, P278, DOI 10.1016/j.yhbeh.2008.03.010; Holmes MM, 2007, P NATL ACAD SCI USA, V104, P10548, DOI 10.1073/pnas.0610344104; Holmes MM, 2011, BEHAV BRAIN RES, V218, P234, DOI 10.1016/j.bbr.2010.11.056; Holmes MM, 2009, FRONT NEUROENDOCRIN, V30, P519, DOI 10.1016/j.yfrne.2009.04.010; Hu GF, 2014, GEN COMP ENDOCR, V208, P94, DOI 10.1016/j.ygcen.2014.08.009; Hulanicka B., 1999, J REPROD INFANT PSYC, V17, P14; Hunter DJ, 1997, CANCER CAUSE CONTROL, V8, P49, DOI 10.1023/A:1018431104786; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; JONES B, 1972, MED J AUSTRALIA, V2, P533, DOI 10.5694/j.1326-5377.1972.tb47460.x; Keebaugh AC, 2015, SOC NEUROSCI-UK, V10, P561, DOI 10.1080/17470919.2015.1040893; Kelly Y, 2017, ARCH DIS CHILD, V102, P232, DOI 10.1136/archdischild-2016-310475; Kim KS, 1999, J REPROD INFANT PSYC, V17, P16; Kim KS, 1998, INT J BEHAV DEV, V22, P22; Kinouchi R, 2012, INT J DEV NEUROSCI, V30, P596, DOI 10.1016/j.ijdevneu.2012.09.001; Kinsey-Jones JS, 2010, J NEUROENDOCRINOL, V22, P102, DOI 10.1111/j.1365-2826.2009.01940.x; Kiss A, 1996, J NEUROENDOCRINOL, V8, P103, DOI 10.1111/j.1365-2826.1996.tb00830.x; Klein ZA, 2010, DEV PSYCHOBIOL, V52, P62, DOI 10.1002/dev.20413; Koch M, 1996, NEUROREPORT, V7, P1442, DOI 10.1097/00001756-199605310-00024; Korzan WJ, 2014, J EXP BIOL, V217, P3221, DOI 10.1242/jeb.104430; Kubota N, 2014, NEUROSCI LETT, V566, P182, DOI 10.1016/j.neulet.2014.02.064; Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022; Li XF, 2006, J NEUROENDOCRINOL, V18, P602, DOI 10.1111/j.1365-2826.2006.01450.x; Lim WL, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00117; Lim WL, 2014, CELL TISSUE RES, V355, P409, DOI 10.1007/s00441-013-1765-9; Lowrance SA, 2016, PSYCHONEUROENDOCRINO, V68, P163, DOI 10.1016/j.psyneuen.2016.02.027; Luo E, 2016, ENDOCRINOLOGY, V157, P1187, DOI 10.1210/en.2015-1711; Malina RM, 1997, MED SCI SPORT EXER, V29, P99, DOI 10.1097/00005768-199701000-00014; MARGULIS SW, 1995, HORM BEHAV, V29, P227, DOI 10.1006/hbeh.1995.1017; Mathews IZ, 2008, BEHAV BRAIN RES, V190, P33, DOI 10.1016/j.bbr.2008.02.004; McCormick CM, 2008, BEHAV BRAIN RES, V187, P228, DOI 10.1016/j.bbr.2007.09.005; McCormick CM, 2017, NEUROBIOL STRESS, V6, P31, DOI 10.1016/j.ynstr.2016.08.003; Mendle J, 2006, DEV PSYCHOL, V42, P533, DOI 10.1037/0012-1649.42.3.533; Mittelman-Smith MA, 2016, ENDOCRINOLOGY, V157, P2015, DOI 10.1210/en.2015-1740; Mooney SJ, 2015, NEUROSCIENCE, V303, P261, DOI 10.1016/j.neuroscience.2015.06.043; Mooney SJ, 2013, NEUROSCIENCE, V230, P56, DOI 10.1016/j.neuroscience.2012.11.014; Navarro VM, 2012, J NEUROSCI, V32, P2388, DOI 10.1523/JNEUROSCI.4288-11.2012; Nicola SM, 2010, J NEUROSCI, V30, P16585, DOI 10.1523/JNEUROSCI.3958-10.2010; O'Connell LA, 2013, HORM BEHAV, V64, P468, DOI 10.1016/j.yhbeh.2013.07.003; Palmert MR, 2012, NEW ENGL J MED, V366, P443, DOI 10.1056/NEJMcp1109290; Peragine DE, 2016, HORM BEHAV, V81, P28, DOI 10.1016/j.yhbeh.2016.03.005; Peragine DE, 2017, P NATL ACAD SCI USA, V114, P1207, DOI 10.1073/pnas.1616913114; Peroulakis ME, 2002, J NEUROBIOL, V51, P33, DOI 10.1002/neu.10039; Perry AN, 2003, HORM BEHAV, V43, P31, DOI 10.1016/S0018-506X(02)00036-3; Pineda R, 2010, ENDOCRINOLOGY, V151, P722, DOI 10.1210/en.2009-0803; Poling MC, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00150; Prebeg Z, 2000, AM J HUM BIOL, V12, P503; Ralph CR, 2016, REPRODUCTION, V152, pR1, DOI 10.1530/REP-15-0604; REEVE HK, 1992, NATURE, V358, P147, DOI 10.1038/358147a0; Revelle W., 2018, USE PSYCH PACKAGE FA; Romeo RD, 2004, NEUROENDOCRINOLOGY, V80, P387, DOI 10.1159/000084203; Romeo RD, 2010, FRONT NEUROENDOCRIN, V31, P232, DOI 10.1016/j.yfrne.2010.02.004; Sabatinelli D, 2007, J NEUROPHYSIOL, V98, P1374, DOI 10.1152/jn.00230.2007; SCHALLY AV, 1971, SCIENCE, V173, P1036, DOI 10.1126/science.173.4001.1036; Seney ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007477; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith JT, 2011, ENDOCRINOLOGY, V152, P1001, DOI 10.1210/en.2010-1225; Smith JT, 2000, ENDOCRINOLOGY, V141, P2422, DOI 10.1210/en.141.7.2422; Soga T, 2012, NEUROSCIENCE, V218, P56, DOI 10.1016/j.neuroscience.2012.05.023; Solomon-Lane TK, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00210; Stankowich T, 2002, ETHOLOGY, V108, P975, DOI 10.1046/j.1439-0310.2002.00830.x; Sun Y, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4099; Swift-Gallant A, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0050-x; Tahirovic HF, 1998, EUR J PEDIATR, V157, P978, DOI 10.1007/s004310050981; Tendilla-Beltran H, 2016, J CHEM NEUROANAT, V77, P68, DOI 10.1016/j.jchemneu.2016.05.004; Topaloglu AK, 2010, J NEUROENDOCRINOL, V22, P765, DOI 10.1111/j.1365-2826.2010.02013.x; Toth M, 2016, NEUROPSYCHOPHARMACOL, V41, P1681, DOI 10.1038/npp.2015.338; Trillmich F, 2009, PHYSIOL BEHAV, V96, P476, DOI 10.1016/j.physbeh.2008.11.014; VANDENBERGH JG, 1987, AM ZOOL, V27, P891; Veenit V, 2014, J PSYCHIATR RES, V53, P1, DOI 10.1016/j.jpsychires.2014.02.015; Viau V, 2005, ENDOCRINOLOGY, V146, P137, DOI 10.1210/en.2004-0846; Wada H, 2008, GEN COMP ENDOCR, V156, P441, DOI 10.1016/j.ygcen.2008.02.004; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; Warnes M.G.R., 2016, PACKAGE GPLOTS VARIO; Weiser MJ, 2011, J NEUROENDOCRINOL, V23, P1231, DOI 10.1111/j.1365-2826.2011.02217.x; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; WIERSON M, 1993, ADOLESCENCE, V28, P913; Wilson ME, 2008, BIOL REPROD, V78, P736, DOI 10.1095/biolreprod.107.065953; Xiang W, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.128777; Zhou SZ, 2013, J COMP NEUROL, V521, P3003, DOI 10.1002/cne.23327	123	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193417	10.1371/journal.pone.0193417	http://dx.doi.org/10.1371/journal.pone.0193417			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474488	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500105
J	Ahmed, A; Wang, T; Delgado-Olguin, P				Ahmed, Abdalla; Wang, Tao; Delgado-Olguin, Paul			Ezh2 is not required for cardiac regeneration in neonatal mice	PLOS ONE			English	Article							MOUSE HEART; REARRANGEMENT; METHYLATION; EXPRESSION; REPRESSION; RESECTION; PATHWAY; HUMANS; REPAIR	The neonatal mouse heart has the remarkable capacity to regenerate lost myocardium within the first week of life. Neonatal cardiomyocytes re-express fetal genes that control cell proliferation after injury to promote regeneration. The loss of regenerative capacity of the heart one week after birth coincides with repression of a fetal transcriptional program coordinated by epigenetic regulators. The histone methyltransferase enhancer of zeste homolog 2 (Ezh2) is a repressor of fetal cardiac transcriptional programs and suppresses cardiomyo-cyte cell proliferation, suggesting a potential function in heart regeneration. However, it was recently demonstrated that Ezh2 is dispensable for heart regeneration in the neonatal heart. Here, we provide evidence supporting this finding and demonstrate that Ezh2 deficiency does not affect regeneration of the neonatal heart. We inactivated Ezh2 in differentiating embryonic cardiomyocytes, which led to depletion of histone H3 trimethylated at lysine 27 (H3K27me3). Ezh2 deficiency in cardiomyocytes did not affect clearance of the fibrotic scar in myocardial infarction(MI) and apical resection models of cardiac injury at post-natal day 1 (P1). Similarly, cardiomyocyte-specific loss of Ezh2 did not affect fibrotic scar size after MI or apical resection at P7, suggesting that it does not extend the regenerative time window. Our results demonstrate that Ezh2 is not required for innate neonatal cardiac regeneration.	[Ahmed, Abdalla; Wang, Tao; Delgado-Olguin, Paul] Hosp Sick Children, Translat Med, Toronto, ON, Canada; [Ahmed, Abdalla; Wang, Tao; Delgado-Olguin, Paul] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Wang, Tao] Univ Toronto, Human Biol Program, Toronto, ON, Canada; [Delgado-Olguin, Paul] Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Delgado-Olguin, P (corresponding author), Hosp Sick Children, Translat Med, Toronto, ON, Canada.; Delgado-Olguin, P (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.; Delgado-Olguin, P (corresponding author), Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON, Canada.	paul.delgadoolguin@sickkids.ca	Olguin, Paul Delgado/H-9293-2019; Wang, Tao/C-7214-2018	Olguin, Paul Delgado/0000-0002-5355-247X; Wang, Tao/0000-0002-6348-2794	Heart and Stroke Foundation of Canada [G-17-0018613]; Canadian Institutes of Health Research [PJT-149046]; Natural Sciences and Engineering Research Council of Canada [500865]; Hospital for Sick Children; University of Toronto Fellowship	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Hospital for Sick Children; University of Toronto Fellowship(University of Toronto)	PDO is funded by the Heart and Stroke Foundation of Canada (http://www.heartandstroke.ca/) grant number G-17-0018613, the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) grant number PJT-149046, the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca./index_eng.asp) grant number 500865, and Operational Funds from The Hospital for Sick Children (https://www.sickkids.ca/) and University of Toronto Fellowship Award to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Ai SS, 2017, CIRC RES, V121, P106, DOI 10.1161/CIRCRESAHA.117.311212; Andersen DC, 2014, STEM CELL REP, V2, P406, DOI 10.1016/j.stemcr.2014.02.008; Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bryant DM, 2015, J MOL CELL CARDIOL, V79, P315, DOI 10.1016/j.yjmcc.2014.12.011; Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; Chi LJ, 2017, DEVELOPMENT, V144, P1976, DOI 10.1242/dev.148916; Crippa S, 2016, CARDIOVASC RES, V110, P73, DOI 10.1093/cvr/cvw031; Delgado-Olguin P, 2014, DEVELOPMENT, V141, P4610, DOI 10.1242/dev.112607; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Fan Y, 2017, J CELL BIOCHEM, V118, P2828, DOI 10.1002/jcb.25933; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Gamba Laurent, 2014, Curr Treat Options Cardiovasc Med, V16, P288, DOI 10.1007/s11936-013-0288-8; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; He AB, 2012, CIRC RES, V110, P406, DOI 10.1161/CIRCRESAHA.111.252205; Konfino T, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001320; Mahmoud AI, 2014, NAT PROTOC, V9, P305, DOI 10.1038/nprot.2014.021; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; O'Meara CC, 2015, CIRC RES, V116, P804, DOI 10.1161/CIRCRESAHA.116.304269; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Uygur A, 2016, DEV CELL, V36, P362, DOI 10.1016/j.devcel.2016.01.018	25	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192238	10.1371/journal.pone.0192238	http://dx.doi.org/10.1371/journal.pone.0192238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466371	gold, Green Submitted, Green Published			2022-12-26	WOS:000425604300039
J	Wang, SY; Oestricker, LZ; Wallendorf, MJ; Sterl, K; Dunai, J; Kilpatrick, CR; Patterson, BW; Reeds, DN; Wice, BM				Wang, Songyan; Oestricker, Lauren Z.; Wallendorf, Michael J.; Sterl, Karin; Dunai, Judit; Kilpatrick, C. Rachel; Patterson, Bruce W.; Reeds, Dominic N.; Wice, Burton M.			Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance	PLOS ONE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; SPLANCHNIC NEURAL REGULATION; RELEASE; PEPTIDE; ATROPINE; BLOCKADE; IDENTIFICATION; INNERVATION; INCREASE; NEURONS	We previously demonstrated that infusion of an intestinal peptide called xenin-25 (Xen) amplifies the effects of glucose-dependent insulinotropic polypeptide (GIP) on insulin secretion rates (ISRs) and plasma glucagon levels in humans. However, these effects of Xen, but not GIP, were blunted in humans with type 2 diabetes. Thus, Xen rather than GIP signaling to islets fails early during development of type 2 diabetes. The current crossover study determines if cholinergic signaling relays the effects of Xen on insulin and glucagon release in humans as in mice. Fasted subjects with impaired glucose tolerance were studied. On eight separate occasions, each person underwent a single graded glucose infusion-two each with infusion of albumin, Xen, GIP, and GIP plus Xen. Each infusate was administered +/- atropine. Heart rate and plasma glucose, insulin, C-peptide, glucagon, and pancreatic polypeptide (PP) levels were measured. ISRs were calculated from C-peptide levels. All peptides profoundly increased PP responses. From 0 to 40 min, peptide(s) infusions had little effect on plasma glucose concentrations. However, GIP, but not Xen, rapidly and transiently increased ISRs and glucagon levels. Both responses were further amplified when Xen was co-administered with GIP. From 40 to 240 min, glucose levels and ISRs continually increased while glucagon concentrations declined, regardless of infusate. Atropine increased resting heart rate and blocked all PP responses but did not affect ISRs or plasma glucagon levels during any of the peptide infusions. Thus, cholinergic signaling mediates the effects of Xen on insulin and glucagon release in mice but not humans.	[Wang, Songyan; Oestricker, Lauren Z.; Sterl, Karin; Dunai, Judit; Kilpatrick, C. Rachel; Wice, Burton M.] Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Wallendorf, Michael J.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Patterson, Bruce W.; Reeds, Dominic N.] Washington Univ, Sch Med, Dept Internal Med, Div Nutr Sci Metab & Lipid Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wice, BM (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA.	bwice@wustl.edu		Wice, Burton/0000-0002-4372-1399; Patterson, Bruce W/0000-0001-9261-0233	American Diabetes Association [1-13-CE-46]; Blum Kovler Foundation; NIH [1R01DK088126]; Washington University Diabetes Research Center Immunoassay Core [P60 DK020579]; Washington University Nutrition Obesity Research Center Grant from the National Institute of Diabetes and Digestive and Kidney Diseases [P30DK056341]; Washington University Digestive Disease Research Core Center [P30 DK52574-16]; Washington University Clinical and Translational Science Award from the National Center for Advancing Translational Sciences (NCATS) [UL1 TR000448]; Biologic Therapy Core Facility of the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Mo. (NCI Cancer Center Support) [P30 CA91842]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P30DK020579, P30DK052574] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Blum Kovler Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Diabetes Research Center Immunoassay Core; Washington University Nutrition Obesity Research Center Grant from the National Institute of Diabetes and Digestive and Kidney Diseases; Washington University Digestive Disease Research Core Center; Washington University Clinical and Translational Science Award from the National Center for Advancing Translational Sciences (NCATS); Biologic Therapy Core Facility of the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Mo. (NCI Cancer Center Support); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Portions of this research were supported by funds from the American Diabetes Association (Grant #1-13-CE-46); the Blum Kovler Foundation; NIH (Grant number 1R01DK088126); the Washington University Diabetes Research Center Immunoassay Core (P60 DK020579); the Washington University Nutrition Obesity Research Center Grant (P30DK056341) from the National Institute of Diabetes and Digestive and Kidney Diseases; the Washington University Digestive Disease Research Core Center (P30 DK52574-16); the Washington University Clinical and Translational Science Award (UL1 TR000448) from the National Center for Advancing Translational Sciences (NCATS); and the Biologic Therapy Core Facility of the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Mo. (NCI Cancer Center Support Grant P30 CA91842). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADNER N, 1990, PANCREAS, V5, P460, DOI 10.1097/00006676-199007000-00014; Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Ahren B, 2012, DIABETOLOGIA, V55, P3152, DOI 10.1007/s00125-012-2727-6; Ahren B, 2004, INT TXB DIABETES MEL, P153; Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Alexiou C, 1998, BRAIN RES, V800, P294, DOI 10.1016/S0006-8993(98)00535-6; Anlauf M, 2000, J HISTOCHEM CYTOCHEM, V48, P1617, DOI 10.1177/002215540004801205; Balks HJ, 1997, J CLIN ENDOCR METAB, V82, P786, DOI 10.1210/jc.82.3.786; BOYLE PJ, 1988, J CLIN INVEST, V82, P445, DOI 10.1172/JCI113617; BROOKS DC, 1989, JPEN-PARENTER ENTER, V13, P102, DOI 10.1177/0148607189013001102; BRUNICARDI FC, 1987, AM J SURG, V153, P34, DOI 10.1016/0002-9610(87)90198-X; BRUNICARDI FC, 1988, AM J SURG, V155, P63, DOI 10.1016/S0002-9610(88)80259-9; Brunicardi FC, 1995, INT J PANCREATOL, V18, P177; BRUNICARDI FC, 1990, J SURG RES, V48, P273, DOI 10.1016/0022-4804(90)90058-A; BRUNICARDI FC, 1984, SURG FORUM, V35, P214; BRUNICARDI FC, 1989, AM J SURG, V157, P50, DOI 10.1016/0002-9610(89)90419-4; Chowdhury S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156852; Chowdhury S, 2014, AM J PHYSIOL-GASTR L, V306, pG301, DOI 10.1152/ajpgi.00383.2013; Chowdhury S, 2013, REGUL PEPTIDES, V187, P42, DOI 10.1016/j.regpep.2013.10.003; Christensen M, 2011, DIABETES, V60, P3103, DOI 10.2337/db11-0979; Cline MA, 2007, BEHAV BRAIN RES, V179, P28, DOI 10.1016/j.bbr.2007.01.008; Cooke JH, 2009, OBESITY, V17, P1135, DOI 10.1038/oby.2008.652; Cyphert HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094996; de Courten BV, 2004, DIABETES, V53, P663, DOI 10.2337/diabetes.53.3.663; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Feurle GE, 1998, PEPTIDES, V19, P609, DOI 10.1016/S0196-9781(97)00378-1; FEURLE GE, 1992, J BIOL CHEM, V267, P22305; Feurle GE, 1997, J PEPT RES, V49, P324; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Gautam D, 2007, DIABETES OBES METAB, V9, P158, DOI 10.1111/j.1463-1326.2007.00781.x; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gavin JR, 1999, DIABETES CARE, V22, pS5; Kamiyama Y, 2007, NEUROGASTROENT MOTIL, V19, P233, DOI 10.1111/j.1365-2982.2006.00881.x; Kim ER, 2010, NEUROSCI LETT, V481, P59, DOI 10.1016/j.neulet.2010.06.055; Kirchgessner A L, 1991, Z Gastroenterol Verh, V26, P230; KIRCHGESSNER AL, 1992, DEV DYNAM, V194, P142, DOI 10.1002/aja.1001940207; KIRCHGESSNER AL, 1990, J NEUROSCI, V10, P1626; Kirchgessner AL, 1996, J COMP NEUROL, V371, P270; Leckstrom A, 2009, DIABETES, V58, P87, DOI 10.2337/db08-0260; Lidums I, 2000, GUT, V47, P30, DOI 10.1136/gut.47.1.30; Martin CMA, 2012, BIOCHEM PHARMACOL, V84, P312, DOI 10.1016/j.bcp.2012.04.015; Parkman HP, 1999, GUT, V45, P346, DOI 10.1136/gut.45.3.346; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Renuka TR, 2006, NEUROCHEM RES, V31, P313, DOI 10.1007/s11064-005-9022-6; Rodriguez-Diaz R, 2011, CELL METAB, V14, P45, DOI 10.1016/j.cmet.2011.05.008; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Schirra J, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2008.01246.x; SCHNEEBERGER D, 1991, EUR J CLIN INVEST, V21, P608, DOI 10.1111/j.1365-2362.1991.tb01417.x; SCHVARCZ E, 1995, DIABETES CARE, V18, P1463, DOI 10.2337/diacare.18.11.1463; Sparacino G, 1996, IEEE T BIO-MED ENG, V43, P512, DOI 10.1109/10.488799; Sparacino G, 2002, COMPUT METH PROG BIO, V67, P67, DOI 10.1016/S0169-2607(00)00151-6; Sterl K, 2016, PEPTIDES, V82, P76, DOI 10.1016/j.peptides.2016.06.001; Teff KL, 1999, AM J PHYSIOL-REG I, V276, pR707, DOI 10.1152/ajpregu.1999.276.3.R707; Teff KL, 2004, J CLIN ENDOCR METAB, V89, P5606, DOI 10.1210/jc.2003-032094; Teff KL, 1999, AM J PHYSIOL-REG I, V277, pR198, DOI 10.1152/ajpregu.1999.277.1.R198; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; Wice BM, 2012, DIABETES, V61, P1793, DOI 10.2337/db11-1451; Wice BM, 2010, J BIOL CHEM, V285, P19842, DOI 10.1074/jbc.M110.129304; Zawalich WS, 2004, BIOCHEM BIOPH RES CO, V315, P872, DOI 10.1016/j.bbrc.2004.01.139; Zhang S, 2012, AM J PHYSIOL-GASTR L, V303, pG1347, DOI 10.1152/ajpgi.00116.2012	61	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192441	10.1371/journal.pone.0192441	http://dx.doi.org/10.1371/journal.pone.0192441			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466430	gold, Green Published			2022-12-26	WOS:000425604300059
J	Tasbihgou, SR; Netkova, M; Kalmar, AF; Doorduin, J; Struys, MMRF; Schoemaker, RG; Absalom, AR				Tasbihgou, Setayesh R.; Netkova, Mina; Kalmar, Alain F.; Doorduin, Janine; Struys, Michel M. R. F.; Schoemaker, Regien G.; Absalom, Anthony R.			Brain changes due to hypoxia during light anaesthesia can be prevented by deepening anaesthesia; a study in rats	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; GENERAL-ANESTHESIA; NEUROTROPHIC FACTOR; BEHAVIORAL-CHANGES; CEREBRAL-ISCHEMIA; NERVOUS-SYSTEM; NEUROPROTECTION; SURGERY; AGENTS; BDNF	In anaesthetic practice the risk of cerebral ischemic/hypoxic damage is thought to be attenuated by deep anaesthesia. The rationale is that deeper anaesthesia reduces cerebral oxygen demand more than light anaesthesia, thereby increasing the tolerance to ischemia or hypoxia. However, evidence to support this is scarce. We thus investigated the influence of light versus deep anaesthesia on the responses of rat brains to a period of hypoxia. In the first experiment we exposed adult male Wistar rats to deep or light propofol anaesthesia and then performed [F-18]-Fludeoxyglucose (FDG) Positron Emission Tomography (PET) scans to verify the extent of cerebral metabolic suppression. In subsequent experiments, rats were subjected to light/deep propofol anaesthesia and then exposed to a period of hypoxia or ongoing normoxia (n = 9-11 per group). A further 5 rats, not exposed to anaesthesia or hypoxia, served as controls. Four days later a Novel Object Recognition (NOR) test was performed to assess mood and cognition. After another 4 days, the animals were sacrificed for later immunohistochemical analyses of neurogenesis/neuroplasticity (Doublecortin; DCX), Brain Derived Neurotrophic Factor (BDNF) expression and neuroinflammation (Ionized calcium-binding adaptor protein-1; Iba-1) in hippocampal and piriform cortex slices. The hippocampi of rats subjected to hypoxia during light anaesthesia showed lower DCX positivity, and therefore lower neurogenesis, but higher BDNF levels and microglia hyper-ramification. Exploration was reduced, but no significant effect on NOR was observed. In the piriform cortex, higher DCX positivity was observed, associated with neuroplasticity. All these effects were attenuated by deep anaesthesia. Deepening anaesthesia attenuated the brain changes associated with hypoxia. Hypoxia during light anaesthesia had a prolonged effect on the brain, but no impairment in cognitive function was observed. Although reduced hippocampal neurogenesis may be considered unfavourable, higher BDNF expression, associated with microglia hyper-ramification may suggest activation of repair mechanisms. Increased neuroplasticity observed in the piriform cortex supports this, and might reflect a prolonged state of alertness rather than damage.	[Tasbihgou, Setayesh R.; Netkova, Mina; Kalmar, Alain F.; Struys, Michel M. R. F.; Absalom, Anthony R.] Univ Groningen, Univ Med Ctr Groningen, Dept Anaesthesiol, Groningen, Netherlands; [Doorduin, Janine] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [Struys, Michel M. R. F.] Univ Ghent, Dept Anaesthesia, Ghent, Belgium; [Schoemaker, Regien G.] Univ Groningen, GELIFES, Dept Mol Neurobiol, Groningen, Netherlands	University of Groningen; University of Groningen; Ghent University; University of Groningen	Tasbihgou, SR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Anaesthesiol, Groningen, Netherlands.	s.r.tasbihgou@umcg.nl	Absalom, Anthony/GPG-1582-2022	Absalom, Anthony/0000-0001-7563-9157; Doorduin, Janine/0000-0003-2925-9959; Struys, Michel/0000-0003-0421-536X; Kalmar, Alain/0000-0003-2036-9019; Tasbihgou, Setayesh/0000-0002-6147-6163	Dutch association of anaesthesiology (Nederlandse verenining voor anesthesiologie); Dutch association of anaesthesiology (Nederlandse verenining voor anesthesiologie)	Dutch association of anaesthesiology (Nederlandse verenining voor anesthesiologie); Dutch association of anaesthesiology (Nederlandse verenining voor anesthesiologie)	The study qualified for the Young Investigator Grant from the Dutch association of anaesthesiology (Nederlandse verenining voor anesthesiologie http://www.anesthesiologie.nl/wetenschap/yong-investigator-grant) to AFK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Barrientos RM, 2004, J NEUROIMMUNOL, V155, P119, DOI 10.1016/j.jneuroim.2004.06.009; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Cacciaglia R, 2017, PSYCHONEUROENDOCRINO, V76, P19, DOI 10.1016/j.psyneuen.2016.11.012; Capuron L, 2011, PHARMACOL THERAPEUT, V130, P226, DOI 10.1016/j.pharmthera.2011.01.014; Clarkson AN, 2007, LIFE SCI, V80, P1157, DOI 10.1016/j.lfs.2006.12.022; Cortese GP, 2011, J NEUROSCI, V31, P4274, DOI 10.1523/JNEUROSCI.5818-10.2011; Deng M, 2014, BRIT J ANAESTH, V113, P443, DOI 10.1093/bja/aet469; Deshmukh SS, 2012, WIRES COGN SCI, V3, P231, DOI 10.1002/wcs.1164; Dong YL, 2009, ARCH NEUROL-CHICAGO, V66, P620, DOI 10.1001/archneurol.2009.48; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Eggen BJL, 2013, J NEUROIMMUNE PHARM, V8, P807, DOI 10.1007/s11481-013-9490-4; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; Hellwig S, 2016, BRAIN BEHAV IMMUN, V55, P126, DOI 10.1016/j.bbi.2015.11.008; Hovens IB., 2014, NEUROIMMUNOL NEUROIN, V1, P82, DOI [10.4103/2347-8659.139719, DOI 10.4103/2347-8659.139719]; Hovens IB, 2015, AM J PHYSIOL-REG I, V309, pR148, DOI 10.1152/ajpregu.00002.2015; Hovens IB, 2014, BRAIN BEHAV IMMUN, V38, P202, DOI 10.1016/j.bbi.2014.02.002; Hovens IB, 2013, EXP GERONTOL, V48, P1204, DOI 10.1016/j.exger.2013.07.011; Jevtovic-Todorovic V, 2013, BRIT J ANAESTH, V111, P143, DOI 10.1093/bja/aet177; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Klempin F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025760; Knibbe CAJ, 2005, BRIT J CLIN PHARMACO, V59, P705, DOI 10.1111/j.1365-2125.2005.02239.x; Koerner IP, 2006, CURR OPIN ANESTHESIO, V19, P481, DOI 10.1097/01.aco.0000245271.84539.4c; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lindholm ML, 2009, ANESTH ANALG, V108, P508, DOI 10.1213/ane.0b013e31818f603c; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005; McAuliffe JJ, 2009, ANESTHESIOLOGY, V111, P533, DOI 10.1097/ALN.0b013e3181b060d3; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Monk TG, 2011, CURR OPIN CRIT CARE, V17, P376, DOI 10.1097/MCC.0b013e328348bece; Mortier E, 2000, ACTA NEUROL BELG, V100, P225; Pandit JJ, 2014, BRIT J ANAESTH, V113, P549, DOI 10.1093/bja/aeu313; Perez-Gomez A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-72; Raj DDA, 2015, AGING CELL, V14, P1003, DOI 10.1111/acel.12370; Raj DDA, 2014, NEUROBIOL AGING, V35, P2147, DOI 10.1016/j.neurobiolaging.2014.03.025; Sanders RD, 2005, BEST PRACT RES-CLIN, V19, P461, DOI 10.1016/j.bpa.2005.01.005; Schifilliti D, 2010, CNS DRUGS, V24, P893, DOI 10.2165/11584760-000000000-00000; SCHOEMAKER RG, 1994, PHYSIOL BEHAV, V56, P585, DOI 10.1016/0031-9384(94)90305-0; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Walker FR, 2013, CURR DRUG TARGETS, V14, P1262; Wang L, 2008, CURR OPIN PHARMACOL, V8, P104, DOI 10.1016/j.coph.2007.09.005; Warner DS, 1996, ANESTHESIOLOGY, V84, P1475, DOI 10.1097/00000542-199606000-00024; Xie ZC, 2006, EXP GERONTOL, V41, P346, DOI 10.1016/j.exger.2006.01.014; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zwerus R, 2015, CURR OPIN ANESTHESIO, V28, P424, DOI 10.1097/ACO.0000000000000212	50	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0193062	10.1371/journal.pone.0193062	http://dx.doi.org/10.1371/journal.pone.0193062			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451906	Green Published, gold, Green Submitted			2022-12-26	WOS:000425369800038
J	Subramanian, SP; Babu, P; Palakodeti, D; Subramanian, R				Subramanian, Sabarinath Peruvemba; Babu, Ponnusamy; Palakodeti, Dasaradhi; Subramanian, Ramaswamy			Identification of multiple isomeric core chitobiose-modified high-mannose and paucimannose N-glycans in the planarian Schmidtea mediterranea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; invertebrate; mass spectrometry (MS); galactosyltransferase; antisense RNA; Gal1-4Fuc; GALT-1; O-methylation; planaria; S; mediterranea	CAENORHABDITIS-ELEGANS; ACETYLGLUCOSAMINE RESIDUE; DUGESIA-JAPONICA; REGENERATION; GLCNAC; FUCOSYLATION; SPECIFICITY; PROTEIN; OLIGOSACCHARIDES; GLYCOPROTEIN	Cell surface-associated glycans mediate many cellular processes, including adhesion, migration, signaling, and extracellular matrix organization. The galactosylation of core fucose (GalFuc epitope) in paucimannose and complex-type N-glycans is characteristic of protostome organisms, including flatworms (planarians). Although uninvestigated, the structures of these glycans may play a role in planarian regeneration. Whole-organism MALDI-MS analysis of N-linked oligosaccharides from the planarian Schmidtea mediterranea revealed the presence of multiple isomeric high-mannose and paucimannose structures with unusual mono-, di-, and polygalactosylated (n = 3-5) core fucose structures; the latter structures have not been reported in other systems. Di- and trigalactosylated core fucoses were the most dominant glycomers. N-Glycans showed extensive, yet selective, methylation patterns, ranging from non-methylated to polymethylated glycoforms. Although the majority of glycoforms were polymethylated, a small fraction also consisted of non-methylated glycans. Remarkably, monogalactosylated core fucose remained unmethylated, whereas its polygalactosylated forms were methylated, indicating structurally selective methylation. Using database searches, we identified two potential homologs of the Gal1-4Fuc-synthesizing enzyme from nematodes (GALT-1) that were expressed in the prepharyngeal, pharyngeal, and mesenchymal regions in S. mediterranea. The presence of two GALT-1 homologs suggests different requirements for mono- and polygalactosylation of core fucose for the formation of multiple isomers. Furthermore, we observed variations in core fucose glycosylation patterns in different planarian strains, suggesting evolutionary adaptation in fucose glycosylation. The various core chitobiose modifications and methylations create >60 different glycoforms in S. mediterranea. These results contribute greatly to our understanding of N-glycan biosynthesis and suggest the presence of a GlcNAc-independent biosynthetic pathway in S. mediterranea.	[Subramanian, Sabarinath Peruvemba; Palakodeti, Dasaradhi; Subramanian, Ramaswamy] GKVK Post Off, Inst Stem Cell Biol & Regenerat Med inStem, Bellary Rd, Bangalore 560065, Karnataka, India; [Babu, Ponnusamy] GKVK Post Off, C CAMP, Glyc & Glycoprote Facil, Bellary Rd, Bangalore 560065, Karnataka, India	Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Subramanian, R (corresponding author), GKVK Post Off, Inst Stem Cell Biol & Regenerat Med inStem, Bellary Rd, Bangalore 560065, Karnataka, India.	ponbabu@gmail.com; ramas@instem.res.in	Subramanian, Ramaswamy/Q-8671-2019; Subramanian, Sabarinath Peruvemba/AAN-6684-2021; Subramanian, Sabarinath Peruvemba/AAN-4270-2021	Subramanian, Ramaswamy/0000-0002-6709-190X; Subramanian, Sabarinath Peruvemba/0000-0003-3146-0184; Subramanian, Sabarinath Peruvemba/0000-0003-3146-0184	Mass Spectrometry facility at Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India; Sequencing facility at Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India; Centre for Imaging and Flow cytometry facility (CIFF) at Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India	Mass Spectrometry facility at Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India; Sequencing facility at Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India; Centre for Imaging and Flow cytometry facility (CIFF) at Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India	We thank Prof. Bernard Henrissat (Architecture et Fonction des Macromolecules Biologiques, CNRS, Aix-Marseille Universite, Marseille, France) for sharing FASTA sequences of the GT-92 family of galactosyltransferase. We thank Vairavan Lakshmanan, Dr. Shaik Naseer Pasha, Dr. Praveen Anand, and Dr. Anna Protasio for help with bioinformatics. We acknowledge the support from the Mass Spectrometry facility, Sequencing facility, and Centre for Imaging and Flow cytometry facility (CIFF) at Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India. We thank Dr. Swapna Nandakumar for editing and proofreading the manuscript.	Abnave P, 2014, CELL HOST MICROBE, V16, P338, DOI 10.1016/j.chom.2014.08.002; ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; An B, 2015, ANAL CHEM, V87, P4023, DOI 10.1021/acs.analchem.5b00350; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; BAGUNA J, 1981, HYDROBIOLOGIA, V84, P181, DOI 10.1007/BF00026179; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Brandl H, 2016, NUCLEIC ACIDS RES, V44, pD764, DOI 10.1093/nar/gkv1148; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Cebria F, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00008; Chong T, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-69; Cipollo JF, 2005, J BIOL CHEM, V280, P26063, DOI 10.1074/jbc.M503828200; Crispin M, 2006, GLYCOBIOLOGY, V16, P748, DOI 10.1093/glycob/cwj119; Davies EL, 2017, ELIFE, V6, DOI 10.7554/eLife.21052; Eckmair B, 2016, MOL CELL PROTEOMICS, V15, P573, DOI 10.1074/mcp.M115.051573; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Forsthoefel DJ, 2011, DEV BIOL, V356, P445, DOI 10.1016/j.ydbio.2011.05.669; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Hagen KGT, 2009, GLYCOBIOLOGY, V19, P102, DOI 10.1093/glycob/cwn096; Hanneman AJ, 2006, GLYCOBIOLOGY, V16, P874, DOI 10.1093/glycob/cwl011; Hoja-Lukowicz D, 2000, GLYCOBIOLOGY, V10, P551, DOI 10.1093/glycob/10.6.551; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LIN AI, 1994, GLYCOBIOLOGY, V4, P895, DOI 10.1093/glycob/4.6.895; Liwanag AJM, 2012, PLANT CELL, V24, P5024, DOI 10.1105/tpc.112.106625; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Muramatsu T, 2004, GLYCOCONJUGATE J, V21, P41, DOI 10.1023/B:GLYC.0000043746.77504.28; Natsuka S, 2011, FEBS J, V278, P452, DOI 10.1111/j.1742-4658.2010.07966.x; Paschinger K, 2011, J MASS SPECTROM, V46, P561, DOI 10.1002/jms.1925; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Resch AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034447; Rink JC, 2011, DEVELOPMENT, V138, P3769, DOI 10.1242/dev.066852; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ross KG, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.266; Schachter H, 2009, CARBOHYD RES, V344, P1391, DOI 10.1016/j.carres.2009.04.028; Schiller B, 2012, BIOL CHEM, V393, P661, DOI 10.1515/hsz-2012-0150; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SHAO MC, 1994, CARBOHYD RES, V251, P163, DOI 10.1016/0008-6215(94)84283-3; Stepan H, 2010, CARBOHYD RES, V345, P1504, DOI 10.1016/j.carres.2010.03.027; Suzuki N, 2010, J BIOL CHEM, V285, P5178, DOI 10.1074/jbc.M109.018663; Takahashi N, 2003, EUR J BIOCHEM, V270, P2627, DOI 10.1046/j.1432-1033.2003.03636.x; Takeuchi T, 2016, PROTEOMICS, V16, P3137, DOI 10.1002/pmic.201600001; Titz A, 2009, J BIOL CHEM, V284, P36223, DOI 10.1074/jbc.M109.058354; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Williams SA, 2011, ADV EXP MED BIOL, V705, P397, DOI 10.1007/978-1-4419-7877-6_20; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; Wohlschlager T, 2014, P NATL ACAD SCI USA, V111, pE2787, DOI 10.1073/pnas.1401176111; Wuhrer M, 2004, BIOCHEM J, V378, P625, DOI 10.1042/BJ20031380; Wurtzel O, 2015, DEV CELL, V35, P632, DOI 10.1016/j.devcel.2015.11.004; Yan S, 2015, J PROTEOME RES, V14, P5291, DOI 10.1021/acs.jproteome.5b00746; Yan S, 2015, MOL CELL PROTEOMICS, V14, P2111, DOI 10.1074/mcp.M115.049817; Yang Q, 2017, J BIOL CHEM, V292, P14796, DOI 10.1074/jbc.M117.804070; Yang Q, 2016, J BIOL CHEM, V291, P11064, DOI 10.1074/jbc.M116.720789; Zeleny R, 1997, ANAL BIOCHEM, V246, P96, DOI 10.1006/abio.1996.9973; Zhang Y, 1997, GLYCOBIOLOGY, V7, P1153, DOI 10.1093/glycob/7.8.1153	57	9	9	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6707	6720		10.1074/jbc.RA117.000782	http://dx.doi.org/10.1074/jbc.RA117.000782			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29475940	hybrid, Green Published			2022-12-26	WOS:000431487300008
J	Torii, S; Kubota, C; Saito, N; Kawano, A; Hou, N; Kobayashi, M; Torii, R; Hosaka, M; Kitamura, T; Takeuchi, T; Gomi, H				Torii, Seiji; Kubota, Chisato; Saito, Naoya; Kawano, Ayumi; Hou, Ni; Kobayashi, Masaki; Torii, Ryoko; Hosaka, Masahiro; Kitamura, Tadahiro; Takeuchi, Toshiyuki; Gomi, Hiroshi			The pseudophosphatase phogrin enables glucose-stimulated insulin signaling in pancreatic beta cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; RECEPTOR SUBSTRATE-2; GENE-EXPRESSION; IA-2 FAMILY; IRS-2; PROLIFERATION; PHOSPHORYLATION; DISRUPTION; DEGRADATION; MECHANISMS	Autocrine insulin signaling is critical for pancreatic beta-cell growth and activity and is at least partially controlled by protein-tyrosine phosphatases (PTPs) that act on insulin receptors (IRs). The receptor-type PTP phogrin primarily localizes on insulin secretory granules in pancreatic beta cells. We recently reported that phogrin knockdown decreases the protein levels of insulin receptor substrate 2 (IRS2), whereas high-glucose stimulation promotes formation of a phogrin-IR complex that stabilizes IRS2. However, the underlying molecular mechanisms by which phogrin affects IRS2 levels are unclear. Here, we found that relative to wildtype mice, IRS2 levels in phogrin-knockout mice islets decreased by 44%. When phogrin was silenced by shRNA in pancreatic beta-cell lines, glucose-induced insulin signaling led to proteasomal degradation of IRS2 via a negative feedback mechanism. Phogrin overexpression in a murine hepatocyte cell line consistently prevented chronic insulin treatment-induced IRS2 degradation. In vitro, phogrin directly bound the IR without the assistance of other proteins and protected recombinant PTP1B from oxidation to potentiate its activity toward the IR. Furthermore, phogrin expression suppressed insulin-induced local generation of hydrogen peroxide and subsequent PTP1B oxidation, which allowed progression of IR dephosphorylation. Together, these results suggest that a transient interaction of phogrin with the IR enables glucose-stimulated autocrine insulin signaling through the regulation of PTP1B activity, which is essential for suppressing feedback-mediated IRS2 degradation in pancreatic beta cells.	[Torii, Seiji; Kubota, Chisato; Saito, Naoya; Kawano, Ayumi; Hou, Ni; Torii, Ryoko; Takeuchi, Toshiyuki] Gunma Univ, Biosignal Res Ctr, Maebashi, Gunma 3718512, Japan; [Kobayashi, Masaki; Kitamura, Tadahiro] Gunma Univ, Metab Signal Res Ctr, Inst Mol & Cellular Regulat, Maebashi, Gunma 3718512, Japan; [Hosaka, Masahiro] Akita Prefectural Univ, Dept Biotechnol, Akita 0100195, Japan; [Takeuchi, Toshiyuki] Gunma Univ, Adm Off, Maebashi, Gunma 3718512, Japan; [Gomi, Hiroshi] Nihon Univ, Dept Vet Anat, Coll Bioresource Sci, Fujisawa, Kanagawa 2528510, Japan; [Hou, Ni] Xi An Jiao Tong Univ, Sch Basic Med Sci, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China	Gunma University; Gunma University; Akita Prefectural University; Gunma University; Nihon University; Xi'an Jiaotong University	Torii, S (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Biosignal Res Ctr, Maebashi, Gunma 3718512, Japan.	storii@gunma-u.ac.jp		Hosaka, Masahiro/0000-0002-1422-1774	Japanese Society for the Promotion of Science (JSPS KAKENHI) [24390050]; Institute for Molecular and Cellular Regulation, Gunma University [12026, 14022]; Suzuken Memorial Foundation	Japanese Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Institute for Molecular and Cellular Regulation, Gunma University; Suzuken Memorial Foundation	This work was supported by Grants-in-Aid from the Japanese Society for the Promotion of Science (JSPS KAKENHI, Grant 24390050) and in part by the joint research program of the Institute for Molecular and Cellular Regulation, Gunma University (Grants 12026 and 14022) and in part by the Suzuken Memorial Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Aikin R, 2006, DIABETOLOGIA, V49, P2900, DOI 10.1007/s00125-006-0476-0; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Beith JL, 2008, ENDOCRINOLOGY, V149, P2251, DOI 10.1210/en.2007-1557; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Cai T, 2011, DIABETOLOGIA, V54, P2347, DOI 10.1007/s00125-011-2221-6; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Drake PG, 2003, BIOCHEM J, V373, P393, DOI 10.1042/BJ20021851; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Goldfine AB, 2012, DIABETES OBES METAB, V14, P152, DOI 10.1111/j.1463-1326.2012.01647.x; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Gomi H, 2013, J HISTOCHEM CYTOCHEM, V61, P156, DOI 10.1369/0022155412466872; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Gurevitch D, 2010, DIABETES, V59, P2188, DOI 10.2337/db09-0890; Hou N, 2008, ENDOCRINOLOGY, V149, P1654, DOI 10.1210/en.2007-0988; Hou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047921; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kubosaki A, 2004, DIABETES, V53, P1684, DOI 10.2337/diabetes.53.7.1684; Kubota C, 2010, J BIOL CHEM, V285, P667, DOI 10.1074/jbc.M109.053058; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kushner JA, 2004, DIABETES, V53, P61, DOI 10.2337/diabetes.53.1.61; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Martinez SC, 2006, DIABETES, V55, P1581, DOI 10.2337/db05-0678; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Muller D, 2006, FEBS LETT, V580, P6977, DOI 10.1016/j.febslet.2006.11.066; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Mziaut H, 2008, P NATL ACAD SCI USA, V105, P674, DOI 10.1073/pnas.0710931105; Ohsugi M, 2005, J BIOL CHEM, V280, P4992, DOI 10.1074/jbc.M411727200; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Rhodes CJ, 2013, DIABETES, V62, P2157, DOI 10.2337/db13-0246; Rother KI, 1998, J BIOL CHEM, V273, P17491, DOI 10.1074/jbc.273.28.17491; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Saito N, 2011, TRAFFIC, V12, P499, DOI 10.1111/j.1600-0854.2011.01159.x; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Tiganis T, 2013, FEBS J, V280, P445, DOI 10.1111/j.1742-4658.2012.08563.x; Togashi Y, 2014, ENDOCRINOLOGY, V155, P1643, DOI 10.1210/en.2013-1796; Torii S, 2009, ENDOCR J, V56, P639, DOI 10.1507/endocrj.K09E-157; Torii S, 2009, DIABETES, V58, P682, DOI 10.2337/db08-0970; Torkko JM, 2015, MOL CELL BIOL, V35, P914, DOI 10.1128/MCB.00994-14; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009	50	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5920	5933		10.1074/jbc.RA117.000301	http://dx.doi.org/10.1074/jbc.RA117.000301			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29483197	Green Published, hybrid			2022-12-26	WOS:000430497300014
J	Flockhart, DTT; Coe, JB				Flockhart, D. T. Tyler; Coe, Jason B.			Multistate matrix population model to assess the contributions and impacts on population abundance of domestic cats in urban areas including owned cats, unowned cats, and cats in shelters	PLOS ONE			English	Article							TRAP-NEUTER-RETURN; FREE-ROAMING CATS; FERAL CATS; ANIMAL SHELTERS; FELIS-CATUS; SENSITIVITY-ANALYSIS; MANAGEMENT; EUTHANASIA; PROGRAMS; SURVIVAL	Concerns over cat homelessness, over-taxed animal shelters, public health risks, and environmental impacts has raised attention on urban-cat populations. To truly understand cat population dynamics, the collective population of owned cats, unowned cats, and cats in the shelter system must be considered simultaneously because each subpopulation contributes differently to the overall population of cats in a community (e.g., differences in neuter rates, differences in impacts on wildlife) and cats move among categories through human interventions (e.g., adoption, abandonment). To assess this complex socio-ecological system, we developed a multistate matrix model of cats in urban areas that include owned cats, unowned cats (free-roaming and feral), and cats that move through the shelter system. Our model requires three inputs-location, number of human dwellings, and urban area-to provide testable predictions of cat abundance for any city in North America. Model-predicted population size of unowned cats in seven Canadian cities were not significantly different than published estimates (p = 0.23). Model-predicted proportions of sterile feral cats did not match observed sterile cat proportions for six USA cities (p = 0.001). Using a case study from Guelph, Ontario, Canada, we compared model-predicted to empirical estimates of cat abundance in each subpopulation and used perturbation analysis to calculate relative sensitivity of vital rates to cat abundance to demonstrate how management or mismanagement in one portion of the population could have repercussions across all portions of the network. Our study provides a general framework to consider cat population abundance in urban areas and, with refinement that includes city-specific parameter estimates and modeling, could provide a better understanding of population dynamics of cats in our communities.	[Flockhart, D. T. Tyler; Coe, Jason B.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada; [Flockhart, D. T. Tyler] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada; [Flockhart, D. T. Tyler] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 20742 USA	University of Guelph; University of Guelph; University System of Maryland; University of Maryland Center for Environmental Science	Flockhart, DTT (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada.; Flockhart, DTT (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada.; Flockhart, DTT (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 20742 USA.	tyler.flockhart@umces.edu	Flockhart, D. T. Tyler/J-5374-2014	Flockhart, D. T. Tyler/0000-0002-5832-8610	Nestle A Purina PetCare Canada Chair in Communications; Nestle Purina PetCare Canada Chair in Communications	Nestle A Purina PetCare Canada Chair in Communications(Nestle SA); Nestle Purina PetCare Canada Chair in Communications(Nestle SA)	Funding support for this project was provided from the Nestle A Purina PetCare Canada Chair in Communications. We appreciate the assistance of the Guelph Cat Population Taskforce in supporting data collection and encouraging multi-stakeholder collaboration. We are also very grateful for the feedback provided on early drafts of the manuscript by Drs. A. Greer, J. Horrocks, and A. Willms. In addition, we appreciate comments and feedback by several anonymous reviewers and handling editor C. Lepczyk that have enhanced the manuscript.; Funding support for this project was provided by the Nestle Purina PetCare Canada Chair in Communications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MC, 2004, JAVMA-J AM VET MED A, V225, P1871, DOI 10.2460/javma.2004.225.1871; BAARS MA, 1979, OECOLOGIA, V41, P25, DOI 10.1007/BF00344835; Baker PJ, 2005, MAMMAL REV, V35, P302, DOI 10.1111/j.1365-2907.2005.00071.x; Barker SB, 2008, J VET MED EDUC, V35, P487, DOI 10.3138/jvme.35.4.487; Baxter PWJ, 2006, CONSERV BIOL, V20, P893, DOI 10.1111/j.1523-1739.2006.00378.x; Beck AM, 1996, ANNU REV PUBL HEALTH, V17, P247, DOI 10.1146/annurev.pu.17.050196.001335; Blancher P, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00557-080203; BRAULT S, 1993, ECOLOGY, V74, P1444, DOI 10.2307/1940073; Budke CM, 2009, J APPL ANIM WELF SCI, V12, P277, DOI 10.1080/10888700903163419; CALHOON RE, 1989, J ANIM ECOL, V58, P321, DOI 10.2307/5003; Canadian Federation of Humane Societies, 2012, CATS IN CAN; Canadian Federation of Humane Societies, 2015, AN SHELT STAT 2014; Carter TJ, 2012, MODELING DOMESTIC CA; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2007, ECOL LETT, V10, P1, DOI 10.1111/j.1461-0248.2006.01001.x; Caswell H, 2012, THEOR POPUL BIOL, V82, P329, DOI 10.1016/j.tpb.2012.03.008; Chu K, 2009, JAVMA-J AM VET MED A, V234, P1023, DOI 10.2460/javma.234.8.1023; Clancy EA, 2003, J AM VET MED ASSOC, V222, P1541, DOI 10.2460/javma.2003.222.1541; Curb LA, 2013, ANTHROZOOS, V26, P395, DOI 10.2752/175303713X13697429463673; Dabritz HA, 2006, JAVMA-J AM VET MED A, V229, P74, DOI 10.2460/javma.229.1.74; Danner RM, 2010, PAC SCI, V64, P381, DOI 10.2984/64.3.381; Devillard S, 2003, J ANIM ECOL, V72, P203, DOI 10.1046/j.1365-2656.2003.00692.x; Downes M, 2009, PREV VET MED, V92, P140, DOI 10.1016/j.prevetmed.2009.07.005; Finkler H, 2012, PREV VET MED, V104, P125, DOI 10.1016/j.prevetmed.2011.11.006; Flockhart DTT, 2016, ANIM CONSERV, V19, P472, DOI 10.1111/acv.12264; Flockhart T, PERCEPTIONS CO UNPUB; Gehrt SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075718; Gerhold RW, 2013, ZOONOSES PUBLIC HLTH, V60, P189, DOI 10.1111/j.1863-2378.2012.01522.x; Gunther I, 2011, JAVMA-J AM VET MED A, V238, P1134, DOI 10.2460/javma.238.9.1134; Hall CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151962; Hunter CM, 2005, ECOL MODEL, V188, P15, DOI 10.1016/j.ecolmodel.2005.05.002; HURNI H, 1981, LAB ANIM, V15, P229, DOI 10.1258/002367781780893803; Ireland T, 2016, ECOL MODEL, V337, P123, DOI 10.1016/j.ecolmodel.2016.06.014; Janke N, 2017, EFFECT CAPACITY CARE; JEMMETT JE, 1977, J SMALL ANIM PRACT, V18, P31, DOI 10.1111/j.1748-5827.1977.tb05821.x; Kustritz MVR, 2006, THERIOGENOLOGY, V66, P145, DOI 10.1016/j.theriogenology.2006.03.018; Legge S, 2017, BIOL CONSERV, V206, P293, DOI 10.1016/j.biocon.2016.11.032; Lepczyk CA, 2010, CONSERV BIOL, V24, P627, DOI 10.1111/j.1523-1739.2009.01426.x; Levy JK, 2014, VET J, V201, P269, DOI 10.1016/j.tvjl.2014.05.001; Levy JK, 2004, JAVMA-J AM VET MED A, V225, P1354, DOI 10.2460/javma.2004.225.1354; Levy JK, 2011, THERIOGENOLOGY, V76, P1517, DOI 10.1016/j.theriogenology.2011.06.022; Lohr CA, 2013, CONSERV BIOL, V27, P64, DOI 10.1111/j.1523-1739.2012.01935.x; Longcore T, 2009, CONSERV BIOL, V23, P887, DOI 10.1111/j.1523-1739.2009.01174.x; Lord LK, 2007, JAVMA-J AM VET MED A, V230, P217, DOI 10.2460/javma.230.2.217; Lord LK, 2009, JAVMA-J AM VET MED A, V235, P160, DOI 10.2460/javma.235.2.160; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Loyd KAT, 2010, ECOL SOC, V15; MANNING AM, 1992, ANTHROZOOS, V5, P192, DOI 10.2752/089279392787011368; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; McCarthy RJ, 2013, JAVMA-J AM VET MED A, V243, P502, DOI 10.2460/javma.243.4.502; Miller PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113553; Morris KN, 2014, J APPL ANIM WELF SCI, V17, P59, DOI 10.1080/10888705.2014.856250; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; NASSAR R, 1982, AM J VET RES, V43, P167; New John C. Jr, 2004, Journal of Applied Animal Welfare Science, V7, P229, DOI 10.1207/s15327604jaws0704_1; Nowicki Stacy A, 2011, STANFORD J ANIMAL LA, V4, P97; Nutter FB, 2004, JAVMA-J AM VET MED A, V225, P1399, DOI 10.2460/javma.2004.225.1399; Peterson MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044616; Pichancourt JB, 2012, J APPL ECOL, V49, P52, DOI 10.1111/j.1365-2664.2011.02093.x; Roth G, 2016, METHODS ECOL EVOL, V7, P1438, DOI 10.1111/2041-210X.12622; Scarlett J, 2012, J APPL ANIM WELF SCI, V15, P53, DOI 10.1080/10888705.2012.624902; Schmidt P.M., 2007, Wildlife Biology in Practice, V3, P18, DOI 10.2461/wbp.2007.3.3; Schmidt PM, 2007, J WILDLIFE MANAGE, V71, P915, DOI 10.2193/2006-066; Schmidt PM, 2009, WILDLIFE RES, V36, P117, DOI 10.1071/WR08018; Scott KC, 2002, J AM VET MED ASSOC, V221, P1136, DOI 10.2460/javma.2002.221.1136; SCOTT PP, 1959, NATURE, V184, P2022, DOI 10.1038/1842022a0; Shyu E, 2013, ECOL APPL, V23, P1893, DOI 10.1890/12-1712.1; Sims V, 2008, DIVERS DISTRIB, V14, P387, DOI 10.1111/j.1472-4642.2007.00444.x; Slater MR, 2008, PREV VET MED, V85, P267, DOI 10.1016/j.prevetmed.2008.02.001; Statistics Canada, 2012, POP DWELL COUNT HIGH; Statistics Canada, 2012, POP CTR CART BOUND F; Stoskopf MK, 2004, JAVMA-J AM VET MED A, V225, P1361, DOI 10.2460/javma.2004.225.1361; Stott I, 2010, METHODS ECOL EVOL, V1, P242, DOI 10.1111/j.2041-210X.2010.00032.x; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; US Census Bureau, 2010, 2010 CENS URB AR BOU; US Census Bureau, 2010, 2010 CENS URB RUR TO; van Heezik Y, 2010, BIOL CONSERV, V143, P121, DOI 10.1016/j.biocon.2009.09.013; Wald DM, 2013, BIOL CONSERV, V167, P414, DOI 10.1016/j.biocon.2013.07.034; Wallace JL, 2006, J FELINE MED SURG, V8, P279, DOI 10.1016/j.jfms.2006.02.004; Weiss Emily, 2012, Animals (Basel), V2, P301, DOI 10.3390/ani2020301; Weiss Emily, 2012, Animals (Basel), V2, P144, DOI 10.3390/ani2020144; Wenstrup J, 1999, J Appl Anim Welf Sci, V2, P303, DOI 10.1207/s15327604jaws0204_5; White SC, 2010, J APPL ANIM WELF SCI, V13, P191, DOI 10.1080/10888700903579903; YODZIS P, 1992, AM NAT, V139, P1151, DOI 10.1086/285380	84	10	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192139	10.1371/journal.pone.0192139	http://dx.doi.org/10.1371/journal.pone.0192139			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489854	gold, Green Published, Green Submitted			2022-12-26	WOS:000426276000018
J	Ruckert, A; Allen, LN; Ramirez, RA				Ruckert, Alice; Allen, L. Niel; Ramirez, Ricardo A.			Combinations of plant water-stress and neonicotinoids can lead to secondary outbreaks of Banks grass mite (Oligonychus pratensis Banks)	PLOS ONE			English	Article							2-SPOTTED SPIDER-MITE; TETRANYCHUS-URTICAE ACARI; DROUGHT STRESS; DIFFERENTIAL INDUCTION; SEED TREATMENTS; INSECTICIDES; TEMPERATURE; RESISTANCE; TOXICITY; PHYTOSEIIDAE	Spider mites, a cosmopolitan pest of agricultural and landscape plants, thrive under hot and dry conditions, which could become more frequent and extreme due to climate change. Recent work has shown that neonicotinoids, a widely used class of systemic insecticides that have come under scrutiny for non-target effects, can elevate spider mite populations. Both water-stress and neonicotinoids independently alter plant resistance against herbivores. Yet, the interaction between these two factors on spider mites is unclear, particularly for Banks grass mite (Oligonychus pratensis; BGM). We conducted a field study to examine the effects of water-stress (optimal irrigation = 100% estimated evapotranspiration (ET) replacement, water stress = 25% of the water provided to optimally irrigated plants) and neonicotinoid seed treatments (control, clothianidin, thiamethoxam) on resident mite populations in corn (Zea mays, hybrid KSC7112). Our field study was followed by a manipulative field cage study and a parallel greenhouse study, where we tested the effects of water stress and neonicotinoids on BGM and plant responses. We found that water-stress and clothianidin consistently increased BGM densities, while thiamethoxam-treated plants only had this effect when plants were mature. Water-stress and BGM herbivory had a greater effect on plant defenses than neonicotinoids alone, and the combination of BGM herbivory with the two abiotic factors increased the concentration of total soluble proteins. These results suggest that spider mite outbreaks by combinations of changes in plant defenses and protein concentration are triggered by water-stress and neonicotinoids, but the severity of the infestations varies depending on the insecticide active ingredient.	[Ruckert, Alice; Ramirez, Ricardo A.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Allen, L. Niel] Utah State Univ, Civil & Environm Engn Dept, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Ruckert, A (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	ruckert.alice@gmail.com	Ramirez, Ricardo/AAE-8394-2021		United States Department of Agriculture [2012-67013-19346]; National Institute of Food and Agriculture and Agriculture and Food Research Initiative	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institute of Food and Agriculture and Agriculture and Food Research Initiative	This work was supported by the United States Department of Agriculture (https://www.usda.gov/), grant number:2012-67013-19346; and by The National Institute of Food and Agriculture and Agriculture and Food Research Initiative (https://nifa.usda.gov/program/agriculture-and-food-research-initiative-afri). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 1983, RECENT ADV PHYTOCHEM; AVERY DJ, 1968, J HORTIC SCI BIOTECH, V43, P463, DOI 10.1080/00221589.1968.11514274; Barati R, 2015, EXP APPL ACAROL, V66, P481, DOI 10.1007/s10493-015-9910-7; Barto EK, 2005, OECOLOGIA, V146, P169, DOI 10.1007/s00442-005-0207-0; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Blasi EAR, 2015, INT J ACAROL, V41, P10, DOI 10.1080/01647954.2014.988643; Borichenko N., 1982, LOZRSKA NAUKA HORTIC, V19, P44; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAY EA, 2002, BIOCH MOL BIOL PLANT, P1158; Brodbeck B., 1987, P347; Cakir R, 2004, FIELD CROP RES, V89, P1, DOI 10.1016/j.fcr.2004.01.005; Cambier V, 2000, PHYTOCHEMISTRY, V53, P223, DOI 10.1016/S0031-9422(99)00498-7; CHANDLER LD, 1979, ENVIRON ENTOMOL, V8, P196, DOI 10.1093/ee/8.2.196; Cipollini DF, 2000, J CHEM ECOL, V26, P1411, DOI 10.1023/A:1005540107957; CROFT BA, 1988, EXP APPL ACAROL, V4, P277, DOI 10.1007/BF01196191; dal Soglio FK, 1998, BIOL CONTROL, V12, P111, DOI 10.1006/bcon.1998.0623; Douglas MR, 2015, ENVIRON SCI TECHNOL, V49, P5088, DOI 10.1021/es506141g; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Elzen GW, 2001, J ECON ENTOMOL, V94, P55, DOI 10.1603/0022-0493-94.1.55; ENGLISHLOEB GM, 1990, ECOLOGY, V71, P1401, DOI 10.2307/1938277; Fazeli F, 2007, BIOL PLANTARUM, V51, P98, DOI 10.1007/s10535-007-0020-1; FERRO DN, 1979, ENVIRON ENTOMOL, V8, P701, DOI 10.1093/ee/8.4.701; Ford KA, 2010, P NATL ACAD SCI USA, V107, P17527, DOI 10.1073/pnas.1013020107; Gerhards M, 2016, INT J APPL EARTH OBS, V53, P27, DOI 10.1016/j.jag.2016.08.004; Gonias E., 2006, P BELTW COTT C SAN A; Gonias ED, 2008, J PLANT GROWTH REGUL, V27, P77, DOI 10.1007/s00344-007-9033-4; Gouinguene SP, 2012, PLANT PHYSIOL, V129, P1296; Gutbrodt B, 2011, OIKOS, V120, P1732, DOI 10.1111/j.1600-0706.2011.19558.x; Jaleel CA, 2007, COLLOID SURFACE B, V60, P201, DOI 10.1016/j.colsurfb.2007.06.010; James DG, 2003, EXP APPL ACAROL, V31, P275, DOI 10.1023/B:APPA.0000010383.33351.2f; Khajehali J, 2011, PEST MANAG SCI, V67, P1424, DOI 10.1002/ps.2191; Kolodziej A., 1975, P 8 INT C PLANT PROT, P217; Krischik V.A., 1983, P463; Laurino D, 2011, B INSECTOL, V64, P107; Logan JA, 1983, COLORADO AGR EXP S S, V585S, P1; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Mohammadkhani N, 2008, TURK J BIOL, V32, P23; Mondel M., 2006, J LIFE EARTH SCI, V1, P43; Moran PJ, 1999, J PHYTOPATHOL, V147, P313, DOI 10.1046/j.1439-0434.1999.147005313.x; Moser SE, 2009, BIOL CONTROL, V51, P487, DOI 10.1016/j.biocontrol.2009.09.001; National oceanic and atmospheric administration, 2014, US SEAS DROUGHT OUTL; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; PERRING TM, 1984, ENVIRON ENTOMOL, V13, P338, DOI 10.1093/ee/13.2.338; Poletti M, 2007, BIOL CONTROL, V40, P30, DOI 10.1016/j.biocontrol.2006.09.001; PRICE JF, 1982, HORTSCIENCE, V17, P895; REYNOLDS S G, 1970, Journal of Hydrology (Amsterdam), V11, P258, DOI 10.1016/0022-1694(70)90066-1; Rhoades D.F., 1983, P155; Sanchez-Hernandez C, 2004, PHYSIOL PLANTARUM, V122, P254, DOI 10.1111/j.0031-9317.2004.00398.x; Smith JF, 2013, J ECON ENTOMOL, V106, P807, DOI 10.1603/EC10125; Stavrinides MC, 2010, ENVIRON ENTOMOL, V39, P1232, DOI 10.1603/EN09288; STIEFEL VL, 1992, J ECON ENTOMOL, V85, P2170, DOI 10.1093/jee/85.6.2170; STOUT MJ, 1994, J CHEM ECOL, V20, P2575, DOI 10.1007/BF02036193; SUMMERS F M, 1972, Acarologia (Paris), V14, P170; Szczepaniec Adrianna, 2013, Arboriculture & Urban Forestry, V39, P231; Szczepaniec A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062620; Szczepaniec A, 2013, EXP APPL ACAROL, V59, P307, DOI 10.1007/s10493-012-9614-1; Szczepaniec A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020018; Tomczyk A, 1985, SPIDER MITES THEIR A, V1A, P317; Ullah MS, 2016, EXP APPL ACAROL, V69, P453, DOI 10.1007/s10493-016-0053-2; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Walker WR., 1987, SURFACE IRRIGATION T, pxiii; WHITE T C R, 1969, Ecology (Washington D C), V50, P905, DOI 10.2307/1933707; WRENSCH DL, 1975, OECOLOGIA, V18, P259, DOI 10.1007/BF00345850; Ximenez-Embun MG, 2017, J INSECT PHYSIOL, V96, P73, DOI 10.1016/j.jinsphys.2016.10.015; Ximenez-Embun MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145275; Yu LX, 1998, J PLANT PHYSIOL, V153, P745, DOI 10.1016/S0176-1617(98)80230-7	67	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191536	10.1371/journal.pone.0191536	http://dx.doi.org/10.1371/journal.pone.0191536			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489819	gold, Green Published, Green Submitted			2022-12-26	WOS:000426276000008
J	Bleedorn, JA; Hornberger, TA; Goodman, CA; Hao, ZL; Sample, SJ; Amene, E; Markel, MD; Behan, M; Muir, P				Bleedorn, Jason A.; Hornberger, Troy A.; Goodman, Craig A.; Hao, Zhengling; Sample, Susannah J.; Amene, Ermias; Markel, Mark D.; Behan, Mary; Muir, Peter			Temporal mechanically-induced signaling events in bone and dorsal root ganglion neurons after in vivo bone loading	PLOS ONE			English	Article							FUNCTIONAL ADAPTATION; GENE-EXPRESSION; TRANSCRIPTION FACTORS; RAT ULNA; STRAIN; MECHANOTRANSDUCTION; PATHWAYS; OSTEOCYTES; CELLS; OSTEOBLASTS	Mechanical signals play an integral role in the regulation of bone mass and functional adaptation to bone loading. The osteocyte has long been considered the principle mechanosensory cell type in bone, although recent evidence suggests the sensory nervous system may play a role in mechanosensing. The specific signaling pathways responsible for functional adaptation of the skeleton through modeling and remodeling are not clearly defined. In vitro studies suggest involvement of intracellular signaling through mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt), and mammalian target of rapamycin (mTOR). However, anabolic signaling responses to bone loading using a whole animal in vivo model have not been studied in detail. Therefore, we examined mechanically-induced signaling events at five time points from 0 to 24 hours after loading using the rat in vivo ulna endloading model. Western blot analysis of bone for MAPK's, PI3K/Akt, and mTOR signaling, and quantitative reverse transcription polymerase chain reaction (qRT-PCR) to estimate gene expression of calcitonin gene-related protein alpha (CGRP-alpha), brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), c-jun, and c-fos in dorsal root ganglion (DRG) of the brachial intumescence were performed. There was a significant increase in signaling through MAPK's including extracellular signal-related kinase (ERK) and c-Jun N-terminal kinase (JNK) in loaded limbs at 15 minutes after mechanical loading. Ulna loading did not significantly influence expression of the genes of interest in DRG neurons. Bone signaling and DRG gene expression from the loaded and contralateral limbs was correlated (S-R>0.4 0, P<0.05). However, bone signaling did not correlate with expression of the genes of interest in DRG neurons. These results suggest that signaling through the MAPK pathway may be involved in load-induced bone formation in vivo. Further characterization of the molecular events involved in regulation of bone adaptation is needed to understand the timing and impact of loading events, and the contribution of the neuronal signaling to functional adaptation of bone.	[Bleedorn, Jason A.; Hao, Zhengling; Sample, Susannah J.; Markel, Mark D.; Muir, Peter] Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Hornberger, Troy A.; Goodman, Craig A.; Behan, Mary] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI USA; [Goodman, Craig A.] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic, Australia; [Goodman, Craig A.] Victoria Univ, Australian Inst Musculoskeletal Sci AIMSS, St Albans, Vic, Australia; [Amene, Ermias] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Victoria University; Victoria University; University of Wisconsin System; University of Wisconsin Madison	Muir, P (corresponding author), Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	peter.muir@wisc.edu	Bleedorn, Jason A/AAE-2115-2019; Muir, Peter/AAH-8057-2021	Bleedorn, Jason A/0000-0003-2987-7722; Muir, Peter/0000-0003-0028-6005; Goodman, Craig/0000-0002-5874-7743	Graduate School, University of Wisconsin-Madison; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [AR057347]	Graduate School, University of Wisconsin-Madison; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by a grant from the Graduate School, University of Wisconsin-Madison to PM; and the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number AR057347 to TAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; BUCKLEY MJ, 1988, BONE MINER, V4, P225; Burr D B, 1997, Exerc Sport Sci Rev, V25, P171; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; Burr DB, 1996, BONE, V18, P405, DOI 10.1016/8756-3282(96)00028-2; Cowin SC, 1998, BONE, V22, p119S, DOI 10.1016/S8756-3282(98)00011-8; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188; FROST HM, 1983, CLIN ORTHOP RELAT R, P286; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Goodman CA, 2015, BONE, V80, P24, DOI 10.1016/j.bone.2015.04.014; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Gross TS, 1997, J BONE MINER RES, V12, P982, DOI 10.1359/jbmr.1997.12.6.982; HILL EL, 1991, CELL TISSUE RES, V264, P469, DOI 10.1007/BF00319037; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Jessop HL, 2002, BONE, V31, P186, DOI 10.1016/S8756-3282(02)00797-4; Kelly NH, 2016, BONE, V86, P22, DOI 10.1016/j.bone.2016.02.007; Kotha SP, 2004, J BIOMECH, V37, P541, DOI 10.1016/j.jbiomech.2003.08.009; Kyono A, 2012, J BONE MINER METAB, V30, P19, DOI 10.1007/s00774-011-0288-2; Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marenzana M, 2007, BONE, V41, P206, DOI 10.1016/j.bone.2007.04.184; McKenzie JA, 2011, BONE, V48, P250, DOI 10.1016/j.bone.2010.09.005; McNamara LM, 2009, ANAT REC, V292, P355, DOI 10.1002/ar.20869; Millie H-F., 2004, SCI STKE, V2004; Mosley JR, 1997, BONE, V20, P191, DOI 10.1016/S8756-3282(96)00385-7; Muir P, 1999, BONE, V25, P571, DOI 10.1016/S8756-3282(99)00205-7; Niziolek PJ, 2009, J CELL PHYSIOL, V221, P579, DOI 10.1002/jcp.21887; NUNAMAKER DM, 1990, J ORTHOPAED RES, V8, P604, DOI 10.1002/jor.1100080417; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; PALUMBO C, 1986, CELL TISSUE RES, V246, P125; Papachristou D, 2006, EUR J ORTHODONT, V28, P20, DOI 10.1093/ejo/cji101; Papachristou DJ, 2009, BIOESSAYS, V31, P794, DOI 10.1002/bies.200800223; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Rapanelli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008656; Riddle RC, 2009, J ORTHOP RES, V27, P143, DOI 10.1002/jor.20723; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Robling AG, 2009, CRIT REV EUKAR GENE, V19, P319, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.50; RUBIN CT, 1984, J THEOR BIOL, V107, P321, DOI 10.1016/S0022-5193(84)80031-4; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Sample SJ, 2008, J BONE MINER RES, V23, P1372, DOI [10.1359/jbmr.080407, 10.1359/JBMR.080407]; Sample SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113959; Sample SJ, 2010, J BONE MINER RES, V25, P2016, DOI 10.1002/jbmr.101; Saxon LK, 2005, BONE, V36, P454, DOI 10.1016/j.bone.2004.12.001; Schaffler MB, 2014, CALCIFIED TISSUE INT, V94, P5, DOI 10.1007/s00223-013-9790-y; Schriefer JL, 2005, J BIOMECH, V38, P1838, DOI 10.1016/j.jbiomech.2004.08.017; Spencer GJ, 2004, FEBS LETT, V559, P6, DOI 10.1016/S0014-5793(04)00053-5; Squillacioti C, 2009, EUR J HISTOCHEM, V53, P239, DOI 10.4081/ejh.2009.e29; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tomlinson RE, 2017, P NATL ACAD SCI USA, V114, pE3632, DOI 10.1073/pnas.1701054114; TORRANCE AG, 1994, CALCIFIED TISSUE INT, V54, P241, DOI 10.1007/BF00301686; Wadhwa S, 2002, J BONE MINER RES, V17, P266, DOI 10.1359/jbmr.2002.17.2.266; Warden SJ, 2005, J BONE MINER RES, V20, P809, DOI 10.1359/JBMR.041222; Wu Q, 2009, NEUROSCI LETT, V463, P254, DOI 10.1016/j.neulet.2009.07.078	59	0	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0192760	10.1371/journal.pone.0192760	http://dx.doi.org/10.1371/journal.pone.0192760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29486004	Green Published, Green Accepted, gold			2022-12-26	WOS:000426242400011
J	Wu, YM; Luna, MJ; Bonilla, LS; Ryba, NJP; Pickel, JM				Wu, Youmei; Luna, Maria Jose; Bonilla, Lauren S.; Ryba, Nicholas J. P.; Pickel, James M.			Characterization of knockin mice at the Rosa26, Tac1 and Plekhg1 loci generated by homologous recombination in oocytes	PLOS ONE			English	Article							RABIES VIRUS; WEB TOOL; GENOME; CRISPR/CAS9; EFFICIENCY; CHOPCHOP; SYSTEMS; SWEET; TASTE; RATS	Design and engineering of complex knockin mice has revolutionized the in vivo manipulation of genetically defined cells. Recently development of the bacterial clustered regularly interspersed short palindromic repeats (CRISPR) associated protein 9 (Cas9) system for single site cleavage of mammalian genomes has opened the way for rapid generation of knockin mice by targeting homology directed repair to selected cleavage sites. We used this approach to generate new lines of mice that will be useful for a variety of aspects of neuroscience research. These lines have been bred to homozygosity and details of the expression and function of the transgenes are reported. Two lines target the Rosa26-locus and have been engineered to allow Cre-dependent expression of the avian tva receptor, and Cre-dependent expression of a cell surface targeted spaghetti-monster carrying many copies of the "ollas-tag". Another line expresses red fluorescent protein and tva in Tacl-positive neurons; the fourth line targets FlpO expression to Plekhg1 expressing neurons, providing a powerful approach to modify gene expression in thalamic excitatory neurons.	[Wu, Youmei; Luna, Maria Jose; Bonilla, Lauren S.; Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; [Pickel, James M.] NIMH, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Ryba, NJP (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.	nick.ryba@nih.gov	Core, Vector/CAF-4832-2022	Ryba, Nicholas/0000-0002-2060-8393; Bonilla, Lauren/0000-0002-9151-9603	National Institutes of Health, National Institute of Dental and Craniofacial Research [ZIA-DE000561]; National Institute of Mental Health [ZIA-MH002901]	National Institutes of Health, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Intramural program of the National Institutes of Health, National Institute of Dental and Craniofacial Research (N.J.P.R.) ZIA-DE000561 and the National Institute of Mental Health (J.M.P.) ZIA-MH002901. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; Horii T, 2016, ENDOCR J, V63, P213, DOI 10.1507/endocrj.EJ15-0734; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaneko T, 2015, METHODS MOL BIOL, V1239, P307, DOI 10.1007/978-1-4939-1862-1_18; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Ma YW, 2016, RNA BIOL, V13, P605, DOI 10.1080/15476286.2016.1185591; Ma YW, 2014, FEBS J, V281, P3779, DOI 10.1111/febs.12935; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Osakada F, 2013, NAT PROTOC, V8, P1583, DOI 10.1038/nprot.2013.094; Peng YQ, 2015, NATURE, V527, P512, DOI 10.1038/nature15763; Reardon TR, 2016, NEURON, V89, P711, DOI 10.1016/j.neuron.2016.01.004; Sakuma T, 2017, METHODS MOL BIOL, V1630, P25, DOI 10.1007/978-1-4939-7128-2_2; Tan CL, 2016, CELL, V167, P47, DOI 10.1016/j.cell.2016.08.028; Viswanathan S, 2015, NAT METHODS, V12, P568, DOI 10.1038/nmeth.3365; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wu J, 2007, CELL MOL LIFE SCI, V64, P2933, DOI 10.1007/s00018-007-7206-8; Yang HY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/569325	27	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0193129	10.1371/journal.pone.0193129	http://dx.doi.org/10.1371/journal.pone.0193129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29485996	Green Submitted, gold, Green Published			2022-12-26	WOS:000426242400015
J	Palavutitotai, N; Jitmuang, A; Tongsai, S; Kiratisin, P; Angkasekwinai, N				Palavutitotai, Nattawan; Jitmuang, Anupop; Tongsai, Sasima; Kiratisin, Pattarachai; Angkasekwinai, Nasikarn			Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections	PLOS ONE			English	Article							ANTIBIOTIC-THERAPY; BACTEREMIA; PNEUMONIA; COLISTIN; METAANALYSIS; CARBAPENEMS; MONOTHERAPY; POLYMYXINS; PREVENTION; MORTALITY	Background The incidence of nosocomial infections from extensively drug-resistant Pseudomonas aeruginosa (XDR-PA) has been increasing worldwide. We investigated the prevalence and factors associated with XDR-PA infections, including the factors that predict mortality. Methods We retrospectively studied a cohort of adult, hospitalized patients with P. aeruginosa (PA) infections between April and December 2014. Results Of the 255 patients with PA infections, 56 (22%) were due to XDR-PA, 32 (12.5%) to multidrug resistant Pseudomonas aeruginosa (MDR-PA), and 167 (65.5%) to non-MDR PA. Receiving total parenteral nutrition (adjusted OR [aOR] 6.21; 95% CI 1.05-36.70), prior carbapenem use (aOR 4.88; 95% CI 2.36-10.08), and prior fluoroquinolone use (aOR 3.38; 95% CI 1.44-7.97) were independently associated with the XDR-PA infections. All XDR-PA remained susceptible to colistin. Factors associated with mortality attributable to the infections were the presence of sepsis/septic shock (aOR 11.60; 95% CI 4.66-28.82), admission to a medical department (aOR 4.67; 95% CI 1.81-12.06), receiving a central venous catheter (aOR 3.78; 95% CI 1.50-9.57), and XDR-PA infection (aOR 2.73; 95% CI 1.05-7.08). Conclusion The prevalence of XDR-PA infections represented almost a quarter of Pseudomonas aeruginosa hospital-acquired infections and rendered a higher mortality. The prompt administration of an appropriate empirical antibiotic should be considered when an XDR-PA infection is suspected.	[Palavutitotai, Nattawan; Jitmuang, Anupop; Tongsai, Sasima; Angkasekwinai, Nasikarn] Mahidol Univ, Siriraj Hosp, Div Infect Dis & Trop Med, Dept Med,Fac Med, Bangkok, Thailand; [Kiratisin, Pattarachai] Mahidol Univ, Siriraj Hosp, Dept Microbiol, Fac Med, Bangkok, Thailand	Mahidol University; Mahidol University	Angkasekwinai, N (corresponding author), Mahidol Univ, Siriraj Hosp, Div Infect Dis & Trop Med, Dept Med,Fac Med, Bangkok, Thailand.	nasikarn@gmail.com	Angkasekwinai, Nasikarn/AAS-3199-2020	Tongsai, Sasima/0000-0002-2310-8888	Faculty of Medicine Siriraj Hospital, Mahidol University [R015731058]	Faculty of Medicine Siriraj Hospital, Mahidol University	This work was supported by the Faculty of Medicine Siriraj Hospital, Mahidol University, Grant number R015731058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, UNDERSTANDING STUDIE, P61; Bodro M, 2015, TRANSPLANTATION, V99, P616, DOI 10.1097/TP.0000000000000366; CDC, 2013, CDC NHSN SURV DEF HE; Chittawatanarat K, 2014, INFECT DRUG RESIST, V7, P203, DOI 10.2147/IDR.S67267; CISI, 2010, M100S22 CLSI; Dejsirilert Surang, 2009, J Med Assoc Thai, V92 Suppl 4, pS68; Dupont H, 2001, INTENS CARE MED, V27, P355, DOI 10.1007/s001340000640; El Solh AA, 2009, J ANTIMICROB CHEMOTH, V64, P229, DOI 10.1093/jac/dkp201; Falagas ME, 2008, CLIN INFECT DIS, V46, P1121, DOI 10.1086/528867; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012; Falagas ME, 2006, ANTIMICROB AGENTS CH, V50, P2541, DOI 10.1128/AAC.00224-06; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hirsch EB, 2010, EXPERT REV PHARM OUT, V10, P441, DOI [10.1586/erp.10.49, 10.1586/ERP.10.49]; Hu YM, 2013, INT J ANTIMICROB AG, V42, P492, DOI 10.1016/j.ijantimicag.2013.09.002; Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200; Khuntayaporn P, 2013, MICROBIOL IMMUNOL, V57, P170, DOI 10.1111/1348-0421.12021; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Liew YX, 2013, AM J INFECT CONTROL, V41, P140, DOI 10.1016/j.ajic.2012.02.025; Valderrama SL, 2016, BIOMEDICA, V36, P69, DOI 10.7705/biomedica.v36i2.2784; Ly NS, 2015, J ANTIMICROB CHEMOTH, V70, P1434, DOI 10.1093/jac/dku567; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Pena C, 2013, EUR J CLIN MICROBIOL, V32, P413, DOI 10.1007/s10096-012-1758-8; Pena C, 2012, EUR J CLIN MICROBIOL, V31, P2791, DOI 10.1007/s10096-012-1629-3; Petrosillo N, 2008, CLIN MICROBIOL INFEC, V14, P816, DOI 10.1111/j.1469-0691.2008.02061.x; Gomes MZR, 2012, BRAZ J INFECT DIS, V16, P219, DOI 10.1590/S1413-86702012000300001; Rosenthal VD, 2014, AM J INFECT CONTROL, V42, P942, DOI 10.1016/j.ajic.2014.05.029; Samonis G, 2014, INFECTION, V42, P721, DOI 10.1007/s15010-014-0635-z; Siempos II, 2007, EUR RESPIR J, V29, P548, DOI 10.1183/09031936.00080206; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174; Willmann M, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0650-9; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357; Zusman O, 2013, ANTIMICROB AGENTS CH, V57, P5104, DOI 10.1128/AAC.01230-13	34	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193431	10.1371/journal.pone.0193431	http://dx.doi.org/10.1371/journal.pone.0193431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470531	Green Published, Green Submitted, gold			2022-12-26	WOS:000425831000054
J	Sharifi, S; Pakdel, A; Ebrahimi, M; Reecy, JM; Farsani, SF; Ebrahimie, E				Sharifi, Somayeh; Pakdel, Abbas; Ebrahimi, Mansour; Reecy, James M.; Farsani, Samaneh Fazeli; Ebrahimie, Esmaeil			Integration of machine learning and meta-analysis identifies the transcriptomic bio-signature of mastitis disease in cattle	PLOS ONE			English	Article							ESCHERICHIA-COLI MASTITIS; ACUTE-PHASE PROTEINS; KAPPA-B-ZETA; CLINICAL MASTITIS; GENE-EXPRESSION; MILK-YIELD; REPRODUCTIVE-PERFORMANCE; IMMUNE-RESPONSES; NUCLEAR-PROTEIN; DAIRY-COWS	Gram-negative bacteria such as Escherichia coli (E. coli) are assumed to be among the main agents that cause severe mastitis disease with clinical signs in dairy cattle. Rapid detection of this disease is so important in order to prevent transmission to other cows and helps to reduce inappropriate use of antibiotics. With the rapid progress in high-throughput technologies, and accumulation of various kinds of '-omics' data in public repositories, there is an opportunity to retrieve, integrate, and reanalyze these resources to improve the diagnosis and treatment of different diseases and to provide mechanistic insights into host resistance in an efficient way. Meta-analysis is a relatively inexpensive option with good potential to increase the statistical power and generalizability of single-study analysis. In the current meta-analysis research, six microarray-based studies that investigate the transcriptome profile of mammary gland tissue after induced mastitis by E. coli infection were used. This meta-analysis not only reinforced the findings in individual studies, but also several novel terms including responses to hypoxia, response to drug, anti-apoptosis and positive regulation of transcription from RNA polymerase II promoter enriched by up-regulated genes. Finally, in order to identify the small sets of genes that are sufficiently informative in E. coli mastitis, the differentially expressed gene introduced by meta-analysis were prioritized by using ten different attribute weighting algorithms. Twelve meta-genes were detected by the majority of attribute weighting algorithms (with weight above 0.7) as most informative genes including CXCL8 (IL8), NFKBIZ, HP, ZC3H12A, PDE4B, CASP4, CXCL2, CCL20, GRO1 (CXCL1), CFB, S100A9, and S100A8. Interestingly, the results have been demonstrated that all of these genes are the key genes in the immune response, inflammation or mastitis. The Decision tree models efficiently discovered the best combination of the meta-genes as bio-signature and confirmed that some of the top-ranked genes -ZC3H12A, CXCL2, GRO, CFB-as biomarkers for E. coli mastitis (with the accuracy 83% in average). This research properly indicated that by combination of two novel data mining tools, meta-analysis and machine learning, increased power to detect most informative genes that can help to improve the diagnosis and treatment strategies for E. coli associated with mastitis in cattle.	[Sharifi, Somayeh; Pakdel, Abbas] Isfahan Univ Technol, Coll Agr, Dept Anim Sci, Esfahan, Iran; [Sharifi, Somayeh; Reecy, James M.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Ebrahimi, Mansour] Univ Qom, Sch Basic Sci, Qom, Iran; [Farsani, Samaneh Fazeli] Ferdowsi Univ Mashhad, Dept Chem Engn, Mashhad, Iran; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Shiraz Univ, Inst Biotechnol, Shiraz, Iran; [Ebrahimie, Esmaeil] Univ South Australia, Sch Informat Technol & Math Sci, Div Informat Technol Engn & Environm, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Flinders Univ S Australia, Fac Sci & Engn, Sch Biol Sci, Adelaide, SA, Australia	Isfahan University of Technology; Iowa State University; Ferdowsi University Mashhad; University of Adelaide; Shiraz University; University of South Australia; Flinders University South Australia	Pakdel, A (corresponding author), Isfahan Univ Technol, Coll Agr, Dept Anim Sci, Esfahan, Iran.	pakdel@cc.iut.ac.ir	Ebrahimie, Esmaeil/AAN-2611-2020; Sharifi, Somayeh/G-6044-2018; Ebrahimi, Mansour/AAO-9096-2021; Farsani, Soulmaz Fazeli/AAG-9598-2020	Ebrahimie, Esmaeil/0000-0002-4431-2861; Sharifi, Somayeh/0000-0001-6003-8754; Ebrahimi, Mansour/0000-0001-7011-2567; Pakdel, Abbas/0000-0002-9214-9894; Reecy, James/0000-0003-4602-0990				Ahmadzadeh A, 2009, ANIM REPROD SCI, V112, P273, DOI 10.1016/j.anireprosci.2008.04.024; Alisoltani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096320; Ashrafi E, 2011, BIOINFORM BIOL INSIG, V5, P59, DOI 10.4137/BBI.S6206; Bakhtiarizadeh MR, 2014, J THEOR BIOL, V356, P213, DOI 10.1016/j.jtbi.2014.04.040; Bakhtiarizadeh MR, 2013, GENE, V521, P122, DOI 10.1016/j.gene.2013.03.045; Bannerman DD, 2004, CLIN DIAGN LAB IMMUN, V11, P463, DOI 10.1128/CDLI.11.3.463-472.2004; Bar D, 2008, J DAIRY SCI, V91, P2196, DOI 10.3168/jds.2007-0460; Barber MR, 1998, CLIN DIAGN LAB IMMUN, V5, P82, DOI 10.1128/CDLI.5.1.82-86.1998; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blumberg R, 2011, GASTROENTEROLOGY, V140, P1701, DOI 10.1053/j.gastro.2011.03.013; Borenstein M., 2009, INTRO METAANALYSIS; Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; BRAMLEY AJ, 1984, J DAIRY RES, V51, P481, DOI 10.1017/S0022029900023797; Brand B, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-24; Buitenhuis B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-130; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; Busca A, 2009, CURR GENOMICS, V10, P306, DOI 10.2174/138920209788920967; Ceciliani F, 2012, J PROTEOMICS, V75, P4207, DOI 10.1016/j.jprot.2012.04.004; Compton CWR, 2009, VET IMMUNOL IMMUNOP, V127, P357, DOI 10.1016/j.vetimm.2008.10.331; Dancey D, 2007, IEEE T SYST MAN CY B, V37, P794, DOI 10.1109/TSMCB.2007.895334; Drynda S, 2004, PATHOL RES PRACT, V200, P165, DOI 10.1016/j.prp.2004.02.011; Duarte CM, 2015, J VET DIAGN INVEST, V27, P665, DOI 10.1177/1040638715603087; Ebert F, 2017, J DAIRY SCI, V100, P4857, DOI 10.3168/jds.2016-11805; Ebrahimi M, 2009, EXCLI J, V8, P218; Ebrahimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023146; Ebrahimie E, 2015, MOL BIOL REP, V42, P1377, DOI 10.1007/s11033-015-3916-4; Ebrahimie Esmaeil, 2011, Saline Syst, V7, P1, DOI 10.1186/1746-1448-7-1; Eckersall PD, 2006, J DAIRY SCI, V89, P1488, DOI 10.3168/jds.S0022-0302(06)72216-0; Ehinger AM, 1998, BERL MUNCH TIERARZTL, V111, P337; Fogsgaard KK, 2015, J DAIRY SCI, V98, P1730, DOI 10.3168/jds.2014-8347; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Genini S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-225; Grohn YT, 2004, J DAIRY SCI, V87, P3358, DOI 10.3168/jds.S0022-0302(04)73472-4; Gunther J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-17; Gunther J, 2011, INFECT IMMUN, V79, P695, DOI 10.1128/IAI.01071-10; Gunther J, 2009, VET RES, V40, DOI 10.1051/vetres/2009014; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hagiwara S, 2016, J VET MED SCI, V78, P905, DOI 10.1292/jvms.15-0400; Hall MA, 2003, IEEE T KNOWL DATA EN, V15, P1437, DOI 10.1109/TKDE.2003.1245283; Heikkila AM, 2012, J DAIRY SCI, V95, P139, DOI 10.3168/jds.2011-4321; Hiss S, 2004, J DAIRY SCI, V87, P3778, DOI 10.3168/jds.S0022-0302(04)73516-X; Hogeveen H, 2010, SENSORS-BASEL, V10, P7991, DOI 10.3390/s100907991; Hortet P, 1998, PREV VET MED, V37, P1, DOI 10.1016/S0167-5877(98)00104-4; Hosseinpour B, 2013, GENE, V531, P212, DOI 10.1016/j.gene.2013.09.011; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jacob T, 2017, VET SCI, V4; Jensen DB, 2016, J DAIRY SCI, V99, P7344, DOI 10.3168/jds.2015-10060; Johnzon C, 2016, FRONT MICROBIOL, V7; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kawai K, 2013, VET IMMUNOL IMMUNOP, V153, P298, DOI 10.1016/j.vetimm.2013.03.002; Kempf F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147954; Kim AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147255; Kim Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05740-z; KOLB WP, 1989, COMPLEMENT INFLAMMAT, V6, P175, DOI 10.1159/000463093; Kossaibati MA, 1997, VET J, V154, P41, DOI 10.1016/S1090-0233(05)80007-3; Kumar N, 2017, TROP ANIM HEALTH PRO, V49, P663, DOI 10.1007/s11250-017-1253-4; Lai YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177182; Lakshmanan U, 2007, J IMMUNOL, V179, P8480, DOI 10.4049/jimmunol.179.12.8480; Lauzon K, 2006, J DAIRY SCI, V89, P3846, DOI 10.3168/jds.S0022-0302(06)72427-4; Lee J, 2000, CELL BIOL INT, V24, P889, DOI 10.1006/cbir.2000.0562; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Mimoso C, 2014, METHODS MOL BIOL, V1195, P61, DOI 10.1007/7651_2013_60; Mitterhuemer S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-138; Mohammadi A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-12; Moreau Y, 2003, TRENDS GENET, V19, P570, DOI 10.1016/j.tig.2003.08.006; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Noman ASM, 2010, CELL IMMUNOL, V264, P114, DOI 10.1016/j.cellimm.2010.05.007; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Oliver SP, 2012, VET CLIN N AM-FOOD A, V28, P165, DOI 10.1016/j.cvfa.2012.03.005; Pashaiasl M, 2016, MOL BIOL REP, V43, P923, DOI 10.1007/s11033-016-4025-8; Peters MDP, 2015, ANIMAL, V9, P2024, DOI 10.1017/S1751731115001391; Pieterse R, 2010, BRAZ J MICROBIOL, V41, P542, DOI 10.1590/S1517-83822010000300003; Pyorala S, 2009, IRISH VET J, V62, P40, DOI 10.1186/2046-0481-62-S4-S40; Rajala-Schultz PJ, 1999, PREV VET MED, V41, P195, DOI 10.1016/S0167-5877(99)00046-X; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Schafer PH, 2014, CELL SIGNAL, V26, P2016, DOI 10.1016/j.cellsig.2014.05.014; Schafer P, 2012, BIOCHEM PHARMACOL, V83, P1583, DOI 10.1016/j.bcp.2012.01.001; Schukken YH, 2009, J DAIRY SCI, V92, P3091, DOI 10.3168/jds.2008-1557; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Sipka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085579; Skov L, 2008, J IMMUNOL, V181, P669, DOI 10.4049/jimmunol.181.1.669; Smolenski GA, 2011, VET IMMUNOL IMMUNOP, V143, P125, DOI 10.1016/j.vetimm.2011.06.034; Song C, 2014, ANN APPL STAT, V8, P777, DOI 10.1214/13-AOAS683; Suojala L, 2010, J DAIRY SCI, V93, P1960, DOI 10.3168/jds.2009-2462; Swanson KM, 2009, J DAIRY SCI, V92, P117, DOI 10.3168/jds.2008-1382; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Thai KM, 2009, MOL DIVERS, V13, P321, DOI 10.1007/s11030-009-9117-0; USDA, 2016, DAIR MILK QUAL MILK; Wang XB, 2012, BIOINFORMATICS, V28, P2534, DOI 10.1093/bioinformatics/bts485; Wenz JR, 2006, J DAIRY SCI, V89, P3408, DOI 10.3168/jds.S0022-0302(06)72377-3; Yagdiran Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161346; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2008, J BIOL CHEM, V283, P32404, DOI 10.1074/jbc.M802148200; Yoon S, 2006, BIOINFORMATICS, V22, P2898, DOI 10.1093/bioinformatics/btl500; Younis S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148562; Zinati Z, 2014, COMPUT BIOL MED, V54, P14, DOI 10.1016/j.compbiomed.2014.08.019	102	52	53	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0191227	10.1371/journal.pone.0191227	http://dx.doi.org/10.1371/journal.pone.0191227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470489	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000425831000002
J	Kaitu'u-Lino, TJ; Brownfoot, FC; Beard, S; Cannon, P; Hastie, R; Nguyen, TV; Binder, NK; Tong, S; Hannan, NJ				Kaitu'u-Lino, Tu'uhevaha J.; Brownfoot, Fiona C.; Beard, Sally; Cannon, Ping; Hastie, Roxanne; Nguyen, Tuong V.; Binder, Natalie K.; Tong, Stephen; Hannan, Natalie J.			Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia	PLOS ONE			English	Article							PROTON-PUMP INHIBITORS; TYROSINE KINASE-1; HYPERTENSION; PATHOGENESIS; EXPRESSION; DISEASE; WOMEN; E15A	Introduction The discovery of new treatments that prevent or treat preeclampsia would be a major advance. Antiangiogenic factors soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sENG) are secreted in excess from the placenta, causing hypertension, endothelial dysfunction, and multiorgan injury. We recently identified metformin and esomeprazole as potential treatments for preeclampsia. Both reduce placental and endothelial secretion of sFlt-1 and soluble endoglin, and reduce endothelial dysfunction. Objectives We set out to assess whether combining metformin and esomeprazole would additively reduce sFlt-1 and soluble endoglin secretion and reduce endothelial dysfunction (verses drug alone). Metformin and esomeprazole were added to primary placental cells and tissues, and endothelial cells and their effects on sFlt-1 and soluble endoglin secretion were assessed in vitro. Tumor necrosis factor-alpha (TNF-alpha) was added to endothelial cells to induce dysfunction in vitro. We examined the ability of metformin + esomeprazole to rescue TNF-alpha induced vascular cell adhesion molecule-1 (VCAM-1) and Endothelin-1 (ET-1) expression, leukocyte adhesion (markers of endothelial dysfunction). Results Combining metformin and esomeprazole was additive at reducing sFlt-1 secretion and expression of sFlt-1 e15a mRNA isoform in primary cytotrophoblast, placental explants and endothelial cells. In contrast, no additive reduction in sENG was observed with combined metformin and esomeprazole. The low-dose combination of metformin + esomeprazole additively reduced TNF-alpha-induced VCAM-1 mRNA, but not VCAM-1 protein expression. There was no additive reduction when combining metformin and esomeprazole on TNF-alpha induced PBMC adhesion to endothelial cells. However, combining metformin and esome-prazole additively reduced ET-1 mRNA expression. Conclusions In conclusion combining metformin and esomeprazole additively reduced secretion of sFlt-1, and markers of endothelial dysfunction. The combination of metformin and esomeprazole may provide a more effective treatment or prevention for preeclampsia compared to either as single agents.	[Hannan, Natalie J.] Univ Melbourne, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic, Australia; Mercy Hosp Women, Mercy Perinatal, Heidelberg, Vic, Australia	University of Melbourne	Hannan, NJ (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic, Australia.	nhannan@unimelb.edu.au		Hastie, Roxanne/0000-0002-4342-1943; Tong, Stephen/0000-0002-2319-0586; Hannan, Natalie/0000-0001-8446-2250; Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737; Binder, Natalie K/0000-0002-8943-2269; Brownfoot, Fiona/0000-0002-1439-7016	Norman Beischer Medical Research Foundation; National Health and Medical Research Council of Australia (NHMRC) [1101871]; NHMRC [1050765, 1062418]; University of Melbourne CR Roper Fellowship	Norman Beischer Medical Research Foundation; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne CR Roper Fellowship(University of Melbourne)	This study was funded by the Norman Beischer Medical Research Foundation and a grant from the National Health and Medical Research Council of Australia (NHMRC #1101871). The NHMRC also provided salary support (#1050765 to ST #1062418 to TKL). NJH salary was supported by a University of Melbourne CR Roper Fellowship. The funders had no role in study design, data collection, analysis or decision to publish.	Austgulen R, 1997, EUR J OBSTET GYN R B, V71, P53, DOI 10.1016/S0301-2115(96)02647-4; Brownfoot FC, 2015, AM J OBSTET GYNECOLO; Brownfoot FC, 2015, HYPERTENSION, V66, P687, DOI 10.1161/HYPERTENSIONAHA.115.05445; Brownfoot FC, 2015, MOL CELL ENDOCRINOL, V413, P202, DOI 10.1016/j.mce.2015.06.033; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Chen Q, 2017, TRANSL RES, V190, P40, DOI 10.1016/j.trsl.2017.09.003; Cluver CA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008211; Corbet C, 2017, NAT REV CANCER, V17, P577, DOI 10.1038/nrc.2017.77; Dhulkotia JS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.044; Faupel-Badger JM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.035; Gong L, 2012, PHARMACOGENET GENOM, V22, P820, DOI 10.1097/FPC.0b013e3283559b22; Gui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064585; Holme AM, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.07.056; Jebbink J, 2011, HYPERTENSION, V58, P70, DOI 10.1161/HYPERTENSIONAHA.110.164079; Kaitu'u-Lino TJ, 2014, PREGNANCY HYPERTENS, V4, P287, DOI 10.1016/j.preghy.2014.09.003; Kajbaf F, 2016, CLIN PHARMACOKINET, V55, P439, DOI 10.1007/s40262-015-0323-x; Kim MY, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.09.066; Kumasawa K, 2010, P NATL ACAD SCI US; Labarrere CA, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.12.029; Lee MS, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.03.032; Levine RJ, 2006, AM J OBSTET GYNECOL, V194, P1034, DOI 10.1016/j.ajog.2005.10.192; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Matok I, 2012, DIGEST DIS SCI, V57, P699, DOI 10.1007/s10620-011-1940-3; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; O'Gorman N., 2017, ULTRASOUND OBSTET GY; Onda K, 2017, HYPERTENSION, V69, P457, DOI 10.1161/HYPERTENSIONAHA.116.08408; Onda K, 2015, HYPERTENSION, V65, P855, DOI 10.1161/HYPERTENSIONAHA.114.04781; Palmer K.R., 2016, MOL HUM REPROD; Palmer KR, 2017, J MATERN-FETAL NEO M, V30, P635, DOI 10.1080/14767058.2016.1182975; Palmer KR, 2015, HYPERTENSION, V66, P1251, DOI 10.1161/HYPERTENSIONAHA.115.05883; Pasternak B, 2010, NEW ENGL J MED, V363, P2114, DOI 10.1056/NEJMoa1002689; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Redman CWG, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.003; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Romero R, 2017, AM J OBSTET GYNECOL, V217, P282, DOI 10.1016/j.ajog.2017.06.003; Rowan JA, 2008, NEW ENGL J MED, V358, P2003, DOI 10.1056/NEJMoa0707193; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Spaulonci CP, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.03.022; Syngelaki A, 2016, NEW ENGL J MED, V374, P434, DOI 10.1056/NEJMoa1509819; Thornton C, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.042; Valent AM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.1090; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wilder-Smith CH, 2005, EUR J GASTROEN HEPAT, V17, P191, DOI 10.1097/00042737-200502000-00010; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149	46	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0188845	10.1371/journal.pone.0188845	http://dx.doi.org/10.1371/journal.pone.0188845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466360	Green Published, gold			2022-12-26	WOS:000425604300001
J	Makino, Y; Nishimura, Y; Oshita, S; Mizosoe, T; Akihiro, T				Makino, Yoshio; Nishimura, Yuto; Oshita, Seiichi; Mizosoe, Takaharu; Akihiro, Takashi			Storage in high-barrier pouches increases the sulforaphane concentration in broccoli florets	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; ARABIDOPSIS; L.	Sulforaphane is a phytochemical that is usually found in cruciferous vegetables and is known to have a depressive effect on gastric cancer. Preliminary investigations showed that the sulforaphane concentration in broccoli (Brassica oleracea var. italica) florets increased under anoxia. Therefore, in the present study, we examined the effect of different atmospheric conditions on the sulforaphane concentration in broccoli and also tested whether there are concurrent effects on the concentration of ethanol, which is an unfavorable byproduct of fermentation. The sulforaphane concentration in broccoli florets was significantly elevated by 1.9- to 2.8-fold after 2 d of storage under hypoxia at ca. 0% O-2 and ca. 24% CO2 at 20 degrees C, whereas no such increase was observed following storage under normoxia at ca. 0% O-2 without CO2 at 20 degrees C. Furthermore, after 2 d, the sulforaphane concentration under hypoxia was 1.6-to 2.3-fold higher than that under normoxia. These results suggest that storage under hypoxia with high CO2 levels can elevate the sulforaphane concentration in broccoli florets. However, the elevated sulforaphane concentration could not be maintained beyond 2 d. There was no significant difference in the concentration of ethanol between florets that were stored under hypoxia with/without CO2 or normoxia at 2 d. However, the ethanol concentrations inside the pouches significantly increased between 2 d and 7 d. These findings indicate that the quality of broccoli florets can be improved through storage under hypoxia with high CO2 levels at 20 degrees C for 2 d.	[Makino, Yoshio; Nishimura, Yuto; Oshita, Seiichi] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Mizosoe, Takaharu] Sumitomo Bakelite Co Ltd, Dept P Plus Project, Tokyo, Japan; [Akihiro, Takashi] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane, Japan	University of Tokyo; Shimane University	Makino, Y (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	amakino@mail.ecc.u-tokyo.ac.jp	Makino, Yoshio/AAF-5105-2020	Makino, Yoshio/0000-0002-8635-8382	Japan Society for the Promotion of Science [15KT0026]; FY Kieikai Research Foundation; Sumitomo Bakelite Co. Ltd	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); FY Kieikai Research Foundation; Sumitomo Bakelite Co. Ltd	This work received support from the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (B) 15KT0026 to YM, https://kaken.nii.acpienigrant/KAKENHlPROJECT-15KT0026/ and the FY 2016 Kieikai Research Foundation to YM,[http://www.nakashima-foundation.org/kieikai/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sumitomo Bakelite Co. Ltd provided support in the form of salaries for author [Takaharu Mizosoe], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andreasson E, 2001, PLANT PHYSIOL, V127, P1750, DOI 10.1104/pp.010334; Choi KM, 2014, J NUTR BIOCHEM, V25, P201, DOI 10.1016/j.jnutbio.2013.10.007; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Egner PA, 2011, CANCER PREV RES, V4, P384, DOI 10.1158/1940-6207.CAPR-10-0296; Elbarbry F, 2011, J MED PLANTS RES, V5, P473; Esaki H., 1982, J HOME EC JPN, V33, P513; Fahey JW, 2002, P NATL ACAD SCI USA, V99, P7610, DOI 10.1073/pnas.112203099; Gu ZX, 2012, J INTEGR AGR, V11, P1804, DOI 10.1016/S2095-3119(12)60185-3; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Kader A.A, 2002, POSTHARVEST TECHNOLO; Liang H, 2006, J FOOD COMPOS ANAL, V19, P473, DOI 10.1016/j.jfca.2005.11.005; Mae N, 2012, J AGR FOOD CHEM, V60, P1013, DOI 10.1021/jf2046812; Makino Y, 2008, J AGR FOOD CHEM, V56, P7189, DOI 10.1021/jf801516e; Matusheski NV, 2004, PHYTOCHEMISTRY, V65, P1273, DOI 10.1016/j.phytochem.2004.04.013; Van Eylen D, 2009, FOOD CHEM, V112, P646, DOI 10.1016/j.foodchem.2008.06.025; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399	16	6	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192342	10.1371/journal.pone.0192342	http://dx.doi.org/10.1371/journal.pone.0192342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466374	gold, Green Published, Green Submitted			2022-12-26	WOS:000425604300049
J	Yang, YF; Wang, YN; Jia, LC; Yang, GH; Xu, XZ; Zhai, H; He, SZ; Li, JX; Dai, XD; Qin, N; Zhu, CC; Liu, QC				Yang, Yufeng; Wang, Yannan; Jia, Licong; Yang, Guohong; Xu, Xinzhi; Zhai, Hong; He, Shaozhen; Li, Junxia; Dai, Xiaodong; Qin, Na; Zhu, Cancan; Liu, Qingchang			Involvement of an ABI-like protein and a Ca2+-ATPase in drought tolerance as revealed by transcript profiling of a sweetpotato somatic hybrid and its parents Ipomoea batatas (L.) Lam. and I-triloba L.	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; GENE-EXPRESSION; RNA-SEQ; SIGNAL-TRANSDUCTION; ANION CHANNEL; WAVE COMPLEX; ARABIDOPSIS; IDENTIFICATION; SALT; DEGRADATION	Previously, we obtained the sweetpotato somatic hybrid KT1 from a cross between sweetpotato (Ipomoea batatas (L.) Lam.) cv. Kokei No. 14 and its drought-tolerant wild relative I. triloba L. KT1 not only inherited the thick storage root characteristic of Kokei No. 14 but also the drought-tolerance trait of I. triloba L. The aim of this study was to explore the molecular mechanism of the drought tolerance of KT1. Four-week-old in vitro-grown plants of KT1, Kokei No. 14, and I. triloba L. were subjected to a simulated drought stress treatment (30% PEG6000) for 0, 6, 12 and 24 h. Total RNA was extracted from samples at each time point, and then used for transcriptome sequencing. The gene transcript profiles of KT1 and its parents were compared to identify differentially expressed genes, and drought-related modules were screened by a weighted gene co-expression network analysis. The functions of ABI-like protein and Ca2+-ATPase, two proteins screened from the cyan and light yellow modules, were analyzed in terms of their potential roles in drought tolerance in KT1 and its parents. These analyses of the drought responses of KT1 and its somatic donors at the transcriptional level provide new annotations for the molecular mechanism of drought tolerance in the somatic hybrid KT1 and its parents.	[Yang, Yufeng; Wang, Yannan; Yang, Guohong; Xu, Xinzhi; Li, Junxia; Dai, Xiaodong; Qin, Na; Zhu, Cancan] Henan Acad Agr Sci, Food Crop Inst, Zhengzhou, Henan, Peoples R China; [Yang, Yufeng; Wang, Yannan; Jia, Licong; Zhai, Hong; He, Shaozhen; Liu, Qingchang] China Agr Univ, Minist Agr, Key Lab Sweetpotato Biol & Biotechnol, Beijing, Peoples R China	Henan Academy of Agricultural Sciences; China Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, QC (corresponding author), China Agr Univ, Minist Agr, Key Lab Sweetpotato Biol & Biotechnol, Beijing, Peoples R China.	liuqc@cau.edu.cn			National Natural Science Foundation of China [U1404316]; Earmarked Fund for China Agriculture Research System [CARS-11-C-14]; Independent Innovation Fund of Henan Academy of Agricultural Sciences [2015ZZ09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for China Agriculture Research System; Independent Innovation Fund of Henan Academy of Agricultural Sciences	U1404316 was granted by "National Natural Science Foundation of China" (http://www.nsfc.gov.cn) to YFY (Yuafeng Yang). CARS-11-C-14 was granted by "Earmarked Fund for China Agriculture Research System" (http://119.253.58.231/) to GHY (Guohong Yang). 2015ZZ09 was granted by "Independent Innovation Fund of Henan Academy of Agricultural Sciences" (http://www. hnagri.org.cn) to YFY (Yufeng Yang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Basu D, 2005, PLANT CELL, V17, P502, DOI 10.1105/tpc.104.027987; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brandt B, 2012, P NATL ACAD SCI USA, V109, P10593, DOI 10.1073/pnas.1116590109; Cao QH, 2016, TROP PLANT BIOL, V9, P63, DOI 10.1007/s12042-016-9162-7; Cao QH, 2009, EUPHYTICA, V169, P345, DOI 10.1007/s10681-009-9967-7; del Olmo I, 2016, NUCLEIC ACIDS RES, V44, P5597, DOI 10.1093/nar/gkw156; Diaz M, 2016, P NATL ACAD SCI USA, V113, pE396, DOI 10.1073/pnas.1512779113; DiLeo MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026683; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Firon N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-460; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Guo Y, 2002, DEV CELL, V3, P233, DOI 10.1016/S1534-5807(02)00229-0; Hashimoto K, 2011, BIOCHIMIE, V93, P2054, DOI 10.1016/j.biochi.2011.05.019; Hopper DW, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0804-6; Huang JC, 2000, THEOR APPL GENET, V100, P1050, DOI 10.1007/s001220051386; Isner JC, 2017, NEW PHYTOL, V215, P1059, DOI 10.1111/nph.14655; Jensen TP, 2004, DEV BRAIN RES, V152, P129, DOI 10.1016/j.devbrainres.2004.06.004; Jia LC, 2017, J INTEGR AGR, V16, P36, DOI [10.1016/S2095-3119(16)61359-X, 10.1016/s2095-3119(16)61359-x]; Kivuva BM, 2015, FIELD CROP RES, V171, P11, DOI 10.1016/j.fcr.2014.10.018; Kohler C, 2010, CURR OPIN GENET DEV, V20, P541, DOI 10.1016/j.gde.2010.04.015; Kong LY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9630; Konishi M, 2006, PLANT PHYSIOL, V140, P591, DOI 10.1104/pp.105.074724; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Qiang, 2008, Acta Agronomica Sinica, V34, P972, DOI 10.3724/SP.J.1006.2008.00972; Li RJ, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/843802; Liu QC, 2011, PLANT OMICS, V4, P295; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Ma PY, 2016, GENE, V575, P641, DOI 10.1016/j.gene.2015.09.056; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Melcher K, 2010, NAT STRUCT MOL BIOL, V17, P1102, DOI 10.1038/nsmb.1887; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Mingler MK, 2006, MOL BIOCHEM PARASIT, V150, P37, DOI 10.1016/j.molbiopara.2006.06.006; Okamoto M, 2013, P NATL ACAD SCI USA, V110, P12132, DOI 10.1073/pnas.1305919110; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rao YC, 2015, PLANT PHYSIOL, V169, P1225, DOI 10.1104/pp.15.00991; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Solis J, 2014, J AM SOC HORTIC SCI, V139, P317, DOI 10.21273/JASHS.139.3.317; Sun MZ, 2016, PLANT MOL BIOL, V90, P419, DOI 10.1007/s11103-015-0426-7; Szymanski DB, 2005, CURR OPIN PLANT BIOL, V8, P103, DOI 10.1016/j.pbi.2004.11.004; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang B, 2016, SCI HORTIC-AMSTERDAM, V201, P153, DOI 10.1016/j.scienta.2016.01.027; Wang Z, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-619; Wilkins KA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01296; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Xie WC, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00829; Yang SJ, 2010, MOL PLANT, V3, P469, DOI 10.1093/mp/ssq016; Yang Y, 2009, PLANT CELL TISS ORG, V99, P83, DOI 10.1007/s11240-009-9578-y; Zhao Y, 2016, P NATL ACAD SCI USA, V113, P1949, DOI 10.1073/pnas.1522840113; Zhou WQ, 2016, J EXP BOT, V67, P4311, DOI 10.1093/jxb/erw214; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	65	10	10	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193193	10.1371/journal.pone.0193193	http://dx.doi.org/10.1371/journal.pone.0193193			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466419	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300094
J	Yang, Z; Yang, RX; Kwak, MJ; Qdaisat, A; Lin, JZ; Begley, CE; Reyes-Gibby, CC; Yeung, SCJ				Yang, Zhi; Yang, Runxiang; Kwak, Min Ji; Qdaisat, Aiham; Lin, Junzhong; Begley, Charles E.; Reyes-Gibby, Cielito C.; Yeung, Sai-Ching Jim			Oncologic emergencies in a cancer center emergency department and in general emergency departments countywide and nationwide	PLOS ONE			English	Article								Background Although cancer patients (CPs) are increasingly likely to visit emergency department (ED), no population-based study has compared the characteristics of CPs and non-cancer patients (NCPs) who visit the ED and examined factors associated with hospitalization via the ED. In this study, we (1) compared characteristics and diagnoses between CPs and NCPs who visited the ED in a cancer center or general hospital; (2) compared characteristics and diagnoses between CPs and NCPs who were hospitalized via the ED in a cancer center or general hospital; and (3) investigated important factors associated with such hospitalization. Methods and findings We analyzed patient characteristic and diagnosis [based on International Classification of Diseases-9 (ICD-9) codes] data from the ED of a comprehensive cancer center (MDACC), 24 general EDs in Harris County, Texas (HCED), and the National Hospital Ambulatory Medical Care Survey (NHAMCS) from 1/1/2007-12/31/2009. Approximately 3.4 million ED visits were analyzed: 47,245, 3,248,973, and 104,566 visits for MDACC, HCED, and NHAMCS, respectively, of which 44,143 (93.4%), 44,583 (1.4%), and 632 (0.6%) were CP visits. CPs were older than NCPs and stayed longer in EDs. Lung, gastrointestinal excluding colorectal), and genitourinary (excluding prostate) cancers were the three most common diagnoses related to ED visits at general EDs. CPs visiting MDACC were more likely than CPs visiting HCED to be privately insured. CPs were more likely than NCPs to be hospitalized. Pneumonia and influenza, fluid and electrolyte disorders, and fever were important predictive factors for CP hospitalization; coronary artery disease, cerebrovascular disease, and heart failure were important factors for NCP hospitalization. Conclusions CPs consumed more ED resources than NCPs and had a higher hospitalization rate. Given the differences in characteristics and diagnoses between CPs and NCPs, ED physicians must pay special attention to CPs and be familiar with their unique set of oncologic emergencies.	[Yang, Zhi; Yang, Runxiang; Kwak, Min Ji; Qdaisat, Aiham; Lin, Junzhong; Reyes-Gibby, Cielito C.; Yeung, Sai-Ching Jim] Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX 77030 USA; [Begley, Charles E.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Management Policy & Community Hlth, Houston, TX 77030 USA; [Yeung, Sai-Ching Jim] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA; [Yang, Zhi] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Intens Care, Guangzhou, Guangdong, Peoples R China; [Yang, Runxiang] Tumor Hosp Yunnan Prov, Dept Med Oncol 2, Kunming, Yunnan, Peoples R China; [Kwak, Min Ji] Univ Texas Hlth Sci Ctr Houston, Dept Med, Houston, TX 77030 USA; [Lin, Junzhong] Sun Yat Sen Univ, Canc Ctr, Dept Colorectal Surg, Guangzhou, Guangdong, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; UTMD Anderson Cancer Center; Guangzhou Medical University; University of Texas System; University of Texas Health Science Center Houston; Sun Yat Sen University	Yeung, SCJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX 77030 USA.; Yeung, SCJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA.	syeung@mdanderson.org	Qdaisat, Aiham/AAF-8763-2021; Yeung, Sai-Ching/AAI-6178-2021; Kwak, Min Ji/AAI-2683-2021; Qdaisat, Aiham/AHE-6024-2022; Yeung, Sai-Ching/AAP-8079-2020	Yeung, Sai-Ching/0000-0001-5170-0822; Qdaisat, Aiham/0000-0003-0063-8461; 	Guangzhou First People's Hospital, Guangzhou Medical University; National Natural Science Foundation of China [81360393, 81560432]; Yat-sen University Cancer Center; Program in Oncologic Emergency Medicine of The University of Texas MD Anderson Cancer Center; National Institutes of Health through Cancer Center Support Grant [P30 CA016672]	Guangzhou First People's Hospital, Guangzhou Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yat-sen University Cancer Center; Program in Oncologic Emergency Medicine of The University of Texas MD Anderson Cancer Center; National Institutes of Health through Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	ZY is supported by Guangzhou First People's Hospital, Guangzhou Medical University. RY is partially supported by the National Natural Science Foundation of China (81360393 and 81560432). JL is supported by Sun Yat-sen University Cancer Center. CRG is the Principal Investigator of and is supported by the Program in Oncologic Emergency Medicine of The University of Texas MD Anderson Cancer Center. The University of Texas MD Anderson Cancer Center is supported in part by the National Institutes of Health through Cancer Center Support Grant P30 CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbera L, 2010, CAN MED ASSOC J, V182, P563, DOI 10.1503/cmaj.091187; BOZDEMIR NURI E O, 2009, TURKISH J MED SCI, P235; Bureau UC, 2012, 2012 POP EST PROGR; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Geraci JM, 2006, SUPPORT CARE CANCER, V14, P1038, DOI 10.1007/s00520-006-0053-6; Gorham J, 2013, LUNG CANCER, V80, P203, DOI 10.1016/j.lungcan.2012.12.006; Guddati AK, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0669-6; Health TUoTHSCaHSoP, HLTH SERV RES COLL; Kotajima F, 2014, MOL CLIN ONCOL, V2, P322, DOI 10.3892/mco.2014.241; Lee YH, 2015, BMC PALLIAT CARE, V14, DOI 10.1186/s12904-015-0016-0; Mayer DK, 2011, J CLIN ONCOL, V29, P2683, DOI 10.1200/JCO.2010.34.2816; Melling PP, 2002, BRIT J CANCER, V86, P36, DOI 10.1038/sj.bjc.6600029; Nawar E NR, 2007, ADV DATA VITAL HLTH; Oatley M, 2016, INT EMERG NURS, V24, P35, DOI 10.1016/j.ienj.2015.05.007; Porta M, 1998, BRIT J CANCER, V77, P477, DOI 10.1038/bjc.1998.76; Sadik M, 2014, WORLD J EMERG MED, V5, P85, DOI [10.5847/wjem.j.issn.1920-8642.2014.02.001, 10.5847/wjem.j.1920-8642.2014.02.001]; Statistics NCfH, 2011, NAT HOSP AMB MED CAR; Yildirim B, 2014, ASIAN PAC J CANCER P, V15, P349, DOI 10.7314/APJCP.2014.15.1.349; Yucel N, 2012, J BUON, V17, P174	19	18	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0191658	10.1371/journal.pone.0191658	http://dx.doi.org/10.1371/journal.pone.0191658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462166	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200010
J	Anayannis, NV; Schlecht, NF; Ben-Dayan, M; Smith, RV; Belbin, TJ; Ow, TJ; Blakaj, DM; Burk, RD; Leonard, SM; Woodman, CB; Parish, JL; Prystowsky, MB				Anayannis, Nicole V.; Schlecht, Nicolas F.; Ben-Dayan, Miriam; Smith, Richard V.; Belbin, Thomas J.; Ow, Thomas J.; Blakaj, Duk M.; Burk, Robert D.; Leonard, Sarah M.; Woodman, Ciaran B.; Parish, Joanna L.; Prystowsky, Michael B.			Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; RISK HUMAN-PAPILLOMAVIRUS; CERVICAL-CARCINOMA; SEQUENCE VARIATION; INTEGRATION SITES; CANCER; DISRUPTION; GENOME; SURVIVAL; TRANSCRIPTION	To assess the relationship of E2 gene disruption with viral gene expression and clinical outcome in human papillomavirus (HPV) positive head and neck squamous cell carcinoma, we evaluated 31 oropharyngeal and 17 non-oropharyngeal HPV16 positive carcinomas using two PCR-based methods to test for disruption of E2, followed by Sanger sequencing. Expression of HPV16 E6, E7 and E2 transcripts, along with cellular ARF and INK4A, were also assessed by RT-qPCR. Associations between E2 disruption, E2/E6/E7 expression, and clinical outcome were evaluated by Kaplan-Meier analysis for loco-regional recurrence and disease-specific survival. The majority (n = 21, 68%) of HPV16 positive oropharyngeal carcinomas had an intact E2 gene, whereas the majority of HPV16 positive non-oropharyngeal carcinomas (n = 10, 59%) had a disrupted E2 gene. Three of the oropharyngeal tumors and two of the non-oropharyngeal tumors had deletions within E2. Detection of an intact E2 gene was associated with a higher DNA viral load and increased E2/E6/E7, ARF and INK4A expression in oropharyngeal tumors. Oropharyngeal carcinomas with an intact E2 had a lower risk of loco-regional recurrence (log-rank p = 0.04) and improved disease-specific survival (p = 0.03) compared to tumors with disrupted E2. In addition, high E7 expression was associated with lower risk of loco-regional recurrence (p = 0.004) as was high E6 expression (p = 0.006). In summary, an intact E2 gene is more common in HPV16 positive oropharyngeal than non-oropharyngeal carcinomas; the presence of an intact E2 gene is associated with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome compared to patients with a disrupted E2 gene in oropharyngeal cancer.	[Anayannis, Nicole V.; Ben-Dayan, Miriam; Smith, Richard V.; Belbin, Thomas J.; Ow, Thomas J.; Prystowsky, Michael B.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Anayannis, Nicole V.; Schlecht, Nicolas F.; Ben-Dayan, Miriam; Smith, Richard V.; Belbin, Thomas J.; Ow, Thomas J.; Burk, Robert D.; Prystowsky, Michael B.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Anayannis, Nicole V.; Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Schlecht, Nicolas F.] Albert Einstein Coll Med, Dept Med Oncol, Bronx, NY 10467 USA; [Schlecht, Nicolas F.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Smith, Richard V.; Ow, Thomas J.] Albert Einstein Coll Med, Dept Otolaryngol Head & Neck Surg, Bronx, NY 10467 USA; [Belbin, Thomas J.] Mem Univ Newfoundland, Discipline Oncol, Fac Med, St John, NF, Canada; [Blakaj, Duk M.] Ohio State Univ, James Canc Ctr, Columbus, OH 43210 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat Genet, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Leonard, Sarah M.; Woodman, Ciaran B.; Parish, Joanna L.] Univ Birmingham, Inst Canc & Genom Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Roswell Park Cancer Institute; Yeshiva University; Albert Einstein College of Medicine; Memorial University Newfoundland; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Birmingham	Anayannis, NV (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.; Anayannis, NV (corresponding author), Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA.	nicolevja@gmail.com	Parish, Joanna L/L-4820-2015	Parish, Joanna L/0000-0002-7111-4211; Schlecht, Nicolas/0000-0003-2482-244X	Albert Einstein College of Medicine, Inc [3A7078]; Medical Research Council grant [MR/N023498/1]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; MRC [MR/N023498/1] Funding Source: UKRI; Medical Research Council [MR/N023498/1] Funding Source: researchfish	Albert Einstein College of Medicine, Inc; Medical Research Council grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by Albert Einstein College of Medicine, Inc, https://www.einstein.yu.edu/administration/grant-support/, funding number 3A7078, recipient Dr. Michael Prystowsky; and Medical Research Council grant, https://www.mrc.ac.uk/funding/how-we-fund-research/research-grant/, fund number MR/N023498/1, recipient JLP.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; BAKER CC, 1987, J VIROL, V61, P962, DOI 10.1128/JVI.61.4.962-971.1987; Ben-Dayan MM, 2017, CANCER MED-US, V6, P397, DOI 10.1002/cam4.961; Castle PE, 2002, J MED VIROL, V68, P417, DOI 10.1002/jmv.10220; Cheung JLK, 2013, GYNECOL ONCOL, V131, P374, DOI 10.1016/j.ygyno.2013.08.026; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Collins SI, 2009, CANCER RES, V69, P3828, DOI 10.1158/0008-5472.CAN-08-3099; Deng ZY, 2013, HEAD NECK-J SCI SPEC, V35, P800, DOI 10.1002/hed.23034; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Doorbar J, 2007, DIS MARKERS, V23, P297, DOI 10.1155/2007/613150; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Faust H, 2016, J GEN VIROL; Ferris RL, 2005, EUR J CANCER, V41, P807, DOI 10.1016/j.ejca.2004.11.023; Gao G, 2014, J CLIN VIROL, V59, P195, DOI 10.1016/j.jcv.2013.12.006; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; GIRI I, 1988, EMBO J, V7, P2823, DOI 10.1002/j.1460-2075.1988.tb03138.x; Graham DA, 2000, J CLIN PATHOL-MOL PA, V53, P201, DOI 10.1136/mp.53.4.201; Gravitt PE, 2007, INT J CANCER, V121, P2787, DOI 10.1002/ijc.23012; Gravitt PE, 2003, CANCER EPIDEM BIOMAR, V12, P477; Hafner N, 2008, ONCOGENE, V27, P1610, DOI 10.1038/sj.onc.1210791; Harris T, 2012, AM J PATHOL, V180, P917, DOI 10.1016/j.ajpath.2011.12.004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Kalantari M, 1998, INT J GYNECOL PATHOL, V17, P146, DOI 10.1097/00004347-199804000-00009; Koneva LA, 2017, MOL CANC RES; Kotorashvili A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034683; Lace MJ, 2011, J VIROL, V85, P1645, DOI 10.1128/JVI.02093-10; Lindel K, 2008, INT J RADIAT ONCOL, V72, pS686, DOI 10.1016/j.ijrobp.2008.06.573; Lindel K, 2001, CANCER-AM CANCER SOC, V92, P805, DOI 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9; Lindel K, 2006, INT J RADIAT ONCOL, V65, P760, DOI 10.1016/j.ijrobp.2006.01.023; Lleras RA, 2011, AM J PATHOL, V178, P1965, DOI 10.1016/j.ajpath.2011.01.049; Loudig O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm510; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; Nulton TJ, 2017, ONCOTARGET, V8, P17684, DOI 10.18632/oncotarget.15179; Olthof NC, 2015, INT J CANCER, V136, pE207, DOI 10.1002/ijc.29112; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Ragin CCR, 2004, INT J CANCER, V110, P701, DOI 10.1002/ijc.20193; Reuschenbach M, 2015, CANCER-AM CANCER SOC, V121, P1966, DOI 10.1002/cncr.29315; Salazar CR, 2014, INT J CANCER, V135, P2404, DOI 10.1002/ijc.28876; Sathish Narayanan, 2004, Mol Diagn, V8, P57; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schlecht NF, 2015, CANCER MED-US, V4, P342, DOI 10.1002/cam4.374; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; Shin HY, 2014, PLOS ONE, V10, P9, DOI DOI 10.1371/J0URNAL.P0NE.0078995; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; Smith EM, 2010, INT J CANCER, V127, P111, DOI 10.1002/ijc.25015; Smith JA, 2014, VIROLOGY, V468, P311, DOI 10.1016/j.virol.2014.08.022; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; Steinmann K, 2009, ONCOL REP, V22, P1519, DOI 10.3892/or_00000596; Tsakogiannis D, 2015, J MED VIROL, V87, P1973, DOI 10.1002/jmv.24256; Tsakogiannis D, 2012, ARCH VIROL, V157, P825, DOI 10.1007/s00705-012-1236-8; Vernon SD, 1997, INT J CANCER, V74, P50, DOI 10.1002/(SICI)1097-0215(19970220)74:1<50::AID-IJC9>3.3.CO;2-P; Vinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754; Vojtechova Z, 2016, INT J CANCER, V138, P386, DOI 10.1002/ijc.29712; Walline HM, 2017, HEAD NECK-J SCI SPEC, V39, P840, DOI 10.1002/hed.24729; Weinberger PM, 2004, CLIN CANCER RES, V10, P5684, DOI 10.1158/1078-0432.CCR-04-0448; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Xu F, 2015, VIRUS GENES, V50, P210, DOI 10.1007/s11262-014-1164-7; Zhang YX, 2016, CLIN CANCER RES, V22, P4735, DOI 10.1158/1078-0432.CCR-16-0323; Zou NX, 2000, J VIROL, V74, P3761, DOI 10.1128/JVI.74.8.3761-3770.2000; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	63	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0191581	10.1371/journal.pone.0191581	http://dx.doi.org/10.1371/journal.pone.0191581			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451891	Green Published, gold, Green Submitted			2022-12-26	WOS:000425369800005
J	Agoro, R; Montagna, A; Goetz, R; Aligbe, O; Singh, G; Coe, LM; Mohammadi, M; Rivella, S; Sitara, D				Agoro, Rafiou; Montagna, Anna; Goetz, Regina; Aligbe, Onyedikachi; Singh, Gurinder; Coe, Lindsay M.; Mohammadi, Moosa; Rivella, Stefano; Sitara, Despina			Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia	FASEB JOURNAL			English	Article						chronic kidney disease; erythropoietin; FGF23; iron	CHRONIC KIDNEY-DISEASE; DOMINANT HYPOPHOSPHATEMIC RICKETS; VITAMIN-D METABOLISM; ERYTHROPOIETIN DEFICIENCY; CARDIOVASCULAR EVENTS; IRON; PHOSPHATE; FIBROBLAST-GROWTH-FACTOR-23; INFLAMMATION; EXPRESSION	Severe anemia and iron deficiency are common complications in chronic kidney disease. The cause of renal anemia is multifactorial and includes decreased erythropoietin (Epo) production, iron deficiency, and inflammation, and it is currently treated with injections of synthetic Epo. However, the use of recombinant Epo has several adverse effects. We previously reported that high fibroblast growth factor 23 (FGF23) levels in mice are associated with decreased red blood cell production, whereas genetic inactivation of Fgf23 results in expansion of the erythroid lineage. The present study is the first to show that high FGF23 levels in a mouse model of renal failure contribute to renal anemia, and inhibiting FGF23 signaling stimulates erythropoiesis and abolishes anemia and iron deficiency. Moreover, we show that inhibition of FGF23 signaling significantly decreases erythroid cell apoptosis and influences the commitment of hematopoietic stem cells toward the erythroid linage. Furthermore, we show that blocking FGF23 signaling attenuates inflammation, resulting in increased serum iron and ferritin levels. Our data clearly demonstrate that elevated FGF23 is a causative factor in the development of renal anemia and iron deficiency, and importantly, blocking FGF23 signaling represents a novel approach to stimulate erythropoiesis and possibly improve survival for millions of chronic kidney disease patients worldwide.Agoro, R., Montagna, A., Goetz, R., Aligbe, O., Singh, G., Coe, L. M., Mohammadi, M., Rivella, S., Sitara, D. Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia.	[Agoro, Rafiou; Montagna, Anna; Aligbe, Onyedikachi; Singh, Gurinder; Coe, Lindsay M.; Sitara, Despina] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [Goetz, Regina; Mohammadi, Moosa] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10010 USA; [Sitara, Despina] NYU, Sch Med, Dept Med, New York, NY 10010 USA; [Rivella, Stefano] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA	New York University; New York University; New York University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sitara, D (corresponding author), NYU, Coll Dent, 345 East 24th St,Room 902C, New York, NY 10010 USA.	ds199@nyu.edu	kasaei, fahime/T-7197-2018; Mohammadi, Moosa/ABA-6745-2020; Goetz, Regina/M-2411-2019; Agoro, Rafiou/AAI-2916-2020	Mohammadi, Moosa/0000-0003-2434-9437; Goetz, Regina/0000-0003-3681-4703; AGORO, RAFIOU/0000-0002-5461-7685; SITARA, DESPINA/0000-0002-4836-5039	American Heart Association [12SDG12080152]; U.S. Department of Defense [W81XWH-16-1-0598]; U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research [DE 13686]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. Department of Defense(United States Department of Defense); U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank M. N. T. Wada (University of Sao Paulo, Sao Paulo, Brazil and New York University School of Dentistry, New York, USA) and R. C. Bernstein (New York University College of Dentistry) for technical assistance. The authors are grateful to W. R. Abrams (New York University College of Dentistry) for invaluable assistance with the technical visualization of the data, and M. Gregory and P. Lopez (New York University School of Medicine) for assistance with flow cytometry and flow data analyses. This work was supported in part by funds from the American Heart Association (12SDG12080152) and the U.S. Department of Defense (W81XWH-16-1-0598; to D.S.), and the U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research (DE 13686; to M. M.). The authors declare no conflicts of interest.	Andrukhova O, 2014, EMBO MOL MED, V6, P744, DOI 10.1002/emmm.201303716; Andrukhova O, 2014, EMBO J, V33, P229, DOI 10.1002/embj.201284188; Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; Asari S, 2005, EXP HEMATOL, V33, P26, DOI 10.1016/j.exphem.2004.10.001; Barreto DV, 2010, KIDNEY INT, V77, P550, DOI 10.1038/ki.2009.503; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Braithwaite V, 2012, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2012-27; Coe LM, 2014, J BIOL CHEM, V289, P9795, DOI 10.1074/jbc.M113.527150; Cole J, 2000, J CLIN INVEST, V106, P1391, DOI 10.1172/JCI10557; David V, 2016, KIDNEY INT, V89, P135, DOI 10.1038/ki.2015.290; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Fishbane S, 2009, CLIN J AM SOC NEPHRO, V4, P57, DOI 10.2215/CJN.01670408; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Frede S, 2011, BLOOD, V117, P4905, DOI 10.1182/blood-2010-07-298083; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Ganz T, 2007, J AM SOC NEPHROL, V18, P394, DOI 10.1681/ASN.2006070802; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONAHA.105.577577; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Grabner A, 2015, CELL METAB, V22, P1020, DOI 10.1016/j.cmet.2015.09.002; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Ichikawa S, 2007, J CLIN INVEST, V117, P2684, DOI 10.1172/JCI31330; Imel EA, 2011, J CLIN ENDOCR METAB, V96, P3541, DOI 10.1210/jc.2011-1239; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Kalantar-Zadeh K, 2004, NEPHROL DIAL TRANSPL, V19, P141, DOI 10.1093/ndt/gfg493; Komaba H, 2010, KIDNEY INT, V77, P232, DOI 10.1038/ki.2009.414; Koulnis M, 2011, JOVE-J VIS EXP, DOI 10.3791/2809; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Leelahavanichkul A, 2010, KIDNEY INT, V78, P1136, DOI 10.1038/ki.2010.287; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; LIPKIN GW, 1990, NEPHROL DIAL TRANSPL, V5, P920, DOI 10.1093/ndt/5.11.920; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Mendoza JM, 2017, KIDNEY INT, V91, P711, DOI 10.1016/j.kint.2016.10.021; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Pan XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025839; Perwad F, 2007, AM J PHYSIOL-RENAL, V293, pF1577, DOI 10.1152/ajprenal.00463.2006; Querbes W, 2012, BLOOD, V120, P1916, DOI 10.1182/blood-2012-04-423715; Scialla JJ, 2014, J AM SOC NEPHROL, V25, P349, DOI 10.1681/ASN.2013050465; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF769, DOI 10.1152/ajprenal.00248.2006; Shalhoub V, 2012, J CLIN INVEST, V122, P2543, DOI 10.1172/JCI61405; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Silverberg D, 2003, NEPHROL DIAL TRANSPL, V18, P7, DOI [10.1093/ndt//gfg1084, 10.1093/ndt/gfg1056]; Singh S, 2016, KIDNEY INT, V90, P985, DOI 10.1016/j.kint.2016.05.019; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Souma T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00167; Sun CC, 2012, AM J HEMATOL, V87, P392, DOI 10.1002/ajh.23110; Tsai MH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003049; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wolf M, 2013, J BONE MINER RES, V28, P1793, DOI 10.1002/jbmr.1923; Zhang F, 1996, EXP HEMATOL, V24, P1469	61	68	71	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3752	3764		10.1096/fj.201700667R	http://dx.doi.org/10.1096/fj.201700667R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29481308	Green Published			2022-12-26	WOS:000435104500023
J	Pack, TF; Orlen, MI; Ray, C; Peterson, SM; Caron, MG				Pack, Thomas F.; Orlen, Margo I.; Ray, Caroline; Peterson, Sean M.; Caron, Marc G.			The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; SIGNAL-TRANSDUCTION; FUNCTIONAL SELECTIVITY; ADP-RIBOSYLATION; ARRESTIN; KINASES; PHOSPHORYLATION; DESENSITIZATION; DISCOVERY; COMPLEX	The dopamine D2 receptor (D2R) is a G protein-coupled receptor (GPCR) that is critical for many central nervous system functions. The D2R carries out these functions by signaling through two transducers: G proteins and beta-arrestins (beta arrs). Selectively engaging either the G protein or beta arr pathway may be a way to improve drugs targeting GPCRs. The current model of GPCR signal transduction posits a chain of events where G protein activation ultimately leads to beta arr recruitment. GPCR kinases (GRKs), which are regulated by G proteins and whose kinase action facilitates beta arr recruitment, bridge these pathways. Therefore, beta arr recruitment appears to be intimately tied to G protein activation via GRKs. Here we sought to understand howGRK2action at theD2Rwould be disrupted whenGprotein activation is eliminated and the effect of this on beta arr recruitment. Weused two recently developed biased D2R mutants that can preferentially interact either withGproteins or beta arrs as well as a beta arr-biased D2R ligand, UNC9994. With these functionally selective tools, we investigated the mechanism whereby the beta arr-preferring D2R achieves beta arr pathway activation in the complete absence of G protein activation. We describe how direct, G protein-independent recruitment of GRK2 drives interactions at the beta arr-preferring D2R and also contributes to beta arr recruitment at the WT D2R. Additionally, we found an additive interaction between the beta arr-preferring D2R mutant and UNC9994. These results reveal that the D2R can directly recruit GRK2 without G protein activation and that this mechanism may have relevance to achieving beta arr-biased signaling.	[Pack, Thomas F.] Duke Univ, Med Ctr, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Pack, Thomas F.; Orlen, Margo I.; Ray, Caroline; Peterson, Sean M.; Caron, Marc G.] Duke Univ, Med Ctr, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Sch Med, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3287, Durham, NC 27710 USA.	marc.caron@duke.edu		Pack, Thomas/0000-0002-1240-8324; Orlen, Margo/0000-0002-9834-6282; Peterson, Sean/0000-0003-4873-0283	National Institute on Drug Abuse Ruth L. Kirschstein National Research Service [F31 DA041160]; Duke University Biological Sciences Undergraduate Research Fellowship; National Institute of Mental Health [R37 MH073853, U19 MH082441]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH073853, U19MH082441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA041160] Funding Source: NIH RePORTER	National Institute on Drug Abuse Ruth L. Kirschstein National Research Service; Duke University Biological Sciences Undergraduate Research Fellowship; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institute on Drug Abuse Ruth L. Kirschstein National Research Service Award F31 DA041160 (to T.F.P.), a Duke University Biological Sciences Undergraduate Research Fellowship (to M.I.O.), and National Institute of Mental Health Grants R37 MH073853 and U19 MH082441 (to M.G.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Beautrait A, 2014, J BIOL CHEM, V289, P25262, DOI 10.1074/jbc.M114.593178; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich EV, 2016, PHARMACOL RES, V111, P1, DOI 10.1016/j.phrs.2016.05.010; Ikeda S., 2007, World patent, Patent No. [WO2007034846, 2007034846]; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Ito K, 1999, EUR J BIOCHEM, V260, P112, DOI 10.1046/j.1432-1327.1999.00125.x; KATADA T, 1982, J BIOL CHEM, V257, P7210; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Komolov KE, 2017, CELL SIGNAL, V41, P17, DOI 10.1016/j.cellsig.2017.07.004; Komolov KE, 2017, CELL, V169, P407, DOI 10.1016/j.cell.2017.03.047; KONG GH, 1994, J BIOL CHEM, V269, P13084; KUROSE H, 1983, J BIOL CHEM, V258, P4870; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Manglik A, 2016, NATURE, V537, P185, DOI 10.1038/nature19112; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; NEVE KA, 1991, MOL PHARMACOL, V39, P733; Peterson SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141637; Peterson SM, 2015, P NATL ACAD SCI USA, V112, P7097, DOI 10.1073/pnas.1502742112; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Urs N M, 2014, Int J Obes Suppl, V4, pS5, DOI 10.1038/ijosup.2014.3; Urs NM, 2016, P NATL ACAD SCI USA, V113, pE8178, DOI 10.1073/pnas.1614347113; Urs NM, 2017, BIOL PSYCHIAT, V81, P78, DOI 10.1016/j.biopsych.2016.10.011; Urs NM, 2015, P NATL ACAD SCI USA, V112, pE2517, DOI 10.1073/pnas.1502740112; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Yao XQ, 2017, J BIOL CHEM, V292, P16032, DOI 10.1074/jbc.M117.807461	45	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6161	6171		10.1074/jbc.RA117.001300	http://dx.doi.org/10.1074/jbc.RA117.001300			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29487132	Green Published, hybrid			2022-12-26	WOS:000430497300032
J	Joshi, SS; Jiang, SL; Unni, E; Goding, SR; Fang, T; Antony, PA; Hornyak, TJ				Joshi, Sandeep S.; Jiang, Shunlin; Unni, Emmanuel; Goding, Stephen R.; Fang, Tao; Antony, Paul A.; Hornyak, Thomas J.			17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model	PLOS ONE			English	Article							CD4(+) T-CELLS; B-RAF; ESTABLISHED MELANOMA; SIGNALING PATHWAY; HSP90 INHIBITORS; HUMAN CANCER; WILD-TYPE; IN-VITRO; BRAF; PROTEIN	Heat shock protein 90 (HSP90) is a molecular chaperone which stabilizes client proteins with important roles in tumor growth. 17-allylamino-17-demethoxygeldanamycin (17-AAG), an inhibitor of HSP90 ATPase activity, occupies the ATP binding site of HSP90 causing a conformational change which destabilizes client proteins and directs them towards proteosomal degradation. Malignant melanomas have active RAF-MEK-ERK signaling which can occur either through an activating mutation in BRAF (BRAF(V600E)) or through activation of signal transduction upstream of BRAF. Prior work showed that 17-AAG inhibits cell growth in BRAF(V600E) and BRAF wildtype (BRAF(WT)) melanomas, although there were conflicting reports about the dependence of BRAF(V600E) and BRAF(WT) upon HSP90 activity for stability. Here, we demonstrate that BRAF(WT) and CRAF are bound by HSP90 in BRAF(WT), NRAS mutant melanoma cells. HSP90 inhibition by 17-AAG inhibits ERK signaling and cell growth by destabilizing CRAF but not BRAF(WT) in the majority of NRAS mutant melanoma cells. The highly-selective BRAF(V600E) inhibitor, PLX4032 (vemurafenib), inhibits ERK signaling and cell growth in mutant BRAF melanoma cells, but paradoxically enhances signaling in cells with wild-type BRAF. In our study, we examined whether 17-AAG could inhibit PLX4032-enhanced ERK signaling in BRAF(WT) melanoma cells. As expected, PLX4032 alone enhanced ERK signaling in the BRAF(WT) melanoma cell lines Mel-Juso, SK-Mel-2, and SK-Mel-30, and inhibited signaling and cell growth in BRAF(V600E) A375 cells. However, HSP90 inhibition by 17-AAG inhibited PLX4032-enhanced ERK signaling and inhibited cell growth by destabilizing CRAF. Surprisingly, 17-AAG also stimulated melanin production in SK-Mel-30 cells and enhanced TYRP1 and DCT expression without stimulating TYR production in all three BRAF(WT) cell lines studied as well as in B16F10 mouse melanoma cells. In vivo, the combination of 17-AAG and cellular immunotherapy directed against Tyrp1 enhanced the inhibition of tumor growth compared to either therapy alone. Our studies support a role for 17-AAG and HSP90 inhibition in enhancing cellular immunotherapy for melanoma.	[Joshi, Sandeep S.; Unni, Emmanuel; Hornyak, Thomas J.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Jiang, Shunlin; Fang, Tao; Hornyak, Thomas J.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Goding, Stephen R.; Antony, Paul A.; Hornyak, Thomas J.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Hornyak, Thomas J.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Hornyak, Thomas J.] VA Maryland Hlth Care Syst, Res & Dev Serv, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Hornyak, TJ (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.; Hornyak, TJ (corresponding author), NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Hornyak, TJ (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Hornyak, TJ (corresponding author), Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA.; Hornyak, TJ (corresponding author), VA Maryland Hlth Care Syst, Res & Dev Serv, Baltimore, MD USA.	thornyak@som.umaryland.edu			Intramural Research Program, Center for Cancer Research, NCI, NIH; NIH/NIAMS [R01 AR064810, RO1 AR064810]; US Department of Health and Human Services; United States Department of Veteran Affairs Biomedical Laboratory Research and Development Service [1 I01BX002582]	Intramural Research Program, Center for Cancer Research, NCI, NIH; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US Department of Health and Human Services; United States Department of Veteran Affairs Biomedical Laboratory Research and Development Service	This research was supported in part by the Intramural Research Program, Center for Cancer Research, NCI, NIH, and by NIH/NIAMS R01 AR064810. US Department of Health and Human Services and Merit Review Award 1 I01BX002582, United States Department of Veteran Affairs Biomedical Laboratory Research and Development Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the assistance of Oleg Chertov (Protein Chemistry Lab, SAIC-Frederick) for mass spectroscopic analysis of BRAF binding partners. We also acknowledge Len Neckers and Jane Trepel (CCR, NCI, NIH) for providing 17-AAG and for helpful discussions. This research was supported in part by the Intramural Research Program, Center for Cancer Research, NCI, NIH, and by NIH/NIAMS RO1 AR064810. US Department of Health and Human Services and Merit Review Award 1 I01BX002582, United States Department of Veteran Affairs Biomedical Laboratory Research and Development Service. The contents do not represent the views of US Department of Veteran Affairs, the US Department of Health and Human Services and the US government.	An WG, 2000, CELL GROWTH DIFFER, V11, P355; Babchia N, 2008, INVEST OPHTH VIS SCI, V49, P2348, DOI 10.1167/iovs.07-1305; Banerji U, 2008, MOL CANCER THER, V7, P737, DOI 10.1158/1535-7163.MCT-08-0145; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Basso AD, 2002, ONCOGENE, V21, P1159, DOI 10.1038/sj.onc.1205184; Burger AM, 2004, ANTI-CANCER DRUG, V15, P377, DOI 10.1097/00001813-200404000-00011; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Diwakar G, 2008, J CELL SCI, V121, P167, DOI 10.1242/jcs.013912; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Englaro W, 1998, J BIOL CHEM, V273, P9966, DOI 10.1074/jbc.273.16.9966; Fukuyo Y, 2008, CANCER RES, V68, P6324, DOI 10.1158/0008-5472.CAN-07-6602; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Goding SR, 2013, J IMMUNOL, V190, P4899, DOI 10.4049/jimmunol.1300271; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Hearing Vincent J, 2011, J Invest Dermatol, V131, pE8, DOI 10.1038/skinbio.2011.4; HEARING VJ, 1992, PIGM CELL RES, V5, P264, DOI 10.1111/j.1600-0749.1992.tb00547.x; Hingorani SR, 2003, CANCER RES, V63, P5198; Hu DN, 2008, PHOTOCHEM PHOTOBIOL, V84, P645, DOI 10.1111/j.1751-1097.2007.00228.x; Jaiswal RK, 1996, J BIOL CHEM, V271, P23626, DOI 10.1074/jbc.271.39.23626; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Mbofung RM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00449-z; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Nissan MH, 2014, CANCER RES, V74, P2340, DOI 10.1158/0008-5472.CAN-13-2625; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pacey S, 2012, INVEST NEW DRUG, V30, P341, DOI 10.1007/s10637-010-9493-4; Paraiso KHT, 2012, CLIN CANCER RES, V18, P2502, DOI 10.1158/1078-0432.CCR-11-2612; Phadke M, 2015, J INVEST DERMATOL, V135, P2542, DOI 10.1038/jid.2015.205; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Schulte TW, 1997, BIOCHEM BIOPH RES CO, V239, P655, DOI 10.1006/bbrc.1997.7527; SEPPLORENZINO L, 1995, J BIOL CHEM, V270, P16580, DOI 10.1074/jbc.270.28.16580; Smith V, 2005, CANCER CHEMOTH PHARM, V56, P126, DOI 10.1007/s00280-004-0947-2; Smyth T, 2014, MOL CANCER THER, V13, P2793, DOI 10.1158/1535-7163.MCT-14-0452; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Su F, 2012, CANCER RES, V72, P969, DOI 10.1158/0008-5472.CAN-11-1875; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang RF, 1996, J EXP MED, V184, P2207, DOI 10.1084/jem.184.6.2207; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0191264	10.1371/journal.pone.0191264	http://dx.doi.org/10.1371/journal.pone.0191264			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481571	gold, Green Submitted, Green Published			2022-12-26	WOS:000426202700002
J	Fidler, RY; Carroll, J; Rynerson, KW; Matthews, DF; Turingan, RG				Fidler, Robert Y.; Carroll, Jessica; Rynerson, Kristen W.; Matthews, Danielle F.; Turingan, Ralph G.			Coral reef fishes exhibit beneficial phenotypes inside marine protected areas	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; COD GADUS-MORHUA; GREAT-BARRIER-REEF; ECOLOGICAL CONSEQUENCES; ACANTHURUS-NIGROFUSCUS; CONTEMPORARY EVOLUTION; PLECTROPOMUS-LEOPARDUS; BATCH FECUNDITY; REACTION NORMS; TRAIT CHANGES	Human fishing effort is size-selective, preferentially removing the largest individuals from harvested stocks. Intensive, size-specific fishing mortality induces directional shifts in phe-notypic frequencies towards the predominance of smaller and earlier-maturing individuals, which are among the primary causes of declining fish biomass. Fish that reproduce at smaller size and younger age produce fewer, smaller, and less viable larvae, severely reducing the reproductive capacity of harvested populations. Marine protected areas (MPAs) are extensively utilized in coral reefs for fisheries management, and are thought to mitigate the impacts of size-selective fishing mortality and supplement fished stocks through larval export. However, empirical evidence of disparities in fitness-relevant phenotypes between MPAs and adjacent fished reefs is necessary to validate this assertion. Here, we compare key life-history traits in three coral-reef fishes (Acanthurus nigrofuscus, Cteno-chaetus striatus, and Parupeneus multifasciatus) between MPAs and fished reefs in the Philippines. Results of our analyses support previous hypotheses regarding the impacts of MPAs on phenotypic traits. Asymptotic length (L-inf) and growth rates (K) differed between conspecifics in MPAs and fished reefs, with protected populations exhibiting phenotypes that are known to confer higher fecundity. Additionally, populations demonstrated increases in length at 50% maturity (L-50) inside MPAs compared to adjacent areas, although age at 50% maturity (A(50)) did not appear to be impacted by MPA establishment. Shifts toward advantageous phenotypes were most common in the oldest and largest MPAs, but occurred in all of the MPAs examined. These results suggest that MPAs may provide protection against the impacts of size-selective harvest on life-history traits in coral-reef fishes.	[Fidler, Robert Y.; Matthews, Danielle F.; Turingan, Ralph G.] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; [Carroll, Jessica; Rynerson, Kristen W.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL USA	Florida Institute of Technology; Florida Fish & Wildlife Conservation Commission	Fidler, RY (corresponding author), Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA.	rfidler2011@my.fit.edu		Fidler, Robert/0000-0001-8796-9161	U.S. Student Fulbright Fellowship; Philippine-American Education Foundation [34143036]	U.S. Student Fulbright Fellowship; Philippine-American Education Foundation	This research was funded through a U.S. Student Fulbright Fellowship (https://us.fulbrightonline.org/fulbright-us-student-program) in association with the Philippine-American Education Foundation (https://fulbright.org.ph/) awarded to RYF (ID #34143036). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2000, CAN J FISH AQUAT SCI, V57, P1448, DOI 10.1139/cjfas-57-7-1448; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Baskett ML, 2005, ECOL APPL, V15, P882, DOI 10.1890/04-0723; Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706; Birkeland C, 2005, TRENDS ECOL EVOL, V20, P356, DOI 10.1016/j.tree.2005.03.015; Bobko SJ, 2003, FISH B, V102, P418; Boonzaier L, 2016, ORYX, V50, P27, DOI 10.1017/S0030605315000848; Carter AB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10180-w; Carter AB, 2014, CORAL REEFS, V33, P751, DOI 10.1007/s00338-014-1164-z; Choat JH, 1996, MAR ECOL PROG SER, V134, P15, DOI 10.3354/meps134015; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Conover DO, 2009, P ROY SOC B-BIOL SCI, V276, P2015, DOI 10.1098/rspb.2009.0003; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; de Roos AM, 2006, P ROY SOC B-BIOL SCI, V273, P1873, DOI 10.1098/rspb.2006.3518; Devine JA, 2012, CAN J FISH AQUAT SCI, V69, P1105, DOI 10.1139/F2012-047; Dunlop ES, 2015, ECOL APPL, V25, P1860, DOI 10.1890/14-1862.1; Dunlop ES, 2009, EVOL APPL, V2, P371, DOI 10.1111/j.1752-4571.2009.00089.x; Edeline E, 2007, P NATL ACAD SCI USA, V104, P15799, DOI 10.1073/pnas.0705908104; Eikeset AM, 2016, P NATL ACAD SCI USA, V113, P15030, DOI 10.1073/pnas.1525749113; Enberg K, 2009, EVOL APPL, V2, P394, DOI 10.1111/j.1752-4571.2009.00077.x; Ernande B, 2004, P ROY SOC B-BIOL SCI, V271, P415, DOI 10.1098/rspb.2003.2519; Evans RD, 2008, CORAL REEFS, V27, P179, DOI 10.1007/s00338-007-0309-8; Fidler RY, 2017, MAR ECOL PROG SER, V570, P187, DOI 10.3354/meps12067; Fidler Robert Y., 2014, Biology - Basel, V3, P264, DOI 10.3390/biology3020264; Grift RE, 2003, MAR ECOL PROG SER, V257, P247, DOI 10.3354/meps257247; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Hart AM, 1996, MAR ECOL PROG SER, V136, P25, DOI 10.3354/meps136025; Haugen TO, 2001, GENETICA, V112, P475, DOI 10.1023/A:1013315116795; Heino M, 2002, EVOLUTION, V56, P669, DOI 10.1111/j.0014-3820.2002.tb01378.x; Heino M, 2002, B MAR SCI, V70, P639; Heino M, 2009, ENCY LIFE SCI ELS; Hsieh CH, 2010, AQUAT SCI, V72, P165, DOI 10.1007/s00027-009-0122-2; Hutchings JA, 2011, CAN J ZOOL, V89, P386, DOI [10.1139/z11-022, 10.1139/Z11-022]; Januchowski-Hartley FA, 2012, MAR ECOL PROG SER, V469, P113, DOI 10.3354/meps09971; Januchowski-Hartley FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022761; Jennings S, 2000, REV FISH BIOL FISHER, V10, P209, DOI 10.1023/A:1016619102955; KIMURA DK, 1980, FISH B-NOAA, V77, P765; Krone R, 2008, CORAL REEFS, V27, P619, DOI 10.1007/s00338-008-0365-8; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Kuparinen A, 2012, P ROY SOC B-BIOL SCI, V279, P2571, DOI 10.1098/rspb.2012.0120; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Law R, 2007, MAR ECOL PROG SER, V335, P271, DOI 10.3354/meps335271; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Martins GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044297; MAZEROLL AI, 1995, ETHOLOGY, V99, P89; McClanahan TR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1938; McClanahan TR, 2012, MAR ECOL PROG SER, V469, P121, DOI 10.3354/meps10009; McCormick MI, 1997, MAR ECOL PROG SER, V153, P247, DOI 10.3354/meps153247; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Miethe T, 2010, ICES J MAR SCI, V67, P412, DOI 10.1093/icesjms/fsp248; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Mosqueira I, 2000, ANIM CONSERV, V3, P321, DOI 10.1017/S1367943000001049; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P33, DOI 10.2960/J.v33.a3; Myers RA, 1997, CAN J FISH AQUAT SCI, V54, P1, DOI 10.1139/f96-262; Nelson G. A, 2017, FISHMETHODS FISHERY; Ogle D, 2017, FSA FISHERIES STOCK; Olsen E, 2005, CAN J FISH AQUAT SCI, V62, P811, DOI 10.1139/F05-065; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Palkovacs EP, 2012, EVOL APPL, V5, P183, DOI 10.1111/j.1752-4571.2011.00212.x; ROBERTSON DR, 1983, ENVIRON BIOL FISH, V9, P193, DOI 10.1007/BF00692372; Rose GA, 2015, CAN J FISH AQUAT SCI, V72, P1789, DOI 10.1139/cjfas-2015-0346; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Russ GR, 1998, CORAL REEFS, V17, P399, DOI 10.1007/s003380050146; RUSS GR, 1989, MAR ECOL PROG SER, V56, P13, DOI 10.3354/meps056013; Sharpe DMT, 2009, EVOL APPL, V2, P260, DOI 10.1111/j.1752-4571.2009.00080.x; Soykan CU, 2015, CONSERV BIOL, V29, P775, DOI 10.1111/cobi.12445; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Stokes K, 2000, MAR ECOL PROG SER, V208, P307; Swain DP, 2007, P ROY SOC B-BIOL SCI, V274, P1015, DOI 10.1098/rspb.2006.0275; Swain DP, 2011, EVOL APPL, V4, P18, DOI 10.1111/j.1752-4571.2010.00128.x; Taborsky B, 2003, P ROY SOC B-BIOL SCI, V270, P713, DOI 10.1098/rspb.2002.2255; Trexler JC, 2000, B MAR SCI, V66, P853; Uusi-Heikkila S, 2015, EVOL APPL, V8, P597, DOI 10.1111/eva.12268; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x	75	5	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193426	10.1371/journal.pone.0193426	http://dx.doi.org/10.1371/journal.pone.0193426			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470525	Green Submitted, Green Published, gold			2022-12-26	WOS:000425831000053
J	Davie, G; Samaranayaka, A; Derrett, S				Davie, Gabrielle; Samaranayaka, Ari; Derrett, Sarah			The role of pre-existing comorbidity on the rate of recovery following injury: A longitudinal cohort study	PLOS ONE			English	Article							DISABILITY; OUTCOMES; HEALTH	Understanding the role of comorbidity in recovery following injury is an important challenge given the increasing prevalence of multimorbidity (2 or more comorbidities) in many countries. The Prospective Outcomes of Injury Study recruited 2856 injured 18-64 year olds that had registered for entitlements with New Zealand's universal no-fault injury insurer. Recovery, or lack of, in this longitudinal cohort was measured using the World Health Organization Disability Assessment Schedule at 3, 12 and 24 months post-injury. Twenty-one pre-existing chronic conditions were used to identify comorbidity. To investigate whether rates of recovery differed by pre-injury comorbidity, the interaction between time and comorbidity was modelled using Generalised Estimating Equations. Of 1,862 participants with complete data, the distribution reporting none, one comorbidity, or multimorbidity pre-injury was 51%, 27%, and 21% respectively. Longitudinal analysis estimated no difference (log odds per year 0.05, 95% Confidence Interval -0.17 to 0.27) between the rate of change of disability for those with one pre-injury comorbidity compared to those with none. Those with pre-injury multimorbidity had significantly slower reduction in disability over time than those with no pre-injury comorbidity (log odds per year 0.27, 95% Confidence Interval 0.05 to 0.48). In a working age cohort, the rate of recovery in the 24 months following injury was similar for those with none or one pre-existing comorbidity and significantly slower for those with multimorbidity. It is important that further research explores mechanisms driving this, and that researchers and health providers identify and implement better supports for injured people with multimorbidity.	[Davie, Gabrielle; Derrett, Sarah] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand; [Samaranayaka, Ari] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand	University of Otago; University of Otago	Davie, G (corresponding author), Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand.	gabrielle.davie@otago.ac.nz		Davie, Gabrielle/0000-0001-5466-5364	Health Research Council of New Zealand; Accident Compensation Corporation, New Zealand [10/052]	Health Research Council of New Zealand(Health Research Council of New Zealand); Accident Compensation Corporation, New Zealand	This study was funded by the Health Research Council of New Zealand www.hrc.govt.nz (2007-2013), and co-funded by the Accident Compensation Corporation, New Zealand www.acc.co.nz (2007-2010; ID 10/052). The views and conclusions expressed herein are the authors' and may not reflect those of the funders. The Accident Compensation Corporation sent out invitations to eligible potential participants on the research team's behalf, and also provided, following participants' consent, information from the electronic record about participants' injuries. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Accident Compensation Corporation, 2017, ACC TREATM PROV HDB; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Carlin JB, 1999, STAT MED, V18, P2655, DOI 10.1002/(SICI)1097-0258(19991015)18:19<2655::AID-SIM202>3.0.CO;2-#; Derrett S, 2009, INJURY PREV, V15, DOI [10.1136/ip.2009.022558a, 10.1136/ip.2009.022558]; Derrett S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080194; Derrett S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044909; Derrett S, 2011, INJURY PREV, V17, P415, DOI 10.1136/injuryprev-2011-040044; Derrett S, 2009, J TRAUMA, V67, P883, DOI 10.1097/TA.0b013e3181ae6409; Gabbe BJ, 2016, ANN SURG, V263, P623, DOI 10.1097/SLA.0000000000001564; Gabbe BJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-30; Goodman RA, 2016, J GERONTOL A-BIOL, V71, P215, DOI 10.1093/gerona/glv199; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Health Information Standards Organisation (HISO), 2017, 10001 HISO MIN HLTH; Langley J, 2013, ARCH PHYS MED REHAB, V94, P1277, DOI 10.1016/j.apmr.2013.02.012; Langley J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-68; Langley JD, 2013, INJURY PREV, V19, P428, DOI 10.1136/injuryprev-2012-040685; Ministry of Health, 2008, PORTR HLTH KEY RES 2; Ministry of Health Singapore, 2016, SING HLTH FACTS TOP; Ministry of Social Development, 2000, DIR MEAS LIV STAND N; National Health Board Business Unit, 2014, NAT MIN DAT HOSP EV; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Public Health Agency of Canada, 2009, LEAD CAUS HOSP; StataCorp, 2013, STATA STAT SOFTW REL; Statistics New Zealand, 2006, CENS POP DWELL; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; stun TBK N, 2010, MEASURING HLTH DISAB; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van der Aa Maartje J, 2017, J Comorb, V7, P11, DOI 10.15256/joc.2017.7.97; VERBRUGGE LM, 1989, MILBANK Q, V67, P450, DOI 10.2307/3350223; World Health Organization (WHO), 2011, BMI CLASSIFICATION	30	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193019	10.1371/journal.pone.0193019	http://dx.doi.org/10.1371/journal.pone.0193019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466432	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300078
J	Gumus, HG; Illa, M; Pla, L; Zamora, M; Crispi, F; Gratacos, E				Gulcin Gumus, Hatice; Illa, Miriam; Pla, Laura; Zamora, Monica; Crispi, Fatima; Gratacos, Eduard			Nutritional intra-amniotic therapy increases survival in a rabbit model of fetal growth restriction	PLOS ONE			English	Article							AMNIOTIC-FLUID; ANIMAL-MODEL; TRANSPORT; INFUSION	Objective To evaluate the perinatal effects of a prenatal therapy based on intra-amniotic nutritional supplementation in a rabbit model of intrauterine growth restriction (IUGR). Methods IUGR was surgically induced in pregnant rabbits at gestational day 25 by ligating 40-50% of uteroplacental vessels of each gestational sac. At the same time, modified-parenteral nutrition solution (containing glucose, amino acids and electrolytes) was injected into the amniotic sac of nearly half of the IUGR fetuses (IUGR-T group n = 106), whereas sham injections were performed in the rest of fetuses (IUGR group n = 118). A control group without IUGR induction but sham injection was also included (n = 115). Five days after the ligation procedure, a cesarean section was performed to evaluate fetal cardiac function, survival and birth weight. Results Survival was significantly improved in the IUGR fetuses that were treated with intra-amniotic nutritional supplementation as compared to non-treated IUGR animals (survival rate: controls 71% vs. IUGR 44% p = 0.003 and IUGR-T 63% vs. IUGR 44% p = 0.02), whereas, birth weight (controls mean 43g +/- SD 9 vs. IUGR 36g +/- SD 9 vs. IUGR-T 35g +/- SD 8, p = 0.001) and fetal cardiac function were similar among the IUGR groups. Conclusion Intra-amniotic injection of a modified-parenteral nutrient solution appears to be a promising therapy for reducing mortality among IUGR. These results provide an opportunity to develop new intra-amniotic nutritional strategies to reach the fetus by bypassing the placental insufficiency.	[Gulcin Gumus, Hatice; Illa, Miriam; Pla, Laura; Zamora, Monica; Crispi, Fatima; Gratacos, Eduard] Univ Barcelona, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Hosp Clin, Fetal I D Fetal Med Res Ctr, Barcelona, Spain; [Gulcin Gumus, Hatice; Illa, Miriam; Pla, Laura; Zamora, Monica; Crispi, Fatima; Gratacos, Eduard] Univ Barcelona, Hosp San Juan Deu, Inst Clin Ginecol Obstet & Neonatal, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Crispi, Fatima; Gratacos, Eduard] Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Gumus, HG (corresponding author), Univ Barcelona, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Hosp Clin, Fetal I D Fetal Med Res Ctr, Barcelona, Spain.; Gumus, HG (corresponding author), Univ Barcelona, Hosp San Juan Deu, Inst Clin Ginecol Obstet & Neonatal, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.	hgumusgu8@alumnes.ub.edu	Gratacos, Eduard/AAR-4939-2020	Gratacos, Eduard/0000-0002-7405-7224; Gumus, Hatice Gulcin/0000-0002-1613-1721; Illa, Miriam/0000-0002-8366-830X	Plan Nacional de I+D+I from Instituto de Salud Carlos III -Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) [PI15/00130]; "la Caixa" Foundation; AGAUR SGR grant [928]; Erasmus + Programme of the European Union [2013-0040]	Plan Nacional de I+D+I from Instituto de Salud Carlos III -Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); "la Caixa" Foundation(La Caixa Foundation); AGAUR SGR grant; Erasmus + Programme of the European Union	This study was supported by Plan Nacional de I+D+I (PI15/00130) from Instituto de Salud Carlos III -Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) Una manera de hacer Europa. Additionally, the research leading to these results has received funding from la Caixa Foundation and AGAUR 2014 SGR grant no 928. This project has been funded with support of the Erasmus + Programme of the European Union (Framework Agreement number: 2013-0040). This publication reflects the views only of the author, and the Commission cannot be held responsible for any use, which may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth CJ, 2001, REPRODUCTION, V122, P527, DOI 10.1530/rep.0.1220527; Bautista A, 2015, PHYSIOL BEHAV, V138, P101, DOI 10.1016/j.physbeh.2014.10.028; Bernstein IM, 1997, AM J OBSTET GYNECOL, V176, P176; Buchmiller TL, 1992, UPREGULATION NUTR TR, V447, P443; Cetin I, 2005, ACTA PAEDIATR, V94, P7, DOI 10.1080/08035320510043709; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Eixarch E, 2011, PLACENTA, V32, P304, DOI 10.1016/j.placenta.2011.01.014; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; FLAKE AW, 1986, J PEDIATR SURG, V21, P481, DOI 10.1016/S0022-3468(86)80216-0; FOWDEN AL, 1989, Q J EXP PHYSIOL CMS, V74, P703, DOI 10.1113/expphysiol.1989.sp003322; GULMEZOGLU AM, 2001, COCHRANE DB SYST REV; GULMEZOGLU AM, 2000, COCHRANE DB SYST REV; HARRISON MR, 1982, J PEDIATR SURG, V17, P376, DOI 10.1016/S0022-3468(82)80493-4; Hofmeyr G.J., 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000148, DOI 10.1002/14651858.CD000148]; Illa M, 2013, PLOS ONE, V8; Illa M, 2017, FETAL DIAGN THER, P1; Kady SM, 2004, BEST PRACT RES CL OB, V18, P397, DOI 10.1016/j.bpobgyn.2004.02.009; Kilkenny C., 2013, ANIMALS, V4, P35, DOI DOI 10.3390/ani4010035; Lassala A, 2010, J NUTR, V140, P1242, DOI 10.3945/jn.110.125658; LAURIN J, 1987, ACTA OBSTET GYN SCAN, V66, P407, DOI 10.3109/00016348709022043; Liberato SC, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.20499; Lin G, 2014, AMINO ACIDS, V46, P1605, DOI 10.1007/s00726-014-1725-z; Makrides M, 2003, AM J CLIN NUTR, V78, P145, DOI 10.1093/ajcn/78.1.145; Marconi AM, 2008, SEMIN PERINATOL, V32, P178, DOI 10.1053/j.semperi.2008.02.007; Merialdi M, 2003, J NUTR, V133, p1626S, DOI 10.1093/jn/133.5.1626S; MULVIHILL SJ, 1986, J SURG RES, V40, P291, DOI 10.1016/0022-4804(86)90189-7; MULVIHILL SJ, 1985, SURGERY, V98, P500; ORLIC D, 1973, J CELL BIOL, V56, P106, DOI 10.1083/jcb.56.1.106; PHILLIPS JD, 1991, J PEDIATR SURG, V26, P374, DOI 10.1016/0022-3468(91)90982-Y; Pritchard J., 1966, OBSTET GYNECOL, V606, P610; Regnault TRH, 2005, PLACENTA, V26, pS52, DOI 10.1016/j.placenta.2005.01.003; SIMMER K, 1985, CLIN SCI, V68, P395, DOI 10.1042/cs0680395; Skarsgard ED, 2001, J SURG RES, V99, P142, DOI 10.1006/jsre.2001.6120; Somm E, 2014, PEDIATR RES, V75, P51, DOI 10.1038/pr.2013.199; Tarrade A, 2013, SEXUAL DIMORPHISM FE, V8; Torre I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113067; Trahair JF, 2000, REPROD FERT DEVELOP, V12, P87, DOI 10.1071/RD00024; Wallace JM, 2003, J PHYSIOL-LONDON, V547, P85, DOI 10.1113/jphysiol.2002.023333; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193240	10.1371/journal.pone.0193240	http://dx.doi.org/10.1371/journal.pone.0193240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466434	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300102
J	Nakamura, H; Bono, H; Hiyama, K; Kawamoto, T; Kato, Y; Nakanishi, T; Nishiyama, M; Hiyama, E; Hirohashi, N; Sueoka, E; Poellinger, L; Tanimoto, K				Nakamura, Hideaki; Bono, Hidemasa; Hiyama, Keiko; Kawamoto, Takeshi; Kato, Yukio; Nakanishi, Takeshi; Nishiyama, Masahiko; Hiyama, Eiso; Hirohashi, Nobuyuki; Sueoka, Eisaburo; Poellinger, Lorenz; Tanimoto, Keiji			Differentiated embryo chondrocyte plays a crucial role in DNA damage response via transcriptional regulation under hypoxic conditions	PLOS ONE			English	Article							MISMATCH REPAIR GENE; TUMOR-SUPPRESSOR PROTEIN; DOWN-REGULATION; CANCER-THERAPY; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; PROBE LEVEL; FACTOR DEC1; EXPRESSION; REPRESSION	Tumor hypoxia contributes to a biologically aggressive phenotype and therapeutic resistance. Recent studies have revealed that hypoxia reduces expression of several DNA damage recognition and repair (DRR) genes via both hypoxia-inducible factor (HIF)-independent and - dependent pathways, and this induced genomic instability in cancer cells. We show here that one of the HIF-target genes D differentiated embryo chondrocyte (DEC) D plays a role in DNA damage response via transcriptional repression. Comprehensive gene expression and database analyses have revealed systemic repression of DNA-DRR genes in cancer and non-cancer cells under hypoxic conditions. Hypoxic repression in typical cases was confirmed by quantitative RT-PCR and promoter reporter experiments, and knockdown experiments indicated the critical role of DEC2 in such repression. Assessment of histone H2AX phosphorylation revealed that recognition and repair of DNA double-strand breaks (DSBs) induced by bleomycin or.-ray irradiation were attenuated; moreover, Cleaved Caspase-3 levels were decreased with pre-conditioning under hypoxia: opposing phenomena were ascertained by knockdown of DEC2. Finally, pre-conditioning under hypoxia decreased the sensitivity of cancer cells to DSBs, and knockdown of DEC2 increased.-ray sensitivity. These data imply that a critical reduction of DNA-DRR occurs via DEC-dependent transcriptional repression and suggest that DEC is a potential molecular target for anti-cancer strategies.	[Nakamura, Hideaki; Hirohashi, Nobuyuki; Tanimoto, Keiji] Hiroshima Univ, Dept Radiat Med, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Nakamura, Hideaki; Hiyama, Keiko; Hiyama, Eiso] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan; [Nakamura, Hideaki; Sueoka, Eisaburo] Saga Univ Hosp, Dept Lab Med, Saga, Japan; [Nakamura, Hideaki; Poellinger, Lorenz] Karolinska Inst, Med Nobel Inst, Cell & Mol Biol, Stockholm, Sweden; [Bono, Hidemasa] Res Org Informat & Syst, Database Ctr Life Sci, Joint Support Ctr Data Sci Res, Mishima, Shizuoka, Japan; [Kawamoto, Takeshi; Kato, Yukio] Hiroshima Univ, Dept Dent & Med Biochem, Hiroshima, Japan; [Nakanishi, Takeshi] Nippon Kayaku Co Ltd, Tokyo, Japan; [Hirohashi, Nobuyuki] Gunma Univ, Grad Sch Med, Dept Mol Pharmacol & Oncol, Gunma, Japan	Hiroshima University; Hiroshima University; Saga University; Karolinska Institutet; Research Organization of Information & Systems (ROIS); Hiroshima University; Nippon Kayaku Co., Ltd.; Gunma University	Tanimoto, K (corresponding author), Hiroshima Univ, Dept Radiat Med, Res Inst Radiat Biol & Med, Hiroshima, Japan.	ktanimo@hiroshima-u.ac.jp	Keiji, Tanimoto/U-1839-2019; , 河本健/D-7938-2015; Hiyama, Eiso/A-2013-2019; Bono, Hidemasa/AAF-3649-2020	Keiji, Tanimoto/0000-0003-4912-4197; , 河本健/0000-0003-3337-1775; Hiyama, Eiso/0000-0001-9179-5037; Bono, Hidemasa/0000-0003-4413-0651	Japan Society for the Promotion of Science [23592766]; National Bioscience Database Center (NBDC) of Japan Science and Technology Agency (JST); Nippon Kayaku Co., Ltd	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Bioscience Database Center (NBDC) of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Nippon Kayaku Co., Ltd	This work was supported by Grants-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (No.23592766) to KT, and also by the National Bioscience Database Center (NBDC) of Japan Science and Technology Agency (JST) to HB. These funders were not involved in study design, data analysis, decision to publish, or preparation of the manuscript. Nippon Kayaku Co., Ltd provided support in the form of salary for one of the authors (T. Nakanishi), but did not have any additional role in the study as described above. The specific role of this author is articulated in the 'author contributions' section.	Abdisalaam S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt908; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bindra RS, 2007, ONCOGENE, V26, P2048, DOI 10.1038/sj.onc.1210001; Bindra RS, 2007, CANCER LETT, V252, P93, DOI 10.1016/j.canlet.2006.12.011; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Bindra RS, 2004, MOL CELL BIOL, V24, P8504, DOI 10.1128/MCB.24.19.8504-8518.2004; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Brown JM, 1998, CANCER RES, V58, P1408; Cairns R, 2006, MOL CANCER RES, V4, P61, DOI 10.1158/1541-7786.MCR-06-0002; Cavadas MAS, 2017, EXP CELL RES, V356, P173, DOI 10.1016/j.yexcr.2017.02.024; Chan N, 2008, CANCER RES, V68, P605, DOI 10.1158/0008-5472.CAN-07-5472; Choi SM, 2008, NUCLEIC ACIDS RES, V36, P6372, DOI 10.1093/nar/gkn620; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Feige E, 2011, P NATL ACAD SCI USA, V108, pE924, DOI 10.1073/pnas.1106351108; Fleck O, 2004, J CELL SCI, V117, P515, DOI 10.1242/jcs.00952; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Inaguma S, 2013, CANCER RES, V73, P7313, DOI 10.1158/0008-5472.CAN-13-2008; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivanov SV, 2007, ONCOGENE, V26, P802, DOI 10.1038/sj.onc.1209842; Ivanova AV, 2001, J BIOL CHEM, V276, P15306, DOI 10.1074/jbc.M010516200; Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Komatsu M, 2006, MOL CANCER THER, V5, P767, DOI 10.1158/1535-7163.MCT-05-0408; Kondo A, 2001, CANCER RES, V61, P7603; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Liu JJ, 2010, FEBS LETT, V584, P619, DOI 10.1016/j.febslet.2009.12.011; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mihaylova VT, 2003, MOL CELL BIOL, V23, P3265, DOI 10.1128/MCB.23.9.3265-3273.2003; Miyazaki K, 2002, J BIOL CHEM, V277, P47014, DOI 10.1074/jbc.M204938200; Nakamura H, 2008, ONCOGENE, V27, P4200, DOI 10.1038/onc.2008.58; Noguchi T, 2004, CLIN CANCER RES, V10, P7100, DOI 10.1158/1078-0432.CCR-04-0337; Ow JR, 2014, CURR TOP DEV BIOL, V110, P317, DOI 10.1016/B978-0-12-405943-6.00009-9; Peng Y, 2012, TOXICOLOGY, V301, P58, DOI 10.1016/j.tox.2012.06.022; Reynolds TY, 1996, CANCER RES, V56, P5754; Sato F, 2004, EUR J BIOCHEM, V271, P4409, DOI 10.1111/j.1432-1033.2004.04379.x; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tanimoto K, 2003, CARCINOGENESIS, V24, P1779, DOI 10.1093/carcin/bgg132; TEICHER BA, 1994, CANCER METAST REV, V13, P139, DOI 10.1007/BF00689633; To KKW, 2006, EMBO J, V25, P4784, DOI 10.1038/sj.emboj.7601369; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yuan JL, 2000, CANCER RES, V60, P4372; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4	53	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192136	10.1371/journal.pone.0192136	http://dx.doi.org/10.1371/journal.pone.0192136			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466367	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300030
J	Ravago-Gotanco, R; de la Cruz, TL; Pante, MJ; Borsa, P				Ravago-Gotanco, Rachel; Lorena de la Cruz, Talna; Josefa Pante, Ma.; Borsa, Philippe			Cryptic genetic diversity in the mottled rabbitfish Siganus fuscescens with mitochondrial introgression at a contact zone in the South China Sea	PLOS ONE			English	Article							POPULATION-STRUCTURE; INDO-PACIFIC; DNA; PATTERNS; HYBRIDIZATION; SOFTWARE; NUCLEAR; FISH; PHYLOGEOGRAPHY; DIVERGENCE	The taxonomy of the mottled rabbitfish Siganus fuscescens species complex has long been challenging. In this study, we analyzed microsatellite genotypes, mitochondrial lineages, and morphometric data from 373 S. fuscescens individuals sampled from the northern Philippines and Hong Kong (South China Sea, Philippine Sea and Sulu Sea basins), to examine putative species boundaries in samples comprising three co-occurring mitochondrial lineages previously reported to characterize S. fuscescens (Clade A and Clade B) or S. canaliculatus (Clade C). We report the existence of two cryptic species within S. fuscescens in the northeast region of the South China Sea and northern Philippine Sea, supported by genetic and morphological differences. Individual-based assignment methods recovered concordant groupings of individuals into two nuclear genotype clusters (Cluster 1, Cluster 2) with (1) limited gene flow, if any, between them (F-ST = 0.241; P < 0.001); (2) low frequency of later-generation hybrids; (3) significant association with mitochondrial Clade A and Clade B, respectively; and (4) subtle yet significant body shape differences as inferred from geometric morphometric analysis. The divergence between mitochondrial Clade C and the two other clades was not matched by genetic differences at microsatellite marker loci. The occurrence of discordant mitonuclear combinations (20.5% of the total number of individuals) is thought to result from mitochondrial introgression, consistent with a scenario of demographic, and presumably spatial, post-Pleistocene expansion of populations from northern regions into a secondary contact zone in the South China Sea. Mitonuclear discordance due to introgression obscures phylogenetic relationships for recently-diverged lineages, and cautions against the use of mitochondrial markers alone for species identification within the mottled rabbitfish species complex in the South China Sea region.	[Ravago-Gotanco, Rachel; Lorena de la Cruz, Talna; Josefa Pante, Ma.] Univ Philippines, Inst Marine Sci, Quezon City, Philippines; [Borsa, Philippe] Univ Udayana, Indonesian Biodivers Res Ctr, Ecol Marine Trop Oceans Pacifique & Indien, IRD, Denpasar, Indonesia	University of the Philippines System; University of the Philippines Diliman; Institut de Recherche pour le Developpement (IRD); Universitas Udayana	Ravago-Gotanco, R (corresponding author), Univ Philippines, Inst Marine Sci, Quezon City, Philippines.	rrgotanco@msi.upd.edu.ph	Borsa, Philippe/AAC-7915-2019; Ravago-Gotanco, Rachel/AAE-3149-2020	Ravago-Gotanco, Rachel/0000-0003-3570-2005	Global Environment Facility-Coral Reef Targeted Research Capability Building for Management Project (GEF-CRTR) through the Southeast Asia Center of Excellence grant; Office of the Vice Chancellor for Research and Development, University of the Philippines Diliman (OVCRD Grant PhDIA) [121206]; University of the Philippines Marine Science Institute; GEF-Coral Reef Targeted Research Center of Excellence (Philippines) Program; University of the Philippines Office of the Vice Chancellor for Research and Development (PhD IA Grant) [121206]; UP Marine Science Institute	Global Environment Facility-Coral Reef Targeted Research Capability Building for Management Project (GEF-CRTR) through the Southeast Asia Center of Excellence grant; Office of the Vice Chancellor for Research and Development, University of the Philippines Diliman (OVCRD Grant PhDIA); University of the Philippines Marine Science Institute; GEF-Coral Reef Targeted Research Center of Excellence (Philippines) Program; University of the Philippines Office of the Vice Chancellor for Research and Development (PhD IA Grant); UP Marine Science Institute	Funding for this research was provided by the Global Environment Facility-Coral Reef Targeted Research Capability Building for Management Project (GEF-CRTR) through the Southeast Asia Center of Excellence grant to the University of the Philippines Marine Science Institute. Additional funding was provided by the Office of the Vice Chancellor for Research and Development, University of the Philippines Diliman (OVCRD Grant PhDIA # 121206 to RRG) and the University of the Philippines Marine Science Institute (DRP, RRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the GEF-Coral Reef Targeted Research Center of Excellence (Philippines) Program, University of the Philippines Office of the Vice Chancellor for Research and Development (PhD IA Grant #121206 to RRG), and the UP Marine Science Institute. We thank C. Lumibao, and C. Balitaan for assistance in the field and laboratory.	Adams A., 1994, P 4 IND PAC FISH BAN, P373; Anderson EC, 2002, GENETICS, V160, P1217; [Anonymous], 2004, LAB GENOME; ASMUSSEN MA, 1987, GENETICS, V115, P755; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bar Yaacov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031372; Barber PH, 2009, J BIOGEOGR, V36, P1845, DOI 10.1111/j.1365-2699.2009.02198.x; Basten CJ, 1997, GENETICS, V146, P1165; Bellefleur D, 1997, THESIS; Bertrand JAM, 2017, MOL ECOL, V26, P2527, DOI 10.1111/mec.14044; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Borsa P, 2007, MOL PHYLOGENET EVOL, V44, P427, DOI 10.1016/j.ympev.2007.01.015; Borsa P, 2016, CR BIOL, V339, P417, DOI 10.1016/j.crvi.2016.07.004; Borsa P, 2014, CR BIOL, V337, P709, DOI 10.1016/j.crvi.2014.09.001; Borsa P, 2012, J EXP MAR BIOL ECOL, V438, P32, DOI 10.1016/j.jembe.2012.09.010; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Bowen BW, 2006, J HERED, V97, P1, DOI 10.1093/jhered/esj006; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Chan KMA, 2005, EVOLUTION, V59, P720; Cheviron ZA, 2009, EVOLUTION, V63, P1593, DOI 10.1111/j.1558-5646.2009.00644.x; Cianchi R, 2003, MOL ECOL, V12, P1461, DOI 10.1046/j.1365-294X.2003.01813.x; Cowman PF, 2013, J BIOGEOGR, V40, P209, DOI 10.1111/jbi.12003; Crochet PA, 2003, EVOLUTION, V57, P2865; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; de la Paz Reynaldo M., 1990, Philippine Journal of Science, V119, P223; Del Norte AGC, 1990, VIRTUAL POPULATION E, P851; DiBattista JD, 2016, MOL PHYLOGENET EVOL, V101, P203, DOI 10.1016/j.ympev.2016.04.036; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fauvelot C, 2011, BIOL J LINN SOC, V104, P886, DOI 10.1111/j.1095-8312.2011.01754.x; Fu YX, 1997, GENETICS, V147, P915; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gaither MR, 2013, J BIOGEOGR, V40, P1638, DOI 10.1111/jbi.12126; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harrison RG, 1997, EVOLUTION, V51, P493, DOI 10.1111/j.1558-5646.1997.tb02437.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Horne JB, 2013, J EVOLUTION BIOL, V26, P783, DOI 10.1111/jeb.12092; Hsu TH, 2011, J FISH BIOL, V79, P1350, DOI 10.1111/j.1095-8649.2011.03104.x; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Iwamoto Kensuke, 2015, Biogeography, V17, P61; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Karahan A, 2014, FISH RES, V159, P45, DOI 10.1016/j.fishres.2014.05.009; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kokita T, 2011, MOL ECOL, V20, P143, DOI 10.1111/j.1365-294X.2010.04920.x; Kuriiwa K, 2007, MOL PHYLOGENET EVOL, V45, P69, DOI 10.1016/j.ympev.2007.04.018; Lam Y., 2010, THESIS; Lemer S, 2007, CR BIOL, V330, P86, DOI 10.1016/j.crvi.2006.09.002; Liu SYV, 2014, BIOL J LINN SOC, V113, P931, DOI 10.1111/bij.12378; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martinsen GD, 2001, EVOLUTION, V55, P1325, DOI 10.1111/j.0014-3820.2001.tb00655.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2001, GENETICS, V158, P885; Noda M, 2011, NIPPON SUISAN GAKK, V77, P1008, DOI 10.2331/suisan.77.1008; Nydam ML, 2011, EVOLUTION, V65, P429, DOI 10.1111/j.1558-5646.2010.01153.x; Oh DJ, 2007, DNA SEQUENCE, V18, P295, DOI 10.1080/10425170701248525; Pages M, 2013, MOL ECOL, V22, P1019, DOI 10.1111/mec.12149; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Petit RJ, 2004, NEW PHYTOL, V161, P151, DOI 10.1046/j.1469-8137.2003.00944.x; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pianka ER, 1978, EVOL ECOL, V2nd; Pillans RD, 2004, J FISH BIOL, V64, P297, DOI 10.1111/j.0022-1112.2004.00261.x; Pritchard JK, 2000, GENETICS, V155, P945; Qiu F, 2016, MOL PHYLOGENET EVOL, V96, P112, DOI 10.1016/j.ympev.2015.11.020; Randall JE, 2005, CYBIUM, V29, P185; Ravago-Gotanco RG, 2010, MOL ECOL, V19, P4520, DOI 10.1111/j.1365-294X.2010.04803.x; Ravago-Gotanco R, 2010, CONSERV GENET RESOUR, V2, P225, DOI 10.1007/s12686-009-9148-y; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rocha LA, 2008, J FISH BIOL, V72, P1101, DOI 10.1111/j.1095-8649.2007.01770.x; Rodriguez SF, 1997, THESIS; Rohit FJ, 2005, TPSDIG DIGITIZE LAND; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruehl CB, 2011, BIOL J LINN SOC, V103, P147, DOI 10.1111/j.1095-8312.2011.01626.x; Russo T, 2008, J FISH BIOL, V73, P809, DOI 10.1111/j.1095-8649.2008.01964.x; Sanz N, 2009, CONSERV GENET, V10, P225, DOI 10.1007/s10592-008-9550-0; SCHNABEL A, 1989, GENETICS, V123, P199; Sethuraman A, 2016, MOL ECOL RESOUR, V16, P206, DOI 10.1111/1755-0998.12437; Shen KN, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-83; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; Sullivan JP, 2004, EVOLUTION, V58, P825; TAJIMA F, 1989, GENETICS, V123, P597; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Tornabene L, 2015, MOL PHYLOGENET EVOL, V82, P200, DOI 10.1016/j.ympev.2014.09.012; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; Whitney KD, 2006, AM NAT, V167, P794, DOI 10.1086/504606; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Woodland DJ, 2014, ZOOTAXA, V3811, P129, DOI 10.11646/zootaxa.3811.1.8; Woodland David J., 1990, Indo-Pacific Fishes, V19, P1; Yagishita N, 2016, FISHERIES SCI, V82, P289, DOI 10.1007/s12562-015-0964-6; Yamada M, 2001, ENVIRON BIOL FISH, V61, P269, DOI 10.1023/A:1010874117127; Yue GH, 2005, ELECTROPHORESIS, V26, P3081, DOI 10.1002/elps.200410411; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	117	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193220	10.1371/journal.pone.0193220	http://dx.doi.org/10.1371/journal.pone.0193220			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466431	gold, Green Published, Green Submitted			2022-12-26	WOS:000425604300098
J	Todd, R; Bhalerao, S; Vu, MT; Soklaridis, S; Cusimano, MD				Todd, Ryan; Bhalerao, Shree; Vu, Michael T.; Soklaridis, Sophie; Cusimano, Michael D.			Understanding the psychiatric effects of concussion on constructed identity in hockey players: Implications for health professionals	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; BIOGRAPHICAL DISRUPTION; LIVED EXPERIENCE; LEAGUE PLAYERS; ICE HOCKEY; DEPRESSION; RECOVERY; CHILDREN; SUICIDE	Objective The following study was undertaken to investigate the effect of concussion and psychiatric illness on athletes and their caregivers. Methods Semi-structured interviews with 20 ice hockey stakeholders (17 men and 3 women) including minor and professional players, coaches, parents, and physicians were conducted over two years (2012-2014). These interviews were analyzed using grounded theory. Results From this analysis, a common biographical theme emerged whereby the subject's identity as a hockey player, constructed early in life over many years, was disrupted by concussion. Furthermore, some players underwent a biographical deconstruction when they experienced post-concussive mental illness, which was amplified by isolation, stigma from peers, and lack of a clear life trajectory. Many players obtained support from family and peers and were able to recover, as evidenced by the biographical reconstruction of their identity posthockey concussion. Conclusions and implications for practice Understanding the process of biographical deconstruction and reconstruction has significant psychosocial treatment implications for both healthcare professionals and caregivers of this population. Specifically, the authors suggest that interpersonal psychotherapy (IPT) that focuses on role transitions may create opportunities to facilitate the process of biographical reconstruction and life transition.	[Todd, Ryan] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [Bhalerao, Shree] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Bhalerao, Shree] St Michaels Hosp, Med Psychiat, Toronto, ON, Canada; [Vu, Michael T.] St Michaels Hosp, Toronto, ON, Canada; [Soklaridis, Sophie] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Soklaridis, Sophie] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Surg Educ & Publ Hlth, Toronto, ON, Canada; [Cusimano, Michael D.] St Michaels Hosp, Dept Surg, Toronto, ON, Canada	University of Calgary; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Todd, R (corresponding author), Univ Calgary, Dept Psychiat, Calgary, AB, Canada.	ryan.todd@albertahealthservices.ca	Soklaridis, Sophie/ABG-2223-2020; Cusimano, Michael/X-4059-2019; Cusimano, Michael/GWR-1025-2022	Soklaridis, Sophie/0000-0001-5119-8473; Vu, Michael/0000-0001-7875-8901	Physicians' Services Incorporated (PSI) Foundation - Resident Research Grant	Physicians' Services Incorporated (PSI) Foundation - Resident Research Grant	The authors would like to acknowledge the support of the Physicians' Services Incorporated (PSI) Foundation - Resident Research Grant in funding this research. Further information can be found at http://www.psifoundation.org/	[Anonymous], 2012, NEW SPORT EXERCISE P; Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Block CK, 2013, BRAIN INJURY, V27, P775, DOI 10.3109/02699052.2013.775487; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Bourke A, 2003, J SPORT SOC ISSUES, V27, P399, DOI 10.1177/0193732503255478; Brock S. C., 1994, QUAL HLTH RES, P411, DOI [10.1177/104973239400, DOI 10.1177/104973239400400405]; Burns GN, 2012, PERS INDIV DIFFER, V52, P280, DOI 10.1016/j.paid.2011.10.020; Burt RS, 2005, BROKERAGE CLOSURE IN; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Busch R, 1998, NEUROPSYCHOL REV, V8, P950; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Carr D., 1986, TIME NARRATIVE HIST; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Epstein RS, 1994, NEUROPSYCHIATRY TRAU; Faircloth CA, 2004, SOCIOL HEALTH ILL, V26, P242, DOI 10.1111/j.1467-9566.2004.00388.x; Finkbeiner NW, 2016, CANADIAN J PSYCHIAT, V61; Fleming J, 2012, SCAND J OCCUP THER, V19, P184, DOI 10.3109/11038128.2011.611531; Fralick M, 2016, CANADIAN MED ASS J; Frank Ellen, 2014, Am J Psychother, V68, P385; Gee CJ, 2010, AGGRESSION COMPETITI; Gould D, 1997, SPORT PSYCHOL, V11, P361, DOI 10.1123/tsp.11.4.361; Green G, 2007, SOC SCI MED, V65, P524, DOI 10.1016/j.socscimed.2007.03.007; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hunt S., MASTER STATUS; Johnson T. S., 2009, W J BLACK STUDIES, V33, P98; Klerman GL, 1984, INTERPERSONAL PSYCHO; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Leamy M, 2011, BRIT J PSYCHIAT, V199, P445, DOI 10.1192/bjp.bp.110.083733; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Malagon-Maldonado G, 2014, HERD-HEALTH ENV RES, V7, P120, DOI 10.1177/193758671400700411; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Markowitz John C, 2004, World Psychiatry, V3, P136; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2016, CAN J PSYCHIAT, V61, P257, DOI 10.1177/0706743716644952; Messner MichaelA., 2007, OUT PLAY CRITICAL ES; Miller MD, 2007, INT J GERIATR PSYCH, V22, P101, DOI 10.1002/gps.1699; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morse J., 2004, ENCY SOCIAL SCI RES, P1123; Novotna G, 2013, DRUG-EDUC PREV POLIC, V20, P140, DOI 10.3109/09687637.2012.714015; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Purposive sampling, SAGE DICT SOCIAL RES; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Soklaridis S, 2011, DISABIL REHABIL, V33, P2372, DOI 10.3109/09638288.2011.573056; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Strauss A., 1990, BASICS QUALITATIVE R; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; WIDMEYER WN, 1984, J PSYCHOL, V117, P77, DOI 10.1080/00223980.1984.9923661; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	58	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192125	10.1371/journal.pone.0192125	http://dx.doi.org/10.1371/journal.pone.0192125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	29466377	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300029
J	Callendret, B; Vellinga, J; Wunderlich, K; Rodriguez, A; Steigerwald, R; Dirmeier, U; Cheminay, C; Volkmann, A; Brasel, T; Carrion, R; Giavedoni, LD; Patterson, JL; Mire, CE; Geisbert, TW; Hooper, JW; Weijtens, M; Hartkoorn-Pasma, J; Custers, J; Pau, MG; Schuitemaker, H; Zahn, R				Callendret, Benoit; Vellinga, Jort; Wunderlich, Kerstin; Rodriguez, Ariane; Steigerwald, Robin; Dirmeier, Ulrike; Cheminay, Cedric; Volkmann, Ariane; Brasel, Trevor; Carrion, Ricardo; Giavedoni, Luis D.; Patterson, Jean L.; Mire, Chad E.; Geisbert, Thomas W.; Hooper, Jay W.; Weijtens, Mo; Hartkoorn-Pasma, Jutta; Custers, Jerome; Pau, Maria Grazia; Schuitemaker, Hanneke; Zahn, Roland			A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates	PLOS ONE			English	Article							ATTENUATED RECOMBINANT VACCINE; VIRUS-BASED VACCINES; IMMUNE-RESPONSES; INTRAMUSCULAR ELECTROPORATION; CYNOMOLGUS MACAQUES; RANDOMIZED-TRIAL; CROSS-PROTECTION; DOUBLE-BLIND; OPEN-LABEL; DISEASE	The search for a universal filovirus vaccine that provides protection against multiple filovirus species has been prompted by sporadic but highly lethal outbreaks of Ebolavirus and Marburgvirus infections. A good prophylactic vaccine should be able to provide protection to all known filovirus species and as an upside potentially protect from newly emerging virus strains. We investigated the immunogenicity and protection elicited by multivalent vaccines expressing glycoproteins (GP) from Ebola virus (EBOV), Sudan virus (SUDV), Tai Forest virus (TAFV) and Marburg virus (MARV). Immune responses against filovirus GP have been associated with protection from disease. The GP antigens were expressed by adenovirus serotypes 26 and 35 (Ad26 and Ad35) and modified Vaccinia virus Ankara (MVA) vectors, all selected for their strong immunogenicity and good safety profile. Using fully lethal NHP intramuscular challenge models, we assessed different vaccination regimens for immunogenicity and protection from filovirus disease. Heterologous multivalent Ad26-Ad35 prime-boost vaccination regimens could give full protection against MARV (range 75%-100% protection) and EBOV (range 50% to 100%) challenge, and partial protection (75%) against SUDV challenge. Heterologous multivalent Ad26-MVA prime-boost immunization gave full protection against EBOV challenge in a small cohort study. The use of such multivalent vaccines did not show overt immune interference in comparison with monovalent vaccines. Multivalent vaccines induced GP-specific antibody responses and cellular IFN. responses to each GP expressed by the vaccine, and cross-reactivity to TAFV GP was detected in a trivalent vaccine expressing GP from EBOV, SUDV and MARV. In the EBOV challenge studies, higher humoral EBOV GP-specific immune responses (p = 0.0004) were associated with survival from EBOV challenge and less so for cellular immune responses (p = 0.0320). These results demonstrate that it is feasible to generate a multivalent filovirus vaccine that can protect against lethal infection by multiple members of the filovirus family.	[Callendret, Benoit; Vellinga, Jort; Wunderlich, Kerstin; Rodriguez, Ariane; Weijtens, Mo; Hartkoorn-Pasma, Jutta; Custers, Jerome; Pau, Maria Grazia; Schuitemaker, Hanneke; Zahn, Roland] Janssen Vaccines & Prevent BV, Leiden, Netherlands; [Steigerwald, Robin; Dirmeier, Ulrike; Cheminay, Cedric] Bavarian Nord GmbH, Martinsried, Germany; [Brasel, Trevor; Mire, Chad E.; Geisbert, Thomas W.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Carrion, Ricardo; Giavedoni, Luis D.; Patterson, Jean L.] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX USA; [Hooper, Jay W.] US Army, Med Res Inst Infect Dis, Virol Div, Ft Detrick, MD 21702 USA; [Wunderlich, Kerstin] BBraun, Melsungen, Germany; [Cheminay, Cedric] ViraTherapeut GmbH, Innsbruck, Austria	Bavarian Nordic; University of Texas System; University of Texas Medical Branch Galveston; Texas Biomedical Research Institute	Zahn, R (corresponding author), Janssen Vaccines & Prevent BV, Leiden, Netherlands.	rzahn@its.jnj.com	Zahn, Roland/ABE-8779-2021; Mire, Chad/Z-6338-2019; callendret, benoit/U-4193-2019; Hooper, Jay/K-2362-2017	Mire, Chad/0000-0001-7596-1808; Hooper, Jay/0000-0002-4475-0415	Janssen Vaccines; Prevention B.V.; Bavaria Nordic GmbH; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011133] Funding Source: NIH RePORTER	Janssen Vaccines; Prevention B.V.; Bavaria Nordic GmbH; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All costs associated with development of this manuscript were funded by Janssen Vaccines and Prevention B.V.. Bavaria Nordic GmbH and Janssen Vaccines and Prevention B.V. provided support in the form of salaries for authors [Bavaria Nordic GmbH: RS, UD, CC, AV; Janssen Vaccines and Prevention B.V.: BC, JV, KW, MW, JH-P, JC, MGP, HS, RZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alfson KJ, 2015, J INFECT DIS, V212, pS295, DOI 10.1093/infdis/jiv216; Alfson KJ, 2015, J VIROL, V89, P6773, DOI 10.1128/JVI.00649-15; Barouch DH, 2013, J INFECT DIS, V207, P248, DOI 10.1093/infdis/jis671; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Baur K, 2010, J VIROL, V84, P8743, DOI 10.1128/JVI.00604-10; Bradfute SB, 2011, VIRUSES-BASEL, V3, P982, DOI 10.3390/v3070982; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; COCHRAN MA, 1985, J VIROL, V54, P30, DOI 10.1128/JVI.54.1.30-37.1985; Coltart CEM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0477-2; Daddario-DiCaprio KM, 2006, J VIROL, V80, P9659, DOI 10.1128/JVI.00959-06; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Falzarano D, 2011, EXPERT REV VACCINES, V10, P63, DOI [10.1586/erv.10.152, 10.1586/ERV.10.152]; Geisbert TW, 2011, J INFECT DIS, V204, pS1075, DOI 10.1093/infdis/jir349; Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Goeijenbier M, 2014, NETH J MED, V72, P442; Grant-Klein RJ, 2015, HUM VACC IMMUNOTHER, V11, P1991, DOI 10.1080/21645515.2015.1039757; Grant-Klein RJ, 2012, HUM VACC IMMUNOTHER, V8, P1703, DOI 10.4161/hv.21873; Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Hirschberg R, 2014, VIRUSES-BASEL, V6, P2673, DOI 10.3390/v6072673; Hoft DF, 2012, VACCINE, V30, P2098, DOI 10.1016/j.vaccine.2012.01.048; Huttner A, 2015, LANCET INFECT DIS, V15, P1156, DOI 10.1016/S1473-3099(15)00154-1; International Committee on Taxonomy of Viruses, 2016, VIR TAX 2016 REL; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Krause PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8202; Kugelman JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150919; Kuhn JH, 2014, ARCH VIROL, V159, P1229, DOI 10.1007/s00705-013-1877-2; Majhen D, 2014, HUM GENE THER, V25, P301, DOI 10.1089/hum.2013.235; Martins K, 2015, VIRAL IMMUNOL, V28, P62, DOI 10.1089/vim.2014.0071; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Matassov D, 2015, J INFECT DIS, V212, pS443, DOI 10.1093/infdis/jiv316; Milligan ID, 2016, JAMA-J AM MED ASSOC, V315, P1610, DOI 10.1001/jama.2016.4218; Mire CE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002600; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Ockenhouse CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131571; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Pigott DM, 2015, T ROY SOC TROP MED H, V109, P366, DOI 10.1093/trstmh/trv024; Pigott DM, 2014, ELIFE, V3, DOI 10.7554/eLife.04395; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Staib Caroline, 2004, Methods Mol Biol, V269, P77; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Sullivan NJ, 2006, PLOS MED, V3, pe177; Swenson DL, 2008, CLIN VACCINE IMMUNOL, V15, P460, DOI 10.1128/CVI.00431-07; Tapia MD, 2016, LANCET INFECT DIS, V16, P31, DOI 10.1016/S1473-3099(15)00362-X; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06; Trefry JC, 2015, VIRUSES-BASEL, V7, P6739, DOI 10.3390/v7122969; WHO, 2017, EB VIR DIS; Wilkinson DE, 2017, VACCINE, V35, P1347, DOI 10.1016/j.vaccine.2016.11.083; Winslow RL, 2017, JAMA-J AM MED ASSOC, V317, P1074, DOI 10.1001/jama.2016.20644; Wong G, 2012, SCI TRANSL MED, V4, p158ra46; Wong G, 2014, EXPERT REV CLIN IMMU, V10, P781, DOI 10.1586/1744666X.2014.908705; Wulff Niels H, 2012, J Clin Bioinforma, V2, P5, DOI 10.1186/2043-9113-2-5; Zahn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044115	61	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192312	10.1371/journal.pone.0192312	http://dx.doi.org/10.1371/journal.pone.0192312			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462200	Green Submitted, Green Published, gold			2022-12-26	WOS:000425554200013
J	Zhang, MR; Qin, S; Xu, PZ; Zhang, GZ				Zhang, Meirong; Qin, Sheng; Xu, Pingzhen; Zhang, Guozheng			Identifying potential maternal genes of Bombyx mori using digital gene expression profiling	PLOS ONE			English	Article							TO-ZYGOTIC TRANSITION; MESSENGER-RNA; CELL-CYCLE; DROSOPHILA EMBRYO; SILKWORM; PATHWAY; OOCYTE; EGGS; DPP	Maternal genes present in mature oocytes play a crucial role in the early development of silkworm. Although maternal genes have been widely studied in many other species, there has been limited research in Bombyx mori. High-throughput next generation sequencing provides a practical method for gene discovery on a genome-wide level. Herein, a transcriptome study was used to identify maternal-related genes from silkworm eggs. Unfertilized eggs from five different stages of early development were used to detect the changing situation of gene expression. The expressed genes showed different patterns over time. Seventy- six maternal genes were annotated according to homology analysis with Drosophila melanogaster. More than half of the differentially expressed maternal genes fell into four expression patterns, while the expression patterns showed a downward trend over time. The functional annotation of these material genes was mainly related to transcription factor activity, growth factor activity, nucleic acid binding, RNA binding, ATP binding, and ion binding. Additionally, twenty-two gene clusters including maternal genes were identified from 18 scaffolds. Altogether, we plotted a profile for the maternal genes of Bombyx mori using a digital gene expression profiling method. This will provide the basis for maternal-specific signature research and improve the understanding of the early development of silkworm.	[Zhang, Meirong; Qin, Sheng; Xu, Pingzhen; Zhang, Guozheng] Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Meirong; Qin, Sheng; Xu, Pingzhen; Zhang, Guozheng] Chinese Acad Agr Sci, Sericulture Res Inst, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University of Science & Technology; Chinese Academy of Agricultural Sciences	Zhang, GZ (corresponding author), Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Jiangsu, Peoples R China.; Zhang, GZ (corresponding author), Chinese Acad Agr Sci, Sericulture Res Inst, Zhenjiang, Jiangsu, Peoples R China.	zgzsri@163.com		Zhang, Guozheng/0000-0003-2358-0864	National Natural Science Foundation of China [31302035, 31272499]; Jiangsu Provincial Natural Science Foundation of China [BK2012273]; Natural science fund for colleges and universities in Jiangsu Province [13KJD230001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province); Natural science fund for colleges and universities in Jiangsu Province	This research was financially supported by the National Natural Science Foundation of China (grant no. 31302035), Jiangsu Provincial Natural Science Foundation of China (grant no. BK2012273), National Natural Science Foundation of China (grant no. 31272499) and Natural science fund for colleges and universities in Jiangsu Province (grant no. 13KJD230001).; This research was financially supported by the National Natural Science Foundation of China (grant no. 31302035), Jiangsu Provincial Natural Science Foundation of China (grant no. BK2012273), National Natural Science Foundation of China (grant no. 31272499) and Natural science fund for colleges and universities in Jiangsu Province (grant no. 13KJD230001).	Assou S, 2011, HUM REPROD UPDATE, V17, P272, DOI 10.1093/humupd/dmq036; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081; Chen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071984; Desvignes T, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130575; Dhawan S, 2003, DEV GENES EVOL, V213, P435, DOI 10.1007/s00427-003-0343-7; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hadar N, 2012, GENE, V494, P65, DOI 10.1016/j.gene.2011.11.047; Honda S, 2013, RNA, V19, P1405, DOI 10.1261/rna.040428.113; Hu XL, 2016, MOL IMMUNOL, V73, P122, DOI 10.1016/j.molimm.2016.04.004; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jurkowski TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028104; Kadono-Okuda K, 2002, INSECT MOL BIOL, V11, P443, DOI 10.1046/j.1365-2583.2002.00353.x; Kawaoka S, 2008, BIOCHEM BIOPH RES CO, V367, P755, DOI 10.1016/j.bbrc.2008.01.013; KNOBLICH JA, 1993, EMBO J, V12, P65, DOI 10.1002/j.1460-2075.1993.tb05632.x; Kriventseva EV, 2015, NUCLEIC ACIDS RES, V43, pD250, DOI 10.1093/nar/gku1220; LEHMANN R, 1991, DEVELOPMENT, V112, P679; Li ZH, 2013, DEV CELL, V24, P133, DOI 10.1016/j.devcel.2012.12.010; Mager J, 2006, MAMM GENOME, V17, P941, DOI 10.1007/s00335-006-0034-6; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; Mitsudome T, 2015, INSECT BIOCHEM MOLEC, V58, P55, DOI 10.1016/j.ibmb.2015.01.008; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Nakao H, 1999, DEV GENES EVOL, V209, P312, DOI 10.1007/s004270050257; Nishida KM, 2009, EMBO J, V28, P3820, DOI 10.1038/emboj.2009.365; Pan MH, 2013, SCI CHINA LIFE SCI, V56, P360, DOI 10.1007/s11427-013-4459-3; Peng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030344; Rauwerda H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147151; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Swevers L, 1998, MECH DEVELOP, V72, P3, DOI 10.1016/S0925-4773(97)00180-9; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Takahashi M, 1996, DEV GENES EVOL, V206, P288, DOI 10.1007/s004270050054; Tatsuke T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092313; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Walser CB, 2011, CURR OPIN GENET DEV, V21, P431, DOI 10.1016/j.gde.2011.03.003; WESTENDORF JM, 1989, J CELL BIOL, V108, P1431, DOI 10.1083/jcb.108.4.1431; Xiang H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-646; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; XU X, 1994, DEVELOPMENT, V120, P277; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yu J, 2016, ONCOTARGET, V7, P42303, DOI 10.18632/oncotarget.9789	47	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192745	10.1371/journal.pone.0192745	http://dx.doi.org/10.1371/journal.pone.0192745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462160	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200024
J	Klonoff-Cohen, H; Navarro, A; Klonoff, EA				Klonoff-Cohen, Hillary; Navarro, Ana; Klonoff, Elizabeth A.			Late effects awareness website for pediatric survivors of acute lymphocytic leukemia	PLOS ONE			English	Article							CHILDHOOD-CANCER; ADULT SURVIVORS; ADOLESCENT; CARE; PREFERENCES; KNOWLEDGE	Objectives Every day 43 children are newly diagnosed with cancer. Fortunately, almost 90% of these childhood cancer patients will survive. However, 60-90% of these survivors will experience late effects, health problems that occur months or years after treatment has ended. Late effects could occur as a result of the disease, its treatment, and patient-related factors. The two main objectives of this research are to: 1) Examine the existence of all web-based resources for childhood cancer survivors with acute lymphocytic leukemia which focus on medical and psychological aspects of late effects, and 2) Create an innovative website specifically designed to fill this void. Materials and methods A systematic literature review, followed by input from >20 different organizations, resulted in the creation of LEAP 3 AHEAD (Late Effects Awareness for Patients, Physicians and the Public; Advancing Health and Eliminating All Disparities), a multi-dimensional website centering on late effects. Results An extensive review revealed 14 pediatric cancer websites, none of which focused exclusively on late effects. LEAP 3 AHEAD is the first interactive website for acute lympocytic leukemia childhood cancer survivors and families, as well as physicians, and the public to: a) increase awareness about risks, detection, diagnosis, treatment, and prevention of medical and psychological late effects, b) provide suggestions to successfully reintegrate into schools, careers, and socially, and c) present opportunities including camps, scholarships, and pet therapy programs. Conclusion LEAP 3 AHEAD is the first national website to provide a comprehensive, accessible, affordable, and multi-dimensional resource for pediatricians, internists, nurse practitioners, psychologists, survivors and their families, as well as the public about late effects.	[Klonoff-Cohen, Hillary] Univ Illinois, Champaign, IL 61820 USA; [Navarro, Ana] Univ Calif San Diego, La Jolla, CA 92093 USA; [Klonoff, Elizabeth A.] Univ Cent Florida, Orlando, FL 32816 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Diego; State University System of Florida; University of Central Florida	Klonoff, EA (corresponding author), Univ Cent Florida, Orlando, FL 32816 USA.	klonoffc@illinois.edu			National Cancer Institute [U54 CA132379]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work received support from the National Cancer Institute (grant number U54 CA132379) [to EK, AN].	American Cancer Society, 2017, CANC FACTS FIG 2017; [Anonymous], 2016, LAT EFF TREATM CHILD; [Anonymous], 2014, SPEC SECT CANC CHILD; [Anonymous], 2016, KEY STAT CHILDH CANC; [Anonymous], 2006, CANC CHILDR AD; Armstrong GT, 2016, NEW ENGL J MED, V374, P833, DOI 10.1056/NEJMoa1510795; Knijnenburg SL, 2013, SUPPORT CARE CANCER, V21, P919, DOI 10.1007/s00520-012-1604-7; Nathan PC, 2009, J CLIN ONCOL, V27, P2363, DOI 10.1200/JCO.2008.21.1441; Nathan PC, 2013, J CANCER SURVIV, V7, P275, DOI 10.1007/s11764-013-0271-0; Patterson P, 2015, SEMIN ONCOL NURS, V31, P53, DOI 10.1016/j.soncn.2014.11.006; Prevatt FF, 2000, J SCHOOL PSYCHOL, V38, P447, DOI 10.1016/S0022-4405(00)00046-7; Robison LL, 2014, NAT REV CANCER, V14, P61, DOI 10.1038/nrc3634; Simone J.V., 2003, CHILDHOOD CANC SURVI; Suh E, 2014, ANN INTERN MED, V160, P11, DOI 10.7326/M13-1941; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Zebrack BJ, 2003, CURR PROB CANCER, V27, P198, DOI 10.1016/S0147-0272(03)00027-8	16	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0193141	10.1371/journal.pone.0193141	http://dx.doi.org/10.1371/journal.pone.0193141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451924	gold, Green Published, Green Submitted			2022-12-26	WOS:000425369800041
J	Zhao, J; Liu, J; Liang, H; Huang, J; Chen, Z; Nie, YJ; Wang, CBA; Wang, YG				Zhao, Jia; Liu, Jiang; Liang, Hong; Huang, Jing; Chen, Zhe; Nie, Yuanjun; Wang, Changbiao; Wang, Yuguo			Manipulation of the rhizosphere microbial community through application of a new bio-organic fertilizer improves watermelon quality and health	PLOS ONE			English	Article							FUSARIUM-WILT DISEASE; F-SP NIVEUM; BIOFERTILIZER APPLICATION; BACILLUS-SUBTILIS; CUCUMBER PLANTS; BACTERIAL WILT; SOIL; OXYSPORUM; SUPPRESSION; DIVERSITY	Bio-organic fertilizers (BOFs) combine functional microbes with a suitable substrate and have been shown to effectively suppress soil-borne diseases and promote plant growth. Here, we developed a novel bio-organic fertilizer (BOF) by fermentation of a cow plus chicken manure (M) compost using Fen-liquor Daqu (FLD) as a fermentation starter and compared the compositions of bacterial and fungal communities in the rhizosphere soil of watermelon plants after treatment with different fertilizers. Further, we aimed to explore the mechanisms underlying plant-promoting and disease (Fusarium wilt)-suppressing activities of each rhizosphere microbial community. The microbial communities of soil amended with cow plus chicken manure compost (S+M), soil amended with the BOF (S+BOF), and untreated control soil (S) without plants were analyzed through sequence analysis using the Illumina MiSeq platform. The results showed that a new microbial community was formed in the manure compost after fermentation by the Daqu. Application of the BOF to the soil induced remarkable changes in the rhizosphere microbial communities, with increased bacterial diversity and decreased fungal diversity. Most importantly, S+BOF showed the lowest abundance of Fusarium. Moreover, watermelon quality was higher (P < 0.05) in the S+BOF than in the S+M treatment. Thus, application of the BOF favorably altered the composition of the rhizosphere microbial community, suppressing Fusarium wilt disease and promoting plant quality.	[Zhao, Jia] Shanxi Acad Agr Sci, Biotechnol Res Ctr, Taiyuan, Shanxi, Peoples R China; [Zhao, Jia; Liu, Jiang; Liang, Hong; Huang, Jing; Chen, Zhe; Wang, Changbiao; Wang, Yuguo] Shanxi Agr Univ, Coll Agr, Taigu, Shanxi, Peoples R China; [Nie, Yuanjun] Shanxi Acad Agr Sci, Inst Agr Resources & Econ, Taiyuan, Shanxi, Peoples R China	Shanxi Agricultural University; Shanxi Agricultural University; Shanxi Agricultural University	Wang, YG (corresponding author), Shanxi Agr Univ, Coll Agr, Taigu, Shanxi, Peoples R China.	yuguowangtg@126.com			Shanxi Normal University Science and Technology Development and Application Fund [YK1502]; Shanxi Province key research and development programs Fund [201703D221026-1]; Basic Research Project of Shanxi Province [201701D221169]	Shanxi Normal University Science and Technology Development and Application Fund; Shanxi Province key research and development programs Fund; Basic Research Project of Shanxi Province	This work was financially supported in part by grants from the Shanxi Normal University Science and Technology Development and Application Fund (YK1502); Shanxi Province key research and development programs Fund (201703D221026-1) and the Basic Research Project of Shanxi Province (201701D221169). The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Alguacil MM, 2011, SOIL BIOL BIOCHEM, V43, P1498, DOI 10.1016/j.soilbio.2011.03.026; Ali MM, 2017, SCI HORTIC-AMSTERDAM, V225, P689, DOI 10.1016/j.scienta.2017.08.012; Almario J, 2013, SOIL BIOL BIOCHEM, V57, P144, DOI 10.1016/j.soilbio.2012.09.003; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bargabus RL, 2003, MOL PLANT MICROBE IN, V16, P1145, DOI 10.1094/MPMI.2003.16.12.1145; Bever JD, 2012, ANNU REV MICROBIOL, V66, P265, DOI 10.1146/annurev-micro-092611-150107; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Cao Y, 2011, BIOL FERT SOILS, V47, P495, DOI 10.1007/s00374-011-0556-2; Chen LH, 2012, J SCI FOOD AGR, V92, P2465, DOI 10.1002/jsfa.5653; Ding CY, 2013, PLANT SOIL, V366, P453, DOI 10.1007/s11104-012-1425-y; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; El-Hassan SA, 2006, J PHYTOPATHOL, V154, P148, DOI 10.1111/j.1439-0434.2006.01075.x; Faheem M, 2015, BIOL CONTROL, V81, P101, DOI 10.1016/j.biocontrol.2014.11.012; Fang SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061461; Fu L, 2017, SOIL BIOL BIOCHEM, V104, P39, DOI 10.1016/j.soilbio.2016.10.008; Garbeva P, 2006, ENVIRON MICROBIOL, V8, P233, DOI 10.1111/j.1462-2920.2005.00888.x; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Gopalakrishnan S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-574; Janvier C, 2007, SOIL BIOL BIOCHEM, V39, P1, DOI 10.1016/j.soilbio.2006.07.001; Karp NA, 2005, PROTEOMICS, V5, P81, DOI 10.1002/pmic.200400881; Kent AD, 2002, ANNU REV MICROBIOL, V56, P211, DOI 10.1146/annurev.micro.56.012302.161120; Kinkel LL, 2011, ANNU REV PHYTOPATHOL, V49, P47, DOI 10.1146/annurev-phyto-072910-095232; Li XG, 2015, BIOL FERT SOILS, V51, P935, DOI 10.1007/s00374-015-1038-8; Ling N, 2014, MICROBIOL RES, V169, P570, DOI 10.1016/j.micres.2013.10.004; Ling N, 2012, APPL SOIL ECOL, V59, P13, DOI 10.1016/j.apsoil.2012.05.001; Liu XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36773; Luo J, 2010, SOIL SCI SOC AM J, V74, P2039, DOI 10.2136/sssaj2009.0437; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Poulsen PHB, 2013, SOIL BIOL BIOCHEM, V57, P784, DOI 10.1016/j.soilbio.2011.12.023; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen ZZ, 2015, BIOL FERT SOILS, V51, P553, DOI 10.1007/s00374-015-1002-7; Shen ZZ, 2013, EUR J SOIL BIOL, V57, P1, DOI 10.1016/j.ejsobi.2013.03.006; Sturz AV, 2003, SOIL TILL RES, V72, P107, DOI 10.1016/S0167-1987(03)00082-5; Tautges NE, 2016, APPL SOIL ECOL, V108, P258, DOI 10.1016/j.apsoil.2016.09.003; Tjamos SE, 2005, MOL PLANT MICROBE IN, V18, P555, DOI 10.1094/MPMI-18-0555; Xiong W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136946; Xu WH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00899; Yang W, 2017, BIOCONTROL SCI TECHN, V27, P311, DOI 10.1080/09583157.2016.1252313; Zhang G, 2015, PLOS ONE, V10; Zhang HX, 2016, J I BREWING, V122, P34, DOI 10.1002/jib.292; Zhang N, 2014, PEDOSPHERE, V24, P613, DOI 10.1016/S1002-0160(14)60047-3; Zhang SS, 2008, BIOL FERT SOILS, V44, P1073, DOI 10.1007/s00374-008-0296-0; Zhao QY, 2011, APPL SOIL ECOL, V47, P67, DOI 10.1016/j.apsoil.2010.09.010; Zhao S, 2014, BIOL FERT SOILS, V50, P765, DOI 10.1007/s00374-014-0898-7	47	46	50	7	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192967	10.1371/journal.pone.0192967	http://dx.doi.org/10.1371/journal.pone.0192967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451918	gold, Green Published, Green Submitted			2022-12-26	WOS:000425369800028
J	Okamoto, Y; Shikano, S				Okamoto, Yukari; Shikano, Sojin			Positive zip coding in small protein translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						endoplasmic reticulum (ER); translocation; signal recognition particle (SRP); secretion; ribosome; charge; positive; posttranslational; signal peptide	CONTRIBUTES	Most newly synthesized proteins destined for the secretory pathway contain a signal peptide (SP) that triggers cotranslational translocation into the endoplasmic reticulum (ER). However, how small polypeptides undergo ER translocation is not fully understood. In this issue of JBC, Guo et al. describe a mechanism for posttranslational translocation of small secretory proteins featuring a positive charge within the SP N-terminal region. Defects in this element disrupt proper secretion and explain the effects of genetic mutations associated with one type of diabetes.	[Okamoto, Yukari; Shikano, Sojin] Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,MBRB 2002, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shikano, S (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,MBRB 2002, Chicago, IL 60607 USA.	sshikano@uic.edu			National Institutes of Health [R01 GM099974]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM099974 (to S. S.). The authors declare that they have no conflicts of interests with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Guo H, 2018, J BIOL CHEM, V293, P1899, DOI 10.1074/jbc.RA117.000922; Guo H, 2014, J BIOL CHEM, V289, P16290, DOI 10.1074/jbc.M114.562355; Johnson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075394; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Johnson ST, 2008, APPL PHYSIOL NUTR ME, V33, P797, DOI 10.1139/H08-055; NOTHWEHR SF, 1989, J BIOL CHEM, V264, P3979; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	10	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1908	1909		10.1074/jbc.H118.001415	http://dx.doi.org/10.1074/jbc.H118.001415			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29462795	hybrid, Green Published			2022-12-26	WOS:000424948000006
J	Fang, C; Bian, GL; Ren, P; Xiang, J; Song, J; Yu, CY; Zhang, Q; Liu, L; Chen, K; Liu, FF; Zhang, K; Wu, CF; Sun, RX; Hu, D; Ju, G; Wang, J				Fang, Chao; Bian, Ganlan; Ren, Pan; Xiang, Jie; Song, Jun; Yu, Caiyong; Zhang, Qian; Liu, Ling; Chen, Kun; Liu, Fangfang; Zhang, Kun; Wu, Chunfeng; Sun, Ruixia; Hu, Dan; Ju, Gong; Wang, Jian			S1P transporter SPNS2 regulates proper postnatal retinal morphogenesis	FASEB JOURNAL			English	Article						retinal progenitor cell; apical junctional complex; cell cycle; migration; angiogenesis	SPHINGOSINE KINASE 1; ASYMMETRIC CELL-DIVISION; N-CADHERIN; SPHINGOSINE-1-PHOSPHATE; MIGRATION; NEUROGENESIS; PROLIFERATION; POLARITY; DIFFERENTIATION; MAINTENANCE	Spinster homolog 2 (SPNS2) is the membrane transporter of sphingosine-1-phosphate (S1P), and it participates in several physiologic processes by activating different S1P receptors (S1PRs). However, its functions in the nervous system remain largely unclear. We explored the important role of SPNS2 in the process of retinal morphogenesis using a spns2-deficient rat model. In the absence of the functional SPNS2 transporter, we observed progressively aggravating laminar disorganization of the epithelium at the postnatal stage of retinal development. Disrupted cell polarity, delayed cell-cycle exit of retinal progenitor cells, and insufficient migration of newborn neurons were proposed in this study as potential mechanisms accounting for this structural disorder. In addition, we analyzed the expression profiles of spns2 and s1prs, and proposed that SPNS2 regulated retinal morphogenesis by establishing the S1P level in the eye and activating S1PR3 signaling. These data indicate that SPNS2 is indispensable for normal retinal morphogenesis and provide new insights on the role of S1P in the developing retina using an established in vivo model.-Fang, C., Bian, G., Ren, P., Xiang, J., Song, J., Yu, C., Zhang, Q., Liu, L., Chen, K., Liu, F., Zhang, K., Wu, C., Sun, R., Hu, D., Ju, G., Wang, J. S1P transporter SPNS2 regulates proper postnatal retinal morphogenesis.	[Fang, Chao; Bian, Ganlan; Xiang, Jie; Song, Jun; Yu, Caiyong; Liu, Ling; Chen, Kun; Liu, Fangfang; Zhang, Kun; Ju, Gong] Fourth Mil Med Univ, Dept Neurobiol, 169 West Changle Rd, Xian 710032, Shaanxi, Peoples R China; [Ren, Pan] Fourth Mil Med Univ, Tangdu Hosp, Dept Plast Surg, Xian, Shaanxi, Peoples R China; [Hu, Dan] Fourth Mil Med Univ, Xijing Hosp, Dept Ophthalmol, Xian, Shaanxi, Peoples R China; [Zhang, Qian] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Neurol, Sanya, Peoples R China; [Wu, Chunfeng; Sun, Ruixia; Wang, Jian] BIOS Biosci & Technol Ltd Co, BIOS Lab, Guangzhou, Guangdong, Peoples R China; [Wang, Jian] South China Univ Technol, Inst Life Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Jian] South China Univ Technol, Sch Med, Guangzhou, Guangdong, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Chinese People's Liberation Army General Hospital; South China University of Technology; South China University of Technology	Ju, G (corresponding author), Fourth Mil Med Univ, Dept Neurobiol, 169 West Changle Rd, Xian 710032, Shaanxi, Peoples R China.; Wang, J (corresponding author), South China Univ Technol, Guangzhou Higher Educ Mega Ctr, Med Sch, 382 Zhonghuan Rd East, Guangzhou 510006, Guangdong, Peoples R China.	jugong@fmmu.edu.cn; jwangsc@scut.edu.cn		Fang, Chao/0000-0003-1011-2113; yu, caiyong/0000-0002-4482-2319; Liu, Ling/0000-0002-8681-3656	National Natural Science Foundation of China [31571428, 31271127, 81371364, 81401019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank J. Qiu and L. Fei (both from the Department of Neurobiology, Fourth Military Medical University) for their technical assistance. This study was supported by the National Natural Science Foundation of China (Grants 31571428, 31271127, 81371364, and 81401019). The authors declare no conflicts of interest.	Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Balczerski B, 2012, DEV BIOL, V362, P230, DOI 10.1016/j.ydbio.2011.12.010; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Bian G., 2014, THESIS; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Bradley E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110119; Bruce CR, 2012, DIABETES, V61, P3148, DOI 10.2337/db12-0029; Chen J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004688; Das RM, 2014, SCIENCE, V343, P200, DOI 10.1126/science.1247521; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Fu PF, 2016, J BIOL CHEM, V291, P27187, DOI 10.1074/jbc.M116.758946; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Ghosh S, 2008, P NATL ACAD SCI USA, V105, P335, DOI 10.1073/pnas.0705713105; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200; Haldipur P, 2015, BIOL OPEN, V4, P865, DOI 10.1242/bio.009886; Harijith A, 2016, AM J PHYSIOL-LUNG C, V311, pL337, DOI 10.1152/ajplung.00447.2015; Hisano Y, 2013, BIOL OPEN, V2, P789, DOI 10.1242/bio.20134994; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hisano Y, 2011, J BIOL CHEM, V286, P1758, DOI 10.1074/jbc.M110.171116; Hufnagel RB, 2010, DEV BIOL, V340, P490, DOI 10.1016/j.ydbio.2010.02.002; Kanda A, 2013, J NEUROSCI, V33, P19341, DOI 10.1523/JNEUROSCI.1362-13.2013; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Koike C, 2005, J NEUROSCI, V25, P10290, DOI 10.1523/JNEUROSCI.3657-05.2005; Konno D, 2005, J BIOL CHEM, V280, P5082, DOI 10.1074/jbc.M408251200; Kurusu M, 2012, DEV BIOL, V366, P204, DOI 10.1016/j.ydbio.2012.04.006; Lad EM, 2009, STEM CELLS DEV, V18, P7, DOI 10.1089/scd.2008.0169; Laurenzana A, 2015, J MOL MED, V93, P1145, DOI 10.1007/s00109-015-1292-0; Leung L, 2011, DEVELOPMENT, V138, P5003, DOI 10.1242/dev.071522; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Martin-Bermudo MD, 2015, DEVELOPMENT, V142, P1492, DOI 10.1242/dev.110585; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; MATSUNAGA M, 1988, NEURON, V1, P289, DOI 10.1016/0896-6273(88)90077-3; Mendelson K, 2013, J BIOL CHEM, V288, P2143, DOI 10.1074/jbc.M112.427344; Mendoza A, 2012, CELL REP, V2, P1104, DOI 10.1016/j.celrep.2012.09.021; Miranda GE, 2009, INVEST OPHTH VIS SCI, V50, P4416, DOI 10.1167/iovs.09-3388; Miyamoto Y, 2015, CELL ADHES MIGR, V9, P183, DOI 10.1080/19336918.2015.1005466; Mongan M, 2011, DEVELOPMENT, V138, P4001, DOI 10.1242/dev.065003; Morillo SM, 2010, P NATL ACAD SCI USA, V107, P109, DOI 10.1073/pnas.0906121107; Nagahashi M, 2013, FASEB J, V27, P1001, DOI 10.1096/fj.12-219618; Nijnik A, 2012, J IMMUNOL, V189, P102, DOI 10.4049/jimmunol.1200282; Nishi T, 2014, BBA-MOL CELL BIOL L, V1841, P759, DOI 10.1016/j.bbalip.2013.07.012; Nohata N, 2016, DEV BIOL, V411, P183, DOI 10.1016/j.ydbio.2016.02.005; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Oyama O, 2008, CARDIOVASC RES, V78, P301, DOI 10.1093/cvr/cvn002; Paridaen JTML, 2014, EMBO REP, V15, P351, DOI 10.1002/embr.201438447; Paulson AF, 2014, CELL ADHES MIGR, V8, P19, DOI 10.4161/cam.27839; Rago L, 2014, EMBO J, V33, P906, DOI 10.1002/embj.201386591; Ranty ML, 2009, GRAEF ARCH CLIN EXP, V247, P215, DOI 10.1007/s00417-008-0957-6; ROARK EF, 1992, DEVELOPMENT, V114, P973; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Romero-Aleman MM, 2012, J COMP NEUROL, V520, P2163, DOI 10.1002/cne.23034; Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916; Rotstein NP, 2010, J LIPID RES, V51, P1247, DOI 10.1194/jlr.R003442; Rousso DL, 2012, NEURON, V74, P314, DOI 10.1016/j.neuron.2012.02.024; Rungger-Brandle E, 2010, DEV NEUROBIOL, V70, P764, DOI 10.1002/dneu.20816; Shitamukai A, 2012, DEV GROWTH DIFFER, V54, P277, DOI 10.1111/j.1440-169X.2012.01345.x; Shkumatava A, 2005, EMBO REP, V6, P563, DOI 10.1038/sj.embor.7400416; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Takabe K, 2014, J LIPID RES, V55, P1839, DOI 10.1194/jlr.R046656; Takuwa N, 2010, CARDIOVASC RES, V85, P484, DOI 10.1093/cvr/cvp312; Takuwa Y, 2002, BBA-MOL CELL BIOL L, V1582, P112, DOI 10.1016/S1388-1981(02)00145-2; Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801; Venugopalan P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10472; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Wert KJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4286; Yamaguchi M, 2010, MECH DEVELOP, V127, P247, DOI 10.1016/j.mod.2010.03.004; Yu C.Y., 2016, THESIS; Zhang M, 2015, BIOMATERIALS, V72, P163, DOI 10.1016/j.biomaterials.2015.08.052	77	11	12	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3597	3613		10.1096/fj.201701116R	http://dx.doi.org/10.1096/fj.201701116R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29452570				2022-12-26	WOS:000435104500010
J	Han, X; Xie, HB; Wang, YD; Zhao, CT				Han, Xiao; Xie, Haibo; Wang, Yadong; Zhao, Chengtian			Radial spoke proteins regulate otolith formation during early zebrafish development	FASEB JOURNAL			English	Article						lrrc23; rsph4a; rsph3; otic vesicle; cilia	PRIMARY CILIARY DYSKINESIA; INNER-EAR; HAIR-CELLS; CENTRAL APPARATUS; CENTRAL-COMPLEX; DYNEIN; MUTATIONS; FLAGELLA; DEFECTS; MOTILITY	Radial spokes are structurally conserved, macromolecular complexes that are essential for the motility of 9 + 2 motile cilia. In Chlamydomonas species, mutations in radial spoke proteins result in ciliary motility defects. However, little is known about the function of radial spoke proteins during embryonic development. Here, we investigated the role of a novel radial spoke protein, leucine-rich repeat containing protein 23 (Lrrc23), during zebrafish embryonic development. Mutations in lrrc23 resulted in a selective otolith formation defect during early ear development. Similar otolith defects were also present in the radial spoke head 3 homolog (rsph3) and radial spoke head 4 homolog A (rsph4a) radial spoke mutants. Notably, the radial spoke protein mutations specifically affected ciliary motility in the otic vesicle (OV), whereas motile cilia in other organs functioned normally. Via high-speed video microscopy, we found that motile cilia formation was stochastic and transient in the OV. Importantly, all the motile cilia in the OV beat circularly, in contrast to the planar beating pattern of typical 9 + 2 motile cilia. We identified the key time frame for motile cilia formation during OV development. Finally, we showed that the functions of radial spoke proteins were conserved between zebrafish and Tetrahymena. Together, our results suggest that radial spoke proteins are essential for ciliary motility in the OV and that radial spoke-regulated OV motile cilia represent a unique type of cilia during early zebrafish embryonic development.Han, X., Xie, H., Wang, Y., Zhao, C. Radial spoke proteins regulate otolith formation during early zebrafish development.	[Han, Xiao; Xie, Haibo; Wang, Yadong; Zhao, Chengtian] Ocean Univ China, Coll Marine Life Sci, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China; [Zhao, Chengtian] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Zhao, CT (corresponding author), Ocean Univ China, 5 Yu Shan Rd, Qingdao 266003, Peoples R China.	chengtian_zhao@ouc.edu.cn		WANG, YADONG/0000-0003-3210-9900	Shandong Provincial Natural Science Foundation [JQ201506]; National Natural Science Foundation of China [31772456, 31422051]; Fundamental Research Funds for Central Universities [201762003, 201564011]	Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	The authors thank Dr. Shan Gao (Ocean University of China) and members of the Gao laboratory for the excellent support of the Tetrahymena experiments. The authors also thank members of the C.Z. laboratory for the helpful comments on an earlier version of this manuscript. This work was supported by the National Natural Science Foundation of China (Grants 31772456 and 31422051), Shandong Provincial Natural Science Foundation (JQ201506), and the Fundamental Research Funds for Central Universities (Grants 201762003 and 201564011). The authors declare no conflicts of interest.	Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Colantonio JR, 2009, NATURE, V457, P205, DOI 10.1038/nature07520; Diener DP, 2011, CYTOSKELETON, V68, P389, DOI 10.1002/cm.20520; El Khouri E, 2016, AM J HUM GENET, V99, P489, DOI 10.1016/j.ajhg.2016.06.022; Gaertig J, 2013, METHOD ENZYMOL, V525, P265, DOI 10.1016/B978-0-12-397944-5.00013-4; GOODENOUGH UW, 1985, J CELL BIOL, V100, P2008, DOI 10.1083/jcb.100.6.2008; Gupta A, 2012, J CELL BIOL, V198, P115, DOI 10.1083/jcb.201111041; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; HOWARD DR, 1994, J CELL BIOL, V127, P1683, DOI 10.1083/jcb.127.6.1683; Jeanson L, 2015, AM J HUM GENET, V97, P153, DOI 10.1016/j.ajhg.2015.05.004; Kott E, 2013, AM J HUM GENET, V93, P561, DOI 10.1016/j.ajhg.2013.07.013; Lin JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6727; Mochizuki K, 2008, GENE, V425, P79, DOI 10.1016/j.gene.2008.08.007; Oda T, 2014, J CELL BIOL, V204, P807, DOI 10.1083/jcb.201312014; Onoufriadis A, 2014, HUM MOL GENET, V23, P3362, DOI 10.1093/hmg/ddu046; Padma P, 2003, MOL BIOL CELL, V14, P774, DOI 10.1091/mbc.02-06-0089; Pigino Gaia, 2012, Bioarchitecture, V2, P50; Pigino G, 2011, J CELL BIOL, V195, P673, DOI 10.1083/jcb.201106125; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sedykh I, 2016, SCI REP-UK, V6, DOI 10.1038/srep34437; Shinohara K, 2015, DEV CELL, V35, P236, DOI 10.1016/j.devcel.2015.10.001; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; SMITH EF, 1992, SCIENCE, V257, P1557, DOI 10.1126/science.1387971; Song Z, 2016, J GENET GENOMICS, V43, P107, DOI 10.1016/j.jgg.2016.02.001; Stooke-Vaughan GA, 2012, DEVELOPMENT, V139, P1777, DOI 10.1242/dev.079947; Tanimoto M, 2011, J NEUROSCI, V31, P3784, DOI 10.1523/JNEUROSCI.5554-10.2011; Urbanska P, 2015, MOL BIOL CELL, V26, P1463, DOI 10.1091/mbc.E14-11-1545; Vasudevan KK, 2015, MOL BIOL CELL, V26, P696, DOI 10.1091/mbc.E14-11-1506; WITMAN GB, 1978, J CELL BIOL, V76, P729, DOI 10.1083/jcb.76.3.729; Wu D, 2011, DEV CELL, V20, P271, DOI 10.1016/j.devcel.2010.12.006; Yang C, 2008, J CELL BIOL, V180, P403, DOI 10.1083/jcb.200705069; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Yu XW, 2011, DEVELOPMENT, V138, P487, DOI 10.1242/dev.057752; Zhao CT, 2007, MECH DEVELOP, V124, P605, DOI 10.1016/j.mod.2007.04.004	37	8	8	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3984	3992		10.1096/fj.201701359R	http://dx.doi.org/10.1096/fj.201701359R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29475374				2022-12-26	WOS:000435104500042
J	Tusa, I; Gagliardi, S; Tubita, A; Pandolfi, S; Urso, C; Borgognoni, L; Wang, JH; Deng, XM; Gray, NS; Stecca, B; Rovida, E				Tusa, Ignazia; Gagliardi, Sinforosa; Tubita, Alessandro; Pandolfi, Silvia; Urso, Carmelo; Borgognoni, Lorenzo; Wang, Jinhua; Deng, Xianming; Gray, Nathanael S.; Stecca, Barbara; Rovida, Elisabetta			ERK5 is activated by oncogenic BRAF and promotes melanoma growth	ONCOGENE			English	Article							SIGNAL-REGULATED KINASE-5; CELL-PROLIFERATION; MEK5/ERK5 PATHWAY; IMPROVED SURVIVAL; BREAST-CANCER; TUMOR-GROWTH; PROTEIN; INHIBITORS; MUTATIONS; RESISTANCE	Malignant melanoma is among the most aggressive cancers and its incidence is increasing worldwide. Targeted therapies and immunotherapy have improved the survival of patients with metastatic melanoma in the last few years; however, available treatments are still unsatisfactory. While the role of the BRAF-MEK1/2-ERK1/2 pathway in melanoma is well established, the involvement of mitogen-activated protein kinases MEK5-ERK5 remains poorly explored. Here we investigated the function of ERK5 signaling in melanoma. We show that ERK5 is consistently expressed in human melanoma tissues and is active in melanoma cells. Genetic silencing and pharmacological inhibition of ERK5 pathway drastically reduce the growth of melanoma cells and xenografts harboring wild-type (wt) or mutated BRAF (V600E). We also found that oncogenic BRAF positively regulates expression, phosphorylation, and nuclear localization of ERK5. Importantly, ERK5 kinase and transcriptional transactivator activities are enhanced by BRAF. Nevertheless, combined pharmacological inhibition of BRAFV600E and MEK5 is required to decrease nuclear ERK5, that is critical for the regulation of cell proliferation. Accordingly, combination of MEK5 or ERK5 inhibitors with BRAFV600E inhibitor vemurafenib is more effective than single treatments in reducing colony formation and growth of BRAFV600E melanoma cells and xenografts. Overall, these data support a key role of the ERK5 pathway for melanoma growth in vitro and in vivo and suggest that targeting ERK5, alone or in combination with BRAF-MEK1/2 inhibitors, might represent a novel approach for melanoma treatment.	[Tusa, Ignazia; Tubita, Alessandro; Rovida, Elisabetta] Univ Florence, Dept Clin & Expt Biomed Sci, Florence, Italy; [Gagliardi, Sinforosa; Pandolfi, Silvia; Stecca, Barbara] Ist Toscano Tumori, Core Res Lab, Florence, Italy; [Pandolfi, Silvia] VIB KU Leuven Ctr Canc Biol, Leuven, Belgium; [Urso, Carmelo] SM Annunziata Hosp, Dermatopathol Sect, Anat Pathol Unit, Florence, Italy; [Borgognoni, Lorenzo] SM Annunziata Hosp, Plast Surg Unit, Reg Melanoma Referral Ctr, Florence, Italy; [Wang, Jinhua; Deng, Xianming; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Wang, Jinhua; Deng, Xianming; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Deng, Xianming] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China	University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Flanders Institute for Biotechnology (VIB); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Xiamen University	Rovida, E (corresponding author), Univ Florence, Dept Clin & Expt Biomed Sci, Florence, Italy.; Stecca, B (corresponding author), Ist Toscano Tumori, Core Res Lab, Florence, Italy.	barbara.stecca@ittumori.it; erovida@unifi.it	Rovida, Elisabetta/F-3565-2015; Borgognoni, Lorenzo/X-1981-2019	Rovida, Elisabetta/0000-0002-5949-3239; Borgognoni, Lorenzo/0000-0002-3571-0366; Stecca, Barbara/0000-0003-1197-1622; URSO, CARMELO/0000-0002-3746-2917; Deng, Xianming/0000-0002-9354-5864	Associazione Italiana per la Ricerca sul Cancro, AIRC [IG-15282, IG-14184]	Associazione Italiana per la Ricerca sul Cancro, AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a grant from Associazione Italiana per la Ricerca sul Cancro, AIRC, (IG-15282 to ER and IG-14184 to BS). We are grateful to Dr P. Dello Sbarba (University of Florence, Florence, Italy) and to Dr Chiariello (Istituto Toscano Tumori, Siena, Italy) for critical revision of the manuscript. We also thank Dr A. Pandiella for providing antibodies and Dr L. Poliseno (Istituto Toscano Tumori, Pisa, Italy) for providing melanoma cells and plasmids.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Al-Ejeh F, 2014, ONCOTARGET, V5, P3145, DOI 10.18632/oncotarget.1865; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Carvajal-Vergara X, 2005, BLOOD, V105, P4492, DOI 10.1182/blood-2004-08-2985; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cohen C, 2002, CLIN CANCER RES, V8, P3728; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Jong PR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11551; Diaz-Rodriguez E, 2010, J CELL SCI, V123, P3146, DOI 10.1242/jcs.070516; Drew BA, 2012, BBA-REV CANCER, V1825, P37, DOI 10.1016/j.bbcan.2011.10.002; Erazo T, 2013, MOL CELL BIOL, V33, P1671, DOI 10.1128/MCB.01246-12; Esparis-Ogando A, 2002, MOL CELL BIOL, V22, P270, DOI 10.1128/MCB.22.1.270-285.2002; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gomez N, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00105; Honda T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117914; Inesta-Vaquera FA, 2010, CELL SIGNAL, V22, P1829, DOI 10.1016/j.cellsig.2010.07.010; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; Lin ECK, 2016, P NATL ACAD SCI USA, V113, P11865, DOI 10.1073/pnas.1609019113; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; Lochhead PA, 2016, CELL CYCLE, V15, P506, DOI 10.1080/15384101.2015.1120915; Loveridge CJ, 2017, CANCER RES, V77, P3158, DOI 10.1158/0008-5472.CAN-16-2565; McCracken SRC, 2008, ONCOGENE, V27, P2978, DOI 10.1038/sj.onc.1210963; Morimoto H, 2007, J BIOL CHEM, V282, P35449, DOI 10.1074/jbc.M704079200; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Nithianandarajah-Jones GN, 2012, CELL SIGNAL, V24, P2187, DOI 10.1016/j.cellsig.2012.07.007; Paoluzzi L, 2016, CANCER MED-US, V5, P1183, DOI 10.1002/cam4.667; Perez-Madrigal D, 2012, CELL SIGNAL, V24, P2360, DOI 10.1016/j.cellsig.2012.08.001; Raviv Z, 2004, J CELL SCI, V117, P1773, DOI 10.1242/jcs.01040; Rovida E, 2008, J IMMUNOL, V180, P4166, DOI 10.4049/jimmunol.180.6.4166; Rovida E, 2015, GUT, V64, P1454, DOI 10.1136/gutjnl-2014-306761; Rovira-Clave X, 2016, J LEUKOCYTE BIOL, V99, P143, DOI 10.1189/jlb.2A0115-034R; Sala E, 2008, MOL CANCER RES, V6, P751, DOI 10.1158/1541-7786.MCR-07-2001; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Simoes AES, 2016, DRUG DISCOV TODAY, V21, P1654, DOI 10.1016/j.drudis.2016.06.010; Song CL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46244; Tatake RJ, 2008, BIOCHEM BIOPH RES CO, V377, P120, DOI 10.1016/j.bbrc.2008.09.087; Teixido C, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.05.07; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Williams CAC, 2016, CELL REP, V16, P1820, DOI 10.1016/j.celrep.2016.07.033; Xia SY, 2017, CELL METAB, V25, P358, DOI 10.1016/j.cmet.2016.12.010; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646; Yang QK, 2011, CLIN CANCER RES, V17, P3527, DOI 10.1158/1078-0432.CCR-10-2504; Yang QK, 2010, CANCER CELL, V18, P258, DOI 10.1016/j.ccr.2010.08.008	50	35	35	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	19								10.1038/s41388-018-0164-9	http://dx.doi.org/10.1038/s41388-018-0164-9			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GF3RN	29483645	Green Published, hybrid			2022-12-26	WOS:000431873400001
J	Nesbitt, NM; Zheng, XL; Li, ZD; Manso, JA; Yen, WY; Malone, LE; Ripoll-Rozada, J; Pereira, PJB; Mantle, TJ; Wang, J; Bahou, WF				Nesbitt, Natasha M.; Zheng, Xiliang; Li, Zongdong; Manso, Jose A.; Yen, Wan-Yi; Malone, Lisa E.; Ripoll-Rozada, Jorge; Barbosa Pereira, Pedro Jose; Mantle, Timothy J.; Wang, Jin; Bahou, Wadie F.			In silico and crystallographic studies identify key structural features of biliverdin IX beta reductase inhibitors having nanomolar potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN REDUCTASE; PYRROLOQUINOLINE QUINONE; ALPHA REDUCTASE; CATALYTIC MECHANISM; AUTOMATED DOCKING; SUBSTRATE-BINDING; SCORING FUNCTION; WEB SERVER; BILIRUBIN; ZINC	Heme cytotoxicity is minimized by a two-step catabolic reaction that generates biliverdin (BV) and bilirubin (BR) tetrapyrroles. The second step is regulated by two non-redundant biliverdin reductases (IX beta (BLVRA) and IX beta (BLVRB)), which retain isomeric specificity and NAD(P)H-dependent redox coupling linked to BR's antioxidant function. Defective BLVRB enzymatic activity with antioxidant mishandling has been implicated in metabolic consequences of hematopoietic lineage fate and enhanced platelet counts in humans. We now outline an integrated platform of in silico and crystallographic studies for the identification of an initial class of compounds inhibiting BLVRB with potencies in the nanomolar range. We found that the most potent BLVRB inhibitors contain a tricyclic hydrocarbon core structure similar to the isoalloxazine ring of flavin mononucleotide and that both xanthene-and acridine-based compounds inhibit BLVRB's flavin and dichlorophenolindophenol (DCPIP) reductase functions. Crystallographic studies of ternary complexes with BLVRB-NADP(+)-xanthene-based compounds confirmed inhibitor binding adjacent to the cofactor nicotinamide and interactions with the Ser-111 side chain. This residue previously has been identified as critical for maintaining the enzymatic active site and cellular reductase functions in hematopoietic cells. Both acridine-and xanthene-based compounds caused selective and concentration-dependent loss of redox coupling in BLVRB-overexpressing promyelocytic HL-60 cells. These results provide promising chemical scaffolds for the development of enhanced BLVRB inhibitors and identify chemical probes to better dissect the role of biliverdins, alternative substrates, and BLVRB function in physiologically relevant cellular contexts.	[Nesbitt, Natasha M.; Li, Zongdong; Yen, Wan-Yi; Malone, Lisa E.; Bahou, Wadie F.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA; [Zheng, Xiliang] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Manso, Jose A.; Ripoll-Rozada, Jorge; Barbosa Pereira, Pedro Jose] Univ Porto, IBMC Inst Biol Mol & Celular, P-4200135 Porto, Portugal; [Manso, Jose A.; Ripoll-Rozada, Jorge; Barbosa Pereira, Pedro Jose] Univ Porto, Inst Invest & Inovaco Saude I3S, P-4200135 Porto, Portugal; [Mantle, Timothy J.] Trinity Coll Dublin, Dept Biochem, Dublin 2, Ireland	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Trinity College Dublin	Nesbitt, NM (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.; Wang, J (corresponding author), SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA.	natasha.nesbitt@stonybrook.edu; jin.wang.1@stonybrook.edu	Ripoll Rozada, Jorge/L-1574-2016; Rozada, Jorge Ripoll/AAA-8049-2020; Manso, José Antonio/S-3983-2019; Manso, José/GWV-5180-2022; Pereira, Pedro/F-8972-2011	Ripoll Rozada, Jorge/0000-0001-7235-317X; Rozada, Jorge Ripoll/0000-0001-7235-317X; Manso, José Antonio/0000-0002-2565-6239; Pereira, Pedro/0000-0003-0969-5438; Nesbitt, Natasha M/0000-0001-5549-0383	National Institutes of Health [HL091939, HL129545]; NewYork State Stem Cell Foundation [C026716]; National Natural Science Foundation of China [91430217]; MOST [2016YFA0203200, 2013YQ170585]; National Science Foundation [PHY-76066]; Portuguese funds through Fundacao para a Ciencia e a Tecnologia postdoctoral fellowship [SFRH/BPD/108004/2015]; project "Institute for Research and Innovation in Health Sciences" [POCI-01-0145-FEDER-007274]; European Regional Development Fund (FEDER) through the COMPETE-Operational Programme for Competitiveness and Internationalization (POCI); European Regional Development Fund (FEDER) - Norte Portugal Regional Operational Programme (NORTE), under the PORTUGAL Partnership Agreement through FEDER [Norte-01-0145-FEDER-000012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119096, R43HL129545, R01HL091939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NewYork State Stem Cell Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST; National Science Foundation(National Science Foundation (NSF)); Portuguese funds through Fundacao para a Ciencia e a Tecnologia postdoctoral fellowship; project "Institute for Research and Innovation in Health Sciences"; European Regional Development Fund (FEDER) through the COMPETE-Operational Programme for Competitiveness and Internationalization (POCI); European Regional Development Fund (FEDER) - Norte Portugal Regional Operational Programme (NORTE), under the PORTUGAL Partnership Agreement through FEDER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL091939 (to W. F. B.) and HL129545 (to N. M. N.), NewYork State Stem Cell Foundation Grant C026716 (to W. F. B.), National Natural Science Foundation of China Grant 91430217, MOST Grants 2016YFA0203200 and 2013YQ170585 (to X. L. Z. and J. W.), National Science Foundation Grant PHY-76066 (to J. W.), Portuguese funds through Fundacao para a Ciencia e a Tecnologia postdoctoral fellowship SFRH/BPD/108004/2015 (to J. R.-R.) and project "Institute for Research and Innovation in Health Sciences" Grant POCI-01-0145-FEDER-007274, co-funded by the European Regional Development Fund (FEDER) through the COMPETE 2020-Operational Programme for Competitiveness and Internationalization (POCI), PORTUGAL 2020, the "Structured program on bioengineered therapies for infectious diseases and tissue regeneration" Grant Norte-01-0145-FEDER-000012, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement through FEDER. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; Awale M, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-014-0051-5; Awale M, 2014, NUCLEIC ACIDS RES, V42, pW234, DOI 10.1093/nar/gku379; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Barker KD, 2012, J BIOL CHEM, V287, P18342, DOI 10.1074/jbc.M112.359265; Bulmer AC, 2008, ATHEROSCLEROSIS, V199, P390, DOI 10.1016/j.atherosclerosis.2007.11.022; Cai ZW, 2002, J BIOL CHEM, V277, P19546, DOI 10.1074/jbc.M108023200; Chu WT, 2017, CHEM-EUR J, V23, P1891, DOI 10.1002/chem.201604517; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Cunningham O, 2000, BIOCHEM J, V345, P393, DOI 10.1042/0264-6021:3450393; Cunningham O, 2000, J BIOL CHEM, V275, P19009, DOI 10.1074/jbc.275.25.19009; Cunningham O, 1997, BIOCHEM SOC T, V25, pS613, DOI 10.1042/bst025s613; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Drwal MN, 2014, NUCLEIC ACIDS RES, V42, pW53, DOI 10.1093/nar/gku401; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Franklin EM, 2009, FEBS J, V276, P4405, DOI 10.1111/j.1742-4658.2009.07148.x; Fu G, 2012, J PHYS CHEM B, V116, P9580, DOI 10.1021/jp301456j; Ganesan L, 2011, BIOCHEM PHARMACOL, V81, P810, DOI 10.1016/j.bcp.2010.12.020; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Goldstein A, 1944, J GEN PHYSIOL, V27, P529, DOI 10.1085/jgp.27.6.529; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; HAGERHALL C, 1992, BIOCHEMISTRY-US, V31, P7411, DOI 10.1021/bi00147a028; Huan L, 2016, CANCER SCI, V107, P258, DOI 10.1111/cas.12869; HULTQUIST DE, 1993, AM J HEMATOL, V42, P13, DOI 10.1002/ajh.2830420105; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jordheim LP, 2013, MOL PHARMACOL, V84, P12, DOI 10.1124/mol.112.082347; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kapitulnik J, 2009, TRENDS PHARMACOL SCI, V30, P129, DOI 10.1016/j.tips.2008.12.003; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kikuchi A, 2001, NAT STRUCT BIOL, V8, P221, DOI 10.1038/84955; Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378; KUMAZAWA T, 1992, BIOCHIM BIOPHYS ACTA, V1156, P62, DOI 10.1016/0304-4165(92)90096-D; KUTTY RK, 1981, J BIOL CHEM, V256, P3956; Lagorce D, 2015, NUCLEIC ACIDS RES, V43, pW200, DOI 10.1093/nar/gkv353; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu XF, 2011, J CHEM INF MODEL, V51, P2372, DOI 10.1021/ci200060s; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; MACK CP, 1995, BIOCHEM BIOPH RES CO, V212, P35, DOI 10.1006/bbrc.1995.1932; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonagh AF, 2001, NAT STRUCT BIOL, V8, P198, DOI 10.1038/84915; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Mitchell AE, 1999, ANAL BIOCHEM, V269, P317, DOI 10.1006/abio.1999.4039; Mizutani T, 2009, J ENVIRON PUBLIC HEA, V2009, DOI 10.1155/2009/953952; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q; NOGUCHI M, 1979, J BIOCHEM, V86, P833, DOI 10.1093/oxfordjournals.jbchem.a132615; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; Pereira PJB, 2001, NAT STRUCT BIOL, V8, P215, DOI 10.1038/84948; Peters WHM, 2003, J HEPATOL, V38, P3, DOI 10.1016/S0168-8278(02)00306-9; Quintus F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-245; Schluchter WM, 1997, J BIOL CHEM, V272, P13562, DOI 10.1074/jbc.272.21.13562; SCHWERTNER HA, 1994, CLIN CHEM, V40, P18; Shalloe F, 1996, BIOCHEM J, V316, P385, DOI 10.1042/bj3160385; Smith LJ, 2008, BIOCHEM J, V411, P475, DOI 10.1042/BJ20071495; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOUTHERN JA, 1991, J GEN VIROL, V72, P1551, DOI 10.1099/0022-1317-72-7-1551; Stivers J., 2008, U. S. Patent, Patent No. [20080020973A1, 20080020973]; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Straus OH, 1943, J GEN PHYSIOL, V26, P559, DOI 10.1085/jgp.26.6.559; Theobald DL, 2012, BIOINFORMATICS, V28, P1972, DOI 10.1093/bioinformatics/bts243; Uesugi N, 2006, J HEALTH SCI, V52, P549, DOI 10.1248/jhs.52.549; Velec HFG, 2005, J MED CHEM, V48, P6296, DOI 10.1021/jm050436v; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Wang J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.198101; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057288; Wu S, 2016, BLOOD, V128, P699, DOI 10.1182/blood-2016-02-696997; XU F, 1993, BIOCHEM BIOPH RES CO, V193, P434, DOI 10.1006/bbrc.1993.1642; Xu X, 2012, BLOOD, V120, P3575, DOI 10.1182/blood-2012-02-411264; YAMAGUCHI T, 1994, J BIOL CHEM, V269, P24343; YAMAGUCHI T, 1995, EUR J BIOCHEM, V233, P467, DOI 10.1111/j.1432-1033.1995.467_2.x; Yan ZH, 2007, J MED CHEM, V50, P4096, DOI 10.1021/jm070305p; YUBISUI T, 1979, J BIOCHEM, V85, P719	81	4	4	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5431	5446		10.1074/jbc.RA118.001803	http://dx.doi.org/10.1074/jbc.RA118.001803			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29487133	Green Published, hybrid			2022-12-26	WOS:000430044100008
J	Shen, YQ; Sherman, JW; Chen, XY; Wang, RN				Shen, Yuqing; Sherman, John William; Chen, Xuyong; Wang, Ruoning			Phosphorylation of CDC25C by AMP-activated protein kinase mediates a metabolic checkpoint during cell-cycle G(2)/M-phase transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); mitosis; protein phosphorylation; cell cycle; metabolic regulation; CDC25C; metabolic checkpoint	DNA-DAMAGE; WEE1 KINASE; XENOPUS OOCYTES; GENETIC-CONTROL; MITOTIC ENTRY; P53 PROTEINS; S-PHASE; PROLIFERATION; CANCER; GROWTH	From unicellular to multicellular organisms, cell-cycle progression is tightly coupled to biosynthetic and bioenergetic demands. Accumulating evidence has demonstrated the G(1)/S-phase transition as a key checkpoint where cells respond to their metabolic status and commit to replicating the genome. However, the mechanism underlying the coordination of metabolism and the G(2)/M-phase transition in mammalian cells remains unclear. Here, we show that the activation of AMP-activated protein kinase (AMPK), a highly conserved cellular energy sensor, significantly delays mitosis entry. The cell-cycle G(2)/M-phase transition is controlled by mitotic cyclin-dependent kinase complex (CDC2-cyclin B), which is inactivated by WEE1 family protein kinases and activated by the opposing phosphatase CDC25C. AMPK directly phosphorylates CDC25C on serine 216, a well-conserved inhibitory phosphorylation event, which has been shown to mediate DNA damage-induced G(2)-phase arrest. The acute induction of CDC25C or suppression of WEE1 partially restores mitosis entry in the context of AMPK activation. These findings suggest that AMPK-dependent phosphorylation of CDC25C orchestrates a metabolic checkpoint for the cell-cycle G(2)/M-phase transition.	[Shen, Yuqing; Sherman, John William; Chen, Xuyong; Wang, Ruoning] Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc & Blood Dis,Hematol Oncol & BM, Columbus, OH 43205 USA; [Shen, Yuqing] Southeast Univ, Key Lab Dev Genes & Human Dis, Dept Microbiol & Immunol, Minist Educ,Med Sch, Nanjing 210009, Jiangsu, Peoples R China	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Southeast University - China	Wang, RN (corresponding author), Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc & Blood Dis,Hematol Oncol & BM, Columbus, OH 43205 USA.	ruoning.wang@nationwidechildrens.org			National Institute of Health [1R01AI114581]; V-Foundation [V2014-001]; American Cancer Society [128436-RSG-15-180-01-LIB]; CancerFree KIDs Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114581] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V-Foundation; American Cancer Society(American Cancer Society); CancerFree KIDs Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Health Grant 1R01AI114581, V-Foundation Grant V2014-001, American Cancer Society Grant 128436-RSG-15-180-01-LIB, and a research grant from the CancerFree KIDs Foundation (to R. W). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320; Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Allen JJ, 2005, J AM CHEM SOC, V127, P5288, DOI 10.1021/ja050727t; Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012; BENDICK C, 1989, ARCH DERMATOL, V125, P1285, DOI 10.1001/archderm.125.9.1285; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; BRAND K, 1984, BIOCHEM J, V221, P471, DOI 10.1042/bj2210471; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Buchakjian MR, 2010, NAT REV MOL CELL BIO, V11, P715, DOI 10.1038/nrm2972; Cai L, 2012, ANNU REV CELL DEV BI, V28, P59, DOI 10.1146/annurev-cellbio-092910-154010; Colombo SL, 2010, P NATL ACAD SCI USA, V107, P18868, DOI 10.1073/pnas.1012362107; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI 10.1107/S0907444907009110; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Do K, 2015, J CLIN ONCOL, V33, P3409, DOI 10.1200/JCO.2014.60.4009; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P556, DOI 10.1016/j.tibs.2014.09.003; Ferrell JE, 2013, CURR OPIN CELL BIOL, V25, P676, DOI 10.1016/j.ceb.2013.07.007; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; Giglia-Mari G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000745; Ginzberg MB, 2015, SCIENCE, V348, DOI 10.1126/science.1245075; Goodwin GW, 2001, AM J PHYSIOL-ENDOC M, V280, pE502, DOI 10.1152/ajpendo.2001.280.3.E502; Green DR, 2016, CURR BIOL, V26, pR620, DOI 10.1016/j.cub.2016.05.023; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2016, ACTA PHARM SIN B, V6, P1, DOI 10.1016/j.apsb.2015.06.002; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hirai H, 2009, MOL CANCER THER, V8, P2992, DOI 10.1158/1535-7163.MCT-09-0463; Ho A, 2002, CURR OPIN GENET DEV, V12, P47, DOI 10.1016/S0959-437X(01)00263-5; HOCHACHKA PW, 2002, BIOCH ADAPTATION MEC, P101; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Hustedt N, 2017, NAT CELL BIOL, V19, P1, DOI 10.1038/ncb3452; Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Karisson-Rosenthal C, 2006, TRENDS CELL BIOL, V16, P285, DOI 10.1016/j.tcb.2006.04.002; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kawabe T, 2004, MOL CANCER THER, V3, P513; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Kultz D, 2003, J EXP BIOL, V206, P3119, DOI 10.1242/jeb.00549; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Langerak P, 2011, PHILOS T R SOC B, V366, P3562, DOI 10.1098/rstb.2011.0070; Lee IH, 2013, CURR OPIN CELL BIOL, V25, P724, DOI 10.1016/j.ceb.2013.07.002; Leijen S, 2016, J CLIN ONCOL, V34, P4371, DOI 10.1200/JCO.2016.67.5991; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liu LL, 2016, P NATL ACAD SCI USA, V113, P1564, DOI 10.1073/pnas.1518000113; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; MATLASHEWSKI G, 1986, EUR J BIOCHEM, V154, P665, DOI 10.1111/j.1432-1033.1986.tb09449.x; MAY E, 1991, ONCOGENE, V6, P1363; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; Mitchison J. M., 1972, BIOL CELL CYCLE, P192; MOON A, 1987, J CLIN INVEST, V79, P59, DOI 10.1172/JCI112808; Morgan D. O., 2006, CELL CYCLE PRINCIPLE, P90; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Mueller S, 2015, J CLIN ONCOL, V33, P3485, DOI 10.1200/JCO.2015.62.2290; NEELY JR, 1972, BIOCHEM J, V128, P147, DOI 10.1042/bj1280147; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Pederson T, 2003, TRENDS BIOCHEM SCI, V28, P125, DOI 10.1016/S0968-0004(03)00030-6; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perdiguero E, 2004, CELL CYCLE, V3, P733; Perdiguero E, 2003, EMBO J, V22, P5746, DOI 10.1093/emboj/cdg559; Perry JA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-12; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; ROBBINS E, 1969, J CELL BIOL, V43, P629, DOI 10.1083/jcb.43.3.629; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shen YQ, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2517; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; SWANN MM, 1957, CANCER RES, V17, P727; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang RN, 2010, P NATL ACAD SCI USA, V107, P19885, DOI 10.1073/pnas.1003528107; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wang YL, 2000, CELL GROWTH DIFFER, V11, P211; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WILLEMS HL, 1978, CLIN CHEM, V24, P200; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	123	18	18	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5185	5199		10.1074/jbc.RA117.001379	http://dx.doi.org/10.1074/jbc.RA117.001379			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29467227	Green Published, hybrid			2022-12-26	WOS:000429409300023
J	Chavez, G; Richman, IB; Kaimal, R; Bentley, J; Yasukawa, LA; Altman, RB; Periyakoil, VS; Chen, JH				Chavez, Gustavo; Richman, Ilana B.; Kaimal, Rajani; Bentley, Jason; Yasukawa, Lee Ann; Altman, Russ B.; Periyakoil, Vyjeyanthi S.; Chen, Jonathan H.			Reversals and limitations on high-intensity, life-sustaining treatments	PLOS ONE			English	Article							NOT-RESUSCITATE ORDERS; CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; LIVING WILLS; CARE; PREFERENCES; WITHDRAWAL; DECISIONS; OUTCOMES; DNR	Importance Critically ill patients often receive high-intensity life sustaining treatments (LST) in the intensive care unit (ICU), although they can be ineffective and eventually undesired. Determining the risk factors associated with reversals in LST goals can improve patient and provider appreciation for the natural history and epidemiology of critical care and inform decision making around the (continued) use of LSTs. Methods This is a single institution retrospective cohort study of patients receiving life sustaining treatment in an academic tertiary hospital from 2009 to 2013. Deidentified patient electronic medical record data was collected via the clinical data warehouse to study the outcomes of treatment limiting Comfort Care and do-not-resuscitate (DNR) orders. Extended multivariable Cox regression models were used to estimate the association of patient and clinical factors with subsequent treatment limiting orders. Results 10,157 patients received life-sustaining treatment while initially Full Code (allowing all resuscitative measures). Of these, 770 (8.0%) transitioned to Comfort Care (with discontinuation of any life-sustaining treatments) while 1,669 (16%) patients received new DNR orders that reflect preferences to limit further life-sustaining treatment options. Patients who were older (Hazard Ratio(HR) 1.37 [95% CI 1.28-1.47] per decade), with cerebrovascular disease (HR 2.18 [95% CI 1.69-2.81]), treated by the Medical ICU (HR 1.92 [95% CI 1.49-2.49]) and Hematology-Oncology (HR 1.87 [95% CI 1.27-2.74]) services, receiving vasoactive infusions (HR 1.76 [95% CI 1.28, 2.43]) or continuous renal replacement (HR 1.83 [95% CI 1.34, 2.48]) were more likely to transition to Comfort Care. Any new DNR orders were more likely for patients who were older (HR 1.43 [95% CI 1.38-1.48] per decade), female (HR 1.30 [95% CI 1.17-1.44]), with cerebrovascular disease (HR 1.45 [95% CI 1.25-1.67]) or metastatic solid cancers (HR 1.92 [95% CI 1.48-2.49]), or treated by Medical ICU (HR 1.63 [95% CI 1.42-1.86]), Hematology-Oncology (HR 1.63 [95% CI 1.33-1.98]) and Cardiac Care Unit-Heart Failure (HR 1.41 [95% CI 1.15-1.72]). Conclusion Decisions to reverse or limit treatment goals occurs after more than 1 in 13 trials of LST, and is associated with older female patients, receiving non-ventilator forms of LST, cerebrovascular disease, and treatment by certain medical specialty services.	[Chavez, Gustavo] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Richman, Ilana B.] Yale Med, Ctr Outcomes Res & Evaluat, New Haven, CT USA; [Kaimal, Rajani; Bentley, Jason] Stanford Quantitat Sci, Stanford, CA USA; [Yasukawa, Lee Ann] Stanford Ctr Clin Informat, Stanford, CA USA; [Altman, Russ B.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Periyakoil, Vyjeyanthi S.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Periyakoil, Vyjeyanthi S.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Chen, Jonathan H.] Stanford Univ, Ctr Biomed Informat Res, Sch Med, Stanford, CA 94305 USA; [Chen, Jonathan H.] Stanford Univ, Dept Med, Sch Med, Div Hosp Med, Stanford, CA 94305 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Stanford University	Chen, JH (corresponding author), Stanford Univ, Ctr Biomed Informat Res, Sch Med, Stanford, CA 94305 USA.; Chen, JH (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Hosp Med, Stanford, CA 94305 USA.	jonc101@stanford.edu		Altman, Russ/0000-0003-3859-2905; Chen, Jonathan H./0000-0002-4387-8740	Stanford University School of Medicine Center of Excellence; Stanford University School of Medicine Medical Scholars Research Program; NIH Big Data 2 Knowledge Award through the National Institutes of Health and National Institute of Environmental Health Sciences [K01ES026837]; US Department of Veterans Affairs Office of Academic Affiliations and Health Services Research and Development Service Research Funds; Department of Veterans Affairs; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 RR025744];  [R25 MD006857];  [5U54MD010724]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES026837] Funding Source: NIH RePORTER	Stanford University School of Medicine Center of Excellence; Stanford University School of Medicine Medical Scholars Research Program; NIH Big Data 2 Knowledge Award through the National Institutes of Health and National Institute of Environmental Health Sciences; US Department of Veterans Affairs Office of Academic Affiliations and Health Services Research and Development Service Research Funds; Department of Veterans Affairs(US Department of Veterans Affairs); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Gustavo A. Chavez was supported by Stanford University School of Medicine Center of Excellence and Stanford University School of Medicine Medical Scholars Research Program. Jonathan H. Chen was supported by NIH Big Data 2 Knowledge Award Number K01ES026837 through the National Institutes of Health and National Institute of Environmental Health Sciences. Ilana Richman was supported by the US Department of Veterans Affairs Office of Academic Affiliations and Health Services Research and Development Service Research Funds. Vyjeyanthi S. Periyakoil's time is supported in part by grants R25 MD006857, 5U54MD010724 and the Department of Veterans Affairs. Patient data extracted and de-identified by Gomathi Krishnan and Lee Ann Yasukawa of the STRIDE (Stanford Translational Research Integrated Database Environment) project, a research and development project at Stanford University to create a standards-based informatics platform supporting clinical and translational research. The STRIDE project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through grant UL1 RR025744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WG, 2011, J GEN INTERN MED, V26, P359, DOI 10.1007/s11606-010-1568-6; [Anonymous], 2011, METR TRANSP COMM GA; [Anonymous], 2015, DYING IN AMERICA IMP; Auriemma CL, 2014, JAMA INTERN MED, V174, P1085, DOI 10.1001/jamainternmed.2014.1183; Bailey FA, 2012, J PALLIAT MED, V15, P751, DOI 10.1089/jpm.2011.0321; Barnato AE, 2009, J GEN INTERN MED, V24, P695, DOI 10.1007/s11606-009-0952-6; Boerner K, 2013, J GERONTOL B-PSYCHOL, V68, P246, DOI 10.1093/geronb/gbs161; Boyd K, 1996, ARCH INTERN MED, V156, P1821, DOI 10.1001/archinte.156.16.1821; Bureau UC, 2014, 2009 2013 5 YEAR AM; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; Diem SJ, 1996, NEW ENGL J MED, V334, P1578, DOI 10.1056/NEJM199606133342406; Downar J, 2011, J GEN INTERN MED, V26, P582, DOI 10.1007/s11606-010-1616-2; Einav S, 2012, EMERG MED J, V29, P709, DOI 10.1136/emermed-2011-200206; Elmer J, 2016, RESUSCITATION, V102, P127, DOI 10.1016/j.resuscitation.2016.01.016; Field M.J, 1997, APPROACHING DEATH IM; Frank C, 2003, CAN MED ASSOC J, V169, P795; Garland A, 2007, J PALLIAT MED, V10, P1298, DOI 10.1089/jpm.2007.0061; Goodlin SJ, JAMA, V282, P2333; Jawa RS, 2015, AM J SURG, V210, P814, DOI 10.1016/j.amjsurg.2015.04.007; Jayes RL, 1996, CHEST, V110, P1332, DOI 10.1378/chest.110.5.1332; Kelly WF, 2002, CHEST, V121, P957, DOI 10.1378/chest.121.3.957; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kostoulakos NM, 1997, PERCEPT MOTOR SKILL, V84, P1409, DOI 10.2466/pms.1997.84.3c.1409; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Love A, 2014, PALLIATIVE MED, V28, P1026, DOI 10.1177/0269216314531313; Lowe Henry J, 2009, AMIA Annu Symp Proc, V2009, P391; Mirarchi FL, 2007, J EMERG MED, V33, P299, DOI 10.1016/j.jemermed.2007.02.026; Mirarchi FL, 2015, J PATIENT SAF, V11, P1, DOI 10.1097/PTS.0000000000000165; Mirarchi FL, 2012, J EMERG MED, V42, P511, DOI 10.1016/j.jemermed.2011.07.015; Mirarchi FL, 2017, J PATIENT SAF, P1; Moore KA, 2016, JAMA-J AM MED ASSOC, V315, P259, DOI 10.1001/jama.2015.17362; Periyakoil VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098246; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rajan S, 2016, RESUSCITATION, V105, P45, DOI 10.1016/j.resuscitation.2016.05.004; Roberts D, 2000, AM J EMERG MED, V18, P465, DOI 10.1053/ajem.2000.7338; Siracuse JJ, 2015, ANN VASC SURG, V29, P1339, DOI 10.1016/j.avsg.2015.05.014; US Census, 2015, ED ATT US 2015; Van den Bulck Jan J M, 2002, Eur J Emerg Med, V9, P325; Zingmond DS, 2005, ARCH INTERN MED, V165, P1705, DOI 10.1001/archinte.165.15.1705	39	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0190569	10.1371/journal.pone.0190569	http://dx.doi.org/10.1371/journal.pone.0190569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489814	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000005
J	Kasyap, AK; Sah, SK; Chaudhary, S				Kasyap, Akhilesh Kumar; Sah, Shiv Kumar; Chaudhary, Sitaram			Clinical spectrum and risk factors associated with asymptomatic erosive esophagitis as determined by Los Angeles classification: A cross-sectional study	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; ENDOSCOPIC ASSESSMENT; NATURAL-HISTORY; POPULATION; PREVALENCE; EPIDEMIOLOGY; DISORDERS; CHINESE	Background Gastro esophageal reflux disease (GERD) is a chronic and recurrent disease, and it varies in regions. However, to date, there are no reports available on clinical features and the risk factors for the asymptomatic reflux esophagitis in Nepalese adults. Methods Data were gathered from 142 erosive patients who had undergone endoscopy at Bir Hospital, Kathmandu. Los Angeles classification was used to grade the severity of the disease. Patients were interviewed to find out the presence of various reflux symptoms. Results Based on the Los Angeles classification, the severity of the disease assessed was; grade A 31.8% (31/142), grade B 39.4% (56/142), grade C 33.8% (48/142), and grade D 4.9% (7/142). One hundred and twenty six (88.7%) subjects had reflux symptoms. Prevalence of asymptomatic esophagitis was 16(11.3%). Age was independently linked to asymptomatic esophagitis (P<0.05), and the odd of being asymptomatic appeared lower in younger adults (P<0.05; OR: 0.118; CI: 0.014-.994). Conclusion A low prevalence of asymptomatic reflux esophagitis (RE) was seen. Most subjects experienced mild to moderate RE. Age remained an independent factor associated with reflux esophagitis, and the odds of being asymptomatic was lower in younger age.	[Kasyap, Akhilesh Kumar; Chaudhary, Sitaram] Bir Hosp Mahabauddha, Natl Acad Med Sci, Dept Med, Gastroenterol Unit, Kathmandu, Nepal; [Sah, Shiv Kumar] Purbanchal Univ, Little Buddha Coll Hlth Sci, Fac Pharmaceut Sci, Kathmandu, Nepal		Sah, SK (corresponding author), Purbanchal Univ, Little Buddha Coll Hlth Sci, Fac Pharmaceut Sci, Kathmandu, Nepal.	phrshiv@gmail.com		Sah, Shiv Kumar/0000-0002-8284-5925				A Gallup Organization National Survey, 1988, HEARTB AM; Agreus L, 2001, AM J GASTROENTEROL, V96, P2905; Armstrong D, 1996, GASTROENTEROLOGY, V111, P85, DOI 10.1053/gast.1996.v111.pm8698230; Chakour MC, 1996, PAIN, V64, P143, DOI 10.1016/0304-3959(95)00102-6; Chang CS, 1997, AM J GASTROENTEROL, V92, P668; Chen TS, 2007, J CLIN GASTROENTEROL, V41, P819, DOI 10.1097/01.mcg.0000225658.30803.79; Cho JH, 2011, J GASTROEN HEPATOL, V26, P1034, DOI 10.1111/j.1440-1746.2011.06686.x; Fass Ronnie, 2006, Curr Gastroenterol Rep, V8, P195, DOI 10.1007/s11894-006-0075-8; Franceschi M, 2009, BEST PRACT RES CL GA, V23, P839, DOI 10.1016/j.bpg.2009.10.004; Fujiwara Y, 2009, J GASTROENTEROL, V44, P518, DOI 10.1007/s00535-009-0047-5; Inamori M, 2003, J GASTROEN HEPATOL, V18, P172, DOI 10.1046/j.1440-1746.2003.02932.x; Johnsson F J B, 1987, GASTROENTEROLOGY, V2, P714; Jung HK, 2011, J NEUROGASTROENTEROL, V17, P14, DOI 10.5056/jnm.2011.17.1.14; Jung SH, 2014, TURK J GASTROENTEROL, V25, P248, DOI 10.5152/tjg.2014.5033; Lee SJ, 2001, J GASTROEN HEPATOL, V16, P373, DOI 10.1046/j.1440-1746.2001.02464.x; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Nagahara A, 2012, J GASTROEN HEPATOL, V27, P53, DOI 10.1111/j.1440-1746.2012.07073.x; Nozu T, 2008, J GASTROENTEROL, V43, P27, DOI 10.1007/s00535-007-2120-2; Ronkainen J, 2005, SCAND J GASTROENTERO, V40, P275, DOI 10.1080/00365520510011579; Uetake T, 2000, SHOKAKIKA, V30, P139; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Wang FW, 2010, DIGEST DIS SCI, V55, P1320, DOI 10.1007/s10620-009-0888-z	22	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0192739	10.1371/journal.pone.0192739	http://dx.doi.org/10.1371/journal.pone.0192739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29486003	gold, Green Published, Green Submitted			2022-12-26	WOS:000426242400010
J	Ahmad, R; Suzilah, I; Najdah, WMAW; Topek, O; Mustafakamal, I; Lee, HL				Ahmad, Rohani; Suzilah, Ismail; Najdah, Wan Mohamad Ali Wan; Topek, Omar; Mustafakamal, Ibrahim; Lee, Han Lim			Factors determining dengue outbreak in Malaysia	PLOS ONE			English	Article							AEDES-AEGYPTI; TRANSMISSION; VIRUSES; SURVEILLANCE; TEMPERATURE; DYNAMICS; CLIMATE; RISK	A large scale study was conducted to elucidate the true relationship among entomological, epidemiological and environmental factors that contributed to dengue outbreak in Malaysia. Two large areas (Selayang and Bandar Baru Bangi) were selected in this study based on five consecutive years of high dengue cases. Entomological data were collected using ovitraps where the number of larvae was used to reflect Aedes mosquito population size; followed by RT-PCR screening to detect and serotype dengue virus in mosquitoes. Notified cases, date of disease onset, and number and type of the interventions were used as epidemiological endpoint, while rainfall, temperature, relative humidity and air pollution index (API) were indicators for environmental data. The field study was conducted during 81 weeks of data collection. Correlation and Autoregressive Distributed Lag Model were used to determine the relationship. The study showed that, notified cases were indirectly related with the environmental data, but shifted one week, i.e. last 3 weeks positive PCR; last 4 weeks rainfall; last 3 weeks maximum relative humidity; last 3 weeks minimum and maximum temperature; and last 4 weeks air pollution index (API), respectively. Notified cases were also related with next week intervention, while conventional intervention only happened 4 weeks after larvae were found, indicating ample time for dengue transmission. Based on a significant relationship among the three factors (epidemiological, entomological and environmental), estimated Autoregressive Distributed Lag (ADL) model for both locations produced high accuracy 84.9% for Selayang and 84.1% for Bandar Baru Bangi in predicting the actual notified cases. Hence, such model can be used in forestalling dengue outbreak and acts as an early warning system. The existence of relationships among the entomological, epidemiological and environmental factors can be used to build an early warning system for the prediction of dengue outbreak so that preventive interventions can be taken early to avert the outbreaks.	[Ahmad, Rohani; Najdah, Wan Mohamad Ali Wan; Lee, Han Lim] Inst Med Res, Med Entomol Unit, Kuala Lumpur, Malaysia; [Ahmad, Rohani; Najdah, Wan Mohamad Ali Wan; Lee, Han Lim] Inst Med Res, WHO, Collaborating Ctr Vectors, Kuala Lumpur, Malaysia; [Suzilah, Ismail] Univ Utara Malaysia, Sch Quantitat Sci, Sintok, Kedah, Malaysia; [Najdah, Wan Mohamad Ali Wan] Univ Malaya, Fac Med, Parasitol Dept, Kuala Lumpur, Malaysia; [Topek, Omar] Minist Hlth, Dis Control Div, Putrajaya, Malaysia; [Mustafakamal, Ibrahim] Selangor State Hlth Dept, Shah Alam, Selangor, Malaysia	Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; World Health Organization; Universiti Utara Malaysia; Universiti Malaya; Kementerian Kesihatan Malaysia	Ahmad, R (corresponding author), Inst Med Res, Med Entomol Unit, Kuala Lumpur, Malaysia.; Ahmad, R (corresponding author), Inst Med Res, WHO, Collaborating Ctr Vectors, Kuala Lumpur, Malaysia.	rohania@imr.gov.my	Wan Mohamad Ali, Wan Najdah/GBG-1170-2022		National Institute of Health-Ministry of Health Malaysia [JPP-IMR: 13-059]; National Institute of Health, Ministry of Health, Malaysia [NIH-JPP-IMR-13-059];  [NMRR-13-942-17801]	National Institute of Health-Ministry of Health Malaysia(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health, Ministry of Health, Malaysia(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This study was funded by National Institute of Health-Ministry of Health Malaysia (Grant No. JPP-IMR: 13-059). All the funding or sources of support received during this study is specific for this research project 'New Model for Predicting Dengue Outbreak' (NMRR-13-942-17801). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Director-General of Health, Malaysia for permission to publish this paper. We especially thank the staff of Medical Entomology Unit of IMR, Health State Vector Gombak and Health State Vector Ulu Langat without whose diligence and hard work under difficult field conditions this research would not have been accomplished. The study was funded by National Institute of Health (NIH-JPP-IMR-13-059), Ministry of Health, Malaysia.	Arunachalam N., 1999, Tropical Biomedicine, V16, P25; Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578; Crisis Preparedness and Response Centre (CPRC), 2016, BAH KAW PEN KEB KEM; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; DYE C, 1986, Parasitology Today, V2, P203; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Griffiths W., 2017, PRINCIPLES ECONOMETR; Gunasekera M, 2013, AEDES AEGYPTI DENSIT; Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908; Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lee H. L., 2005, Dengue Bulletin, V29, P106; Lim KW, 2010, TROP BIOMED, V27, P185; Massad E, 2010, EPIDEMIOL INFECT, V138, P951, DOI 10.1017/S0950268809990501; Metrological Department Ministry of Science Technology and Innovation Malaysia., ANN REP 2015; Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556; Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486; Pena-Garcia VH, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070734; Perich MJ, 2003, MED VET ENTOMOL, V17, P205, DOI 10.1046/j.1365-2915.2003.00427.x; Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378; Ramachandran VG, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016052; Richards SL, 2006, J MED ENTOMOL, V43, P976, DOI 10.1603/0022-2585(2006)43[976:SAOAAD]2.0.CO;2; RODRIGUEZFIGUEROA L, 1995, AM J TROP MED HYG, V52, P496, DOI 10.4269/ajtmh.1995.52.496; Rohani A, 2011, TROP BIOMED, V28, P237; Rohani A, 2009, SE ASIAN J TROP MED, V40, P942; Rozilawati H, 2015, TROP BIOMED, V32, P49; Sanchez L, 2006, EMERG INFECT DIS, V12, P800; Scott T. W., 2004, ECOLOGICAL ASPECTS A, V2, P187; Severson DW, 2004, INSECT BIOCHEM MOLEC, V34, P715, DOI 10.1016/j.ibmb.2004.03.024; Strickman D, 2003, AM J TROP MED HYG, V68, P209, DOI 10.4269/ajtmh.2003.68.209; Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x; WHO, 2016, MOSQ VECT CONTR EM R; Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7; World Health Organization, 2009, DENGUE GUIDELINES DI	39	31	33	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193326	10.1371/journal.pone.0193326	http://dx.doi.org/10.1371/journal.pone.0193326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474401	Green Submitted, gold, Green Published			2022-12-26	WOS:000426049500083
J	Huang, YH; Chen, CM; Lee, YS; Chang, KH; Chen, HW; Chen, YC				Huang, Yu-hua; Chen, Chiung-Mei; Lee, Yun-Shien; Chang, Kuo-Hsuan; Chen, Huei-Wen; Chen, Yi-Chun			Detection of mitochondrial DNA with 4977 bp deletion in leukocytes of patients with ischemic stroke	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ATHEROSCLEROTIC LESIONS; DAMAGE; MUTATIONS; CANCER; CELLS; CLASSIFICATION; VARIANTS; SUBTYPE; SYSTEM	Background Coronary artery disease is associated with a common mitochondrial DNA alteration, a 4977 bp deletion (mtDNA(4977)). The role of mtDNA(4977) in ischemic stroke is unknown. Methods Real-time quantitative PCR was performed to quantify total mtDNA and mtDNA(4977) in leukocytes in 283 ischemic stroke cases and 135 controls. Ratios of mtDNA(4977) to total-mtDNA and total-mtDNA to nuclear-DNA were calculated. Nested PCR and Sanger sequencing were used to confirm undetectable levels of mtDNA(4977). Results For 191 patients and 74 control subjects in the male group and 92 patients and 61 control subjects in the female group, there were no significant between-group differences in age, cholesterol level, body mass index, stroke severity, or 4977 deletion. After adjusting for confounding factors, there was no correlation between mtDNA(4977) amount and infarction risk, recurrent stroke, or stroke severity. However, mtDNA(4977) was undetected in 6.94% subjects, and these individuals had a higher prevalence of stroke than those with detectable mtDNA(4977) (OR: 0.181, 95% CI 0.041-0.798, p = 0.024). Additionally, mtDNA(4977) status had no effect on stroke prognosis, including stroke severity and recurrent stroke. Conclusion In conclusion, there was no apparent association between mtDNA(4977) deletion and cerebral infarction. Undetectable mtDNA(4977) may be a marker or risk factor for ischemic stroke.	[Huang, Yu-hua; Chen, Chiung-Mei; Chang, Kuo-Hsuan; Chen, Huei-Wen; Chen, Yi-Chun] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taoyuan, Taiwan; [Huang, Yu-hua; Chen, Chiung-Mei; Chang, Kuo-Hsuan; Chen, Huei-Wen; Chen, Yi-Chun] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Yun-Shien] Ming Chuan Univ, Dept Biotechnol, Taoyuan, Taiwan; [Lee, Yun-Shien] Chang Gung Mem Hosp, Genom Med Res Core Lab, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Ming Chuan University; Chang Gung Memorial Hospital	Chen, YC (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taoyuan, Taiwan.; Chen, YC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	asd108@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020	Chen, Yi-Chun/0000-0002-2457-5023	National Science Council in Taiwan [NSC 103-2314-B-182A-027]; Chang Gung Memorial Hospital [CMRPG3C174, CMRPG3E1502, CMRPG 3G0961]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by the National Science Council in Taiwan (NSC 103-2314-B-182A-027) and Chang Gung Memorial Hospital (CMRPG3C174, CMRPG3E1502, CMRPG 3G0961) (YC). All authors report no conflicts of interest. The funders had no role in study design, data collection and analysis, decision publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Agodi A, 2014, MUTAGENESIS, V29, P101, DOI 10.1093/mutage/get065; Anderson CD, 2013, STROKE, V44, P612, DOI 10.1161/STROKEAHA.112.672089; Anderson CD, 2011, ANN NEUROL, V69, P471, DOI 10.1002/ana.22108; Andreazza AC, 2010, ARCH GEN PSYCHIAT, V67, P360, DOI 10.1001/archgenpsychiatry.2010.22; Bogliolo M, 1999, MUTAGENESIS, V14, P77, DOI 10.1093/mutage/14.1.77; Borghini A, 2013, ATHEROSCLEROSIS, V230, P202, DOI 10.1016/j.atherosclerosis.2013.07.038; Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; Dai Ji Gang, 2006, Indian J Cancer, V43, P20; Dani SU, 2003, MED HYPOTHESES, V61, P60, DOI 10.1016/S0306-9877(03)00105-1; Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Dimberg J, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0843-8; Fahn HJ, 1996, AM J RESP CRIT CARE, V154, P1141, DOI 10.1164/ajrccm.154.4.8887618; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; Knight-Lozano CA, 2002, CIRCULATION, V105, P849, DOI 10.1161/hc0702.103977; Lai LP, 2003, CHEST, V123, P539, DOI 10.1378/chest.123.2.539; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Marnane M, 2010, STROKE, V41, P1579, DOI 10.1161/STROKEAHA.109.575373; Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004; Nie HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067953; Pavicic WH, 2009, MUTAT RES-FUND MOL M, V670, P99, DOI 10.1016/j.mrfmmm.2009.07.009; Peinado JR, 2014, PROTEOMICS, V14, P452, DOI 10.1002/pmic.201300376; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; Sabatino L, 2013, ENVIRON MOL MUTAGEN, V54, P299, DOI 10.1002/em.21783; Sobenin IA, 2013, CURR PHARM DESIGN, V19, P5942; Tsao JW, 2005, ARCH NEUROL-CHICAGO, V62, P1126, DOI 10.1001/archneur.62.7.1126; von Wurmb-Schwark N, 2010, MECH AGEING DEV, V131, P179, DOI 10.1016/j.mad.2010.01.005; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Ye CZ, 2008, BREAST CANCER RES TR, V108, P427, DOI 10.1007/s10549-007-9613-9; Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271; Zheng YJ, 2012, BOSNIAN J BASIC MED, V12, P187, DOI 10.17305/bjbms.2012.2480	38	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193175	10.1371/journal.pone.0193175	http://dx.doi.org/10.1371/journal.pone.0193175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474453	gold, Green Submitted, Green Published			2022-12-26	WOS:000426049500065
J	Maurer, C; Heller, S; Sure, JJ; Fuchs, D; Mickel, C; Wanke, EM; Groneberg, DA; Ohlendorf, D				Maurer, Christian; Heller, Sebastian; Sure, Jil-Julia; Fuchs, Daniel; Mickel, Christoph; Wanke, Eileen M.; Groneberg, David A.; Ohlendorf, Daniela			Strength improvements through occlusal splints? The effects of different lower jaw positions on maximal isometric force production and performance in different jumping types	PLOS ONE			English	Article							BITE-ALIGNING MOUTHPIECE; PHYSICAL PERFORMANCE; DENTAL OCCLUSION; SOCCER PLAYERS; TRAINED MEN; POSTURE; POWER; MOUTHGUARDS; SPEED; MALOCCLUSION	Objective The influence of the jaw position on postural control, body posture, walking and running pattern has been reported in the literature. All these movements have in common that a relatively small, but well controlled muscle activation is required. The induced effects on motor output through changed jaw positions have been small. Therefore, it has been questioned if it could still be observed in maximal muscle activation. Method Twenty-three healthy, mid age recreational runners (mean age = 34.0 +/- 10.3 years) participated in this study. Three different jump tests (squat jump, counter movement jump, and drop jumps from four different heights) and three maximal strength tests (trunk flexion and extension, leg press of the right and left leg) were conducted. Four different dental occlusion conditions and an additional familiarization condition were tested. Subjects performed the tests on different days for which the four occlusion conditions were randomly changed. Results No familiarization effect was found. Occlusion conditions with a relaxation position and with a myocentric condylar position showed significantly higher values for several tests compared to the neutral condition and the maximal occlusion position. Significance was found in the squat jump, countermovement jump, the drop jump from 32cm and 40cm, trunk extension, leg press force and rate of force development. The effect due to the splint conditions is an improvement between 3% and 12% (min and max). No influence of the jaw position on symmetry or balance between extension and flexion muscle was found. Conclusion An influence of occlusion splints on rate of force development (RFD) and maximal strength tests could be confirmed. A small, but consistent increase in the performance parameters could be measured. The influence of the occlusion condition is most likely small compared to other influences as for example training status, age, gender and circadian rhythm.	[Maurer, Christian] Move Funct, Salzburg, Austria; [Heller, Sebastian; Mickel, Christoph] Goethe Univ Frankfurt Main, Inst Sport Sci, Dept Movement & Exercise Sci, Frankfurt, Germany; [Sure, Jil-Julia; Fuchs, Daniel; Wanke, Eileen M.; Groneberg, David A.; Ohlendorf, Daniela] Goethe Univ Frankfurt Main, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Ohlendorf, D (corresponding author), Goethe Univ Frankfurt Main, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany.	ohlendorf@med.uni-frankfurt.de	Maurer, Christian/AAS-9688-2020; Groneberg, David/A-5132-2018; Wanke, Eileen M/AAC-5376-2022	Maurer, Christian/0000-0002-8426-813X; Groneberg, David/0000-0001-8551-6556; Heller, Sebastian/0000-0002-6651-0877				AlKofide EA, 2007, CRANIO, V25, P98, DOI 10.1179/crn.2007.016; Allen CR, 2014, J STRENGTH COND RES, V28, P499, DOI 10.1519/JSC.0b013e3182a95250; Arent SM, 2010, COMP EXERC PHYSIOL, V7, P73, DOI 10.1017/S1755254010000231; Baldini A, 2013, AVIAT SPACE ENVIR MD, V84, P823, DOI 10.3357/ASEM.3541.2013; Bevilaqua-Grossi Debora, 2008, J Clin Pediatr Dent, V32, P159; Bracco P, 1998, CRANIO, V16, P252, DOI 10.1080/08869634.1998.11746065; Bracco P, 2004, NEUROSCI LETT, V356, P228, DOI 10.1016/j.neulet.2003.11.055; Bumann A., 2002, TMJ DISORDERS OROFAC; Busca B, 2016, J STRENGTH COND RES, V30, P1102, DOI 10.1519/JSC.0000000000001192; Cetin C, 2009, DENT TRAUMATOL, V25, P272, DOI 10.1111/j.1600-9657.2009.00780.x; Collares K, 2014, DENT TRAUMATOL, V30, P55, DOI 10.1111/edt.12040; Cuccia AM, 2011, J BODYW MOV THER, V15, P242, DOI 10.1016/j.jbmt.2010.10.007; D'Ermes Vittorio, 2012, Ann Stomatol (Roma), V3, P113; Denner A., 1995, MUSKULARE PROFILE WI; di Vico Rosa, 2013, Muscles Ligaments Tendons J, V3, P318; Duddy FA, 2012, DENT TRAUMATOL, V28, P263, DOI 10.1111/j.1600-9657.2011.01106.x; Dunn-Lewis C, 2012, J STRENGTH COND RES, V26, P1085, DOI 10.1519/JSC.0b013e31824b4d5b; Ebben WP, 2008, J STRENGTH COND RES, V22, P1850, DOI 10.1519/JSC.0b013e3181875117; Fernandez-Gonzalo R, 2010, J STRENGTH COND RES, V24, P1790, DOI 10.1519/JSC.0b013e3181def871; Fimgh U, 1991, LEISTUNGSSPORT, V21, P48; Fujimoto Mariko, 2001, Journal of Medical and Dental Sciences, V48, P131; Golem DL, 2015, J STRENGTH COND RES, V29, P500, DOI 10.1519/JSC.0000000000000641; Hartmann H, 2015, SPORTS MED, V45, P1373, DOI 10.1007/s40279-015-0355-2; Hellmann D, 2011, J ORAL REHABIL, V38, P729, DOI 10.1111/j.1365-2842.2011.02211.x; Hemmling G., 1994, ANPASSUNG NEUROMUSKU; Herzog W, 2014, J EXP BIOL, V217, P2825, DOI 10.1242/jeb.099127; Hirschfelder U, 1983, Fortschr Kieferorthop, V44, P457, DOI 10.1007/BF02005965; Isselee H., 2016, PHYS MED REHABIL RES, V1, P19, DOI [10.15761/PMRR.1000107, DOI 10.15761/PMRR.1000107]; Keiner M, 2013, J STRENGTH COND RES, V27, P1591, DOI 10.1519/JSC.0b013e318270fc99; Kopp S., 2005, OKKLUSALE KLINISCH F; Korbmacher H, 2007, EUR J ORTHODONT, V29, P100, DOI 10.1093/ejo/cjl066; Lai V, 2004, Minerva Stomatol, V53, P41; Maurer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135712; Meibodi SE, 2011, J CRANIOVERTEBRAL JU, V2, P73, DOI 10.4103/0974-8237.100059; Miller AJ, 2002, CRIT REV ORAL BIOL M, V13, P409, DOI 10.1177/154411130201300505; Moore JD, 2014, TRENDS NEUROSCI, V37, P370, DOI 10.1016/j.tins.2014.05.001; Nobili A, 1996, CRANIO, V14, P274, DOI 10.1080/08869634.1996.11745978; Ohlendorf D, 2013, Minerva Stomatol, V62, P409; Schmidtbleicher D, 1992, STRENGTH POWER SPORT, P381; Shemmell J, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00002; Tardieu C, 2009, NEUROSCI LETT, V450, P221, DOI 10.1016/j.neulet.2008.12.005; Tecco S, 2008, Minerva Stomatol, V57, P399; Tecco Simona, 2010, BMC Res Notes, V3, P141, DOI 10.1186/1756-0500-3-141; Valls-Sole J, 2008, EXP BRAIN RES, V187, P497, DOI 10.1007/s00221-008-1402-0; Queiroz AFVR, 2013, DENT TRAUMATOL, V29, P450, DOI 10.1111/edt.12026; Wirth K, 2012, DTSCH Z SPORTMEDIZIN, V62, P345; Wirth K, 2016, J HUM KINET, V53, P201, DOI 10.1515/hukin-2016-0023; Wirth K, 2015, J STRENGTH COND RES, V29, P1837, DOI 10.1519/JSC.0000000000000528	48	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193540	10.1371/journal.pone.0193540	http://dx.doi.org/10.1371/journal.pone.0193540			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474465	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500127
J	Obembe, AO; Goldsmith, CH; Simpson, LA; Sakakibara, BM; Eng, JJ				Obembe, Adebimpe O.; Goldsmith, Charlie H.; Simpson, Lisa A.; Sakakibara, Brodie M.; Eng, Janice J.			Support service utilization and out-of-pocket payments for health services in a population-based sample of adults with neurological conditions	PLOS ONE			English	Article							SOCIAL SUPPORT; STROKE; PEOPLE; LIFE; CARE; HOME	Background Social support can help to deal with the consequences of neurological conditions and promote functional independence and quality of life. Our aim was to evaluate the impact of neurological conditions on the use of support and health-care services in a population-based sample of community-dwelling adults with neurological conditions. Methods Data were from the Survey of Living with Neurological Conditions in Canada, which was derived from a representative sample of household residents. Formal and informal support received and out-of-pocket payments were assessed by personal interviews. Logistic regression was used to explore the association between support service utilization and six common neurological conditions (Stroke, Parkinson's disease, Alzheimer's disease/dementias, traumatic brain injury, spinal cord injury and multiple sclerosis) with stroke as the reference category. Results The sample contained 2,410 respondents and equate to an estimated 459,770 when sample weights were used. A larger proportion of people within each of the neurological conditions received informal support than formal support (at least twice as much). Samples with the non-stroke conditions were more likely to receive formal assistance for personal (odds ratios 2.7 to 5.6; P < 0.05) and medical (odds ratios 2.4 to 4.4; P < 0.05) care compared to the stroke group. Also, the non-stroke conditions were more likely to receive informal assistance (odds ratios 2.7 to 17.9; P < 0.05) and less likely to make out-of-pocket payments for rehabilitation therapy (odds ratios 0.2 to 0.3; P < 0.05) than the stroke group. The Alzheimer's disease/dementia group had the highest proportion who received formal and informal support services. Conclusions Our findings suggest that Canadians with neurological conditions receive more informal assistance than formal assistance. Furthermore, it appears that stroke survivors receive less support services, while those with Alzheimer's disease/dementia receive the most compared to other adult neurological conditions. Such data can help inform the development of support services in the community.	[Obembe, Adebimpe O.; Sakakibara, Brodie M.; Eng, Janice J.] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada; [Obembe, Adebimpe O.; Simpson, Lisa A.; Sakakibara, Brodie M.; Eng, Janice J.] Vancouver Coastal Hlth Res Inst, GF Strong Rehab Ctr, Rehabil Res Program, Vancouver, BC, Canada; [Goldsmith, Charlie H.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Goldsmith, Charlie H.] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC, Canada; [Simpson, Lisa A.] Univ British Columbia, Grad Program Rehabil Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; Simon Fraser University; University of British Columbia; University of British Columbia	Eng, JJ (corresponding author), Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada.; Eng, JJ (corresponding author), Vancouver Coastal Hlth Res Inst, GF Strong Rehab Ctr, Rehabil Res Program, Vancouver, BC, Canada.	janice.eng@ubc.ca		Obembe, Adebimpe/0000-0003-1282-304X	Canadian Research Data Centre Network (CRDCN) from the Social Sciences and Humanities Research Council (SSHRC); Canadian Institute for Health Research (CIHR); Canadian Foundation for Innovation (CFI); Statistics Canada; Canada Research Chairs Program; Michael Smith Foundation for Health Research Trainee Award	Canadian Research Data Centre Network (CRDCN) from the Social Sciences and Humanities Research Council (SSHRC); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Statistics Canada; Canada Research Chairs Program(Canada Research Chairs); Michael Smith Foundation for Health Research Trainee Award(Michael Smith Foundation for Health Research)	This research was supported by funds to the Canadian Research Data Centre Network (CRDCN) from the Social Sciences and Humanities Research Council (SSHRC), the Canadian Institute for Health Research (CIHR), the Canadian Foundation for Innovation (CFI), and Statistics Canada. Although the research and analysis are based on data from Statistics Canada, the opinions expressed do not represent the views of Statistics Canada. This work was also supported in part by the Canada Research Chairs Program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). AOO is also supported by the Michael Smith Foundation for Health Research Trainee Award (http://www.msfhr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler G, 2008, TRAFFIC INJ PREV, V9, P299, DOI 10.1080/15389580801895186; Akinwuntan AE, 2012, J STROKE CEREBROVASC, V21, P478, DOI 10.1016/j.jstrokecerebrovasdis.2010.12.001; Anderson C, 2000, STROKE, V31, P1032, DOI 10.1161/01.STR.31.5.1032; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; [Anonymous], 2011, WORLD REP DIS; Chard Sarah E, 2006, NeuroRx, V3, P525, DOI 10.1016/j.nurx.2006.07.002; Clarke A, 2001, EUR J PUBLIC HEALTH, V11, P166, DOI 10.1093/eurpub/11.2.166; Fargen KM, 2015, J NEUROSURG, V122, P870, DOI 10.3171/2014.12.JNS14646; Guerriere DN, 2008, HEALTH SOC CARE COMM, V16, P126, DOI 10.1111/j.1365-2524.2007.00732.x; Heart and Stroke Foundation, 2015, HEART STROK FDN 2015; Hogg-Johnson Sheilah, 2011, Healthc Policy, V6, pe93; Howe Edmund, 2008, Psychiatry (Edgmont), V5, P51; Jacoby WG, 2000, ELECT STUD, V19, P577, DOI 10.1016/S0261-3794(99)00028-1; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Mitchell LA, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1010-1; Mossialos E, 2016, 2015 INT PROFILES HL; Muller R, 2012, SPINAL CORD, V50, P94, DOI 10.1038/sc.2011.116; Newsom JT, 1996, PSYCHOL AGING, V11, P34, DOI 10.1037/0882-7974.11.1.34; Piersma D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149566; Public Health Agency of Canada, 2014, MAPP CONN UND NEUR C; Romanow RJ, 2002, SHAPE FUTURE HLTH CA; Singhpoo K, 2012, J STROKE CEREBROVASC, V21, P776, DOI 10.1016/j.jstrokecerebrovasdis.2011.04.005; Statistics Canada, 2011, SURV LIV NEUR COND C; Sunnerhagen KS, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-66; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259; Verbeeten D., 2015, UNDERSTANDING HLTH S; Verdonschot MML, 2009, J INTELL DISABIL RES, V53, P303, DOI 10.1111/j.1365-2788.2008.01144.x; Wong SL, 2014, HEALTH REP, V25, P10	30	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192911	10.1371/journal.pone.0192911	http://dx.doi.org/10.1371/journal.pone.0192911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX4LV	29474391	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500047
J	Salm, F; Ernsting, C; Kuhlmey, A; Kanzler, M; Gastmeier, P; Gellert, P				Salm, Florian; Ernsting, Clemens; Kuhlmey, Adelheid; Kanzler, Melanie; Gastmeier, Petra; Gellert, Paul			Antibiotic use, knowledge and health literacy among the general population in Berlin, Germany and its surrounding rural areas	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ANTIMICROBIAL RESISTANCE; PRIMARY-CARE; BEHAVIOR; OUTCOMES; INTERVENTIONS; PRESCRIPTION; COUNTRIES	Objectives Knowledge concerning antibiotic use in the general population is insufficient. The way health literacy is related to antibiotic use aside from knowledge needs further investigation. Our aim was to compare the levels of knowledge of antibiotics and health literacy in individuals who had taken antibiotics in recent years compared with those who not had taken antibiotics. Methods A population-based cross-sectional survey of 2,000 individuals aged 35 and older from Berlin, Germany and its surrounding rural and suburban areas (response rate 59%) with strata urban/rural, sex, age, and education. Computer-assisted personal interviews were conducted by external, trained interviewers during home visits. Knowledge, health literacy, and antibiotic use were assessed using standardized questionnaires. Results In all, 33.3% (666/2,000) of the participants indicated having had an antimicrobial therapy during the previous 12 months. Adjusting for sex, age, educational level and health literacy, individuals with four correct answers regarding antibiotics were 1.70 times and those with three correct answers 1.94 more likely to have had a history of recent antibiotic use than those who did not have any correct answers. Individuals with sufficient health literacy were 0.57 times less likely to have had a recent history of antibiotic use than individuals with insufficient health literacy. Conclusion Patients who have used antibiotics might have more knowledge as a result of their recent involvement with the topic of antibiotic use; health literacy may be a preventive mechanism to use antibiotics more critically. Besides improving the health knowledge of the general population and of vulnerable groups such as patients with low levels of health literacy, intervention strategies should focus on providers as well.	[Salm, Florian; Gastmeier, Petra] Charite, Inst Hyg & Environm Med, Berlin, Germany; [Salm, Florian] Univ Freiburg, Fac Med, Med Ctr, Inst Infect Prevent & Hosp Epidemiol, Freiburg, Germany; [Ernsting, Clemens; Kuhlmey, Adelheid; Gellert, Paul] Charite, Inst Med Sociol, Berlin, Germany; [Kanzler, Melanie] DEKV, German Protestant Hosp Assoc, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Salm, F (corresponding author), Charite, Inst Hyg & Environm Med, Berlin, Germany.; Salm, F (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Inst Infect Prevent & Hosp Epidemiol, Freiburg, Germany.	florian.salm@charite.de		Gellert, Paul/0000-0001-7492-7210; Gastmeier, Petra/0000-0001-5520-4287; Kuhlmey, Adelheid/0000-0003-4088-4675	Pfizer Deutschland GmbH	Pfizer Deutschland GmbH	This material is based on work supported by the Pfizer Deutschland GmbH. Any findings and conclusions expressed in this publication are those of the authors and do not necessarily reflect the views of the Pfizer Deutschland GmbH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Batzing-Feigenbaum J, 2016, DTSCH ARZTEBL INT, V113, P454, DOI 10.3238/arztebl.2016.0454; Baker DW, 2006, J GEN INTERN MED, V21, P878, DOI 10.1111/j.1525-1497.2006.00540.x; Bandura Albert, 1977, SOCIAL LEARNING THEO; Batzing-Feigenbaum J, 2015, ENTWICKLUNG ANTIBIOT; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Boyle J, 2017, J HOSP MED, V12, P918, DOI 10.12788/jhm.2841; Broniatowski DA, 2014, MED DECIS MAKING; Bundesamt fuer Verbraucherschutz und Lebensmittelsicherheit Paul-Ehrlich-Gesellschaft fuer Chemotherapie e. V. Infektiologie Freiburg, 2014, GERMAP 2012 BER UEB; Chin TL, 2016, J ANTIMICROB CHEMOTH, V71, P2723, DOI 10.1093/jac/dkw223; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; David CM, 2017, INT J PHARM PRACT; Davies SC, 2013, LANCET, V381, P1606, DOI 10.1016/S0140-6736(13)60604-2; Devraj Radhika, 2013, J Pain Palliat Care Pharmacother, V27, P19, DOI 10.3109/15360288.2012.751955; European Union, 2016, SPEC EUR 445; Gellert P., EUR HLTH PSYCHOL, V17; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gualano MR, 2015, PHARMACOEPIDEM DR S, V24, P2, DOI 10.1002/pds.3716; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Lee GC, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-96; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Meeker D, 2016, JAMA-J AM MED ASSOC, V315, P562, DOI 10.1001/jama.2016.0275; Mehta N, 2017, J ANTIMICROB CHEMOTH, V72, P914, DOI 10.1093/jac/dkw497; Micallef C, 2017, J ANTIMICROB CHEMOTH, V72, P311, DOI 10.1093/jac/dkw387; Molstad S, 2002, SCAND J INFECT DIS, V34, P366, DOI 10.1080/00365540110080034; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Pears S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3684-7; Schaeffer D, 2017, DTSCH ARZTEBL INT, V114, P53, DOI 10.3238/arztebl.2017.0053; Schneider S, 2016, BUNDESGESUNDHEITSBLA, V59, P1162, DOI 10.1007/s00103-016-2417-5; Shallcross L, 2017, J ANTIMICROB CHEMOTH; Sniehotta FF, 2007, J DENT RES, V86, P641, DOI 10.1177/154405910708600711; Sorensen K, 2015, EUR J PUBLIC HEALTH, V25, P1053, DOI 10.1093/eurpub/ckv043; Sorensen K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-948; Swart E, 2015, GESUNDHEITSWESEN, V77, P120, DOI [10.1055/s-0034-1396815, 10.1055/s-0035-1562981]; WHO, 2015, ANT RES MULT PUBL AW; WHO, 2017, EV ANT AW CAMP; Wolff JK, GERONTOLOGIST	39	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193336	10.1371/journal.pone.0193336	http://dx.doi.org/10.1371/journal.pone.0193336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX4LV	29474470	Green Published, gold, Green Submitted			2022-12-26	WOS:000426049500088
J	Yoshikawa, T; Fujii, H; Okutani, A; Shibamura, M; Omura, N; Egawa, K; Kato, H; Inagakil, T; Haradal, S; Yamada, S; Morikawa, S; Saijol, M				Yoshikawa, Tomoki; Fujii, Hikaru; Okutani, Akiko; Shibamura, Miho; Omura, Natsumi; Egawa, Kazutaka; Kato, Hirofumi; Inagakil, Takuya; Haradal, Shizuko; Yamada, Souichi; Morikawa, Shigeru; Saijol, Masayuki			Construction and characterization of bacterial artificial chromosomes harboring the full-length genome of a highly attenuated vaccinia virus LC16m8	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS GENOME; SMALLPOX VACCINE; ESCHERICHIA-COLI; DNA; SEQUENCE; RECOMBINATION; MUTAGENESIS; PROTECTION; CLONING; STRAIN	LC16m8 (m8), a highly attenuated vaccinia virus (VAC) strain, was developed as a smallpox vaccine, and its safety and immunogenicity have been confirmed. Here, we aimed to develop a system that recovers infectious m8 from a bacterial artificial chromosome (BAC) that retains the full-length viral genomic DNA (m8-BAC system). The infectious virus was successfully recovered from a VAC-BAC plasmid, named pLC16m8-BAC. Furthermore, the bacterial replicon-free virus was generated by intramolecular homologous recombination and was successfully recovered from a modified VAC-BAC plasmid, named pLC16m8.8S-BAC. Also, the growth of the recovered virus was indistinguishable from that of authentic m8. The full genome sequence of the plasmid, which harbors identical inverted terminal repeats (ITR) to that of authentic m8, was determined by long-read next-generation sequencing (NGS). The ITR contains x 18 to 32 of the 70 and x 30 to 45 of 54 base pair tandem repeats, and the number of tandem repeats was different between the ITR left and right. Since the virus recovered from pLC16m8.8S-BAC was expected to retain the identical viral genome to that of m8, including the ITR, a reference-based alignment following a short-read NGS was performed to validate the sequence of the recovered virus. Based on the pattern of coverage depth in the ITR, no remarkable differences were observed between the virus and m8, and the other region was confirmed to be identical as well. In summary, this new system can recover the virus, which is geno- and phenotypically indistinguishable from authentic m8.	[Yoshikawa, Tomoki; Fujii, Hikaru; Shibamura, Miho; Omura, Natsumi; Egawa, Kazutaka; Kato, Hirofumi; Inagakil, Takuya; Haradal, Shizuko; Yamada, Souichi; Saijol, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, Toyama, Tokyo, Japan; [Okutani, Akiko; Morikawa, Shigeru] Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, Toyama, Tokyo, Japan; [Omura, Natsumi; Inagakil, Takuya] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Wakamatsu Cho, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Waseda University	Saijol, M (corresponding author), Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, Toyama, Tokyo, Japan.	msaijo@nih.go.jp		MORIKAWA, SHIGERU/0000-0001-6249-6716; Saijo, Masayuki/0000-0001-5458-7298; Yoshikawa, Tomoki/0000-0001-7601-4036	Ministry of Health, Labor and Welfare of Japan [H26-Sinkogyousei-Shitei-002, H29-Sinkogyousei-Shitei-002]; Japan Agency for Medical Research and Development (AMED)	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	TY, SM and MS greatly acknowledge financial support by the Ministry of Health, Labor and Welfare of Japan (Grant No. H26-Sinkogyousei-Shitei-002, and H29-Sinkogyousei-Shitei-002), and Japan Agency for Medical Research and Development (AMED).	Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Aragon TJ, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-26; BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; BAROUDY BM, 1982, NUCLEIC ACIDS RES, V10, P5673, DOI 10.1093/nar/10.18.5673; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Borst Eva-Maria, 2004, Methods Mol Biol, V256, P221; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cottingham Matthew G, 2012, Methods Mol Biol, V890, P37, DOI 10.1007/978-1-61779-876-4_3; Cottingham MG, 2010, J VIROL METHODS, V168, P233, DOI 10.1016/j.jviromet.2010.04.012; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Domi A, 2005, NAT METHODS, V2, P95, DOI 10.1038/NMETH734; Domi A, 2002, P NATL ACAD SCI USA, V99, P12415, DOI 10.1073/pnas.192420599; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Empig C, 2006, VACCINE, V24, P3686, DOI 10.1016/j.vaccine.2005.03.029; Gilbert SC, 2013, VACCINE, V31, P4241, DOI 10.1016/j.vaccine.2013.03.020; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kenner J, 2006, VACCINE, V24, P7009, DOI 10.1016/j.vaccine.2006.03.087; Kidokoro M, 2005, P NATL ACAD SCI USA, V102, P4152, DOI 10.1073/pnas.0406671102; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Meeting of the Strategic Advisory Group of Experts on Immunization, 2014, WKLY EPIDEMIOL REC, V89, P1, DOI DOI 10.1016/j.compfluid.2013.10.031; Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005; MORITA M, 1977, ARCH VIROL, V53, P197, DOI 10.1007/BF01314664; MOSS B, 1981, P NATL ACAD SCI-BIOL, V78, P1614, DOI 10.1073/pnas.78.3.1614; Moss B., 2013, COLD SPRING HARB PER, V5; Nagel CH, 2008, J VIROL, V82, P3109, DOI 10.1128/JVI.02124-07; Richards AL, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0295-4; Roth SJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-3; Saijo M, 2006, J VIROL, V80, P5179, DOI 10.1128/JVI.02642-05; Smith GA, 2000, P NATL ACAD SCI USA, V97, P4873, DOI 10.1073/pnas.080502497; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Stanton RJ, 2010, J CLIN INVEST, V120, P3191, DOI 10.1172/JCI42955; SUGIMOTO M, 1985, MICROBIOL IMMUNOL, V29, P421, DOI 10.1111/j.1348-0421.1985.tb00843.x; Tcherepanov V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-150; Tischer BK, 2007, J VIROL, V81, P13200, DOI 10.1128/JVI.01148-07; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Walsh SR, 2011, EXPERT REV VACCINES, V10, P1221, DOI [10.1586/ERV.11.79, 10.1586/erv.11.79]; Wyatt LS, 2004, P NATL ACAD SCI USA, V101, P4590, DOI 10.1073/pnas.0401165101; Yamaguchi M, 1975, CLIN VIROL, V3, P269; Yokote H, 2014, CLIN VACCINE IMMUNOL, V21, P1261, DOI 10.1128/CVI.00199-14; Yu D, 2002, J VIROL, V76, P2316, DOI 10.1128/JVI.76.5.2316-2328.2002; Yuan M, 2015, J VIROL, V89, P5176, DOI 10.1128/JVI.00339-15	47	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192725	10.1371/journal.pone.0192725	http://dx.doi.org/10.1371/journal.pone.0192725			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474493	gold, Green Published, Green Submitted			2022-12-26	WOS:000426049500032
J	Yu, JH; Han, K; Kim, NH; Yoo, HJ; Seo, JA; Kim, SG; Choi, KM; Baik, SH; Kim, NH				Yu, Ji Hee; Han, Kyungdo; Kim, Nam Hoon; Yoo, Hye Jin; Seo, Ji A.; Kim, Sin Gon; Choi, Kyung Mook; Baik, Sei Hyun; Kim, Nan Hee			U-shaped association between sleep duration and urinary albumin excretion in Korean adults: 2011-2014 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GENDER-SPECIFIC ASSOCIATIONS; GLOMERULAR-FILTRATION-RATE; LONG-SLEEP; GENERAL-POPULATION; UNITED-STATES; WHITEHALL-II; RISK-FACTOR; METAANALYSIS; HYPERTENSION	Although sleep duration has been extensively studied in metabolic diseases, few studies have investigated the impact of sleep duration on chronic kidney disease. The aim of this study was to examine the relationship between sleep duration and albuminuria in the general population. Among 24,948 adults who participated in the 2011-2014 KNHANES, a total of 19,994 subjects were included in this analysis. Subjects were categorized into the following five groups according to self-reported sleep duration: less than 5 h, 6 h, 7 h, 8 h, and more than 9 h. The association between sleep duration and urinary albumin-creatinine ratio (UACR) was examined cross-sectionally. Subjects with both short and long sleep durations were significantly associated with higher UACR levels and higher proportions of patients with microalbuminuria (30-299 mg/g) and macroalbuminuria (>= 300 mg/g) compared to those with a sleep duration of 7 hours. The U-shaped association between sleep duration and UACR remained significant even after adjustment for potential confounders, including age, sex, body mass index, smoking, alcohol, education, income, exercise, estimated glomerular filtration rate, diabetes mellitus, hypertension and hypercholesterolemia. The U-shaped association is more evident in the subgroup aged 65 or older, or in female subjects. Our findings suggest that both short and long sleep durations have a U-shaped association with UACR levels in the general population, independent of potential confounders.	[Yu, Ji Hee; Kim, Nam Hoon; Yoo, Hye Jin; Seo, Ji A.; Kim, Sin Gon; Choi, Kyung Mook; Baik, Sei Hyun; Kim, Nan Hee] Korea Univ, Coll Med, Div Endocrinol & Metab, Dept Internal Med, Ansan, South Korea; [Han, Kyungdo] Catholic Univ Korea, Dept Biostat, Coll Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea	Kim, NH (corresponding author), Korea Univ, Coll Med, Div Endocrinol & Metab, Dept Internal Med, Ansan, South Korea.	nhkendo@gmail.com	SEO, JI A/AAU-7968-2020; Kim, Nan Hee/T-8627-2019; Choi, Kyung Mook/C-4195-2018	SEO, JI A/0000-0002-1927-2618; Choi, Kyung Mook/0000-0001-6175-0225; Kim, Sin Gon/0000-0002-7430-3675; Kim, Nan Hee/0000-0003-4378-520X; Yu, Ji Hee/0000-0003-1907-2859; Kim, Nam Hoon/0000-0002-9926-1344	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2015R1A2A2A01003167, 2015R1C1A2A01052010]; Korea University Grant [K1421551]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Korea University Grant	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP), (No. 2015R1A2A2A01003167 to NHK, 2015R1C1A2A01052010); and the Korea University Grant (K1421551) to NHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsar B, 2013, PRIM CARE DIABETES, V7, P39, DOI 10.1016/j.pcd.2013.01.002; Basta M, 2007, SLEEP MED CLIN, V2, P279, DOI 10.1016/j.jsmc.2007.04.002; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cappuccio FP, 2007, HYPERTENSION, V50, P693, DOI 10.1161/HYPERTENSIONAHA.107.095471; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Cheungpasitporn W, 2017, NEPHROL DIAL TRANSPL, V32, P991, DOI 10.1093/ndt/gfw072; Choi H, 2017, KOREAN J INTERN MED, V32, P323, DOI 10.3904/kjim.2015.400; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Genuth S, 2003, DIABETES CARE, V26, P3160; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guo XF, 2015, J SLEEP RES, V24, P351, DOI 10.1111/jsr.12274; Innes KE, 2012, SLEEP MED REV, V16, P309, DOI 10.1016/j.smrv.2011.04.001; Irwin MR, 2016, BIOL PSYCHIAT, V80, P40, DOI 10.1016/j.biopsych.2015.05.014; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lamb EJ, 2005, ANN CLIN BIOCHEM, V42, P321, DOI 10.1258/0004563054889936; Leproult R, 1997, SLEEP, V20, P865; Levey AS, 2015, JAMA-J AM MED ASSOC, V313, P837, DOI 10.1001/jama.2015.0602; Ohkuma T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078968; Patel SR, 2006, SLEEP, V29, P881, DOI 10.1093/sleep/29.7.881; Petrov ME, 2014, SLEEP MED, V15, P1140, DOI 10.1016/j.sleep.2014.05.021; Pilcher JJ, 1997, J PSYCHOSOM RES, V42, P583, DOI 10.1016/S0022-3999(97)00004-4; Roderick PJ, 2009, AM J KIDNEY DIS, V53, P950, DOI 10.1053/j.ajkd.2008.12.036; Stang A, 2008, HYPERTENSION, V51, pE15, DOI 10.1161/HYPERTENSIONAHA.107.108456; Stranges S, 2008, AM J EPIDEMIOL, V168, P1353, DOI 10.1093/aje/kwn337; Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027515; Turek NF, 2012, AM J KIDNEY DIS, V60, P823, DOI 10.1053/j.ajkd.2012.04.027; Verhave JC, 2004, KIDNEY INT, V66, pS18, DOI 10.1111/j.1523-1755.2004.09205.x; Weil BR, 2010, CAN J PHYSIOL PHARM, V88, P777, DOI 10.1139/Y10-046; Wolff B, 2008, ATHEROSCLEROSIS, V196, P727, DOI 10.1016/j.atherosclerosis.2006.12.023; Yamamoto R, 2012, AM J KIDNEY DIS, V59, P343, DOI 10.1053/j.ajkd.2011.08.032; Youngstedt SD, 2004, SLEEP MED REV, V8, P159, DOI 10.1016/j.smrv.2003.10.002; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	37	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192980	10.1371/journal.pone.0192980	http://dx.doi.org/10.1371/journal.pone.0192980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470498	gold, Green Published, Green Submitted			2022-12-26	WOS:000425831000029
J	Cui, QK; Fu, QT; Zhao, XH; Song, X; Yu, JK; Yang, Y; Sun, K; Bai, L; Tian, Y; Chen, SF; Jia, RY; Zou, YF; Li, LX; Liang, XX; He, CL; Yin, LZ; Ye, G; Lv, C; Yue, GZ; Yin, ZQ				Cui, Qiankun; Fu, Qiuting; Zhao, Xinghong; Song, Xu; Yu, Jiankang; Yang, Yi; Sun, Kai; Bai, Lu; Tian, Ye; Chen, Shufan; Jia, Renyong; Zou, Yuanfeng; Li, Lixia; Liang, Xiaoxia; He, Changliang; Yin, Lizi; Ye, Gang; Lv, Cheng; Yue, Guizhou; Yin, Zhongqiong			Protective effects and immunomodulation on piglets infected with rotavirus following resveratrol supplementation	PLOS ONE			English	Article							GROUP-A ROTAVIRUSES; DIETARY SUPPLEMENTATION; IMMUNITY; DIARRHEA; PIGS; PATHOGENESIS; INHIBITION; RESPONSES; VIRULENT; ACTIVATION	Rotavirus (RV), belonging to Reoviridae family, is the leading cause of acute severe viral diarrhea in children (under 5 years old) and infant animals worldwide. Although vaccines are commonly used to prevent infection, episodes of diarrhea caused by RV frequently occur. Thus, this study was conducted to determine whether resveratrol had protective effects against RV infection in piglets. Following pretreatment with resveratrol dry suspension through adding into the basal diet for 3 weeks, the piglets were orally challenged with RV. We found that resveratrol could alleviate diarrhea induced by RV infection. Resveratrol-treatment inhibited the TNF-alpha production, indicating that the anti-RV activity of resveratrol may be achieved by reducing the inflammatory response. The IFN-gamma level was elevated in 10mg/kg/d resveratrol-treated group and 30mg/kg/d resveratrol-treated group after RV infection. The ratios of CD4+/CD8+ in resveratrol-treated groups were the same as that in mock infected group, suggesting that resveratrol could maintain the immune function in RV-infected piglets. It was found that resveratrol could alleviate diarrhea induced by RV infection. These results revealed that resveratrol dry suspension could be a new control measure for RV infection.	[Cui, Qiankun; Fu, Qiuting; Zhao, Xinghong; Song, Xu; Yu, Jiankang; Yang, Yi; Sun, Kai; Bai, Lu; Tian, Ye; Chen, Shufan; Zou, Yuanfeng; Li, Lixia; Liang, Xiaoxia; He, Changliang; Yin, Lizi; Ye, Gang; Lv, Cheng; Yin, Zhongqiong] Sichuan Agr Univ, Coll Vet Med, Nat Med Res Ctr, Chengdu, Sichuan, Peoples R China; [Jia, Renyong] Sichuan Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Yue, Guizhou] Sichuan Agr Univ, Coll Life Sci, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University; Sichuan Agricultural University	Yin, ZQ (corresponding author), Sichuan Agr Univ, Coll Vet Med, Nat Med Res Ctr, Chengdu, Sichuan, Peoples R China.	yinzhongq@163.com	Zhao, Xinghong/AAK-6568-2020		National Natural Science Foundation of China [31372477]; Sichuan Strategic Research and Development Project for Emerging Products [2015GZX0010]; Sichuan Science and Technology Plan Project [2015NZ0077]; Chengdu Agricultural Technology Research and Development Project / Functional Feed Additive [2015-NY02-00266-NC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Strategic Research and Development Project for Emerging Products; Sichuan Science and Technology Plan Project; Chengdu Agricultural Technology Research and Development Project / Functional Feed Additive	This research was financially supported by National Natural Science Foundation of China (Grant No. = 31372477, URL = http://www.nsfc.gov.cn), Sichuan Strategic Research and Development Project for Emerging Products (Grant No. = 2015GZX0010, URL = http://www.scst.gov.cn), Sichuan Science and Technology Plan Project (Grant No. = 2015NZ0077, URL = http://www.scst.gov.cn), Chengdu Agricultural Technology Research and Development Project / Functional Feed Additive (Grant No. = 2015-NY02-00266-NC, URL = http://www.cdst.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel J, 2007, NAT REV MICROBIOL, V5, P529, DOI 10.1038/nrmicro1692; Azevedo MSP, 2006, J VIROL, V80, P372, DOI 10.1128/JVI.80.1.372-382.2006; Azim T, 1999, CLIN DIAGN LAB IMMUN, V6, P690, DOI 10.1128/CDLI.6.5.690-695.1999; Barreiros MAB, 2003, VET RES COMMUN, V27, P505, DOI 10.1023/A:1025797809680; Cecilio AB, 2012, J ETHNOPHARMACOL, V141, P975, DOI 10.1016/j.jep.2012.03.031; Chan MMY, 2002, BIOCHEM PHARMACOL, V63, P99, DOI 10.1016/S0006-2952(01)00886-3; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; de la Fuente R, 1999, VET PARASITOL, V80, P179, DOI 10.1016/S0304-4017(98)00218-0; De UK, 2014, TROP ANIM HEALTH PRO, V46, P1127, DOI 10.1007/s11250-014-0616-3; Dennehy Penelope H, 2012, Adv Pediatr, V59, P47, DOI 10.1016/j.yapd.2012.04.002; Dennehy PH, 2000, PEDIATR INFECT DIS J, V19, pS103, DOI 10.1097/00006454-200010001-00003; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; Docherty JJ, 2006, ANTIVIR RES, V72, P171, DOI 10.1016/j.antiviral.2006.07.004; ENGLAND JJ, 1980, AM J VET RES, V41, P782; Faith SA, 2006, ANTIVIR RES, V72, P242, DOI 10.1016/j.antiviral.2006.06.011; Feng J, 2009, ANIM FEED SCI TECH, V150, P106, DOI 10.1016/j.anifeedsci.2008.07.004; Franco MA, 1996, J INFECT DIS, V174, pS47, DOI 10.1093/infdis/174.Supplement_1.S47; Franco MA, 1999, J INFECT DIS, V179, pS466, DOI 10.1086/314805; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Galindo I, 2011, ANTIVIR RES, V91, P57, DOI 10.1016/j.antiviral.2011.04.013; Gao You-Gui, 2006, Zhongguo Dang Dai Er Ke Za Zhi, V8, P304; HAIN R, 1990, PLANT MOL BIOL, V15, P325, DOI 10.1007/BF00036918; HALL GA, 1993, VET PATHOL, V30, P223, DOI 10.1177/030098589303000302; HAO H-d, 2003, CHINESE TRADITIONAL, V5; HOSHINO Y, 1981, J GEN VIROL, V54, P313, DOI 10.1099/0022-1317-54-2-313; Hoshino Yasutaka, 1994, Trends in Microbiology, V2, P242, DOI 10.1016/0966-842X(94)90629-7; Hung LM, 2000, CARDIOVASC RES, V47, P549, DOI 10.1016/S0008-6363(00)00102-4; HUNG T, 1984, LANCET, V1, P1139, DOI 10.1016/S0140-6736(84)91391-6; Jiang B, 2003, CLIN DIAGN LAB IMMUN, V10, P995, DOI 10.1128/CDLI.10.6.995-1001.2003; Lee EO, 2011, EXP NEUROL, V229, P399, DOI 10.1016/j.expneurol.2011.03.006; Li YQ, 2006, EUR J MED CHEM, V41, P1084, DOI 10.1016/j.ejmech.2006.03.024; Murphy TV, 2003, J INFECT DIS, V187, P1309, DOI 10.1086/374420; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; PEARSON GR, 1977, J COMP PATHOL, V87, P363, DOI 10.1016/0021-9975(77)90026-3; Ramesh Vidavalur M, 2006, SIGNIFICANCE WINE RE; Reed LJ, 1937, AM J TROPICAL MED HY, V27; REESE DE, 1984, AM J VET RES, V45, P978; Sanchez-Fidalgo S, 2010, EUR J PHARMACOL, V633, P78, DOI 10.1016/j.ejphar.2010.01.025; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; SNODGRASS DR, 1977, ARCH VIROL, V55, P263, DOI 10.1007/BF01315048; Sun AY, 2002, FREE RADICAL BIO MED, V32, P314, DOI 10.1016/S0891-5849(01)00803-6; SVENSMARK B, 1989, ACTA VET SCAND, V30, P63; van Zyl WB, 2006, APPL ENVIRON MICROB, V72, P4554, DOI 10.1128/AEM.02119-05; Wang L, 2015, AMINO ACIDS, V47, P1309, DOI 10.1007/s00726-015-1966-5; Ward LA, 1996, CLIN DIAGN LAB IMMUN, V3, P342, DOI 10.1128/CDLI.3.3.342-350.1996; Ward LA, 1996, J GEN VIROL, V77, P1431, DOI 10.1099/0022-1317-77-7-1431; Waters WR, 2000, IMMUNOLOGY, V101, P333, DOI 10.1046/j.1365-2567.2000.00114.x; WILL LA, 1994, J VET DIAGN INVEST, V6, P416, DOI 10.1177/104063879400600403; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065213; Yang H, 1996, IMMUNOLOGY, V88, P577, DOI 10.1046/j.1365-2567.1996.d01-682.x; Yang Li-Ming, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P371; Yao J, 2010, ARCH MED RES, V41, P288, DOI 10.1016/j.arcmed.2010.05.002; Yin YM, 2015, IRAN J PUBLIC HEALTH, V44, P185; Yuan JS, 2012, REJUV RES, V15, P507, DOI 10.1089/rej.2012.1321; Yuan LJ, 1996, J VIROL, V70, P3075, DOI 10.1128/JVI.70.5.3075-3083.1996; Zhang CY, 2014, AM J VET RES, V75, P752, DOI 10.2460/ajvr.75.8.752; Zhang J, 2015, PEDIATR INFECT DIS J, V34, pE233, DOI 10.1097/INF.0000000000000799; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116879; Zhao XH, 2016, ANTIVIR RES, V130, P93, DOI 10.1016/j.antiviral.2016.03.014; ZIJLSTRA RT, 1994, J PEDIATR GASTR NUTR, V19, P382, DOI 10.1097/00005176-199411000-00003	60	21	22	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192692	10.1371/journal.pone.0192692	http://dx.doi.org/10.1371/journal.pone.0192692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466421	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300068
J	Kasurinen, S; Happo, MS; Ronkko, TJ; Orasche, J; Jokiniemi, J; Kortelainen, M; Tissari, J; Zimmermann, R; Hirvonen, MR; Jalava, PI				Kasurinen, Stefanie; Happo, Mikko S.; Ronkko, Teemu J.; Orasche, Juergen; Jokiniemi, Jorma; Kortelainen, Miika; Tissari, Jarkko; Zimmermann, Ralf; Hirvonen, Maija-Riitta; Jalava, Pasi I.			Differences between co-cultures and monocultures in testing the toxicity of particulate matter derived from log wood and pellet combustion	PLOS ONE			English	Article							LUNG INFLAMMATION; GASEOUS EMISSIONS; EPITHELIAL-CELLS; OXIDATIVE DAMAGE; SMOKE PARTICLES; FINE-PARTICLE; HUMAN A549; IN-VITRO; RESPONSES; AIR	Background In vitro studies with monocultures of human alveolar cells shed deeper knowledge on the cellular mechanisms by which particulate matter (PM) causes toxicity, but cannot account for mitigating or aggravating effects of cell-cell interactions on PM toxicity. Methods We assessed inflammation, oxidative stress as well as cytotoxic and genotoxic effects induced by PM from the combustion of different types of wood logs and softwood pellets in three cell culture setups: two monocultures of either human macrophage-like cells or human alveolar epithelial cells, and a co-culture of these two cell lines. The adverse effects of the PM samples were compared between these setups. Results We detected clear differences in the endpoints between the mono-and co-cultures. Inflammatory responses were more diverse in the macrophage monoculture and the co-culture compared to the epithelial cells where only an increase of IL-8 was detected. The production of reactive oxygen species was the highest in epithelial cells and macrophages seemed to have protective effects against oxidative stress from the PM samples. With no metabolically active cells at the highest doses, the cytotoxic effects of the PM samples from the wood log combustion were far more pronounced in the macrophages and the co-culture than in the epithelial cells. All samples caused DNA damage in macrophages, whereas only beech and spruce log combustion samples caused DNA damage in epithelial cells. The organic content of the samples was mainly associated with cytotoxicity and DNA damage, while the metal content of the samples correlated with the induction of inflammatory responses. Conclusions All of the tested PM samples induce adverse effects and the chemical composition of the samples determines which pathway of toxicity is induced. In vitro testing of the toxicity of combustion-derived PM in monocultures of one cell line, however, is inadequate to account for all the possible pathways of toxicity.	[Kasurinen, Stefanie; Happo, Mikko S.; Ronkko, Teemu J.; Jokiniemi, Jorma; Kortelainen, Miika; Tissari, Jarkko; Hirvonen, Maija-Riitta; Jalava, Pasi I.] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland; [Orasche, Juergen; Jokiniemi, Jorma; Zimmermann, Ralf; Hirvonen, Maija-Riitta] HICE Helmholtz Virtual Inst Complex Mol Syst Envi, Munich, Germany; [Kasurinen, Stefanie; Orasche, Juergen; Zimmermann, Ralf] German Res Ctr Environm Hlth, Cooperat Grp Comprehens Mol Analyt, Helmholtz Zentrum Munchen, Munich, Germany; [Zimmermann, Ralf] Univ Rostock, Inst Chem, Rostock, Germany	University of Eastern Finland; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Rostock	Kasurinen, S (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland.; Kasurinen, S (corresponding author), German Res Ctr Environm Hlth, Cooperat Grp Comprehens Mol Analyt, Helmholtz Zentrum Munchen, Munich, Germany.	stefanie.kasurinen@uef.fi		Orasche, Jurgen/0000-0002-1037-7544; Jokiniemi, Jorma/0000-0002-1201-6144; Kortelainen, Miika/0000-0002-1051-4617; Ronkko, Teemu/0000-0003-0805-4380	Academy of Finland; University of Eastern Finland; Doctoral Program in Aerosol Research of the University of Eastern Finland; Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health	Academy of Finland(Academy of Finland); University of Eastern Finland; Doctoral Program in Aerosol Research of the University of Eastern Finland; Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health	This study was supported by the Academy of Finland to MSH, JJ, JT, MRH, and PIJ, the strategic funding of the University of Eastern Finland for the project on sustainable bioenergy, climate change and health to SK, TJR, and MK, the Doctoral Program in Aerosol Research of the University of Eastern Finland and the Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health to JO and RZ. The funding sources had no role in the study design, collection, analysis and interpretation of the data, nor in the writing of the report or the decision to submit the manuscript for publication.	Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1; Arsura M, 1996, IMMUNITY, V5, P31, DOI 10.1016/S1074-7613(00)80307-6; Bolling AK, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-45; Bolling AK, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-29; Chen LC, 2009, INHAL TOXICOL, V21, P1, DOI [10.1080/08958370802105405, 10.1080/08958370802105405 ]; Chen SZ, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0144-6; Dandley EC, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0141-9; Danielsen PH, 2009, MUTAT RES-GEN TOX EN, V674, P116, DOI 10.1016/j.mrgentox.2008.10.014; Delfino RJ, 2008, ENVIRON HEALTH PERSP, V116, P898, DOI 10.1289/ehp.11189; Dilger M, 2016, ARCH TOXICOL, V90, P3029, DOI 10.1007/s00204-016-1659-1; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Happo MS, 2013, SCI TOTAL ENVIRON, V443, P256, DOI 10.1016/j.scitotenv.2012.11.004; Heyder Joachim, 2004, Proc Am Thorac Soc, V1, P315, DOI 10.1513/pats.200409-046TA; Hofmann F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117056; IARC, 2010, INT AG RES CANC MON, V95; Jalava PI, 2008, TOXICOL APPL PHARM, V229, P146, DOI 10.1016/j.taap.2008.01.006; Jalava PI, 2012, ATMOS ENVIRON, V50, P24, DOI 10.1016/j.atmosenv.2012.01.009; Kasurinen S, 2017, ENVIRON TOXICOL, V32, P1487, DOI 10.1002/tox.22369; Kasurinen S, 2016, AEROSOL SCI TECH, V50, P41, DOI 10.1080/02786826.2015.1121198; Kasurinen S, 2015, ATMOS ENVIRON, V103, P321, DOI 10.1016/j.atmosenv.2014.12.055; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; Lamberg H, 2013, ENERG FUEL, V27, P7044, DOI 10.1021/ef401267t; Musah S, 2012, TOXICOLOGY, V299, P125, DOI 10.1016/j.tox.2012.05.014; Nuutinen K, 2014, BIOMASS BIOENERG, V67, P167, DOI 10.1016/j.biombioe.2014.04.033; Pal S, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-23; Persson HL, 2013, EXP TOXICOL PATHOL, V65, P81, DOI 10.1016/j.etp.2011.06.004; Pratt MM, 2011, INT J ENV RES PUB HE, V8, P2675, DOI 10.3390/ijerph8072675; Reda AA, 2015, ENERG FUEL, V29, P3897, DOI 10.1021/ef502877c; Roque PJ, 2016, NEUROTOXICOLOGY, V56, P204, DOI 10.1016/j.neuro.2016.08.006; Ruusunen J, 2011, ANAL BIOANAL CHEM, V401, P3183, DOI 10.1007/s00216-011-5424-2; Schaumann F, 2004, AM J RESP CRIT CARE, V170, P898, DOI 10.1164/rccm.200403-423OC; SCHUTZE S, 1995, IMMUNOBIOLOGY, V193, P193, DOI 10.1016/S0171-2985(11)80543-7; Schwarze PE, 2006, HUM EXP TOXICOL, V25, P559, DOI 10.1177/096032706072520; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Sigsgaard T, 2015, EUR RESPIR J, V46, P1577, DOI 10.1183/13993003.01865-2014; Sunjog K, 2013, ANAL BIOANAL CHEM, V405, P4879, DOI 10.1007/s00216-013-6909-y; Torres- Duque C, 2010, P NATL ACAD SCI USA, V5, P577; Uski O, 2015, SCI TOTAL ENVIRON, V511, P331, DOI 10.1016/j.scitotenv.2014.12.061; Uski OJ, 2012, INHAL TOXICOL, V24, P952, DOI 10.3109/08958378.2012.742172; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; WHO Regional Office for Europe, 2015, RESIDENTIAL HEATING; Wu WD, 2014, AM J RESP CELL MOL, V51, P802, DOI 10.1165/rcmb.2013-0265OC; Xing Z, 1997, AM J PATHOL, V150, P59; Zou YJ, 2016, ENVIRON POLLUT, V212, P627, DOI 10.1016/j.envpol.2016.03.022	44	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192453	10.1371/journal.pone.0192453	http://dx.doi.org/10.1371/journal.pone.0192453			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466392	gold, Green Submitted, Green Published			2022-12-26	WOS:000425604300060
J	Sommerville, R; Brown, AF; Upjohn, M				Sommerville, Rebecca; Brown, Ashleigh F.; Upjohn, Melissa			A standardised equine-based welfare assessment tool used for six years in low and middle income countries	PLOS ONE			English	Article							WORKING HORSES; RISK-FACTORS; INDICATORS; BEHAVIOR; DONKEYS; DEHYDRATION; ANIMALS; SYSTEM; HEALTH; MULES	The majority of horses, donkeys and mules (equids) are in low-and middle-income countries, where they remain a key source of labour in the construction, agriculture and tourism industries, as well as supporting households daily through transporting people and staple goods. Globally, approximately 600 million people depend on working equids for their livelihood. Safeguarding the welfare of these animals is essential for them to work, as well as for the intrinsic value of the animal's quality of life. In order to manage animal welfare, it must be measured. Over the past decade, welfare assessment methodologies have emerged for different species, more recently for equids. We present the Standardised Equine-Based Welfare Assessment Tool (SEBWAT) for working equids. The tool is unique, in that it has been applied in practice by a non-governmental organisation (NGO) for six years across Low-Middle-Income Countries (LMICs). We describe the revision of the tool from an original to a second version, the tool methodology and user training process and how data collection and analysis have been conducted. We describe its application at scale, where it has been used more than 71,000 times in 11 countries. Case study examples are given from the tool being used for a needs assessment in Guatemala and monitoring welfare change in Jordan. We conclude by describing the main benefits and limitations for how the tool could be applied by others on working equids in LMICs and how it may develop in the future.	[Sommerville, Rebecca; Brown, Ashleigh F.; Upjohn, Melissa] Brooke, Action Working Horses & Donkeys, London, England		Sommerville, R (corresponding author), Brooke, Action Working Horses & Donkeys, London, England.	rebecca.sommerville@thebrooke.org		Sommerville, Rebecca/0000-0003-0275-0393	Brooke Hospital for Animals	Brooke Hospital for Animals	The authors were employed by Brooke Hospital for Animals, which funded and conducted the work.	Ali ABA, 2016, APPL ANIM BEHAV SCI, V176, P52, DOI 10.1016/j.applanim.2015.12.001; Andreasen SN, 2013, APPL ANIM BEHAV SCI, V143, P9, DOI 10.1016/j.applanim.2012.11.013; Bachmann I, 2003, EQUINE VET J, V35, P158, DOI 10.2746/042516403776114216; Bateson M, 2016, BIOESSAYS, V38, P201, DOI 10.1002/bies.201500127; Bekele M., 2014, Proceedings of the 7th International Colloquium on Working Equids, Royal Holloway, University of London, UK. 1st-3rd July, 2014, P10; Bhardwaj N, 2016, INT C INT SOC APPL E; Blokhuis HJ, 2010, ACTA AGR SCAND A-AN, V60, P129, DOI 10.1080/09064702.2010.523480; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Broster CE, 2009, EQUINE VET J, V41, P474, DOI 10.2746/042516409X373907; Brown A, 2011, P 5 INT C ASS AN WEL; Burn C., 2014, UFAW AN WELF C 26 JU; Burn CC, 2010, VET J, V186, P385, DOI 10.1016/j.tvjl.2009.09.016; Costa ED, 2014, ANIM WELFARE, V23, P323, DOI 10.7120/09627286.23.3.323; Dalla Costa E, 2016, ANIM WELFARE, V25, P481, DOI 10.7120/09627286.25.4.481; Dalla Costa E, 2016, ANIMAL, P1; Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281; Dawkins MS, 2012, ANIM BEHAV, V84, P219, DOI 10.1016/j.anbehav.2012.04.036; de Vere AJ, 2016, WIRES COGN SCI, V7, P354, DOI 10.1002/wcs.1399; Emanuela DC, 2015, AWIN WELFARE ASSESSM, V1; Ferrante V, 2015, AWIN WELFARE ASSESSM, V1; Food and Agriculture Organization of the United Nations, 2014, DAT FAOSTAT; Fraser A.F, 2010, BEHAV WELFARE HORSE; Fureix C, 2015, APPL ANIM BEHAV SCI, V162, P26, DOI 10.1016/j.applanim.2014.11.007; Galindo F, 2018, J APPL ANIM WELF SCI, V21, P93, DOI 10.1080/10888705.2017.1351365; Geiger M, 2015, DEV PRACT, V25, P1091, DOI 10.1080/09614524.2015.1078776; Hausberger M, 2016, APPL ANIM BEHAV SCI, V175, P41, DOI 10.1016/j.applanim.2015.09.005; Hausberger M, 2012, NATURWISSENSCHAFTEN, V99, P291, DOI 10.1007/s00114-012-0902-8; Hausberger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007625; Haverbeke N.S., 2002, DR HAV FDN WORKSH HO; Heleski CR, 2012, J VET BEHAV, V7, P169, DOI 10.1016/j.jveb.2011.08.003; Hemsworth LM, 2015, APPL ANIM BEHAV SCI, V165, P1, DOI 10.1016/j.applanim.2014.11.019; Hemsworth PH, 2015, NEW ZEAL VET J, V63, P24, DOI 10.1080/00480169.2014.966167; Hockenhull J, 2014, EQUINE VET EDUC, V26, P159, DOI 10.1111/eve.12129; Holcomb K, 2013, 9 INT EQ SCI C 17 20, P45; Kithuka J, 2016, VETED S JUL GLASG UK; Kithuka J, 2015, INT S VET EP EC 3 7; Kumar S., 2002, METHODS COMMUNITY PA; Leach MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0013347; Lesimple C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00021; Lesimple C, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-209; Lesimple C, 2011, APPL ANIM BEHAV SCI, V129, P92, DOI 10.1016/j.applanim.2010.11.005; Liszewski M, 2016, 1 INT C HUM BEH CHAN; Luna D, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7080056; Main DCJ, 2003, ANIM WELFARE, V12, P523; McBride SD, 2001, VET REC, V148, P799, DOI 10.1136/vr.148.26.799; McKenna C., 2008, BEARING HEAVY BURDEN, V1; Mellor DJ, 2015, ANIM WELFARE, V24, P241, DOI 10.7120/09627286.24.3.241; Minero M, 2016, APPL ANIM BEHAV SCI, V174, P147, DOI 10.1016/j.applanim.2015.10.010; Mitra D, 2017, ENV HUMAN LABOUR ANI, V1; Parker RA, 2012, EQUINE VET J, V44, P244, DOI 10.1111/j.2042-3306.2011.00411.x; Phythian CJ, 2013, ANIMAL, V7, P1182, DOI 10.1017/S1751731113000487; Popescu S, 2014, RES VET SCI, V96, P406, DOI 10.1016/j.rvsc.2013.12.014; Popescu S, 2013, J EQUINE VET SCI, V33, P1, DOI 10.1016/j.jevs.2012.04.001; Pritchard JC, 2008, EQUINE VET J, V40, P558, DOI 10.2746/042516408X297462; Pritchard JC, 2007, ANIM WELFARE, V16, P181; Pritchard JC, 2005, PREV VET MED, V69, P265, DOI 10.1016/j.prevetmed.2005.02.002; Regan FH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101877; Sankey C, 2010, ANIM COGN, V13, P753, DOI 10.1007/s10071-010-0326-9; Serg R, 2014, P 7 INT C WORK EQ RO; Stringer A, 2015, EQUINE VET J, V47, P6, DOI 10.1111/evj.12359; Stringer AP, 2017, EQUINE VET J, V49, P501, DOI 10.1111/evj.12633; The Brooke, 2013, WORKING EQUID VET MA, P351; The Donkey Sanctuary, 2017, UNDER THE SKIN; Upjohn MM, 2013, PREV VET MED, V108, P313, DOI 10.1016/j.prevetmed.2012.11.008; Upjohn M, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00092; Upjohn MM, 2014, VET J, V199, P210, DOI 10.1016/j.tvjl.2013.09.065; Valette D., 2015, INVISIBLE WORKERS EC, V1; van Dijk L, 2011, SHARING THE LOAD; Viksten SM, 2017, ANIM WELFARE, V26, P59, DOI 10.7120/09627286.26.1.059; Wathan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131738; Weston S., 2009, NO FEAR NO FORCE GUI; Whay HR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126160; Wolfensohn S, 2015, ANIM WELFARE, V24, P139, DOI 10.7120/09627286.24.2.139; World Organization for Animal Health, 2016, TERR AN HLTH COD; Worldbank, 2017, DAT WORLD BANK OP DA	75	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192354	10.1371/journal.pone.0192354	http://dx.doi.org/10.1371/journal.pone.0192354			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466391	gold, Green Published, Green Submitted			2022-12-26	WOS:000425604300051
J	Dennison, L; Brown, M; Kirby, S; Galea, I				Dennison, Laura; Brown, Martina; Kirby, Sarah; Galea, Ian			Do people with multiple sclerosis want to know their prognosis? A UK nationwide study	PLOS ONE			English	Article							COMMUNICATING PROGNOSIS; NATURAL-HISTORY; LONG; DISEASE; CANCER; DEPRESSION; PREDICTION; ANXIETY; STYLE; END	Background Multiple sclerosis (MS) has a varied and uncertain trajectory. The recent development of analytical processing tools that draw on large longitudinal patient databases facilitates personalised long-term prognosis estimates. This has the potential to improve both shared treatment decision-making and psychological adjustment. However, there is limited research on how people with MS feel about prognosis communication and forecasting. This study investigated the prognosis communication experiences and preferences of people with MS and explored whether clinical, demographic and psychological factors are associated with prognosis information preferences. Methods 3175 UK MS Register members (59% of those with active accounts) completed an online survey containing 17 questions about prognosis communication experiences, attitudes and preferences. Participants also completed validated questionnaires measuring coping strategies, tendencies to seek out ('monitor) or avoid ('blunt') information in threatening situations, and MS risk perceptions and reported their clinical and sociodemographic characteristics. Data already held on the MS Register about participants' quality of life, anxiety and depression symptoms and MS impact were obtained and linked to the survey data. Results 53.1% of participants had never discussed long-term prognosis with healthcare professionals. 54.2% lacked clarity about their long-term prognosis. 76% had strong preferences for receiving long-term prognosis information. 92.8% were interested in using tools that generate personalised predictions. Most participants considered prognostication useful for decision-making. Participants were more receptive to receiving prognosis information at later time-points, versus at diagnosis. A comprehensive set of sociodemographic, clinical and psychological variables predicted only 7.9% variance in prognosis information preferences. Conclusions People with MS have an appetite for individualised long-term prognosis forecasting and their need for information is frequently unmet. Clinical studies deploying and evaluating interventions to support prognostication in MS are now needed. This study indicates suitable contexts and patient preferences for initial trials of long-term prognosis tools in clinical settings.	[Dennison, Laura; Kirby, Sarah] Univ Southampton, Dept Psychol, Ctr Clin & Community Applicat Hlth Psychol, Southampton, Hants, England; [Brown, Martina] Univ Southampton, Hlth Sci, Southampton, Hants, England; [Galea, Ian] Univ Southampton, Fac Med, Clin Neurosci Clin & Expt Sci, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton	Galea, I (corresponding author), Univ Southampton, Fac Med, Clin Neurosci Clin & Expt Sci, Southampton, Hants, England.	I.Galea@soton.ac.uk	Galea, Ian/B-7997-2011; Kirby, Sarah/M-6390-2015	Galea, Ian/0000-0002-1268-5102; Dennison, Laura/0000-0003-0122-6610; Kirby, Sarah/0000-0003-1759-1356	UK MS Society; NIHR	UK MS Society; NIHR(National Institute for Health Research (NIHR))	The UK MS Register https://ukmsregister.org/Portal/Home is funded by the UK MS Society. MB was funded by NIHR to complete an MRes degree and she conducted data collection for this study as part of her degree.	Arribas-Ayllon M, 2011, BRIT MED BULL, V100, P7, DOI 10.1093/bmb/ldr023; Beran TM, 2009, J GENET COUNS, V18, P265, DOI 10.1007/s10897-009-9223-2; Bergamaschi R, 2007, J NEUROL NEUROSUR PS, V78, P757, DOI 10.1136/jnnp.2006.107052; Bernat JL, 2004, NEUROCRIT CARE, V1, P107, DOI 10.1385/NCC:1:1:107; Boeije HR, 2004, SOC SCI MED, V59, P861, DOI 10.1016/j.socscimed.2003.11.040; Buecken R, 2012, PATIENT EDUC COUNS, V88, P318, DOI 10.1016/j.pec.2012.03.010; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cook SA, 2009, EYE, V23, P581, DOI 10.1038/eye.2008.54; Degenhardt A, 2009, NAT REV NEUROL, V5, P672, DOI 10.1038/nrneurol.2009.178; Dennison L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158982; Dennison L, 2009, CLIN PSYCHOL REV, V29, P141, DOI 10.1016/j.cpr.2008.12.001; Duncan LR, 2013, J CANCER EDUC, V28, P119, DOI 10.1007/s13187-012-0431-3; Finlayson M., 2005, BRIT J OCCUPATIONAL, V68, P117, DOI DOI 10.1177/030802260506800304; Galea I, 2013, EUR J NEUROL, V20, P1107, DOI 10.1111/ene.12016; Gourraud PA, 2014, ANN NEUROL, V76, P633, DOI 10.1002/ana.24282; Hagerty RG, 2005, ANN ONCOL, V16, P1005, DOI 10.1093/annonc/mdi211; Heesen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059042; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Holloway RG, 2013, NEUROLOGY, V80, P764, DOI 10.1212/WNL.0b013e318282509c; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lamont EB, 2001, ANN INTERN MED, V134, P1096, DOI 10.7326/0003-4819-134-12-200106190-00009; Mohr DC, 2001, J CLIN PSYCHOL, V57, P479, DOI 10.1002/jclp.1042; Osborne LA, 2014, PHYS THER REV, V19, P24, DOI 10.1179/1743288X13Y.0000000094; Rich BA, 2001, THEOR MED BIOETH, V22, P177, DOI 10.1023/A:1011466711211; Roberts JS, 2013, PROG NEUROBIOL, V110, P89, DOI 10.1016/j.pneurobio.2013.02.005; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Schuermeyer I, 2016, JAMA OPHTHALMOL, V134, P51, DOI 10.1001/jamaophthalmol.2015.4343; Solari A, 2014, MULT SCLER J, V20, P397, DOI 10.1177/1352458514523061; Somerset Maggie, 2002, J Health Serv Res Policy, V7, P151, DOI 10.1258/135581902760082454; STEPTOE A, 1989, BRIT J CLIN PSYCHOL, V28, P183, DOI 10.1111/j.2044-8260.1989.tb00830.x; Synnot AJ, 2016, HEALTH EXPECT, V19, P727, DOI 10.1111/hex.12253; Tams R, 2016, NEUROREHABILITATION, V38, P257, DOI 10.3233/NRE-161317; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	22	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193407	10.1371/journal.pone.0193407	http://dx.doi.org/10.1371/journal.pone.0193407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489869	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000426276000072
J	Sanchez-Sandoval, AL; Carrillo, ZH; Velasquez, CED; Delgadillo, DM; Rivera, HM; Gomora, JC				Laura Sanchez-Sandoval, Ana; Herrera Carrillo, Zazil; Diaz Velasquez, Clara Estela; Maria Delgadillo, Dulce; Manuel Rivera, Heriberto; Carlos Gomora, Juan			Contribution of S4 segments and S4-S5 linkers to the low-voltage activation properties of T-type Ca(v)3.3 channels	PLOS ONE			English	Article							CALCIUM-CHANNEL; CA2+ CHANNELS; MOLECULAR REGIONS; GATING PROPERTIES; KINETICS; CELLS; DIFFERENTIATION; INACTIVATION; MIBEFRADIL; PHYSIOLOGY	Voltage-gated calcium channels contain four highly conserved transmembrane helices known as S4 segments that exhibit a positively charged residue every third position, and play the role of voltage sensing. Nonetheless, the activation range between high-voltage (HVA) and low-voltage (LVA) activated calcium channels is around 30-40 mV apart, despite the high level of amino acid similarity within their S4 segments. To investigate the contribution of S4 voltage sensors for the low-voltage activation characteristics of Ca(v)3.3 channels we constructed chimeras by swapping S4 segments between this LVA channel and the HVA Ca(v)1.2 channel. The substitution of S4 segment of Domain II in Ca(v)3.3 by that of Ca(v)1.2 (chimera IIS4C) induced a similar to 35 mV shift in the voltage-dependence of activation towards positive potentials, showing an /-Vcurve that almost overlaps with that of Ca(v)1.2 channel. This HVA behavior induced by IIS4C chimera was accompanied by a 2-fold decrease in the voltage-dependence of channel gating. The IVS4 segment had also a strong effect in the voltage sensing of activation, while substitution of segments IS4 and IIIS4 moved the activation curve of Ca(v)3.3 to more negative potentials. Swapping of IIS4 voltage sensor influenced additional properties of this channel such as steady-state inactivation, current decay, and deactivation. Notably, Domain I voltage sensor played a major role in preventing Ca(v)3.3 channels to inactivate from closed states at extreme hyperpolarized potentials. Finally, site-directed mutagenesis in the Ca(v)3.3 channel revealed a partial contribution of the S4-S5 linker of Domain II to LVA behavior, with synergic effects observed in double and triple mutations. These findings indicate that IIS4 and, to a lesser degree IVS4, voltage sensors are crucial in determining the LVA properties of Ca(v)3.3 channels, although the accomplishment of this function involves the participation of other structural elements like S4-S5 linkers.	[Laura Sanchez-Sandoval, Ana; Herrera Carrillo, Zazil; Carlos Gomora, Juan] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neuropatol Mol, Mexico City, DF, Mexico; [Diaz Velasquez, Clara Estela] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Programa Neurociencias, Tlalnepantla De Baz, Estado De Mexic, Mexico; [Maria Delgadillo, Dulce] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Labs Nacl Serv Expt, Mexico City, DF, Mexico; [Manuel Rivera, Heriberto] Univ Autonoma Estado Morelos, Fac Med, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Autonoma del Estado de Morelos	Gomora, JC (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neuropatol Mol, Mexico City, DF, Mexico.	jgomora@ifc.unam.mx	Sanchez-Sandoval, Ana Laura/GPK-6264-2022; Rivera, Manuel/AAG-1449-2020	Sanchez-Sandoval, Ana Laura/0000-0002-9478-4779; Rivera, Manuel/0000-0001-9343-8383; Delgadillo, Dulce Maria/0000-0002-5057-7727; Gomora, Juan Carlos/0000-0002-9871-1307	Consejo Nacional de Ciencia y Tecnologia-Mexico [167790-B]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Universidad Nacional Autonoma de Mexico [IN207614]	Consejo Nacional de Ciencia y Tecnologia-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Universidad Nacional Autonoma de Mexico	This study was supported by Consejo Nacional de Ciencia y Tecnologia-Mexico, grant number 167790-B to JCG, https://www.conacyt.gob.mx/; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Universidad Nacional Autonoma de Mexico, grant number IN207614 to JCG, http://dgana.unam.mx/index.php/impulso-a-la-investigacion/papiit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Astori S, 2013, J NEUROSCI, V33, P624, DOI 10.1523/JNEUROSCI.3185-12.2013; Astori S, 2011, P NATL ACAD SCI USA, V108, P13823, DOI 10.1073/pnas.1105115108; Baumgart JP, 2008, PLOS ONE, V3; BEAN BP, 1985, J GEN PHYSIOL, V86, P1, DOI 10.1085/jgp.86.1.1; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Choi S, 2015, P NATL ACAD SCI USA, V112, P7839, DOI 10.1073/pnas.1420983112; Coutelier M, 2015, AM J HUM GENET, V97, P726, DOI 10.1016/j.ajhg.2015.09.007; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; Demers-Giroux PO, 2013, J BIOL CHEM, V288, P29281, DOI 10.1074/jbc.M113.500975; Enyeart JJ, 2015, AM J PHYSIOL-CELL PH, V308, pC899, DOI 10.1152/ajpcell.00002.2015; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Frazier CJ, 2001, J GEN PHYSIOL, V118, P457, DOI 10.1085/jgp.118.5.457; Gomora JC, 2001, MOL PHARMACOL, V60, P1121, DOI 10.1124/mol.60.5.1121; Gomora JC, 2000, J PHARMACOL EXP THER, V292, P96; Gomora JC, 2002, BIOPHYS J, V83, P229, DOI 10.1016/S0006-3495(02)75164-3; Hamid J, 2006, NEUROSCIENCE, V143, P717, DOI 10.1016/j.neuroscience.2006.08.023; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Huang WF, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0171-4; Huguenard John R., 2004, Epilepsy Curr, V4, P7, DOI 10.1111/j.1535-7597.2004.04102.x; Kraus RL, 2010, J PHARMACOL EXP THER, V335, P409, DOI 10.1124/jpet.110.171058; Kuo IYT, 2014, PFLUG ARCH EUR J PHY, V466, P767, DOI 10.1007/s00424-013-1430-x; Kurejova M, 2007, PFLUG ARCH EUR J PHY, V455, P527, DOI 10.1007/s00424-007-0302-7; Lam AD, 2002, BIOPHYS J, V82, p101A; Lam AD, 2005, PFLUG ARCH EUR J PHY, V451, P349, DOI 10.1007/s00424-005-1407-5; Lambert RC, 2014, PFLUG ARCH EUR J PHY, V466, P415, DOI 10.1007/s00424-013-1353-6; Lee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200; Li JY, 2005, EUR BIOPHYS J BIOPHY, V34, P1017, DOI 10.1007/s00249-005-0487-7; Li JY, 2004, J BIOL CHEM, V279, P26858, DOI 10.1074/jbc.M313981200; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; Lopez-Charcas O, 2012, MOL PHARM; Lory P, 2006, CELL CALCIUM, V40, P135, DOI 10.1016/j.ceca.2006.04.017; Mariot P, 2002, J BIOL CHEM, V277, P10824, DOI 10.1074/jbc.M108754200; MATTESON DR, 1986, J GEN PHYSIOL, V87, P161, DOI 10.1085/jgp.87.1.161; Morino H, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0180-4; Pellegrini C, 2016, SLEEP, V39, P875, DOI 10.5665/sleep.5646; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Perez-Reyes E, 2010, CHANNELS, V4, P453, DOI 10.4161/chan.4.6.12889; Pluteanu F, 2011, AM J PHYSIOL-CELL PH, V300, pC517, DOI 10.1152/ajpcell.00107.2010; Poulsen CB, 2011, KIDNEY INT, V79, P443, DOI 10.1038/ki.2010.429; Powell KL, 2007, EPILEPSIA, V48, P390; Powell KL, 2014, BRIT J CLIN PHARMACO, V77, P729, DOI 10.1111/bcp.12205; Reimer EN, 2016, ENDOCRINOLOGY, V157, P3016, DOI 10.1210/en.2016-1170; Rossier MF, 1998, J PHARMACOL EXP THER, V287, P824; Serrano JR, 1999, J GEN PHYSIOL, V114, P185, DOI 10.1085/jgp.114.2.185; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Svenningsen P, 2014, PFLUG ARCH EUR J PHY, V466, P2205, DOI 10.1007/s00424-014-1492-4; Talley EM, 1999, J NEUROSCI, V19, P1895; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Thuesen AD, 2016, ACTA PHYSL OXF; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Tuluc P, 2016, STRUCTURE, V24, P261, DOI 10.1016/j.str.2015.11.011; Turner RW, 2014, PFLUG ARCH EUR J PHY, V466, P661, DOI 10.1007/s00424-013-1434-6; Valerie NCK, 2013, BIOCHEM PHARMACOL, V85, P888, DOI 10.1016/j.bcp.2012.12.017; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Weiss N, 2013, BBA-BIOMEMBRANES, V1828, P1579, DOI 10.1016/j.bbamem.2012.07.031; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Yamaguchi H, 1999, P NATL ACAD SCI USA, V96, P1357, DOI 10.1073/pnas.96.4.1357; Yan Z, 2017, CELL, V170, P470, DOI 10.1016/j.cell.2017.06.039; Yue J, 2013, SPINE, V38, P463, DOI 10.1097/BRS.0b013e318272fbf8; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654; Zhang Y, 2012, BRIT J PHARMACOL, V166, P1247, DOI 10.1111/j.1476-5381.2012.01852.x	66	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193490	10.1371/journal.pone.0193490	http://dx.doi.org/10.1371/journal.pone.0193490			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474447	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500118
J	Bakhtiarizadeh, MR; Salehi, A; Rivera, RM				Bakhtiarizadeh, Mohammad Reza; Salehi, Abdolreza; Rivera, Rocio Melissa			Genome-wide identification and analysis of A-to-I RNA editing events in bovine by transcriptome sequencing	PLOS ONE			English	Article							GENE-EXPRESSION; NONCODING RNAS; SEQ DATA; SITES; BRAIN; DNA; EVOLUTIONARY; DEAMINASES; LANDSCAPE; CONTAINS	RNA editing increases the diversity of the transcriptome and proteome. Adenosine-to-inosine (A-to-I) editing is the predominant type of RNA editing in mammals and it is catalyzed by the adenosine deaminases acting on RNA (ADARs) family. Here, we used a largescale computational analysis of transcriptomic data from brain, heart, colon, lung, spleen, kidney, testes, skeletal muscle and liver, from three adult animals in order to identify RNA editing sites in bovine. We developed a computational pipeline and used a rigorous strategy to identify novel editing sites from RNA-Seq data in the absence of corresponding DNA sequence information. Our methods take into account sequencing errors, mapping bias, as well as biological replication to reduce the probability of obtaining a false-positive result. We conducted a detailed characterization of sequence and structural features related to novel candidate sites and found 1,600 novel canonical A-to-I editing sites in the nine bovine tissues analyzed. Results show that these sites 1) occur frequently in clusters and short interspersed nuclear elements (SINE) repeats, 2) have a preference for guanines depletion/enrichment in the flanking 50/30 nucleotide, 3) occur less often in coding sequences than other regions of the genome, and 4) have low evolutionary conservation. Further, we found that a positive correlation exists between expression of ADAR family members and tissue-specific RNA editing. Most of the genes with predicted A-to-I editing in each tissue were significantly enriched in biological terms relevant to the function of the corresponding tissue. Lastly, the results highlight the importance of the RNA editome in nervous system regulation. The present study extends the list of RNA editing sites in bovine and provides pipelines that may be used to investigate the editome in other organisms.	[Bakhtiarizadeh, Mohammad Reza; Salehi, Abdolreza] Univ Tehran, Dept Anim & Poultry Sci, Coll Aburaihan, Tehran, Iran; [Rivera, Rocio Melissa] Univ Missouri, Dept Anim Sci, Columbia, MO USA	University of Tehran; University of Missouri System; University of Missouri Columbia	Bakhtiarizadeh, MR (corresponding author), Univ Tehran, Dept Anim & Poultry Sci, Coll Aburaihan, Tehran, Iran.	mrbaktiari@ut.ac.ir	Salehi, Abdolreza/Y-8437-2019	Salehi, Abdolreza/0000-0003-3938-717X; , mohammad reza/0000-0001-5336-6987	University of Tehran; University of Missouri F21C Reproduction Biology Cluster	University of Tehran(University of Tehran); University of Missouri F21C Reproduction Biology Cluster	This work was supported by the University of Tehran and the University of Missouri F21C Reproduction Biology Cluster. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson DL, 2009, P NATL ACAD SCI USA, V106, P12855, DOI 10.1073/pnas.0901282106; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Blanc V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r79; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cattenoz PB, 2013, RNA, V19, P257, DOI 10.1261/rna.036202.112; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen JY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004274; Chen ZY, 2016, EPIGENETICS-US, V11, P501, DOI 10.1080/15592294.2016.1184805; Cingolani P., 2012, SNPEFF VARIANT EFFEC; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; De Summa S, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1537-8; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fresard L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126776; Funkhouser SA, 2017, BIORXIV; Goodhead I, 2015, CURR OPIN MICROBIOL, V23, P102, DOI 10.1016/j.mib.2014.11.012; Gu TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033720; Gunter C, 2012, NATURE, V489, P5774; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; He T, 2015, MOL GENET GENOMICS, V290, P929, DOI 10.1007/s00438-014-0968-4; Heale BS, 2010, EFFECT RNA EDITING A, P76; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Holmes AP, 2013, BIOGERONTOLOGY, V14, P395, DOI 10.1007/s10522-013-9433-8; Hwang T, 2016, NATURE NEUROSCIENCE; Jepson JEC, 2008, BBA-GENE REGUL MECH, V1779, P459, DOI 10.1016/j.bbagrm.2007.11.009; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Lagarrigue S, 2013, GENETICS, V193, P1107, DOI 10.1534/genetics.112.149054; Le TD, 2016, BRIEF BIOINFORM; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li Q, 2014, NATURE COMMUNICATION, P5; Liu XS, 2015, INT J MOL SCI, V16, P3377, DOI 10.3390/ijms16023377; Maas Stefan, 2006, RNA Biol, V3, P1; Martinez-Montes A, 2016, ANIMAL GENETICS; Martinez-Montes AM, 2017, ANIM GENET, V48, P151, DOI 10.1111/age.12507; Mazloomian A, 2015, RNA BIOL, V12, P1391, DOI 10.1080/15476286.2015.1107703; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Mo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101431; Moran B, 2017, BIORXIV2017101733; Nishikura K, 2015, NATURE REV MOL CELL; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Oguejiofor CF, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.128876; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Picardi E, 2015, SCI REPORTS, P5; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; Piro RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023149; Piskol R, 2013, AM J HUM GENET, V93, P641, DOI 10.1016/j.ajhg.2013.08.008; Piskol R, 2013, NAT BIOTECHNOL, V31, P19, DOI 10.1038/nbt.2472; Porath HT, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1315-y; Ramaswami G, 2016, METHODS, V107, P42, DOI 10.1016/j.ymeth.2016.05.011; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Reenan RA, 2005, NATURE, V434, P409, DOI 10.1038/nature03364; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Roux PF, 2016, G3-GENES GENOM GENET, V6, P321, DOI 10.1534/g3.115.022251; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Smit A. F. A., 1996, REPEATMASKER; Solomon O, 2014, PROTEINS, V82, P3117, DOI 10.1002/prot.24672; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang XW, 2013, BIOINFORMATION, V9, P541, DOI 10.6026/97320630009541; Wang ZJ, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0143-4; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Xiong H, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix012; Zhao HQ, 2015, GENOME RES, V25, P66, DOI 10.1101/gr.176107.114; Zhu SS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-206	74	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193316	10.1371/journal.pone.0193316	http://dx.doi.org/10.1371/journal.pone.0193316			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470549	Green Published, gold, Green Submitted			2022-12-26	WOS:000425831000048
J	Conrad, T; Paxton, RJ; Assum, G; Ayasse, M				Conrad, Taina; Paxton, Robert J.; Assum, Guenter; Ayasse, Manfred			Divergence in male sexual odor signal and genetics across populations of the red mason bee, Osmia bicornis, in Europe	PLOS ONE			English	Article							MATING-BEHAVIOR; CHEMICAL COMMUNICATION; FEMALE CHOICE; HYMENOPTERA; DIFFERENTIATION; RECOGNITION; PHEROMONE; KIN; RELATEDNESS; PREFERENCES	In some insect species, females may base their choice for a suitable mate on male odor. In the red mason bee, Osmia bicornis, female choice is based on a male's odor bouquet as well as its thorax vibrations, and its relatedness to the female, a putative form of optimal outbreeding. Interestingly, O. bicornis can be found as two distinct color morphs in Europe, which are thought to represent subspecies and between which we hypothesize that female discrimination may be particularly marked. Here we investigated (i) if these two colors morphs do indeed represent distinct, reproductively differentiated populations, (ii) how odor bouquets of male O. bicornis vary within and between populations, and (iii) whether variation in male odor correlates with genetic distance, which might represent a cue by which females could optimally outbreed. Using GC and GC-MS analysis of male odors and microsatellite analysis of males and females from 9 populations, we show that, in Denmark, an area of subspecies sympatry, the two color morphs at any one site do not differ, either in odor bouquet or in population genetic differentiation. Yet populations across Europe are distinct in their odor profile as well as being genetically differentiated. Odor differences do not, however, mirror genetic differentiation between populations. We hypothesize that populations from Germany, England and Denmark may be under sexual selection through female choice for local odor profiles, which are not related to color morph though which could ultimately lead to population divergence and speciation.	[Conrad, Taina; Ayasse, Manfred] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, Ulm, Germany; [Paxton, Robert J.] Martin Luther Univ Halle Wittenberg, Inst Biol Gen Zool, Halle, Germany; [Assum, Guenter] Univ Ulm, Inst Human Genet, Ulm, Germany	Ulm University; Martin Luther University Halle Wittenberg; Ulm University	Conrad, T (corresponding author), Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, Ulm, Germany.	Taina.Conrad@gmx.de	Paxton, Robert John/D-7082-2015	Paxton, Robert John/0000-0003-2517-1351; Conrad, Taina/0000-0002-0115-498X	German Federal Environmental Foundation	German Federal Environmental Foundation	Taina Conrad was funded by the German Federal Environmental Foundation for her PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; [Anonymous], 1995, PALSTAT STAT PALAEON; Ayasse M, 1999, BEHAV ECOL SOCIOBIOL, V45, P95, DOI 10.1007/s002650050543; Ayasse M, 2001, ANNU REV ENTOMOL, V46, P31, DOI 10.1146/annurev.ento.46.1.31; Ayasse M, 2014, ANNU REV ENTOMOL, V59, P299, DOI 10.1146/annurev-ento-011613-161949; BATESON P, 1978, NATURE, V273, P659, DOI 10.1038/273659a0; Bateson P., 1983, MATE CHOICE; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Boake CRB, 2002, GENETICA, V116, P205, DOI 10.1023/A:1021224207727; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; Busquet N, 2005, ANIM BEHAV, V70, P997, DOI 10.1016/j.anbehav.2004.12.023; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conrad T, 2017, ECOL EVOL, V1, pe11; Conrad T, 2017, CHEMOECOLOGY, V40, P804; Conrad T, 2015, CURR BIOL, V25, P2819, DOI 10.1016/j.cub.2015.08.059; Conrad T, 2010, J EXP BIOL, V213, P4065, DOI 10.1242/jeb.038174; Coyne J.A., 2004, SPECIATION; Davis ES, 2010, MOL ECOL, V19, P4922, DOI 10.1111/j.1365-294X.2010.04868.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; EICKWORT GC, 1980, ANNU REV ENTOMOL, V25, P421, DOI 10.1146/annurev.en.25.010180.002225; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fraberger RJ, 2007, J KANSAS ENTOMOL SOC, V80, P348, DOI 10.2317/0022-8567(2007)80[348:MBMTAC]2.0.CO;2; Gerlach G, 2006, ANIM BEHAV, V71, P1371, DOI 10.1016/j.anbehav.2005.10.010; Ibarra F., 2000, THESIS; Iyengar VK, 2001, BEHAV ECOL SOCIOBIOL, V49, P283, DOI 10.1007/s002650000292; Jarau S, 2009, CONTEMP TOP ENTOMOL, P1, DOI 10.1201/9781420075618; KLUN JA, 1979, SCIENCE, V204, P1328, DOI 10.1126/science.204.4399.1328; Krieger GM, 2006, J CHEM ECOL, V32, P453, DOI 10.1007/s10886-005-9013-8; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Neumann K, 2006, APIDOLOGIE, V37, P75, DOI 10.1051/apido:2005060; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Paxton RJ, 1996, MOL ECOL, V5, P511, DOI 10.1111/j.1365-294X.1996.tb00343.x; PETERS D S, 1978, Senckenbergiana Biologica, V58, P287; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosner B, 1994, THESIS; Rottler AM, 2013, J CHEM ECOL, V39, P67, DOI 10.1007/s10886-012-0229-0; Rousset F, 1997, GENETICS, V145, P1219; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Seidelmann K., 1995, THESIS; SIMMONS LW, 1991, ANIM BEHAV, V41, P493, DOI 10.1016/S0003-3472(05)80852-8; SMITH BH, 1987, BEHAV ECOL SOCIOBIOL, V20, P313, DOI 10.1007/BF00300676; SMITH BH, 1983, P NATL ACAD SCI-BIOL, V80, P4551, DOI 10.1073/pnas.80.14.4551; Soro A, 2010, MOL ECOL, V19, P3351, DOI 10.1111/j.1365-294X.2010.04753.x; Sun LX, 1997, ANIM BEHAV, V54, P493, DOI 10.1006/anbe.1996.0440; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vereecken NJ, 2007, BEHAV ECOL SOCIOBIOL, V61, P811, DOI 10.1007/s00265-006-0312-z; Westrich P, 1989, WILDBIENEN BADEN WUR; Westrich P., 1989, WILDBIENEN BADEN WU; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1	51	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193153	10.1371/journal.pone.0193153	http://dx.doi.org/10.1371/journal.pone.0193153			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470539	Green Submitted, gold, Green Published			2022-12-26	WOS:000425831000040
J	Loughran, G; Firth, AE; Atkins, JF; Ivanov, IP				Loughran, Gary; Firth, Andrew E.; Atkins, John F.; Ivanov, Ivaylo P.			Translational autoregulation of BZW1 and BZW2 expression by modulating the stringency of start codon selection	PLOS ONE			English	Article							40S RIBOSOMAL-SUBUNIT; INITIATION-FACTORS EIF1; EIF5-MIMIC PROTEIN; MESSENGER-RNAS; RECOGNITION; MECHANISM; SEQUENCES; COMPLEX; CONFORMATION; GENOMES	The efficiency of start codon selection during ribosomal scanning in eukaryotic translation initiation is influenced by the context or flanking nucleotides surrounding the AUG codon. The levels of eukaryotic translation initiation factors 1 (eIF1) and 5 (eIF5) play critical roles in controlling the stringency of translation start site selection. The basic leucine zipper and W2 domain-containing proteins 1 and 2 (BZW1 and BZW2), also known as eIF5-mimic proteins, are paralogous human proteins containing C-terminal HEAT domains that resemble the HEAT domain of eIF5. We show that translation of mRNAs encoding BZW1 and BZW2 homologs in fungi, plants and metazoans is initiated by AUG codons in conserved unfavorable initiation contexts. This conservation is reminiscent of the conserved unfavorable initiation context that enables autoregulation of EIF1. We show that overexpression of BZW1 and BZW2 proteins enhances the stringency of start site selection, and that their poor initiation codons confer autoregulation on BZW1 and BZW2 mRNA translation. We also show that overexpression of these two proteins significantly diminishes the effect of overexpressing eIF5 on stringency of start codon selection, suggesting they antagonize this function of eIF5. These results reveal a surprising role for BZW1 and BZW2 in maintaining homeostatic stringency of start codon selection, and taking into account recent biochemical, genetic and structural insights into eukaryotic initiation, suggest a model for BZW1 and BZW2 function.	[Loughran, Gary; Firth, Andrew E.; Atkins, John F.; Ivanov, Ivaylo P.] Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Firth, Andrew E.] Univ Cambridge, Div Virol, Dept Pathol, Cambridge, England; [Atkins, John F.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Ivanov, Ivaylo P.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	University College Cork; University of Cambridge; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ivanov, IP (corresponding author), Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland.; Ivanov, IP (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA.	ivaylo.ivanov@nih.gov	Loughran, Gary/AAQ-8791-2020	Loughran, Gary/0000-0002-2683-5597; Ivanov, Ivaylo/0000-0002-6008-3261; Firth, Andrew/0000-0002-7986-9520	Science Foundation Ireland [12/IP/1492, 13/1A/1853]; Wellcome Trust [106207]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from Science Foundation Ireland (12/IP/1492 and 13/1A/1853 to J.F.A.), and a grant from the Wellcome Trust to A.E.F. [106207]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2000, GENOME RES, V10, P1172, DOI 10.1101/gr.10.8.1172; Asano K, 2007, GENE DEV, V21, P1280, DOI 10.1101/gad.1562707; Barth-Baus D, 2013, TRANSLATION, V1, DOI 10.4161/trla.24419; Bazykin GA, 2011, NUCLEIC ACIDS RES, V39, P567, DOI 10.1093/nar/gkq806; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Das S, 2001, J BIOL CHEM, V276, P6720, DOI 10.1074/jbc.M008863200; Fijalkowska D, 2017, NUCL ACIDS RES; Grentzmann G, 1998, RNA, V4, P479; Hinnebusch AG, 2007, TRANSLATIONAL CONTRO; Hinnebusch AG, 2017, TRENDS BIOCHEM SCI, V42, P589, DOI 10.1016/j.tibs.2017.03.004; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Hiraishi H, 2014, NUCLEIC ACIDS RES, V42, P10321, DOI 10.1093/nar/gku670; Ivanov IP, 2010, P NATL ACAD SCI USA, V107, P18056, DOI 10.1073/pnas.1009269107; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jacobs GH, 2009, NUCLEIC ACIDS RES, V37, pD72, DOI 10.1093/nar/gkn763; Jennings MD, 2010, NATURE, V465, P378, DOI 10.1038/nature09003; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kozel C, 2016, NUCLEIC ACIDS RES, V44, P8704, DOI 10.1093/nar/gkw559; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee S, 2007, DEVELOPMENT, V134, P1767, DOI 10.1242/dev.02842; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Loughran G, 2012, NUCLEIC ACIDS RES, V40, P2898, DOI 10.1093/nar/gkr1192; Luna RE, 2012, CELL REPORTS, V1, P689, DOI 10.1016/j.celrep.2012.04.007; Martin-Marcos P, 2011, MOL CELL BIOL, V31, P4814, DOI 10.1128/MCB.05819-11; Miyasaka H, 2010, J BIOSCI BIOENG, V109, P635, DOI 10.1016/j.jbiosc.2009.11.022; Nakagawa S, 2008, NUCLEIC ACIDS RES, V36, P861, DOI 10.1093/nar/gkm1102; Nanda JS, 2013, J BIOL CHEM, V288, P5316, DOI 10.1074/jbc.M112.440693; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Obayashi E, 2017, CELL REP, V18, P2651, DOI 10.1016/j.celrep.2017.02.052; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Paulin FEM, 2001, CURR BIOL, V11, P55, DOI 10.1016/S0960-9822(00)00025-7; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Singh CR, 2011, NUCLEIC ACIDS RES, V39, P8314, DOI 10.1093/nar/gkr339; Tang LM, 2017, NUCLEIC ACIDS RES, V45, P11941, DOI 10.1093/nar/gkx808; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102	41	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192648	10.1371/journal.pone.0192648	http://dx.doi.org/10.1371/journal.pone.0192648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470543	Green Published, Green Submitted, gold			2022-12-26	WOS:000425831000015
J	Chisty, LT; Quaglia, D; Webb, MR				Chisty, Liisa T.; Quaglia, Daniela; Webb, Martin R.			Fluorescent single-stranded DNA-binding protein from Plasmodium falciparum as a biosensor for single-stranded DNA	PLOS ONE			English	Article							C-TERMINAL TAILS; E. COLI SSB; ESCHERICHIA-COLI; INORGANIC-PHOSPHATE; HELICASE ACTIVITY; CRYSTAL-STRUCTURE; MECHANISM; MULTIPLE; DOMAIN; REPLICATION	Single-stranded DNA (ssDNA) is a product of many cellular processes that involve double-stranded DNA, for example during DNA replication and repair, and is formed transiently in many others. Measurement of ssDNA formation is fundamental for understanding many such processes. The availability of a fluorescent biosensor for the determination of single-stranded DNA provides an important route to achieve this. Single-stranded DNA binding proteins (SSBs) protect ssDNA from degradation, but can be displaced to allow processing of the ssDNA. Their tight binding of ssDNA means that they are very good candidates for the development of a biosensor. Previously, the single stranded DNA binding protein from Escherichia coli, labeled with a fluorophore, (DCC-EcSSB) was developed and used for this purpose. However, the multiple binding modes of this protein meant that interpretation of DCC-EcSSB fluorescence was potentially complex in terms of determining the amount of ssDNA. Here, we present an improved biosensor, developed using the tetrameric SSB from Plasmodium falciparum as a new scaffold for fluorophore attachment. Each subunit of this tetrameric SSB was labeled with a diethylaminocoumarin fluorophore at a single site on its surface, such that there is a very large, 20-fold, fluorescence increase when it binds to ssDNA. This adduct can be used as a biosensor to report ssDNA formation. Because SSB from this organism has a single mode of binding ssDNA, namely 65-70 bases per tetramer, over a wide range of conditions, the fluorescent SSB allows simple quantitation of ssDNA. The binding is fast, possibly diffusion controlled, and tight (dissociation constant for DCC-PfSSB < 5 pM). Its suitability for real-time assays of ssDNA formation was demonstrated by measurement of AddAB helicase activity, unwinding double-stranded DNA.	[Chisty, Liisa T.; Quaglia, Daniela; Webb, Martin R.] Francis Crick Inst, London, England; [Quaglia, Daniela] Univ Montreal, Dept Biochem, 2900 Blvd Edouard Montpetit, Montreal, PQ, Canada	Francis Crick Institute; Universite de Montreal	Webb, MR (corresponding author), Francis Crick Inst, London, England.	martin.webb@crick.ac.uk		Quaglia, Daniela/0000-0003-3756-3782; Webb, Martin/0000-0002-0134-9621	Francis Crick Institute from Cancer Research UK [FC001211]; UK Medical Research Council [FC001211]; Wellcome Trust [FC001211]; MRC Technology [A853/0164]	Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC Technology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001211; www.cancerresearchuk.org), the UK Medical Research Council (FC001211; https://www.mrc.ac.uk), and the Wellcome Trust (FC001211; wellcome.ac.uk). In addition, this research was supported by a grant from MRC Technology (A853/0164; www.lifearc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony E, 2013, J MOL BIOL, V425, P4802, DOI 10.1016/j.jmb.2013.08.021; Antony E, 2012, J MOL BIOL, V420, P284, DOI 10.1016/j.jmb.2012.04.022; Antony E, 2012, J MOL BIOL, V420, P269, DOI 10.1016/j.jmb.2012.04.021; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; CHAURASIA CS, 1990, J HETEROCYCLIC CHEM, V27, P727, DOI 10.1002/jhet.5570270347; CORRIE JET, 1994, J CHEM SOC PERK T 1, P2967, DOI 10.1039/p19940002967; CORRIE JET, 1994, J CHEM SOC PERK T 1, P2975, DOI 10.1039/p19940002975; Dillingham MS, 2008, BIOPHYS J, V95, P3330, DOI 10.1529/biophysj.108.133512; Eggleston AK, 1996, NUCLEIC ACIDS RES, V24, P1179, DOI 10.1093/nar/24.7.1179; FLETCHER AN, 1978, APPL PHYS, V16, P289, DOI 10.1007/BF00885124; Green M, 2014, BIOSENS BIOELECTRON, V61, P579, DOI 10.1016/j.bios.2014.06.011; Hirshberg M, 1998, BIOCHEMISTRY-US, V37, P10381, DOI 10.1021/bi980428z; Kozlov AG, 2015, J MOL BIOL, V427, P763, DOI 10.1016/j.jmb.2014.12.020; Kunzelmann S., 2014, FLUORESCENT METHODS, V105, P25, DOI DOI 10.1007/978-3-0348-0856-9_; Kunzelmann S, 2010, BIOCHEMISTRY-US, V49, P843, DOI 10.1021/bi901743k; Leatherbarrow R.J., 2009, GRAFIT VERSION 7; LOHMAN TM, 1986, J MOL BIOL, V187, P603, DOI 10.1016/0022-2836(86)90338-4; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Prusty D, 2010, NUCLEIC ACIDS RES, V38, P7037, DOI 10.1093/nar/gkq565; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Ranjit V, 2006, ARKIVOC, P143, DOI 10.3998/ark.5550190.0007.217; REYNOLDS GA, 1975, OPT COMMUN, V13, P222, DOI 10.1016/0030-4018(75)90085-1; RYE HS, 1991, NUCLEIC ACIDS RES, V19, P327, DOI 10.1093/nar/19.2.327; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Shishmarev D, 2014, NUCLEIC ACIDS RES, V42, P2750, DOI 10.1093/nar/gkt1238; Slatter AF, 2009, BIOCHEMISTRY-US, V48, P6326, DOI 10.1021/bi900101h; Yeeles JTP, 2007, J MOL BIOL, V371, P66, DOI 10.1016/j.jmb.2007.05.053; Yeeles JTP, 2011, NUCLEIC ACIDS RES, V39, P2271, DOI 10.1093/nar/gkq1124	30	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193272	10.1371/journal.pone.0193272	http://dx.doi.org/10.1371/journal.pone.0193272			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466468	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300106
J	Diaz, TG; Branco, AF; Jacovaci, FA; Jobim, CC; Bolson, DC; Daniel, JLP				Diaz, Tatiana Garcia; Branco, Antonio Ferriani; Jacovaci, Fernando Alberto; Jobim, Cloves Cabreira; Bolson, Dheyme Cristina; Pratti Daniel, Joao Luiz			Inclusion of live yeast and mannan-oligosaccharides in high grain-based diets for sheep: Ruminal parameters, inflammatory response and rumen morphology	PLOS ONE			English	Article							NUTRIENT DIGESTIBILITY; ACIDOSIS CHALLENGES; GROWTH-PERFORMANCE; DRIED YEAST; DAIRY-COWS; CELL-WALL; LIPOPOLYSACCHARIDE; FERMENTATION; SUPPLEMENTATION; ABSCESSES	The objective of this study was to evaluate the effects of dietary supplementation with live yeast (Saccharomyces cerevisiae), mannan-oligosaccharides and the combination of these additives on the inflammatory response, ruminal parameters and rumen morphology of sheep fed a high grain-based diet. Thirty-Two Dorper x Santa Ines crossbred lambs with an average weight of 24 +/- 2 kg were distributed in a completely randomized design. The animals were housed in individual stalls and fed ad libitum. Diet treatments were: Control (without additive); LY (2 g/kg DM of live yeast, Saccharomyces cerevisiae), MOS (2 g/kg DM of mannan- oligosaccharides) and LY+MOS (2 g/kg DM of LY + 2 g/kg DM of MOS). The experiment lasted 42 days. The supplementation with MOS alone and the additives combination resulted in increased ruminal pH (P<0.01), while the total concentrations of short chain fatty acids (SCFA) in the rumen were higher (P<0.05) only in the diets with LY and MOS. Ammonia (NH3) concentration in the rumen decreased (P<0.04) with the additives usage. Diets with LY, MOS and with additives combination reduced (P<0.01) the levels of lipopolysaccharides (LPS) in the plasma with values of 0.46; 0.44 and 0.04 EU/mL, respectively when compared to the control (0.93 EU/mL). MOS and LY+MOS treatments had reduced stratum corneum thickness (P<0.01) in comparison to the control treatment. The total thickness of ruminal epithelium was lower with the addition of MOS in the diet (P<0.03) than with LY additive. The incidence and severity of hepatic abscesses in animals whose diet was supplemented with LY and LY+MOS was lower (P<0.05) than in animals fed the control diet. The use of LY, MOS and LY+MOS in the high-concentrate diets for sheep reduced NH3 concentrations and LPS translocation into the bloodstream. Diets containing MOS and LY+MOS enhanced the health of the ruminal epithelium by reducing the thickness of the stratum corneum, and diets containing LY and LY+MOS decreased the incidence and severity of hepatic abscesses.	[Diaz, Tatiana Garcia; Branco, Antonio Ferriani; Jacovaci, Fernando Alberto; Jobim, Cloves Cabreira; Bolson, Dheyme Cristina; Pratti Daniel, Joao Luiz] Univ Estadual Maringa, Dept Anim Sci, Av Colombo,Bloco J45, Maringa, Parana, Brazil	Universidade Estadual de Maringa	Branco, AF (corresponding author), Univ Estadual Maringa, Dept Anim Sci, Av Colombo,Bloco J45, Maringa, Parana, Brazil.	tatianagarcia.diaz@gmail.com	Branco, Antonio F/V-9850-2017; Daniel, Joao/I-1355-2012	Daniel, Joao/0000-0003-0569-899X; Garcia Diaz, Tatiana/0000-0003-1700-3382; Jobim, Cloves/0000-0002-1623-1685	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/ Student Agreement Program Graduate (PEC-PG) [14820-12-9]; Student Agreement Program Graduate (PEC-PG)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/ Student Agreement Program Graduate (PEC-PG); Student Agreement Program Graduate (PEC-PG)	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)/ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/ Student Agreement Program Graduate (PEC-PG), Process number: 14820-12-9 (http://www.capes.gov.br/cooperacao-internacional/multinacional/pec-pg) Doctoral scholarships (up to 48 months, CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Student Agreement Program Graduate (PEC-PG) granting the scholarship.	Abdela N., 2016, ACHIEV LIFE SCI, V10, P187, DOI [10.1016/j.als.2016.11., DOI 10.1016/J.ALS.2016.11.006, 10.1016/j.als.2016.11.006]; Alshaikh MA, 2002, J ANIM SCI, V15, P352; Amachawadi RG, 2016, J ANIM SCI, V94, P1620, DOI 10.2527/jas.2015-0261; AOAC, 2002, OFFICIAL METHODS ANA, Vfifteenth; Bach A, 2007, FEED SCI TECHNOL, V136, P146; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; BRINK DR, 1990, J ANIM SCI, V68, P1201; Brown TR, 2010, J ANIM SCI, V88, P4037, DOI 10.2527/jas.2010-3219; CHANEY AL, 1962, CLIN CHEM, V8, P130; Chang GJ, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0376-y; Chung YH, 2011, J DAIRY SCI, V94, P2431, DOI 10.3168/jds.2010-3277; Ding J, 2008, ASIAN AUSTRAL J ANIM, V21, P547, DOI 10.5713/ajas.2008.70353; Dohme F, 2008, J DAIRY SCI, V91, P3554, DOI 10.3168/jds.2008-1264; Emmanuel DGV, 2008, J DAIRY SCI, V91, P606, DOI 10.3168/jds.2007-0256; Emmanuel DGV, 2007, J DAIRY SCI, V90, P5552, DOI 10.3168/jds.2007-0257; Hady MM, 2012, J CHEM ENG APPL, V3, P264, DOI DOI 10.7763/IJCEA.2012.V3.197; Heinrichs AJ, 2003, J DAIRY SCI, V86, P4064, DOI 10.3168/jds.S0022-0302(03)74018-1; HINDERS RG, 1965, J DAIRY SCI, V48, P1069, DOI 10.3168/jds.S0022-0302(65)88393-X; Huo WJ, 2013, ASIAN AUSTRAL J ANIM, V26, P1437, DOI 10.5713/ajas.2013.13143; Khafipour E, 2009, J DAIRY SCI, V92, P1060, DOI 10.3168/jds.2008-1389; Kleen JL, 2003, J VET MED A, V50, P406, DOI 10.1046/j.1439-0442.2003.00569.x; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Lei CL, 2013, LIVEST SCI, V158, P57, DOI 10.1016/j.livsci.2013.08.019; Li GH, 2011, REV MED VET-TOULOUSE, V162, P192; Meissner S, 2017, J DAIRY SCI, V100, P6662, DOI 10.3168/jds.2016-12262; Mertens DR, 2001, J AOAC, V85, P1217; Mohebbi M., 2010, Comparative Clinical Pathology, V19, P541, DOI 10.1007/s00580-009-0918-4; Nagaraja TG, 1998, J ANIM SCI, V76, P287; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Nocek JE, 1997, J DAIRY SCI, V80, P1005, DOI 10.3168/jds.S0022-0302(97)76026-0; Nowroozi-Asl A, 2008, IRAN J VET RES, V9, P171; Oeztuerk H, 2016, VET MED-CZECH, V61, P195, DOI 10.17221/8820-VETMED; Pinloche E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067824; Prophet E.M., 1992, LAB METHODS IS HISTO; SAS Institute, 2009, SAS PROP SOFTW REL 9; Silberberg M, 2013, ANIMAL, V7, P1910, DOI 10.1017/S1751731113001705; Steele MA, 2012, J DAIRY SCI, V95, P318, DOI 10.3168/jds.2011-4465; Steele MA, 2011, AM J PHYSIOL-REG I, V300, pR1515, DOI 10.1152/ajpregu.00120.2010; Steele MA, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-39; VANSOEST PJ, 1973, J ASSOC OFF ANA CHEM, V56, P781; Vyas D, 2014, J ANIM SCI, V92, P724, DOI 10.2527/jas.2013-7072; Zebeli Q, 2008, J DAIRY SCI, V91, P2046, DOI 10.3168/jds.2007-0572	42	26	29	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193313	10.1371/journal.pone.0193313	http://dx.doi.org/10.1371/journal.pone.0193313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466450	Green Submitted, Green Published, gold			2022-12-26	WOS:000425604300114
J	Jiang, YH; Wang, CC; Kuo, HC				Jiang, Yuan-Hong; Wang, Chung-Cheng; Kuo, Hann-Chorng			Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment	PLOS ONE			English	Article							OVERACTIVE BLADDER; EAU GUIDELINES; TOLTERODINE; PATHOPHYSIOLOGY; OBSTRUCTION; MIRABEGRON	Objective To analyze the underlying lower urinary tract dysfunctions by video-urodynamic studies in men who have persistent storage symptoms after initial drug therapy for lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH). Methods The medical records of 614 men >= 40 years of age with LUTS and an International Prostate Symptom Score of >= 8 were retrospectively analyzed. All patients had persistent storage symptoms after medical treatment for at least 6 months. A video-urodynamic study was done to investigate the underlying bladder or bladder outlet dysfunction. Predictors of bladder outlet obstruction (BOO) by baseline urine flow metrics and prostate parameters were investigated. Results The final results revealed bladder neck dysfunction (BND) in 137/614 (22.3%), benign prostatic obstruction (BPO) in 246/614 (40.1%), detrusor overactivity (DO) in 193/614 (31.4%), and DO with detrusor underactivity (DO+DU) in 38/614 (6.2%) patients. Among the patients, 221/281 (78.6%) with a total prostatic volume (TPV) >= 40 ml had BOO, including 43/281 (15.3%) with BND and 178/281 (63.3%) with BPO. If we combined TPV >= 40 ml and Qmax <12 ml/s as predictors of BOO, BOO was found in 176/215 (81.8%) patients including 34/215 (15.8%) with BND and 142/215 (66.0%) with BPO. BOO was also found in 48.8% of men with a TPV <40ml, and in 36.3% of men with TPV< 40 ml and Qmax >= 12 ml/s. In 102 men with TPV < 40 ml and Qmax >= 12 ml/s, 64 (62.7%) had DO. Conclusion BOO, including BND and BPO, comprise 62.4% (383/614) of men with persistent storage symptoms after initial medical treatment for LUTS/BPH. In men who have persistent storage symptoms after medical treatment for LUTS/BPH, BOO should be carefully investigated and appropriate management being given to improve LUTS.	[Jiang, Yuan-Hong; Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Jiang, Yuan-Hong; Kuo, Hann-Chorng] Tzu Chi Univ, Hualien, Taiwan; [Wang, Chung-Cheng] Natl Taiwan Univ, Coll Med, En Chu Kong Hosp, Dept Urol, New Taipei, Taiwan; [Wang, Chung-Cheng] Chung Yuan Christian Univ, Dept Biomed Engn, Taoyuan, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; National Taiwan University; Chung Yuan Christian University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.; Kuo, HC (corresponding author), Tzu Chi Univ, Hualien, Taiwan.	hck@tzuchi.com.tw						Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Abrams P, 2015, EUR UROL, V67, P577, DOI 10.1016/j.eururo.2014.02.012; AUA Practise Guidelines Committee, 2003, J UROLOGY, V170, P530, DOI 10.1097/01.ju.0000078083.38675.79; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Chen JL., 2006, JUTA, V17, P41; Chung SD, 2011, NEUROUROL URODYNAM, V30, P568, DOI 10.1002/nau.20923; Cockett A. T., 1994, P 2 INT CONS BEN PRO, P553; de la Rosette JJMCH, 2001, EUR UROL, V40, P256, DOI 10.1159/000049784; Eckhardt MD, 2001, UROLOGY, V58, P966, DOI 10.1016/S0090-4295(01)01413-3; Gnanapragasam VJ, 2011, UROL INT, V86, P85, DOI 10.1159/000318568; Gomes CM, 2008, UROL INT, V81, P129, DOI 10.1159/000144049; Ignjatovic Ivan, 2001, International Urology and Nephrology, V32, P655, DOI 10.1023/A:1014457808748; Kaplan SA, 2006, JAMA-J AM MED ASSOC, V296, P2319, DOI 10.1001/jama.296.19.2319; Ke QS, 2015, LUTS, V7, P143, DOI 10.1111/luts.12067; Kuo HC, 2007, UROLOGY, V70, P272, DOI 10.1016/j.urology.2007.03.063; Kuo HC, 2015, NEUROUROL URODYNAM, V34, P685, DOI 10.1002/nau.22645; Kuo HC, 2002, UROL INT, V68, P99, DOI 10.1159/000048427; Lee JY, 2004, BJU INT, V94, P817, DOI 10.1111/j.1464-410X.2004.05039.x; Liao CH, 2011, INT J CLIN PRACT, V65, P552, DOI 10.1111/j.1742-1241.2011.02638.x; Maeda T, 2015, UROLOGY, V85, P1151, DOI 10.1016/j.urology.2015.01.028; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Milsom I, 2001, BJU INT, V87, P760, DOI 10.1046/j.1464-410x.2001.02228.x; NEAL DE, 1989, BRIT MED J, V299, P762, DOI 10.1136/bmj.299.6702.762; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Rutman MP, 2012, CURR UROL REP, V13, P370, DOI 10.1007/s11934-012-0265-x	25	12	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0190704	10.1371/journal.pone.0190704	http://dx.doi.org/10.1371/journal.pone.0190704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462145	Green Submitted, Green Published, gold			2022-12-26	WOS:000425554200007
J	Li, HZ; Li, M; Yang, XR; Gui, X; Chen, GF; Chu, JY; He, XW; Wang, WT; Han, F; Li, P				Li, Haizhou; Li, Min; Yang, Xinrui; Gui, Xin; Chen, Guofeng; Chu, Jiuyun; He, Xingwang; Wang, Weitao; Han, Feng; Li, Ping			Microbial diversity and component variation in Xiaguan Tuo Tea during pile fermentation	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CATALYZED REPORTER DEPOSITION; YEAST ARXULA-ADENINIVORANS; FREE AMINO-ACIDS; PU-ERH TEA; CARD-FISH; CAFFEINE; FUNGI; BLACK; OPTIMIZATION	Xiaguan Tuo Tea is largely consumed by the Chinese, but there is little research into the microbial diversity and component changes during the fermentation of this tea. In this study, we first used fluorescence in situ hybridization (FISH), next-generation sequencing (NGS) and chemical analysis methods to determine the microbial abundance and diversity and the chemical composition during fermentation. The FISH results showed that the total number of microorganisms ranges from 2.3x10(2) to 4.0x10(8) cells per gram of sample during fermentation and is mainly dominated by fungi. In the early fermentation stages, molds are dominant (0.6x10(2)similar to 2.8x10(6) cells/g, 0 similar to 35 d). However, in the late stages of fermentation, yeasts are dominant (3.6x10(4)similar to 9.6x10(6) cells/g, 35 similar to 56 d). The bacteria have little effect during the fermentation of tea (10(2)similar to 10(3) cells/g, <1% of fungus values). Of these fungi, A. niger (Aspergillus niger) and B. adeninivorans (Blastobotrys adeninivorans) are identified as the two most common strains, based on Next-generation Sequencing (NGS) analysis. Peak diversity in tea was observed at day 35 of fermentation (Shannon-Weaver index: 1.195857), and lower diversity was observed on days 6 and 56 of fermentation (Shannon-Weaver index 0.860589 and 1.119106, respectively). During the microbial fermentation, compared to the unfermented tea, the tea polyphenol content decreased by 54%, and the caffeine content increased by 59%. Theanine and free amino acid contents were reduced during fermentation by 81.1 and 92.85%, respectively.	[Li, Haizhou; Li, Min; Yang, Xinrui; Gui, Xin; Li, Ping] Tongji Univ, Sch Life Sci & Technol, Shanghai East Hosp, Res Ctr Translat Med, Shanghai, Peoples R China; [Chen, Guofeng; Chu, Jiuyun; He, Xingwang; Wang, Weitao] Yunnan Xiaguan Tuo Tea Grp Co Ltd, Dali, Yunnan, Peoples R China; [Han, Feng] Tongji Univ, Coll Architecture & Urban Planning, Shanghai, Peoples R China	Tongji University; Tongji University	Li, P (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai East Hosp, Res Ctr Translat Med, Shanghai, Peoples R China.	liping01@tongji.edu.cn			National Key Technology R&D Program of China [2015BAD16601]; National Natural Science Foundation of China [21476176]; National High Technology Research and Development Program of China (863 Program) [2015AA021002]; Yunnan Xiaguan Tuo Tea (Group) Co.	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Yunnan Xiaguan Tuo Tea (Group) Co.	This study was funded by the National Key Technology R&D Program of China (No. 2015BAD16601), the National Natural Science Foundation of China (No. 21476176), the National High Technology Research and Development Program of China (863 Program, No. 2015AA021002). We would like to acknowledge the Yunnan Xiaguan Tuo Tea (Group) Co., Ltd, which provided support in the form of salaries and research materials for authors [GC, JC, XH, WW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, INT J FOOD MICROBIOL, V124, P199, DOI 10.1016/j.ijfoodmicro.2008.03.008; Alcazar A, 2007, J AGR FOOD CHEM, V55, P5960, DOI 10.1021/jf070601a; Bae IK, 2015, FOOD CHEM, V172, P469, DOI 10.1016/j.foodchem.2014.09.050; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Baruah AM, 2003, J AGR FOOD CHEM, V51, P6578, DOI 10.1021/jf030019w; Belay A, 2008, FOOD CHEM, V108, P310, DOI 10.1016/j.foodchem.2007.10.024; Beresniak A, 2012, BMJ OPEN, V2; Chakravorty S, 2016, INT J FOOD MICROBIOL, V220, P63, DOI 10.1016/j.ijfoodmicro.2015.12.015; DeLong EF, 1999, APPL ENVIRON MICROB, V65, P5554; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1883, DOI 10.1016/j.soilbio.2008.03.024; Gong Z, 2014, BIOSCIENCE BIOTECHNO, V57, P1745; Horie H, 2000, J CHROMATOGR A, V881, P425, DOI 10.1016/S0021-9673(99)01345-X; Jobard M, 2010, J MICROBIOL METH, V83, P236, DOI 10.1016/j.mimet.2010.09.006; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kunamneni A, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-32; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee Y, 2015, J SCI FOOD AGR, V95, P2686, DOI 10.1002/jsfa.7003; Li HZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17056; Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b; Lyu CY, 2013, J SCI FOOD AGR, V93, P3165, DOI 10.1002/jsfa.6149; Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000; MIDDELHOVEN WJ, 1984, A VAN LEEUW J MICROB, V50, P369, DOI 10.1007/BF00394651; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; REINHARD A, 1994, MICROBIOL RES, V149, P75; Sahay R, 2009, APPL BIOCHEM BIOTECH, V157, P311, DOI 10.1007/s12010-008-8265-5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Subramanian N, 1999, J AGR FOOD CHEM, V47, P2571, DOI 10.1021/jf981042y; Tian JQ, 2013, J FOOD SCI, V78, pM1249, DOI 10.1111/1750-3841.12218; Trevisanato SI, 2000, NUTR REV, V58, P1, DOI 10.1111/j.1753-4887.2000.tb01818.x; Wang XG, 2005, J AGR FOOD CHEM, V53, P7238, DOI 10.1021/jf050495h; Wartmann T, 2000, APPL MICROBIOL BIOT, V54, P619, DOI 10.1007/s002530000444; Widlansky ME, 2005, FREE RADICAL BIO MED, V38, P499, DOI 10.1016/j.freeradbiomed.2004.11.013; Xu AQ, 2011, INT J FOOD MICROBIOL, V146, P14, DOI 10.1016/j.ijfoodmicro.2011.01.024; Xu X, 2005, ENG LIFE SCI, V5, P382, DOI 10.1002/elsc.200520083; Yang XX, 2000, ANTON LEEUW INT J G, V77, P303, DOI 10.1023/A:1002636606282; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang QZ, 2006, MOL CANCER THER, V5, P1227, DOI 10.1158/1535-7163.MCT-05-0490; Zhang W, 2016, INT J FOOD MICROBIOL, V227, P29, DOI 10.1016/j.ijfoodmicro.2016.03.025; Zhang Y, 2016, PLOS ONE, V11; Zhu YC, 2016, FOOD CHEM, V194, P643, DOI 10.1016/j.foodchem.2015.08.054	43	9	11	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0190318	10.1371/journal.pone.0190318	http://dx.doi.org/10.1371/journal.pone.0190318			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462204	Green Published, gold, Green Submitted			2022-12-26	WOS:000425554200006
J	Taramasso, L; Di Biagio, A; Bovis, F; Nicolini, LA; Antinori, A; Milazzo, L; Sollima, S; Gubertini, G; Niero, F; Saracino, A; Bruno, R; Borghi, V; Montagnani, F; Cattelan, A; Hasson, H; Taliani, G; Monforte, AD; Mastroianni, C; Di Perri, G; Bigoni, S; Puoti, M; Spinetti, A; Gori, A; Boffa, N; Cacopardo, B; Giacometti, A; Parruti, G; Vullo, V; Chirianni, A; Teti, E; Pasquazzi, C; Segala, D; Andreoni, M				Taramasso, Lucia; Di Biagio, Antonio; Bovis, Francesca; Nicolini, Laura Ambra; Antinori, Andrea; Milazzo, Laura; Sollima, Salvatore; Gubertini, Guido; Niero, Fosca; Saracino, Annalisa; Bruno, Raffaele; Borghi, Vanni; Montagnani, Francesca; Cattelan, Annamaria; Hasson, Hamid; Taliani, Gloria; Monforte, Antonella D'Arminio; Mastroianni, Claudio; Di Perri, Giovanni; Bigoni, Sara; Puoti, Massimo; Spinetti, Angiola; Gori, Andrea; Boffa, Nicola; Cacopardo, Bruno; Giacometti, Andrea; Parruti, Giustino; Vullo, Vincenzo; Chirianni, Antonio; Teti, Elisabetta; Pasquazzi, Caterina; Segala, Daniela; Andreoni, Massimo			Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir +/- ribavirin in HIV/HCV co-infected patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GENOTYPE 1 INFECTION; TREATMENT-EXPERIENCED PATIENTS; SUSTAINED VIROLOGICAL RESPONSE; CLINICAL-PRACTICE GUIDELINE; DIRECT-ACTING ANTIVIRALS; TREATMENT-NAIVE PATIENTS; HEPATITIS-C; VIRUS-INFECTION; OPEN-LABEL	The renal function is a key-issue in HIV/HCV co-infected patients, nevertheless, it has not established so far whether HCV treatment with new direct acting agents could impact on estimated glomerular filtration rate (eGFR) variations. In the present work, we examined the real-life data on renal function that have been prospectively collected in the SIMIT compassionate-use program of ombitasvir/paritaprevir/ritonavir plus dasabuvir (OBV/PTV/r + DSV) in 144 HIV/HCV genotype 1 co-infected patients. The population was 74% male, 30.5% in CDC stage C, with median age of 52 years (48.0-56.5) and median liver stiffness of 7.8 kPa (6.7-9.2). Median baseline eGFR was 102.0 (90.8-108.1), changing to 99.8 (83.5-104.8) at the end of treatment (EoT), and 100.0 (87.3-105.6) 12 weeks after the EoT (FU12), p < 0.0001. No patient had grade 3-4 increase of creatinine. At EoT 60/144 (41.7%) patients had >= 5% reduction in their eGFR, confirmed at FU12 in 39/60 (65.0%) cases. Longer duration of HCV infection (cut-off 12.9 years), lower HCV-RNA viral load (cut-off 1,970,160 IU/ml) and lower platelet count (cut-off 167,000 x 10(6)/L) were significantly associated with eGFR decline at logistic analysis (adjOR 2.9, 95% CI 1.0-8.8, p = 0.05; adjOR 3.5, 95%CI 1.2-10.4, p = 0.02; adjOR 2.8, 95% CI 1.1-6.8, p = 0.03, respectively). After repeating the analysis throughout a mixed model, a higher eGFR decline was highlighted in patients concomitantly treated with tenofovir (p = 0.0001), ribavirin (p = 0.0001), or integrase inhibitors (p < 0.0001), with longer duration of HIV (p = 0.0002) and HCV infection (p = 0.035), lower baseline HCV RNA (p < 0.0001), previous HCV treatment (p < 0.0001), and older age (p < 0.0001). In conclusion, our study confirms a good renal safety profile of OBV/PTV/r + DSV treatment in HIV/HCV patients, and the median decline of 2 ml/min in eGFR, albeit statistically significant, is of doubtful clinical significance. The role of aging, concomitant therapies and duration of HIV/HCV infection needs to be further investigated.	[Taramasso, Lucia; Nicolini, Laura Ambra] Univ Genova DISSAL, Infect Dis Clin, Policlin Hosp San Martino, Genoa, Italy; [Di Biagio, Antonio] Policlin Hosp San Martino, Infect Dis Clin, Genoa, Italy; [Bovis, Francesca] Univ Genoa, Dept Hlth Sci, Biostat Unit, Genoa, Italy; [Antinori, Andrea] INMI L Spallanzani, Natl Inst Infect Dis, Clin Dept, Rome, Italy; [Nicolini, Laura Ambra; Antinori, Andrea] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy; [Gubertini, Guido; Niero, Fosca] ASST Fatebenefratelli Sacco, Div Infect Dis 1, Milan, Italy; [Saracino, Annalisa] Univ Bari, Inst Infect Dis, Bari, Italy; [Bruno, Raffaele] IRCCS, Policlin San Matteo, Div Infect & Trop Dis, Pavia, Italy; [Borghi, Vanni] Univ Hosp, Infect Dis Clin, Modena, Italy; [Montagnani, Francesca] Univ Infect Dis Unit, AOU Senese, Dept Internal & Specialty Med, Siena, Italy; [Cattelan, Annamaria] Univ Hosp, Dept Infect & Trop Dis, Padua, Italy; [Hasson, Hamid] Ist Sci San Raffaele, Dept Infect Dis, Milan, Italy; [Taliani, Gloria] Sapienza Univ Rome, Dept Clin Med, Policlin Umberto 1, Rome, Italy; [Monforte, Antonella D'Arminio] Univ Milan, Dept Hlth Sci, Clin Infect & Trop Dis, Milan, Italy; [Mastroianni, Claudio] Sapienza Univ Rome, Infect Dis Unit, Latina, Italy; [Mastroianni, Claudio] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Policlin Umberto, Rome, Italy; [Di Perri, Giovanni] Univ Turin, Amedeo Savoia Hosp, Dept Med Sci, Unit Infect Dis, Turin, Italy; [Bigoni, Sara] AO Papa Giovanni XXIII, Div Infect Dis, Bergamo, Italy; [Puoti, Massimo] AO Niguarda Ca Granda Hosp, Div Infect Dis, Milan, Italy; [Spinetti, Angiola] Univ Brescia, Div Infect & Trop Dis, Brescia, Italy; [Spinetti, Angiola] Spedali Civili Gen Hosp, Brescia, Italy; [Gori, Andrea] Univ Milano Bicocca, San Gerardo Hosp, Div Infect Dis, Dept Internal Med, Milan, Italy; [Boffa, Nicola] S Giovanni Dio & Ruggi Aragona Hosp, Div Infect Dis 1, Salerno, Italy; [Cacopardo, Bruno] Univ Catania, ARNAS Garibaldi Hosp, Div Infect Dis, Dept Clin & Expt Med, Catania, Italy; [Giacometti, Andrea] Marche Polytech Univ, Infect Dis Unit, Osped Riuniti, Dept Biomed Sci & Publ Hlth, Ancona, Italy; [Parruti, Giustino] Pescara Gen Hosp, Infect Dis Unit, Pescara, Italy; [Vullo, Vincenzo] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Policlin Umberto 1, Rome, Italy; [Chirianni, Antonio] AORN Osped Colli, UOCPO Cotugno 3, Naples, Italy; [Teti, Elisabetta; Andreoni, Massimo] Tor Vergata Univ, Dept Syst Med, Clin Infect Dis, Rome, Italy; [Pasquazzi, Caterina] Sapienza Univ Rome, St Andrea Hosp, Clin Infect Dis, Rome, Italy; [Segala, Daniela] Univ Hosp Ferrara, Unit Infect Dis, Ferrara, Italy	University of Genoa; IRCCS Lazzaro Spallanzani; University of Milan; Universita degli Studi di Bari Aldo Moro; IRCCS Fondazione San Matteo; University of Pavia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; University of Siena; University Hospital of Siena; University of Padua; Azienda Ospedaliera - Universita di Padova; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sapienza University Rome; University Hospital Sapienza Rome; University of Milan; Sapienza University Rome; Sapienza University Rome; University Hospital Sapienza Rome; University of Turin; ASST Papa Giovanni XXIII; University of Brescia; Hospital Spedali Civili Brescia; San Gerardo Hospital; University of Milano-Bicocca; University of Catania; Marche Polytechnic University; Sapienza University Rome; University Hospital Sapienza Rome; University of Rome Tor Vergata; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Ferrara; Arcispedale Sant'Anna	Di Biagio, A (corresponding author), Policlin Hosp San Martino, Infect Dis Clin, Genoa, Italy.	antonio.dibiagio@hsanmartino.it	CATTELAN, ANNA MARIA/AAL-3654-2020; Montagnani, Francesca/R-3334-2016; MASTROIANNI, Claudio Maria/O-9741-2019; Antinori, Andrea/K-7125-2016; Taramasso, Lucia/J-3358-2019; Bruno, Raffaele/AAB-9491-2022; Puoti, Massimo/AAA-6580-2020; Andreoni, Masimo/AAL-2214-2020; Di Perri, Giovanni/AAC-1882-2019; Gori, Andrea/AAC-6078-2022; Di Biagio, Antonio/J-4901-2019	CATTELAN, ANNA MARIA/0000-0003-2869-2945; Montagnani, Francesca/0000-0002-2267-1337; MASTROIANNI, Claudio Maria/0000-0002-1286-467X; Antinori, Andrea/0000-0003-2121-4684; Taramasso, Lucia/0000-0002-6622-6358; Bruno, Raffaele/0000-0002-0235-9207; Di Biagio, Antonio/0000-0003-1436-5089; BOVIS, FRANCESCA/0000-0002-3823-4000; Segala, Daniela/0000-0001-6133-0386; Puoti, Massimo/0000-0003-3278-7138; cacopardo, bruno/0000-0002-7465-0714				Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; American Association for the Study of Liver Diseases Infectious Diseases Society of America, HCV GUID REC TEST MA; Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; Andreoni M, 2017, CLIN INFECT DIS, V64, P680, DOI 10.1093/cid/ciw846; Ble M, 2014, LIVER TRANSPLANT, V20, P25, DOI 10.1002/lt.23756; Buti M, 2016, CLIN INFECT DIS, V62, P32, DOI 10.1093/cid/civ722; Butt AA, 2017, ALIMENT PHARM THER, V45, P150, DOI 10.1111/apt.13837; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Campos P, 2016, CLIN KIDNEY J, V9, P772, DOI 10.1093/ckj/sfw104; Carrier P, 2016, WORLD J HEPATOL, V8, P1343, DOI 10.4254/wjh.v8.i32.1343; Dore GJ, 2016, J HEPATOL, V64, P19, DOI 10.1016/j.jhep.2015.08.015; Electronic Medicines Compendium (eMC), COP EU SUMM PROD CHA; Ellis CL, 2017, SEMIN DIAGN PATHOL, V34, P377, DOI [10.1053/jsemdp.2017.04.009, 10.1053/j.semdp.2017.04.009]; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; European Medicines Agency, 2016, EPAR SUMM PUBL; European Medicines Agency, 2016, EXV SUMM PROD CHAR; Feld JJ, 2016, J HEPATOL, V64, P301, DOI 10.1016/j.jhep.2015.10.005; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Gallant JE, 2009, AIDS, V23, P1971, DOI 10.1097/QAD.0b013e32832c96e9; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; Hawkins C, 2016, J ANTIMICROB CHEMOTH, V71, P2642, DOI 10.1093/jac/dkw203; Hezode C, 2015, LANCET, V385, P2502, DOI 10.1016/S0140-6736(15)60159-3; Kamara DA, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-51; Kopp JB, 2017, J INFECT DIS, V216, P619, DOI 10.1093/infdis/jix205; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Lai TS, 2017, KIDNEY INT, V92, P703, DOI 10.1016/j.kint.2017.03.021; Lawitz E, 2015, LANCET, V385, P1075, DOI 10.1016/S0140-6736(14)61795-5; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Leone S, 2016, EUR J CLIN MICROBIOL, V35, P1511, DOI 10.1007/s10096-016-2692-y; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Lucas GM, 2014, CLIN INFECT DIS, V59, pE96, DOI 10.1093/cid/ciu617; Lucas GM, 2013, J INFECT DIS, V208, P1240, DOI 10.1093/infdis/jit373; Luetkemeyer AF, 2016, CLIN INFECT DIS, V62, P1489, DOI 10.1093/cid/ciw163; Mehta DA, 2017, INFECT DIS THER; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Milazzo L, 2017, HIV MED, V18, P284, DOI 10.1111/hiv.12429; Mocroft A, 2016, LANCET HIV, V3, pE23, DOI 10.1016/S2352-3018(15)00211-8; Mocroft A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040245; Molina JM, 2015, LANCET, V385, P1098, DOI 10.1016/S0140-6736(14)62483-1; Naggie S, 2015, NEW ENGL J MED, V373, P705, DOI 10.1056/NEJMoa1501315; National Institutes of Health US Department of Health and Human Services, 2014, TABL GRAD SEV AD PED; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Ozkok A, 2014, WORLD J GASTROENTERO, V20, P7544, DOI 10.3748/wjg.v20.i24.7544; Peters L, 2012, AIDS, V26, P1917, DOI 10.1097/QAD.0b013e3283574e71; Pockros PJ, 2016, GASTROENTEROLOGY, V150, P1590, DOI 10.1053/j.gastro.2016.02.078; Poordad F, 2016, HEPATOLOGY, V63, P1493, DOI 10.1002/hep.28446; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Rogal SS, 2016, DIGEST DIS SCI, V61, P930, DOI 10.1007/s10620-015-3918-z; Roth D, 2015, LANCET, V386, P1537, DOI 10.1016/S0140-6736(15)00349-9; Satapathy SK, 2012, HEPATOL INT, V6, P369, DOI 10.1007/s12072-011-9284-9; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Sulkowski MS, 2015, JAMA-J AM MED ASSOC, V313, P1223, DOI 10.1001/jama.2015.1328; Sulkowski MS, 2014, JAMA-J AM MED ASSOC, V312, P353, DOI 10.1001/jama.2014.7734; Taramasso L, 2017, CLIN RES HEPATOL GAS, V41, pE76, DOI 10.1016/j.clinre.2017.03.006; Williams BA., 2006, TECHNICAL REPORT SER, V79; Wyles D, 2017, J INFECT DIS, V215, P599, DOI 10.1093/infdis/jiw597; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	60	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192627	10.1371/journal.pone.0192627	http://dx.doi.org/10.1371/journal.pone.0192627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462201	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200019
J	Yoon, D; Bae, K; Lee, MK; Kim, JH; Yoon, KA				Yoon, Daseul; Bae, Kieun; Lee, Min-Kyeong; Kim, Jin Hee; Yoon, Kyong-Ah			Galanin is an epigenetically silenced tumor suppressor gene in gastric cancer cells	PLOS ONE			English	Article							NECK-CANCER; CARCINOMA-CELLS; HEAD; PROLIFERATION; METHYLATION; APOPTOSIS; PATHWAY; INACTIVATION; NEUROPEPTIDE; EXPRESSION	Galanin is a 30 amino-acid active neuropeptide that acts via three G-protein coupled galanin receptors, GALR1, GALR2 and GALR3. Recently, GALR1 was also suggested as a tumor suppressor gene that was frequently silenced in head and neck squamous cell carcinoma; moreover, galanin and GALR1 were reported to inhibit human oral cancer cell proliferation. However, the exact role of galanin in gastric cancer is unclear. Here, we describe the epigenetic silencing of galanin in human gastric cancer. Five gastric cancer cell lines (SNU-1, SNU-601, SNU-638, KATOIII, and AGS) showed a significant reduction in galanin expression that was restored by the demethylating agent 5-aza-2'-deoxycytidine. We confirmed the hypermethylation of CpG islands in the galanin promoter region by methylation-specific and bisulfate sequencing polymerase chain reaction (PCR). Interestingly, hypermethylated galanin did not affect galanin receptor expression. Exogenous galanin expression in silenced cells induced apoptosis and decreased phosphorylated Akt expression. Taken together, these data suggest that galanin hypermethylation impairs its tumor suppressor function in gastric cancer carcinogenesis.	[Yoon, Daseul; Bae, Kieun; Yoon, Kyong-Ah] Konkuk Univ, Dept Biochem, Coll Vet Med, Seoul, South Korea; [Lee, Min-Kyeong] Natl Canc Ctr, Dept Canc Biomed Sci, Grad Sch Canc Sci & Policy, Goyang, South Korea; [Kim, Jin Hee] Cheongju Univ, Dept Biomed Lab Sci, Coll Hlth Sci, Cheongju, South Korea	Konkuk University; National Cancer Center - Korea (NCC); Cheongju University	Yoon, KA (corresponding author), Konkuk Univ, Dept Biochem, Coll Vet Med, Seoul, South Korea.	kayoon@konkuk.ac.kr			Konkuk University [KU 2016-A019-0081]	Konkuk University	This work was supported by Konkuk University (KU 2016-A019-0081) "www.konkuk.ac.kr". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Konkuk University (KU 2016-A019-0081).	Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Berger A, 2005, NEUROPEPTIDES, V39, P353, DOI 10.1016/j.npep.2004.12.016; Berger A, 2004, ENDOCRINOLOGY, V145, P500, DOI 10.1210/en.2003-0649; El-Salhy M, 2005, ONCOL REP, V13, P787; Floren A, 2000, NEUROPEPTIDES, V34, P331, DOI 10.1054/npep.2000.0808; Henson BS, 2005, J BIOL CHEM, V280, P22564, DOI 10.1074/jbc.M414589200; Hokfelt T, 2008, CELL MOL LIFE SCI, V65, P1793, DOI 10.1007/s00018-008-8152-9; Huang WY, 2015, NUCLEIC ACIDS RES, V43, pD856, DOI 10.1093/nar/gku1151; Iishi H, 1998, INT J CANCER, V75, P396, DOI 10.1002/(SICI)1097-0215(19980130)75:3<396::AID-IJC12>3.0.CO;2-7; Jung KW, 2017, CANCER RES TREAT, V49, P292, DOI 10.4143/crt.2017.118; Kanazawa T, 2007, ONCOGENE, V26, P5762, DOI 10.1038/sj.onc.1210384; Kanazawa T, 2009, CLIN CANCER RES, V15, P2222, DOI 10.1158/1078-0432.CCR-08-2443; Kim KY, 2007, CANCER EPIDEM BIOMAR, V16, P2373, DOI 10.1158/1055-9965.EPI-06-0740; Ku Ja-Lok, 2005, Cancer Res Treat, V37, P1, DOI 10.4143/crt.2005.37.1.1; Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Misawa K, 2017, MOL CARCINOGEN, V56, P1107, DOI 10.1002/mc.22577; Misawa K, 2016, CLIN EXP METASTAS, V33, P187, DOI 10.1007/s10585-015-9768-4; Misawa K, 2008, CLIN CANCER RES, V14, P7604, DOI 10.1158/1078-0432.CCR-07-4673; Ormandy CJ, 1998, CANCER RES, V58, P1353; PARK JG, 1990, CANCER RES, V50, P2773; Scanlon CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7885; SCHMIDT WE, 1991, P NATL ACAD SCI USA, V88, P11435, DOI 10.1073/pnas.88.24.11435; Sugimoto T, 2009, GENE CHROMOSOME CANC, V48, P132, DOI 10.1002/gcc.20626; Tofighi R, 2008, P NATL ACAD SCI USA, V105, P2717, DOI 10.1073/pnas.0712300105; Tycko B, 2000, J CLIN INVEST, V105, P401, DOI 10.1172/JCI9462; Uehara T, 2014, CANCER SCI, V105, P72, DOI 10.1111/cas.12315; Vrontakis ME, 2002, CNS NEUROL DISORD-DR, V1, P533, DOI 10.2174/1568007023338914	28	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0193275	10.1371/journal.pone.0193275	http://dx.doi.org/10.1371/journal.pone.0193275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462183	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200061
J	Gori, Y; Stradiotti, A; Camin, F				Gori, Yuri; Stradiotti, Ana; Camin, Federica			Timber isoscapes. A case study in a mountain area in the Italian Alps	PLOS ONE			English	Article							LIGNIN METHOXYL GROUPS; STABLE-ISOTOPE RATIOS; GEOGRAPHICAL ORIGIN; PICEA-ABIES; WOOD; AUTHENTICITY; HYDROGEN; CARBON; PRECIPITATION; GEOSTATISTICS	Background Local timber is still one of the main sources of work and income for mountain communities. However, illegal logging is a major cause of deforestation in many countries and has significant impacts on local communities and biodiversity. Techniques for tracing timber would provide a useful tool to protect local timber industries and contribute to the fight against illegal logging. Although considerable progress has been made in food traceability, timber provenance is still a somewhat neglected research area. Stable isotope ratios in plants are known to reflect geographical variations. This study reports accurate spatial distribution of delta O-18 and delta H-2 in timber from north-eastern Italy (Trentino) in order to trace geographical origin. Methodology and principal findings We tested the accuracy of four kriging methods using an annual resolution of delta O-18 and delta H-2 measured in Picea abies. Pearson's correlation coefficients revealed altitude to be the most appropriate covariate for the cokriging model, which has ultimately proved to be the best method due to its low estimation error. Conclusions We present regional maps of interpolated delta O-18 and delta H-2 in Picea abies wood together with the 95% confidence intervals. The strong spatial structure of the data demonstrates the potential of multivariate spatial interpolation, even in a highly heterogeneous area such as the Alps. We believe that this geospatial approach can be successfully applied on a wider scale in order to combat illegal logging.	[Gori, Yuri; Camin, Federica] Fdn Edmund Mach FEM, Res & Innovat Ctr, Dept Food Qual & Nutr, San Michele All Adige, Trento, Italy; [Stradiotti, Ana] Sao Paulo State Univ UNESP, Inst Biosci, Stable Isotopes Ctr, Botucatu Campus, Botucatu, SP, Brazil	Fondazione Edmund Mach; Universidade Estadual Paulista	Gori, Y (corresponding author), Fdn Edmund Mach FEM, Res & Innovat Ctr, Dept Food Qual & Nutr, San Michele All Adige, Trento, Italy.	yuri.gori@gmail.com		Camin, Federica/0000-0003-0509-6745; Gori, Yuri/0000-0001-8302-1787	CARITRO (Cassa di risparmio di Trento e Rovereto) under the TRETI project (Trentino Timber Isotopes) [P15120101]; Edmund Mach Foundation (Edmund Mach Foundation)	CARITRO (Cassa di risparmio di Trento e Rovereto) under the TRETI project (Trentino Timber Isotopes); Edmund Mach Foundation (Edmund Mach Foundation)	The work was co-funded by CARITRO (Cassa di risparmio di Trento e Rovereto, http://www.fondazionecaritro.it/) under the TRETI project (Trentino Timber Isotopes, grant P15120101) and, finally, by Edmund Mach Foundation (as internal funding of our Research Centre, Edmund Mach Foundation). There was no additional external funding received for this study.	Araguas-Araguas L, 2000, HYDROL PROCESS, V14, P1341, DOI 10.1002/1099-1085(20000615)14:8&lt;1341::AID-HYP983&gt;3.0.CO;2-Z; Asif MJ, 2005, PLANT MOL BIOL REP, V23, P185, DOI 10.1007/BF02772709; Bank TW, 2006, GUID FORM IMPL NAT A; Boner M, 2004, ANAL BIOANAL CHEM, V378, P301, DOI 10.1007/s00216-003-2347-6; Bontempo L, 2009, RAPID COMMUN MASS SP, V23, P1043, DOI 10.1002/rcm.3968; Bowen GJ, 2009, J GEOCHEM EXPLOR, V102, pV, DOI 10.1016/j.gexplo.2009.05.001; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bowen GJ, 2002, GEOLOGY, V30, P315, DOI 10.1130/0091-7613(2002)030<0315:SDOOIM>2.0.CO;2; Brand WA, 2014, PURE APPL CHEM, V86, P425, DOI 10.1515/pac-2013-1023; Bridge M, 2012, J ARCHAEOL SCI, V39, P2828, DOI 10.1016/j.jas.2012.04.028; Camin F, 2007, ANAL BIOANAL CHEM, V389, P309, DOI 10.1007/s00216-007-1302-3; Camin F, 2016, COMPR REV FOOD SCI F, V15, P868, DOI 10.1111/1541-4337.12219; Chiles J.P., 2012, GEOSTATISTICS MODELI, Vsecond, DOI DOI 10.1002/9781118136188; Chiocchini F, 2016, FOOD CHEM, V202, P291, DOI 10.1016/j.foodchem.2016.01.146; DAGOSTINO V, 1992, INT J CLIMATOL, V12, P749, DOI 10.1002/joc.3370120707; Danezis GP, 2016, TRAC-TREND ANAL CHEM, V85, P123, DOI 10.1016/j.trac.2016.02.026; DANSGAARD W, 1964, TELLUS, V16, P436; Dawson T.E, 2007, STABLE ISOTOPES INDI; Degen B, 2007, P INT WORKSH FING ME; Deguilloux MF, 2004, ANN FOREST SCI, V61, P97, DOI 10.1051/forest:2003089; Deguilloux MF, 2002, P ROY SOC B-BIOL SCI, V269, P1039, DOI 10.1098/rspb.2002.1982; Douglas J, 2010, FUTURE WORLDS FOREST; Dudley N, 1995, BAD HARVEST TIMBER T; Ehleringer JR, 2000, NATURE, V408, P311, DOI 10.1038/35042680; Ehtesham E, 2013, J AGR FOOD CHEM, V61, P8914, DOI 10.1021/jf4024883; Gartner H, 2010, DENDROCHRONOLOGIA, V28, P85, DOI 10.1016/j.dendro.2009.09.002; Goovaerts P., 1997, GEOSTATISTICS NATURA, DOI DOI 10.2307/1270969; Gori Y, 2013, RAPID COMMUN MASS SP, V27, P265, DOI 10.1002/rcm.6446; Gori Y, 2013, EUR J FOREST RES, P1; Gori Y, 2014, FOREST PATHOL, P44; Gori Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118941; Gori Y, 2014, FOREST ECOL MANAG, V319, P99, DOI 10.1016/j.foreco.2014.02.009; Hengl T., 2011, PRACTICAL GUIDE GEOS; Hobson KA, 2008, TERR ECOL SER, V2, P45, DOI 10.1016/S1936-7961(07)00003-6; HOLDSWORTH G, 1991, J GEOPHYS RES-ATMOS, V96, P7483, DOI 10.1029/91JD00048; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Horacek M, 2009, RAPID COMMUN MASS SP, V23, P3688, DOI 10.1002/rcm.4309; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Kagawa A, 2010, J WOOD SCI, V56, P175, DOI 10.1007/s10086-009-1085-6; Kaseke KF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154598; Keppler F, 2007, NEW PHYTOL, V176, P600, DOI 10.1111/j.1469-8137.2007.02213.x; Kimmins J.P., 2004, FOREST ECOLOGY FDN S, V3rd; Laumer W, 2009, RAPID COMMUN MASS SP, V23, P1934, DOI 10.1002/rcm.4105; Leavitt SW, 2010, SCI TOTAL ENVIRON, V408, P5244, DOI 10.1016/j.scitotenv.2010.07.057; Leng MJ, 2006, DEV PALEOENVIRON RES, V10, P147; Li J, 2011, ECOL INFORM, V6, P228, DOI 10.1016/j.ecoinf.2010.12.003; Lowe A., 2007, P INT WORKSH FING ME; Manca G, 2001, J AGR FOOD CHEM, V49, P1404, DOI 10.1021/jf000706c; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Neteler M, 2010, REMOTE SENS-BASEL, V2, P333, DOI 10.3390/rs1020333; Nielsen LR, 2008, TRACING TIMBER FORES; Oliver M, 2013, PRECISION AGR SUSTAI; Oliver MA, 2014, CATENA, V113, P56, DOI 10.1016/j.catena.2013.09.006; OLIVER MA, 1987, SOIL USE MANAGE, V3, P8, DOI 10.1111/j.1475-2743.1987.tb00703.x; R Development Core Team, 2010, LANG ENV STAT COMP, V333, P852, DOI DOI 10.1038/333852A0; ROBARDS K, 1995, ANALYST, V120, P1, DOI 10.1039/an9952000001; ROZANSKI K, 1982, TELLUS, V34, P142, DOI 10.1111/j.2153-3490.1982.tb01801.x; Schweingruber F. H., 1996, Tree rings and environment: dendroecology.; Sheikha AF, 2013, J TROP FOR SCI, V25, P387; Tacconi L., 2007, ILLEGAL LOGGING LAW; Tarr Alison B., 2005, Precision Agriculture, V6, P255, DOI 10.1007/s11119-005-1385-9; Torresan C, 2014, EUR J REMOTE SENS, V47, P75, DOI 10.5721/EuJRS20144706; van der Veer G, 2013, WOODHEAD PUBL FOOD S, V245, P60, DOI 10.1533/9780857097590.2.60; Webster R, 1997, EUR J SOIL SCI, V48, P173, DOI 10.1111/j.1365-2389.1997.tb00196.x; West JB, 2007, J AGR FOOD CHEM, V55, P7075, DOI 10.1021/jf071211r; Zuur Alain F., 2009, P1	67	9	10	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192970	10.1371/journal.pone.0192970	http://dx.doi.org/10.1371/journal.pone.0192970			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451907	Green Published, gold, Green Submitted			2022-12-26	WOS:000425369800029
J	Janga, H; Aznaourova, M; Boldt, F; Damm, K; Grunweller, A; Schulte, LN				Janga, Harshavardhan; Aznaourova, Marina; Boldt, Fabian; Damm, Katrin; Gruenweller, Arnold; Schulte, Leon N.			Cas9-mediated excision of proximal DNaseI/H3K4me3 signatures confers robust silencing of microRNA and long non-coding RNA genes	PLOS ONE			English	Article							MALAT1; TRANSCRIPTION; EXPRESSION; LNCRNA; DELETION; ELEMENTS; MIR-155	CRISPR/Cas9-based approaches have greatly facilitated targeted genomic deletions. Contrary to coding genes however, which can be functionally knocked out by frame-shift mutagenesis, non-coding RNA (ncRNA) gene knockouts have remained challenging. Here we present a universal ncRNA knockout approach guided by epigenetic hallmarks, which enables robust gene silencing even in provisionally annotated gene loci. We build on previous work reporting the presence of overlapping histone H3 lysine 4 tri-methylation (H3K4me3) and DNaseI hypersensitivity sites around the transcriptional start sites of most genes. We demonstrate that excision of this gene-proximal signature leads to loss of microRNA and lincRNA transcription and reveals ncRNA phenotypes. Exemplarily we demonstrate silencing of the constitutively transcribed MALAT1 lincRNA gene as well as of the inducible miR-146a and miR-155 genes in human monocytes. Our results validate a role of miR-146a and miR-155 in negative feedback control of the activity of inflammation master-regulator NF kappa B and suggest that cell-cycle control is a unique feature of miR-55. We suggest that our epigenetically guided CRISPR approach may improve existing ncRNA knockout strategies and contribute to the development of high-confidence ncRNA phenotyping applications.	[Janga, Harshavardhan; Aznaourova, Marina; Boldt, Fabian; Schulte, Leon N.] Philipps Univ, Inst Lung Res, Marburg, Germany; [Damm, Katrin; Gruenweller, Arnold] Philipps Univ, Inst Pharmaceut Chem, Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Schulte, LN (corresponding author), Philipps Univ, Inst Lung Res, Marburg, Germany.	leon.schulte@uni-marburg.de		Janga, Harshavardhan/0000-0002-3142-2850; Aznaourova, Marina/0000-0002-3834-9705; Schulte, Leon/0000-0001-6814-9344	von Behring-Rontgen-Stiftung (vBR project) [63-0036]; Forschungsforderfonds, Philipps Universitat Marburg	von Behring-Rontgen-Stiftung (vBR project); Forschungsforderfonds, Philipps Universitat Marburg	This work was supported by von Behring-Rontgen-Stiftung (vBR project 63-0036, to L.N.S.) and Forschungsforderfonds, Philipps Universitat Marburg (to L.N.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio-Prat E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2086-z; Arun G, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.NONRNA15-PR11; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Goyal A, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw883; Gutschner T, 2011, GENOME RES, V21, P1944, DOI 10.1101/gr.122358.111; Han JX, 2014, RNA BIOL, V11, P829, DOI 10.4161/rna.29624; He XB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/945169; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Pulido-Quetglas C, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005341; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Vigorito E, 2013, IMMUNOL REV, V253, P146, DOI 10.1111/imr.12057; Yoshimoto R, 2016, BBA-GENE REGUL MECH, V1859, P192, DOI 10.1016/j.bbagrm.2015.09.012; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	38	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0193066	10.1371/journal.pone.0193066	http://dx.doi.org/10.1371/journal.pone.0193066			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451908	Green Published, Green Submitted, gold			2022-12-26	WOS:000425369800040
J	Duan, HD; Lubner, CE; Tokmina-Lukaszewska, M; Gauss, GH; Bothner, B; King, PW; Peters, JW; Miller, AF				Duan, H. Diessel; Lubner, Carolyn E.; Tokmina-Lukaszewska, Monika; Gauss, George H.; Bothner, Brian; King, Paul W.; Peters, John W.; Miller, Anne-Frances			Distinct properties underlie flavin-based electron bifurcation in a novel electron transfer flavoprotein FixAB from Rhodopseudomonas palustris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATION-REDUCTION POTENTIALS; METHYLOTROPHIC BACTERIUM W3A1; CHARGE-TRANSFER COMPLEXES; EXCITED-STATE DYNAMICS; ACYL-COA DEHYDROGENASE; METHYLOPHILUS-METHYLOTROPHUS; RIBONUCLEOTIDE REDUCTASE; MEGASPHAERA-ELSDENII; ENERGY-CONSERVATION; KINETIC-ANALYSIS	A newly recognized third fundamental mechanism of energy conservation in biology, electron bifurcation, uses free energy from exergonic redox reactions to drive endergonic redox reactions. Flavin-based electron bifurcation furnishes low-potential electrons to demanding chemical reactions, such as reduction of dinitrogen to ammonia. We employed the heterodimeric flavoenzyme FixAB from the diazotrophic bacterium Rhodopseudomonas palustris to elucidate unique properties that underpin flavin-based electron bifurcation. FixAB is distinguished from canonical electron transfer flavoproteins (ETFs) by a second FAD that replaces the AMP of canonical ETF. We exploited near-UV-visible CD spectroscopy to resolve signals from the different flavin sites in FixAB and to interrogate the putative bifurcating FAD. CD aided in assigning the measured reduction midpoint potentials (E degrees values) to individual flavins, and the E degrees values tested the accepted model regarding the redox properties required for bifurcation. We found that the higher-E degrees flavin displays sequential one-electron (1-e(-)) reductions to anionic semiquinone and then to hydroquinone, consistent with the reactivity seen in canonical ETFs. In contrast, the lower-E degrees flavin displayed a single two-electron (2-e(-)) reduction without detectable accumulation of semiquinone, consistent with unstable semiquinone states, as required for bifurcation. This is the first demonstration that a FixAB protein possesses the thermodynamic prerequisites for bifurcating activity, and the separation of distinct optical signatures for the two flavins lays a foundation for mechanistic studies to learn how electron flow can be directed in a protein environment. We propose that a novel optical signal observed at long wavelength may reflect electron delocalization between the two flavins.	[Duan, H. Diessel; Miller, Anne-Frances] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; [Lubner, Carolyn E.; King, Paul W.] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Tokmina-Lukaszewska, Monika; Gauss, George H.; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Peters, John W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99163 USA	University of Kentucky; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Montana State University System; Montana State University Bozeman; Washington State University	Miller, AF (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.	afmill3r2@gmail.com	King, Paul W./D-9979-2011	King, Paul W./0000-0001-5039-654X	UNICAT; Murdock Charitable Trust; NIGMS, National Institutes of Health [P20GM103474]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103474] Funding Source: NIH RePORTER	UNICAT; Murdock Charitable Trust; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Professor Caroline Harwood (University of Washington) for the gift of R. palustris genomic DNA, Professor Edith Glazer (University of Kentucky) for the access to a high-capacity centrifuge, and the Montana State University Microfabrication Facility for help in preparation of gold-coated borosilicate glass capillaries for non-covalent mass spectrometry. We thank Rhesa Ledbetter, Amaya Garcia Costas, and Gerrit Schut for insightful conversations. A. F. M. acknowledges the hospitality of the Technische Universitat-Berlin and the support of UNICAT during the revision of the manuscript. The Proteomics, Metabolomics, and Mass Spectrometry Facility at Montana State University has received support from the Murdock Charitable Trust and NIGMS, National Institutes of Health, under Grant P20GM103474.	ABRAMOVITZ AS, 1976, J BIOL CHEM, V251, P5327; [Anonymous], 2006, THESIS; BOCK RM, 1956, ARCH BIOCHEM BIOPHYS, V62, P253, DOI 10.1016/0003-9861(56)90123-0; BYRON CM, 1989, BIOCHEMISTRY-US, V28, P8582, DOI 10.1021/bi00447a047; Chowdhury NP, 2015, FEBS J, V282, P3149, DOI 10.1111/febs.13308; Chowdhury NP, 2016, J BIOL CHEM, V291, P11993, DOI 10.1074/jbc.M116.726299; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Clark W. M., 1960, OXIDATION REDUCTION; Costas AMG, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00440-17; Demmer JK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01746-3; Demmer JK, 2015, J BIOL CHEM, V290, P21985, DOI 10.1074/jbc.M115.656520; DUPLESSIS ER, 1994, BIOCHEM MOL BIOL INT, V32, P195; Dutton P L, 1978, Methods Enzymol, V54, P411; Dwyer TM, 1999, BBA-PROTEIN STRUCT M, V1433, P139, DOI 10.1016/S0167-4838(99)00139-9; EARL CD, 1987, J BACTERIOL, V169, P1127, DOI 10.1128/jb.169.3.1127-1136.1987; Edgren T, 2004, J BACTERIOL, V186, P2052, DOI 10.1128/JB.186.7.2052-2060.2004; Efimov I, 2014, FEBS LETT, V588, P701, DOI 10.1016/j.febslet.2013.12.030; Enescu M, 1998, PHOTOCHEM PHOTOBIOL, V68, P150, DOI 10.1111/j.1751-1097.1998.tb02482.x; FRERMAN FE, 1985, P NATL ACAD SCI USA, V82, P4517, DOI 10.1073/pnas.82.13.4517; Gadda G, 1997, J BIOL CHEM, V272, P5563, DOI 10.1074/jbc.272.9.5563; Geng JF, 2013, P NATL ACAD SCI USA, V110, P9639, DOI 10.1073/pnas.1301544110; Gray HB, 2015, P NATL ACAD SCI USA, V112, P10920, DOI 10.1073/pnas.1512704112; Griffin KJ, 1997, BIOCHEMISTRY-US, V36, P4194, DOI 10.1021/bi962572v; GUSTAFSON WG, 1986, J BIOL CHEM, V261, P7733; HAID E, 1975, CLIN CHEM, V21, P884; Hardman SJO, 2013, BIOPHYS J, V105, P2549, DOI 10.1016/j.bpj.2013.10.015; Hay S, 2009, ANGEW CHEM INT EDIT, V48, P1452, DOI 10.1002/anie.200805502; Henriques BJ, 2010, BBA-MOL BASIS DIS, V1802, P1070, DOI 10.1016/j.bbadis.2010.07.015; HERRICK KR, 1994, J BIOL CHEM, V269, P32239; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Hoben JP, 2017, J BIOL CHEM, V292, P14039, DOI 10.1074/jbc.M117.794214; Huang JJ, 2010, APPL ENVIRON MICROB, V76, P7717, DOI 10.1128/AEM.01143-10; HUSAIN M, 1983, BIOCHEM J, V209, P541, DOI 10.1042/bj2090541; HUSAIN M, 1984, BIOCHEM J, V219, P1043, DOI 10.1042/bj2191043; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; Ledbetter RN, 2017, BIOCHEMISTRY-US, V56, P4177, DOI 10.1021/acs.biochem.7b00389; Lin TY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.374918; Liu ZY, 2012, J AM CHEM SOC, V134, P8104, DOI 10.1021/ja2105009; Lubner CE, 2017, NAT CHEM BIOL, V13, P655, DOI 10.1038/nchembio.2348; Luo ML, 2016, NUCLEIC ACIDS RES, V44, P7385, DOI 10.1093/nar/gkw421; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; Mataga N, 2002, J PHYS CHEM B, V106, P8917, DOI 10.1021/jp0205741; Mathes T, 2012, J BIOL CHEM, V287, P31725, DOI 10.1074/jbc.M112.391896; Mayhew SG, 1999, EUR J BIOCHEM, V265, P698, DOI 10.1046/j.1432-1327.1999.00767.x; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; MILLER SM, 1990, BIOCHEMISTRY-US, V29, P2831, DOI 10.1021/bi00463a028; Mishanina TV, 2015, J BIOL CHEM, V290, P25072, DOI 10.1074/jbc.M115.682369; Morrison E, 2013, BIOCHEMISTRY-US, V52, P6063, DOI 10.1021/bi400763h; Nitschke W, 2012, BIOESSAYS, V34, P106, DOI 10.1002/bies.201100134; NORDEN B, 1982, BIOPOLYMERS, V21, P1713, DOI 10.1002/bip.360210904; O'Reilly JP, 2005, J AM CHEM SOC, V127, P1632, DOI 10.1021/ja0443326; Peters JW, 2016, CURR OPIN CHEM BIOL, V31, P146, DOI 10.1016/j.cbpa.2016.03.007; Pudney CR, 2007, J AM CHEM SOC, V129, P13949, DOI 10.1021/ja074463h; Roberts DL, 1999, BIOCHEMISTRY-US, V38, P1977, DOI 10.1021/bi9820917; RODKEY FL, 1955, J BIOL CHEM, V213, P777; SAKURAI T, 1966, BIOCHIM BIOPHYS ACTA, V112, P459, DOI 10.1016/0926-6585(66)90248-2; Salazar D, 1997, J BIOL CHEM, V272, P26425, DOI 10.1074/jbc.272.42.26425; Sato K, 2003, J BIOCHEM, V134, P719, DOI 10.1093/jb/mvg199; Sato K, 1996, J BIOCHEM-TOKYO, V120, P276; SATO K, 1993, J BIOCHEM, V114, P215, DOI 10.1093/oxfordjournals.jbchem.a124157; SATO K, 1992, J BIOCHEM-TOKYO, V112, P804, DOI 10.1093/oxfordjournals.jbchem.a123980; Sato K, 2013, J BIOCHEM, V153, P565, DOI 10.1093/jb/mvt026; Seyedsayamdost MR, 2007, J AM CHEM SOC, V129, P15060, DOI 10.1021/ja076043y; TAGAWA K, 1968, BIOCHIM BIOPHYS ACTA, V153, P602, DOI 10.1016/0005-2728(68)90188-6; Talfournier F, 2001, J BIOL CHEM, V276, P20190, DOI 10.1074/jbc.M010853200; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Trimmer EE, 2005, BIOCHEMISTRY-US, V44, P6809, DOI 10.1021/bi0477236; Wang J, 2015, ANTIOXID REDOX SIGN, V23, P283, DOI 10.1089/ars.2013.5397; Warren JJ, 2012, COORDIN CHEM REV, V256, P2478, DOI 10.1016/j.ccr.2012.03.032; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Westphal AH, 1998, EUR J BIOCHEM, V257, P160, DOI 10.1046/j.1432-1327.1998.2570160.x; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; Wilson EK, 1997, BIOCHEMISTRY-US, V36, P41, DOI 10.1021/bi961224q; Yang KY, 2007, BIOCHEMISTRY-US, V46, P2289, DOI 10.1021/bi0616293; Yee CS, 2003, J AM CHEM SOC, V125, P10506, DOI 10.1021/ja036242r; Zhang P, 2017, ACCOUNTS CHEM RES, V50, P2410, DOI 10.1021/acs.accounts.7b00327	77	14	14	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4688	4701		10.1074/jbc.RA117.000707	http://dx.doi.org/10.1074/jbc.RA117.000707			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29462786	Green Published, hybrid			2022-12-26	WOS:000428848300012
J	Scherer, AM; Reisinger, HS; Schweizer, ML; Askelson, NM; Fagerlin, A; Lynch, CF				Scherer, Aaron M.; Reisinger, Heather Schacht; Schweizer, Marin L.; Askelson, Natoshia M.; Fagerlin, Angela; Lynch, Charles F.			Cross-sectional associations between psychological traits, and HPV vaccine uptake and intentions in young adults from the United States	PLOS ONE			English	Article							COGNITIVE REFLECTION TEST; HEALTH-CARE; INDIVIDUAL-DIFFERENCES; UNCONSCIOUS THOUGHT; GENDER-DIFFERENCES; INFORMATION; UNCERTAINTY; THINKING; NEED; ACCEPTABILITY	Human papillomavirus (HPV) is the most prevalent sexually transmitted infection worldwide and can lead to the development of genital warts, and cancers throughout the body. Despite the availability of HPV vaccines for over a decade, uptake in the United States among adolescents and young adults remains well below national targets. While most efforts to improve HPV vaccine uptake have rightly focused on adolescents, there is still a tremendous opportunity to improve vaccination among young adults who have not been vaccinated against HPV. To that end, we report an exploratory examination of associations between HPV vaccination status and intentions with psychological traits that may impact HPV vaccine uptake with a national, demographically diverse sample of young adults (N = 1358) who completed an online survey. These psychological traits conceptually mapped onto motivations to: 1) understand health-related information, 2) deliberate, 3) manage uncertainty, and 4) manage threats. We found notable gender differences for the association of these motivations and vaccination status. For women, higher interest in and ability to understand health related information seemed to distinguish those who reported receiving the HPV vaccine from those who did not. For men, less need to deliberate and greater needs to manage threat and uncertainty seemed to be the distinguishing motives for those who reported receiving the HPV vaccine compared to those who did not. Results for vaccination intentions were less consistent, but there was some evidence to indicate that, regardless of gender, greater health-related information interest and understanding and need to manage uncertainty and threats were associated with increased intention to receive the HPV vaccine, while greater need to deliberate was associated with decreased vaccination intentions. These results suggest that there are psychological differences that are associated with HPV vaccination decisions and that these motivations should be considered in efforts to improve that no competing interests exist. HPV vaccine uptake.	[Scherer, Aaron M.; Reisinger, Heather Schacht; Schweizer, Marin L.] Univ Iowa, Dept Internal Med, Div Gen Internal Med, Iowa City, IA 52242 USA; [Reisinger, Heather Schacht; Schweizer, Marin L.] Iowa City Vet Affairs Hlth Care Syst, Ctr Comprehens Access & Delivery Res & Evaluat, Iowa City, IA USA; [Askelson, Natoshia M.] Univ Iowa, Dept Community & Behav Hlth, Iowa City, IA USA; [Fagerlin, Angela] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA; [Fagerlin, Angela] Salt Lake City Vet Affairs Hlth Care Syst, Ctr Informat Decis Enhancement & Surveillance, Salt Lake City, UT USA; [Lynch, Charles F.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; University of Iowa	Scherer, AM (corresponding author), Univ Iowa, Dept Internal Med, Div Gen Internal Med, Iowa City, IA 52242 USA.	aaron-scherer@uiowa.edu		Schweizer, Marin/0000-0002-3604-0093; Scherer, Aaron M/0000-0002-4134-9300; Reisinger, Heather/0000-0002-5348-063X	Department of Internal Medicine, University of Iowa; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	Department of Internal Medicine, University of Iowa; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by funds provided to Aaron M. Scherer by the Department of Internal Medicine, University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2010, VACCINE, V28, P4027, DOI 10.1016/j.vaccine.2010.03.063; [Anonymous], 1974, Health Education Monograph, V2, P324; Bernstein HH, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4186; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; CACIOPPO JT, 1984, J PERS ASSESS, V48, P306, DOI 10.1207/s15327752jpa4803_13; Cacioppo JT, 1996, PSYCHOL BULL, V119, P197, DOI 10.1037/0033-2909.119.2.197; Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5; Daniel-Ulloa J, 2016, AM J PUBLIC HEALTH, V106, P746, DOI 10.2105/AJPH.2015.303039; Dijksterhuis A, 2006, PERSPECT PSYCHOL SCI, V1, P95, DOI 10.1111/j.1745-6916.2006.00007.x; Duckitt J, 2002, J PERS SOC PSYCHOL, V83, P75, DOI 10.1037//0022-3514.83.1.75; Epstein S, 1996, J PERS SOC PSYCHOL, V71, P390, DOI 10.1037/0022-3514.71.2.390; Fagerlin A, 2007, MED DECIS MAKING, V27, P672, DOI 10.1177/0272989x07304449; Fischer P, 2011, J EXP PSYCHOL GEN, V140, P51, DOI 10.1037/a0021595; Fishbein M., 1975, BELIEF ATTITUDE INTE; Greenberg J., 2012, MEANING MORTALITY CH, P17, DOI DOI 10.1037/13748-001; Han PKJ, 2011, MED DECIS MAKING, V31, P828, DOI 10.1177/0272989X11393976; Haran U, 2013, JUDGM DECIS MAK, V8, P188; Hart W, 2015, COGNITION, V137, P1, DOI 10.1016/j.cognition.2014.12.003; *I MED, 2004, HLTH LIT PRESCR END; Kahan DM, 2017, POLIT PSYCHOL, V38, P179, DOI 10.1111/pops.12396; Kahan DM, 2017, J RISK RES, V20, P995, DOI 10.1080/13669877.2016.1148067; Lavine H, 2005, POLIT PSYCHOL, V26, P219, DOI 10.1111/j.1467-9221.2005.00416.x; Maver P.J., 2017, VACCINE; McNaughton CD, 2015, MED DECIS MAKING, V35, P932, DOI 10.1177/0272989X15581800; Noone JH, 2008, SOCIOL HEALTH ILL, V30, P711, DOI 10.1111/j.1467-9566.2008.01095.x; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Ragan KR, 2017, VACCINE; Rains SA, 2015, HEALTH COMMUN, V30, P339, DOI 10.1080/10410236.2013.858285; Reagan-Steiner S, 2016, MMWR-MORBID MORTAL W, V65, P850, DOI 10.15585/mmwr.mm6533a4; Roets A, 2011, PERS INDIV DIFFER, V50, P90, DOI 10.1016/j.paid.2010.09.004; Scherer AM, PERSONALITY TRAITS H; Stillo M, 2015, EXPERT OPIN DRUG SAF, V14, P697, DOI 10.1517/14740338.2015.1013532; Strick M, 2011, SOC COGNITION, V29, P738, DOI 10.1521/soco.2011.29.6.738; Thomson KS, 2016, JUDGM DECIS MAK, V11, P99; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; Tyler RE, 2014, J HEALTH PSYCHOL, V19, P457, DOI 10.1177/1359105312473784; U. S. Department of Health and Human Services, INCR VACC COV LEV 3; US Census Bureau, US CENS BUR QUICKF; Vaidya V, 2012, J WOMENS HEALTH, V21, P140, DOI 10.1089/jwh.2011.2876; Viens LJ, 2016, MMWR-MORBID MORTAL W, V65, P661, DOI 10.15585/mmwr.mm6526a1; Vukasovic T, 2015, PSYCHOL BULL, V141, P769, DOI 10.1037/bul0000017; WEBSTER DM, 1994, J PERS SOC PSYCHOL, V67, P1049, DOI 10.1037/0022-3514.67.6.1049; West RF, 2008, J EDUC PSYCHOL, V100, P930, DOI 10.1037/a0012842; Williams WW, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6501a1; Zikmund-Fisher BJ, 2014, SOC MED DECISION MAK	46	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193363	10.1371/journal.pone.0193363	http://dx.doi.org/10.1371/journal.pone.0193363			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX4LV	29474403	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500093
J	Shave, S; Mann, S; Koszela, J; Kerr, A; Auer, M				Shave, Steven; Mann, Stefan; Koszela, Joanna; Kerr, Alastair; Auer, Manfred			PuLSE: Quality control and quantification of peptide sequences explored by phage display libraries	PLOS ONE			English	Article							FILAMENTOUS PHAGE; RECOMBINANT ANTIBODIES; MOLECULAR RECOGNITION; TECHNOLOGY; SURFACE; CONSTRUCTION; GENERATION; DIVERSITY; SCAFFOLDS	The design of highly diverse phage display libraries is based on assumption that DNA bases are incorporated at similar rates within the randomized sequence. As library complexity increases and expected copy numbers of unique sequences decrease, the exploration of library space becomes sparser and the presence of truly random sequences becomes critical. We present the program PuLSE (Phage Library Sequence Evaluation) as a tool for assessing randomness and therefore diversity of phage display libraries. PuLSE runs on a collection of sequence reads in the fastq file format and generates tables profiling the library in terms of unique DNA sequence counts and positions, translated peptide sequences, and normalized 'expected' occurrences from base to residue codon frequencies. The output allows at-a-glance quantitative quality control of a phage library in terms of sequence coverage both at the DNA base and translated protein residue level, which has been missing from toolsets and literature. The open source program PuLSE is available in two formats, a C++ source code package for compilation and integration into existing bioinformatics pipelines and precompiled binaries for ease of use.	[Shave, Steven; Auer, Manfred] Univ Edinburgh, Sch Biol Sci, Kings Bldg, Edinburgh, Midlothian, Scotland; Univ Edinburgh, Edinburgh Med Sch Biomed Sci, Kings Bldg, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Shave, S; Auer, M (corresponding author), Univ Edinburgh, Sch Biol Sci, Kings Bldg, Edinburgh, Midlothian, Scotland.	s.shave@ed.ac.uk; manfred.auer@ed.ac.uk		Auer, Manfred/0000-0001-8920-3522; Shave, Steven/0000-0001-6996-3663; Kerr, Alastair/0000-0001-9207-6050	Scottish Universities Life Sciences Alliance ((SULSA)); Medical Research Council ((MRC)) [J54359]; European Community [278568]; Wellcome Trust [203149]	Scottish Universities Life Sciences Alliance ((SULSA)); Medical Research Council ((MRC))(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors acknowledge financial support from the Scottish Universities Life Sciences Alliance ((SULSA- http://www.sulsa.ac.uk) (MA, SS, SM, JK), the Medical Research Council ((MRC- www.mrc.ac.uk, J54359) Strategic Grant (MA), and from the European Community's 7th Framework Program (FP7/2007-2013) under grant agreement no 278568 'PRIMES' (MA, SS). The Wellcome Trust Centre for Cell Biology is supported by core funding from the Wellcome Trust [203149] (AK).	Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0; Bottger V, 1996, ONCOGENE, V13, P2141; BREITLING F, 1991, GENE, V104, P147, DOI 10.1016/0378-1119(91)90244-6; Brinton LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155244; BURTON DR, 1995, IMMUNOTECHNOLOGY, V1, P87, DOI 10.1016/1380-2933(95)00013-5; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Dong DX, 2013, APPL MICROBIOL BIOT, V97, P8023, DOI 10.1007/s00253-013-5049-9; ENGELBERGKULKA H, 1979, MOL GEN GENET, V170, P155, DOI 10.1007/BF00337791; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Gonzalez-Techera A, 2008, BIOCONJUGATE CHEM, V19, P993, DOI 10.1021/bc700279y; Haque A, 2012, NAT PROTOC, V7, P2127, DOI 10.1038/nprot.2012.132; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Hoogenboom HR, 2000, IMMUNOL TODAY, V21, P371, DOI 10.1016/S0167-5699(00)01667-4; Hosse RJ, 2006, PROTEIN SCI, V15, P14, DOI 10.1110/ps.051817606; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; Koide A, 2012, J MOL BIOL, V415, P393, DOI 10.1016/j.jmb.2011.12.019; Kuzmicheva G. A., 2016, Biomeditsinskaya Khimiya, V62, P481, DOI 10.18097/PBMC20166205481; LADNER RC, 1995, TRENDS BIOTECHNOL, V13, P426, DOI 10.1016/S0167-7799(00)88997-0; Lindner T, 2011, MOLECULES, V16, P1625, DOI 10.3390/molecules16021625; Makowski L, 2003, BIOINFORMATICS, V19, P483, DOI 10.1093/bioinformatics/btg013; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Munoz E, 2008, PROTEIN ENG DES SEL, V21, P311, DOI 10.1093/protein/gzn007; NERI D, 1995, CELL BIOPHYS, V27, P47, DOI 10.1007/BF02822526; Noren KA, 2001, METHODS, V23, P169, DOI 10.1006/meth.2000.1118; Rodi DJ, 2002, J MOL BIOL, V322, P1039, DOI 10.1016/S0022-2836(02)00844-6; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Skerra A, 2000, J MOL RECOGNIT, V13, P167, DOI 10.1002/1099-1352(200007/08)13:4<167::AID-JMR502>3.3.CO;2-0; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793	31	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193332	10.1371/journal.pone.0193332	http://dx.doi.org/10.1371/journal.pone.0193332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474422	gold, Green Published, Green Submitted			2022-12-26	WOS:000426049500086
J	Kidholm, CL; Beck, HC; Madsen, JB; Palstrom, NB; Lindholt, JS; Rasmussen, LM				Kidholm, Christina Lund; Beck, Hans Christian; Madsen, Julie Bukh; Palstrom, Nikolai Bjodstrup; Lindholt, Jes Sanddal; Rasmussen, Lars Melholt			Preliminary analysis of proteome alterations in non-aneurysmal, internal mammary artery tissue from patients with abdominal aortic aneurysms	PLOS ONE			English	Article							DNA METHYLATION; POTENTIAL ROLE; CELL CLUSTERS; MATRIX; ELASTIN; COLLAGEN; DISEASE; TROPOELASTIN; PATHOGENESIS; METAANALYSIS	Objective The pathogenesis of abdominal aortic aneurysms (AAA) involves a disturbed balance of breakdown and buildup of arterial proteins. We envision that individuals with AAA carry generalized arterial protein alterations either because of effects of genetically or environmental AAA risk factors or because of compensatory changes due to signaling molecules released from the affected aneurysmal tissue. Approach Protein extraction and quantitative proteome analysis by LC-MS/MS (liquid chromatography-mass spectrometry) was done on individual samples from the internal mammary artery from 11 individuals with AAA and 33 sex-and age-matched controls without AAA. Samples were selected from a biobank of leftover internal mammary arterial tissue gathered at coronary by-pass operations. Results We identified and quantitated 877 proteins, of which 44 were differentially expressed between the two groups (nominal p-values without correction for multiple testing). Some proteins related to the extracellular matrix displayed altered concentrations in the AAA group, particularly among elastin-related molecules [elastin, microfibrillar-associated protein 4 (MFAP4), lysyl oxidase]. In addition, several histones e.g. (e.g. HIST1H1E, HIST1H2BB) and other vascular cell proteins (e.g. versican, type VI collagen) were altered. Conclusions Our results support the notion that generalized alterations occur in the arterial tree in patients with AAA. Elastin-related proteins and histones seem to be part of such changes, however these preliminary results require replication in an independent set of specimens and validation by functional studies.	[Kidholm, Christina Lund; Madsen, Julie Bukh; Palstrom, Nikolai Bjodstrup; Lindholt, Jes Sanddal; Rasmussen, Lars Melholt] Odense Univ Hosp, Ctr Individualized Med Arterial Dis CIMA, Odense, Denmark; [Kidholm, Christina Lund; Beck, Hans Christian; Madsen, Julie Bukh; Palstrom, Nikolai Bjodstrup; Rasmussen, Lars Melholt] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Odense, Denmark; [Lindholt, Jes Sanddal] Odense Univ Hosp, Dept Vasc Surg, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Kidholm, CL (corresponding author), Odense Univ Hosp, Ctr Individualized Med Arterial Dis CIMA, Odense, Denmark.; Kidholm, CL (corresponding author), Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Odense, Denmark.	chlund37@hotmail.com	Beck, Hans Christian/AAK-9147-2021; Palstrøm, Nicolai Bjødstrup/AAM-2387-2020; Lindholt, Jes/J-2907-2014	Palstrøm, Nicolai Bjødstrup/0000-0003-1480-6550; Lindholt, Jes/0000-0001-9536-4488; Rasmussen, Lars Melholt/0000-0001-5795-4794; Beck, Hans Christian/0000-0002-7763-3637	Danish Medical Research Council	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding is from the Danish Medical Research Council as a grant for a scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANIDJAR S, 1990, CIRCULATION, V82, P973, DOI 10.1161/01.CIR.82.3.973; Antoniades C, 2011, CIRCULATION, V124, P335, DOI 10.1161/CIRCULATIONAHA.110.985150; BAXTER BT, 1992, J VASC SURG, V16, P192, DOI 10.1016/0741-5214(92)90107-J; Beck HC, 2014, NEUROCHEM RES, V39, P1199, DOI 10.1007/s11064-014-1298-y; Beck HC, 2011, NEUROCHEM RES, V36, P2002, DOI 10.1007/s11064-011-0524-0; Burillo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep38477; Bylund D, 2015, AM J CARDIOVASC DIS, V5, P140; Cangemi C, 2011, CLIN CHEM, V57, P1556, DOI 10.1373/clinchem.2011.162966; Cornuz J, 2004, EUR J PUBLIC HEALTH, V14, P343, DOI 10.1093/eurpub/14.4.343; Daly KJ, 2004, GERONTOLOGY, V50, P349, DOI 10.1159/000080172; Davis V, 1998, ARTERIOSCL THROM VAS, V18, P1625, DOI 10.1161/01.ATV.18.10.1625; Didangelos A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008128; Faarvang ASA, 2016, ATHEROSCLEROSIS, V247, P201, DOI 10.1016/j.atherosclerosis.2016.02.022; Ghorpade A, 1996, ANN NY ACAD SCI, V800, P138, DOI 10.1111/j.1749-6632.1996.tb33305.x; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Han YS, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0169-6; Hansen ML, 2015, J DIABETES COMPLICAT, V29, P362, DOI 10.1016/j.jdiacomp.2015.01.003; HUNTER GC, 1991, P SOC EXP BIOL MED, V196, P273; Joergensen TM, 2016, J VASC SURG, V64, P537, DOI [10.1016/j.jvs.2016.05.051, DOI 10.1016/J.JVS.2016.05.051]; Johnsen SH, 2010, ARTERIOSCL THROM VAS, V30, P1263, DOI 10.1161/ATVBAHA.110.203588; Jones GT, 2017, CIRC RES, V120, P341, DOI 10.1161/CIRCRESAHA.116.308765; Kuivaniemi H, 2015, EXPERT REV CARDIOVAS, V13, P975, DOI 10.1586/14779072.2015.1074861; Lindholt JS, 1997, EUR J VASC ENDOVASC, V14, P12, DOI 10.1016/S1078-5884(97)80219-5; Lindholt JS, 2000, EUR J VASC ENDOVASC, V20, P281, DOI 10.1053/ejvs.2000.1151; Lindholt JS, 1999, EUR J VASC ENDOVASC, V17, P472, DOI 10.1053/ejvs.1999.0835; Lindholt JS, 2001, EUR J VASC ENDOVASC, V21, P235, DOI 10.1053/ejvs.2001.1329; Liu RJ, 2015, BBA-GENE REGUL MECH, V1849, P448, DOI 10.1016/j.bbagrm.2014.06.004; Martinez-Pinna R, 2014, PROTEOM CLIN APPL, V8, P620, DOI 10.1002/prca.201400010; Martinez-Pinna R, 2014, PROTEOM CLIN APPL, V8, P626, DOI 10.1002/prca.201400035; MINION DJ, 1994, J SURG RES, V57, P443, DOI 10.1006/jsre.1994.1168; Morris DR, 2014, HEART, V100, P295, DOI 10.1136/heartjnl-2013-304129; Moxon JV, 2014, PROTEOM CLIN APPL, V8, P762, DOI 10.1002/prca.201300119; Petersen E, 2000, EUR J VASC ENDOVASC, V20, P457, DOI 10.1053/ejvs.2000.1211; Pilecki B, 2016, J BIOL CHEM, V291, P1103, DOI 10.1074/jbc.M115.681775; Preil SAR, 2015, CIRC-CARDIOVASC GENE, V8, P727, DOI 10.1161/CIRCGENETICS.115.001165; Remus EW, 2012, AM J PHYSIOL-HEART C, V303, pH1067, DOI 10.1152/ajpheart.00217.2012; RIZZO RJ, 1989, J VASC SURG, V10, P365; Ryer EJ, 2015, INT J MOL SCI, V16, P11259, DOI 10.3390/ijms160511259; Selvin E, 2010, ATHEROSCLEROSIS, V208, P69, DOI 10.1016/j.atherosclerosis.2009.06.025; Sun JS, 2011, ARTERIOSCL THROM VAS, V31, P2500, DOI 10.1161/ATVBAHA.111.230201; Theocharis AD, 2001, ATHEROSCLEROSIS, V154, P367, DOI 10.1016/S0021-9150(00)00504-9; Tian XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108105; Toghill BJ, 2015, ATHEROSCLEROSIS, V241, P121, DOI 10.1016/j.atherosclerosis.2015.05.001; Urbonavicius S, 2010, INTERACT CARDIOV TH, V11, P433, DOI 10.1510/icvts.2010.238139; Wahlgren CM, 2010, J VASC SURG, V51, P3, DOI 10.1016/j.jvs.2009.08.036; Xiong J, 2008, J VASC SURG, V48, P965, DOI 10.1016/j.jvs.2008.04.016	46	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192957	10.1371/journal.pone.0192957	http://dx.doi.org/10.1371/journal.pone.0192957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470511	Green Published, gold, Green Submitted			2022-12-26	WOS:000425831000026
J	Wagner, J; Strosing, KM; Spassov, SG; Lin, ZW; Engelstaedter, H; Tacke, S; Hoetzel, A; Faller, S				Wagner, Julie; Strosing, Karl M.; Spassov, Sashko G.; Lin, Ziwei; Engelstaedter, Helen; Tacke, Sabine; Hoetzel, Alexander; Faller, Simone			Sevoflurane posttreatment prevents oxidative and inflammatory injury in ventilator-induced lung injury	PLOS ONE			English	Article							POST-CONDITIONING PROTECTS; ISOLATED RAT HEARTS; VOLATILE ANESTHETICS; REPERFUSION INJURY; SURGERY; ACTIVATION; SURVIVAL; BRAIN	Mechanical ventilation is a life-saving clinical treatment but it can induce or aggravate lung injury. New therapeutic strategies, aimed at reducing the negative effects of mechanical ventilation such as excessive production of reactive oxygen species, release of pro-inflammatory cytokines, and transmigration as well as activation of neutrophil cells, are needed to improve the clinical outcome of ventilated patients. Though the inhaled anesthetic sevoflurane is known to exert organ-protective effects, little is known about the potential of sevoflurane therapy in ventilator-induced lung injury. This study focused on the effects of delayed sevoflurane application in mechanically ventilated C57BL/6N mice. Lung function, lung injury, oxidative stress, and inflammatory parameters were analyzed and compared between non-ventilated and ventilated groups with or without sevoflurane anesthesia. Mechanical ventilation led to a substantial induction of lung injury, reactive oxygen species production, pro-inflammatory cytokine release, and neutrophil influx. In contrast, sevoflurane posttreatment time dependently reduced histological signs of lung injury. Most interestingly, increased production of reactive oxygen species was clearly inhibited in all sevoflurane posttreatment groups. Likewise, the release of the pro-inflammatory cytokines interleukin-1 beta and MIP-1 beta and neutrophil transmigration were completely prevented by sevoflurane independent of the onset of sevoflurane administration. In conclusion, sevoflurane posttreatment time dependently limits lung injury, and oxidative and pro-inflammatory responses are clearly prevented by sevoflurane irrespective of the onset of posttreatment. These findings underline the therapeutic potential of sevoflurane treatment in ventilator-induced lung injury.	[Wagner, Julie; Strosing, Karl M.; Spassov, Sashko G.; Lin, Ziwei; Engelstaedter, Helen; Hoetzel, Alexander; Faller, Simone] Univ Freiburg, Fac Med, Dept Anesthesiol & Crit Care Med, Med Ctr, Freiburg, Germany; [Wagner, Julie; Tacke, Sabine] Justus Liebig Univ Giessen, Dept Vet Clin Sci, Clin Small Anim Surg, Giessen, Germany	University of Freiburg; Justus Liebig University Giessen	Faller, S (corresponding author), Univ Freiburg, Fac Med, Dept Anesthesiol & Crit Care Med, Med Ctr, Freiburg, Germany.	simone.faller@uniklinik-freiburg.de	Tacke, Sabine/A-3213-2019; Spassov, Sashko/C-2105-2013	Spassov, Sashko/0000-0002-3585-3682; Faller, Simone/0000-0001-5345-8523	German Research Foundation [DFG HO 2464/3-1]; Department of Anesthesiology and Critical Care Medicine, University Medical Center Freiburg, Freiburg, Germany; German Research Foundation (DFG); University of Freiburg	German Research Foundation(German Research Foundation (DFG)); Department of Anesthesiology and Critical Care Medicine, University Medical Center Freiburg, Freiburg, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	This work was supported by a grant from the German Research Foundation, dedicated to AH (DFG HO 2464/3-1, Bonn, Germany) and by the Department of Anesthesiology and Critical Care Medicine, University Medical Center Freiburg, Freiburg, Germany. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk S, 2010, BRIT J ANAESTH, V104, P191, DOI 10.1093/bja/aep365; Annecke T, 2008, ACTA ANAESTH SCAND, V52, P977, DOI 10.1111/j.1399-6576.2008.01665.x; Belperio JA, 2006, SEMIN RESP CRIT CARE, V27, P350, DOI 10.1055/s-2006-948289; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cai JR, 2014, J THORAC CARDIOV SUR, V148, P3127, DOI 10.1016/j.jtcvs.2014.07.085; Chapman KE, 2005, AM J PHYSIOL-LUNG C, V289, pL834, DOI 10.1152/ajplung.00069.2005; Du GZ, 2017, ANESTH ANALG, V124, P1555, DOI [10.1213/ANE.0000000000002034, 10.1213/ane.0000000000002034]; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Faller S, 2012, LAB INVEST, V92, P999, DOI 10.1038/labinvest.2012.55; Faller S, 2012, ANESTH ANALG, V114, P747, DOI 10.1213/ANE.0b013e31824762f0; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Fanelli Vito, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS3, DOI 10.1513/AnnalsATS.201407-340MG; Frank JA, 2008, THORAX, V63, P147, DOI 10.1136/thx.2007.079608; Gong JS, 2012, MOL BIOL REP, V39, P6417, DOI 10.1007/s11033-012-1447-9; Head BP, 2007, CURR OPIN ANESTHESIO, V20, P395, DOI 10.1097/ACO.0b013e3282efa69d; Kalb R, 2008, EUR J ANAESTH, V25, P454, DOI 10.1017/S0265021508003682; Landoni G, 2008, CURR VASC PHARMACOL, V6, P108, DOI 10.2174/157016108783955284; Lee HT, 2007, SHOCK, V27, P373, DOI 10.1097/01.shk.0000248595.17130.24; Li H, 2008, CLIN EXP PHARMACOL P, V35, P1043, DOI 10.1111/j.1440-1681.2008.04952.x; Lionetti V, 2005, CURR OPIN CRIT CARE, V11, P82, DOI 10.1097/00075198-200502000-00013; Mesnil M, 2011, INTENS CARE MED, V37, P933, DOI 10.1007/s00134-011-2187-3; Neto AS, 2015, CRIT CARE MED, V43, P2155, DOI 10.1097/CCM.0000000000001189; Otsuki T, 2015, BIOMED REP, V3, P408, DOI 10.3892/br.2015.428; Pagel PS, 2011, J CARDIOTHOR VASC AN, V25, P1125, DOI 10.1053/j.jvca.2010.09.017; Redel A, 2009, EXP BIOL MED, V234, P1186, DOI 10.3181/0902-RM-58; Ricard JD, 2003, EUR RESPIR J, V22, p2S, DOI 10.1183/09031936.03.00420103; Neto AS, 2015, ANESTHESIOLOGY, V123, P66, DOI 10.1097/ALN.0000000000000706; Spassov SG, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3715037; Strosing KM, 2016, ANESTH ANALG, V123, P143, DOI 10.1213/ANE.0000000000001296; Suter D, 2007, ANESTH ANALG, V104, P638, DOI 10.1213/01.ane.0000255046.06058.58; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Tsushima K, 2009, INTERNAL MED, V48, P621, DOI 10.2169/internalmedicine.48.1741; Voigtsberger S, 2009, ANESTHESIOLOGY, V111, P1238, DOI 10.1097/ALN.0b013e3181bdf857; WRIGHT DT, 1994, ENVIRON HEALTH PERSP, V102, P85, DOI 10.2307/3432221; Xie H, 2014, ACTA PHARMACOL SIN, V35, P1504, DOI 10.1038/aps.2014.78; Xiong XQ, 2013, INT J NANOMED, V8, P1075, DOI 10.2147/IJN.S41625; Yao YT, 2010, MOL BIOL REP, V37, P2439, DOI 10.1007/s11033-009-9755-4; Ye Z, 2015, J NEUROL SCI, V348, P216, DOI 10.1016/j.jns.2014.12.011; Yu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134666; Yu QB, 2015, GENET MOL RES, V14, P19016, DOI 10.4238/2015.December.29.9; Zhang Y, 2017, LIFE SCI, V173, P68, DOI 10.1016/j.lfs.2017.02.006; Zhao SP, 2014, MOL MED REP, V9, P2435, DOI 10.3892/mmr.2014.2094; Zurek M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151211	43	28	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192896	10.1371/journal.pone.0192896	http://dx.doi.org/10.1371/journal.pone.0192896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470503	gold, Green Published, Green Submitted			2022-12-26	WOS:000425831000021
J	Policicchio, BB; Sette, P; Xu, CL; Haret-Richter, G; Dunsmore, T; Pandrea, I; Ribeiro, RM; Apetrei, C				Policicchio, Benjamin Bruno; Sette, Paola; Xu, Cuiling; Haret-Richter, George; Dunsmore, Tammy; Pandrea, Ivona; Ribeiro, Ruy M.; Apetrei, Cristian			Emergence of resistance mutations in simian immunodeficiency virus (SIV)-infected rhesus macaques receiving non-suppressive antiretroviral therapy (ART)	PLOS ONE			English	Article							STRAND TRANSFER INHIBITORS; AFRICAN-GREEN MONKEYS; REVERSE-TRANSCRIPTASE; DRUG-RESISTANCE; M184V MUTATION; NAIVE SUBJECTS; HIV-1; REPLICATION; TENOFOVIR; SUSCEPTIBILITY	Two SIVmac251-infected rhesus macaques received tenofovir/emtricitabine with raltegravir intensification. Viral rebound occurred during treatment and sequencing of reverse transcriptase and integrase genes identified multiple resistance mutations. Similar to HIV infection, antiretroviral-resistance mutations may occur in SIV-infected nonhuman primates receiving nonsuppressive ART. As ART administration to nonhuman primates is currently dramatically expanding, fueled by both cure research and the study of HIV-related comorbidities, viral resistance should be factored in the study design and data interpretation.	[Policicchio, Benjamin Bruno; Sette, Paola; Xu, Cuiling; Haret-Richter, George; Dunsmore, Tammy; Pandrea, Ivona; Apetrei, Cristian] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Policicchio, Benjamin Bruno; Pandrea, Ivona; Apetrei, Cristian] Univ Pittsburgh, Grad Sch Publ Hlth, Infect Dis & Microbiol, Pittsburgh, PA 15260 USA; [Sette, Paola; Xu, Cuiling; Haret-Richter, George; Dunsmore, Tammy; Pandrea, Ivona] Univ Pittsburgh, Sch Med, Pathol, Pittsburgh, PA USA; [Ribeiro, Ruy M.] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM USA; [Ribeiro, Ruy M.] Univ Lisbon, Lab Biomatemat, Fac Med, Lisbon, Portugal; [Apetrei, Cristian] Univ Pittsburgh, Sch Med, Microbiol & Mol Genet, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Energy (DOE); Los Alamos National Laboratory; Universidade de Lisboa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Apetrei, C (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.; Apetrei, C (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.; Apetrei, C (corresponding author), Univ Pittsburgh, Sch Med, Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	apetreic@pitt.edu	Apetrei, Cristian/AAG-9032-2021	Apetrei, Cristian/0000-0002-0322-7185; Ribeiro, Ruy/0000-0002-3988-8241	National Institutes of Health /National Institute of Allergy and Infectious Diseases / National Heart, Lung and Blood Institute [R01 A1104373, R01 HL117715, R01 A1119346, R01 HU 23096]; NIH [T32 A1065380]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117715, R01HL123096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI119346, T32AI065380, R01AI104373] Funding Source: NIH RePORTER	National Institutes of Health /National Institute of Allergy and Infectious Diseases / National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded through National Institutes of Health /National Institute of Allergy and Infectious Diseases / National Heart, Lung and Blood Institute grants R01 A1104373 (RMR), R01 HL117715 (IP), R01 A1119346 (CA) and R01 HU 23096 (IP). BBP was supported by the NIH Training Grant T32 A1065380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreatta KN, 2016, ANTIMICROB AGENTS CH, V60, P757, DOI 10.1128/AAC.02096-15; Collins SE, 2016, DRUGS, V76, P75, DOI 10.1007/s40265-015-0515-6; Del Prete GQ, 2016, AIDS RES HUM RETROV, V32, P163, DOI [10.1089/AID.2015.0130, 10.1089/aid.2015.0130]; Gordon SN, 2008, J VIROL, V82, P3725, DOI 10.1128/JVI.02408-07; Hassounah SA, 2015, J VIROL, V89, P12002, DOI 10.1128/JVI.02131-15; Hassounah SA, 2014, J VIROL, V88, P9683, DOI 10.1128/JVI.00947-14; Hazuda DJ, 2004, SCIENCE, V305, P528, DOI 10.1126/science.1098632; Lloyd SB, 2016, VIROLOGY, V492, P1, DOI 10.1016/j.virol.2016.02.008; Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1; Margot NA, 2009, JAIDS-J ACQ IMM DEF, V52, P209, DOI 10.1097/QAI.0b013e3181b05f7c; McColl DJ, 2011, HIV CLIN TRIALS, V12, P61, DOI 10.1310/hct1202-61; Murry JP, 2003, J VIROL, V77, P1120, DOI 10.1128/JVI.77.2.1120-1130.2003; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; Pandrea I, 2008, J VIROL, V82, P3713, DOI 10.1128/JVI.02402-07; Pandrea I, 2006, J VIROL, V80, P4858, DOI 10.1128/JVI.80.10.4858-4867.2006; Pennings PS, 2013, INFECT DIS REP, V5, P21, DOI 10.4081/idr.2013.s1.e5; Policicchio BB, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00012; Sluis-Cremer N, 2015, FUTURE MICROBIOL, V10, P1773, DOI 10.2217/fmb.15.106; Svarovskaia ES, 2003, FRONT BIOSCI-LANDMRK, V8, pD117, DOI 10.2741/957; Van Rompay KKA, 2004, J VIROL, V78, P5324, DOI 10.1128/JVI.78.10.5324-5337.2004; Van Rompay KKA, 2002, J VIROL, V76, P6083, DOI 10.1128/JVI.76.12.6083-6092.2002; Van Rompay KKA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-25	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0190908	10.1371/journal.pone.0190908	http://dx.doi.org/10.1371/journal.pone.0190908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466356	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300005
J	Sanchez-Garcia, A; Penalver, E; Delclos, X; Engel, MS				Sanchez-Garcia, Alba; Penalver, Enrique; Delclos, Xavier; Engel, Michael S.			Mating and aggregative behaviors among basal hexapods in the Early Cretaceous	PLOS ONE			English	Article							INDIRECT SPERM TRANSFER; COLLEMBOLA; AMBER; ISOTOMIDAE; MORPHOLOGY; MARGIN; SPAIN	Among the many challenges in paleobiology is the inference and reconstruction of behaviors that rarely, if ever, leave a physical trace on the environment that is suitable for fossilization. Of particular significance are those behaviors tied to mating and courtship, individual interactions critical for species integrity and continuance, as well as those for dispersal, permitting the taxon to expand its distribution as well as access new habitats in the face of local or long-term environmental change. In this context, two recently discovered fossils from the Early Cretaceous amber of Spain (ca. 105 mya) give a detailed view of otherwise fleeting ethologies in Collembola. These occurrences are phylogenetically spaced across the class, and from species representing the two major clades of springtails-Symphypleona and Entomobryomorpha. Specifically, we report unique evidence from a symphypleonan male (Pseudosminthurides stoechus Sa A nchez-Garcia & Engel, 2016) with modified antennae that may have functioned as a clasping organ for securing females during mating on water's surface, and from an aggregation of entomobryomorphan individuals (Proisotoma communis Sa A nchez-Garcia & Engel, 2016) purportedly representing a swarming episode on the forest floor. We demonstrate that the mating behavioral repertoire in P. stoechus, which is associated with considerable morphological adaptations, likely implied elaborate courtship and maneuvering for guarantee sperm transfer in an epineustic species. These discoveries reveal significant behaviors consistent with modern counterparts and a generalized stasis for some ancient hexapod ethologies associated with complex mating and courtship and social or pre-social aggregations, so critical to specific constancy and dispersal.	[Sanchez-Garcia, Alba; Delclos, Xavier] Univ Barcelona, Fac Ciencies Terra, Dept Dinam Terra & Ocea, Barcelona, Spain; [Sanchez-Garcia, Alba; Delclos, Xavier] Univ Barcelona, Fac Ciencies Terra, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Penalver, Enrique] Inst Geol & Minero Espana, Museo Geominero, Madrid, Spain; [Engel, Michael S.] Univ Kansas, Museum Nat Hist, Div Entomol, Lawrence, KS 66045 USA; [Engel, Michael S.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Engel, Michael S.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA	University of Barcelona; University of Barcelona; University of Kansas; University of Kansas; American Museum of Natural History (AMNH)	Engel, MS (corresponding author), Univ Kansas, Museum Nat Hist, Div Entomol, Lawrence, KS 66045 USA.; Engel, MS (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.; Engel, MS (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	msengel@ku.edu	DELCLOS, Xavier/N-1652-2019; DELCLOS, Xavier/D-4363-2014; Engel, Michael S/C-5461-2012	DELCLOS, Xavier/0000-0002-2233-5480; DELCLOS, Xavier/0000-0002-2233-5480; Engel, Michael S/0000-0003-3067-077X; Sanchez-Garcia, Alba/0000-0003-0911-2001	Spanish Ministry of Economy and Competitiveness [CGL2014-52163]; Spanish Ministry of Economy and Competitiveness [CGL2014-52163]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government)	Financial support was provided by the Spanish Ministry of Economy and Competitiveness project CGL2014-52163. This is also a contribution to the Division of Entomology, University of Kansas Natural History Museum.	Aguilar M.J., 1971, ESTUD GEOL-MADRID, V27, P497; [Anonymous], [No title captured]; Barron E, 2015, CRETACEOUS RES, V52, P292, DOI 10.1016/j.cretres.2014.10.003; BETSCH J-M, 1980, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V116, P1; BETSCHPINOT MC, 1977, REV ECOL BIOL SOL, V14, P15; BLANCQUAERT JP, 1981, PEDOBIOLOGIA, V22, P1; Boucot A.J., 2010, FOSSIL BEHAV COMPEND; Cervera A, 1976, TECNITERRAE, V3, P25; Chaboo CS, 2009, NATURWISSENSCHAFTEN, V96, P1121, DOI 10.1007/s00114-009-0573-2; Danyi L., 2013, Opuscula Zoologica (Budapest), V44, P157; Davies WM, 1932, NATURE, V130, P94, DOI 10.1038/130094b0; Deharveng L, 2008, HYDROBIOLOGIA, V595, P329, DOI 10.1007/s10750-007-9116-z; Eberhard WG, 2004, EVOLUTION, V58, P1947; Eisenbeis G, 1987, ATLAS BIOL SOIL, DOI [10.1007/978-3-642-72634-7, DOI 10.1007/978-3-642-72634-7]; ELLIS W N, 1976, Tijdschrift voor Entomologie, V119, P221; Engel MS, 2016, CURR BIOL, V26, P522, DOI 10.1016/j.cub.2015.12.061; Engel MS, 2015, CURR BIOL, V25, pR868, DOI 10.1016/j.cub.2015.07.059; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; FJELLBERG A, 2007, FAUNA ENTOMOL SCAD, V42, P1; Garcia-Mondejar J., 2004, GEOLOGIA ESPANA, P340; Grimaldi David, 2005, pi; Gruenemaier Margarita, 2016, Palaeodiversity, V9, P9, DOI 10.18476/pale.v9.a2; Palacios-Vargas JG, 2009, PESQUI AGROPECU BRAS, V44, P959, DOI 10.1590/S0100-204X2009000800024; Hagvar Sigmund, 1995, Acta Zoologica Fennica, V196, P200; Hirst S., 1926, Geological Magazine London, V1926, P69; Hopkin S.P., 1997, BIOL SPRINGTAILS INS; LYFORD WH, 1975, AM MIDL NAT, V94, P205, DOI 10.2307/2424550; Martinez-Torres L.M., 2003, ESTUDIOS MUSEO CIENC, V18, P9; MASSOUD Z, 1972, Revue d'Ecologie et de Biologie du Sol, V9, P55; MUTT J A M, 1978, Transactions of the Illinois State Academy of Science, V71, P236; NOBLENESBITT J, 1963, J EXP BIOL, V40, P681; Park O., 1949, Annals of the Entomological Society of America, V42, P7; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Rodriguez-Lopez JP, 2008, SEDIMENTOLOGY, V55, P1253, DOI 10.1111/j.1365-3091.2007.00945.x; Penalver E, 2005, T ROY SOC EDIN-EARTH, V96, P177, DOI 10.1017/S0263593300001292; Penalver Enrique, 2010, P236; Penney D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047651; Poinar George, 2000, Historical Biology, V14, P229; Poinar Jr G. O., 1999, THE AMBER FOREST; Potapov AA, 2016, SOIL BIOL BIOCHEM, V101, P20, DOI 10.1016/j.soilbio.2016.07.002; Proctor HC, 1998, ANNU REV ENTOMOL, V43, P153, DOI 10.1146/annurev.ento.43.1.153; Rodriaguez-Lopez JP, 1980, MEM MUS NATL HIST A, V116, P1; Rodriguez-Lopez JP, 2007, SEDIMENT GEOL, V201, P461, DOI 10.1016/j.sedgeo.2007.07.009; Sanchez-Garcia A, 2017, J SYST PALAEONTOL, V15, P513, DOI 10.1080/14772019.2016.1194575; Sanchez-Garcia A, 2016, AM MUS NOVIT, P1; Sanchez-Garcia A, 2016, CRETACEOUS RES, V57, P111, DOI 10.1016/j.cretres.2015.07.010; Sanchez-Garcia A, 2015, J SYST PALAEONTOL, V13, P645, DOI 10.1080/14772019.2014.944946; SCHALLER F, 1971, ANNU REV ENTOMOL, V16, P407, DOI 10.1146/annurev.en.16.010171.002203; Schmidt AR, 2007, P NATL ACAD SCI USA, V104, P16581, DOI 10.1073/pnas.0707949104; Simonsen V, 1999, ZOOL SCR, V28, P281, DOI 10.1046/j.1463-6409.1999.00025.x; Turk FA, 1932, NATURE, V129, P830, DOI 10.1038/129830c0; Wappler T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133330; Wedmann S, 2009, NATURWISSENSCHAFTEN, V96, P703, DOI 10.1007/s00114-009-0525-x; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	54	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0191669	10.1371/journal.pone.0191669	http://dx.doi.org/10.1371/journal.pone.0191669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466382	Green Submitted, gold, Green Published			2022-12-26	WOS:000425604300014
J	Schirmer, I; Bualeong, T; Budde, H; Cimiotti, D; Appukuttan, A; Klein, N; Steinwascher, P; Reusch, P; Mugge, A; Meyer, R; Ladilov, Y; Jaquet, K				Schirmer, Ilona; Bualeong, Tippaporn; Budde, Heidi; Cimiotti, Diana; Appukuttan, Avinash; Klein, Nicole; Steinwascher, Philip; Reusch, Peter; Muegge, Andreas; Meyer, Rainer; Ladilov, Yury; Jaquet, Kornelia			Soluble adenylyl cyclase: A novel player in cardiac hypertrophy induced by isoprenaline or pressure overload	PLOS ONE			English	Article							INDUCED CARDIOMYOCYTE HYPERTROPHY; ADULT-RAT CARDIOMYOCYTES; PROSTATE-CANCER CELLS; TRANSCRIPTION FACTOR; HEART-FAILURE; KINASE-II; BICARBONATE; STIMULATION; MICE; CALCIUM	Aims In contrast to the membrane bound adenylyl cyclases, the soluble adenylyl cyclase (sAC) is activated by bicarbonate and divalent ions including calcium. sAC is located in the cytosol, nuclei and mitochondria of several tissues including cardiac muscle. However, its role in cardiac pathology is poorly understood. Here we investigate whether sAC is involved in hypertrophic growth using two different model systems. Methods and results In isolated adult rat cardiomyocytes hypertrophy was induced by 24 h beta(1)-adrenoceptor stimulation using isoprenaline (ISO) and a beta(2)-adrenoceptor antagonist (ICI118,551). To monitor hypertrophy cell size along with RNA/DNA- and protein/DNA ratios as well as the expression level of a-skeletal actin were analyzed. sAC activity was suppressed either by treatment with its specific inhibitor KH7 or by knockdown. Both pharmacological inhibition and knockdown blunted hypertrophic growth and reduced expression levels of alpha-skeletal actin in ISO/ICI treated rat cardiomyocytes. To analyze the underlying cellular mechanism expression levels of phosphorylated CREB, B-Raf and Erk1/2 were examined by western blot. The results suggest the involvement of B-Raf, but not of Erk or CREB in the pro-hypertrophic action of sAC. In wild type and sAC knockout mice pressure overload was induced by transverse aortic constriction. Hemodynamics, heart weight and the expression level of the atrial natriuretic peptide were analyzed. In accordance, transverse aortic constriction failed to induce hypertrophy in sAC knockout mice. Mechanistic analysis revealed a potential role of Erk1/2 in TAC-induced hypertrophy. Conclusion Soluble adenylyl cyclase might be a new pivotal player in the cardiac hypertrophic response either to long-term beta(1)-adrenoceptor stimulation or to pressure overload.	[Schirmer, Ilona; Budde, Heidi; Cimiotti, Diana; Klein, Nicole; Steinwascher, Philip; Muegge, Andreas; Jaquet, Kornelia] Ruhr Univ Bochum, Cardiol, Res Lab Mol Cardiol, BG Bergmannsheil & St Josef Hosp, Bochum, Germany; [Bualeong, Tippaporn; Meyer, Rainer] Friedrich Wilhelms Univ Bonn, Inst Physiol 2, Bonn, Germany; [Appukuttan, Avinash; Reusch, Peter; Ladilov, Yury] Ruhr Univ Bochum, Clin Pharmacol, Fac Med, Bochum, Germany; [Schirmer, Ilona] Ruhr Univ Bochum, Erich & Hanna Klessmann Inst, Heart & Diabet Ctr Bad Oeynhausen, Bad Oeynhausen, Germany; [Bualeong, Tippaporn] Naresuan Univ, Dept Physiol, Fac Med Sci, Phitsanulok, Thailand	Ruhr University Bochum; University of Bonn; Ruhr University Bochum; Ruhr University Bochum; Naresuan University	Jaquet, K (corresponding author), Ruhr Univ Bochum, Cardiol, Res Lab Mol Cardiol, BG Bergmannsheil & St Josef Hosp, Bochum, Germany.	kornelia.jaquet@ruhr-uni-bochum.de	Meyer, Rainer/H-5871-2013; Ladilov, Yury/AAN-2603-2020; Ladilov, Yury/AAD-3547-2021; Cimiotti, Diana/AAX-5991-2021	Cimiotti, Diana/0000-0002-0527-1526; Bualeong, Tippaporn/0000-0003-2598-0378	Medical Faculty of the Ruhr-university of Bochum (FORUM) [F720-011-Yury Ladiiov]	Medical Faculty of the Ruhr-university of Bochum (FORUM)	This work was partly funded by the Medical Faculty of the Ruhr-university of Bochum (FORUM): F720-011-Yury Ladiiov. The Funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Antos CL, 2002, PNAS, V22, P907; Appukuttan A, 2014, BBA-MOL BASIS DIS, V1842, P2656, DOI 10.1016/j.bbadis.2014.09.008; Appukuttan A, 2012, CARDIOVASC RES, V93, P340, DOI 10.1093/cvr/cvr306; Baumgarten G, 2006, BASIC RES CARDIOL, V101, P427, DOI 10.1007/s00395-006-0597-0; Bitterman JL, 2013, J PHARMACOL EXP THER, V347, P589, DOI 10.1124/jpet.113.208496; BRAUN T, 1991, METHOD ENZYMOL, V195, P130; BRAUN T, 1975, P NATL ACAD SCI USA, V72, P1097, DOI 10.1073/pnas.72.3.1097; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Chen X, 2014, AM J RESP CELL MOL, V51, P750, DOI 10.1165/rcmb.2013-0542OC; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Di Benedetto G, 2013, CELL METAB, V17, P965, DOI 10.1016/j.cmet.2013.05.003; El-Armouche A, 2009, HEART FAIL REV, V14, P225, DOI 10.1007/s10741-008-9132-8; Enns LC, 2010, BMC RES NOTES, V16, P307; Farell J, 2008, PLOS ONE, P3; Flacke JP, 2013, J BIOL CHEM, V288, P3126, DOI 10.1074/jbc.M112.403279; FORTE LR, 1983, MOL PHARMACOL, V24, P42; Gelb BD, 2011, J CLIN INVEST, V121, P844, DOI 10.1172/JCI46399; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Ha CH, 2010, P NATL ACAD SCI USA, V107, P15467, DOI 10.1073/pnas.1000462107; Harrison JG, 2004, BBA-MOL CELL RES, V1644, P17, DOI 10.1016/j.bbamcr.2003.10.008; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kleinboelting S, 2014, FEBS J, V281, P4151, DOI 10.1111/febs.12913; Kumar S, 2009, J BIOL CHEM, V284, P14760, DOI 10.1074/jbc.M900925200; Ladilov Y, 2014, BBA-MOL BASIS DIS, V1842, P2646, DOI 10.1016/j.bbadis.2014.06.034; Lefkimmiatis K, 2014, PHARMACOL THERAPEUT, V143, P295, DOI 10.1016/j.pharmthera.2014.03.008; Liao YL, 2002, AM J PHYSIOL-HEART C, V282, pH1703, DOI 10.1152/ajpheart.00238.2001; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; London B, 2006, J AM COLL CARDIOL, V48, P506, DOI 10.1016/j.jacc.2006.05.020; Matus M, 2007, FASEB J, V21, P1884, DOI 10.1096/fj.06-7915com; Metrich M, 2008, CIRC RES, V102, P959, DOI 10.1161/CIRCRESAHA.107.164947; Mokni W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014227; NEER EJ, 1978, J BIOL CHEM, V253, P5808; Rahman N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00343; Reis S, 2008, PFLUG ARCH EUR J PHY, V457, P17, DOI 10.1007/s00424-008-0487-4; Roos KP, 2007, J CARD FAIL, V13, P318, DOI 10.1016/j.cardfail.2007.01.004; Schafer M, 2000, AM J PHYSIOL-CELL PH, V279, pC495, DOI 10.1152/ajpcell.2000.279.2.C495; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Songstad NT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089559; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Tresguerres M, 2010, PFLUG ARCH EUR J PHY, V460, P953, DOI 10.1007/s00424-010-0865-6; Ulm S, 2014, J MOL CELL CARDIOL, V72, P104, DOI 10.1016/j.yjmcc.2014.03.002; Vidal M, 2012, CARDIOVASC RES, V96, P255, DOI 10.1093/cvr/cvs249; Wilson CM, 2016, J EXP BIOL, V219, P3227, DOI 10.1242/jeb.138198; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje; Zippin JH, 2013, J BIOL CHEM, V288, P33283, DOI 10.1074/jbc.M113.510073; Zoccarato A, 2015, CIRC RES, V117, P707, DOI 10.1161/CIRCRESAHA.114.305892; Zou YZ, 1999, J BIOL CHEM, V274, P9760, DOI 10.1074/jbc.274.14.9760	53	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192322	10.1371/journal.pone.0192322	http://dx.doi.org/10.1371/journal.pone.0192322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466442	Green Submitted, Green Published, gold			2022-12-26	WOS:000425604300048
J	Chegeni, M; Amiri, M; Nichols, BL; Naim, HY; Hamaker, BR				Chegeni, Mohammad; Amiri, Mahdi; Nichols, Buford L.; Naim, Hassan Y.; Hamaker, Bruce R.			Dietary starch breakdown product sensing mobilizes and apically activates -glucosidases in small intestinal enterocytes	FASEB JOURNAL			English	Article						carbohydrates; gut epithelium; glycosylation; maltose	LACTASE-PHLORHIZIN HYDROLASE; SUCRASE-ISOMALTASE COMPLEX; MALTASE-GLUCOAMYLASE; DIFFERENTIAL EXPRESSION; AMINOPEPTIDASE N; TASTE RECEPTORS; CACO-2 CELLS; GLUCOSE; DIGESTION; GLYCOSYLATION	Dietary starch is finally converted to glucose for absorption by the small intestine mucosal -glucosidases (sucrase-isomaltase [SI] and maltase-glucoamylase), and control of this process has health implications. Here, the molecular mechanisms were analyzed associated with starch-triggered maturation and transport of SI. Biosynthetic pulse-chase in Caco-2 cells revealed that the high MW SI species (265 kDa) induced by maltose (an -amylase starch digestion product) had a higher rate of early trafficking and maturation compared with a glucose-induced SI (245 kDa). The maltose-induced SI was found to have higher affinity to lipid rafts, which are associated with enhanced targeting to the apical membrane and higher activity. Accordingly, in situ maltose-hydrolyzing action was enhanced in the maltose-treated cells. Thus, starch digestion products at the luminal surface of small intestinal enterocytes are sensed and accelerate the intracellular processing of SI to enhance starch digestion capacity in the intestinal lumen.Chegeni, M., Amiri, M., Nichols, B. L., Naim, H. Y., Hamaker, B. R. Dietary starch breakdown product sensing mobilizes and apically activates -glucosidases in small intestinal enterocytes.	[Chegeni, Mohammad; Hamaker, Bruce R.] Purdue Univ, Whistler Ctr Carbohydrate Res, Dept Food Sci, Smith Hall, W Lafayette, IN 47907 USA; [Amiri, Mahdi; Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, Bunteweg 17, D-30559 Hannover, Germany; [Nichols, Buford L.] ARS, Dept Pediat, USDA, Childrens Nutr Res Ctr,Baylor Coll Med, Houston, TX USA; [Amiri, Mahdi] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Veterinary Medicine Hannover, Foundation; Baylor College of Medicine; United States Department of Agriculture (USDA); Hannover Medical School	Naim, HY (corresponding author), Univ Vet Med Hannover, Dept Physiol Chem, Bunteweg 17, D-30559 Hannover, Germany.; Hamaker, BR (corresponding author), Purdue Univ, Whistler Ctr Carbohydrate Res, 765 Agr Mall Dr, W Lafayette, IN 47907 USA.	hassan.naim@tiho-hannover.de; hamakerb@purdue.edu	Amiri, Mahdi/L-6934-2019	Amiri, Mahdi/0000-0003-4775-9535				Alfalah M, 1999, CURR BIOL, V9, P593, DOI 10.1016/S0960-9822(99)80263-2; BEAULIEU JF, 1991, BIOCHEM J, V280, P599, DOI 10.1042/bj2800599; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; CHANTRET I, 1994, J CELL SCI, V107, P213; Cheng MW, 2014, J CLIN BIOCHEM NUTR, V54, P55, DOI 10.3164/jcbn.13-59; Christian MT, 2002, J PEDIATR GASTR NUTR, V34, P158, DOI 10.1097/00005176-200202000-00010; Cisse F, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020124; DAHLQVIST A, 1969, BIOCHEM J, V111, P139, DOI 10.1042/bj1110139; DAHLQVIST A, 1962, J CLIN INVEST, V41, P463, DOI 10.1172/JCI104499; DANIELSEN EM, 1982, BIOCHEM J, V204, P639, DOI 10.1042/bj2040639; GRAY GM, 1979, J BIOL CHEM, V254, P6038; Hardy K, 2015, Q REV BIOL, V90, P251, DOI 10.1086/682587; HEYMANN H, 1995, BIOL CHEM H-S, V376, P249; HUNZIKER W, 1986, CELL, V46, P227, DOI 10.1016/0092-8674(86)90739-7; Jacob R, 2000, J BIOL CHEM, V275, P10630, DOI 10.1074/jbc.275.14.10630; Le Gall M, 2007, J CELL PHYSIOL, V213, P834, DOI 10.1002/jcp.21245; Lee BH, 2014, MOL NUTR FOOD RES, V58, P1111, DOI 10.1002/mnfr.201300599; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; MAHRAOUI L, 1994, BIOCHEM J, V298, P629, DOI 10.1042/bj2980629; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Moran AW, 2010, BRIT J NUTR, V104, P637, DOI 10.1017/S0007114510000917; NAIM HY, 1988, J BIOL CHEM, V263, P7242; Naim HY, 1999, J BIOL CHEM, V274, P17961, DOI 10.1074/jbc.274.25.17961; NAIM HY, 1987, BIOCHEM J, V241, P427, DOI 10.1042/bj2410427; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; PETERSON MD, 1992, J CELL SCI, V102, P581; Quezada-Calvillo R, 2007, J PEDIATR GASTR NUTR, V45, P32, DOI 10.1097/MPG.0b013e31804216fc; Robayo-Torres CC, 2006, CLIN GASTROENTEROL H, V4, P276, DOI 10.1016/j.cgh.2005.12.023; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; STERCHI EE, 1980, CLIN CHIM ACTA, V102, P49, DOI 10.1016/0009-8981(80)90432-5; Treesukosol Y, 2009, AM J PHYSIOL-REG I, V296, pR855, DOI 10.1152/ajpregu.90869.2008; van Avesaat M, 2015, INT J OBESITY, V39, P235, DOI 10.1038/ijo.2014.112; VANBEERS EH, 1995, BIOCHEM J, V308, P769, DOI 10.1042/bj3080769; Wetzel G, 2009, BIOL CHEM, V390, P545, DOI 10.1515/BC.2009.077	35	8	8	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3903	3911		10.1096/fj.201701029R	http://dx.doi.org/10.1096/fj.201701029R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29465310				2022-12-26	WOS:000435104500035
J	Du, YY; Liu, Y; Xu, YJ; Juan, JX; Zhang, ZB; Xu, Z; Cao, BY; Wang, Q; Zeng, YY; Mao, XL				Du, Yanyun; Liu, Yan; Xu, Yujia; Juan, Jiaxiang; Zhang, Zubin; Xu, Zhuan; Cao, Biyin; Wang, Qi; Zeng, Yuanying; Mao, Xinliang			The transmembrane protein TMEPAI induces myeloma cell apoptosis by promoting degradation of the c-Maf transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; GROWTH-FACTOR-BETA; MULTIPLE-MYELOMA; TGF-BETA; NEDD4-BINDING PROTEIN; ANDROGEN RECEPTOR; PMEPA1; GENE; UBIQUITINATION; PROLIFERATION	TMEPAI (transmembrane prostate androgen-induced protein, also called prostate transmembrane protein, androgen-induced 1 (PMEPA1)) is a type I transmembrane (TM) protein, but its cellular function is largely unknown. Here, studying factors influencing the stability of c-Maf, a critical transcription factor in multiple myeloma (MM), we found that TMEPAI induced c-Maf degradation. We observed that TMEPAI recruited NEDD4 (neural precursor cell expressed, developmentally down-regulated 4), aWWdomain-containing ubiquitin ligase, to c-Maf, leading to its degradation through the proteasomal pathway. Further investigation revealed that TMEPAI interacts with NEDD4 via its conserved PY motifs. Alanine substitution or deletion of these motifs abrogated the TMEPAI complex formation with NEDD4, resulting in failed c-Maf degradation. Functionally, TMEPAI suppressed the transcriptional activity of c-Maf. Of note, increased TMEPAI expression was positively associated with the overall survival of MM patients. Moreover, TMEPAI was down-regulated in MMcells, and re-expression of TMEPAI induced MM cell apoptosis. In conclusion, this study highlights that TMEPAI decreases c-Maf stability by recruiting the ubiquitin ligase NEDD4 to c-Maf for proteasomal degradation. Our findings suggest that the restoration of functional TMEPAI expression may represent a promising complementary therapeutic strategy for treating patients with MM.	[Du, Yanyun; Liu, Yan; Xu, Yujia; Juan, Jiaxiang; Zhang, Zubin; Cao, Biyin; Mao, Xinliang] Soochow Univ, Dept Pharmacol, Coll Pharmaceut Sci, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215123, Jiangsu, Peoples R China; [Xu, Zhuan] Soochow Univ, Dept Neurol, Affiliated Hosp 1, Suzhou 215100, Peoples R China; [Zeng, Yuanying] Suzhou Municipal Hosp, Dept Oncol, Suzhou 215100, Peoples R China; [Wang, Qi; Mao, Xinliang] Guangzhou Univ Chinese Med, Inst Clin Pharmacol, Guangzhou 510405, Guangdong, Peoples R China	Soochow University - China; Soochow University - China; Guangzhou University of Chinese Medicine	Zeng, YY (corresponding author), Dept Oncol, Suzhou Municipal Hosp East Campus, Suzhou 215100, Peoples R China.; Mao, XL (corresponding author), Soochow Univ, Dept Pharmacol, Coll Pharmaceut Sci, 199 Ren Ai Rd,Suzhou Ind Pk, Suzhou 215123, Peoples R China.	zengyuanying@163.com; xinliangmao@suda.edu.cn			National Natural Science Foundation of China [81320108023, 81600171, 81770215]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Key Laboratory for Neuropsychiatric Diseases Grant [BK2013003]; Suzhou Key Laboratory for Pediatric Leukemia Grant [SZS201615]; Suzhou Key Medical Center Grant [Szzx201506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Key Laboratory for Neuropsychiatric Diseases Grant; Suzhou Key Laboratory for Pediatric Leukemia Grant; Suzhou Key Medical Center Grant	This work was partly supported by National Natural Science Foundation of China Grants 81320108023 (to X.M.), 81600171 (to Z.Z.), and 81770215 (to B.C.), by funds from the Priority Academic Program Development of Jiangsu Higher Education Institutions (to X.M.), and by Jiangsu Key Laboratory for Neuropsychiatric Diseases Grant BK2013003 (to X.M.). This work was also supported in part by Suzhou Key Laboratory for Pediatric Leukemia Grant SZS201615 (to X.M.) and by Suzhou Key Medical Center Grant Szzx201506 (to Y.Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Azamil S, 2015, BIOCHEM BIOPH RES CO, V456, P580, DOI 10.1016/j.bbrc.2014.11.107; Bai XL, 2014, CELL SIGNAL, V26, P2030, DOI 10.1016/j.cellsig.2014.06.001; Chang H, 2007, LEUKEMIA, V21, P1572, DOI 10.1038/sj.leu.2404669; Chen GD, 2014, INT J BIOCHEM CELL B, V57, P157, DOI 10.1016/j.biocel.2014.10.024; Fournier PGJ, 2015, CANCER CELL, V27, P809, DOI 10.1016/j.ccell.2015.04.009; Goswami Chirayu Pankaj, 2013, J Clin Bioinforma, V3, P22, DOI 10.1186/2043-9113-3-22; Hu Y, 2013, CARCINOGENESIS, V34, P1764, DOI 10.1093/carcin/bgt132; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Li HY, 2008, J BIOL CHEM, V283, P28988, DOI 10.1074/jbc.M710528200; Li H, 2015, ONCOTARGET, V6, P15137, DOI 10.18632/oncotarget.3526; Liu R, 2011, J PATHOL, V223, P683, DOI 10.1002/path.2834; Luo SH, 2016, INT J BIOCHEM CELL B, V76, P98, DOI 10.1016/j.biocel.2016.05.004; Morito N, 2011, CANCER RES, V71, P339, DOI 10.1158/0008-5472.CAN-10-1057; OHAINMHIRE E, 2014, PLOS ONE, V0009; Persaud A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005290; Rae FK, 2001, MOL CARCINOGEN, V32, P44, DOI 10.1002/mc.1063; Singha Prajjal K, 2014, Genes Cancer, V5, P320; Singha PK, 2010, CANCER RES, V70, P6377, DOI 10.1158/0008-5472.CAN-10-1180; Nguyen TTV, 2014, CANCER SCI, V105, P334, DOI 10.1111/cas.12355; Wang SY, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.450; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214; Xu LL, 2003, CANCER RES, V63, P4299; Xu YJ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0499-7; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; Zhang ZB, 2016, BLOOD, V127, P1676, DOI 10.1182/blood-2015-07-658203	25	14	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5847	5859		10.1074/jbc.RA117.000972	http://dx.doi.org/10.1074/jbc.RA117.000972			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29467225	hybrid, Green Published			2022-12-26	WOS:000430497300009
J	Eaton, JRO; Alenazi, Y; Singh, K; Davies, G; Geis-Asteggiante, L; Kessler, B; Robinson, CV; Kawamura, A; Bhattacharya, S				Eaton, James R. O.; Alenazi, Yara; Singh, Kamayani; Davies, Graham; Geis-Asteggiante, Lucia; Kessler, Benedikt; Robinson, Carol V.; Kawamura, Akane; Bhattacharya, Shoumo			The N-terminal domain of a tick evasin is critical for chemokine binding and neutralization and confers specific binding activity to other evasins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; RECEPTORS; ANTAGONISM; EXPRESSION; DISEASE; DISPLAY; UPDATE; FAMILY; CELLS; HIV	Tick chemokine-binding proteins (evasins) are an emerging class of biologicals that target multiple chemokines and show anti-inflammatory activities in preclinical disease models. Using yeast surface display, we identified a CCL8-binding evasin, P672, from the tick Rhipicephalus pulchellus. We found that P672 binds CCL8 and eight other CC-class chemokines with a K-d < 10 nM and four other CC chemokines with a K-d between 10 and 100 nM and neutralizes CCL3, CCL3L1, and CCL8 with an IC50 < 10 nM. The CC chemokine-binding profile was distinct from that of evasin 1 (EVA1), which does not bind CCL8. We also show that P672's binding activity can be markedly modulated by the location of a StrepII-His purification tag. Combining native MS and bottom-up proteomics, we further demonstrated that P672 is glycosylated and forms a 1: 1 complex with CCL8, disrupting CCL8 homodimerization. Homology modeling of P672 using the crystal structure of the EVA1 and CCL3 complex as template suggested that 44 N-terminal residues of P672 form most of the contacts with CCL8. Replacing the 29 N-terminal residues of EVA1 with the 44 N-terminal residues of P672 enabled this hybrid evasin to bind and neutralize CCL8, indicating that the CCL8-binding properties of P672 reside, in part, in its N-terminal residues. This study shows that the function of certain tick evasins can be manipulated simply by adding a tag. We conclude that homology modeling helps identify regions with transportable chemokine-binding functions within evasins, which can be used to construct hybrid evasins with altered properties.	[Eaton, James R. O.; Alenazi, Yara; Singh, Kamayani; Davies, Graham; Kawamura, Akane; Bhattacharya, Shoumo] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford OX3 7BN, England; [Eaton, James R. O.; Geis-Asteggiante, Lucia; Robinson, Carol V.; Kawamura, Akane; Bhattacharya, Shoumo] Univ Oxford, Dept Chem, Oxford OX3 7BN, England; [Kessler, Benedikt] Univ Oxford, Radcliffe Dept Med, Oxford OX3 7BN, England	University of Oxford; University of Oxford; University of Oxford	Bhattacharya, S (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	sbhattac@well.ox.ac.uk	Kawamura, Akane/I-4047-2018; Kessler, Benedikt/AAY-8614-2021; Bhattacharya, Shoumo/F-4127-2010	Kawamura, Akane/0000-0003-1169-5082; Kessler, Benedikt/0000-0002-8160-2446; Bhattacharya, Shoumo/0000-0002-5571-0478; Geis Asteggiante, Lucia/0000-0002-4305-3044; robinson, carol/0000-0001-7829-5505	British Heart Foundation (BHF) Chair Award [CH/09/003]; Oxford BHF Centre of Research Excellence Award [RE/13/1/30181]; BHF Oxbridge Centre for Regenerative Medicine Award [AVMEBCA1]; Radcliffe Department of Medicine, University of Oxford; Lab282; Oxford BHF Centre of Research Excellence; Saudi Arabian Cultural Bureau; Medical Research Council (MRC) [MR/N020413/1]; Royal Society Dorothy Hodgkin Fellowship; MRC [MR/N020413/1] Funding Source: UKRI	British Heart Foundation (BHF) Chair Award; Oxford BHF Centre of Research Excellence Award; BHF Oxbridge Centre for Regenerative Medicine Award; Radcliffe Department of Medicine, University of Oxford; Lab282; Oxford BHF Centre of Research Excellence; Saudi Arabian Cultural Bureau; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Dorothy Hodgkin Fellowship(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by British Heart Foundation (BHF) Chair Award CH/09/003 (to S.B.); Oxford BHF Centre of Research Excellence Award RE/13/1/30181; BHF Oxbridge Centre for Regenerative Medicine Award AVMEBCA1; and the Radcliffe Department of Medicine, University of Oxford. The CKBP sequences and hybrid CKBP concept form part of the basis of a patent application. S. B. has received funding from Lab282 for development of tick CKBPs as therapeutics in partnership with Evotec AG.; Supported by a studentship from the Oxford BHF Centre of Research Excellence.; Supported by a studentship from the Saudi Arabian Cultural Bureau.; Supported by Grant MR/N020413/1 from the Medical Research Council (MRC).; Supported by a Royal Society Dorothy Hodgkin Fellowship.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Bonvin P, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00208; Bonvin P, 2014, J BIOL CHEM, V289, P31846, DOI 10.1074/jbc.M114.599233; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Deruaz M, 2013, FEBS J, V280, P4876, DOI 10.1111/febs.12463; Detheux M, 2000, J EXP MED, V192, P1501, DOI 10.1084/jem.192.10.1501; Dias JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008514; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Fischer R, 2015, PROTEOMICS, V15, P1224, DOI 10.1002/pmic.201400436; Garin A, 2011, EXP CELL RES, V317, P602, DOI 10.1016/j.yexcr.2010.12.021; Gonzalez-Motos V, 2016, CYTOKINE GROWTH F R, V30, P71, DOI 10.1016/j.cytogfr.2016.02.007; Gouwy M, 2012, IMMUNOL LETT, V145, P10, DOI 10.1016/j.imlet.2012.04.005; Harding SD, 2018, NUCLEIC ACIDS RES, V46, pD1091, DOI 10.1093/nar/gkx1121; Hayward J, 2017, J BIOL CHEM, V292, P15670, DOI 10.1074/jbc.M117.807255; Huma ZE, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai8529; Janson G, 2017, BIOINFORMATICS, V33, P444, DOI 10.1093/bioinformatics/btw638; Jubb HC, 2017, J MOL BIOL, V429, P365, DOI 10.1016/j.jmb.2016.12.004; Keates T, 2012, NEW BIOTECHNOL, V29, P515, DOI 10.1016/j.nbt.2011.10.007; Krohn S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00193; Kufareva I, 2017, ANNU REV BIOPHYS, V46, P175, DOI 10.1146/annurev-biophys-051013-022942; Kufareva I, 2016, CURR OPIN PHARMACOL, V30, P27, DOI 10.1016/j.coph.2016.07.006; Kufareva I, 2015, IMMUNOL CELL BIOL, V93, P372, DOI 10.1038/icb.2015.15; Lampinen M, 2004, ALLERGY, V59, P793, DOI 10.1111/j.1398-9995.2004.00469.x; Lubman OY, 2016, STRUCTURE, V24, P57, DOI 10.1016/j.str.2015.10.018; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Singh K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04378-1; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Szpakowska M, 2012, BIOCHEM PHARMACOL, V84, P1366, DOI 10.1016/j.bcp.2012.08.008; Tiller KE, 2015, ANNU REV BIOMED ENG, V17, P191, DOI 10.1146/annurev-bioeng-071114-040733; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Van Coillie E, 1998, BIOCHEMISTRY-US, V37, P12672, DOI 10.1021/bi980497d; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Yen TY, 2013, BIOMOLECULES, V3, P270, DOI 10.3390/biom3020270; Zhao YG, 2011, J STRUCT BIOL, V175, P209, DOI 10.1016/j.jsb.2011.04.017; Zheng Y, 2017, IMMUNITY, V46, P1005, DOI 10.1016/j.immuni.2017.05.002	44	15	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6134	6146		10.1074/jbc.RA117.000487	http://dx.doi.org/10.1074/jbc.RA117.000487			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29487134	Green Published, hybrid			2022-12-26	WOS:000430497300030
J	Verstraete, MM; Perez-Borrajero, C; Brown, KL; Heinrichs, DE; Murphy, MEP				Verstraete, Meghan M.; Perez-Borrajero, Cecilia; Brown, Kirstin L.; Heinrichs, David E.; Murphy, Michael E. P.			SbnI is a free serine kinase that generates O-phospho-L-serine for staphyloferrin B biosynthesis in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-STRUCTURE; CITRATE SYNTHASE; SULFINIC ACID; IRON; SIDEROPHORE; CYSTEINE; GENE; VIRULENCE; IDENTIFICATION; PEROXIREDOXIN	Staphyloferrin B (SB) is an iron-chelating siderophore produced by Staphylococcus aureus in invasive infections. Proteins for SB biosynthesis and export are encoded by the sbnABCDEF-GHI gene cluster, in which SbnI, a member of the ParB/Srx superfamily, acts as a heme-dependent transcriptional regulator of the sbn locus. However, no structural or functional information about SbnI is available. Here, a crystal structure of SbnI revealed striking structural similarity to an ADP-dependent free serine kinase, SerK, from the archaea Thermococcus kodakarensis. We found that features of the active sites are conserved, and biochemical assays and P-31 NMR and HPLC analyses indicated that SbnI is also a free serine kinase but uses ATP rather than ADP as phosphate donor to generate the SB precursor O-phospho-L-serine (OPS). SbnI consists of two domains, and elevated B-factors in domain II were consistent with the open-close reaction mechanism previously reported for SerK. Mutagenesis of Glu(20) and Asp(58) in SbnI disclosed that they are required for kinase activity. The only known OPS source in bacteria is through the phosphoserine aminotransferase activity of SerC within the serine biosynthesis pathway, and we demonstrate that an S. aureus serC mutant is a serine auxotroph, consistent with a function in L-serine biosynthesis. However, the serC mutant strain could produce SB when provided L-serine, suggesting that SbnI produces OPS for SB biosynthesis in vivo. These findings indicate that besides transcriptionally regulating the sbn locus, SbnI also has an enzymatic role in the SB biosynthetic pathway.	[Verstraete, Meghan M.; Brown, Kirstin L.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Perez-Borrajero, Cecilia] Univ British Columbia, Genome Sci & Technol Program Life Sci, Vancouver, BC V6T 1Z3, Canada; [Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada	University of British Columbia; University of British Columbia; Western University (University of Western Ontario)	Murphy, MEP (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	michael.murphy@ubc.ca	Heinrichs, David/ABD-5702-2021	Verstraete, Meghan/0000-0003-0422-2826; Perez-Borrajero, Cecilia/0000-0002-3167-7159; Heinrichs, David/0000-0002-7217-2456	Canadian Institutes of Health Research (CIHR) [MOP-49597, MOP-38002]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grants MOP-49597 (to M.E.P.M) and MOP-38002 (to D.E.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arsic B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045952; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Beasley FC, 2011, INFECT IMMUN, V79, P2345, DOI 10.1128/IAI.00117-11; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Bhatt G, 2004, J BACTERIOL, V186, P7896, DOI 10.1128/JB.186.23.7896-7904.2004; Canova MJ, 2014, J BIOL CHEM, V289, P9473, DOI 10.1074/jbc.R113.529917; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chen BW, 2015, P NATL ACAD SCI USA, V112, P6613, DOI 10.1073/pnas.1421927112; Cheung J, 2012, CHEM BIOL, V19, P1568, DOI 10.1016/j.chembiol.2012.10.003; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; CLARKE SJ, 1973, J BACTERIOL, V113, P1091, DOI 10.1128/JB.113.3.1091-1095.1973; COHN M, 1960, J BIOL CHEM, V235, P3250; Cotton JL, 2009, BIOCHEMISTRY-US, V48, P1025, DOI 10.1021/bi801844c; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; Dale SE, 2004, J BACTERIOL, V186, P8356, DOI 10.1128/JB.186.24.8356-8362.2004; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erdmann N, 1999, P NATL ACAD SCI USA, V96, P14905, DOI 10.1073/pnas.96.26.14905; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Fodje M, 2014, J SYNCHROTRON RADIAT, V21, P633, DOI 10.1107/S1600577514005578; Friedman DB, 2006, PLOS PATHOG, V2, P777, DOI 10.1371/journal.ppat.0020087; Gomme PT, 2005, DRUG DISCOV TODAY, V10, P267, DOI 10.1016/S1359-6446(04)03333-1; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; HAAG H, 1994, FEMS MICROBIOL LETT, V115, P125; Halsey CR, 2017, MBIO, V8, DOI 10.1128/mBio.01434-16; Hames C, 2005, APPL ENVIRON MICROB, V71, P4097, DOI 10.1128/AEM.71.7.4097-4100.2005; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Hanses F, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0093-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iglesias-Baena I, 2010, J EXP BOT, V61, P1509, DOI 10.1093/jxb/erq016; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jonsson TJ, 2009, J BIOL CHEM, V284, P33305, DOI 10.1074/jbc.M109.036400; Jones RN, 2003, SEMIN RESP CRIT CARE, V24, P121, DOI 10.1055/s-2003-37923; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kobylarz MJ, 2016, BIOCHEMISTRY-US, V55, P927, DOI 10.1021/acs.biochem.5b01045; Kobylarz MJ, 2014, J BIOL CHEM, V289, P33797, DOI 10.1074/jbc.M114.603175; Kobylarz MJ, 2014, CHEM BIOL, V21, P379, DOI 10.1016/j.chembiol.2013.12.011; KONETSCHNYRAPP S, 1990, EUR J BIOCHEM, V191, P65, DOI 10.1111/j.1432-1033.1990.tb19094.x; Laakso HA, 2016, J BIOL CHEM, V291, P29, DOI 10.1074/jbc.M115.696625; Lamb AL, 2015, BBA-PROTEINS PROTEOM, V1854, P1054, DOI 10.1016/j.bbapap.2015.05.001; Leonard TA, 2004, MOL MICROBIOL, V53, P419, DOI 10.1111/j.1365-2958.2004.04133.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MacPherson IS, 2010, PROTEIN ENG DES SEL, V23, P137, DOI 10.1093/protein/gzp084; Maindola P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6322; Makino Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13446; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Nagata R, 2017, ACS CHEM BIOL, V12, P1514, DOI 10.1021/acschembio.7b00064; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Ratledge C, 2007, FOOD NUTR BULL, V28, pS515, DOI 10.1177/15648265070284S405; Robb Frank T., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P101; Rudolph F B, 1979, Methods Enzymol, V63, P22; Schumacher MA, 2015, SCIENCE, V349, P1120, DOI 10.1126/science.aaa9046; Sebulsky MT, 2004, J BIOL CHEM, V279, P53152, DOI 10.1074/jbc.M409793200; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Sheldon JR, 2014, MOL MICROBIOL, V92, P824, DOI 10.1111/mmi.12593; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Smaldone GT, 2012, J BACTERIOL, V194, P2594, DOI 10.1128/JB.05990-11; Spahich NA, 2016, MOL MICROBIOL, V100, P759, DOI 10.1111/mmi.13347; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Xu YJ, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0695-6; Zhao J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-311	72	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6147	6160		10.1074/jbc.RA118.001875	http://dx.doi.org/10.1074/jbc.RA118.001875			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29483190	hybrid, Green Published			2022-12-26	WOS:000430497300031
J	Giovannone, AJ; Winterstein, C; Bhattaram, P; Reales, E; Low, SH; Section, JEB; Xu, MM; Lalli, MA; Paragraph, JBH; Weimbs, T				Giovannone, Adrian J.; Winterstein, Christine; Bhattaram, Pallavi; Reales, Elena; Low, Seng Hui; Section, Julie E. Baggs; Xu, Mimi; Lalli, Matthew A.; Paragraph, John B. Hogenesch; Weimbs, Thomas			Soluble syntaxin 3 functions as a transcriptional regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE TRAFFICKING; ALTERNATIVE SPLICE VARIANT; EPITHELIAL-CELL POLARITY; HPC-1/SYNTAXIN 1A; SIGNALING PATHWAY; MAMMALIAN-CELLS; NOBEL LECTURE; FACTOR PEA3; LOCALIZATION; FUSION	Syntaxins are a conserved family of SNARE proteins and contain C-terminal transmembrane anchors required for their membrane fusion activity. Here we show that Stx3 (syntaxin 3) unexpectedly also functions as a nuclear regulator of gene expression. We found that alternative splicing creates a soluble isoform that we termed Stx3S, lacking the transmembrane anchor. Soluble Stx3S binds to the nuclear import factor RanBP5 (RAN-binding protein 5), targets to the nucleus, and interacts physically and functionally with several transcription factors, including ETV4 (ETS variant 4) and ATF2 (activating transcription factor 2). Stx3S is differentially expressed in normal human tissues, during epithelial cell polarization, and in breast cancer versus normal breast tissue. Inhibition of endogenous Stx3S expression alters the expression of cancer-associated genes and promotes cell proliferation. Similar nuclear-targeted, soluble forms of other syntaxins were identified, suggesting that nuclear signaling is a conserved, novel function common among these membrane-trafficking proteins.	[Xu, Mimi; Lalli, Matthew A.; Weimbs, Thomas] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Xu, Mimi; Lalli, Matthew A.; Weimbs, Thomas] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Section, Julie E. Baggs] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Paragraph, John B. Hogenesch] Cincinnati Childrens Hosp Med Ctr, Ctr Chronobiol, Cincinnati, OH 45229 USA; [Winterstein, Christine] Biogen GmbH, D-85737 Ismaning, Germany; [Bhattaram, Pallavi] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Reales, Elena] CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Reales, Elena] Univ Autonoma Madrid, E-28049 Madrid, Spain	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Pennsylvania; Pennsylvania Medicine; Cincinnati Children's Hospital Medical Center; Cleveland Clinic Foundation; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Weimbs, T (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	weimbs@ucsb.edu		REALES RODRIGUEZ, ELENA/0000-0001-6082-3306; Weimbs, Thomas/0000-0001-9423-5561	National Institutes of Health [DK095248, DK62338]; NINDS, National Institutes of Health [1R01NS054794]; NHBLI, National Institutes of Health [1R01HL097800]; California Cancer Research Coordinating Committee; Cancer Center of Santa Barbara; Spanish Ministry of Education and Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK095248, R01DK062338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHBLI, National Institutes of Health; California Cancer Research Coordinating Committee; Cancer Center of Santa Barbara; Spanish Ministry of Education and Science(Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant DK095248 and DK62338 (to T.W.); NINDS, National Institutes of Health Grant 1R01NS054794 (to J.B.H.); and NHBLI, National Institutes of Health Grant 1R01HL097800 (to J.B.H.); funds from the California Cancer Research Coordinating Committee (to T.W.); and postdoctoral fellowships from the Cancer Center of Santa Barbara (to C.W.) and the Spanish Ministry of Education and Science (to E.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Deane R, 1997, MOL CELL BIOL, V17, P5087, DOI 10.1128/MCB.17.9.5087; Delgrossi MH, 1997, J CELL SCI, V110, P2207; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Eswaran J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01689; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Gozdecka M, 2012, BIOCHEM SOC T, V40, P230, DOI 10.1042/BST20110630; Guo BQ, 2006, MOL CELL BIOL, V26, P4529, DOI 10.1128/MCB.01667-05; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Horvath A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02256; IBARAKI K, 1995, BIOCHEM BIOPH RES CO, V211, P997, DOI 10.1006/bbrc.1995.1910; Jagadish MN, 1997, BIOCHEM J, V321, P151, DOI 10.1042/bj3210151; Jurado S, 2013, NEURON, V77, P542, DOI 10.1016/j.neuron.2012.11.029; Keld R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-313; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kottakis F, 2014, CANCER RES, V74, P3935, DOI 10.1158/0008-5472.CAN-13-2733; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kuster A, 2015, J BIOL CHEM, V290, P28056, DOI 10.1074/jbc.M115.666362; Kuure S, 2010, DEVELOPMENT, V137, P1975, DOI 10.1242/dev.051656; Li X, 2002, AM J PHYSIOL-RENAL, V283, pF1111, DOI 10.1152/ajprenal.00185.2002; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Low SH, 2000, MOL BIOL CELL, V11, P3045, DOI 10.1091/mbc.11.9.3045; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Low SH, 2003, DEV CELL, V4, P753, DOI 10.1016/S1534-5807(03)00122-9; Low SH, 2002, J CELL SCI, V115, P4545, DOI 10.1242/jcs.00116; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; Martin-Martin B, 1999, J LEUKOCYTE BIOL, V65, P397, DOI 10.1002/jlb.65.3.397; Nakayama T, 2004, J BIOL CHEM, V279, P23728, DOI 10.1074/jbc.M314297200; Nakayama T, 2003, FEBS LETT, V536, P209, DOI 10.1016/S0014-5793(03)00015-2; Nakayama T, 2012, J CELL SCI, V125, P817, DOI 10.1242/jcs.081943; Nishida T, 2007, BIOCHEM BIOPH RES CO, V360, P226, DOI 10.1016/j.bbrc.2007.06.037; OHagan RC, 1996, ONCOGENE, V13, P1323; Pereira S, 2008, GENE, V423, P160, DOI 10.1016/j.gene.2008.07.010; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; PETERSON MD, 1992, J CELL SCI, V102, P581; Quinones B, 1999, J CELL SCI, V112, P4291; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Rothman JE, 2014, ANGEW CHEM INT EDIT, V53, P12676, DOI 10.1002/anie.201402380; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Singha PK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.192; Sudhof TC, 2014, ANGEW CHEM INT EDIT, V53, P12696, DOI 10.1002/anie.201406359; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Talbot JJ, 2011, P NATL ACAD SCI USA, V108, P7985, DOI 10.1073/pnas.1103816108; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Weimbs T, 1997, TRENDS CELL BIOL, V7, P393, DOI 10.1016/S0962-8924(97)01130-6; Weimbs T, 2003, METHODS, V30, P191, DOI 10.1016/S1046-2023(03)00025-2; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Weimbs T, 1998, TRENDS CELL BIOL, V8, P260, DOI 10.1016/S0962-8924(98)01285-9; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Zhang Q, 2005, J HISTOCHEM CYTOCHEM, V53, P1371, DOI 10.1369/jhc.4A6508.2005	55	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5478	5491		10.1074/jbc.RA117.000874	http://dx.doi.org/10.1074/jbc.RA117.000874			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475951	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000430044100012
J	Zhu, XL; Yuan, CM; Tian, CY; Li, C; Nie, F; Song, XM; Zeng, R; Wu, DQ; Hao, XJ; Li, L				Zhu, Xiaoliang; Yuan, Chunmao; Tian, Chenyang; Li, Chen; Nie, Fen; Song, Xiaomin; Zeng, Rong; Wu, Dianqing; Hao, Xiaojiang; Li, Lin			The plant sesquiterpene lactone parthenolide inhibits Wnt/beta-catenin signaling by blocking synthesis of the transcriptional regulators TCF4/LEF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inhibitor; protein synthesis; small molecule; T-cell factor (TCF); Wnt signaling	BETA-CATENIN; CELL-DEATH; PROTEIN; STEM; APOPTOSIS; PATHWAY; AXIN	The Wnt/-catenin pathway is essential for embryonic development and homeostasis, but excessive activation of this pathway is frequently observed in various human diseases, including cancer. Current therapeutic drugs targeting the Wnt pathway often lack sufficient efficacy, and new compounds targeting this pathway are therefore greatly needed. Here we report that the plant-derived natural product parthenolide (PTL), a sesquiterpene lactone, inhibits Wnt signaling. We found that PTL dose-dependently inhibits Wnt3a- and CHIR99021-induced transcriptional activity assessed with the T-cell factor (TCF)/lymphoid enhancer factor (LEF) firefly luciferase (TOPFlash) assay in HEK293 cells. Further investigations revealed that PTL decreases the levels of the transcription factors TCF4/LEF1 without affecting -catenin stability or subcellular distribution. Moreover, this effect of PTL on TCF4/LEF1 was related to protein synthesis rather than to proteasome-mediated degradation. Of note, siRNA-mediated knockdown of RPL10, a ribosome protein PTL binds, substantially decreased TCF4/LEF1 protein levels and also Wnt3a-induced TOPFlash activities, suggesting a potential mechanism by which PTL may repress Wnt/-catenin signaling. In summary, PTL binds RPL10 and thereby potently inhibits the Wnt/-catenin pathway.	[Zhu, Xiaoliang; Tian, Chenyang; Nie, Fen; Song, Xiaomin; Li, Lin] Chinese Acad Sci, State Key Lab Mol Biol, Ctr Excellence Mol Cell Sci,Shanghai Inst Biol Sc, Innovat Ctr Cell Signaling Networks,Inst Biochem, Shanghai 200031, Peoples R China; [Yuan, Chunmao; Hao, Xiaojiang] Guizhou Med Univ, State Key Lab Funct & Applicat Med Plants, Guiyang 550014, Guizhou, Peoples R China; [Hao, Xiaojiang] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650204, Yunnan, Peoples R China; [Tian, Chenyang; Li, Lin] Shanghai Tech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China; [Li, Chen; Zeng, Rong] Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Wu, Dianqing] Yale Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Wu, Dianqing] Yale Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Chinese Academy of Sciences; Guizhou Medical University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Yale University; Yale University	Li, L (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Ctr Excellence Mol Cell Sci,Shanghai Inst Biol Sc, Innovat Ctr Cell Signaling Networks,Inst Biochem, Shanghai 200031, Peoples R China.; Hao, XJ (corresponding author), Guizhou Med Univ, State Key Lab Funct & Applicat Med Plants, Guiyang 550014, Guizhou, Peoples R China.; Hao, XJ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650204, Yunnan, Peoples R China.; Li, L (corresponding author), Shanghai Tech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.	haoxj@mail.kib.ac.cn; lli@sibs.ac.cn	li, li/HII-4157-2022; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022; li, chen/ABG-9343-2020		National Key RAMP;D Program of China [2017YFA0503600]; National Natural Science Foundation of China [31530094, 31571456]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000, XDA12010301]; Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112182] Funding Source: NIH RePORTER	National Key RAMP;D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Key R&D Program of China Grant 2017YFA0503600), National Natural Science Foundation of China Grants 31530094 and 31571456, and Strategic Priority Research Program of the Chinese Academy of Sciences Grants XDB19000000 and XDA12010301. This work was also supported by the Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams. The authors declare that they have no conflicts of interest with the contents of this article.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Birnie R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r83; BOHLMANN F, 1982, PHYTOCHEMISTRY, V21, P2543, DOI 10.1016/0031-9422(82)85253-9; Bork PM, 1997, FEBS LETT, V402, P85, DOI 10.1016/S0014-5793(96)01502-5; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Czyz M, 2013, CANCER BIOL THER, V14, P135, DOI 10.4161/cbt.22952; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Franz A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006700; Ghantous A, 2013, DRUG DISCOV TODAY, V18, P894, DOI 10.1016/j.drudis.2013.05.005; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Gopal YV, 2007, CHEM BIOL, V14, P813, DOI 10.1016/j.chembiol.2007.06.007; Goudarzi KM, 2016, INT J ONCOL, V48, P1313, DOI 10.3892/ijo.2016.3387; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; He XL, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.3; Hrckulak D, 2016, CANCERS, V8, DOI 10.3390/cancers8070070; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Hwang SY, 2016, CELL REP, V16, P28, DOI 10.1016/j.celrep.2016.05.071; Ishiguro H, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0006-0; Kawasaki BT, 2009, PROSTATE, V69, P827, DOI 10.1002/pros.20931; KNIGHT DW, 1995, NAT PROD REP, V12, P271, DOI 10.1039/np9951200271; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Liu ZF, 2009, J PHARMACOL EXP THER, V329, P505, DOI 10.1124/jpet.108.147934; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mao L, 2016, CELL RES, V26, P1067, DOI 10.1038/cr.2016.97; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Qu Y, 2018, NAT CHEM BIOL, V14, P94, DOI [10.1038/NCHEMBIO.2510, 10.1038/nchembio.2510]; Schuijers J, 2014, EMBO J, V33, P146, DOI 10.1002/embj.201385358; Sendoel A, 2017, NATURE, V541, P494, DOI 10.1038/nature21036; Shi C, 2017, ONCOTARGET, V8, P35009, DOI 10.18632/oncotarget.16557; Shi Z, 2017, MOL CELL, V67, P71, DOI 10.1016/j.molcel.2017.05.021; Stojakowska A, 1997, PLANT CELL TISS ORG, V47, P159, DOI 10.1023/A:1005930209494; Trosset JY, 2006, PROTEINS, V64, P60, DOI 10.1002/prot.20955; Uchibori R, 2013, CANCER RES, V73, P364, DOI 10.1158/0008-5472.CAN-12-0088; Wang W, 2011, CELL RES, V21, P730, DOI 10.1038/cr.2011.30; Wen J, 2002, J BIOL CHEM, V277, P38954, DOI 10.1074/jbc.M203842200; Yang C, 2016, CELL PHYSIOL BIOCHEM, V40, P146, DOI 10.1159/000452532; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y; Zuch D, 2012, J CELL BIOCHEM, V113, P1282, DOI 10.1002/jcb.24002	39	30	30	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5335	5344		10.1074/jbc.M117.819300	http://dx.doi.org/10.1074/jbc.M117.819300			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29462785	Green Published, hybrid			2022-12-26	WOS:000429409300036
J	Guo, YX; Walsh, AM; Canavan, M; Wechalekar, MD; Cole, S; Yin, XF; Scott, B; Loza, M; Orr, C; McGarry, T; Bombardieri, M; Humby, F; Proudman, SM; Pitzalis, C; Smith, MD; Friedman, JR; Anderson, I; Madakamutil, L; Veale, DJ; Fearon, U; Nagpal, S				Guo, Yanxia; Walsh, Alice M.; Canavan, Mary; Wechalekar, Mihir D.; Cole, Suzanne; Yin, Xuefeng; Scott, Brittney; Loza, Mathew; Orr, Carl; McGarry, Trudy; Bombardieri, Michele; Humby, Frances; Proudman, Susanna M.; Pitzalis, Costantino; Smith, Malcolm D.; Friedman, Joshua R.; Anderson, Ian; Madakamutil, Loui; Veale, Douglas J.; Fearon, Ursula; Nagpal, Sunil			Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression	PLOS ONE			English	Article							T-CELL RESPONSES; SOLUBLE PD-1; INFLAMMATORY ARTHRITIS; ABERRANT REGULATION; NIVOLUMAB; FAMILY; ACTIVATION; MOLECULES; ANTI-PD-1; RECEPTOR	Immune checkpoint blockade with therapeutic anti-cytotoxic T lymphocyte-associated antigen (CTLA)-4 (Ipilimumab) and anti-programmed death (PD)-1 (Nivolumab and Pembrolizumab) antibodies alone or in combination has shown remarkable efficacy in multiple cancer types, concomitant with immune-related adverse events, including arthralgia and inflammatory arthritis (IA) in some patients. Herein, using Nivolumab (anti-PD-1 antagonist)-responsive genes along with transcriptomics of synovial tissue from multiple stages of rheumatoid arthritis (RA) disease progression, we have interrogated the activity status of PD-1 pathway during RA development. We demonstrate that the expression of PD-1 was increased in early and established RA synovial tissue compared to normal and OA synovium, whereas that of its ligands, programmed death ligand-1 (PD-L1) and PD-L2, was increased at all the stages of RA disease progression, namely arthralgia, IA/undifferentiated arthritis, early RA and established RA. Further, we show that RA patients expressed PD-1 on a majority of synovial tissue infiltrating CD4(+) and CD8(+) T cells. Moreover, enrichment of Nivolumab gene signature was observed in IA and RA, indicating that the PD-1 pathway was downregulated during RA disease progression. Furthermore, serum soluble (s) PD-1 levels were increased in autoantibody positive early RA patients. Interestingly, most of the early RA synovium tissue sections showed negative PD-L1 staining by immunohistochemistry. Therefore, downregulation in PD-1 inhibitory signaling in RA could be attributed to increased serum sPD-1 and decreased synovial tissue PD-L1 levels. Taken together, these data suggest that agonistic PD1 anti-body-based therapeutics may show efficacy in RA treatment and interception.	[Guo, Yanxia; Walsh, Alice M.; Cole, Suzanne; Yin, Xuefeng; Scott, Brittney; Loza, Mathew; Friedman, Joshua R.; Anderson, Ian; Madakamutil, Loui; Nagpal, Sunil] Janssen Res, Immunol, Horsham, PA 19044 USA; [Canavan, Mary; McGarry, Trudy; Fearon, Ursula] Trinity Coll Dublin, Trinity Biomed Sci Inst, Mol Rheumatol, Dublin, Ireland; [Wechalekar, Mihir D.; Smith, Malcolm D.] Repatriat Gen Hosp, Rheumatol Unit, Adelaide, SA, Australia; [Wechalekar, Mihir D.; Smith, Malcolm D.] Flinders Univ S Australia, Adelaide, SA, Australia; [Orr, Carl; Veale, Douglas J.] Univ Coll Dublin, St Vincents Univ Hosp, Ctr Arthrit & Rheumat Dis, Elm Pk, Dublin, Ireland; [Bombardieri, Michele; Humby, Frances; Pitzalis, Costantino] Queen Mary Univ London, Charterhouse Sq, London, England; [Proudman, Susanna M.] Royal Adelaide Hosp, Rheumatol Unit, Adelaide, SA, Australia; [Proudman, Susanna M.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia	Trinity College Dublin; Flinders University South Australia; Flinders University South Australia; University College Dublin; Saint Vincent's University Hospital; University of London; Queen Mary University London; Royal Adelaide Hospital; University of Adelaide	Nagpal, S (corresponding author), Janssen Res, Immunol, Horsham, PA 19044 USA.; Fearon, U (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Mol Rheumatol, Dublin, Ireland.	ursula.fearon@ucd.ie; snagpal2@its.jnj.com	humby, frances/GSE-3706-2022; Friedman, Joshua/Q-9367-2019; Wechalekar, Mihir/H-8114-2013; humby, frances/AAG-1787-2019	Friedman, Joshua/0000-0001-9382-8429; Wechalekar, Mihir/0000-0001-6668-9638; humby, frances/0000-0003-1280-9133; Fearon, Ursula/0000-0001-8084-0429; Walsh, Alice/0000-0001-5905-5768; Loza, Matthew/0000-0002-8609-118X; Canavan, Mary/0000-0003-2310-2563; Pitzalis, Costantino/0000-0003-1326-5051; Veale, Douglas/0000-0003-2802-4971	Johnson Johnson; MRC [G0800648] Funding Source: UKRI	Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by funding from Johnson & Johnson. The funder provided support in the form of funding for data generation and salaries for authors [YG, AMW, SC, XY, BS, ML, JRF, IA, LM, SN], but did not have any additional role in the study design, decision to publish, or preparation of the manuscript.	Amancha PK, 2013, J IMMUNOL, V191, P6060, DOI 10.4049/jimmunol.1302044; BANKHURST AD, 1976, ARTHRITIS RHEUM, V19, P555, DOI 10.1002/art.1780190307; Bommarito D, 2017, CLIN EXP IMMUNOL, V188, P455, DOI 10.1111/cei.12949; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Cappelli LC, 2017, ANN RHEUM DIS, V76, P43, DOI 10.1136/annrheumdis-2016-209595; Chan MMK, 2015, J IMMUNOTHER, V38, P37, DOI 10.1097/CJI.0000000000000060; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Choueiri TK, 2016, CLIN CANCER RES, V22, P5461, DOI 10.1158/1078-0432.CCR-15-2839; Dai SY, 2014, CELL IMMUNOL, V290, P72, DOI 10.1016/j.cellimm.2014.05.006; De Felice KM, 2015, MELANOMA RES, V25, P321, DOI 10.1097/CMR.0000000000000165; Deane KD, 2012, ARTHRITIS RHEUM-US, V64, P1708, DOI 10.1002/art.34445; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Greisen SR, 2014, SCAND J RHEUMATOL, V43, P101, DOI 10.3109/03009742.2013.823517; Guo Y, 2017, J IMMUNOL; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hatachi S, 2003, J RHEUMATOL, V30, P1410; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Isaacs JD, 2008, RHEUMATOLOGY, V47, P1461, DOI 10.1093/rheumatology/ken163; Keating GM, 2013, DRUGS, V73, P1095, DOI 10.1007/s40265-013-0080-9; Law-Ping-Man S, 2016, RHEUMATOLOGY, V55, P2087, DOI 10.1093/rheumatology/kew281; Liu CP, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0859-z; Moret FM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0497-x; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Onlamoon N, 2008, IMMUNOLOGY, V124, P277, DOI 10.1111/j.1365-2567.2007.02766.x; Pitzalis C, 2013, CURR OPIN RHEUMATOL, V25, P334, DOI 10.1097/BOR.0b013e32835fd8eb; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Raptopoulou AP, 2010, ARTHRITIS RHEUM-US, V62, P1870, DOI 10.1002/art.27500; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shin SP, 2013, MOL THER, V21, P688, DOI 10.1038/mt.2012.252; Wan B, 2006, J IMMUNOL, V177, P8844, DOI 10.4049/jimmunol.177.12.8844; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; Wu HJ, 2009, IMMUNOL INVEST, V38, P408, DOI 10.1080/08820130902912332; Zhu XX, 2017, ONCOTARGET, V8, P97671, DOI 10.18632/oncotarget.18311; Zimmer L, 2016, EUR J CANCER, V60, P210, DOI 10.1016/j.ejca.2016.02.024	39	68	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192704	10.1371/journal.pone.0192704	http://dx.doi.org/10.1371/journal.pone.0192704			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489833	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000039
J	Kolie, D; Camara, BS; Delamou, A; Beavogul, AH; Hermans, V; Edwards, JK; Benedetti, G; Muller, CP; van Griensven, J; Zachariah, R				Kolie, Delphin; Camara, Bienvenu S.; Delamou, Alexandre; Beavogul, Abdoul H.; Hermans, Veerle; Edwards, Jeffrey K.; Benedetti, Guido; Muller, Claude P.; van Griensven, Johan; Zachariah, Rony			The Ebola-effect in Guinea 2014-15: Tangled trends of malaria care in children under-five	PLOS ONE			English	Article							OUTBREAK	Introduction The 2014-15 Ebola outbreak in West Africa was disruptive for the general health services in the affected countries. This study assessed the impact of the outbreak on the reported number and management of malaria in children under-five in rural Guinea. Materials and methods A retrospective cross-sectional study was conducted in nineteen health centres in two rural, malaria-endemic health districts, one at the epicentre of the outbreak (Gueckedou) and one (Koubia) spared by Ebola. Routine surveillance data at health facility level were compared over similar periods of high malaria transmission in both districts before, during and after the outbreak. Results There were significant declines in the number of visits during the Ebola outbreak (3,700) in Gueckedou compared to before (4,616) and after it (4,195), while this trend remained more stable within the three periods for Koubia. Differences were nonetheless significant in both districts (p<0.001). In 2014, during the peak of the outbreak, the overall number of malaria cases treated exceeded the number of confirmed malaria cases in Gueckedou. There were decreases in antimalarial treatment provision in August and November 2014. In contrast, during 2015 and 2016, the proportion of malaria positive cases and those treated were closely aligned. During the peak of the Ebola outbreak, there was a significant decrease in oral antimalarial drug administration, which corresponded to an increase in injectable antimalarial treatments. Stock-outs in rapid diagnostic tests were evident and prolonged in Gueckedou during the outbreak, while more limited in Koubia. Conclusion The Ebola outbreak of 2014-15 in Guinea had a significant impact on the admission and management of malaria in children under-five. This study identifies potential challenges in the delivery of care for those at highest risk for malaria mortality during an Ebola outbreak and the need to improve preparedness strategies pre-Ebola and health systems recovery post-Ebola.	[Kolie, Delphin; Camara, Bienvenu S.; Delamou, Alexandre; Beavogul, Abdoul H.] Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea; [Delamou, Alexandre; Beavogul, Abdoul H.] Gamal Univ Conakry, Dept Publ Hlth, Conakry, Guinea; [Delamou, Alexandre] Woman & Child Hlth Res Ctr, Inst Trop Med, Antwerp, Belgium; [Hermans, Veerle; Edwards, Jeffrey K.; Benedetti, Guido; Zachariah, Rony] Operat Ctr Brussels, Med Sans Frontieres, Med Dept Operat Res, Luxembourg, Luxembourg; [Edwards, Jeffrey K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Muller, Claude P.] Luxembourg Inst Hlth, Dept Infect & Immun, Esch Sur Alzette, Luxembourg; [Muller, Claude P.] Lab Natl Sante, Dudelange, Luxembourg; [van Griensven, Johan] Inst Trop Med, Clin Sci Dept, Antwerp, Belgium	Institute of Tropical Medicine (ITM); Doctors Without Borders; University of Washington; University of Washington Seattle; Luxembourg Institute of Health; Institute of Tropical Medicine (ITM)	Kolie, D (corresponding author), Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea.	dkolie@maferinyah.org	Camara, Bienvenu/HGA-3369-2022	Hermans, Veerle/0000-0002-5232-992X; Benedetti, Guido/0000-0002-0788-8562; zachariah, rony/0000-0002-2915-9328	SORT-IT programme	SORT-IT programme	Open access publication cost was covered by the SORT-IT programme. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Barry M, 2014, MED MALADIES INFECT, V44, P491, DOI 10.1016/j.medmal.2014.09.009; Bolkan HA, 2014, PLOS CURR, DOI 10. 1371/currents. outbreaks. 0307d588df619f9c9447f8ead5b72b2d.; Camara BS, 2017, PUBLIC HEALTH ACTION, V7, P161, DOI 10.5588/pha.16.0120; Coordination Nationale Ebola en Guinee, 2015, RAPP HEBD SIT MAL EB; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176; Guilavogui T, 2016, IMPLEMENTING SEASONA; Guinean Ministry of Heath and World Health Organization, 2016, EB SIT REP; Hermans V, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0786-z; Leuenberger D, 2015, AIDS, V29, P1883, DOI 10.1097/QAD.0000000000000784; MOH, DEM HLTH SURV 2012; MOH, 2014, GUID TREATM MAL GUIN; Moisan F, 2016, EPIDEMIOL INFECT, V144, P2338, DOI 10.1017/S0950268816000728; Piot P, 2014, LANCET INFECT DIS; Plucinski MM, 2015, LANCET INFECT DIS; Ribacke KJB, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00222; Siekmans K, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-4012-y; Skrable K, 2017, NATURAL HIST ACUTE E; Thiam AB, 2015, PAN AFR MED J, V20, DOI [10.11694/pamj.supp.2015.22.1.6626, 10.11604/pamj.2015.20.379.6070]; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Waxman M, 2017, LANCET INFECT DIS, V17, P654, DOI 10.1016/S1473-3099(17)30112-3; WHO, EB RESP ROADM SIT RE; WHO, WORLD MAL REP 2016; 2013, SEAS MAL CHEM SULF, P1	24	11	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192798	10.1371/journal.pone.0192798	http://dx.doi.org/10.1371/journal.pone.0192798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489836	Green Submitted, Green Published, gold			2022-12-26	WOS:000426276000042
J	Detweiler, ND; Vigil, KG; Resta, TC; Walker, BR; Jernigan, NL				Detweiler, Neil D.; Vigil, Kenneth G.; Resta, Thomas C.; Walker, Benjimen R.; Jernigan, Nikki L.			Role of acid-sensing ion channels in hypoxia-and hypercapnia-induced ventilatory responses	PLOS ONE			English	Article							K+ CHANNEL; PH SENSITIVITY; TASK CHANNELS; CONTRIBUTE; EXPRESSION; NEURONS; NUCLEUS; CELLS	Previous reports indicate roles for acid-sensing ion channels (ASICs) in both peripheral and central chemoreception, but the contributions of ASICs to ventilatory drive in conscious, unrestrained animals remain largely unknown. We tested the hypotheses that ASICs contribute to hypoxic-and hypercapnic-ventilatory responses. Blood samples taken from conscious, unrestrained mice chronically instrumented with femoral artery catheters were used to assess arterial O-2, CO2, and pH levels during exposure to inspired gas mixtures designed to cause isocapnic hypoxemia or hypercapnia. Whole-body plethysmography was used to monitor ventilatory parameters in conscious, unrestrained ASIC1, ASIC2, or ASIC3 knockout ((-/-)) and wild-type (WT) mice at baseline, during isocapnic hypoxemia and during hypercapnia. Hypercapnia increased respiratory frequency, tidal volume, and minute ventilation in all groups of mice, but there were no differences between ASIC1(-/-), ASIC2(-/-), or ASIC3(-/-) and WT. Isocapnic hypoxemia also increased respiratory frequency, tidal volume, and minute ventilation in all groups of mice. Minute ventilation in ASIC2(-/-) mice during isocapnic hypoxemia was significantly lower compared to WT, but there were no differences in the responses to isocapnic hypoxemia between ASIC1(-/-) or ASIC3(-/-) compared to WT. Surprisingly, these findings show that loss of individual ASIC subunits does not substantially alter hypercapnic or hypoxic ventilatory responses.	[Detweiler, Neil D.; Vigil, Kenneth G.; Resta, Thomas C.; Walker, Benjimen R.; Jernigan, Nikki L.] Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Vasc Physiol Grp, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Jernigan, NL (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Vasc Physiol Grp, Albuquerque, NM 87131 USA.	NJernigan@salud.unm.edu	Jernigan, Nikki/AAE-7649-2020	Detweiler, Neil/0000-0003-4014-9988; Jernigan, Nikki/0000-0001-6269-2274; Resta, Thomas/0000-0002-7219-6159	National Heart, Lung, and Blood Institute [HL111084, HL007736]; National Institute of General Medical Sciences [GM088021, GM060201]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088021] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Heart, Lung, and Blood Institute, HL111084 to Dr. Nikki L Jernigan (PI of grant), the National Heart, Lung, and Blood Institute, HL007736 to Dr. Thomas C Resta (PI of grant), the National Institute of General Medical Sciences, GM088021 (training grant that supported Neil Detweiler), and the National Institute of General Medical Sciences, GM060201 (training grant that supported Kenneth Vigil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoi T, 2014, P NATL ACAD SCI USA, V111, P8281, DOI 10.1073/pnas.1324060111; Bayliss DA, 2001, RESP PHYSIOL, V129, P159, DOI 10.1016/S0034-5687(01)00288-2; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Buckler KJ, 1997, J PHYSIOL-LONDON, V498, P649, DOI 10.1113/jphysiol.1997.sp021890; DRORBAUGH JE, 1955, PEDIATRICS, V16, P81; Dube GR, 2005, PAIN, V117, P88, DOI 10.1016/j.pain.2005.05.021; FENCL V, 1966, AM J PHYSIOL, V210, P459, DOI 10.1152/ajplegacy.1966.210.3.459; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Huda R, 2012, J PHYSIOL-LONDON, V590, P4761, DOI 10.1113/jphysiol.2012.232470; Izumizaki M, 2004, J APPL PHYSIOL, V97, P1401, DOI 10.1152/japplphysiol.00025.2004; Kim D, 2009, J PHYSIOL-LONDON, V587, P2963, DOI 10.1113/jphysiol.2009.171181; Kress M, 2006, ACID SENSING IONIC C, P241; Liu X, 2011, AM J PHYSIOL-LUNG C, V301, pL985, DOI 10.1152/ajplung.00132.2011; Lopez-Lopez JR, 2007, RESP PHYSIOL NEUROBI, V157, P65, DOI 10.1016/j.resp.2007.01.022; Lu YJ, 2013, J PHYSIOL-LONDON, V591, P919, DOI 10.1113/jphysiol.2012.247189; Mulkey DK, 2007, J NEUROSCI, V27, P14049, DOI 10.1523/JNEUROSCI.4254-07.2007; Nattie E, 2012, COMPR PHYSIOL, V2, P221, DOI 10.1002/cphy.c100083; Nitta CH, 2014, AM J PHYSIOL-HEART C, V306, pH41, DOI 10.1152/ajpheart.00269.2013; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Song N, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0UR-NAL.P0NE.0039982; Song NN, 2016, SCI REP-UK, V6, DOI 10.1038/srep38777; Tan ZY, 2007, CIRC RES, V101, P1009, DOI 10.1161/CIRCRESAHA.107.154377; Tan ZY, 2010, CIRC RES, V106, P536, DOI 10.1161/CIRCRESAHA.109.206946; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; WALKER BR, 1985, J APPL PHYSIOL, V59, P1955, DOI 10.1152/jappl.1985.59.6.1955; Wang S, 2013, J NEUROSCI, V33, P16033, DOI 10.1523/JNEUROSCI.2451-13.2013; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong Zhi-Gang, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P655; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	36	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192724	10.1371/journal.pone.0192724	http://dx.doi.org/10.1371/journal.pone.0192724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474404	gold, Green Published, Green Submitted			2022-12-26	WOS:000426049500031
J	Kwon, H; Kim, Y; Kim, K; Jung, JY; Kim, J; Choi, SI; Chun, EJ; Bae, WK				Kwon, Hyuksool; Kim, Yeokoon; Kim, Kyuseok; Jung, Jae Yun; Kim, Joonghee; Choi, Sang Ii; Chun, Eun Ju; Bae, Woo Kyung			Where is the left ventricle during cardiopulmonary resuscitation based on chest computed tomography in the expiration with arms down position?	PLOS ONE			English	Article							AUTOMATED EXTERNAL DEFIBRILLATION; BASIC LIFE-SUPPORT; 2015 INTERNATIONAL CONSENSUS; CARDIOVASCULAR CARE SCIENCE; TREATMENT RECOMMENDATIONS; CARDIAC RESUSCITATION; COMPRESSION; COMPLICATIONS; CHILDREN; ARREST	Objective Patients usually receive cardiopulmonary resuscitation during ventilatory expiration and with their arms down, which does not reflect the normal imaging position. This study used scout images from low-dose chest computed tomography to compare the locations of the left ventricle (LV) in the expiration with arms down position (EAD) and in the full inspirational with arms raised position (IAR). Methods This cross-sectional study used a convenience sample and evaluated scout images that were obtained during screening with the participants in the EAD and IAR positions. The effective compression point was defined as being on the sternum above the longest anteroposterior diameter (APD) of the LV (using axial computed tomography images). The sternum was divided into three parts and the heart's position was evaluated on the EAD and the IAR images, and the distance from the xiphoid process to the LV's sternum landmark (XLVD) was measured. We also examined the compressible organs during CPR based on the EAD and IAR images. Results We enrolled 127 participants. The LVs were located in the middle of the sternum at EAD for 117 participants (92%) and in the lower half of the sternum at IAR for 107 participants (84%). The mean XLVD was significantly different between the EAD and IAR positions (mean: 85 +/- 21 mm vs. 33 +/- 17 mm, respectively). The liver's left lobe was located in the lower half of the sternum at EAD for 118 participants (93%). Conclusions These findings indicate that the location of the LV during cardiopulmonary resuscitation might be in the middle of the sternum if the patient is treated in the EAD position.	[Kwon, Hyuksool; Kim, Kyuseok; Jung, Jae Yun; Kim, Joonghee] Seoul Natl Univ, Dept Emergency Med, Bundang Hosp, Sungnam Si, Gyeonggi Do, South Korea; [Kim, Yeokoon; Choi, Sang Ii; Chun, Eun Ju] Seoul Natl Univ, Dept Radiol, Bundang Hosp, Sungnam Si, Gyeonggi Do, South Korea; [Bae, Woo Kyung] Seoul Natl Univ, Dept Family Med, Bundang Hosp, Hlth Promot Ctr, Sungnam Si, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, K (corresponding author), Seoul Natl Univ, Dept Emergency Med, Bundang Hosp, Sungnam Si, Gyeonggi Do, South Korea.	dremkks@snu.ac.kr	Lee, Jae Hyuk/W-5616-2018; Kim, Joonghee/C-9811-2014; Kwon, Hyuksool/R-5142-2016	Lee, Jae Hyuk/0000-0003-2429-4085; Kim, Joonghee/0000-0001-5080-7097; Kim, Kyuseok/0000-0002-7991-9428; Kwon, Hyuksool/0000-0002-0960-0198	Seoul National University Bundang Hospital [02-2014-004]; Seoul National University Invitation Program for Distinguished Scholar	Seoul National University Bundang Hospital; Seoul National University Invitation Program for Distinguished Scholar	This study was supported, in part, by Seoul National University Bundang Hospital (Grant 02-2014-004) and Seoul National University Invitation Program for Distinguished Scholar. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abed Y, 2008, BRIT J RADIOL, V81, P855, DOI 10.1259/bjr/73789148; Buschmann CT, 2009, INTENS CARE MED, V35, P397, DOI 10.1007/s00134-008-1255-9; Cha KC, 2013, J EMERG MED, V44, P691, DOI 10.1016/j.jemermed.2012.09.026; FITZGERALD KR, 1981, AM J PHYSIOL, V241, pH442, DOI 10.1152/ajpheart.1981.241.3.H442; Klouche K, 2002, CRIT CARE MED, V30, P2626, DOI 10.1097/00003246-200212000-00002; KRISCHER JP, 1987, CHEST, V92, P287, DOI 10.1378/chest.92.2.287; ORLOWSKI JP, 1986, ANN EMERG MED, V15, P667, DOI 10.1016/S0196-0644(86)80423-1; Park YS, 2011, RESUSCITATION, V82, P1030, DOI 10.1016/j.resuscitation.2010.11.004; Perkins GD, 2015, RESUSCITATION, V95, pE43, DOI 10.1016/j.resuscitation.2015.07.041; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Pickard A, 2006, RESUSCITATION, V71, P387, DOI 10.1016/j.resuscitation.2006.04.012; Qvigstad E, 2013, RESUSCITATION, V84, P1203, DOI 10.1016/j.resuscitation.2013.03.010; Seung MK, 2016, RESUSCITATION, V98, P64, DOI 10.1016/j.resuscitation.2015.11.004; Shin J, 2007, RESUSCITATION, V75, P305, DOI 10.1016/j.resuscitation.2007.05.003; Travers AH, 2015, CIRCULATION, V132, pS51, DOI 10.1161/CIR.0000000000000272; VOORHEES WD, 1980, CRIT CARE MED, V8, P134, DOI 10.1097/00003246-198003000-00008; Zhang Z., 2016, ANN TRANSLATIONAL ME, V4	17	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193364	10.1371/journal.pone.0193364	http://dx.doi.org/10.1371/journal.pone.0193364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474460	Green Submitted, gold, Green Published			2022-12-26	WOS:000426049500094
J	Minich, JJ; Morris, MM; Brown, M; Doane, M; Edwards, MS; Michael, TP; Dinsdale, EA				Minich, Jeremiah J.; Morris, Megan M.; Brown, Matt; Doane, Michael; Edwards, Matthew S.; Michael, Todd P.; Dinsdale, Elizabeth A.			Elevated temperature drives kelp microbiome dysbiosis, while elevated carbon dioxide induces water microbiome disruption	PLOS ONE			English	Article							CLIMATE-CHANGE; GIANT-KELP; MACROCYSTIS-PYRIFERA; OCEAN ACIDIFICATION; MARINE BACTERIUM; FUNCTIONAL-CHARACTERIZATION; SEA-SURFACE; BROWN-ALGAE; FOOD-WEB; DISEASE	Global climate change includes rising temperatures and increased pCO(2) concentrations in the ocean, with potential deleterious impacts on marine organisms. In this case study we conducted a four-week climate change incubation experiment, and tested the independent and combined effects of increased temperature and partial pressure of carbon dioxide (pCO(2)), on the microbiomes of a foundation species, the giant kelp Macrocystis pyrifera, and the surrounding water column. The water and kelp microbiome responded differently to each of the climate stressors. In the water microbiome, each condition caused an increase in a distinct microbial order, whereas the kelp microbiome exhibited a reduction in the dominant kelp-associated order, Alteromondales. The water column microbiomes were most disrupted by elevated pCO(2), with a 7.3 fold increase in Rhizobiales. The kelp microbiome was most influenced by elevated temperature and elevated temperature in combination with elevated pCO(2). Kelp growth was negatively associated with elevated temperature, and the kelp microbiome showed a 5.3 fold increase Flavobacteriales and a 2.2 fold increase alginate degrading enzymes and sulfated polysaccharides. In contrast, kelp growth was positively associated with the combination of high temperature and high pCO(2) 'future conditions', with a 12.5 fold increase in Planctomycetales and 4.8 fold increase in Rhodo-bacteriales. Therefore, the water and kelp microbiomes acted as distinct communities, where the kelp was stabilizing the microbiome under changing pCO(2) conditions, but lost control at high temperature. Under future conditions, a new equilibrium between the kelp and the microbiome was potentially reached, where the kelp grew rapidly and the commensal microbes responded to an increase in mucus production.	[Minich, Jeremiah J.; Morris, Megan M.; Brown, Matt; Doane, Michael; Edwards, Matthew S.; Dinsdale, Elizabeth A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Michael, Todd P.] Ibis Biosci, Carlsbad, CA USA; [Minich, Jeremiah J.] Univ Calif San Diego, Scripps Inst Oceanog, Dept Marine Biol, La Jolla, CA 92093 USA; [Michael, Todd P.] J Craig Venter Inst, La Jolla, CA USA	California State University System; San Diego State University; University of California System; University of California San Diego; Scripps Institution of Oceanography; J. Craig Venter Institute	Dinsdale, EA (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	Elizabeth.dinsdale@hotmail.com	Morris, Megan/AAK-2190-2020	Morris, Megan/0000-0002-7024-8234; dinsdale, elizabeth/0000-0002-2177-203X; Doane, Michael/0000-0001-9820-2193	National Science Foundation; Division of Undergraduate Education [1323809]; Division of Molecular and Cellular Biology [1330800]	National Science Foundation(National Science Foundation (NSF)); Division of Undergraduate Education(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); Division of Molecular and Cellular Biology	The authors would like to thank the support of the National Science Foundation, with Elizabeth Dinsdale being supported by grants from the Division of Undergraduate Education #1323809 and the Division of Molecular and Cellular Biology # 1330800. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the support of the National Science Foundation, with Dinsdale being supported by grants from the Division of Undergraduate Education #1323809 and the Division of Molecular and Cellular Biology # 1330800. At the time of the research, Todd P Michael was an employee at Ibis Biosciences, an Abbott Laboratories company, and he was involved as a committee member on Minich's Masters Thesis committee and contributed intellectually to the manuscript by interpretation of the results. This commercial affiliation does not alter our adherence to all PLOS ONE policies on sharing data and materials. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Axelsson L, 2000, EUR J PHYCOL, V35, P53, DOI 10.1080/09670260010001735621; Behera S., 2015, FRONT BIOENG BIOTECH, V2; Bengtsson MM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-261; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown MB, 2014, ALGAE-SEOUL, V29, P203, DOI 10.4490/algae.2014.29.3.203; Brown MB., 2013, EFFECTS RISING OCEAN; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Buschmann AH, 2004, MAR BIOL, V145, P849, DOI 10.1007/s00227-004-1393-8; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Campbell AH, 2011, GLOBAL CHANGE BIOL, V17, P2958, DOI 10.1111/j.1365-2486.2011.02456.x; Christian N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00869; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; Danese I, 2004, INFECT IMMUN, V72, P5783, DOI 10.1128/IAI.72.10.5783-5790.2004; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; DeLorenzo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046695; Descamps V, 2006, MAR BIOTECHNOL, V8, P27, DOI 10.1007/s10126-005-5107-0; Gaitan-Espitia JD, 2014, J EXP MAR BIOL ECOL, V457, P51, DOI 10.1016/j.jembe.2014.03.018; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dong S, 2012, MAR DRUGS, V10, P2481, DOI 10.3390/md10112481; Ekborg NA, 2006, APPL ENVIRON MICROB, V72, P3396, DOI 10.1128/AEM.72.5.3396-3405.2006; Eloe EA, 2011, ENV MICROBIOL REP, V3, P449, DOI 10.1111/j.1758-2229.2010.00223.x; FAIN SR, 1982, J PHYCOL, V18, P92, DOI 10.1111/j.0022-3646.1982.00092.x; Falk S, 2010, SYST APPL MICROBIOL, V33, P337, DOI 10.1016/j.syapm.2010.06.004; Fredriksen S, 2003, MAR ECOL PROG SER, V260, P71, DOI 10.3354/meps260071; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glass EM, 2011, METAGENOMICS COMPLEM, V8, P325, DOI [10.1002/9781118010518.CH37, DOI 10.1002/9781118010518.CH37, 10.1002/9781118010518.ch37]; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Graham MH, 2001, OIKOS, V93, P505, DOI 10.1034/j.1600-0706.2001.930317.x; Graham MH, 2007, OCEANOGR MAR BIOL AN; Haas AF, 2014, JOVE-J VIS EXP, DOI 10.3791/52131; Hamersley MR, 2015, AQUAT BOT, V125, P57, DOI 10.1016/j.aquabot.2015.05.003; Harley CDG, 2012, J PHYCOL, V48, P1064, DOI 10.1111/j.1529-8817.2012.01224.x; HAY CH, 1990, J ROY SOC NEW ZEAL, V20, P313, DOI 10.1080/03036758.1990.10426716; Hoff KJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-520; Kabisch A, 2014, ISME J, V8, P1492, DOI 10.1038/ismej.2014.4; Kanagasabhapathy M, 2006, ANN MICROBIOL, V56, P167, DOI 10.1007/BF03175000; KESHTACHERLIEBSON E, 1995, APPL ENVIRON MICROB, V61, P2439, DOI 10.1128/AEM.61.6.2439-2441.1995; Kim HT, 2012, APPL MICROBIOL BIOT, V93, P2233, DOI 10.1007/s00253-012-3882-x; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Lachnit T, 2011, ENVIRON MICROBIOL, V13, P655, DOI 10.1111/j.1462-2920.2010.02371.x; Lage OM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00267; Lage OM, 2011, FEMS MICROBIOL ECOL, V78, P366, DOI 10.1111/j.1574-6941.2011.01168.x; Lee HS, 2011, J BACTERIOL; Liu F, 2010, J APPL PHYCOL, V22, P221, DOI 10.1007/s10811-009-9445-6; Lomas MW, 2002, GLOBAL CHANGE BIOL, V8, P51, DOI 10.1046/j.1365-2486.2002.00454.x; Martin M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01487; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; MAZURE HGF, 1980, J EXP MAR BIOL ECOL, V43, P173, DOI 10.1016/0022-0981(80)90024-6; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mensch B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00434; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Michelou VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067480; Minich J, 2013, ENCY METAGENOMICS, P1; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Raulf F.F., 2015, ENV MICROBIOL; Roleda MY, 2012, GLOBAL CHANGE BIOL, V18, P854, DOI 10.1111/j.1365-2486.2011.02594.x; Rothausler E, 2011, J EXP MAR BIOL ECOL, V405, P33, DOI 10.1016/j.jembe.2011.05.018; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sarmento H, 2010, PHILOS T R SOC B, V365, P2137, DOI 10.1098/rstb.2010.0045; Sawabe T, 1998, INT J SYST BACTERIOL, V48, P769, DOI 10.1099/00207713-48-3-769; Schiel DR, 2015, BIOL ECOLOGY GIANT K; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Singh RP, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01488; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Solomon S, 2007, CONTRIBUTION WORKING; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Subiabre F, 2016, THESIS; SUNAIRI M, 1995, J APPL BACTERIOL, V79, P225, DOI 10.1111/j.1365-2672.1995.tb00939.x; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Tang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041204; Taylor LE, 2006, J BACTERIOL, V188, P3849, DOI 10.1128/JB.01348-05; UCHIDA M, 1995, FISHERIES SCI, V61, P117, DOI 10.2331/fishsci.61.117; Vairappan CS, 2001, HYDROBIOLOGIA, V445, P183, DOI 10.1023/A:1017517832302; Wagner-Dobler I, 2010, ISME J, V4, P61, DOI 10.1038/ismej.2009.94; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yu XH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00056	84	57	57	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192772	10.1371/journal.pone.0192772	http://dx.doi.org/10.1371/journal.pone.0192772			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474389	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500038
J	Abe, K; Nakamura, T; Yamabe, E; Oshio, K; Miyamoto, T; Nakamura, M; Matsumoto, M; Sato, K				Abe, Koji; Nakamura, Toshiyasu; Yamabe, Eiko; Oshio, Koichi; Miyamoto, Takeshi; Nakamura, Masaya; Matsumoto, Morio; Sato, Kazuki			Quantification of edematous changes by diffusion magnetic resonance imaging in gastrocnemius muscles after spinal nerve ligation	PLOS ONE			English	Article							REFLEX SYMPATHETIC DYSTROPHY; REGIONAL PAIN SYNDROME; ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; NEUROPATHIC PAIN; APPARENT DIFFUSION; SKELETAL-MUSCLE; WHITE-MATTER; RAT MODEL; ANTINOCICEPTIVE ACTIVITY	Patients with complex regional pain syndrome (CRPS) exhibit diverse symptoms, such as neuropathic pain, allodynia, local edema and skin color changes in the affected lesion. Although nerve injury may cause CRPS, pathophysiological mechanisms underlying the syndrome are unclear, and local edema, a characteristic of CRPS, has not been evaluated quantitatively for technical reasons. Here, using a rat spinal nerve ligation-induced CRPS model, we show that edematous changes in gastrocnemius muscle can be detected quantitatively by diffusion magnetic resonance imaging (MRI). Using the line-scan diffusion spectrum on a 1.5 T clinical MR imager, we demonstrate significant elevation of the apparent diffusion coefficient (ADC) ratios in gastrocnemius muscle on the ligated versus the sham-operated rats by one day after surgery, those ratios gradually decreased over time. Meanwhile, T2 ratios in gastrocnemius muscle on the ligated rats increased gradually and significantly, peaking two weeks after surgery, and those ratios remained high and were consistent with edema. Expression of vascular endothelial growth factor (VEGF), a key regulator of blood vessel formation and function, was significantly lower in gastrocnemius muscle on the ligated versus non-ligated side, suggesting that nerve ligation promotes edematous changes and perturbs VEGF expression in target muscle.	[Abe, Koji; Nakamura, Toshiyasu; Miyamoto, Takeshi; Nakamura, Masaya; Matsumoto, Morio; Sato, Kazuki] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Nakamura, Toshiyasu] Int Univ Hlth & Welf, Clin Res Ctr, Tokyo, Japan; [Yamabe, Eiko] Saiseikai Yokohama Shi Tobu Hosp, Dept Orthopaed Surg, Yokohama, Kanagawa, Japan; [Oshio, Koichi] Keio Univ, Sch Med, Dept Diagnost Radiol, Tokyo, Japan	Keio University; International University of Health & Welfare; Keio University	Nakamura, T (corresponding author), Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan.; Nakamura, T (corresponding author), Int Univ Hlth & Welf, Clin Res Ctr, Tokyo, Japan.	toshiyasu@ae.em-net.ne.jp	Sato, Kazuki/AAL-2166-2021; Nakamura, Masaya/K-4111-2013		JSPS KAKENHI [25462452]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25462452. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aty H, 2007, J MAGN RESON IMAGING, V26, P452, DOI 10.1002/jmri.21028; Abdi S, 1998, ANESTH ANALG, V87, P1360, DOI 10.1097/00000539-199812000-00027; Anderson AW, 2000, MAGN RESON IMAGING, V18, P689, DOI 10.1016/S0730-725X(00)00147-8; [Anonymous], 1994, CLASSIFICATION CHRON; AWERBUCH MS, 1991, MED J AUSTRALIA, V154, P441, DOI 10.5694/j.1326-5377.1991.tb121171.x; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BEJ MD, 1991, ARCH NEUROL-CHICAGO, V48, P912, DOI 10.1001/archneur.1991.00530210038020; BICKERSTAFF DR, 1993, BRIT J RHEUMATOL, V32, P46; Birklein F, 2015, PAIN, V156, pS94, DOI 10.1097/01.j.pain.0000460344.54470.20; Blaes F, 2007, ANN NY ACAD SCI, V1107, P168, DOI 10.1196/annals.1381.018; Bley TA, 2009, MAGN RESON IMAGING C, V17, P263, DOI 10.1016/j.mric.2009.01.005; BOAS RA, 1996, REFLEX SYMPATHETIC D, P79; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brown Jennifer, 2004, Clin J Oncol Nurs, V8, P35, DOI 10.1188/04.CJON.35-38; Bruehl S, 2010, ANESTHESIOLOGY, V113, P713, DOI 10.1097/ALN.0b013e3181e3db38; Chung JM, 2004, METH MOLEC MED, P35; Coste O, 2012, BEHAV BRAIN RES, V234, P121, DOI 10.1016/j.bbr.2012.06.017; D'Amore PA, 2002, CELL, V110, P289, DOI 10.1016/S0092-8674(02)00869-3; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; EBISU T, 1993, JMRI-J MAGN RESON IM, V3, P863, DOI 10.1002/jmri.1880030612; Fukuoka T, 2001, J NEUROSCI, V21, P4891, DOI 10.1523/JNEUROSCI.21-13-04891.2001; Gaitan G, 2004, BRIT J PHARMACOL, V143, P533, DOI 10.1038/sj.bjp.0705958; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; GENANT HK, 1975, RADIOLOGY, V117, P21, DOI 10.1148/117.1.21; Gulevich SJ, 1997, CLIN J PAIN, V13, P50, DOI 10.1097/00002508-199703000-00008; Han HC, 2000, PAIN, V84, P253; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; HEERSCHAP A, 1993, MUSCLE NERVE, V16, P367, DOI 10.1002/mus.880160405; HELPERN JA, 1993, MAGN RESON IMAGING, V11, P241, DOI 10.1016/0730-725X(93)90028-C; HOEHNBERLAGE M, 1995, MAGN RESON MED, V34, P824, DOI 10.1002/mrm.1910340607; Hulse RP, 2015, CLIN SCI, V129, P741, DOI 10.1042/CS20150124; Huygen FJPM, 2002, MEDIAT INFLAMM, V11, P47, DOI 10.1080/09629350210307; Jaffrin MY, 2008, MED ENG PHYS, V30, P1257, DOI 10.1016/j.medengphy.2008.06.009; Kalmar B, 2003, EXP NEUROL, V184, P636, DOI 10.1016/S0014-4886(03)00343-1; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; KOZIN F, 1981, RADIOLOGY, V138, P437, DOI 10.1148/radiology.138.2.7455127; Kuroiwa T, 1998, STROKE, V29, P859, DOI 10.1161/01.STR.29.4.859; KURVERS HAJM, 1995, PAIN, V60, P333, DOI 10.1016/0304-3959(94)00133-Y; Lebel A, 2008, BRAIN, V131, P1854, DOI 10.1093/brain/awn123; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEE GW, 1995, J HAND SURG-AM, V20A, P458, DOI 10.1016/S0363-5023(05)80107-8; Lee HL, 2015, NEUROREPORT, V26, P399, DOI 10.1097/WNR.0000000000000359; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; LEE YW, 1995, NEUROSCI LETT, V199, P111, DOI 10.1016/0304-3940(95)12034-2; Lever I, 2003, EUR J NEUROSCI, V18, P1169, DOI 10.1046/j.1460-9568.2003.02848.x; MACKINNON SE, 1984, J HAND SURG-AM, V9A, P556, DOI 10.1016/S0363-5023(84)80110-0; Maihofner C, 2004, NEUROLOGY, V63, P693, DOI 10.1212/01.WNL.0000134661.46658.B0; Matthews EA, 2002, ANESTHESIOLOGY, V96, P633, DOI 10.1097/00000542-200203000-00020; Moon DE, 1999, PAIN, V80, P589, DOI 10.1016/S0304-3959(98)00252-8; Mulkern RV, 1999, NMR BIOMED, V12, P51, DOI 10.1002/(SICI)1099-1492(199902)12:1<51::AID-NBM546>3.0.CO;2-E; Nirogi R, 2012, J PHARMACOL TOX MET, V66, P8, DOI 10.1016/j.vascn.2012.04.006; Nishida Y, 2009, INTERNAL MED, V48, P209, DOI 10.2169/internalmedicine.48.1611; Oaklander AL, 2006, PAIN, V120, P235, DOI 10.1016/j.pain.2005.09.036; Obata K, 2004, J NEUROSCI, V24, P10211, DOI 10.1523/JNEUROSCI.3388-04.2004; Ota H, 2014, PAIN, V155, P1976, DOI 10.1016/j.pain.2014.06.016; Parkitny L, 2013, NEUROLOGY, V80, P106, DOI 10.1212/WNL.0b013e31827b1aa1; SCHWEITZER ME, 1995, RADIOLOGY, V195, P211, DOI 10.1148/radiology.195.1.7892471; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SHERMAN RA, 1987, ARCH PHYS MED REHAB, V68, P273; Shunmugavel A, 2013, J NEUROIMMUNE PHARM, V8, P274, DOI 10.1007/s11481-012-9419-3; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Stanton AWB, 2000, LYMPHOLOGY, V33, P122; Stanton-Hicks Michael D, 2002, Pain Pract, V2, P1, DOI 10.1046/j.1533-2500.2002.02009.x; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Tando T, 2016, J BIOL CHEM, V291, P12184, DOI 10.1074/jbc.M115.680579; Verhaert D, 2011, JACC-CARDIOVASC IMAG, V4, P269, DOI 10.1016/j.jcmg.2010.09.023; Verheyen A, 2012, BRAIN, V135, P2629, DOI 10.1093/brain/aws145; Villetti G, 2003, J PHARMACOL EXP THER, V306, P804, DOI 10.1124/jpet.103.050039; WARREN JB, 1993, CLIN SCI, V84, P581, DOI 10.1042/cs0840581; WERNER R, 1989, J HAND SURG-AM, V14A, P520, DOI 10.1016/S0363-5023(89)80016-4; Xie JG, 2001, J PAIN, V2, P270, DOI 10.1054/jpai.2001.24559; Yamabe E, 2008, RADIOLOGY, V247, P409, DOI 10.1148/radiol.2472070403; Yamabe E, 2007, J MAGN RESON IMAGING, V26, P1585, DOI 10.1002/jmri.21184; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0; Zhang EJ, 2017, MOL MED REP, V16, P2009, DOI 10.3892/mmr.2017.6853; Zhang H, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120042	77	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193306	10.1371/journal.pone.0193306	http://dx.doi.org/10.1371/journal.pone.0193306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470522	Green Published, gold, Green Submitted			2022-12-26	WOS:000425831000046
J	Brown, T; Brown, N; Stollar, EJ				Brown, Tom; Brown, Nick; Stollar, Elliott J.			Most yeast SH3 domains bind peptide targets with high intrinsic specificity	PLOS ONE			English	Article							PROTEIN INTERACTIONS; INTERACTION NETWORK; LIGAND-BINDING; RECOGNITION; DETERMINANTS; MOTIFS; GRB2; IDENTIFICATION; EVOLUTION; AFFINITY	A need exists to develop bioinformatics for predicting differences in protein function, especially for members of a domain family who share a common fold, yet are found in a diverse array of proteins. Many domain families have been conserved over large evolutionary spans and representative genomic data during these periods are now available. This allows a simple method for grouping domain sequences to reveal common and unique/specific binding residues. As such, we hypothesize that sequence alignment analysis of the yeast SH3 domain family across ancestral species in the fungal kingdom can determine whether each member encodes specific information to bind unique peptide targets. With this approach, we identify important specific residues for a given domain as those that show little conservation within an alignment of yeast domain family members (paralogs) but are conserved in an alignment of its direct relatives (orthologs). We find most of the yeast SH3 domain family members have maintained unique amino acid conservation patterns that suggest they bind peptide targets with high intrinsic specificity through varying degrees of non-canonical recognition. For a minority of domains, we predict a less diverse binding surface, likely requiring additional factors to bind targets specifically. We observe that our predictions are consistent with high throughput binding data, which suggests our approach can probe intrinsic binding specificity in any other interaction domain family that is maintained during evolution.	[Brown, Tom] Eastern New Mexico Univ, Math & Comp Sci Dept, Portales, NM USA; [Brown, Nick] Portales High Sch, Portales, NM USA; [Stollar, Elliott J.] Eastern New Mexico Univ, Dept Phys Sci, Portales, NM 88130 USA; [Brown, Nick] Texas Tech Univ, Lubbock, TX 79409 USA; [Stollar, Elliott J.] Univ Liverpool, Sch Life Sci, Liverpool, Merseyside, England	Texas Tech University System; Texas Tech University; University of Liverpool	Stollar, EJ (corresponding author), Eastern New Mexico Univ, Dept Phys Sci, Portales, NM 88130 USA.; Stollar, EJ (corresponding author), Univ Liverpool, Sch Life Sci, Liverpool, Merseyside, England.	e.stollar@liverpool.ac.uk		Stollar, Elliott/0000-0001-9895-0335; Brown, Thomas/0000-0003-2204-4082	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103451] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health(General Electric); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103451 (EJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrasiabi C, 2013, NUCLEIC ACIDS RES, V41, pW242, DOI 10.1093/nar/gkt399; Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; Bauer F, 2005, PROTEIN SCI, V14, P2487, DOI 10.1110/ps.051563605; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; Chakraborty A, 2015, BRIEF BIOINFORM, V16, P71, DOI 10.1093/bib/bbt092; Creixell P, 2015, CELL, V163, P187, DOI 10.1016/j.cell.2015.08.057; CUSSAC D, 1994, EMBO J, V13, P4011, DOI 10.1002/j.1460-2075.1994.tb06717.x; Das S, 2015, CURR OPIN GENET DEV, V35, P40, DOI 10.1016/j.gde.2015.09.005; Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9; Emmanouilidis L, 2016, BBA-MOL CELL RES, V1863, P804, DOI 10.1016/j.bbamcr.2015.09.034; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Fernandez-Ballester G, 2004, J MOL BIOL, V335, P619, DOI 10.1016/j.jmb.2003.10.060; Freund C, 2002, EMBO J, V21, P5985, DOI 10.1093/emboj/cdf602; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gorelik M., 2011, THESIS; Gorelik M, 2012, J BIOL CHEM, V287, P9168, DOI 10.1074/jbc.M111.330753; Greenspan NS, 2010, TRENDS IMMUNOL, V31, P138, DOI 10.1016/j.it.2010.01.001; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kaneko T, 2011, TRENDS BIOCHEM SCI, V36, P183, DOI 10.1016/j.tibs.2010.12.001; Kang HJ, 2015, J BIOL CHEM, V290, P2870, DOI 10.1074/jbc.M114.622233; Kelil A, 2016, P NATL ACAD SCI USA, V113, pE3862, DOI 10.1073/pnas.1518469113; Kim JM, 2008, J MOL BIOL, V377, P889, DOI 10.1016/j.jmb.2008.01.063; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson SM, 2000, PROTEIN SCI, V9, P2170, DOI 10.1110/ps.9.11.2170; Lee D, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004926; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lichtarge O, 1997, J MOL BIOL, V274, P325, DOI 10.1006/jmbi.1997.1395; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Mayer BJ, 2001, J CELL SCI, V114, P1253; McDonald CB, 2009, BIOCHEMISTRY-US, V48, P4074, DOI 10.1021/bi802291y; Medina EM, 2011, J MOL EVOL, V73, P116, DOI 10.1007/s00239-011-9461-4; Michaud GA, 2003, NAT BIOTECHNOL, V21, P1509, DOI 10.1038/nbt910; Mirny LA, 2002, J MOL BIOL, V321, P7, DOI 10.1016/S0022-2836(02)00587-9; Nishida M, 2001, EMBO J, V20, P2995, DOI 10.1093/emboj/20.12.2995; Nussinov R, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002306; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pires JR, 2003, J MOL BIOL, V326, P1427, DOI 10.1016/S0022-2836(03)00039-1; Rausell A, 2010, P NATL ACAD SCI USA, V107, P1995, DOI 10.1073/pnas.0908044107; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; SHENKIN PS, 1991, PROTEINS, V11, P297, DOI 10.1002/prot.340110408; Stajich JE, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0055-2016; Stamenova SD, 2007, MOL CELL, V25, P273, DOI 10.1016/j.molcel.2006.12.016; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Stollar EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051282; Stollar EJ, 2009, J BIOL CHEM, V284, P26918, DOI 10.1074/jbc.M109.028431; Szwajkajzer D, 1997, BIOPOLYMERS, V44, P181, DOI 10.1002/(SICI)1097-0282(1997)44:2<181::AID-BIP5>3.0.CO;2-R; Takaku T, 2010, J BIOL CHEM, V285, P19346, DOI 10.1074/jbc.M110.116749; TAKEDA Y, 1989, P NATL ACAD SCI USA, V86, P439, DOI 10.1073/pnas.86.2.439; Tatebayashi K, 2006, EMBO J, V25, P3033, DOI 10.1038/sj.emboj.7601192; Teyra J, 2017, STRUCTURE, V25, P1598, DOI 10.1016/j.str.2017.07.017; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Verschueren E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129229; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Wunderlich L, 1999, CELL SIGNAL, V11, P253, DOI 10.1016/S0898-6568(98)00054-0; Ye K, 2006, PROTEINS, V63, P1018, DOI 10.1002/prot.20899; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	71	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193128	10.1371/journal.pone.0193128	http://dx.doi.org/10.1371/journal.pone.0193128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470497	Green Published, Green Submitted, gold			2022-12-26	WOS:000425831000036
J	Ferencziova, V; Harami, GM; Nemath, JB; Vellai, T; Kovacs, M				Ferencziova, Veronika; Harami, Gabor M.; Nemath, Julianna B.; Vellai, Tibor; Kovacs, Mihaly			Functional fine-tuning between bacterial DNA recombination initiation and quality control systems	PLOS ONE			English	Article							ESCHERICHIA-COLI; REPLICATION FORKS; RECQ HELICASES; RECBCD ENZYME; ILLEGITIMATE RECOMBINATION; SYNDROME GENE; HRDC DOMAIN; E. COLI; REPAIR; STRAND	Homologous recombination (HR) is crucial for the error-free repair of DNA double-strand breaks (DSBs) and the restart of stalled replication. However, imprecise HR can lead to genome instability, highlighting the importance of HR quality control. After DSB formation, HR proceeds via DNA end resection and recombinase loading, whereas helicase-catalyzed disruption of a subset of subsequently formed DNA invasions is thought to be essential for maintaining HR accuracy via inhibiting illegitimate (non-allelic) recombination. Here we show that in vitro characterized mechanistic aberrations of E. coli RecBCD (resection and recombinase loading) RecQ (multifunctional DNA-restructuring helicase) mutant enzyme variants, on one hand, cumulatively deteriorate cell survival under certain conditions of genomic stress. On the other hand, we find that RecBCD and RecQ defects functionally compensate each other in terms of HR accuracy. The abnormally long resection and unproductive recombinase loading activities of a mutant RecBCD complex (harboring the D1080A substitution in RecB) cause enhanced illegitimate recombination. However, this compromised HR-accuracy phenotype is suppressed in double mutant strains harboring mutant RecQ variants with abnormally enhanced helicase and inefficient invasion disruptase activities. These results frame an in vivo context for the interplay of biochemical activities leading to illegitimate recombination, and underscore its long-range genome instability effects manifest in higher eukaryotes.	[Ferencziova, Veronika; Harami, Gabor M.; Nemath, Julianna B.; Kovacs, Mihaly] Eotvos Lorand Univ, ELTE MTA Momentum Motor Enzymol Res Grp, Dept Biochem, Pazmany Ps 1-C, Budapest, Hungary; [Vellai, Tibor] Eotvos Lorand Univ, Dept Genet, Pazmany Ps 1-C, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University	Kovacs, M (corresponding author), Eotvos Lorand Univ, ELTE MTA Momentum Motor Enzymol Res Grp, Dept Biochem, Pazmany Ps 1-C, Budapest, Hungary.	mihaly.kovacs@ttk.elte.hu	Kovacs, Mihaly/A-6841-2011; Vellai, Tibor/AAG-2154-2020	Kovacs, Mihaly/0000-0002-1200-4741	Human Frontier Science Program [RGY0072/2010]; "Momentum" Program of the Hungarian Academy of Sciences [LP2011-006/2011]; ELTE [KMOP-4.2.1/B-10-2011-0002]; NKFIH [K-116072, K-123989]; NKFIH ERC_HU [117680]; Premium Postdoctoral Fellowship Program of the Hungarian Academy of Sciences [PPD-017/2017]	Human Frontier Science Program(Human Frontier Science Program); "Momentum" Program of the Hungarian Academy of Sciences; ELTE; NKFIH(National Research, Development & Innovation Office (NRDIO) - Hungary); NKFIH ERC_HU(National Research, Development & Innovation Office (NRDIO) - Hungary); Premium Postdoctoral Fellowship Program of the Hungarian Academy of Sciences	This work was supported by the Human Frontier Science Program (RGY0072/2010), the "Momentum" Program of the Hungarian Academy of Sciences (LP2011-006/2011), ELTE KMOP-4.2.1/B-10-2011-0002, NKFIH K-116072, NKFIH K-123989 and NKFIH ERC_HU 117680 grants to M.K.; and the Premium Postdoctoral Fellowship Program of the Hungarian Academy of Sciences (PPD-017/2017) to G.M.H.	Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Anderson DG, 1998, CELL, V95, P975, DOI 10.1016/S0092-8674(00)81721-3; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bernstein DA, 2005, STRUCTURE, V13, P1173, DOI 10.1016/j.str.2005.04.018; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Buljubasic M, 2013, RES MICROBIOL, V164, P987, DOI [10.1016/j.resmic.2013.08.008, 10.1016/j.resmic.2013.]; Buljubasic M, 2012, DNA REPAIR, V11, P419, DOI 10.1016/j.dnarep.2012.01.011; Courcelle J, 1999, MOL GEN GENET, V262, P543, DOI 10.1007/s004380051116; Courcelle J, 2015, DNA REPAIR, V32, P86, DOI 10.1016/j.dnarep.2015.04.018; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Croteau DL, 2012, BBA-MOL BASIS DIS, V1822, P1727, DOI 10.1016/j.bbadis.2012.07.014; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Greinert R, 2012, NUCLEIC ACIDS RES, V40, P10263, DOI 10.1093/nar/gks824; Guarino E, 2007, J BACTERIOL, V189, P5782, DOI 10.1128/JB.00411-07; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Harami GM, 2017, P NATL ACAD SCI USA, V114, pE466, DOI 10.1073/pnas.1615439114; Harami GM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11091; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; IKEDA H, 1995, ADV BIOPHYS, V31, P197, DOI 10.1016/0065-227X(95)99392-3; Ivancic-Bace I, 2006, J BACTERIOL, V188, P5024, DOI 10.1128/JB.00130-06; Ivankovic S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039030; Jockovich ME, 2001, MOL MICROBIOL, V41, P949, DOI 10.1046/j.1365-2958.2001.02573.x; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; MCOSKER CC, 1994, J ANTIMICROB CHEMOTH, V33, P23, DOI 10.1093/jac/33.suppl_A.23; Orlovetskie N, 2017, BBA-REV CANCER, V1867, P42, DOI 10.1016/j.bbcan.2016.11.004; Persky NS, 2008, CRIT REV BIOCHEM MOL, V43, P347, DOI [10.1080/10409230802485358, 10.1080/10409230802485358 ]; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Sczepanski JT, 2009, BIOCHEMISTRY-US, V48, P7565, DOI 10.1021/bi901006b; SENGUPTA S, 1990, MUTAT RES, V244, P55, DOI 10.1016/0165-7992(90)90108-V; Suski C, 2008, MOL CELL, V30, P779, DOI 10.1016/j.molcel.2008.04.020; Tikoo Shweta, 2010, Genome Integr, V1, P14, DOI 10.1186/2041-9414-1-14; Vlasic I, 2011, J BACTERIOL, V193, P4643, DOI 10.1128/JB.00368-11; Vos M, 2009, TRENDS MICROBIOL, V17, P226, DOI 10.1016/j.tim.2009.03.001; WEKSBERG R, 1995, AM J HUM GENET, V57, P994; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	40	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192483	10.1371/journal.pone.0192483	http://dx.doi.org/10.1371/journal.pone.0192483			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470542	Green Published, gold, Green Submitted			2022-12-26	WOS:000425831000012
J	Lin, HF; Chen, YD; Chen, SC				Lin, Heng-Fu; Chen, Ying-Da; Chen, Shyr-Chyr			Value of diagnostic and therapeutic laparoscopy for patients with blunt abdominal trauma: A 10-year medical center experience	PLOS ONE			English	Article							NONOPERATIVE MANAGEMENT; INJURIES; SURGERY; ASSOCIATION; GUIDELINES	Laparoscopy has been used for the diagnosis and treatment for hemodynamically stable patients with penetrating abdominal trauma. This study evaluated whether diagnostic and therapeutic laparoscopy can be used as effectively in select patients with blunt abdominal trauma. All hemodynamically stable patients undergoing operations for blunt abdominal trauma over a 10-year period (2006-2015) at a tertiary medical center were included. Patients undergoing laparotomy were categorized as group A. Patients who underwent laparoscopy were categorized as group B. The clinical outcomes of the 2 groups were compared. There were 139 patients in group A and 126 patients in group B. Group A patients were more severely injured (mean injury severity score of 23.3 vs. 18.9, P < .001) and had a higher frequency of traumatic brain injuries (25.2% vs. 14.3%, P = .039). The sensitivity and specificity of diagnostic laparoscopy for patients in group B was 99.1% and 100.0%, respectively. No non-therapeutic laparotomies were performed in group B, and the success rate of therapeutic laparoscopy was 92.0% (103/112) for patients with significant intra-abdominal injuries. Patients in the 2 groups had similar perioperative and postoperative outcomes in terms of operation times, blood loss, blood transfusion requirements, mortality, and complications (all, P > .05). Laparoscopy is a feasible and safe tool for the diagnosis and treatment of hemodynamically stable patients with blunt abdominal trauma who require surgery.	[Lin, Heng-Fu; Chen, Ying-Da] Far Eastern Mem Hosp, Dept Surg, New Taipei, Taiwan; [Lin, Heng-Fu; Chen, Shyr-Chyr] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Lin, Heng-Fu; Chen, Shyr-Chyr] Natl Taiwan Univ, Coll Med, Taipei, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chen, SC (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.; Chen, SC (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.	scchen@ntu.edu.tw		CHEN, SHYR-CHYR/0000-0002-5858-3013; Lin, Heng Fu/0000-0002-5466-9231				Ahmed N, 2005, J AM COLL SURGEONS, V201, P213, DOI 10.1016/j.jamcollsurg.2005.04.021; Carobbi A, 2010, SURG ENDOSC, V24, P1325, DOI 10.1007/s00464-009-0768-9; Chen RJ, 1998, J TRAUMA, V44, P691, DOI 10.1097/00005373-199804000-00024; Choi YB, 2003, SURG ENDOSC, V17, P421, DOI 10.1007/s00464-002-8808-8; Como JJ, 2010, J TRAUMA, V68, P721, DOI 10.1097/TA.0b013e3181cf7d07; Croce MA, 2015, J TRAUMA ACUTE CARE, V78, P1074, DOI 10.1097/TA.0000000000000655; IVATURY RR, 1993, J TRAUMA, V34, P822, DOI 10.1097/00005373-199306000-00013; Johnson JJ, 2013, AM J SURG, V205, P317, DOI 10.1016/j.amjsurg.2012.10.021; JOSEPHS LG, 1994, J TRAUMA, V36, P815, DOI 10.1097/00005373-199406000-00011; Kawahara NT, 2009, J TRAUMA, V67, P589, DOI 10.1097/TA.0b013e3181a60593; Koto MZ, 2015, J LAPAROENDOSC ADV S, V25, P730, DOI 10.1089/lap.2015.0042; Lee PC, 2014, SURG INNOV, V21, P155, DOI 10.1177/1553350612474496; Lim KH, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0007-8; Lin HF, 2015, AM J SURG, V210, P326, DOI 10.1016/j.amjsurg.2014.11.009; Lin HF, 2014, SURG INNOV, V21, P355, DOI 10.1177/1553350613505717; Lin HF, 2010, WORLD J SURG, V34, P1653, DOI 10.1007/s00268-010-0485-5; Nicolau AE, 2011, CHIRURGIA-BUCHAREST, V106, P59; O'Malley E, 2013, WORLD J SURG, V37, P113, DOI 10.1007/s00268-012-1790-y; Peitzman AB, 2000, J TRAUMA, V49, P177, DOI 10.1097/00005373-200008000-00002; Sauerland S, 2006, SURG ENDOSC, V20, P14, DOI 10.1007/s00464-005-0564-0; Sitnikov V, 2009, SURG ENDOSC, V23, P125, DOI 10.1007/s00464-008-9910-3; SMITH RS, 1995, AM J SURG, V170, P632; Uranues S, 2015, WORLD J SURG, V39, P1381, DOI 10.1007/s00268-014-2904-5; Velmahos GC, 2003, ARCH SURG-CHICAGO, V138, P844, DOI 10.1001/archsurg.138.8.844; Zafar SN, 2015, AM J SURG, V209, P627, DOI 10.1016/j.amjsurg.2014.12.011	25	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193379	10.1371/journal.pone.0193379	http://dx.doi.org/10.1371/journal.pone.0193379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470527	Green Submitted, Green Published, gold			2022-12-26	WOS:000425831000051
J	van den Akker, PC; Pasmooij, AMG; Joenje, H; Hofstra, RMW; te Meerman, GJ; Jonkman, MF				van den Akker, Peter C.; Pasmooij, Anna M. G.; Joenje, Hans; Hofstra, Robert M. W.; te Meerman, Gerard J.; Jonkman, Marcel F.			A "late-but-fitter revertant cell" explains the high frequency of revertant mosaicism in epidermolysis bullosa	PLOS ONE			English	Article							NATURAL GENE-THERAPY; SEVERE COMBINED IMMUNODEFICIENCY; WISKOTT-ALDRICH-SYNDROME; IN-VIVO REVERSION; NORMAL HUMAN-SKIN; FANCONI-ANEMIA; SOMATIC MOSAICISM; STEM-CELLS; MITOTIC RECOMBINATION; T-CELL	Revertant mosaicism, or "natural gene therapy", is the phenomenon in which germline mutations are corrected by somatic events. In recent years, revertant mosaicism has been identified in all major types of epidermolysis bullosa, the group of heritable blistering disorders caused by mutations in the genes encoding epidermal adhesion proteins. Moreover, revertant mosaicism appears to be present in all patients with a specific subtype of recessive epidermolysis bullosa. We therefore hypothesized that revertant mosaicism should be expected at least in all patients with recessive forms of epidermolysis bullosa. Naturally corrected, patient-own cells are of extreme interest for their promising therapeutic potential, and their presence in all patients would open exciting, new treatment perspectives to those patients. To test our hypothesis, we determined the probability that single nucleotide reversions occur in patients' skin using a mathematical developmental model. According to our model, reverse mutations are expected to occur frequently ( estimated 216x) in each patient's skin. Reverse mutations should, however, occur early in embryogenesis to be able to drive the emergence of recognizable revertant patches, which is expected to occur in only one per similar to 10,000 patients. This underestimate, compared to our clinical observations, can be explained by the "late-but-fitter revertant cell" hypothesis: reverse mutations arise at later stages of development, but provide revertant cells with a selective growth advantage in vivo that drives the development of recognizable healthy skin patches. Our results can be extrapolated to any other organ with stem cell division numbers comparable to skin, which may offer novel future therapeutic options for other genetic conditions if these revertant cells can be identified and isolated.	[van den Akker, Peter C.; te Meerman, Gerard J.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van den Akker, Peter C.; Pasmooij, Anna M. G.; Jonkman, Marcel F.] Univ Groningen, Univ Med Ctr Groningen, Dept Dermatol, Groningen, Netherlands; [Joenje, Hans] Vrije Univ Amsterdam, Med Ctr, VUmc Inst Canc & Immunol, Dept Clin Genet, Amsterdam, Netherlands; [Joenje, Hans] Vrije Univ Amsterdam, Med Ctr, VUmc Inst Canc & Immunol, Canc Ctr Amsterdam, Amsterdam, Netherlands; [Hofstra, Robert M. W.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands	University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	van den Akker, PC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.; van den Akker, PC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Dermatol, Groningen, Netherlands.	p.c.van.den.akker@umcg.nl	van den Akker, Peter C./HDM-6594-2022	Pasmooij, Anna Maria Gerdina/0000-0003-0641-3829; van den Akker, Peter/0000-0002-3734-753X	Netherlands Organization for Health Research and Development (ZonMw) [92003541]; Priority Medicines Rare Diseases (E-RARE) from ZonMw [113301091]; Vlinderkind (Dutch Butterfly Child) Foundation	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Priority Medicines Rare Diseases (E-RARE) from ZonMw; Vlinderkind (Dutch Butterfly Child) Foundation	This study was supported in part by the Netherlands Organization for Health Research and Development (ZonMw) grant 92003541 to PCvdA, the Priority Medicines Rare Diseases (E-RARE) grant 113301091 from ZonMw to AMGP, and the Vlinderkind (Dutch Butterfly Child) Foundation to MFJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhishek S, 2016, CELL J, V18, P1; Almaani N, 2010, J INVEST DERMATOL, V130, P1937, DOI 10.1038/jid.2010.64; Arao H, 1998, J Tissue Viability, V8, P17; Ariga T, 1998, BLOOD, V92, P699, DOI 10.1182/blood.V92.2.699; Ban SA, 2014, J CLIN IMMUNOL, V34, P941, DOI 10.1007/s10875-014-0088-2; Bayer DK, 2014, CLIN EXP IMMUNOL, V178, P459, DOI 10.1111/cei.12421; BERGSTRESSER PR, 1978, J INVEST DERMATOL, V70, P280, DOI 10.1111/1523-1747.ep12541516; Blaschko A., 1901, NERVENVERTEILUNG HAU; Botchkarev VA, 2017, J INVEST DERMATOL, V137, pE93, DOI 10.1016/j.jid.2016.04.040; BRUNNER HG, 1993, NEW ENGL J MED, V328, P476, DOI 10.1056/NEJM199302183280705; Burger B, 2012, BRIT J DERMATOL, V166, P434, DOI 10.1111/j.1365-2133.2011.10639.x; BURROW KL, 1991, NEUROLOGY, V41, P661, DOI 10.1212/WNL.41.5.661; Choate KA, 2015, J CLIN INVEST, V125, P1703, DOI 10.1172/JCI64415; Choate KA, 2010, SCIENCE, V330, P94, DOI 10.1126/science.1192280; Cohen ASA, 2015, CLIN GENET, V87, P554, DOI 10.1111/cge.12502; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Colom B, 2016, CURR OPIN CELL BIOL, V43, P14, DOI 10.1016/j.ceb.2016.07.002; Darling TN, 1999, J CLIN INVEST, V103, P1371, DOI 10.1172/JCI4338; Dorsman JC, 2007, CELL ONCOL, V29, P211; ELLIS NA, 1995, AM J HUM GENET, V57, P1019; Erickson RP, 2010, MUTAT RES-REV MUTAT, V705, P96, DOI 10.1016/j.mrrev.2010.04.002; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; Ghadially R, 2012, J INVEST DERMATOL, V132, P797, DOI 10.1038/jid.2011.434; Giangreco A, 2010, J INVEST DERMATOL, V130, P604, DOI 10.1038/jid.2009.297; Gostynski A, 2014, J AM ACAD DERMATOL, V70, P98, DOI 10.1016/j.jaad.2013.08.052; Gross M, 2002, CYTOGENET GENOME RES, V98, P126, DOI 10.1159/000069805; Hamanoue S, 2006, BRIT J HAEMATOL, V132, P630, DOI 10.1111/j.1365-2141.2005.05916.x; HAPPLE R, 1984, HAUTARZT, V35, P366; Hirsch T, 2017, NATURE, V551, P327, DOI 10.1038/nature24487; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721; Hirschhorn R, 1996, NAT GENET, V13, P290, DOI 10.1038/ng0796-290; Hotz A, 2016, ACTA DERM-VENEREOL, V96, P473, DOI 10.2340/00015555-2299; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Jongmans MCJ, 2012, AM J HUM GENET, V90, P426, DOI 10.1016/j.ajhg.2012.01.004; Jonkman MF, 2009, NEW ENGL J MED, V360, P1680, DOI 10.1056/NEJMc0809896; Jonkman MF, 1997, CELL, V88, P543, DOI 10.1016/S0092-8674(00)81894-2; Kiritsi D, 2014, J INVEST DERMATOL, V134, P2097, DOI 10.1038/jid.2014.118; Kiritsi D, 2012, J CLIN INVEST, V122, P1742, DOI 10.1172/JCI61976; Koehler MJ, 2011, SKIN RES TECHNOL, V17, P479, DOI 10.1111/j.1600-0846.2011.00522.x; Konno A, 2004, BLOOD, V103, P676, DOI 10.1182/blood-2003-05-1739; Kowalewski C, 2016, BRIT J DERMATOL, V174, P1375, DOI 10.1111/bjd.14374; KVITTINGEN EA, 1993, J CLIN INVEST, V91, P1816, DOI 10.1172/JCI116393; Lai-Cheong JE, 2012, J INVEST DERMATOL, V132, P730, DOI 10.1038/jid.2011.352; Liehr T, 1996, HUM GENET, V98, P22, DOI 10.1007/s004390050154; Loomis CA, 2008, DERMATOLOGY, V1, P37; LoTenFoe JR, 1997, EUR J HUM GENET, V5, P137, DOI 10.1159/000484749; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Mulder KW, 2012, NAT CELL BIOL, V14, P753, DOI 10.1038/ncb2520; Nachman MW, 2000, GENETICS, V156, P297; Nishikomori R, 2004, BLOOD, V103, P4565, DOI 10.1182/blood-2003-10-3655; Pasmooij AMG, 2005, AM J HUM GENET, V77, P727, DOI 10.1086/497344; Pasmooij AMG, 2007, J CLIN INVEST, V117, P1240, DOI 10.1172/JCI30465; Pasmooij AMG, 2012, DISCOV MED, V14, P167; Pasmooij AMG, 2012, J INVEST DERMATOL, V132, P1374, DOI 10.1038/jid.2011.477; Pasmooij AMG, 2010, J INVEST DERMATOL, V130, P2407, DOI 10.1038/jid.2010.163; Perdigoto CN, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015263; Potten C S, 1986, Br J Radiol Suppl, V19, P82; Ra HJ, 2015, NEOPLASIA, V17, P201, DOI 10.1016/j.neo.2014.12.009; Reish RG, 2009, WOUND REPAIR REGEN, V17, P806, DOI 10.1111/j.1524-475X.2009.00546.x; Rieux-Laucat F, 2006, NEW ENGL J MED, V354, P1913, DOI 10.1056/NEJMoa053750; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Roehl AC, 2012, HUM MUTAT, V33, P541, DOI 10.1002/humu.22013; Schuilenga-Hut PHL, 2002, J INVEST DERMATOL, V118, P626, DOI 10.1046/j.1523-1747.2002.01715.x; Smith FJD, 2004, J INVEST DERMATOL, V122, P73, DOI 10.1046/j.0022-202X.2003.22129.x; Soulier J, 2005, BLOOD, V105, P1329, DOI 10.1182/blood-2004-05-1852; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; Strachan LR, 2008, STEM CELL REV, V4, P149, DOI 10.1007/s12015-008-9020-6; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Tone Y, 2007, BLOOD, V109, P1182, DOI 10.1182/blood-2006-08-039057; Umegaki-Arao N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009342; van den Akker PC, 2012, ARCH DERMATOL, V148, P213, DOI 10.1001/archdermatol.2011.298; Wada T, 2005, BLOOD, V106, P2099, DOI 10.1182/blood-2005-03-0936; Wada T, 2001, P NATL ACAD SCI USA, V98, P8697, DOI 10.1073/pnas.151260498; Waisfisz Q, 1999, NAT GENET, V22, P379, DOI 10.1038/11956; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; YANG TP, 1988, SOMAT CELL MOLEC GEN, V14, P293, DOI 10.1007/BF01534590	77	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192994	10.1371/journal.pone.0192994	http://dx.doi.org/10.1371/journal.pone.0192994			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470523	Green Published, Green Submitted, gold			2022-12-26	WOS:000425831000030
J	Anasdass, JR; Kannaiyan, P; Raghavachary, R; Gopinath, SCB; Chen, Y				Anasdass, Jaculin Raiza; Kannaiyan, Pandian; Raghavachary, Raghunathan; Gopinath, Subash C. B.; Chen, Yeng			Palladium nanoparticle-decorated reduced graphene oxide sheets synthesized using Ficus carica fruit extract: A catalyst for Suzuki cross-coupling reactions	PLOS ONE			English	Article							GREEN SYNTHESIS; PD NANOPARTICLES; HECK REACTION; LEAF EXTRACT; HETEROGENEOUS CATALYST; ARYLBORONIC ACIDS; REUSABLE CATALYST; REDUCTION; EFFICIENT; MIYAURA	We present a biogenic method for the synthesis of palladium nanoparticle (PdNP)-modified by reducing graphene oxide sheets (rGO) in a one-pot strategy using Ficus carica fruit juice as the reducing agent. The synthesized material was well characterized by morphological and structural analyses, including, Ultraviolet-Visible spectroscopy (UV-Vis), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR) and Transmission Electron Microscopy (TEM) and Raman spectroscopy. The results revealed that the PdNP modified GO are spherical in shape and estimated to be a dimension of similar to 0.16 nm. The PdNP/graphene exhibits a great catalytic activity in Suzuki cross-coupling reactions for the synthesis of biaryl compounds with various substrates under both aqueous and aerobic conditions. The catalyst can be recovered easily and is suitable for repeated use because it retains its original catalytic activity. The PdNP/rGO catalyst synthesized by an eco-friendly protocol was used for the Suzuki coupling reactions. The method offers a mild and effective substitute to the existing methods and may significantly contribute to green chemistry.	[Anasdass, Jaculin Raiza; Kannaiyan, Pandian] Univ Madras, Dept Inorgan Chem, Madras, Tamil Nadu, India; [Raghavachary, Raghunathan] Univ Madras, Dept Organ Chem, Madras, Tamil Nadu, India; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Sch Bioproc Engn, Perlis, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Inst Nano Elect Engn, Perlis, Malaysia; [Chen, Yeng] Univ Malaya, Fac Dent, Dept Oral & Craniofacial Sci, Kuala Lumpur, Malaysia; [Chen, Yeng] Univ Malaya, Fac Dent, OCRCC, Kuala Lumpur, Malaysia	University of Madras; University of Madras; Universiti Malaysia Perlis; Universiti Malaysia Perlis; Universiti Malaya; Universiti Malaya	Kannaiyan, P (corresponding author), Univ Madras, Dept Inorgan Chem, Madras, Tamil Nadu, India.	jeevapandian@yahoo.co.uk	pandian, Kannaiyan/AAZ-3539-2020; Chen, Yeng -/A-6873-2011; Gopinath, Subash/D-2953-2015	Chen, Yeng -/0000-0002-0064-7678; Gopinath, Subash/0000-0002-8347-4687	DST PURSE (PHASE II); University of Malaya Research Grants (UMRG) [RG454-12HTM]	DST PURSE (PHASE II); University of Malaya Research Grants (UMRG)	Authors express sincere thanks to DST PURSE (PHASE II) for providing financial assistant to carry out a part of this work. Dr. Yeng Chen would like to thank University of Malaya Research Grants (UMRG) RG454-12HTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the Director of the Center for Nanoscience and Nanotechnology for the support of this study. The authors thank SAIF, IIT Madras for permitting the use of their XRD facilities. We also acknowledge the Director of Chonnam National University for providing HR-TEM facilities. The authors express sincere thanks to DST-PURSE (PHASE II) for providing financial assistant to carry out a part of this work.	[Anonymous], J BIOMAT NANOTECH; Balanta A, 2011, CHEM SOC REV, V40, P4973, DOI 10.1039/c1cs15195a; Bedford RB, 2005, CHEM MATER, V17, P701, DOI 10.1021/cm048860s; Bhanage BM, 2001, CATAL REV, V43, P315, DOI 10.1081/CR-100107480; Biffis A, 2001, EUR J INORG CHEM, P1131; Biying AO, 2014, DALTON T, V43, P5014, DOI 10.1039/c3dt52560k; Borah RK, 2017, APPL ORGANOMET CHEM, V31, DOI 10.1002/aoc.3784; Carrera-Cerritos R, 2014, APPL CATAL B-ENVIRON, V144, P554, DOI 10.1016/j.apcatb.2013.07.057; Chen XC, 2008, J PHYS CHEM C, V112, P8172, DOI 10.1021/jp800610q; Dauthal P, 2013, IND ENG CHEM RES, V52, P18131, DOI 10.1021/ie403410z; Djakovitch L, 1999, J MOL CATAL A-CHEM, V142, P275, DOI 10.1016/S1381-1169(98)00292-1; Djakovitch L, 2001, J AM CHEM SOC, V123, P5990, DOI 10.1021/ja001087r; Dreyer D. R., 2010, ANGEW CHEM, V122, P6965, DOI DOI 10.1002/ANGE.201002160; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Gerhartz W, 1986, ULLMANNS ENCY IND CH; Gniewek A, 2005, J CATAL, V229, P332, DOI 10.1016/j.jcat.2004.11.003; Gomez-Martinez M, 2015, J MOL CATAL A-CHEM, V404, P1, DOI 10.1016/j.molcata.2015.03.022; Hassan J, 2002, CHEM REV, V102, P1359, DOI 10.1021/cr000664r; Hazarika M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184936; Huang YX, 2010, NANOSCALE, V2, P1485, DOI 10.1039/c0nr00142b; Huang YX, 2014, ACS APPL MATER INTER, V6, P15795, DOI 10.1021/am504664r; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Hussain N, 2015, NEW J CHEM, V39, P6631, DOI 10.1039/c5nj01221j; Jacob SJP, 2017, FOOD CHEM TOXICOL, V109, P951, DOI 10.1016/j.fct.2017.03.066; Jana S, 2008, INORG CHEM, V47, P5512, DOI 10.1021/ic8004294; Kanchana A, 2010, NANO-MICRO LETT, V2, P169, DOI 10.1007/BF03353637; Khan M, 2014, DALTON T, V43, P9026, DOI 10.1039/c3dt53554a; Kilic B, 2012, J MOL CATAL A-CHEM, V361, P104, DOI 10.1016/j.molcata.2012.05.008; Leadbeater NE, 2002, CHEM REV, V102, P3217, DOI 10.1021/cr010361c; Lebaschi S, 2017, J COLLOID INTERF SCI, V485, P223, DOI 10.1016/j.jcis.2016.09.027; Lee HJ, 2008, J AM CHEM SOC, V130, P5406, DOI 10.1021/ja800656y; Li Y, 2010, NANO RES, V3, P429, DOI 10.1007/s12274-010-0002-z; Lim B, 2009, SCIENCE, V324, P1302, DOI 10.1126/science.1170377; Logaranjan K, 2012, NANO BIOMED ENG, V4, P177; Loh KP, 2010, J MATER CHEM, V20, P2277, DOI 10.1039/b920539j; Martin R, 2008, ACCOUNTS CHEM RES, V41, P1461, DOI 10.1021/ar800036s; Mawa S, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1155/2013/974256; Miyaura N, 2002, TOP CURR CHEM, V219, P11; Molander GA, 2007, ACCOUNTS CHEM RES, V40, P275, DOI 10.1021/ar050199q; Movahed SK, 2014, APPL CATAL A-GEN, V488, P265, DOI 10.1016/j.apcata.2014.09.045; Narayanan R, 2003, J AM CHEM SOC, V125, P8340, DOI 10.1021/ja035044x; Nasrollahzadeh M, 2015, NEW J CHEM, V39, P4745, DOI 10.1039/c5nj00244c; Nasrollahzadeh M, 2015, J MOL CATAL A-CHEM, V396, P31, DOI 10.1016/j.molcata.2014.09.029; Nasrollahzadeh M, 2015, J MOL CATAL A-CHEM, V396, P297, DOI 10.1016/j.molcata.2014.10.019; Park JH, 2014, TETRAHEDRON LETT, V55, P3426, DOI 10.1016/j.tetlet.2014.04.078; Parker HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087192; Poliakoff M, 2002, SCIENCE, V297, P807, DOI 10.1126/science.297.5582.807; Ramchandani RK, 1997, CHEM COMMUN, P2071, DOI 10.1039/a705870e; Sakurai H, 2002, J ORG CHEM, V67, P2721, DOI 10.1021/jo016342k; Segal M, 2009, NAT NANOTECHNOL, V4, P611, DOI 10.1038/nnano.2009.279; Shendage SS, 2014, COLLOID INTERFAC SCI, V1, P47, DOI 10.1016/j.colcom.2014.06.008; Shendage SS, 2013, TETRAHEDRON LETT, V54, P3457, DOI 10.1016/j.tetlet.2013.04.092; Siamaki AR, 2011, J CATAL, V279, P1, DOI 10.1016/j.jcat.2010.12.003; Singh AS, 2013, CATAL COMMUN, V35, P11, DOI 10.1016/j.catcom.2013.02.003; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; Sun T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02527; Wang DS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00037; Watt J, 2010, ACS NANO, V4, P396, DOI 10.1021/nn901277k; Yang SB, 2011, ANGEW CHEM INT EDIT, V50, P5339, DOI 10.1002/anie.201100170; Yin LX, 2007, CHEM REV, V107, P133, DOI 10.1021/cr0505674; Zeng XQ, 2011, NANO LETT, V11, P262, DOI 10.1021/nl103682s; Zhao FY, 2000, CHEM-EUR J, V6, P843, DOI 10.1002/(SICI)1521-3765(20000303)6:5<843::AID-CHEM843>3.0.CO;2-G	64	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193281	10.1371/journal.pone.0193281	http://dx.doi.org/10.1371/journal.pone.0193281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466453	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300109
J	Beshr, EH; Abdelghany, H; Eteiba, M				Beshr, Eman Hassan; Abdelghany, Hazem; Eteiba, Mahmoud			Novel optimization technique of isolated microgrid with hydrogen energy storage	PLOS ONE			English	Article							FLOWER POLLINATION ALGORITHM; PEM FUEL-CELL; POWER	This paper presents a novel optimization technique for energy management studies of an isolated microgrid. The system is supplied by various Distributed Energy Resources (DERs), Diesel Generator (DG), a Wind Turbine Generator (WTG), Photovoltaic (PV) arrays and supported by fuel cell/electrolyzer Hydrogen storage system for short term storage. Multi-objective optimization is used through non-dominated sorting genetic algorithm to suit the load requirements under the given constraints. A novel multi-objective flower pollination algorithm is utilized to check the results. The Pros and cons of the two optimization techniques are compared and evaluated. An isolated microgrid is modelled using MATLAB software package, dispatch of active/reactive power, optimal load flow analysis with slack bus selection are carried out to be able to minimize fuel cost and line losses under realistic constraints. The performance of the system is studied and analyzed during both summer and winter conditions and three case studies are presented for each condition. The modified IEEE 15 bus system is used to validate the proposed algorithm.	[Beshr, Eman Hassan; Abdelghany, Hazem] Arab Acad Sci Technol & Maritime Transport, Dept Elect & Control Engn, Cairo, Egypt; [Eteiba, Mahmoud] Fayoum Univ, Dept Elect Power & Machines, Al Fayyum, Egypt	Egyptian Knowledge Bank (EKB); Arab Academy for Science, Technology & Maritime Transport; Egyptian Knowledge Bank (EKB); Fayoum University	Beshr, EH (corresponding author), Arab Acad Sci Technol & Maritime Transport, Dept Elect & Control Engn, Cairo, Egypt.	eman.beshr@gmail.com		Abdelghany, Hazem Ayman/0000-0002-8628-6024				Abedini M, 2016, INT T ELECTR ENERGY, V26, P2727, DOI 10.1002/etep.2231; Barocio E, 2017, IET GENER TRANSM DIS, V11, P1012, DOI 10.1049/iet-gtd.2016.1135; Chowdhury S, 2009, MICROGRIDS ACTIVE DI; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; El-Sharkh MY, 2006, J POWER SOURCES, V161, P1198, DOI 10.1016/j.jpowsour.2006.06.046; El-Sharkh MY, 2005, J POWER SOURCES, V139, P165, DOI 10.1016/j.jpowsour.2004.07.011; Esmaeli A, 2016, RENEW ENERG, V96, P914, DOI 10.1016/j.renene.2016.04.077; Jianxin Xu, 2011, IECON 2011 - 37th Annual Conference of IEEE Industrial Electronics, P3192, DOI 10.1109/IECON.2011.6119821; Kim KangSuk, 2012, International Proceedings of Chemical, Biological and Environmental Engineering (IPCBEE), V30, P1; Modiri-Delsha M., 2014, PROC 3 IET INT C CLE, P1, DOI [10.1049/cp.2014.1457, DOI 10.1049/CP.2014.1457]; Narkhede MS, 2012, 2012 1ST INTERNATIONAL CONFERENCE ON POWER AND ENERGY IN NERIST (ICPEN); Nelson D. B., 2005, P IEEE POW ENG SOC G, V3, P2115; Odolfo Dufo-Lopez, 2007, RENEW ENERG, V32, P1102; Patel MR, 1999, WIND SOLAR POWER SYS; Salgotra R, 2017, EXPERT SYST APPL, V79, P112, DOI 10.1016/j.eswa.2017.02.035; Sarjiya, 2017, P 2016 8 INT C INF T; Shilaja C, 2017, RENEW ENERG, V107, P550, DOI 10.1016/j.renene.2017.02.021; Tamalouzt S., 2015, 2015 3 INT REN SUST, P1, DOI DOI 10.1109/IRSEC.2015.7455060; Vaculik Jan, 2014, 2014 15th International Scientific Conference on Electric Power Engineering (EPE). Proceedings, P381, DOI 10.1109/EPE.2014.6839440; Wang CK, 2008, 2008 IEEE WORKSHOP ON ADVANCED ROBOTICS AND ITS SOCIAL IMPACTS, P1; Xin-She Yang, 2012, Unconventional Computation and Natural Computation. Proceedings of the 11th International Conference, UCNC 2012, P240, DOI 10.1007/978-3-642-32894-7_27; Xu SH, 2017, INT J ADV MANUF TECH, V89, P503, DOI 10.1007/s00170-016-9112-4; Zahran I.I., 2012, THESIS; Zhang WY, 2017, ENERG CONVERS MANAGE, V136, P439, DOI 10.1016/j.enconman.2017.01.022	25	12	12	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193224	10.1371/journal.pone.0193224	http://dx.doi.org/10.1371/journal.pone.0193224			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466433	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300099
J	Busse, P; Miranda, JJ				Busse, Peter; Jaime Miranda, J.			Perceived behavioral control as a potential precursor of walking three times a week: Patient's perspectives	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PLANNED BEHAVIOR; REASONED ACTION; PROMOTION; CAMPAIGNS; SMOKING	Background Behavior change theories can identify people's main motivations to engage in recommended health practices and thus provide better tools to design interventions, particularly human centered design interventions. Objectives This study had two objectives: (a) to identify salient beliefs about walking three times a week for 30 minutes nonstop among patients with hypertension in a low-resource setting and, (b) to measure the relationships among intentions, attitudes, perceived social pressure and perceived behavioral control about this behavior. Methods Face-to-face interviews with 34 people living with hypertension were conducted in September-October 2011 in Lima, Peru, and data analysis was performed in 2015. The Reasoned Action Approach was used to study the people's decisions to walk. We elicited people's salient beliefs and measured the theoretical constructs associated with this behavior. Results Results pointed at salient key behavioral, normative and control beliefs. In particular, perceived behavioral control appeared as an important determinant of walking and a small set of control beliefs were identified as potential targets of health communication campaigns, including (not) having someone to walk with, having work or responsibilities, or having no time. Conclusions This theory-based study with a focus on end-users provides elements to inform the design of an intervention that would motivate people living with hypertension to walk on a regular basis in low-resource settings.	[Busse, Peter] Univ Lima, Inst Invest Cient, Lima, Peru; [Busse, Peter] Inst Estudios Peruanos, Lima, Peru; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru	Universidad de Lima; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Busse, P (corresponding author), Univ Lima, Inst Invest Cient, Lima, Peru.; Busse, P (corresponding author), Inst Estudios Peruanos, Lima, Peru.	pbusse@ulima.edu.pe		Miranda, J. Jaime/0000-0002-4738-5468; Busse, Peter/0000-0002-5570-1299	International Development Research Centre-IDRC, Canada, under the Think Tank Initiative program; International Development Research Centre-IDRC, Canada, under the Think Tank Initiative program, within Instituto de Estudios Peruanos	International Development Research Centre-IDRC, Canada, under the Think Tank Initiative program; International Development Research Centre-IDRC, Canada, under the Think Tank Initiative program, within Instituto de Estudios Peruanos	The study reported in this article was possible thanks to the financial support of International Development Research Centre-IDRC, Canada, under the Think Tank Initiative program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study reported in this article was possible thanks to the financial support of International Development Research Centre-IDRC, Canada, under the Think Tank Initiative program, within Instituto de Estudios Peruanos. The authors thank Lic. Sarita Moran and Lic. Diamante Fernandez for their support with the research tasks involved in this project, and Andrea O. Ruiz-Alejos for editorial assistance.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Albarracin D, 2001, PSYCHOL BULL, V127, P142, DOI 10.1037//0033-2909.127.1.142; Atkin CK, THEORY PRINCIPLES ME, P3; Busse P., 2014, DESIGUALDAD HIPERTEN, P55; Cappella JN, 2006, J COMMUN, V56, pS265, DOI 10.1111/j.1460-2466.2006.00293.x; Centers Disease Control and Prevention, 2014, HIGH BLOOD PRESSURE; Chib A, 2015, J HEALTH COMMUN, V20, P4, DOI 10.1080/10810730.2013.864735; Fishbein M., 1975, BELIEF ATTITUDE INTE; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; Fishbein M, 2008, MED DECIS MAKING, V28, P834, DOI 10.1177/0272989X08326092; Hagger MS, 2002, J SPORT EXERCISE PSY, V24, P3, DOI 10.1123/jsep.24.1.3; Hennessy M, 2014, AM J PUBLIC HEALTH, V104, P721, DOI 10.2105/AJPH.2013.301634; Hennessy M, 2014, NICOTINE TOB RES, V16, P69, DOI 10.1093/ntr/ntt119; Hernandez-Hernandez R, 2010, J HYPERTENS, V28, P24, DOI 10.1097/HJH.0b013e328332c353; Hornik R., 1999, SOCIAL MARKETING Q, V5, P34, DOI [10.1080/15245004.1999.9961044, DOI 10.1080/15245004.1999.9961044]; Jordan A, 2012, ANN AM ACAD POLIT SS, V640, P118, DOI 10.1177/0002716211425656; Kallgren CA, 2000, PERS SOC PSYCHOL B, V26, P1002, DOI 10.1177/01461672002610009; Lee LL, 2010, INT J NURS STUD, V47, P1545, DOI 10.1016/j.ijnurstu.2010.08.008; Mendez RD, 2012, REV LAT-AM ENFERM, V20, P1015, DOI 10.1590/S0104-11692012000600002; Noar SM, 2010, HEALTH COMMUN, V25, P593, DOI 10.1080/10410236.2010.496832; Noar SM, 2009, J HEALTH COMMUN, V14, P15, DOI 10.1080/10810730802592239; Noar SM, 2006, J HEALTH COMMUN, V11, P21, DOI 10.1080/10810730500461059; Perel P, 2006, PLOS MED, V3, P1448, DOI 10.1371/journal.pmed.0030344; Rebar AL, 2014, J SPORT EXERCISE PSY, V36, P157, DOI 10.1123/jsep.2013-0173; Riley WT, 2011, TRANSL BEHAV MED, V1, P53, DOI 10.1007/s13142-011-0021-7; Sanchez RA, 2009, J HYPERTENS, V27, P905, DOI 10.1097/HJH.0b013e32832aa6d2; Seclén-Palacín Juan A., 2003, Rev Panam Salud Publica, V14, P255, DOI 10.1590/S1020-49892003000900006; World Health Organization, 2013, SIL KILL GLOB PUBL H	28	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192915	10.1371/journal.pone.0192915	http://dx.doi.org/10.1371/journal.pone.0192915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW5PR	29451917	Green Published, Green Submitted, gold			2022-12-26	WOS:000425369800024
J	Byrd, KM; Blagg, BSJ				Byrd, Katherine M.; Blagg, Brian S. J.			Chaperone substrate provides missing link for cancer drug discovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							HSP90; HSP70	Both Hsp70 and Hsp90 chaperones are overexpressed in cancer, making them relevant targets for the development of cancer chemotherapeutics, but a lack of biomolecular readouts for Hsp70 inhibition has limited the pursuit of specific inhibitors for this enzyme. A new study from Cesa et al. identifies two inhibitors of apoptosis proteins (IAPs) as specific client substrates of Hsp70. These results establish biomarkers that can be utilized to monitor Hsp70 inhibition and provide a framework for future efforts to deconvolute chaperone networks.	[Byrd, Katherine M.; Blagg, Brian S. J.] Univ Notre Dame, Dept Chem & Biochem, 305 McCourtney Hall, Notre Dame, IN 46545 USA	University of Notre Dame	Blagg, BSJ (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 305 McCourtney Hall, Notre Dame, IN 46545 USA.	bblagg@nd.edu	blagg, brian s j/X-7770-2018	blagg, brian s j/0000-0002-6200-3480				Cesa LC, 2018, J BIOL CHEM, V293, P2370, DOI 10.1074/jbc.RA117.000634; Hong DS, 2013, CANCER TREAT REV, V39, P375, DOI 10.1016/j.ctrv.2012.10.001; Leu JIJ, 2014, ACS CHEM BIOL, V9, P2508, DOI 10.1021/cb500236y; Li XK, 2013, ACS MED CHEM LETT, V4, P1042, DOI 10.1021/ml400204n; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	9	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2381	2382		10.1074/jbc.H118.001591	http://dx.doi.org/10.1074/jbc.H118.001591			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29453286	Green Published, hybrid			2022-12-26	WOS:000425308300012
J	Paulitti, A; Andreuzzi, E; Bizzotto, D; Pellicani, R; Tarticchio, G; Marastoni, S; Pastrello, C; Jurisica, I; Ligresti, G; Bucciotti, F; Doliana, R; Colladel, R; Braghetta, P; Poletto, E; Di Silvestre, A; Bressan, G; Colombatti, A; Bonaldo, P; Mongiat, M				Paulitti, Alice; Andreuzzi, Eva; Bizzotto, Dario; Pellicani, Rosanna; Tarticchio, Giulia; Marastoni, Stefano; Pastrello, Chiara; Jurisica, Igor; Ligresti, Giovanni; Bucciotti, Francesco; Doliana, Roberto; Colladel, Roberta; Braghetta, Paola; Poletto, Evelina; Di Silvestre, Alessia; Bressan, Giorgio; Colombatti, Alfonso; Bonaldo, Paolo; Mongiat, Maurizio			The ablation of the matricellular protein EMILIN2 causes defective vascularization due to impaired EGFR-dependent IL-8 production affecting tumor growth	ONCOGENE			English	Article							EXTRACELLULAR-MATRIX; VESSEL NORMALIZATION; ANGIOGENESIS; THERAPY; METASTASIS; DEFICIENCY; PATHWAY; BREAST; CANCER; IDENTIFICATION	EMILIN2 is an extracellular matrix constituent playing an important role in angiogenesis; however, the underlying mechanism is unknown. Here we show that EMILIN2 promotes angiogenesis by directly binding epidermal growth factor receptor (EGFR), which enhances interleukin-8 (IL-8) production. In turn, IL-8 stimulates the proliferation and migration of vascular endothelial cells. Emilin2 null mice were generated and exhibited delayed retinal vascular development, which was rescued by the administration of the IL-8 murine ortholog MIP-2. Next, we assessed tumor growth and tumor-associated angiogenesis in these mice. Tumor cell growth in Emilin2 null mice was impaired as well as the expression of MIP-2. The vascular density of the tumors developed in Emilin2 null mice was prejudiced and vessels perfusion, as well as response to chemotherapy, decreased. Accordingly, human tumors expressing high levels of EMILIN2 were more responsive to chemotherapy. These results point at EMILIN2 as a key microenvironmental cue affecting vessel formation and unveil the possibility to develop new prognostic tools to predict chemotherapy efficacy.	[Paulitti, Alice; Andreuzzi, Eva; Pellicani, Rosanna; Tarticchio, Giulia; Bucciotti, Francesco; Doliana, Roberto; Colladel, Roberta; Poletto, Evelina; Di Silvestre, Alessia; Colombatti, Alfonso; Mongiat, Maurizio] CRO, Div Mol Oncol, Dept Translat Res, Aviano, Italy; [Bizzotto, Dario; Braghetta, Paola; Bressan, Giorgio; Bonaldo, Paolo] Univ Padua, Dept Mol Med, Padua, Italy; [Marastoni, Stefano; Pastrello, Chiara; Jurisica, Igor] Princess Margaret Canc Ctr, Dept Comp Sci, Toronto, ON, Canada; [Jurisica, Igor] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Ligresti, Giovanni] Mayo Clin, Dept Tissue Repair & Meccano Biol, Rochester, NY USA	IRCCS Aviano (CRO); University of Padua; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Mayo Clinic	Mongiat, M (corresponding author), CRO, Div Mol Oncol, Dept Translat Res, Aviano, Italy.; Bonaldo, P (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	bonaldo@bio.unipd.it; mmongiat@cro.it	Bucciotti, Francesco/AAZ-1255-2020; Doliana, Roberto/AAA-1479-2019; Andreuzzi, Eva/AAX-5692-2020; Mongiat, Maurizio/H-8297-2018; Poletto, Evelina/AAW-3671-2020; Ligresti, Giovanni/AAB-9881-2019; Pellicani, Rosanna/J-1263-2018	Bucciotti, Francesco/0000-0002-4253-855X; Doliana, Roberto/0000-0002-8324-7564; Andreuzzi, Eva/0000-0002-5925-5230; Mongiat, Maurizio/0000-0001-6509-0068; Poletto, Evelina/0000-0001-5675-3026; BIZZOTTO, Dario/0000-0002-9036-5016; Pellicani, Rosanna/0000-0002-0952-0403; DI SILVESTRE, ALESSIA/0000-0003-4878-293X; Bonaldo, Paolo/0000-0002-9571-8140	AIRC [IG-2012-12718, IG-13126 AColombatti]; Italian Ministry of Health [RF-2010-2312580]; Italian Ministry of University and Research (grant PRIN); Italian Ministry of University and Research (Progetto Strategico) [01.00858.ST97]; University of Padova [CDPA075559/07, CPDA148982/14]	AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University and Research (grant PRIN)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of University and Research (Progetto Strategico); University of Padova	This work was supported by AIRC (grant # IG-2012-12718 to MM, IG-13126 AColombatti), the Italian Ministry of Health (grant#RF-2010-2312580 to MM), the Italian Ministry of University and Research (grants PRIN 2007 and Progetto Strategico 01.00858.ST97 to GB), and the University of Padova (grants CDPA075559/07 to PBraghetta and CPDA148982/14 to PBonaldo).	Allegra CJ, 2013, J CLIN ONCOL, V31, P359, DOI 10.1200/JCO.2012.44.4711; Andreuzzi E, 2017, MATRIX BIOL, V64, P40, DOI 10.1016/j.matbio.2017.04.002; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bot S, 2015, MATRIX BIOL, V41, P44, DOI 10.1016/j.matbio.2014.10.001; Braghetta P, 2004, MATRIX BIOL, V22, P549, DOI 10.1016/j.matbio.2003.10.005; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Cantelmo AR, 2016, CANCER CELL, V30, P968, DOI 10.1016/j.ccell.2016.10.006; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Colladel R, 2016, ONCOTARGET, V7, P2022, DOI 10.18632/oncotarget.6515; COLOMBATTI A, 1989, J HISTOCHEM CYTOCHEM, V37, P757, DOI 10.1177/37.5.2703709; Colombatti A, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00093; Danussi C, 2008, MOL CELL BIOL, V28, P4026, DOI 10.1128/MCB.02062-07; Doliana R, 2000, J BIOL CHEM, V275, P785, DOI 10.1074/jbc.275.2.785; Doliana R, 2008, MATRIX BIOL, V27, P96, DOI 10.1016/j.matbio.2007.09.008; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fukui A, 2013, MICROBIOL IMMUNOL, V57, P198, DOI 10.1111/1348-0421.12022; Galvagni F, 2017, MATRIX BIOL, V64, P112, DOI 10.1016/j.matbio.2017.08.003; Gharavi NM, 2007, J BIOL CHEM, V282, P31460, DOI 10.1074/jbc.M704267200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hill VK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-51; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Lorenzon E, 2012, ONCOGENE, V31, P3136, DOI 10.1038/onc.2011.487; Maes H, 2014, CANCER CELL, V26, P190, DOI 10.1016/j.ccr.2014.06.025; Marastoni S, 2014, J PATHOL, V232, P391, DOI 10.1002/path.4316; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; McIntyre A, 2015, EMBO MOL MED, V7, P368, DOI 10.15252/emmm.201404271; Mongiat M, 2007, MOL CELL BIOL, V27, P7176, DOI 10.1128/MCB.00696-07; Mongiat M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111822; Mongiat M, 2010, NEOPLASIA, V12, P294, DOI 10.1593/neo.91930; Nakatsu Martin N, 2007, J Vis Exp, P186, DOI 10.3791/186; Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393; Nguyen-Jackson HT, 2012, J LEUKOCYTE BIOL, V92, P1215, DOI 10.1189/jlb.0312126; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park JS, 2016, CANCER CELL, V30, P953, DOI 10.1016/j.ccell.2016.10.018; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Schiavinato A, 2016, J INVEST DERMATOL, V136, P1150, DOI 10.1016/j.jid.2016.02.021; Scott A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011863; Serini G, 2015, EMBO MOL MED, V7, P1251, DOI 10.15252/emmm.201505551; Veljkovic V, 2007, CURR MED CHEM, V14, P441, DOI 10.2174/092986707779941014; Vincenzi B, 2008, CRIT REV ONCOL HEMAT, V68, P93, DOI 10.1016/j.critrevonc.2008.07.006; Wong PP, 2015, CANCER CELL, V27, P123, DOI 10.1016/j.ccell.2014.10.015; Xia L, 2002, J BIOL CHEM, V277, P30716, DOI 10.1074/jbc.M202823200; Zhou J, 2014, CELL SIGNAL, V26, P2896, DOI 10.1016/j.cellsig.2014.08.027	53	29	29	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2018	37	25					3399	3414		10.1038/s41388-017-0107-x	http://dx.doi.org/10.1038/s41388-017-0107-x			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GK7TC	29483644	Green Published			2022-12-26	WOS:000436411300006
J	McKinnon, T; Venier, R; Yohe, M; Sindiri, S; Gryder, BE; Shern, JF; Kabaroff, L; Dickson, B; Schleicher, K; Chouinard-Pelletier, G; Menezes, S; Gupta, A; Zhang, XH; Guha, R; Ferrer, M; Thomas, CJ; Wei, YH; Davani, D; Guidos, CJ; Khan, J; Gladdy, RA				McKinnon, Timothy; Venier, Rosemarie; Yohe, Marielle; Sindiri, Sivasish; Gryder, Berkley E.; Shern, Jack F.; Kabaroff, Leah; Dickson, Brendan; Schleicher, Krista; Chouinard-Pelletier, Guillaume; Menezes, Serena; Gupta, Abha; Zhang, Xiaohu; Guha, Rajarashi; Ferrer, Marc; Thomas, Craig J.; Wei, Yuhong; Davani, Dariush; Guidos, Cynthia J.; Khan, Javed; Gladdy, Rebecca A.			Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma	ONCOGENE			English	Article							B-CELL LYMPHOMA; ALVEOLAR RHABDOMYOSARCOMA; EMBRYONAL RHABDOMYOSARCOMA; MUSCLE REGENERATION; FUSION GENE; MUTATIONS; CANCER; FGFR4; DIFFERENTIATION; PATHOGENESIS	Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma and outcomes have stagnated, highlighting a need for novel therapies. Genomic analysis of RMS has revealed that alterations in the receptor tyrosine kinase (RTK)/RAS/PI3K axis are common and that FGFR4 is frequently mutated or overexpressed. Although FGFR4 is a potentially druggable receptor tyrosine kinase, its functions in RMS are undefined. This study tested FGFR4-activating mutations and overexpression for the ability to generate RMS in mice. Murine tumor models were subsequently used to discover potential therapeutic targets and to test a dual PI3K/mTOR inhibitor in a preclinical setting. Specifically, we provide the first mechanistic evidence of differential potency in the most common human RMS mutations, V550E or N535K, compared to FGFR4(wt) overexpression as murine myoblasts expressing FGFR4(V550E) undergo higher rates of cellular transformation, engraftment into mice, and rapidly form sarcomas that highly resemble human RMS. Murine tumor cells overexpressing FGFR4(V550E) were tested in an in vitro dose-response drug screen along with human RMS cell lines. Compounds were grouped by target class, and potency was determined using average percentage of area under the dose-response curve (AUC). RMS cells were highly sensitive to PI3K/mTOR inhibitors, in particular, GSK2126458 (omipalisib) was a potent inhibitor of FGFR4V550E tumor-derived cell and human RMS cell viability. FGFR4(V550E)-overexpressing myoblasts and tumor cells had low nanomolar GSK2126458 EC50 values. Mass cytometry using mouse and human RMS cell lines validated GSK2126458 specificity at single-cell resolution, decreasing the abundance of phosphorylated Akt as well as decreasing phosphorylation of the downstream mTOR effectors 4ebp1, Eif4e, and S6. Moreover, PI3K/mTOR inhibition also robustly decreased the growth of RMS tumors in vivo. Thus, by developing a preclinical platform for testing novel therapies, we identified PI3K/mTOR inhibition as a promising new therapy for this devastating pediatric cancer.	[McKinnon, Timothy; Venier, Rosemarie; Kabaroff, Leah; Schleicher, Krista; Chouinard-Pelletier, Guillaume; Menezes, Serena; Gladdy, Rebecca A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Yohe, Marielle; Sindiri, Sivasish; Gryder, Berkley E.; Shern, Jack F.; Khan, Javed] NCI, Genet Branch, Oncogen Sect, Ctr Canc Res, Gaithersburg, MD USA; [Gryder, Berkley E.] Mt Sinai Hosp, Dept Pathol, Toronto, ON, Canada; [Gupta, Abha] Hosp Sick Children, Div Hematol Oncol, Toronto, ON, Canada; [Zhang, Xiaohu; Guha, Rajarashi; Ferrer, Marc; Thomas, Craig J.] Natl Ctr Adv Translat Sci, Div Preclin Innovat, NIH, Bethesda, MD USA; [Wei, Yuhong; Davani, Dariush; Guidos, Cynthia J.] Hosp Sick Children, Dev & Stem Cell Biol, Toronto, ON, Canada; [Gladdy, Rebecca A.] Ontario Inst Canc Res, Toronto, ON, Canada; [Gladdy, Rebecca A.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto	Gladdy, RA (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.; Gladdy, RA (corresponding author), Ontario Inst Canc Res, Toronto, ON, Canada.; Gladdy, RA (corresponding author), Univ Toronto, Dept Surg, Toronto, ON, Canada.	gladdy@lunenfeld.ca	Khan, Javed/P-9157-2014; Shern, Jack/V-4002-2019; Gladdy, Rebecca/A-2516-2013; Khan, Javed/AAG-3538-2019	Gladdy, Rebecca/0000-0003-4143-6620; Venier, Rosemarie/0000-0001-6063-7562; Thomas, Craig/0000-0001-9386-9001	Canadian Cancer Society Research Institute; Cancer Stem Cells Program of the Ontario Institute for Cancer Research; Ontario Institute for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011002, ZIABC010806] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000047] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Stem Cells Program of the Ontario Institute for Cancer Research; Ontario Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	CJG was supported by funding from the Canadian Cancer Society Research Institute and the Cancer Stem Cells Program of the Ontario Institute for Cancer Research; RAG was supported by a Clinical Investigator Award from Ontario Institute for Cancer Research.	Abraham J, 2014, GENE DEV, V28, P1578, DOI 10.1101/gad.238733.114; Barr FG, 1999, CANCER RES, V59, p1711S; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Ceribelli M, 2014, P NATL ACAD SCI USA, V111, P11365, DOI 10.1073/pnas.1411701111; Chen L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005075; Chmielecki J, 2017, CANCER RES, V77, P509, DOI 10.1158/0008-5472.CAN-16-1106; Crose LES, 2012, CLIN CANCER RES, V18, P3780, DOI 10.1158/1078-0432.CCR-10-3063; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Griner LAM, 2014, P NATL ACAD SCI USA, V111, P2349, DOI 10.1073/pnas.1311846111; Gryder BE, 2017, CANCER DISCOV, V7, P884, DOI 10.1158/2159-8290.CD-16-1297; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kashi VP, 2015, NAT REV CANCER, V15, P426, DOI 10.1038/nrc3961; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kikuchi K, 2011, CURR TOP DEV BIOL, V96, P33, DOI 10.1016/B978-0-12-385940-2.00002-4; Knight SD, 2010, ACS MED CHEM LETT, V1, P39, DOI 10.1021/ml900028r; Lewin J, 2015, J CLIN ONCOL, V33, P3372, DOI 10.1200/JCO.2015.62.7380; Li S, 2013, PLOS ONE, V8; Linardic CM, 2008, CANCER LETT, V270, P10, DOI 10.1016/j.canlet.2008.03.035; Marics I, 2002, DEVELOPMENT, V129, P4559; McKinnon T, 2015, ONCOTARGET, V6, P14220, DOI 10.18632/oncotarget.3856; Ognjanovic S, 2009, CANCER-AM CANCER SOC, V115, P4218, DOI 10.1002/cncr.24465; Paulson V, 2011, GENE CHROMOSOME CANC, V50, P397, DOI 10.1002/gcc.20864; Perova T, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008661; Poschl J, 2014, ACTA NEUROPATHOL, V128, P123, DOI 10.1007/s00401-014-1297-8; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Seki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8557; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Tenente IM, 2017, ELIFE, V6, DOI 10.7554/eLife.19214; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weigel BJ, 2016, J CLIN ONCOL, V34, P117, DOI 10.1200/JCO.2015.63.4048; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200; Zhao P, 2004, DEV DYNAM, V229, P380, DOI 10.1002/dvdy.10457	39	26	26	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	20					2630	2644		10.1038/s41388-017-0122-y	http://dx.doi.org/10.1038/s41388-017-0122-y			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG2TH	29487419	Green Accepted			2022-12-26	WOS:000432545100002
J	Amin, MA; McKenney, RJ; Varma, D				Amin, Mohammed A.; McKenney, Richard J.; Varma, Dileep			Antagonism between the dynein and Ndc80 complexes at kinetochores controls the stability of kinetochore-microtubule attachments during mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; CENP-E; CHROMOSOME ALIGNMENT; MITOTIC SPINDLE; CYTOPLASMIC DYNEIN; CONGRESSION; POLEWARD; CELLS; HEC1; MECHANISMS	Chromosome alignment and segregation during mitosis require kinetochore-microtubule (kMT) attachments that are mediated by the molecular motor dynein and the kMT-binding complex Ndc80. The Rod-ZW10-Zwilch (RZZ) complex is central to this coordination as it has an important role in dynein recruitment and has recently been reported to have a key function in the regulation of stable kMT attachments in Caenorhabditis elegans besides its role in activating the spindle assembly checkpoint (SAC). However, the mechanism by which these protein complexes control kMT attachments to drive chromosome motility during early mitosis is still unclear. Here, using in vitro total internal reflection fluorescence microscopy, we observed that higher concentrations of Ndc80 inhibited dynein binding to MTs, providing evidence that Ndc80 and dynein antagonize each other's function. High-resolution microscopy and siRNAmediated functional disruption revealed that severe defects in chromosome alignment induced by depletion of dynein or the dynein adapter Spindly are rescued by codepletion of the RZZ component Rod in human cells. Interestingly, rescue of the chromosome alignment defects was independent of Rod function in SAC activation and was accompanied by a remarkable restoration of stable kMT attachments. Furthermore, the chromosome alignment rescue depended on the plus-end-directed motility of centromere protein E (CENP-E) because cells codepleted of CENP-E, Rod, and dynein could not establish stable kMT attachments or align their chromosomes properly. Our findings support the idea that dynein may control the function of the Ndc80 complex in stabilizing kMT attachments directly by interfering with Ndc80-MTbinding or indirectly by controlling the Rod-mediated inhibition of Ndc80.	[Amin, Mohammed A.; Varma, Dileep] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [McKenney, Richard J.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Northwestern University; Feinberg School of Medicine; University of California System; University of California Davis	Varma, D (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA.	dileep.varma@northwestern.edu			National Institutes of Health NCI Grant [R00CA178188]; National Institutes of Health NINDS Grant [R00NS089428]; National Institutes of Health NIGMS Grant [R35GM124889]; NATIONAL CANCER INSTITUTE [R00CA178188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS089428] Funding Source: NIH RePORTER	National Institutes of Health NCI Grant; National Institutes of Health NINDS Grant; National Institutes of Health NIGMS Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health NCI Grant R00CA178188 (to D.V.), NINDS Grant R00NS089428 (to R.J.M.), and NIGMS Grant R35GM124889 (to R.J.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Amin MA, 2015, FEBS LETT, V589, P2739, DOI 10.1016/j.febslet.2015.07.036; Barisic M, 2016, TRENDS CELL BIOL, V26, P766, DOI 10.1016/j.tcb.2016.06.001; Barisic M, 2015, CELL CYCLE, V14, P3356, DOI 10.1080/15384101.2015.1089369; Barisic M, 2014, NAT CELL BIOL, V16, P1249, DOI 10.1038/ncb3060; Barisic M, 2010, MOL BIOL CELL, V21, P1968, DOI 10.1091/mbc.E09-04-0356; Bennett A, 2015, ONCOTARGET, V6, P20921, DOI 10.18632/oncotarget.4879; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Caldas GV, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150160; Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167; Cheerambathur DK, 2013, SCIENCE, V342, P1239, DOI 10.1126/science.1246232; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cross RA, 2014, NAT REV MOL CELL BIO, V15, P257, DOI 10.1038/nrm3768; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kline-Smith SL, 2005, CURR OPIN CELL BIOL, V17, P35, DOI 10.1016/j.ceb.2004.12.009; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Li Y, 2007, CELL RES, V17, P701, DOI 10.1038/cr.2007.65; Maiato H, 2004, J CELL BIOL, V167, P831, DOI 10.1083/jcb.200407090; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Maiato H., 2017, BIOLOGY, V6, pE13; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McIntosh JR, 2012, Q REV BIOPHYS, V45, P147, DOI 10.1017/S0033583512000017; McKenney RJ, 2016, EMBO J, V35, P1175, DOI 10.15252/embj.201593071; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; MITCHISON T, 1986, CELL, V45, P515, DOI 10.1016/0092-8674(86)90283-7; Raaijmakers JA, 2013, J CELL BIOL, V201, P201, DOI 10.1083/jcb.201208098; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Silio V, 2015, DEV CELL, V35, P600, DOI 10.1016/j.devcel.2015.11.012; Simoes PA, 2018, J CELL SCI, V131, DOI 10.1242/jcs.212159; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Starr DA, 1997, J CELL BIOL, V138, P1289, DOI 10.1083/jcb.138.6.1289; Sundin LJR, 2011, MOL BIOL CELL, V22, P759, DOI 10.1091/mbc.E10-08-0671; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Umbreit NT, 2012, P NATL ACAD SCI USA, V109, P16113, DOI 10.1073/pnas.1209615109; Varma D, 2013, J CELL BIOL, V202, P735, DOI 10.1083/jcb.201304197; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Vorozhko VV, 2008, CHROMOSOMA, V117, P169, DOI 10.1007/s00412-007-0135-3; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Winey M, 2012, GENETICS, V190, P1197, DOI 10.1534/genetics.111.128710; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yamamoto TG, 2008, J CELL BIOL, V183, P187, DOI 10.1083/jcb.200805185; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056	60	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5755	5765		10.1074/jbc.RA117.001699	http://dx.doi.org/10.1074/jbc.RA117.001699			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29475948	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000430497300001
J	Karthik, IP; Desai, P; Sukumar, S; Dimitrijevic, A; Rajalingam, K; Mahalingam, S				Karthik, Isai Pratha; Desai, Pavitra; Sukumar, Sudarkodi; Dimitrijevic, Aleksandra; Rajalingam, Krishnaraj; Mahalingam, Sundarasamy			E4BP4/NFIL3 modulates the epigenetically repressed RAS effector RASSF8 function through histone methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTLY TARGETING RASSF8; TUMOR-SUPPRESSOR GENE; CELL LUNG-CANCER; DNA METHYLATION; TRANSCRIPTIONAL REPRESSION; SURVIVAL FACTOR; DOWN-REGULATION; KAPPA-B; PROMOTES; E4BP4	RAS proteins are major human oncogenes, and most of the studies are focused on enzymatic RAS effectors. Recently, nonenzymatic RAS effectors (RASSF, RAS association domain family) have garnered special attention because of their tumor-suppressive properties in contrast to the oncogenic potential of the classical enzymatic RAS effectors. Whereas most members of RASSF family are deregulated by promoter hypermethylation, RASSF8 promoter remains unmethylated in many cancers but the mechanism(s) of its down-regulation remains unknown. Here, we unveil E4BP4 as a critical transcriptional modulator repressing RASSF8 expression through histone methyltransferases, G9a and SUV39H1. In line with these observations, we noticed a negative correlation of RASSF8 and E4BP4 expression in primary breast tumor samples. In addition, our data provide evidence that E4BP4 attenuates RASSF8-mediated anti-proliferation and apoptosis, shedding mechanistic insights into RASSF8 down-regulation in breast cancers. Collectively, our study provides a better understanding on the epigenetic regulation of RASSF8 function and implicates the development of better treatment strategies.	[Karthik, Isai Pratha; Desai, Pavitra; Sukumar, Sudarkodi; Mahalingam, Sundarasamy] Indian Inst Technol Madras, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Natl Canc Tissue Biobank,Lab Mol Virol, Madras 600036, Tamil Nadu, India; [Dimitrijevic, Aleksandra; Rajalingam, Krishnaraj] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Forschungszentrum Immuntherapie, Inst Immunol,Mol Signaling Unit, D-55131 Mainz, Germany	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Johannes Gutenberg University of Mainz	Mahalingam, S (corresponding author), Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	mahalingam@iitm.ac.in			Department of Science and Technology, Government of India [VI-D&P/411/2012-2013/TDT (G)]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by Department of Science and Technology Grant VI-D&P/411/2012-2013/TDT (G), Government of India (to S.M.). The authors declare that they have no conflicts of interest with the contents of this article.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Chan Jia Jia, 2013, Advances in Biological Regulation, V53, P258, DOI [10.1016/j.jbior.2013.07.008, 10.1016/j.jbior.2012.12.001]; Chiba T, 2015, INT J CANCER, V136, P289, DOI 10.1002/ijc.28985; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; COWELL IG, 1994, NUCLEIC ACIDS RES, V22, P59, DOI 10.1093/nar/22.1.59; Datta D, 2015, J BIOL CHEM, V290, P21536, DOI 10.1074/jbc.M115.637280; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Deleris A, 2010, EMBO REP, V11, P950, DOI 10.1038/embor.2010.158; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Djos A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-40; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Falvella FS, 2006, ONCOGENE, V25, P3934, DOI 10.1038/sj.onc.1209422; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Gade P, 2012, METHODS MOL BIOL, V809, P85, DOI 10.1007/978-1-61779-376-9_6; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; He C, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0603-1; Hesson LB, 2005, ONCOGENE, V24, P3987, DOI 10.1038/sj.onc.1208566; Hesson LB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-42; Hua KT, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-189; Huang TH, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.65; Huang YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162378; Junghans D, 2004, DEVELOPMENT, V131, P4425, DOI 10.1242/dev.01313; Keniry M, 2013, GENE DEV, V27, P916, DOI 10.1101/gad.214049.113; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Kuribara R, 1999, MOL CELL BIOL, V19, P2754; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lock FE, 2010, ONCOGENE, V29, P4307, DOI 10.1038/onc.2010.192; MacFarlane M, 2000, J CELL BIOL, V148, P1239, DOI 10.1083/jcb.148.6.1239; MacGillavry HD, 2009, J NEUROSCI, V29, P15542, DOI 10.1523/JNEUROSCI.3938-09.2009; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Richter AM, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00021; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Shin G, 2011, CANCER INFORM, V10, P149, DOI 10.4137/CIN.S7226; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Spyropoulou A, 2014, NEUROMOL MED, V16, P70, DOI 10.1007/s12017-013-8254-x; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Tong X, 2013, J BIOL CHEM, V288, P5417, DOI 10.1074/jbc.M112.433482; Twiddy D, 2006, J BIOL CHEM, V281, P3876, DOI 10.1074/jbc.M507393200; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Volodko N, 2014, FEBS LETT, V588, P2671, DOI 10.1016/j.febslet.2014.02.041; Wan Q, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav019; Wang JH, 2015, ONCOTARGET, V6, P30165, DOI 10.18632/oncotarget.5030; Wang L, 2017, EUR REV MED PHARMACO, V21, P3223; Wang YF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00350-9; Watanabe K, 2015, CANCER MED-US, V4, P1573, DOI 10.1002/cam4.505; Wei L, 2017, J HEPATOL, V67, P758, DOI 10.1016/j.jhep.2017.05.015; Wei MC, 2000, GENE DEV, V14, P2060; Weng YJ, 2010, MOL CELL BIOCHEM, V340, P187, DOI 10.1007/s11010-010-0417-6; Zhang L, 2015, ONCOTARGET, V6, P34510, DOI 10.18632/oncotarget.5923	52	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5624	5635		10.1074/jbc.RA117.000623	http://dx.doi.org/10.1074/jbc.RA117.000623			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29467226	hybrid, Green Published			2022-12-26	WOS:000430044100023
J	Song, B; Hamdan, SM; Hingorani, MM				Song, Bo; Hamdan, Samir M.; Hingorani, Manju M.			Positioning the 5 '-flap junction in the active site controls the rate of flap endonuclease-1-catalyzed DNA cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFUSION-CONTROLLED REACTIONS; SUBSTRATE-SPECIFICITY; STRUCTURAL BASIS; FEN1; CATALYSIS; ENDONUCLEASES; RECOGNITION; SUPERFAMILY; EXONUCLEASE; COMPLEXES	Flap endonucleases catalyze cleavage of single-stranded DNA flaps formed during replication, repair, and recombination and are therefore essential for genome processing and stability. Recent crystal structures of DNA-bound human flap endonuclease (hFEN1) offer new insights into how conformational changes in the DNA and hFEN1 may facilitate the reaction mechanism. For example, previous biochemical studies of DNA conformation performed under non-catalytic conditions with Ca2+ have suggested that base unpairing at the 5'-flap: template junction is an important step in the reaction, but the new structural data suggest otherwise. To clarify the role of DNA changes in the kinetic mechanism, we measured a series of transient steps, from substrate binding to product release, during the hFEN1-catalyzed reaction in the presence of Mg2+. We found that whereas hFEN1 binds and bends DNA at a fast, diffusion-limited rate, much slower Mg2+-dependent conformational changes in DNA around the active site are subsequently necessary and rate-limiting for 5'-flap cleavage. These changes are reported overall by fluorescence of 2-aminopurine at the 5'-flap: template junction, indicating that local DNA distortion (e.g. disruption of base stacking observed in structures), associated with positioning the 5'-flap scissile phosphodiester bond in the hFEN1 active site, controls catalysis. hFEN1 residues with distinct roles in the catalytic mechanism, including those binding metal ions (Asp-34 and Asp-181), steering the 5'-flap through the active site and binding the scissile phosphate (Lys-93 and Arg-100), and stacking against the base 5' to the scissile phosphate (Tyr-40), all contribute to these rate-limiting conformational changes, ensuring efficient and specific cleavage of 5'-flaps.	[Song, Bo; Hingorani, Manju M.] Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA; [Hamdan, Samir M.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal 23955, Saudi Arabia	Wesleyan University; King Abdullah University of Science & Technology	Hingorani, MM (corresponding author), Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA.	mhingorani@wesleyan.edu		Hamdan, Samir/0000-0001-5192-1852	National Institutes of Health [R15 GM114743]; King Abdullah University of Science and Technology [CRG3]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM114743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R15 GM114743 (to M. M. H.) and a Competitive Research Award (CRG3) by King Abdullah University of Science and Technology (to S. M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBERTY RA, 1958, J PHYS CHEM-US, V62, P154, DOI 10.1021/j150560a005; Algasaier SI, 2016, J BIOL CHEM, V291, P8258, DOI 10.1074/jbc.M115.698993; Allawi HT, 2003, J MOL BIOL, V328, P537, DOI 10.1016/S0022-2836(03)00351-6; AlMalki FA, 2016, NAT STRUCT MOL BIOL, V23, P640, DOI 10.1038/nsmb.3241; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Craggs TD, 2014, NUCLEIC ACIDS RES, V42, P1857, DOI 10.1093/nar/gkt1116; Dehe PM, 2017, NAT REV MOL CELL BIO, V18, P315, DOI 10.1038/nrm.2016.177; Finger LD, 2013, NUCLEIC ACIDS RES, V41, P9839, DOI 10.1093/nar/gkt737; Finger L David, 2012, Subcell Biochem, V62, P301, DOI 10.1007/978-94-007-4572-8_16; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; Grasby JA, 2012, TRENDS BIOCHEM SCI, V37, P74, DOI 10.1016/j.tibs.2011.10.003; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Liu YJ, 2015, CELL REP, V13, P2565, DOI 10.1016/j.celrep.2015.11.042; Nowotny M, 2006, EMBO J, V25, P1924, DOI 10.1038/sj.emboj.7601076; Patel N, 2013, J BIOL CHEM, V288, P34239, DOI 10.1074/jbc.M113.509489; Patel N, 2012, NUCLEIC ACIDS RES, V40, P4507, DOI 10.1093/nar/gks051; Rashid F, 2017, ELIFE, V6, DOI 10.7554/eLife.21884; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Shi YQ, 2017, P NATL ACAD SCI USA, V114, P6010, DOI 10.1073/pnas.1704845114; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sobhy MA, 2013, CELL REP, V3, P1785, DOI 10.1016/j.celrep.2013.05.001; Stodola JL, 2016, NAT STRUCT MOL BIOL, V23, P402, DOI 10.1038/nsmb.3207; Tarantino ME, 2015, J BIOL CHEM, V290, P21154, DOI 10.1074/jbc.M115.666438; Tsutakawa SE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15855; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; van Pel DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003254; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zaher M. S., 2018, NUCL ACIDS IN PRESS; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884; ZHOU GQ, 1982, EUR J BIOCHEM, V128, P383	35	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4792	4804		10.1074/jbc.RA117.001137	http://dx.doi.org/10.1074/jbc.RA117.001137			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29462789	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000428848300020
J	Ambe, Y; Aoi, S; Nachstedt, T; Manoonpong, P; Worgotter, F; Matsuno, F				Ambe, Yuichi; Aoi, Shinya; Nachstedt, Timo; Manoonpong, Poramate; Woergoetter, Florentin; Matsuno, Fumitoshi			Simple analytical model reveals the functional role of embodied sensorimotor interaction in hexapod gaits	PLOS ONE			English	Article							INTER-LEG COORDINATION; SELF-ORGANIZING MODEL; QUADRUPEDAL GAITS; INSECT LOCOMOTION; WALKING PATTERNS; BEHAVIOR; ORGANIZATION; DYNAMICS; MOVEMENTS; INSIGHTS	Insects have various gaits with specific characteristics and can change their gaits smoothly in accordance with their speed. These gaits emerge from the embodied sensorimotor interactions that occur between the insect's neural control and body dynamic systems through sensory feedback. Sensory feedback plays a critical role in coordinated movements such as locomotion, particularly in stick insects. While many previously developed insect models can generate different insect gaits, the functional role of embodied sensorimotor interactions in the interlimb coordination of insects remains unclear because of their complexity. In this study, we propose a simple physical model that is amenable to mathematical analysis to explain the functional role of these interactions clearly. We focus on a foot contact sensory feedback called phase resetting, which regulates leg retraction timing based on touchdown information. First, we used a hexapod robot to determine whether the distributed decoupled oscillators used for legs with the sensory feedback generate insect-like gaits through embodied sensorimotor interactions. The robot generated two different gaits and one had similar characteristics to insect gaits. Next, we proposed the simple model as a minimal model that allowed us to analyze and explain the gait mechanism through the embodied sensorimotor interactions. The simple model consists of a rigid body with massless springs acting as legs, where the legs are controlled using oscillator phases with phase resetting, and the governed equations are reduced such that they can be explained using only the oscillator phases with some approximations. This simplicity leads to analytical solutions for the hexapod gaits via perturbation analysis, despite the complexity of the embodied sensorimotor interactions. This is the first study to provide an analytical model for insect gaits under these interaction conditions. Our results clarified how this specific foot contact sensory feedback contributes to generation of insect-like ipsilateral interlimb coordination during hexapod locomotion.	[Ambe, Yuichi] Tohoku Univ, Grad Sch Informat Sci, Dept Appl Informat Sci, Sendai, Miyagi, Japan; [Aoi, Shinya] Kyoto Univ, Grad Sch Engn, Dept Aeronaut & Astronaut, Kyoto, Japan; [Nachstedt, Timo; Woergoetter, Florentin] Georg August Univ Gottingen, Inst Phys 3, Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Manoonpong, Poramate] Univ Southern Denmark, Maersk Mc Kinney Moller Inst, Embodied Al & Neurorobot Lab, Ctr Biorobot, Odense M, Denmark; [Manoonpong, Poramate] Vidyasirimedhi Inst Sci & Technol, Sch Informat Sci & Technol, Bioinspired Robot & Neural Engn Lab, Rayong, Thailand; [Matsuno, Fumitoshi] Kyoto Univ, Grad Sch Engn, Dept Mech Engn & Sci, Kyoto, Japan	Tohoku University; Kyoto University; University of Gottingen; University of Southern Denmark; Vidyasirimedhi Institute of Science & Technology; Kyoto University	Ambe, Y (corresponding author), Tohoku Univ, Grad Sch Informat Sci, Dept Appl Informat Sci, Sendai, Miyagi, Japan.	ambe@rm.is.tohoku.ac.jp	Manoonpong, Poramate/Y-8479-2018	Manoonpong, Poramate/0000-0002-4806-7576; Ambe, Yuichi/0000-0003-4725-5513; Matsuno, Fumitoshi/0000-0001-9685-3267	JSPS Institutional Program for Young Researcher Overseas Visits; JSPS [17H04914]; Bernstein Center for Computational Neuroscience II Goettingen (BCCN) [01GQ1005A]; Human Frontier Science Program [RGP0002/2017]; Centre for BioRobotics (CBR) at University of Southern Denmark (SDU, Denmark); HeKKSaGOn network	JSPS Institutional Program for Young Researcher Overseas Visits(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bernstein Center for Computational Neuroscience II Goettingen (BCCN); Human Frontier Science Program(Human Frontier Science Program); Centre for BioRobotics (CBR) at University of Southern Denmark (SDU, Denmark); HeKKSaGOn network	YA is supported by the JSPS Institutional Program for Young Researcher Overseas Visits, http://www.jsps.go.jp/english/e-daikokai/. SA is supported by the JSPS Grant-in-Aid for Young Scientists (A) (grant no. 17H04914), https://www.jsps.go.jp/english/e-grants/. PM and FW are supported by the Bernstein Center for Computational Neuroscience II Goettingen (BCCN grant 01GQ1005A, project D1), http://www.bccn-goettingen.de/. PM is supported by the Human Frontier Science Program (grant no. RGP0002/2017), http://www.hfsp.org/funding and the Centre for BioRobotics (CBR) at University of Southern Denmark (SDU, Denmark), https://www.sdu.dk/en/om_sdu/institutter_centre/mmmi_maersk_mckinney_moeller/forskning/forskningsprojekter. FW and FM are supported by the HeKKSaGOn network, http://www.hekksagon.net/61.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partly supported by the JSPS Institutional Program for Young Researcher Overseas Visits, the HeKKSaGOn network, the JSPS Grant-in-Aid for Young Scientists (A) (grant no. 17H04914), the Bernstein Center for Computational Neuroscience II Goettingen (BCCN grant no. 01GQ1005A, project D1), the Centre for BioRobotics (CBR) at University of Southern Denmark (SDU, Denmark) and the Human Frontier Science Program (grant no. RGP0002/2017).	Akay T, 2004, J NEUROPHYSIOL, V92, P42, DOI 10.1152/jn.01271.2003; Akimoto K., 1999, Artificial Life and Robotics, V3, P102, DOI 10.1007/BF02481255; ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; Alexander RM, 2006, PRINCIPLES ANIMAL LO; Aoi S, 2017, FRONT NEUROROBOTICS, V11, DOI 10.3389/fnbot.2017.00039; Aoi S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0908; Aoi S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061909; Aoi S, 2008, ADV ROBOTICS, V22, P1697, DOI 10.1163/156855308X3689785; Arena P, 2004, IEEE T SYST MAN CY B, V34, P1823, DOI 10.1109/TSMCB.2004.828593; Bender JA, 2011, J EXP BIOL, V214, P2057, DOI 10.1242/jeb.056481; Borgmann A, 2011, BIOL CYBERN, V105, P399, DOI 10.1007/s00422-012-0473-y; Borgmann A, 2009, J NEUROSCI, V29, P2972, DOI 10.1523/JNEUROSCI.3155-08.2009; Buschges A, 2008, BRAIN RES REV, V57, P162, DOI 10.1016/j.brainresrev.2007.06.028; BUSCHGES A, 1995, J EXP BIOL, V198, P435; Buschges A, 2005, J NEUROPHYSIOL, V93, P1127, DOI 10.1152/jn.00615.2004; BUSCHGES A, 1995, J NEUROBIOL, V27, P488, DOI 10.1002/neu.480270405; Buschmann T, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/4/041001; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; CRUSE H, 1990, TRENDS NEUROSCI, V13, P15, DOI 10.1016/0166-2236(90)90057-H; CRUSE H, 1982, J EXP BIOL, V101, P161; Cruse H, 1998, NEURAL NETWORKS, V11, P1435, DOI 10.1016/S0893-6080(98)00067-7; Cruse H, 2007, PHILOS T R SOC A, V365, P221, DOI 10.1098/rsta.2006.1913; Daun-Gruhn S, 2011, J COMPUT NEUROSCI, V30, P255, DOI 10.1007/s10827-010-0254-3; Daun-Gruhn S, 2011, BIOL CYBERN, V105, P71, DOI 10.1007/s00422-011-0446-6; Delcomyn F, 2004, ANNU REV ENTOMOL, V49, P51, DOI 10.1146/annurev.ento.49.061802.123257; DELCOMYN F, 1971, J EXP BIOL, V54, P443; DIEDRICH FJ, 1995, J EXP PSYCHOL HUMAN, V21, P183, DOI 10.1037/0096-1523.21.1.183; Durr V, 2005, J EXP BIOL, V208, P2253, DOI 10.1242/jeb.01638; Durr V, 2004, ARTHROPOD STRUCT DEV, V33, P237, DOI 10.1016/j.asd.2004.05.004; Ekeberg O, 2004, ARTHROPOD STRUCT DEV, V33, P287, DOI 10.1016/j.asd.2004.05.002; Fujiki S, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012717; Fukuoka Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08169; Full RJ, 1999, J EXP BIOL, V202, P3325; Full RJ., 1997, HDB COMP PHYSL; Grabowska M, 2012, J EXP BIOL, V215, P4255, DOI 10.1242/jeb.073643; GRAHAM D, 1985, J EXP BIOL, V118, P287; GRAHAM D, 1972, J COMP PHYSIOL, V81, P23, DOI 10.1007/BF00693548; Holmes P, 2006, SIAM REV, V48, P207, DOI 10.1137/S0036144504445133; HUGHES GM, 1952, J EXP BIOL, V29, P267; Ijspeert AJ, 2014, SCIENCE, V346, P196, DOI 10.1126/science.1254486; JAYES AS, 1978, J ZOOL, V185, P289, DOI 10.1111/j.1469-7998.1978.tb03334.x; KIMURA S, 1993, BIOL CYBERN, V69, P183, DOI 10.1007/BF00198958; KIMURA S, 1994, BIOL CYBERN, V70, P505, DOI 10.1007/BF00198803; Kindermann T, 2001, ADAPT BEHAV, V9, P16, DOI 10.1177/105971230200900103; Kukillaya RP, 2007, BIOL CYBERN, V97, P379, DOI 10.1007/s00422-007-0180-2; Manoonpong P, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00012; Martius G., SOFTWARE LPZROBOTS; Owaki D, 2017, FRONT NEUROROBOTICS, V11, DOI 10.3389/fnbot.2017.00029; Owaki D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00348-9; Owaki D, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0669; Pearson K, 2006, TRENDS NEUROSCI, V29, P625, DOI 10.1016/j.tins.2006.08.007; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Rutter BL, 2007, IEEE INT CONF ROBOT, P630, DOI 10.1109/ROBOT.2007.363057; Schilling M, 2013, BIOL CYBERN, V107, P397, DOI 10.1007/s00422-013-0563-5; Schneider A, 2005, IEEE T SYST MAN CY B, V35, P1120, DOI 10.1109/TSMCB.2005.850147; SCHONER G, 1990, J THEOR BIOL, V142, P359, DOI 10.1016/S0022-5193(05)80558-2; Seipel JE, 2004, BIOL CYBERN, V91, P76, DOI 10.1007/s00422-004-0498-y; Steingrube S, 2010, NAT PHYS, V6, P224, DOI 10.1038/NPHYS1508; Szczecinski NS, 2014, BIOL CYBERN, V108, P1, DOI 10.1007/s00422-013-0573-3; Toth TI, 2016, J NEUROPHYSIOL, V115, P887, DOI 10.1152/jn.00693.2015; WILSON DM, 1966, ANNU REV ENTOMOL, V11, P103, DOI 10.1146/annurev.en.11.010166.000535; Wosnitza A, 2013, J EXP BIOL, V216, P480, DOI 10.1242/jeb.078139; XIONG XH, 2016, SYSTEMS MAN CYBERN A, V12, P1195, DOI DOI 10.1142/S1793042116500731; Xiong XF, 2014, ROBOT AUTON SYST, V62, P1777, DOI 10.1016/j.robot.2014.07.008; Zill SN, 2015, ARTHROPOD STRUCT DEV, V44, P541, DOI 10.1016/j.asd.2015.07.001; Zill SN, 2012, J NEUROPHYSIOL, V108, P1453, DOI 10.1152/jn.00274.2012	66	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192469	10.1371/journal.pone.0192469	http://dx.doi.org/10.1371/journal.pone.0192469			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489831	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000028
J	Bartonkova, I; Kallay, E; Dvorak, Z				Bartonkova, Iveta; Kallay, Enikoe; Dvorak, Zdenek			Effects of human interleukins in the transgenic gene reporter cell lines IZ-VDRE and IZ-CYP24 designed to assess the transcriptional activity of vitamin D receptor	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; PREGNANE-X-RECEPTOR; ANDROGEN RECEPTOR; GLUCOCORTICOID RESISTANCE; D METABOLISM; EXPRESSION; ACTIVATION; DEPRESSION; RELEVANCE; CYTOKINES	The role of vitamin D receptor (VDR) in immune responses has been broadly studied and it has been shown that activated VDR alters the levels of some interleukins (ILs). In this study, we studied the opposite, i.e. whether 13 selected pro-inflammatory and anti-inflammatory ILs influence the transcriptional activity of human VDR. The experimental models of choice were two human stably transfected gene reporter cell lines IZ-VDRE and IZ-CYP24, which were designed to evaluate the transcriptional activity of VDR. The gene reporter assays revealed inhibition of calcitriol-induced luciferase activity by IL-4 and IL-13, when 1 ng/mL of these two compounds decreased the effect of calcitriol down to 60% of the control value. Consistently, calcitriol-induced expression of CYP24A1 mRNA was also significantly decreased by IL-4 and IL-13. The expression of VDR and CYP27B1 mRNAs was not influenced by any of the 13 tested ILs. These data suggest possible cross-talk between the VDR signalling pathway and IL-4- and IL-13-mediated cell signalling.	[Bartonkova, Iveta; Dvorak, Zdenek] Palacky Univ, Fac Sci, Dept Cell Biol & Genet, Olomouc, Czech Republic; [Kallay, Enikoe] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria	Palacky University Olomouc; Medical University of Vienna	Dvorak, Z (corresponding author), Palacky Univ, Fac Sci, Dept Cell Biol & Genet, Olomouc, Czech Republic.	moulin@email.cz		Kallay, Eniko/0000-0002-4996-0104	Czech Science Foundation GACR [P303/12/G163]; Palacky University [PrF-2017-004, PrF-2018-005]; Operational Programme Research, Development and Education Regional Development Fund of the Ministry of Education, Youth and Sports of the Czech Republic [CZ.02.1.01/0.0/0.0/16_019/0000754]	Czech Science Foundation GACR(Grant Agency of the Czech Republic); Palacky University; Operational Programme Research, Development and Education Regional Development Fund of the Ministry of Education, Youth and Sports of the Czech Republic	Our laboratory is supported by a grant from the Czech Science Foundation GACR P303/12/G163, by the student grants from Palacky University (Grant no. PrF-2017-004 and No. PrF-2018-005) and by the Operational Programme Research, Development and Education Regional Development Fund, project no. CZ.02.1.01/0.0/0.0/16_019/0000754 of the Ministry of Education, Youth and Sports of the Czech Republic (all received by Zdenek Dvorak).	AXEN E, 1995, BIOCHEM BIOPH RES CO, V215, P136, DOI 10.1006/bbrc.1995.2443; Bartonkova I, 2016, CHEM RES TOXICOL, V29, P1211, DOI 10.1021/acs.chemrestox.6b00170; BHALLA AK, 1986, CELL IMMUNOL, V98, P311, DOI 10.1016/0008-8749(86)90291-1; Biola A, 2001, MOL ENDOCRINOL, V15, P1062, DOI 10.1210/me.15.7.1062; Cross HS, 2011, MOL CELL ENDOCRINOL, V347, P70, DOI 10.1016/j.mce.2011.07.022; Hii CS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030135; Hobisch A, 1998, CANCER RES, V58, P4640; Hummel DM, 2014, J STEROID BIOCHEM, V144, P91, DOI 10.1016/j.jsbmb.2013.09.017; Kallay E, 2005, CARCINOGENESIS, V26, P1581, DOI 10.1093/carcin/bgi124; Lin DL, 2001, CLIN CANCER RES, V7, P1773; Marcotorchino J, 2012, MOL NUTR FOOD RES, V56, P1771, DOI 10.1002/mnfr.201200383; Miller AH, 1999, ADV EXP MED BIOL, V461, P107; Pace TWW, 2007, BRAIN BEHAV IMMUN, V21, P9, DOI 10.1016/j.bbi.2006.08.009; Pascussi JM, 2008, ANNU REV PHARMACOL, V48, P1, DOI 10.1146/annurev.pharmtox.47.120505.105349; Pascussi JM, 2005, J CLIN INVEST, V115, P177, DOI 10.1172/JCI200521867; Pascussi JM, 2000, BIOCHEM BIOPH RES CO, V274, P707, DOI 10.1006/bbrc.2000.3219; Rostkowska-Nadolska B, 2010, ADV MED SCI-POLAND, V55, P86, DOI 10.2478/v10039-010-0012-9; Schrumpf JA, 2012, INFECT IMMUN, V80, P4485, DOI 10.1128/IAI.06224-11; TSOUKAS CD, 1984, SCIENCE, V224, P1438, DOI 10.1126/science.6427926; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; Wobke TK, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00244; Yang L, 2003, BIOCHEM BIOPH RES CO, V305, P462, DOI 10.1016/S0006-291X(03)00792-7	22	1	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193655	10.1371/journal.pone.0193655	http://dx.doi.org/10.1371/journal.pone.0193655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489902	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000099
J	Cunha, CCDB; Gama, AR; Cintra, LC; Bataus, LAM; Ulhoa, CJ				de Queiroz Brito Cunha, Carolina Candida; Gama, Aline Rodrigues; Cintra, Lorena Cardoso; Mendes Bataus, Luiz Artur; Ulhoa, Cirano Jose			Improvement of bread making quality by supplementation with a recombinant xylanase produced by Pichia pastoris	PLOS ONE			English	Article							MICROBIAL XYLANASES; PROTEIN EXPRESSION; ENDOXYLANASES; PERSPECTIVES; PURIFICATION; FAMILIES; ENZYMES; IMPACT; FOOD	Xylanases (EC 3.2.1.8) are hydrolytic enzymes, which randomly cleave the beta-1,4-linked xylose residues from xylan. The synthetic gene xynBS27 from Streptomyces sp. S27 was successfully cloned and expressed in Pichia pastoris. The full-length gene consists of 729 bp and encodes 243 amino acids including 51 residues of a putative signal peptide. This enzyme was purified in two steps and was shown to have a molecular weight of 20 kDa. The purified r-XynBS27 was active against beechwood xylan and oat spelt xylan as expected for GH 11 family. The optimum pH and temperature values for the enzyme were 6.0 and 75 degrees C, respectively. The Km and Vmax were 12.38 mg/mL and 13.68 mu mol min/mg, respectively. The r-XynBS27 showed high xylose tolerance and was inhibited by some metal ions and by SDS. r-XynBS27 was employed as an additive in the bread making process. A decrease in firmness, stiffness and consistency, and improvements in specific volume and reducing sugar content were recorded.	[de Queiroz Brito Cunha, Carolina Candida; Gama, Aline Rodrigues; Cintra, Lorena Cardoso; Mendes Bataus, Luiz Artur; Ulhoa, Cirano Jose] Univ Fed Goias, Campus Samambaia, Goiania, Go, Brazil; [Cintra, Lorena Cardoso; Ulhoa, Cirano Jose] Univ Brasilia, Campus Darcy Ribeiro, Brasilia, DF, Brazil	Universidade Federal de Goias; Universidade de Brasilia	Ulhoa, CJ (corresponding author), Univ Fed Goias, Campus Samambaia, Goiania, Go, Brazil.; Ulhoa, CJ (corresponding author), Univ Brasilia, Campus Darcy Ribeiro, Brasilia, DF, Brazil.	ulhoa@ufg.br	Cintra, Lorena/AAF-3468-2020; Ulhoa, CIRANO/AAV-9374-2020	Cardoso Cintra, Lorena/0000-0002-6348-9005; Ulhoa, Cirano/0000-0002-4171-6465	Research Foundation of the State of Goias (FAPEG, GO, Brazil); National Council for Scientific and Technological Development (CNPq, Brazil) [407804/2013-7]; National Council for Scientific and Technological Development (CNPq, Brazil)	Research Foundation of the State of Goias (FAPEG, GO, Brazil); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work of CCQBC, ARG and LCC was funded by Research Foundation of the State of Goias (FAPEG, GO, Brazil) and National Council for Scientific and Technological Development (CNPq, Brazil; grant 407804/2013-7 to CJU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work of CCQBC, ARG and LCC was funded by Research Foundation of the State of Goias (FAPEG, GO, Brazil) and National Council for Scientific and Technological Development (CNPq, Brazil). The authors wish to thank Dr. Robert Pogue for the English revision of the text and for fruitful discussions.	Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; BASTAWDE KB, 1992, WORLD J MICROB BIOT, V8, P353, DOI 10.1007/BF01198746; Beaugrand J, 2004, CARBOHYD RES, V339, P2529, DOI 10.1016/j.carres.2004.08.012; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bull AT, 2005, ANTON LEEUW INT J G, V87, P65, DOI 10.1007/s10482-004-6562-8; Butt MS, 2008, FOOD TECHNOL BIOTECH, V46, P22; Celik E, 2012, BIOTECHNOL ADV, V30, P1108, DOI 10.1016/j.biotechadv.2011.09.011; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Chakdar H., 2016, BIO-TECHNOL, V3, P6; Choi JH, 2006, J MICROBIOL BIOTECHN, V16, P57; Cintra LC, 2017, INT J BIOL MACROMOL; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Courtin CM, 2001, J CEREAL SCI, V33, P301, DOI 10.1006/jcrs.2000.0354; Brito-Cunha CCD, 2013, APPL BIOCHEM BIOTECH, V170, P598, DOI 10.1007/s12010-013-0193-3; Deesukon W, 2013, MOL BIOTECHNOL, V54, P37, DOI 10.1007/s12033-012-9541-8; Ergun BG, 2016, BIOPROC BIOSYST ENG, V39, P1, DOI 10.1007/s00449-015-1476-6; Gokmen V, 2008, EUR FOOD RES TECHNOL, V226, P1031, DOI 10.1007/s00217-007-0628-6; Goesaert H, 2005, TRENDS FOOD SCI TECH, V16, P12, DOI 10.1016/j.tifs.2004.02.011; Juturu V, 2012, BIOTECHNOL ADV, V30, P1219, DOI 10.1016/j.biotechadv.2011.11.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li N, 2009, APPL BIOCHEM BIOTECH, V159, P521, DOI 10.1007/s12010-008-8411-0; Luo L, 2016, J CHEM TECHNOL BIOT, V91, P1093, DOI 10.1002/jctb.4690; Mander P, 2014, PROCESS BIOCHEM, V49, P451, DOI 10.1016/j.procbio.2013.12.011; MartinezAnaya MA, 1997, Z LEBENSM UNTERS F A, V205, P209, DOI 10.1007/s002170050152; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Ning L, 2008, J MICROBIOL BIOTECHN, V18, P410; Paes G, 2012, BIOTECHNOL ADV, V30, P564, DOI 10.1016/j.biotechadv.2011.10.003; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Poutanen K, 1997, TRENDS FOOD SCI TECH, V8, P300, DOI 10.1016/S0924-2244(97)01063-7; Pradeep GC, 2013, PROCESS BIOCHEM, V48, P1188, DOI 10.1016/j.procbio.2013.06.007; Puls J, 1997, MACROMOL SYMP, V120, P183, DOI 10.1002/masy.19971200119; Qiu ZH, 2010, ENZYME MICROB TECH, V46, P506, DOI 10.1016/j.enzmictec.2010.02.003; Spohner SC, 2015, J BIOTECHNOL, V202, P118, DOI 10.1016/j.jbiotec.2015.01.027; Wanderley MSO, 2013, CHEM PAP, V67, P682, DOI 10.2478/s11696-013-0363-3; Xu B, 2016, J MICROBIOL BIOTECHN, V26, P9, DOI 10.4014/jmb.1504.04021; Xu Y, 2016, J IND MICROBIOL BIOT, V43, P663, DOI 10.1007/s10295-016-1736-8; Yan QJ, 2009, J MOL CATAL B-ENZYM, V58, P72, DOI 10.1016/j.molcatb.2008.11.010; Yegin S, 2017, FOOD CHEM, V221, P67, DOI 10.1016/j.foodchem.2016.10.003	39	16	18	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0192996	10.1371/journal.pone.0192996	http://dx.doi.org/10.1371/journal.pone.0192996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481569	Green Published, Green Submitted, gold			2022-12-26	WOS:000426202700007
J	Figueiredo, LA; Reboucas, TF; Ferreira, SR; Rodrigues-Luiz, GF; Miranda, RC; Araujo, RN; Fujiwara, RT				Figueiredo, Luiza Almeida; Reboucas, Thais Fuscaldi; Ferreira, Sebastiao Rodrigo; Rodrigues-Luiz, Gabriela Flavia; Miranda, Rodrigo Cambraia; Araujo, Ricardo Nascimento; Fujiwara, Ricardo Toshio			Dominance of P-glycoprotein 12 in phenotypic resistance conversion against ivermectin in Caenorhabditis elegans	PLOS ONE			English	Article							ONCHOCERCIASIS-ENDEMIC FOCI; MULTIDRUG-RESISTANCE; MULTIPLE TREATMENTS; HAEMONCHUS; GENE; ANTHELMINTICS; EXPRESSION; SUSCEPTIBILITY; INFECTIONS; NEMATODES	While diseases caused by nematodes remains a considerable drawback for the livestock, agriculture and public health, anthelmintics drug resistance has been observed over the past years and is a major concern for parasite control. Ivermectin, initially considered as a highly potent drug, currently presents a reduced anti-helminthic efficacy, which is influenced by expression of several ATP-binding cassette transporters (ABC), among them the P-glycoproteins (Pgps). Here we present some evidences of Pgps dominance during Ivermectin resistance/susceptibility using Pgps double silencing in C. elegans and the phylogenetic relationship of Pgps among nematodes, which strengthen the use of this model for study of drug resistance in nematodes. Firstly, we evaluated the quantitative gene expression of 12 out the 15 known Pgps from resistant and WT strains of C. elegans, we demonstrated the upregulation of Pgps 12 and 13 and downregulation of all remaining Pgps in ivermectin resistant strain. By using an RNAi loss-of-function approach we observed that Pgp 12 gene silencing reverts the resistance phenotype to ivermectin, while Pgp 4 gene silencing does not alter the resistance phenotype but induces a resistance in wild type strain. Interestingly, the dual silencing of Pgp 12 and Pgp 4 expression demonstrates the dominance of phenotype promoted by Pgp 12 silencing. Finally, in silico analysis reveals a close relationship between Pgps from C. elegans and several nematodes parasites. Taken together, our results indicate that Pgp 12 is crucial for the resistance to ivermectin and thus a good candidate for further studies aiming to develop specific inhibitors to this transporter, allowing the continuous use of ivermectin to control the burden on animal and human health inflicted by nematode parasites globally.	[Figueiredo, Luiza Almeida; Reboucas, Thais Fuscaldi; Ferreira, Sebastiao Rodrigo; Rodrigues-Luiz, Gabriela Flavia; Araujo, Ricardo Nascimento; Fujiwara, Ricardo Toshio] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil; [Miranda, Rodrigo Cambraia] Univ Estadual Vale Acarau, Ctr Agr & Biol Sci, Sobral, Ceara, Brazil	Universidade Federal de Minas Gerais; Universidade Estadual Vale do Acarau	Fujiwara, RT (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil.	fujiwara@icb.ufmg.br	Rodrigues-Luiz, Gabriela Flavia/AAE-4937-2020; Araujo, Ricardo N/O-1967-2017; Cambraia-de-Miranda, Rodrigo Rodrigues/ABG-6704-2021; Ferreira, Sebastiao Rodrigo/AAU-5852-2020; Fujiwara, Ricardo Toshio/J-7579-2012	Rodrigues-Luiz, Gabriela Flavia/0000-0003-3838-1008; Araujo, Ricardo N/0000-0002-1272-4386; Cambraia-de-Miranda, Rodrigo Rodrigues/0000-0003-2039-9656; Ferreira, Sebastiao Rodrigo/0000-0002-1531-4980; Fujiwara, Ricardo Toshio/0000-0002-4713-575X	FAPEMIG; CAPES	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	LAF received a Master Degree Fellowship from FAPEMIG. TFR received fellowships from CAPES and FAPEMIG. RTF is a Research Fellow from CNPq (Bolsa de Produtividade em Pesquisa).	Amarante AFT, 2004, VET PARASITOL, V120, P91, DOI 10.1016/j.vetpar.2003.12.004; Ardelli BF, 2013, VET PARASITOL, V191, P264, DOI 10.1016/j.vetpar.2012.09.021; Areskog M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-13; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P231, DOI 10.1179/000349804225003253; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P359, DOI 10.1179/000349804225003442; Bartley DJ, 2009, PARASITOLOGY, V136, P1081, DOI 10.1017/S0031182009990345; Blackhall WJ, 1998, MOL BIOCHEM PARASIT, V95, P193, DOI 10.1016/S0166-6851(98)00087-5; Bourguinat C, 2011, VET PARASITOL, V176, P374, DOI 10.1016/j.vetpar.2011.01.024; BRENNER S, 1974, GENETICS, V77, P71; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; De Graef J, 2013, PARASITOLOGY, V140, P499, DOI 10.1017/S0031182012001849; Dicker AJ, 2011, INT J PARASITOL, V41, P935, DOI 10.1016/j.ijpara.2011.03.015; Ferreira SR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/879263; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Geary TG, 2005, TRENDS PARASITOL, V21, P530, DOI 10.1016/j.pt.2005.08.014; Holsback L, 2015, SEMIN-CIENC AGRAR, V36, P2031, DOI 10.5433/1679-0359.2015v36n3Supl1p2031; Hunt PR, 2012, FOOD CHEM TOXICOL, V50, P3280, DOI 10.1016/j.fct.2012.06.051; James CE, 2007, PARASITOL RES, V101, P975, DOI 10.1007/s00436-007-0572-1; James CE, 2009, INT J PARASITOL, V39, P213, DOI 10.1016/j.ijpara.2008.06.009; Janssen IJI, 2013, EXP PARASITOL, V134, P171, DOI 10.1016/j.exppara.2013.03.005; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Kerboeuf D, 2003, PARASITOL RES, V91, P79, DOI 10.1007/s00436-003-0942-2; Lespine A, 2012, INT J PARASITOL-DRUG, V2, P58, DOI 10.1016/j.ijpddr.2011.10.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moncayo AL, 2006, INT J BIOCHEM CELL B, V38, P1031, DOI 10.1016/j.biocel.2005.11.003; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Osei-Atweneboana MY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000998; Park IK, 2007, J NEMATOL, V39, P275; Pulaski CN, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0494-6; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; SIMPKIN KG, 1981, J CHEM TECHNOL BIOT, V31, P66, DOI 10.1002/jctb.280310110; Stiernagle T., 2006, MAINTENANCE C ELEGAN; Stiernagle T., 2005, WORMBOOK ONLINE REV; Tamura K, 2002, MOL BIOL EVOL, V19, P1727, DOI 10.1093/oxfordjournals.molbev.a003995; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Xu M, 1998, MOL BIOCHEM PARASIT, V91, P327, DOI 10.1016/S0166-6851(97)00215-6; Yan RF, 2012, VET PARASITOL, V190, P519, DOI 10.1016/j.vetpar.2012.06.038	40	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192995	10.1371/journal.pone.0192995	http://dx.doi.org/10.1371/journal.pone.0192995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474375	gold, Green Published, Green Submitted			2022-12-26	WOS:000426049500051
J	Rabold, D; Espelage, W; Abu Sine, M; Eckmanns, T; Schneebereg, A; Neubauer, H; Mobius, N; Hille, K; Wieler, LH; Seyboldt, C; Lubke-Becker, A				Rabold, Denise; Espelage, Werner; Abu Sine, Muna; Eckmanns, Tim; Schneebereg, Alexander; Neubauer, Heinrich; Moebius, Nadine; Hille, Katja; Wieler, Lothar H.; Seyboldt, Christian; Luebke-Becker, Antina			The zoonotic potential of Clostridium difficile from small companion animals and their owners	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; CHANGING EPIDEMIOLOGY; PCR RIBOTYPES; PREVALENCE; INFECTION; DOGS; RISK; COLONIZATION; DIARRHEA; CALVES	Background Clostridium difficile infections (CDI) in humans range from asymptomatic carriage to life threatening intestinal disease. Findings on C. difficile in various animal species and an overlap in ribotypes (RTs) suggest potential zoonotic transmission. However, the impact of animals for human CDI remains unclear. Methods In a large-scale survey we collected 1,447 fecal samples to determine the occurrence of C. difficile in small companion animals (dogs and cats) and their owners and to assess potential epidemiological links within the community. The Germany-wide survey was conducted from July 2012-August 2013. PCR ribotyping, Multilocus VNTR Analysis (MLVA) and PCR detection of toxin genes were used to characterize isolated C. difficile strains. A database was defined and logistic regression used to identify putative factors associated with fecal shedding of C. difficile. Results In total, 1,418 samples met the inclusion criteria. The isolation rates for small companion animals and their owners within the community were similarly low with 3.0% (25/840) and 2.9% (17/578), respectively. PCR ribotyping revealed eight and twelve different RTs in animals and humans, respectively, whereas three RTs were isolated in both, humans and animals. RT 014/0, a well-known human hospital-associated lineage, was predominantly detected in animal samples. Moreover, the potentially highly pathogenic RTs 027 and 078 were isolated from dogs. Even though, C. difficile did not occur simultaneously in animals and humans sharing the same household. The results of the epidemiological analysis of factors associated with fecal shedding of C. difficile support the hypothesis of a zoonotic potential. Conclusions Molecular characterization and epidemiological analysis revealed that the zoonotic risk for C. difficile associated with dogs and cats within the community is low but cannot be excluded.	[Rabold, Denise; Wieler, Lothar H.; Luebke-Becker, Antina] Free Univ Berlin, Inst Microbiol & Epizoot, Dept Vet Med, Berlin, Germany; [Espelage, Werner; Abu Sine, Muna; Eckmanns, Tim; Wieler, Lothar H.] Robert Koch Inst, Berlin, Germany; [Schneebereg, Alexander; Neubauer, Heinrich; Seyboldt, Christian] Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Fed Res Inst Anim Hlth, Jena, Germany; [Moebius, Nadine; Hille, Katja] Univ Vet Med Hannover, Dept Biometry Epidemiol & Informat Proc, Fdn, Hannover, Germany; [Schneebereg, Alexander] Landestierarztekammer Thuringen, Erfurt, Germany	Free University of Berlin; Robert Koch Institute; Friedrich Loeffler Institute; University of Veterinary Medicine Hannover, Foundation	Rabold, D (corresponding author), Free Univ Berlin, Inst Microbiol & Epizoot, Dept Vet Med, Berlin, Germany.	Denise.Rabold@fu-berlin.de		Wieler, Lothar H./0000-0003-4365-3717; Hille, Katja/0000-0001-9483-1435	Bundesministerium fur Bildung and Forschung [01KI1107, 01KI1108]; Friedrich Naumann Stiftung; Federal Ministry of Education and Research [01KI1107, 01KI1108]; Friedrich Naumann Foundation for Freedom, Potsdam, NY	Bundesministerium fur Bildung and Forschung(Federal Ministry of Education & Research (BMBF)); Friedrich Naumann Stiftung; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Friedrich Naumann Foundation for Freedom, Potsdam, NY	This work was supported by the Bundesministerium fur Bildung and Forschung - 01KI1107 (Mrs Denise Rabold)/01KI1108 (FLI, Jena) (https://www.bmbf.de/) and the Friedrich Naumann Stiftung (Mr Alexander Schneeberg) (https://www.freiheit.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This survey was funded by the Federal Ministry of Education and Research [No. "Clostridium difficile", 01KI1107 (Mrs. Denise Rabold, IMT)/01KI1108 (FLI, Jena)]. Alexander Schneeberg was funded by the Friedrich Naumann Foundation for Freedom, Potsdam, NY.	Alvarez-Perez S, 2015, J SMALL ANIM PRACT, V56, P190, DOI 10.1111/jsap.12311; Arroyo LG, 2005, J MED MICROBIOL, V54, P163, DOI 10.1099/jmm.0.45805-0; Bakker D, 2010, J CLIN MICROBIOL, V48, P3744, DOI 10.1128/JCM.01171-10; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Chen YJC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006408; Debast SB, 2009, ENVIRON MICROBIOL, V11, P505, DOI 10.1111/j.1462-2920.2008.01790.x; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Freeman J, 1999, MICROBES INFECT, V1, P377, DOI 10.1016/S1286-4579(99)80054-9; Galdys AL, 2014, EXPERT REV ANTI-INFE, V12, P967, DOI 10.1586/14787210.2014.920252; Hensgens MPM, 2012, CLIN MICROBIOL INFEC, V18, P635, DOI 10.1111/j.1469-0691.2012.03853.x; Janezic S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-48; Janezic S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-173; Keel K, 2007, J CLIN MICROBIOL, V45, P1963, DOI 10.1128/JCM.00224-07; Keessen EC, 2011, VET MICROBIOL, V153, P205, DOI 10.1016/j.vetmic.2011.03.020; Kern WV, 2010, WAS GIBT NEUES NEUEN; Knetsch C, 2014, EURO SURVEILL, V19; Knight DR, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02138; Koene MGJ, 2012, CLIN MICROBIOL INFEC, V18, P778, DOI 10.1111/j.1469-0691.2011.03651.x; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; Lefebvre SL, 2009, J HOSP INFECT, V72, P268, DOI 10.1016/j.jhin.2009.02.019; Lefebvre SL, 2006, EMERG INFECT DIS, V12, P1036, DOI 10.3201/eid1206.060115; Lefebvre SL, 2006, J HOSP INFECT, V62, P458, DOI 10.1016/j.jhin.2005.09.025; Loo VG, 2016, INFECT CONT HOSP EP, P1; Lowe DO, 2006, CLIN INFECT DIS, V43, P1272, DOI 10.1086/508453; Rodriguez-Palacios A, 2007, EMERG INFECT DIS, V13, P485, DOI 10.3201/eid1303.060988; Schneeberg A, 2013, J CLIN MICROBIOL, V51, P3796, DOI 10.1128/JCM.01440-13; Schneeberg A, 2013, J MED MICROBIOL, V62, P1190, DOI 10.1099/jmm.0.056473-0; Schneeberg A, 2012, ANAEROBE, V18, P484, DOI 10.1016/j.anaerobe.2012.08.002; Schneider T, 2007, DEUT ARZTEBLATT, V104, P1588; Seekatz AM, 2014, J CLIN INVEST, V124, P4182, DOI 10.1172/JCI72336; Shaughnessy MK, 2016, APPL ENVIRON MICROB, V82, P2686, DOI 10.1128/AEM.03888-15; Suissa D, 2012, BRIT J CLIN PHARMACO, V74, P370, DOI 10.1111/j.1365-2125.2012.04191.x; Tran QD, 2008, J SCI FOOD AGR, V88, P1487, DOI 10.1002/jsfa.3247; van Rooijen C, 2014, ANIM FEED SCI TECH, V198, P238, DOI 10.1016/j.anifeedsci.2014.10.006; WEBER A, 1989, J VET MED B, V36, P568, DOI 10.1111/j.1439-0450.1989.tb00647.x; WEBER A, 1988, DEUT MED WOCHENSCHR, V113, P1617; Weese JS, 2010, EPIDEMIOL INFECT, V138, P1100, DOI 10.1017/S0950268809991312; Weese JS, 2001, J VET INTERN MED, V15, P374, DOI 10.1892/0891-6640(2001)015&lt;0374:TRODAE&gt;2.3.CO;2; Wetterwik KJ, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-23; Zomer TP, 2017, EPIDEMIOL INFECT, V145, P2745, DOI 10.1017/S0950268817001753	42	35	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193411	10.1371/journal.pone.0193411	http://dx.doi.org/10.1371/journal.pone.0193411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474439	gold, Green Submitted, Green Published			2022-12-26	WOS:000426049500102
J	Nguyen, TH; Zhang, C; Weichselbaum, E; Knyazev, DG; Pohl, P; Carloni, P				Trung Hai Nguyen; Zhang, Chao; Weichselbaum, Ewald; Knyazev, Denis G.; Pohl, Peter; Carloni, Paolo			Interfacial water molecules at biological membranes: Structural features and role for lateral proton diffusion	PLOS ONE			English	Article							DENSITY-FUNCTIONAL THEORY; DYNAMICS SIMULATIONS; SURFACE; EXCHANGE	Proton transport at water/membrane interfaces plays a fundamental role for a myriad of bioenergetic processes. Here we have performed ab initio molecular dynamics simulations of proton transfer along two phosphatidylcholine bilayers. As found in previous theoretical studies, the excess proton is preferably located at the water/membrane interface. Further, our simulations indicate that it interacts not only with phosphate head groups, but also with water molecules at the interfaces. Interfacial water molecules turn out to be oriented relative to the lipid bilayers, consistently with experimental evidence. Hence, the specific water-proton interaction may help explain the proton mobility experimentally observed at the membrane interface.	[Trung Hai Nguyen; Zhang, Chao; Carloni, Paolo] Forschungszentrum Julich, Computat Biomed IAS5 INM9, Julich, Germany; [Trung Hai Nguyen; Zhang, Chao; Carloni, Paolo] Rhein Westfal TH Aachen, Aachen, Germany; [Weichselbaum, Ewald; Knyazev, Denis G.; Pohl, Peter] Johannes Kepler Univ Linz, Inst Biophys, Linz, Austria; [Trung Hai Nguyen] IIT, Dept Chem, Chicago, IL 60616 USA; [Zhang, Chao] Angstrom Lab, Dept Chem, Uppsala, Sweden	Helmholtz Association; Research Center Julich; RWTH Aachen University; Johannes Kepler University Linz; Illinois Institute of Technology	Zhang, C; Carloni, P (corresponding author), Forschungszentrum Julich, Computat Biomed IAS5 INM9, Julich, Germany.; Zhang, C; Carloni, P (corresponding author), Rhein Westfal TH Aachen, Aachen, Germany.; Zhang, C (corresponding author), Angstrom Lab, Dept Chem, Uppsala, Sweden.	chao.zhang@kemi.uu.se; p.carloni@fz-juelich.de	Pohl, Peter/A-5361-2008; Nguyen, Trung Hai/W-4797-2019; Nguyen, Trung Hai/R-3048-2018; Zhang, Chao/F-1379-2010; Knyazev, Denis G/E-5045-2019	Pohl, Peter/0000-0002-1792-2314; Nguyen, Trung Hai/0000-0003-1848-3963; Nguyen, Trung Hai/0000-0003-1848-3963; Zhang, Chao/0000-0002-7167-0840; Knyazev, Denis G/0000-0003-3197-1849	Austrian Science Fund FWF [P25981]; PRACE (Partnership for Advanced Computing in Europe); Austrian Science Fund (FWF) [P 25981] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); PRACE (Partnership for Advanced Computing in Europe); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This project was supported by grant (P25981) of the Austrian Science Fund FWF to PP and PRACE (Partnership for Advanced Computing in Europe) to PC.	ADELMAN SA, 1976, J CHEM PHYS, V64, P2375, DOI 10.1063/1.432526; Adhikari A, 2016, J PHYS CHEM C, V120, P23692, DOI 10.1021/acs.jpcc.6b08980; Agmon N, 2016, CHEM REV, V116, P7642, DOI 10.1021/acs.chemrev.5b00736; Antonenko YN, 2008, EUR BIOPHYS J BIOPHY, V37, P865, DOI 10.1007/s00249-008-0295-y; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Berkelbach TC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238302; Chen XK, 2010, J AM CHEM SOC, V132, P11336, DOI 10.1021/ja1048237; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dreyer J, 2013, J CHEM THEORY COMPUT, V9, P3826, DOI 10.1021/ct400374n; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; GAWRISCH K, 1992, BIOPHYS J, V61, P1213, DOI 10.1016/S0006-3495(92)81931-8; Giberti F, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4986082; Grimme S, 2004, J COMPUT CHEM, V25, P1463, DOI 10.1002/jcc.20078; Hassanali A, 2013, P NATL ACAD SCI USA, V110, P13723, DOI 10.1073/pnas.1306642110; HEBERLE J, 1994, NATURE, V370, P379, DOI 10.1038/370379a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2012, J PHYS CHEM B, V116, P9424, DOI 10.1021/jp304056p; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940; Marx D, 2006, CHEMPHYSCHEM, V7, P1848, DOI 10.1002/cphc.200600128; Marx D, 2010, CHEM REV, V110, P2174, DOI 10.1021/cr900233f; NICHOLLS DG, 2013, BIOENERGETICS; Ojemyr LN, 2010, P NATL ACAD SCI USA, V107, P15763, DOI 10.1073/pnas.1006109107; Peterson U, 2002, CHEM PHYS LIPIDS, V117, P19, DOI 10.1016/S0009-3084(02)00013-0; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poger D, 2010, J CHEM THEORY COMPUT, V6, P325, DOI 10.1021/ct900487a; Pohl P, 1997, BBA-BIOMEMBRANES, V1323, P163, DOI 10.1016/S0005-2736(96)00185-X; Sanden T, 2010, P NATL ACAD SCI USA, V107, P4129, DOI 10.1073/pnas.0908671107; Schmidt J, 2009, J PHYS CHEM B, V113, P11959, DOI 10.1021/jp901990u; Serowy S, 2003, BIOPHYS J, V84, P1031, DOI 10.1016/S0006-3495(03)74919-4; Siu SWI, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2897760; Smondyrev AM, 2002, BIOPHYS J, V83, P1987, DOI 10.1016/S0006-3495(02)73960-X; Springer A, 2011, P NATL ACAD SCI USA, V108, P14461, DOI 10.1073/pnas.1107476108; Tristram-Nagle S, 2010, CHEM PHYS LIPIDS, V163, P630, DOI 10.1016/j.chemphyslip.2010.04.011; Vilciauskas L, 2012, NAT CHEM, V4, P461, DOI [10.1038/NCHEM.1329, 10.1038/nchem.1329]; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weichselbaum E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04675-9; Willard AP, 2010, J PHYS CHEM B, V114, P1954, DOI 10.1021/jp909219k; WILLIAMS RJP, 1988, ANNU REV BIOPHYS BIO, V17, P71; Wolf MG, 2014, BIOPHYS J, V107, P76, DOI 10.1016/j.bpj.2014.04.062; Wraight CA, 2006, BBA-BIOENERGETICS, V1757, P886, DOI 10.1016/j.bbabio.2006.06.017; Yamashita T, 2010, J PHYS CHEM B, V114, P592, DOI 10.1021/jp908768c; Zhang C, 2012, P NATL ACAD SCI USA, V109, P9744, DOI 10.1073/pnas.1121227109; Zhang C, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/12/124109; ZHOU F, 1995, J PHYS CHEM-US, V99, P2194, DOI 10.1021/j100007a059	46	4	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193454	10.1371/journal.pone.0193454	http://dx.doi.org/10.1371/journal.pone.0193454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474432	Green Published, gold			2022-12-26	WOS:000426049500110
J	Bidewell, CA; Williamson, SM; Rogers, J; Tang, Y; Ellis, RJ; Petrovska, L; AbuOun, M				Bidewell, Cornelia A.; Williamson, Susanna M.; Rogers, Jon; Tang, Yue; Ellis, Richard J.; Petrovska, Liljana; AbuOun, Manal			Emergence of Klebsiella pneumoniae subspecies pneumoniae as a cause of septicaemia in pigs in England	PLOS ONE			English	Article							SEQUENCE	Between 2011 and 2014 outbreaks of septicaemia due to Klebsiella pneumoniae subspecies pneumoniae (Kpp) were diagnosed on thirteen English pig farms. The most consistent features were rapid deaths of pigs from ten-days-old to weaning, seasonal occurrence (May to September), affected farms being outdoor breeding herds and the location of all but one of the outbreaks in the East Anglia region in Eastern England. Molecular characterisation of the outbreak Kpp isolates showed that by multilocus sequencing all were sequence type 25 (ST25) of K2 capsular type with a combination of a 4.3kb plasmid (pKPMC25), three phage sequences and the rmpA virulence gene. No archived Kpp isolates of porcine origin pre-dating 2011 were identified as ST25. In 2013 there was the first detection of an outbreak Kpp isolate showing antimicrobial resistance to six antibiotics. Human infection with Kpp ST25 has not been reported in the UK.	[Bidewell, Cornelia A.; Williamson, Susanna M.; Rogers, Jon] APHA, Rougham Hill, Bury St Edmunds, Suffolk, England; [Tang, Yue; Ellis, Richard J.; Petrovska, Liljana; AbuOun, Manal] APHA Weybridge, Addlestone, Surrey, England		AbuOun, M (corresponding author), APHA Weybridge, Addlestone, Surrey, England.	manal.abuoun@apha.gsi.gov.uk			Defra [ED1200, FZ2200]; Swine Influenza Surveillance [SV3041]	Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Swine Influenza Surveillance	The APHA laboratory and staff costs of this work were funded by Defra through the "Scanning surveillance for Pig Diseases in England and Wales" (ED1200), "Monitoring of antimicrobial resistance in bacteria from animals and their environment" (FZ2200) and the Swine Influenza Surveillance (SV3041) projects. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Amorim Jaime H, 2014, F1000Res, V3, P74, DOI 10.12688/f1000research.3718.2; [Anonymous], 2012, KLEBSIELLA SEPTICAEM; [Anonymous], 2012, VET INV DIAGN AN VID; [Anonymous], 2012, DIS SWINE; Bowring BG, 2017, VET MICROBIOL, V203, P267, DOI 10.1016/j.vetmic.2017.03.018; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Coletti M, 2001, VET REC, V149, P626, DOI 10.1136/vr.149.20.626; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Hansen DS, 2002, CLIN MICROBIOL INFEC, V8, P397, DOI 10.1046/j.1469-0691.2002.00411.x; Holt KE, 2015, P NATL ACAD SCI USA, V112, pE3574, DOI 10.1073/pnas.1501049112; ORSKOV I, 1984, METHOD MICROBIOL, V14, P143, DOI 10.1016/S0580-9517(08)70449-5; Pan YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080670; Pig Health and Welfare Council, 2015, PIG HLTH WELF COUNC; Quinn PJ, 2011, VET MICROBIOLOGY MIC, P357; Radostits O. M., 2007, VET MED A TXB DIS CA, P673; Shin SH, 2012, J BACTERIOL, V194, P2736, DOI 10.1128/JB.00027-12; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	19	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0191958	10.1371/journal.pone.0191958	http://dx.doi.org/10.1371/journal.pone.0191958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470491	Green Submitted, Green Published, gold			2022-12-26	WOS:000425831000005
J	Lasalvia, M; Scrima, R; Perna, G; Piccoli, C; Capitanio, N; Biagi, PF; Schiavulli, L; Ligonzo, T; Centra, M; Casamassima, G; Ermini, A; Capozzi, V				Lasalvia, M.; Scrima, R.; Perna, G.; Piccoli, C.; Capitanio, N.; Biagi, P. F.; Schiavulli, L.; Ligonzo, T.; Centra, M.; Casamassima, G.; Ermini, A.; Capozzi, V.			Exposure to 1.8 GHz electromagnetic fields affects morphology, DNA-related Raman spectra and mitochondrial functions in human lympho-monocytes	PLOS ONE			English	Article							ADAPTIVE RESPONSE; BLOOD; SPECTROSCOPY; RADIATION; MICROSPECTROSCOPY	Blood is a fluid connective tissue of human body, where it plays vital functions for the nutrition, defense and well-being of the organism. When circulating in peripheral districts, it is exposed to some physical stresses coming from outside the human body, as electromagnetic fields (EMFs) which can cross the skin. Such fields may interact with biomolecules possibly inducing non thermal-mediated biological effects at the cellular level. In this study, the occurrence of biochemical/biological modifications in human peripheral blood lympho-monocytes exposed in a reverberation chamber for times ranging from 1 to 20 h to EMFs at 1.8 GHz frequency and 200 V/m electric field strength was investigated. Morphological analysis of adherent cells unveiled, in some of these, appearance of an enlarged and deformed shape after EMFs exposure. Raman spectra of the nuclear compartment of cells exposed to EMFs revealed the onset of biochemical modifications, mainly consisting in the reduction of the DNA backbone-linked vibrational modes. Respirometric measurements of mitochondrial activity in intact lympho-monocytes resulted in increase of the resting oxygen consumption rate after 20 h of exposure, which was coupled to a significant increase of the FoF1-ATP synthase-related oxygen consumption. Notably, at lower time-intervals of EMFs exposure (i.e. 5 and 12 h) a large increase of the proton leak-related respiration was observed which, however, recovered at control levels after 20 h exposure. Confocal microscopy analysis of the mitochondrial membrane potential supported the respiratory activities whereas no significant variations in the mitochondrial mass/morphology was observed in EMFs-exposed lympho-monocytes. Finally, altered redox homeostasis was shown in EMFs-exposed lympho-monocytes, which progressed differently in nucleated cellular subsets. This results suggest the occurrence of adaptive mechanisms put in action, likely via redox signaling, to compensate for early impairments of the oxidative phosphorylation system caused by exposure to EMFs. Overall the data presented warn for health safety of people involved in long-term exposure to electromagnetic fields, although further studies are required to pinpoint the leukocyte cellular subset(s) selectively targeted by the EMFs action and the mechanisms by which it is achieved.	[Lasalvia, M.; Scrima, R.; Perna, G.; Piccoli, C.; Capitanio, N.; Capozzi, V.] Univ Foggia, Dipartimento Med Clin & Sperimentale, Foggia, Italy; [Lasalvia, M.; Perna, G.; Schiavulli, L.; Ligonzo, T.; Casamassima, G.; Capozzi, V.] Ist Nazl Fis Nucl, Sez Bari, Bari, Italy; [Biagi, P. F.; Schiavulli, L.; Ligonzo, T.; Casamassima, G.] Univ Bari, Dipartimento Interateneo Fis, Bari, Italy; [Centra, M.] Osped Riuniti Foggia, Banca Sangue, Foggia, Italy; [Ermini, A.] Univ Tor Vergata, Dipartimento Ingn Ind, Rome, Italy	University of Foggia; Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro; University of Rome Tor Vergata	Perna, G (corresponding author), Univ Foggia, Dipartimento Med Clin & Sperimentale, Foggia, Italy.; Perna, G (corresponding author), Ist Nazl Fis Nucl, Sez Bari, Bari, Italy.	giuseppe.perna@unifg.it	Perna, Giuseppe/AET-7080-2022; biagi, pier francesco/I-4256-2019; Ermini, Anita/N-8562-2015	Ermini, Anita/0000-0001-9323-6087; PERNA, GIUSEPPE/0000-0001-8315-0634; Ligonzo, Teresa/0000-0002-6644-9076	University of Foggia	University of Foggia	This research was supported by local funds from the University of Foggia.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Aly A. A., 2011, ADV COMPUTING INT J, V2, P1, DOI DOI 10.5121/acij.2011.2301; [Anonymous], 1999, OFFICIAL J EUROPEA L; Atkins CG, 2017, APPL SPECTROSC, V71, P767, DOI 10.1177/0003702816686593; Biagi PF, 2009, PROG ELECTROMAGN RES, V94, P133, DOI 10.2528/PIER09061006; Biagi PF, 2011, J INSTRUM, V6, DOI 10.1088/1748-0221/6/07/T07002; Corona P, 1996, IEEE T ELECTROMAGN C, V38, P348, DOI 10.1109/15.536065; de Pomerai DI, 2003, FEBS LETT, V543, P93, DOI 10.1016/S0014-5793(03)00413-7; Delfino I, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.3.035003; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Donnellan M, 1997, CELL BIOL INT, V21, P427, DOI 10.1006/cbir.1997.0162; Duguid JG, 1996, BIOPHYS J, V71, P3350, DOI 10.1016/S0006-3495(96)79528-0; Esmekaya MA, 2011, SCI TOTAL ENVIRON, V410, P59, DOI 10.1016/j.scitotenv.2011.09.036; Farhane Z, 2017, J BIOPHOTONICS, V10, P151, DOI 10.1002/jbio.201600019; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Harder SJ, 2015, APPL SPECTROSC, V69, P193, DOI 10.1366/14-07561; Hill DA, 1998, 1506 NIST, P80303; International standard ISO 6710, 6710 ISO; Johansson Olle, 2009, Pathophysiology, V16, P157, DOI 10.1016/j.pathophys.2009.03.004; Kumar S, 2016, CHEM SOC REV, V45, P1879, DOI 10.1039/c5cs00540j; Lasalvia M, 2014, APPL SPECTROSC, V68, P1123, DOI 10.1366/13-07299; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Movileanu L, 2002, BIOPOLYMERS, V63, P181, DOI 10.1002/bip.10022; Murbach M, 2013, PLOS ONE, V8, P1; Nicholls DG, 1997, BIOSCIENCE REP, V17, P251, DOI 10.1023/A:1027376426860; Pappagallo MT, 2014, ADV RES, V2, P478; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Perna G, 2012, J MOL STRUCT, V1010, P123, DOI 10.1016/j.molstruc.2011.11.042; Piccoli C, 2013, HUM MOL GENET, V22, P1218, DOI 10.1093/hmg/dds529; Pokorny J, 2013, INTEGR BIOL-UK, V5, P1439, DOI 10.1039/c3ib40166a; Poljak D, 2004, HUMAN EXPOSURE ELECT; Quarato G, 2012, HEPATOLOGY, V55, P1333, DOI 10.1002/hep.25514; Quarato G, 2011, MITOCHONDRION, V11, P764, DOI 10.1016/j.mito.2011.06.014; Quarato G, 2011, BBA-BIOENERGETICS, V1807, P1114, DOI 10.1016/j.bbabio.2011.04.001; Repacholi MH, 2012, BIOELECTROMAGNETICS, V33, P187, DOI 10.1002/bem.20716; Sannino A, 2014, J RADIAT RES, V55, P210, DOI 10.1093/jrr/rrt106; SCHWAN HP, 1983, BLUT, V46, P185, DOI 10.1007/BF00320638; Srobar F, 2013, ELECTROMAGN BIOL MED, V32, P401, DOI 10.3109/15368378.2012.735207; Vijayalaxmi, 2014, MUTAT RES-REV MUTAT, V760, P36, DOI 10.1016/j.mrrev.2014.02.002; Wang HZ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102175; Zeni O, 2012, MUTAT RES-GEN TOX EN, V747, P29, DOI 10.1016/j.mrgentox.2012.03.013; Zinin PV, 2010, J RAMAN SPECTROSC, V41, P268, DOI 10.1002/jrs.2444	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192894	10.1371/journal.pone.0192894	http://dx.doi.org/10.1371/journal.pone.0192894			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462174	Green Published, gold, Green Submitted			2022-12-26	WOS:000425554200030
J	Matsuda, T; Ito, T; Takemoto, C; Katsura, K; Ikeda, M; Wakiyama, M; Kukimoto-Niino, M; Yokoyama, S; Kurosawa, Y; Shirouzu, M				Matsuda, Takayoshi; Ito, Takuhiro; Takemoto, Chie; Katsura, Kazushige; Ikeda, Mariko; Wakiyama, Motoaki; Kukimoto-Niino, Mutsuko; Yokoyama, Shigeyuki; Kurosawa, Yoshikazu; Shirouzu, Mikako			Cell-free synthesis of functional antibody fragments to provide a structural basis for antibody-antigen interaction	PLOS ONE			English	Article							FREE PROTEIN-SYNTHESIS; GROWTH-FACTOR RECEPTOR; IN-VITRO; EXPRESSION; SYSTEM; CRYSTALLIZATION; INHIBITION; ACTIVATION; BINDING	Growing numbers of therapeutic antibodies offer excellent treatment strategies for many diseases. Elucidation of the interaction between a potential therapeutic antibody and its target protein by structural analysis reveals the mechanism of action and offers useful information for developing rational antibody designs for improved affinity. Here, we developed a rapid, high-yield cell-free system using dialysis mode to synthesize antibody fragments for the structural analysis of antibody-antigen complexes. Optimal synthesis conditions of fragments (Fv and Fab) of the anti-EGFR antibody 059-152 were rapidly determined in a day by using a 30-mu l-scale unit. The concentration of supplemented disulfide isomerase, DsbC, was critical to obtaining soluble antibody fragments. The optimal conditions were directly applicable to a 9-ml-scale reaction, with linear scalable yields of more than 1 mg/ml. Analyses of purified 059-152-Fv and Fab showed that the cell-free synthesized antibody fragments were disulfide-bridged, with antigen binding activity comparable to that of clinical antibodies. Examination of the crystal structure of cell-free synthesized 059-152-Fv in complex with the extracellular domain of human EGFR revealed that the epitope of 059-152-Fv broadly covers the EGF binding surface on domain III, including residues that formed critical hydrogen bonds with EGF (Asp355(EGFR), Gln384(EGFR), H409(EGFR), and Lys465(EGFR)), so that the antibody inhibited EGFR activation. We further demonstrated the application of the cell-free system to site-specific integration of non-natural amino acids for antibody engineering, which would expand the availability of therapeutic antibodies based on structural information and rational design. This cell-free system could be an ideal antibody-fragment production platform for functional and structural analysis of potential therapeutic antibodies and for engineered antibody development.	[Matsuda, Takayoshi; Ito, Takuhiro; Takemoto, Chie; Katsura, Kazushige; Ikeda, Mariko; Wakiyama, Motoaki; Kukimoto-Niino, Mutsuko; Shirouzu, Mikako] RIKEN, Ctr Life Sci Technol, Div Struct & Synthet Biol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa, Japan; [Katsura, Kazushige; Ikeda, Mariko; Wakiyama, Motoaki; Kukimoto-Niino, Mutsuko; Yokoyama, Shigeyuki; Shirouzu, Mikako] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa, Japan; [Yokoyama, Shigeyuki] RIKEN, Struct Biol Lab, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa, Japan; [Kurosawa, Yoshikazu] Fujita Hlth Univ, Sch Med, Innovat Ctr Adv Med, Toyoake, Aichi, Japan	RIKEN; RIKEN; RIKEN; Fujita Health University	Shirouzu, M (corresponding author), RIKEN, Ctr Life Sci Technol, Div Struct & Synthet Biol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa, Japan.; Shirouzu, M (corresponding author), RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa, Japan.	mikako.shirouzu@riken.jp	Ito, Takuhiro/N-6893-2015; Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016; Kukimoto-Niino, Mutsuko/C-6704-2017	Ito, Takuhiro/0000-0003-3704-5205; Yokoyama, Shigeyuki/0000-0003-3133-7338; Kukimoto-Niino, Mutsuko/0000-0002-4178-1611; Matsuda, Takayoshi/0000-0002-6746-7639	Ministry of Education, Culture, Sports, Science and Technology, Japan; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science); Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [16H04756] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by the following: Ministry of Education, Culture, Sports, Science and Technology, Japan, http://www.mext.go.jp/en/, to RIKEN Center for Life Science Technologies; Ministry of Education, Culture, Sports, Science and Technology, Japan, http://www.mext.go.jp/en/, Targeted Proteins Research Program to Shigeyuki Yokoyama; Ministry of Education, Culture, Sports, Science and Technology, Japan, http://www.mext.go.jp/en/, The Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) to Shigeyuki Yokoyama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Yuri Tomabechi for help with the protein purification and the crystallization experiments. We appreciate Dr. Noboru Ohsawa, Mio Inoue, and Ken Ishii for the plasmid construction, and Dr. Takehisa Matsumoto for providing advice on the kinetic analysis. We thank the staff members of the Photon Factory (Ibaraki, Japan) beamlines for their help with data collection. This work was partly supported by the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aoki M, 2009, PROTEIN EXPRES PURIF, V68, P128, DOI 10.1016/j.pep.2009.07.017; Backer Marina V., 2008, V494, P275, DOI 10.1007/978-1-59745-419-3_16; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frey S, 2008, BIOL CHEM, V389, P37, DOI 10.1515/BC.2008.007; GLOCKSHUBER R, 1992, BIOCHEMISTRY-US, V31, P1270, DOI 10.1021/bi00120a002; Goerke AR, 2009, BIOTECHNOL BIOENG, V102, P400, DOI 10.1002/bit.22070; Groff D, 2014, MABS-AUSTIN, V6, P671, DOI 10.4161/mabs.28172; Hino T, 2013, CURR OPIN STRUC BIOL, V23, P563, DOI 10.1016/j.sbi.2013.04.007; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Katsura K, 2017, J BIOCHEM, V162, P357, DOI 10.1093/jb/mvx039; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Kim DM, 2004, BIOTECHNOL BIOENG, V85, P122, DOI 10.1002/bit.10865; Kunaparaju R, 2005, BIOTECHNOL BIOENG, V91, P670, DOI 10.1002/bit.20534; Kurosawa G, 2008, P NATL ACAD SCI USA, V105, P7287, DOI 10.1073/pnas.0712202105; LaGuerre A, 2015, METHOD ENZYMOL, V565, P367, DOI 10.1016/bs.mie.2015.06.001; Lewis MR, 2001, BIOCONJUGATE CHEM, V12, P320, DOI 10.1021/bc0000886; Li S, 2008, STRUCTURE, V16, P216, DOI 10.1016/j.str.2007.11.009; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Matsuda Takayoshi, 2006, Journal of Structural and Functional Genomics, V7, P93, DOI 10.1007/s10969-006-9012-1; Matsuda T, 2013, BIOCHEM BIOPH RES CO, V431, P296, DOI 10.1016/j.bbrc.2012.12.107; Matsuda T, 2012, BIOORGAN MED CHEM, V20, P6579, DOI 10.1016/j.bmc.2012.09.038; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukai T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09699; Ohtake K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09762; OSTERMEIER C, 1995, NAT STRUCT BIOL, V2, P842, DOI 10.1038/nsb1095-842; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ryabova LA, 1997, NAT BIOTECHNOL, V15, P79, DOI 10.1038/nbt0197-79; Schmiedel J, 2008, CANCER CELL, V13, P365, DOI 10.1016/j.ccr.2008.02.019; Shinoda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30442; Tanabe Hiroaki, 2015, Journal of Structural and Functional Genomics, V16, P11, DOI 10.1007/s10969-014-9192-z; Terada T, 2015, METHOD ENZYMOL, V565, P311, DOI 10.1016/bs.mie.2015.08.035; Wada T, 2003, ACTA CRYSTALLOGR D, V59, P1213, DOI 10.1107/S0907444903010515; Yabuki Takashi, 2007, Journal of Structural and Functional Genomics, V8, P173, DOI 10.1007/s10969-007-9038-z; Yamaguchi A, 2016, BIOCONJUGATE CHEM, V27, P198, DOI 10.1021/acs.bioconjchem.5b00602; Yanagisawa T, 2014, CHEMBIOCHEM, V15, P1830, DOI 10.1002/cbic.201402291; Yin G, 2012, MABS-AUSTIN, V4, P217, DOI 10.4161/mabs.4.2.19202; Yokoyama J, 2011, ANAL BIOCHEM, V411, P223, DOI 10.1016/j.ab.2011.01.017; Zemella A, 2015, CHEMBIOCHEM, V16, P2420, DOI 10.1002/cbic.201500340	44	15	15	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0193158	10.1371/journal.pone.0193158	http://dx.doi.org/10.1371/journal.pone.0193158			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462206	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200051
J	Zoia, A; Drigo, M; Piek, CJ; Simioni, P; Caldin, M				Zoia, Andrea; Drigo, Michele; Piek, Christine J.; Simioni, Paolo; Caldin, Marco			Hemostatic findings of pleural fluid in dogs and the association between pleural effusions and primary hyperfibrino(geno)lysis: A cohort study of 99 dogs	PLOS ONE			English	Article							D-DIMER; FIBRINOLYTIC-ACTIVITY; PRIMARY HYPERFIBRINOGENOLYSIS; PERICARDIAL-EFFUSIONS; DEGRADATION PRODUCTS; COAGULATION-FACTORS; PROSTATE-CANCER; ASCITIC FLUID; PLASMA; PERITONEAL	The primary objective of this study was to determine if activation of coagulation and fibrinolysis occurs in canine pleural effusions. Thirty-three dogs with pleural effusions of different origin were studied. Pleural effusion fibrinogen concentrations were significantly lower, while pleural fibrin-fibrinogen degradation products (FDPs) and D-dimer concentrations were significantly higher than those in plasma (P < 0.001 for all comparisons). These results show that, in canine pleural fluids, there is evidence of coagulation activation and fibrinolysis. The secondary aims of the current study were to determine if primary hyperfibrinolysis ([PHF] i.e., elevated plasma FDPs with a normal D-dimer concentrations), occurs in dogs with pleural effusion, and whether the presence of a concurrent inflammatory process may have activated the hemostatic cascade, with its intrinsically linked secondary hyperfibrinolysis, masking the concurrent PHF. The previously 33 selected dogs with pleural effusion (group 1) were compared to two control groups of 33 healthy (group 2) and 33 sick dogs without pleural effusion (group 3). Serum fibrinogen, FDPs, D-dimer, C-reactive protein (CRP), fibrinogen/CRP ratio, and frequency of PHF were determined. Fibrinogen, FDPs, D-dimer and CRP concentrations in group 1 were significantly increased compared to group 2 (P < 0.001 for all comparisons). FDPs and CRP concentrations in group 1 were also significantly increased compared to group 3 (P = 0.001 and P < 0.001, respectively). The fibrinogen/CRP ratio was significantly decreased in group 1 compared to groups 2 and 3 (P < 0.001 for both comparison). The frequency of PHF was significantly higher in group 1 compared to groups 2 (P = 0.004), but not compared to group 3. These results support the hypothesis that PHF occurs significantly more often in dogs with pleural effusion compared to healthy dogs. Nevertheless, the decrease in the fibrinogen/CRP ratio in group 1 compared to group 3, considering the higher FDPs and similar D-dimer concentrations, would suggest that PHF is also more frequent in dogs with pleural effusion compared to sick control dogs, and that this phenomenon is hidden due to concurrent secondary hyperfibrinolysis.	[Zoia, Andrea] San Marco Vet Clin, Dept Internal Med, Padua, Italy; [Drigo, Michele] Univ Padua, Dept Med Anim Prod & Salute, Legnaro, Italy; [Piek, Christine J.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Simioni, Paolo] Univ Padua, Med Sch, Dept Cardiol Thorac & Vasc Sci, Padua, Italy; [Caldin, Marco] Lab Anal Vet San Marco, Dept Clin Pathol, Padua, Italy	University of Padua; Utrecht University; University of Padua	Zoia, A (corresponding author), San Marco Vet Clin, Dept Internal Med, Padua, Italy.	zoia.andrea06@googlemail.com	SIMIONI, PAOLO/AAC-5438-2022; Zoia, Andrea/AAK-1118-2021; Simioni, Paolo/AAC-5416-2022	SIMIONI, PAOLO/0000-0002-6744-383X; Zoia, Andrea/0000-0003-3592-0360; Drigo, Michele/0000-0002-7267-9388				Agarwal S, 2000, AM J GASTROENTEROL, V95, P3218; BLANKENSTEIJN JD, 1992, TRANSPLANT INT, V5, P43, DOI 10.1007/BF00337189; BOGGS DS, 1995, AM J MED SCI, V309, P53, DOI 10.1097/00000441-199501000-00008; BROADIE TA, 1981, ANN EMERG MED, V10, P127, DOI 10.1016/S0196-0644(81)80375-7; Burgess LJ, 2004, CLIN CHIM ACTA, V343, P61, DOI 10.1016/j.cccn.2004.02.002; Caldin M, 2000, VET CLIN PATH, V29, P51, DOI 10.1111/j.1939-165X.2000.tb00398.x; Carey M., 2009, CLIN RISK, V15, P188, DOI [10.1258/cr.2009.090028, DOI 10.1258/CR.2009.090028]; Delgado MA, 2009, J VET INTERN MED, V23, P882, DOI 10.1111/j.1939-1676.2009.0344.x; Denny GP, 1916, AM J PHYSIOL, V39, P455, DOI 10.1152/ajplegacy.1916.39.4.455; Diab S.M., 2005, ARAB J GASTROENTEROL, V6, P124; Duran I, 2006, J GEN INTERN MED, V21, pC6, DOI 10.1111/j.1525-1497.2006.00506.x; FOSSUM TW, 1986, J AM VET MED ASSOC, V188, P49; FRADE LJG, 1992, ACTA HAEMATOL-BASEL, V88, P7; GABEL JC, 1980, AM J PHYSIOL, V239, pH810, DOI 10.1152/ajpheart.1980.239.6.H810; GLAUSER FL, 1976, RESPIRATION, V33, P396, DOI 10.1159/000193755; GLAUSER FL, 1975, CHEST, V68, P205, DOI 10.1378/chest.68.2.205; GROOTENDORST AF, 1988, INTENS CARE MED, V14, P554, DOI 10.1007/BF00263529; HENDERSON JM, 1980, ANN SURG, V192, P738, DOI 10.1097/00000658-198012000-00008; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Hunt BJ, 1996, J CLIN PATHOL, V49, P958, DOI 10.1136/jcp.49.12.958; IDELL S, 1991, AM REV RESPIR DIS, V144, P187, DOI 10.1164/ajrccm/144.1.187; Kopcinovic LM, 2014, BIOCHEM MEDICA, V24, P123, DOI 10.11613/BM.2014.014; Levi M, 2003, CARDIOVASC RES, V60, P26, DOI 10.1016/S0008-6363(02)00857-X; LEVY VG, 1975, POSTGRAD MED J, V51, P564, DOI 10.1136/pgmj.51.598.564; Lombardini Cristina, 2009, Am J Emerg Med, V27, DOI 10.1016/j.ajem.2009.02.005; Martinez-Subiela S, 2005, ARCH MED VET, V37, P61, DOI 10.4067/S0301-732X2005000100009; Maskell NA, 2003, THORAX, V58, pII8, DOI 10.1136/thorax.58.suppl_2.ii8; MAZZI G, 1994, HAEMATOLOGICA, V79, P283; NAPOLI VM, 1987, J TRAUMA, V27, P296, DOI 10.1097/00005373-198703000-00012; NAVAR PD, 1977, AM J PHYSIOL, V233, pH295, DOI 10.1152/ajpheart.1977.233.2.H295; OKAJIMA K, 1992, THROMB RES, V66, P717, DOI 10.1016/0049-3848(92)90047-E; PATRASSI GM, 1985, EUR J CLIN INVEST, V15, P161, DOI 10.1111/j.1365-2362.1985.tb00162.x; PHILIPJOET F, 1995, EUR RESPIR J, V8, P1352, DOI 10.1183/09031936.95.08081352; Porcel JM, 2006, AM FAM PHYSICIAN, V73, P1211; Rodgers M.G., 2014, WINTROBES CLIN HEMAT, V13, P1186; Rose BD, 2001, CLIN PHYSL ACID BASE, P478; Sallah S, 2000, CANCER INVEST, V18, P191, DOI 10.3109/07357900009031823; SATO N, 1995, AM J HEMATOL, V48, P168, DOI 10.1002/ajh.2830480306; SCHOLMERICH J, 1988, J HEPATOL, V6, P359, DOI 10.1016/S0168-8278(88)80054-0; SCHVED JF, 1991, ANN FR ANESTH, V10, P104, DOI 10.1016/S0750-7658(05)80449-6; SCOTTCOOMBES DM, 1993, GUT, V34, P1120, DOI 10.1136/gut.34.8.1120; Skouras V, 2010, CURR OPIN PULM MED, V16, P387, DOI 10.1097/MCP.0b013e328338dde2; Smith S., 2010, SCHALMS VET HEMATOLO, P635; Song KS, 1999, YONSEI MED J, V40, P107, DOI 10.3349/ymj.1999.40.2.107; VIOLI F, 1993, HEPATOLOGY, V17, P78, DOI 10.1016/0270-9139(93)90195-S; von Sommoggy S, 1991, Eur J Vasc Surg, V5, P247; WIDSTROM O, 1978, SCAND J RESPIR DIS, V59, P210; Zoia A, 2017, J VET INTERN MED, V31, P43, DOI 10.1111/jvim.14610; Zoia A, 2017, VET J, V223, P16, DOI 10.1016/j.tvjl.2017.03.008; Zoia A, 2012, JAVMA-J AM VET MED A, V241, P1336, DOI 10.2460/javma.241.10.1336; Zorio E, 2008, CURR MED CHEM, V15, P923, DOI 10.2174/092986708783955455	51	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192371	10.1371/journal.pone.0192371	http://dx.doi.org/10.1371/journal.pone.0192371			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462172	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200015
J	Jimenez, S; Mordillo-Mateos, L; Dileone, M; Campolo, M; Carrasco-Lopez, C; Moitinho-Ferreira, F; Gallego-Izquierdo, T; Siebner, HR; Valls-Sole, J; Aguilar, J; Oliviero, A				Jimenez, Samuel; Mordillo-Mateos, Laura; Dileone, Michele; Campolo, Michela; Carrasco-Lopez, Carmen; Moitinho-Ferreira, Fabricia; Gallego-Izquierdo, Tomas; Siebner, Hartwig R.; Valls-Sole, Josep; Aguilar, Juan; Oliviero, Antonio			Effects of patterned peripheral nerve stimulation on soleus spinal motor neuron excitability	PLOS ONE			English	Article							POST-ACTIVATION DEPRESSION; RECIPROCAL IA INHIBITION; THETA-BURST STIMULATION; LOWER-LIMB MOTONEURONS; H-REFLEX; PRESYNAPTIC INHIBITION; POTENTIATION; MODULATION; INDUCTION; PLASTICITY	Spinal plasticity is thought to contribute to sensorimotor recovery of limb function in several neurological disorders and can be experimentally induced in animals and humans using different stimulation protocols. In healthy individuals, electrical continuous Theta Burst Stimulation (TBS) of the median nerve has been shown to change spinal motoneuron excitability in the cervical spinal cord as indexed by a change in mean H-reflex amplitude in the flexor carpi radialis muscle. It is unknown whether continuous TBS of a peripheral nerve can also shift motoneuron excitability in the lower limb. In 26 healthy subjects, we examined the effects of electrical TBS given to the tibial nerve in the popliteal fossa on the excitability of lumbar spinal motoneurons as measured by H-reflex amplitude of the soleus muscle evoked by tibial nerve stimulation. Continuous TBS was given at 110% of H-reflex threshold intensity and compared to non-patterned regular electrical stimulation at 15 Hz. To disclose any pain-induced effects, we also tested the effects of TBS at individual sensory threshold. Moreover, in a subgroup of subjects we evaluated paired-pulse inhibition of H-reflex. Continuous TBS at 110% of H-reflex threshold intensity induced a short-term reduction of H-reflex amplitude. The other stimulation conditions produced no after effects. Paired-pulse H-reflex inhibition was not modulated by continuous TBS or non-patterned repetitive stimulation at 15 Hz. An effect of pain on the results obtained was discarded, since non-patterned 15 Hz stimulation at 110% HT led to pain scores similar to those induced by EcTBS at 110% HT, but was not able to induce any modulation of the H reflex amplitude. Together, the results provide first time evidence that peripheral continuous TBS induces a short-lasting change in the excitability of spinal motoneurons in lower limb circuitries. Future studies need to investigate how the TBS protocol can be optimized to produce a larger and longer effect on spinal cord physiology and whether this might be a useful intervention in patients with excessive excitability of the spinal motorneurons.	[Jimenez, Samuel; Mordillo-Mateos, Laura; Dileone, Michele; Campolo, Michela; Carrasco-Lopez, Carmen; Moitinho-Ferreira, Fabricia; Oliviero, Antonio] SESCAM, Hosp Nacl Paraplejicos, FENNSI Grp, Toledo, Spain; [Jimenez, Samuel] Univ Autonoma Madrid, Physiotherapy Dept, Ctr Super Estudios Univ La Salle, Madrid, Spain; [Jimenez, Samuel; Gallego-Izquierdo, Tomas] Alcala de Henares Univ, Physiotherapy Dept, Alcala De Henares, Spain; [Dileone, Michele] Hosp Madrid, HM Puerta Sur, CINAC, Mostoles, Spain; [Campolo, Michela; Valls-Sole, Josep] Univ Barcelona, Hosp Clin, Neurol Dept, EMG & Motor Control Sect, Barcelona, Spain; [Moitinho-Ferreira, Fabricia] Sarah Network Rehabil Hosp, Salvador De Bahia, Brazil; [Siebner, Hartwig R.] Copenhagen Univ Hosp, Ctr Funct & Diagnost Imaging & Res, Danish Res Ctr Magnet Resonance, Hvidovre, Denmark; [Siebner, Hartwig R.] Copenhagen Univ Hosp Bispebjerg, Dept Neurol, Copenhagen, Denmark; [Aguilar, Juan] SESCAM, Hosp Nacl Paraplejicos, Expt Neurophysiol Grp, Toledo, Spain	Hospital Nacional de Paraplejicos; Autonomous University of Madrid; Universidad de Alcala; University of Barcelona; Hospital Clinic de Barcelona; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Hospital Nacional de Paraplejicos	Oliviero, A (corresponding author), SESCAM, Hosp Nacl Paraplejicos, FENNSI Grp, Toledo, Spain.	antonioo@sescam.jccm.es	Oliviero, Antonio/ABH-4485-2020; Mordillo-Mateos, Laura/M-2548-2014; Aguilar, Juan/Q-2206-2015; Aguilar, Juan/N-3850-2019; Dileone, Michele/J-5255-2019	Oliviero, Antonio/0000-0001-7723-0478; Mordillo-Mateos, Laura/0000-0003-3754-2279; Aguilar, Juan/0000-0002-8070-3923; Aguilar, Juan/0000-0002-8070-3923; Dileone, Michele/0000-0001-9871-6581; Carrasco-Lopez, Carmen/0000-0003-1280-5087	"Ministerio de Economia y Competitividad" of Spain; Fondo Europeo de Desarrollo Regional- FEDER [SAF2012- 39589, SAF2016- 80647]; Lundbeck Foundation [R59 A5399]; Novo Nordisk Foundation [NNF14OC0011413]	"Ministerio de Economia y Competitividad" of Spain; Fondo Europeo de Desarrollo Regional- FEDER(European Commission); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This research was funded by the "Ministerio de Economia y Competitividad" of Spain and the "Fondo Europeo de Desarrollo Regional- FEDER" (SAF2012- 39589 and SAF2016- 80647). H.R.S. was supported by the Lundbeck Foundation (Grant of Excellence "ContAct" R59 A5399) and the Novo Nordisk Foundation (Interdisciplinary Synergy Programme Grant "BASICS" NNF14OC0011413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OK, 2000, PAIN, V84, P29, DOI 10.1016/S0304-3959(99)00174-8; Andrews JC, 2015, NEUROSCI LETT, V589, P144, DOI 10.1016/j.neulet.2015.01.041; Aymard C, 2000, BRAIN, V123, P1688, DOI 10.1093/brain/123.8.1688; BROUWER B, 1992, EXP BRAIN RES, V89, P649; BURKE D, 1989, BRAIN, V112, P417, DOI 10.1093/brain/112.2.417; CAPOCCHI G, 1992, BRAIN RES, V591, P332, DOI 10.1016/0006-8993(92)91715-Q; Cortes M, 2011, CLIN NEUROPHYSIOL, V122, P2254, DOI 10.1016/j.clinph.2011.02.038; CRONE C, 1985, EXP BRAIN RES, V59, P418; CRONE C, 1990, EXP BRAIN RES, V81, P35; CRONE C, 1989, EXP BRAIN RES, V78, P28, DOI 10.1007/bf00230683; Dalpozzo F, 2002, CLIN NEUROPHYSIOL, V113, P284, DOI 10.1016/S1388-2457(01)00732-5; Di Lazzaro V, 2011, J NEUROPHYSIOL, V105, P2150, DOI 10.1152/jn.00781.2010; DIAMOND DM, 1988, J NEUROSCI, V8, P4079; ELIOT LS, 1994, J NEUROSCI, V14, P3280; Hosoido T, 2009, NEUROSCI LETT, V450, P239, DOI 10.1016/j.neulet.2008.11.045; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hultborn H, 1996, EXP BRAIN RES, V108, P450; Kaczmarek D, 2017, J PHYSIOL-LONDON, V595, P1743, DOI 10.1113/JP272902; Kitago T, 2004, CLIN NEUROPHYSIOL, V115, P858, DOI 10.1016/j.clinph.2003.11.029; Knikou M, 2008, J NEUROSCI METH, V171, P1, DOI 10.1016/j.jneumeth.2008.02.012; Lamy JC, 2012, J NEUROPHYSIOL, V108, P906, DOI 10.1152/jn.10898.2011; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; LARSON J, 1989, BRAIN RES, V489, P49, DOI 10.1016/0006-8993(89)90007-3; Le Pera D, 2001, CLIN NEUROPHYSIOL, V112, P1633, DOI 10.1016/S1388-2457(01)00631-9; Leukel C, 2012, EUR J NEUROSCI, V35, P1622, DOI 10.1111/j.1460-9568.2012.08067.x; LEVTOV A, 1992, J PHYSIOL-LONDON, V447, P149, DOI 10.1113/jphysiol.1992.sp018996; McNulty PA, 2008, J NEUROPHYSIOL, V100, P3275, DOI 10.1152/jn.90435.2008; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Perez MA, 2003, J NEUROSCI, V23, P2014; POCKETT S, 1993, NEUROREPORT, V4, P97, DOI 10.1097/00001756-199301000-00025; Ridding MC, 2000, EXP BRAIN RES, V131, P135, DOI 10.1007/s002219900269; ROSSI A, 1995, BRAIN RES, V700, P164, DOI 10.1016/0006-8993(95)00947-O; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Suppa A, 2016, BRAIN STIMUL, V9, P323, DOI 10.1016/j.brs.2016.01.006; Taube W, 2015, CEREB CORTEX, V25, P1629, DOI 10.1093/cercor/bht359; Winkler T, 2010, CLIN NEUROPHYSIOL, V121, P957, DOI 10.1016/j.clinph.2010.01.014; Wolpaw JR, 1983, J NEUROSCIENCE BRAIN, V4, P2718; Yeh KL, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/704849	38	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192471	10.1371/journal.pone.0192471	http://dx.doi.org/10.1371/journal.pone.0192471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451889	gold, Green Published, Green Submitted			2022-12-26	WOS:000425369800015
J	Li, J; Guo, A; Wang, QY; Li, YY; Zhao, J; Lu, J; Pei, G				Li, Juan; Guo, Ao; Wang, Qinying; Li, Yuanyuan; Zhao, Jian; Lu, Jing; Pei, Gang			NF-kappa B directly regulates -arrestin-1 expression and forms a negative feedback circuit in TNF-alpha-induced cell death	FASEB JOURNAL			English	Article						promoter; inflammation; apoptosis; cell survival	PROTEIN-KINASE-C; BETA-ARRESTIN 2; GENE-EXPRESSION; RAT-BRAIN; BETA-ARRESTIN1; DEFICIENCY; ACTIVATION; HETERODIMERS; INFLAMMATION; CONTRIBUTES	beta-Arrestins (beta-arrestin-1 and -2) are multifunctional proteins that play important roles in the regulation of inflammation and cell survival that need to be tightly controlled; however, the mechanism that underlies their gene expression is largely unclear. Here, we demonstrate that -arrestin-1 is a transcriptional target of NF-B. mRNA and protein levels of -arrestin-1 were up-regulated by NF-B inducers. Inhibition of NF-B prevented the up-regulation of -arrestin-1 mRNA, whereas activation of NF-B led to increased -arrestin-1 expression. -Arrestin-1 promoter activity was consistently enhanced upon NF-B activation as a result of the presence of a highly conserved B site. -Arrestin-1, in turn, suppressed the transcriptional activity of NF-B by interfering with the interaction between p65 and p50. -Arrestin-1-deficient mice displayed reduced TNF--induced cell death and increased expression of antiapoptotic genes. Reintroduction of -arrestin-1, but not its mutant, which is unable to interfere with the p65-p50 interaction, into -arrestin-deficient mouse embryonic fibroblasts partially restored sensitivity to TNF--induced cell death. These findings reveal NF-B and -arrestin-1 to be key components of a negative feedback circuit that is necessary to regulate cell death.Li, J., Guo, A., Wang, Q., Li, Y., Zhao, J., Lu, J., Pei, G. NF-B directly regulates beta-arrestin-1 expression and forms a negative feedback circuit in TNF-alpha-induced cell death.	[Li, Juan; Guo, Ao; Wang, Qinying; Li, Yuanyuan; Lu, Jing; Pei, Gang] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol,CAS Ctr Excellence Mol Cel, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Zhao, Jian] Tongji Univ, Sch Med, Shanghai East Hosp, Translat Med Ctr Stem Cell Therapy, Shanghai, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Collaborat Innovat Ctr Brain Sci, Shanghai, Peoples R China; [Li, Juan] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, 1230 York Ave, New York, NY 10021 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Tongji University; Tongji University; Rockefeller University	Lu, J; Pei, G (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol,CAS Ctr Excellence Mol Cel, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	lu.jing@sibcb.ac.cn; gpei@sibs.ac.cn	Zhao, Jian/E-2008-2019	Zhao, Jian/0000-0002-8862-0591; Guo, Ao/0000-0003-2597-7558	Ministry of Science and Technology of China [2014CB964802, 2015CB964502]; International Science and Technology Cooperation Program of China [2016YFE0103500]; Shanghai Municipal Commission for Science and Technology [15JC1400202]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); International Science and Technology Cooperation Program of China; Shanghai Municipal Commission for Science and Technology	The authors thank Robert J. Lefkowitz (Duke University Medical Center, Durham, NC, USA) for A1CT Ab and Arrb1<SUP>-/-</SUP> Arrb2<SUP>-/-</SUP> MEFs; Chen Wang (Shanghai Institute of Biochemistry and Cell Biology) for plasmids encoding HA-p50, FLAG-p50, and HA-I kappa B alpha S32/36A; and Chang Liu and Jiuhong Kang (Tongji University) for helpful discussions. The authors thank all laboratory members for sharing reagents and advice. This study was supported by the Ministry of Science and Technology of China (Grants 2014CB964802 and 2015CB964502), the International Science and Technology Cooperation Program of China (Grant 2016YFE0103500), and the Shanghai Municipal Commission for Science and Technology (Grant 15JC1400202). The authors declare no conflicts of interest.	Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Chuang SE, 2002, BIOCHEM PHARMACOL, V63, P1709, DOI 10.1016/S0006-2952(02)00931-0; Cianfrocca R, 2014, LIFE SCI, V118, P179, DOI 10.1016/j.lfs.2014.01.078; Fan XL, 2003, NEUROSCIENCE, V117, P383, DOI 10.1016/S0306-4522(02)00930-2; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; GRIMM S, 1993, BIOCHEM J, V290, P297, DOI 10.1042/bj2900297; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; KELLEHER D, 1988, IMMUNOLOGY, V65, P351; Knuefermann P, 2002, J BIOL CHEM, V277, P23888, DOI 10.1074/jbc.M202937200; Kook S, 2014, CELL DEATH DIFFER, V21, P172, DOI 10.1038/cdd.2013.143; Lee T, 2016, J CELL PHYSIOL, V231, P992, DOI 10.1002/jcp.25216; Lee T, 2013, AM J PATHOL, V182, P1114, DOI 10.1016/j.ajpath.2012.12.025; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Li J, 2013, P NATL ACAD SCI USA, V110, P7395, DOI 10.1073/pnas.1221608110; Li PF, 2011, MOL IMMUNOL, V49, P64, DOI 10.1016/j.molimm.2011.07.021; Liu XS, 2013, CELL RES, V23, P351, DOI 10.1038/cr.2012.167; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; Luan B, 2005, EMBO J, V24, P4237, DOI 10.1038/sj.emboj.7600882; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Ma XY, 2003, J BIOL CHEM, V278, P23008, DOI 10.1074/jbc.M302105200; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Oakley RH, 2012, P NATL ACAD SCI USA, V109, P17591, DOI 10.1073/pnas.1209411109; Porter KJ, 2010, J CELL PHYSIOL, V225, P406, DOI 10.1002/jcp.22289; Sharma D, 2015, GENES IMMUN, V16, P499, DOI 10.1038/gene.2015.37; Sharma D, 2014, AM J PATHOL, V184, P2297, DOI 10.1016/j.ajpath.2014.05.002; Shenoy SK, 2012, ONCOGENE, V31, P282, DOI 10.1038/onc.2011.238; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Urs NM, 2016, P NATL ACAD SCI USA, V113, pE8178, DOI 10.1073/pnas.1614347113; Wang CB, 2016, SCI REP-UK, V6, DOI 10.1038/srep26526; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Zhang MF, 2010, DEV BIOL, V339, P407, DOI 10.1016/j.ydbio.2009.12.042	44	1	1	3	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4096	4106		10.1096/fj.201700642RRR	http://dx.doi.org/10.1096/fj.201700642RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29485902				2022-12-26	WOS:000439325400004
J	Bi, GL; Wu, L; Huang, PX; Islam, S; Heruth, DP; Zhang, LQ; Li, DY; Sampath, V; Huang, WM; Simon, BA; Easley, RB; Ye, SQ				Bi, Guangliang; Wu, Lei; Huang, Peixin; Islam, Shamima; Heruth, Daniel P.; Zhang, Li Qin; Li, Ding-You; Sampath, Venkatesh; Huang, Weimin; Simon, Brett A.; Easley, Ronald Blaine; Ye, Shui Qing			Up-regulation of SFTPB expression and attenuation of acute lung injury by pulmonary epithelial cell-specific NAMPT knockdown	FASEB JOURNAL			English	Article						surfactant proteins B; gene expression; JNK pathway; mouse model	SURFACTANT PROTEIN-B; COLONY-ENHANCING FACTOR; RESPIRATORY-DISTRESS-SYNDROME; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; DEFICIENT MICE; RISK; GENE; ARDS; POLYMORPHISMS; INHIBITOR	Although a deficiency of surfactant protein B (SFTPB) has been associated with lung injury, SFTPB expression has not yet been linked with nicotinamide phosphoribosyltransferase (NAMPT), a potential biomarker of acute lung injury (ALI). The effects of Nampt in the pulmonary epithelial cell on both SFTPB expression and lung inflammation were investigated in a LPS-induced ALI mouse model. Pulmonary epithelial cell-specific knockdown of Nampt gene expression, achieved by the crossing of Nampt gene exon 2 floxed mice with mice expressing epithelial-specific transgene Cre or by the use of epithelial-specific expression of anti-Nampt antibody cDNA, significantly attenuated LPS-induced ALI. Knockdown of Nampt expression was accompanied by lower levels of bronchoalveolar lavage (BAL) neutrophil infiltrates, total protein and TNF-alpha levels, as well as lower lung injury scores. Notably, Nampt knockdown was also associated with significantly increased BAL SFTPB levels relative to the wild-type control mice. Down-regulation of NAMPT increased the expression of SFTPB and rescued TNF-alpha-induced inhibition of SFTPB, whereas overexpression of NAMPT inhibited SFTPB expression in both H441 and A549 cells. Inhibition of NAMPT up-regulated SFTPB expression by enhancing histone acetylation to increase its transcription. Additional data indicated that these effects were mainly mediated by NAMPT nonenzymatic function via the JNK pathway. This study shows that pulmonary epithelial cell-specific knockdown of NAMPT expression attenuated ALI, in part, via up-regulation of SFTPB expression. Thus, epithelial cell-specific knockdown of Nampt may be a potential new and viable therapeutic modality to ALI.-Bi, G., Wu, L., Huang, P., Islam, S., Heruth, D. P., Zhang, L. Q., Li, D.-Y., Sampath, V., Huang, W., Simon, B. A., Easley, R. B., Ye, S. Q. Up-regulation of SFTPB expression and attenuation of acute lung injury by pulmonary epithelial cell-specific NAMPT knockdown.	[Bi, Guangliang; Wu, Lei; Huang, Peixin; Islam, Shamima; Heruth, Daniel P.; Zhang, Li Qin; Li, Ding-You; Sampath, Venkatesh; Ye, Shui Qing] Univ Missouri, Sch Med, Dept Pediat, Childrens Mercy, 2401 Gillham Rd,PRC 4th Floor, Kansas City, MO 64108 USA; [Ye, Shui Qing] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Childrens Mercy, Kansas City, MO 64108 USA; [Bi, Guangliang; Huang, Weimin] Southern Med Univ, Dept Neonatol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Wu, Lei] Changsha Cent Hosp, Dept Pediat, Changsha, Hunan, Peoples R China; [Simon, Brett A.] Cornell Univ, Mem Sloan Kettering Canc Ctr, Josie Robertson Surg Ctr, Weill Cornell Med Coll,Dept Anesthesiol, New York, NY USA; [Easley, Ronald Blaine] Baylor Coll Med, Dept Pediat Anesthesiol, Houston, TX 77030 USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Southern Medical University - China; Cornell University; Memorial Sloan Kettering Cancer Center; Baylor College of Medicine	Ye, SQ (corresponding author), Univ Missouri, Sch Med, Dept Pediat, Childrens Mercy, 2401 Gillham Rd,PRC 4th Floor, Kansas City, MO 64108 USA.	sqye@cmh.edu		Bi, Guangliang/0000-0001-8659-162X	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL080042]; Guangdong Province Science and Technology Plan Project [2013B051000049]; Southern Medical University; Children's Mercy Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128374, R01HL080042] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Guangdong Province Science and Technology Plan Project; Southern Medical University; Children's Mercy Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank our colleagues, Marianne Nsumu and Suman Chaudhary for their excellent technical assistance, and Maria Bradshaw for her able service in reagent procurements (all from Children's Mercy Hospital, University of Missouri, Kansas City, MO, USA). This work is supported, in part, by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant HL080042 (to S.Q.Y.); the Start-Up Fund and William R. Brown/Missouri Endowment of the Children's Mercy Hospital (to S.Q.Y.); a Guangdong Province Science and Technology Plan Project (2013B051000049 to W.H. and G.B.); and a Postdoctoral Fellowship from Southern Medical University (to G.B.). The authors declare no conflicts of interest.	Bae YH, 2011, J CONTROL RELEASE, V153, P198, DOI 10.1016/j.jconrel.2011.06.001; Bajwa EK, 2007, CRIT CARE MED, V35, P1290, DOI 10.1097/01.CCM.0000260243.22758.4F; Baron Rebecca M, 2016, F1000Res, V5, DOI 10.12688/f1000research.7646.1; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Devaney J, 2011, CRIT CARE, V15, DOI 10.1186/cc10216; Epaud R, 2003, AM J RESP CELL MOL, V28, P373, DOI 10.1165/rcmb.2002-0071OC; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Gandhi VD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00147; Ge L, 2016, BIOCHEM BIOPH RES CO, V469, P171, DOI 10.1016/j.bbrc.2015.11.089; Gill SE, 2017, CELL TISSUE RES, V367, P495, DOI 10.1007/s00441-016-2521-8; Gong MN, 2004, CHEST, V125, P203, DOI 10.1378/chest.125.1.203; GREGORY TJ, 1991, J CLIN INVEST, V88, P1976, DOI 10.1172/JCI115523; Hasmann M, 2003, CANCER RES, V63, P7436; Hong SB, 2008, AM J RESP CRIT CARE, V178, P605, DOI 10.1164/rccm.200712-1822OC; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Li HL, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-15; Liu P, 2009, J BIOL CHEM, V284, P27344, DOI 10.1074/jbc.M109.002519; Liu P, 2009, CELL BIOL INT, V33, P19, DOI 10.1016/j.cellbi.2008.10.015; Matthay M A, 1993, New Horiz, V1, P613; Melton KR, 2003, AM J PHYSIOL-LUNG C, V285, pL543, DOI 10.1152/ajplung.00011.2003; Meyer NJ, 2014, CLIN CHEST MED, V35, P673, DOI 10.1016/j.ccm.2014.08.006; Ota C, 2015, EXP LUNG RES, V41, P422, DOI 10.3109/01902148.2015.1060275; Quasney MW, 2004, CRIT CARE MED, V32, P1115, DOI 10.1097/01.CCM.0000124872.55243.5A; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Schmidt R, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-55; Thompson BT, 2011, CRIT CARE CLIN, V27, P459, DOI 10.1016/j.ccc.2011.05.011; Tokieda K, 1999, PEDIATR RES, V46, P708, DOI 10.1203/00006450-199912000-00012; Tokieda K, 1999, AM J RESP CELL MOL, V21, P463, DOI 10.1165/ajrcmb.21.4.3436; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Yamagata K, 2018, INT REV CEL MOL BIO, V335, P143, DOI 10.1016/bs.ircmb.2017.07.009; Yanagi S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/573210; Ye SQ, 2005, MICROVASC RES, V70, P142, DOI 10.1016/j.mvr.2005.08.003; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zhang LQ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.132; Zhang Li Qin, 2011, J Bioanal Biomed, V3, P13; Zhang LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031229	39	8	8	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3583	3596		10.1096/fj.201701059R	http://dx.doi.org/10.1096/fj.201701059R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29452569	Green Published			2022-12-26	WOS:000435104500009
J	Shin, Y; Kim, DY; Ko, JY; Woo, YM; Park, JH				Shin, Yubin; Kim, Do Yeon; Ko, Je Yeong; Woo, Yu Mi; Park, Jong Hoon			Regulation of KLF12 by microRNA-20b and microRNA-106a in cystogenesis	FASEB JOURNAL			English	Article						Pkd2; cyst; proliferation; ADPKD	POLYCYSTIC KIDNEY-DISEASE; KRUPPEL-LIKE FACTORS; PATHWAYS; PROMOTER; CANCER	Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common inherited disorders. ADPKD is caused by mutations in the gene encoding either polycystic kidney disease 1 (PKD1) or polycystic kidney disease 2 (PKD2). Patients with ADPKD show progressive growth of cystic fluid-filled renal cysts. Here, we used Pkd2(f/f) control mice and Pkd2(f/f):HoxB7-Cre experimental mice, which are bred to have a conditional deletion of Pkd2 in the collecting ducts, and analyzed the expression pattern of microRNAs (miRNAs) of kidney tissues from Pkd2(f/f) and Pkd2(f/f):HoxB7-Cre mice. Decreased expression of miR-20b-5p and miR-106a-5p in Pkd2(f/f):HoxB7-Cre mice compared to that in Pkd2(f/f) mice was observed. These miRNAs target Klf12 (Kruppel-like factor 12), which has low expression in kidney tissues of Pkd2(f/f) mice; however, its expression is enhanced in Pkd2(f/f):HoxB7-Cre mice over time. Moreover, miR-20b-5p and miR-106a-5p directly target Klf12 mRNA by binding to the 3-UTR of Klf12. In addition, human and mouse cell lines exhibit similar patterns. These findings were also consistent with the data from Pkd2 knockout mouse embryonic fibroblasts. Furthermore, direct and indirect knockdown of Klf12 slows cyst growth and cell proliferation in mouse inner medullary collecting duct cells. Taken together, we suggest that the induction of miR-20b-5p or miR-106a-5p or the down-regulation of KLF12 could be used as potential novel therapies for inhibiting cyst growth in patients with ADPKD.-Shin, Y., Kim, D. Y., Ko, J. Y., Woo, Y. M., Park, J. H. Regulation of KLF12 by microRNA-20b and microRNA-106a in cystogenesis.	[Shin, Yubin; Kim, Do Yeon; Ko, Je Yeong; Woo, Yu Mi; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul 04310, South Korea	Sookmyung Women's University	Park, JH (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Seoul 04310, South Korea.	parkjh@sook-myung.ac.kr			Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation (NRF) [2015M3A9B6027555]; Bio and Medical Technology Development Program [2014M3C9A2067613]; Korean Ministry of Science and Information and Communications Technology (ICT) [2017R1C1B2002806]	Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation (NRF); Bio and Medical Technology Development Program; Korean Ministry of Science and Information and Communications Technology (ICT)	This work was supported by grants from the Bio and Medical Technology Development Program (2014M3C9A2067613), the Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation (NRF) (2015M3A9B6027555), and Basic Science Program funded by the Korean Ministry of Science and Information and Communications Technology (ICT) (2017R1C1B2002806). The authors declare no conflicts of interest.	Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59; Fedeles SV, 2014, TRENDS MOL MED, V20, P251, DOI 10.1016/j.molmed.2014.01.004; Harris PC, 2014, J CLIN INVEST, V124, P2315, DOI 10.1172/JCI72272; Imhof A, 1999, MOL CELL BIOL, V19, P194; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kumar P, 2013, MOL CELL BIOL, V33, P1782, DOI 10.1128/MCB.01228-12; Lariviere WB, 2015, TRANSL RES, V165, P488, DOI 10.1016/j.trsl.2014.11.003; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Nakamura Y, 2009, INT J CANCER, V125, P1859, DOI 10.1002/ijc.24538; Paul BM, 2014, WIRES DEV BIOL, V3, P465, DOI 10.1002/wdev.152; Suda S, 2006, BIOCHEM BIOPH RES CO, V344, P246, DOI 10.1016/j.bbrc.2006.03.138; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Woo YM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14083-8; Zitman-Gal T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-8	16	12	12	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3574	3582		10.1096/fj.201700923R	http://dx.doi.org/10.1096/fj.201700923R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29475398				2022-12-26	WOS:000435104500008
J	Schnabel, J; Hombach, P; Waksman, T; Giuriani, G; Petersen, J; Christie, JM				Schnabel, Jonathan; Hombach, Peter; Waksman, Thomas; Giuriani, Giovanni; Petersen, Jan; Christie, John M.			A chemical genetic approach to engineer phototropin kinases for substrate labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT; FUNCTIONAL-CHARACTERIZATION; ARABIDOPSIS NPH1; VOLTAGE DOMAINS; PROTEIN; RECEPTOR; PHOTORECEPTOR; FLAVOPROTEIN; PERCEPTION; ACTIVATION	Protein kinases (PKs) control many aspects of plant physiology by regulating signaling networks through protein phosphorylation. Phototropins (phots) are plasma membrane-associated serine/threonine PKs that control a range of physiological processes that collectively serve to optimize photosynthetic efficiency in plants. These include phototropism, leaf positioning and flattening, chloroplast movement, and stomatal opening. Despite their identification over two decades ago, only a handful of substrates have been identified for these PKs. Progress in this area has been hampered by the lack of a convenient means to confirm the identity of potential substrate candidates. Here we demonstrate that the kinase domain of Arabidopsis phot1 and phot2 can be successfully engineered to accommodate non-natural ATP analogues by substituting the bulky gatekeeper residue threonine for glycine. This approach circumvents the need for radioactivity to track phot kinase activity and follow light-induced receptor autophosphorylation in vitro by incorporating thiophosphate from N-6-benzyl-ATP gamma S. Consequently, thio-phosphorylation of phot substrate candidates can be readily monitored when added or co-expressed with phots in vitro. Furthermore, gatekeeper-modified phot1 retained its functionality and its ability to accommodate N-6-benzyl-ATP gamma S as a phospho-donor when expressed in Arabidopsis. We therefore anticipate that this chemical genetic approach will provide new opportunities for labeling and identifying substrates for phots and other related AGC kinases under in vitro and near-native in vivo conditions.	[Schnabel, Jonathan; Hombach, Peter; Waksman, Thomas; Giuriani, Giovanni; Petersen, Jan; Christie, John M.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Bower Bldg, Glasgow G12 8QQ, Lanark, Scotland; [Hombach, Peter] Bielefeld Univ, Fac Biol, RNA Biol & Mol Physiol, D-33615 Bielefeld, Germany; [Schnabel, Jonathan] Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England; [Petersen, Jan] Friedrich Schiller Univ, Inst Gen Bot & Plant Physiol, Planetarium 1, D-07743 Jena, Germany	University of Glasgow; University of Bielefeld; University of Cambridge; Friedrich Schiller University of Jena	Christie, JM (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Bower Bldg, Glasgow G12 8QQ, Lanark, Scotland.	john.christie@glasgow.ac.uk		Waksman, Thomas/0000-0001-5939-8517; Schnabel, Jonathan/0000-0002-9515-332X; Christie, John/0000-0002-9976-0055; Hombach, Peter/0000-0002-1154-5060; Petersen, Jan/0000-0002-8469-6679	United Kingdom Biotechnology and Biological Sciences Research Council [BB/J016047/1, BB/M002128/1]; Dobbie Smith Scholarship; Erasmus+ Scholarship; Doctoral Training Programme Studentship from the College of Medical, Veterinary, and Life Sciences, University of Glasgow; Biotechnology and Biological Sciences Research Council [BB/J016047/1, BB/M002128/1] Funding Source: researchfish; BBSRC [BB/J016047/1, BB/M002128/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dobbie Smith Scholarship; Erasmus+ Scholarship; Doctoral Training Programme Studentship from the College of Medical, Veterinary, and Life Sciences, University of Glasgow; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the United Kingdom Biotechnology and Biological Sciences Research Council (BB/J016047/1 and BB/M002128/1 to J.M.C.). This work was also supported by a Dobbie Smith Scholarship (to G.G.), an Erasmus+ Scholarship (to P.H.), and a Doctoral Training Programme Studentship from the College of Medical, Veterinary, and Life Sciences, University of Glasgow (to T.W.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn NG, 2001, NAT BIOTECHNOL, V19, P317, DOI 10.1038/86687; Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Allen JJ, 2005, J AM CHEM SOC, V127, P5288, DOI 10.1021/ja050727t; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Boccalandro HE, 2008, PLANT PHYSIOL, V146, P108, DOI 10.1104/pp.107.106468; Brodersen P, 2006, PLANT J, V47, P532, DOI 10.1111/j.1365-313X.2006.02806.x; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2015, PLANT CELL PHYSIOL, V56, P401, DOI 10.1093/pcp/pcu196; Christie JM, 2013, AM J BOT, V100, P35, DOI 10.3732/ajb.1200340; Christie JM, 2012, MOL PLANT, V5, P533, DOI 10.1093/mp/sss020; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; de Carbonnel M, 2010, PLANT PHYSIOL, V152, P1391, DOI 10.1104/pp.109.150441; Demarsy E, 2012, EMBO J, V31, P3457, DOI 10.1038/emboj.2012.186; Deng ZP, 2014, J PROTEOME RES, V13, P2524, DOI 10.1021/pr500010z; Doi M, 2004, J EXP BOT, V55, P517, DOI 10.1093/jxb/erh044; Geldner N, 2008, PLANT PHYSIOL, V147, P1565, DOI 10.1104/pp.108.120287; Hiyama A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01237-5; Inoue S, 2008, P NATL ACAD SCI USA, V105, P5626, DOI 10.1073/pnas.0709189105; Inoue S, 2011, PLANT PHYSIOL, V156, P117, DOI 10.1104/pp.111.175943; Jensen ON, 2006, NAT REV MOL CELL BIO, V7, P391, DOI 10.1038/nrm1939; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kaiserli E, 2009, PLANT CELL, V21, P3226, DOI 10.1105/tpc.109.067876; Katsir L, 2011, CURR BIOL, V21, pR356, DOI 10.1016/j.cub.2011.03.012; Kong SG, 2014, BBA-BIOENERGETICS, V1837, P522, DOI 10.1016/j.bbabio.2013.12.004; Kornev AP, 2015, TRENDS BIOCHEM SCI, V40, P628, DOI 10.1016/j.tibs.2015.09.002; Lariguet P, 2006, P NATL ACAD SCI USA, V103, P10134, DOI 10.1073/pnas.0603799103; Lehti-Shiu MD, 2012, PHILOS T R SOC B, V367, P2619, DOI 10.1098/rstb.2012.0003; Leissing F, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0731-6; LISCUM E, 1995, PLANT CELL, V7, P473, DOI 10.1105/tpc.7.4.473; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Logemann E, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-16; Lopez MS, 2014, METHOD ENZYMOL, V548, P189, DOI 10.1016/B978-0-12-397918-6.00008-2; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mishra NS, 2006, ARCH BIOCHEM BIOPHYS, V452, P55, DOI 10.1016/j.abb.2006.05.001; Petersen J, 2017, J BIOL CHEM, V292, P13843, DOI 10.1074/jbc.M117.799643; Preuten T, 2015, NEW PHYTOL, V206, P1038, DOI 10.1111/nph.13299; Rademacher EH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00250; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sakamoto K, 2002, PLANT CELL, V14, P1723, DOI 10.1105/tpc.003293; Salomon D, 2011, METHODS MOL BIOL, V779, P185, DOI 10.1007/978-1-61779-264-9_10; Salomon D, 2009, J BIOL CHEM, V284, P15289, DOI 10.1074/jbc.M809724200; Schwessinger B, 2012, ANNU REV PLANT BIOL, V63, P451, DOI 10.1146/annurev-arplant-042811-105518; Suetsugu N, 2005, PLANT PHYSIOL, V139, P151, DOI 10.1104/pp.105.067371; Sullivan S, 2008, MOL PLANT, V1, P178, DOI 10.1093/mp/ssm017; Sullivan S, 2016, PLANT J, V88, P907, DOI 10.1111/tpj.13313; Sullivan S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00290; Sullivan S, 2016, NEW PHYTOL, V209, P612, DOI 10.1111/nph.13640; Sullivan S, 2009, FEBS LETT, V583, P2187, DOI 10.1016/j.febslet.2009.06.011; Takemiya A, 2005, PLANT CELL, V17, P1120, DOI 10.1105/tpc.104.030049; Takemiya A, 2016, J PLANT RES, V129, P167, DOI 10.1007/s10265-015-0780-1; Takemiya A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3094; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Trejo-Tapia G, 2007, BIOTECHNOL PROGR, V23, P359, DOI 10.1021/bp0602597; Tseng TS, 2012, PLANT CELL, V24, P1114, DOI 10.1105/tpc.111.092130; Xu J, 2014, METHODS MOL BIOL, V1171, P91, DOI 10.1007/978-1-4939-0922-3_8; Zhang C, 2005, NAT METHODS, V2, P435, DOI 10.1038/NMETH764	63	7	7	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5613	5623		10.1074/jbc.RA118.001834	http://dx.doi.org/10.1074/jbc.RA118.001834			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475950	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000430044100022
J	Cameron, MF; Frost, KJ; Ver Hoef, JM; Breed, GA; Whiting, AV; Goodwin, J; Boveng, PL				Cameron, Michael F.; Frost, Kathryn J.; Ver Hoef, Jay M.; Breed, Greg A.; Whiting, Alex V.; Goodwin, John; Boveng, Peter L.			Habitat selection and seasonal movements of young bearded seals (Erignathus barbatus) in the Bering Sea	PLOS ONE			English	Article							ST-LAWRENCE ISLAND; ANIMAL MOVEMENT; RESOURCE SELECTION; CHUKCHI SEAS; TELEMETRY DATA; MODEL; ABUNDANCE; DIET; LACTATION; BEHAVIOR	The first year of life is typically the most critical to a pinniped's survival, especially for Arctic phocids which are weaned at only a few weeks of age and left to locate and capture prey on their own. Their seasonal movements and habitat selection are therefore important factors in their survival. During a cooperative effort between scientists and subsistence hunters in October 2004, 2005, and 2006, 13 female and 13 male young (i.e., age <2) bearded seals (Erignathus barbatus) were tagged with satellite-linked dive recorders (SDRs) in Kotzebue Sound, Alaska. Shortly after being released, most seals moved south with the advancing sea-ice through the Bering Strait and into the Bering Sea where they spent the winter and early spring. The SDRs of 17 (8 female and 9 male) seals provided frequent high-quality positions in the Bering Sea; their data were used in our analysis. To investigate habitat selection, we simulated 20 tracks per seal by randomly selecting from the pooled distributions of the absolute bearings and swim speeds of the tagged seals. For each point in the observed and simulated tracks, we obtained the depth, sea-ice concentration, and the distances to sea-ice, open water, the shelf break and coastline. Using logistic regression with a stepwise model selection procedure, we compared the simulated tracks to those of the tagged seals and obtained a model for describing habitat selection. The regression coefficients indicated that the bearded seals in our study selected locations near the ice edge. In contrast, aerial surveys of the bearded seal population, predominantly composed of adults, indicated higher abundances in areas farther north and in heavier pack ice. We hypothesize that this discrepancy is the result of behavioral differences related to age. Ice concentration was also shown to be a statistically significant variable in our model. All else being equal, areas of higher ice concentration are selected for up to about 80%. The effects of sex and bathymetry were not statistically significant. The close association of young bearded seals to the ice edge in the Bering Sea is important given the likely effects of climate warming on the extent of sea-ice and subsequent changes in ice edge habitat.	[Cameron, Michael F.; Ver Hoef, Jay M.; Boveng, Peter L.] NOAA, Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98177 USA; [Frost, Kathryn J.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Breed, Greg A.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Whiting, Alex V.; Goodwin, John] Native Village Kotzebue, Kotzebue, AK USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Cameron, MF (corresponding author), NOAA, Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98177 USA.	michael.cameron@noaa.gov	Hoef, Jay M Ver/C-8577-2017	Cameron, Michael/0000-0002-5961-6796	Tribal Wildlife Grants Program of the U.S. Fish and Wildlife Service [U-4-IT]; NOAAs National Marine Fisheries Service	Tribal Wildlife Grants Program of the U.S. Fish and Wildlife Service; NOAAs National Marine Fisheries Service(National Oceanic Atmospheric Admin (NOAA) - USA)	This study was funded by the Tribal Wildlife Grants Program of the U.S. Fish and Wildlife Service (https://www.fws.gov/nativeamerican/grants.html; Grant no. U-4-IT awarded to AVW and KJF) and received significant additional support from NOAAs National Marine Fisheries Service.; This project was designed as a cooperative effort, combining the expertise of biologists' at data analysis, handling and tagging seals, and the knowledge of Kotzebue-area Alaska Natives about the local distribution and habits of bearded seals and traditional hunting methods. Many people and institutions were involved in this project and were critical to its success. In particular, we would like to thank Willie Goodwin, Ross Schaeffer, John Goodwin, Chuck Schaeffer, Rob Delong, Gay Sheffield, Cyrus Harris, Doc Harris, Grover Harris, Lee Harris, Brenda Goodwin, Pearl Goodwin, Dan Savetilik, Tom Jones, Lloyd Lowry, the Alaska Department of Fish and Game and the Selawik National Wildlife Refuge. This study was funded by the Tribal Wildlife Grants Program of the U.S. Fish and Wildlife Service (https://www.fws.gov/nativearnerican/grants.html; Grant no. U-4-IT awarded to AVW and KJF) and received significant additional support from NOAA's National Marine Fisheries Service. All work was conducted in accordance with and under the authority of United States Marine Mammal Protection Act Scientific Research Permits 358-1585 and 358-1787. The project was reviewed and approved by the State of Alaska Institutional Animal Care and Use Committee (IACUC) Permit No. 06-16 in 2007-2009. All satellite telemetry and associated metadata are archived and available through the Research Workspace DataONE member node at https://dx.doi.org/10. 24431/rw1k118 [69]. More detailed project information, along with maps and field photos pictures can be found at: www.kotzebueira.org/environmental-projects/young-bearded-seal/index/html	ANTONELIS GA, 1994, ARCTIC, V47, P74; Barnard G., 1963, J R STAT SOC B, V25, P294; Blackwell PG, 1997, ECOL MODEL, V100, P87, DOI 10.1016/S0304-3800(97)00153-1; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Boyd JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063051; Braham HW, 1981, DISTRIBUTION DENSITY; Burns J.J., 1981, P145; Burns JJ, 1983, ENV ASSESSMENT ALASK, V19, P311; Burns JJ, 1979, 02500253 AL DEP FISH; Burns JJ, 1967, PACIFIC BEARDED SEAL; BURNS JJ, 2002, ENCY MARINE MAMMALS, P39; Burns JJ, 1977, ENV ASSESSMENT ALASK, V1, P58; Cameron M, 2017, SATELLITE TELEMETRY; Cavalieri D. J., 2004, AMSR E AQUA DAILY L3; Christ A, 2008, ENVIRON ECOL STAT, V15, P27, DOI 10.1007/s10651-007-0036-x; CLS, 2013, ARG US MAN; Conn PB, 2014, METHODS ECOL EVOL, V5, P1280, DOI 10.1111/2041-210X.12127; Cooper LW, 2002, MAR ECOL PROG SER, V226, P13, DOI 10.3354/meps226013; Crawford JA, 2015, PROG OCEANOGR, V136, P133, DOI 10.1016/j.pocean.2015.05.011; Crawford JA, 2012, POLAR BIOL, V35, P241, DOI 10.1007/s00300-011-1067-1; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Eisner L, 2013, POLAR BIOL, V36, P87, DOI 10.1007/s00300-012-1241-0; FAY FH, 1974, OCEANOGRAPHY BERING, P383; Fedoseev G.A., 1984, P130; Fedoseev G. A., 2000, POPULATION BIOL ICE; Fedoseev GA, 1965, IZV TINRO, V65, P212; FELTZ ET, 1966, CRYOBIOLOGY, V3, P261, DOI 10.1016/S0011-2240(66)80020-2; Fetterer F., 2016, **DATA OBJECT**; FINLEY KJ, 1983, ARCTIC, V36, P82; Fiscus CH, 1976, BASELINE CHARACTERIZ; Forester JD, 2009, ECOLOGY, V90, P3554, DOI 10.1890/08-0874.1; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Frost KJ, 2005, P 16 BIENN C BIOL MA, P98; Gjertz I, 2000, POLAR BIOL, V23, P559, DOI 10.1007/s003000000121; Grebmeier J, 2009, PACMARS SURFACE SEDI; Grebmeier JM, 2015, PROG OCEANOGR, V136, P92, DOI 10.1016/j.pocean.2015.05.006; Heptner LVG, 1976, MAMMALS SOVIET UNI 3, VII, P166; Hoef JMV, 2014, STAT METHODOL, V17, P46, DOI 10.1016/j.stamet.2013.03.001; Hooten M. B., 2017, ANIMAL MOVEMENT STAT; Hooten MB, 2010, J AGR BIOL ENVIR ST, V15, P523, DOI 10.1007/s13253-010-0038-2; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Johnson DS, 2008, BIOMETRICS, V64, P968, DOI 10.1111/j.1541-0420.2007.00943.x; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; KINGSLEY MCS, 1985, CAN J FISH AQUAT SCI, V42, P1189, DOI 10.1139/f85-147; Kosygin G. M., 1971, IZV TINRO, V75, P144; Kovacs K. M., 2002, ENCY MARINE MAMMALS, P84; Krafft BA, 2000, CAN J ZOOL, V78, P1408, DOI 10.1139/cjz-78-8-1408; Lauth R, 2011, RESULTS 2010 E NO BE; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; LOWRY LF, 1980, ARCTIC, V33, P330; LOWRY LF, 1987, CAN FIELD NAT, V101, P6; Lydersen C, 1999, MAR ECOL PROG SER, V187, P265, DOI 10.3354/meps187265; Manly B.F.J., 2002, RESOURCE SELECTION A; Manly BFJ, 1997, RANDOMIZATION BOOTST; McClintock BT, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0021-6; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; National Marine Fisheries Service, 2012, FED REGISTER, P76739; NELSON RR, 1984, MARINE MAMMAL SPECIE, V7, P1; Potts JR, 2014, METHODS ECOL EVOL, V5, P253, DOI 10.1111/2041-210X.12150; Quakenbush L. T., 2011, BIOL BEARDED SEAL ER; R Core Development Team, 2015, R LANG ENV STAT COMP; R Core Team, 2018, R LANG ENV STAT COMP; Simpkins MA, 2003, POLAR BIOL, V26, P577, DOI 10.1007/s00300-003-0527-7; Smith TG., 1981, 1042 DEP FISH OC ARC; Waring GT, 2010, STATUS REV BEARDED S; Whiting A., 2011, COMBINING INUPIAQ SC; Young BG, 2010, POLAR BIOL, V33, P153, DOI 10.1007/s00300-009-0693-3	68	20	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192743	10.1371/journal.pone.0192743	http://dx.doi.org/10.1371/journal.pone.0192743			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489846	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000041
J	Dona, D; Zingarella, S; Gastaldi, A; Lundin, R; Perilongo, G; Frigo, AC; Hamdy, RF; Zaoutis, T; Da Dalt, L; Giaquinto, C				Dona, Daniele; Zingarella, Silvia; Gastaldi, Andrea; Lundin, Rebecca; Perilongo, Giorgio; Frigo, Anna Chiara; Hamdy, Rana F.; Zaoutis, Theoklis; Da Dalt, Liviana; Giaquinto, Carlo			Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia	PLOS ONE			English	Article							ANTIBACTERIAL DRUG-USE; KLEBSIELLA-PNEUMONIAE; CHILDREN; RESISTANCE; EPIDEMIOLOGY; INFECTIONS; MANAGEMENT; RISK	Background Italian pediatric antimicrobial prescription rates are among the highest in Europe. As a first step in an Antimicrobial Stewardship Program, we implemented a Clinical Pathway (CP) for Community Acquired Pneumonia with the aim of decreasing overall prescription of antibiotics, especially broad-spectrum. Materials and methods The CP was implemented on 10/01/2015. We collected antibiotic prescribing and outcomes data from children aged 3 months-15 years diagnosed with CAP from 10/15/2014 to 04/15/2015 (pre-intervention period) and from 10/15/2015 to 04/15/2016 (post-intervention period). We assessed antibiotic prescription differences pre-and post-CP, including rates, breadth of spectrum, and duration of therapy. We also compared length of hospital stay for inpatients and treatment failure for inpatients and outpatients. Chi-square and Fisher's exact test were used to compare categorical variables and Wilcoxon rank sum test was used to compare quantitative outcomes. Results 120 pre-and 86 post-intervention clinic visits were identified with a diagnosis of CAP. In outpatients, we observed a decrease in broad-spectrum regimens (50% pre-CP vs. 26.8% post-CP, p = 0.02), in particular macrolides, and an increase in narrow-spectrum (amoxicillin) post-CP. Post-CP children received fewer antibiotic courses (median DOT from 10 pre-CP to 8 post-CP, p<0.0001) for fewer days (median LOT from 10 pre-CP to 8 post-CP, p<0.0001) than their pre-CP counterparts. Physicians prescribed narrow-spectrum mono-therapy more frequently than broad-spectrum combination therapy (DOT/LOT ratio 1.157 pre-CP vs. 1.065 post-CP). No difference in treatment failure was reported before and after implementation (2.3% pre-CP vs. 11.8% post-CP, p = 0.29). Among inpatients we also noted a decrease in broad-spectrum regimens (100% pre-CP vs. 66.7% post-CP, p = 0.02) and the introduction of narrow-spectrum regimens (0% pre-CP vs. 33.3% post-CP, p = 0.02) post-CP. Hospitalized patients received fewer antibiotic courses post-CP (median DOT from 18.5 pre-CP to 10 post-CP, p = 0.004), while there was no statistical difference in length of therapy (median LOT from 11 pre-CP to 10 post-CP, p = 0.06). Days of broad spectrum therapy were notably lower post-CP (median bsDOT from 17 pre-CP to 4.5 postCP, p<0.0001). No difference in treatment failure was reported before and after CP implementation (16.7% pre-CP vs. 15.4% post-CP, p = 1). Conclusions Introduction of a CP for CAP in a Pediatric Emergency Department led to reduction of broad-spectrum antibiotic prescriptions, of combination therapy and of duration of treatment both for outpatients and inpatients.	[Dona, Daniele; Zaoutis, Theoklis] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Dona, Daniele; Zaoutis, Theoklis] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA; [Dona, Daniele; Gastaldi, Andrea; Giaquinto, Carlo] Univ Padua, Div Pediat Infect Dis, Dept Woman & Child Hlth, Padua, Italy; [Dona, Daniele; Lundin, Rebecca; Giaquinto, Carlo] PENTA Fdn, Padua, Italy; [Zingarella, Silvia] Univ Padua, Dept Woman & Child Hlth, Pediat Emergency Dept, Padua, Italy; [Perilongo, Giorgio] Univ Padua, Dept Woman & Child Hlth, Padua, Italy; [Frigo, Anna Chiara] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Biostat Epidemiol & Publ Hlth Unit, Padua, Italy; [Hamdy, Rana F.] Childrens Natl Hlth Syst, Dept Pediat, Washington, DC USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Padua; University of Padua; University of Padua; University of Padua; Children's National Health System	Dona, D (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA.; Dona, D (corresponding author), Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA.; Dona, D (corresponding author), Univ Padua, Div Pediat Infect Dis, Dept Woman & Child Hlth, Padua, Italy.; Dona, D (corresponding author), PENTA Fdn, Padua, Italy.	daniele.dona@phd.unipd.it	Giaquinto, Carlo/AAB-5016-2020; Donà, Daniele/W-7088-2019	Donà, Daniele/0000-0001-7105-2105; Gastaldi, Andrea/0000-0002-8110-210X; Lundin, Rebecca/0000-0002-8380-4834; PERILONGO, GIORGIO/0000-0002-3712-0386; GIAQUINTO, CARLO/0000-0001-9365-0413				Ambroggio L, 2013, PEDIATRICS, V131, pE1623, DOI 10.1542/peds.2012-2635; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Bradley JS, 2010, PEDIATR INFECT DIS J, V29, P1043, DOI 10.1097/INF.0b013e3181f42a53; Bratu S, 2005, ANTIMICROB AGENTS CH, V49, P3018, DOI 10.1128/AAC.49.7.3018-3020.2005; Center for Disease Control and Prevention, 2015, AMB HLTH CAR DAT; Clavenna A, 2011, ARCH DIS CHILD, V96, P590, DOI 10.1136/adc.2010.183541; De Luca M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154662; Don M, 2010, ACTA PAEDIATR, V99, P1602, DOI 10.1111/j.1651-2227.2010.01924.x; Frei CR, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-188; Gagliotti C, 2014, USO ANTIBIOTICI RESI; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hasegawa J, 2015, PEDIATR INT, V57, P582, DOI 10.1111/ped.12587; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Jenkins TC, 2013, AM J MED, V126, P327, DOI 10.1016/j.amjmed.2012.10.027; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Launay E, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0661-3; Leyenaar JK, 2014, J PEDIATR-US, V165, P585, DOI 10.1016/j.jpeds.2014.04.062; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Nascimento-Carvalho CM, 2008, PEDIATR INFECT DIS J, V27, P939, DOI 10.1097/INF.0b013e3181723751; Pakyz AL, 2008, ARCH INTERN MED, V168, P2254, DOI 10.1001/archinte.168.20.2254; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Polk RE, 2011, CLIN INFECT DIS, V53, P1100, DOI 10.1093/cid/cir672; Polk RE, 2007, CLIN INFECT DIS, V44, P664, DOI 10.1086/511640; Rosenblut A, 2006, ANN OTO RHINOL LARYN, V115, P186, DOI 10.1177/000348940611500305; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Samore MH, 2005, JAMA-J AM MED ASSOC, V294, P2305, DOI 10.1001/jama.294.18.2305; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Simbalista R, 2011, CLINICS, V66, P95, DOI 10.1590/S1807-59322011000100017; Smith J, 2012, PEDIATRICS, V129, pE1326, DOI 10.1542/peds.2011-2412; South M, 2003, MED J AUSTRALIA, V178, P207, DOI 10.5694/j.1326-5377.2003.tb05163.x; Stein RT, 2007, PEDIATR PULM, V42, P1095, DOI 10.1002/ppul.20652; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; WATANABE M, 1991, ANTIMICROB AGENTS CH, V35, P147, DOI 10.1128/AAC.35.1.147; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001	36	19	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193581	10.1371/journal.pone.0193581	http://dx.doi.org/10.1371/journal.pone.0193581			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489898	Green Published, gold			2022-12-26	WOS:000426276000092
J	Holtzman, O; Usherwood, T				Holtzman, Orit; Usherwood, Tim			Australian general practitioners' knowledge, attitudes and practices towards breastfeeding	PLOS ONE			English	Article							PHYSICIANS; PEDIATRICIANS; LACTATION; EDUCATION; RISK; GYNECOLOGISTS; EXPERIENCES; BELIEFS; WOMEN	The aim of this study was to explore the knowledge, attitudes and practices of established general practitioners (GPs) in relation to breastfeeding. 10 GPs in the Australian Nepean Blue Mountains Health District were interviewed and the interviews transcribed and analyzed thematically. Emergent themes from each interview were identified and then compared between and across the 10 interviews. Five themes emerged following the analysis: breastfeeding knowledge and training; attitudes towards breastfeeding; GPs' role in relation to breast feeding; GPs' practices; influence of male gender. All the GPs interviewed had positive attitudes towards breastfeeding, however they were often lacking in knowledge and conviction to be able to provide strong support to women during their breastfeeding journey. Some reported ambivalence in their encouragement of breastfeeding due to their desire to maintain a good relationship with women who chose not to feed this way. Nine of the GPs had little or no formal breastfeeding training and relied mainly on personal experience. Their clinics did not provide formal breastfeeding support including a written breastfeeding friendly policy and most GPs were not proactive in creating such an environment. We hope that the results from this study will assist in developing breastfeeding policies and professional education to support GPs in this role.	[Holtzman, Orit; Usherwood, Tim] Univ Sydney, Dept Gen Practice, Sydney Med Sch Westmead, Sydney, NSW, Australia; [Holtzman, Orit] Hornsby Ku Ring Gai Hosp, Hornsby, NSW, Australia	University of Sydney	Holtzman, O (corresponding author), Univ Sydney, Dept Gen Practice, Sydney Med Sch Westmead, Sydney, NSW, Australia.; Holtzman, O (corresponding author), Hornsby Ku Ring Gai Hosp, Hornsby, NSW, Australia.	ohol8210@uni.sydney.edu.au			GP Synergy medical student scholarship	GP Synergy medical student scholarship	Orit Holtzman's work was supported by GP Synergy medical student scholarship (https://gpsynergy.com.au/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nassaj H H, 2004, East Mediterr Health J, V10, P871; Amir LH, 2009, MED J AUSTRALIA, V191, P126, DOI 10.5694/j.1326-5377.2009.tb02712.x; Anchondo I, 2012, SOUTH MED J, V105, P243, DOI 10.1097/SMJ.0b013e3182522927; Australian Institute of Health and Welfare, 2011, 2010 AUSTR NAT INF F; Ayton J, 2015, AUST J PRIM HEALTH, V21, P299, DOI 10.1071/PY13152; BARNETT E, 1995, BIRTH-ISS PERINAT C, V22, P15; Bentley M E, 1999, J Hum Lact, V15, P27, DOI 10.1177/089033449901500109; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brodribb W E, 2007, Rural Remote Health, V7, P737; Brodribb W, 2008, J HUM LACT, V24, P422, DOI 10.1177/0890334408323547; Brodribb W, 2008, MATERN CHILD NUTR, V4, P264, DOI 10.1111/j.1740-8709.2008.00141.x; Brodribb W, 2007, AUST FAM PHYSICIAN, V36, P283; Brodribb Wendy, 2010, Breastfeed Rev, V18, P5; Brodribb W, 2009, AUST FAM PHYSICIAN, V38, P26; Brodribb WE, 2014, MATERN CHILD HLTH J, V18, P1591, DOI 10.1007/s10995-013-1398-3; Burglehaus MJ, 1997, CAN J PUBLIC HEALTH, V88, P383, DOI 10.1007/BF03403911; Burt S, 2006, MATERN CHILD NUTR, V2, P91, DOI 10.1111/j.1740-8709.2006.00046.x; Chen Chao-Huei, 2001, Acta Paediatrica Taiwanica, V42, P207; COUNSILMAN JJ, 1983, AUST NZ J OBSTET GYN, V23, P208, DOI 10.1111/j.1479-828X.1983.tb00580.x; DEWEY KG, 1993, AM J CLIN NUTR, V58, P162, DOI 10.1093/ajcn/58.2.162; DiGirolamo AM, 2003, BIRTH-ISS PERINAT C, V30, P94, DOI 10.1046/j.1523-536X.2003.00227.x; Finneran B, 2004, Ir Med J, V97, P268; FREED GL, 1995, JAMA-J AM MED ASSOC, V273, P472, DOI 10.1001/jama.273.6.472; FREED GL, 1995, J FAM PRACTICE, V40, P263; Goldstein A O, 1993, Fam Med, V25, P524; Grawey AE, 2013, BREASTFEED MED, V8, P237, DOI 10.1089/bfm.2013.9994; Guise JM, 2000, BIRTH-ISS PERINAT C, V27, P49, DOI 10.1046/j.1523-536x.2000.00049.x; Holmes AV, 2012, BREASTFEED MED, V7, P403, DOI 10.1089/bfm.2012.0028; Ingram J, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-9; Kim HS, 1996, SOUTHERN MED J, V89, P684, DOI 10.1097/00007611-199607000-00007; Li L, 2004, J HUM LACT, V20, P188, DOI 10.1177/0890334404263992; Lu MC, 2001, OBSTET GYNECOL, V97, P290, DOI 10.1016/S0029-7844(00)01116-9; Meyers D, 2001, AM FAM PHYSICIAN, V64, P931; Nakar S, 2007, ACTA PAEDIATR, V96, P848, DOI 10.1111/j.1651-2227.2007.00310.x; Newcomb C, 2009, NEW BEGINNINGS, V299, P56; NEWCOMB PA, 1994, NEW ENGL J MED, V330, P81, DOI 10.1056/NEJM199401133300201; ROSENBLATT KA, 1993, INT J EPIDEMIOL, V22, P192, DOI 10.1093/ije/22.2.192; ROSENBLATT KA, 1995, INT J EPIDEMIOL, V24, P499, DOI 10.1093/ije/24.3.499; Scott J., 2003, BREASTFEEDING OPINIO; Sulaiman Z, 2016, J ADV NURS, V72, P825, DOI 10.1111/jan.12884; Taveras EM, 2003, PEDIATRICS, V112, P108, DOI 10.1542/peds.112.1.108; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO (World Health Organization), 2011, EXCLUSIVE BREASTFEED; WILLIAMS EL, 1995, AM J PREV MED, V11, P26, DOI 10.1016/S0749-3797(18)30497-5; World Health Organization, 2007, P CONCL CONS M WASH	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191854	10.1371/journal.pone.0191854	http://dx.doi.org/10.1371/journal.pone.0191854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489841	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000011
J	Kong, TH; Yu, S; Jung, B; Choi, JS; Seo, YJ				Kong, Tae Hoon; Yu, Sunkon; Jung, Byungjo; Choi, Jin Sil; Seo, Young Joon			Monitoring blood-flow in the mouse cochlea using an endoscopic laser speckle contrast imaging system	PLOS ONE			English	Article							INFERIOR CEREBELLAR ARTERY; SENSORINEURAL HEARING-LOSS; GERBIL COCHLEA; GUINEA-PIGS; ISCHEMIA; FLOWGRAPHY; OCCLUSION; PATHOLOGY; EXPOSURE; DOPPLER	Laser speckle contrast imaging (LSCI) enables continuous high-resolution assessment of microcirculation in real-time. We applied an endoscope to LSCI to measure cochlear blood-flow in an ischemia-reperfusion mouse model. We also explored whether using xenon light in combination with LSCI facilitates visualization of anatomical position. Based on a previous preliminary study, the appropriate wavelength for penetrating the thin bony cochlea was 830 nm. A 2.7-mm-diameter endoscope was used, as appropriate for the size of the mouse cochlea. Our endoscopic LSCI system was used to illuminate the right cochlea after dissection of the mouse. We observed changes in the speckle signals when we applied the endoscopic LSCI system to the ischemia-reperfusion mouse model. The anatomical structure of the mouse cochlea and surrounding structures were clearly visible using the xenon light. The speckle signal of the cochlea was scattered, with an intensity that varied between that of the stapes (with the lowest signal), the negative control, and the stapedial artery (with the highest signal), the positive control. In the cochlear ischemia-reperfusion mouse model, the speckle signal of the cochlea decreased during the ischemic phase, and increased during the reperfusion phase, clearly reflecting cochlear blood-flow. The endoscopic LSCI system generates high-resolution images in real-time, allowing visualization of blood-flow and its changes in the mouse cochlea. Anatomical structures were clearly matched using LSCI along with visible light.	[Kong, Tae Hoon; Choi, Jin Sil; Seo, Young Joon] Yonsei Univ, Wonju Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Wonju, South Korea; [Yu, Sunkon; Jung, Byungjo] Yonsei Univ, Coll Hlth Sci, Dept Biomed Engn, Wonju, South Korea	Yonsei University; Yonsei University	Seo, YJ (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Wonju, South Korea.	okas2000@hanmail.net	KONG, TAEHOON/AAG-5079-2020; Seo, Young Joon/AAS-6148-2021	Kong, Taehoon/0000-0002-5612-5705; Seo, Young Joon/0000-0002-2839-4676	Gangwon Institute for Regional Program Evaluation - Korea government (Ministry of Trade, Industry and Energy) [R0005797]; Ministry of Trade, Industry & Energy (MOTIE, Korea) [10070232]	Gangwon Institute for Regional Program Evaluation - Korea government (Ministry of Trade, Industry and Energy); Ministry of Trade, Industry & Energy (MOTIE, Korea)	This work was supported by the Gangwon Institute for Regional Program Evaluation grant funded by the Korea government (Ministry of Trade, Industry and Energy) (No. R0005797) and by the Technology Innovation Program (or Industrial Strategic Technology Development Program (10070232) funded By the Ministry of Trade, Industry & Energy (MOTIE, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Gangwon Institute for Regional Program Evaluation grant funded by the Korea government (Ministry of Trade, Industry and Energy) (No. R0005797) and by the Technology Innovation Program (or Industrial Strategic Technology Development Program(10070232) funded By the Ministry of Trade, Industry & Energy(MOTIE, Korea).	Ambrus R, 2016, EUR SURG RES, V56, P87, DOI 10.1159/000442790; Badr-el-Dine M, 2002, OTOL NEUROTOL, V23, P631, DOI 10.1097/00129492-200209000-00004; Bennett ML, 2016, OTOL NEUROTOL, V37, P362, DOI 10.1097/MAO.0000000000000988; Bezemer R, 2010, MICROVASC RES, V79, P139, DOI 10.1016/j.mvr.2010.01.004; Cantos R, 2000, P NATL ACAD SCI USA, V97, P11707, DOI 10.1073/pnas.97.22.11707; Davis MA, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086001; Dziennis S, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.106003; Hakuba N, 2000, J COMP NEUROL, V418, P217, DOI 10.1002/(SICI)1096-9861(20000306)418:2<217::AID-CNE7>3.0.CO;2-L; Iwase T, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001256; Kim JS, 1999, NEUROLOGY, V52, P40, DOI 10.1212/WNL.52.1.40; KIMURA R., 1958, ANN OTOL RHINOL AND LARYNGOL, V67, P5; Luft N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168190; Makino Kouji, 1994, Auris Nasus Larynx, V21, P75; MCCABE BF, 1979, ANN OTO RHINOL LARYN, V88, P585, DOI 10.1177/000348947908800501; MILLER JM, 1995, OTOLARYNG HEAD NECK, V112, P101, DOI 10.1016/S0194-5998(95)70308-X; Mom T, 2001, J ACOUST SOC AM, V110, P1477, DOI 10.1121/1.1390337; Mosnier I, 2011, AUDIOL NEURO-OTOL, V16, P55, DOI 10.1159/000312640; Nakashima T, 2006, CLIN OTOLARYNGOL, V31, P110, DOI 10.1111/j.1749-4486.2006.01151.x; Nakashima T, 2003, BRAIN RES REV, V43, P17, DOI 10.1016/S0165-0173(03)00189-9; Nakashima T, 2001, HEARING RES, V162, P85, DOI 10.1016/S0378-5955(01)00372-0; Nuttall Alfred L., 1999, Noise Health, V2, P17; Ogawa K, 1996, ACTA OTO-LARYNGOL, V116, P253, DOI 10.3109/00016489609137835; PERLMAN H B, 1959, Laryngoscope, V69, P591; Ponticorvo A, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.090501; Reif R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052041; Ren TY, 1995, HEARING RES, V92, P30, DOI 10.1016/0378-5955(95)00192-1; REN TY, 1994, J APPL PHYSIOL, V76, P212, DOI 10.1152/jappl.1994.76.1.212; SANTI PA, 1978, OTOLARYNG HEAD NECK, V86, P354, DOI 10.1177/019459987808600229; Santi PA, 2008, HEARING RES, V243, P11, DOI 10.1016/j.heares.2008.04.014; SEIDMAN MD, 1992, EUR ARCH OTO-RHINO-L, V249, P332; Shi XR, 2011, HEARING RES, V282, P10, DOI 10.1016/j.heares.2011.08.006; Shiga Y, 2016, CURR EYE RES, V41, P1447, DOI 10.3109/02713683.2015.1127974; Shiga Y, 2013, CURR EYE RES, V38, P691, DOI 10.3109/02713683.2012.758292; Shim HS, 2017, J AUDIOL OTOL, V21, P33, DOI 10.7874/jao.2017.21.1.33; Spicer SS, 2002, HEARING RES, V172, P172, DOI 10.1016/S0378-5955(02)00581-6; Subhash HM, 2011, IEEE T MED IMAGING, V30, P224, DOI 10.1109/TMI.2010.2072934; Suzuki T, 1998, ANN OTO RHINOL LARYN, V107, P648, DOI 10.1177/000348949810700803; THORNE PR, 1987, HEARING RES, V27, P1, DOI 10.1016/0378-5955(87)90021-9; VAN DISHOECK H A, 1957, Ann Otol Rhinol Laryngol, V66, P963; Vaz Pedro G, 2016, IEEE Rev Biomed Eng, V9, P106, DOI 10.1109/RBME.2016.2532598; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Yamamoto H, 2003, HEARING RES, V186, P69, DOI 10.1016/S0378-5955(03)00310-1; Yazawa Y, 1998, ORL J OTO-RHINO-LARY, V60, P4, DOI 10.1159/000027554	43	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191978	10.1371/journal.pone.0191978	http://dx.doi.org/10.1371/journal.pone.0191978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489849	gold, Green Submitted, Green Published			2022-12-26	WOS:000426276000013
J	Zhang, R; Ji, QL; Han, DL; Wan, HJ; Li, XJ; Luo, G; Xue, SL; Ma, SS; Yang, MM; Li, JQ				Zhang, Rui; Ji, Qiaoli; Han, Dianlei; Wan, Haijin; Li, Xiujuan; Luo, Gang; Xue, Shuliang; Ma, Songsong; Yang, Mingming; Li, Jianqiao			Phalangeal joints kinematics in ostrich (Struthio camelus) locomotion on sand	PLOS ONE			English	Article							BIPEDAL LOCOMOTION; MECHANICS; RATITES; SPEED; BIRDS	In ostriches, the toes are the only body parts that contact loose sand surfaces. Thus, toe interphalangeal joint motions may play vital biomechanical roles. However, there is little research on ostrich phalangeal joint movements while walking or running on sand. The results from the three-dimensional motion track analysis system Simi Motion show that gait pattern has no significant effect on the key indicators (angles at touch-down, mid-stance, liftoff and range of motion) of the toe joint angles. The motion of the toe phalanges when walking and running on sand is basically the same. The ground medium is the key factor that changes the toe postures adopted by ostriches during the stance phase in slow to fast locomotion. The 3rd toe and the 4th toe are connected by the interphalangeal ligament, and the motions of the MTP3 and MTP4 joints are highly synchronized on a loose sand substrate. The 3rd toe and 4th toe are coupled to maintain static balance in slow locomotion and dynamic balance in fast locomotion. In addition, the gait pattern has a marked effect on the range of forward displacement of the toenail (Y-TN). The ostrich toenail plays an important role in preventing slip and provides traction at push-off in a sandy environment. The metatarsophalangeal joint plays an important role in energy saving during fast locomotion on loose sand substrates. Simulation reveals that the particle velocity field, particle force field and sand particle disturbance in the running gait are denser than those in the walking gait.	[Zhang, Rui; Ji, Qiaoli; Han, Dianlei; Wan, Haijin; Li, Xiujuan; Luo, Gang; Xue, Shuliang; Ma, Songsong; Yang, Mingming; Li, Jianqiao] Jilin Univ, Key Lab Bion Engn, Minist Educ, Changchun, Jilin, Peoples R China	Jilin University	Zhang, R (corresponding author), Jilin Univ, Key Lab Bion Engn, Minist Educ, Changchun, Jilin, Peoples R China.	zhangrui@jlu.edu.cn		Zhang, Rui/0000-0001-9933-2475	National Natural Science Foundation of China [51675221, 51275199]; Science and Technology Development Planning Project of Jilin Province of China [20180101077JC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning Project of Jilin Province of China	This study was supported by: the National Natural Science Foundation of China 51675221, the National Natural Science Foundation of China 51275199, and the Science and Technology Development Planning Project of Jilin Province of China 20180101077JC.	Abourachid A, 2000, IBIS, V142, P538, DOI 10.1111/j.1474-919X.2000.tb04455.x; ALEXANDER RM, 1979, J ZOOL, V187, P169; Deeming D. C., 2003, OSTRICH BIOL PRODUCT; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; El-Gendy SAA, 2012, VET RES COMMUN, V36, P129, DOI 10.1007/s11259-012-9522-1; Falkingham PL, 2014, P NATL ACAD SCI USA, V111, P18279, DOI 10.1073/pnas.1416252111; FOWLER ME, 1991, J ZOO WILDLIFE MED, V22, P204; Fung Y.C., 1993, BIOMECHANICS MECH PR; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; Li C, 2013, SCIENCE, V339, P1408, DOI 10.1126/science.1229163; Li C, 2012, J EXP BIOL, V215, P3293, DOI 10.1242/jeb.061937; Rubenson J, 2004, P ROY SOC B-BIOL SCI, V271, P1091, DOI 10.1098/rspb.2004.2702; Rubenson J, 2007, J EXP BIOL, V210, P2548, DOI 10.1242/jeb.02792; Rubenson J, 2011, J R SOC INTERFACE, V8, P740, DOI 10.1098/rsif.2010.0466; Rui Z., 2017, PEERJ, V5, pe2587; Schache AG, 2011, MED SCI SPORT EXER, V43, P1260, DOI 10.1249/MSS.0b013e3182084929; Schaller NU, 2009, J ANAT, V214, P830, DOI 10.1111/j.1469-7580.2009.01083.x; Schaller NU, 2011, J EXP BIOL, V214, P1123, DOI 10.1242/jeb.043596; Stoessel A, 2012, J EXP BIOL, V215, P4055, DOI 10.1242/jeb.070458; WILLIAMS JB, 1993, ECOLOGY, V74, P390, DOI 10.2307/1939301; Zeng, 2014, THESIS; [张锐 Zhang Rui], 2017, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V48, P49	22	7	7	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191986	10.1371/journal.pone.0191986	http://dx.doi.org/10.1371/journal.pone.0191986			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489844	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000015
J	Clow, KM; Ogden, NH; Lindsay, LR; Russell, CB; Michel, P; Pearl, DL; Jardine, CM				Clow, Katie M.; Ogden, Nicholas H.; Lindsay, L. Robbin; Russell, Curtis B.; Michel, Pascal; Pearl, David L.; Jardine, Claire M.			A field-based indicator for determining the likelihood of Ixodes scapularis establishment at sites in Ontario, Canada	PLOS ONE			English	Article							AMBLYOMMA-AMERICANUM ACARI; PASSIVE SURVEILLANCE; BORRELIA-BURGDORFERI; LONG POINT; ANAPLASMA-PHAGOCYTOPHILUM; RELATIVE-HUMIDITY; RANGE EXPANSION; IXODIDAE; HABITAT; INFECTION	The emergence of the vector Ixodes scapularis in Ontario, Canada poses a significant public health risk. Both passive and active surveillance approaches have been employed by public health professionals (i.e., government employees) to monitor for the range expansion of this tick. Field surveillance using drag sampling for questing ticks is a recognized and effective method to identify reproducing tick populations. The degree of effort (i.e., number of visits per site) can enhance the sensitivity and specificity of surveillance, but increased effort conflicts with the cost to public health for field surveillance. Here we developed an indicator to determine the likelihood of I. scapularis establishment based on field sampling results. Field data from two established populations of I. scapularis in Ontario were incorporated with previous analyses of surveillance data to create the indicator, which is in the form of a scoring system. The life stage(s) collected, overall abundance and past surveillance findings from a site are all considered and a level is assigned for the likelihood of I. scapularis establishment based on current field sampling results. The likelihood levels are non-zero (i.e., no I. scapularis detected, but risk still present due to adventitious ticks), low, medium or high, and recommendations for future surveillance and public health measures are provided. The indicator was validated against field sampling results from five other established sites in the province and correctly categorized all five areas as high likelihood of establishment. The indicator was also applied to field sampling results from 36 sites of unknown status that were visited twice during the period of 2014-2016. There was substantial agreement of levels between measurements, as calculated using a weighted kappa. The indicator can assist public health professionals with the interpretation of field sampling results and direct their efforts for ongoing surveillance and public health interventions for I. scapularis-borne diseases, including Lyme disease.	[Clow, Katie M.; Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON, Canada; [Ogden, Nicholas H.] Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada; [Lindsay, L. Robbin] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Russell, Curtis B.] Publ Hlth Ontario, Enter Zoonot & Vector Borne Dis, Communicable & Infect Dis Prevent & Control, Toronto, ON, Canada; [Michel, Pascal] Publ Hlth Agcy Canada, Off Chief Sci Officer, Ottawa, ON, Canada; [Pearl, David L.] Univ Guelph, Dept Populat Med, Ontario Vet Coll, Guelph, ON, Canada; [Jardine, Claire M.] Univ Guelph, Ontario Vet Coll, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada	University of Guelph; Public Health Agency of Canada; Public Health Agency of Canada; Public Health Agency of Canada; University of Guelph; University of Guelph	Clow, KM (corresponding author), Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON, Canada.	kclow@uoguelph.ca			Public Health Agency of Canada; Natural Sciences and Engineering Research Council; Canadian Wildlife Health Cooperative; Ontario Veterinary College Fellowship; Blake Graham Fellowship	Public Health Agency of Canada; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Wildlife Health Cooperative; Ontario Veterinary College Fellowship; Blake Graham Fellowship	This work was supported by the Public Health Agency of Canada, www.phac-aspc.gc.ca; Natural Sciences and Engineering Research Council, http://www.nserc-crsng.gc.ca; Canadian Wildlife Health Cooperative, www.cwhc-rcsf.ca. KMC received stipend support from an Ontario Veterinary College Fellowship, a PostGraduate Scholarship-Doctoral from the Natural Sciences and Engineering Research Council and a Blake Graham Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NHO, LRL and PM are all employees of the PHAC and CMJ is affiliated with CWHC, but they were not directly instructed by the funders.	[Anonymous], 1991, Can J Infect Dis, V2, P49; Berger KA, 2014, J MED ENTOMOL, V51, P769, DOI 10.1603/ME13186; Clow KM, 2017, TICKS TICK-BORNE DIS, V8, P554, DOI 10.1016/j.ttbdis.2017.03.003; Clow KM, 2016, VECTOR-BORNE ZOONOT, V16, P215, DOI 10.1089/vbz.2015.1890; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; Dibernardo A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-183; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Dobson ADM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-344; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Koffi JK, 2012, J MED ENTOMOL, V49, P400, DOI 10.1603/ME11210; Kulkarni MA, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.33; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Lindquist EE., 2016, HDB TICKS CANADA IXO, DOI DOI 10.3752/9780968932186; Lindsay LR, 1999, J MED ENTOMOL, V36, P255, DOI 10.1093/jmedent/36.3.255; Lindsay LR, 1998, J MED ENTOMOL, V35, P189, DOI 10.1093/jmedent/35.3.189; Lindsay LR, 1999, J MED ENTOMOL, V36, P243, DOI 10.1093/jmedent/36.3.243; May RM, 2001, PHILOS T R SOC B, V356, P901, DOI 10.1098/rstb.2001.0866; McPherson M, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP57, 10.1289/ehp57]; Nakajima R, 2009, J VET MED SCI, V71, P55, DOI 10.1292/jvms.71.55; Nelder MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105358; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Ogden NH, 2006, J MED ENTOMOL, V43, P600, DOI 10.1603/0022-2585(2006)43[600:ISTCBP]2.0.CO;2; Ogden NH, 2007, PARASITOLOGY, V134, P209, DOI 10.1017/S0031182006001417; Ogden N H, 2014, Can Commun Dis Rep, V40, P74; Ogden N H, 2015, Can Commun Dis Rep, V41, P132; Ogden N H, 2014, Can Commun Dis Rep, V40, P83; Ogden NH, 2004, J MED ENTOMOL, V41, P622, DOI 10.1603/0022-2585-41.4.622; Ogden NH, 2006, J MED ENTOMOL, V43, P403, DOI 10.1603/0022-2585(2006)043[0403:IOGLAR]2.0.CO;2; Ogden NH, 2013, J APPL ECOL, V50, P510, DOI [10.1111/1365-2664.12050, 10.1111/]; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2016, ONT LYM DIS MAP EST; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2015, ACT TICK DRAGG STAND; SCHOLTEN T, 1977, CAN J PUBLIC HEALTH, V68, P494; Schulze TL, 2005, J MED ENTOMOL, V42, P285, DOI 10.1603/0022-2585(2005)042[0285:IOMAMH]2.0.CO;2; Schulze TL, 2001, ENVIRON ENTOMOL, V30, P568, DOI 10.1603/0046-225X-30.3.568; Sider D, 2012, TECHNICAL REPORT; Vail SG, 2002, J MED ENTOMOL, V39, P842, DOI 10.1603/0022-2585-39.6.842	38	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0193524	10.1371/journal.pone.0193524	http://dx.doi.org/10.1371/journal.pone.0193524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29486007	Green Published, gold, Green Submitted			2022-12-26	WOS:000426242400020
J	Ferguson, R; Subramanian, V				Ferguson, Ross; Subramanian, Vasanta			The cellular uptake of angiogenin, an angiogenic and neurotrophic factor is through multiple pathways and largely dynamin independent	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; BREFELDIN-A; NUCLEAR TRANSLOCATION; ENDOCYTIC PATHWAY; TRANSFER-RNA; INHIBITOR; TRANSPORT; LOCALIZATION; RIBONUCLEASE; MICROTUBULE	Angiogenin (ANG), a member of the RNase superfamily (also known as RNase 5) has neurotrophic, neuroprotective and angiogenic activities. Recently it has also been shown to be important in stem cell homeostasis. Mutations in ANG are associated with neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and Fronto-temporal dementia (FTD). ANG is a secreted protein which is taken up by cells and translocated to the nucleus. However, the import pathway/s through which ANG is taken up is/are still largely unclear. We have characterised the uptake of ANG in neuronal, astrocytic and microglial cell lines as well as primary neurons and astrocytes using pharmacological agents as well as dominant negative dynamin and Rab5 to perturb uptake and intracellular trafficking. We find that uptake of ANG is largely clathrin/dynamin independent and microtubule depolymerisation has a marginal effect. Perturbation of membrane ruffling and macropinocytosis significantly inhibited ANG uptake suggesting an uptake mechanism similar to RNase A. Our findings shed light on why mutations which do not overtly affect RNase activity but cause impaired localization are associated with neurodegenerative disease.	[Ferguson, Ross; Subramanian, Vasanta] Univ Bath, Dept Biol & Biochem, Bath, Avon, England	University of Bath	Subramanian, V (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.	bssvss@bath.ac.uk						ACHARYA KR, 1994, P NATL ACAD SCI USA, V91, P2915, DOI 10.1073/pnas.91.8.2915; ALBERTS AW, 1988, AM J CARDIOL, V62, pJ10, DOI 10.1016/0002-9149(88)90002-1; ALEXIANU ME, 1994, J NEUROCHEM, V63, P2365; ALLIOT F, 1984, BRAIN RES, V306, P283, DOI 10.1016/0006-8993(84)90377-9; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Banach-Orlowska M, 2009, BIOCHEM J, V423, P389, DOI 10.1042/BJ20090086; BIEDLER JL, 1973, CANCER RES, V33, P2643; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bosch M, 2004, BIOCHEMISTRY-US, V43, P2167, DOI 10.1021/bi035729+; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Chao TY, 2011, BIOCHEMISTRY-US, V50, P8374, DOI 10.1021/bi2009079; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Christianson HC, 2014, MATRIX BIOL, V35, P51, DOI 10.1016/j.matbio.2013.10.004; Cobbold C, 2004, MOL MEMBR BIOL, V21, P59, DOI 10.1080/096870310001607350; Crabtree B, 2007, BIOCHEMISTRY-US, V46, P11810, DOI 10.1021/bi701333h; Cronin S, 2006, NEUROLOGY, V67, P1833, DOI 10.1212/01.wnl.0000244466.46020.47; DEBRABANDER MJ, 1976, CANCER RES, V36, P905; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Dunmore BJ, 2013, HUM MOL GENET, V22, P3667, DOI 10.1093/hmg/ddt216; Elfenbein A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002495; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Fan TC, 2007, TRAFFIC, V8, P1778, DOI 10.1111/j.1600-0854.2007.00650.x; FETT JW, 1994, BIOCHEMISTRY-US, V33, P5421, DOI 10.1021/bi00184a010; Glotzer JB, 2001, J VIROL, V75, P2421, DOI 10.1128/JVI.75.5.2421-2434.2001; Goncalves KA, 2016, CELL, V166, P894, DOI 10.1016/j.cell.2016.06.042; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Haigis MC, 2003, J CELL SCI, V116, P313, DOI 10.1242/jcs.00214; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; HU GF, 1994, P NATL ACAD SCI USA, V91, P12096, DOI 10.1073/pnas.91.25.12096; HU GF, 1993, P NATL ACAD SCI USA, V90, P1217, DOI 10.1073/pnas.90.4.1217; Hu GF, 1997, P NATL ACAD SCI USA, V94, P2204, DOI 10.1073/pnas.94.6.2204; Humphries WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026626; Irwin ME, 2011, J CELL PHYSIOL, V226, P2316, DOI 10.1002/jcp.22570; Jones SM, 1997, J CELL BIOL, V139, P339, DOI 10.1083/jcb.139.2.339; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; King MC, 2004, P NATL ACAD SCI USA, V101, P8957, DOI 10.1073/pnas.0403167101; Kjeken R, 2001, BIOCHEM J, V357, P497, DOI 10.1042/0264-6021:3570497; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Ledoux S, 2002, CIRC RES, V90, P420, DOI 10.1161/hh0402.105668; Li RS, 1997, BIOCHEM BIOPH RES CO, V238, P305, DOI 10.1006/bbrc.1997.7290; Lixin R, 2001, BIOCHEM BIOPH RES CO, V284, P185, DOI 10.1006/bbrc.2001.4953; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mayor S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016758; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; Norkin LC, 2002, J VIROL, V76, P5156, DOI 10.1128/JVI.76.10.5156-5166.2002; Ohkawa T, 2010, J CELL BIOL, V190, P187, DOI 10.1083/jcb.201001162; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Peng Y, 2014, CELL SIGNAL, V26, P2782, DOI 10.1016/j.cellsig.2014.08.021; Preta G, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0102-1; PRYDZ K, 1992, J CELL BIOL, V119, P259, DOI 10.1083/jcb.119.2.259; Rodriguez M, 2007, J CELL SCI, V120, P1405, DOI 10.1242/jcs.03427; Saponaro C, 2012, IMMUNOPHARM IMMUNOT, V34, P858, DOI 10.3109/08923973.2012.665461; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sever S, 2013, TRAFFIC, V14, P1194, DOI 10.1111/tra.12116; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P2238, DOI 10.1073/pnas.84.8.2238; Sierra A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106048; Skorupa A, 2012, J NEUROSCI, V32, P5024, DOI 10.1523/JNEUROSCI.6366-11.2012; Soncin F, 1997, J BIOL CHEM, V272, P9818; SONCIN F, 1994, J BIOL CHEM, V269, P8999; STENSETH K, 1989, EUR J CELL BIOL, V49, P326; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Subramanian V, 2007, HUM MOL GENET, V16, P1445, DOI 10.1093/hmg/ddm095; Szymanski CJ, 2011, ANALYST, V136, P3527, DOI 10.1039/c0an00855a; Thiyagarajan N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2126; Trouillon R, 2011, CHEM COMMUN, V47, P3421, DOI 10.1039/c0cc04527f; UHLINHANSEN L, 1995, BIOCHEM J, V310, P271, DOI 10.1042/bj3100271; van Es MA, 2009, NEUROLOGY, V72, P287, DOI 10.1212/01.wnl.0000339487.84908.00; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wang YZ, 2000, TRAFFIC, V1, P952, DOI 10.1034/j.1600-0854.2000.011205.x; Wha-Soo Kim, 2006, Communication Sciences and Disorders, V11, P47; Won JS, 2008, J NEUROCHEM, V105, P1536, DOI 10.1111/j.1471-4159.2008.05283.x; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yea C, 2007, J VIROL, V81, P6899, DOI 10.1128/JVI.02330-05; Yoder A, 2011, J VIROL, V85, P3020, DOI 10.1128/JVI.02462-10; Yuyama K, 2006, FEBS LETT, V580, P6972, DOI 10.1016/j.febslet.2006.11.072; Zhang JZ, 2002, NUCLEIC ACIDS RES, V30, P1169, DOI 10.1093/nar/30.5.1169	82	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0193302	10.1371/journal.pone.0193302	http://dx.doi.org/10.1371/journal.pone.0193302			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29486010	gold, Green Published, Green Submitted			2022-12-26	WOS:000426242400017
J	Pak, K; Kim, K; Kim, MH; Eom, JS; Lee, MK; Cho, JS; Kim, YS; Kim, BS; Kim, SJ; Kim, IJ				Pak, Kyoungjune; Kim, Keunyoung; Kim, Mi-Hyun; Eom, Jung Seop; Lee, Min Ki; Cho, Jeong Su; Kim, Yun Seong; Kim, Bum Soo; Kim, Seong Jang; Kim, In Joo			A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT	PLOS ONE			English	Article							DIAGNOSIS; CT	We aimed to develop a decision tree model to improve diagnostic performance of positron emission tomography/computed tomography (PET/CT) to detect metastatic lymph nodes (LN) in non-small cell lung cancer (NSCLC). 115 patients with NSCLC were included in this study. The training dataset included 66 patients. A decision tree model was developed with 9 variables, and validated with 49 patients: short and long diameters of LNs, ratio of short and long diameters, maximum standardized uptake value (SUVmax) of LN, mean houns-field unit, ratio of LN SUVmax and ascending aorta SUVmax (LN/AA), and ratio of LN SUVmax and superior vena cava SUVmax. A total of 301 LNs of 115 patients were evaluated in this study. Nodular calcification was applied as the initial imaging parameter, and LN SUVmax (>= 3.95) was assessed as the second. LN/AA (>= 2.92) was required to high LN SUVmax. Sensitivity was 50% for training dataset, and 40% for validation dataset. However, specificity was 99.28% for training dataset, and 96.23% for validation dataset. In conclusion, we have developed a new decision tree model for interpreting mediastinal LNs. All LNs with nodular calcification were benign, and LNs with high LN SUVmax and high LN/AA were metastatic Further studies are needed to incorporate subjective parameters and pathologic evaluations into a decision tree model to improve the test performance of PET/CT.	[Pak, Kyoungjune; Kim, Keunyoung; Kim, In Joo] Pusan Natl Univ Hosp, Dept Nucl Med, Busan, South Korea; [Pak, Kyoungjune; Kim, Keunyoung; Kim, Mi-Hyun; Eom, Jung Seop; Lee, Min Ki; Cho, Jeong Su; Kim, In Joo] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Kim, Mi-Hyun; Eom, Jung Seop; Lee, Min Ki] Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea; [Cho, Jeong Su] Pusan Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Busan, South Korea; [Kim, Yun Seong] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan, South Korea; [Kim, Yun Seong; Kim, Bum Soo; Kim, Seong Jang] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea; [Kim, Bum Soo; Kim, Seong Jang] Pusan Natl Univ, Yangsan Hosp, Dept Nucl Med, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Kim, IJ (corresponding author), Pusan Natl Univ Hosp, Dept Nucl Med, Busan, South Korea.; Kim, IJ (corresponding author), Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.	pnuhnm@gmail.com	Pak, Kyoungjune/F-3004-2013; Pak, Kyoungjune/CAE-5230-2022	Pak, Kyoungjune/0000-0001-5051-1894	National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1B03029352]	National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A1B03029352 to KP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A1B03029352).	Dwamena BA, 1999, RADIOLOGY, V213, P530, DOI 10.1148/radiology.213.2.r99nv46530; Ettinger DS, 2015, J NATL COMPR CANC NE, V13, P515, DOI 10.6004/jnccn.2015.0071; Figueroa AL, 2013, JACC-CARDIOVASC IMAG, V6, P1250, DOI 10.1016/j.jcmg.2013.08.006; Hwangbo B, 2009, CHEST, V135, P1280, DOI 10.1378/chest.08-2019; Institute NC, 2015, SEER STAT FACT SHEET; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kim YN, 2012, EUR RADIOL, V22, P1537, DOI 10.1007/s00330-012-2388-3; Kim YK, 2007, CANCER-AM CANCER SOC, V109, P1068, DOI 10.1002/cncr.22518; Lee AY, 2014, NUCL MED MOLEC IMAG, V48, P41, DOI 10.1007/s13139-013-0244-2; Lee HS, 2009, ADDICT RES THEORY, V17, P622, DOI 10.3109/16066350802168613; Lee SM, 2012, EUR RADIOL, V22, P1556, DOI 10.1007/s00330-012-2395-4; Lu PO, 2014, LUNG CANCER, V85, P53, DOI 10.1016/j.lungcan.2014.04.004; Ose N, 2012, EUR J CARDIO-THORAC, V42, P89, DOI 10.1093/ejcts/ezr287; Pak K, 2015, ANN NUCL MED; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Vansteenkiste J, 2013, ANN ONCOL, V24, P89, DOI 10.1093/annonc/mdt241	16	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0193403	10.1371/journal.pone.0193403	http://dx.doi.org/10.1371/journal.pone.0193403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29486012	Green Submitted, gold, Green Published			2022-12-26	WOS:000426242400019
J	Hjortbak, MV; Hjort, J; Povlsen, JA; Jensen, RV; Stottrup, NB; Laursen, MR; Jespersen, NR; Lofgren, B; Botker, HE				Hjortbak, Marie Vognstoft; Hjort, Johanne; Povlsen, Jonas Agerlund; Jensen, Rebekka Vibjerg; Stottrup, Nicolaj Brejnholdt; Laursen, Mia R.; Jespersen, Nichlas Riise; Lofgren, Bo; Botker, Hans Erik			Influence of diabetes mellitus duration on the efficacy of ischemic preconditioning in a Zucker diabetic fatty rat model	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY; ELECTRON-TRANSPORT; ANIMAL-MODELS; RISK-FACTORS; HEART; CARDIOPROTECTION; MORTALITY	Augmented mortality and morbidity following an acute myocardial infarction in patients with diabetes mellitus Type 2 (T2DM) may be caused by increased sensitivity to ischemia reper-fusion (IR) injury or altered activation of endogenous cardioprotective pathways modified by T2DM per se or ischemic preconditioning (IPC). We aimed to investigate, whether the duration of T2DM influences sensitivity against IR injury and the efficacy of IPC, and how myocardial glucose oxidation rate was involved. Male Zucker diabetic fatty rats (homozygote (fa/fa)) at ages 6-(prediabetic), 12-(onset diabetes) and 24-weeks of age (late diabetes) and their age-matched non-diabetic controls (heterozygote (fa/+) were subjected to IR injury in the Langendorff model and randomised to IPC stimulus or control. T2DM rats were endogenously protected at onset of diabetes, as infarct size was lower in 12-weeks T2DM animals than in 6-(35 +/- 2% vs 53 +/- 4%; P = 0.006) and 24-weeks animals (35 +/- 2% vs 72 +/- 4%; P< 0.0001). IPC reduced infarct size in all groups irrespective of the presence of T2DM and its duration (32 +/- 3%; 20 +/- 2%; 36 +/- 4% respectively; (ANOVA P< 0.0001). Compared to prediabetic rats, myocardial glucose oxidation rates were reduced during stabilisation and early reperfusion at onset of T2DM, but these animals retained the ability to increase oxidation rate in late reperfusion. Late diabetic rats had low glucose oxidation rates throughout stabilisation and reperfusion. Despite inherent differences in sensitivity to IR injury, the cardioprotective effect of IPC was preserved in our animal model of pre-, early and late stage T2DM and associated with adaptations to myocardial glucose oxidation capacity.	[Hjortbak, Marie Vognstoft; Hjort, Johanne; Povlsen, Jonas Agerlund; Jensen, Rebekka Vibjerg; Stottrup, Nicolaj Brejnholdt; Jespersen, Nichlas Riise; Lofgren, Bo; Botker, Hans Erik] Aarhus Univ Hosp, Dept Cardiol, Palle Juul Jensens Blvd, Aarhus N, Denmark; [Laursen, Mia R.] Aarhus Univ Hosp, Dept Forens Med, Palle Juul Jensens Blvd, Aarhus N, Denmark	Aarhus University; Aarhus University	Hjortbak, MV (corresponding author), Aarhus Univ Hosp, Dept Cardiol, Palle Juul Jensens Blvd, Aarhus N, Denmark.	hjortbak@clin.au.dk		Jespersen, Nichlas Riise/0000-0003-2502-2102; Botker, Hans Erik/0000-0001-6358-8962	Danish Council for Independent Research [11-108354]; Danish Council for Strategic Research [11-115818]; Foundation Leducq [06CVD]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Foundation Leducq(Leducq Foundation)	The work was supported by the Danish Council for Independent Research (11-108354), the Danish Council for Strategic Research (11-115818), and Foundation Leducq (06CVD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamimi TR, 2017, THESIS; Andrienko T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167300; Andrienko TN, 2017, J MOL CELL CARDIOL, V110, P1, DOI 10.1016/j.yjmcc.2017.06.016; Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bolukoglu H, 1996, AM J PHYSIOL-HEART C, V270, pH817, DOI 10.1152/ajpheart.1996.270.3.H817; Bouchard JF, 1998, CARDIOVASC RES, V37, P82, DOI 10.1016/S0008-6363(97)00234-4; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Burwell LS, 2009, J MOL CELL CARDIOL, V46, P804, DOI 10.1016/j.yjmcc.2009.02.026; Chen Q, 2006, J PHARMACOL EXP THER, V316, P200, DOI 10.1124/jpet.105.091702; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Ferdinandy P, 2014, PHARMACOL REV, V66, P1142, DOI 10.1124/pr.113.008300; Gaster M, 2009, BIOCHEM BIOPH RES CO, V387, P651, DOI 10.1016/j.bbrc.2009.07.064; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Herrett E, 2014, EUR HEART J, V35, P2363, DOI 10.1093/eurheartj/ehu286; HOCHACHKA PW, 1975, SCIENCE, V187, P613, DOI 10.1126/science.163485; Hoff JA, 2003, J AM COLL CARDIOL, V41, P1008, DOI 10.1016/S0735-1097(02)02975-3; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Kleinbongard P, 2016, CARDIOLOGY, V133, P128, DOI 10.1159/000441216; Kristiansen SB, 2004, DIABETOLOGIA, V47, P1716, DOI 10.1007/s00125-004-1514-4; Laplante A, 1997, AM J PHYSIOL-ENDOC M, V272, pE74, DOI 10.1152/ajpendo.1997.272.1.E74; Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Lonborg J, 2012, EUR HEART J-CARD IMG, V13, P433, DOI 10.1093/ejechocard/jer296; Malfitano C, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0308-y; Malfitano C, 2010, EUR J HEART FAIL, V12, P659, DOI 10.1093/eurjhf/hfq053; Miki T, 2009, DIABETES, V58, P2863, DOI 10.2337/db09-0158; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; Povlsen JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064093; Pryds K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013314; Reimer KA, 1996, ANN NY ACAD SCI, V793, P13, DOI 10.1111/j.1749-6632.1996.tb33501.x; Reiter R, 2013, CIRC-CARDIOVASC INTE, V6, P52, DOI 10.1161/CIRCINTERVENTIONS.112.973164; Sakamoto M, 1998, SURG TODAY, V28, P522, DOI 10.1007/s005950050177; Schmidt M, 2015, INT J CARDIOL, V187, P462, DOI 10.1016/j.ijcard.2015.03.328; Sloth AD, 2014, EUR HEART J, V35, P168, DOI 10.1093/eurheartj/eht369; Sloth AD, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006923; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stottrup NB, 2010, CARDIOVASC RES, V88, P257, DOI 10.1093/cvr/cvq205; Tsang A, 2005, DIABETES, V54, P2360, DOI 10.2337/diabetes.54.8.2360; Vogt AM, 2002, J BIOL CHEM, V277, P24411, DOI 10.1074/jbc.M201138200; Wang PP, 2004, AM J PHYSIOL-ENDOC M, V286, pE725, DOI 10.1152/ajpendo.00295.2003; Whittington HJ, 2013, CARDIOVASC RES, V99, P694, DOI 10.1093/cvr/cvt140; Whittington HJ, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/845698; Xu G, 2004, EXP MOL PATHOL, V76, P57, DOI 10.1016/j.yexmp.2003.08.003	45	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192981	10.1371/journal.pone.0192981	http://dx.doi.org/10.1371/journal.pone.0192981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474385	Green Published, gold, Green Submitted			2022-12-26	WOS:000426049500050
J	Jin, JF; Lu, ZY; Li, YC; Cowart, LA; Lopes-Virella, MF; Yan, H				Junfei Jin; Zhongyang Lu; Yanchun Li; Cowart, L. Ashley; Lopes-Virella, Maria F.; Yan Huang			Docosahexaenoic acid antagonizes the boosting effect of palmitic acid on LPS inflammatory signaling by inhibiting gene transcription and ceramide synthesis	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; FACTOR-KAPPA-B; SPHINGOLIPID METABOLISM; DEFICIENT MICE; MACROPHAGES; PATHWAY; LIPOPOLYSACCHARIDE; CELLS; OBESITY; STRESS	It is well known that saturated fatty acids (SFAs) and unsaturated fatty acid, in particular omega-3 polyunsaturated fatty acids (n-3 PUFAs), have different effects on inflammatory signaling: SFAs are pro-inflammatory but n-3 PUFAs have strong anti-inflammatory properties. We have reported that palmitic acid (PA), a saturated fatty acid, robustly amplifies lipopolysaccharide (LPS) signaling to upregulate proinflammatory gene expression in macrophages. We also reported that the increased production of ceramide (CER) via sphingomyelin (SM) hydrolysis and CER de novo synthesis plays a key role in the synergistic effect of LPS and PA on proinflammatory gene expression. However, it remains unclear if n-3 PUFAs are capable of antagonizing the synergistic effect of LPS and PA on gene expression and CER production. In this study, we employed the above macrophage culture system and lipidomical analysis to assess the effect of n-3 PUFAs on proinflammatory gene expression and CER production stimulated by LPS and PA. Results showed that DHA strongly inhibited the synergistic effect of LPS and PA on proinflammatory gene expression by targeting nuclear factor kappa B (NFKB)-dependent gene transcription. Results also showed that DHA inhibited the cooperative effect of LPS and PA on CER production by targeting CER de novo synthesis, but not SM hydrolysis. Furthermore, results showed that myriocin, a specific inhibitor of serine palmitoyltransferase, strongly inhibited both LPS-PA-stimulated CER synthesis and proinflammatory gene expression, indicating that CER synthesis is associated with proinflammatory gene expression and that inhibition of CER synthesis contributes to DHA-inhibited proinflammatory gene expression. Taken together, this study demonstrates that DHA antagonizes the boosting effect of PA on LPS signaling on proinflammatory gene expression by targeting both NFKB-dependent transcription and CER de novo synthesis in macrophages.	[Junfei Jin; Yanchun Li; Lopes-Virella, Maria F.; Yan Huang] Med Univ South Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29401 USA; [Zhongyang Lu; Lopes-Virella, Maria F.; Yan Huang] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Cowart, L. Ashley] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Junfei Jin] Guilin Med Univ, Guangxi Key Lab Mol Med Liver Injury & Repair, Affiliated Hosp, Lab Liver Biliary Tract Pancreas Surg, Guilin, Guangxi, Peoples R China; [Cowart, L. Ashley] Virginia Commonwealth Univ, Dept Biochem, Coll Med, Richmond, VA USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Guilin Medical University; Virginia Commonwealth University	Yan, H (corresponding author), Med Univ South Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29401 USA.; Yan, H (corresponding author), Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA.	huangyan@musc.edu	li, yan/GTI-4638-2022	Jin, Junfei/0000-0002-9237-9024; Lu, Zhongyang/0000-0002-2182-7854	Biomedical Laboratory Research and Development Program of the Department of Veterans Affairs [BX000854]; NIH [DE016353]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE027070] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000854] Funding Source: NIH RePORTER	Biomedical Laboratory Research and Development Program of the Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit Review grant BX000854 from the Biomedical Laboratory Research and Development Program of the Department of Veterans Affairs (Yan Huang) and NIH grant DE016353 (Yan Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire J, 2016, AM J CLIN NUTR, V104, P280, DOI 10.3945/ajcn.116.131896; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Chang ZQ, 2011, PROSTAG OTH LIPID M, V94, P44, DOI 10.1016/j.prostaglandins.2010.12.003; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Das Mithun, 2010, J Cardiovasc Dis Res, V1, P130, DOI 10.4103/0975-3583.70911; De Boer AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085037; Demarchi F, 2005, CELL DEATH DIFFER, V12, P512, DOI 10.1038/sj.cdd.4401592; Gomes JMG, 2017, METABOLISM, V68, P133, DOI 10.1016/j.metabol.2016.12.009; Green CD, 2011, AM J PHYSIOL-ENDOC M, V300, pE640, DOI 10.1152/ajpendo.00544.2010; Hamblin M, 2009, ANTIOXID REDOX SIGN, V11, P1415, DOI [10.1089/ars.2008.2280, 10.1089/ARS.2008.2280]; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Hellmann J, 2013, J IMMUNOL, V191, P1383, DOI 10.4049/jimmunol.1203369; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Itariu BK, 2012, AM J CLIN NUTR, V96, P1137, DOI 10.3945/ajcn.112.037432; Jin JF, 2013, AM J PHYSIOL-ENDOC M, V305, pE853, DOI 10.1152/ajpendo.00251.2013; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Komatsu W, 2003, FREE RADICAL BIO MED, V34, P1006, DOI 10.1016/S0891-5849(03)00027-3; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Li H, 2005, KIDNEY INT, V67, P867, DOI 10.1111/j.1523-1755.2005.00151.x; Lu ZY, 2017, ATHEROSCLEROSIS, V265, P231, DOI 10.1016/j.atherosclerosis.2017.09.008; Memon RA, 2001, J LIPID RES, V42, P452; Mullen A, 2010, J NUTR BIOCHEM, V21, P444, DOI 10.1016/j.jnutbio.2009.02.008; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Novotny NM, 2008, CYTOKINE, V43, P215, DOI 10.1016/j.cyto.2008.05.015; Pinel A, 2014, J PHYSIOL BIOCHEM, V70, P647, DOI 10.1007/s13105-013-0303-2; Qi HY, 2011, J IMMUNOL, V187, P5286, DOI 10.4049/jimmunol.1004004; Robinson LE, 2013, LIPIDS, V48, P319, DOI 10.1007/s11745-013-3774-6; Ruiz-Nunez B, 2016, J NUTR BIOCHEM, V36, P1, DOI 10.1016/j.jnutbio.2015.12.007; Sasset L, 2016, TRENDS ENDOCRIN MET, V27, P807, DOI 10.1016/j.tem.2016.07.005; Schilling JD, 2013, J BIOL CHEM, V288, P2923, DOI 10.1074/jbc.M112.419978; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Stiban J, 2006, APOPTOSIS, V11, P773, DOI 10.1007/s10495-006-5882-8; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Xue BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045990; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zeidan YH, 2010, CURR MOL MED, V10, P454, DOI 10.2174/156652410791608225	43	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193343	10.1371/journal.pone.0193343	http://dx.doi.org/10.1371/journal.pone.0193343			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474492	gold, Green Published, Green Submitted			2022-12-26	WOS:000426049500090
J	Kraan, CM; Cornish, KM; Bui, QM; Li, X; Slater, HR; Godler, DE				Kraan, Claudine M.; Cornish, Kim M.; Bui, Quang M.; Li, Xin; Slater, Howard R.; Godler, David E.			beta-glucuronidase use as a single internal control gene may confound analysis in FMR1 mRNA toxicity studies	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; CEREBELLAR-TREMOR/ATAXIA-SYNDROME; REAL-TIME PCR; INTRANUCLEAR INCLUSIONS; CGG; PREMUTATION; EXPRESSION; POPULATION; CARRIERS; DYSFUNCTION	Relationships between Fragile X Mental Retardation 1 (FMR1) mRNA levels in blood and intragenic FMR1 CGG triplet expansions support the pathogenic role of RNA gain of function toxicity in premutation (PM: 55-199 CGGs) related disorders. Real-time PCR (RTPCR) studies reporting these findings normalised FMR1 mRNA level to a single internal control gene called beta-glucuronidase (GUS). This study evaluated FMR1 mRNA-CGG correlations in 33 PM and 33 age-and IQ-matched control females using three normalisation strategies in peripheral blood mononuclear cells (PBMCs): (i) GUS as a single internal control; (ii) the mean of GUS, Eukaryotic Translation Initiation Factor 4A2 (EIF4A2) and succinate dehydrogenase complex flavoprotein subunit A (SDHA); and (iii) the mean of EIF4A2 and SDHA (with no contribution from GUS). GUS mRNA levels normalised to the mean of EIF4A2 and SDHA mRNA levels and EIF4A2/SDHA ratio were also evaluated. FMR1mRNA level normalised to the mean of EIF4A2 and SDHA mRNA levels, with no contribution from GUS, showed the most significant correlation with CGG size and the greatest difference between PM and control groups (p = 10-11). Only 15% of FMR1 mRNA PM results exceeded the maximum control value when normalised to GUS, compared with over 42% when normalised to the mean of EIF4A2 and SDHA mRNA levels. Neither GUS mRNA level normalised to the mean RNA levels of EIF4A2 and SDHA, nor to the EIF4A2/SDHA ratio were correlated with CGG size. However, greater variability in GUS mRNA levels were observed for both PM and control females across the full range of CGG repeat as compared to the EIF4A2/SDHA ratio. In conclusion, normalisation with multiple control genes, excluding GUS, can improve assessment of the biological significance of FMR1 mRNA-CGG size relationships.	[Kraan, Claudine M.; Li, Xin; Slater, Howard R.; Godler, David E.] Royal Childrens Hosp, Victorian Clin Genet Serv, Cytomol Diagnost Res Lab, Melbourne, Vic, Australia; [Kraan, Claudine M.; Li, Xin; Slater, Howard R.; Godler, David E.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Kraan, Claudine M.; Cornish, Kim M.] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Kraan, Claudine M.; Cornish, Kim M.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia; [Kraan, Claudine M.; Slater, Howard R.; Godler, David E.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Bui, Quang M.] Univ Melbourne Carlton, Ctr Epidemiol & Biostat, Carlton, Vic, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Monash University; Monash University; University of Melbourne	Godler, DE (corresponding author), Royal Childrens Hosp, Victorian Clin Genet Serv, Cytomol Diagnost Res Lab, Melbourne, Vic, Australia.; Godler, DE (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Godler, DE (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.	david.godler@mcri.edu.au	Kraan, Claudine/AAD-2454-2019	Godler, David/0000-0002-6405-269X; Kraan, Claudine/0000-0003-1805-6339; Cornish, Kim/0000-0003-2014-0193	Australian Research Council (ARC) [DP110103346]; Australian Postgraduate Award Scholarship, Monash University Faculty of Medicine; Nursing and Health Sciences Bridging Postdoctoral Fellowship; NHMRC Early Career fellowship [1112934]; Next Generation Clinical Researchers Program - Career Development Fellowship - Medical Research Future Fund [MRFF 1141334]; Victorian Government's Operational Infrastructure Support Program; NHM RC project grants [104299, 1103389]; Murdoch Children's Research Institute, Royal Children's Hospital Foundation	Australian Research Council (ARC)(Australian Research Council); Australian Postgraduate Award Scholarship, Monash University Faculty of Medicine; Nursing and Health Sciences Bridging Postdoctoral Fellowship; NHMRC Early Career fellowship(National Health and Medical Research Council (NHMRC) of Australia); Next Generation Clinical Researchers Program - Career Development Fellowship - Medical Research Future Fund(Medical Research Future Fund (MRFF)); Victorian Government's Operational Infrastructure Support Program; NHM RC project grants(National Health and Medical Research Council (NHMRC) of Australia); Murdoch Children's Research Institute, Royal Children's Hospital Foundation	This study was supported by an Australian Research Council (ARC) Discovery grant (DP110103346) to K.M.C, an Australian Postgraduate Award Scholarship, Monash University Faculty of Medicine, Nursing and Health Sciences Bridging Postdoctoral Fellowship and NHMRC Early Career fellowship to C.M.K. (no. 1112934); a Next Generation Clinical Researchers Program - Career Development Fellowship, funded by the Medical Research Future Fund (MRFF 1141334) to D.E.G.; and by the Victorian Government's Operational Infrastructure Support Program, with the salaries for the molecular component supported by NHM RC project grants (no. 104299, and no. 1103389 to H.R.S. and D.E.G.) and Murdoch Children's Research Institute, Royal Children's Hospital Foundation (D.E.G.). The authors thank the Fragile X Association of Australia and Fragile X Alliance for supporting recruitment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by an Australian Research Council (ARC) Discovery grant (DP110103346) to K.M.C, an Australian Postgraduate Award Scholarship, Monash University Faculty of Medicine, Nursing and Health Sciences Bridging Postdoctoral Fellowship and NHMRC Early Career fellowship to C.M.K. (no. 1112934); a Next Generation Clinical Researchers Program Career Development Fellowship, funded by the Medical Research Future Fund (MRFF 1141334) to D.E.G.; and by the Victorian Government's Operational Infrastructure Support Program, with the salaries for the molecular component supported by NHMRC project grants (no. 104299, and no. 1103389 to H.R.S. and D.E.G.) and Murdoch Children's Research Institute, Royal Children's Hospital Foundation (D.E.G.). The authors thank the Fragile X Association of Australia and Fragile X Alliance for supporting recruitment. They also sincerely thank all the women who participated in this research.	Bennion BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121092; Birch RC, 2015, GENES BRAIN BEHAV; Chen LJ, 2010, J MOL DIAGN, V12, P589, DOI 10.2353/jmoldx.2010.090227; Cobben NAM, 1999, CLIN BIOCHEM, V32, P659, DOI 10.1016/S0009-9120(99)00070-3; Ferraz FB, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017720; Fu J, 2010, ACTA BIOCH BIOPH SIN, V42, P568, DOI 10.1093/abbs/gmq062; Godler DE, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-5; Godler DE, 2005, RHEUMATOLOGY, V44, P1122, DOI 10.1093/rheumatology/keh690; Greco CM, 2002, BRAIN, V125, P1760, DOI 10.1093/brain/awf184; Greco CM, 2006, BRAIN, V129, P243, DOI 10.1093/brain/awh683; Hagerman R, 2013, LANCET NEUROL, V12, P786, DOI 10.1016/S1474-4422(13)70125-X; Hagerman RJ, 2016, NAT REV NEUROL, V12, P403, DOI 10.1038/nrneurol.2016.82; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Hashem V, 2009, HUM MOL GENET, V18, P2443, DOI 10.1093/hmg/ddp182; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hocking DR, 2017, NEUROBIOL AGING, V50, P5, DOI 10.1016/j.neurobiolaging.2016.10.017; Hukema RK, 2014, CELL CYCLE, V13, P2600, DOI 10.4161/15384101.2014.943112; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Kraan CM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29366; Leehey MA, 2008, NEUROLOGY, V70, P1397, DOI 10.1212/01.wnl.0000281692.98200.f5; Loesch DZ, 2011, GENET MED, V13, P392, DOI 10.1097/GIM.0b013e3182064362; Lombardo A, 1996, CLIN CHIM ACTA, V247, P39, DOI 10.1016/0009-8981(95)06218-1; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Niu YQ, 2014, PARKINSONISM RELAT D, V18; Nyquist PA, 2017, NEUROLOGY, V88, P2070, DOI 10.1212/WNL.0000000000003994; Pastori C, 2014, HUM GENET, V133, P59, DOI 10.1007/s00439-013-1356-6; Perez A, 2014, PHARMACOL RES, V89, P11, DOI 10.1016/j.phrs.2014.07.005; Pietrobono R, 2005, HUM MOL GENET, V14, P267, DOI 10.1093/hmg/ddi024; Seltzer MM, 2012, AM J MED GENET B, V159B, P589, DOI 10.1002/ajmg.b.32065; Shelton AL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.250; Shelton AL, 2017, NEUROLOGY; Sherman SL, 2000, AM J MED GENET, V97, P189, DOI 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J; TAPPEL AL, 1967, J BIOL CHEM, V242, P2463; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Turabelidze A, 2010, WOUND REPAIR REGEN, V18, P460, DOI 10.1111/j.1524-475X.2010.00611.x; Ueyama J, 2010, TOXICOL LETT, V193, P115, DOI 10.1016/j.toxlet.2009.12.009; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vega-Sanchez R, 2015, PLACENTA, V36, P240, DOI 10.1016/j.placenta.2014.11.010; Wang J.Y., 2013, JAMA NEUROL, V10, P1; Wenzel HJ, 2010, BRAIN RES, V1318, P155, DOI 10.1016/j.brainres.2009.12.077; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114	45	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192151	10.1371/journal.pone.0192151	http://dx.doi.org/10.1371/journal.pone.0192151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474364	Green Published, gold, Green Submitted			2022-12-26	WOS:000426049500014
J	Leijendekkers, RA; Marra, MA; Kolk, S; van Bon, G; Schreurs, BW; Weerdesteyn, V; Verdonschot, N				Leijendekkers, Ruud A.; Marra, Marco A.; Kolk, Sjoerd; van Bon, Geert; Schreurs, B. Wim; Weerdesteyn, Vivian; Verdonschot, Nico			Gait symmetry and hip strength in women with developmental dysplasia following hip arthroplasty compared to healthy subjects: A cross-sectional study	PLOS ONE			English	Article							LEG LENGTH DISCREPANCY; MUSCLE STRENGTH; PARAMETERS; ADULTS; REPLACEMENT; DISLOCATION	Introduction Untreated unilateral developmental dysplasia of the hip (DDH) results in asymmetry of gait and hip strength and may lead to early osteoarthritis, which is commonly treated with a total hip arthroplasty (THA). There is limited knowledge about the obtained symmetry of gait and hip strength after the THA. The objectives of this cross-sectional study were to: a) identify asymmetries between the operated and non-operated side in kinematics, kinetics and hip strength, b) analyze if increased walking speed changed the level of asymmetry in patients c) compare these results with those of healthy subjects. Methods Women (18-70 year) with unilateral DDH who had undergone unilateral THA were eligible for inclusion. Vicon gait analysis system was used to collect frontal and sagittal plane kinematic and kinetic parameters of the hip joint, pelvis and trunk during walking at comfortable walking speed and increased walking speed. Furthermore, hip abductor and extensor muscle strength was measured. Results Six patients and eight healthy subjects were included. In the patients, modest asymmetries in lower limb kinematics and kinetics were present during gait, but trunk lateral flexion asymmetry was evident. Patients' trunk lateral flexion also differed compared to healthy subjects. Walking speed did not significantly influence the level of asymmetry. The hip abduction strength asymmetry of 23% was not statistically significant, but the muscle strength of both sides were significantly weaker than those of healthy subjects. Conclusions In patients with a DDH treated with an IBG THA modest asymmetries in gait kinematics and kinetics were present, with the exception of a substantial asymmetry of the trunk lateral flexion. Increased walking speed did not result in increased asymmetries in gait kinematics and kinetics. Hip muscle strength was symmetrical in patients, but significantly weaker than in healthy subjects. Trunk kinematics should be included as an outcome measure to assess the biomechanical benefits of the THA surgery after DDH.	[Leijendekkers, Ruud A.] Radboud Univ Nijmegen, Med Ctr, Dept Orthoped, Phys Therapy, Nijmegen, Netherlands; [Marra, Marco A.; Verdonschot, Nico] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci Nijmegen, Orthoped Res Lab, Nijmegen, Netherlands; [Kolk, Sjoerd; van Bon, Geert; Weerdesteyn, Vivian] Radboud Univ Nijmegen, Med Ctr, Donders Inst Neurosci, Dept Rehabil, Nijmegen, Netherlands; [Schreurs, B. Wim] Radboud Univ Nijmegen, Med Ctr, Dept Orthoped, Nijmegen, Netherlands; [Weerdesteyn, Vivian] Sint Maartenskliniek Res, Nijmegen, Netherlands; [Verdonschot, Nico] Univ Twente, Lab Biomech Engn, Enschede, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Sint Maartens Clinic; University of Twente	Leijendekkers, RA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Orthoped, Phys Therapy, Nijmegen, Netherlands.	Ruud.Leijendekkers@radboudumc.nl	Verdonschot, N.J.J./H-8104-2014; Schreurs, B.W./L-4639-2015; van Bon, Geert E.A./E-4140-2018; Weerdesteyn, Vivian/A-9599-2014; Leijendekkers, R.A./L-4485-2015; Marra, Marco Antonio/P-5705-2015	Verdonschot, N.J.J./0000-0002-7531-6523; Weerdesteyn, Vivian/0000-0003-4327-7600; Leijendekkers, R.A./0000-0002-6158-6901; Marra, Marco Antonio/0000-0003-1582-6668	European Commission; European Research Council under European Union / ERC [323091]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council under European Union / ERC(European Research Council (ERC))	We gratefully acknowledge financial support by the European Commission FP7 Programme for the TLEMsafe project (http://www.tlemsafe.eu). Furthermore, research funding was received from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n. 323091. The funding agencies played no role in design, collection, analysis, interpretation of data, writing process, or in the decision to submit the paper for publication.	Andersen MS, 2010, COMPUT METHOD BIOMEC, V13, P171, DOI 10.1080/10255840903067080; Andersen MS, 2009, COMPUT METHOD BIOMEC, V12, P371, DOI 10.1080/10255840802459412; Arvin M, 2015, GAIT POSTURE, V42, P545, DOI 10.1016/j.gaitpost.2015.08.011; Benedetti MG, 2010, INT ORTHOP, V34, P1115, DOI 10.1007/s00264-009-0855-5; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Damsgaard M, 2010, SIMUL MODEL PRACT TH, V14, P100; Dawson J, 1996, J BONE JOINT SURG BR, V78B, P185, DOI 10.1302/0301-620X.78B2.0780185; Eftekhar NS, 1993, TOTAL HIP ARTHROPLAS, P927; Foucher KC, 2012, GAIT POSTURE, V35, P61, DOI 10.1016/j.gaitpost.2011.08.006; HADLEY NA, 1990, J ORTHOP RES, V8, P504, DOI 10.1002/jor.1100080406; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Horsman MDK, 2007, CLIN BIOMECH, V22, P239, DOI 10.1016/j.clinbiomech.2006.10.003; JASTY M, 1995, CLIN ORTHOP RELAT R, P40; Kiss RM, 2012, HUM MOVEMENT SCI, V31, P1302, DOI 10.1016/j.humov.2012.02.004; Kolk S, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0524-3; Kolk S, 2014, CLIN BIOMECH, V29, P705, DOI 10.1016/j.clinbiomech.2014.05.008; Lai KA, 2001, J ORTHOP RES, V19, P1147, DOI 10.1016/S0736-0266(01)00032-8; Leigh RJ, 2016, CLIN BIOMECH, V34, P12, DOI 10.1016/j.clinbiomech.2015.12.010; Liu RY, 2014, ARCH ORTHOP TRAUM SU, V134, P113, DOI 10.1007/s00402-013-1899-y; Marangoz S, 2010, HIP INT, V20, P466, DOI 10.1177/112070001002000409; Mockel G, 2003, ARCH ORTHOP TRAUM SU, V123, P278, DOI 10.1007/s00402-003-0513-0; Murray DW, 2007, J BONE JOINT SURG BR, V89B, P1010, DOI 10.1302/0301-620X.89B8; Nie Y, 2017, ORTHOPEDICS, V40, pE425, DOI 10.3928/01477447-20170109-04; Pedersen ENG, 2004, ACTA ORTHOP SCAND, V75, P2, DOI 10.1080/00016470410001708010; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; Resende RA, 2016, GAIT POSTURE, V46, P147, DOI 10.1016/j.gaitpost.2016.03.012; Romano CL, 1996, J BONE JOINT SURG AM, V78A, P1468, DOI 10.2106/00004623-199610000-00003; Rutherford DJ, 2009, CLIN BIOMECH, V24, P267, DOI 10.1016/j.clinbiomech.2008.12.006; Schreurs BW, 2001, ACTA ORTHOP SCAND, V72, P120, DOI 10.1080/000164701317323354; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; TROUSDALE RT, 1995, J BONE JOINT SURG AM, V77A, P73, DOI 10.2106/00004623-199501000-00010; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Weinstein SL, 1997, CLIN ORTHOP RELAT R, P227; Wittink H, 2003, SPINE, V28, P2407, DOI 10.1097/01.BRS.0000085304.01483.17; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Yilmaz S, 2010, J PEDIATR ORTHOPED, V30, P44, DOI 10.1097/BPO.0b013e3181c6b390; Zhao X, 2011, J BONE JOINT SURG BR, V93B, P1189, DOI 10.1302/0301-620X.93B9.25914	37	13	13	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193487	10.1371/journal.pone.0193487	http://dx.doi.org/10.1371/journal.pone.0193487			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474431	Green Published, gold, Green Submitted			2022-12-26	WOS:000426049500117
J	Bokanyi, E; Szallasi, Z; Vattay, G				Bokanyi, Eszter; Szallasi, Zoltan; Vattay, Gabor			Universal scaling laws in metro area election results	PLOS ONE			English	Article							MODEL	We explain the anomaly of election results between large cities and rural areas in terms of urban scaling in the 1948-2016 US elections and in the 2016 EU referendum of the UK. The scaling curves are all universal and depend on a single parameter only, and one of the parties always shows superlinear scaling and drives the process, while the sublinear exponent of the other party is merely the consequence of probability conservation. Based on the recently developed model of urban scaling, we give a microscopic model of voter behavior in which we replace diversity characterizing humans in creative aspects with social diversity and tolerance. The model can also predict new political developments such as the fragmentation of the left and the immigration paradox.	[Bokanyi, Eszter; Vattay, Gabor] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary; [Szallasi, Zoltan] Harvard Med Sch, Childrens Hosp, Boston, MA USA	Eotvos Lorand University; Harvard University; Boston Children's Hospital; Harvard Medical School	Bokanyi, E (corresponding author), Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary.	bokanyi@complex.elte.hu	Vattay, Gabor/Q-4266-2019; Vattay, Gabor/G-9638-2017	Vattay, Gabor/0000-0002-0919-9429; Szallasi, Zoltan/0000-0001-5395-7509; Bokanyi, Eszter/0000-0002-8625-1139	Hungarian National Research, Development and Innovation Office [125280]; Ericsson Inc.	Hungarian National Research, Development and Innovation Office; Ericsson Inc.	Authors were supported by the Hungarian National Research, Development and Innovation Office under Grant No. 125280 and by the grant of Ericsson Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LGA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134862; Alves LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069580; [Anonymous], 1999, NETWORKS GLOBAL VILL; Araujo NAM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012446; Arbesman S, 2011, PHYSICA A, V390, P2155, DOI 10.1016/j.physa.2011.02.013; Arbesman S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016115; Batty M., 2007, CITIES COMPLEXITY UN; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bernardes AT, 2002, EUR PHYS J B, V25, P123, DOI 10.1140/e10051-002-0013-y; Bettencourt LMA, 2013, 2013010037 SFI, P37; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Borghesi C, 2010, EUR PHYS J B, V75, P395, DOI 10.1140/epjb/e2010-00151-1; Borghesi C, 2012, PLOS ONE, V7, P1; Braha D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177970; Chatterjee A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01049; Costa RN, 2003, PHYSICA A, V322, P698, DOI 10.1016/S0378-4371(02)01823-X; Costa RN, 1999, PHYS REV E, V60, P1067, DOI 10.1103/PhysRevE.60.1067; DENVER D, 1990, ELECT STUD, V9, P19, DOI 10.1016/0261-3794(90)90039-B; Fernandez-Gracia J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.158701; Fischer C. S., 1982, DWELL FRIENDS PERSON; Florida R, 2014, RISE CREATIVE CLASS; Florida R, 2016, MAPPING AM METROAREA; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Fujita M, 2001, SPATIAL EC CITIES RE, P1; Glaeser EL, 2011, TRIUMPH CITY OUR GRE; Gomez-Lievano A, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0012; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Goodwin MJ, 2016, POLIT QUART, V87, P323, DOI 10.1111/1467-923X.12285; Henderson J. V., 1991, URBAN DEV THEORY FAC; Isard W, 1972, LOCATION SPACE EC GE; Kennedy C., 2011, EVOLUTION GREAT WORL; Klimek P, 2012, P NATL ACAD SCI USA, V109, P16469, DOI 10.1073/pnas.1210722109; Leip D, 2016, DAVE LEIP US PRESIDN; Lobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058407; Lyra ML, 2002, EPL-EUROPHYS LETT, V62, P5; Mantovani MC, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.024802; Mantovani MC, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48001; McCarthy N, 2008, RASSEGNA ITALIANA SO, V49, P495; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Newman M., 2011, STRUCTURE DYNAMICS N; Palombi F, 2014, J STAT PHYS, V156, P336, DOI 10.1007/s10955-014-1003-1; Pan W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2961; Pumain D., 2006, CYBERGEO REV EUROPEE, V343, P1; RABINOWITZ G, 1989, AM POLIT SCI REV, V83, P93, DOI 10.2307/1956436; Samaniego H, 2008, J TRANSPORT LAND USE, V1; Schlapfer M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0789; Sim A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0315	50	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192913	10.1371/journal.pone.0192913	http://dx.doi.org/10.1371/journal.pone.0192913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470518	gold, Green Published, Green Submitted			2022-12-26	WOS:000425831000022
J	Shrivastava, S; Tiraki, D; Diwan, A; Lalwani, SK; Modak, M; Mishra, AC; Arankalle, VA				Shrivastava, Shubham; Tiraki, Divya; Diwan, Arundhati; Lalwani, Sanjay K.; Modak, Meera; Mishra, Akhilesh Chandra; Arankalle, Vidya A.			Co-circulation of all the four dengue virus serotypes and detection of a novel clade of DENV-4 (genotype I) virus in Pune, India during 2016 season	PLOS ONE			English	Article							RIO-DE-JANEIRO; HEMORRHAGIC-FEVER; EMERGENCE; TYPE-3; DELHI; EVOLUTION; OUTBREAK; PHYLOGEOGRAPHY; REEMERGENCE; TRAVELERS	Dengue is the most common mosquito-borne viral infection in tropical and sub-tropical countries. In recent years, India has reported increased incidences of concurrent infection with multiple serotypes of dengue viruses (DENV). In the present study, we have characterized DENV circulating during a single season of 2016 in Pune, India. A total of 64 serum samples from NS1 ELISA positive dengue patients were used for PCR amplification of CprM region of the viral genome and sequencing. Phylogenetic analysis documented circulation of all the four DENV serotypes with predominance of DENV-2 (40.6%). DENV genotyping classified DENV-1 to Genotype V, DENV-2 to Genotype IV, DENV-3 to Genotype III and DENV-4 to Genotype I. Further analysis revealed emergence of a novel clade (D) of genotype I of DENV-4. Subsequent isolation of three DENV-4 viruses in cell culture followed by complete genome sequence analysis confirmed this observation. Additionally, a new genotype within serotype-4 with >6.7% sequence variation from other genotypes was identified. This first report of significant co-circulation of all the four serotypes in a single outbreak in Pune reconfirms need for molecular monitoring of DENV.	[Shrivastava, Shubham; Tiraki, Divya; Mishra, Akhilesh Chandra; Arankalle, Vidya A.] Bharati Vidyapeeth Deemed Univ, Interact Res Sch Hlth Affairs, Dept Communicable Dis, Pune, Maharashtra, India; [Diwan, Arundhati] Bharati Vidyapeeth Deemed Univ Med Coll, Dept Med, Pune, Maharashtra, India; [Lalwani, Sanjay K.] Bharati Vidyapeeth Deemed Univ Med Coll, Dept Pediat, Pune, Maharashtra, India; [Modak, Meera] Bharati Vidyapeeth Deemed Univ Med Coll, Dept Microbiol, Pune, Maharashtra, India	Bharati Vidyapeeth Deemed University; Bharati Vidyapeeth Deemed University; Bharati Vidyapeeth Deemed University; Bharati Vidyapeeth Deemed University	Arankalle, VA (corresponding author), Bharati Vidyapeeth Deemed Univ, Interact Res Sch Hlth Affairs, Dept Communicable Dis, Pune, Maharashtra, India.	varankalle@yahoo.com		Shrivastava, Shubham/0000-0002-5980-8536; Arankalle, Vidya/0000-0002-9940-3437	Indian Council of Medical Research (ICMR) [ECD/NTF/8/2016-17]	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	This work is supported by Indian Council of Medical Research (ICMR) grant number: ECD/NTF/8/2016-17 received by ACM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afreen N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004511; Afreen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141628; [Anonymous], 2012, WHO REPORT; Bai Z, 2013, GENOME ANNOUNC, V1; Bharaj P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-1; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555; Cecilia D, 2017, VIROLOGY, V510, P40, DOI 10.1016/j.virol.2017.07.004; Cecilia D, 2012, NIV GOLDEN DIAMOND J, P141; Cecilia Dayaraj, 2014, WHO South East Asia J Public Health, V3, P22, DOI 10.4103/2224-3151.206879; Cecilia D, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-46; Chakravarti A, 2010, INDIAN J MED MICROBI, V28, DOI 10.4103/0255-0857.71806; Chakravarti A, 2012, T ROY SOC TROP MED H, V106, P273, DOI 10.1016/j.trstmh.2011.12.007; Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562; Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006; Choudhary MC, 2017, TROP MED INT HEALTH, V22, P871, DOI 10.1111/tmi.12898; Dar L, 2006, EMERG INFECT DIS, V12, P352; Das B, 2013, INFECT GENET EVOL, V16, P401, DOI 10.1016/j.meegid.2013.03.016; Dash PK, 2011, EPIDEMIOL INFECT, V139, P857, DOI 10.1017/S0950268810001706; Dash PK, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-55; Dash PK, 2015, VIRUS RES, V195, P124, DOI 10.1016/j.virusres.2014.08.018; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55; Halstead SB, 2015, MICROBIOL MOL BIOL R, V79, P281, DOI 10.1128/MMBR.00009-15; Hapuarachchi HC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1606-z; Heringer M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2488-4; Heringer M, 2015, T ROY SOC TROP MED H, V109, P268, DOI 10.1093/trstmh/trv006; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kukreti H, 2010, J MICROBIOL IMMUNOL, V43, P53, DOI 10.1016/S1684-1182(10)60008-4; Kumar NP, 2013, J MED MICROBIOL, V62, P545, DOI 10.1099/jmm.0.052696-0; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Mishra B, 2017, INDIAN J MED MICROBI, V35, P293, DOI 10.4103/ijmm.IJMM_15_536; National Vector Borne Disease Control Programme (NVBDCP) Government of India, DENG CAS DEATHS COUN; Ospina MC, 2010, AM J TROP MED HYG, V83, P672, DOI 10.4269/ajtmh.2010.09-0766; Patil JA, 2012, INFECT GENET EVOL, V12, P1759, DOI 10.1016/j.meegid.2012.07.009; Reddy MN, 2017, PEERJ, V5, DOI 10.7717/peerj.2970; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; Saha K, 2016, J MED VIROL, V88, P1697, DOI 10.1002/jmv.24529; Sasmono RT, 2015, INFECT GENET EVOL, V32, P165, DOI 10.1016/j.meegid.2015.03.006; Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412; Sharma S, 2011, J GEN VIROL, V92, P1595, DOI 10.1099/vir.0.030437-0; Shihada S, 2017, EMERG INFECT DIS, V23, P272, DOI 10.3201/eid2302.160751; Singh UB, 1999, J INFECT DIS, V180, P959, DOI 10.1086/315043; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tazeen A, 2017, EPIDEMIOL INFECT, V145, P67, DOI 10.1017/S0950268816001990; Vaddadi K, 2017, EPIDEMIOL INFECT, V145, P2563, DOI 10.1017/S0950268817001479; Vaddadi K, 2017, EPIDEMIOL INFECT, V145, P1443, DOI 10.1017/S0950268817000243; VinodKumar CS, 2013, J INFECT PUBLIC HEAL, V6, P302, DOI 10.1016/j.jiph.2013.01.004; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Zhang FC, 2014, INT J INFECT DIS, V27, P4, DOI 10.1016/j.ijid.2014.03.1392; Zhao H, 2012, J VIROL, V86, P7021, DOI 10.1128/JVI.00858-12	52	46	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192672	10.1371/journal.pone.0192672	http://dx.doi.org/10.1371/journal.pone.0192672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470509	Green Published, gold, Green Submitted			2022-12-26	WOS:000425831000016
J	Jayaraman, A; Kumar, P; Marin, S; de Atauri, P; Mateo, F; Thomson, TM; Centelles, JJ; Graham, SF; Cascante, M				Jayaraman, Anusha; Kumar, Praveen; Marin, Silvia; de Atauri, Pedro; Mateo, Francesca; Thomson, Timothy M.; Centelles, Josep J.; Graham, Stewart F.; Cascante, Marta			Untargeted metabolomics reveals distinct metabolic reprogramming in endothelial cells co-cultured with CSC and non-CSC prostate cancer cell subpopulations	PLOS ONE			English	Article							GAP-JUNCTION COMMUNICATION; FATTY-ACID AMIDES; STEM-CELLS; ALZHEIMERS-DISEASE; LIPID OLEAMIDE; BREAST-CANCER; IN-VITRO; ANGIOGENESIS; METABOANALYST; METASTASIS	Tumour angiogenesis is an important hallmark of cancer and the study of its metabolic adaptations, downstream to any cellular change, can reveal attractive targets for inhibiting cancer growth. In the tumour microenvironment, endothelial cells (ECs) interact with heterogeneous tumour cell types that drive angiogenesis and metastasis. In this study we aim to characterize the metabolic alterations in ECs influenced by the presence of tumour cells with extreme metastatic abilities. Human umbilical vein endothelial cells (HUVECs) were subjected to different microenvironmental conditions, such as the presence of highly metastatic PC-3M and highly invasive PC-3S prostate cancer cell lines, in addition to the angiogenic activator vascular endothelial growth factor (VEGF), under normoxia. Untargeted high resolution liquid chromatography-mass spectrometry (LC-MS) based metabolomics revealed significant metabolite differences among the various conditions and a total of 25 significantly altered metabolites were identified including acetyl L-carnitine, NAD+, hypoxanthine, guanine and oleamide, with profile changes unique to each of the experimental conditions. Biochemical pathway analysis revealed the importance of fatty acid oxidation and nucleotide salvage pathways. These results provide a global metabolic preview that could help in selectively targeting the ECs aiding in either cancer cell invasion or metastasis in the heterogeneous tumour microenvironment.	[Jayaraman, Anusha; Marin, Silvia; de Atauri, Pedro; Centelles, Josep J.; Cascante, Marta] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biomed, Barcelona, Spain; [Jayaraman, Anusha; Kumar, Praveen; Graham, Stewart F.] Beaumont Hlth Syst, Beaumont Res Inst, Royal Oak, MI USA; [Marin, Silvia; de Atauri, Pedro; Thomson, Timothy M.; Centelles, Josep J.; Cascante, Marta] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Mateo, Francesca; Thomson, Timothy M.] CSIC, Dept Cell Biol, Mol Biol Inst Barcelona, Natl Res Council,IBMB, Barcelona, Spain; [Kumar, Praveen] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA	University of Barcelona; Beaumont Health; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Michigan System; University of Michigan	Cascante, M (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biomed, Barcelona, Spain.	martacascante@ub.edu	Centelles, Josep J./K-2972-2014; Marin, Silvia/C-5492-2017; CASCANTE, MARTA/AFK-5991-2022; Graham, Stewart/AAE-9772-2020; de Atauri, Pedro Ramón/R-3957-2019; CASCANTE, MARTA/AAG-4355-2022; de Atauri, Pedro/AAG-2384-2020; Mateo, Francesca/K-7746-2015	Centelles, Josep J./0000-0002-6289-9678; Marin, Silvia/0000-0003-0693-2207; CASCANTE, MARTA/0000-0002-2062-4633; de Atauri, Pedro Ramón/0000-0002-7754-7851; CASCANTE, MARTA/0000-0002-2062-4633; Mateo, Francesca/0000-0002-2342-7010; Kumar, Praveen/0000-0003-2425-7014; Jayaraman, Anusha/0000-0001-8548-155X; Graham, Stewart/0000-0003-1001-0002	MICINN [SAF2014-56059-R, SAF2015-70270-REDT]; Agenda Catalana d'Ajuts Universitaris i de Recerca (AGAUR) [2014SGR-1017]; Agenda Catalana d'Ajuts Universitaris i de Recerca (AGAUR) (FI-DGR grant); ICREA Foundation (Generalitat de Catalunya); European Commission (Metaflux) [PITN-GA-2010-264780]; MINECO [SAF2015-66984-C2-1-R]; Xarxa de Referencia en Biotecnologia; MICINN (Feder Funds "una manera de hacer Europa")	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Agenda Catalana d'Ajuts Universitaris i de Recerca (AGAUR); Agenda Catalana d'Ajuts Universitaris i de Recerca (AGAUR) (FI-DGR grant); ICREA Foundation (Generalitat de Catalunya)(ICREA); European Commission (Metaflux)(European Commission); MINECO(Spanish Government); Xarxa de Referencia en Biotecnologia; MICINN (Feder Funds "una manera de hacer Europa")	This work was supported by grants to MC from MICINN (SAF2014-56059-R, with Feder Funds "una manera de hacer Europa"; and SAF2015-70270-REDT); Agenda Catalana d'Ajuts Universitaris i de Recerca (AGAUR) (2014SGR-1017, and FI-DGR 2015 grant to AJ), ICREA Foundation (Generalitat de Catalunya) and European Commission (Metaflux, PITN-GA-2010-264780, fellowship granted to AJ) and to TMT from MINECO (SAF2015-66984-C2-1-R) and the Xarxa de Referencia en Biotecnologia.	Aguilar E, 2016, STEM CELLS, V34, P1163, DOI 10.1002/stem.2286; ARAFAT ES, 1989, LIFE SCI, V45, P1679, DOI 10.1016/0024-3205(89)90278-6; Beckert S, 2006, WOUND REPAIR REGEN, V14, P321, DOI 10.1111/j.1743-6109.2006.00127.x; Bisogno T, 1997, BIOCHEM BIOPH RES CO, V239, P473, DOI 10.1006/bbrc.1997.7431; Bisogno T, 1998, EUR J BIOCHEM, V254, P634, DOI 10.1046/j.1432-1327.1998.2540634.x; Boger DL, 1998, P NATL ACAD SCI USA, V95, P4810, DOI 10.1073/pnas.95.9.4810; Boitano S, 2000, AM J PHYSIOL-LUNG C, V279, pL623, DOI 10.1152/ajplung.2000.279.4.L623; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chen F, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0278-7; Chevallier OP, 2015, SCI REP-UK, V5, DOI 10.1038/srep09818; Chua CC, 1998, FREE RADICAL BIO MED, V25, P891, DOI 10.1016/S0891-5849(98)00115-4; Connolly JM, 1998, J UROLOGY, V160, P932, DOI 10.1016/S0022-5347(01)62835-0; CRAVATT BF, 1995, SCIENCE, V268, P1506, DOI 10.1126/science.7770779; Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; de Mas IM, 2014, FUTURE MED CHEM, V6, P1791, DOI 10.4155/FMC.14.119; Decrouy X, 2004, J CELL PHYSIOL, V200, P146, DOI 10.1002/jcp.10473; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; Ehrlich HP, 2006, J CELL BIOCHEM, V98, P735, DOI 10.1002/jcb.20852; El Hallani S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/827327; Fantozzi A, 2014, CANCER RES, V74, P1566, DOI 10.1158/0008-5472.CAN-13-1641; Fernandes S, 2016, MOL NEUROBIOL, V53, P408, DOI 10.1007/s12035-014-8973-5; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gacche RN, 2014, BBA-REV CANCER, V1846, P161, DOI 10.1016/j.bbcan.2014.05.002; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Gowda H, 2014, ANAL CHEM, V86, P6931, DOI 10.1021/ac500734c; Graham SF, 2013, ANAL CHEM, V85, P1803, DOI 10.1021/ac303163f; Guan XJ, 1997, J CELL BIOL, V139, P1785, DOI 10.1083/jcb.139.7.1785; Hiley CR, 2007, CARDIOVASC DRUG REV, V25, P46, DOI 10.1111/j.1527-3466.2007.00004.x; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Khodarev NN, 2003, J CELL SCI, V116, P1013, DOI 10.1242/jcs.00281; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Krutovskikh VA, 2002, ONCOGENE, V21, P1989, DOI 10.1038/sj.onc.1205187; Lin RZ, 2011, J CELL PHYSIOL, V226, P1750, DOI 10.1002/jcp.22504; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McMackin Craig J, 2007, J Clin Hypertens (Greenwich), V9, P249; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mueller GP, 2009, VITAM HORM, V81, P55, DOI 10.1016/S0083-6729(09)81003-0; Nojima H, 2007, CURR DRUG SAF, V2, P204, DOI 10.2174/157488607781668837; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Parra-Bonilla G, 2010, AM J PHYSIOL-LUNG C, V299, pL513, DOI 10.1152/ajplung.00274.2009; Pettegrew JW, 2000, MOL PSYCHIATR, V5, P616, DOI 10.1038/sj.mp.4000805; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Stanley C, 2014, BRIT J PHARMACOL, V171, P1361, DOI 10.1111/bph.12560; Sudhahar V, 2009, EUR J PHARMACOL, V607, P143, DOI 10.1016/j.ejphar.2009.02.002; Sumner LW, 2014, METABOLOMICS, V10, P1047, DOI 10.1007/s11306-014-0739-6; Szot CS, 2013, TISSUE ENG PART C-ME, V19, P864, DOI [10.1089/ten.tec.2012.0684, 10.1089/ten.TEC.2012.0684]; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Veeravagu A, 2008, STEM CELLS DEV, V17, P859, DOI 10.1089/scd.2008.0047; Vekemans Katrien, 2004, Comp Hepatol, V3 Suppl 1, pS49, DOI 10.1186/1476-5926-2-S1-S49; Verdegem D, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-19; Wang XH, 2013, MOL CANCER THER, V12, P1026, DOI 10.1158/1535-7163.MCT-12-0895; Wang YX, 2011, AM J PHYSIOL-CELL PH, V301, pC695, DOI 10.1152/ajpcell.00322.2010; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329; Yao H, 2016, CANCER LETT, V379, P213, DOI 10.1016/j.canlet.2016.03.014; Zhou B, 2012, MOL BIOSYST, V8, P470, DOI 10.1039/c1mb05350g; Zibara K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12598	66	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e192175	10.1371/journal.pone.0192175	http://dx.doi.org/10.1371/journal.pone.0192175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466368	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300033
J	Lerner, JE; Ono, K; Hernandez, KM; Runstadler, JA; Puryear, WB; Polito, MJ				Lerner, Jacob E.; Ono, Kathryn; Hernandez, Keith M.; Runstadler, Jonathan A.; Puryear, Wendy B.; Polito, Michael J.			Evaluating the use of stable isotope analysis to infer the feeding ecology of a growing US gray seal (Halichoerus grypus) population	PLOS ONE			English	Article							LION NEOPHOCA-CINEREA; MIXING MODELS; PHOCA-VITULINA; GREY SEALS; FOOD-WEB; MATERNAL INVESTMENT; NORTHWEST ATLANTIC; DIET COMPOSITION; MARINE MAMMALS; SCOTIAN SHELF	Gray seals (Halichoerus grypus) have been rapidly recolonizing the Northeast US coast, eliciting concern from the fishing industry. However, the ecological effect of this recovery is still unknown and as such, research is needed to better understand how the diet composition of gray seals in US waters will contribute to the ecological impact. While previous research on seal diets has focused on the analysis of hard prey remains, stable isotope analysis presents an alternative method that can be used to describe marine mammal diets when direct observation is impossible. To address this issue, we used stable isotope analysis of gray seal pup vibrissae and lanugo from Monomoy Island, Cape Cod, MA during the 2015/2016 winter breeding season to estimate adult female diet composition during pregnancy. Stable isotope mixing models (SIMM) suggested adult female gray seals were consuming greater amounts of cephalopod prey and less sand lance than previously indicated from analysis of hard prey remains. However, using SIMMs to estimate the diet composition of gray seals remains difficult due to the large number of isotopically similar prey species and uncertainty in tissue-specific, stable isotope trophic enrichment factors. Even so, by combining prey sources into ecologically informative groups and integrating prior information into SIMMs it is possible to obtain additional insights into the diet of this generalist predator.	[Lerner, Jacob E.; Ono, Kathryn] Univ New England, Dept Marine Sci, Biddeford, ME USA; [Hernandez, Keith M.; Polito, Michael J.] Lousiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA USA; [Runstadler, Jonathan A.; Puryear, Wendy B.] Tufts Univ, Cummings Sch Vet Med, Boston, MA 02111 USA	University of New England - Maine; Louisiana State University System; Louisiana State University; Tufts University	Lerner, JE (corresponding author), Univ New England, Dept Marine Sci, Biddeford, ME USA.	jlerner1@une.edu	Hernandez, Keith M/AAN-1394-2021	Hernandez, Keith M/0000-0001-9847-1158	University of New England; Louisiana State University; Lerner Gray Memorial Fund of the American Museum of Natural History; National Institute of Allergy and Infectious Diseases [HHSN272201400008C]; Northwest Atlantic Seal Research Consortium	University of New England; Louisiana State University; Lerner Gray Memorial Fund of the American Museum of Natural History; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Northwest Atlantic Seal Research Consortium	Funding for this project was provided by the University of New England (http://www.une.edu/), Louisiana State University (http://www.isu.edu/), the Lerner Gray Memorial Fund of the American Museum of Natural History (http://www.amnh.org/) to JEL and partly supported by by National Institute of Allergy and Infectious Diseases contract HHSN272201400008C (https://www.niaid.nih.gov/) to JAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jakub Kircun and Frederick Wenzel of the NOAA, National Marine Fisheries Service Northeast Science Center for supplying prey samples. Thank you to H. Bair for help with lipid extractions. Thank you to T. Mauney for assistance with stable isotope analysis. We also acknowledge the efforts and support of the Northwest Atlantic Seal Research Consortium during pup sampling.	Ampela K, 2006, GRAY SEAL HALICHOERU; Ampela K., 2009, THESIS, V188; ANDERSON SS, 1987, J ZOOL, V211, P667, DOI 10.1111/j.1469-7998.1987.tb04478.x; Beck CA, 2007, J ANIM ECOL, V76, P490, DOI 10.1111/j.1365-2656.2007.01215.x; Beltran RS, 2016, RAPID COMMUN MASS SP, V30, P1115, DOI 10.1002/rcm.7539; Bjorge A, 2002, MAR MAMMAL SCI, V18, P963, DOI 10.1111/j.1748-7692.2002.tb01085.x; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Bowen WD, 2013, MAMMAL REV, V43, P207, DOI 10.1111/j.1365-2907.2012.00217.x; Bowen WD, 1997, MAR ECOL PROG SER, V158, P267, DOI 10.3354/meps158267; BOWEN WD, 1992, J ZOOL, V227, P607, DOI 10.1111/j.1469-7998.1992.tb04418.x; BOWEN WD, 1993, CAN J FISH AQUAT SCI, V50, P1768, DOI 10.1139/f93-198; BOWEN WD, 1994, MAR ECOL PROG SER, V112, P1, DOI 10.3354/meps112001; Bowen WD, 2000, CAN J FISH AQUAT SCI, V57, P898, DOI 10.1139/cjfas-57-5-898; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Browne P, 2002, FISH B-NOAA, V100, P423; Burns JM, 1998, POLAR BIOL, V19, P272, DOI 10.1007/s003000050245; Chiaradia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092665; Crawford K, 2008, MAMMAL REV, P87; Cronin M, 2013, MAR BIOL, V160, P531, DOI 10.1007/s00227-012-2109-0; Edwards MA, 2011, OECOLOGIA, V165, P877, DOI 10.1007/s00442-010-1869-9; Elorriaga-Verplancken FR, 2016, J MAR BIOL ASSOC UK, V96, P903, DOI 10.1017/S0025315415002143; Franco-Trecu V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080019; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; GALES NJ, 1992, WILDLIFE RES, V19, P447, DOI 10.1071/WR9920447; Galvan DE, 2012, OECOLOGIA, V169, P1083, DOI 10.1007/s00442-012-2273-4; Greaves DK, 2004, MAR MAMMAL SCI, V20, P296, DOI 10.1111/j.1748-7692.2004.tb01158.x; Grellier K, 2006, CAN J FISH AQUAT SCI, V63, P1982, DOI 10.1139/F06-092; Gruber CP, 2014, THESIS; Hammill MO, 2014, ICES J MAR SCI, V71, P1332, DOI 10.1093/icesjms/fsu123; HARVEY JT, 1989, J ZOOL, V219, P101, DOI 10.1111/j.1469-7998.1989.tb02569.x; Healy K, 2017, ECOGRAPHY IN PRESS; Hendrickson LC, 2004, ESSENTIAL FISH HABIT; HEWER HR, 1968, J ZOOL, V155, P507; Hindell MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038307; HOBSON KA, 1992, MAR ECOL PROG SER, V84, P9, DOI 10.3354/meps084009; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Hopkins JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028478; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; Jacobson LD, 2005, LONGFIN INSHORE SQUI; Kim SL, 2012, ENVIRON BIOL FISH, V95, P53, DOI 10.1007/s10641-011-9860-9; Lelli B, 2009, NORTHEAST NAT, V16, P239, DOI 10.1656/045.016.0206; Lesage V, 2002, MAR MAMMAL SCI, V18, P182, DOI 10.1111/j.1748-7692.2002.tb01027.x; Lowther AD, 2011, MAR MAMMAL SCI, V27, P567, DOI 10.1111/j.1748-7692.2010.00425.x; MacKenzie KM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00021; Mohn R, 1996, CAN J FISH AQUAT SCI, V53, P2722, DOI 10.1139/cjfas-53-12-2722; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Moxley JH, 2017, BIOSCIENCE, V89, P490; National Marine Fisheries Service (NMFS), 2017, STAT REV REP THORN S; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Phillips DL, 2012, J MAMMAL, V93, P342, DOI 10.1644/11-MAMM-S-158.1; Phillips EM, 2009, MAR MAMMAL SCI, V25, P373, DOI 10.1111/j.1748-7692.2008.00265.x; Polito MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026642; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; PRIME JH, 1990, J APPL ECOL, V27, P435, DOI 10.2307/2404292; Rea LD, 2013, SCI TOTAL ENVIRON, V454, P277, DOI 10.1016/j.scitotenv.2013.02.095; Scherer RD, 2015, MAR ECOL PROG SER, V527, P261, DOI 10.3354/meps11255; SMISETH PT, 1995, BEHAV ECOL SOCIOBIOL, V36, P145, DOI 10.1007/BF00177790; Smith JA, 2013, METHODS ECOL EVOL, V4, P612, DOI 10.1111/2041-210X.12048; Soreide JE, 2006, PROG OCEANOGR, V71, P59, DOI 10.1016/j.pocean.2006.06.001; STEWART REA, 1980, J MAMMAL, V61, P670, DOI 10.2307/1380312; Stock BC, 2016, MIXSIAR GUI USER MAN; Stricker CA, 2015, MAR ECOL PROG SER, V523, P255, DOI 10.3354/meps11205; Tollit DJ, 2009, ECOL APPL, V19, P889, DOI 10.1890/07-1701.1; Tucker S, 2008, MAR ECOL PROG SER, V354, P267, DOI 10.3354/meps07263; Tucker S, 2007, MAR ECOL PROG SER, V339, P271, DOI 10.3354/meps339271; Tucker S, 2013, MAR MAMMAL SCI, V29, pE428, DOI 10.1111/mms.12009; Ward EJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00190.1; Waring G. T., 2015, NMFSNE231 NOAA; Wood SA, 2011, CAN J ZOOL, V89, P490, DOI 10.1139/Z11-012; Yodzis P, 2001, TRENDS ECOL EVOL, V16, P78, DOI 10.1016/S0169-5347(00)02062-0	74	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192241	10.1371/journal.pone.0192241	http://dx.doi.org/10.1371/journal.pone.0192241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466372	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300040
J	Okano, J; Okuda, N				Okano, Jun-ichi; Okuda, Noboru			Effects of resource-dependent cannibalism on population size distribution and individual life history in a case-bearing caddisfly	PLOS ONE			English	Article							SURFACE-ROUGHNESS; PREDATION RISK; GROWTH; COMPETITION; DENSITY; PREY; ADAPTATION; BIMODALITY; STRATEGIES; PREFERENCE	Resource availability often determines the intensity of cannibalism, which has a considerable effect on population size distribution and individual life history. Larvae of the caddisfly Psilotreta kisoensis build portable cases from sedimentary sands and often display cannibalism. For this species, the availability of preferable case material is a critical factor that affects larval fitness, and material is locally variable depending on the underlying geology. In this study, we investigated how sand quality as a case material determines cannibalism frequency among larvae and, in turn, how the differential cannibalism frequency affects the body-size distribution and voltinism. Rearing experiments within a cohort revealed that a bimodal size distribution developed regardless of material quality. However, as the preferable material became abundant, the proportion of larger to smaller individuals increased. Consecutive experiments suggested that smaller larvae were more frequently cannibalized by larger ones and excluded from the population when preferable smooth material was abundant. This frequent cannibalism resulted in a bimodal size distribution with a significantly higher proportion of larger compared to smaller individuals. The size-dependent cannibalism was significantly suppressed when the larvae were raised in an environment with a scarcity of the preferable case material. This is probably because larvae cannot enjoy the benefit of rapid growth by cannibalism due to the difficulties in enlarging their case. At low cannibalism the growth of smaller individuals was stunted, and this was probably due to risk of cannibalism by larger individuals. This growth reduction in small individuals led to a bimodal size-distribution but with a lower proportion of larger to smaller individuals compared to at high cannibalism. A field study in two streams showed a similar size distribution of larvae as was found in the rearing experiment. The bimodal ratio has consequences for life history, since a size-bimodal population causes a cohort splitting: only larvae that were fully grown at 1 year had a univoltine life cycle, whereas larvae with a stunted growth continued their larval life for another year (semivoltine). This study suggests that availability of preferable case building material is an important factor that affects cannibalism, which in turn affects larval population size structure and cohort splitting.	[Okano, Jun-ichi; Okuda, Noboru] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Okuda, Noboru] Res Inst Humanity & Nat, Kyoto, Japan	Kyoto University; Research Institute for Humanity & Nature (RIHN)	Okano, J (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.	j.oj.o55222@gmail.com		Okano, Jun-ichi/0000-0002-1295-4114	Japan Society for the Promotion of Science [12J01273, 26840146]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (12J01273, 26840146) to JIO. URL:https://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F., 2009, P ROYAL SOC B; Amundsen PA, 2007, J ANIM ECOL, V76, P149, DOI 10.1111/j.1365-2656.2006.01179.x; Bogut I, 2007, POLJOPRIVREDA, V13; Claessen D, 2004, P ROY SOC B-BIOL SCI, V271, P333, DOI 10.1098/rspb.2003.2555; Claessen D, 2000, AM NAT, V155, P219, DOI 10.1086/303315; CORBET PS, 1957, J ANIM ECOL, V26, P1, DOI 10.2307/1781; CROWLEY PH, 1994, AM NAT, V143, P117, DOI 10.1086/285598; Crowley PH, 2015, ECOL MODEL, V308, P1, DOI 10.1016/j.ecolmodel.2015.03.018; DeAngelis D.L., 1979, ECOL MODEL, V8, P133; Elgar M. A., 1992, CANNIBALISM ECOLOGY, P1; Ferreras-Romero M, 1999, HYDROBIOLOGIA, V405, P39, DOI 10.1023/A:1003763819991; Fitzgerald GJ, CANNIBALISM ECOLOGY; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Fraley C., 2007, J STAT SOFTW, V18, P1, DOI DOI 10.18637/JSS.V018.I06; Habashy Madlen M., 2005, Egyptian Journal of Aquatic Research, V31, P403; Huss M, 2010, OIKOS, V119, P2000, DOI 10.1111/j.1600-0706.2010.18454.x; HUSTON MA, 1987, AM NAT, V129, P678, DOI 10.1086/284666; Johansson F., 2008, Aquatic insects: challenges to populations, P36, DOI 10.1079/9781845933968.0036; Johansson F, 1996, ARCH HYDROBIOL, V137, P523; JOHNSON D M, 1986, Odonatologica, V15, P81; Kishida O, 2011, J ANIM ECOL, V80, P1278, DOI 10.1111/j.1365-2656.2011.01871.x; Kobe City Government Bureau of Environment Environmental Protection Department, 2013, KOB CIT GOV BUR ENV; LEONARDSSON K, 1991, ECOLOGY, V72, P1273, DOI 10.2307/1941101; Lovrich GA, 1997, J EXP MAR BIOL ECOL, V211, P225, DOI 10.1016/S0022-0981(96)02715-3; Lund JO, 2016, FRESHW SCI, V35, P619, DOI 10.1086/685583; Lundvall D, 1999, CAN J FISH AQUAT SCI, V56, P1285, DOI 10.1139/cjfas-56-7-1285; MARTIN TH, 1991, J N AM BENTHOL SOC, V10, P271, DOI 10.2307/1467600; Matsumoto M, 1999, REPORTS IND RES I TO, V17, P88; Mayntz D, 2006, J ANIM ECOL, V75, P288, DOI 10.1111/j.1365-2656.2006.01046.x; McPeek MA, 2004, AM NAT, V163, pE88, DOI 10.1086/382755; Okano J., 2017, CANNIBALISM BY CADDI; Okano J, 2017, ZOOL SCI, V34, P461, DOI 10.2108/zs160207; Okano J, 2016, FRESHW SCI, V35, P611, DOI 10.1086/685713; Okano JI, 2012, ECOL ENTOMOL, V37, P426, DOI 10.1111/j.1365-2311.2012.01382.x; Okano J, 2011, BEHAV ECOL, V22, P1053, DOI 10.1093/beheco/arr089; Okano J, 2010, BEHAV ECOL, V21, P826, DOI 10.1093/beheco/arq066; Okano J, 2009, ANIM BEHAV, V77, P595, DOI 10.1016/j.anbehav.2008.10.027; Peron G, 2013, J ANIM ECOL, V82, P408, DOI 10.1111/1365-2656.12014; Persson L, 2004, ECOL MONOGR, V74, P135, DOI 10.1890/02-4092; Pfennig DW, 1998, ANIM BEHAV, V55, P1255, DOI 10.1006/anbe.1997.9996; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; RIDGWAY LL, 1994, CAN J ZOOL, V72, P1576, DOI 10.1139/z94-209; Roberts JA, 2003, BEHAV ECOL SOCIOBIOL, V54, P416, DOI 10.1007/s00265-003-0646-8; Rudolf VHW, 2007, ECOLOGY, V88, P2991, DOI 10.1890/07-0179.1; SIH A, 1982, ECOLOGY, V63, P786, DOI 10.2307/1936799; Stoeckli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035723; Stoks R, 2012, J ANIM ECOL, V81, P1034, DOI 10.1111/j.1365-2656.2012.01987.x; Takatsu K, 2015, ECOLOGY, V96, P1887, DOI 10.1890/14-1616.1; Wissinger S, 2004, OECOLOGIA, V138, P39, DOI 10.1007/s00442-003-1397-y; WISSINGER SA, 1992, ECOLOGY, V73, P1431, DOI 10.2307/1940688; Wissinger SA, 2010, ECOLOGY, V91, P549, DOI 10.1890/08-1366.1; Woodward G, 2005, ADV ECOL RES, V36, P85, DOI 10.1016/S0065-2504(05)36002-8; Yamanaka T, 2008, J ANIM ECOL, V77, P585, DOI 10.1111/j.1365-2656.2008.01367.x; Ylikarjula J, 1999, EVOL ECOL, V13, P433, DOI 10.1023/A:1006755702230; Ziemba RE, 1999, OECOLOGIA, V120, P524, DOI 10.1007/s004420050886; Ziemba RE, 2000, OECOLOGIA, V124, P225, DOI 10.1007/s004420050010	57	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0191925	10.1371/journal.pone.0191925	http://dx.doi.org/10.1371/journal.pone.0191925			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466375	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300019
J	Gonzalez, JDS; Corral, JAR; Garcia, GM; Ojeda, GR; Larios, LD; Holland, JB; Medrano, RM; Romero, GEG				Sanchez Gonzalez, Jose de Jesus; Ruiz Corral, Jose Ariel; Medina Garcia, Guillermo; Ramirez Ojeda, Gabriela; De la Cruz Larios, Lino; Holland, James Brendan; Miranda Medrano, Roberto; Garcia Romero, Giovanni Emmanuel			Ecogeography of teosinte	PLOS ONE			English	Article							ZEA GRAMINEAE; MAIZE; IDENTIFICATION; RESISTANCE; EVOLUTION; SELECTION; TAXONOMY; POACEAE; COMPLEX; MEXICO	Adaptation of crops to climate change has motivated an increasing interest in the potential value of novel traits from wild species; maize wild relatives, the teosintes, harbor traits that may be useful to maize breeding. To study the ecogeographic distribution of teosinte we constructed a robust database of 2363 teosinte occurrences from published sources for the period 1842-2016. A geographical information system integrating 216 environmental variables was created for Mexico and Central America and was used to characterize the environment of each teosinte occurrence site. The natural geographic distribution of teosinte extends from the Western Sierra Madre of the State of Chihuahua, Mexico to the Pacific coast of Nicaragua and Costa Rica, including practically the entire western part of Mesoamerica. The Mexican annuals Zea mays ssp. parviglumis and Zea mays ssp. mexicana show a wide distribution in Mexico, while Zea diploperennis, Zea luxurians, Zea perennis, Zea mays ssp. huehuetenangensis, Zea vespertilio and Zea nicaraguensis had more restricted and distinct ranges, representing less than 20% of the total occurrences. Only 11.2% of teosinte populations are found in Protected Natural Areas in Mexico and Central America. Ecogeographical analysis showed that teosinte can cope with extreme levels of precipitation and temperatures during growing season. Modelling teosinte geographic distribution demonstrated congruence between actual and potential distributions; however, some areas with no occurrences appear to be within the range of adaptation of teosintes. Field surveys should be prioritized to such regions to accelerate the discovery of unknown populations. Potential areas for teosintes Zea mays ssp. mexicana races Chalco, Nobogame, and Durango, Zea mays ssp. huehuetenangensis, Zea luxurians, Zea diploperennis and Zea nicaraguensis are geographically separated; however, partial overlapping occurs between Zea mays ssp. parviglumis and Zea perennis, between Zea mays ssp. parviglumis and Zea diploperennis, and between Zea mays ssp. mexicana race Chalco and Zea mays ssp. mexicana race Central Plateau. Assessing priority of collecting for conservation showed that permanent monitoring programs and in-situ conservation projects with participation of local farmer communities are critically needed; Zea mays ssp. mexicana (races Durango and Nobogame), Zea luxurians, Zea diploperennis, Zea perennis and Zea vespertilio should be considered as the highest priority taxa.	[Sanchez Gonzalez, Jose de Jesus; De la Cruz Larios, Lino; Miranda Medrano, Roberto] Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Zapopan, Jalisco, Mexico; [Ruiz Corral, Jose Ariel; Ramirez Ojeda, Gabriela; Garcia Romero, Giovanni Emmanuel] Inst Nacl Invest Forestales Agr & Pecuarias, Ctr Invest Reg Pacifico Ctr, Campo Expt Ctr Altos Jalisco, Guadalajara, Jalisco, Mexico; [Medina Garcia, Guillermo] Inst Nacl Invest Forestales Agr & Pecuarias, Ctr Invest Reg Norte Ctr, Campo Expt Zacatecas, Calera, Zacatecas, Mexico; [Holland, James Brendan] North Carolina State Univ, USDA ARS, Plant Sci Res Unit, Dept Crop & Soil Sci, Raleigh, NC 27695 USA	Universidad de Guadalajara; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University	Corral, JAR (corresponding author), Inst Nacl Invest Forestales Agr & Pecuarias, Ctr Invest Reg Pacifico Ctr, Campo Expt Ctr Altos Jalisco, Guadalajara, Jalisco, Mexico.	ruiz.ariel@inifap.gob.mx	CORRAL, JOSE ARIEL RUIZ/J-3765-2016	CORRAL, JOSE ARIEL RUIZ/0000-0002-7945-8107; Holland, James/0000-0002-4341-9675	Comision Nacional para la Biodiversidad (Mexico); Universidad de Guadalajara (Mexico); Instituto Nacional de Investigaciones Forestales Agricolas y Pecuarias (Mexico); Direct For Biological Sciences [1238014] Funding Source: National Science Foundation	Comision Nacional para la Biodiversidad (Mexico); Universidad de Guadalajara (Mexico); Instituto Nacional de Investigaciones Forestales Agricolas y Pecuarias (Mexico); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a) Comision Nacional para la Biodiversidad (Mexico), JJSG, www.gob.mx/conabio; b) Universidad de Guadalajara (Mexico), JJSG, www.udg.mx; c) Instituto Nacional de Investigaciones Forestales Agricolas y Pecuarias (Mexico), JARC, www.inifap.gob.mx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JL, 2014, J CLASSIF, V31, P136, DOI 10.1007/s00357-013-9139-2; [Anonymous], 2015, STAT AN SYST; Avila CA, 2014, REV MEX CIEN FOR, V5, P92; Balbuena MA., 2011, CTR AGR, V38, P5; Castaneda-Alvarez NP, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.22, 10.1038/nplants.2016.22]; Collins GN, 1921, J HERED, V12, P339, DOI 10.1093/oxfordjournals.jhered.a102119; Collins GN, 1932, J HERED, V23, P261, DOI 10.1093/oxfordjournals.jhered.a103626; Collins GW, 1937, YEAR BOOK, V36, P149; Silva NCD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139034; Dempewolf H, 2014, AGROECOL SUST FOOD, V38, P369, DOI 10.1080/21683565.2013.870629; Devkota N. R., 2015, Nepalese Journal of Agricultural Sciences, V13, P131; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; DOEBLEY J, 1990, ECON BOT, V44, P6, DOI 10.1007/BF02860472; DOEBLEY JF, 1980, AM J BOT, V67, P982, DOI 10.2307/2442441; Donegan Thomas M., 2010, Bulletin of the British Ornithologists' Club, V130, P13; Eastman J.R, 2012, IDRISI PROD CLARK U; EFSA (European Food Safety Authority), 2016, EFSA SUPP PUBL, V1094; El-Nahrawy M.A, 2011, COUNTRY PASTURE FORA; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Endresen DTF, 2011, CROP SCI, V51, P2036, DOI 10.2135/cropsci2010.12.0717; Escalante Tania, 2013, TIP Revista Especializada en Ciencias Quimico-Biologicas, V16, P5; Espinosa G, 1997, MANUAL MALEZAS VALLE; Food and Agriculture Organization of the United Nations, 2010, 2 REP STAT WORLDS PL; Food and Agriculture Organization of the United Nations (FAO), 1978, 48 FAO UN, V1; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gomez-Laurito J., 2013, NEW SPECIES ZEA POAC, V80, P36; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hitchcock AS, 1971, MANUAL GRASSES US; Hufford MB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003477; Hutchinson M.F., 2004, ANUSPLIN VERSION 4 3; Ibrahim HIM, 2015, WORLD J AGR SCI, V11, P268; Iltis HH, 2000, NOVON, V10, P382, DOI 10.2307/3392992; ILTIS HH, 1980, AM J BOT, V67, P994, DOI 10.2307/2442442; Kato YTA, 1976, MASS AGR EXPER STAT, V635; Kempton JH, 1937, CONTRIBUTIONS AM ARC, V4, P201; Kundu CK, 2015, FORAGE RES, V40, P243; Kwabiah AB, 2003, CAN J PLANT SCI, V83, P689, DOI 10.4141/P02-127; Lamson-Scribner F., 1899, FARMERS B, V102; Lennon JR, 2016, CROP SCI, V56, P209, DOI 10.2135/cropsci2014.07.0468; Lumholtz C., 1902, UNKNOWN MEXICO, V1, P429; Mangelsdorf Paul C., 1974, CORN ITS ORIGIN EVOL; Mano Y, 2015, EUPHYTICA, V205, P255, DOI 10.1007/s10681-015-1449-5; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Maxted N, 2009, 39 FAO UN COMM GEN R; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Nault L., 1983, P INT MAIZ VIR DIS C, P75; NDDB, 2012, NUTR VAL COMM AV FEE; Pardo G., 2015, XV Congreso de la Sociedad Espanola de Malherbologia, SEMh 2015, "La Malherbologia y la Transferencia Tecnologica" Sevilla, Espana, 19 al 22 de octubre de 2015, P417; Pardo G., 2016, VIDA RURAL, V408, P42; Pawar S, 2007, BIOL CONSERV, V136, P346, DOI 10.1016/j.biocon.2006.12.012; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips S., 2011, P 25 AAAI C ART INT, P1384; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ramirez-Villegas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013497; Rich PJ, 2008, PLANT SIGNAL BEHAV, V3, P618, DOI 10.4161/psb.3.9.5750; Rohit FJ, 2000, NTSYS PC NUMERICAL T; Royal Gardens Kew, 1894, B MISCELLANEOUS INFO, V95, P373; Corral JAR, 2008, CROP SCI, V48, P1502, DOI 10.2135/cropsci2007.09.0518; Ruiz JA, 2001, MAYDICA, V46, P105; Sanchez JJ, 2011, AM J BOT, V98, P1537, DOI 10.3732/ajb.1100193; Sanchez G JJ, 1987, SYSTEMATIC ECOGEOGRA, V2; Sanchez GJJ, 1998, DISTRIBUCION CARACTE, V2; SANCHEZ GJJ, 1997, GENE FLOW MAIZE LAND, P18; Sanchez-Ken J. G., 2012, CATALOGO MALEZAS GRA; Sarukhan J., 2009, CAPITAL NATURAL MEXI; Soberon J, 2011, REV MEX BIODIVERS, V82, P1348; Stockle CO, 1999, CLIMGEN MANUAL; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; vanDevender TR, 2016, RES SIERRA MADRE OCC; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Vasey G., 1887, BULLETIN, V3; Vibrans H, 1998, MAYDICA, V43, P45; Warburton ML, 2011, GENET RESOUR CROP EV, V58, P1243, DOI 10.1007/s10722-010-9658-1; WHITE RP, 1978, CAN J PLANT SCI, V58, P629, DOI 10.4141/cjps78-098; Wilkes G, 2007, MAYDICA, V52, P49; Wilkes Garrison, 2004, CORN ORIGIN HIST TEC, P3; Wilkes H. G., 1979, Crop Improvement, V6, P1; Wilkes H.G., 1967, TEOSINTE CLOSEST REL; Wilkes H.G., 1997, GENE FLOW MAIZE LAND, P10; WILKES HG, 1977, ECON BOT, V31, P254, DOI 10.1007/BF02866877; WILKES HG, 1985, MAYDICA, V30, P209; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zhang X, 2004, RCLIMDEX 1 0 USER MA	84	33	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192676	10.1371/journal.pone.0192676	http://dx.doi.org/10.1371/journal.pone.0192676			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451888	gold, Green Submitted, Green Published			2022-12-26	WOS:000425369800020
J	Campbell, GR; Bruckman, RS; Herns, SD; Joshi, S; Durden, DL; Spector, SA				Campbell, Grant R.; Bruckman, Rachel S.; Herns, Shayna D.; Joshi, Shweta; Durden, Donald L.; Spector, Stephen A.			Induction of autophagy by PI3K/MTOR and PI3K/MTOR/BRD4 inhibitors suppresses HIV-1 replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; IMMUNODEFICIENCY-VIRUS TYPE-1; RAPAMYCIN INHIBITOR; CELL-DEATH; MAMMALIAN TARGET; TUMOR-GROWTH; PHASE-II; NVP-BEZ235; PI3K; APOPTOSIS	In this study, we investigated the effects of the dual phosphatidylinositol 3-kinase/mechanistic target of rapamycin (PI3K/MTOR) inhibitor dactolisib (NVP-BEZ235), the PI3K/MTOR/bromodomain-containing protein 4 (BRD4) inhibitor SF2523, and the bromodomain and extra terminal domain inhibitor JQ1 on the productive infection of primary macrophages with human immunodeficiency type-1 (HIV). These inhibitors did not alter the initial susceptibility of macrophages to HIV infection. However, dactolisib, JQ1, and SF2523 all decreased HIV replication in macrophages in a dose-dependent manner via degradation of intracellular HIV through autophagy. Macrophages treated with dactolisib, JQ1, or SF2523 displayed an increase in LC3B lipidation combined with SQSTM1 degradation without inducing increased cell death. LC3B-II levels were further increased in the presence of pepstatin A suggesting that these inhibitors induce autophagic flux. RNA interference for ATG5 and ATG7 and pharmacological inhibitors of autophagosome- lysosome fusion and of lysosomal hydrolases all blocked the inhibition of HIV. Thus, we demonstrate that the mechanism of PI3K/MTOR and PI3K/MTOR/BRD4 inhibitor suppression of HIV requires the formation of autophagosomes, as well as their subsequent maturation into autolysosomes. These data provide further evidence in support of a role for autophagy in the control of HIV infection and open new avenues for the use of this class of drugs in HIV therapy.	[Campbell, Grant R.; Bruckman, Rachel S.; Herns, Shayna D.; Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, Div Infect Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Joshi, Shweta; Durden, Donald L.] Univ Calif San Diego, Dept Pediat, Div Pediat Hematol Oncol, La Jolla, CA 92093 USA; [Joshi, Shweta; Durden, Donald L.; Spector, Stephen A.] Rady Childrens Hosp, San Diego, CA 92123 USA; [Durden, Donald L.] SignalRx Pharmaceut Inc, San Diego, CA 92130 USA; [Bruckman, Rachel S.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL 60064 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Chicago Medical School; Rosalind Franklin University Medical & Science	Spector, SA (corresponding author), Univ Calif San Diego, Dept Pediat, Div Infect Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA.	saspector@ucsd.edu	Campbell, Grant/C-9018-2011	Campbell, Grant/0000-0003-3927-1994	National Institutes of Health Awards from NIAID [UM1AI068632, UM1AI068616, UM1AI106716]; Eunice Kennedy Shriver NICHD; Eunice Kennedy Shriver NIMH; NATIONAL CANCER INSTITUTE [R42CA192656, R01CA172513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069536, UM1AI106716, UM1AI068632, UM1AI068616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS104015, R01NS084912] Funding Source: NIH RePORTER	National Institutes of Health Awards from NIAID; Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver NIMH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network was provided by the National Institutes of Health Awards UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC), and UM1AI106716 (IMPAACT LC) from NIAID, with co-funding from the Eunice Kennedy Shriver NICHD and the NIMH.	Andrews FH, 2017, P NATL ACAD SCI USA, V114, pE1072, DOI 10.1073/pnas.1613091114; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Baumann P, 2009, EXP CELL RES, V315, P485, DOI 10.1016/j.yexcr.2008.11.007; Bendell JC, 2015, INVEST NEW DRUG, V33, P187, DOI 10.1007/s10637-014-0177-3; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Borel S, 2015, AIDS, V29, P275, DOI 10.1097/QAD.0000000000000554; Button RW, 2016, ONCOTARGET, V7, P5157, DOI 10.18632/oncotarget.6986; Calcagno A, 2014, CLIN PHARMACOKINET, V53, P891, DOI 10.1007/s40262-014-0171-0; Campbell GR, 2008, J BIOL CHEM, V283, P30745, DOI 10.1074/jbc.M804112200; Campbell GR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005018; Campbell GR, 2015, J BIOL CHEM, V290, P5028, DOI 10.1074/jbc.M114.605428; Campbell GR, 2011, AIDS RES HUM RETROV, V27, P647, DOI [10.1089/aid.2010.0192, 10.1089/AID.2010.0192]; Campbell GR, 2013, CURR OPIN MICROBIOL, V16, P349, DOI 10.1016/j.mib.2013.05.006; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003017; Campbell GR, 2012, AUTOPHAGY, V8, P1523, DOI 10.4161/auto.21154; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Campbell GR, 2011, J BIOL CHEM, V286, P18890, DOI 10.1074/jbc.M110.206110; Herrero-Sanchez MC, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0343-5; Cerniglia GJ, 2012, MOL PHARMACOL, V82, P1230, DOI 10.1124/mol.112.080408; Chang ZX, 2013, INT J MOL MED, V31, P1449, DOI 10.3892/ijmm.2013.1351; Chiarini F, 2010, CANCER RES, V70, P8097, DOI 10.1158/0008-5472.CAN-10-1814; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Donia M, 2010, BRIT J CLIN PHARMACO, V70, P784, DOI 10.1111/j.1365-2125.2010.03735.x; Espert L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005787; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Fazio N, 2016, ANTICANCER RES, V36, P713; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003; Frankfurt OS, 2001, J IMMUNOL METHODS, V253, P133, DOI 10.1016/S0022-1759(01)00387-8; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gomez-Mora E, 2017, JAIDS-J ACQ IMM DEF, V74, P201, DOI 10.1097/QAI.0000000000001201; Hewings DS, 2012, J MED CHEM, V55, P9393, DOI 10.1021/jm300915b; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Ji YH, 2015, CLIN LAB, V61, P1043, DOI 10.7754/Clin.Lab.2015.150144; Joshi S, 2014, MOL CANCER RES, V12, P1520, DOI 10.1158/1541-7786.MCR-13-0682; Kandathil AJ, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0323-4; Karn J, 2013, CELL CYCLE, V12, P545, DOI 10.4161/cc.23679; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kuger S, 2014, BREAST CANCER-BASIC, V8, P39, DOI 10.4137/BCBCR.S13693; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Lin F, 2015, HUM MOL GENET, V24, P2899, DOI 10.1093/hmg/ddv052; Lu PP, 2016, SCI REP-UK, V6, DOI 10.1038/srep24100; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morales GA, 2013, J MED CHEM, V56, P1922, DOI 10.1021/jm301522m; Nardacci R, 2014, AUTOPHAGY, V10, P1167, DOI 10.4161/auto.28678; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popovic M., 1988, RETROVIRUSES HUMAN A, P21; Rahmani M, 2013, CANCER RES, V73, P1340, DOI 10.1158/0008-5472.CAN-12-1365; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sakamaki JI, 2017, MOL CELL, V66, P517, DOI 10.1016/j.molcel.2017.04.027; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Schnell CR, 2008, CANCER RES, V68, P6598, DOI 10.1158/0008-5472.CAN-08-1044; Seront E, 2016, BJU INT, V118, P408, DOI 10.1111/bju.13415; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Singh A, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.AM2016-2142; Smallwood HS, 2017, CELL REP, V19, P1640, DOI 10.1016/j.celrep.2017.04.039; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Urata S, 2012, J VIROL, V86, P4578, DOI 10.1128/JVI.06604-11; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wise-Draper TM, 2017, TARGET ONCOL, V12, P323, DOI 10.1007/s11523-017-0482-9; Yang XY, 2016, ONCOL LETT, V12, P102, DOI 10.3892/ol.2016.4590; Yu XL, 2015, AUTOPHAGY, V11, P1711, DOI 10.1080/15548627.2015.1043076; Yu Y, 2016, INT J ONCOL, V49, P285, DOI 10.3892/ijo.2016.3507; Zheng YH, 2012, J MOL MED, V90, P695, DOI 10.1007/s00109-011-0849-9; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836	78	37	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5808	5820		10.1074/jbc.RA118.002353	http://dx.doi.org/10.1074/jbc.RA118.002353			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29475942	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000430497300006
J	Jones, RB; Dorsett, KA; Hjelmeland, AB; Bellis, SL				Jones, Robert B.; Dorsett, Kaitlyn A.; Hjelmeland, Anita B.; Bellis, Susan L.			The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1 alpha signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTORS; PROMOTES CHEMORESISTANCE; TRANSCRIPTION FACTORS; CANCER CELLS; STEM-CELLS; EXPRESSION; HIF-1; GLYCOSYLATION; SIALYLATION	Aberrant cell surface glycosylation is prevalent in tumor cells, and there is ample evidence that glycans have functional roles in carcinogenesis. Nonetheless, many molecular details remain unclear. Tumor cells frequently exhibit increased alpha 2-6 sialylation on N-glycans, a modification that is added by the ST6Gal-I sialyltransferase, and emerging evidence suggests that ST6Gal-I-mediated sialylation promotes the survival of tumor cells exposed to various cell stressors. Here we report that ST6Gal-I protects cancer cells from hypoxic stress. It is well known that hypoxia-inducible factor 1 alpha (HIF-1 alpha) is stabilized in hypoxic cells, and, in turn, HIF-1 alpha directs the transcription of genes important for cell survival. To investigate a putative role for ST6Gal-I in the hypoxic response, we examined HIF-1 alpha accumulation in ovarian and pancreatic cancer cells in ST6Gal-I overexpression or knockdown experiments. We found that ST6Gal-I activity augmented HIF-1 alpha accumulation in cells grown in a hypoxic environment or treated with two chemical hypoxia mimetics, deferoxamine and dimethyloxalylglycine. Correspondingly, hypoxic cells with high ST6Gal-I expression had increased mRNA levels of HIF-1 alpha transcriptional targets, including the glucose transporter genes GLUT1 and GLUT3 and the glycolytic enzyme gene PDHK1. Interestingly, high ST6Gal-I-expressing cells also had an increased pool of HIF-1 alpha mRNA, suggesting that ST6Gal-I may influence HIF-1 alpha expression. Finally, cells grown in hypoxia for several weeks displayed enriched ST6Gal-I expression, consistent with a pro-survival function. Taken together, these findings unravel a glycosylation-dependent mechanism that facilitates tumor cell adaptation to a hypoxic milieu.	[Jones, Robert B.; Dorsett, Kaitlyn A.; Hjelmeland, Anita B.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), 1918 Univ Blvd,350 MCLM, Birmingham, AL 35294 USA.	bellis@uab.edu			University of Alabama at Birmingham Flow Cytometry Core Facility [P30AR048311, P30AI027767]; National Institutes of Health [R01 GM111093]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111, R01GM111093] Funding Source: NIH RePORTER	University of Alabama at Birmingham Flow Cytometry Core Facility; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the University of Alabama at Birmingham Flow Cytometry Core Facility (P30AR048311 and P30AI027767) for assistance.; This work was supported by National Institutes of Health Grant R01 GM111093 (to S. L. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; Britain CM, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0385-0; Britain CM, 2017, J BIOL CHEM, V292, P4663, DOI 10.1074/jbc.M116.763862; Carnero A, 2016, BIOESSAYS, V38, pS65, DOI 10.1002/bies.201670911; Chakraborty A, 2018, J BIOL CHEM, V293, P984, DOI 10.1074/jbc.M117.808584; Chang Q, 2011, CANCER RES, V71, P3110, DOI 10.1158/0008-5472.CAN-10-4049; Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7; Chen XX, 2016, ONCOTARGET, V7, P51955, DOI 10.18632/oncotarget.10192; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Chun YS, 2002, J KOREAN MED SCI, V17, P581, DOI 10.3346/jkms.2002.17.5.581; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P2752, DOI 10.1016/j.bbagen.2014.06.006; Dhani N, 2015, SEMIN NUCL MED, V45, P110, DOI 10.1053/j.semnuclmed.2014.11.002; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Gorlach Agnes, 2008, Biochem J, V412, pe17, DOI 10.1042/BJ20080920; Hao J, 2008, CANCER GENE THER, V15, P449, DOI 10.1038/cgt.2008.4; Harduin-Lepers Anne, 2012, Front Biosci (Elite Ed), V4, P499; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Holdbrooks AT, 2018, J BIOL CHEM, V293, P1610, DOI 10.1074/jbc.M117.801480; Hsieh CC, 2017, ONCOTARGET, V8, P7691, DOI 10.18632/oncotarget.13845; Jiang BH, 1997, CANCER RES, V57, P5328; Jung YJ, 2003, BIOCHEM J, V370, P1011, DOI 10.1042/BJ20021279; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li S, 2015, CANCER BIOL THER, V16, P866, DOI 10.1080/15384047.2015.1040958; Lim CS, 2012, J VASC SURG, V55, P1427, DOI 10.1016/j.jvs.2011.10.111; Lin SQ, 2002, EXP CELL RES, V276, P101, DOI 10.1006/excr.2002.5521; Lise M, 2000, HYBRIDOMA, V19, P281, DOI 10.1089/027245700429828; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Mendez O, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-133; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Munkley J, 2016, ONCOTARGET, V7, P35478, DOI 10.18632/oncotarget.8155; Park JJ, 2012, BIOCHEM PHARMACOL, V83, P849, DOI 10.1016/j.bcp.2012.01.007; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Qin J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09244-8; Recchi MA, 1998, CANCER RES, V58, P4066; Schultz MJ, 2016, CANCER RES, V76, P3978, DOI 10.1158/0008-5472.CAN-15-2834; Schultz MJ, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-25; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Shibuya K, 2015, ONCOTARGET, V6, P651, DOI 10.18632/oncotarget.2892; Sowa T, 2017, CANCER MED-US, V6, P288, DOI 10.1002/cam4.991; Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; Tavare AN, 2012, INT J CANCER, V130, P1237, DOI 10.1002/ijc.26448; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Varki A, 2015, ESSENTIALS GLYCOBIOL, DOI DOI 10.1101/GLYCOBIOLOGY.3E.047; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wang YC, 2015, 2015 14TH IAPR INTERNATIONAL CONFERENCE ON MACHINE VISION APPLICATIONS (MVA), P1, DOI 10.1109/MVA.2015.7153119; Zhu YT, 2001, BBA-MOL BASIS DIS, V1536, P148, DOI 10.1016/S0925-4439(01)00044-8	65	39	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5659	5667		10.1074/jbc.RA117.001194	http://dx.doi.org/10.1074/jbc.RA117.001194			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475939	hybrid, Green Published			2022-12-26	WOS:000430044100026
J	Tamura, I; Jozaki, K; Sato, S; Shirafuta, Y; Shinagawa, M; Maekawa, R; Taketani, T; Asada, H; Tamura, H; Sugino, N				Tamura, Isao; Jozaki, Kosuke; Sato, Shun; Shirafuta, Yuichiro; Shinagawa, Masahiro; Maekawa, Ryo; Taketani, Toshiaki; Asada, Hiromi; Tamura, Hiroshi; Sugino, Norihiro			The distal upstream region of insulin-like growth factor-binding protein-1 enhances its expression in endometrial stromal cells during decidualization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocrinology; epigenetics; histone acetylation; CCAAT-enhancer-binding protein (C; EBP); cyclic AMP (cAMP)	HISTONE ACETYLATION STATUS; MANGANESE SUPEROXIDE-DISMUTASE; C/EBP-BETA; PROGESTERONE-RECEPTOR; FORKHEAD TRANSCRIPTION; PROMOTER REGION; HUMAN GENOME; DISTINCT FUNCTIONS; DNA METHYLATION; GRANULOSA-CELLS	We have previously shown that decidualization of human endometrial stromal cells (ESCs) causes a genome-wide increase in the levels of acetylation of histone-H3 Lys-27 (H3K27ac). We also reported that the distal gene regions, more than 3 kb up- or downstream of gene transcription start sites have increased H3K27ac levels. Insulin-like growth factor-binding protein-1 (IGFBP-1) is a specific decidualization marker and has increased H3K27ac levels in its distal upstream region (-4701 to -7501 bp). Here, using a luciferase reporter gene construct containing this IGFBP-1 upstream region, we tested the hypothesis that it is an IGFBP-1 enhancer. To induce decidualization, we incubated ESCs with cAMP and found that cAMP increased luciferase expression, indicating that decidualization increased the transcriptional activity from the IGFBP-1 upstream region. Furthermore, CRISPR/Cas9-mediated deletion of this region in HepG2 cells significantly reduced IGFBP-1 expression, confirming its role as an IGFBP-1 enhancer. A ChIP assay revealed that cAMP increased the recruitment of the transcriptional regulators CCAAT enhancer-binding protein (C/EBP), forkhead box O1 (FOXO1), and p300 to the IGFBP-1 enhancer in ESCs. Of note, C/EBP knockdown inhibited the stimulatory effects of cAMP on the levels of H3K27ac, chromatin opening, and p300 recruitment at the IGFBP-1 enhancer. These results indicate that the region -4701 to -7501 bp upstream of IGFBP-1 functions as an enhancer for IGFBP-1 expression in ESCs undergoing decidualization, that C/EBP and FOXO1 bind to the enhancer region to up-regulate IGFBP-1 expression, and that C/EBP induces H3K27ac by recruiting p300 to the IGFBP-1 enhancer.	[Tamura, Isao; Jozaki, Kosuke; Sato, Shun; Shirafuta, Yuichiro; Shinagawa, Masahiro; Maekawa, Ryo; Taketani, Toshiaki; Asada, Hiromi; Tamura, Hiroshi; Sugino, Norihiro] Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Minamikogushi 1-1-1, Ube, Yamaguchi 7558505, Japan	Yamaguchi University	Sugino, N (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Minamikogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	sugino@yamaguchi-u.ac.jp	Maekawa, Ryo/AAR-4233-2020	Maekawa, Ryo/0000-0003-0923-376X	Japan Society for the Promotion of Science KAKENHI [15K10720, 15K20146, 16K11091, 16K11142, 16K20191, 16K20194, 17K11240, 17K11239]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 15K10720, 15K20146, 16K11091, 16K11142, 16K20191, 16K20194, 17K11240, and 17K11239. The authors declare that they have no conflicts of interest with the contents of this article.	Aghajanova L, 2010, ENDOCRINOLOGY, V151, P1341, DOI 10.1210/en.2009-0923; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eijkelenboom A, 2013, CELL REP, V5, P1664, DOI 10.1016/j.celrep.2013.11.031; Gao JG, 1999, MOL CELL ENDOCRINOL, V153, P11, DOI 10.1016/S0303-7207(99)00096-9; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Hatta M, 2009, BIOCHEM BIOPH RES CO, V379, P1005, DOI 10.1016/j.bbrc.2009.01.014; Hatta M, 2007, J BIOL CHEM, V282, P35583, DOI 10.1074/jbc.M704735200; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kim JJ, 2005, BIOL REPROD, V73, P833, DOI 10.1095/biolreprod.105.043182; Kim JJ, 2003, BIOL REPROD, V68, P24, DOI 10.1095/biolreprod.102.009316; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Laird S, 2006, REPROD BIOMED ONLINE, V13, P13, DOI 10.1016/S1472-6483(10)62011-1; Lalmansingh AS, 2012, BBA-GENE REGUL MECH, V1819, P707, DOI 10.1016/j.bbagrm.2012.02.018; Lee L, 2013, ENDOCRINOLOGY, V154, P458, DOI 10.1210/en.2012-1610; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Maekawa R, 2016, MOL ENDOCRINOL, V30, P335, DOI 10.1210/me.2015-1058; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsuoka A, 2010, J CLIN ENDOCR METAB, V95, pE291, DOI 10.1210/jc.2010-0619; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Okada M, 2016, ENDOCRINOLOGY, V157, P3344, DOI 10.1210/en.2016-1264; Perrot V, 2005, MOL ENDOCRINOL, V19, P2283, DOI 10.1210/me.2004-0292; Plachetka A, 2008, MOL CELL BIOL, V28, P2102, DOI 10.1128/MCB.01943-07; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Qiu X, 2008, J BIOL CHEM, V283, P25774, DOI 10.1074/jbc.M801178200; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Sultana S, 2017, REPROD MED BIOL, V16, P170, DOI 10.1002/rmb2.12028; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Tamura I, 2017, ENDOCRINOLOGY, V158, P3696, DOI 10.1210/en.2017-00478; Tamura I, 2014, MOL ENDOCRINOL, V28, P1656, DOI 10.1210/me.2014-1117; Tamura I, 2014, ENDOCRINOLOGY, V155, P275, DOI 10.1210/en.2013-1569; Tamura I, 2012, ENDOCRINOLOGY, V153, P5612, DOI 10.1210/en.2012-1420; Tamura I, 2011, J CLIN ENDOCR METAB, V96, pE1073, DOI 10.1210/jc.2010-2489; Tang MY, 2005, MOL HUM REPROD, V11, P237, DOI 10.1093/molehr/gah149; Wang W, 2012, MOL ENDOCRINOL, V26, P2016, DOI 10.1210/me.2012-1169; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Yalley A, 2016, J BIOL CHEM, V291, P8848, DOI 10.1074/jbc.M115.677583; Zhang Qian, 2016, Reproductive Medicine and Biology, V15, P95, DOI 10.1007/s12522-015-0226-4; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	45	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5270	5280		10.1074/jbc.RA117.000234	http://dx.doi.org/10.1074/jbc.RA117.000234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29453285	Green Published, hybrid			2022-12-26	WOS:000429409300031
J	Pagani, G; Pereira, JPV; Stoldt, VR; Beck, A; Scharf, RE; Gohlke, H				Pagani, Giulia; Pereira, Joana P. V.; Stoldt, Volker R.; Beck, Andreas; Scharf, Ruediger E.; Gohlke, Holger			The human platelet antigen-1b (Pro(33)) variant of alpha(IIb)beta(3) allosterically shifts the dynamic conformational equilibrium of this integrin toward the active state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHERITED RISK-FACTOR; MOLECULAR-DYNAMICS; OUTSIDE-IN; STRUCTURAL BASIS; MYOCARDIAL-INFARCTION; FORCE-FIELDS; SIDE-CHAIN; PSI DOMAIN; ACTIVATION; POLYMORPHISM	Integrins are heterodimeric cell-adhesion receptors comprising alpha and beta subunits that transmit signals allosterically in both directions across the membrane by binding to intra- and extracellular components. The human platelet antigen-1 (HPA-1) polymorphism in alpha(IIb)beta(3) arises from a Leu -> Pro exchange at residue 33 in the genu of the beta(3) subunit, resulting in Leu(33) (HPA-1a) or Pro(33) (HPA-1b) isoforms. Although clinical investigations have provided conflicting results, some studies have suggested that Pro(33) platelets exhibit increased thrombogenicity. Under flow-dynamic conditions, the Pro(33) variant displays prothrombotic properties, characterized by increased platelet adhesion, aggregate/thrombus formation, and outside-in signaling. However, the molecular events underlying this prothrombotic phenotype have remained elusive. As residue 33 is located > 80 angstrom away from extracellular binding sites or transmembrane domains, we hypothesized that the Leu -> Pro exchange allosterically shifts the dynamic conformational equilibrium of alpha(IIb)beta(3) toward an active state. Multiple microsecondlong, all-atom molecular dynamics simulations of the ectodomain of the Leu(33) and Pro(33) isoforms provided evidence that the Leu -> Pro exchange weakens interdomain interactions at the genu and alters the structural dynamics of the integrin to a more unbent and splayed state. Using FRET analysis of fluorescent proteins fused with alpha(IIb)beta(3) in transfected HEK293 cells, we found that the Pro33 variant in its resting state displays a lower energy transfer than the Leu(33) isoform. This finding indicated a larger spatial separation of the cytoplasmic tails in the Pro(33) variant. Together, our results indicate that the Leu -> Pro exchange allosterically shifts the dynamic conformational equi-librium of alpha(IIb)beta(3) to a structural state closer to the active one, promoting the fully active state and fostering the prothrombotic phenotype of Pro(33) platelets.	[Pagani, Giulia; Gohlke, Holger] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Univ Str 1, D-40225 Dusseldorf, Germany; [Beck, Andreas] Heinrich Heine Univ Dusseldorf, Inst Informat, D-40225 Dusseldorf, Germany; [Scharf, Ruediger E.] Heinrich Heine Univ Dusseldorf, Biol Med Res Ctr, D-40225 Dusseldorf, Germany; [Pereira, Joana P. V.; Stoldt, Volker R.; Scharf, Ruediger E.] Heinrich Heine Univ, Med Ctr, Inst Transplantat Diagnost & Cell Therapeut, Div Expt & Clin Hemostasis Hemotherapy & Transfus, D-40225 Dusseldorf, Germany; [Gohlke, Holger] Forschungszentrum Julich, JSC, John von Neumann Inst Comp NIC, D-52425 Julich, Germany; [Gohlke, Holger] Forschungszentrum Julich, Inst Complex Syst Struct Biochem ICS 6, D-52425 Julich, Germany; [Pereira, Joana P. V.; Stoldt, Volker R.] Heinrich Heine Univ, Med Ctr, Dept Gen Visceral & Pediat Surg, D-40225 Dusseldorf, Germany; [Pereira, Joana P. V.; Stoldt, Volker R.] Heinrich Heine Univ, Fac Med, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Gohlke, H (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Univ Str 1, D-40225 Dusseldorf, Germany.	gohlke@uni-duesseldorf.de	Portugal-Pereira, Joana/ABF-1654-2020	Portugal-Pereira, Joana/0000-0003-1260-6950	Julich Supercomputing Center (JSC) [6710, 8348, 10307]	Julich Supercomputing Center (JSC)	We are grateful for computational support and infrastructure provided by the Zentrum fur Informations und Medientechnologie (ZIM) at the Heinrich Heine University Dusseldorf and the computing time provided by the John von Neumann Institute for Computing (NIC) to H. G. on the supercomputers JUROPA and JURECA at Julich Supercomputing Center (JSC) (Projects 6710, 8348, and 10307; user, HDD11). We thank Dr. Rainer B. Zotz and Beate Maruhn-Dembowski for genotyping HPA-1 of alpha<INF>IIb</INF>beta<INF>3</INF> and alpha<INF>2</INF>C807T of alpha<INF>2</INF>beta<INF>1</INF>. The assistance of Bianca Maassen-Weingart and Jan Peveling-Oberhag in the platelet experiments is also gratefully acknowledged. The FRET measurements were performed at the Center of Advanced Imaging at Heinrich Heine University Dusseldorf. We thank Dr. Stefanie Weidtkamp-Peters for scientific assistance.	Abraham DG, 1997, MOL PHARMACOL, V52, P227, DOI 10.1124/mol.52.2.227; [Anonymous], 2010, R LANG ENV STAT COMP; AQVIST J, 1992, J MOL STRUC-THEOCHEM, V88, P135, DOI 10.1016/0166-1280(92)87163-T; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Arnaout MA, 2002, IMMUNOL REV, V186, P125, DOI 10.1034/j.1600-065X.2002.18612.x; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; Aurich V., 2002, BILDVERARBEITUNG MED, P389; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Bennett JS, 2009, J THROMB HAEMOST, V7, P200, DOI 10.1111/j.1538-7836.2009.03378.x; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Bleckmann A, 2010, PLANT PHYSIOL, V152, P166, DOI 10.1104/pp.109.149930; Bledzka K, 2013, CIRC RES, V112, P1189, DOI 10.1161/CIRCRESAHA.112.300570; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001086; Chodera JD, 2016, J CHEM THEORY COMPUT, V12, P1799, DOI 10.1021/acs.jctc.5b00784; Coppolino MG, 2000, INT J BIOCHEM CELL B, V32, P171, DOI 10.1016/S1357-2725(99)00043-6; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Donner L, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf6240; El Khattouti A, 2010, BLOOD, V116, P843; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Galindo-Murillo R, 2015, BBA-GEN SUBJECTS, V1850, P1041, DOI 10.1016/j.bbagen.2014.09.007; Gohlke H, 2013, HEPATOLOGY, V57, P1117, DOI 10.1002/hep.25992; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hermans M. A., 2017, REV COMPUT MOL SCI, V7, pe1311; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JACOBS DJ, 1995, PHYS REV LETT, V75, P4051, DOI 10.1103/PhysRevLett.75.4051; Jallu V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047304; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kelley C., 2011, GNUPLOT 4 5 INTERACT; Kritzik M, 1998, BLOOD, V92, P2382, DOI 10.1182/blood.V92.7.2382; Li J, 2017, EMBO J, V36, P629, DOI 10.15252/embj.201695803; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Loncar R., 2007, THROMB J, DOI [10.1186/1477-9560-1185-1182, DOI 10.1186/1477-9560-1185-1182]; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mould AP, 1996, J CELL SCI, V109, P2613; Perez A, 2015, J CHEM THEORY COMPUT, V11, P4770, DOI 10.1021/acs.jctc.5b00662; Pfleger C, 2013, J CHEM INF MODEL, V53, P1007, DOI 10.1021/ci400044m; Pfleger C, 2013, J COMPUT CHEM, V34, P220, DOI 10.1002/jcc.23122; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Puklin-Faucher E, 2009, J BIOL CHEM, V284, P36557, DOI 10.1074/jbc.M109.041194; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Radestock S, 2008, ENG LIFE SCI, V8, P507, DOI 10.1002/elsc.200800043; Reinehr R, 2010, J BIOL CHEM, V285, P29348, DOI 10.1074/jbc.M110.155135; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Savage B., 2013, HEMOSTASIS THROMBOSI, P400; Scharf R. E., 2009, 22 C INT SOC THORMB; Shi ML, 2007, J BIOL CHEM, V282, P30198, DOI 10.1074/jbc.M701670200; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Stoldt VR, 2005, BLOOD, V106, p70B; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Thorpe M., 1996, CONDENSED MATTER THE, V11, P407; Vijayan KV, 2000, J CLIN INVEST, V105, P793, DOI 10.1172/JCI6982; Vijayan KV, 2005, J BIOL CHEM, V280, P21756, DOI 10.1074/jbc.M500872200; Watson S. P., 2013, HAEMOSTASIS THROMBOS, P420; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703; Whiteley W, 2005, PHYS BIOL, V2, pS116, DOI 10.1088/1478-3975/2/4/S06; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zotz RB, 2005, J THROMB HAEMOST, V3, P1522, DOI 10.1111/j.1538-7836.2005.01432.x; Zotz RB, 1998, THROMB HAEMOSTASIS, V79, P731, DOI 10.1055/s-0037-1615054; Zotz RB, 2000, THROMB HAEMOSTASIS, V83, P404	80	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4830	4844		10.1074/jbc.RA118.002149	http://dx.doi.org/10.1074/jbc.RA118.002149			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29462793	hybrid, Green Published			2022-12-26	WOS:000428848300023
J	Koo, YC; Chang, JS; Chen, YC				Koo, Yu-Chin; Chang, Jung-Su; Chen, Yi Chun			Food claims and nutrition facts of commercial infant foods	PLOS ONE			English	Article							FEEDING GUIDELINES; MAGAZINES; PARENTS; HEALTHY; SODIUM; SUGAR	Composition claim, nutrition claim and health claim are often found on the commercial complementary food packaging. The introduction of complementary foods (CFs) to infants is a turning point in the development of their eating behavior, and their commercial use for Taiwanese infants is growing. In Taiwan, lots of the advertisements for CFs employed health or nutrition claims to promote the products, but the actual nutritional content of these CFs is not clear. The aim of this study was to compare the food claims of commercial complementary food products with their actual nutrition facts. A sample of 363 commercial CFs was collected from websites, local supermarkets, and other food stores, and their nutrition-related claims were classified into composition, nutrition, and health categories. Although the World Health Organization recommends that infants should be exclusively breastfed for the first 6 months, 48.2% of the commercial CFs were targeted at infants younger than 6 months. Therefore, marketing regulations should be implemented to curb early weaning as a result of products targeted at infants younger than 6 months. More than 50% of Taiwanese commercial CFs have high sugar content and more than 20% were high in sodium. Products with health claims, such as "provides good nutrition to children" or "improves appetite," have higher sodium or sugar content than do those without such claims. Moreover, products with calcium or iron content claims did not contain more calcium or iron than products without such claims. Additionally, a significantly greater proportion of the products with "no added sugar" claims were classified as having high sugar content as compared to those without such claims. Parents cannot choose the healthiest food products for their children by simply focusing on food claims. Government should regulate the labeling of nutrition facts and food claims for foods targeted at infants younger than 12 months.	[Koo, Yu-Chin; Chang, Jung-Su; Chen, Yi Chun] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan	Taipei Medical University	Chen, YC (corresponding author), Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan.	yichun@tmu.edu.tw			National Science Council [MOST103-2511-S-038-004-MY2 (2-2)]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council [grant number MOST103-2511-S-038-004-MY2 (2-2)].	Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; [Anonymous], 2013, FOOD LAB GUID GUID I; Butte N, 2004, J AM DIET ASSOC, V104, P442, DOI 10.1016/j.jada.2004.01.027; Canadian Food Inspection Agency, 2014, FOOD LAB IND COMP QU; Carstairs SA, 2016, MATERN CHILD NUTR, V12, P860, DOI 10.1111/mcn.12185; Cavaliere A, 2015, FOOD QUAL PREFER, V41, P44, DOI 10.1016/j.foodqual.2014.11.002; Chen YC, 2015, J HUM LACT, V31, P458, DOI 10.1177/0890334415576513; Codex Alimentarius Commission, 1997, 231997 CACGL WHO FAO; Cogswell ME, 2015, PEDIATRICS, V135, P416, DOI 10.1542/peds.2014-3251; Colby SE, 2010, J NUTR EDUC BEHAV, V42, P92, DOI 10.1016/j.jneb.2008.11.002; Dixon H, 2011, PUBLIC HEALTH NUTR, V14, P1071, DOI 10.1017/S1368980010003691; Eidelman AI, 2012, PEDIATRICS, V129, pE827, DOI 10.1542/peds.2011-3552; Elliott C, 2008, OBES REV, V9, P368, DOI 10.1111/j.1467-789X.2007.00418.x; Elliott CD., 2011, J PUBLIC HLTH, V33, P36; Frerichs L, 2006, WOMEN HEALTH, V44, P95, DOI 10.1300/J013v44n01_06; Garcia AL, 2013, ARCH DIS CHILD, V98, P793, DOI 10.1136/archdischild-2012-303386; Garcia AL, 2016, MATERN CHILD NUTR, V12, P838, DOI 10.1111/mcn.12208; Hamilton K, 2012, J HEALTH PSYCHOL, V17, P121, DOI 10.1177/1359105311409786; Harris JL, 2011, PUBLIC HEALTH NUTR, V14, P2207, DOI 10.1017/S1368980011001741; Klienman RE., 2014, PEDIAT NUTR, V7th ed., P123; Lin JR, 2011, ASIA PAC J CLIN NUTR, V20, P337; Ministry of Health and Welfare, 2014, REG NUTR LAB PREP FO; Ministry of Health and Welfare, 2014, CHILDR HLTH BOOKL; Munsell CR, 2016, PUBLIC HEALTH NUTR, V19, P46, DOI 10.1017/S1368980015000397; New Zealand Ministry of Health, 2013, EAT HLTH BAB TODDL; Nicklaus S, 2011, APPETITE, V57, P812, DOI 10.1016/j.appet.2011.05.321; Sahoo Krushnapriya, 2015, J Family Med Prim Care, V4, P187, DOI 10.4103/2249-4863.154628; Wong CL, 2013, AM J CLIN NUTR, V97, P1288, DOI 10.3945/ajcn.112.052910; World Alliance for Breastfeeding Action, 2006, COD WATCH 25 YEARS P; World Health Assembly, 2016, WHA699; World Health Organization, 2016, INF YOUNG CHILD NUTR; World Health Organization, 2015, GUID SUG INT AD CHIL; World Health Organization, 2009, INF YOUNG CHILD FEED, P23; World Health Organization, 2016, MARK BREAST MILK SUB	35	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191982	10.1371/journal.pone.0191982	http://dx.doi.org/10.1371/journal.pone.0191982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489848	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000014
J	Schlott, F; Steubl, D; Ameres, S; Moosmann, A; Dreher, S; Heemann, U; Hosel, V; Busch, DH; Neuenhahn, M				Schlott, Fabian; Steubl, Dominik; Ameres, Stefanie; Moosmann, Andreas; Dreher, Stefan; Heemann, Uwe; Hoesel, Volker; Busch, Dirk H.; Neuenhahn, Michael			Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8(+) T cells	PLOS ONE			English	Article							STEM-CELL; KIDNEY-TRANSPLANTATION; ADOPTIVE TRANSFER; IMMUNITY; LYMPHOCYTES; INFECTION; CMV; DONOR; RECIPIENTS; RECEPTORS	Human Cytomegalovirus (CMV) reactivation remains a major source of morbidity in patients after solid organ and hematopoietic stem cell transplantation (HSCT). Adoptive T cell therapy (ACT) with CMV-specific T cells is a promising therapeutic approach for HSCT recipients, but might be counteracted by CMV's immune evasion strategies. HLA-C*07:02 is less susceptible to viral immune evasion suggesting HLA-C*07:02-restricted viral epitopes as promising targets for ACT. For a better understanding of HLA-C*07: 02-restricted CMV-specific T cells we used recently generated reversible HLA-C*07:02/IE-1 multimers (Streptamers) recognizing a CMV-derived Immediate-Early-1 (IE-1) epitope and analyzed phenotypic and functional T cell characteristics. Initially, we detected very high frequencies of HLA-C*07:02/IE-1 multimer(+) T cells (median = 11.35%), as well as robust functional responses after stimulation with IE-1 peptide (IFN gamma(+); median = 5.02%) in healthy individuals. However, MHC-multimer(+) and IFN gamma-secreting T cell frequencies showed a relatively weak correlation (r(2) = 0.77), which could be attributed to an unexpected contribution of CMV-epitope-independent KIR2DL2/3-binding of HLA-C*07:02/IE-1 multimers. Therefore, we developed a MHC-multimer double-staining approach against a cancer epitope-specific HLA-C* 07: 02 multimer to identify truly HLA-C*07:02/IE-1 epitope-specific T cells. The frequencies of these truly HLA-C*07:02/IE-1 multimer(+) T cells were still high (median = 6.86%) and correlated now strongly (r(2) = 0.96) with IFN gamma-secretion. Interestingly, HLA-C*07:02/IE-1-restricted T cells contain substantial numbers with a central memory T cell phenotype, indicating high expansion potential e.g. for ACT. In line with that, we developed a clinical enrichment protocol avoiding epitope-independent KIR-binding to make HLA-C* 07: 02/IE-1-restricted T cells available for ACT. Initial depletion of KIR-expressing CD8(+) T cells followed by HLA-C*07:02/IE-1 Streptamer positive selection using paramagnetic labeling techniques allowed to enrich successfully HL-AC* 07:02/IE-1-restricted T cells. Such specifically enriched populations of functional HL-AC* 07:02/IE-1-restricted T cells with significant central memory T cell content could become a potent source for ACT.	[Schlott, Fabian; Dreher, Stefan; Busch, Dirk H.; Neuenhahn, Michael] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Schlott, Fabian; Moosmann, Andreas; Heemann, Uwe; Busch, Dirk H.; Neuenhahn, Michael] DZIF Natl Ctr Infect Res, Munich, Germany; [Steubl, Dominik; Heemann, Uwe] Tech Univ Munich, Klinikum Rechts Isar, Dept Nephrol, Munich, Germany; [Ameres, Stefanie; Moosmann, Andreas] Helmholtz Zentrum Munchen, Res Unit Gene Vectors, DZIF Res Grp Host Control Viral Latency & Reactiv, Munich, Germany; [Hoesel, Volker] Tech Univ Munich, Chair Biomath, Garching, Germany	Technical University of Munich; German Center for Infection Research; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Neuenhahn, M (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany.; Neuenhahn, M (corresponding author), DZIF Natl Ctr Infect Res, Munich, Germany.	michael.neuenhahn@tum.de		Moosmann, Andreas/0000-0001-8044-5146	German Center for Infection Research (DZIF) [TTU 07.801]; Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich TR36-A10]	German Center for Infection Research (DZIF); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the German Center for Infection Research (DZIF, TTU 07.801) (MN), and the Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereich TR36-A10 (MN and DHB).	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Ameres S, 2014, J IMMUNOL, V192, P5894, DOI 10.4049/jimmunol.1302281; Ameres S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003383; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Boeckh M, 2011, J CLIN INVEST, V121, P1673, DOI 10.1172/JCI45449; Brestrich G, 2009, AM J TRANSPLANT, V9, P1679, DOI 10.1111/j.1600-6143.2009.02672.x; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Feuchtinger T, 2010, BLOOD, V116, P4360, DOI 10.1182/blood-2010-01-262089; Gerna G, 2006, AM J TRANSPLANT, V6, P2356, DOI 10.1111/j.1600-6143.2006.01488.x; Giulieri S, 2011, EXPERT REV MOL DIAGN, V11, P17, DOI [10.1586/erm.10.109, 10.1586/ERM.10.109]; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Jacobsen T, 2010, AM J HEALTH-SYST PH, V67, P1417, DOI 10.2146/ajhp090424; Knabel M, 2002, NAT MED, V8, P631, DOI 10.1038/nm0602-631; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Lucia M, 2014, TRANSPL INT, V27, P643, DOI 10.1111/tri.12318; McMahon CW, 2001, CURR OPIN IMMUNOL, V13, P465, DOI 10.1016/S0952-7915(00)00242-9; Mees ST, 2014, SURG INFECT, V15, P274, DOI 10.1089/sur.2013.083; Moretta A, 1997, IMMUNOL REV, V155, P105, DOI 10.1111/j.1600-065X.1997.tb00943.x; Neudorfer J, 2007, J IMMUNOL METHODS, V320, P119, DOI 10.1016/j.jim.2007.01.001; Neuenhahn M, 2017, LEUKEMIA, V31, P2161, DOI 10.1038/leu.2017.16; Odendahl M, 2014, CYTOTHERAPY, V16, P1245, DOI 10.1016/j.jcyt.2014.05.023; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; Peggs KS, 2011, CLIN INFECT DIS, V52, P49, DOI 10.1093/cid/ciq042; QUINNAN GV, 1984, REV INFECT DIS, V6, P156; QUINNAN GV, 1982, NEW ENGL J MED, V307, P7, DOI 10.1056/NEJM198207013070102; Reischig T, 2012, J AM SOC NEPHROL, V23, P1588, DOI 10.1681/ASN.2012010100; Scheinberg P, 2009, BLOOD, V114, P5071, DOI 10.1182/blood-2009-04-214684; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Schmitt A, 2011, TRANSFUSION, V51, P591, DOI 10.1111/j.1537-2995.2010.02940.x; Shabir S, 2013, J AM SOC NEPHROL, V24, P1698, DOI 10.1681/ASN.2013040340; Stemberger C, 2014, BLOOD, V124, P628, DOI 10.1182/blood-2013-12-547349; Stemberger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035798; Sund F, 2010, CLIN TRANSPLANT, V24, P401, DOI 10.1111/j.1399-0012.2009.00976.x; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Yao JX, 2008, CLIN INFECT DIS, V46, pE96, DOI 10.1086/587749	40	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193554	10.1371/journal.pone.0193554	http://dx.doi.org/10.1371/journal.pone.0193554			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489900	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000089
J	Stumpf, MJ; Schaefer, CA; Krycki, J; Schueler, R; Pizarro, C; Nickenig, G; Steinmetz, M; Skowasch, D; Tuleta, I				Stumpf, Max Jonathan; Schaefer, Christian Alexander; Krycki, Jan; Schueler, Robert; Pizarro, Carmen; Nickenig, Georg; Steinmetz, Martin; Skowasch, Dirk; Tuleta, Izabela			Impairment of vascular strain in patients with obstructive sleep apnea	PLOS ONE			English	Article							INCREASED ARTERIAL STIFFNESS; SPECKLE-TRACKING; CAROTID-ARTERY; INFLAMMATORY MARKERS; INTERMITTENT HYPOXIA; ENDOTHELIAL DYSFUNCTION; METABOLIC CONSEQUENCES; RISK-FACTOR; ATHEROSCLEROSIS; OBESITY	Background Obstructive sleep apnea (OSA) is an independent risk factor for the development of cardiovascular diseases. Aim of this present study was to evaluate and extend recent research on the influence of obstructive sleep apnea on vascular strain. Methods A total number of 98 patients were integrated in the study. Patients were grouped according to the Apnea-Hypopnea-lndex (AHI) in patients with mild-to-moderate OSA (5/h < AHI < 30/ h), severe OSA (AHI > 30/h) and controls (AHI < 5/h). Groups were matched in age, body mass-index and cardiovascular risks. Vascular strain of common carotid arteries was assessed by ultrasound speckle-tracking. A minor group of 30 patients and controls further underwent assessment of vascular strain of brachial and femoral arteries. Additionally, all patients underwent blood testing to reveal potential influences of inflammatory markers on arterial stiffness. In additional analysis we examined the effect of statin therapy on vascular strain. Results Patients with OSA showed significantly reduced values of vascular strain of common carotid arteries. Radial and circumferential strains were significantly lower in both patients with mild-to-moderate (p =.05) and patients with severe OSA (p =.001) compared to control. Vascular strain parameters of brachial and femoral arteries showed no consistent results. There were no significant correlations of inflammatory markers with vascular strain parameters. No significant differences in vascular strain were detected between statin and nonstatin groups. Conclusion Patients with OSA show significantly reduced vascular strain assessed by ultrasound-based speckle-tracking. Vascular stiffness increases with the severity of the disease. Target	[Stumpf, Max Jonathan; Schaefer, Christian Alexander; Krycki, Jan; Schueler, Robert; Pizarro, Carmen; Nickenig, Georg; Steinmetz, Martin; Skowasch, Dirk; Tuleta, Izabela] Univ Bonn, Dept Internal Med Cardiol Pulmonol & Angiol 2, Bonn, Germany	University of Bonn	Tuleta, I (corresponding author), Univ Bonn, Dept Internal Med Cardiol Pulmonol & Angiol 2, Bonn, Germany.	izat@gmx.de	Schueler, Robert/Z-1059-2019	Steinmetz, Martin/0000-0002-5452-6687; Stumpf, Max Jonathan/0000-0003-4558-1833				Alvarez-Martins I, 2016, PFLUG ARCH EUR J PHY, V468, P919, DOI 10.1007/s00424-016-1797-6; Archontogeorgis K, 2014, PULMONARY MED, V2014, P15; Arnardottir ES, 2012, SLEEP, V35, P921, DOI 10.5665/sleep.1952; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bjallmark A, 2010, EUR J ECHOCARDIOGR, V11, P630, DOI 10.1093/ejechocard/jeq033; Bouloukaki Izolde, 2015, World J Exp Med, V5, P77, DOI 10.5493/wjem.v5.i2.77; Buratti L, 2016, CNS NEUROL DISORD-DR, V15, P678, DOI 10.2174/1871527315666160518123930; Buratti L, 2014, J ALZHEIMERS DIS, V38, P445, DOI 10.3233/JAD-131046; Charwat-Resl S, 2016, ULTRASCHALL MED, V37, P503, DOI 10.1055/s-0035-1553299; Cho JG, 2011, SLEEP, V34, P751, DOI 10.5665/SLEEP.1042; Choi JB, 2006, SLEEP BREATH, V10, P155, DOI 10.1007/s11325-006-0064-z; Ciccone MM, 2014, MOLECULES, V19, P1651, DOI 10.3390/molecules19021651; Drager LF, 2010, BEST PRACT RES CL EN, V24, P843, DOI 10.1016/j.beem.2010.08.011; Drager LF, 2010, CURR OPIN ENDOCRINOL, V17, P161, DOI 10.1097/MED.0b013e3283373624; Drakatos P, 2016, J CLIN SLEEP MED, V12, P195, DOI 10.5664/jcsm.5484; Elkind MS, 2005, ATHEROSCLEROSIS, V180, P181, DOI 10.1016/j.atherosclerosis.2004.11.015; Gharibeh T, 2010, NAT SCI SLEEP, V2, P233, DOI 10.2147/NSS.S6844; Hammerstingl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076352; Joyeux-Faure M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/423120; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Larsson M, 2015, ULTRASONICS, V56, P399, DOI 10.1016/j.ultras.2014.09.005; Lee SA, 2008, SLEEP, V31, P1207; Li J, 2005, INTERMITTENT HYPOXIA; Nadeem R, 2013, J CLIN SLEEP MED, V9, P1003, DOI 10.5664/jcsm.3070; Patinkin ZW, 2017, CHILD OBES, V13, P102, DOI 10.1089/chi.2016.0248; Podgorski M, 2015, ARCH MED SCI, V11, P122, DOI 10.5114/aoms.2015.49205; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Ryan S, 2009, THORAX, V64, P631, DOI 10.1136/thx.2008.105577; Sahlman J, 2010, J SLEEP RES, V19, P341, DOI 10.1111/j.1365-2869.2009.00787.x; Schaefer CA, 2015, CLIN RES CARDIOL, V104, P719, DOI 10.1007/s00392-015-0834-3; Schaefer CA, 2017, VASA, V46, P108, DOI 10.1024/0301-1526/a000596; Schwartz Alan R, 2008, Proc Am Thorac Soc, V5, P185, DOI 10.1513/pats.200708-137MG; Seetho IW, 2014, J SLEEP RES, V23, P700, DOI 10.1111/jsr.12156; Totoson P, 2013, EXP BIOL MED, V238, P223, DOI 10.1177/1535370212473696; Tuleta I, 2016, ADV EXP MED BIOL, V910, P9, DOI 10.1007/5584_2016_215; Tuleta I, 2015, ADV EXP MED BIOL, V858, P1, DOI 10.1007/5584_2015_114; Tuleta I, 2014, ATHEROSCLEROSIS, V236, P400, DOI 10.1016/j.atherosclerosis.2014.08.021; Tuleta I, 2011, EPMA J, V2, P39, DOI 10.1007/s13167-011-0070-5; Wang JY, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002454; Wang YY, 2017, MED SCI MONITOR, V23, P1069, DOI 10.12659/MSM.899716; Wendell CR, 2012, STROKE, V43, P3319, DOI 10.1161/STROKEAHA.112.672527	41	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193397	10.1371/journal.pone.0193397	http://dx.doi.org/10.1371/journal.pone.0193397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489881	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000070
J	Langer, M; Girton, AW; Popescu, NI; Burgett, T; Metcalf, JP; Coggeshall, KM				Langer, Marybeth; Girton, Alanson W.; Popescu, Narcis I.; Burgett, Tarea; Metcalf, Jordan P.; Coggeshall, K. Mark			Neither Lys- and DAP-type peptidoglycans stimulate mouse or human innate immune cells via Toll-like receptor 2	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS INFECTION; BACTERIAL PEPTIDOGLYCAN; MURAMYL DIPEPTIDE; RECOGNITION; ACTIVATION; SEPSIS; ACID; COMPLEMENT; SENSOR; NOD1	Peptidoglycan (PGN), a major component of bacterial cell walls, is a pathogen-associated molecular pattern (PAMP) that causes innate immune cells to produce inflammatory cytokines that escalate the host response during infection. In order to better understand the role of PGN in infection, we wanted to gain insight into the cellular receptor for PGN. Although the receptor was initially identified as Toll-like receptor 2 (TLR2), this receptor has remained controversial and other PGN receptors have been reported. We produced PGN from live cultures of Bacillus anthracis and Staphylococcus aureus and tested samples of PGN isolated during the purification process to determine at what point TLR2 activity was removed, if at all. Our results indicate that although live B. anthracis and S. aureus express abundant TLR2 ligands, highly-purified PGN from either bacterial source is not recognized by TLR2.	[Langer, Marybeth; Girton, Alanson W.; Popescu, Narcis I.; Burgett, Tarea; Coggeshall, K. Mark] Oklahoma Med Res Fdn, Program Arthrit & Immunol, Oklahoma City, OK 73104 USA; [Girton, Alanson W.; Coggeshall, K. Mark] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Metcalf, Jordan P.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Pulm & Crit Care Div, Oklahoma City, OK 73190 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Coggeshall, KM (corresponding author), Oklahoma Med Res Fdn, Program Arthrit & Immunol, Oklahoma City, OK 73104 USA.; Coggeshall, KM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	mark-coggeshall@omrf.org		Coggeshall, K. Mark/0000-0003-4797-9095; Popescu, Narcis/0000-0002-4809-9885	NIH grants [3 U19 AI062629, R21 AI113020]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062629, R21AI113020] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001937] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported by NIH grants 3 U19 AI062629 and R21 AI113020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Marybeth Langer and Lance Girton made equal contributions to this work. The work was supported by NIH grants 3 U19 AI062629 and R21 AI113020.	Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; Gao JJ, 2001, INFECT IMMUN, V69, P751, DOI 10.1128/IAI.69.2.751-757.2001; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Iyer JK, 2011, J IMMUNOL, V186, P3841, DOI 10.4049/jimmunol.1004058; Iyer JK, 2010, INFECT IMMUN, V78, P2418, DOI 10.1128/IAI.00170-10; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Langer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003706; Loving CL, 2009, INFECT IMMUN, V77, P4529, DOI 10.1128/IAI.00563-09; Lupu F, 2014, THROMB RES, V133, pS28, DOI 10.1016/j.thromres.2014.03.014; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Qiu P, 2013, J INFECT DIS, V208, P978, DOI 10.1093/infdis/jit247; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Sharif S, 2009, J AM CHEM SOC, V131, P7023, DOI 10.1021/ja808971c; Smith P, 2012, P NATL ACAD SCI USA, V109, P6181, DOI 10.1073/pnas.1203954109; Sun DW, 2013, BLOOD, V122, P571, DOI 10.1182/blood-2013-02-486613; Sun DW, 2012, J IMMUNOL, V189, P2423, DOI 10.4049/jimmunol.1201302; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Wang QL, 2001, INFECT IMMUN, V69, P2270, DOI 10.1128/IAI.69.4.2270-2276.2001; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103; Wolf AJ, 2016, CELL, V166, P624, DOI 10.1016/j.cell.2016.05.076; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	30	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193207	10.1371/journal.pone.0193207	http://dx.doi.org/10.1371/journal.pone.0193207			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474374	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500067
J	St Clair, SB; Hoines, J				St Clair, Samuel B.; Hoines, Joshua			Reproductive ecology and stand structure of Joshua tree forests across climate gradients of the Mojave Desert	PLOS ONE			English	Article							YUCCA-BREVIFOLIA; DROUGHT; VARIABILITY; WILDFIRE; SURVIVORSHIP; TOLERANCE; IMPACTS; HISTORY; FIRE	Climate change is restructuring plant populations and can result in range shifts depending on responses at various life stages of plants. In 2013, a widespread and episodic flowering event provided an opportunity to characterize how Joshua tree's reproductive success and population structure vary in response to the climate variability across its range. We examined the reproductive success and stand structure of 10 Joshua tree populations distributed across the Mojave Desert. Joshua tree density varied by more than an order of magnitude across sites. At 8 of the 10 sites, nearly 80% of the Joshua trees were in bloom, and at the other two 40% were in bloom. The range of seed production and fruit set across the study populations varied by more than an order of magnitude. Fruit production occurred at all of our study sites suggesting that yucca moth pollinators were present at our sites. Increasing temperature had strong positive correlations with the number of trees in bloom (R-2 = 0.42), inflorescences per tree (R-2 = 0.37), and fruit mass (R-2 = 0.77) and seed size (R-2 = 0.89) In contrast, temperature was negatively correlated with Joshua tree stand density (R-2 = -0.80). Positive correlations between temperature and greater flower and seed production suggest that warming may positively affect Joshua Tree reproduction while negative relationships between temperature and stand density are suggestive of potential constraints of warmer temperatures on establishment success.	[St Clair, Samuel B.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [Hoines, Joshua] Div Resources Management, Death Valley Natl Pk, Death Valley, CA USA	Brigham Young University	St Clair, SB (corresponding author), Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA.	stclair@byu.edu	St.Clair, Sam/GZA-4592-2022	St. Clair, Sam/0000-0001-6612-0329	Brigham Young University	Brigham Young University	This work was supported by a mentoring environment grant from Brigham Young University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer E., 2016, RFPERMUTE ESTIMATE P; ARONSON J, 1992, OECOLOGIA, V89, P17, DOI 10.1007/BF00319010; Barton K, 2015, MUMLN MULTIMODEL INF; Borchert MI, 2016, AM J BOT, V103, P830, DOI 10.3732/ajb.1500516; Brittingham S, 2000, WEST N AM NATURALIST, V60, P374; Bryant M, 2012, AM J BOT, V99, P1647, DOI 10.3732/ajb.1200099; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Christensen JH, 2007, CONTRIBUTION WORKING; Cole KL, 2011, ECOL APPL, V21, P137, DOI 10.1890/09-1800.1; DeFalco LA, 2010, AM J BOT, V97, P243, DOI 10.3732/ajb.0900032; DIGGLE PJ, 1975, BIOMETRIKA, V62, P39, DOI 10.1093/biomet/62.1.39; Dole KP, 2003, GLOBAL PLANET CHANGE, V36, P137, DOI 10.1016/S0921-8181(02)00179-0; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Esque TC, 2003, MORTALITY ADULT JOSH, P1; Esque TC, 2015, AM J BOT, V102, P85, DOI 10.3732/ajb.1400257; Gilliland KD, 2006, WEST N AM NATURALIST, V66, P202, DOI 10.3398/1527-0904(2006)66[202:AAPSOJ]2.0.CO;2; Hereford R, 2006, J ARID ENVIRON, V67, P13, DOI 10.1016/j.jaridenv.2006.09.019; Horn KJ, 2012, J ARID ENVIRON, V77, P54, DOI 10.1016/j.jaridenv.2011.10.003; Horn KJ, 2017, LANDSCAPE ECOL, V32, P635, DOI 10.1007/s10980-016-0466-7; Horn KJ, 2015, PLANT ECOL, V216, P1623, DOI 10.1007/s11258-015-0546-9; Koenig WD, 2005, AM SCI, V93, P340, DOI 10.1511/2005.54.970; Loik ME, 2000, J ARID ENVIRON, V46, P43, DOI 10.1006/jare.2000.0653; Lybbert A, 2017, J PLANT ECO IN PRESS; Meyer-Grunefeldt M, 2015, J ECOL, V103, P1141, DOI 10.1111/1365-2745.12446; Ng GHC, 2015, WATER RESOUR RES, V51, P3884, DOI 10.1002/2015WR017240; Pellmyr O, 2003, ANN MO BOT GARD, V90, P35, DOI 10.2307/3298524; Sanford MP, 2009, WEST N AM NATURALIST, V69, P165, DOI 10.3398/064.069.0203; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; SMITH SD, 1983, OECOLOGIA, V60, P10, DOI 10.1007/BF00379313; Smith SD, 2012, PHYSIOLOGICAL ECOLOG; SORK VL, 1993, ECOLOGY, V74, P528, DOI 10.2307/1939313; St Clair SB, 2016, ECOLOGY, V97, P1700, DOI 10.1002/ecy.1391; Sun Y, 2007, J CLIMATE, V20, P4801, DOI 10.1175/JCLI4263.1; Vamstad MS, 2010, J ARID ENVIRON, V74, P1309, DOI 10.1016/j.jaridenv.2010.04.002; Vander Wall SB, 2006, ECOSCIENCE, V13, P539, DOI 10.2980/1195-6860(2006)13[539:JTYBSA]2.0.CO;2; Waitman BA, 2012, J ARID ENVIRON, V81, P1, DOI 10.1016/j.jaridenv.2011.12.012; Yoder CK, 1999, J ARID ENVIRON, V42, P81, DOI 10.1006/jare.1999.0504; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	38	6	6	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193248	10.1371/journal.pone.0193248	http://dx.doi.org/10.1371/journal.pone.0193248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474414	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500070
J	Abril, S; Diaz, M; Lenoir, A; Paris, CI; Boulay, R; Gomez, C				Abril, Silvia; Diaz, Mireia; Lenoir, Alain; Paris, Carolina Ivon; Boulay, Raphael; Gomez, Crisanto			Cuticular hydrocarbons correlate with queen reproductive status in native and invasive Argentine ants (Linepithema humile, Mayr)	PLOS ONE			English	Article							IRIDOMYRMEX-HUMILIS; NESTMATE RECOGNITION; SOCIAL INSECTS; CHEMICAL RECOGNITION; HYMENOPTERA; FORMICIDAE; PROFILES; SUPERCOLONIES; EVOLUTION; DYNAMICS	In insect societies, chemical communication plays an important role in colony reproduction and individual social status. Many studies have indicated that cuticular hydrocarbons (CHCs) are the main chemical compounds encoding reproductive status. However, these studies have largely focused on queenless or monogynous species whose workers are capable of egg laying and have mainly explored the mechanisms underlying queen-worker or worker-worker reproductive conflicts. Less is known about what occurs in highly polygynous ant species with permanently sterile workers. Here, we used the Argentine ant as a model to examine the role of CHCs in communicating reproductive information in such insect societies. The Argentine ant is unicolonial, highly polygynous, and polydomous. We identified several CHCs whose presence and levels were correlated with queen age, reproductive status, and fertility. Our results also provide new insights into queen executions in the Argentine ant, a distinctive feature displayed by this species in its introduced range. Each spring, just before new sexuals appear, workers eliminate up to 90% of the mated queens in their colonies. We discovered that queens that survived execution had different CHC profiles from queens present before and during execution. More specifically, levels of some CHCs were higher in the survivors, suggesting that workers could eliminate queens based on their chemical profiles. In addition, queen CHC profiles differed based on season and species range (native vs. introduced). Overall, the results of this study provide new evidence that CHCs serve as queen signals and do more than just regulate worker reproduction.	[Abril, Silvia; Diaz, Mireia; Gomez, Crisanto] Univ Girona, Dept Ciencies Ambientals, Girona, Spain; [Lenoir, Alain; Boulay, Raphael] Univ Francois Rabelais Tours, Inst Rech Biol Insecte, Tours, France; [Paris, Carolina Ivon] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina	Universitat de Girona; University of Buenos Aires	Abril, S (corresponding author), Univ Girona, Dept Ciencies Ambientals, Girona, Spain.	silvia.abril@udg.edu	ABRIL, SILVIA/N-3620-2015; Gomez, Crisanto/AAA-3501-2019	ABRIL, SILVIA/0000-0003-1298-7597; Gomez, Crisanto/0000-0002-5430-2253; Paris, Carolina Ivon/0000-0001-7582-0546	Administration of National Parks of Argentina (APN) [DCM 427]	Administration of National Parks of Argentina (APN)	We are grateful to the authorities of the Administration of National Parks of Argentina (APN) for their permission to conduct our study in the Natural Reserve of Otamendi (project number: DCM 427). We would like to thank the Argentinian Ministry of the Environment and Sustainable Development for the exportation permits: 12353/2013 and 1614/2013. CIP would like to thank Dr. Adriana Cirigliano of the Department of Organic Chemistry, Faculty of Exact and Natural Sciences (FCEyN), University of Buenos Aires, for providing us with dichloromethane and helpful advice, and two anonymous referees for helpful comments on the manuscript.	Abril S, 2008, SOCIOBIOLOGY, V51, P645; Abril S, 2008, J INSECT PHYSIOL, V54, P265, DOI 10.1016/j.jinsphys.2007.09.009; Abril S, 2014, J INSECT PHYSIOL, V62, P21, DOI 10.1016/j.jinsphys.2014.01.004; Abril S, 2013, MYRMECOL NEWS, V18, P19; BENOIS A, 1973, INSECT SOC, V20, P267, DOI 10.1007/BF02223196; Berville L, 2013, CHEMOECOLOGY, V23, P213, DOI 10.1007/s00049-013-0135-0; Blight O, 2012, MOL ECOL, V21, P4106, DOI 10.1111/j.1365-294X.2012.05668.x; Blight O, 2010, BIOL INVASIONS, V12, P1491, DOI 10.1007/s10530-009-9561-x; Blight O, 2017, BIOL INVASIONS, V19, P1389, DOI 10.1007/s10530-016-1353-5; Brandt M, 2009, MOL ECOL, V18, P997, DOI 10.1111/j.1365-294X.2008.04056.x; Brandt M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-71; BROPHY JJ, 1983, INSECT BIOCHEM, V13, P381, DOI 10.1016/0020-1790(83)90021-5; Buczkowski G, 2005, J CHEM ECOL, V31, P829, DOI 10.1007/s10886-005-3547-7; Cini A, 2013, INSECT SOC, V60, P393, DOI 10.1007/s00040-013-0305-7; Cuvillier-Hot V, 2004, ANIM BEHAV, V68, P1209, DOI 10.1016/j.anbehav.2003.11.026; Cuvillier-Hot V, 2001, J INSECT PHYSIOL, V47, P485, DOI 10.1016/S0022-1910(00)00137-2; D'Ettorre P, 2004, J EXP BIOL, V207, P1085, DOI 10.1242/jeb.00865; de Biseau JC, 2004, J INSECT PHYSIOL, V50, P585, DOI 10.1016/j.jinsphys.2004.04.005; Diaz M, 2014, BIOL INVASIONS, V16, P315, DOI 10.1007/s10530-013-0520-1; Enriquez ML, 2013, INSECT SOC, V60, P507, DOI 10.1007/s00040-013-0317-3; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Greene MJ, 2007, J EXP BIOL, V210, P897, DOI 10.1242/jeb.02706; Hefetz Abraham, 2007, Myrmecological News, V10, P59; Heinze J, 2009, J EXP BIOL, V212, P1775, DOI 10.1242/jeb.015008; Heller NE, 2006, ECOL ENTOMOL, V31, P499, DOI 10.1111/j.1365-2311.2006.00806.x; HOLLDOBLER B, 1977, NATURWISSENSCHAFTEN, V64, P8, DOI 10.1007/BF00439886; Holman L, 2010, P ROY SOC B-BIOL SCI, V277, P3793, DOI 10.1098/rspb.2010.0984; Holman L, 2010, P ROY SOC B-BIOL SCI, V277, P2007, DOI 10.1098/rspb.2009.2311; Hora RR, 2008, NATURWISSENSCHAFTEN, V95, P55, DOI 10.1007/s00114-007-0287-2; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Ingram KK, 2002, OECOLOGIA, V133, P492, DOI 10.1007/s00442-002-1069-3; KELLER L, 1989, PHYSIOL ENTOMOL, V14, P157, DOI 10.1111/j.1365-3032.1989.tb00947.x; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Kocher SD, 2011, J CHEM ECOL, V37, P1263, DOI 10.1007/s10886-011-0036-z; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Liang D, 2001, COMP BIOCHEM PHYS B, V129, P871, DOI 10.1016/S1096-4959(01)00404-3; Liang D, 2000, NATURWISSENSCHAFTEN, V87, P412, DOI 10.1007/s001140050752; Liu ZB, 1998, J ETHOL, V16, P57, DOI 10.1007/BF02769283; Liu ZB, 2001, INSECT SOC, V48, P342, DOI 10.1007/PL00001787; MARKIN GP, 1970, ANN ENTOMOL SOC AM, V63, P1238, DOI 10.1093/aesa/63.5.1238; Monnin T, 1998, J CHEM ECOL, V24, P473, DOI 10.1023/A:1022360718870; Monnin T, 2006, ANN ZOOL FENN, V43, P515; Mothapo NP, 2016, AFR ZOOL, V51, P161, DOI 10.1080/15627020.2016.1236670; Mothapo Natasha P., 2011, BMC Ecology, V11, P6, DOI 10.1186/1472-6785-11-6; Nielsen J, 1999, INSECT SOC, V46, P58, DOI 10.1007/s000400050113; PASSERA L, 1988, INSECT SOC, V35, P19, DOI 10.1007/BF02224135; PASSERA L, 1994, WESTV STUD, P23; Pedersen JS, 2006, EVOLUTION, V60, P782, DOI 10.1111/j.0014-3820.2006.tb01156.x; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; Ruel C, 2013, BEHAV ECOL SOCIOBIOL, V67, P1295, DOI 10.1007/s00265-013-1558-x; Silverman J, 2001, NATURWISSENSCHAFTEN, V88, P73, DOI 10.1007/s001140000198; Sledge MF, 2004, J INSECT PHYSIOL, V50, P73, DOI 10.1016/j.jinsphys.2003.10.001; Suarez AV, 2008, AM NAT, V172, pS72, DOI 10.1086/588638; Sunamura E, 2009, INSECT SOC, V56, P143, DOI 10.1007/s00040-009-0001-9; Sunamura E, 2011, NATURWISSENSCHAFTEN, V98, P361, DOI 10.1007/s00114-011-0778-z; Sunamura E, 2009, BIOL INVASIONS, V11, P2329, DOI 10.1007/s10530-008-9419-7; Teseo S, 2014, J CHEM ECOL, V40, P429, DOI 10.1007/s10886-014-0428-y; Torres CW, 2007, INSECT SOC, V54, P363, DOI 10.1007/s00040-007-0954-5; van Wilgenburg E, 2012, BIOL LETTERS, V8, P17, DOI 10.1098/rsbl.2011.0643; van Wilgenburg E, 2010, J CHEM ECOL, V36, P751, DOI 10.1007/s10886-010-9812-4; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Vasquez GM, 2008, J EXP BIOL, V211, P1249, DOI 10.1242/jeb.017301; Vasquez GM, 2009, J CHEM ECOL, V35, P922, DOI 10.1007/s10886-009-9656-y; Vogel V, 2009, EVOLUTION, V63, P1627, DOI 10.1111/j.1558-5646.2009.00628.x; Young HP, 1997, ANN ENTOMOL SOC AM, V90, P655, DOI 10.1093/aesa/90.5.655	65	8	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193115	10.1371/journal.pone.0193115	http://dx.doi.org/10.1371/journal.pone.0193115			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470506	Green Published, gold, Green Submitted			2022-12-26	WOS:000425831000035
J	Burger, D; Meuwly, C; Thomas, S; Sieme, H; Oberthur, M; Wedekind, C; Meinecke-Tillmann, S				Burger, Dominik; Meuwly, Charles; Thomas, Selina; Sieme, Harald; Oberthuer, Michael; Wedekind, Claus; Meinecke-Tillmann, Sabine			Cycle-specific female preferences for visual and non-visual cues in the horse (Equus caballus)	PLOS ONE			English	Article							MATE CHOICE; SEXUAL SELECTION; MENSTRUAL-CYCLE; RED DEER; REPRODUCTIVE SUCCESS; BEHAVIOR; MARES; DISPERSAL; SIGNALS; BIRDS	Although female preferences are well studied in many mammals, the possible effects of the oestrous cycle are not yet sufficiently understood. Here we investigate female preferences for visual and non-visual male traits relative to the periodically cycling of sexual proceptivity (oestrus) and inactivity (dioestrus), respectively, in the polygynous horse (Equus caballus). We individually exposed mares to stallions in four experimental situations: (i) mares in oestrus and visual contact to stallions allowed, (ii) mares in oestrus, with blinds (wooden partitions preventing visual contact but allowing for acoustic and olfactory communication), (iii) mares in dioestrus, no blinds, and (iv) mares in dioestrus, with blinds. Contact times of the mares with each stallion, defined as the cumulative amount of time a mare was in the vicinity of an individual stallion and actively searching contact, were used to rank stallions according to each mare's preferences. We found that preferences based on visual traits differed significantly from preferences based on non-visual traits in dioestrous mares. The mares then showed a preference for older and larger males, but only if visual cues were available. In contrast, oestrous mares showed consistent preferences with or without blinds, i.e. their preferences were mainly based on non-visual traits and could not be predicted by male age or size. Stallions who were generally preferred displayed a high libido that may have positively influenced female interest or may have been a consequence of it. We conclude that the oestrous cycle has a significant influence on female preferences for visual and nonvisual male traits in the horse.	[Burger, Dominik; Meuwly, Charles; Thomas, Selina] Univ Bern, Swiss Inst Equine Med ISME, Avenches, Switzerland; [Burger, Dominik; Meuwly, Charles; Thomas, Selina] Agroscope, Avenches, Switzerland; [Sieme, Harald] Univ Vet Med Hannover, Unit Reprod Med, Clin Horses, Hannover, Germany; [Oberthuer, Michael; Meinecke-Tillmann, Sabine] Univ Vet Med Hannover, Inst Reprod Biol, Hannover, Germany; [Wedekind, Claus] Univ Lausanne, Dept Ecol & Evolut, Biophore, Lausanne, Switzerland	University of Bern; Swiss Federal Research Station Agroscope; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Lausanne	Burger, D (corresponding author), Univ Bern, Swiss Inst Equine Med ISME, Avenches, Switzerland.; Burger, D (corresponding author), Agroscope, Avenches, Switzerland.	dominik.burger@vetsuisse.unibe.ch						Alvergne A, 2010, TRENDS ECOL EVOL, V25, P171, DOI 10.1016/j.tree.2009.08.003; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Asa CS, 1999, BEHAV ECOL SOCIOBIOL, V47, P89, DOI 10.1007/s002650050653; Aurich C, 2011, ANIM REPROD SCI, V124, P220, DOI 10.1016/j.anireprosci.2011.02.005; BALMFORD A, 1991, TRENDS ECOL EVOL, V6, P87, DOI 10.1016/0169-5347(91)90181-V; BALMFORD A, 1992, BEHAVIOUR, V120, P177, DOI 10.1163/156853992X00598; Bartos L, 2011, BEHAV ECOL SOCIOBIOL, V65, P1567, DOI 10.1007/s00265-011-1166-6; BEACH FA, 1967, ANIM BEHAV, V15, P546, DOI 10.1016/0003-3472(67)90057-7; Beauchamp GK, 2003, BIOCHEM SOC T, V31, P147; Brandt R, 2011, ANIM BEHAV, V82, P353, DOI 10.1016/j.anbehav.2011.05.011; Brooks R, 2001, TRENDS ECOL EVOL, V16, P308, DOI 10.1016/S0169-5347(01)02147-4; Burger D, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1824; Burger D, 2017, THERIOGENOLOGY, V89, P318, DOI 10.1016/j.theriogenology.2016.09.015; Burger D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0407; Cafazzo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098594; CARROLL CL, 1988, EQUINE VET J, V20, P41, DOI 10.1111/j.2042-3306.1988.tb01451.x; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Charlton BD, 2013, J EXP BIOL, V216, P1127, DOI 10.1242/jeb.070318; Choleris E, 2012, FRONT NEUROENDOCRIN, V33, P140, DOI 10.1016/j.yfrne.2012.02.001; Clutton-Brock T, 2009, Q REV BIOL, V84, P3, DOI 10.1086/596461; CLUTTONBROCK T, 1993, BEHAV ECOL, V4, P191, DOI 10.1093/beheco/4.3.191; Craul M, 2004, PRIMATES, V45, P271, DOI 10.1007/s10329-004-0097-5; Crowell-Davis SL, 2007, HORM BEHAV, V52, P12, DOI 10.1016/j.yhbeh.2007.03.020; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; Dall'Olio S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037332; Davies D. M., 2013, COMPATIBILITY GENE; DINGER JE, 1986, J ANIM SCI, V62, P1220, DOI 10.2527/jas1986.6251220x; DUNCAN P, 1982, APPL ANIM ETHOL, V8, P567, DOI 10.1016/0304-3762(82)90221-8; ESTEP DQ, 1989, APPL ANIM BEHAV SCI, V24, P287, DOI 10.1016/0168-1591(89)90057-9; Feh C, 2008, BEHAV PROCESS, V78, P335, DOI 10.1016/j.beproc.2007.12.009; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Ginther O.J., 1992, REPROD BIOL MARE BAS; Gosling LM, 2001, ADV STUD BEHAV, V30, P169, DOI 10.1016/S0065-3454(01)80007-3; GOSLING LM, 2001, ANIM BEHAV, V62, P7; GRAMMER K, 1993, ETHOL SOCIOBIOL, V14, P201, DOI 10.1016/0162-3095(93)90006-4; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Havlicek J, 2005, BIOL LETTERS, V1, P256, DOI 10.1098/rsbl.2005.0332; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Jeannerat E, 2018, MOL ECOL IN PRESS; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones AG, 2009, P NATL ACAD SCI USA, V106, P10001, DOI 10.1073/pnas.0901129106; KASEDA Y, 1995, EQUINE VET J, V27, P368, DOI 10.1111/j.2042-3306.1995.tb04072.x; KAVALIERS M, 1995, P ROY SOC B-BIOL SCI, V261, P31, DOI 10.1098/rspb.1995.0113; Klingel H, 1982, J Reprod Fertil Suppl, V32, P89; KLINGEL H, 1975, J REPROD FERTIL, P7; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P1533, DOI 10.1098/rspb.1996.0224; KOMERS PE, 1989, ANIM BEHAV, V37, P645, DOI 10.1016/0003-3472(89)90043-2; Linklater WL, 2009, ANIM BEHAV, V77, P1085, DOI 10.1016/j.anbehav.2009.01.017; Little AC, 2007, BIOL PSYCHOL, V76, P209, DOI 10.1016/j.biopsycho.2007.08.003; Longpre KM, 2011, HORM BEHAV, V60, P505, DOI 10.1016/j.yhbeh.2011.07.019; Longpre KM, 2011, HORM BEHAV, V59, P98, DOI 10.1016/j.yhbeh.2010.10.014; Malo AF, 2005, P ROY SOC B-BIOL SCI, V272, P149, DOI 10.1098/rspb.2004.2933; MANNING JT, 1985, J THEOR BIOL, V116, P349, DOI 10.1016/S0022-5193(85)80273-3; Marjamaki PH, 2013, ECOL EVOL, V3, P3073, DOI 10.1002/ece3.694; Martin AM, 2016, J EVOLUTION BIOL, V29, P1437, DOI 10.1111/jeb.12883; MCCOMB K, 1987, NATURE, V330, P648, DOI 10.1038/330648a0; MCCOMB KE, 1991, ANIM BEHAV, V41, P79, DOI 10.1016/S0003-3472(05)80504-4; McDonnell SM, 2000, ANIM REPROD SCI, V60, P211, DOI 10.1016/S0378-4320(00)00136-6; McElligott AG, 2001, BEHAV ECOL, V12, P41, DOI 10.1093/oxfordjournals.beheco.a000376; Monard AM, 1996, ANIM BEHAV, V52, P565, DOI 10.1006/anbe.1996.0198; Pal SK, 1999, APPL ANIM BEHAV SCI, V62, P267, DOI 10.1016/S0168-1591(98)00220-2; Pawlowski B, 2005, BIOL PSYCHOL, V70, P38, DOI 10.1016/j.biopsycho.2005.02.002; Penn D, 1998, TRENDS ECOL EVOL, V13, P391, DOI 10.1016/S0169-5347(98)01473-6; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; PICKEREL TM, 1993, APPL ANIM BEHAV SCI, V38, P1, DOI 10.1016/0168-1591(93)90037-P; Pillay N, 2000, BEHAVIOUR, V137, P1431, DOI 10.1163/156853900502655; POOLE JH, 1984, J REPROD FERTIL, V70, P255; Ruff JS, 2012, ADV EXP MED BIOL, V738, P290, DOI 10.1007/978-1-4614-1680-7_17; RUTBERG AT, 1990, ANIM BEHAV, V40, P945, DOI 10.1016/S0003-3472(05)80996-0; SAETRE GP, 1995, J ANIM ECOL, V64, P21, DOI 10.2307/5824; STEVENS EF, 1990, BEHAVIOUR, V112, P149, DOI 10.1163/156853990X00167; Waring G, 1983, HORSE BEHAV BEHAV TR; WEDEKIND C, 1994, PHILOS T R SOC B, V346, P303, DOI 10.1098/rstb.1994.0147; WEDEKIND C, 1994, J THEOR BIOL, V170, P57, DOI 10.1006/jtbi.1994.1167; Wespi B, 2014, THERIOGENOLOGY, V82, P189, DOI 10.1016/j.theriogenology.2014.03.019; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zeh JA, 1998, P NATL ACAD SCI USA, V95, P13732, DOI 10.1073/pnas.95.23.13732; Zinck L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066064; [No title captured]	81	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0191845	10.1371/journal.pone.0191845	http://dx.doi.org/10.1371/journal.pone.0191845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	29466358	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300017
J	Marcuello, M; Mayol, X; Felipe-Fumero, E; Costa, J; Lopez-Hierro, L; Salvans, S; Alonso, S; Pascual, M; Grande, L; Pera, M				Marcuello, Maria; Mayol, Xavier; Felipe-Fumero, Eloisa; Costa, Jaume; Lopez-Hierro, Laia; Salvans, Silvia; Alonso, Sandra; Pascual, Marta; Grande, Luis; Pera, Miguel			Modulation of the colon cancer cell phenotype by pro-inflammatory macrophages: A preclinical model of surgery-associated inflammation and tumor recurrence	PLOS ONE			English	Article							POSTOPERATIVE INTRAABDOMINAL INFECTION; LONG-TERM SURVIVAL; TO-MESENCHYMAL TRANSITION; ANASTOMOTIC LEAKAGE; CURATIVE RESECTION; IMPACT; METASTASIS; DIFFERENTIATION; COMPLICATIONS; ESTABLISHMENT	Peritoneal infection after colorectal cancer surgery is associated with a higher rate of tumor relapse. We have recently proposed that soluble inflammatory factors released in response to a postoperative infection enhance tumor progression features in residual tumor cells. In an effort to set up models to study the mechanisms of residual tumor cell activation during surgery-associated inflammation, we have analyzed the phenotypic response of colon cancer cell lines to the paracrine effects of THP-1 and U937 differentiated human macrophages, which release an inflammatory medium characteristic of an innate immune response. The exposure of the colon cancer cell lines HT-29 and SW620 to conditioned media isolated from differentiated THP-1 and U937 macrophages induced a mesenchymal-like phenotypic shift, involving the activation of in vitro invasiveness. The inflammatory media activated the beta-catenin/TCF4 transcriptional pathway and induced the expression of several mesenchymal (e.g., FN1 and VIM) and TCF4 target genes (e.g., MMP7, PTGS2, MET, and CCD1). Similarly, differential expression of some transcription factors involved in epithelial-to-mesenchymal transitions (i.e. ZEB1, SNAI1, and SNAI2) was variably observed in the colon cancer cell lines when exposed to the inflammatory media. THP-1 and U937 macrophages, which displayed characteristics of M1 differentiation, overexpressed some cytokines previously shown to be induced in colorectal cancer patients with increased rates of tumor recurrence associated with postoperative peritoneal infections, thus suggesting their pro-tumoral character. Therefore, the environment created by inflammatory M1 macrophages enhances features of epithelial-to-mesenchymal transition, and may be useful as a model to characterize pro-inflammatory cytokines as putative biomarkers of tumor recurrence risk.	[Marcuello, Maria; Mayol, Xavier; Felipe-Fumero, Eloisa; Costa, Jaume; Lopez-Hierro, Laia; Salvans, Silvia; Alonso, Sandra; Pascual, Marta; Grande, Luis; Pera, Miguel] IMIM Hosp del Mar Med Res Inst, Canc Res Program, Colorectal Canc Res Grp, Barcelona, Spain; [Salvans, Silvia; Alonso, Sandra; Pascual, Marta; Grande, Luis; Pera, Miguel] Hosp del Mar, Sect Colon & Rectal Surg, Dept Surg, Barcelona, Spain; [Marcuello, Maria] Hosp Clin Barcelona, Gastrointestinal & Pancreat Oncol Res Grp, Barcelona, Spain; [Felipe-Fumero, Eloisa] Univ Munster, Dept Med Hematol & Oncol A, Munster, Germany	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Hospital Clinic de Barcelona; University of Munster	Pera, M (corresponding author), IMIM Hosp del Mar Med Res Inst, Canc Res Program, Colorectal Canc Res Grp, Barcelona, Spain.; Pera, M (corresponding author), Hosp del Mar, Sect Colon & Rectal Surg, Dept Surg, Barcelona, Spain.	mpera@hospitaldelmar.cat	Grande, Luis P/D-9716-2013; Grande, Luis/HGB-6658-2022	Grande, Luis P/0000-0001-9146-9004; Pera, Miguel/0000-0001-7764-6481; Mayol, Xavier/0000-0001-7288-195X	Fundacion Mutua Madrilena [2014/5554/I]; Fundacion Asociacion Espanola de Coloproctologia [2014/5144/I]; Instituto de Salud Carlos III [PI2015/00458]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacion Asociacion Espanola de Coloproctologia; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Fundacion Mutua Madrilena (PI Marta Pascual, #2014/5554/I), URL:https://www.fundacionmutua.es/; Fundacion Asociacion Espanola de Coloproctologia (PI Miguel Pera, #2014/5144/I), URL: https://www.aecp-es.org/; Instituto de Salud Carlos III (PI Miguel Pera, #PI2015/00458), URL:http://www.isciii.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2017, COLORECTAL DIS, V19, pO115, DOI 10.1111/codi.13635; Alonso S, 2015, EJSO-EUR J SURG ONC, V41, P208, DOI 10.1016/j.ejso.2014.10.052; Artinyan A, 2015, ANN SURG, V261, P497, DOI 10.1097/SLA.0000000000000854; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Berkovich L, 2016, GASTROENT RES PRACT, V2016; Bohle B, 2010, SURGERY, V147, P120, DOI 10.1016/j.surg.2009.06.035; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Chang GJ, 2012, DIS COLON RECTUM, V55, P831, DOI 10.1097/DCR.0b013e3182567e13; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; Frasson M, 2015, ANN SURG, V262, P321, DOI 10.1097/SLA.0000000000000973; Friedlander TW, 2014, PHARMACOL THERAPEUT, V142, P271, DOI 10.1016/j.pharmthera.2013.12.011; GIVENS KT, 1990, INVEST OPHTH VIS SCI, V31, P1856; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Kang J, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001202; Katoh H, 2011, J GASTROINTEST SURG, V15, P120, DOI 10.1007/s11605-010-1379-4; Kim IY, 2015, INT J SURG, V22, P3, DOI 10.1016/j.ijsu.2015.08.017; Krarup PM, 2014, ANN SURG, V259, P930, DOI 10.1097/SLA.0b013e3182a6f2fc; Krezalek MA, 2016, CURR PROB SURG, V53, P252, DOI [10.1067/j.cpsurg.2016.06.002, 10.1067/j.cpsurg.2016.06.001]; Law WL, 2007, J GASTROINTEST SURG, V11, P8, DOI 10.1007/s11605-006-0049-z; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Liang J, 2015, BRIT J SURG, V102, P847, DOI 10.1002/bjs.9805; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markar S, 2015, ANN SURG, V262, P972, DOI 10.1097/SLA.0000000000001011; McArdle CS, 2005, BRIT J SURG, V92, P1150, DOI 10.1002/bjs.5054; Min BS, 2012, ONCOL LETT, V4, P123, DOI 10.3892/ol.2012.691; Mirnezami A, 2011, ANN SURG, V253, P890, DOI 10.1097/SLA.0b013e3182128929; Mokart D, 2002, BRIT J SURG, V89, P1450, DOI 10.1046/j.1365-2168.2002.02218.x; Orosz E, 2013, PATHOL ONCOL RES, V19, P619, DOI 10.1007/s12253-013-9672-7; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Park EJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003271; Pascual M, 2011, BRIT J SURG, V98, P50, DOI 10.1002/bjs.7258; Pascual M, 2017, AM J SUG; Salvans S, 2014, ANN SURG, V260, P939, DOI 10.1097/SLA.0000000000000958; Sanchez-Tillo E, 2011, AM J CANCER RES, V1, P897; Satsu H, 2006, EXP CELL RES, V312, P3909, DOI 10.1016/j.yexcr.2006.08.018; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tohme S, 2017, CANCER RES, V77, P1548, DOI 10.1158/0008-5472.CAN-16-1536; Tsai YC, 2017, MOL CELL ENDOCRINOL, V452, P74, DOI 10.1016/j.mce.2017.05.015; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Waldner MJ, 2014, SEMIN IMMUNOL, V26, P75, DOI 10.1016/j.smim.2013.12.003; Walker KG, 2004, ANN SURG, V240, P255, DOI 10.1097/01.sla.0000133186.81222.08; Werther K, 2003, ACTA ONCOL, V42, P837, DOI 10.1080/02841860310003509; Wu MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134122; Xu JM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002502; Yamada S, 2014, ANN SURG ONCOL, V21, P3882, DOI 10.1245/s10434-014-3779-2; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	48	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192958	10.1371/journal.pone.0192958	http://dx.doi.org/10.1371/journal.pone.0192958			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462209	Green Published, gold, Green Submitted			2022-12-26	WOS:000425554200038
J	Mokondoko, P; Manson, RH; Ricketts, TH; Geissert, D				Mokondoko, Pierre; Manson, Robert H.; Ricketts, Taylor H.; Geissert, Daniel			Spatial analysis of ecosystem service relationships to improve targeting of payments for hydrological services	PLOS ONE			English	Article							MEXICO NATIONAL PAYMENTS; ENVIRONMENTAL SERVICES; TRADE-OFFS; DESIGNING PAYMENTS; BIODIVERSITY CONSERVATION; FOREST CONSERVATION; LAND-USE; SYNERGIES; INVESTMENTS; EFFICIENCY	Payment for hydrological services (PHS) are popular tools for conserving ecosystems and their water-related services. However, improving the spatial targeting and impacts of PHS, as well as their ability to foster synergies with other ecosystem services (ES), remain challenging. We aimed at using spatial analyses to evaluate the targeting performance of Mexico's National PHS program in central Veracruz. We quantified the effectiveness of areas targeted for PHS in actually covering areas of high HS provision and social priority during 2003-2013. First, we quantified provisioning and spatial distributions of two target (water yield and soil retention), and one non-target ES (carbon storage) using InVEST. Subsequently, pairwise relationships among ES were quantified by using spatial correlation and overlap analyses. Finally, we evaluated targeting by: (i) prioritizing areas of individual and overlapping ES; (ii) quantifying spatial co-occurrences of these priority areas with those targeted by PHS; (iii) evaluating the extent to which PHS directly contribute to HS delivery; and (iv), testing if PHS targeted areas disproportionately covered areas with high ecological and social priority. We found that modelled priority areas exhibited non-random distributions and distinct spatial patterns. Our results show significant pairwise correlations between all ES suggesting synergistic relationships. However, our analysis showed a significantly lower overlap than expected and thus significant mismatches between PHS targeted areas and all types of priority areas. These findings suggest that the targeting of areas with high HS provisioning and social priority by Mexico's PHS program could be improved significantly. This study underscores: (1) the importance of using maps of HS provisioning as main targeting criteria in PHS design to channel payments towards areas that require future conservation, and (2) the need for future research that helps balance ecological and socioeconomic targeting criteria.	[Mokondoko, Pierre] Inst Ecol AC, Postgrad Div, Xalapa, Veracruz, Mexico; [Mokondoko, Pierre; Manson, Robert H.] Inst Ecol AC, Funct Ecol Netwrok, Xalapa, Veracruz, Mexico; [Ricketts, Taylor H.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA; [Ricketts, Taylor H.; Geissert, Daniel] Univ Vermont, Gund Inst Environm, Burlington, VT USA	Instituto de Ecologia - Mexico; Instituto de Ecologia - Mexico; University of Vermont; University of Vermont	Manson, RH (corresponding author), Inst Ecol AC, Funct Ecol Netwrok, Xalapa, Veracruz, Mexico.	robert.manson@inecol.mx	Manson, Robert Hunter/AAD-6443-2021; Manson, Robert H/Q-9015-2018	Manson, Robert H/0000-0001-9732-8894	Natural Capital Project of the Stanford Woods Institute for the Environment; Gordon and Betty Moore Foundation [60338495]; Mexican National Council for Science and Technology (CONACyT) [212533]; INECOL; NSF-CNH [1313804]; SEMARNAT-CONACyT [249270]; Gordon and Betty Moore Foundation (Stanford-INECOL)	Natural Capital Project of the Stanford Woods Institute for the Environment; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Mexican National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); INECOL; NSF-CNH; SEMARNAT-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Gordon and Betty Moore Foundation (Stanford-INECOL)(Gordon and Betty Moore Foundation)	This work was financially supported by the Natural Capital Project of the Stanford Woods Institute for the Environment and The Gordon and Betty Moore Foundation (Grant Agreement No. 60338495 to RHM; Stanford-INECOL). The PhD research of the first author was supported by a doctoral degree grant (No. 212533) from the Mexican National Council for Science and Technology (CONACyT). INECOL provided support through an academic retreat program. Funder had no role in study design, data analyses, decision to publish or the preparation of the manuscript.; We thank the Natural Capital Project team for providing feedback and technical support. Logistic and in-kind support was provided by NSF-CNH project 1313804 and SEMARNAT-CONACyT project 249270. We are grateful to Ignacio Gonzalez, who contributed to the LULC mapping. We also thank our many colleagues from INECOL who graciously provided access to their biophysical data and facilities for this study, especially to Rosario Landgrave and Juan Von Thaden who provided several key layers of spatial data. Tree anonymous reviewers provided valuable suggestions that significantly improved the manuscript. The contents of this study are the sole responsibility of the authors.	Alix-Garcia J, 2008, ENVIRON DEV ECON, V13, P375, DOI 10.1017/S1355770X08004336; Alix-Garcia JM, 2012, LAND ECON, V88, P613, DOI 10.3368/le.88.4.613; Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 2005, SYNTHESIS; Asbjornsen H, 2017, ECOL SOC, V22, DOI 10.5751/ES-09144-220225; Asbjornsen H, 2015, BIOSCIENCE, V65, P579, DOI 10.1093/biosci/biv051; Bagstad KJ, 2013, ECOSYST SERV, V5, pE40, DOI 10.1016/j.ecoser.2013.07.007; Bai Y, 2011, ECOL COMPLEX, V8, P177, DOI 10.1016/j.ecocom.2011.01.007; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Bhagabati NK, 2014, BIOL CONSERV, V169, P147, DOI 10.1016/j.biocon.2013.11.010; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Brouwer R, 2011, ENVIRON CONSERV, V38, P380, DOI 10.1017/S0376892911000543; Bruijnzeel LA, 2011, HYDROL PROCESS, V25, P465, DOI 10.1002/hyp.7974; Bruijnzeel LA, 2001, LAND USE WATER RESOU, V1, P1; Bryan BA, 2010, LANDSCAPE URBAN PLAN, V97, P111, DOI 10.1016/j.landurbplan.2010.05.002; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chen XD, 2010, CONSERV BIOL, V24, P1469, DOI 10.1111/j.1523-1739.2010.01551.x; CONAPO, 2010, IND MARG NIV LOC 201; Corbera E, 2009, ECOL ECON, V68, P743, DOI 10.1016/j.ecolecon.2008.06.008; Corbera E, 2008, WORLD DEV, V36, P1956, DOI 10.1016/j.worlddev.2007.09.010; Cord AF, 2017, ECOSYST SERV, V28, P264, DOI 10.1016/j.ecoser.2017.07.012; Costedoat S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119881; Cotler H., 2010, CUENCAS HIDROGRAFICA, V1, P210; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; Egoh B, 2008, AGR ECOSYST ENVIRON, V127, P135, DOI 10.1016/j.agee.2008.03.013; Egoh BN, 2011, J ENVIRON MANAGE, V92, P1642, DOI 10.1016/j.jenvman.2011.01.019; Eigenbrod F, 2010, J APPL ECOL, V47, P377, DOI 10.1111/j.1365-2664.2010.01777.x; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Ezzine-de-Blas D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152514; Ezzine-De-Blas D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149847; Farley J, 2010, ECOL ECON, V69, P2060, DOI 10.1016/j.ecolecon.2010.06.010; Farley KA, 2011, ENVIRON CONSERV, V38, P393, DOI 10.1017/S037689291100049X; Ferraro PJ, 2004, AM J AGR ECON, V86, P905, DOI 10.1111/j.0002-9092.2004.00642.x; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Galicia Leopoldo, 2014, International Journal of Biodiversity Science Ecosystem Services & Management, V10, P275, DOI 10.1080/21513732.2014.973907; Gomez-Baggethun E, 2010, ECOL ECON, V69, P1209, DOI 10.1016/j.ecolecon.2009.11.007; Guerry AD, 2015, P NATL ACAD SCI USA, V112, P7348, DOI 10.1073/pnas.1503751112; Haines-Young R, 2011, PROG PHYS GEOG, V35, P681, DOI 10.1177/0309133311422977; Hamel P, 2015, SCI TOTAL ENVIRON, V524, P166, DOI 10.1016/j.scitotenv.2015.04.027; Honey-Roses J, 2009, ENVIRON CONSERV, V36, P120, DOI 10.1017/S0376892909990063; Hoyer R, 2014, APPL GEOGR, V53, P402, DOI 10.1016/j.apgeog.2014.06.023; Jack BK, 2008, P NATL ACAD SCI USA, V105, P9465, DOI 10.1073/pnas.0705503104; Jopke C, 2015, ECOL INDIC, V49, P46, DOI 10.1016/j.ecolind.2014.09.037; Martinez-Harms MJ, 2016, ECOSYST SERV, V22, P32, DOI 10.1016/j.ecoser.2016.09.007; Jose Martinez-Harms Maria, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P17, DOI 10.1080/21513732.2012.663792; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Kolinjivadi V, 2015, GEOFORUM, V58, P1, DOI 10.1016/j.geoforum.2014.10.004; Lacombe G, 2016, HYDROL EARTH SYST SC, V20, P2691, DOI 10.5194/hess-20-2691-2016; Lautenbach S, 2013, ENVIRON MODELL SOFTW, V48, P98, DOI 10.1016/j.envsoft.2013.06.006; Lavorel S, 2011, J ECOL, V99, P135, DOI 10.1111/j.1365-2745.2010.01753.x; Le Velly G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149374; Leh MDK, 2013, AGR ECOSYST ENVIRON, V165, P6, DOI 10.1016/j.agee.2012.12.001; Locatelli B, 2014, ENVIRON CONSERV, V41, P27, DOI 10.1017/S0376892913000234; Maes J, 2012, BIOL CONSERV, V155, P1, DOI 10.1016/j.biocon.2012.06.016; Malczewski J, 2003, ENVIRON PLANN A, V35, P1769, DOI 10.1068/a35156; Manson R, 2013, SERVICIOS ECOSYSTEMI, P245; Manson R. H., 2004, Madera y Bosques, V10, P3; McAfee K, 2010, ANN ASSOC AM GEOGR, V100, P579, DOI 10.1080/00045601003794833; Mokondoko P, 2016, ECOSYST SERV, V22, P161, DOI 10.1016/j.ecoser.2016.09.001; Munoz-Pina C., 2011, REV ESP ESTUD AGROSO, V228, P87; Munoz-Pina C, 2008, ECOL ECON, V65, P725, DOI 10.1016/j.ecolecon.2007.07.031; Munoz-Villers LE, 2008, INT J REMOTE SENS, V29, P71, DOI 10.1080/01431160701280967; Muradian R, 2013, CONSERV LETT, V6, P274, DOI 10.1111/j.1755-263X.2012.00309.x; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Naidoo R, 2006, PLOS BIOL, V4, P2153, DOI 10.1371/journal.pbio.0040360; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pan Ying, 2013, Ecosystem Services, V5, P4; Paz F, 2011, ESTADO ACTUAL CONOCI, P17; Penuela-Arevalo LA, 2013, ENVIRON EARTH SCI, V68, P999, DOI 10.1007/s12665-012-1803-z; Polasky S, 2014, P NATL ACAD SCI USA, V111, P6248, DOI 10.1073/pnas.1404484111; Polasky S, 2012, OXFORD REV ECON POL, V28, P139, DOI 10.1093/oxrep/grs011; Ponette-Gonzalez AG, 2010, ECOL APPL, V20, P1820, DOI 10.1890/09-1125.1; Ponette-Gonzalez AG, 2015, AMBIO, V44, P367, DOI 10.1007/s13280-014-0578-8; Qiu JX, 2013, P NATL ACAD SCI USA, V110, P12149, DOI 10.1073/pnas.1310539110; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Remme RP, 2014, ECOSYST SERV, V10, P6, DOI 10.1016/j.ecoser.2014.07.006; Garcia-Amado LR, 2011, ECOL ECON, V70, P2361, DOI 10.1016/j.ecolecon.2011.07.016; Robertson M, 2014, FRONT ECOL ENVIRON, V12, P186, DOI 10.1890/110292; Rodriguez JP, 2006, ECOL SOC, V11; Ruckelshaus M, 2015, ECOL ECON, V115, P11, DOI 10.1016/j.ecolecon.2013.07.009; Sanchez-Azofeifa GA, 2007, CONSERV BIOL, V21, P1165, DOI 10.1111/j.1523-1739.2007.00751.x; Schelhas J, 2006, HUM ECOL, V34, P407, DOI 10.1007/s10745-006-9024-2; Shapiro-Garza E, 2013, GEOFORUM, V46, P5, DOI 10.1016/j.geoforum.2012.11.018; Sims KRE, 2014, CONSERV BIOL, V28, P1151, DOI 10.1111/cobi.12318; Sutherland WJ, 2006, J APPL ECOL, V43, P617, DOI 10.1111/j.1365-2664.2006.01188.x; Syrbe RU, 2012, ECOL INDIC, V21, P80, DOI 10.1016/j.ecolind.2012.02.013; Tallis, 2010, INVEST 1 004 BETA US; Tallis H, 2008, P NATL ACAD SCI USA, V105, P9457, DOI 10.1073/pnas.0705797105; Tallis H, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P34; The National Forestry Commission of Mexico ( CONAFOR), 2014, INV NAC FOR SUEL INF; Troy C, 2006, ECOLOGICAL EC, V60, P435; Turner KG, 2014, LANDSCAPE URBAN PLAN, V125, P89, DOI 10.1016/j.landurbplan.2014.02.007; Vigerstol KL, 2011, J ENVIRON MANAGE, V92, P2403, DOI 10.1016/j.jenvman.2011.06.040; Wendland KJ, 2010, ECOL ECON, V69, P2093, DOI 10.1016/j.ecolecon.2009.01.002; Williams-Linera G., 2002, Madera y Bosques, V8, P73; Wunscher T, 2008, ECOL ECON, V65, P822, DOI 10.1016/j.ecolecon.2007.11.014; Wunder S., 2009, Journal of Sustainable Forestry, V28, P576, DOI 10.1080/10549810902905669; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x; Wunder S, 2015, ECOL ECON, V117, P234, DOI 10.1016/j.ecolecon.2014.08.016; Zander KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023154; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zhang L, 2008, J HYDROL, V360, P117, DOI 10.1016/j.jhydrol.2008.07.021; Zhang W, 2011, ENVIRON CONSERV, V38, P406, DOI 10.1017/S0376892911000555	107	14	17	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192560	10.1371/journal.pone.0192560	http://dx.doi.org/10.1371/journal.pone.0192560			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8CI	29462205	Green Published, gold			2022-12-26	WOS:000425554200017
J	Pericas, JM; Cervera, C; Moreno, A; Garcia-de-la-Maria, C; Almel, M; Falces, C; Quintana, E; Vida, B; Llopis, J; Fuster, D; Mestres, CA; Marco, F; Miro, JM				Pericas, Juan M.; Cervera, Carlos; Moreno, Asuncion; Garcia-de-la-Maria, Cristina; Almel, Manel; Falces, Carles; Quintana, Eduard; Vida, Barbara; Llopis, Jaume; Fuster, David; Mestres, Carlos A.; Marco, Francesc; Miro, Jose M.		Hosp Clinic Endocarditis Study Grp	Outcome of Enterococcus faecalis infective endocarditis according to the length of antibiotic therapy: Preliminary data from a cohort of 78 patients	PLOS ONE			English	Article							AMPICILLIN PLUS CEFTRIAXONE; NATIVE-VALVE ENDOCARDITIS; HEALTH-CARE PROFESSIONALS; ANTIMICROBIAL THERAPY; GENTAMICIN; DIAGNOSIS; RESISTANT; COMPLICATIONS; MANAGEMENT; STATEMENT	Background International guidelines recommend 4 weeks of treatment with ampicillin plus gentamicin (A + G) for uncomplicated native valve Enterococcus faecalis infective endocarditis (EFIE) and 6 weeks in the remaining cases. Ampicillin plus ceftriaxone (A + C) is always recommended for at least 6w, with no available studies assessing its suitability for 4w. We aimed to investigate differences in the outcome of EFIE according to the duration (4 versus 6 weeks) of antibiotic treatment (A + G or A + C). Methods Retrospective analysis from a prospectively collected cohort of 78 EFIE patients treated with either A + G or A + C. Results 32 cases (41%) were treated with A + G (9 for 4w, 28%) and 46 (59%) with A + C (14 for 4w, 30%). No significant differences were found in 1-year mortality according to the type of treatment (31% and 24% in A + G and A + C, respectively; P = 0.646) or duration (26% and 27% at 4 and 6w, respectively; P = 0.863). Relapses were more frequent among survivors treated for 4w than in those treated for 6w (3/18 [17%] at 4w and 1/41 [2%] at 6w; P = 0.045). Three out of 4 (75%) relapses occurred in cirrhotic patients. Conclusions A 4-week course of antibiotic treatment might not be suitable neither for A + G nor A + C for treating uncomplicated native valve EFIE.	[Pericas, Juan M.; Moreno, Asuncion; Garcia-de-la-Maria, Cristina; Miro, Jose M.] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Infect Dis Serv, Barcelona, Spain; [Cervera, Carlos] Univ Alberta, Div Infect Dis, Edmonton, AB, Canada; [Almel, Manel] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Microbiol Serv, Barcelona, Spain; [Falces, Carles; Vida, Barbara] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Cardiol Serv, Barcelona, Spain; [Quintana, Eduard; Mestres, Carlos A.] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Cardiovasc Surg Serv, Barcelona, Spain; [Llopis, Jaume] Univ Barcelona, Fac Biol, Dept Stat, Barcelona, Spain; [Fuster, David] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Nucl Med Serv, Barcelona, Spain; [Mestres, Carlos A.] Univ Zurich, Dept Cardiovasc Surg, Zurich, Switzerland; [Marco, Francesc] Univ Barcelona, Hosp Clin, ISGlobal, Microbiol Serv, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Alberta; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Zurich; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona	Miro, JM (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Infect Dis Serv, Barcelona, Spain.	jmmiro@ub.edu	Pericàs, Juan M/N-5674-2019; Cervera, Carlos/U-4538-2018; Marco, Francesc/K-2900-2017	Pericàs, Juan M/0000-0002-3645-3293; Cervera, Carlos/0000-0002-0161-1749; Moreno Camacho, Asuncion/0000-0002-5850-5007; Quintana, Eduard/0000-0002-5386-7463; Marco, Francesc/0000-0002-1863-6379	"Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III" (Madrid, Spain); Spanish Network for Research in Infectious Diseases [REIPI RD06/0008]; "Fundacion Maximo Soriano Jimenez" (Barcelona, Spain); Hospital Clinic, Barcelona (Spain); Instituto de Salud Carlos III [CM14/00135]; 'Ministerio de Economia and Competitividad', Madrid (Spain); Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid (Spain) [INT15/00168]; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain	"Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III" (Madrid, Spain)(Instituto de Salud Carlos III); Spanish Network for Research in Infectious Diseases; "Fundacion Maximo Soriano Jimenez" (Barcelona, Spain); Hospital Clinic, Barcelona (Spain); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); 'Ministerio de Economia and Competitividad', Madrid (Spain)(Spanish Government); Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid (Spain)(Spanish Government); Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain	This study was supported in part by a grant from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain), the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008), and the Fundacion Maximo Soriano Jimenez (Barcelona, Spain). During the drafting of the manuscript, JMP received an Emili Letang Post-residency Scholarship (2013-14) from Hospital Clinic, Barcelona (Spain) and a Rio Hortega Research Grant (CM14/00135; 2015-16) from the Instituto de Salud Carlos III and the Ministerio de Economia and Competitividad, Madrid (Spain). During 2016, JMM received a personal research intensification grant (#INT15/00168) from Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid (Spain) and a personal 80:20 research grant from the Institut dInvestigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain during 2017-19. None of the sponsors/funders had a significant role in the design and conduct of the study or in data collection, management, analysis, and interpretation. Similarly, they were not involved in the drafting, review, or approval of the manuscript.	Alexopoulou A, 2013, LIVER INT, V33, P975, DOI 10.1111/liv.12152; Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Benito N, 2009, ANN INTERN MED, V150, P586, DOI 10.7326/0003-4819-150-9-200905050-00004; Chirouze C, 2013, CLIN MICROBIOL INFEC, V19, P1140, DOI 10.1111/1469-0691.12166; Christou L, 2007, AM J GASTROENTEROL, V102, P1510, DOI 10.1111/j.1572-0241.2007.01286.x; CLSI. Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Dahl A, 2013, CIRCULATION, V127, P1810, DOI 10.1161/CIRCULATIONAHA.112.001170; Guerrero MLF, 2010, EUR J CLIN MICROBIOL, V29, P1271, DOI 10.1007/s10096-010-0998-8; Fernandez-Hidalgo N, 2013, CLIN INFECT DIS, V56, P1261, DOI 10.1093/cid/cit052; Gavalda J, 1999, ANTIMICROB AGENTS CH, V43, P639, DOI 10.1128/AAC.43.3.639; Gavalda Joan, 2007, Ann Intern Med, V146, P574; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; MAINARDI JL, 1995, ANTIMICROB AGENTS CH, V39, P1984, DOI 10.1128/AAC.39.9.1984; Miro JM, 2013, CIRCULATION, V127, P1763, DOI 10.1161/CIRCULATIONAHA.113.002431; Miro JM, 2008, SCAND J INFECT DIS, V40, P968, DOI 10.1080/00365540802398945; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Olaison L, 2002, CLIN INFECT DIS, V34, P159, DOI 10.1086/338233; Pericas JM, 2014, CLIN MICROBIOL INFEC, V20, pO1075, DOI 10.1111/1469-0691.12756; WILSON WR, 1984, ANN INTERN MED, V100, P816, DOI 10.7326/0003-4819-100-6-816; WILSON WR, 1995, JAMA-J AM MED ASSOC, V274, P1706, DOI 10.1001/jama.274.21.1706	23	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192387	10.1371/journal.pone.0192387	http://dx.doi.org/10.1371/journal.pone.0192387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462176	Green Accepted, gold, Green Published			2022-12-26	WOS:000425554200016
J	Kim, HY; Go, J; Lee, KM; Oh, YT; Yoon, SS				Kim, Hwa Young; Go, Junhyeok; Lee, Kang-Mu; Oh, Young Taek; Yoon, Sang Sun			Guanosine tetra- and pentaphosphate increase antibiotic tolerance by reducing reactive oxygen species production in Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EL-TOR STRAINS; TOXIN-COREGULATED PILUS; STRINGENT RESPONSE; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; ANTIMICROBIAL AGENTS; STRESS-RESPONSE; RESISTANCE; (P)PPGPP; PPGPP	The pathogen Vibrio cholerae is the causative agent of cholera. Emergence of antibiotic-resistant V. cholerae strains is increasing, but the underlying mechanisms remain unclear. Herein, we report that the stringent response regulator and stress alarmone guanosinetetra- and pentaphosphate ((p)ppGpp) significantly contributes to antibiotic tolerance in V. cholerae. We found that N16961, a pandemic V. cholerae strain, and its isogenic (p)ppGpp-overexpressing mutant Delta relA Delta spoT are both more antibiotic-resistant than (p)ppGpp(o) (Delta relA Delta relV Delta spoT) and Delta dksA mutants, which cannot produce or utilize (p)ppGpp, respectively. We also found that additional disruption of the aconitase B-encoding and tricarboxylic acid (TCA) cycle gene acnB in the (p)ppGpp(o) mutant increases its antibiotic tolerance. Moreover, expression of TCA cycle genes, including acnB, was increased in (p)ppGpp(o), but not in the antibiotic-resistant Delta relA Delta spoT mutant, suggesting that (p)ppGpp suppresses TCA cycle activity, thereby entailing antibiotic resistance. Importantly, when grown anaerobically or incubated with an iron chelator, the (p)ppGpp(o) mutant became antibiotic-tolerant, suggesting that reactive oxygen species (ROS) are involved in antibiotic-mediated bacterial killing. Consistent with that hypothesis, tetracycline treatment markedly increased ROS production in the antibiotic-susceptible mutants. Interestingly, expression of the Fe(III) ABC transporter substrate-binding protein FbpA was increased 10-fold in (p)ppGpp(o), and fbpA gene deletion restored viability of tetracycline-exposed (p)ppGpp(o) cells. Of note, FbpA expression was repressed in the (p)ppGpp-accumulating mutant, resulting in a reduction of intracellular free iron, required for the ROS-generating Fenton reaction. Our results indicate that (p)ppGpp-mediated suppression of central metabolism and iron uptake reduces antibiotic-induced oxidative stress in V. cholerae.	[Kim, Hwa Young; Go, Junhyeok; Lee, Kang-Mu; Oh, Young Taek; Yoon, Sang Sun] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Microbiol & Immunol, Seoul 03722, South Korea; [Kim, Hwa Young; Go, Junhyeok; Lee, Kang-Mu; Yoon, Sang Sun] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul 03722, South Korea; [Oh, Young Taek] Nakdonggang Natl Inst Biol Resources, Freshwater Bioresources Utilizat Div, Sangju 37242, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Oh, YT (corresponding author), Nakdonggang Natl Inst Biol Resources, Freshwater Bioresources Utilizat Div, Sangju 37242, South Korea.; Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol & Immunol, 250 Seongsanno, Seoul 120752, South Korea.	ohyt@nnibr.re.kr; sangsun_yoon@yuhs.ac		Yoon, Sang Sun/0000-0003-2979-365X	National Research Foundation (NRF) of Korea - Korean government [2017R1A2A2A05019987, 2015M3C9A2054024, 2014R1A1A2056139, 2014R1A4A1008625, 2017M3A9F3041233]	National Research Foundation (NRF) of Korea - Korean government	This work was supported by National Research Foundation (NRF) of Korea Grants 2017R1A2A2A05019987, 2015M3C9A2054024, 2014R1A1A2056139, 2014R1A4A1008625, and 2017M3A9F3041233, funded by the Korean government. The authors declare that they have no conflicts of interest with the contents of this article.	Abranches J, 2009, J BACTERIOL, V191, P2248, DOI 10.1128/JB.01726-08; Aedo S, 2016, ANTIMICROB AGENTS CH, V60, P2311, DOI 10.1128/AAC.02697-15; [Anonymous], 2012, Wkly Epidemiol Rec, V87; Baharoglu Z, 2011, ANTIMICROB AGENTS CH, V55, P2438, DOI 10.1128/AAC.01549-10; Brandt KG, 2015, J PEDIAT-BRAZIL, V91, pS36, DOI 10.1016/j.jped.2015.06.002; Brynildsen MP, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.34; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; Chomvarin C, 2013, J MED MICROBIOL, V62, P599, DOI 10.1099/jmm.0.053801-0; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Das B, 2009, MOL MICROBIOL, V72, P380, DOI 10.1111/j.1365-2958.2009.06653.x; Das JK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S10; Dasgupta S, 2014, MICROBIOL-SGM, V160, P1855, DOI 10.1099/mic.0.079319-0; Davies BW, 2011, P NATL ACAD SCI USA, V108, P12467, DOI 10.1073/pnas.1107894108; DE S, 1976, B WORLD HEALTH ORGAN, V54, P177; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Fonseca NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107026; Gaca AO, 2015, J BACTERIOL, V197, P1146, DOI 10.1128/JB.02577-14; Gaca AO, 2013, MBIO, V4, DOI 10.1128/mBio.00646-13; GREENOUGH WB, 1964, LANCET, V1, P355; Greenway DLA, 1999, LETT APPL MICROBIOL, V29, P323, DOI 10.1046/j.1472-765X.1999.00642.x; GRIFFITHS GL, 1984, J BIOL CHEM, V259, P383; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; HEATH RJ, 1994, J BIOL CHEM, V269, P26584; Hesketh A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-226; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; ISHIGURO EE, 1980, CAN J MICROBIOL, V26, P1514, DOI 10.1139/m80-253; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x; Jesudason M V, 2006, Indian J Med Microbiol, V24, P152; Jiang MX, 2007, J BACTERIOL, V189, P6140, DOI 10.1128/JB.00315-07; Jubair M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045187; Kaushik JS, 2010, INDIAN PEDIATR, V47, P309, DOI 10.1007/s13312-010-0059-5; Khakimova M, 2013, J BACTERIOL, V195, P2011, DOI 10.1128/JB.02061-12; Kim C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082814; Klontz EH, 2014, CLIN INFECT DIS, V58, pE133, DOI 10.1093/cid/ciu040; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Krebs SJ, 2011, J BACTERIOL, V193, P5260, DOI 10.1128/JB.00378-11; Lee KM, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394932; Leibovici-Weissman Y, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008625.pub2; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; LINDENBA.J, 1967, B WORLD HEALTH ORGAN, V36, P871; Lobritz MA, 2015, P NATL ACAD SCI USA, V112, P8173, DOI 10.1073/pnas.1509743112; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Mandal J, 2012, J HEALTH POPUL NUTR, V30, P12; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Mey AR, 2002, INFECT IMMUN, V70, P3419, DOI 10.1128/IAI.70.7.3419-3426.2002; Mwansa JCL, 2007, EPIDEMIOL INFECT, V135, P847, DOI 10.1017/S0950268806007254; Oh YT, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00156; Oh YT, 2015, J BIOL CHEM, V290, P13178, DOI 10.1074/jbc.M115.640466; Oh YT, 2014, J BIOL CHEM, V289, P13232, DOI 10.1074/jbc.M113.540088; Pal RR, 2012, J BACTERIOL, V194, P5638, DOI 10.1128/JB.00518-12; PATRA FC, 1989, BMJ-BRIT MED J, V298, P1353, DOI 10.1136/bmj.298.6684.1353; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Possel H, 1997, FEBS LETT, V416, P175, DOI 10.1016/S0014-5793(97)01197-6; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; RAHAMAN MM, 1976, ANTIMICROB AGENTS CH, V10, P610, DOI 10.1128/AAC.10.4.610; RODIONOV DG, 1995, J BACTERIOL, V177, P4224, DOI 10.1128/jb.177.15.4224-4229.1995; Rogers MB, 2000, J BACTERIOL, V182, P2350, DOI 10.1128/JB.182.8.2350-2353.2000; Ronayne EA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005797; Roy SK, 1998, T ROY SOC TROP MED H, V92, P460, DOI 10.1016/S0035-9203(98)91094-X; Sikora AE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003126; Sugisaki K, 2013, MICROBIOL-SGM, V159, P1379, DOI 10.1099/mic.0.066597-0; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; TOWNER KJ, 1980, B WORLD HEALTH ORGAN, V58, P747; Wang RB, 2012, INT J ANTIMICROB AG, V40, P361, DOI 10.1016/j.ijantimicag.2012.06.010; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; WEBER JT, 1994, EPIDEMIOL INFECT, V112, P1, DOI 10.1017/S0950268800057368; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925; World Health Organization, 2014, Weekly Epidemiological Record, V89, P345; Wu J, 2010, J CELL PHYSIOL, V224, P300, DOI 10.1002/jcp.22158; Wyckoff EE, 1999, J BACTERIOL, V181, P7588, DOI 10.1128/JB.181.24.7588-7596.1999; Wyckoff EE, 2006, J BACTERIOL, V188, P6515, DOI 10.1128/JB.00626-06; Yoon MY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11606; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105; Yoon MY, 2014, J MICROBIOL, V52, P983, DOI 10.1007/s12275-014-4655-2	81	23	23	6	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5679	5694		10.1074/jbc.RA117.000383	http://dx.doi.org/10.1074/jbc.RA117.000383			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475943	Green Published, hybrid			2022-12-26	WOS:000430044100028
J	Susorov, D; Zakharov, N; Shuvalova, E; Ivanov, A; Egorova, T; Shuvalov, A; Shatsky, IN; Alkalaeva, E				Susorov, Denis; Zakharov, Nikita; Shuvalova, Ekaterina; Ivanov, Alexander; Egorova, Tatiana; Shuvalov, Alexey; Shatsky, Ivan N.; Alkalaeva, Elena			Eukaryotic translation elongation factor 2 (eEF2) catalyzes reverse translocation of the eukaryotic ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribosome function; translation elongation factor; translocation; ribosome; ADP-ribosylation	TRANSFER-RNA TRANSLOCATION; STRUCTURAL BASIS; 70S RIBOSOME; AMINOGLYCOSIDE ANTIBIOTICS; CONFORMATIONAL-CHANGES; PROTEIN-BIOSYNTHESIS; ADP-RIBOSYLATION; DIPHTHERIA-TOXIN; GTP HYDROLYSIS; FACTOR-II	During protein synthesis, a ribosome moves along the mRNA template and, using aminoacyl-tRNAs, decodes the template nucleotide triplets to assemble a protein amino acid sequence. This movement is accompanied by shifting of mRNA-tRNA complexes within the ribosome in a process called translocation. In living cells, this process proceeds in a unidirectional manner, bringing the ribosome to the 3 end of mRNA, and is catalyzed by the GTPase translation elongation factor 2 (EF-G in prokaryotes and eEF2 in eukaryotes). Interestingly, the possibility of spontaneous backward translocation has been shown in vitro for bacterial ribosomes, suggesting a potential reversibility of this reaction. However, this possibility has not yet been tested for eukaryotic ribosomes. Here, using a reconstituted mammalian translation system, we show that the eukaryotic elongation factor eEF2 catalyzes ribosomal reverse translocation at one mRNA triplet. We found that this process requires a cognate tRNA in the ribosomal E-site and cannot occur spontaneously without eEF2. The efficiency of this reaction depended on the concentrations of eEF2 and cognate tRNAs and increased in the presence of nonhydrolyzable GTP analogues. Of note, ADP-ribosylation of eEF2 domain IV blocked reverse translocation, suggesting a crucial role of interactions of this domain with the ribosome for the catalysis of the reaction. In summary, our findings indicate that eEF2 is able to induce ribosomal translocation in forward and backward directions, highlighting the universal mechanism of tRNA-mRNA movements within the ribosome.	[Susorov, Denis; Shuvalova, Ekaterina; Ivanov, Alexander; Egorova, Tatiana; Shuvalov, Alexey; Alkalaeva, Elena] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Susorov, Denis; Ivanov, Alexander] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 119234, Russia; [Zakharov, Nikita] Moscow Inst Phys & Technol, Dept Biol & Med Phys, Dolgoprudnyi 141700, Russia; [Egorova, Tatiana] Pirogov Russian Natl Res Med Univ, Moscow 117997, Russia; [Shatsky, Ivan N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119992, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University; Moscow Institute of Physics & Technology; Pirogov Russian National Research Medical University; Lomonosov Moscow State University	Alkalaeva, E (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia.	alkalaeva@eimb.ru	Alkalaeva, Elena/ABC-3888-2021; Ivanov, Alexandr/AAM-6231-2021; Egorova, Tatiana/P-9982-2017; Shuvalova, Ekaterina/F-2469-2019; Ivanov, Alexander V/Q-9672-2017; Zakharov, Nikita/AGN-6144-2022	Alkalaeva, Elena/0000-0003-2078-7261; Ivanov, Alexandr/0000-0002-0000-0401; Ivanov, Alexander V/0000-0002-0000-0401; Zakharov, Nikita/0000-0003-0096-1824; Shuvalova, Ekaterina/0000-0003-2379-4328	Russian Foundation for Basic Research [16-34-00406]; Russian Science Foundation [14-14-00487]; Russian Science Foundation [17-14-00106] Funding Source: Russian Science Foundation	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	The study of reverse translocation of the eukaryotic ribosome was supported by Russian Foundation for Basic Research Grant 16-34-00406. The study of the influence of different tRNAs on reverse translocation was supported by Russian Science Foundation Grant 14-14-00487. The authors declare that they have no conflicts of interest with the contents of this article.	Abeyrathne PD, 2016, ELIFE, V5, DOI 10.7554/eLife.14874; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Atkinson GC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1289-7; Behrmann E, 2015, CELL, V161, P845, DOI 10.1016/j.cell.2015.03.052; Belardinelli R, 2016, RNA BIOL, V13, P1197, DOI 10.1080/15476286.2016.1240140; Borovinskaya MA, 2008, RNA, V14, P1590, DOI 10.1261/rna.1076908; Brown A, 2015, NATURE, V524, P493, DOI 10.1038/nature14896; Budkevich T, 2011, MOL CELL, V44, P214, DOI 10.1016/j.molcel.2011.07.040; CABANAS MJ, 1978, BIOCHEM BIOPH RES CO, V83, P991; Chen CL, 2011, MOL CELL, V42, P367, DOI 10.1016/j.molcel.2011.03.024; Chen J, 2013, NAT STRUCT MOL BIOL, V20, P718, DOI 10.1038/nsmb.2567; DAVIES J, 1965, MOL PHARMACOL, V1, P93; DAVYDOVA EK, 1990, FEBS LETT, V261, P350, DOI 10.1016/0014-5793(90)80589-B; de Loubresse NG, 2014, NATURE, V513, P517, DOI 10.1038/nature13737; Dmitriev SE, 2006, MOL BIOL+, V40, P25; Dmitriev SE, 2003, FEBS LETT, V533, P99, DOI 10.1016/S0014-5793(02)03776-6; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Gould PS, 2005, BIOTECHNIQUES, V38, P397, DOI 10.2144/05383ST02; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; Konevega AL, 2007, NAT STRUCT MOL BIOL, V14, P318, DOI 10.1038/nsmb1221; Li W, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500169; Lin JZ, 2015, CELL, V160, P219, DOI 10.1016/j.cell.2014.11.049; Liu GQ, 2014, NAT STRUCT MOL BIOL, V21, P817, DOI 10.1038/nsmb.2869; Mateyak MK, 2013, J BIOL CHEM, V288, P24647, DOI 10.1074/jbc.M113.488783; Matheisl S, 2015, NUCLEIC ACIDS RES, V43, P8615, DOI 10.1093/nar/gkv909; MORIMOTO H, 1992, J IMMUNOL, V149, P2089; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Ramrath DJF, 2013, P NATL ACAD SCI USA, V110, P20964, DOI 10.1073/pnas.1320387110; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; RHEINBERGER HJ, 1987, J BIOMOL STRUCT DYN, V5, P435, DOI 10.1080/07391102.1987.10506403; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Sharma H, 2016, CELL REP, V16, P2187, DOI 10.1016/j.celrep.2016.07.051; Shirokikh NE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1025; Shoji S, 2006, MOL CELL, V24, P931, DOI 10.1016/j.molcel.2006.11.025; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Stepanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020991; Su XY, 2013, CRIT REV BIOCHEM MOL, V48, P515, DOI 10.3109/10409238.2013.831023; Susorov D, 2015, NUCLEIC ACIDS RES, V43, P3332, DOI 10.1093/nar/gkv171; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Wasserman MR, 2016, NAT STRUCT MOL BIOL, V23, P333, DOI 10.1038/nsmb.3177; Yamamoto H, 2014, NAT REV MICROBIOL, V12, P89, DOI 10.1038/nrmicro3176; Youngman EM, 2007, CURR BIOL, V17, pR136, DOI 10.1016/j.cub.2006.12.029; Zhang DJ, 2016, NAT STRUCT MOL BIOL, V23, P125, DOI 10.1038/nsmb.3160; Zhou J, 2014, SCIENCE, V345, P1188, DOI 10.1126/science.1255030	52	14	14	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5220	5229		10.1074/jbc.RA117.000761	http://dx.doi.org/10.1074/jbc.RA117.000761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29453282	hybrid, Green Published			2022-12-26	WOS:000429409300026
J	Sherp, AM; Westfall, CS; Alvarez, S; Jez, JM				Sherp, Ashley M.; Westfall, Corey S.; Alvarez, Sophie; Jez, Joseph M.			Arabidopsis thaliana GH3.15 acyl acid amido synthetase has a highly specific substrate preference for the auxin precursor indole-3-butyric acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATES AMINO-ACIDS; LATERAL ROOT-FORMATION; PLANT HORMONES; ENZYME ACTION; FAMILY; HYPOCOTYL; RESPONSES; VECTORS; REVEALS; GROWTH	Various phytohormones control plant growth and development and mediate biotic and abiotic stress responses. Gretchen Hagen 3 (GH3) acyl acid amido synthetases are plant enzymes that typically conjugate amino acids to indole-3-acetic acid (IAA) or jasmonic acid (JA) to inactivate or activate these phytohormones, respectively; however, the physiological and biological roles of many of these enzymes remain unclear. Using a biochemical approach, we found that the Arabidopsis thaliana GH3.15 (AtGH3.15) preferentially uses indole-3-butyric acid (IBA) and glutamine as substrates. The X-ray crystal structure of the AtGH3.15 center dot AMP complex, modeling of IBA in the active site, and biochemical analysis of site-directed mutants provide insight on active site features that lead to AtGH3.15's preference for IBA. Assay-based in planta analysis of AtGH3.15-overexpressing lines indicated that their root elongation and lateral root density were resistant to IBA treatment but not to treatment with either IAA or JA. These findings suggest that AtGH3.15 may play a role in auxin homeostasis by modulating the levels of IBA for peroxisomal conversion to IAA. Analysis of AtGH3.15 promoter-driven yellow fluorescent protein reporter lines revealed that AtGH3.15 is expressed at significant levels in seedlings, roots, and parts of the siliques. We conclude that AtGH3.15 is unique in the GH3 protein family for its role in modifying IBA in auxin homeostasis and that it is the first GH3 protein shown to primarily modify a plant growth regulator other than IAA and JA.	[Sherp, Ashley M.; Westfall, Corey S.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Alvarez, Sophie] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA	Washington University (WUSTL); University of Nebraska System; University of Nebraska Lincoln	Jez, JM (corresponding author), Washington Univ, Dept Biol, St Louis, MO 63130 USA.	jjez@wustl.edu			National Science Foundation [DBI-1427621]; Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]	National Science Foundation(National Science Foundation (NSF)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE))	The mass spectrometry measurement was performed at the Proteomics and Mass Spectrometry Facility at the Danforth Plant Science Center based upon work supported by National Science Foundation Grant DBI-1427621 for acquisition of the 6500 QTRAP LC-MS/MS. Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the Department of Energy Office of Biological and Environmental Research under Grant DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bajguz A, 2009, PHYTOCHEMISTRY, V70, P957, DOI 10.1016/j.phytochem.2009.05.006; Bartel B, 2001, J PLANT GROWTH REGUL, V20, P198, DOI 10.1007/s003440010025; Basu MM, 2013, PLANT PHYSIOL, V162, P96, DOI 10.1104/pp.113.216234; Chen QF, 2010, J BIOL CHEM, V285, P29780, DOI 10.1074/jbc.M110.146431; Chen QF, 2009, ANAL BIOCHEM, V390, P149, DOI 10.1016/j.ab.2009.04.027; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enders TA, 2015, AM J BOT, V102, P180, DOI 10.3732/ajb.1400285; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; Kroin J., 1992, COMB P INT PLANT PRO, V42, P489; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Ludwig-Muller J, 2000, PLANT GROWTH REGUL, V32, P219, DOI 10.1023/A:1010746806891; Michniewicz Marta, 2015, BMC Res Notes, V8, P63, DOI 10.1186/s13104-015-1010-6; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nakazawa M, 2001, PLANT J, V25, P213, DOI 10.1046/j.1365-313x.2001.00957.x; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Okrent RA, 2009, J BIOL CHEM, V284, P9742, DOI 10.1074/jbc.M806662200; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Peat TS, 2012, PLANT CELL, V24, P4525, DOI 10.1105/tpc.112.102921; Round A, 2013, ACTA CRYSTALLOGR D, V69, P2072, DOI 10.1107/S0907444913019276; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Schlicht M, 2013, NEW PHYTOL, V200, P473, DOI 10.1111/nph.12377; Simon S, 2011, PLANT SCI, V180, P454, DOI 10.1016/j.plantsci.2010.12.007; Spiess Gretchen M, 2013, Subcell Biochem, V69, P257, DOI 10.1007/978-94-007-6889-5_14; STASINOPOULOS TC, 1990, PLANT PHYSIOL, V93, P1365, DOI 10.1104/pp.93.4.1365; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Strader Lucia C, 2010, Plant Physiol, V153, P1577, DOI 10.1104/pp.110.157461; Strader LC, 2011, PLANT CELL, V23, P984, DOI 10.1105/tpc.111.083071; Strader LC, 2011, MOL PLANT, V4, P477, DOI 10.1093/mp/ssr006; Sugawara S, 2015, PLANT CELL PHYSIOL, V56, P1641, DOI 10.1093/pcp/pcv088; Takase T, 2004, PLANT J, V37, P471, DOI 10.1046/j.1365-313X.2003.01973.x; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; van Gelderen K, 2016, MOL PLANT, V9, P857, DOI 10.1016/j.molp.2016.03.005; Westfall CS, 2016, P NATL ACAD SCI USA, V113, P13917, DOI 10.1073/pnas.1612635113; Westfall CS, 2013, J BIOL CHEM, V288, P19304, DOI 10.1074/jbc.R113.475160; Westfall CS, 2012, SCIENCE, V336, P1708, DOI 10.1126/science.1221863; Westfall CS, 2010, PLANT SIGNAL BEHAV, V5, P1607, DOI 10.4161/psb.5.12.13941; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zheng ZY, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.25, 10.1038/nplants.2016.25]; Zolman BR, 2008, GENETICS, V180, P237, DOI 10.1534/genetics.108.090399; Zolman BK, 2000, GENETICS, V156, P1323	46	20	21	3	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4277	4288		10.1074/jbc.RA118.002006	http://dx.doi.org/10.1074/jbc.RA118.002006			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29462792	Green Published, hybrid			2022-12-26	WOS:000428204300004
J	Ambrosetti, D; Dufies, M; Dadone, B; Durand, M; Borchiellini, D; Amiel, J; Pouyssegur, J; Rioux-Leclercq, N; Pages, G; Burel-Vandenbos, F; Mazure, NM				Ambrosetti, Damien; Dufies, Maeva; Dadone, Berengere; Durand, Matthieu; Borchiellini, Delphine; Amiel, Jean; Pouyssegur, Jacques; Rioux-Leclercq, Nathalie; Pages, Gilles; Burel-Vandenbos, Fanny; Mazure, Nathalie M.			The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; LACTATE/H+ SYMPORTERS MCT1; INDUCIBLE FACTOR 1-ALPHA; OXIDATIVE-PHOSPHORYLATION; MATRIX-METALLOPROTEINASE; INDEPENDENT PREDICTOR; CANCER-CELLS; EXPRESSION; PROGRESSION; HIF-1	Background Clear-cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. Although ccRCC is characterized by common recurrent genetic abnormalities, including inactivation of the von Hippel-Lindau (vhl) tumor suppressor gene resulting in stabilization of hypoxia-inducible factors (HIFs), the tumor aggressiveness and outcome of ccRCC is variable. New biomarkers are thus required to improve ccRCC diagnosis, prognosis and therapeutic options. This work aims to investigate the expression of HIF and proteins involved in metabolism and pH regulation. Their correlation to histoprognostic parameters and survival was analyzed. Methods ccRCC of 45 patients were analyzed. HIF-l alpha, HIF-2 alpha, HAF, GLUT1, MCT1, MCT4, CAIX and CAXII expression was assessed by immunohistochemistry in a semi-quantitative and qualitative manner. The GLUT1, MCT1, MCT4, CAIX and CAXII mRNA levels were analyzed in an independent cohort of 43 patients. Results A significant correlation was observed between increased GLUT1, MCT1, CAXII protein expression and a high Fuhrman grade in ccRCC patients. Moreover, while HIF-l alpha, HIF-2 alpha and HAF expression was heterogenous within tumors, we observed and confirmed that HIF-2 alpha co-localized with HAF. We confirmed, in an independent cohort, that GLUT1, MCT1 and CAXII mRNA levels correlated with the Fuhrman grade. Moreover, we demonstrated that the high mRNA level of both MCT1 and GLUT1 correlated with poor prognosis. Conclusions This study demonstrates for the first time a link between the aggressiveness of high-Fuhrman grade ccRCC and metabolic reprogramming. It also confirms the role of HIF-2 alpha and HAF in tumor invasiveness. Finally, these results demonstrate that MCT1 and GLUT1 are strong prognostic markers and promising therapeutic targets.	[Ambrosetti, Damien; Dadone, Berengere; Burel-Vandenbos, Fanny] Nice Univ Hosp, Dept Pathol, Nice, France; [Ambrosetti, Damien; Dufies, Maeva; Pouyssegur, Jacques; Pages, Gilles; Mazure, Nathalie M.] UCA, Nice Sophia Antipolis, Inst Res Canc & Aging Nice, CNRS UMR 7284 Inserm U1081, Nice, France; [Dufies, Maeva; Pouyssegur, Jacques] CSM, Monaco, Monaco; [Durand, Matthieu; Amiel, Jean] Nice Univ Hosp, Dept Urol, Nice, France; [Borchiellini, Delphine] Antoine Lacassagne Canc Ctr, Dept Oncol, Nice, France; [Rioux-Leclercq, Nathalie] Rennes Univ Hosp, Dept Pathol, Rennes, France	CHU Nice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UNICANCER; Centre Antoine Lacassagne; CHU Rennes; Universite de Rennes	Ambrosetti, D (corresponding author), Nice Univ Hosp, Dept Pathol, Nice, France.; Ambrosetti, D (corresponding author), UCA, Nice Sophia Antipolis, Inst Res Canc & Aging Nice, CNRS UMR 7284 Inserm U1081, Nice, France.	ambrosetti.d@chu-nice.fr	Pages, Gilles/N-7135-2017; Ambrosetti, Damien/E-2131-2015; Dadone-Montaudié, Bérengère/AAI-3177-2021; PAGES, jean-marie/F-2555-2013	Ambrosetti, Damien/0000-0001-8665-0546; PAGES, jean-marie/0000-0001-7092-7977; Dufies, Maeva/0000-0003-1732-0388				Baldewijns MM, 2007, BRIT J CANCER, V96, P1888, DOI 10.1038/sj.bjc.6603796; Bui MHT, 2003, CLIN CANCER RES, V9, P802; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheville JC, 2002, CANCER, V94, P2180, DOI 10.1002/cncr.10433; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Hao J, 2010, BRIT J CANCER, V103, P1008, DOI 10.1038/sj.bjc.6605839; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim Y, 2015, HUM PATHOL, V46, P104, DOI 10.1016/j.humpath.2014.09.013; Klatte T, 2007, CLIN CANCER RES, V13, P7388, DOI 10.1158/1078-0432.CCR-07-0411; Klatte T, 2009, J CLIN ONCOL, V27, P746, DOI 10.1200/JCO.2007.15.8345; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Koh MY, 2015, CANCER RES, V75, P316, DOI 10.1158/0008-5472.CAN-13-2190; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Leibovich BC, 2007, J CLIN ONCOL, V25, P4757, DOI 10.1200/JCO.2007.12.1087; Lidgren A, 2008, BJU INT, V101, P480, DOI 10.1111/j.1464-410X.2007.07238.x; Lim HY, 2015, BIOCHEM BIOPH RES CO, V460, P938, DOI 10.1016/j.bbrc.2015.03.130; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Ozcan A, 2007, AM J CLIN PATHOL, V128, P245, DOI 10.1309/HV6NJVRQKK4QHM9F; Petrella BL, 2005, ONCOGENE, V24, P1043, DOI 10.1038/sj.onc.1208305; Pinheiro C, 2008, INT J GYNECOL PATHOL, V27, P568, DOI 10.1097/PGP.0b013e31817b5b40; Pinheiro C, 2010, HISTOPATHOLOGY, V56, P860, DOI 10.1111/j.1365-2559.2010.03560.x; Pinthus JH, 2011, CUAJ-CAN UROL ASSOC, V5, P274, DOI 10.5489/cuaj.10196; Rafajova M, 2004, INT J ONCOL, V24, P995; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sandlund J, 2007, BJU INT, V100, P556, DOI 10.1111/j.1464-410X.2007.07006.x; Sera T, 2008, EUR J CANCER, V44, P600, DOI 10.1016/j.ejca.2008.01.008; Walenta S, 2000, CANCER RES, V60, P916; Younes M, 1996, CANCER RES, V56, P1164; Yu LL, 2017, CANCER RES, V77, P1564, DOI 10.1158/0008-5472.CAN-16-2074	37	28	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0193477	10.1371/journal.pone.0193477	http://dx.doi.org/10.1371/journal.pone.0193477			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481555	Green Published, Green Submitted, gold			2022-12-26	WOS:000426202700013
J	Iwamoto, M; Sekiguchi, Y; Nakamura, K; Kawaguchi, Y; Honda, T; Hasegawa, J				Iwamoto, Mitsuhiro; Sekiguchi, Yukiko; Nakamura, Kensuke; Kawaguchi, Yoshirou; Honda, Takeshi; Hasegawa, Jun			Generation of efficient mutants of endoglycosidase from Streptococcus pyogenes and their application in a novel one-pot transglycosylation reaction for antibody modification	PLOS ONE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; BETA-N-ACETYLGLUCOSAMINIDASE; FC-GAMMA-RIIIA; ANTIINFLAMMATORY ACTIVITY; CHEMOENZYMATIC SYNTHESIS; GLYCOSYNTHASE MUTANTS; IMMUNOGLOBULIN-G; IGG ANTIBODIES; OLIGOSACCHARIDE; BINDING	The fine structures of Fc N-glycan modulate the biological functions and physicochemical properties of antibodies. By remodeling N-glycan to obtain a homogeneous glycoform or chemically modified glycan, antibody characteristics can be controlled or modified. Such remodeling can be achieved by transglycosylation reactions using a mutant of endoglycosidase from Streptococcus pyogenes (Endo-S) and glycan oxazoline. In this study, we generated improved mutants of Endo-S by introducing additional mutations to the D233Q mutant. Notably, Endo-S D233Q/Q303L, D233Q/E350Q, and several other mutations resulted in transglycosylation efficiencies exceeding 90%, with a single-digit donor-to-substrate ratio of five, and D233QN402F/D405A and several other mutations resulted in slightly reduced transglycosylation efficiencies accompanied by no detectable hydrolysis activity for 48 h. We further demonstrated that the combined use of mutants of Endo-S with Endo-M or Endo-CC, endoglycosidases from Mucor hiemalis and Coprinopsis cinerea, enables one pot transglycosylation from sialoglycopeptide to antibodies. This novel reaction enables glycosylation remodeling of antibodies, without the chemical synthesis of oxazoline in advance or in situ.	[Iwamoto, Mitsuhiro; Sekiguchi, Yukiko; Nakamura, Kensuke; Kawaguchi, Yoshirou; Hasegawa, Jun] Daiichi Sankyo Co Ltd, Biol Div, Modal Res Labs, Tokyo, Japan; [Honda, Takeshi] Daiichi Sankyo Co Ltd, Res Funct Div, Med Chem Management Grp, Tokyo, Japan	Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited	Iwamoto, M (corresponding author), Daiichi Sankyo Co Ltd, Biol Div, Modal Res Labs, Tokyo, Japan.	iwamoto.mitsuhiro.f3@daiichisankyo.co.jp		Kawaguchi, Yoshirou/0000-0003-0171-6476	Daiichi Sankyo Co., Ltd	Daiichi Sankyo Co., Ltd(Daiichi Sankyo Company Limited)	The authors received no specific funding for this work. Daiichi Sankyo Co., Ltd provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles ofthese authors are articulated in the 'author contributions' section.	Agarwal P, 2015, BIOCONJUGATE CHEM, V26, P176, DOI 10.1021/bc5004982; Allhorn M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-3; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Fan SQ, 2012, J BIOL CHEM, V287, P11272, DOI 10.1074/jbc.M112.340497; Giddens JP, 2016, J BIOL CHEM, V291, P9356, DOI 10.1074/jbc.M116.721597; Goodfellow JJ, 2012, J AM CHEM SOC, V134, P8030, DOI 10.1021/ja301334b; Higuchi Y, 2017, BIOTECHNOL LETT, V39, P157, DOI 10.1007/s10529-016-2230-0; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; Iida S, 2006, CLIN CANCER RES, V12, P2879, DOI 10.1158/1078-0432.CCR-05-2619; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Katoh T, 2016, J BIOL CHEM, V291, P23305, DOI 10.1074/jbc.M116.737395; Kurogochi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132848; Li TZ, 2016, J BIOL CHEM, V291, P16508, DOI 10.1074/jbc.M116.738765; Lin CW, 2015, P NATL ACAD SCI USA, V112, P10611, DOI 10.1073/pnas.1513456112; Noguchi M, 2012, HELV CHIM ACTA, V95, P1928, DOI 10.1002/hlca.201200414; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Parsons TB, 2016, ANGEW CHEM INT EDIT, V55, P2361, DOI 10.1002/anie.201508723; Quast I, 2015, J CLIN INVEST, V125, P4160, DOI 10.1172/JCI82695; Rouwendal GJA, 2007, GLYCOBIOLOGY, V17, P334, DOI 10.1093/glycob/cwl078; Schwab I, 2014, EUR J IMMUNOL, V44, P1444, DOI 10.1002/eji.201344230; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Tang F, 2016, ORG BIOMOL CHEM, V14, P9501, DOI 10.1039/c6ob01751g; Trastoy B, 2014, P NATL ACAD SCI USA, V111, P6714, DOI 10.1073/pnas.1322908111; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Washburn N, 2015, P NATL ACAD SCI USA, V112, pE4339, DOI 10.1073/pnas.1512309112; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Ye JX, 2011, BIOTECHNOL PROGR, V27, P1744, DOI 10.1002/btpr.695; Zou GZ, 2011, J AM CHEM SOC, V133, P18975, DOI 10.1021/ja208390n	33	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193534	10.1371/journal.pone.0193534	http://dx.doi.org/10.1371/journal.pone.0193534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474426	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500125
J	Kano, F; Shepherd, SV; Hirata, S; Call, J				Kano, Fumihiro; Shepherd, Stephen V.; Hirata, Satoshi; Call, Josep			Primate social attention: Species differences and effects of individual experience in humans, great apes, and macaques	PLOS ONE			English	Article							EYE CONTACT; JOINT ATTENTION; GAZE; CHIMPANZEES; PAN; MONKEYS; PATTERNS; BONOBOS; FACES; COMPREHENSION	When viewing social scenes, humans and nonhuman primates focus on particular features, such as the models' eyes, mouth, and action targets. Previous studies reported that such viewing patterns vary significantly across individuals in humans, and also across closely-related primate species. However, the nature of these individual and species differences remains unclear, particularly among nonhuman primates. In large samples of human and nonhuman primates, we examined species differences and the effects of experience on patterns of gaze toward social movies. Experiment 1 examined the species differences across rhesus macaques, nonhuman apes (bonobos, chimpanzees, and orangutans), and humans while they viewed movies of various animals' species-typical behaviors. We found that each species had distinct viewing patterns of the models' faces, eyes, mouths, and action targets. Experiment 2 tested the effect of individuals' experience on chimpanzee and human viewing patterns. We presented movies depicting natural behaviors of chimpanzees to three groups of chimpanzees (individuals from a zoo, a sanctuary, and a research institute) differing in their early social and physical experiences. We also presented the same movies to human adults and children differing in their expertise with chimpanzees (experts vs. novices) or movie-viewing generally (adults vs. preschoolers). Individuals varied within each species in their patterns of gaze toward models' faces, eyes, mouths, and action targets depending on their unique individual experiences. We thus found that the viewing patterns for social stimuli are both individual-and species-specific in these closely-related primates. Such individual/species-specificities are likely related to both individual experience and species-typical temperament, suggesting that primate individuals acquire their unique attentional biases through both ontogeny and evolution. Such unique attentional biases may help them learn efficiently about their particular social environments.	[Kano, Fumihiro; Hirata, Satoshi] Kyoto Univ, Wildlife Res Ctr, Kumamoto Sanctuary, Kumamoto, Japan; [Shepherd, Stephen V.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Call, Josep] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Call, Josep] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	Kyoto University; Rockefeller University; Max Planck Society; University of St Andrews	Kano, F (corresponding author), Kyoto Univ, Wildlife Res Ctr, Kumamoto Sanctuary, Kumamoto, Japan.; Shepherd, SV (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	fkanou@gmail.com; stephen.v.shepherd@gmail.com		Kano, Fumihiro/0000-0003-4534-6630; Call Balaguer, Josep/0000-0002-8597-8336; Shepherd, Stephen/0000-0001-6353-8180	Japan Society for Promotion of Science (JSPS) [KAKENHI 26885040, 16K21108, KAKENHI 26245069, 16H06301, 16H06283, JSPS-LGP-U04]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [K-CONNEX]; European Research Council [SOMICS 609819]; Grants-in-Aid for Scientific Research [26245069] Funding Source: KAKEN	Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) [K-CONNEX](Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Research Council(European Research Council (ERC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support came from Japan Society for Promotion of Science (JSPS) [grant numbers: KAKENHI 26885040, 16K21108 to FK, KAKENHI 26245069, 16H06301, 16H06283, JSPS-LGP-U04 to SH] and Ministry of Education, Culture, Sports, Science and Technology (MEXT) [K-CONNEX to FK], and the European Research Council [SOMICS 609819 to JC].	Berg DJ, 2009, J VISION, V9, DOI 10.1167/9.5.19; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Bloomsmith M.A., 2006, NURSERY REARING NONH, P289; Borg I, 2010, MODERN MULTIDIMENSIO; Brauer J, 2005, J COMP PSYCHOL, V119, P145, DOI 10.1037/0735-7036.119.2.145; CALL J, 1994, J COMP PSYCHOL, V108, P307, DOI 10.1037/0735-7036.108.4.307; Call J, 2017, BONOBOS: UNIQUE IN MIND, BRAIN, AND BEHAVIOR, P171, DOI 10.1093/oso/9780198728511.003.0012; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; CARPENTER M, 1995, SOC DEV, V4, P217, DOI 10.1111/j.1467-9507.1995.tb00063.x; Constantino JN, 2017, NATURE IN PRESS; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Ebitz RB, 2013, P NATL ACAD SCI USA, V110, P11630, DOI 10.1073/pnas.1305230110; Einhauser W, 2006, VISION RES, V46, P1194, DOI 10.1016/j.visres.2005.08.032; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Ferrari PF, 2009, CURR BIOL, V19, P1768, DOI 10.1016/j.cub.2009.08.055; Frank MC, 2012, INFANCY, V17, P355, DOI 10.1111/j.1532-7078.2011.00086.x; Freeman HD, 2016, DEV PSYCHOBIOL, V58, P519, DOI 10.1002/dev.21395; Freeman HD, 2014, PEERJ, V2, DOI 10.7717/peerj.579; Furuichi T, 2014, BEHAVIOUR, V152, P3; Gegenfurtner A, 2011, EDUC PSYCHOL REV, V23, P523, DOI 10.1007/s10648-011-9174-7; Ghazanfar AA, 2004, NAT REV NEUROSCI, V5, P603, DOI 10.1038/nrn1473; Ghazanfar AA, 2006, COGNITION, V101, P515, DOI 10.1016/j.cognition.2005.12.007; Ghazanfar AA, 2011, PROJECTIONS, V5, P1, DOI 10.3167/proj.2011.050202; Gomez Juan Carlos, 1996, P131; Gothard KM, 2004, ANIM COGN, V7, P25, DOI 10.1007/s10071-003-0179-6; Gredeback G, 2010, DEVELOPMENTAL SCI, V13, P839, DOI 10.1111/j.1467-7687.2009.00945.x; Gruber T, 2010, ANIM BEHAV, V80, P1023, DOI 10.1016/j.anbehav.2010.09.005; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Guo K, 2003, EXP BRAIN RES, V150, P363, DOI 10.1007/s00221-003-1429-1; Hattori Y, 2010, BIOL LETTERS, V6, P610, DOI 10.1098/rsbl.2010.0120; Herrmann I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013474; Hirata S, 2010, ANIM COGN, V13, P679, DOI 10.1007/s10071-010-0316-y; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Kalcher E, 2008, DEV PSYCHOBIOL, V50, P777, DOI 10.1002/dev.20330; Kano F, 2017, BRAIN SCIE SER, P187, DOI 10.1007/978-4-431-56559-8_9; Kano F, 2015, CURR BIOL, V25, P2513, DOI 10.1016/j.cub.2015.08.004; Kano F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129684; Kano F, 2014, PSYCHOL SCI, V25, P1691, DOI 10.1177/0956797614536402; Kano F, 2014, ANIM BEHAV, V91, P137, DOI 10.1016/j.anbehav.2014.03.011; Kano F, 2012, J COMP PSYCHOL, V126, P388, DOI 10.1037/a0029615; Kano F, 2011, VISION RES, V51, P2348, DOI 10.1016/j.visres.2011.09.006; Kano F, 2010, ANIM BEHAV, V79, P227, DOI 10.1016/j.anbehav.2009.11.003; KEATING CF, 1982, PERCEPTION, V11, P211, DOI 10.1068/p110211; Kelly DJ, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00006; Klein JT, 2009, CURR BIOL, V19, pR958, DOI 10.1016/j.cub.2009.08.010; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Koops K, 2015, SCI REP-UK, V5, DOI 10.1038/srep11356; Krupenye C, 2016, SCIENCE, V354, P110, DOI 10.1126/science.aaf8110; Lutchmaya S, 2002, INFANT BEHAV DEV, V25, P327, DOI 10.1016/S0163-6383(02)00094-2; Lyn H, 2010, PSYCHOL SCI, V21, P360, DOI 10.1177/0956797610362218; Maranesi M, 2013, EUR J NEUROSCI, V38, P3721, DOI 10.1111/ejn.12376; McIntyre MH, 2009, J HUM EVOL, V56, P361, DOI 10.1016/j.jhevol.2008.12.004; Mosher CP, 2014, CURR BIOL, V24, P2459, DOI 10.1016/j.cub.2014.08.063; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; Myowa-Yamakoshi M, 2003, COGNITION, V89, pB53, DOI 10.1016/S0010-0277(03)00071-4; Myowa-Yamakoshi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1695; Nahm FKD, 1997, J COGNITIVE NEUROSCI, V9, P611, DOI 10.1162/jocn.1997.9.5.611; Okamoto S, 2002, ANIM COGN, V5, P107, DOI 10.1007/s10071-002-0133-z; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; Renevey N, 2010, P ROY SOC B, V277, P2105; Rilling JK, 2012, SOC COGN AFFECT NEUR, V7, P369, DOI 10.1093/scan/nsr017; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rochat MJ, 2008, CURR BIOL, V18, P227, DOI 10.1016/j.cub.2007.12.021; Sannen A, 2003, BEHAVIOUR, V140, P683, DOI 10.1163/156853903322149504; Senju A, 2015, CURR BIOL, V25, P3086, DOI 10.1016/j.cub.2015.10.019; Senju A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0436; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Shepherd SV, 2010, CURR BIOL, V20, P649, DOI 10.1016/j.cub.2010.02.032; Shepherd SV, 2010, FRONT INTEGR NEUROSC, V4, pe5; Staes N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113364; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Thierry B, 2007, EVOL ANTHROPOL, V16, P224, DOI 10.1002/evan.20147; THOMSEN CE, 1974, ANIM BEHAV, V22, P144, DOI 10.1016/S0003-3472(74)80063-1; Tomasello M, 1998, ANIM BEHAV, V55, P1063, DOI 10.1006/anbe.1997.0636; Tomasello M., 1995, JOINT ATTENTION ITS, P103; TOTH N, 1993, J ARCHAEOL SCI, V20, P81, DOI 10.1006/jasc.1993.1006; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; Vogt S, 2007, PERCEPTION, V36, P91, DOI 10.1068/p5262; YAMAGIWA J, 1992, PRIMATES, V33, P523, DOI 10.1007/BF02381153	83	19	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193283	10.1371/journal.pone.0193283	http://dx.doi.org/10.1371/journal.pone.0193283			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX4LV	29474416	Green Published, gold			2022-12-26	WOS:000426049500076
J	Melnikova, L; Kostyuchenko, M; Parshikov, A; Georgiev, P; Golovnin, A				Melnikova, Larisa; Kostyuchenko, Margarita; Parshikov, Alexander; Georgiev, Pavel; Golovnin, Anton			Role of Su(Hw) zinc finger 10 and interaction with CP190 and Mod(mdg4) proteins in recruiting the Su(Hw) complex to chromatin sites in Drosophila	PLOS ONE			English	Article							ENHANCER-PROMOTER COMMUNICATION; LONG-DISTANCE INTERACTIONS; GYPSY-INDUCED MUTATIONS; HAIRY-WING PROTEIN; INSULATOR FUNCTION; REGULATORY ELEMENTS; RANGE INTERACTIONS; BITHORAX COMPLEX; BINDING SITES; YELLOW LOCUS	Su(Hw) belongs to the class of proteins that organize chromosome architecture and boundaries/insulators between regulatory domains. This protein contains a cluster of 12 zinc finger domains most of which are responsible for binding to three different modules in the consensus site. Su(Hw) forms a complex with CP190 and Mod(mdg4)-67.2 proteins that binds to well-known Drosophila insulators. To understand how Su(Hw) performs its activities and binds to specific sites in chromatin, we have examined the previously described su(Hw)(f) mutation that disrupts the 10th zinc finger (ZF10) responsible for Su(Hw) binding to the upstream module. The results have shown that Su(Hw)(f) loses the ability to interact with CP190 in the absence of DNA. In contrast, complete deletion of ZF10 does not prevent the interaction between Su(Hw)(Delta 10) and CP190. Having studied insulator complex formation in different mutant backgrounds, we conclude that both association with CP190 and Mod (mdg4)-67.2 partners and proper organization of DNA binding site are essential for the efficient recruitment of the Su(Hw) complex to chromatin insulators.	[Melnikova, Larisa; Kostyuchenko, Margarita; Golovnin, Anton] Russian Acad Sci, Inst Gene Biol, Dept Drosophila Mol Genet, Moscow, Russia; [Parshikov, Alexander; Georgiev, Pavel] Russian Acad Sci, Inst Gene Biol, Dept Control Genet Proc, Moscow, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Golovnin, A (corresponding author), Russian Acad Sci, Inst Gene Biol, Dept Drosophila Mol Genet, Moscow, Russia.; Georgiev, P (corresponding author), Russian Acad Sci, Inst Gene Biol, Dept Control Genet Proc, Moscow, Russia.	georgiev_p@mail.ru; agolovnin@mail.ru			Russian Science Foundation [14-24-00166]; Russian Science Foundation [17-24-00019] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	All the experiments, except the genetic analysis experiments were supported by the Russian Science Foundation (http://www.rscf.ru/), project no. 14-24-00166 (to P.G.). Genetic analysis experiments were supported by Molecular and Cellular Biology Program of the Russian Academy of Sciences (http://molbiol.edu.ru/data/index.html) (a grant to A.G.).	Ahanger SH, 2013, NUCLEUS-AUSTIN, V4, P115, DOI 10.4161/nucl.23389; Alekseyenko AA, 2014, GENE DEV, V28, P1445, DOI 10.1101/gad.241950.114; Ali T, 2016, CURR OPIN GENET DEV, V37, P17, DOI 10.1016/j.gde.2015.11.009; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Baxley RM, 2017, NUCLEIC ACIDS RES, V45, P4463, DOI 10.1093/nar/gkx040; Baxley RM, 2011, DEV BIOL, V356, P398, DOI 10.1016/j.ydbio.2011.05.666; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bonchuk A, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0168-7; Bonchuk A, 2011, J MOL BIOL, V412, P423, DOI 10.1016/j.jmb.2011.07.052; Buxa MK, 2016, BIOL OPEN, V5, P1266, DOI 10.1242/bio.019455; CAMPUZANO S, 1985, CELL, V40, P327, DOI 10.1016/0092-8674(85)90147-3; Chetverina D, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600233; Chetverina D, 2014, BIOESSAYS, V36, P163, DOI 10.1002/bies.201300125; Comet I, 2006, DEV CELL, V11, P117, DOI 10.1016/j.devcel.2006.05.009; Cuartero S, 2014, EMBO J, V33, P637, DOI 10.1002/embj.201386001; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fedotova AA, 2017, ACTA NATURAE, V9, P47, DOI 10.32607/20758251-2017-9-2-47-58; Fujioka M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005889; Gause M, 2001, MOL CELL BIOL, V21, P4807, DOI 10.1128/MCB.21.14.4807-4817.2001; Gdula DA, 1997, GENETICS, V145, P153; Georgiev P, 1996, GENETICS, V142, P425; Georgieva S. G., 2001, Genetika, V37, P24; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; GERASIMOVA TI, 1995, CELL, V82, P587, DOI 10.1016/0092-8674(95)90031-4; GEYER PK, 1987, GENE DEV, V1, P996, DOI 10.1101/gad.1.9.996; GEYER PK, 1986, EMBO J, V5, P2657, DOI 10.1002/j.1460-2075.1986.tb04548.x; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Ghirlando R, 2016, GENE DEV, V30, P881, DOI 10.1101/gad.277863.116; Ghosh D, 2001, EMBO J, V20, P2518, DOI 10.1093/emboj/20.10.2518; Golovnin A, 2008, EMBO REP, V9, P440, DOI 10.1038/embor.2008.32; Golovnin A, 2007, MOL CELL BIOL, V27, P963, DOI 10.1128/MCB.00795-06; Golovnin A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140991; Golovnin A, 2012, J CELL SCI, V125, P2064, DOI 10.1242/jcs.100172; HARRISON DA, 1993, GENE DEV, V7, P1966, DOI 10.1101/gad.7.10.1966; Heger P, 2013, EVOLUTION, V67, P2945, DOI 10.1111/evo.12155; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Kassis JA, 2017, GENETICS, V206, P1699, DOI 10.1534/genetics.115.185116; King MR, 2014, J CELL SCI, V127, P2956, DOI 10.1242/jcs.151126; Kuhn-Parnell EJ, 2008, GENETICS, V179, P1263, DOI 10.1534/genetics.108.087254; Kurshakova M, 2007, MOL CELL, V27, P332, DOI 10.1016/j.molcel.2007.05.035; Kyrchanova O, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006188; Kyrchanova O, 2015, MECH DEVELOP, V138, P122, DOI 10.1016/j.mod.2015.07.002; Kyrchanova O, 2014, FEBS LETT, V588, P8, DOI 10.1016/j.febslet.2013.10.039; Kyrchanova O, 2011, NUCLEIC ACIDS RES, V39, P3042, DOI 10.1093/nar/gkq1248; Kyrchanova O, 2008, NUCLEIC ACIDS RES, V36, P7019, DOI 10.1093/nar/gkn781; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Maksimenko O, 2015, GENOME RES, V25, P89, DOI 10.1101/gr.174169.114; Maksimenko O, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00028; Mallin DR, 1998, GENETICS, V148, P331; Matzat LH, 2014, BBA-GENE REGUL MECH, V1839, P203, DOI 10.1016/j.bbagrm.2013.10.007; Matzat LH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003069; Mazur A M, 2005, Dokl Biochem Biophys, V400, P1, DOI 10.1007/s10628-005-0018-6; Melnikova L, 2017, CHROMOSOMA; Melnikova L, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170150; Melnikova L, 2017, CHROMOSOMA, V126, P299, DOI 10.1007/s00412-016-0596-3; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Oliver D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-101; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; Panteleev D Iu, 2006, Tsitologiia, V48, P653; Pauli T, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3205-1; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Persikov AV, 2014, NUCLEIC ACIDS RES, V42, P97, DOI 10.1093/nar/gkt890; Plevock KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144174; QIAN S, 1992, GENETICS, V131, P79; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; Razin SV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P217, DOI 10.1134/S0006297912030017; Saldana-Meyer R, 2014, GENE DEV, V28, P723, DOI 10.1101/gad.236869.113; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Schoborg T, 2013, J CELL BIOL, V202, P261, DOI 10.1083/jcb.201304181; Schwartz YB, 2017, GENETICS, V205, P5, DOI 10.1534/genetics.115.185132; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Scott KC, 1999, GENETICS, V153, P787; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sigrist CJA, 1997, GENETICS, V147, P209; Soshnev AA, 2012, NUCLEIC ACIDS RES, V40, P5415, DOI 10.1093/nar/gks225; Ulianov SV, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700104; Ulianov SV, 2016, GENOME RES, V26, P70, DOI 10.1101/gr.196006.115; Ulianov SV, 2015, INT REV CEL MOL BIO, V315, P183, DOI 10.1016/bs.ircmb.2014.11.004; Vogelmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004544; Zolotarev N, 2016, NUCLEIC ACIDS RES, V44, P7228, DOI 10.1093/nar/gkw371	84	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193497	10.1371/journal.pone.0193497	http://dx.doi.org/10.1371/journal.pone.0193497			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474480	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500120
J	Thompson, K; Chen, J; Luo, QY; Xiao, YC; Cummins, TR; Bhatwadekar, AD				Thompson, Kayla; Chen, Jonathan; Luo, Qianyi; Xiao, Yucheng; Cummins, Theodore R.; Bhatwadekar, Ashay D.			Advanced glycation end (AGE) product modification of laminin downregulates Kir4.1 in retinal Muller cells	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; RAT RETINA; EXPRESSION; DEGENERATION; FIBRONECTIN; DYSFUNCTION; MEMBRANE; RECEPTOR; LINE	Diabetic retinopathy (DR) is a major cause of adult blindness. Retinal Muller cells maintain water homeostasis and potassium concentration via inwardly rectifying Kir4.1 channels. Accumulation of advanced glycation end products (AGEs) is a major pathologic event in DR. While diabetes leads to a decrease in the Kir4.1 channels, it remains unknown whether AGEs-linked to the basement membrane (BM) affect normal Kir4.1 channels. For this study, we hypothesized that AGE-modification of laminin is detrimental to Kir4.1 channels, therefore, disrupting Muller cell function. The AGE-modified laminin-coated substrates were prepared by incubating Petri-dishes with laminin and methylglyoxal for seven days. The rat Muller cells (rMC-1) were propagated on AGE-modified laminin, and Kir4.1 expression and function were evaluated. Quantification of AGEs using ELISA revealed a dose-dependent increase in methylglyoxal-hydro-imidazolone adducts. The rMC-1 propagated on AGE-modified laminin demonstrated a decrease in Kir4.1 levels in immunofluorescence and western blot studies and a decrease in the Kir4.1 channel function. Kir4.1 decrease on AGE-modified laminin resulted in a disorganization of an actin cytoskeleton and disruption of alpha-dystroglycan-syntrophin-dystrophin complexes. Our studies suggest that AGE-modification of laminin is detrimental to Kir4.1 channels. By studying the role of AGEs in Kir4.1 channels we have identified a novel mechanism of Muller cell dysfunction and its subsequent involvement in DR.	[Thompson, Kayla; Chen, Jonathan; Luo, Qianyi; Bhatwadekar, Ashay D.] Indiana Univ Sch Med, Eugene & Marilyn Glick Eye Inst, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Xiao, Yucheng; Cummins, Theodore R.] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46205 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Bhatwadekar, AD (corresponding author), Indiana Univ Sch Med, Eugene & Marilyn Glick Eye Inst, Dept Ophthalmol, Indianapolis, IN 46202 USA.	abhatwad@iupui.edu	Bhatwadekar, Ashay/AAT-5933-2020		National Eye Institute [1R01 EY027779]; Showalter Trust; Center for Diabetes and Metabolic Diseases; NATIONAL EYE INSTITUTE [R01EY027779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Showalter Trust; Center for Diabetes and Metabolic Diseases; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	AB was supported by: 1R01 EY027779National Eye Institute (https://nei.nih.gov/); Showalter Trust (https://www.indianactsi.org/funding/all-open-rfps/); and Center for Diabetes and Metabolic Diseases. Pilot & Feasibility Program http://cdmd.indiana.edu/pilot-feasibility-program/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2003, INVEST OPHTH VIS SCI, V44, P5287, DOI 10.1167/iovs.03-0573; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Bhatwadekar A, 2007, EXPERT REV OPHTHALMO, V2, P105, DOI 10.1586/17469899.2.1.105; Bhatwadekar AD, 2008, INVEST OPHTH VIS SCI, V49, P1232, DOI 10.1167/iovs.07-1015; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Cantero AV, 2007, FASEB J, V21, P3096, DOI 10.1096/fj.06-7536com; Curtis TM, 2011, DIABETOLOGIA, V54, P690, DOI 10.1007/s00125-010-1971-x; Duran-Jimenez B, 2009, DIABETES, V58, P2893, DOI 10.2337/db09-0320; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; Hassan I, 2017, INVEST OPHTH VIS SCI, V58, P3473, DOI 10.1167/iovs.16-20712; Ishii M, 1997, J NEUROSCI, V17, P7725; Liu BF, 2004, INVEST OPHTH VIS SCI, V45, P1983, DOI 10.1167/iovs.03-0995; McDonald DM, 2009, MOL VIS, V15, P1509; Nagaraj RH, 2005, ANN NY ACAD SCI, V1043, P158, DOI 10.1196/annals.1333.020; Noel G, 2005, J NEUROCHEM, V94, P691, DOI 10.1111/j.1471-4159.2005.03191.x; Padayatti PS, 2001, CURR EYE RES, V23, P106, DOI 10.1076/ceyr.23.2.106.5472; Pannicke T, 2006, DIABETES, V55, P633, DOI 10.2337/diabetes.55.03.06.db05-1349; Reichenbach A, 2007, GRAEF ARCH CLIN EXP, V245, P627, DOI 10.1007/s00417-006-0516-y; Sarthy VP, 1998, INVEST OPHTH VIS SCI, V39, P212; Shamsi FA, 1998, J BIOL CHEM, V273, P6928, DOI 10.1074/jbc.273.12.6928; Stitt AW, 2010, INVEST OPHTH VIS SCI, V51, P4867, DOI 10.1167/iovs.10-5881; Stitt AW, 2005, PHARMACOL REP, V57, P156; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Wang HB, 2012, AM J PATHOL, V180, P1243, DOI 10.1016/j.ajpath.2011.11.031; Xi HK, 2016, J EXP MED, V213, P189, DOI 10.1084/jem.20150894; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Yu D, 2009, CELL MOL BIOENG, V2, P144, DOI 10.1007/s12195-008-0039-1; Zhang Y, 2011, J INT MED RES, V39, P464, DOI 10.1177/147323001103900214	28	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193280	10.1371/journal.pone.0193280	http://dx.doi.org/10.1371/journal.pone.0193280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474462	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500075
J	de Kam, D; Roelofs, JMB; Geurts, ACH; Weerdesteyn, V				de Kam, Digna; Roelofs, Jolanda M. B.; Geurts, Alexander C. H.; Weerdesteyn, Vivian			Body configuration at first stepping-foot contact predicts backward balance recovery capacity in people with chronic stroke	PLOS ONE			English	Article							REACTIVE BALANCE; PERTURBATIONS; RESPONSES; INDIVIDUALS; MODULATION; MECHANISMS; STABILITY; FALLS; AGE	Objective To determine the predictive value of leg and trunk inclination angles at stepping-foot contact for the capacity to recover from a backward balance perturbation with a single step in people after stroke. Methods Twenty-four chronic stroke survivors and 21 healthy controls were included in a cross-sectional study. We studied reactive stepping responses by subjecting participants to multidirectional stance perturbations at different intensities on a translating platform. In this paper we focus on backward perturbations. Participants were instructed to recover from the perturbations with maximally one step. A trial was classified as 'success' if balance was restored according to this instruction. We recorded full-body kinematics and computed: 1) body configuration parameters at first stepping-foot contact (leg and trunk inclination angles) and 2) spatiotemporal step parameters (step onset, step length, step duration and step velocity). We identified predictors of balance recovery capacity using a stepwise logistic regression. Perturbation intensity was also included as a predictor. Results The model with spatiotemporal parameters (perturbation intensity, step length and step duration) could correctly classify 85% of the trials as success or fail (Nagelkerke R-2 = 0.61). In the body configuration model (Nagelkerke R-2 = 0.71), perturbation intensity and leg and trunk angles correctly classified the outcome of 86% of the recovery attempts. The goodness of fit was significantly higher for the body configuration model compared to the model with spatiotemporal variables (p<0.01). Participant group and stepping leg (paretic or nonparetic) did not significantly improve the explained variance of the final body configuration model. Conclusions Body configuration at stepping-foot contact is a valid and clinically feasible indicator of backward fall risk in stroke survivors, given its potential to be derived from a single sagittal screenshot.	[de Kam, Digna; Roelofs, Jolanda M. B.; Geurts, Alexander C. H.; Weerdesteyn, Vivian] Radboud Univ Nijmegen, Med Ctr, Dept Rehabil, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Geurts, Alexander C. H.; Weerdesteyn, Vivian] Sint Maartensklin Res, Nijmegen, Netherlands	Radboud University Nijmegen; Sint Maartens Clinic	Roelofs, JMB (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Rehabil, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	Jolanda.MB.Roelofs@radboudumc.nl	Weerdesteyn, Vivian/A-9599-2014; Geurts, Alexander/H-8032-2014; Roelofs, Jolanda/P-8710-2015; de Kam, Digna/AAI-1945-2019	Weerdesteyn, Vivian/0000-0003-4327-7600; Geurts, Alexander/0000-0001-7478-1119; Roelofs, Jolanda/0000-0002-0492-7562; de Kam, Digna/0000-0001-6383-0106	Veni Grant (NWO, the Netherlands) [916.10.106]	Veni Grant (NWO, the Netherlands)	This research was funded by a Veni Grant (NWO, the Netherlands, 916.10.106) given to Dr. Vivian Weerdesteyn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chockalingam N, 2008, SCOLIOSIS SPINAL DIS, V3, DOI 10.1186/1748-7161-3-10; Crenshaw JR, 2012, J BIOMECH, V45, P129, DOI 10.1016/j.jbiomech.2011.09.022; Gard SA, 2004, HUM MOVEMENT SCI, V22, P597, DOI 10.1016/j.humov.2003.11.002; Gillespie LD, 2012, COCHRANE DATABASE SY; Honeycutt CF, 2016, J BIOMECH; Hsiao ET, 2001, J GERONTOL A-BIOL, V56, pM42, DOI 10.1093/gerona/56.1.M42; Inness EL, 2016, J NEUROL PHYS THER, V40, P196, DOI 10.1097/NPT.0000000000000132; Kajrolkar T, 2014, J BIOMECH, V47, P2751, DOI 10.1016/j.jbiomech.2014.04.051; Madigan ML, 2005, J GERONTOL A-BIOL, V60, P910, DOI 10.1093/gerona/60.7.910; Mansfield A, 2013, NEUROREHAB NEURAL RE, V27, P526, DOI 10.1177/1545968313478486; Nonnekes J, 2013, EXPERT REV NEUROTHER, V13, P1303, DOI 10.1586/14737175.2013.839231; Owings TM, 2001, CLIN BIOMECH, V16, P813, DOI 10.1016/S0268-0033(01)00077-8; Patel P, 2015, EXP BRAIN RES, V233, P3047, DOI 10.1007/s00221-015-4367-9; Patel PJ, 2016, NEUROSCIENCE, V333, P252, DOI 10.1016/j.neuroscience.2016.06.044; Roelofs JMB, 2017, NEUROREHABI IN PRESS; Salot P, 2016, PHYS THER, V96, P338, DOI 10.2522/ptj.20150197; Verheyden GSAF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008728.pub2; Weerdesteyn V, 2012, GAIT POSTURE, V35, P462, DOI 10.1016/j.gaitpost.2011.11.008; Weerdesteyn V, 2008, J REHABIL RES DEV, V45, P1195, DOI 10.1682/JRRD.2007.09.0145	19	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192961	10.1371/journal.pone.0192961	http://dx.doi.org/10.1371/journal.pone.0192961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX1SB	29470535	gold, Green Submitted, Green Published			2022-12-26	WOS:000425831000027
J	Cajander, S; Rasmussen, G; Tina, E; Magnuson, A; Sodsrquist, B; Kallman, J; Stralin, K				Cajander, Sara; Rasmussen, Gunlog; Tina, Elisabet; Magnuson, Anders; Sodsrquist, Bo; Kallman, Jan; Stralin, Kristoffer			Dynamics of monocytic HLA-DR expression differs between bacterial etiologies during the course of bloodstream infection	PLOS ONE			English	Article							SEPTIC SHOCK; SEVERE SEPSIS; ORGAN FAILURE; IMMUNOSUPPRESSION; MARKERS	Objective In the pathogenesis of sepsis, activation of both pro- and anti-inflammatory responses are key components, but knowledge is lacking on the association between bacterial etiology and development of dysregulated responses with sustained immunosuppression. The aim of this study was to evaluate how the immunosupression marker HLA-DR on monocytes (mHLA-DR) is associated with bacterial etiology and markers of inflammation during the clinical trajectory of bloodstream infection (BSI). Methods Ninety-one adults, predominantly non-ICU patients, with BSI caused by Streptococcus pneumoniae (n = 27), Staphylococcus aureus (n = 22), Escherichia coli/Klebsiella pneumoniae (n = 23), and other species (n = 19) were prospectively included, and sampled on admission (day 0) and on days 1-2, 3, 7 +/- 1, 14 +/- 2, and 28 +/- 4. Results The dynamics of mHLA-DR, measured by flow cytometry, differed significantly between etiology groups (p<0.001). Patients with S. pneumoniae and S. aureus BSI demonstrated low initial mHLA-DR, with the S. aureus group showing delayed recovery over time. Eleven patients (55% S. aureus) had negative outcome (secondary bacteremia or death) and they demonstrated sustained C-reactive protein elevation, neutrophilia, lymphocytopenia, and loss of mHLA-DR. Conclusions Dynamics of mHLA-DR varied according to the bacterial etiology of infection, with delayed recovery in patients with S. aureus BSI. Patients with negative outcome showed sustained CRP elevation, neutrophilia, lymphocytopenia, and low levels of mHLA-DR, supporting the theory of a dysregulated host response with persistent inflammation and immunosuppression in late stages of deleterious sepsis.	[Cajander, Sara; Rasmussen, Gunlog; Kallman, Jan] Orebro Univ, Fac Med & Hlth, Dept Infect Dis, Orebro, Sweden; [Tina, Elisabet] Orebro Univ, Fac Med & Hlth, Dept Clin Res Lab, Orebro, Sweden; [Magnuson, Anders] Orebro Univ, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden; [Sodsrquist, Bo] Orebro Univ, Fac Med & Hlth, Sch Med Sci, Orebro, Sweden; [Stralin, Kristoffer] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Stralin, Kristoffer] Karolinska Inst, Dept Med, Stockholm, Sweden	Orebro University; Orebro University; Orebro University; Orebro University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Cajander, S (corresponding author), Orebro Univ, Fac Med & Hlth, Dept Infect Dis, Orebro, Sweden.	sara.cajander@regionorebrolan.se		Soderquist, Bo/0000-0001-5939-2932; Cajander, Sara/0000-0003-3921-4244	Research Committee of Orebro County Council; ALF research funding (Orebro University); Nyckelfonden (Orebro University Hospital); ALF research funding (Orebro)	Research Committee of Orebro County Council; ALF research funding (Orebro University); Nyckelfonden (Orebro University Hospital); ALF research funding (Orebro)	The study was supported by grants from the Research Committee of Orebro County Council and ALF research funding (Orebro University) to Sara Cajander, Nyckelfonden (Orebro University Hospital) to Kristoffer Stralin and Jan Kallman, and ALF research funding (Orebro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Cain DJ, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/2197-425X-2-6; Cajander S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154690; Cajander S, 2013, CRIT CARE, V17, DOI 10.1186/cc13046; Caliendo AM, 2017, NEW ENGL J MED, V377, P1685, DOI 10.1056/NEJMcibr1704902; Canzoneri CN, 2017, CLIN INFECT DIS; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Delano MJ, 2016, IMMUNOL REV, V274, P330, DOI 10.1111/imr.12499; Docke WD, 2005, CLIN CHEM, V51, P2341, DOI 10.1373/clinchem.2005.052639; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Gomez HG, 2014, CRIT CARE MED, V42, P771, DOI 10.1097/CCM.0000000000000100; Hamers L, 2015, MINERVA ANESTESIOL, V81, P426; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, SEPSIS SEPTIC SHOCK; Janols H, 2014, EUR J CLIN MICROBIOL, V33, P313, DOI 10.1007/s10096-013-1957-y; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Le Tulzo Y, 2004, AM J RESP CRIT CARE, V169, P1144, DOI 10.1164/rccm.200309-1329OC; Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007; Mathias B., 2016, ANN SURG; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Mira JC, 2017, CRIT CARE MED, V45, P253, DOI [10.1097/CCM.0000000000002074, 10.1097/ccm.0000000000002074]; Pak TR, 2015, CLIN INFECT DIS, V61, P1695, DOI 10.1093/cid/civ670; Poujol F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144375; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stortz JA, 2017, SHOCK; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Torgersen C, 2009, ANESTH ANALG, V108, P1841, DOI 10.1213/ane.0b013e318195e11d; Trimmel H, 2012, SHOCK, V37, P140, DOI 10.1097/SHK.0b013e31823f1866; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang J, 2012, SCI REPORTS, V2; Zhao GJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38361	37	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192883	10.1371/journal.pone.0192883	http://dx.doi.org/10.1371/journal.pone.0192883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466395	Green Submitted, Green Published, gold			2022-12-26	WOS:000425604300071
J	Fisher, DW; Luu, P; Agarwal, N; Kurz, JE; Chetkovich, DM				Fisher, Daniel W.; Luu, Phillip; Agarwal, Neha; Kurz, Jonathan E.; Chetkovich, Dane M.			Loss of HCN2 leads to delayed gastrointestinal motility and reduced energy intake in mice	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNELS; INTERSTITIAL-CELLS; I-H; CONGENITAL HYPOTHYROIDISM; MISSENSE MUTATION; ABSENCE EPILEPSY; NEUROPATHIC PAIN; GENE-EXPRESSION; MOUSE MODEL; DELETION	Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) channels are important regulators of excitability in neural, cardiac, and other pacemaking cells, which are often altered in disease. In mice, loss of HCN2 leads to cardiac dysrhythmias, persistent spike-wave discharges similar to those seen in absence epilepsy, ataxia, tremor, reduced neuropathic and inflammatory pain, antidepressant-like behavior, infertility, and severely restricted growth. While many of these phenotypes have tissue-specific mechanisms, the cause of restricted growth in HCN2 knockout animals remains unknown. Here, we characterize a novel, 3kb insertion mutation of Hcn2 in the Tremor and Reduced Lifespan 2 (TRLS/2J) mouse that leads to complete loss of HCN2 protein, and we show that this mutation causes many phenotypes similar to other mice lacking HCN2 expression. We then demonstrate that while TRLS/2J mice have low blood glucose levels and impaired growth, dysfunction in hormonal secretion from the pancreas, pituitary, and thyroid are unlikely to lead to this phenotype. Instead, we find that homozygous TRLS/2J mice have abnormal gastrointestinal function that is characterized by less food consumption and delayed gastrointestinal transit as compared to wildtype mice. In summary, a novel mutation in HCN2 likely leads to impaired GI motility, causing the severe growth restriction seen in mice with mutations that eliminate HCN2 expression.	[Fisher, Daniel W.; Luu, Phillip; Agarwal, Neha; Chetkovich, Dane M.] Northwestern Univ, Davee Dept Neurol & Clin Neurosci, Feinberg Sch Med, Chicago, IL 60611 USA; [Kurz, Jonathan E.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Chetkovich, Dane M.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37235 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Vanderbilt University	Chetkovich, DM (corresponding author), Northwestern Univ, Davee Dept Neurol & Clin Neurosci, Feinberg Sch Med, Chicago, IL 60611 USA.; Chetkovich, DM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37235 USA.	dane.m.chetkovich@vanderbilt.edu	Chetkovich, Dane/AAV-5457-2021	Kurz, Jonathan/0000-0002-2259-4263	National Institutes of Health [2R01NS059934, R01MH106511, R21MH104471, F30MH109249]; Brain Research Foundation [SG 2012-01]; Chicago Biomedical Consortium [HTS-004]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH109249, R01MH106511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Research Foundation; Chicago Biomedical Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This work was supported by National Institutes of Health (www.nih.gov) Grants 2R01NS059934, R01MH106511, R21MH104471 (D.M.C), and F30MH109249 (D.W.F.), Brain Research Foundation (www.thebrf.org) SG 2012-01 (D.M.C.), and a Chicago Biomedical Consortium (www.chicagobiomedicalconsortium.org) HTS-004 (D.M.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institutes of Health Grants 2R01NS059934, R01MH106511, R21MH104471 (D.M.C), and F30MH109249 (D.W.F.), Brain Research Foundation SG 2012-01 (D.M.C.), and a Chicago Biomedical Consortium HTS-004 (D.M.C.).	Abell Thomas L, 2006, Nutr Clin Pract, V21, P23, DOI 10.1177/011542650602100123; Amendola E, 2005, ENDOCRINOLOGY, V146, P5038, DOI 10.1210/en.2005-0882; Bolivar JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC893, DOI 10.1152/ajpcell.00616.2006; Buniel M, 2008, J COMP NEUROL, V510, P367, DOI 10.1002/cne.21796; Calejo AI, 2014, J NEUROSCI, V34, P15638, DOI 10.1523/JNEUROSCI.5290-13.2014; Carrisoza-Gaytan R, 2011, KIDNEY INT, V80, P832, DOI 10.1038/ki.2011.230; Chan CS, 2011, NAT NEUROSCI, V14, P85, DOI 10.1038/nn.2692; Chitkara DK, 2006, NEUROGASTROENT MOTIL, V18, P251, DOI 10.1111/j.1365-2982.2005.00751.x; Chung WK, 2009, NEUROBIOL DIS, V33, P499, DOI 10.1016/j.nbd.2008.12.004; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Fazeli PK, 2014, J ENDOCRINOL, V220, pR56, DOI 10.1530/JOE-13-0477; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Guo TY, 2017, ONCOL LETT, V13, P1601, DOI 10.3892/ol.2017.5652; Hauck Andrew L, 2005, Birth Defects Res C Embryo Today, V75, P58, DOI 10.1002/bdrc.20032; Heuermann RJ, 2016, NEUROBIOL DIS, V85, P81, DOI 10.1016/j.nbd.2015.10.005; Hurtado R, 2016, J ANAT, V228, P812, DOI 10.1111/joa.12444; Johnson KR, 2007, MOL ENDOCRINOL, V21, P1593, DOI 10.1210/me.2007-0085; Jost WH, 2010, J NEUROL SCI, V289, P69, DOI 10.1016/j.jns.2009.08.020; Karst SY, 2008, TREMOR REDUCED LIFE; Kretschmannova K, 2012, MOL ENDOCRINOL, V26, P153, DOI 10.1210/me.2011-1207; Lewis AS, 2011, J NEUROSCI, V31, P7424, DOI 10.1523/JNEUROSCI.0936-11.2011; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lewis AS, 2010, CHANNELS, V4, P215, DOI 10.4161/chan.4.3.11630; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Mao YK, 2006, J NEUROPHYSIOL, V96, P998, DOI 10.1152/jn.00204.2006; Mostafa RM, 2010, WORLD J GASTROENTERO, V16, P3239, DOI 10.3748/wjg.v16.i26.3239; Noam Y, 2014, J BIOL CHEM, V289, P5889, DOI 10.1074/jbc.M113.522060; O'Donnell AM, 2015, WORLD J GASTROENTERO, V21, P5635, DOI 10.3748/wjg.v21.i18.5635; Pellegrini C, 2015, PARKINSONISM RELAT D, V21, P1407, DOI 10.1016/j.parkreldis.2015.10.011; Psichas A, 2015, J CLIN INVEST, V125, P908, DOI 10.1172/JCI76309; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Shahi PK, 2014, J GASTROENTEROL, V49, P1001, DOI 10.1007/s00535-013-0849-3; SHI ZX, 1993, BRAIN RES, V606, P1, DOI 10.1016/0006-8993(93)91561-6; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; Si XM, 2012, DIGESTION, V85, P266, DOI 10.1159/000337077; Stenson WF, 2013, CURR OPIN GASTROEN, V29, P107, DOI 10.1097/MOG.0b013e32835d9ec3; Takabayashi S, 2006, MOL ENDOCRINOL, V20, P2584, DOI 10.1210/me.2006-0099; Tsantoulas C, 2016, BIOCHEM J, V473, P2717, DOI 10.1042/BCJ20160287; Tu H, 2010, NEUROSCIENCE, V165, P39, DOI 10.1016/j.neuroscience.2009.10.002; Ukleja A, 2010, NUTR CLIN PRACT, V25, P16, DOI 10.1177/0884533609357568; VanSchouwen B, 2016, HDB EXPT PHARM, P123; Vittal H, 2007, NAT CLIN PRACT GASTR, V4, P336, DOI 10.1038/ncpgasthep0838; Xiao J, 2004, NEUROSCIENCE, V129, P603, DOI 10.1016/j.neuroscience.2004.08.027; Xie TY, 2015, J NEUROENDOCRINOL, V27, P872, DOI 10.1111/jne.12327; Yang S, 2012, J ANAT, V221, P303, DOI 10.1111/j.1469-7580.2012.01546.x; Zhang Y, 2009, J ENDOCRINOL, V203, P45, DOI 10.1677/JOE-09-0068; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	48	6	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193012	10.1371/journal.pone.0193012	http://dx.doi.org/10.1371/journal.pone.0193012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466436	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300077
J	Fujiwara, MT; Yasuzawa, M; Kojo, KH; Niwa, Y; Abe, T; Yoshida, S; Nakano, T; Itoh, RD				Fujiwara, Makoto T.; Yasuzawa, Mana; Kojo, Kei H.; Niwa, Yasuo; Abe, Tomoko; Yoshida, Shigeo; Nakano, Takeshi; Itoh, Ryuuichi D.			The Arabidopsis arc5 and arc6 mutations differentially affect plastid morphology in pavement and guard cells in the leaf epidermis	PLOS ONE			English	Article							CHLOROPLAST DIVISION MACHINERY; GREEN FLUORESCENT PROTEIN; STROMULE FORMATION; SITE PLACEMENT; HIGHER-PLANTS; FTSZ-RING; THALIANA; MUTANT; ATMINE1; HOMOLOG	Chloroplasts, or photosynthetic plastids, multiply by binary fission, forming a homogeneous population in plant cells. In Arabidopsis thaliana, the division apparatus (or division ring) of mesophyll chloroplasts includes an inner envelope transmembrane protein ARC6, a cytoplasmic dynamin-related protein ARC5 (DRP5B), and members of the FtsZ1 and FtsZ2 families of proteins, which co-assemble in the stromal mid-plastid division ring (FtsZ ring). FtsZ ring placement is controlled by several proteins, including a stromal factor MinE (AtMinE1). During leaf mesophyll development, ARC6 and AtMinE1 are necessary for FtsZ ring formation and thus plastid division initiation, while ARC5 is essential for a later stage of plastid division. Here, we examined plastid morphology in leaf epidermal pavement cells (PCs) and stomatal guard cells (GCs) in the arc5 and arc6 mutants using stroma-targeted fluorescent proteins. The arc5 PC plastids were generally a bit larger than those of the wild type, but most had normal shapes and were division-competent, unlike mutant mesophyll chloroplasts. The arc6 PC plastids were heterogeneous in size and shape, including the formation of giant and mini-plastids, plastids with highly developed stromules, and grape-like plastid clusters, which varied on a cell-by-cell basis. Moreover, unique plastid phenotypes for stomatal GCs were observed in both mutants. The arc5 GCs rarely lacked chlorophyll-bearing plastids (chloroplasts), while they accumulated minute chlorophyll-less plastids, whereas most GCs developed wild type-like chloroplasts. The arc6 GCs produced large chloroplasts and/or chlorophyll-less plastids, as previously observed, but unexpectedly, their chloroplasts/plastids exhibited marked morphological variations. We quantitatively analyzed plastid morphology and partitioning in paired GCs from wild-type, arc5, arc6, and atminE1 plants. Collectively, our results support the notion that ARC5 is dispensable in the process of equal division of epidermal plastids, and indicate that dysfunctions in ARC5 and ARC6 differentially affect plastid replication among mesophyll cells, PCs, and GCs within a single leaf.	[Fujiwara, Makoto T.; Yasuzawa, Mana; Kojo, Kei H.] Sophia Univ, Dept Mat & Life Sci, Fac Sci & Technol, Chiyoda Ku, Tokyo, Japan; [Fujiwara, Makoto T.; Abe, Tomoko; Yoshida, Shigeo] RIKEN, Nishina Ctr & Plant Funct Lab, Wako, Saitama, Japan; [Niwa, Yasuo] Univ Shizuoka, Lab Plant Mol Improvement, Grad Sch Nutrit & Environm Sci, Shizuoka, Japan; [Nakano, Takeshi] RIKEN, Gene Discovery Res Grp, Ctr Sustainable Resource Sci, Wako, Saitama, Japan; [Nakano, Takeshi] JST Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Itoh, Ryuuichi D.] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa, Japan	Sophia University; RIKEN; University of Shizuoka; RIKEN; Japan Science & Technology Agency (JST); University of the Ryukyus	Fujiwara, MT (corresponding author), Sophia Univ, Dept Mat & Life Sci, Fac Sci & Technol, Chiyoda Ku, Tokyo, Japan.; Fujiwara, MT (corresponding author), RIKEN, Nishina Ctr & Plant Funct Lab, Wako, Saitama, Japan.; Itoh, RD (corresponding author), Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa, Japan.	mtf1@mac.com; ryuitoh@sci.u-ryukyu.ac.jp	Fujiwara, Makoto T/A-2122-2008; Nakano, Takeshi/E-9171-2013	Fujiwara, Makoto T/0000-0002-4668-276X; Nakano, Takeshi/0000-0002-3188-7770	Ministry of Education, Culture, Sports, Science and Technology grants [14760068, 25450136, 26440152]; Japan Society for the Promotion of Science grant [16J06044]; RIKEN Special Postdoctoral Researcher Program; Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology grants; Japan Society for the Promotion of Science grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN Special Postdoctoral Researcher Program; Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by three Ministry of Education, Culture, Sports, Science and Technology grants (14760068, 25450136, and 26440152) to MF and RI, and a Japan Society for the Promotion of Science grant (16J06044) to KK. This work was supported by the RIKEN Special Postdoctoral Researcher Program and a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Arabidopsis Biological Resource Center (ABRC, USA) and the Institut National de la Recherche Agronomique (INRA, France) for maintaining and distributing the Arabidopsis seeds and to Dr. Kevin Pyke and Dr. Rachel Leech (UK) for their donation of arc mutant seeds. The authors also thank Y. Kazama and H. Ishikawa for helpful discussions and T. Motoyama, I. Yamaguchi, H. Ichikawa, N. Suzuki, S. Shimada, A. Yamagami, S. Ohbu, and the staff at RIKEN BOCC for experimental support. This work was supported by the RIKEN Special Postdoctoral Researcher Program and a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science.	[Anonymous], 2010, PLANT PHYSL 5 EDITIO; Asano T, 2004, PLANT J, V38, P448, DOI 10.1111/j.1365-313X.2004.02057.x; Barton KA, 2018, J CELL SCI, V131, DOI 10.1242/jcs.202275; Barton KA, 2016, PLANT PHYSIOL, V171, P723, DOI 10.1104/pp.16.00608; Bramham L., 2017, Bioscience Horizons, V10, phzx001, DOI 10.1093/biohorizons/hzx001; Chen C, 2017, PLANT PHYSL; Chen YL, 2009, PLANT CELL PHYSIOL, V50, P956, DOI 10.1093/pcp/pcp047; Colletti KS, 2000, CURR BIOL, V10, P507, DOI 10.1016/S0960-9822(00)00466-8; Forth D, 2006, J EXP BOT, V57, P1971, DOI 10.1093/jxb/erj144; Fujiwara MT, 2008, PLANT CELL PHYSIOL, V49, P345, DOI 10.1093/pcp/pcn012; Fujiwara MT, 2017, PLANT SIGNAL BEHAV, V12, DOI 10.1080/15592324.2017.1343776; Fujiwara MT, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00823; Fujiwara MT, 2009, PLANT CELL PHYSIOL, V50, P1116, DOI 10.1093/pcp/pcp063; Fujiwara MT, 2004, J CELL SCI, V117, P2399, DOI 10.1242/jcs.01092; Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; Glynn JM, 2008, PLANT CELL, V20, P2460, DOI 10.1105/tpc.108.061440; Glynn JM, 2007, TRAFFIC, V8, P451, DOI 10.1111/j.1600-0854.2007.00545.x; Glynn JM, 2009, PLANT J, V59, P700, DOI 10.1111/j.1365-313X.2009.03905.x; Grosche C, 2017, PROTOPLASMA, V254, P1879, DOI 10.1007/s00709-017-1096-x; Ho J, 2017, ARABIDOPSIS; Holzinger A, 2008, PHOTOCHEM PHOTOBIOL, V84, P1324, DOI 10.1111/j.1751-1097.2008.00437.x; Ichihashi Y, 2015, FRONT PLANT SCI, V6, P20115; Ichihashi Y, 2011, PLANT PHYSIOL, V157, P1151, DOI 10.1104/pp.111.185066; Itoh R, 2001, PLANT PHYSIOL, V127, P1644, DOI 10.1104/pp.010386; Itoh RD, 2017, PHYSL PLANT; Itoh RD, 2010, PHYSIOL PLANTARUM, V139, P144, DOI 10.1111/j.1399-3054.2010.01352.x; Johnson CB, 2015, ADV STRUCT CHEM IMAG, V1, DOI 10.1186/s40679-015-0013-7; Kojo KH, 2009, BIOSCI BIOTECH BIOCH, V73, P2632, DOI 10.1271/bbb.90473; Kwok EY, 2004, PLANT CELL REP, V23, P188, DOI 10.1007/s00299-004-0824-9; LEECH RM, 1981, NEW PHYTOL, V87, P1, DOI 10.1111/j.1469-8137.1981.tb01686.x; Maple J, 2005, PLANT J, V43, P811, DOI 10.1111/j.1365-313X.2005.02493.x; Maple J, 2002, PLANT J, V31, P269, DOI 10.1046/j.1365-313X.2002.01358.x; Maple J, 2007, EMBO REP, V8, P293, DOI 10.1038/sj.embor.7400902; Marrison JL, 1999, PLANT J, V18, P651, DOI 10.1046/j.1365-313x.1999.00500.x; Miyagishima SY, 2006, PLANT CELL, V18, P2517, DOI 10.1105/tpc.106.045484; Nakanishi H, 2009, CURR BIOL, V19, P151, DOI 10.1016/j.cub.2008.12.018; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Okazaki K, 2009, PLANT CELL, V21, P1769, DOI 10.1105/tpc.109.067785; Osteryoung KW, 2014, ANNU REV PLANT BIOL, V65, P443, DOI 10.1146/annurev-arplant-050213-035748; Ottesen E, 2010, PLANT SCI, V178, P114, DOI 10.1016/j.plantsci.2009.10.009; POSSINGHAM JV, 1983, INT REV CYTOL, V84, P1, DOI 10.1016/S0074-7696(08)61014-1; Pyke K. A., 2016, MOL CELL BIOL GROWTH, P37, DOI [10.1201/b20316, DOI 10.1201/B20316]; Pyke KA, 1999, PLANT CELL, V11, P549, DOI 10.1105/tpc.11.4.549; PYKE KA, 1994, PLANT PHYSIOL, V104, P201, DOI 10.1104/pp.104.1.201; PYKE KA, 1991, PLANT PHYSIOL, V96, P1193, DOI 10.1104/pp.96.4.1193; Pyke KA, 1998, PLANT PHYSIOL, V116, P797, DOI 10.1104/pp.116.2.797; Pyke KA, 1997, AM J BOT, V84, P1017, DOI 10.2307/2446145; PYKE KA, 1994, PLANT PHYSIOL, V106, P1169, DOI 10.1104/pp.106.3.1169; Pyke K, 2009, PLASTID BIOLOGY, P1; Pyke Kevin, 2007, V19, P1, DOI 10.1007/4735-2007_0226; Pyke KA, 2013, PLANTA, V237, P381, DOI 10.1007/s00425-012-1739-2; Pyke KA, 2010, AOB PLANTS, DOI 10.1093/aobpla/plq016; Reddy MSS, 2002, PLANTA, V215, P167, DOI 10.1007/s00425-001-0728-7; Robertson EJ, 1996, PLANT PHYSIOL, V112, P149, DOI 10.1104/pp.112.1.149; ROBERTSON EJ, 1995, J CELL SCI, V108, P2937; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; Santelia D, 2016, PLANT PHYSIOL, V172, P1371, DOI 10.1104/pp.16.00767; Schattat M, 2011, PLANT PHYSIOL, V155, P1667, DOI 10.1104/pp.110.170480; Schattat MH, 2012, PLANT CELL, V24, P1465, DOI 10.1105/tpc.111.095398; Schattat MH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-115; Tirlapur UK, 1999, EUR J CELL BIOL, V78, P233, DOI 10.1016/S0171-9335(99)80056-9; Vitha S, 2003, PLANT CELL, V15, P1918, DOI 10.1105/tpc.013292; Wang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071190; Wang SW, 2014, PLANT CELL ENVIRON, V37, P2201, DOI 10.1111/pce.12297; Wang WH, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.11; Waters MT, 2004, PLANT J, V39, P655, DOI 10.1111/j.1365-313X.2004.02164.x; Yamamoto K, 2002, PHYSIOL PLANTARUM, V114, P627, DOI 10.1034/j.1399-3054.2002.1140417.x; Yoshida Y, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.95, 10.1038/nplants.2016.95]; Yoshida Y, 2012, CURR OPIN PLANT BIOL, V15, P714, DOI 10.1016/j.pbi.2012.07.002; Zhang M, 2013, PLANT CELL, V25, P1787, DOI 10.1105/tpc.113.111047; Zhang M, 2009, CELL RES, V19, P877, DOI 10.1038/cr.2009.78	71	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192380	10.1371/journal.pone.0192380	http://dx.doi.org/10.1371/journal.pone.0192380			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466386	Green Submitted, Green Published, gold			2022-12-26	WOS:000425604300054
J	Gomez, FR; Semenyna, SW; Court, L; Vasey, PL				Gomez, Francisco R.; Semenyna, Scott W.; Court, Lucas; Vasey, Paul L.			Familial patterning and prevalence of male androphilia among Istmo Zapotec men and muxes	PLOS ONE			English	Article							SEPARATION ANXIETY DISORDER; MALE SEXUAL ORIENTATION; BIRTH-ORDER; AVUNCULAR TENDENCIES; REPRODUCTIVE OUTPUT; MALE HOMOSEXUALITY; KIN; WOMEN; GAY; CHILDHOOD	Male androphilia (i.e., male sexual attraction to other adult males) is known to cluster within families. Some studies demonstrate that male androphilia clusters in both the paternal and maternal familial lines, whereas other studies demonstrated that it clusters only in the latter. Most of these studies were conducted in Euro-American populations where fertility is low and the sexual orientation of male relatives can sometimes be difficult to ascertain. These two factors can potentially confound the results of such studies. To address these limitations, we examined the familial patterning of male androphilia among the Istmo Zapotec of Oaxaca, Mexico-a high fertility, non-Euro-American population where androphilic males are known locally as muxes, a third gender category. The Istmo Zapotec recognize two types of muxes-muxe gunaa and muxe nguiiu-who typify the transgender and cisgender forms of male androphilia, respectively. We compared the familial patterning of male androphilia between muxe gunaa and muxe nguiiu, as well as between gynephilic men and muxes (both cisgender and transgender forms combined). Istmo Zapotec muxe gunaa and muxe nguiiu exhibit similar familial patterning of male androphilia. Overall, muxes were characterized by significantly more muxe relatives than gynephilic men. This familial patterning was equivalent in both the paternal and maternal lines of muxes. The population prevalence rate of male androphilia was estimated to fall between 3.37-6.02% in the Istmo Zapotec. This is the first study that has compared cisgender and transgender androphilic males from the same high fertility population and demonstrated that the two do not differ with respect to the familial patterning of male androphilia.	[Gomez, Francisco R.; Semenyna, Scott W.; Court, Lucas; Vasey, Paul L.] Univ Lethbridge, Dept Psychol, Lethbridge, AB, Canada	University of Lethbridge	Gomez, FR (corresponding author), Univ Lethbridge, Dept Psychol, Lethbridge, AB, Canada.	francisco.gomez@uleth.ca	Semenyna, Scott/O-7818-2019	Semenyna, Scott/0000-0001-7007-7976; Gomez Jimenez, Francisco R./0000-0003-2929-7402	University of Lethbridge Research Development Fund [13261]; University of Lethbridge Office of Research Service [41730]; Social Sciences and Humanities Research Council of Canada [41140]	University of Lethbridge Research Development Fund; University of Lethbridge Office of Research Service; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	Various stages of this research were supported by grants awarded by the University of Lethbridge Research Development Fund (www.uleth.ca; grant number 13261), the University of Lethbridge Office of Research Service (grant number 41730), and the Social Sciences and Humanities Research Council of Canada (www.sshrc ca; grant number 41140) to PLV. The funders had no role in the study design, data, collection, and analysis, decision to publish, or preparation of the manuscript.	Abild ML, 2014, J COGN CULT, V14, P41, DOI 10.1163/15685373-12342109; Alanko K, 2010, ARCH SEX BEHAV, V39, P81, DOI 10.1007/s10508-008-9457-3; [Anonymous], 2006, REG IND MEX; Arcelus J, 2015, EUR PSYCHIAT, V30, P807, DOI 10.1016/j.eurpsy.2015.04.005; Bailey J. M, 2003, MAN WHO WOULD BE QUE; Bailey JM, 2016, PSYCHOL SCI PUBL INT, V17, P45, DOI 10.1177/1529100616637616; Bailey JM, 2000, J PERS SOC PSYCHOL, V78, P524, DOI 10.1037//0022-3514.78.3.524; Bailey JM, 1999, BEHAV GENET, V29, P79, DOI 10.1023/A:1021652204405; Blanchard R, 2007, ARCH SEX BEHAV, V36, P163, DOI 10.1007/s10508-006-9159-7; Bobrow D, 2001, EVOL HUM BEHAV, V22, P361, DOI 10.1016/S1090-5138(01)00074-5; BOWEN RC, 1990, J AM ACAD CHILD PSY, V29, P753, DOI 10.1097/00004583-199009000-00013; Camperio-Ciani A, 2004, P ROY SOC B-BIOL SCI, V271, P2217, DOI 10.1098/rspb.2004.2872; Central Intelligence Agency, 2016, WORLD FACTB COUNTR C; Ciani AC, 2016, J SEX RES, V53, P137, DOI 10.1080/00224499.2014.993748; Ciani AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051088; Cohen J.E., 1988, STAT POWER ANAL BEHA; Consejo Nacional de Poblacion, 2016, PROYECCIONES POBLACI; Consulado de Carrera de Mexico en Leamington, 2016, VIS WHO NOT REQ VIS; D'Augelli AR, 1998, AM J ORTHOPSYCHIAT, V68, P361, DOI 10.1037/h0080345; D'Augelli AR, 2001, J INTERPERS VIOLENCE, V16, P1008, DOI 10.1177/088626001016010003; Danver SL, 2015, NATIVE PEOPLES WORLD; Em N, 2010, ARCH SEX BEHAV, V39, P75; Forrester DL, 2011, J COGN CULT, V11, P339, DOI 10.1163/156853711X591288; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gates Gary J., 2011, MANY PEOPLE ARE LESB; Gomez FR, 2017, ARCH SEX BEHAV, V46, P109, DOI 10.1007/s10508-016-0917-x; HAMER D, 2002, MOL GENETICS HUMAN P, P257; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; Iemmola F, 2009, ARCH SEX BEHAV, V38, P393, DOI 10.1007/s10508-008-9381-6; Instituto Nacional de Estadistica y Geografia, 2009, PERF SOC POBL QUE HA; Isthmus B., 1995, LATIN AM MALE HOMOSE; Kendler KS, 2000, AM J PSYCHIAT, V157, P1843, DOI 10.1176/appi.ajp.157.11.1843; King M, 2005, ARCH SEX BEHAV, V34, P117, DOI 10.1007/s10508-005-1006-8; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Lippa RA, 2002, ARCH SEX BEHAV, V31, P83, DOI 10.1023/A:1014035302843; Lippa RA, 2000, J PERS, V68, P899, DOI 10.1111/1467-6494.00120; Lippa RA, 2008, ARCH SEX BEHAV, V37, P173, DOI 10.1007/s10508-007-9267-z; Miano Borruso M., 1999, THESIS; Mirande A, 2016, MEN MASC, V19, P384, DOI 10.1177/1097184X15602746; Murray S. O., 2000, HOMOSEXUALITIES; Mustanski BS, 2005, HUM GENET, V116, P272, DOI 10.1007/s00439-004-1241-4; Pattatucci AM, 1998, HUM BIOL, V70, P367; Rahman Q, 2005, ARCH SEX BEHAV, V34, P461, DOI 10.1007/s10508-005-4345-6; Rahman Q, 2008, ARCH SEX BEHAV, V37, P962, DOI 10.1007/s10508-007-9191-2; Sanders AR, 2015, PSYCHOL MED, V45, P1379, DOI 10.1017/S0033291714002451; Schwartz G, 2010, ARCH SEX BEHAV, V39, P93, DOI 10.1007/s10508-009-9499-1; Semenyna SW, 2017, J SEX RES, V54, P1077, DOI 10.1080/00224499.2016.1218416; Semenyna SW, 2017, ARCH SEX BEHAV, V46, P87, DOI 10.1007/s10508-016-0765-8; Semenyna SW, 2016, HUM NATURE-INT BIOS, V27, P283, DOI 10.1007/s12110-016-9258-7; Shear K, 2006, AM J PSYCHIAT, V163, P1074, DOI 10.1176/appi.ajp.163.6.1074; VanderLaan DP, 2017, ARCH SEX BEHAV, V46, P95, DOI 10.1007/s10508-016-0884-2; VanderLaan DP, 2013, HUM NATURE-INT BIOS, V24, P375, DOI 10.1007/s12110-013-9182-z; VanderLaan DP, 2013, ARCH SEX BEHAV, V42, P361, DOI 10.1007/s10508-012-0037-1; VanderLaan DP, 2013, ARCH SEX BEHAV, V42, P353, DOI 10.1007/s10508-012-0015-7; Vanderlaan DP, 2012, PERS RELATIONSHIP, V19, P326, DOI 10.1111/j.1475-6811.2011.01364.x; Vanderlaan DP, 2010, J GAY LESBIAN MENT H, V15, P30, DOI 10.1080/19359705.2011.530570; Vasey PL, 2014, CAN J HUM SEX, V23, P137, DOI 10.3138/cjhs.23.3-CO1; Vasey PL, 2014, ARCH SEX BEHAV, V43, P363, DOI 10.1007/s10508-013-0195-9; Vasey PL, 2010, EVOL HUM BEHAV, V31, P373, DOI 10.1016/j.evolhumbehav.2010.04.001; Vasey PL, 2010, PSYCHOL SCI, V21, P292, DOI 10.1177/0956797609359623; Vasey PL, 2009, HUM NATURE-INT BIOS, V20, P269, DOI 10.1007/s12110-009-9066-4; Vasey PL, 2010, ARCH SEX BEHAV, V39, P821, DOI 10.1007/s10508-008-9404-3; WHITAM FL, 1986, MALE HOMOSEXUALITY 4; Wilson E.O., 1975, P1; Xu Y, 2017, J SEX RES, V54, P10, DOI 10.1080/00224499.2015.1104530; Zheng LJ, 2011, ARCH SEX BEHAV, V40, P533, DOI 10.1007/s10508-010-9700-6; Zucker KJ, 2007, PSYCHIAT CLIN NEUROS, V61, P529, DOI 10.1111/j.1440-1819.2007.01703.x; Zucker KJ, 2017, SEX HEALTH, V14, P404, DOI 10.1071/SH17067; Zucker KJ, 2009, INT J TRANSGENDERISM, V11, P8, DOI 10.1080/15532730902799946	70	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192683	10.1371/journal.pone.0192683	http://dx.doi.org/10.1371/journal.pone.0192683			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	29466410	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300067
J	Hayes, MA; Piaggio, AJ				Hayes, Mark A.; Piaggio, Antoinette J.			Assessing the potential impacts of a changing climate on the distribution of a rabies virus vector	PLOS ONE			English	Article							VAMPIRE BATS; SPATIAL AUTOCORRELATION; TEMPERATURE REGULATION; ECOLOGY; MODELS	Common vampire bats (Desmodus rotundus) occur throughout much of South America to northern Mexico. Vampire bats have not been documented in recent history in the United States, but have been documented within about 50 km of the U.S. state of Texas. Vampire bats feed regularly on the blood of mammals and can transmit rabies virus to native species and livestock, causing impacts on the health of prey. Thus cattle producers, wildlife management agencies, and other stakeholders have expressed concerns about whether vampire bats might spread into the southern United States. On the other hand, concerns about vampire-borne rabies can also result in wanton destruction at bat roosts in areas occupied by vampire bats, but also in areas not known to be occupied by this species. This can in turn negatively affect some bat roosts, populations, and species that are of conservation concern, including vampire bats. To better understand the current and possible future distribution of vampire bats in North America and help mitigate future cattle management problems, we used 7,094 vampire bat occurrence records from North America and species distribution modeling (SDM) to map the potential distribution of vampire bats in North America under current and future climate change scenarios. We analysed and mapped the potential distribution of this species using 5 approaches to species distribution modeling: logistic regression, multivariate adaptive regression splines, boosted regression trees, random forest, and maximum entropy. We then projected these models into 17 "worst-case" future climate scenarios for year 2070 to generate hypotheses about how the vampire bat distribution in North America might change in the future. Of the variables used in this analysis, minimum temperature of the coldest month had the highest variable importance using all 5 SDM approaches. These results suggest two potential near-future routes of vampire bat dispersal into the U.S., one via southern Texas, and a second into southern Florida. Some of our SDM models support the hypothesis that suitable habitat for vampire bats may currently exist in parts of the Me A xico-U.S. borderlands, including extreme southern portions of Texas, as well as in southern Florida. However, this analysis also suggests that extensive expansion into the south-eastern and south-western U.S. over the coming similar to 60 years appears unlikely.	[Hayes, Mark A.] Normandeau Associates Inc, Gainesville, FL 32609 USA; [Piaggio, Antoinette J.] USDA, Natl Wildlife Res Ctr, Ft Collins, CO USA	United States Department of Agriculture (USDA)	Hayes, MA (corresponding author), Normandeau Associates Inc, Gainesville, FL 32609 USA.	mhayes@normandeau.com		Piaggio, Antoinette/0000-0002-4701-0746	U.S. Department of Agriculture	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	Cherokee Nation Businesses provided support in the form of salary for MAH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.vertical bar Recipient: Mark A. Hayes, Ph.D. Normandeau Associates, Inc. provided support in the form of salary for MAH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. I Recipient: Mark A. Hayes, Ph.D. The U.S. Department of Agriculture provided support in the form of salary for AJP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.vertical bar Recipient: Antoinette J. Piaggio. The specific roles of these authors are articulated in the Author Contributions section.	Adams RA, 2008, J ANIM ECOL, V77, P1115, DOI 10.1111/j.1365-2656.2008.01447.x; Adams RA, 2010, ECOLOGY, V91, P2437, DOI 10.1890/09-0091.1; Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; Ammerman L. K., 2012, BATS OF TEXAS; Ancillotto L, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1334-7; Anderson A., 2012, TRANSBOUND EMERG DIS, V61, P1; [Anonymous], 2000, ESA BULL-EUR SPACE; Baddeley A, 2017, SPATSTAT; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Ceballos GS, 2006, MODELING DISTRIBUTIO; Clarke B, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-98135-2; DALQUEST WALTER W., 1955, AMER MIDLAND NAT, V53, P79, DOI 10.2307/2422300; DiMiceli C. M., 2017, ANN GLOBAL AUTOMATED; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Flores-Crespo R., 1991, P461; Franklin J, 2009, MAPPING SPECIES DIST; Galetti M, 2016, FRONT ECOL ENVIRON, V14, P505, DOI 10.1002/fee.1431; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; GREENHALL A M, 1983, Mammalian Species, P1, DOI 10.2307/3503895; GREENHALL A M, 1984, Mammalian Species, P1, DOI 10.2307/3504022; Griffith G., 2007, ECOREGIONS TEXAS AUS, P125; Hayes MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180693; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchison J, 1967, PALEOBIOS, V3, P1; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Johnson N, 2014, VIRUSES-BASEL, V6, P1911, DOI 10.3390/v6051911; Koopman K.F., 1988, P7; KOOPMAN K. F., 1958, BREVIORA MUS COMP ZOOL [HARVARD], V90., P1; Lee DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042466; Linhart S.B., 1975, P221; LYMAN CP, 1966, PHYSIOL ZOOL, V39, P101, DOI 10.1086/physzool.39.2.30152422; McClure ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133771; MCNAB BK, 1969, COMP BIOCHEM PHYSIOL, V31, P227, DOI 10.1016/0010-406X(69)91651-X; MCNAB BK, 1973, J MAMMAL, V54, P131, DOI 10.2307/1378876; Mistry S, 2008, BATS, V26, P8; Morisette JT, 2013, ECOGRAPHY, V36, P129, DOI 10.1111/j.1600-0587.2012.07815.x; Naimi B, 2011, J BIOGEOGR, V38, P1497, DOI 10.1111/j.1365-2699.2011.02523.x; O'Shea TJ, 2016, MAMMAL REV, V46, P175, DOI 10.1111/mam.12064; Orihuela J., 2010, CARIBBEAN J SCI, V46, P297, DOI DOI 10.18475/CJ0S.V46I2.A17; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2014, MAPPING DISEASE TRANSMISSION RISK: ENRICHING MODELS USING BIOGEOGRAPHY AND ECOLOGY, P1; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Piaggio AJ, 2017, ECOL EVOL, V7, P5343, DOI 10.1002/ece3.3087; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; R Development Core Team, 2017, R PROJ STAT COMP; Ray C.E., 1988, P19; Rebelo H, 2010, GLOBAL CHANGE BIOL, V16, P561, DOI 10.1111/j.1365-2486.2009.02021.x; REDDELL JR, 1968, J MAMMAL, V49, P769, DOI 10.2307/1378745; Robinson Timothy P, 2014, PLoS One, V9, pe96084, DOI 10.1371/journal.pone.0096084; Ruschi A, 1952, B MUSEU BIOL MELLO Z, V9A, P1; Stohlgren TJ, 2010, RISK ANAL, V30, P224, DOI 10.1111/j.1539-6924.2009.01343.x; Stohlgren TJ, 2006, RISK ANAL, V26, P163, DOI 10.1111/j.1539-6924.2006.00707.x; Streicker DG, 2016, P NATL ACAD SCI USA, V113, P10926, DOI 10.1073/pnas.1606587113; Streicker DG, 2016, J APPL ECOL, V53, P1280, DOI 10.1111/1365-2664.12690; Streicker DG, 2012, P ROY SOC B-BIOL SCI, V279, P3384, DOI 10.1098/rspb.2012.0538; Tan B, 2011, IEEE J-STARS, V4, P361, DOI 10.1109/JSTARS.2010.2075916; Taylor K. E., 2012, AM METEROLOGICAL SOC, V485, P498; Uhrin M, 2016, MAMMAL REV, V46, P1, DOI 10.1111/mam.12050; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Villa R. B., 1953, B OFICINA SANITARIA, V35, P426; Warshall P, 1995, USDA FOR SERV MOUNT, P6; Wilson D.E., 1993, TAXONOMIC GEOGRAPHIC, V2nd ed.; Zarza H, 2017, IMPLICATIONS BOVINE, P4	66	25	28	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192887	10.1371/journal.pone.0192887	http://dx.doi.org/10.1371/journal.pone.0192887			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466401	Green Published, gold			2022-12-26	WOS:000425604300072
J	Herrero, O; Aquilino, M; Sanchez-Arguello, P; Planello, R				Herrero, Oscar; Aquilino, Monica; Sanchez-Arguello, Paloma; Planello, Rosario			The BPA-substitute bisphenol S alters the transcription of genes related to endocrine, stress response and biotransformation pathways in the aquatic midge Chironomus riparius (Diptera, Chironomidae)	PLOS ONE			English	Article							OXIDATIVE STRESS; PHTHALATE BBP; HUMAN HEALTH; SURFACE-WATER; TAIHU LAKE; IN-VITRO; ANALOGS; EXPRESSION; LARVAE; EXPOSURE	Bisphenol S (BPS) is an industrial alternative to the endocrine disruptor bisphenol A (BPA), and can be found in many products labeled "BPA-free". Its use has grown in recent years, and presently it is considered a ubiquitous emerging pollutant. To date there is a lack of information on the effects of BPS on invertebrates, although they represent more than 95% of known species in the animal kingdom and are crucial for the structure and proper function of ecosystems. In this study, real-time RT-PCR was used to determine the early detrimental effects of BPS on the transcriptional rate of genes in the model species Chironomus riparius, specifically those related to the ecdysone pathway (EcR, ERR, E74, Vtg, cyp18a1) crucial for insect development and metamorphosis, stress and biotransformation mechanisms (hsp70, hsp40, cyp4g, GPx, GSTd3) that regulate adaptive responses and determine survival, and ribosome biogenesis (its2, rpL4, rpL13) which is essential for protein synthesis and homeostasis. While 24-hour exposure to 0.5, 5, 50, and 500 mu g/L BPS had no effect on larval survival, almost all the studied genes were upregulated following a non-monotonic dose-response curve. Genes with the greatest increases in transcriptional activity (fold change relative to control) were EcR (3.8), ERR (2), E74 (2.4), cyp18a1 (2.5), hsp70 (1.7), hsp40 (2.5), cyp4g (6.4), GPx (1.8), and GST (2.1), while others including Vtg, GAPDH, and selected ribosomal genes remained stable. We also measured the transcriptional activity of these genes 24 hours after BPS withdrawal and a general downregulation compared to controls was observed, though not significant in most cases. Our findings showed that BPS exposure altered the transcriptional profile of these genes, which may have consequences for the hormone system and several metabolic pathways. Although further research is needed to elucidate its mode of action, these results raise new concerns about the safety of BPA alternatives.	[Herrero, Oscar; Aquilino, Monica; Planello, Rosario] UNED, Fac Ciencias, Grp Biol & Toxicol Ambiental, Madrid, Spain; [Sanchez-Arguello, Paloma] INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Medio Ambiente, Lab Ecotoxicol, Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Herrero, O (corresponding author), UNED, Fac Ciencias, Grp Biol & Toxicol Ambiental, Madrid, Spain.	oscar.herrero@ccia.uned.es	Herrero, Óscar/B-3782-2012; Aquilino Amez, Mónica/AGO-4358-2022; Planelló, Rosario/E-9975-2015; Planello, Rosario/V-1462-2019; Planelló, Rosario/AAQ-5881-2020; Sanchez-Arguello, Paloma/H-3338-2015; Aquilino, Mónica/AAA-6146-2021	Herrero, Óscar/0000-0002-1410-368X; Aquilino Amez, Mónica/0000-0003-2817-8997; Planelló, Rosario/0000-0003-3730-9549; Planelló, Rosario/0000-0003-3730-9549; Sanchez-Arguello, Paloma/0000-0003-1198-4722; Aquilino, Mónica/0000-0003-2817-8997	Ministerio de Economia y Competitividad (Spain) [CTM2015-64913-R]	Ministerio de Economia y Competitividad (Spain)	This research was supported by Ministerio de Economia y Competitividad (Spain) contract grant number CTM2015-64913-R (http://www.idi.mineco.gob.es). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilino M, 2016, AQUAT TOXICOL, V174, P179, DOI 10.1016/j.aquatox.2016.03.001; Bhandari RK, 2015, GEN COMP ENDOCR, V214, P195, DOI 10.1016/j.ygcen.2014.09.014; Boucher JG, 2016, ENDOCRINOLOGY, V157, P1397, DOI 10.1210/en.2015-1872; Castro B, 2015, ENVIRON RES, V142, P281, DOI 10.1016/j.envres.2015.07.001; Chen MY, 2002, ENVIRON TOXICOL, V17, P80, DOI 10.1002/tox.10035; Clark E., 2012, KIRK OTHMER ENCY CHE; Davies L, 2006, ARCH BIOCHEM BIOPHYS, V453, P4, DOI 10.1016/j.abb.2006.06.016; Dos Santos Moyses F, 2017, ENV SCI POLLUT RES I; Eladak S, 2015, FERTIL STERIL, V103, P11, DOI 10.1016/j.fertnstert.2014.11.005; Engels W., 1990, Advances in Invertebrate Reproduction, V5, P495; Feng YX, 2016, CHEMOSPHERE, V147, P9, DOI 10.1016/j.chemosphere.2015.12.081; Fromme H, 2002, WATER RES, V36, P1429, DOI 10.1016/S0043-1354(01)00367-0; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Guittard E, 2011, DEV BIOL, V349, P35, DOI 10.1016/j.ydbio.2010.09.023; Hahn T, 2002, ENVIRON POLLUT, V120, P525, DOI 10.1016/S0269-7491(02)00189-6; Herrero O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171719; Herrero O, 2016, CHEMOSPHERE, V144, P1874, DOI 10.1016/j.chemosphere.2015.10.051; Herrero O, 2015, CHEMOSPHERE, V128, P266, DOI 10.1016/j.chemosphere.2015.01.059; Jin HB, 2016, WATER RES, V103, P343, DOI 10.1016/j.watres.2016.07.059; Jurek A, 2017, FOOD ADDIT CONTAM A, V34, P1225, DOI 10.1080/19440049.2017.1319076; Kim B, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0051-6; Le Fol V, 2017, ECOTOX ENVIRON SAFE, V142, P150, DOI 10.1016/j.ecoenv.2017.04.009; Lee SM, 2006, CHEMOSPHERE, V65, P1074, DOI 10.1016/j.chemosphere.2006.02.042; Liao CY, 2014, FOOD ADDIT CONTAM A, V31, P319, DOI 10.1080/19440049.2013.868611; Liao CY, 2012, ENVIRON SCI TECHNOL, V46, P6860, DOI 10.1021/es301334j; Liao HL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006348; Liu YH, 2017, SCI TOTAL ENVIRON, V599, P1090, DOI 10.1016/j.scitotenv.2017.05.069; Macczak A, 2017, TOXICOL IN VITRO, V41, P143, DOI 10.1016/j.tiv.2017.02.018; Martinez-Paz P, 2012, COMP BIOCHEM PHYS C, V155, P333, DOI 10.1016/j.cbpc.2011.10.001; Mersha MD, 2015, BEHAV BRAIN FUNCT, V11, DOI 10.1186/s12993-015-0071-y; Molina-Molina JM, 2013, TOXICOL APPL PHARM, V272, P127, DOI 10.1016/j.taap.2013.05.015; Morales M, 2013, COMP BIOCHEM PHYS C, V158, P57, DOI 10.1016/j.cbpc.2013.05.005; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Naderi M, 2014, AQUAT TOXICOL, V148, P195, DOI 10.1016/j.aquatox.2014.01.009; Nair PMG, 2012, COMP BIOCHEM PHYS B, V163, P37, DOI 10.1016/j.cbpb.2012.04.004; OECD, 2006, OECD SER TEST ASS, V55, P125; OECD, 2010, TEST NO 233 SED WAT; Ozaez I, 2016, SCI TOTAL ENVIRON, V557, P240, DOI 10.1016/j.scitotenv.2016.03.078; Park Kiyun, 2012, Ocean Science Journal, V47, P435, DOI 10.1007/s12601-012-0039-x; Park K, 2010, CHEMOSPHERE, V79, P934, DOI 10.1016/j.chemosphere.2010.03.002; Planello R, 2008, CHEMOSPHERE, V71, P1870, DOI 10.1016/j.chemosphere.2008.01.033; Planello R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140239; Planello R, 2015, ENVIRON TOXICOL, V30, P383, DOI 10.1002/tox.21893; Planello R, 2011, AQUAT TOXICOL, V105, P62, DOI 10.1016/j.aquatox.2011.05.011; Quinn L., 2012, STEROIDS BASIC SCI, P141, DOI DOI 10.5572/27927; Rochester JR, 2015, ENVIRON HEALTH PERSP, V123, P643, DOI 10.1289/ehp.1408989; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Sanchez P, 2005, J SOIL SEDIMENT, V5, P53, DOI 10.1065/jss2004.10.114; Sanchez-Arguello P, 2009, SCI TOTAL ENVIRON, V407, P1937, DOI 10.1016/j.scitotenv.2008.12.004; Sun Q, 2017, ENVIRON POLLUT, V225, P542, DOI 10.1016/j.envpol.2017.03.018; Swevers L., 2009, ECDYSONE STRUCTURES, P127, DOI 10.1007/978-1-4020-9112-4; Taenzler V, 2007, ECOTOXICOLOGY, V16, P221, DOI 10.1007/s10646-006-0117-x; Thayer KA, 2016, ENVIRON HEALTH PERSP, V124, P437, DOI 10.1289/ehp.1409427; Ullah H, 2016, CHEMOSPHERE, V152, P383, DOI 10.1016/j.chemosphere.2016.02.125; Usman A, 2016, CHEMOSPHERE, V158, P131, DOI 10.1016/j.chemosphere.2016.05.070; Vandenberg L.N., 2013, ENDOCR DISRUPTORS, V1, DOI [DOI 10.4161/ENDO.26490, 10.4161/endo.26490]; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Wiseman SB, 2013, AQUAT TOXICOL, V142, P414, DOI 10.1016/j.aquatox.2013.09.003; World Commission on the Ethics of Scientific Knowledge and Technology, 2005, PRECAUTIONARY PRINCI; Yamazaki E, 2015, ECOTOX ENVIRON SAFE, V122, P565, DOI 10.1016/j.ecoenv.2015.09.029; Yan ZY, 2017, CHEMOSPHERE, V184, P318, DOI 10.1016/j.chemosphere.2017.06.010; Yang CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120833; Zalmanova T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00570-5; Zhang DH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176927; Zhang R, 2016, J AGR FOOD CHEM, V64, P6630, DOI 10.1021/acs.jafc.6b02656; Zhang T, 2016, ENVIRON SCI TECHNOL, V50, P4045, DOI 10.1021/acs.est.6b00032; Zhao F., 2017, ECOTOX ENVIRON SAFE, V147, P794	67	41	41	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193387	10.1371/journal.pone.0193387	http://dx.doi.org/10.1371/journal.pone.0193387			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466445	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300116
J	Klemmer, J; Njeru, J; Emam, A; El-Sayed, A; Moawad, AA; Henning, K; Elbeskawy, MA; Sauter-Louis, C; Straubinger, RK; Neubauer, H; El-Diasty, MM				Klemmer, Jessica; Njeru, John; Emam, Aya; El-Sayed, Ahmed; Moawad, Amira A.; Henning, Klaus; Elbeskawy, Mohamed A.; Sauter-Louis, Carola; Straubinger, Reinhard K.; Neubauer, Heinrich; El-Diasty, Mohamed M.			Q fever in Egypt: Epidemiological survey of Coxiella burnetii specific antibodies in cattle, buffaloes, sheep, goats and camels	PLOS ONE			English	Article							NILE RIVER DELTA; VIRAL ANTIBODY; NETHERLANDS; LIVESTOCK; PREVALENCE; INFECTION; ANIMALS; HERDS; MILK	Q fever is a zoonotic disease caused by the bacterium Coxiella burnetii. Clinical presentation in humans varies from asymptomatic to flu-like illness and severe sequelae may be seen. Ruminants are often sub-clinically infected or show reproductive disorders such as abortions. In Egypt, only limited data on the epidemiology of Q fever in animals are available. Using a stratified two stage random sampling approach, we evaluated the prevalence of Coxiella burnetii specific antibodies among ruminants and camels in 299 herds. A total of 2,699 blood samples was investigated using enzyme-linked-immunosorbent assay (ELISA). Coxiella burnetii specific antibodies were detected in 40.7% of camels (215/528), 19.3% of cattle (162/840), 11.2% of buffaloes (34/304), 8.9% of sheep (64/716) and 6.8% of goats (21/311), respectively. Odds of seropositivity were significantly higher for cattle (aOR: 3.17; 95% CI: 1.96-5.13) and camels (aOR: 9.75; 95% CI: 6.02-15.78). Significant differences in seropositivity were also found between domains (Western Desert, Eastern Desert and Nile Valley and Delta) and 25 governorates (p < 0.001), respectively. Animal rearing in the Eastern Desert domain was found to be a significant risk factor (aOR: 2.16; 95% CI: 1.62-2.88). Most seropositive animals were older than four years. No correlation between positive titers and husbandry practices or animal origin were found (p > 0.05). Only 8.7% of the interviewed people living on the farms consumed raw camel milk and none reported prior knowledge on Q fever. Findings from this nationwide study show that exposure to Coxiella burnetii is common in ruminants and camels. Disease awareness among physicians, veterinarians and animal owners has to be raised. Future epidemiological investigations have to elucidate the impact of Q fever on human health and on the economy of Egypt.	[Klemmer, Jessica; Moawad, Amira A.; Henning, Klaus; Neubauer, Heinrich] Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Jena, Germany; [Njeru, John] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Emam, Aya; El-Diasty, Mohamed M.] Inst Anim Hlth Res, Mansoura Prov Lab, Mansoura, Egypt; [El-Sayed, Ahmed] Inst Anim Hlth Res, Alshalateen Prov Lab, Alshalateen, Egypt; [Elbeskawy, Mohamed A.] Mansoura Univ, Fac Vet Med, Dept Internal Med Infect Dis & Fish Dis, Mansoura, Egypt; [Sauter-Louis, Carola] Friedrich Loeffler Inst, Inst Epidemiol, Greifswald, Germany; [Straubinger, Reinhard K.] Ludwig Maximilians Univ Munchen, Fac Vet Med, Dept Vet Sci, Inst Infect Dis & Zoonoses, Munich, Germany	Friedrich Loeffler Institute; Kenya Medical Research Institute; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Mansoura University; Friedrich Loeffler Institute; University of Munich	Klemmer, J (corresponding author), Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Jena, Germany.	Klemmer.Jessica@aol.de	Moawad, Amira A./AAE-4498-2019; Sauter-Louis, Carola/ABB-1186-2021; Elbeskawy, mohamed A.A/N-1150-2018; Elsayed, Ahmed/AAC-9689-2020; Straubinger, Reinhard K/D-1719-2010	Moawad, Amira A./0000-0002-5105-4637; Sauter-Louis, Carola/0000-0002-6440-1933; Straubinger, Reinhard/0000-0001-8382-7182	German Federal Foreign Office	German Federal Foreign Office	This project was funded by the German Federal Foreign Office (https://www.auswaertiges-amt.de/de/). The funding was received by the Friedrich-Loeffler-Institut. No grant number exists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Moein KA, 2017, ACTA TROP, V166, P92, DOI 10.1016/j.actatropica.2016.11.011; [Anonymous], EPIDEMIOL INFECT; Barlow J, 2008, VET RES, V39, DOI 10.1051/vetres:2007060; CORWIN A, 1993, AM J TROP MED HYG, V48, P776, DOI 10.4269/ajtmh.1993.48.776; CORWIN A, 1992, T ROY SOC TROP MED H, V86, P677, DOI 10.1016/0035-9203(92)90189-J; DERRICK EH, 1983, REV INFECT DIS, V5, P790; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Gwida Mayada, 2014, BMC Res Notes, V7, P881, DOI 10.1186/1756-0500-7-881; Heinzen RA, 1999, TRENDS MICROBIOL, V7, P149, DOI 10.1016/S0966-842X(99)01475-4; HILBINK F, 1993, INT J EPIDEMIOL, V22, P945, DOI 10.1093/ije/22.5.945; Honarmand H., 2012, Interdisciplinary Perspectives on Infectious Diseases, V2012, P131932, DOI 10.1155/2012/131932; Horton KC, 2014, VECTOR-BORNE ZOONOT, V14, P633, DOI 10.1089/vbz.2013.1525; Ibeagha-Awemu EM, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-50; IDEXX-Laboratories, 2015, SENS SPEC ELISA ASS; KAPLAN M M, 1955, Bull World Health Organ, V13, P829; LeJeune JT, 2009, CLIN INFECT DIS, V48, P93, DOI 10.1086/595007; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mazyad Said A. M., 2007, Journal of the Egyptian Society of Parasitology, V37, P135; MCCAUL TF, 1981, J BACTERIOL, V147, P1063, DOI 10.1128/JB.147.3.1063-1076.1981; Mohammed OB, 2014, ASIAN PAC J TROP MED, V7, P715, DOI 10.1016/S1995-7645(14)60122-X; Morroy G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131777; Nahed H. G., 2012, The Journal of American Science, V8, P619; Nusinovici S, 2015, EPIDEMIOL INFECT, V143, P3316, DOI 10.1017/S0950268814003926; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Pirouz HJ, 2015, TROP ANIM HEALTH PRO, V47, P1293, DOI 10.1007/s11250-015-0862-z; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Rodolakis A, 2007, J DAIRY SCI, V90, P5352, DOI 10.3168/jds.2006-815; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; van Asseldonk MAPM, 2013, PREV VET MED, V112, P27, DOI 10.1016/j.prevetmed.2013.06.002; van der Hoek W, 2012, EUROSURVEILLANCE, V17, P16	30	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192188	10.1371/journal.pone.0192188	http://dx.doi.org/10.1371/journal.pone.0192188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466380	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300035
J	Ponnaiya, B; Buonanno, M; Welch, D; Shuryak, I; Randers-Pehrson, G; Brenner, DJ				Ponnaiya, Brian; Buonanno, Manuela; Welch, David; Shuryak, Igor; Randers-Pehrson, Gerhard; Brenner, David J.			Far-UVC light prevents MRSA infection of superficial wounds in vivo	PLOS ONE			English	Article							SURGICAL SITE INFECTION; LAMINAR AIR-FLOW; ULTRAVIOLET-RADIATION; CONTAMINATION; DISINFECTION; IRRADIATION; GUIDELINE; ROOM; SKIN	Background Prevention of superficial surgical wound infections from drug-resistant bacteria such as methicillin resistant Staphylococcus aureus (MRSA) currently present major health care challenges. The majority of surgical site infections (SSI) are believed to be caused by airborne transmission of bacteria alighting onto the wound during surgical procedures. We have previously shown that far-ultraviolet C light in the wavelength range of 207-222 nm is significantly harmful to bacteria, but without damaging mammalian cells and tissues. It is important that the lamp be fitted with a filter to remove light emitted at wavelengths longer than 230 nm which are harmful. Aims Using a hairless mouse model of infection of superficial wounds, here we tested the hypothesis that 222-nm light kills MRSA alighting onto a superficial skin incisions as efficiently as typical germicidal light (254 nm), but without inducing skin damage. Methods To simulate the scenario wherein incisions are infected during surgical procedures as pathogens in the room alight on a wound, MRSA was spread on a defined area of the mouse dorsal skin; the infected skin was then exposed to UVC light (222 nm or 254 nm) followed by a superficial incision within the defined area, which was immediately sutured. Two and seven days post procedure, bactericidal efficacy was measured as MRSA colony formation unit (CFU) per gram of harvested skin whereas fixed samples were used to assess skin damage measured in terms of epidermal thickness and DNA photodamage. Results In the circumstance of superficial incisions infected with bacteria alighting onto the wound, 222-nm light showed the same bactericidal properties of 254-nm light but without the associated skin damage. Conclusions Being safe for patient and hospital staff, our results suggested that far-UVC light (222 nm) might be a convenient approach to prevent transmission of drug-resistant infectious agents in the clinical setting.	[Ponnaiya, Brian; Buonanno, Manuela; Welch, David; Shuryak, Igor; Randers-Pehrson, Gerhard; Brenner, David J.] Columbia Univ, Dept Radiat Oncol, Ctr Radiol Res, Med Ctr, New York, NY 10027 USA	Columbia University	Ponnaiya, B (corresponding author), Columbia Univ, Dept Radiat Oncol, Ctr Radiol Res, Med Ctr, New York, NY 10027 USA.	bp156@cumc.columbia.edu	buonanno, manuela/AAM-1588-2020	buonanno, manuela/0000-0002-3455-3602	Shostack Foundation; USHIO Inc. [PG006603-02-USHIO CU15-1452]	Shostack Foundation; USHIO Inc.	This work was supported by Shostack Foundation and USHIO Inc., grant number PG006603-02-USHIO CU15-1452 to DJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2011, INFECT DIS CLIN N AM, V25, P135, DOI 10.1016/j.idc.2010.11.004; [Anonymous], 2007, GUIDELINE ISOLATION; Balasubramanian D, 2000, J OCUL PHARMACOL TH, V16, P285, DOI 10.1089/jop.2000.16.285; BASFORD JR, 1986, ARCH PHYS MED REHAB, V67, P151, DOI 10.1016/0003-9993(86)90053-5; Bratzler DW, 2013, SURG INFECT, V14, P73, DOI 10.1089/sur.2013.9999; Buonanno M, 2017, RAD RES; Buonanno M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0138418; Buonanno M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076968; Chauveaux D, 2015, ORTHOP TRAUMATOL-SUR, V101, pS77, DOI 10.1016/j.otsr.2014.07.028; Diab-Elschahawi M, 2011, AM J INFECT CONTROL, V39, pE25, DOI 10.1016/j.ajic.2010.10.035; Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043; Gosden PE, 1998, J HOSP INFECT, V39, P173, DOI 10.1016/S0195-6701(98)90255-9; Gupta A, 2013, ADV WOUND CARE, V2, P422, DOI 10.1089/wound.2012.0366; HOWORTH FH, 1985, LANCET, V1, P386; JAMES LC, 1991, SKIN PHARMACOL, V4, P61; Kraissl CJ, 1940, ANN SURG, V111, P161, DOI 10.1097/00000658-194002000-00001; LIDWELL OM, 1983, J HOSP INFECT, V4, P111, DOI 10.1016/0195-6701(83)90041-5; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; McHugh SM, 2015, SURG-J R COLL SURG E, V13, P52, DOI 10.1016/j.surge.2014.10.003; Michael CA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00145; Nardell E, 2013, PHOTOCHEM PHOTOBIOL, V89, P764, DOI 10.1111/php.12098; Narita K, 2017, J PHOTOCH PHOTOBIO B, V178, P10; Noguchi C, 2017, BMC SURG, V17, DOI 10.1186/s12893-017-0275-1; Overholt R. H., 1940, J THORAC SURG, V9, P520; Ritter MA, 2007, J BONE JOINT SURG AM, V89A, P1935, DOI 10.2106/JBJS.F.01037; SETLOW RB, 1993, P NATL ACAD SCI USA, V90, P6666, DOI 10.1073/pnas.90.14.6666; Stocks GW, 2011, J ARTHROPLASTY, V26, P771, DOI 10.1016/j.arth.2010.07.001; TAYLOR GJS, 1995, J HOSP INFECT, V30, P85, DOI 10.1016/0195-6701(95)90148-5; Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030; Woods JA, 2015, PHOTODERMATOL PHOTO, V31, P159, DOI 10.1111/phpp.12156	31	31	33	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192053	10.1371/journal.pone.0192053	http://dx.doi.org/10.1371/journal.pone.0192053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466457	Green Submitted, gold, Green Published			2022-12-26	WOS:000425604300026
J	Vuong-Brender, TTK; Boutillon, A; Rodriguez, D; Lavilley, V; Labouesse, M				Vuong-Brender, Thanh Thi Kim; Boutillon, Arthur; Rodriguez, David; Lavilley, Vincent; Labouesse, Michel			HMP-1/alpha-catenin promotes junctional mechanical integrity during morphogenesis	PLOS ONE			English	Article							CELL-CELL CONTACTS; CAENORHABDITIS-ELEGANS EMBRYO; E-CADHERIN; C.-ELEGANS; ALPHA-CATENIN; EPITHELIAL MORPHOGENESIS; ADHERENS JUNCTIONS; APICAL JUNCTIONS; ACTIN; TENSION	Adherens junctions (AJs) are key structures regulating tissue integrity and maintaining adhesion between cells. During morphogenesis, junctional proteins cooperate closely with the actomyosin network to drive cell movement and shape changes. How the junctions integrate the mechanical forces in space and in time during an in vivo morphogenetic event is still largely unknown, due to a lack of quantitative data. To address this issue, we inserted a functional Fluorescence Resonance Energy Transfer (FRET)-based force biosensor within HMP-1/alpha-catenin of Caenorhabditis elegans. We find that the tension exerted on HMP-1 has a cell-specific distribution, is actomyosin-dependent, but is regulated differently from the tension on the actin cortex during embryonic elongation. By using time-lapse analysis of mutants and tissue-specific rescue experiments, we confirm the role of VAB-9/Claudin as an actin bundle anchor. Nevertheless, the tension exerted on HMP-1 did not increase in the absence of VAB-9/Claudin, suggesting that HMP-1 activity is not upregulated to compensate for loss of VAB-9. Our data indicate that HMP-1 does not modulate HMR-1/E-cadherin turnover, is required to recruit junctional actin but not stress fiber-like actin bundles. Altogether, our data suggest that HMP-1/alpha-catenin acts to promote the mechanical integrity of adherens junctions.	[Vuong-Brender, Thanh Thi Kim; Boutillon, Arthur; Labouesse, Michel] UPMC Univ Paris 06, Sorbonne Univ, CNRS, LBD,IBPS, Paris, France; [Vuong-Brender, Thanh Thi Kim; Rodriguez, David; Lavilley, Vincent; Labouesse, Michel] Univ Strasbourg, Dev & Stem Cells Program, IGBMC, CNRS,UMR7104,INSERM,U964, 1 Rue Laurent Fries, Illkirch Graffenstaden, France; [Boutillon, Arthur] Ecole Polytech, INSERM, U1182, Lab Opt & Biosci, Palaiseau, France; [Lavilley, Vincent] Rue Edmond Poupe, Frejus, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris	Vuong-Brender, TTK; Labouesse, M (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, CNRS, LBD,IBPS, Paris, France.; Vuong-Brender, TTK; Labouesse, M (corresponding author), Univ Strasbourg, Dev & Stem Cells Program, IGBMC, CNRS,UMR7104,INSERM,U964, 1 Rue Laurent Fries, Illkirch Graffenstaden, France.	vuongthikimthanh@gmail.com; michel.labouesse@upmc.fr	Boutillon, Arthur/AAP-9315-2021	Boutillon, Arthur/0000-0002-0968-6059; labouesse, michel/0000-0001-7995-5843	European Research Council [294744]; Centre National de la Recherche Scientifique (CNRS); University of Strasbourg; University Pierre et Marie Curie (UPMC); CNRS; UPMC;  [ANR-10-LABX-0030-INRT];  [ANR-10-IDEX-0002-02]	European Research Council(European Research Council (ERC)European Commission); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; University Pierre et Marie Curie (UPMC); CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC; ; 	This work was supported by a European Research Council grant (294744 to M.L.), by institutional funds from the Centre National de la Recherche Scientifique (CNRS), University of Strasbourg and University Pierre et Marie Curie (UPMC), the grant ANR-10-LABX-0030-INRT which is a French State fund managed by the Agence Nationale de la Recherche under the frame programme Investissements d'Avenir labeled ANR-10-IDEX-0002-02 to the Institute of Genetics and Molecular and Cellular Biology, and by installation grants from the CNRS and UPMC (to M.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARSTEAD RJ, 1991, J CELL BIOL, V114, P715, DOI 10.1083/jcb.114.4.715; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; BRENNER S, 1974, GENETICS, V77, P71; Cassata G, 2005, DEVELOPMENT, V132, P739, DOI 10.1242/dev.01638; Chan BG, 2015, DEV BIOL, V405, P250, DOI 10.1016/j.ydbio.2015.07.010; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Cox-Paulson EA, 2012, CURR BIOL, V22, P1500, DOI 10.1016/j.cub.2012.06.025; de Beco S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128281; Dickinson DJ, 2015, GENETICS, V200, P1035, DOI 10.1534/genetics.115.178335; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Diogon M, 2007, DEVELOPMENT, V134, P2469, DOI 10.1242/dev.005074; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Engl W, 2014, NAT CELL BIOL, V16, P584, DOI 10.1038/ncb2973; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; Gally C, 2009, DEVELOPMENT, V136, P3109, DOI 10.1242/dev.039412; Gilleard JS, 1999, DEV BIOL, V208, P265, DOI 10.1006/dbio.1999.9202; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Hardin J, 2013, PROG MOL BIOL TRANSL, V116, P239, DOI 10.1016/B978-0-12-394311-8.00011-X; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kim TJ, 2015, CURR BIOL, V25, P218, DOI 10.1016/j.cub.2014.11.017; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Krieg M, 2014, NAT CELL BIOL, V16, P224, DOI 10.1038/ncb2915; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; le Duc Q, 2010, J CELL BIOL, V191, P891, DOI 10.1083/jcb.20100114920101020c; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Lockwood C, 2008, CURR BIOL, V18, P1333, DOI 10.1016/j.cub.2008.07.086; Lynch AM, 2012, CURR BIOL, V22, P1891, DOI 10.1016/j.cub.2012.08.024; Maiden SL, 2013, J BIOL CHEM, V288, P5694, DOI 10.1074/jbc.M112.438093; Marston DJ, 2016, CURR BIOL, V26, P2079, DOI 10.1016/j.cub.2016.06.010; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin E, 2016, J CELL BIOL, V215, P483, DOI 10.1083/jcb.201604015; McMahon L, 2001, J CELL SCI, V114, P2265; Mege RM, 2017, COLD SPRING HARB PER, V9; Miyabayashi T, 1999, DEV BIOL, V215, P314, DOI 10.1006/dbio.1999.9470; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Piekny AJ, 2003, DEVELOPMENT, V130, P5695, DOI 10.1242/dev.00807; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Raich WB, 1999, CURR BIOL, V9, P1139, DOI 10.1016/S0960-9822(00)80015-9; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Simske JS, 2003, NAT CELL BIOL, V5, P619, DOI 10.1038/ncb1002; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Stetak A, 2011, DEV BIOL, V350, P24, DOI 10.1016/j.ydbio.2010.10.026; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Vasquez CG, 2016, DEV DYNAM, V245, P361, DOI 10.1002/dvdy.24384; Vuong-Brender TTK, 2016, CURR TOP DEV BIOL, V116, P597, DOI 10.1016/bs.ctdb.2015.11.012; Vuong-Brender TTK, 2017, ELIFE, V6, DOI [10.7554/eLife.23866, 10.17554/eLife.23866, 10.7554/elife.23866]; Vuong-Brender TTK, 2017, DEVELOPMENT; Wei Q, 2013, INT REV CEL MOL BIO, V306, P187, DOI 10.1016/B978-0-12-407694-5.00005-5; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Wu Y, 2015, DEV CELL, V32, P139, DOI 10.1016/j.devcel.2014.12.003; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765; Zilberman Y, 2017, J CELL BIOL	59	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193279	10.1371/journal.pone.0193279	http://dx.doi.org/10.1371/journal.pone.0193279			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466456	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300108
J	Yu, JM; Wang, DP; Ries, TR; Pierson, LS; Pierson, EA				Yu, Jun Myoung; Wang, Dongping; Ries, Tessa R.; Pierson, Leland S., III; Pierson, Elizabeth A.			An upstream sequence modulates phenazine production at the level of transcription and translation in the biological control strain Pseudomonas chlororaphis 30-84	PLOS ONE			English	Article							PHENAZINE-1-CARBOXYLIC ACID; FLUORESCENT PSEUDOMONAS; ANTIBIOTIC PRODUCTION; BIOFILM FORMATION; DIFFERENTIAL REGULATION; PHZ OPERON; ROOT-ROT; BIOSYNTHESIS; AUREOFACIENS; BIOCONTROL	Phenazines are bacterial secondary metabolites and play important roles in the antagonistic activity of the biological control strain P. chlororaphis 30-84 against take-all disease of wheat. The expression of the P. chlororaphis 30-84 phenazine biosynthetic operon (phzXY-FABCD) is dependent on the PhzR/PhzI quorum sensing system located immediately upstream of the biosynthetic operon as well as other regulatory systems including Gac/Rsm. Bioinformatic analysis of the sequence between the divergently oriented phzR and phzX promoters identified features within the 5'-untranslated region (5'-UTR) of phzX that are conserved only among 2OHPCA producing Pseudomonas. The conserved sequence features are potentially capable of producing secondary structures that negatively modulate one or both promoters. Transcriptional and translational fusion assays revealed that deletion of 90-bp of sequence at the 5'-UTR of phzX led to up to 4-fold greater expression of the reporters with the deletion compared to the controls, which indicated this sequence negatively modulates phenazine gene expression both transcriptionally and translationally. This 90-bp sequence was deleted from the P. chlororaphis 30-84 chromosome, resulting in 30-84Enh, which produces significantly more phenazine than the wild-type while retaining quorum sensing control. The transcriptional expression of phzR/phzI and amount of AHL signal produced by 30-84Enh also were significantly greater than for the wild-type, suggesting this 90-bp sequence also negatively affects expression of the quorum sensing genes. In addition, deletion of the 90-bp partially relieved RsmE-mediated translational repression, indicating a role for Gac/RsmE interaction. Compared to the wild-type, enhanced phenazine production by 30-84Enh resulted in improvement in fungal inhibition, biofilm formation, extracellular DNA release and suppression of take-all disease of wheat in soil without negative consequences on growth or rhizosphere persistence. This work provides greater insight into the regulation of phenazine biosynthesis with potential applications for improved biological control.	[Yu, Jun Myoung; Pierson, Elizabeth A.] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA; [Yu, Jun Myoung; Wang, Dongping; Ries, Tessa R.; Pierson, Leland S., III; Pierson, Elizabeth A.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; Oil Dri Corp Amer, Vernon Hills, IL USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Pierson, EA (corresponding author), Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA.; Pierson, EA (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	eapierson@tamu.edu		Yu, Jun Myoung/0000-0003-1654-3053; Pierson, Elizabeth/0000-0001-8867-0743	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) [2008-35319-04490]; Texas AM University	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA)(United States Department of Agriculture (USDA)); Texas AM University	This project was supported in part by United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) award no. 2008-35319-04490 to LSP, and in part by internal discretionary funds from Texas A&M University to E. Pierson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Bailey MJ, 1995, MOL ECOL, V4, P755, DOI 10.1111/j.1365-294X.1995.tb00276.x; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Chancey ST, 1999, APPL ENVIRON MICROB, V65, P2294; Chen YW, 2015, GENOM DATA, V4, P33, DOI 10.1016/j.gdata.2015.01.006; Chin-A-Woeng TFC, 1998, MOL PLANT MICROBE IN, V11, P1069, DOI 10.1094/MPMI.1998.11.11.1069; Chin-A-Woeng TFC, 2003, NEW PHYTOL, V157, P503, DOI 10.1046/j.1469-8137.2003.00686.x; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P969, DOI 10.1094/MPMI.2001.14.8.969; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P1006, DOI 10.1094/MPMI.2001.14.8.1006; Das T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058299; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; Delaney SM, 2001, J BACTERIOL, V183, P318, DOI 10.1128/JB.183.1.318-327.2001; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Duss O, 2014, NATURE, V509, P588, DOI 10.1038/nature13271; Dwivedi D, 2009, MYCORRHIZA, V19, P559, DOI 10.1007/s00572-009-0253-2; Girard G, 2011, MICROBIOL-SGM, V157, P398, DOI 10.1099/mic.0.043075-0; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hu HB, 2005, J MICROBIOL BIOTECHN, V15, P86; Huang ZY, 2004, FEMS MICROBIOL ECOL, V49, P243, DOI 10.1016/j.femsec.2004.03.010; Humair B, 2010, APPL ENVIRON MICROB, V76, P1497, DOI 10.1128/AEM.02014-09; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Khan SR, 2007, APPL ENVIRON MICROB, V73, P7443, DOI 10.1128/AEM.01354-07; Khan SR, 2005, J BACTERIOL, V187, P6517, DOI 10.1128/JB.187.18.6517-6527.2005; Kulkarni PR, 2014, NUCLEIC ACIDS RES, V42, P6811, DOI 10.1093/nar/gku309; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lesic B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-20; Li Y, 2011, WOODHEAD PUBL MATER, P10; Maddula VSRK, 2008, J BACTERIOL, V190, P2759, DOI 10.1128/JB.01587-07; Maddula VSRK, 2006, MICROB ECOL, V52, P289, DOI 10.1007/s00248-006-9064-6; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mavrodi DV, 2013, ENVIRON MICROBIOL, V15, P675, DOI 10.1111/j.1462-2920.2012.02846.x; MAZZOLA M, 1992, APPL ENVIRON MICROB, V58, P2616, DOI 10.1128/AEM.58.8.2616-2624.1992; Mercante J, 2009, J MOL BIOL, V392, P511, DOI 10.1016/j.jmb.2009.07.034; Miller JH., 1972, EXPT MOL GENETICS; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; PIERSON LS, 1992, MOL PLANT MICROBE IN, V5, P330, DOI 10.1094/MPMI-5-330; PIERSON LS, 1994, J BACTERIOL, V176, P3966, DOI 10.1128/JB.176.13.3966-3974.1994; Powell JF, 2000, PLANT DIS, V84, P19, DOI 10.1094/PDIS.2000.84.1.19; Ramos I, 2010, RES MICROBIOL, V161, P187, DOI 10.1016/j.resmic.2010.01.003; Reimmann C, 2005, J BACTERIOL, V187, P276, DOI 10.1128/JB.187.1.276-285.2005; Ren B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089653; Sambrook J., 2001, MOL CLONING LAB MANU; Selin C, 2014, BIOL CONTROL, V69, P24, DOI 10.1016/j.biocontrol.2013.10.015; Selin C, 2012, MICROBIOL-SGM, V158, P896, DOI 10.1099/mic.0.054254-0; STASKAWICZ B, 1987, J BACTERIOL, V169, P5789, DOI 10.1128/jb.169.12.5789-5794.1987; Tambong JT, 2001, EUR J PLANT PATHOL, V107, P511, DOI 10.1023/A:1011274321759; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; THOMASHOW LS, 1990, APPL ENVIRON MICROB, V56, P908, DOI 10.1128/AEM.56.4.908-912.1990; Thomashow LS, 1993, ADV MOL GENETICS PLA, V2, P535; Timms-Wilson TM, 2000, MOL PLANT MICROBE IN, V13, P1293, DOI 10.1094/MPMI.2000.13.12.1293; Wang DS, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017453; Wang DP, 2013, MICROBIOLOGYOPEN, V2, P505, DOI 10.1002/mbo3.90; Wang DP, 2012, MICROBIOL-SGM, V158, P1745, DOI 10.1099/mic.0.059352-0; Whistler CA, 2003, J BACTERIOL, V185, P3718, DOI 10.1128/JB.185.13.3718-3725.2003; WILKINSON HT, 1985, PHYTOPATHOLOGY, V75, P98, DOI 10.1094/Phyto-75-98; Wood DW, 1996, GENE, V168, P49, DOI 10.1016/0378-1119(95)00754-7; Wood DW, 1997, J BACTERIOL, V179, P7663, DOI 10.1128/jb.179.24.7663-7670.1997; Yu JM, 2017, MICROBIOL-SGM, V163, P94, DOI 10.1099/mic.0.000409; Zhang XH, 2005, WORLD J MICROB BIOT, V21, P883, DOI 10.1007/s11274-004-6358-z; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	11	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0193063	10.1371/journal.pone.0193063	http://dx.doi.org/10.1371/journal.pone.0193063			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451920	Green Submitted, Green Published, gold			2022-12-26	WOS:000425369800039
J	He, H; Sinha, I; Fan, RR; Haldosen, LA; Yan, FF; Zhao, CY; Dahlman-Wright, K				He, Huan; Sinha, Indranil; Fan, Rongrong; Haldosen, Lars-Arne; Yan, Feifei; Zhao, Chunyan; Dahlman-Wright, Karin			c-Jun/AP-1 overexpression reprograms ER alpha signaling related to tamoxifen response in ER alpha-positive breast cancer	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; ENDOCRINE RESISTANCE; MATRIX PROTEIN; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; PHOSPHOLIPASE-D; DNA-BINDING; TGF-BETA; CELLS; FOXA1	A critical mechanism that has been proposed for transcription regulation by estrogen receptor a (ER) is the tethering of ER to DNA via other transcription factors, such as AP-1. However, genome-wide assessment of the overlap in chromatin binding repertoires of these two transcription factors has not been reported. Here, we show that the AP-1 transcription factor c-Jun interacts with ER and that c-Jun chromatin binding shows extensive overlap with ER binding at the global level. Further, we show that c-Jun overexpression reprograms ER chromatin binding and modulates ER-mediated gene regulation. Our data are consistent with a mechanism where estrogen/ER-dependent crosstalk with AP-1 at the transcriptional level is mediated through the tethering of ER to DNA bound AP-1. Additionally, in our system c-Jun overexpression causes reduced sensitivity to tamoxifen in ER+ breast cancer cells. Integrated cistrome, transcriptome, and clinical data reveal TGFBI as a candidate gene which may confer tamoxifen resistance by ER and AP-1 crosstalk. Further, we show that TGFBI expression is elevated in breast cancer compared to normal breast. Together, our data provide a novel genome-wide footprint of ER and AP-1 crosstalk and suggest AP-1 and TGFBI signaling as potential therapeutic targets in AP-1-overexpressing ER-positive breast tumors.	[He, Huan; Sinha, Indranil; Fan, Rongrong; Haldosen, Lars-Arne; Yan, Feifei; Zhao, Chunyan; Dahlman-Wright, Karin] Karolinska Inst, Dept Biosci & Nutr, Novum, SE-14183 Huddinge, Sweden	Karolinska Institutet	Zhao, CY (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Novum, SE-14183 Huddinge, Sweden.	chunyan.zhao@ki.se	He, Huan/AAF-9644-2019; Fan, Rongrong/N-3446-2017; Fan, Rongrong/AAG-2200-2019	Fan, Rongrong/0000-0002-5707-1497; Fan, Rongrong/0000-0002-5707-1497; Sinha, Indranil/0000-0002-2513-5927; He, Huan/0000-0001-8123-5765	China Scholarship Council; Karolinska Institutet; Swedish Cancer Society (Cancerfonden)	China Scholarship Council(China Scholarship Council); Karolinska Institutet(Karolinska Institutet); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society)	The authors thank the Bioinformatic and Expression Analysis core facility at the Karolinska Institute (http://www.bea.ki.se/) for performing the Affymetrix and ChIP-seq assays and Hui Gao for critically reading the manuscript. This work was supported by scholarship from the China Scholarship Council, a PhD student grant (KID) from the Karolinska Institutet and grants from the Swedish Cancer Society (Cancerfonden).	Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Ali S, 2016, BIOINFORMATION, V12, P135, DOI 10.6026/97320630012135; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Brown HA, 2017, NAT REV DRUG DISCOV, V16, P351, DOI 10.1038/nrd.2016.252; Brunen D, 2013, CELL CYCLE, V12, P2960, DOI 10.4161/cc.26034; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Cheung E, 2005, P NATL ACAD SCI USA, V102, P559, DOI 10.1073/pnas.0407113102; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dahlman-Wright K, 2012, CARCINOGENESIS, V33, P1684, DOI 10.1093/carcin/bgs223; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; den Hollander P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00250; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fu XY, 2016, P NATL ACAD SCI USA, V113, pE6600, DOI 10.1073/pnas.1612835113; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heldring N, 2011, MOL ENDOCRINOL, V25, P564, DOI 10.1210/me.2010-0425; Hung MS, 2015, ONCOL REP, V34, P3187, DOI 10.3892/or.2015.4324; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Ji ZL, 2012, MOL CELL BIOL, V32, P385, DOI 10.1128/MCB.05504-11; Jia M, 2016, CANCER RES, V76, P5634, DOI 10.1158/0008-5472.CAN-15-2910; Jin HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4972; Johnston SRD, 1999, CLIN CANCER RES, V5, P251; Kharman-Biz A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-441; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Luo M, 2005, MOL CELL BIOL, V25, P7386, DOI 10.1128/MCB.25.16.7386-7398.2005; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Malorni L, 2016, MOL CANCER RES, V14, P470, DOI 10.1158/1541-7786.MCR-15-0423; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Robinson JLL, 2014, ONCOGENE, V33, P5666, DOI 10.1038/onc.2013.508; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Schneider D, 2002, BBA-MOL BASIS DIS, V1588, P1, DOI 10.1016/S0925-4439(02)00052-2; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Shen Q, 2011, J BIOL CHEM, V286, P14554, DOI 10.1074/jbc.M110.165704; Stender JD, 2017, MOL CELL, V65, P1122, DOI 10.1016/j.molcel.2017.02.008; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; Sun M, 2012, MOL ENDOCRINOL, V26, P736, DOI 10.1210/me.2011-1158; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; TINIAKOS DG, 1994, J PATHOL, V172, P19, DOI 10.1002/path.1711720106; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Ween MP, 2012, INT J MOL SCI, V13, P10461, DOI 10.3390/ijms130810461; Wright TM, 2014, MOL CANCER RES, V12, P1829, DOI 10.1158/1541-7786.MCR-14-0195; Zhang Y, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-145; Zhao CY, 2007, CANCER RES, V67, P3955, DOI 10.1158/0008-5472.CAN-06-3505; Zhao CY, 2014, CANCER RES, V74, P3983, DOI 10.1158/0008-5472.CAN-13-3396; Zhao CY, 2010, J BIOL CHEM, V285, P39575, DOI 10.1074/jbc.R110.180109; Zhu J, 2014, ONCOGENE, V33, P4340, DOI 10.1038/onc.2013.573	52	24	27	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	19					2586	2600		10.1038/s41388-018-0165-8	http://dx.doi.org/10.1038/s41388-018-0165-8			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GF3RN	29467493				2022-12-26	WOS:000431873400010
J	Zhang, HY; Wang, QY; Gu, JZ; Yin, Y; Liang, SH; Wu, LD; Xu, H; Zhao, C; Gu, YC				Zhang, Huiyuan; Wang, Qinyi; Gu, Junzhong; Yin, Le; Liang, Shenghui; Wu, Lida; Xu, Hao; Zhao, Chao; Gu, Yuchun			Elevated mitochondrial SLC25A29 in cancer modulates metabolic status by increasing mitochondria-derived nitric oxide	ONCOGENE			English	Article							TRANSPORTER FAMILY SLC25; SYNTHASE; RESPIRATION; IDENTIFICATION; GLYCOLYSIS; PATHWAY; KINASE; OXYGEN	Warburg effect has been recognized as a hallmark of cancer cells for many years, but its modulation mechanism remains a great focus. Our current study found a member of solute carrier family 25 (SLC25A29), the main arginine transporter on mitochondria, significantly elevated in various cancer cells. Knockout of SLC25A29 by CRISPR/Cas9 inhibited proliferation and migration of cancer cells both in vitro and in vivo. SLC25A29-knockout cells also showed an altered metabolic status with enhanced mitochondrial respiration and reduced glycolysis. All of above impacts could be reversed after rescuing SLC25A29 expression in SLC25A29-knockout cells. Arginine is transported into mitochondria partly for nitric oxide (NO) synthesis. Deletion of SLC25A29 resulted in severe decrease of NO production, indicating that the mitochondria is a significant source of NO. SLC25A29-knockout cells dramatically altered the variation of metabolic processes, whereas addition of arginine failed to reverse the effect, highlighting the necessity of transporting arginine into mitochondria by SLC25A29. In conclusion, aberrant elevated SLC25A29 in cancer functioned to transport more arginine into mitochondria, improved mitochondria-derived NO levels, thus modulated metabolic status to facilitate increased cancer progression.	[Zhang, Huiyuan; Wang, Qinyi; Gu, Junzhong; Yin, Le; Liang, Shenghui; Wu, Lida; Xu, Hao; Gu, Yuchun] Peking Univ, Inst Mol Med, Lab Mol Pharmacol, Beijing, Peoples R China; [Zhao, Chao] Univ Cambridge, WT MRC Cambridge Stem Cell Inst, Dept Clin Neurosci, Cambridge, England; [Gu, Yuchun] Aston Univ, Translat & Regenerat Med Ctr, Aston Med Res Inst, Birmingham, W Midlands, England	Peking University; University of Cambridge; Aston University	Gu, YC (corresponding author), Peking Univ, Inst Mol Med, Lab Mol Pharmacol, Beijing, Peoples R China.; Gu, YC (corresponding author), Aston Univ, Translat & Regenerat Med Ctr, Aston Med Res Inst, Birmingham, W Midlands, England.	ycgu@pku.edu.cn	wu, lida/ABD-8498-2020	wu, lida/0000-0001-7059-0788; gu, yuchun/0000-0002-7558-0447	973 Project [2013CB531206, 2012CB517803]; NSF [81170236, 31127001]	973 Project(National Basic Research Program of China); NSF(National Science Foundation (NSF))	This work is supported by the research grants held by Yuchun Gu (973 Project Number 2013CB531206, 973 Project Number 2012CB517803, and NSF Number 81170236 and Number 31127001).	Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Brix B, 2012, J NEUROSCI, V32, P9727, DOI 10.1523/JNEUROSCI.0879-12.2012; Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; BROWN GC, 1995, FEBS LETT, V369, P136, DOI 10.1016/0014-5793(95)00763-Y; Brown GC, 2007, CARDIOVASC RES, V75, P283, DOI 10.1016/j.cardiores.2007.03.022; Brune B, 2007, CARDIOVASC RES, V75, P275, DOI 10.1016/j.cardiores.2007.03.005; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Camacho JA, 2009, PEDIATR RES, V66, P35, DOI 10.1203/PDR.0b013e3181a283c1; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chang CF, 2015, FREE RADICAL BIO MED, V79, P324, DOI 10.1016/j.freeradbiomed.2014.11.012; Cidad P, 2004, BIOCHEM J, V384, P629, DOI 10.1042/BJ20040886; Conacci-Sorrell Maralice, 2014, Cold Spring Harb Perspect Med, V4, pa014357, DOI 10.1101/cshperspect.a014357; Contractor T, 2012, CANCER RES, V72, P560, DOI 10.1158/0008-5472.CAN-11-1215; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; Dedkova EN, 2009, J PHYSIOL-LONDON, V587, P851, DOI 10.1113/jphysiol.2008.165423; Finocchietto PV, 2009, EXP BIOL MED, V234, P1020, DOI 10.3181/0902-MR-81; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ghafourifar P, 2005, METHOD ENZYMOL, V396, P424, DOI 10.1016/S0076-6879(05)96036-9; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Ghafourifar P, 1997, FEBS LETT, V418, P291, DOI 10.1016/S0014-5793(97)01397-5; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lacza Z, 2009, FRONT BIOSCI, V14, P4436, DOI 10.2741/3539; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Monne M, 2015, AMINO ACIDS, V47, P1763, DOI 10.1007/s00726-015-1990-5; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Persichini T, 2005, NEUROSCI LETT, V384, P254, DOI 10.1016/j.neulet.2005.04.085; Porcelli V, 2014, J BIOL CHEM, V289, P13374, DOI 10.1074/jbc.M114.547448; Quintero M, 2006, CANCER RES, V66, P770, DOI 10.1158/0008-5472.CAN-05-0333; Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009; Sekoguchi E, 2003, J BIOL CHEM, V278, P38796, DOI 10.1074/jbc.M306372200; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Switzer CH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3319; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhong H, 1999, CANCER RES, V59, P5830	48	11	11	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	19					2545	2558		10.1038/s41388-018-0139-x	http://dx.doi.org/10.1038/s41388-018-0139-x			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GF3RN	29459713				2022-12-26	WOS:000431873400007
J	Eckersley, A; Mellody, KT; Pilkington, S; Griffiths, CEM; Watson, REB; O'Cualain, R; Baldock, C; Knight, D; Sherratt, MJ				Eckersley, Alexander; Mellody, Kieran T.; Pilkington, Suzanne; Griffiths, Christopher E. M.; Watson, Rachel E. B.; O'Cualain, Ronan; Baldock, Clair; Knight, David; Sherratt, Michael J.			Structural and compositional diversity of fibrillin microfibrils in human tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix; skin; eye; fibroblast; proteomics; atomic force microscopy (AFM); protein structure; collagen VI; fibrillin microfibril	EXTRACELLULAR-MATRIX ASSEMBLIES; COLLAGEN VI MICROFIBRILS; TGF-BETA ACTIVATION; TIGHT-SKIN MOUSE; MARFAN-SYNDROME; ELASTIC FIBERS; RICH MICROFIBRILS; SUPRAMOLECULAR ORGANIZATION; DEVELOPMENTAL EXPRESSION; RELATIVE ABUNDANCE	Elastic fibers comprising fibrillin microfibrils and elastin are present in many tissues, including the skin, lungs, and arteries, where they confer elasticity and resilience. Although fibrillin microfibrils play distinct and tissue-specific functional roles, it is unclear whether their ultrastructure and composition differ between elastin-rich (skin) and elastin-poor (ciliary body and zonule) organs or after in vitro synthesis by cultured cells. Here, we used atomic force microscopy, which revealed that the bead morphology of fibrillin microfibrils isolated from the human eye differs from those isolated from the skin. Using newly developed pre-MS preparation methods and LC-MS/MS, we detected tissue-specific regions of the fibrillin-1 primary structure that were differentially susceptible to proteolytic extraction. Comparing tissue- and culture-derived microfibrils, we found that dermis- and dermal fibroblast-derived fibrillin microfibrils differ in both bead morphology and periodicity and also exhibit regional differences in fibrillin-1 proteolytic susceptibility. In contrast, collagen VI microfibrils from the same dermal or fibroblast samples were invariant in ultrastructure (periodicity) and protease susceptibility. Finally, we observed that skin- and eye-derived microfibril suspensions were enriched in elastic fiber- and basement membrane-associated proteins, respectively. LC-MS/MS also identified proteins (such as calreticulin and protein-disulfide isomerase) that are potentially fundamental to fibrillin microfibril biology, regardless of their tissue source. Fibrillin microfibrils synthesized in cell culture lacked some of these key proteins (MFAP2 and -4 and fibrillin-2). These results showcase the structural diversity of these key extracellular matrix assemblies, which may relate to their distinct roles in the tissues where they reside.	[Eckersley, Alexander; Mellody, Kieran T.; Baldock, Clair] Univ Manchester, Fac Biol Med & Hlth, Div Cell Matrix Biol & Regenerat Med, Manchester M13 9PT, Lancs, England; [Pilkington, Suzanne; Griffiths, Christopher E. M.; Watson, Rachel E. B.] Univ Manchester, Fac Biol Med & Hlth, Div Musculoskeletal & Dermatol Sci, Manchester M13 9PT, Lancs, England; [O'Cualain, Ronan; Knight, David; Sherratt, Michael J.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Manchester M13 9PT, Lancs, England; [Baldock, Clair] Univ Manchester, Fac Biol Med & Hlth, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Griffiths, Christopher E. M.; Watson, Rachel E. B.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester	Sherratt, MJ (corresponding author), Univ Manchester, 1-529 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	michael.sherratt@manchester.ac.uk	Watson, Rachel E B/F-1090-2013; Eckersley, Alexander/AAH-6975-2020	Watson, Rachel E B/0000-0002-5162-7503; Eckersley, Alexander/0000-0003-1602-4851; Pilkington, Suzanne/0000-0002-0426-1414; O'Cualain, Ronan/0000-0002-4767-6142; Baldock, Clair/0000-0003-3497-1959	Wellcome Trust Centre for Cell-Matrix Research; Walgreens Boots Alliance (Nottingham, UK); Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N015398/1]; BBSRC [BB/N015398/1] Funding Source: UKRI; MRC [MR/L016540/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N015398/1] Funding Source: researchfish; Medical Research Council [MR/L016540/1] Funding Source: researchfish	Wellcome Trust Centre for Cell-Matrix Research(Wellcome Trust); Walgreens Boots Alliance (Nottingham, UK); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a program grant from Walgreens Boots Alliance (Nottingham, UK). The authors declare that they have no conflicts of interest with the contents of this article. Walgreens Boots Alliance has approved this manuscript's submission but exerted no editorial control over the content.; Supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/N015398/1.	Ashworth JL, 2000, BRIT J OPHTHALMOL, V84, P1312, DOI 10.1136/bjo.84.11.1312; Ashworth JL, 1999, J CELL SCI, V112, P3549; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Atanasova M, 2009, GERONTOLOGY, V55, P73, DOI 10.1159/000157436; Baldock C, 2003, J MOL BIOL, V330, P297, DOI 10.1016/S0022-2836(03)00585-0; Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045; Baldwin AK, 2014, J CELL SCI, V127, P158, DOI 10.1242/jcs.134270; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beecher N, 2011, J BIOL CHEM, V286, P40266, DOI 10.1074/jbc.M111.265595; Buckley M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2671; Cain SA, 2006, PROTEOMICS, V6, P111, DOI 10.1002/pmic.200401340; Cain SA, 2009, MOL CELL PROTEOMICS, V8, P2715, DOI 10.1074/mcp.M900008-MCP200; COTTAPEREIRA G, 1976, J INVEST DERMATOL, V66, P143, DOI 10.1111/1523-1747.ep12481882; DAHLBACK K, 1990, J INVEST DERMATOL, V94, P284, DOI 10.1111/1523-1747.ep12874430; De Maria A, 2017, INVEST OPHTH VIS SCI, V58, P573, DOI 10.1167/iovs.16-20866; Dziadek M, 2002, MATRIX BIOL, V21, P227, DOI 10.1016/S0945-053X(02)00009-4; Erickson B, 2013, BIOTECHNOL J, V8, P117, DOI 10.1002/biot.201200174; Fang M, 2012, ACS NANO, V6, P9503, DOI 10.1021/nn302483x; Fang M, 2012, J INVEST DERMATOL, V132, P1791, DOI 10.1038/jid.2012.47; Gayraud B, 2000, J CELL BIOL, V150, P667, DOI 10.1083/jcb.150.3.667; Gibson MA, 1998, J HISTOCHEM CYTOCHEM, V46, P871, DOI 10.1177/002215549804600802; GIBSON MA, 1989, J BIOL CHEM, V264, P4590; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Haynes SL, 1997, BRIT J DERMATOL, V137, P17, DOI 10.1046/j.1365-2133.1997.1762185.x; Henderson M, 1996, J HISTOCHEM CYTOCHEM, V44, P1389, DOI 10.1177/44.12.8985131; Hibbert SA, 2017, J PHOTOCH PHOTOBIO B, V175, P58, DOI 10.1016/j.jphotobiol.2017.08.020; Hibbert SA, 2015, REDOX BIOL, V5, P101, DOI 10.1016/j.redox.2015.04.003; Hirani R, 2007, MATRIX BIOL, V26, P213, DOI 10.1016/j.matbio.2006.12.006; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hustoft HK, 2012, INTEGRATIVE PROTEOMICS, P73; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jensen SA, 2014, P NATL ACAD SCI USA, V111, P10155, DOI 10.1073/pnas.1401697111; Kaartinen V, 2003, NAT GENET, V33, P331, DOI 10.1038/ng0303-331; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kielty CM, 1998, ANAL BIOCHEM, V255, P108, DOI 10.1006/abio.1997.2442; KIELTY CM, 1995, J MED GENET, V32, P1, DOI 10.1136/jmg.32.1.1; KIELTY CM, 1991, J CELL SCI, V99, P797; KIELTY CM, 1993, MATRIX, V13, P103, DOI 10.1016/S0934-8832(11)80069-7; Kielty CM, 1998, J CELL BIOL, V140, P1159, DOI 10.1083/jcb.140.5.1159; KIELTY CM, 1993, FEBS LETT, V336, P323, DOI 10.1016/0014-5793(93)80829-J; Kielty CM, 2002, J CELL SCI, V115, P2817; Kinsey R, 2008, J CELL SCI, V121, P2696, DOI 10.1242/jcs.029819; KOCSIS E, 1991, J STRUCT BIOL, V107, P6, DOI 10.1016/1047-8477(91)90025-R; Lennon R, 2014, J AM SOC NEPHROL, V25, P939, DOI 10.1681/ASN.2013030233; Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0; Lonnqvist L, 1998, HUM MOL GENET, V7, P2039, DOI 10.1093/hmg/7.13.2039; Lu YH, 2006, J STRUCT BIOL, V155, P285, DOI 10.1016/j.jsb.2006.03.021; MARIENCHECK MC, 1995, CONNECT TISSUE RES, V31, P87, DOI 10.3109/03008209509028396; Marson A, 2005, J BIOL CHEM, V280, P5013, DOI 10.1074/jbc.M409029200; Meirelles T, 2016, INT J BIOCHEM CELL B, V71, P81, DOI 10.1016/j.biocel.2015.12.009; Moore R., 2016, GENET ENG BIOTECHNOL, V36, P20; Naylor EC, 2011, MATURITAS, V69, P249, DOI 10.1016/j.maturitas.2011.04.011; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohno-Jinno A, 2008, INVEST OPHTH VIS SCI, V49, P2870, DOI 10.1167/iovs.07-1488; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Penner AS, 2002, J BIOL CHEM, V277, P35044, DOI 10.1074/jbc.M206363200; Pilecki B, 2016, J BIOL CHEM, V291, P1103, DOI 10.1074/jbc.M115.681775; Ponamarczuk H, 2018, FRONT BIOSCI-LANDMRK, V23, P1612, DOI 10.2741/4663; Ratcliff GC, 2001, J AM CHEM SOC, V123, P5632, DOI 10.1021/ja005750n; Reinhardt DP, 2000, J BIOL CHEM, V275, P2205, DOI 10.1074/jbc.275.3.2205; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231, DOI 10.1074/jbc.272.2.1231; Rietschel B, 2009, MOL CELL PROTEOMICS, V8, P1029, DOI 10.1074/mcp.M800223-MCP200; ROARK EF, 1995, J HISTOCHEM CYTOCHEM, V43, P401, DOI 10.1177/43.4.7534784; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Schiavinato A, 2016, J INVEST DERMATOL, V136, P1150, DOI 10.1016/j.jid.2016.02.021; Schilling B, 2015, ANAL CHEM, V87, P10222, DOI 10.1021/acs.analchem.5b02983; Sell D.R., 2010, COMPREHENSIVE PHYSL, P235; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Sherratt MJ, 2007, MATRIX BIOL, V26, P156, DOI 10.1016/j.matbio.2006.10.015; Sherratt MJ, 2010, J PATHOL, V222, P32, DOI 10.1002/path.2730; Sherratt MJ, 1997, INT J BIOCHEM CELL B, V29, P1063, DOI 10.1016/S1357-2725(97)00028-9; Sherratt MJ, 2003, J MOL BIOL, V332, P183, DOI 10.1016/S0022-2836(03)00829-5; Sherratt MJ, 2005, BIOMATERIALS, V26, P7192, DOI 10.1016/j.biomaterials.2005.05.010; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Stahnke T, 2012, EXP EYE RES, V100, P88, DOI 10.1016/j.exer.2012.04.015; SZIEGOLEIT A, 1985, EUR J BIOCHEM, V151, P595, DOI 10.1111/j.1432-1033.1985.tb09145.x; Tiedemann K, 2005, J BIOL CHEM, V280, P11404, DOI 10.1074/jbc.M409882200; Trask BC, 2000, MOL BIOL CELL, V11, P1499, DOI 10.1091/mbc.11.5.1499; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Walji TA, 2016, MATRIX BIOL, V55, P63, DOI 10.1016/j.matbio.2016.02.006; Wang Z, 2014, AGING CELL, V13, P226, DOI 10.1111/acel.12164; Watson REB, 1999, J INVEST DERMATOL, V112, P782, DOI 10.1046/j.1523-1747.1999.00562.x; Watson REB, 2001, BRIT J DERMATOL, V144, P751, DOI 10.1046/j.1365-2133.2001.04012.x; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; WRIGHT RR, 1961, AM J PATHOL, V39, P355; Yamanouchi K, 2012, CONNECT TISSUE RES, V53, P14, DOI 10.3109/03008207.2011.602767; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	94	29	30	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5117	5133		10.1074/jbc.RA117.001483	http://dx.doi.org/10.1074/jbc.RA117.001483			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29453284	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000429409300018
J	Helfenberger, KE; Villalba, NM; Buchholz, B; Boveris, A; Poderoso, JJ; Gelpi, RJ; Poderoso, C				Helfenberger, Katia E.; Villalba, Nerina M.; Buchholz, Bruno; Boveris, Alberto; Jose Poderoso, Juan; Gelpi, Ricardo J.; Poderoso, Cecilia			Subcellular distribution of ERK phosphorylation in tyrosine and threonine depends on redox status in murine lung cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASES; DEPHOSPHORYLATION; TRANSLOCATION; SPECIFICITY; APOPTOSIS; LINE	Activation of ERK1/2 implies the phosphorylation of tyrosine (pTyr) and threonine (pThr) by MEK1/2; both reactions were thought to be cytoplasmic, promoting ERK to reach the nucleus where it activates several transcription factors. In addition, H2O2 concentrations are known to modulate ERK intracellular translocation, which impacts on cellular proliferation. In this context, the objective of this work was to study the sequence of ERK phosphorylation under two redox conditions and to analyze a putative mitochondrial contribution to this process, in LP07 murine lung cells. A time-course of H2O2 administration was used and ERK phosphorylation was analyzed in cytosol, mitochondria and nuclei. At 1 mu M H2O2, a proliferative redox stimulus, immunoblot revealed a fast and transient increase in cytosol pTyr and a sustained increase in mitochondrial pTyr content. The detection for pThr/pTyrERK (2pERK) showed in cytosol a marked increase at 5 minutes with a fast dephosphorylation after that time, for both H2O2 concentrations. However, at 50 mu M H2O2, an anti-proliferative condition, 2pERK was gradually retained in mitochondria. Interestingly, these results were confirmed by in vivo experiments using mice treated with a highly oxidizing agent [H2O2]. By the use of two ERK2 mutant constructions, where Tyr and Thr were replaced by alanine, we confirmed that 2pERK relied almost completely on pThr183. Confocal microscopy confirmed ERK subcellular distribution dependence on the incidence of cytosolic pTyr and mitochondrial pThr at 1 mu M H2O2. This work shows for the first time, both in vitro and in vivo, an ERK cycle involving a cross-talk between cytosol and mitochondria phosphorylation events, which may play a significant role in cell cycle progression, proliferation or differentiation under two different redox conditions.	[Helfenberger, Katia E.; Poderoso, Cecilia] Univ Buenos Aires, Fac Med, Dept Bioquim Humana, Buenos Aires, DF, Argentina; [Helfenberger, Katia E.; Poderoso, Cecilia] Univ Buenos Aires, CONICET, Inst Invest Biomed INBIOMED, Buenos Aires, DF, Argentina; [Villalba, Nerina M.; Jose Poderoso, Juan] Univ Buenos Aires, Fac Med, Hosp Clin Jose de San Martin, Lab Metab Oxigeno, Buenos Aires, DF, Argentina; [Villalba, Nerina M.; Jose Poderoso, Juan] Univ Buenos Aires, CONICET, Inst Imunol Genet & Metabolismo INIGEM, Buenos Aires, DF, Argentina; [Buchholz, Bruno; Boveris, Alberto; Gelpi, Ricardo J.] Univ Buenos Aires, Fac Med, Dept Patol, Buenos Aires, DF, Argentina; [Buchholz, Bruno; Boveris, Alberto; Gelpi, Ricardo J.] Univ Buenos Aires, CONICET, Inst Bioquim & Med Mol IBIMOL, Buenos Aires, DF, Argentina; [Villalba, Nerina M.] Univ Buenos Aires, Fac Med, CONICET, IBCN, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Poderoso, C (corresponding author), Univ Buenos Aires, Fac Med, Dept Bioquim Humana, Buenos Aires, DF, Argentina.; Poderoso, C (corresponding author), Univ Buenos Aires, CONICET, Inst Invest Biomed INBIOMED, Buenos Aires, DF, Argentina.	cepoderos@yahoo.com	Buchholz, Bruno/AAJ-1916-2021	Buchholz, Bruno/0000-0001-6712-8103; Villalba, Nerina Mariel/0000-0003-0397-3409; Poderoso, Cecilia/0000-0001-8606-2840	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT-2010-2430]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 5495]; Universidad de Buenos Aires (UBA)	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBA)(University of Buenos Aires)	Funding was provided by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, www.agencia.mincyt.gob.ar) PICT-2010-2430, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, www.conicet.gov.ar) (PIP 5495) and Universidad de Buenos Aires (UBA, www.uba.ar) to J.J.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Arciuch VGA, 2009, ADV DRUG DELIVER REV, V61, P1234, DOI 10.1016/j.addr.2009.04.025; Arciuch VGA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007523; Antunes F, 2001, FREE RADICAL BIO MED, V30, P1008, DOI 10.1016/S0891-5849(01)00493-2; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bendetz-Nezer S, 2007, J BIOL CHEM, V282, P25114, DOI 10.1074/jbc.M703120200; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Boveris A, 2000, ANN NY ACAD SCI, V899, P121; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Busca R, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00053; Butch ER, 1996, J BIOL CHEM, V271, P4230; Carreras Maria C., 2004, Molecular Aspects of Medicine, V25, P125, DOI 10.1016/j.mam.2004.02.014; Casar B, 2008, MOL CELL, V31, P708, DOI 10.1016/j.molcel.2008.07.024; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; Galli S, 2003, CANCER RES, V63, P6370; Galli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002379; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Kidger AM, 2016, SEMIN CELL DEV BIOL, V50, P125, DOI 10.1016/j.semcdb.2016.01.009; Kim JY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-27; Kreft M, 2004, COMPUT METH PROG BIO, V74, P63, DOI 10.1016/S0169-2607(03)00071-3; LENORMAND P, 1993, ADV SEC MESS PHOSPH, V28, P237; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Paz C, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00060; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Poderoso C, 2008, PLOS ONE, V3; Ramsey MR, 2006, NAT CELL BIOL, V8, P1213, DOI 10.1038/ncb1106-1213; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Satoh Y, 2011, J NEUROSCI, V31, P1149, DOI 10.1523/JNEUROSCI.2243-10.2011; Urtreger AJ, 2001, INT J ONCOL, V18, P639; Woolley JF, 2013, ANTIOXID REDOX SIGN, V19, P1815, DOI 10.1089/ars.2012.5028; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	36	4	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193022	10.1371/journal.pone.0193022	http://dx.doi.org/10.1371/journal.pone.0193022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489891	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000051
J	Kesler, MA; Kaul, R; Loutfy, M; Myers, T; Brunetta, J; Remis, RS; Gesink, D				Kesler, Maya A.; Kaul, Rupert; Loutfy, Mona; Myers, Ted; Brunetta, Jason; Remis, Robert S.; Gesink, Dionne			Prosecution of non-disclosure of HIV status: Potential impact on HIV testing and transmission among HIV-negative men who have sex with men	PLOS ONE			English	Article							SEROSTATUS DISCLOSURE; PREVENTION; RISK; EXPOSURE; LAWS; ENGAGEMENT; INFECTION; ATTITUDES; BEHAVIOR; CANADA	Background Non-disclosure criminal prosecutions among gay, bisexual and other men who have sex with men (MSM) are increasing, even though transmission risk is low when effective antiretroviral treatment (ART) is used. Reduced HIV testing may reduce the impact of HIV "test and treat" strategies. We aimed to quantify the potential impact of non-disclosure prosecutions on HIV testing and transmission among MSM. Methods MSM attending an HIV and primary care clinic in Toronto completed an audio computer-assisted self-interview questionnaire. HIV-negative participants were asked concern over non-disclosure prosecution altered their likelihood of HIV testing. Responses were characterized using cross-tabulations and bivariate logistic regressions. Flow charts modelled how changes in HIV testing behaviour impacted HIV transmission rates controlling for ART use, condom use and HIV status disclosure. Results 150 HIV-negative MSM were recruited September 2010 to June 2012. 7% (9/124) were less or much less likely to be tested for HIV due to concern over future prosecution. Bivariate regression showed no obvious socio/sexual demographic characteristics associated with decreased willingness of HIV testing to due concern about prosecution. Subsequent models estimated that this 7% reduction in testing could cause an 18.5% increase in community HIV transmission, 73% of which was driven by the failure of HIV-positive but undiagnosed MSM to access care and reduce HIV transmission risk by using ART. Conclusions Fear of prosecution over HIV non-disclosure was reported to reduce HIV testing willingness by a minority of HIV-negative MSM in Toronto; however, this reduction has the potential to significantly increase HIV transmission at the community level which has important public health implications.	[Kesler, Maya A.; Myers, Ted; Remis, Robert S.; Gesink, Dionne] Univ Toronto, Dalla Lana Sch Publ Hlth, Dept Epidemiol, Toronto, ON, Canada; [Kaul, Rupert] Univ Toronto, Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Loutfy, Mona] Womens Coll Hosp, Toronto, ON, Canada; [Loutfy, Mona; Brunetta, Jason] Maple Leaf Med Clin, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Kesler, MA (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Dept Epidemiol, Toronto, ON, Canada.	maya.kesler@alum.utoronto.ca		Kaul, Rupert/0000-0002-1586-4093	Canadian Institute of Health Research, Canada; Canadian Institutes of Health Research, Canada [HET 85518]	Canadian Institute of Health Research, Canada(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research, Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research, Canada, Doctoral Research Award: MK, http://www.cihr-irsc.gc.ca/e/ 193.html; Canadian Institutes of Health Research, Canada, Emerging Team Grant: grant number HET 85518, RK, RR, http://www.cihr-irsc.gc.cate/193. html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COCHRANE DATABASE SY; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Burchell AN, 2015, JAIDS-J ACQ IMM DEF, V70, pE10, DOI 10.1097/QAI.0000000000000690; Burris S, 2007, ARIZONA STATE LAW J; Cameron Edwin, 2009, HIV AIDS POLICY LAW, V14, P1; Canadian HIV/AIDS Legal Network, HIV NOND CRIM LAW AN; Canadian HIV/AIDS Legal Network, CRIM LAW HIV NOND CA; Canadian HIV/AIDS Legal Network HIV/AIDS Legal Clinic Ontario (HALCO) Coalition des organismes communautaires quebecois de lutte contre le sida (COCQ-SIDA) Positive Living Society of British Columbia (Positive Living BC) Canadian AIDS Society (CAS) Toronto People With AIDS Foundation (PWA), UNJ SUPR COURT RUL C; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Davis KR, 1999, FAM PLANN PERSPECT, V31, P272, DOI 10.2307/2991537; Fox J, 2009, HIV MED, V10, P432, DOI 10.1111/j.1468-1293.2009.00708.x; Galletly CL, 2008, J LAW MED ETHICS, V36, P577, DOI 10.1111/j.1748-720X.2008.306.x; Galletly CL, 2012, AM J PUBLIC HEALTH, V102, P2135, DOI 10.2105/AJPH.2012.300664; Galletly CL, 2012, AIDS CARE, V24, P174, DOI 10.1080/09540121.2011.603493; Grulich AE, 2015, C RETR OPP INF CROI; Hermann Donald H J, 1990, St Louis Univ Public Law Rev, V9, P351; Horvath KJ, 2010, AIDS CARE, V22, P1221, DOI 10.1080/09540121003668078; Horvath KJ, 2016, AIDS BEHAV; Kesler MA, 2016, BMC PUBLIC IN PRESS; Lazzarini Z, 2002, J LAW MED ETHICS, V30, P239, DOI 10.1111/j.1748-720X.2002.tb00390.x; Lehman JS, 2014, AIDS BEHAV, V18, P997, DOI 10.1007/s10461-014-0724-0; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Miller WC, 2010, CURR OPIN HIV AIDS, V5, P277, DOI 10.1097/COH.0b013e32833a0d3a; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Myers T, MALE CALL CANADA TEC; Mykhalovskiy E., 2010, HIV NONDISCLOSURE CR; Mykhalovskiy E., 2016, RACIALIZATION IMMIGR; Mykhalovskiy E, 2012, CAN J LAW SOC, V27, P31, DOI 10.3138/cjls.27.1.031; O'Byrne P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-94; O'Byrne P, 2013, J ASSOC NURSE AIDS C, V24, P81, DOI 10.1016/j.jana.2012.01.009; O'Connell AA, 2015, AIDS BEHAV, V19, P283, DOI 10.1007/s10461-014-0848-2; Ontario Advisory Committee on HIV/ AIDS, 2017, HIV AIDS STRAT 2026; Patterson SE, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20572; Pinkerton SD, 2007, AIDS BEHAV, V11, P698, DOI 10.1007/s10461-006-9187-2; Public Health Agency of Canada, 2015, SUMM EST HIV INC PRE; Remis RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158090; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Shimeles H, 2011, AFRICAN CAIBBEAN BLA; Smith DK, 2015, JAIDS-J ACQ IMM DEF, V68, P337, DOI 10.1097/QAI.0000000000000461; Smith K, 2011, CURR OPIN HIV AIDS, V6, P315, DOI 10.1097/COH.0b013e32834788e7; Tanner Z, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1926-z; Wainberg MA, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-108; Wilson C., 2013, HLTH TOMORROW, V1, P109	43	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193269	10.1371/journal.pone.0193269	http://dx.doi.org/10.1371/journal.pone.0193269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489890	gold, Green Published, Green Submitted			2022-12-26	WOS:000426276000059
J	Molcho, L; Ben-Zur, T; Barhum, Y; Offen, D				Molcho, Lior; Ben-Zur, Tali; Barhum, Yael; Offen, Daniel			DJ-1 based peptide, ND-13, promote functional recovery in mouse model of focal ischemic injury	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ZINC SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; PARKINSONS-DISEASE; CEREBRAL-ISCHEMIA; GLUTAMATE NEUROTOXICITY; STROKE REHABILITATION; MOTOR RECOVERY; NEURONAL DEATH; CELL-DEATH	Stroke is a leading cause of death worldwide and inflicts serious long-term damage and disability. The vasoconstrictor Endothelin-1, presenting long-term neurological deficits associated with excitotoxicity and oxidative stress is being increasingly used to induce focal ischemic injury as a model of stroke. A DJ-1 based peptide named ND-13 was shown to protect against glutamate toxicity, neurotoxic insults and oxidative stress in various animal models. Here we focus on the benefits of treatment with ND-13 on the functional outcome of focal ischemic injury. Wild type C57BL/6 mice treated with ND-13, after ischemic induction in this model, showed significant improvement in motor function, including improved body balance and motor coordination, and decreased motor asymmetry. We found that DJ-1 knockout mice are more sensitive to Endothelin-1 ischemic insult than wild type mice, contributing thereby additional evidence to the widely reported relevance of DJ-1 in neuroprotection. Furthermore, treatment of DJ-1 knockout mice with ND-13, following Endothelin-1 induced ischemia, resulted in significant improvement in motor functions, suggesting that ND-13 provides compensation for DJ-1 deficits. These preliminary results demonstrate a possible basis for clinical application of the ND-13 peptide to enhance neuroprotection in stroke patients.	[Molcho, Lior; Offen, Daniel] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Ben-Zur, Tali; Barhum, Yael; Offen, Daniel] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Lab Neurosci, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Offen, D (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.; Offen, D (corresponding author), Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Lab Neurosci, Tel Aviv, Israel.	danioffen@gmail.com			UGH Pharma, Inc. [ND-13]	UGH Pharma, Inc.	UGH Pharma, Inc. supplied the peptide (ND-13) used in the studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2002, MOL BIOL CELL GARLAN; Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; BEEM KM, 1974, J BIOL CHEM, V249, P7298; Brooks SP, 2011, NEUROMETHODS, V61, P65, DOI 10.1007/978-1-61779-298-4_5; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Chao NJ, 2014, CURR MED CHEM, V21, P2043, DOI 10.2174/0929867321666131228204533; Chehaibi K, 2016, J STROKE CEREBROVASC; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; Deng P, 2011, J CEREBR BLOOD F MET, V31, P1823, DOI 10.1038/jcbfm.2011.88; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doeppner TR, 2010, EXP NEUROL, V223, P548, DOI 10.1016/j.expneurol.2010.02.001; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fisher M, 1996, NEUROLOGY, V47, P884, DOI 10.1212/WNL.47.4.884; FUXE K, 1989, ACTA PHYSIOL SCAND, V137, P155, DOI 10.1111/j.1748-1716.1989.tb08733.x; Girotto S, 2014, J BIOL CHEM, V289, P10887, DOI 10.1074/jbc.M113.535112; Glat MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148170; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Gou X, 2010, TAT NEP1 40 NOVEL TH; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; Horie N, 2008, J NEUROSCI METH, V173, P286, DOI 10.1016/j.jneumeth.2008.06.013; Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200; Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kaneko Y, 2014, CNS NEUROSCI THER, V20, P275, DOI 10.1111/cns.12208; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kitamura Y, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-48; KUROSAWA M, 1991, J CARDIOVASC PHARM, V17, pS340, DOI 10.1097/00005344-199100177-00097; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lev N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127549; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; MELLORS A, 1966, J BIOL CHEM, V241, P4353; MELLORS A, 1966, LIPIDS, V1, P282, DOI 10.1007/BF02531617; Milani P, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/836760; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Murphy AN, 1999, J CEREBR BLOOD F MET, V19, P231, DOI 10.1097/00004647-199903000-00001; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nguemeni C, 2015, J NEUROSCI METH, V242, P72, DOI 10.1016/j.jneumeth.2015.01.005; O'Dell MW, 2009, ANNU REV MED, V60, P55, DOI 10.1146/annurev.med.60.042707.104248; Pantcheva P, 2014, NEURAL REGEN RES, V9, P1430, DOI 10.4103/1673-5374.139458; Runden-Pran E, 2002, NEUROSCIENCE, V112, P277, DOI 10.1016/S0306-4522(02)00092-1; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schwenk J, 2008, J BIOL CHEM, V283, P18937, DOI 10.1074/jbc.M800976200; Shah NH, 2014, TRANSL STROKE RES, V5, P38, DOI 10.1007/s12975-013-0297-7; Shalit T, 2015, J PROTEOME RES, V14, P1979, DOI 10.1021/pr501045t; Singh P, 2003, MOL CELL BIOCHEM, V243, P139, DOI 10.1023/A:1021668314070; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Tao F, 2008, MOL THER, V16, P1776, DOI 10.1038/mt.2008.192; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; van der Merwe C, 2015, EUR J NEUROSCI, V41, P1113, DOI 10.1111/ejn.12872; Van Vranken JG, 2014, CELL METAB, V20, P241, DOI 10.1016/j.cmet.2014.05.012; Vergun O, 2001, J PHYSIOL-LONDON, V531, P147, DOI 10.1111/j.1469-7793.2001.0147j.x; Vonk WIM, 2010, J BIOL CHEM, V285, P28991, DOI 10.1074/jbc.M110.101477; Waak J, 2009, FASEB J, V23, P2478, DOI 10.1096/fj.08-125153; WADE DT, 1992, CURR OPIN NEUROL NEU, V5, P682; WAHL F, 1992, STROKE, V23, P267, DOI 10.1161/01.STR.23.2.267; Wang YQ, 2015, AUTOPHAGY, V11, P595, DOI 10.1080/15548627.2015.1034408; Yanagida T, 2009, OXID MED CELL LONGEV, V2, P36, DOI 10.4161/oxim.2.1.7985; Yanagisawa D, 2008, J CEREBR BLOOD F MET, V28, P563, DOI 10.1038/sj.jcbfm.9600553	70	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192954	10.1371/journal.pone.0192954	http://dx.doi.org/10.1371/journal.pone.0192954			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489843	gold, Green Published, Green Submitted			2022-12-26	WOS:000426276000048
J	Lee, K; Park, N; Jung, H; Rim, YA; Nam, Y; Lee, J; Park, SH; Ju, H				Lee, Kijun; Park, Narae; Jung, Hyerin; Rim, Yeri Alice; Nam, Yoojun; Lee, Jennifer; Park, Sung-Hwan; Ju, Hyeon			Mesenchymal stem cells ameliorate experimental arthritis via expression of interleukin-1 receptor antagonist	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; TH17 CELLS; GM-CSF; IL-1; CYTOKINE; COLLAGEN; PATHOGENESIS; PATHWAYS; ANAKINRA	Human bone marrow-derived mesenchymal stem cells (MSCs) have been observed to inhibit arthritis in experimental animal models such as collagen-induced arthritis. However, the exact anti-inflammatory mechanisms remain poorly understood. Interleukin-1 receptor antagonist (IL-1Ra) is an anti-inflammatory cytokine produced by immune and stromal cells. We postulated that MSCs could produce IL-1Ra and attenuate experimental arthritis. In this study, 5x10(6) MSCs were injected into the peritoneal cavity of IL-1Ra knockout (IL-1RaKO) mice. MSCs reduced the severity of the arthritis by histology and decreased pro-inflammatory cytokine levels in IL-1RaKO mice. The ratio of splenic T helper 17 (Th17) cells to regulatory T cells (Treg) was significantly decreased in MSC-injected IL-1RaKO mice. Purified splenic CD4+ T cells from mice in each of the treatment groups were cultured under Th17 polarizing conditions and analyzed by flow cytometry. Less expansion of the Th17 population was observed in the MSC-treated group. Interestingly, MSCs expressed inducible IL-1Ra against inflammatory environmental stimuli. Human recombinant IL-1Ra could suppress Th17 cells differentiation under Th17 polarizing conditions. These results indicate that IL-1Ra expressed by MSCs can inhibit Th17 polarization and decrease the immune response in IL-1RaKO mice. Therefore, MSC-derived IL-1Ra may inhibit inflammation in IL-1RaKO mice via effects on Th17 differentiation.	[Lee, Kijun; Park, Narae; Jung, Hyerin; Rim, Yeri Alice; Nam, Yoojun; Ju, Hyeon] Catholic Univ Korea, Coll Med, Catholic iPSC Res Ctr, Seoul, South Korea; [Lee, Jennifer; Park, Sung-Hwan; Ju, Hyeon] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Rheumatol,Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Ju, H (corresponding author), Catholic Univ Korea, Coll Med, Catholic iPSC Res Ctr, Seoul, South Korea.; Ju, H (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Rheumatol,Dept Internal Med, Seoul, South Korea.	juji@catholic.ac.kr		Ju, Ji Hyeon/0000-0002-1381-5466	Korea Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [HI16C2177]; Ministry of Food and Drug Safety [14172MFDS974]	Korea Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This work was supported by a grant of the Korea Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (HI16C2177) and by a grant (14172MFDS974) from Ministry of Food and Drug Safety.	Arend WP, 2001, SEMIN ARTHRITIS RHEU, V30, P1, DOI 10.1053/sarh.2001.23693; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Ben-Ami E, 2011, AUTOIMMUN REV, V10, P410, DOI 10.1016/j.autrev.2011.01.005; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; Chiang CY, 1999, INFECT IMMUN, V67, P4231, DOI 10.1128/IAI.67.8.4231-4236.1999; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Cohen SB, 2004, RHEUM DIS CLIN N AM, V30, P365, DOI 10.1016/j.rdc.2004.01.005; Cunnane G, 2001, RHEUMATOLOGY, V40, P62, DOI 10.1093/rheumatology/40.1.62; De Miguel MP, 2012, CURR MOL MED, V12, P574; DEBLECOURT J, 1961, ANN RHEUM DIS, V20, P215, DOI 10.1136/ard.20.3.215; Farooq SM, 2014, J CELL MOL MED, V18, P2512, DOI 10.1111/jcmm.12376; Farooq SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048635; Figueroa FE, 2012, BIOL RES, V45, P269, DOI 10.4067/S0716-97602012000300008; Fleischmann R, 2004, EXPERT OPIN BIOL TH, V4, P1333, DOI 10.1517/14712598.4.8.1333; Gabay C, 1998, SPRINGER SEMIN IMMUN, V20, P229, DOI 10.1007/s002810050032; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Gathungu G, 2013, INFLAMM BOWEL DIS, V19, P1671, DOI 10.1097/MIB.0b013e318281f506; GEIGER T, 1993, CLIN EXP RHEUMATOL, V11, P515; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Goolaerts A, 2014, AM J PHYSIOL-LUNG C, V306, pL975, DOI 10.1152/ajplung.00242.2013; Haddad CS, 2016, AUTOIMMUNITY, V49, P298, DOI 10.1080/08916934.2016.1183657; Herder C, 2009, DIABETES CARE, V32, P421, DOI 10.2337/dc08-1161; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Ikeda S, 2014, J IMMUNOL, V192, P1449, DOI 10.4049/jimmunol.1300387; Kean TJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/732742; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Koenders MI, 2008, ARTHRITIS RHEUM-US, V58, P3461, DOI 10.1002/art.23957; Kyurkchiev Dobroslav, 2014, World J Stem Cells, V6, P552, DOI 10.4252/wjsc.v6.i5.552; Listing J, 2013, RHEUMATOLOGY, V52, P53, DOI 10.1093/rheumatology/kes305; Luz-Crawford P, 2016, STEM CELLS, V34, P483, DOI 10.1002/stem.2254; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Malyak M, 1998, J IMMUNOL, V161, P2004; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Park N, 2017, SCI REP-UK, V7, DOI 10.1038/srep39593; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Schett G, 2016, NAT REV RHEUMATOL, V12, P14, DOI 10.1038/nrrheum.2016.166; Schiff MH, 2000, ANN RHEUM DIS, V59, P103, DOI 10.1136/ard.59.suppl_1.i103; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Volarevic V, 2010, AUTOIMMUNITY, V43, P255, DOI 10.3109/08916930903305641; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; Walker JG, 1999, RHEUMATOLOGY, V38, P1050, DOI 10.1093/rheumatology/38.11.1050; Wilson T, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/345806; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762	46	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0193086	10.1371/journal.pone.0193086	http://dx.doi.org/10.1371/journal.pone.0193086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481574	Green Published, gold, Green Submitted			2022-12-26	WOS:000426202700008
J	Arroyo, AI; Pueyo, Y; Giner, ML; Foronda, A; Sanchez-Navarrete, P; Saiz, H; Alados, CL				Arroyo, Antonio I.; Pueyo, Yolanda; Luz Giner, M.; Foronda, Ana; Sanchez-Navarrete, Pedro; Saiz, Hugo; Alados, Concepcion L.			Evidence for chemical interference effect of an allelopathic plant on neighboring plant species: A field study	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITIES; ARTEMISIA-HERBA-ALBA; ACTIVATED CARBON; GERMINATION; COMPETITION; FACILITATION; RESTORATION; MECHANISM; GRADIENT; STRESS	Many studies have reported the phytotoxicity of allelopathic compounds under controlled conditions. However, more field studies are required to provide realistic evidences for the significance of allelopathic interference in natural communities. We conducted a 2-years field experiment in a semiarid plant community (NE Spain). Specifically, we planted juvenile individuals and sowed seeds of Salsola vermiculata L., Lygeum spartum L. and Artemisia herba-alba Asso. (three co-dominant species in the community) beneath adult individuals of the allelopathic shrub A. herba-alba, and assessed the growth, vitality, seed germination and seedling survival of those target species with and without the presence of chemical interference by the incorporation of activated carbon (AC) to the soil. In addition, juveniles and seeds of the same three target species were planted and sown beneath the canopy of adults of S. vermiculata (a shrub similar to A. herba-alba, but non-allelopathic) and in open bare soil to evaluate whether the allelopathic activity of A. herba-alba modulates the net outcome of its interactions with neighboring plants under contrasting abiotic stress conditions. We found that vitality of A. herba-alba juveniles was enhanced beneath A. herba-alba individuals when AC was present. Furthermore, we found that the interaction outcome in A. herba-alba microsite was neutral, whereas a positive outcome was found for S. vermiculata microsite, suggesting that allelopathy may limit the potential facilitative effects of the enhanced microclimatic conditions in A. herba-alba microsite. Yet, L. spartum juveniles were facilitated in A. herba-alba microsite. The interaction outcome in A. herba-alba microsite was positive under conditions of very high abiotic stress, indicating that facilitative interactions predominated over the interference of allelopathic plants under those conditions. These results highlight that laboratory studies can overestimate the significance of allelopathy in nature, and consequently, results obtained under controlled conditions should be interpreted carefully.	[Arroyo, Antonio I.; Pueyo, Yolanda; Luz Giner, M.; Foronda, Ana; Sanchez-Navarrete, Pedro; Alados, Concepcion L.] CSIC, Inst Pirenaico Ecol, Zaragoza, Spain; [Saiz, Hugo] Univ Rey Juan Carlos, Dept Biol & Geol, Fis & Quim Inorgan, Mostoles, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Universidad Rey Juan Carlos	Arroyo, AI (corresponding author), CSIC, Inst Pirenaico Ecol, Zaragoza, Spain.	antoigam@gmail.com	Alados, Concepción L/K-8085-2014; Pueyo, Yolanda/I-4248-2015; SANCHEZ NAVARRRETE, PEDRO/K-7753-2014	Alados, Concepción L/0000-0002-6227-861X; Foronda, Ana/0000-0002-6001-2228; Pueyo, Yolanda/0000-0001-6970-7790; Arroyo Martinez, Antonio Ignacio/0000-0002-9559-5785; SANCHEZ NAVARRRETE, PEDRO/0000-0002-6924-8771	Spanish Ministry of Education, Culture and Sport [AP-2012-4126]; Spanish Ministry of Economy, Industry and Competitiveness [CGL-2012-37508, CGL-2016-80783-R]; European Research Council (ERC) [647038]	Spanish Ministry of Education, Culture and Sport; Spanish Ministry of Economy, Industry and Competitiveness; European Research Council (ERC)(European Research Council (ERC)European Commission)	This research was funded by the Spanish Ministry of Education, Culture and Sport (grant AP-2012-4126 to A.I.A.; FPU Program) and the Spanish Ministry of Economy, Industry and Competitiveness (projects CGL-2012-37508 and CGL-2016-80783-R). H.S. is supported by the European Research Council (ERC Grant agreement 647038 [BIODESERT]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas C, 2005, J ECOL, V93, P978, DOI 10.1111/j.1365-2745.2005.01033.x; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Armas C, 2011, ACTA OECOL, V37, P284, DOI 10.1016/j.actao.2011.02.013; Arroyo AI, 2018, J ARID ENVIRON, V151, P1, DOI 10.1016/j.jaridenv.2017.11.010; Arroyo AI, 2017, J PLANT ECOL, V10, P927, DOI 10.1093/jpe/rtw120; Arroyo AI, 2015, ECOL EVOL, V5, P5305, DOI 10.1002/ece3.1770; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Castaldi S, 2009, PLANT SOIL, V315, P273, DOI 10.1007/s11104-008-9750-x; Chomel M, 2016, J ECOL, V104, P1527, DOI 10.1111/1365-2745.12644; Cipollini KA, 2008, AM MIDL NAT, V160, P117, DOI 10.1674/0003-0031(2008)160[117:SAABEO]2.0.CO;2; da Silva ER, 2015, PLANT ECOL, V216, P87, DOI 10.1007/s11258-014-0418-8; Del Fabbro C, 2014, BIOL INVASIONS, V16, P1035, DOI 10.1007/s10530-013-0555-3; Dobbertin M, 2005, EUR J FOREST RES, V124, P319, DOI 10.1007/s10342-005-0085-3; Ehlers BK, 2014, J ECOL, V102, P176, DOI 10.1111/1365-2745.12171; EINHELLIG FA, 1995, ACS SYM SER, V582, P1; Escudero A, 2000, PLANT ECOL, V148, P71, DOI 10.1023/A:1009848215019; FRIEDMAN J, 1977, J ECOL, V65, P413, DOI 10.2307/2259491; FRIEDMAN J, 1987, ACS SYM SER, V330, P53; Gardener M, 2014, DATA WILD, P1; Gniazdowska A, 2005, ACTA PHYSIOL PLANT, V27, P395, DOI 10.1007/s11738-005-0017-3; Gomez-Aparicio L, 2008, J ECOL, V96, P447, DOI 10.1111/j.1365-2745.2007.01352.x; Grondahl E, 2008, J ECOL, V96, P981, DOI 10.1111/j.1365-2745.2008.01407.x; HEANES DL, 1984, COMMUN SOIL SCI PLAN, V15, P1191, DOI 10.1080/00103628409367551; Hierro JL, 2003, PLANT SOIL, V256, P29, DOI 10.1023/A:1026208327014; Hille M, 2005, OIKOS, V108, P202, DOI 10.1111/j.0030-1299.2005.13482.x; Inderjit, 2000, J CHEM ECOL, V26, P2111, DOI 10.1023/A:1005516431969; Inderjit, 2005, J PLANT INTERACT, V1, P69, DOI 10.1080/17429140600622535; Jankju M, 2013, J ARID ENVIRON, V89, P103, DOI 10.1016/j.jaridenv.2012.09.008; Kabouw P, 2010, SOIL BIOL BIOCHEM, V42, P1165, DOI 10.1016/j.soilbio.2010.02.022; Kaur H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004700; Kikvidze Z, 2010, POSITIVE PLANT INTERACTIONS AND COMMUNITY DYNAMICS, P17; Kobayashi Katsuichiro, 2004, Weed Biology and Management, V4, P1, DOI 10.1111/j.1445-6664.2003.00112.x; Kulmatiski A, 2011, RESTOR ECOL, V19, P102, DOI 10.1111/j.1526-100X.2009.00632.x; Lau JA, 2008, NEW PHYTOL, V178, P412, DOI 10.1111/j.1469-8137.2007.02360.x; Li S, 2016, FIELD CROP RES, V196, P452, DOI 10.1016/j.fcr.2016.08.005; Li YP, 2017, J APPL ECOL, V54, P1281, DOI 10.1111/1365-2664.12878; Lorenzo P, 2017, J PLANT ECOL, V10, P610, DOI 10.1093/jpe/rtw061; Macek P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00662; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; NILSSON MC, 1994, OECOLOGIA, V98, P1, DOI 10.1007/BF00326083; Nilsson MC, 2000, OECOLOGIA, V123, P122, DOI 10.1007/s004420050997; Lopez RP, 2016, ECOLOGY, V97, P1593, DOI 10.1890/15-1152.1; Pedrol N, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P171, DOI 10.1007/1-4020-4280-9_9; Pinheiro J, R PACKAGE VERSION; Pisula NL, 2010, AM MIDL NAT, V163, P161, DOI 10.1674/0003-0031-163.1.161; Pueyo Y, 2005, THESIS; Pueyo Y, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1514; R Core Team, 2016, R FDN STAT COMP; Rice E. L., 1984, Allelopathy.; Schob C, 2013, OIKOS, V122, P1371, DOI 10.1111/j.1600-0706.2013.00390.x; Sotomayor DA, 2014, AUSTRAL ECOL, V39, P786, DOI 10.1111/aec.12144; STOWE LG, 1979, J ECOL, V67, P1065, DOI 10.2307/2259228; Therneau T., 2015, PACKAGE SURVIVAL ANA; Thorpe AS, 2011, J ECOL, V99, P729, DOI 10.1111/j.1365-2745.2011.01802.x; Tilaki GAD, 2013, LEGUME RES, V36, P33; TILMAN D, 1988; Vivanco JM, 2004, ECOL LETT, V7, P285, DOI 10.1111/j.1461-0248.2004.00576.x; Wardle DA, 1998, BIOL REV, V73, P305, DOI 10.1017/S0006323198005192; Weisshuhn K, 2009, BASIC APPL ECOL, V10, P500, DOI 10.1016/j.baae.2008.10.009; Woods NN, 2016, J ARID ENVIRON, V124, P72, DOI 10.1016/j.jaridenv.2015.07.012; Yuan YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097163; Zhang CL, 2016, FOREST ECOL MANAG, V375, P76, DOI 10.1016/j.foreco.2016.05.013	66	7	8	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193421	10.1371/journal.pone.0193421	http://dx.doi.org/10.1371/journal.pone.0193421			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474430	Green Published, gold			2022-12-26	WOS:000426049500106
J	Misterska, E; Glowacki, J; Glowacki, M; Okret, A				Misterska, Ewa; Glowacki, Jakub; Glowacki, Maciej; Okret, Adam			Long-term effects of conservative treatment of Milwaukee brace on body image and mental health of patients with idiopathic scoliosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; FOLLOW-UP; RESEARCH-SOCIETY; HARRINGTON INSTRUMENTATION; NATURAL-HISTORY; SURGICAL-TREATMENT; CURVE PROGRESSION; TREATED SCOLIOSIS; BACK-PAIN; QUESTIONNAIRE	We aimed to provide a complex assessment of adult females with adolescent idiopathic scoliosis (AIS) after a minimum of 23 years after completed Milwaukee brace treatment. In the present study, a comparison between healthy female and AIS patients' perception of trunk disfigurement, self-image, mental health, pain level and everyday activity was made. Thirty AIS patients with a mean of 27.77 yrs (SD 3.30) after the treatment were included in the study. The control group consisted of 42 females, matching the age profile of the patient group. Study participants from both groups were examined using the same protocol, except for the radiological evaluation. Patients and healthy controls completed the Polish versions of the Scoliosis Research Society (SRS-22) and Spinal Appearance Questionnaire (SAQ). Patients additionally filled the Bad Sobberheim Stress Questionnaire-Deformity (BSSQ-Deformity) and Bad Sobberheim Stress Questionnaire-Brace (BSSQ-Brace). The study group's SAQ results differ significantly in regard to the total score and all individual domains, indicating better functioning among healthy controls. Except for the General domain (p = 0.002), among the remaining subscales the study group's results differed significantly at p<0.001. Considering SRS-22 results, it was revealed that the patient group scored higher, signaling better functioning with reference to pain level (p = 0.016), function/activity (p< 0.001) and the total score (p<0.001). The findings add to the complexity of long-term effect evaluations of AIS, particularly amongst females treated with a Milwaukee brace. Long-term results were not conclusive in terms of nonverbal assessment of body image and emotional tension regarding the experiences of brace-wearing. Future patients can be reassured that scoliosis treated conservatively does not negatively affect everyday activity, pain level, childbearing and mental health. Subjects who declared to have psychological problems due to scoliosis had a bigger curve size after treatment and in this study than the other AIS patients.	[Misterska, Ewa] Univ Secur, Dept Pedag & Psychol, Poznan, Poland; [Glowacki, Jakub; Okret, Adam] HCP Med Ctr, Poznan, Poland; [Glowacki, Maciej] Poznan Univ Med Sci, Dept Pediat Orthopaed & Traumatol, Poznan, Poland	Poznan University of Medical Sciences	Misterska, E (corresponding author), Univ Secur, Dept Pedag & Psychol, Poznan, Poland.	emisterska1@wp.pl		Glowacki, Jakub/0000-0002-8200-742X				Andersen MO, 2006, SPINE, V31, P350, DOI 10.1097/01.brs.0000197649.29712.de; APTER A, 1978, CLIN ORTHOP RELAT R, P156; ASCANI E, 1986, SPINE, V11, P784, DOI 10.1097/00007632-198610000-00007; Asher M, 2003, SPINE, V28, P74, DOI 10.1097/00007632-200301010-00017; Asher M, 2003, SPINE, V28, P63, DOI 10.1097/00007632-200301010-00015; Asher Marc, 2002, Stud Health Technol Inform, V91, P462; Benli IT, 2007, EUR SPINE J, V16, P381, DOI 10.1007/s00586-006-0147-3; Berven S, 2003, SPINE, V28, P2164, DOI 10.1097/01.BRS.0000084666.53553.D6; Botens-Helmus C, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-22; Chaib Y, 2013, ORTHOP TRAUMATOL-SUR, V99, P441, DOI 10.1016/j.otsr.2013.03.012; CLAYSON D, 1987, SPINE, V12, P983, DOI 10.1097/00007632-198712000-00007; Climent JM, 1999, SPINE, V24, P1903, DOI 10.1097/00007632-199909150-00007; COCHRAN T, 1983, SPINE, V8, P576, DOI 10.1097/00007632-198309000-00003; Coillard C, 2014, EUR J PHYS REHAB MED, V50, P479; CONNOLLY PJ, 1995, J BONE JOINT SURG AM, V77A, P1210, DOI 10.2106/00004623-199508000-00011; Cordover AM, 1997, J SPINAL DISORD, V10, P193; Danielsson AJ, 2007, SPINE, V32, P2198, DOI 10.1097/BRS.0b013e31814b851f; Danielsson AJ, 2001, SPINE, V26, P516; Danielsson AJ, 2001, EUR SPINE J, V10, P278, DOI 10.1007/s005860100309; Danielsson AJ, 2001, SPINE, V26, P1449, DOI 10.1097/00007632-200107010-00015; Danielsson AJ, 2003, SPINE, V28, P2078; DICKSON JH, 1990, J BONE JOINT SURG AM, V72A, P678, DOI 10.2106/00004623-199072050-00006; Dyl J, 2006, CHILD PSYCHIAT HUM D, V36, P369, DOI 10.1007/s10578-006-0008-7; FALLSTROM K, 1986, SPINE, V11, P756; Ferguson CJ, 2011, J SOC CLIN PSYCHOL, V30, P458, DOI 10.1521/jscp.2011.30.5.458; FOWLES JV, 1978, CLIN ORTHOP RELAT R, P212; Gabos PG, 2004, J BONE JOINT SURG AM, V86A, P1891, DOI 10.2106/00004623-200409000-00006; Glowacki M, 2009, SPINE, V34, P1060, DOI 10.1097/BRS.0b013e31819c1ec3; GOLDSTEIN JM, 1991, SPINE, V16, P1150, DOI 10.1097/00007632-199110000-00004; GORTMAKER SL, 1993, J RES ADOLESCENCE, V0003; Gotze C, 2002, SPINE, V27, P1456, DOI 10.1097/00007632-200207010-00016; GRATZ RR, 1984, J ADOLESCENT HEALTH, V5, P237, DOI 10.1016/S0197-0070(84)80124-2; Grevitt M, 1997, J BONE JOINT SURG BR, V79B, P48, DOI 10.1302/0301-620X.79B1.1269; Haher TR, 1999, SPINE, V24, P1435, DOI 10.1097/00007632-199907150-00008; Helenius I, 2002, SPINE, V27, P176, DOI 10.1097/00007632-200201150-00010; Kotwicki T, 2007, SCOLIOSIS SPINAL DIS, V2, DOI 10.1186/1748-7161-2-1; Lonner B, 2013, SPINE, V38, P1049, DOI 10.1097/BRS.0b013e3182893c01; Maruyama Toru, 2011, Physiotherapy Theory and Practice, V27, P43, DOI 10.3109/09593985.2010.503992; Misterska E, 2011, MED SCI MONITOR, V17, pCR404, DOI 10.12659/MSM.881852; Misterska E, 2009, EUR SPINE J, V18, P1911, DOI 10.1007/s00586-009-1126-2; Mori K, 2009, PEDIATR INT, V51, P507, DOI 10.1111/j.1442-200X.2008.02771.x; MOSKOWITZ A, 1980, J BONE JOINT SURG AM, V62, P364, DOI 10.2106/00004623-198062030-00006; NACHEMSON A, 1968, ACTA ORTHOP SCAND, V39, P466, DOI 10.3109/17453676808989664; NACHEMSON AL, 1995, J BONE JOINT SURG AM, V77A, P815, DOI 10.2106/00004623-199506000-00001; Negrini S, 2016, SPINE, V41, P1813, DOI 10.1097/BRS.0000000000001887; NILSONNE U, 1968, ACTA ORTHOP SCAND, V39, P456, DOI 10.3109/17453676808989663; Noonan KJ, 1997, J PEDIATR ORTHOPED, V17, P712, DOI 10.1097/00004694-199711000-00004; Noonan KJ, 1996, J BONE JOINT SURG AM, V78A, P557, DOI 10.2106/00004623-199604000-00009; Reichel Dagmar, 2003, Pediatr Rehabil, V6, P221; Robinson E., 1997, VISIBLY DIFFERENT CO, P102; Sanders JO, 2007, SPINE, V32, P2719, DOI 10.1097/BRS.0b013e31815a5959; Tones MJ, 2007, SCOLIOSIS SPINAL DIS, V2, DOI 10.1186/1748-7161-2-14; WEINSTEIN SL, 1981, J BONE JOINT SURG AM, V63, P702, DOI 10.2106/00004623-198163050-00003; Weinstein SL, 2013, NEW ENGL J MED, V369, P1512, DOI 10.1056/NEJMoa1307337; Weiss HR, 2006, ST HEAL T, V123, P347; Wiggins CG, 2003, NEUROSURG FOCUS, V14, pE3; Wiley JW, 2000, SPINE, V25, P2326, DOI 10.1097/00007632-200009150-00010	57	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193447	10.1371/journal.pone.0193447	http://dx.doi.org/10.1371/journal.pone.0193447			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX4LV	29474440	gold, Green Published, Green Submitted			2022-12-26	WOS:000426049500109
J	Bonar, M; Ellington, EH; Lewis, KP; Vander Wal, E				Bonar, Maegwin; Ellington, E. Hance; Lewis, Keith P.; Vander Wal, Eric			Implementing a novel movement-based approach to inferring parturition and neonate caribou calf survival	PLOS ONE			English	Article							RANGIFER-TARANDUS-CARIBOU; HABITAT SELECTION; SITE FIDELITY; DEER; ELK; BEHAVIOR; AGE	In ungulates, parturition is correlated with a reduction in movement rate. With advances in movement-based technologies comes an opportunity to develop new techniques to assess reproduction in wild ungulates that are less invasive and reduce biases. DeMars et al. (2013, Ecology and Evolution 3: 4149 +/- 4160) proposed two promising new methods (individual-and population-based; the DeMars model) that use GPS inter-fix step length of adult female caribou (Rangifer tarandus caribou) to infer parturition and neonate survival. Our objective was to apply the DeMars model to caribou populations that may violate model assumptions for retrospective analysis of parturition and calf survival. We extended the use of the DeMars model after assigning parturition and calf mortality status by examining herd-wide distributions of parturition date, calf mortality date, and survival. We used the DeMars model to estimate parturition and calf mortality events and compared them with the known parturition and calf mortality events from collared adult females (n = 19). We also used the DeMars model to estimate parturition and calf mortality events for collared female caribou with unknown parturition and calf mortality events (n = 43) and instead derived herd-wide estimates of calf survival as well as distributions of parturition and calf mortality dates and compared them to herd-wide estimates generated from calves fitted with VHF collars (n = 134). For our data, the individual-based method was effective at predicting calf mortality, but was not effective at predicting parturition. The population-based method was more effective at predicting parturition but was not effective at predicting calf mortality. At the herd-level, the predicted distributions of parturition date from both methods differed from each other and from the distribution derived from the parturition dates of VHF-collared calves (log-ranked test:chi(2) = 40.5, df = 2, p < 0.01). The predicted distributions of calf mortality dates from both methods were similar to the observed distribution derived from VHF-collared calves. Both methods underestimated herd-wide calf survival based on VHF-collared calves, however, a combination of the individual-and population-based methods produced herd-wide survival estimates similar to estimates generated from collared calves. The limitations we experienced when applying the DeMars model could result from the shortcomings in our data violating model assumptions. However despite the differences in our caribou systems, with proper validation techniques the framework in the DeMars model is sufficient to make inferences on parturition and calf mortality.	[Bonar, Maegwin; Ellington, E. Hance; Lewis, Keith P.; Vander Wal, Eric] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Ellington, E. Hance] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA; [Lewis, Keith P.] Fisheries & Oceans Canada, St John, NF, Canada	Memorial University Newfoundland; University System of Ohio; Ohio State University; Fisheries & Oceans Canada	Bonar, M (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF, Canada.	m.bonar@mun.ca	Ellington, E. Hance/AAA-9313-2019	Ellington, E. Hance/0000-0001-7899-2781	Natural Science and Engineering Research Council of Canada; Newfoundland and Labrador Research Development Corporation; Atlantic Computational Excellence Network Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Newfoundland and Labrador Research Development Corporation; Atlantic Computational Excellence Network Canada	Funding for this study was provided by the Natural Science and Engineering Research Council of Canada, The Newfoundland and Labrador Research Development Corporation and the Atlantic Computational Excellence Network Canada Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge members of the Newfoundland Wildlife Division including C. Doucet, W. Barney, F. Norman, R. Otto, J. Neville, P. Saunders, T. Porter, P. Tremblett, S. Gullage, T. Hodder, D. Jennings, J. McGinn, for data on NL caribou parturition dates. We thank T. Bergerud and S. Mahoney M. for their vision in initiating much of the work on caribou in NL. Frampton and P. McClement for data entry and management support. Logistical support on Fogo Island was provided by L. Bixby. We acknowledge M. P. Laforge, Q. M. R. Webber, and P. O'Brien for their help monitoring the caribou on Fogo Island. U.E. Schlagel, M. AugerMethe, and C.A. DeMars provided assistance with coding. We thank E. L. Koen, 1 for their helpful feedback on earlier drafts of this manuscript. Funding was provided by the Natural Science and Engineering Research Council of Canada, The Newfoundland and Labrador Research Development Corporation and the Atlantic Computational Excellence Network Canada Fellowship Program.	Barbknecht AE, 2011, J WILDLIFE MANAGE, V75, P646, DOI 10.1002/jwmg.100; Bastille-Rousseau G, 2013, CAN J ZOOL, V91, P820, DOI 10.1139/cjz-2013-0154; Bender LC, 2006, WILDLIFE SOC B, V34, P1225, DOI 10.2193/0091-7648(2006)34[1225:UOHCAA]2.0.CO;2; BERGERUD AT, 1996, RANGIFER, V9, P95, DOI DOI 10.7557/2.16.4.1225; Bergman CM, 2000, OECOLOGIA, V123, P364, DOI 10.1007/s004420051023; Bjorneraas K, 2010, J WILDLIFE MANAGE, V74, P1361, DOI 10.2193/2009-405; Bonar M, 2017, CAN J ZOOL, V95, P133, DOI 10.1139/cjz-2016-0245; Brook RK, 2010, CAN J ZOOL, V88, P968, DOI 10.1139/Z10-061; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carstensen M, 2003, WILDLIFE SOC B, V31, P634; Ciuti S, 2006, J ZOOL, V268, P97, DOI 10.1111/j.1469-7998.2005.00003.x; COSEWIC, 2014, WILDL SPEC ASS NOV 2; DeMars CA, 2013, ECOL EVOL, V3, P4149, DOI 10.1002/ece3.785; Dussault C, 2012, P ROY SOC B-BIOL SCI, V279, P4481, DOI 10.1098/rspb.2012.1700; Dzialak MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014597; Eberhardt LL, 2002, ECOLOGY, V83, P2841, DOI 10.2307/3072020; Ellington EH, 2017, J WILDLIFE MANAGE, P17; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/z11-025, 10.1139/Z11-025]; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Long RA, 2009, WILDLIFE BIOL, V15, P288, DOI 10.2981/09-003; Mahoney SP, 2016, POPUL ECOL, V58, P91, DOI 10.1007/s10144-015-0525-y; Nobert BR, 2016, CAN J ZOOL, V94, P837, DOI 10.1139/cjz-2015-0262; Schaefer JA, 2000, LANDSCAPE ECOL, V15, P731, DOI 10.1023/A:1008160408257; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Team RC, 2016, R LANG ENV STAT COMP; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; van Beest FM, 2013, J MAMMAL, V94, P691, DOI 10.1644/12-MAMM-A-080.1; Vore JM, 2001, WILDLIFE SOC B, V29, P720; Whiting JC, 2012, WILDLIFE RES, V39, P565, DOI 10.1071/WR12059; Wilmers CC, 2015, ECOLOGY, V96, P1741, DOI 10.1890/14-1401.1; Wittmer HU, 2006, CAN J ZOOL, V84, P537, DOI 10.1139/Z06-026; Wittmer HU, 2005, CAN J ZOOL, V83, P407, DOI [10.1139/z05-034, 10.1139/Z05-034]	33	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192204	10.1371/journal.pone.0192204	http://dx.doi.org/10.1371/journal.pone.0192204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466451	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300037
J	Dreyer, N; Olesen, J; Dahl, RB; Chan, BKK; Hoeg, JT				Dreyer, Niklas; Olesen, Jorgen; Dahl, Rikke Beckmann; Chan, Benny Kwok Kan; Hoeg, Jens Thorvald			Sex-specific metamorphosis of cypris larvae in the androdioecious barnacle Scalpellum scalpellum (Crustacea: Cirripedia: Thoracica) and its implications for the adaptive evolution of dwarf males	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; DEEP-SEA; LIFE-HISTORY; SYSTEMS; BALANOMORPHAN; RHIZOCEPHALA; SETTLEMENT; MORPHOLOGY; ANATOMY; HABITAT	Androdioecy (co-existence of hermaphrodites and dwarf males) is a fascinating yet poorly understood phenomenon. The pedunculated barnacle Scalpellum scalpellum is an emerging model species for the system. In S. scalpellum, dwarf males and hermaphrodites are very different in adult morphology (e.g., in feeding structures and reproductive organs), but they share the same larval development with nauplii followed by cypris larvae. Recently, it was found that S. scalpellum cypris larvae display both genetic and environmental sex determination, but no detailed morphological study has yet investigated how the settled cypris larvae differ subsequent to settlement. This study investigates the morphological aspects of the onset of sex determination in the cyprids of S. scalpellum by examining their metamorphosis into either dwarf males or hermaphrodites under laboratory conditions. This study emphasizes morphological differences, such as size and shape of primordial shell plates, development of a flexible peduncle and of thoracopods. It was shown that the cypris larvae start to differ already one day after settlement on either a hydroid (leading to hermaphrodites) or an adult hermaphrodite (leading to dwarf males). Dwarf males gradually developed an ovoid body shape and two pairs of circular scutal and tergal primordia. Such cyprids developed neither a carina nor any peduncle or cirri for feeding. The study concludes that the dwarf males of S. scalpellum are not just hermaphrodites arrested early in development. This entails that dwarf males constitute their own separate developmental pathways and points to S. scalpellum dwarf males being more specialized than previously stated. Finally, the study compares differences in dwarf male morphology between S. scalpellum with two other androdioecious species with less specialized dwarf males and use this to discuss evolutionary implications for the adaptive evolution of dwarf males across the Cirripedia.	[Dreyer, Niklas; Olesen, Jorgen] Nat Hist Museum Denmark, Sect Biosystemat, Copenhagen, Denmark; [Dahl, Rikke Beckmann] Nat Hist Museum Denmark, Sect Evogen, Copenhagen, Denmark; [Chan, Benny Kwok Kan] Acad Sinica, Res Ctr Biodivers, Taipei, Taiwan; [Hoeg, Jens Thorvald] Univ Copenhagen, Marine Biol Sect, Dept Biol, Copenhagen, Denmark	Academia Sinica - Taiwan; University of Copenhagen	Dreyer, N (corresponding author), Nat Hist Museum Denmark, Sect Biosystemat, Copenhagen, Denmark.	dreyer@snm.ku.dk	Olesen, Jørgen/A-3353-2013; Hoeg, Jens Thorvald/D-5784-2015	Olesen, Jørgen/0000-0001-9582-7083; Hoeg, Jens Thorvald/0000-0002-3596-1691; Dreyer, Niklas/0000-0002-1391-1642	Boje Benzons Stottefond; Laege HC Wegges Mindelegat; Danish Agency for Science and Innovation [FI 1370-00089A, 4070-00148B]; Carlsberg Foundation [2013_01_0130]; European Union Synthesys Projects; JSPS Kakenhi [15H04416]; Boje Benzons Stottefond and Laege HC Wegges Mindelegat	Boje Benzons Stottefond; Laege HC Wegges Mindelegat; Danish Agency for Science and Innovation; Carlsberg Foundation(Carlsberg Foundation); European Union Synthesys Projects; JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Boje Benzons Stottefond and Laege HC Wegges Mindelegat	All authors would like to thank the expert skills of the Kristineberg Marine Station in Sweden and the hospitality of Dr. O. Colemann during a visit to the Naturkundemuseum in Berlin. ND greatly acknowledges travel grants from Boje Benzons Stottefond and Laege HC Wegges Mindelegat. All authors thank PhD Terje Berge (University of Copenhagen, Denmark) for invaluable inspiration and discussions. This paper is dedicated to Yoichi Yusa at Nara Women's University in Japan for inspiration, friendship and providing important papers on cirripede sexual evolution.; JTH recieved funding from: The Danish Agency for Science and Innovation (grants FI 1370-00089A, 4070-00148B). URL: http://ufm.dk/acl_users/credentials_cookie_auth/require_login?came_from=http%3A//ufm.dk/en/the-minister-and-the-ministry/organisation/the-danish-agency-for-science-technology-and-innovation. The Carlsberg Foundation (grant 2013_01_0130). URL: http://www.carlsbergfondet.dk/en. The European Union Synthesys Projects and JSPS Kakenhi (grant 15H04416). URL: https://www.jsps.go.jp/english/e-grants/. ND greatly acknowledges travel grants from Boje Benzons Stottefond and Laege HC Wegges Mindelegat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yahya H, 2016, BIOL BULL-US, V231, P120, DOI 10.1086/690092; Bielecki J, 2009, BIOFOULING, V25, P203, DOI 10.1080/08927010802688087; Buhl-Mortensen L, 2006, MAR BIOL, V149, P829, DOI 10.1007/s00227-006-0263-y; Buhl-Mortensen L, 2013, ORG DIVERS EVOL, V13, P545, DOI 10.1007/s13127-013-0137-3; Callan HG, 1941, NATURE, V148, P258, DOI 10.1038/148258a0; CHARNOV E L, 1982; CHARNOV E L, 1987, P89; CRISP DJ, 1983, MAR BIOL LETT, V4, P281; Darwin C., 1873, NATURE, V8, P431, DOI [10.1038/008431b0, DOI 10.1038/008431B0]; Darwin C., 1851, LEPADIDAE PEDUNCULAT; Dreyer N, 2017, ORG DIVERS EVOL; Ewers-Saucedo C, 2015, J CRUSTACEAN BIOL, V35, P166, DOI 10.1163/1937240X-00002318; Gale AS, 2016, ZOOL J LINN SOC-LOND, V176, P266, DOI 10.1111/zoj.12321; GLENNER H, 1993, MAR BIOL, V117, P431; Glenner H, 1998, J CRUSTACEAN BIOL, V18, P463, DOI 10.2307/1549411; Hoeg JT, 2006, INVERTEBR REPROD DEV, V49, P125, DOI 10.1080/07924259.2006.9652204; Hoeg JT, 2016, BIOL J LINN SOC, V118, P359, DOI 10.1111/bij.12735; Hoeg JT, 2012, INTEGR COMP BIOL, V52, P337, DOI 10.1093/icb/ics053; Hoeg Jens T., 1995, Crustacean Issues, V10, P195; HOEG JT, 1984, J EXP MAR BIOL ECOL, V84, P167, DOI 10.1016/0022-0981(84)90209-0; HOEG JT, 1985, ACTA ZOOL-STOCKHOLM, V66, P1, DOI 10.1111/j.1463-6395.1985.tb00645.x; HOEG JT, 1995, J MAR BIOL ASSOC UK, V75, P517, DOI 10.1017/S0025315400038996; Kaufmann R., 1965, Zeitschrift fuer Morphologie und Oekologie der Tiere, V55, P161, DOI 10.1007/BF00399512; Kelly MW, 2010, J EXP MAR BIOL ECOL, V392, P37, DOI 10.1016/j.jembe.2010.04.009; KLEPAL W, 1985, MAR ECOL-P S Z N I, V6, P47, DOI 10.1111/j.1439-0485.1985.tb00320.x; KLEPAL W, 1987, OCEANOGR MAR BIOL, V25, P285; Kuhl H., 1949, VERH DEUT ZOOL, P148; Lin HC, 2015, MOL PHYLOGENET EVOL, V91, P1, DOI 10.1016/j.ympev.2015.04.026; Maruzzo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037408; Moyse John, 1995, Crustacean Issues, V10, P153; Rao XZ, 2014, J MAR BIOL ASSOC UK, V94, P361, DOI 10.1017/S0025315413001173; Sawada K, 2015, INVERTEBR BIOL, V134, P162, DOI 10.1111/ivb.12083; Spremberg U, 2012, J EXP MAR BIOL ECOL, V422, P39, DOI 10.1016/j.jembe.2012.04.004; TAKENAKA M, 1993, DEV GROWTH DIFFER, V35, P245; WALLEY LJ, 1969, PHILOS T ROY SOC B, V256, P237, DOI 10.1098/rstb.1969.0042; Wijayanti H, 2015, BIOL BULL, V230, P51; Yamaguchi S, 2013, J THEOR BIOL, V320, P1, DOI 10.1016/j.jtbi.2012.12.001; Yamaguchi S, 2012, INTEGR COMP BIOL, V52, P356, DOI 10.1093/icb/ics046; Yusa Y, 2013, INTEGR COMP BIOL, V53, P701, DOI 10.1093/icb/ict016; Yusa Y, 2012, P ROY SOC B-BIOL SCI, V279, P959, DOI 10.1098/rspb.2011.1554; Yusa Y, 2010, BIOL BULL-US, V218, P259, DOI 10.1086/BBLv218n3p259; Zardus JD, 2004, J CRUSTACEAN BIOL, V24, P409, DOI 10.1651/C-2476	42	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0191963	10.1371/journal.pone.0191963	http://dx.doi.org/10.1371/journal.pone.0191963			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466363	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300022
J	Franceschini, M; Goffredo, M; Pournajaf, S; Paravati, S; Agosti, M; De Pisi, F; Galafate, D; Posteraro, F				Franceschini, Marco; Goffredo, Michela; Pournajaf, Sanaz; Paravati, Stefano; Agosti, Maurizio; De Pisi, Francesco; Galafate, Daniele; Posteraro, Federico			Predictors of activities of daily living outcomes after upper limb robot-assisted therapy in subacute stroke patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; FRAGILITY INDEX; RECOVERY; REHABILITATION; MOTOR; TRIALS; IMPAIRMENTS; INTERVENTIONS; METAANALYSIS; ASSOCIATION	Background Upper limb recovery is one of the main goals of post-stroke rehabilitation due to its importance for autonomy in Activities of Daily Living (ADL). Although the efficacy of upper limb Robot-assisted Therapy (RT) is well established in literature, the impact of the initial status of the patient on the effects of RT is still understudied. This paper aims to identify whether demographic, clinical and motor characteristics of stroke patients may influence the ability to independently perform ADL after RT. Methods A retrospective study was conducted on sixty stroke patients who conducted planar upper limb goal-directed tasks with the InMotion 2.0 robot. The RT was administered 5 days/week for 4 weeks and each session lasted 45 minutes. The primary outcome measure was the Modified Barthel Index (BI), dichotomized into favourable (BI >= 75) and unfavourable (BI< 75) outcomes. The potential predictors were the demographic and clinical records, and the following clinical assessment scores: Modified Ashworth Scale-Shoulder (MAS-S); Modified Ashworth Scale-Elbow (MAS-E); Fugl-Meyer Assessment Upper Extremity (FMA-UE); upper limb section of the Motricity Index (MIul); total passive Range Of Motion (pROM); and Box and Block Test (BBT). Results Statistical analysis showed that the BBT, FMA-UE and MIul scores were significant predictors of a favourable outcome in ADL. The cut-off scores of the independent variables were calculated (FMA-UE = 32; MIul = 48; BBT = 3) with respect to the dichotomic BI outcome. Their robustness was assessed with the Fragility Index (FMA-UE = 2; MIul = 3; BBT = 7), showing that BBT is the most robust predictor of favourable BI outcome. Moreover, subjects with all predictors higher than the cut-off scores had higher probability to increase their independence in ADL at the end of the therapy. Demographic records, spasticity and pROM were not identified as predictors. Conclusion Stroke patients with greater manual dexterity and less impairment appear to have a higher probability of achieving clinically significant ADL outcomes after upper limb RT. The obtained results can help to optimise the management of RT treatment planning. Further studies on a larger number of patients with a long-term follow up are recommended in order to evaluate other potential predictors and to validate the results.	[Franceschini, Marco; Goffredo, Michela; Pournajaf, Sanaz; Paravati, Stefano; De Pisi, Francesco; Galafate, Daniele] IRCCS San Raffaele Pisana, Dept Neurorehabil, Rome, Italy; [Franceschini, Marco] San Raffaele Univ, Rome, Italy; [Agosti, Maurizio] NHS Univ Hosp Parma, Rehabil Geriatr Dept, Rehabil Med Serv, Parma, Italy; [Posteraro, Federico] Dept Neurorehabil Hlth Area West Tuscany, Viareggio, Italy	IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; University of Parma; University Hospital of Parma	Goffredo, M (corresponding author), IRCCS San Raffaele Pisana, Dept Neurorehabil, Rome, Italy.	michela.goffredo@sanraffaele.it	Pournajaf, Sanaz/K-3924-2018; Goffredo, Michela/K-8805-2016	Pournajaf, Sanaz/0000-0001-8749-2236; Goffredo, Michela/0000-0002-2651-8479; Agosti, Maurizio/0000-0003-2365-3488; Posteraro, Federico/0000-0002-7643-6834				[Anonymous], 2012, GAZZETTA UFFICIALE R, V72, P47; Aparicio HJ, 2016, NEUROLOGY, V86, pI2; Bejot Y, 2016, RISING STROKE INCIDE; Bovolenta F, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-18; Bovolenta F, 2009, J REHABIL MED, V41, P971, DOI 10.2340/16501977-0402; Brewer BR, 2007, TOP STROKE REHABIL, V14, P22, DOI 10.1310/tsr1406-22; Buchner A., 2013, CANCER, V3; Collin C, 1988, Int Disabil Stud, V10, P61; Coupar F, 2012, CLIN REHABIL, V26, P291, DOI 10.1177/0269215511420305; Dobkin BH, 2009, NEUROREHAB NEURAL RE, V23, P197, DOI 10.1177/1545968309331863; Drubach DA., 1994, J NEURAL REHABIL, V8, P881; Duret C, 2015, RESTOR NEUROL NEUROS, V33, P57, DOI 10.3233/RNN-140418; Evaniew N, 2015, SPINE J, V15, P2188, DOI 10.1016/j.spinee.2015.06.004; Fang MC, 2014, AM J MED, V127, P608, DOI 10.1016/j.amjmed.2014.03.017; Fritz SL, 2005, STROKE, V36, P1172, DOI 10.1161/01.STR.0000165922.96430.d0; Hsieh YW, 2014, ARCH PHYS MED REHAB, V95, P316, DOI 10.1016/j.apmr.2013.09.018; Huang PC, 2014, AM J OCCUP THER, V68, P325, DOI 10.5014/ajot.2014.010546; Khellaf M, 2010, STROKE, V41, P2762, DOI 10.1161/STROKEAHA.110.592147; Krebs HI, 2014, STROKE, V45, P200, DOI 10.1161/STROKEAHA.113.002296; Kutner NG, 2010, PHYS THER, V90, P493, DOI 10.2522/ptj.20090160; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Kwakkel G, 2007, RESTOR NEUROL NEUROS, V25, P453; Lipsey MW., 1990, DESIGN SENSITIVITY; Mehrholz J, 2012, COCHRANE DATABASE SY, V6; Mirelman A, 2009, STROKE, V40, P169, DOI 10.1161/STROKEAHA.108.516328; Morone G, 2011, NEUROREHAB NEURAL RE, V25, P636, DOI 10.1177/1545968311401034; Musicco M, 2003, ARCH PHYS MED REHAB, V84, P551, DOI 10.1053/apmr.2003.50084; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Norouzi-Gheidari N, 2012, J REHABIL RES DEV, V49, P479, DOI 10.1682/JRRD.2010.10.0210; Pedersen PM, 1997, ARCH PHYS MED REHAB, V78, P161, DOI 10.1016/S0003-9993(97)90258-6; Ridgeon EE, 2016, CRIT CARE MED, V44, P1278, DOI 10.1097/CCM.0000000000001670; Sale P, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-104; Smania N, 2009, EUR J PHYS REHAB MED, V45, P349; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; Sveen U, 1999, DISABIL REHABIL, V21, P372, DOI 10.1080/096382899297477; Tibaek M, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003158; Uyttenboogaart M, 2005, STROKE, V36, P1984, DOI 10.1161/01.STR.0000177872.87960.61; Wade D T, 1989, Int Disabil Stud, V11, P89; Wagner JM, 2007, PHYS THER, V87, P751, DOI 10.2522/ptj.20060135; Walsh M, 2014, J CLIN EPIDEMIOL, V67, P622, DOI 10.1016/j.jclinepi.2013.10.019	40	25	27	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193235	10.1371/journal.pone.0193235	http://dx.doi.org/10.1371/journal.pone.0193235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	29466440	gold, Green Submitted, Green Published			2022-12-26	WOS:000425604300100
J	Gautam, SS; Mac Aogain, M; Cooley, LA; Haug, G; Fyfe, JA; Globan, M; O'Toole, RF				Gautam, Sanjay S.; Mac Aogain, Micheal; Cooley, Louise A.; Haug, Greg; Fyfe, Janet A.; Globan, Maria; O'Toole, Ronan F.			Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case	PLOS ONE			English	Article							COUNTRY-OF-ORIGIN; EMBB CODON 306; MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE; AUSTRALIAN POPULATION; TRANSMISSION; LINEAGES; BOVIS; ETHAMBUTOL; MUTATIONS	Background The origin and spread of tuberculosis (TB) in Tasmania and the types of strains of Mycobacterium tuberculosis complex (MTBC) present in the population are largely unknown. Objective The aim of this study was to perform the first genomic analysis of MTBC isolates from Tasmania to better understand the epidemiology of TB in the state. Methods Whole-genome sequencing was performed on cultured isolates of MTBC collected from 2014-2016. Single-locus variant analysis was applied to determine the phylogeny of the isolates and the presence of drug-resistance mutations. The genomic data were then cross-referenced against public health surveillance records on each of the cases. Results We determined that 83.3% of TB cases in Tasmania from 2014-2016 occurred in non-Australian born individuals. Two possible TB clusters were identified based on single locus variant analysis, one from November-December 2014 (n = 2), with the second from May-August 2015 (n = 4). We report here the first known isolate of multi-drug resistant (MDR) M. tuberculosis in Tasmania from 2016 for which we established its drug resistance mutations and potential overseas origin. In addition, we characterised a case of M. bovis TB in a Tasmanian-born person who presented in 2014, approximately 40 years after the last confirmed case in the state's bovids. Conclusions TB in Tasmania is predominantly of overseas origin with genotypically-unique drug-susceptible isolates of M. tuberculosis. However, the state also exhibits features of TB that are observed in other jurisdictions, namely, the clustering of cases, and drug resistance. Early detection of TB and contact tracing, particularly of overseas-born cases, coordinated with rapid laboratory drug-susceptibility testing and molecular typing, will be essential for Tasmania to reach the World Health Organisation's TB eradication goals for low-incidence settings.	[Gautam, Sanjay S.; O'Toole, Ronan F.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Mac Aogain, Micheal; O'Toole, Ronan F.] Trinity Coll Dublin, Dept Clin Microbiol, Dublin, Ireland; [Cooley, Louise A.] Royal Hobart Hosp, Hobart, Tas, Australia; [Haug, Greg] Launceston Gen Hosp, Launceston, Tas, Australia; [Fyfe, Janet A.; Globan, Maria] Peter Doherty Inst, Mycobacterium Reference Lab, Victoria Infect Dis Reference Lab, Melbourne, Vic, Australia	University of Tasmania; Trinity College Dublin; Royal Hobart Hospital; Victorian Infectious Diseases Reference Laboratory	O'Toole, RF (corresponding author), Univ Tasmania, Sch Med, Hobart, Tas, Australia.; O'Toole, RF (corresponding author), Trinity Coll Dublin, Dept Clin Microbiol, Dublin, Ireland.	ronan.otoole@utas.edu.au	O'Toole, Ronan F/J-7280-2014; Aogáin, Micheál Mac/M-6782-2013; Cooley, Louise/ABE-9706-2020	O'Toole, Ronan F/0000-0002-4579-4479; Aogáin, Micheál Mac/0000-0002-1726-7700; Gautam, Sanjay/0000-0003-0187-6429	Royal Hobart Hospital Research Foundation [17-104]	Royal Hobart Hospital Research Foundation	This research was supported by funding from the Royal Hobart Hospital Research Foundation, grant reference number 17-104.	Australian Bureau of Statistics, 2011, CENS; Ballif M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-191; Barniol J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-197; Bhakta S, 2004, J EXP MED, V199, P1191, DOI 10.1084/jem.20031956; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Cousins DV, 1999, INT J TUBERC LUNG D, V3, P715; Cousins DV, 1999, INT J TUBERC LUNG D, V3, P722; Cuevas-Cordoba B, 2015, ANTIMICROB AGENTS CH, V59, P5455, DOI 10.1128/AAC.00117-15; Denholm J, 2016, COMMUN DIS INTELL, V40, pE356; Department of Health and Human Services D Tasmanian Government, 2016, NOT DIS 2014 ANN REP; Department of Immigration and Border Protection-Australian Government, 2015, FACT SHEET HLTH REQ; Diel R, 2014, EUR RESPIR J, V43, P554, DOI 10.1183/09031936.00079413; Eldholm V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8119; Feuerriegel S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15; Fox GJ, 2017, INT J TUBERC LUNG D, V21, P297, DOI 10.5588/ijtld.16.0576; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez MC, 2006, EMERG INFECT DIS, V12, P1367, DOI 10.3201/eid1209.050017; Hall R., 1993, Communicable Disease Intelligence, V17, P226; Hanway A, 2016, TUBERCULOSIS, V101, P67, DOI 10.1016/j.tube.2016.07.019; Hasnain SE, 2015, TUBERCULOSIS, V95, P91, DOI 10.1016/j.tube.2014.12.007; Hatherell HA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0566-x; Kamper-Jorgensen Z, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-60; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirby T, 2013, MED J AUSTRALIA, V198, P355, DOI 10.5694/mja13.10178; Mac Aogain M, 2016, GENOME ANNOUNC, V4; Malla B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052297; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Migliori GB, 2008, CLIN INFECT DIS, V46, P958, DOI 10.1086/528875; Miotto P, 2014, MBIO, V5, DOI 10.1128/mBio.01819-14; More SJ, 2015, VET REC, V177, P224, DOI 10.1136/vr.103163; Nikolayevskyy V, 2016, TUBERCULOSIS, V98, P77, DOI 10.1016/j.tube.2016.02.009; NNDSS Annual Report Working Group, 2014, AUSTR NOT DIS STAT 2; Parish T, 2001, BMC Microbiol, V1, P19, DOI 10.1186/1471-2180-1-19; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Ricks PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027405; Ritter C, 2014, J CLIN MICROBIOL, V52, P940, DOI 10.1128/JCM.02597-13; Rodwell TC, 2014, J CLIN MICROBIOL, V52, P781, DOI 10.1128/JCM.02701-13; Roe M, 1999, LIFE DEATH TASMANIAN; Sandgren A, 2014, EUR RESPIR J, V43, P1159, DOI 10.1183/09031936.00117213; Sekizuka T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142951; Siddiqi N, 2002, ANTIMICROB AGENTS CH, V46, P443, DOI 10.1128/AAC.46.2.443-450.2002; Simons SO, 2014, CLIN MICROBIOL INFEC, V20, P1015, DOI 10.1111/1469-0691.12696; Starks AM, 2009, ANTIMICROB AGENTS CH, V53, P1061, DOI 10.1128/AAC.01357-08; Timothy DM, 2014, GLOBAL ALLIANCE TB D; Toms C, 2015, COMMUN DIS INTELL, V39, pE217; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; White RG, 2014, INT J TUBERC LUNG D, V18, P380, DOI 10.5588/ijtld.14.0156; Yang CG, 2012, CLIN INFECT DIS, V55, P1179, DOI 10.1093/cid/cis670; Yen S, 2013, INT J TUBERC LUNG D, V17, P892, DOI 10.5588/ijtld.12.0795	51	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192351	10.1371/journal.pone.0192351	http://dx.doi.org/10.1371/journal.pone.0192351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466411	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000425604300050
J	Ho, PJ; Hartman, M; Young-Afat, DA; Gernaat, SAM; Lee, SC; Verkooijen, HM				Ho, Peh Joo; Hartman, Mikael; Young-Afat, Danny A.; Gernaat, Sofie A. M.; Lee, Soo Chin; Verkooijen, Helena M.			Determinants of satisfaction with cosmetic outcome in breast cancer survivors: A cross-sectional study	PLOS ONE			English	Article							QUALITY-OF-LIFE; BODY-IMAGE; EUROPEAN-ORGANIZATION; WOMEN; DEPRESSION; MASTECTOMY; SURGERY	Little research has been done into cosmetic outcomes in non-Western breast cancer populations. We aimed to study the prevalence and determinants of dissatisfaction with cosmetic outcome after breast cancer surgery of Asian breast cancer survivors, and its association with patient-reported anxiety, depression, and quality of life. In a hospital-based cross-sectional study, 384 breast cancer survivors of at least 12 months after diagnosis completed questionnaires on satisfaction with cosmetic appearance, quality of life (EORTC-QLQ-C30) and anxiety and depression (HADS). Cumulative logit models were used to examine the adjusted association between dissatisfaction with cosmetic appearance and demographic and clinical characteristics. Kruskal-Wallis test was used to test for associations between dissatisfaction with cosmetic appearance and patient-reported outcomes. Overall, 20% of women reported to be (very) dissatisfied with cosmetic appearance. Survivors of Chinese ethnicity were more likely dissatisfied with cosmetic appearance compared to Malay survivors (22% and 14% respectively, adjusted OR = 2.4, 95% CI: 1.4-3.9). Women with DCIS (adjusted OR = 2.2, 95% CI: 1.3-3.7) or advanced stage disease (adjusted OR = 2.2, 95% CI: 1.2-3.9) had a higher risk of being dissatisfied with their cosmetic appearance. Women treated with mastectomy were at a higher risk of dissatisfaction with cosmetic appearance (adjusted OR = 1.7, 95% CI: 1.1-2.5). Dissatisfaction with cosmetic appearance was associated with increased depression scores. In this South-East Asian population, one in five breast cancer patients were (very) dissatisfied with the cosmetic outcome of treatment. Chinese women, women with larger tumors and women treated with mastectomy were most likely to report dissatisfaction with cosmetic appearance.	[Ho, Peh Joo; Hartman, Mikael] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Hartman, Mikael] Natl Univ Singapore, Dept Surg, Singapore, Singapore; [Young-Afat, Danny A.; Gernaat, Sofie A. M.; Verkooijen, Helena M.] Univ Med Ctr Utrecht, Imaging Div, Utrecht, Netherlands; [Lee, Soo Chin] Natl Hlth Syst, Natl Univ Canc Inst, Singapore, Singapore	National University of Singapore; National University of Singapore; Utrecht University; Utrecht University Medical Center; National University of Singapore	Hartman, M (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Hartman, M (corresponding author), Natl Univ Singapore, Dept Surg, Singapore, Singapore.	mikael_hartman@nuhs.edu.sg	Hartman, Mikael/B-4324-2011; Lee, Soo Chin/S-9111-2016	Lee, Soo Chin/0000-0002-5835-6419; Ho, Peh Joo/0000-0002-3017-4023; Gernaat, Sofie/0000-0001-7828-1138	National University Hospital, Singapore; Clinician Scientist Award, National Medical Research Council [R-608-000-093-511]; Asian Breast Cancer Research Fund [N-176-000-023-091]	National University Hospital, Singapore(National University of Singapore); Clinician Scientist Award, National Medical Research Council; Asian Breast Cancer Research Fund	The study was carried-out with the support from the National University Hospital, Singapore, Clinician Scientist Award, National Medical Research Council R-608-000-093-511, and Asian Breast Cancer Research Fund N-176-000-023-091 awarded to Mikael Hartman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Al-Ghazal SK, 2000, EUR J CANCER, V36, P1938, DOI 10.1016/S0959-8049(00)00197-0; Begovic-Juhant A, 2012, J PSYCHOSOC ONCOL, V30, P446, DOI 10.1080/07347332.2012.684856; Bhoo-Pathy N, 2013, EUR J CANCER, V49, P703, DOI 10.1016/j.ejca.2012.09.014; Bober SL, 2013, J SEX MED, V10, P370, DOI 10.1111/j.1743-6109.2012.02852.x; Chen CL, 2012, CANCER NURS, V35, pE10, DOI 10.1097/NCC.0b013e3182336f8b; Dahl CAF, 2010, CANCER-AM CANCER SOC, V116, P3549, DOI 10.1002/cncr.25251; Favez N, 2015, J HLTH PSYCHOL; Figueiredo ML, 2004, J CLIN ONCOL, V22, P4002, DOI 10.1200/JCO.2004.07.030; Harcourt D, 2011, J PLAST RECONSTR AES, V64, P494, DOI 10.1016/j.bjps.2010.06.008; Hopwood P, 2001, EUR J CANCER, V37, P189, DOI 10.1016/S0959-8049(00)00353-1; Jagsi R, 2015, ANN SURG, V261, P1198, DOI 10.1097/SLA.0000000000000908; Kim KR, 2012, SUPPORT CARE CANCER, V20, P2177, DOI 10.1007/s00520-011-1329-z; Kim MK, 2015, EJSO-EUR J SURG ONC, V41, P426, DOI 10.1016/j.ejso.2014.12.002; Mariapun S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117568; Maskarinec G, 2002, INT J CANCER, V102, P29, DOI 10.1002/ijc.10673; McClelland SI, 2015, QUAL LIFE RES, V24, P2939, DOI 10.1007/s11136-015-1034-3; Moreira H, 2010, EUR J ONCOL NURS, V14, P263, DOI 10.1016/j.ejon.2010.04.001; Pikler V, 2003, HEALTH PSYCHOL, V22, P632, DOI 10.1037/0278-6133.22.6.632; Rosenberg SM, 2013, PSYCHO-ONCOLOGY, V22, P1849, DOI 10.1002/pon.3221; Rowland JH, 2000, J NATL CANCER I, V92, P1422, DOI 10.1093/jnci/92.17.1422; Sackey H, 2010, EJSO-EUR J SURG ONC, V36, P756, DOI 10.1016/j.ejso.2010.06.016; Sherman KA, 2016, PSYCHOONCOLOGY; SNEEUW KCA, 1992, RADIOTHER ONCOL, V25, P153, DOI 10.1016/0167-8140(92)90261-R; Sprangers MAG, 1996, J CLIN ONCOL, V14, P2756, DOI 10.1200/JCO.1996.14.10.2756; Vodermaier A, 2009, JNCI-J NATL CANCER I, V101, P1464, DOI 10.1093/jnci/djp336; Youlden Danny R., 2014, Cancer Biology Medicine, V11, P101, DOI 10.7497/j.issn.2095-3941.2014.02.005; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193099	10.1371/journal.pone.0193099	http://dx.doi.org/10.1371/journal.pone.0193099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466412	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300086
J	Janssen, H; Bruckmann, H; Killer, M; Heck, S; Buchholz, G; Lutz, J				Janssen, Hendrik; Brueckmann, Hartmut; Killer, Monika; Heck, Suzette; Buchholz, Grete; Lutz, Juergen			Acute basilar thrombosis: Recanalization following intravenous thrombolysis is dependent on thrombus length	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; MIDDLE CEREBRAL-ARTERY; RANDOMIZED-TRIAL; MICROSURGICAL ANATOMY; OCCLUSION; THROMBECTOMY; THERAPY; INTRAARTERIAL; ANGIOGRAPHY; PROUROKINASE	Introduction We investigated whether thrombus length measured in Computed Tomography Angiography (CTA) is predictive of the success rate of intravenous thrombolysis (IVT) in acute basilar occlusion and whether recanalization can be achieved by additional mechanical endovascular thrombectomy. Methods In 51 patients with acute basilar thrombosis thrombus length was measured on CTA images before intravenous thrombolysis (IVT) with rt-PA was started. After 114 minutes on average success of IVT was evaluated either by CTA or DSA. Patients with persistent basilar occlusion and no major brainstem infarction on CT underwent endovascular recanalization. Results 87% of patients had no recanalization of basilar artery after IVT alone. The average thrombus length was 15 mm in patients with persistent basilar occlusion after IVT and 7 mm in patients with recanalization after IVT. Thrombi longer than 13 mm did not resolve after IVT alone and 80% of thrombi shorter than 13 mm did not resolve either. 41 patients were transferred to endovascular recanalization; endovascular therapy was performed successfully in 90% (37 / 41). Conclusions Recanalization rates in acute basilar occlusion after IVT alone are low and dependent on thrombus length. Additional mechanical endovascular thrombectomy showed to be a very successful recanalization therapy.	[Janssen, Hendrik; Brueckmann, Hartmut; Lutz, Juergen] Ludwig Maximilians Univ Munich Hosp, Dept Neuroradiol, Grosshadern Campus, Munich, Germany; [Janssen, Hendrik] Paracelsus Med Univ, Dept Neuroradiol, Nurnberg, Germany; [Killer, Monika] Paracelsus Med Univ, Dept Neurol, Reseach Inst Neurointervent, Salzburg, Austria; [Heck, Suzette; Buchholz, Grete] Ludwig Maximilian Univ Munich Hosp, Dept Neurol, Grosshadern Campus, Munich, Germany	University of Munich; Paracelsus Private Medical University; University of Munich	Janssen, H (corresponding author), Ludwig Maximilians Univ Munich Hosp, Dept Neuroradiol, Grosshadern Campus, Munich, Germany.; Janssen, H (corresponding author), Paracelsus Med Univ, Dept Neuroradiol, Nurnberg, Germany.	hendrik.janssen@klinikum-nuernberg.de						Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Brandt T, 1996, STROKE, V27, P875, DOI 10.1161/01.STR.27.5.875; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; del Zoppo GJ, 1998, STROKE, V29, P4, DOI 10.1161/01.STR.29.1.4; FIESCHI C, 1989, J NEUROL SCI, V91, P311, DOI 10.1016/0022-510X(89)90060-9; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Grunwald IQ, 2009, EUR J NEUROL, V16, P1210, DOI 10.1111/j.1468-1331.2009.02750.x; HACKE W, 1988, STROKE, V19, P1216, DOI 10.1161/01.STR.19.10.1216; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HUEMER M, 1995, J NEUROL NEUROSUR PS, V58, P227, DOI 10.1136/jnnp.58.2.227; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Lindsberg PJ, 2006, STROKE, V37, P922, DOI 10.1161/01.STR.0000202582.29510.6b; Lindsberg PJ, 2004, JAMA-J AM MED ASSOC, V292, P1862, DOI 10.1001/jama.292.15.1862; Marchal G, 1999, J CEREBR BLOOD F MET, V19, P467, DOI 10.1097/00004647-199905000-00001; Ng KWP, 2012, J NEUROIMAGING, V22, P351, DOI 10.1111/j.1552-6569.2011.00689.x; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Ozsarlak O, 2004, NEURORADIOLOGY, V46, P955, DOI 10.1007/s00234-004-1297-9; Puetz V, 2009, AM J NEURORADIOL, V30, P1877, DOI 10.3174/ajnr.A1723; Puetz V, 2008, INT J STROKE, V3, P230, DOI 10.1111/j.1747-4949.2008.00221.x; Riedel CH, 2011, STROKE, V42, P1775, DOI 10.1161/STROKEAHA.110.609693; Rohan V, 2014, STROKE, V45, P2010, DOI 10.1161/STROKEAHA.114.005731; SAEKI N, 1977, J NEUROSURG, V46, P563, DOI 10.3171/jns.1977.46.5.0563; Sairanen T, 2011, STROKE, V42, P2175, DOI 10.1161/STROKEAHA.110.605584; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Schonewille WJ, 2009, LANCET NEUROL, V8, P724, DOI 10.1016/S1474-4422(09)70173-5; Schulte-Altedorneburg G, 2006, AM J NEURORADIOL, V27, P2042; Seker F, 2017, J NEUROINTERV SURG, V9, P937, DOI 10.1136/neurintsurg-2016-012591; Shu L, 2016, J NEUROINTERV SURG, P1; Strbian D, 2014, STROKE; UMANSKY F, 1984, J NEUROSURG, V61, P458, DOI 10.3171/jns.1984.61.3.0458; Vuillier F, 2008, SURG RADIOL ANAT, V30, P509, DOI 10.1007/s00276-008-0360-3	34	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193051	10.1371/journal.pone.0193051	http://dx.doi.org/10.1371/journal.pone.0193051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466399	Green Submitted, Green Published, gold			2022-12-26	WOS:000425604300081
J	Kulkarni, U; Herrmenau, C; Win, SJ; Bauer, M; Kamradt, T				Kulkarni, Upasana; Herrmenau, Christoph; Win, Stephanie J.; Bauer, Michael; Kamradt, Thomas			IL-7 treatment augments and prolongs sepsis-induced expansion of IL-10-producing B lymphocytes and myeloid-derived suppressor cells	PLOS ONE			English	Article							REGULATORY T-CELLS; SEPTIC SHOCK; INFECTION; IMMUNOSUPPRESSION; DIFFERENTIATION; PROLIFERATION; PHENOTYPE; MORTALITY; BIOMARKER; RESPONSES	Immunological dysregulation in sepsis is associated with often lethal secondary infections. Loss of effector cells and an expansion of immunoregulatory cell populations both contribute to sepsis-induced immunosuppression. The extent and duration of this immunosuppression are unknown. Interleukin 7 (IL-7) is important for the maintenance of lymphocytes and can accelerate the reconstitution of effector lymphocytes in sepsis. How IL-7 influences immunosuppressive cell populations is unknown. We have used the mouse model of peritoneal contamination and infection (PCI) to investigate the expansion of immunoregulatory cells as long-term sequelae of sepsis with or without IL-7 treatment. We analysed the frequencies and numbers of regulatory T cells (Tregs), double negative T cells, IL-10 producing B cells and myeloid-derived suppressor cells (MDSCs) for 3.5 months after sepsis induction. Sepsis induced an increase in IL-10(+) B cells, which was enhanced and prolonged by IL-7 treatment. An increased frequency of MDSCs in the spleen was still detectable 3.5 months after sepsis induction and this was more pronounced in IL-7-treated mice. MDSCs from septic mice were more potent at suppressing T cell proliferation than MDSCs from control mice. Our data reveal that sepsis induces a long lasting increase in IL-10(+) B cells and MDSCs. Late-onset IL-7 treatment augments this increase, which should be relevant for clinical interventions.	[Kulkarni, Upasana; Herrmenau, Christoph; Win, Stephanie J.; Kamradt, Thomas] Jena Univ Hosp, Inst Immunol, Jena, Germany; [Bauer, Michael] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany; [Bauer, Michael] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Kulkarni, Upasana] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Michigan System; University of Michigan	Kamradt, T (corresponding author), Jena Univ Hosp, Inst Immunol, Jena, Germany.	thomas.kamradt@med.uni-jena.de	Ammer-Herrmenau, Christoph/GPK-8096-2022	Bauer, Michael/0000-0002-1521-3514; Kamradt, Thomas/0000-0001-8443-5893	German Ministry of Education and Science (BMBF; Center for Sepsis Control and Care) [01E01502]; Studienstiftung des deutschen Volkes	German Ministry of Education and Science (BMBF; Center for Sepsis Control and Care); Studienstiftung des deutschen Volkes	This work was supported by grants from the German Ministry of Education and Science (BMBF; Center for Sepsis Control and Care to M.B. and T.K.) (www.bmbf.de/; Grant Number: 01E01502). C.H. is supported by the Studienstiftung des deutschen Volkes (ww.studienstrftung. de).; This study was supported by grants from the German Ministry of Education and Science (BMBF, Center for Sepsis Control and Care to MB and TK). CH is supported by the Studienstiftung des deutschen Volkes.	Bauer M, 2016, EBIOMEDICINE, V6, P114, DOI 10.1016/j.ebiom.2016.03.006; Bermejo-Martin JF, 2016, J INFECTION, V72, P525, DOI 10.1016/j.jinf.2016.01.010; Boyman O, 2008, J IMMUNOL, V180, P7265, DOI 10.4049/jimmunol.180.11.7265; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Cohen J, 2012, LANCET INFECT DIS, V12, P503, DOI 10.1016/S1473-3099(12)70136-6; Cuthbertson BH, 2013, CRIT CARE, V17, DOI 10.1186/cc12616; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Delano MJ, 2016, IMMUNOL REV, V274, P330, DOI 10.1111/imr.12499; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; El Daker S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123772; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gonnert FA, 2011, J SURG RES, V170, pE123, DOI 10.1016/j.jss.2011.05.019; GOODWIN RG, 1989, P NATL ACAD SCI USA, V86, P302, DOI 10.1073/pnas.86.1.302; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907; Kim GY, 2012, J IMMUNOL, V188, P5859, DOI 10.4049/jimmunol.1102328; Kuhlhorn F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065109; Kulkarni U, 2016, J ALLERGY CLIN IMMUN, V137, P1487, DOI 10.1016/j.jaci.2015.10.018; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Levy MM, 2014, INTENS CARE MED, V40, P1623, DOI 10.1007/s00134-014-3496-0; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Martin CE, 2013, BLOOD, V121, P4484, DOI 10.1182/blood-2012-08-449215; Mathias B., 2016, ANN SURG; Monneret G, 2003, CRIT CARE MED, V31, P2068, DOI 10.1097/01.CCM.0000069345.78884.0F; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Prescott HC, 2014, AM J RESP CRIT CARE, V190, P62, DOI 10.1164/rccm.201403-0471OC; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Scicluna BP, 2015, AM J RESP CRIT CARE, V192, P826, DOI 10.1164/rccm.201502-0355OC; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tatura R, 2015, IMMUNOLOGY, V146, P144, DOI 10.1111/imm.12490; Tebartz C, 2015, J IMMUNOL, V194, P1100, DOI 10.4049/jimmunol.1400196; Terashima A, 2016, IMMUNITY, V44, P1434, DOI 10.1016/j.immuni.2016.05.012; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; van Vught L. A., 2017, AM J RESP CRIT CARE; Venet F, 2004, CRIT CARE MED, V32, P2329, DOI 10.1097/01.CCM.0000145999.42971.4B; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Zhang ZX, 2001, J MOL MED-JMM, V79, P419, DOI 10.1007/s001090100238; ZLOTNIK A, 1992, J IMMUNOL, V149, P1211	47	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192304	10.1371/journal.pone.0192304	http://dx.doi.org/10.1371/journal.pone.0192304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466409	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300045
J	Shang, Q; Pei, GX; Jin, J; Zhang, WK; Wang, YR; Wang, XY				Shang, Qian; Pei, Guanxiong; Jin, Jia; Zhang, Wuke; Wang, Yuran; Wang, Xiaoyi			ERP evidence for consumer evaluation of copycat brands	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; CONSCIOUS RECOLLECTION; MEMORY; BRAIN; IMITATION; N400; RECOGNITION; CATEGORIZATION; FAMILIARITY; ATTENTION	Copycat brands mimic brand leaders to free ride on the latter's equity. However, little is known regarding if and how consumers confuse copycat as leading brand in purchasing. In this study, we applied a word-pair evaluation paradigm in which the first word was a brand name (copycat vs. normal brand both similar with a leading brand in category), followed by a product name (near vs. far from the leading brand's category). Behavioral results showed that, when the product is near the leader's category, the copycat strategy (CN) was more preferred compared to the normal brand (NN) but not different in the far product condition (CF and NF). Event-related potential (ERP) data provided further insight into the mechanism. The N400 amplitude elicited by the CN condition was significantly smaller than NN. However, when products are far from the leader's category, there was no significant difference in N400 amplitudes. For the late positive component (LPC), the CN gave rise to a larger amplitude than the CF. The N400 amplitude was suggested to reflect the categorization process, and the LPC demonstrated the recollection process in long-term memory. These findings imply that the copycat brand strategy is generally only effective when products are within the category of the leading brand, which offers important implications for marketing practices.	[Shang, Qian] Hangzhou Dianzi Univ, Chinese Acad Sci & Educ Evaluat, Hangzhou, Zhejiang, Peoples R China; [Shang, Qian] Hangzhou Dianzi Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China; [Pei, Guanxiong; Zhang, Wuke; Wang, Yuran; Wang, Xiaoyi] Zhejiang Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China; [Jin, Jia] Ningbo Univ, Sch Business, Ningbo, Zhejiang, Peoples R China; [Jin, Jia] Ningbo Univ, Acad Neuroecon & Neuromanagement, Ningbo, Zhejiang, Peoples R China	Hangzhou Dianzi University; Hangzhou Dianzi University; Zhejiang University; Ningbo University; Ningbo University	Wang, XY (corresponding author), Zhejiang Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China.	kevinwxy@zju.edu.cn	Pei, Guanxiong/ABC-6868-2020	Jin, Jia/0000-0003-1124-2999; Wang, Xiaoyi/0000-0001-7748-2296	Humanities and Social Sciences Foundation of the Ministry of Education of China [15YJC630106, 14YJC630129]; National Natural Science Foundation of China [71602044, 71572176, 71603139]; Zhijiang Youth Social Science Fund [16ZJQN030YB]; Natural Science Foundation of Zhejiang Province of China [LQ16G020006, LQ13G010005]; Philosophy and Social Science Planning Project of Zhejiang Province [15NDJC031YB, 17NDJC013Z]; Research Center of Information Technology & Economic and Social Development of Zhejiang province; Positive Psychology Fund of China [0020344]	Humanities and Social Sciences Foundation of the Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhijiang Youth Social Science Fund; Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); Philosophy and Social Science Planning Project of Zhejiang Province; Research Center of Information Technology & Economic and Social Development of Zhejiang province; Positive Psychology Fund of China	This work was supported by Grant No.15YJC630106 and No. 14YJC630129 from the Humanities and Social Sciences Foundation of the Ministry of Education of China (https://www.sinoss.net/), Grant No. 71602044, No. 71572176, and No. 71603139 from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/), Grant No. 16ZJQN030YB of the Zhijiang Youth Social Science Fund (http://zjskw.gov.cn/), Grant No. LQ16G020006 and No. LQ13G010005 from the Natural Science Foundation of Zhejiang Province of China (http://www.zjnsf.gov.cn/), Grant No.15NDJC031YB and No.17NDJC013Z from the Philosophy and Social Science Planning Project of Zhejiang Province (http://zjskw.gov.cn/), the Research Center of Information Technology & Economic and Social Development of Zhejiang province (http://xxh.hdu.edu.cn), and Grant No. 0020344 of the Positive Psychology Fund of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Humanities and Social Sciences Foundation of the Ministry of Education of China (No. 15YJC630106 and No. 14YJC630129), the National Natural Science Foundation of China (No. 71602044, No. 71572176, and No. 71603139), the Zhijiang Youth Social Science Fund (No. 16ZJQN030YB), the Natural Science Foundation of Zhejiang Province of China (No. LQ16G020006 and No. LQ13G010005), the Philosophy and Social Science Planning Project of Zhejiang Province (No. 15NDJC031YB and No. 17NDJC013Z), the Research Center of Information Technology & Economic and Social Development of Zhejiang province, and the Positive Psychology Fund of China (No. 0020344).	AAKER D, 1990, SLOAN MANAGE REV, V31, P47; Aaker D.A., 1992, J MARKETING, V56, P125, DOI DOI 10.2307/1252048; Aaker D.A., 2012, BUILDING STRONG BRAN; Ariely D, 2010, NAT REV NEUROSCI, V11, P284, DOI 10.1038/nrn2795; Bouaffre S, 2007, BRAIN COGNITION, V63, P123, DOI 10.1016/j.bandc.2006.10.006; BOULDING W, 1994, J MARKETING RES, V31, P159, DOI 10.2307/3152191; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Campbell MC, 2000, J CONSUM RES, V27, P69, DOI 10.1086/314309; Cerf M, 2015, J MARKETING RES, V52, P530, DOI 10.1509/jmr.13.0606; Chen YP, 2015, J MARKETING RES, V52, P453, DOI 10.1509/jmr.14.0606; Curran T, 2004, NEUROPSYCHOLOGIA, V42, P1088, DOI 10.1016/j.neuropsychologia.2003.12.011; Finnigan S, 2002, NEUROPSYCHOLOGIA, V40, P2288, DOI 10.1016/S0028-3932(02)00113-6; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gutchess AH, 2007, J COGNITIVE NEUROSCI, V19, P1089, DOI 10.1162/jocn.2007.19.7.1089; Heinze HJ, 1998, BIOL PSYCHOL, V47, P121, DOI 10.1016/S0301-0511(97)00024-0; Hill H, 2005, INT J PSYCHOPHYSIOL, V56, P209, DOI 10.1016/j.ijpsycho.2004.12.004; Hou MZ, 2013, BRAIN RES, V1518, P48, DOI 10.1016/j.brainres.2013.04.041; Ibanez A, 2012, SOC NEUROSCI-UK, V7, P632, DOI 10.1080/17470919.2012.691078; JACOBY LL, 1989, J PERS SOC PSYCHOL, V56, P326, DOI 10.1037/0022-3514.56.3.326; Jin J, 2015, NEUROREPORT, V26, P572, DOI 10.1097/WNR.0000000000000390; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Laszlo S, 2011, PSYCHOPHYSIOLOGY, V48, P176, DOI 10.1111/j.1469-8986.2010.01058.x; Le Roux A, 2016, J PROD BRAND MANAG, V25, P600, DOI 10.1108/JPBM-07-2015-0923; Le Roux A, 2016, J BUS RES, V69, P349, DOI 10.1016/j.jbusres.2015.08.007; Luck S.J., 2005, EVENT RELATED POTENT; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; Ma QG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114150; Mathalon DH, 2010, INT J PSYCHOPHYSIOL, V75, P157, DOI 10.1016/j.ijpsycho.2009.12.003; Morton FS, 2004, REV IND ORGAN, V24, P161; PALLER KA, 1995, PSYCHOL SCI, V6, P107, DOI 10.1111/j.1467-9280.1995.tb00315.x; PALLER KA, 1992, J COGNITIVE NEUROSCI, V4, P375, DOI 10.1162/jocn.1992.4.4.375; Qin Y, 2016, J CONSUM BEHAV, V15, P117, DOI 10.1002/cb.1530; RUGG MD, 1985, PSYCHOPHYSIOLOGY, V22, P642, DOI 10.1111/j.1469-8986.1985.tb01661.x; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Telpaz A, 2015, J MARKETING RES, V52, P511, DOI 10.1509/jmr.13.0564; Unkelbach C, 2007, J EXP PSYCHOL LEARN, V33, P219, DOI 10.1037/0278-7393.33.1.219; Van Horen F, 2013, J ECON PSYCHOL, V37, P54, DOI 10.1016/j.joep.2013.05.003; van Horen F, 2012, INT J RES MARK, V29, P246, DOI 10.1016/j.ijresmar.2012.04.001; van Horen F, 2012, J MARKETING RES, V49, P83, DOI 10.1509/jmr.08.0405; Voss JL, 2008, NEUROPSYCHOLOGIA, V46, P3021, DOI 10.1016/j.neuropsychologia.2008.07.010; Wang XY, 2012, NEUROSCI LETT, V525, P76, DOI 10.1016/j.neulet.2012.07.043; Warlop L, 2004, J CONSUM PSYCHOL, V14, P21, DOI 10.1207/s15327663jcp1401&2_4; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989; Wolk DA, 2006, BRAIN RES, V1096, P148, DOI 10.1016/j.brainres.2006.04.050; Yu SS, 2010, BRAIN RES, V1320, P74, DOI 10.1016/j.brainres.2009.12.071	46	4	4	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0191475	10.1371/journal.pone.0191475	http://dx.doi.org/10.1371/journal.pone.0191475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	29466469	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300011
J	Hira, D; Koide, H; Nakamura, S; Okada, T; Ishizeki, K; Yamaguchi, M; Koshiyama, S; Oguma, T; Ito, K; Funayama, S; Komase, Y; Morita, S; Nishiguchi, K; Nakano, Y; Terada, T				Hira, Daiki; Koide, Hiroyoshi; Nakamura, Shigemi; Okada, Toyoko; Ishizeki, Kazunori; Yamaguchi, Masafumi; Koshiyama, Setsuko; Oguma, Tetsuya; Ito, Kayoko; Funayama, Saori; Komase, Yuko; Morita, Shin-ya; Nishiguchi, Kohshi; Nakano, Yasutaka; Terada, Tomohiro			Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices	PLOS ONE			English	Article							DRUG-DELIVERY; ELDERLY-PATIENTS; ADMIT SERIES; PERFORMANCE; THERAPY; ASTHMA; RATES; TURBUHALER; DESIGN; ISSUES	The patients' inhalation flow pattern is one of the significant determinants for clinical performance of inhalation therapy. However, the development of inhalation flow meters for various inhalation devices has been unable to keep up with the increasing number of newly launched inhalation devices. In the present study, we developed simple attachment orifices for the inhalation flow pattern monitoring system, which are suitable for all commercial inhalers, and investigated the efficacy of the system on the clinical inhalation instruction for patients co-prescribed dry powder inhaler (DPI) and soft mist inhaler (SMI). First, we constructed simple attachment orifices that were adjusted for 13 commercial inhalers, and examined the correlation between orifice and inhalation device. Second, the inhalation flow patterns (peak inspiratory flow rate, PIFR; inhalation duration time, DT) of patients prescribed a combination of DPI and SMI were monitored before and after inhalation instruction. The inhalation resistance of commercial inhalers are listed in the following order; Twincaps (R) > Handihaler (R) > Swinghaler (R) = Clickhaler (R) > Twisthaler (R) > Turbuhaler (R) > Jenuair (R) > Diskus (R) = Ellipta (R) > Diskhaler (R) > Breezhaler (R) > Respimat (R) = pMDI. The pressure drop via orifice was significantly correlated with that via the commercial inhaler. For the confirmation, all participants achieved the DPI criterion of PIFR. On the other hand, 4 participants (6 clinical visits) of 10 experimented participants could not achieve the essential criterion of DT (> 1.5 sec) for SMI, but all participants improved their duration time after inhalation instruction by pharmacists (P<0.05). In the present study, we successfully developed simple attachment orifice suitable for 13 commercial inhalation devices. These data suggested that our simple attachment orifices for the inhalation flow pattern monitoring system can detect patients with inadequate inhalation patterns via SMI.	[Hira, Daiki; Morita, Shin-ya; Terada, Tomohiro] Shiga Univ Med Sci Hosp, Dept Pharm, Otsu, Shiga, Japan; [Koide, Hiroyoshi; Nishiguchi, Kohshi] Kyoto Pharmaceut Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Kyoto, Kyoto, Japan; [Nakamura, Shigemi; Okada, Toyoko; Ishizeki, Kazunori] Hitachi Automot Syst Ltd, Isesaki, Gunma, Japan; [Yamaguchi, Masafumi; Nakano, Yasutaka] Shiga Univ Med Sci, Dept Med, Div Resp Med, Otsu, Shiga, Japan; [Koshiyama, Setsuko] Kinki Chozai Kadono Sanjo Pharm, Kyoto, Kyoto, Japan; [Oguma, Tetsuya] Oguma Family Clin, Kusatsu, Shiga, Japan; [Ito, Kayoko; Funayama, Saori] Niigata Univ Med & Dent Hosp, Oral Rehabil, Niigata, Niigata, Japan; [Komase, Yuko] St Marianna Univ, Yokohama City Seibu Hosp, Sch Med, Dept Resp Internal Med, Yokohama, Kanagawa, Japan; [Hira, Daiki] Ritsumeikan Univ, Coll Pharmaceut Sci, Kusatsu, Shiga, Japan	Shiga University of Medical Science; Kyoto Pharmaceutical University; Hitachi Limited; Shiga University of Medical Science; Niigata University; Saint Marianna University; Ritsumeikan University	Terada, T (corresponding author), Shiga Univ Med Sci Hosp, Dept Pharm, Otsu, Shiga, Japan.	teradat@belle.shiga-med.ac.jp	Morita, Shin-ya/U-2793-2019	Morita, Shin-ya/0000-0003-4079-707X; Hira, Daiki/0000-0001-8344-2469	Hitachi Automotive Systems, Ltd	Hitachi Automotive Systems, Ltd	SN, TOk, and Kls are employees of Hitachi Automotive Systems, Ltd. The funder provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Showair RAM, 2007, RESP MED, V101, P2395, DOI 10.1016/j.rmed.2007.06.008; Anderson P., 2006, INT J CHRONIC OBSTR, V1, P251, DOI DOI 10.2147/C0PD.2006.1.3.251; Backman P, 2014, CLIN PHARMACOL THER, V95, P509, DOI 10.1038/clpt.2014.27; Bouwmeester C, 2015, RESP MED, V109, P1363, DOI 10.1016/j.rmed.2015.07.013; Brand Peter, 2008, Int J Chron Obstruct Pulmon Dis, V3, P763; Broeders MEAC, 2011, PRIM CARE RESP J, V20, P338, DOI 10.4104/pcrj.2011.00062; Chodosh S, 2001, J AEROSOL MED, V14, P309, DOI 10.1089/089426801316970268; Chrystyn H, 2012, INT J CLIN PRACT, V66, P309, DOI 10.1111/j.1742-1241.2011.02832.x; CLARK AR, 1993, J AEROSOL MED, V6, P99, DOI 10.1089/jam.1993.6.99; Cochrane MG, 2000, CHEST, V117, P542, DOI 10.1378/chest.117.2.542; Dalby RN, 2011, MED DEVICES-EVID RES, V4, P145, DOI 10.2147/MDER.S7409; Demoly P, 2014, RESP MED, V108, P1195, DOI 10.1016/j.rmed.2014.05.009; Dolovich MB, 2011, LANCET, V377, P1032, DOI 10.1016/S0140-6736(10)60926-9; Farkas A, 2016, EUROPEAN J PHARM SCI; Grant AC, 2015, J AEROSOL MED PULM D, V28, P474, DOI 10.1089/jamp.2015.1223; Hira D, 2016, ALLERGOL INT, V65, P444, DOI 10.1016/j.alit.2016.04.002; Hira D, 2012, CHEM PHARM BULL, V60, P341, DOI 10.1248/cpb.60.341; Hira D, 2012, CHEM PHARM BULL, V60, P334, DOI 10.1248/cpb.60.334; Hira D, 2010, PHARM RES-DORDR, V27, P2131, DOI 10.1007/s11095-010-0215-6; Hodder Rick, 2009, Int J Chron Obstruct Pulmon Dis, V4, P225; Komase Y, 2014, INT J CHRONIC OBSTR, V9, P1365, DOI 10.2147/COPD.S72762; LAUBE BL, 1992, J ALLERGY CLIN IMMUN, V89, P510, DOI 10.1016/0091-6749(92)90317-U; Lavorini F, 2010, PRIM CARE RESP J, V19, P335, DOI 10.4104/pcrj.2010.00065; Magnussen H, 2009, RESP MED, V103, P1832, DOI 10.1016/j.rmed.2009.07.006; Melani AS, 2011, RESP MED, V105, P930, DOI 10.1016/j.rmed.2011.01.005; Melani Andrea S, 2007, Acta Biomed, V78, P233; Newhouse MT, 1999, CHEST, V115, P952, DOI 10.1378/chest.115.4.952; Nsour WM, 2001, RESP MED, V95, P965, DOI 10.1053/rmed.2001.1190; Pavkov R, 2010, CURR MED RES OPIN, V26, P2527, DOI 10.1185/03007995.2010.518916; PEDERSEN S, 1990, ARCH DIS CHILD, V65, P308, DOI 10.1136/adc.65.3.308; Singh D, 2016, LANCET, V388, P963, DOI 10.1016/S0140-6736(16)31354-X; Van Der Palen J, 2003, RESP MED, V97, P285, DOI 10.1053/rmed.2003.1289; Westerik JAM, 2016, J ASTHMA, V53, P321, DOI 10.3109/02770903.2015.1099160; Wise RA, 2013, NEW ENGL J MED, V369, P1491, DOI 10.1056/NEJMoa1303342; Yang TT, 2001, J AEROSOL MED, V14, P487, DOI 10.1089/08942680152744695; Yokoyama H, 2007, BIOL PHARM BULL, V30, P162, DOI 10.1248/bpb.30.162	36	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0193082	10.1371/journal.pone.0193082	http://dx.doi.org/10.1371/journal.pone.0193082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462195	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200047
J	Abimpaye, M; Kirk, CM; Iyer, HS; Gupta, N; Remera, E; Mugwaneza, P; Law, MR				Abimpaye, Monique; Kirk, Catherine M.; Iyer, Hari S.; Gupta, Neil; Remera, Eric; Mugwaneza, Placidie; Law, Michael R.			The impact of "Option B" on HIV transmission from mother to child in Rwanda: An interrupted time series analysis	PLOS ONE			English	Article							IMPLEMENTATION; PREVENTION; THERAPY	Background Nearly a quarter of a million children have acquired HIV, prompting the implementation of new protocols-Option B and B+-for treating HIV+ pregnant women. While efficacy has been demonstrated in randomized trials, there is limited real-world evidence on the impact of these changes. Using longitudinal, routinely collected data we assessed the impact of the adoption of WHO Option B in Rwanda on mother to infant transmission. Methods We used interrupted time series analysis to evaluate the impact of Option B on mother-to-child HIV transmission in Rwanda. Our primary outcome was the proportion of HIV tests in infants with positive results at six weeks of age. We included data for 20 months before and 22 months after the 2010 policy change. Results Of the 15,830 HIV tests conducted during our study period, 392 tested positive. We found a significant decrease in both the level (-2.08 positive tests per 100 tests conducted, 95% CI: -2.71 to -1.45, p < 0.001) and trend (-0.11 positive tests per 100 tests conducted per month, 95% CI: -0.16 to -0.07, p < 0.001) of test positivity. This represents an estimated 297 fewer children born without HIV in the post-policy period or a 46% reduction in HIV transmission from mother to child. Conclusions The adoption of Option B in Rwanda contributed to an immediate decrease in the rate of HIV transmission from mother to child. This suggests other countries may benefit from adopting these WHO guidelines.	[Abimpaye, Monique; Remera, Eric; Mugwaneza, Placidie] Rwanda Biomed Ctr, Kigali, Rwanda; [Kirk, Catherine M.; Iyer, Hari S.; Gupta, Neil] Partners Hlth Inshuti Mu Buzima, Rwinkwavu, Rwanda; [Iyer, Hari S.; Gupta, Neil] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Law, Michael R.] Univ British Columbia, Vancouver, BC, Canada; [Law, Michael R.] Univ Rwanda, Kigali, Rwanda; [Law, Michael R.] Harvard Med Sch, Boston, MA USA	Rwanda Biomedical Center; Harvard University; Brigham & Women's Hospital; University of British Columbia; University of Rwanda; Harvard University; Harvard Medical School	Kirk, CM (corresponding author), Partners Hlth Inshuti Mu Buzima, Rwinkwavu, Rwanda.; Law, MR (corresponding author), Univ British Columbia, Vancouver, BC, Canada.; Law, MR (corresponding author), Univ Rwanda, Kigali, Rwanda.; Law, MR (corresponding author), Harvard Med Sch, Boston, MA USA.	kirkcm@gmail.com; michael.law@ubc.ca	Iyer, Hari S./AAZ-1563-2020; Kirk, Catherine/T-2596-2019	Kirk, Catherine/0000-0001-9103-2611	Michael Smith Foundation for Health Research; Canada Excellence Research Chairs, Government of Canada (CA); NATIONAL CANCER INSTITUTE [T32CA009001] Funding Source: NIH RePORTER	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Excellence Research Chairs, Government of Canada (CA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Michael Smith Foundation for Health Research and Canada Excellence Research Chairs, Government of Canada (CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizire J, 2013, CURR HIV RES, V11, P144, DOI 10.2174/1570162X11311020007; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Binagwaho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054180; Binagwaho A, 2013, J PUBLIC HEALTH POL, V34, P2, DOI 10.1057/jphp.2012.62; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Dryden-Peterson S, 2015, JAIDS-J ACQ IMM DEF, V68, P245, DOI 10.1097/QAI.0000000000000482; Fasawe O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057778; Fowler MG, 2015, EFFICACY SAFETY 2 ST; Gopalappa C, 2014, AIDS, V28, pS5, DOI 10.1097/QAD.0000000000000083; Haas AD, 2016, THE LANCET HIV; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kieffer MP, 2014, JAIDS-J ACQ IMM DEF, V67, pS188, DOI 10.1097/QAI.0000000000000372; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V70, P99, DOI 10.1097/QAI.0000000000000692; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Ministry of Health (MOH) (Rwanda), 2012, 3 HLTH SECT STRAT PL; Mylene L, 2011, HLTH POLICY PLAN, P1; National Institute of Statistics, 2016, RWAND DEM HLTH SURV; Nsanzimana S, 2012, JAIDS-J ACQ IMM DEF, V59, pE17, DOI 10.1097/QAI.0b013e31823e2278; Rwanda Biomedical Center, 2014, NAT HIV ANN REP 2013; Rwanda Biomedical Center, 2011, NAT ANN REP HIV AIDS; Scott CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072444; Shaffer N, 2014, AIDS, V28, P599, DOI 10.1097/QAD.0000000000000144; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Treatment and Research AIDS Center National University of Rwanda School of Public Health National Reference Laboratory UNICEF, 2010, EFF NAT PROGR PREV M; UNAIDS, 2014, THE GAP REP; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2021, ANT DRUGS TREAT PREG; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192910	10.1371/journal.pone.0192910	http://dx.doi.org/10.1371/journal.pone.0192910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451925	Green Published, Green Submitted, gold			2022-12-26	WOS:000425369800023
J	Shen, C; Chu, C; Geng, YN; Jin, JH; Chen, F; Shi, L				Shen, Chen; Chu, Chen; Geng, Yini; Jin, Jiahua; Chen, Fei; Shi, Lei			Cooperation enhanced by the coevolution of teaching activity in evolutionary prisoner's dilemma games with voluntary participation	PLOS ONE			English	Article							EMERGENCE; DYNAMICS	Voluntary participation, as an additional strategy involved in repeated games, has been proved to be an efficient way to promote the evolution of cooperation theoretically and empirically. Besides, current studies show that the coevolution of teaching activity can promote cooperation. Thus, inspired by aforementioned above, we investigate the effect of coevolution of teaching activity on the evolution of cooperation for prisoner's dilemma game with voluntary participation: when the focal player successfully enforces its strategy on the opponent, his teaching ability will get an increase. Through numerical simulation, we have shown that voluntary participation could effectively promote the fraction of cooperation, which is also affected by the value of increment. Furthermore, we investigate the influence of the increment value on the density of different strategies and find that there exists an optimal increment value that plays an utmost role on the evolutionary dynamics. With regard to this observation, we unveil that an optimal value of increment can lead to strongest heterogeneity in agents' teaching ability, further promoting the evolution of cooperation.	[Shen, Chen; Chu, Chen; Geng, Yini; Jin, Jiahua; Chen, Fei; Shi, Lei] Yunnan Univ Finance & Econ, Sch Stat & Math, Kunming, Yunnan, Peoples R China; [Jin, Jiahua] Yunnan Normal Univ, Lib, Kunming, Yunnan, Peoples R China	Yunnan University of Finance & Economics; Yunnan Normal University	Shi, L (corresponding author), Yunnan Univ Finance & Econ, Sch Stat & Math, Kunming, Yunnan, Peoples R China.	shi_lei65@hotmail.com	Jin, Jiahua/I-8864-2012	Jin, Jiahua/0000-0002-7592-2160	National Natural Science Foundation of China [11671348]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported from the National Natural Science Foundation of China (grant no. 11671348) to LS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate the support from (i) National Natural Science Foundation of China (grants no. 11671348).	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Chen XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051104; Fehr E, 2004, NATURE, V432, P449, DOI 10.1038/432449a; Gintis H., 1998, GAME THEORY ITS APPL; Guan JY, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056101; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Luo C, 2017, COMMUN NONLINEAR SCI, V47, P407, DOI 10.1016/j.cnsns.2016.12.004; Maynard Smith J., 1982, pi; Nowak M. A., 1992, NATURE, V246, P15; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Perc M., 2012, NEW J PHYS, V14; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Pfeiffer T, 2012, J R SOC INTERFACE, V9, P2791, DOI 10.1098/rsif.2012.0332; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Szabo G, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062903; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2009, EUR PHYS J B, V67, P337, DOI 10.1140/epjb/e2008-00470-8; Szolnoki A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23633; Szolnoki A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1975; Szolnoki A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0735; Szolnoki A, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022804; Szolnoki A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/9/093016; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tanimoto J, 2013, PHYSICA A, V392, P2955, DOI 10.1016/j.physa.2013.02.004; Tanimoto J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.032101; Wang WX, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011917; Wang XW, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/10/103025; Wang XW, 2015, APPL MATH COMPUT, V250, P848, DOI 10.1016/j.amc.2014.11.023; Wang Z, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601444; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xu C, 2011, PHYSICA A, V390, P1607, DOI 10.1016/j.physa.2010.12.044; Zhang BY, 2014, EXP ECON, V17, P285, DOI 10.1007/s10683-013-9367-7	46	23	23	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0193151	10.1371/journal.pone.0193151	http://dx.doi.org/10.1371/journal.pone.0193151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451899	Green Published, gold, Green Submitted			2022-12-26	WOS:000425369800042
J	Carli, JFM; LeDuc, CA; Zhang, YY; Stratigopoulos, G; Leibel, RL				Carli, Jayne F. Martin; LeDuc, Charles A.; Zhang, Yiying; Stratigopoulos, George; Leibel, Rudolph L.			The role of Rpgrip1l, a component of the primary cilium, in adipocyte development and function	FASEB JOURNAL			English	Article						Fto; adipogenesis; obesity	BASAL BODY PROTEIN; ADIPOSE-TISSUE; FTO GENE; 3T3-L1 PREADIPOCYTES; JOUBERT-SYNDROME; TRANSITION-ZONE; ADIPOGENIC DIFFERENTIATION; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; CRE RECOMBINASE	Genetic variants within the FTO (-ketoglutarate-dependent dioxygenase) gene have been strongly associated with a modest increase in adiposity as a result of increased food intake. These risk alleles are associated with decreased expression of both FTO and neighboring RPGRIP1L (retinitis pigmentosa GTPase regulator-interacting protein 1 like). RPGRIP1L encodes a protein that is critical to the function of the primary cilium, which conveys extracellular information to the cell. Rpgrip1l(+/-) mice exhibit increased adiposity, in part, as a result of hyperphagia. Here, we describe the effects of Rpgrip1l in adipocytes that may contribute to the adiposity phenotype observed in these animals and possibly in humans who segregate for FTO risk alleles. Loss of Rpgrip1l in 3T3-L1 preadipocytes increased the number of cells that are capable of differentiating into mature adipocytes. Knockout of Rpgrip1l in mature adipocytes using Adipoq-Cre did not increase adiposity in mice that were fed chow or a high-fat diet. We also did not observe any effects of Rpgrip1l knockdown in mature 3T3-L1 adipocytes. Thus, to the extent that Rpgrip1l affects cell-autonomous adipose tissue function, it may do so as a result of the effects conveyed in preadipocytes in which the primary cilium is functionally important. We propose that decreased RPGRIP1L expression in preadipocytes in humans who segregate for FTO obesity risk alleles may increase the storage capacity of adipose tissue.Martin Carli, J. F., LeDuc, C. A., Zhang, Y., Stratigopoulos, G., Leibel, R. L. The role of Rpgrip1l, a component of the primary cilium, in adipocyte development and function.	[Carli, Jayne F. Martin] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, 1150 St Nicholas Ave,Room 620, New York, NY 10032 USA; [Carli, Jayne F. Martin; LeDuc, Charles A.; Zhang, Yiying; Stratigopoulos, George; Leibel, Rudolph L.] Columbia Univ, Med Ctr, Naomi Berrie Diabet Ctr, New York, NY USA; [Carli, Jayne F. Martin; LeDuc, Charles A.; Zhang, Yiying; Stratigopoulos, George; Leibel, Rudolph L.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Carli, JFM (corresponding author), Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, 1150 St Nicholas Ave,Room 620, New York, NY 10032 USA.	jfm2170@cumc.columbia.edu	Stratigopoulos, George/D-4159-2015	Stratigopoulos, George/0000-0003-4752-9123; LeDuc, Charles/0000-0002-2073-5050	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK097399, DK-P30026687-36, S10-RR027050, 5P30-DK063608]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052431, R01DK097399, P30DK026687, P30DK063608] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK097399, DK-P30026687-36 (New York Obesity Nutrition Research Center), S10-RR027050 (Columbia Center for Translational Immunology Flow Cytometry Core), and 5P30-DK063608 (Diabetes Education and Research Center). The authors declare no conflicts of interest.	Aksanov O, 2014, CELL MOL LIFE SCI, V71, P3381, DOI 10.1007/s00018-014-1571-x; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Berentzen T, 2008, J CLIN ENDOCR METAB, V93, P2904, DOI 10.1210/jc.2008-0007; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Christensen ST, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028167; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Church CD, 2014, METHOD ENZYMOL, V537, P31, DOI 10.1016/B978-0-12-411619-1.00003-3; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Cousin W, 2006, BIOCHEM BIOPH RES CO, V349, P799, DOI 10.1016/j.bbrc.2006.08.112; Dalbay MT, 2015, STEM CELLS, V33, P1952, DOI 10.1002/stem.1975; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Fontaine C, 2008, STEM CELLS, V26, P1037, DOI 10.1634/stemcells.2007-0974; Forcioli-Conti N, 2016, BIOCHIMIE, V124, P112, DOI 10.1016/j.biochi.2015.09.011; Forcioli-Conti N, 2015, BIOCHEM BIOPH RES CO, V458, P117, DOI 10.1016/j.bbrc.2015.01.078; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerdes JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6308; Gerhardt C, 2015, J CELL BIOL, V210, P115, DOI 10.1083/jcb.201408060; Gerhardt C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057545; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Huang-Doran I, 2010, INT J OBESITY, V34, P1554, DOI 10.1038/ijo.2010.92; James AW, 2010, TISSUE ENG PT A, V16, P2605, DOI [10.1089/ten.tea.2010.0048, 10.1089/ten.TEA.2010.0048]; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Jensen V, 2015, EMBO J, V34, P2537, DOI 10.15252/embj.201488044; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Krueger KC, 2014, STEM CELL REP, V3, P1147, DOI 10.1016/j.stemcr.2014.10.009; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Li CM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002416; Li GC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030008; LIEBELT RA, 1963, ANN NY ACAD SCI, V110, P723, DOI 10.1111/j.1749-6632.1963.tb15794.x; Lin YW, 2009, EUR J CANCER, V45, P2041, DOI 10.1016/j.ejca.2009.04.012; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Mahuzier A, 2012, J CELL BIOL, V198, P927, DOI 10.1083/jcb.201111009; Mariman ECM, 2016, BRIT J NUTR, V116, P576, DOI 10.1017/S0007114516002282; Marion V, 2012, CELL METAB, V16, P363, DOI 10.1016/j.cmet.2012.08.005; Marion V, 2009, P NATL ACAD SCI USA, V106, P1820, DOI 10.1073/pnas.0812518106; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Oh EC, 2015, CELL METAB, V21, P21, DOI 10.1016/j.cmet.2014.11.019; Okada Shuichi, 2003, Methods Mol Med, V83, P93; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Ravussin Y, 2014, CELL METAB, V20, P565, DOI 10.1016/j.cmet.2014.09.002; REED BC, 1980, P NATL ACAD SCI-BIOL, V77, P285, DOI 10.1073/pnas.77.1.285; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Russell CD, 1998, AM J PHYSIOL-ENDOC M, V275, pE507, DOI 10.1152/ajpendo.1998.275.3.E507; RUSSELL TR, 1976, P NATL ACAD SCI USA, V73, P4516, DOI 10.1073/pnas.73.12.4516; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sherafat-Kazemzadeh R, 2013, PEDIATR OBES, V8, pE64, DOI 10.1111/j.2047-6310.2013.00182.x; Shi XY, 2017, NAT CELL BIOL, V19, P1178, DOI 10.1038/ncb3599; Slieker LJ, 1998, BIOCHEM BIOPH RES CO, V251, P225, DOI 10.1006/bbrc.1998.9433; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; SMYTH MJ, 1992, EXP CELL RES, V199, P29, DOI 10.1016/0014-4827(92)90458-K; Soriano P, 1997, DEVELOPMENT, V124, P2691; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Stratigopoulos G, 2016, J CLIN INVEST, V126, P1897, DOI 10.1172/JCI85526; Stratigopoulos G, 2014, CELL METAB, V19, P767, DOI 10.1016/j.cmet.2014.04.009; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Sun CY, 2017, DEVELOPMENT, V144, P83, DOI 10.1242/dev.135962; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Vaisse C, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028217; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Zhang Y., 2017, EATING DISORDERS OBE; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	82	8	8	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3946	3956		10.1096/fj.201701216R	http://dx.doi.org/10.1096/fj.201701216R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29466054	Green Published			2022-12-26	WOS:000435104500039
J	Chevre, R; Trigueros-Motos, L; Castano, D; Chua, T; Corliano, M; Patankar, JV; Sng, L; Sim, L; Juin, TL; Carissimo, G; Ng, LFP; Yi, CNJ; Eliathamby, CC; Groen, AK; Hayden, MR; Singaraja, RR				Chevre, Raphael; Trigueros-Motos, Laia; Castano, David; Chua, Tricia; Corliano, Maria; Patankar, Jay V.; Sng, Lareina; Sim, Lauren; Juin, Tan Liang; Carissimo, Guillaume; Ng, Lisa F. P.; Yi, Cheryl Neo Jia; Eliathamby, Chelsea Chandani; Groen, Albert K.; Hayden, Michael R.; Singaraja, Roshni R.			Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice	FASEB JOURNAL			English	Article						NAFLD therapeutics; steatosis; liver targeting; siRNA delivery; intestinal cholesterol absorption	STEROL 12-ALPHA-HYDROXYLASE; NUCLEAR RECEPTOR; CHOLESTEROL; FXR; IDENTIFICATION; HOMEOSTASIS; METABOLISM; LIGANDS; TGR5; RNA	Bile acids (BAs) are surfactant molecules that regulate the intestinal absorption of lipids. Thus, the modulation of BAs represents a potential therapy for nonalcoholic fatty liver disease (NAFLD), which is characterized by hepatic accumulation of fat and is a major cause of liver disease worldwide. Cyp8b1 is a critical modulator of the hydrophobicity index of the BA pool. As a therapeutic proof of concept, we aimed to determine the impact of Cyp8b1 inhibition in vivo on BA pool composition and as protection against NAFLD. Inhibition of Cyp8b1 expression in mice led to a remodeling of the BA pool, which altered its signaling properties and decreased intestinal fat absorption. In a model of cholesterol-induced NAFLD, Cyp8b1 knockdown significantly decreased steatosis and hepatic lipid content, which has been associated with an increase in fecal lipid and BA excretion. Moreover, inhibition of Cyp8b1 not only decreased hepatic lipid accumulation, but also resulted in the clearance of previously accumulated hepatic cholesterol, which led to a regression in hepatic steatosis. Taken together, our data demonstrate that Cyp8b1 inhibition is a viable therapeutic target of crucial interest for metabolic diseases, such as NAFLD.Chevre, R., Trigueros-Motos, L., Castano, D., Chua, T., Corlian, M., Patankar, J. V., Sng, L., Sim, L., Juin, T. L., Carissimo, G., Ng, L. F. P., Yi, C. N. J., Eliathamby, C. C., Groen, A. K., Hayden, M. R., Singaraja, R. R. Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice.	[Chevre, Raphael; Trigueros-Motos, Laia; Castano, David; Chua, Tricia; Corliano, Maria; Sng, Lareina; Sim, Lauren; Juin, Tan Liang; Yi, Cheryl Neo Jia; Eliathamby, Chelsea Chandani; Hayden, Michael R.; Singaraja, Roshni R.] ASTAR, Translat Lab Genet Med, Singapore, Singapore; [Carissimo, Guillaume; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Patankar, Jay V.; Hayden, Michael R.] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC, Canada; [Ng, Lisa F. P.; Singaraja, Roshni R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Groen, Albert K.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Patankar, Jay V.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Erlangen, Germany	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Child & Family Research Institute; University of British Columbia; National University of Singapore; University of Liverpool; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Erlangen Nuremberg	Singaraja, RR (corresponding author), Natl Univ Singapore, Agcy Sci Technol & Res, 8A Biomed Grove,Immunos L5, Singapore 138648, Singapore.	rsingaraja@tlgm.a-star.edu.sg	Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Singaraja, Roshni/0000-0002-3418-3867; Patankar, Jay/0000-0002-1884-7424; Carissimo, Guillaume/0000-0002-9703-9096	A*STAR; National University of Singapore	A*STAR(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore)	Microscopy images were acquired at the Image Microscopy Unit [Institute of Medical Biology, Agency for Science, Technology, and Research (A*STAR)]. Funding was provided by A*STAR and the National University of Singapore. The authors declare no conflicts of interest.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Bajor A, 2010, SCAND J GASTROENTERO, V45, P645, DOI 10.3109/00365521003702734; Barteau B, 2008, CURR GENE THER, V8, P313, DOI 10.2174/156652308786070961; Bertaggia E, 2017, AM J PHYSIOL-ENDOC M, V313, pE121, DOI 10.1152/ajpendo.00409.2016; Bonde Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147772; Eguchi A, 2016, J HEPATOL, V64, P699, DOI 10.1016/j.jhep.2015.11.002; Fitzgerald K, 2017, NEW ENGL J MED, V376, P41, DOI 10.1056/NEJMoa1609243; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Haeusler RA, 2012, CELL METAB, V15, P65, DOI 10.1016/j.cmet.2011.11.010; HOFMANN AF, 1984, J LIPID RES, V25, P1477; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Ioannou GN, 2013, J LIPID RES, V54, P1326, DOI 10.1194/jlr.M034876; Kaur A, 2015, DIABETES, V64, P1168, DOI [10.2337/db14-0716, 10.2337/db15-0518]; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kim EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097841; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li P, 2015, CELL METAB, V21, P455, DOI 10.1016/j.cmet.2015.02.004; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Out C, 2012, CURR OPIN LIPIDOL, V23, P43, DOI 10.1097/MOL.0b013e32834f0ef3; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pathak P, 2013, J BIOL CHEM, V288, P37154, DOI 10.1074/jbc.M113.485987; Porez G, 2012, J LIPID RES, V53, P1723, DOI 10.1194/jlr.R024794; Puri P, 2018, HEPATOLOGY, V67, P534, DOI 10.1002/hep.29359; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Slatis K, 2010, J LIPID RES, V51, P3289, DOI 10.1194/jlr.M009308; Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Thomas C, 2008, THYROID, V18, P167, DOI 10.1089/thy.2007.0255; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Trauner M, 2010, DIGEST DIS, V28, P220, DOI 10.1159/000282091; Wang DQH, 2003, AM J PHYSIOL-GASTR L, V285, pG494, DOI 10.1152/ajpgi.00156.2003; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wierzbicki AS, 2012, CURR OPIN LIPIDOL, V23, P345, DOI 10.1097/MOL.0b013e3283541cfc; Wittrup A, 2015, NAT REV GENET, V16, P543, DOI 10.1038/nrg3978; Yamada M, 2000, BIOL CHEM, V381, P1149, DOI 10.1515/BC.2000.142; Yuan LY, 2015, WORLD J HEPATOL, V7, P2811, DOI 10.4254/wjh.v7.i28.2811; Zezos P, 2014, WORLD J GASTROENTERO, V20, P15532, DOI 10.3748/wjg.v20.i42.15532	49	24	24	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3792	3802		10.1096/fj.201701084RR	http://dx.doi.org/10.1096/fj.201701084RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29481310				2022-12-26	WOS:000435104500026
J	Lin, WS; Yeh, SR; Fan, SZ; Chen, LY; Yen, JH; Fu, TF; Wu, MS; Wang, PY				Lin, Wei-Sheng; Yeh, Sheng-Rong; Fan, Shou-Zen; Chen, Liang-Yu; Yen, Jui-Hung; Fu, Tsai-Feng; Wu, Ming-Shiang; Wang, Pei-Yu			Insulin signaling in female Drosophila links diet and sexual attractiveness	FASEB JOURNAL			English	Article						courtship preference; oenocytes; cuticular hydrocarbons	INSECT CUTICULAR HYDROCARBONS; MALE COURTSHIP BEHAVIOR; LIFE-SPAN; MATE CHOICE; MELANOGASTER; RESTRICTION; PREFERENCE; RECEPTOR; NEURONS	Appropriate sexual selection or individual sexual attractiveness is closely associated with the reproductive success of a species. Here, we report that young male flies exhibit innate courtship preference for female flies that are raised on higher-yeast diets and that have greater body weight and fecundity, but reduced locomotor activity and shortened lifespan. Male flies discriminate among females that have been fed diets that contain 3 different yeast concentrations1, 5, and 20% yeastvia gustatory, but not visual or olfactory, perception. Female flies that are raised on higher-yeast diets exhibit elevated expression levels of Drosophila insulin-like peptides (dilps), and we demonstrate that hypomorphic mutations of dilp2, 3, 5 or foxo, as well as oenocyte-specific gene disruption of the insulin receptor, all abolish this male courtship preference for high yeast-fed females. Moreover, our data demonstrate that disrupted dilp signaling can alter the expression profile of some cuticular hydrocarbons (CHCs) in female flies, and that genetic inhibition of an enzyme involved in the biosynthesis of CHCs in oenocytes, elongase F, also eliminates the male courtship preference. Together, our findings provide mechanistic insights that link female reproductive potential to sexual attractiveness, thereby encouraging adaptive mating and optimal reproductive success.Lin, W.-S., Yeh, S.-R., Fan, S.-Z., Chen, L.-Y., Yen, J.-H., Fu, T.-F., Wu, M.-S., Wang, P.-Y. Insulin signaling in female Drosophila links diet and sexual attractiveness.	[Lin, Wei-Sheng; Yeh, Sheng-Rong; Wang, Pei-Yu] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei, Taiwan; [Wang, Pei-Yu] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei, Taiwan; [Wang, Pei-Yu] Natl Taiwan Univ, Ctr Syst Biol, Taipei, Taiwan; [Lin, Wei-Sheng] Natl Taiwan Univ Hosp Yunlin, Dept Pediat, Yunlin, Taiwan; [Fan, Shou-Zen] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Wu, Ming-Shiang] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Chen, Liang-Yu] Mingchuan Univ, Dept Biotechnol, Taoyuan, Taiwan; [Yen, Jui-Hung] Indiana Univ Sch Med, Dept Microbiol & Immunol, Ft Wayne, IN USA; [Fu, Tsai-Feng] Natl Chinan Univ, Dept Appl Chem, Nantou, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Purdue University System; Indiana University Purdue University Fort Wayne; National Chi Nan University	Wang, PY (corresponding author), Natl Taiwan Univ, 1,Sect 1,Renai Rd, Taipei 10051, Taiwan.	wangpeiyu@ntu.edu.tw	Yen, Jui-Hung/AAV-3455-2020; Lin, Wei-Sheng/AAV-9949-2020	Lin, Wei-Sheng/0000-0002-9016-2067; Fan, Shou-Zen/0000-0002-6849-8453; Chen, Liang-Yu/0000-0002-2981-1945; WANG, PEI-YU/0000-0002-1792-8935; Yen, Jui-Hung Jimmy/0000-0002-7325-9756	Ministry of Science and Technology, Taiwan [MOST 105-2321-B-002-009-, MOST 105-2410-H-002-050-MY2]; National Taiwan University Hospital [UN103-055]; National Taiwan University Hospital Yunlin [NTUHYL107.X017]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); National Taiwan University Hospital Yunlin	The authors thank Frederick Chien (Graduate Institute of Brain and Mind Sciences, National Taiwan University) for technical assistance and the Fly Core in Taiwan for fly stocks and reagents. P.-Y.W., M.-S.W., and W.-S.L. are supported by grants from the Ministry of Science and Technology, Taiwan (MOST 105-2321-B-002-009- and MOST 105-2410-H-002-050-MY2), National Taiwan University Hospital (UN103-055), and National Taiwan University Hospital Yunlin (NTUHYL107.X017). The authors declare no conflicts of interest.	ANTONY C, 1985, J CHEM ECOL, V11, P1617, DOI 10.1007/BF01012116; ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; Arbuthnott D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13953; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Bross TG, 2005, AGING CELL, V4, P309, DOI 10.1111/j.1474-9726.2005.00181.x; Byrne PG, 2006, P ROY SOC B-BIOL SCI, V273, P917, DOI 10.1098/rspb.2005.3372; Chertemps T, 2007, P NATL ACAD SCI USA, V104, P4273, DOI 10.1073/pnas.0608142104; Chou HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058441; Chung H, 2015, BIOESSAYS, V37, P822, DOI 10.1002/bies.201500014; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Fedina TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049799; Gorter JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19441; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Hu YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07777; Huang CW, 2015, J GERONTOL A-BIOL, V70, P1461, DOI 10.1093/gerona/glv094; Ingleby FC, 2015, INSECTS, V6, P732, DOI 10.3390/insects6030732; Kallman BR, 2015, ELIFE, V4, DOI 10.7554/eLife.11188; Khan I, 2013, J INSECT PHYSIOL, V59, P1017, DOI 10.1016/j.jinsphys.2013.07.010; Kuo SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8490; Kuo TH, 2012, PLOS GENET, V8, P640, DOI 10.1371/journal.pgen.1002684; Lin WS, 2014, AGE, V36, P689, DOI 10.1007/s11357-013-9606-z; Makki R, 2014, ANNU REV ENTOMOL, V59, P405, DOI 10.1146/annurev-ento-011613-162056; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Nandy B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00447; Rajpurohit S, 2017, J EVOLUTION BIOL, V30, P66, DOI 10.1111/jeb.12988; Ribeiro C, 2010, CURR BIOL, V20, P1000, DOI 10.1016/j.cub.2010.03.061; Starostina E, 2012, J NEUROSCI, V32, P4665, DOI 10.1523/JNEUROSCI.6178-11.2012; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Toda H, 2012, CELL REP, V1, P599, DOI 10.1016/j.celrep.2012.05.007; Vargas MA, 2010, CURR BIOL, V20, P1006, DOI 10.1016/j.cub.2010.04.009; Vijayan V, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004238; Wang PY, 2009, P NATL ACAD SCI USA, V106, P9262, DOI 10.1073/pnas.0904115106; Yamamoto D, 2014, J COMP PHYSIOL A, V200, P251, DOI 10.1007/s00359-014-0891-5; Zajitschek F, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2016.0914; Zhuang LM, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160086	37	11	11	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3870	3877		10.1096/fj.201800067R	http://dx.doi.org/10.1096/fj.201800067R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29475396				2022-12-26	WOS:000435104500032
J	Oyinlade, O; Wei, S; Lal, B; Laterra, J; Zhu, H; Goodwin, CR; Wang, SY; Ma, D; Wan, J; Xia, SL				Oyinlade, Olutobi; Wei, Shuang; Lal, Bachchu; Laterra, John; Zhu, Heng; Goodwin, C. Rory; Wang, Shuyan; Ma, Ding; Wan, Jun; Xia, Shuli			Targeting UDP-alpha-D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration	ONCOGENE			English	Article							STEM-LIKE CELLS; CANCER PROGRESSION; HYALURONAN; INVASION; DEHYDROGENASE; MULTIFORME	UDP-glucose 6-dehydrogenase (UGDH) produces UDP-alpha-D-glucuronic acid, the precursors for glycosaminoglycans (GAGs) and proteoglycans of the extracellular matrix. Elevated GAG formation has been implicated in a variety of human diseases, including glioblastoma (GBM). In our previous study, we found that Kruppel-like factor 4 (KLF4) promotes GBM cell migration by binding to methylated DNA, mainly methylated CpGs (mCpG) and transactivating gene expression. We identified UDGH as one of the downstream targets of KLF4-mCpG binding activity. In this study, we show that KLF4 upregulates UGDH expression in a mCpG-dependent manner, and UGDH is required for KLF4-induced cell migration in vitro. UGDH knockdown decreases GAG abundance in GBM cells, as well as cell proliferation and migration in vitro. In intracranial xenografts, reduced UGDH inhibits tumor growth and migration, accompanied by a decrease in the expression of extracellular matrix proteins such as tenascin C, brevican. Our studies demonstrate a novel DNA methylation-dependent UGDH upregulation by KLF4. Developing UGDH antagonists to decrease the synthesis of extracellular matrix components will be a useful strategy for GBM therapy.	[Oyinlade, Olutobi; Wei, Shuang; Lal, Bachchu; Laterra, John; Wang, Shuyan; Ma, Ding; Xia, Shuli] Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD 21205 USA; [Oyinlade, Olutobi; Zhu, Heng] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Wei, Shuang; Lal, Bachchu; Laterra, John; Wang, Shuyan; Ma, Ding; Xia, Shuli] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Wei, Shuang] Huazhong Univ Sci & Technol, Dept Resp & Crit Care Med, Tongji Med Coll, Tongji Hosp, Wuhan 430030, Hubei, Peoples R China; [Laterra, John] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Laterra, John] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Zhu, Heng] Johns Hopkins Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Goodwin, C. Rory] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27710 USA; [Wan, Jun] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Huazhong University of Science & Technology; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Duke University; Indiana University System; Indiana University Bloomington	Xia, SL (corresponding author), Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD 21205 USA.; Xia, SL (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	xia@kennedykrieger.org	Wei, Shuang/AAA-4031-2019; Wan, Jun/AAN-1337-2020	Wan, Jun/0000-0001-9286-6562	NIH [R01NS091165, R01 NS096754, NS076759, GM111514, R01 GM111514, R33CA186790, U54 HG006434, U24 CA160036, T32 GM007445]; Ford Foundation pre-doctoral fellowship program; Duke SPORE CEP Award; NIH/NINDS; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS096754, R01NS091165, R01NS073611] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ford Foundation pre-doctoral fellowship program; Duke SPORE CEP Award; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from NIH R01NS091165 (to SX), NIH R01 NS096754 (to JL), NS076759 (to JL), NIH GM111514 (to HZ), NIH R01 GM111514 (to HZ), NIH R33CA186790 (to HZ), NIH U54 HG006434 (to HZ), NIH U24 CA160036 (to HZ), Ford Foundation pre-doctoral fellowship program (to OO) and NIH T32 GM007445 (to OO), NIH/NINDS K12 Physician Scientist Award, Burroughs Wellcome Fund, and Duke SPORE CEP Award (to CRG).	Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; Batash R., 2017, RECENT LIT REV CURR, V24, P3002, DOI DOI 10.2174/0929867324666170516123206; Clarkin CE, 2011, J CELL PHYSIOL, V226, P749, DOI 10.1002/jcp.22393; CRAIG JM, 1994, NAT GENET, V7, P376, DOI 10.1038/ng0794-376; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Medvedeva YA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-119; Nutt CL, 2001, CANCER RES, V61, P7056; Rath P, 2013, TRANSL ONCOL, V6, P104, DOI 10.1593/tlo.13127; Reznik TE, 2008, MOL CANCER RES, V6, P139, DOI 10.1158/1541-7786.MCR-07-0236; Tilghman J, 2014, CANCER RES, V74, P3168, DOI 10.1158/0008-5472.CAN-13-2103; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Venning FA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00224; Wade A, 2013, FEBS J, V280, P2399, DOI 10.1111/febs.12109; Wan J, 2017, ELIFE, V6, DOI 10.7554/eLife.20068; Wang SD, 2012, ONCOGENE, V31, P5132, DOI 10.1038/onc.2012.16; Wen YX, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0484-2; Wiranowska MR, 2011, GLIOMA EXPLORING ITS, P257; Wu YJ, 2012, CANCER SCI, V103, P1028, DOI 10.1111/j.1349-7006.2012.02260.x; Xia SL, 2016, NEURO-ONCOLOGY, V18, P507, DOI 10.1093/neuonc/nov171; Ying MY, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.588988; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591	28	24	25	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	20					2615	2629		10.1038/s41388-018-0138-y	http://dx.doi.org/10.1038/s41388-018-0138-y			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG2TH	29479058	Green Accepted, Green Submitted			2022-12-26	WOS:000432545100001
J	Lee, JS; Wang, RX; Alexeev, EE; Lanis, JM; Battista, KD; Glover, LE; Colgan, SP				Lee, J. Scott; Wang, Ruth X.; Alexeev, Erica E.; Lanis, Jordi M.; Battista, Kayla D.; Glover, Louise E.; Colgan, Sean P.			Hypoxanthine is a checkpoint stress metabolite in colonic epithelial energy modulation and barrier function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; INTESTINAL EPITHELIA; ESCHERICHIA-COLI; TIGHT JUNCTION; ACTIN CYTOSKELETON; ATP DEPLETION; BRUSH-BORDER; FACTOR-I; CHARGE; PHOSPHORYLASE	Intestinal epithelial cells form a selectively permeable barrier to protect colon tissues from luminal microbiota and antigens and to mediate nutrient, fluid, and waste flux in the intestinal tract. Dysregulation of the epithelial cell barrier coincides with profound shifts in metabolic energy, especially in the colon, which exists in an energetically depleting state of physiological hypoxia. However, studies that systematically examine energy flux and adenylate metabolism during intestinal epithelial barrier development and restoration after disruption are lacking. Here, to delineate barrier-related energy flux, we developed an HPLC-based profiling method to track changes in energy flux and adenylate metabolites during barrier development and restoration. Cultured epithelia exhibited pooling of phosphocreatine and maintained ATP during barrier development. EDTA-induced epithelial barrier disruption revealed that hypoxanthine levels correlated with barrier resistance. Further studies uncovered that hypoxanthine supplementation improves barrier function and wound healing and that hypoxanthine appears to do so by increasing intracellular ATP, which improved cytoskeletal G- to F-actin polymerization. Hypoxanthine supplementation increased the adenylate energy charge in the murine colon, indicating potential to regulate adenylate energy charge-mediated metabolism in intestinal epithelial cells. Moreover, experiments in a murine colitis model disclosed that hypoxanthine loss during active inflammation correlates with markers of disease severity. In summary, our results indicate that hypoxanthine modulates energy metabolism in intestinal epithelial cells and is critical for intestinal barrier function.	[Lee, J. Scott; Wang, Ruth X.; Alexeev, Erica E.; Lanis, Jordi M.; Battista, Kayla D.; Colgan, Sean P.] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Lee, J. Scott; Wang, Ruth X.; Alexeev, Erica E.; Lanis, Jordi M.; Battista, Kayla D.; Colgan, Sean P.] Univ Colorado, Sch Med, Mucosal Inflammat Program, Aurora, CO 80045 USA; [Glover, Louise E.] Univ Coll Dublin, Sch Med, Dublin, Ireland	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University College Dublin	Colgan, SP (corresponding author), Univ Colorado, Mucosal Inflammat Program, Anschutz Med Campus,12700 East 19th Ave MS B-146, Aurora, CO 80045 USA.	sean.colgan@ucdenver.edu		Lee, J. Scott/0000-0001-7151-9828	National Institutes of Health [DK050189, DK095491, DK104713, DK103712]; Veterans Affairs Merit Award [BX002182]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103712, R01DK095491, R01DK104713, R37DK050189, P30DK048520] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants DK050189, DK095491, DK104713, and DK103712 and Veterans Affairs Merit Award BX002182. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Aschauer L, 2013, MOL CELL BIOL, V33, P2535, DOI 10.1128/MCB.01435-12; ATKINSON DE, 1967, J BIOL CHEM, V242, P3239; ATKINSON DE, 1977, CELLULAR ENERGY META, P85; BACALLAO R, 1994, J CELL SCI, V107, P3301; BALL WJ, 1975, J BACTERIOL, V121, P975, DOI 10.1128/JB.121.3.975-982.1975; BRETSCHER A, 1991, ANNU REV CELL BIOL, V7, P337, DOI 10.1146/annurev.cb.07.110191.002005; Capaldo CT, 2015, SEMIN CELL DEV BIOL, V42, P22, DOI 10.1016/j.semcdb.2015.04.003; Chapman A G, 1977, Adv Microb Physiol, V15, P253, DOI 10.1016/S0065-2911(08)60318-5; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; Chouraki V, 2017, ALZHEIMERS DEMENT, V13, P1327, DOI 10.1016/j.jalz.2017.04.009; COHEN PF, 1972, BIOCHEMISTRY-US, V11, P1501, DOI 10.1021/bi00758a027; Colgan SP, 2016, ANNU REV PATHOL-MECH, V11, P77, DOI 10.1146/annurev-pathol-012615-044231; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Culic O, 1997, AM J PHYSIOL-CELL PH, V273, pC205, DOI 10.1152/ajpcell.1997.273.1.C205; De la Fuente IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108676; Elion GB, 1978, URIC ACID, P485, DOI [10.1007/978-3-642-66867-8_2, DOI 10.1007/978-3-642-66867-8_2]; Ercan N, 1996, ARCH BIOCHEM BIOPHYS, V328, P255, DOI 10.1006/abbi.1996.0171; Ercan-Fang N, 2002, AM J PHYSIOL-ENDOC M, V283, pE29, DOI 10.1152/ajpendo.00425.2001; FORSCHER P, 1992, NATURE, V357, P515, DOI 10.1038/357515a0; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; Glover LE, 2016, J CLIN INVEST, V126, P3680, DOI 10.1172/JCI84429; Glover LE, 2013, P NATL ACAD SCI USA, V110, P19820, DOI 10.1073/pnas.1302840110; Glover LE, 2011, GASTROENTEROLOGY, V140, P1748, DOI 10.1053/j.gastro.2011.01.056; GRIMBLE GK, 1994, GUT, V35, pS46, DOI 10.1136/gut.35.1_Suppl.S46; HIROKAWA N, 1983, J CELL BIOL, V96, P1325, DOI 10.1083/jcb.96.5.1325; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ibla JC, 2006, AM J PHYSIOL-CELL PH, V291, pC282, DOI 10.1152/ajpcell.00564.2005; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Julicher F, 2007, PHYS REP, V449, P3, DOI 10.1016/j.physrep.2007.02.018; Karhausen J, 2005, CELL CYCLE, V4, P256; Kemp GJ, 2007, NMR BIOMED, V20, P555, DOI 10.1002/nbm.1192; Koch S, 2009, ANN NY ACAD SCI, V1165, P220, DOI 10.1111/j.1749-6632.2009.04025.x; KRENITSKY TA, 1967, J BIOL CHEM, V242, P2675; Lanis JM, 2017, MUCOSAL IMMUNOL, V10, P1133, DOI 10.1038/mi.2016.133; Lazzarino G, 2017, MOL NEUROBIOL, V54, P7520, DOI 10.1007/s12035-016-0257-9; Long Y, 2017, CANCER-AM CANCER SOC, V123, P4066, DOI 10.1002/cncr.30829; Lotz MM, 2000, AM J PATHOL, V156, P985, DOI 10.1016/S0002-9440(10)64966-8; MACKINNON AM, 1973, BIOCHIM BIOPHYS ACTA, V319, P1, DOI 10.1016/0005-2787(73)90034-8; MADARA JL, 1987, J MEMBRANE BIOL, V100, P149, DOI 10.1007/BF02209147; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; MATTHEWS JB, 1992, J CLIN INVEST, V90, P1608, DOI 10.1172/JCI116030; Moffatt Barbara A, 2002, Arabidopsis Book, V1, pe0018, DOI 10.1199/tab.0018; MOOSEKER MS, 1985, ANNU REV CELL BIOL, V1, P209, DOI 10.1146/annurev.cellbio.1.1.209; NATSUMEDA Y, 1990, J BIOL CHEM, V265, P5292; Nelson SW, 2002, J BIOL CHEM, V277, P15539, DOI 10.1074/jbc.M112304200; NISHIDA Y, 1979, AGENTS ACTIONS, V9, P549, DOI 10.1007/BF01968126; NUSRAT A, 1992, J CLIN INVEST, V89, P1501, DOI 10.1172/JCI115741; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Rasmussen I, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-44; REITER S, 1983, BIOCHEM PHARMACOL, V32, P2167, DOI 10.1016/0006-2952(83)90222-8; SAUGSTAD OD, 1975, PEDIATR RES, V9, P158, DOI 10.1203/00006450-197504000-00002; SAVAIANO DA, 1981, J NUTR, V111, P1816, DOI 10.1093/jn/111.10.1816; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; SHEPHERD AP, 1982, FED PROC, V41, P2084; Sun XF, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170104; SWEDES JS, 1975, J BIOL CHEM, V250, P6930; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Tsukamoto T, 1997, J BIOL CHEM, V272, P16133, DOI 10.1074/jbc.272.26.16133; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; WALKERSIMMONS M, 1977, J BACTERIOL, V130, P676, DOI 10.1128/JB.130.2.676-683.1977; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zheng L, 2015, AM J PHYSIOL-CELL PH, V309, pC350, DOI 10.1152/ajpcell.00191.2015	66	59	60	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6039	6051		10.1074/jbc.RA117.000269	http://dx.doi.org/10.1074/jbc.RA117.000269			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29487135	Green Published, hybrid			2022-12-26	WOS:000430497300023
J	Alkhamis, MA; Gallardo, C; Jurado, C; Soler, A; Arias, M; Sanchez-Vizcaino, JM				Alkhamis, Moh A.; Gallardo, Carmina; Jurado, Cristina; Soler, Alejandro; Arias, Marisa; Sanchez-Vizcaino, Jose M.			Phylodynamics and evolutionary epidemiology of African swine fever p72-CVR genes in Eurasia and Africa	PLOS ONE			English	Article							ORNITHODOROS-ERRATICUS; AVIAN INFLUENZA; VIRUS; DYNAMICS; SPREAD; SURVEILLANCE; TRANSMISSION; INFERENCE; OUTBREAKS; SELECTION	African swine fever (ASF) is a complex infectious disease of swine that constitutes devastating impacts on animal health and the world economy. Here, we investigated the evolutionary epidemiology of ASF virus (ASFV) in Eurasia and Africa using the concatenated gene sequences of the viral protein 72 and the central variable region of isolates collected between 1960 and 2015. We used Bayesian phylodynamic models to reconstruct the evolutionary history of the virus, to identify virus population demographics and to quantify dispersal patterns between host species. Results suggest that ASFV exhibited a significantly high evolutionary rate and population growth through time since its divergence in the 18th century from East Africa, with no signs of decline till recent years. This increase corresponds to the growing pig trade activities between continents during the 19th century, and may be attributed to an evolutionary drift that resulted from either continuous circulation or maintenance of the virus within Africa and Eurasia. Furthermore, results implicate wild suids as the ancestral host species (root state posterior probability = 0.87) for ASFV in the early 1700s in Africa. Moreover, results indicate the transmission cycle between wild suids and pigs is an important cycle for ASFV spread and maintenance in pig populations, while ticks are an important natural reservoir that can facilitate ASFV spread and maintenance in wild swine populations. We illustrated the prospects of phylodynamic methods in improving risk-based surveillance, support of effective animal health policies, and epidemic preparedness in countries at high risk of ASFV incursion.	[Alkhamis, Moh A.] Kuwait Univ, Hlth Sci Ctr, Fac Publ Heath, Kuwait, Kuwait; [Alkhamis, Moh A.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Gallardo, Carmina; Soler, Alejandro; Arias, Marisa] INIA CISA, Ctr Invest Sanidad Anim, European Union Reference Lab African Swine Fever, Madrid, Spain; [Jurado, Cristina; Sanchez-Vizcaino, Jose M.] Univ Complutense Madrid, VISAVET Hlth Surveillance Ctr, Madrid, Spain; [Jurado, Cristina; Sanchez-Vizcaino, Jose M.] Univ Complutense Madrid, Anim Hlth Dept, Vet Sch, Madrid, Spain	Kuwait University; University of Minnesota System; University of Minnesota Twin Cities; Complutense University of Madrid; Complutense University of Madrid	Alkhamis, MA (corresponding author), Kuwait Univ, Hlth Sci Ctr, Fac Publ Heath, Kuwait, Kuwait.; Alkhamis, MA (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	malkahmi@umn.edu	Arias, Maria Luisa/X-7566-2018; Gallardo+Frontaura, Carmina/ABE-6878-2021; gallardo, Carmina/AAB-2386-2019	Arias, Maria Luisa/0000-0001-6044-2968; gallardo, Carmina/0000-0003-3293-306X; Alkhamis, Mohammad/0000-0001-6451-5247	Spanish Government; EU project ASFRISK, Evaluating and Controlling the Risk of African Swine Fever in the EU (DG-Research, EC, 7FP Grant) [KBBE211691]; EU Reference laboratory for ASF [UE-LR PPA/03]; EU project ASFORCE [311931, FP7 - KBBE.2012.1.3-02]; Spanish National Project RTA-PPA [RTA201 1-00060-C02-02]	Spanish Government(Spanish GovernmentEuropean Commission); EU project ASFRISK, Evaluating and Controlling the Risk of African Swine Fever in the EU (DG-Research, EC, 7FP Grant); EU Reference laboratory for ASF; EU project ASFORCE; Spanish National Project RTA-PPA	CJ is the recipient of a Spanish Government-funded PhD fellowship for the Training of Future Scholars (FPU) given by the Spanish Ministry of Education, Culture and Sports. This work was partly supported under the EU project ASFRISK, Evaluating and Controlling the Risk of African Swine Fever in the EU (DG-Research, EC, 7FP Grant Agreement, KBBE211691), and the EU Reference laboratory for ASF (grant no UE-LR PPA/03). EU project ASFORCE (Grant Agreement no311931, FP7 - KBBE.2012.1.3-02) and the Spanish National Project RTA-PPA (RTA201 1-00060-C02-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CJ is the recipient of a Spanish Government-funded PhD fellowship for the Training of Future Scholars (FPU) given by the Spanish Ministry of Education, Culture and Sports.; This work was partly supported under the EU project ASFRISK, Evaluating and Controlling the Risk of African Swine Fever in the EU (DG-Research, EC, 7FP Grant Agreement, KBBE211691), and the EU Reference laboratory for ASF (grant no UE-LR PPA/03). We would like to thank all the staff at the EURL INIA-CISA who work in the sequencing department including, above all, Encarnacion Madueno and Oscar Nuero. We also specially thank Covadonga Perez, Alicia Simon and Elena Martin for performing laboratory techniques, including sampling processing and PCR amplification, for further sequence analysis. Gratitude extends to Imbi Nurmoja, Ieva Rozde, Gediminas Pridoktas, and Grzegorz Wozniakowski, the former heads of National Reference Labortories (NRLs) of Estonia, Latvia, Lithuania and Poland, for providing the samples. As an OIE Reference Laboratory, authors would like to thank the OIE for its support in our research on ASF as well as the EU project ASFORCE (Grant Agreement no 311931, FP7-KBBE.2012.1.3-02) and the Spanish National Project RTA-PPA (RTA201 1-00060-C02-02).	Achenbach J. E., 2016, TRANSBOUND EMERG DIS; Alizon S, 2014, VIRULENCE, V5, P825, DOI 10.4161/21505594.2014.976514; Alkhamis MA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00067; Alkhamis MA, 2015, VIRUSES-BASEL, V7, P3310, DOI 10.3390/v7062773; Arias M, 2002, TRENDS EMERGING VIRA, V1; Atuhaire DK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-247; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bastos AD P ML, 2003, ARCH VIROL, V148; Blench RM, 1999, ORIGINS DEV AFRICAN, P335; Boinas FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020383; Boinas FS, 2004, J GEN VIROL, V85, P2177, DOI 10.1099/vir.0.80058-0; Bosch J., 2016, TRANSBOUND EMERG DIS; Boshoff CI, 2007, VET MICROBIOL, V121, P45, DOI 10.1016/j.vetmic.2006.11.007; Campbell V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-64; Chen RB, 2010, J MOL EVOL, V70, P98, DOI 10.1007/s00239-009-9312-8; Costard S, 2013, VIRUS RES, V173, P191, DOI 10.1016/j.virusres.2012.10.030; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; Dixon L., 2005, ASFARVIRIDAE VIRUS T; Dixon LK, 2013, VIRUS RES, V173, P3, DOI 10.1016/j.virusres.2012.10.020; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; EURL-ASF, 2013, STAND OP PROC GEN AF, P1; de Carvalho LMF, 2013, INFECT GENET EVOL, V13, P76, DOI 10.1016/j.meegid.2012.08.016; Fan Y, 2011, MOL BIOL EVOL, V28, P523, DOI 10.1093/molbev/msq224; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; Fraczyk M, 2016, VET MICROBIOL, V193, P133, DOI 10.1016/j.vetmic.2016.08.018; Gallardo C, 2015, J CLIN MICROBIOL, V53, P2555, DOI 10.1128/JCM.00857-15; Gallardo C, 2009, VIRUS GENES, V38, P85, DOI 10.1007/s11262-008-0293-2; Gallardo C, 2014, EMERG INFECT DIS, V20, P1544, DOI 10.3201/eid2009.140554; Gallardo C, 2011, AFR J BIOTECHNOL, V10, P3488; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Griffiths RC, 1994, ANCESTRAL INFERENCE, P307; HARESNAPE JM, 1989, EPIDEMIOL INFECT, V102, P507, DOI 10.1017/S0950268800030223; HARNESNAPE JM, 1986, J HYG-CAMBRIDGE, V96, P535, DOI 10.1017/S0022172400066341; Jori F, 2009, ECOHEALTH, V6, P296, DOI 10.1007/s10393-009-0248-7; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lam TTY, 2012, MOL ECOL, V21, P3062, DOI 10.1111/j.1365-294X.2012.05577.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lubisi BA, 2007, VIRUS GENES, V35, P729, DOI 10.1007/s11262-007-0148-2; Luka P. D., 2016, TRANSBOUND EMERG DIS; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martinez-Lopez B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00314; Michaud V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069662; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Misinzo G, 2014, TROP ANIM HEALTH PRO, V46, P1199, DOI 10.1007/s11250-014-0628-z; MONTGOMERY R. Eustace, 1921, Journal of Comparative Pathology and Therapeutics, V34, P159; Muangkram Y, 2015, GENET MOL RES, V14, P4566, DOI 10.4238/2015.May.4.15; Mur L, 2016, TRANSBOUND EMERG DIS, V63, pE165, DOI 10.1111/tbed.12264; O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003; Oleaga-Perez A, 1994, VETPARASITOL, V52; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; PEREZSANCHEZ R, 1994, VET REC, V135, P207, DOI 10.1136/vr.135.9.207; Pietschmann J, 2016, BMC VET RES, V12, DOI 10.1186/s12917-015-0629-9; PLOWRIGH.W, 1974, RES VET SCI, V17, P106, DOI 10.1016/S0034-5288(18)33716-0; Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109; Quembo CJ, 2016, TRANSBOUND EMERG DIS, V63, P443, DOI 10.1111/tbed.12289; Quembo CJ, 2017, TRANSBOUND EMERG DIS; Rambaut A, 2016, VIRUS EVOLUTION, V2; Rambaut A., 2013, TRACER; Razavi N., 2008, KULLBACK LEIBLER DIV; Sanchez-Vizcaino JM, 2015, REV SCI TECH OIE, V34, P503, DOI 10.20506/rst.34.2.2375; Sanchez-Vizcaino JM, 2015, J COMP PATHOL, V152, P9, DOI 10.1016/j.jcpa.2014.09.003; Sanchez-Vizcaino JM, 2012, TRANSBOUND EMERG DIS, V59, P27, DOI 10.1111/j.1865-1682.2011.01293.x; Sanna G, 2016, TRANSBOUND EMERG DIS; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Simulundu E., 2017, TRANSBOUND EMERG DIS; Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Streicker DG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002720; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; SuYnchez Botija C., 1982, REV SCI TECH OIE, V1, P1065; The MathWorks Inc, 2016, MATL STAT TOOLB REL; Thomas LF, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0830-5; THOMSON GR, 1985, ONDERSTEPOORT J VET, V52, P201; WAHID, 2017, WAHID DAT; Xu JP, 2011, INFECT GENET EVOL, V11, P2125, DOI 10.1016/j.meegid.2011.07.002	82	30	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192565	10.1371/journal.pone.0192565	http://dx.doi.org/10.1371/journal.pone.0192565			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489860	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000032
J	Kallakuri, S; Pace, E; Lu, HC; Luo, H; Cavanaugh, J; Zhang, JS				Kallakuri, Srinivasu; Pace, Edward; Lu, Huichao; Luo, Hao; Cavanaugh, John; Zhang, Jinsheng			Time course of blast-induced injury in the rat auditory cortex	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; AXONAL INJURY; COCHLEAR NUCLEUS; INDUCED TINNITUS; HEARING-LOSS; ACOUSTIC OVERSTIMULATION; EXPOSURE; OVERPRESSURE; DEGENERATION; MODEL	Blast exposure is an increasingly significant health hazard and can have a range of debilitating effects, including auditory dysfunction and traumatic brain injury. To assist in the development of effective treatments, a greater understanding of the mechanisms of blast induced auditory damage and dysfunction, especially in the central nervous system, is critical. To elucidate this area, we subjected rats to a unilateral blast exposure at 22 psi, measured their auditory brainstem responses (ABRs), and histologically processed their brains at 1 day, 1 month, and 3-month survival time points. The left and right auditory cortices was assessed for astrocytic reactivity and axonal degenerative changes using glial fibrillary acidic protein immunoreactivity and a silver impregnation technique, respectively. Although only unilateral hearing loss was induced, astrocytosis was bilaterally elevated at 1 month post-blast exposure compared to shams, and showed a positive trend of elevation at 3 months post-blast. Axonal degeneration, on the other hand, appeared to be more robust at 1 day and 3 months post-blast. Interestingly, while ABR threshold shifts recovered by the 1 and 3-month time-points, a positive correlation was observed between rats' astrocyte counts at 1 month post-blast and their threshold shifts at 1 day post-blast. Taken together, our findings suggest that central auditory damage may have occurred due to biomechanical forces from the blast shockwave, and that different indicators/types of damage may manifest over different timelines.	[Kallakuri, Srinivasu; Lu, Huichao; Cavanaugh, John] Wayne State Univ, Coll Engn, Dept Biomed Engn, Detroit, MI USA; [Pace, Edward; Luo, Hao; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48202 USA; [Zhang, Jinsheng] Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI 48202 USA	Wayne State University; Wayne State University; Wayne State University	Zhang, JS (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48202 USA.; Zhang, JS (corresponding author), Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI 48202 USA.	jinzhang@med.wayne.edu	张, 锦胜/GXF-8167-2022	Zhang, Jinsheng/0000-0002-8311-2678	US Department of Defense [W81XWH-11-2-0031]	US Department of Defense(United States Department of Defense)	This work was supported by the US Department of Defense (grant award W81XWH-11-2-0031).	Carron SF, 2016, J COMP NEUROL, V524, P3530, DOI 10.1002/cne.24014; Chang YM, 2004, NEUROREPORT, V15, P1699, DOI 10.1097/01.wnr.0000134584.10207.1a; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Du XP, 2017, FREE RADICAL BIO MED, V108, P627, DOI 10.1016/j.freeradbiomed.2017.04.343; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Kallakuri S, 2015, J NEUROSCI RURAL PRA, V6, P481, DOI 10.4103/0976-3147.169767; Karch Stephanie J, 2016, US Army Med Dep J, P52; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kim JJ, 2004, J NEUROSCI RES, V77, P829, DOI 10.1002/jnr.20211; Kim JN, 1997, HEARING RES, V103, P169, DOI 10.1016/S0378-5955(96)00173-6; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kujawa SG, 2006, J NEUROSCI, V26, P2115, DOI 10.1523/JNEUROSCI.4985-05.2006; Liberman MC, 2017, HEARING RES, V349, P138, DOI 10.1016/j.heares.2017.01.003; Licona NE, 2016, ARCH PHYS MED REHABI; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Luo H., 2016, NEUROSCIENCE; Luo H, 2014, NEUROSCI LETT, V580, P47, DOI 10.1016/j.neulet.2014.07.041; Luo H, 2014, J NEUROSCI RES, V92, P1466, DOI 10.1002/jnr.23424; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Munjal SK, 2010, BRAIN INJURY, V24, P525, DOI 10.3109/02699050903516872; Nawashiro H, 2002, ACTA NEUROCHIR SUPPL, V81, P269; Nordmann AS, 2000, HEARING RES, V139, P13, DOI 10.1016/S0378-5955(99)00163-X; OUYANG J, 2017, SCI REPORTS, V7, P19374; ROBERTSON D, 1983, HEARING RES, V9, P263, DOI 10.1016/0378-5955(83)90031-X; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smith L, 2002, HEARING RES, V169, P1, DOI 10.1016/S0378-5955(02)00461-6; SPOENDLIN H, 1971, ACTA OTO-LARYNGOL, V71, P166, DOI 10.3109/00016487109125346; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071	39	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193389	10.1371/journal.pone.0193389	http://dx.doi.org/10.1371/journal.pone.0193389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489862	Green Submitted, gold, Green Published			2022-12-26	WOS:000426276000069
J	Gui, SH; Pei, YX; Xu, L; Wang, WP; Jiang, HB; Nachman, RJ; Kaczmarek, K; Zabrocki, J; Wang, JJ				Gui, Shun-Hua; Pei, Yu-Xia; Xu, Li; Wang, Wei-Ping; Jiang, Hong-Bo; Nachman, Ronald J.; Kaczmarek, Krzysztof; Zabrocki, Janusz; Wang, Jin-Jun			Function of the natalisin receptor in mating of the oriental fruit fly, Bactrocera dorsalis (Hendel) and testing of peptidomimetics	PLOS ONE			English	Article							KININ NEUROPEPTIDE FAMILY; RED FLOUR BEETLE; DIPTERA TEPHRITIDAE; TRIBOLIUM-CASTANEUM; ANALOGS; ANTAGONISTS; RESISTANCE; PEPTIDE; FLIES	Natalisins (NTLs) are conservative neuropeptides, which are only found in arthropods and are documented to regulate reproductive behaviors in insects. In our previous study, we have confirmed that NTLs regulate the reproductive process in an important agricultural pest, Bactrocera dorsalis (Hendel). Hence, in this study, to further confirm the in vivo function of NTL receptor (NTLR) and assess the potential of NTLR as an insecticide target, RNA interference targeting NTLR mRNA was performed. We found that mating frequencies of both males and females were reduced by RNAi-mediated knockdown of the NTLR transcript, while there was no effect on mating duration. Moreover, we functionally expressed the B. dorsalis NTLR in Chinese Hamster Ovary (CHO) cells and was co-transfected with an aequorin reporter to measure ligand activities. A total of 13 biostable multi-Aib analogs were tested for agonistic and antagonistic activities. While most of these NTL analogs did not show strong activity, one analog (NLFQV[Aib] DPFF[Aib] TRamide) had moderate antagonistic activity. Taken together, we provided evidence for the important roles of NTLR in regulating mating frequencies of both male and female in this fly and also provided in vitro data on mimetic analogs that serve as leading structures for the development of agonists and antagonists to disrupt the NTL signaling pathway.	[Gui, Shun-Hua; Pei, Yu-Xia; Xu, Li; Wang, Wei-Ping; Jiang, Hong-Bo; Wang, Jin-Jun] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China; [Gui, Shun-Hua; Pei, Yu-Xia; Xu, Li; Wang, Wei-Ping; Jiang, Hong-Bo; Wang, Jin-Jun] Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China; [Nachman, Ronald J.; Kaczmarek, Krzysztof; Zabrocki, Janusz] USDA, Insect Control & Cotton Dis Res Unit, Southern Plains Agr Res Ctr, College Stn, TX USA; [Kaczmarek, Krzysztof; Zabrocki, Janusz] Lodz Univ Technol, Inst Organ Chem, Lodz, Poland	Southwest University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Southwest University - China; United States Department of Agriculture (USDA); Lodz University of Technology	Wang, JJ (corresponding author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.; Wang, JJ (corresponding author), Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China.	wangjinjun@swu.edu.cn	Kaczmarek, Krzysztof/H-5741-2012; Gui, Shunhua/AAC-3070-2022	Kaczmarek, Krzysztof/0000-0001-8806-7792; Shunhua, Gui/0000-0001-7612-2731; Xu, Li/0000-0002-7698-9674	National Key Research and Development Program [2016YFC1200600]; National Nature Science Foundation of China [31572016]; Foundation Project of Southwest University [SWU114049]; earmarked fund for Modern Agro-industry (Citrus) Technology Research System of China [CARS-26]	National Key Research and Development Program; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation Project of Southwest University; earmarked fund for Modern Agro-industry (Citrus) Technology Research System of China	This study was supported in part by the National Key Research and Development Program (2016YFC1200600), National Nature Science Foundation of China (31572016), a Foundation Project of Southwest University (SWU114049), and the earmarked fund for Modern Agro-industry (Citrus) Technology Research System (CARS-26) of China.	Aikins MJ, 2008, INSECT BIOCHEM MOLEC, V38, P740, DOI 10.1016/j.ibmb.2008.04.006; Altstein M, 2001, BIOPOLYMERS, V60, P460, DOI 10.1002/1097-0282(2001)60:6<460::AID-BIP10181>3.0.CO;2-Y; Audsley N, 2015, INSECT BIOCHEM MOLEC, V67, P27, DOI 10.1016/j.ibmb.2015.07.014; Caers Jelle, 2012, Front Endocrinol (Lausanne), V3, P151, DOI 10.3389/fendo.2012.00151; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; Gui SH, 2017, INSECT MOL BIOL, V26, P103, DOI 10.1111/imb.12274; Gui SH, 2017, INSECT BIOCHEM MOLEC, V80, P71, DOI 10.1016/j.ibmb.2016.12.002; Jiang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19547; Jiang HB, 2015, PEPTIDES, V68, P246, DOI 10.1016/j.peptides.2014.11.004; Jiang HB, 2014, PEPTIDES, V53, P243, DOI 10.1016/j.peptides.2013.11.005; Jiang HB, 2013, P NATL ACAD SCI USA, V110, pE3526, DOI 10.1073/pnas.1310676110; Jin T, 2011, PEST MANAG SCI, V67, P370, DOI 10.1002/ps.2076; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XP, 2016, COMP BIOCHEM PHYS C, V180, P40, DOI 10.1016/j.cbpc.2015.11.001; MONNIER D, 1992, J BIOL CHEM, V267, P1298; Nachman RJ, 1997, PEPTIDES, V18, P53, DOI 10.1016/S0196-9781(96)00233-1; Nachman RJ, 2002, PEPTIDES, V23, P735, DOI 10.1016/S0196-9781(01)00654-4; Nachman RJ, 2011, PEPTIDES, V32, P587, DOI 10.1016/j.peptides.2010.09.013; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Smagghe G, 2010, PEPTIDES, V31, P498, DOI 10.1016/j.peptides.2009.07.001; Taneja-Bageshwar S, 2006, ARCH INSECT BIOCHEM, V62, P128, DOI 10.1002/arch.20129; Taneja-Bageshwar S, 2009, GEN COMP ENDOCR, V162, P122, DOI 10.1016/j.ygcen.2008.10.013; Vargas RI, 2015, INSECTS, V6, P297, DOI 10.3390/insects6020297; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei D, 2015, FLA ENTOMOL, V98, P52, DOI 10.1653/024.098.0110; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048	27	5	5	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193058	10.1371/journal.pone.0193058	http://dx.doi.org/10.1371/journal.pone.0193058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474388	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500053
J	Jaskowiak, J; Tkaczyk, O; Slota, M; Kwasniewska, J; Szarejko, I				Jaskowiak, Joanna; Tkaczyk, Oliver; Slota, Michal; Kwasniewska, Jolanta; Szarejko, Iwona			Analysis of aluminum toxicity in Hordeum vulgare roots with an emphasis on DNA integrity and cell cycle	PLOS ONE			English	Article							GROWTH INHIBITION; BARLEY CULTIVARS; TOLERANCE; IDENTIFICATION; RESISTANCE; STRESS; GENE; L.; GENOTYPES; BIOLOGY	Barley is one of the cereals that are most sensitive to aluminum (Al). Al in acid soils limits barley growth and development and, as a result, its productivity. The inhibition of root growth is a widely accepted indicator of Al stress. Al toxicity is affected by many factors including the culture medium, pH, Al concentration and the duration of the treatment. However, Al can act differently in different species and still Al toxicity in barley deserves study. Since the mechanism of Al toxicity is discussed we cytogenetically describe the effects of different doses of bioavailable Al on the barley nuclear genome-mitotic activity, cell cycle profile and DNA integrity. At the same time, we tested an established deep-water culture (DWC) hydroponics system and analyzed the effects of Al on the root system parameters using WinRHIZO software. We demonstrated the cytotoxic and genotoxic effect of Al in barley root cells. We showed that Al treatment significantly reduced the mitotic activity of the root tip cells and it also induced micronuclei and damaged nuclei. The DNA-damaging effect of Al was observed using the TUNEL test. We define the inhibitory influence of Al on DNA replication in barley. Analysis with the labelling and detection of 5-ethynyl-2'-deoxyuridin (EdU) showed that the treatment with Al significantly decreased the frequency of S phase cells. We also demonstrated that Al exposure led to changes in the cell cycle profile of barley root tips. The delay of cell divisions observed as increased frequency of cells in G2/M phase after Al treatment was reported using flow cytometry.	[Jaskowiak, Joanna; Kwasniewska, Jolanta] Univ Silesia Katowice, Dept Plant Anat & Cytol, Katowice, Poland; [Tkaczyk, Oliver; Slota, Michal; Szarejko, Iwona] Univ Silesia Katowice, Dept Genet, Katowice, Poland	University of Silesia in Katowice; University of Silesia in Katowice	Kwasniewska, J (corresponding author), Univ Silesia Katowice, Dept Plant Anat & Cytol, Katowice, Poland.	jolanta.kwasniewska@us.edu.pl	Kwasniewska, Jolanta/ABF-1547-2020	Slota, Michal/0000-0002-0709-8173; Szarejko, Iwona/0000-0001-7390-7234; Kwasniewska, Jolanta/0000-0002-8965-8727	National Centre for Research and Development [ERA-CAPS-II/2/2015]	National Centre for Research and Development	This work was supported by the National Centre for Research and Development (grant ERA-CAPS-II/2/2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Centre for Research and Development (grant ERA-CAPS-II/2/2015).	Aggarwal A., 2015, STRESS RESPONSES PLA, P35, DOI [10.1007/978-3-319-13368-3_2, DOI 10.1007/978-3-319-13368-3_2]; Ali S, 2011, BIOL PLANTARUM, V55, P291, DOI 10.1007/s10535-011-0041-7; Baluska F, 1996, PLANT CELL PHYSIOL, V37, P1013, DOI 10.1093/oxfordjournals.pcp.a029032; BONA L, 1993, LANDSCAPE URBAN PLAN, V27, P175, DOI 10.1016/0169-2046(93)90046-G; Bulanova NV, 2001, RUSS J GENET+, V37, P1455, DOI 10.1023/A:1013268501434; Dai HX, 2011, J PLANT NUTR SOIL SC, V174, P952, DOI 10.1002/jpln.201100148; Dawood M, 2012, J HAZARD MATER, V209, P121, DOI 10.1016/j.jhazmat.2011.12.076; Doncheva S, 2005, J EXP BOT, V56, P1213, DOI 10.1093/jxb/eri115; Eekhout T, 2017, TRENDS PLANT SCI, V22, P102, DOI 10.1016/j.tplants.2016.12.003; Fov CD, 1992, ADV SOIL SCI, V19, P97149; Frank W.B., 2009, ULLMANNS ENCY IND CH; Fujii M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1726; Guo TR, 2004, PLANT SOIL, V258, P241, DOI 10.1023/B:PLSO.0000016554.87519.d6; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Hossain M, 2005, AUST J AGR RES, V56, P475, DOI 10.1071/AR04191; Ishikawa S, 2000, SOIL SCI PLANT NUTR, V46, P751, DOI 10.1080/00380768.2000.10409141; Kochian LV, 2005, PLANT SOIL, V274, P175, DOI 10.1007/s11104-004-1158-7; Kumar G., 2006, Journal of Phytological Research, V19, P175; Kwasniewska J, 2016, MUTAT RES-GEN TOX EN, V812, P20, DOI 10.1016/j.mrgentox.2016.10.006; Ma JF, 2004, J EXP BOT, V55, P1335, DOI 10.1093/jxb/erh152; Ma YL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2551-3; Manoharan V, 2007, ENVIRON POLLUT, V145, P778, DOI 10.1016/j.envpol.2006.05.015; Matsumoto H, 2000, INT REV CYTOL, V200, P1, DOI 10.1016/S0074-7696(00)00001-2; MATSUMOTO H, 1976, PLANT CELL PHYSIOL, V17, P127, DOI 10.1093/oxfordjournals.pcp.a075252; Min Y., 2009, ENV TOX, V25, P124, DOI [10.1002/tox/20482, DOI 10.1002/TOX/20482]; Mohanty S, 2004, ECOTOX ENVIRON SAFE, V59, P7; MORIMURA S, 1978, Z PFLANZENPHYSIOL, V88, P395, DOI 10.1016/S0044-328X(78)80255-4; Nezames CD, 2012, PLANT CELL, V24, P608, DOI 10.1105/tpc.112.095596; Nidhi Gupta, 2013, American Journal of Plant Sciences, V4, P21; Pan JW, 2001, ENVIRON EXP BOT, V46, P71, DOI 10.1016/S0098-8472(01)00083-1; Panda SK, 2009, PLANT SIGNAL BEHAV, V4, P592, DOI 10.4161/psb.4.7.8903; Polle E, 1985, AGRON ABSTR, V67, P117; Qin R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-225; Raman H, 2002, THEOR APPL GENET, V105, P458, DOI 10.1007/s00122-002-0934-0; Rounds MA, 2008, CURR BIOL, V18, P1495, DOI 10.1016/j.cub.2008.08.050; Ryan PR, 2011, J EXP BOT, V62, P9, DOI 10.1093/jxb/erq272; Shaff JE, 2010, PLANT SOIL, V330, P207, DOI 10.1007/s11104-009-0193-9; Silva IR, 2000, PLANT PHYSIOL, V123, P543, DOI 10.1104/pp.123.2.543; Sjorgen CA, 2015, PLANT CELL, V27, P2501; Sjorgen CA, 2017, PLANT CELL ENV; Vardar F, 2016, CARYOLOGIA, V69, P111, DOI 10.1080/00087114.2015.1109954; Vitorello Victor Alexandre, 2005, Braz. J. Plant Physiol., V17, P129, DOI 10.1590/S1677-04202005000100011; Wang Jun-ping, 2006, J Zhejiang Univ Sci B, V7, P769, DOI 10.1631/jzus.2006.B0769; Zhang HM, 2009, ACTA BIOL CRACOV, V51	45	29	33	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193156	10.1371/journal.pone.0193156	http://dx.doi.org/10.1371/journal.pone.0193156			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466444	gold, Green Published, Green Submitted			2022-12-26	WOS:000425604300091
J	Di Lorenzo, P; Lancioni, H; Ceccobelli, S; Colli, L; Cardinali, I; Karsli, T; Capodiferro, MR; Sahin, E; Ferretti, L; Marsan, PA; Sarti, FM; Lasagna, E; Panella, F; Achilli, A				Di Lorenzo, Piera; Lancioni, Hovirag; Ceccobelli, Simone; Colli, Licia; Cardinali, Irene; Karsli, Taki; Capodiferro, Marco Rosario; Sahin, Emine; Ferretti, Luca; Marsan, Paolo Ajmone; Sarti, Francesca Maria; Lasagna, Emiliano; Panella, Francesco; Achilli, Alessandro			Mitochondrial DNA variants of Podolian cattle breeds testify for a dual maternal origin	PLOS ONE			English	Article							GENETIC DIVERSITY; EUROPEAN CATTLE; DOMESTIC CATTLE; AUROCHS; POPULATIONS; SOFTWARE; GENOMES	Background Over the past 15 years, 300 out of 6000 breeds of all farm animal species identified by the Food and Agriculture Organization of the United Nations (FAO) have gone extinct. Among cattle, many Podolian breeds are seriously endangered in various European areas. Podolian cattle include a group of very ancient European breeds, phenotypically close to the aurochs ancestors (Bos primigenius). The aim of the present study was to assess the genetic diversity of Podolian breeds and to reconstruct their origin. Methodology The mitochondrial DNA (mtDNA) control-regions of 18 Podolian breeds have been phylogenetically assessed. Nine non-Podolian breeds have been also included for comparison. Conclusion The overall analysis clearly highlights some peculiarities in the mtDNA gene pool of some Podolian breeds. In particular, a principal component analysis point to a genetic proximity between five breeds (Chianina, Marchigiana, Maremmana, Podolica Italiana and Romagnola) reared in Central Italy and the Turkish Grey. We here propose the suggestive hypothesis of a dual ancestral contribution to the present gene pool of Podolian breeds, one deriving from Eastern European cattle; the other arising from the arrival of Middle Eastern cattle into Central Italy through a different route, perhaps by sea, ferried by Etruscan boats. The historical migration of Podolian cattle from North Eastern Europe towards Italy has not cancelled the mtDNA footprints of this previous ancient migration.	[Di Lorenzo, Piera; Ceccobelli, Simone; Sarti, Francesca Maria; Lasagna, Emiliano; Panella, Francesco] Univ Perugia, Dipartimento Sci Agr Alimentari & Ambientali, Perugia, Italy; [Lancioni, Hovirag; Cardinali, Irene] Univ Perugia, Dipartimento Chim Biol & Biotecnol, Perugia, Italy; [Colli, Licia; Marsan, Paolo Ajmone] Univ Cattolica S Cuore, Inst Zootech, Piacenza, Italy; [Colli, Licia; Marsan, Paolo Ajmone] Univ Cattolica S Cuore, Biodivers & Ancient DNA Res Ctr BioDNA, Piacenza, Italy; [Karsli, Taki] Univ Akdeniz, Fac Agr, Dept Anim Sci, Antalya, Turkey; [Capodiferro, Marco Rosario; Ferretti, Luca; Achilli, Alessandro] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Pavia, Italy; [Sahin, Emine] Univ Akdeniz, Korkuteli Vocat Sch, Antalya, Turkey	University of Perugia; University of Perugia; Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; Akdeniz University; University of Pavia; Akdeniz University	Lancioni, H (corresponding author), Univ Perugia, Dipartimento Chim Biol & Biotecnol, Perugia, Italy.; Achilli, A (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Pavia, Italy.	hovirag.lancioni@unipg.it; alessandro.achilli@unipv.it	Achilli, Alessandro/I-9236-2012; Ceccobelli, Simone/AAZ-9332-2020; Emiliano, Lasagna/I-9304-2019; Colli, Licia/AAC-2985-2021; Sarti, Francesca Maria FMS/Y-4993-2018; Capodiferro, Marco Rosario/AAQ-4941-2020; Cardinali, Irene/R-8751-2017; AJMONE MARSAN, Paolo/M-2466-2018; Lancioni, Hovirag/F-9067-2014	Achilli, Alessandro/0000-0001-6871-3451; Ceccobelli, Simone/0000-0002-0416-5748; Capodiferro, Marco Rosario/0000-0003-2494-5423; SARTI, Francesca Maria/0000-0001-9366-0400; Ferretti, Luca/0000-0001-5044-8442; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Lancioni, Hovirag/0000-0001-5514-1853	Italian Ministry of Education, University and Research: Progetti Futuro in Ricerca [RBFR126B8I]; Italian Ministry of Education, University and Research: Progetti Ricerca Interesse Nazionale [2012JA4BTY]; University of Pavia strategic theme MIGRATions: towards an INterdisciplinary Governance model" (MIGRAT.IN.G)	Italian Ministry of Education, University and Research: Progetti Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Education, University and Research: Progetti Ricerca Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Pavia strategic theme MIGRATions: towards an INterdisciplinary Governance model" (MIGRAT.IN.G)	This research received support from: the Italian Ministry of Education, University and Research: Progetti Futuro in Ricerca 2012 (RBFR126B8I) (to AA) and Progetti Ricerca Interesse Nazionale 2012 (2012JA4BTY) (to AA); the University of Pavia strategic theme MIGRATions: towards an INterdisciplinary Governance model" (MIGRAT.IN.G; to AA). We thank Dr. Giovanni Capuzzello and Dr. Gilberto Leonelli for their precious help in providing biological samples for Modicana and Bianca di Val Padana breeds respectively.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; Ascunce MS, 2007, ZOOL STUD, V46, P123; BARTOSIEWICZ L, 1996, HUNGARIAN AGR RES, V5, P13; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Bodo I, 2004, HUNGARIAN GREY CATTL; Bonadonna T., ETNOLOGIA ZOOTECNICA; Bonfiglio S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038601; Bonfiglio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015760; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Brisighelli F, 2009, EUR J HUM GENET, V17, P693, DOI 10.1038/ejhg.2008.224; Cardinali I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153004; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Colli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2342-2; Cunningham E., 1992, SELECTED ISSUES LIVE; Dadi H, 2009, ANIM GENET, V40, P556, DOI 10.1111/j.1365-2052.2009.01866.x; Di Lorenzo P, 2016, ELECTRON J BIOTECHN, V23, P69, DOI 10.1016/j.ejbt.2016.07.001; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gargani M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00068; Gomez-Carballa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119242; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; Hristov P, 2017, MITOCHONDRIAL DNA A, V28, P383, DOI 10.3109/19401736.2015.1127361; Ilie DE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138736; Ivankovic A, 2014, CZECH J ANIM SCI, V59, P519, DOI 10.17221/7733-CJAS; Lai SJ, 2006, MOL PHYLOGENET EVOL, V38, P146, DOI 10.1016/j.ympev.2005.06.013; Lenstra J. A., 2014, Diversity, V6, P178, DOI 10.3390/d6010178; Lenstra JA, 2012, ANIM GENET, V43, P483, DOI 10.1111/j.1365-2052.2011.02309.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindgren G, 2004, NAT GENET, V36, P335, DOI 10.1038/ng1326; Maretto F, 2012, LIVEST SCI, V150, P256, DOI 10.1016/j.livsci.2012.09.011; Mason I. L., 1996, WORLD DICT LIVESTOCK; Moioli B, 2004, J HERED, V95, P250, DOI 10.1093/jhered/esh032; Olivieri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141170; Pardo-Seco J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105920; Pariset L, 2010, J ANIM BREED GENET, V127, P481, DOI 10.1111/j.1439-0388.2010.00868.x; Pariset L, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-7; Pellecchia M, 2007, P R SOC B, V274, P1175, DOI 10.1098/rspb.2006.0258; Rognoni G, 1983, ATLANTE ETNOGRAFICO; Scherf B.D, 2000, WORLD WATCH LIST DOM; Scheu A, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0203-2; Soysal MI, 2004, TRAK J SCI, V2, P47; Upadhyay MR, 2017, HEREDITY, V118, P169, DOI 10.1038/hdy.2016.79	44	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192567	10.1371/journal.pone.0192567	http://dx.doi.org/10.1371/journal.pone.0192567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462170	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200018
J	Medagama, A; Galgomuwa, M				Medagama, Arjuna; Galgomuwa, Manoj			Lack of infrastructure, social and cultural factors limit physical activity among patients with type 2 diabetes in rural Sri Lanka, a qualitative study	PLOS ONE			English	Article							BARRIERS; FACILITATORS; PREVALENCE; COMMUNITY; MELLITUS; DISEASE; ADULTS; CARE	Introduction South Asians have high prevalence of diabetes, increased cardiovascular risk and low levels of physical activity (PA). Reasons for low levels of PA have not previously been explored among Asians living within their endogenous environment. This qualitative study was performed to explore the contextual reasons that limited PA among type 2 diabetic patients living in a rural community. Methods Purposeful sampling recruited 40 participants with long standing type 2 diabetes for this qualitative study. Semi-structered questions utilising in-depth interviews were used to collect data on PA patterns, barriers to PA and factors that would facilitate PA. The interviews were digitally recorded and transcribed. Data were analyzed using a framework approach. Results The sample consisted of 11 males and 29 females. Mean age was 55.4 (SD 8.9) years. The mean duration of diabetes in the study population was 8.5 (SD 6.8) years. Inability to differentitate household and daily activities from PA emerged as a recurring theme. Most did not have a clear understanding of the type or duration of PA that they should perform. Health related issues, lifestyle and time management, envronmental and social factors like social embarrassment, prioritizing household activities over PA were important factors that limited PA. Most stated that the concept of exercising was alien to their culture and lifestyle. Conclusion Culturally appropriate programmes that strengthen health education and empower communities to overcome socio-economic barriers that limit PA should be implemented to better manage diabetes among rural Sri Lankan diabetic patients.	[Medagama, Arjuna; Galgomuwa, Manoj] Univ Peradeniya, Fac Med, Dept Med, Peradeniya, Sri Lanka	University of Peradeniya	Medagama, A (corresponding author), Univ Peradeniya, Fac Med, Dept Med, Peradeniya, Sri Lanka.	arjuna.medagama@gmail.com						Abeywardena MY, 2003, ATHEROSCLEROSIS, V171, P157, DOI 10.1016/S0021-9150(03)00157-6; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS48; American Diabetes Association, 2015, TYP ACT WHAT WE REC; Bandara R, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/1471-2261-15-1; Casey D, 2010, DIABETIC MED, V27, P79, DOI 10.1111/j.1464-5491.2009.02873.x; Chimen M, 2012, DIABETOLOGIA, V55, P542, DOI 10.1007/s00125-011-2403-2; Department of Census and Statistics Sri Lanka, 2001, POP HOUS CENS SRI LA; Glynn LG, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-157; Grace C, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1931; Herath H.M.A., 2015, VIDYODYA J MANAG, V1, P1; Illangasekera U, 2004, J R SOC PROMO HEALTH, V124, P92, DOI 10.1177/146642400412400214; Jepson R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045333; Katulanda P, 2008, DIABETIC MED, V25, P1062, DOI 10.1111/j.1464-5491.2008.02523.x; Katulanda P, 2013, PUBLIC HEALTH NUTR, V16, P1684, DOI 10.1017/S1368980012003990; Maria Horne DAS, 2013, ETHNICITY HLTH HLTH, V18; Patel N, 2017, J RACIAL ETHN HEALTH, V4, P1107, DOI 10.1007/s40615-016-0316-y; Ranasinghe DCRP, 2014, INT ARCH MED, V4, P15; Ranasinghe P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2518-3; Riley L, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160077; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Smith Joanna, 2011, Nurse Res, V18, P52; Sohal T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136202; Tanasescu M, 2003, CIRCULATION, V107, P2435, DOI 10.1161/01.CIR.0000066906.11109.1F; Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553; Wijewardene K., 2005, Ceylon Medical Journal, V50, P62	25	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192679	10.1371/journal.pone.0192679	http://dx.doi.org/10.1371/journal.pone.0192679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462186	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200023
J	Ji, HR; Li, DX; Wu, Y; Zhang, QL; Gu, Q; Xie, H; Ji, TY; Wang, HF; Zhao, L; Zhao, HJ; Yang, YL; Feng, HC; Xiong, H; Ji, JH; Yang, ZX; Kou, LP; Li, M; Bao, XH; Chang, XZ; Zhang, YH; Li, L; Li, HJ; Niu, ZP; Wu, XR; Xiao, JX; Jiang, YW; Wang, JM				Ji, Haoran; Li, Dongxiao; Wu, Ye; Zhang, Quanli; Gu, Qiang; Xie, Han; Ji, Taoyun; Wang, Huifang; Zhao, Lu; Zhao, Haijuan; Yang, Yanling; Feng, Hongchun; Xiong, Hui; Ji, Jinhua; Yang, Zhixian; Kou, Liping; Li, Ming; Bao, Xinhua; Chang, Xingzhi; Zhang, Yuehua; Li, Li; Li, Huijuan; Niu, Zhengping; Wu, Xiru; Xiao, Jiangxi; Jiang, Yuwu; Wang, Jingmin			Hypomyelinating disorders in China: The clinical and genetic heterogeneity in 119 patients	PLOS ONE			English	Article							PELIZAEUS-MERZBACHER-DISEASE; WHITE-MATTER HYPOMYELINATION; RNA-POLYMERASE; BRAIN HYPOMYELINATION; POL III; PATTERN-RECOGNITION; RING CHROMOSOME-18; GM2 GANGLIOSIDOSIS; NONSENSE MUTATION; CATALYTIC SUBUNIT	Objective Hypomyelinating disorders are a group of clinically and genetically heterogeneous diseases characterized by neurological deterioration with hypomyelination visible on brain MRI scans. This study was aimed to clarify the clinical and genetic features of HMDs in Chinese population. Methods 119 patients with hypomyelinating disorders in Chinese population were enrolled and evaluated based on their history, clinical manifestation, laboratory examinations, series of brain MRI with follow-up, genetic etiological tests including chromosomal analysis, multiplex ligation probe amplification, Sanger sequencing, targeted enrichment-based next-generation sequencing and whole exome sequencing. Results Clinical and genetic features of hypomyelinating disorders were revealed. Nine different hypomyelinating disorders were identified in 119 patients: Pelizaeus-Merzbacher disease (94, 79%), Pelizaeus-Merzbacher-like disease (10, 8%), hypomyelination with atrophy of the basal ganglia and cerebellum (3, 3%), GM1 gangliosidosis (5, 4%), GM2 gangliosidosis (3, 3%), trichothiodystrophy (1, 1%), Pol III-related leukodystrophy (1, 1%), hypomyelinating leukodystrophy type 9 (1, 1%), and chromosome 18q deletion syndrome (1, 1%). Of the sample, 94% (112/119) of the patients were genetically diagnosed, including 111 with mutations distributing across 9 genes including PLP1, GJC2, TUBB4A, GLB1, HEXA, HEXB, ERCC2, POLR3A, and RARS and 1 with mosaic chromosomal change of 46, XX,del(18) (q21.3)/46,XX,r(18)(p11.32q21.3)/45,XX,-18. Eighteen novel mutations were discovered. Mutations in POLR3A and RARS were first identified in Chinese patients with Pol III-related leukodystrophy and hypomyelinating leukodystrophy, respectively. Significance This is the first report on clinical and genetic features of hypomyelinating disorders with a large sample of patients in Chinese population, identifying 18 novel mutations especially mutations in POLR3A and RARS in Chinese patients, expanding clinical and genetic spectrums of hypomyelinating disorders.	[Ji, Haoran; Li, Dongxiao; Wu, Ye; Gu, Qiang; Xie, Han; Ji, Taoyun; Wang, Huifang; Zhao, Lu; Zhao, Haijuan; Yang, Yanling; Feng, Hongchun; Xiong, Hui; Ji, Jinhua; Yang, Zhixian; Kou, Liping; Li, Ming; Bao, Xinhua; Chang, Xingzhi; Zhang, Yuehua; Li, Li; Li, Huijuan; Wu, Xiru; Jiang, Yuwu; Wang, Jingmin] Peking Univ, Dept Pediat, Hosp 1, Beijing, Peoples R China; [Zhang, Quanli; Xiao, Jiangxi] Peking Univ, Dept Radiol, Hosp 1, Beijing, Peoples R China; [Wang, Huifang; Zhao, Lu; Zhao, Haijuan; Feng, Hongchun; Ji, Jinhua; Kou, Liping; Li, Huijuan; Niu, Zhengping] Shanxi Med Univ, Dept Neurol, Hosp 1, Taiyuan, Shanxi, Peoples R China	Peking University; Peking University; Shanxi Medical University	Jiang, YW; Wang, JM (corresponding author), Peking Univ, Dept Pediat, Hosp 1, Beijing, Peoples R China.; Xiao, JX (corresponding author), Peking Univ, Dept Radiol, Hosp 1, Beijing, Peoples R China.	cjr.xiaojiangxi@vip.163.com; jiangyw@263.net; wang66jm@163.com	han, xie/AAO-9359-2021; jiang, yu/HGU-0029-2022	Zhang, Yuehua/0000-0003-1432-5423	Ministry of Science and Technology of the People's Republic of China [2012CB944602, 2012BAI09B04]; National Natural Science Foundation of China [81271257, 81200873]; Beijing Natural Science Foundation [7132208]; Beijing Municipal Science & Technology Commission [BZ0317]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This study was funded by the Ministry of Science and Technology of the People's Republic of China (2012CB944602, 2012BAI09B04; http://www.most.gov.cn/), National Natural Science Foundation of China (81271257, 81200873; http://www.nsfc.gov.cn/), Beijing Natural Science Foundation (7132208; http://bjnsf.bjkw.gov.cn/), and Beijing Municipal Science & Technology Commission (BZ0317; http://www.bjkw.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Arai-Ichinoi N, 2016, HUM GENET, V135, P89, DOI 10.1007/s00439-015-1617-7; Armstrong-Javors A, 2014, NEUROLOGY, V83, pE166, DOI 10.1212/WNL.0000000000000912; Barkovich AJ, 2016, NEUROBIOL DIS, V87, P50, DOI 10.1016/j.nbd.2015.10.015; Barnett CP, 2009, AM J MED GENET A, V149A, P431, DOI 10.1002/ajmg.a.32657; Bekiesinska-Figatowska M, 2010, BRAIN DEV-JPN, V32, P574, DOI 10.1016/j.braindev.2009.07.008; Benini R, 2012, J CHILD NEUROL, V27, P1042, DOI 10.1177/0883073811430268; Bernard G, 2011, AM J HUM GENET, V89, P415, DOI 10.1016/j.ajhg.2011.07.014; Bidchol AM, 2015, GENE, V567, P173, DOI 10.1016/j.gene.2015.04.078; Boespflug-Tanguy O, 2011, AM J HUM GENET, V88, P392, DOI 10.1016/j.ajhg.2010.12.015; Brunetti-Pierri N, 2008, MOL GENET METAB, V94, P391, DOI 10.1016/j.ymgme.2008.04.012; Carrozzo R, 1997, AM J MED GENET, V72, P329, DOI 10.1002/(SICI)1096-8628(19971031)72:3<329::AID-AJMG15>3.3.CO;2-Q; Carvalho CMB, 2012, CLIN GENET, V81, P532, DOI 10.1111/j.1399-0004.2011.01716.x; Cody JD, 2015, AM J MED GENET C, V169, P265, DOI 10.1002/ajmg.c.31446; Corbett MA, 2015, J MED GENET, V52, P269, DOI 10.1136/jmedgenet-2014-102418; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Di Rocco M, 2005, NEUROPEDIATRICS, V36, P265, DOI 10.1055/s-2005-865863; Edvardson S, 2016, J MED GENET, V53, P132, DOI 10.1136/jmedgenet-2015-103232; Faghri S, 2008, J MED GENET, V45, P609, DOI 10.1136/jmg.2008.058743; Farmaki E, 2017, INDIAN J PEDIATR, V84, P89, DOI 10.1007/s12098-016-2209-9; Feinstein M, 2010, AM J HUM GENET, V87, P820, DOI 10.1016/j.ajhg.2010.10.016; Ferreira C, 2014, AM J MED GENET A, V164, P1802, DOI 10.1002/ajmg.a.36526; Gay CT, 1997, AM J MED GENET, V74, P422, DOI 10.1002/(SICI)1096-8628(19970725)74:4<422::AID-AJMG14>3.0.CO;2-K; Hamilton EM, 2014, BRAIN, V137, P1921, DOI 10.1093/brain/awu110; Heller ER, 2015, J INVEST DERMATOL, V135, P734, DOI 10.1038/jid.2014.440; Hersheson J, 2013, ANN NEUROL, V73, P546, DOI 10.1002/ana.23832; Hobson GM, 2012, SEMIN NEUROL, V32, P62, DOI 10.1055/s-0032-1306388; Hortnagel K, 2016, J INHERIT METAB DIS, V39, P849, DOI 10.1007/s10545-016-9961-x; Inoue K, 2001, PRENATAL DIAG, V21, P1133, DOI 10.1002/pd.186; Inoue K, 1999, ANN NEUROL, V46, P313, DOI 10.1002/1531-8249(199909)46:3<313::AID-ANA6>3.0.CO;2-7; Inoue K, 2005, NEUROGENETICS, V6, P1, DOI 10.1007/s10048-004-0207-y; Isakov O, 2015, J GENET GENOMICS, V42, P79, DOI 10.1016/j.jgg.2014.12.004; Ji T, 2016, MINERVA PEDIAT; Karikkineth AC, 2017, AGEING RES REV, V33, P3, DOI 10.1016/j.arr.2016.08.002; Kobayashi Y, 2017, BRAIN DEV-JPN, V39, P266, DOI 10.1016/j.braindev.2016.09.011; Koc A, 2008, EUR J PEDIATR, V167, P655, DOI 10.1007/s00431-007-0568-y; Kong WJ, 2015, EPILEPSIA, V56, P431, DOI 10.1111/epi.12925; Koob M, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20151033; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; Krishna SH, 2014, SEMIN ULTRASOUND CT, V35, P160, DOI 10.1053/j.sult.2013.10.008; Kuschal C, 2016, AM J HUM GENET, V98, P627, DOI 10.1016/j.ajhg.2016.02.008; Kusk MS, 2016, NEUROPEDIATRICS, V47, P332, DOI 10.1055/s-0036-1584564; La Piana R, 2016, NEUROLOGY, V86, P1622, DOI 10.1212/WNL.0000000000002612; La Piana R, 2014, J CHILD NEUROL, V29, P214, DOI 10.1177/0883073813503902; Lancaster JL, 2005, AM J NEURORADIOL, V26, P447; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Linnankivi T, 2006, AM J MED GENET A, V140A, P331, DOI 10.1002/ajmg.a.31072; Magen D, 2008, AM J HUM GENET, V83, P30, DOI 10.1016/j.ajhg.2008.05.016; Mclaughlin M, 2002, GLIA, V39, P31, DOI 10.1002/glia.10091; Meikle PJ, 2004, EXPERT REV MOL DIAGN, V4, P677, DOI 10.1586/14737159.4.5.677; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moriwaki S, 2014, J DERMATOL, V41, P705, DOI 10.1111/1346-8138.12549; Nakayama T, 2015, AM J HUM GENET, V96, P709, DOI 10.1016/j.ajhg.2015.03.003; Nicolai J, 2016, NEUROLOGY, V87, pE4, DOI 10.1212/WNL.0000000000002805; Numata Y, 2014, J NEUROL, V261, P752, DOI 10.1007/s00415-014-7263-5; Pizzino A, 2014, NEUROLOGY, V83, P898, DOI 10.1212/WNL.0000000000000754; Potic A, 2012, ARCH NEUROL-CHICAGO, V69, P920, DOI 10.1001/archneurol.2011.1963; Pouwels PJW, 2014, ANN NEUROL, V76, P5, DOI 10.1002/ana.24194; Prietsch V, 2008, NEUROPEDIATRICS, V39, P51, DOI 10.1055/s-2008-1077048; Regier DS, 1993, GENEREVIEWSR; Saitsu H, 2011, AM J HUM GENET, V89, P644, DOI 10.1016/j.ajhg.2011.10.003; Sandhoff K, 2013, J NEUROSCI, V33, P10195, DOI 10.1523/JNEUROSCI.0822-13.2013; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Severinov K, 1996, J BIOL CHEM, V271, P27969, DOI 10.1074/jbc.271.44.27969; Smith NJ, 2012, DEV MED CHILD NEUROL, V54, P176, DOI 10.1111/j.1469-8749.2011.04160.x; Steenweg ME, 2010, BRAIN, V133, P2971, DOI 10.1093/brain/awq257; Taft RJ, 2013, AM J HUM GENET, V92, P774, DOI 10.1016/j.ajhg.2013.04.006; Takenouchi T, 2015, PEDIATR NEUROL, V52, P226, DOI 10.1016/j.pediatrneurol.2014.09.022; Tanaka R, 2012, BRAIN DEV-JPN, V34, P234, DOI 10.1016/j.braindev.2011.05.008; Terao Y, 2012, J NEUROL SCI, V320, P102, DOI 10.1016/j.jns.2012.07.005; Tetreault M, 2011, AM J HUM GENET, V89, P652, DOI 10.1016/j.ajhg.2011.10.006; Thiffault I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8623; Torii T, 2014, PEDIATR INT, V56, P659, DOI 10.1111/ped.12450; Usuda T, 2011, J HUM GENET, V56, P77, DOI 10.1038/jhg.2010.123; Utsumi K, 2002, ACTA NEUROL SCAND, V105, P427, DOI 10.1034/j.1600-0404.2002.01097.x; Vouyiouklis DA, 2000, J NEUROCHEM, V74, P940, DOI 10.1046/j.1471-4159.2000.0740940.x; Wang JM, 2008, CHINESE MED J-PEKING, V121, P1638, DOI 10.1097/00029330-200809010-00008; Wang JM, 2010, BRAIN DEV-JPN, V32, P236, DOI 10.1016/j.braindev.2009.03.013; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35936; Wolf NI, 2007, NEUROPEDIATRICS, V38, P64, DOI 10.1055/s-2007-985137; Wolf NI, 2014, NEUROLOGY, V83, P1898, DOI 10.1212/WNL.0000000000001002; Wolf NI, 2014, ANN NEUROL, V76, P134, DOI 10.1002/ana.24167; Woodward K, 2000, EUR J HUM GENET, V8, P449, DOI 10.1038/sj.ejhg.5200480; Xie H, 2015, BRAIN DEV-JPN, V37, P797, DOI 10.1016/j.braindev.2014.11.007; Yamamoto T, 2013, CONGENIT ANOM, V53, P3, DOI 10.1111/cga.12005; Zara F, 2006, NAT GENET, V38, P1111, DOI 10.1038/ng1870; Zhang JL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005848; Zhao Y, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-24	88	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0188869	10.1371/journal.pone.0188869	http://dx.doi.org/10.1371/journal.pone.0188869			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451896	Green Published, Green Submitted, gold			2022-12-26	WOS:000425369800001
J	Shell, CE; Klute, GK; Neptune, RR				Shell, Courtney E.; Klute, Glenn K.; Neptune, Richard R.			Identifying classifier input signals to predict a cross-slope during transtibial amputee walking	PLOS ONE			English	Article							LOWER-LIMB PROSTHESES; SURFACE; SYSTEMS	Advanced prosthetic foot designs often incorporate mechanisms that adapt to terrain changes in real-time to improve mobility. Early identification of terrain (e.g., cross-slopes) is critical to appropriate adaptation. This study suggests that a simple classifier based on linear discriminant analysis can accurately predict a cross-slope encountered (0 degrees, -15 degrees, 15 degrees) using measurements from the residual limb, primarily from the prosthesis itself. The classifier was trained and tested offline using motion capture and in-pylon sensor data collected during walking trials in mid-swing and early stance. Residual limb kinematics, especially measurements from the foot, shank and ankle, successfully predicted the cross-slope terrain with high accuracy (99%). Although accuracy decreased when predictions were made for test data instead of the training data, the accuracy was still relatively high for one input signal set (> 89%) and moderate for three others (> 71%). This suggests that classifiers can be designed and generalized to be effective for new conditions and/or subjects. While measurements of shank acceleration and angular velocity from only in-pylon sensors were insufficient to accurately predict the cross-slope terrain, the addition of foot and ankle kinematics from motion capture data allowed accurate terrain prediction. Inversion angular velocity and foot vertical velocity were particularly useful. As in-pylon sensor data and shank kinematics from motion capture appeared interchangeable, combining foot and ankle kinematics from prosthesis-mounted sensors with shank kinematics from in-pylon sensors may provide enough information to accurately predict the terrain.	[Shell, Courtney E.; Neptune, Richard R.] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA; [Klute, Glenn K.] Puget Sound Hlth Care Syst, Dept Vet Affairs, Seattle, WA USA; [Klute, Glenn K.] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA	University of Texas System; University of Texas Austin; University of Washington; University of Washington Seattle	Neptune, RR (corresponding author), Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA.	rneptune@mail.utexas.edu	Shell, Courtney/AAJ-4823-2021	Shell, Courtney/0000-0003-3764-6836; Neptune, Richard/0000-0003-2425-004X; Klute, Glenn/0000-0001-9527-9590	Department of Defense, Deployment Related Medical Research Program of the Office of the Congressionally Directed Medical Research Programs [W81XWH-09-2-0144]	Department of Defense, Deployment Related Medical Research Program of the Office of the Congressionally Directed Medical Research Programs	The in-pylon instrument was developed with funding from Department of Defense, Deployment Related Medical Research Program of the Office of the Congressionally Directed Medical Research Programs, grant W81XWH-09-2-0144 to GKK.	Alimusaj M, 2009, GAIT POSTURE, V30, P356, DOI 10.1016/j.gaitpost.2009.06.009; Au SK, 2007, INT C REHAB ROBOT, P298, DOI 10.1109/ICORR.2007.4428441; Aziz O, 2014, GAIT POSTURE, V39, P506, DOI 10.1016/j.gaitpost.2013.08.034; Basch D, 2007, GUIDE SUSTAINABLE MO; Damavandi M, 2010, GAIT POSTURE, V32, P411, DOI 10.1016/j.gaitpost.2010.07.004; Dixon PC, 2010, J APPL BIOMECH, V26, P17, DOI 10.1123/jab.26.1.17; Duda R.O., 2006, PATTERN CLASSIFICATI; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Farrell MT, 2011, IEEE ENG MED BIO, P6041, DOI 10.1109/IEMBS.2011.6091493; Fukunaga K., 2013, INTRO STAT PATTERN R; Hargrove LJ, 2015, JAMA-J AM MED ASSOC, V313, P2244, DOI 10.1001/jama.2015.4527; Hefferman GM, 2015, PROSTHET ORTHOT INT, V39, P166, DOI 10.1177/0309364613516484; Hitt JK, 2010, J MED DEVICES, V4, DOI 10.1115/1.4001139; Huang H, 2011, IEEE T BIO-MED ENG, V58, P2867, DOI 10.1109/TBME.2011.2161671; Huang H, 2009, IEEE T BIO-MED ENG, V56, P65, DOI 10.1109/TBME.2008.2003293; Jimenez-Fabian R, 2012, MED ENG PHYS, V34, P397, DOI 10.1016/j.medengphy.2011.11.018; Krausz NE, 2015, IEEE T BIO-MED ENG, V62, P2576, DOI 10.1109/TBME.2015.2448457; LaPre A, 2011, ASME 2011 INT MECH E, P1289; Longmuir PE, 2003, ENVIRON BEHAV, V35, P376, DOI 10.1177/0013916503035003004; Mayagoitia RE, 2002, J BIOMECH, V35, P537, DOI 10.1016/S0021-9290(01)00231-7; Miller JD, 2013, IEEE T BIO-MED ENG, V60, P2745, DOI 10.1109/TBME.2013.2264466; Nickel EA, 2012, J MED DEVICES, V6, DOI 10.1115/1.4005787; Srisuwan B, 2016, P 42 AM AC ORTH PROS; Versluys Rino, 2009, 2009 IEEE International Conference on Rehabilitation Robotics: Reaching Users & the Community (ICORR), P658, DOI 10.1109/ICORR.2009.5209535; Way TW, 2010, MED PHYS, V37, P907, DOI 10.1118/1.3284974; Yeates KH, 2016, THESIS; Yeates KH, 2016, J BIOMECH, V49, P2734, DOI 10.1016/j.jbiomech.2016.06.014; Young AJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056021; Young AJ, 2014, IEEE T NEUR SYS REH, V22, P671, DOI 10.1109/TNSRE.2013.2285101; Young AJ, 2013, I IEEE EMBS C NEUR E, P311, DOI 10.1109/NER.2013.6695934; Yousefi MR, 2010, BIOINFORMATICS, V26, P68, DOI 10.1093/bioinformatics/btp605; Zhang F, 2013, IEEE J BIOMED HEALTH, V17, P907, DOI 10.1109/JBHI.2012.2236563	33	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192950	10.1371/journal.pone.0192950	http://dx.doi.org/10.1371/journal.pone.0192950			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451922	Green Published, gold, Green Submitted			2022-12-26	WOS:000425369800027
J	Chen, JM; Hamers, AJP; Finsterbusch, M; Massimo, G; Zafar, M; Corder, R; Colas, RA; Dalli, J; Thiemermann, C; Ahluwalia, A				Chen, Jianmin; Hamers, Alexander J. P.; Finsterbusch, Michaela; Massimo, Gianmichele; Zafar, Maleeha; Corder, Roger; Colas, Romain A.; Dalli, Jesmond; Thiemermann, Christoph; Ahluwalia, Amrita			Endogenously generated arachidonate-derived ligands for TRPV1 induce cardiac protection in sepsis	FASEB JOURNAL			English	Article						heart; CGRP; 20-HETE; endotoxemia; shock	GENE-RELATED PEPTIDE; CAPSAICIN RECEPTOR VR1; INFLAMMATORY RESPONSES; POSTISCHEMIC RECOVERY; VANILLOID RECEPTOR; LIPID MEDIATORS; UNITED-STATES; SEPTIC SHOCK; ACID; ACTIVATION	The severity of cardiac dysfunction predicts mortality in sepsis. Activation of transient receptor potential vanilloid receptor type (TRPV)-1, a predominantly neuronal nonselective cation channel, has been shown to improve outcome in sepsis and endotoxemia. However, the role of TRPV1 and the identity of its endogenous ligands in the cardiac dysfunction caused by sepsis and endotoxemia are unknown. Using TRPV1(-/-) and TRPV1(+/+) mice, we showed that endogenous activation of cardiac TRPV1 during sepsis is key to limiting the ensuing cardiac dysfunction. Use of liquid chromatography-tandem mass spectrometry lipid analysis and selective inhibitors of arachidonic metabolism suggest that the arachidonate-derived TRPV1 activator, 20-hydroxyeicosateraenoic acid (20-HETE), underlies a substantial component of TRPV1-mediated cardioprotection in sepsis. Moreover, using selective antagonists for neuropeptide receptors, we show that this effect of TRPV1 relates to the activity of neuronally released cardiac calcitonin gene-related peptide (CGRP) and that, accordingly, administration of CGRP can rescue cardiac dysfunction in severe endotoxemia. In sum activation of TRPV1 by 20-HETE leads to the release of CGRP, which protects the heart against the cardiac dysfunction in endotoxemia and identifies both TRPV1 and CGRP receptors as potential therapeutic targets in endotoxemia.Chen, J., Hamers, A. J. P., Finsterbusch, M., Massimo, G., Zafar, M., Corder, R., Colas, R. A., Dalli, J., Thiemermann, C., Ahluwalia, A. Endogenously generated arachidonate-derived ligands for TRPV1 induce cardiac protection in sepsis.	[Chen, Jianmin; Hamers, Alexander J. P.; Finsterbusch, Michaela; Massimo, Gianmichele; Zafar, Maleeha; Corder, Roger; Colas, Romain A.; Dalli, Jesmond; Thiemermann, Christoph; Ahluwalia, Amrita] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England	University of London; Queen Mary University London	Ahluwalia, A (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	a.ahluwalia@qmul.ac.uk	Corder, Roger/H-2588-2012	Corder, Roger/0000-0003-1712-6841; Dalli, Jesmond/0000-0001-6328-3640; AHLUWALIA, Amrita/0000-0001-7626-6399; Finsterbusch, Michaela/0000-0001-9470-4313; Thiemermann, Christoph/0000-0003-4228-9722	China Scholarship Council; Derek Willoughby Trust Ph.D. Studentship; Wellcome Trust Dale Fellowship; European Research Council under the European Union's Horizon 2020 Research and Innovation Program [677542]; Barts and The London Charity [753/1722]; Wellcome Trust [107613/Z/15/Z]; Royal Society [107613/Z/15/Z]	China Scholarship Council(China Scholarship Council); Derek Willoughby Trust Ph.D. Studentship; Wellcome Trust Dale Fellowship(Wellcome Trust); European Research Council under the European Union's Horizon 2020 Research and Innovation Program; Barts and The London Charity; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	This work was funded by the China Scholarship Council (to J.C.); a Derek Willoughby Trust Ph.D. Studentship (to A.J.P.H.), and a Wellcome Trust Dale Fellowship and funding from the European Research Council under the European Union's Horizon 2020 Research and Innovation Program Grant Agreement 677542 (to J.D.). This work contributes to the Organ Protection Research Theme of the Barts Centre for Trauma Sciences, supported by the Barts and The London Charity (Award 753/1722). The Sir Henry Dale Fellowship is jointly funded by the Wellcome Trust and the Royal Society Grant 107613/Z/15/Z. The authors declare no conflicts of interest.	Ammann P, 2003, J AM COLL CARDIOL, V41, P2004, DOI 10.1016/S0735-1097(03)00421-2; Ang SF, 2010, CRIT CARE MED, V38, P619, DOI 10.1097/CCM.0b013e3181c0df00; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bhowmick R, 2013, J IMMUNOL, V191, P5115, DOI 10.4049/jimmunol.1300522; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; Bryant P, 2003, J SURG RES, V112, P152, DOI 10.1016/S0022-4804(03)00154-9; Bubb KJ, 2013, HYPERTENSION, V62, P426, DOI 10.1161/HYPERTENSIONAHA.111.00942; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Chen JM, 2017, J AM SOC NEPHROL, V28, P94, DOI 10.1681/ASN.2015060670; Chen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100631; Chen M, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003718; Chen W, 1999, AM J PHYSIOL-HEART C, V276, pH2094, DOI 10.1152/ajpheart.1999.276.6.H2094; Chiang N, 1998, J PHARMACOL EXP THER, V287, P779; CHO H, 1991, J MED CHEM, V34, P1503, DOI 10.1021/jm00108a039; Clark N, 2007, FASEB J, V21, P3747, DOI 10.1096/fj.06-7460com; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; De Winter BY, 2009, EUR J PHARMACOL, V615, P177, DOI 10.1016/j.ejphar.2009.04.055; Demirbilek S, 2004, ANESTH ANALG, V99, P1501, DOI 10.1213/01.ANE.0000132975.02854.65; Eberhardt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5381; Endo J, 2014, J EXP MED, V211, P1673, DOI 10.1084/jem.20132011; Enyeart JA, 2004, AM J PHYSIOL-ENDOC M, V287, pE1154, DOI 10.1152/ajpendo.00223.2004; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernandes CJ, 1999, INTENS CARE MED, V25, P1165, DOI 10.1007/s001340051030; Fernandes ES, 2012, J IMMUNOL, V188, P5741, DOI 10.4049/jimmunol.1102147; Fusi C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6736; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Gomes RN, 2005, SHOCK, V24, P590, DOI 10.1097/01.shk.0000183395.29014.7c; Gong YZ, 2008, EUR J PHARMACOL, V600, P18, DOI 10.1016/j.ejphar.2008.10.010; Harada N, 2006, THROMB HAEMOSTASIS, V95, P788, DOI 10.1160/TH05-09-0636; Harzenetter MD, 2007, J IMMUNOL, V179, P607, DOI 10.4049/jimmunol.179.1.607; Helyes Z, 2007, AM J PHYSIOL-LUNG C, V292, pL1173, DOI 10.1152/ajplung.00406.2006; HOLZER P, 1988, NEUROSCIENCE, V24, P739, DOI 10.1016/0306-4522(88)90064-4; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Kaplan BB, 2004, ANN NY ACAD SCI, V1018, P244, DOI 10.1196/annals.1296.029; Kark T, 2008, MOL PHARMACOL, V73, P1405, DOI 10.1124/mol.107.043323; Koenig E, 2000, J NEUROSCI, V20, P8390, DOI 10.1523/JNEUROSCI.20-22-08390.2000; Lang HM, 2015, BRIT J PHARMACOL, V172, P5548, DOI 10.1111/bph.12987; LECHLEITNER P, 1992, AM HEART J, V124, P1433, DOI 10.1016/0002-8703(92)90054-Y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Merx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359; MUERHOFF AS, 1989, J BIOL CHEM, V264, P749; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; Munt B, 1998, CRIT CARE MED, V26, P1829, DOI 10.1097/00003246-199811000-00023; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483; Patel HH, 2003, CIRC RES, V92, P676, DOI 10.1161/01.RES.0000065167.52922.F6; PERRETTI M, 1993, IMMUNOLOGY, V80, P73; Prescott HC, 2018, JAMA-J AM MED ASSOC, V319, P62, DOI 10.1001/jama.2017.17687; Puneet P, 2006, J IMMUNOL, V176, P3813, DOI 10.4049/jimmunol.176.6.3813; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rivers EP, 2012, MINERVA ANESTESIOL, V78, P712; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Sand CA, 2015, J HISTOCHEM CYTOCHEM, V63, P449, DOI 10.1369/0022155415581014; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Sexton A, 2007, FASEB J, V21, P2695, DOI 10.1096/fj.06-7828com; Shieh DB, 2005, J DENT RES, V84, P468, DOI 10.1177/154405910508400513; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Song JQ, 2009, APOPTOSIS, V14, P1299, DOI 10.1007/s10495-009-0398-7; Spector AA, 2015, BBA-MOL CELL BIOL L, V1851, P356, DOI 10.1016/j.bbalip.2014.07.020; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; Sun T, 2016, INT J CARDIOL, V220, P226, DOI 10.1016/j.ijcard.2016.06.092; Suto B, 2014, PEPTIDES, V54, P49, DOI 10.1016/j.peptides.2014.01.006; Szallasi A, 1999, PHARMACOL REV, V51, P159; Tohda C, 2001, J NEUROCHEM, V76, P1628, DOI 10.1046/j.1471-4159.2001.00193.x; Wang DH, 2005, ACTA PHARMACOL SIN, V26, P286, DOI 10.1111/j.1745-7254.2005.00057.x; Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1; Wang LH, 2005, CIRCULATION, V112, P3617, DOI 10.1161/CIRCULATIONAHA.105.556274; Wang YP, 2008, AM J PHYSIOL-REG I, V294, pR1517, DOI 10.1152/ajpregu.00005.2008; Wang YP, 2013, CLIN VACCINE IMMUNOL, V20, P1008, DOI 10.1128/CVI.00674-12; Wei ZH, 2009, CIRC J, V73, P1127, DOI 10.1253/circj.CJ-08-0945; Wen HR, 2012, J BIOL CHEM, V287, P13868, DOI 10.1074/jbc.M111.334896; Yang DC, 2010, CELL METAB, V12, P130, DOI 10.1016/j.cmet.2010.05.015; Zaky A, 2014, SHOCK, V41, P12, DOI 10.1097/SHK.0000000000000065	81	11	11	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3816	3831		10.1096/fj.201701303R	http://dx.doi.org/10.1096/fj.201701303R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29465314				2022-12-26	WOS:000435104500028
J	Michalski, MN; Seydel, AL; Siismets, EM; Zweifler, LE; Koh, AJ; Sinder, BP; Aguirre, JI; Atabai, K; Roca, H; McCauley, LK				Michalski, Megan N.; Seydel, Anna L.; Siismets, Erica M.; Zweifler, Laura E.; Koh, Amy J.; Sinder, Benjamin P.; Aguirre, J. Ignacio; Atabai, Kamran; Roca, Hernan; McCauley, Laurie K.			Inflammatory bone loss associated with MFG-E8 deficiency is rescued by teriparatide	FASEB JOURNAL			English	Article						osteoporosis; osteoclasts; PTH; immune cells	GROWTH-FACTOR 8; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PARATHYROID-HORMONE; RHEUMATOID-ARTHRITIS; APOPTOTIC CELLS; MACROPHAGE EFFEROCYTOSIS; INTESTINAL INFLAMMATION; MINERAL DENSITY; BOWEL-DISEASE; OSTEOPOROSIS	A prolonged increase in proinflammatory cytokines is associated with osteoporotic and autoimmune bone loss and, conversely, anti-inflammatory pathways are associated with protection against bone loss. Milk fat globule-epidermal growth factor (MFG-E)-8 is a glycoprotein that is proresolving, regulates apoptotic cell clearance, and has been linked to autoimmune disease and skeletal homeostasis. The role of MFG-E8 in the young vs. adult skeleton was determined in mice deficient in MFG-E8 (KO). In vivo, trabecular bone was similar in MFG-E8KO and wild-type (WT) mice at 6 and 16 wk, whereas 22 wk adult MFG-E8KO mice displayed significantly reduced trabecular BV/TV. The number of osteoclasts per bone surface was increased in 22-wk MFG-E8 KO vs. WT mice, and recombinant murine MFG-E8 decreased the number and size of osteoclasts in vitro. Adult MFG-E8KO spleen weight:body weight was increased compared with WT, and flow cytometric analysis showed significantly increased myeloid-derived suppressor cells (CD11b(hi)GR-1(+)) and neutrophils (CD11b(hi)Ly6G(+)) in MFG-E8KO bone marrow, suggesting an inflammatory phenotype. PTH-treated MFG-E8KO mice showed a greater anabolic response (+124% BV/TV) than observed in PTH-treated WT mice (+64% BV/TV). These data give insight into the role of MFG-E8 in the adult skeleton and suggest that anabolic PTH may be a valuable therapeutic approach for autoimmune-associated skeletal disease.Michalski, M. N., Seydel, A. L., Siismets, E. M., Zweifler, L. E., Koh, A. J., Sinder, B. P., Aguirre, J. I., Atabai, K., Roca, H., McCauley, L. K. Inflammatory bone loss associated with MFG-E8 deficiency is rescued by teriparatide.	[Michalski, Megan N.; Seydel, Anna L.; Siismets, Erica M.; Zweifler, Laura E.; Koh, Amy J.; Sinder, Benjamin P.; Roca, Hernan; McCauley, Laurie K.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Aguirre, J. Ignacio] Univ Michigan, Sch Dent, Dept Pathol, Ann Arbor, MI 48109 USA; [Atabai, Kamran] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA; [McCauley, Laurie K.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida; University of California System; University of California San Francisco	McCauley, LK (corresponding author), Univ Michigan, Sch Dent, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	mccauley@umich.edu			U.S. National Institutes of Health (NIH) National Institute of Diabetes, Digestive, and Kidney Disease [R01DK053904]; NIH National Institute of Dental and Craniofacial Research [F30DE025154]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022327, F30DE025154, T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053904, R01DK110098] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes, Digestive, and Kidney Disease; NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Michelle Lynch for mCT technical support and Chris Strayhorn and Theresa Cody for histology sectioning (all from the University of Michigan). Funding was provided by U.S. National Institutes of Health (NIH) National Institute of Diabetes, Digestive, and Kidney Disease Grant R01DK053904 (to L.K.M.), and NIH National Institute of Dental and Craniofacial Research Grant F30DE025154 (to M.N.M.). The authors declare no conflicts of interest.	Abe T, 2014, J IMMUNOL, V193, P1383, DOI 10.4049/jimmunol.1400970; Albus E, 2016, J BONE MINER RES, V31, P596, DOI 10.1002/jbmr.2721; Ali T, 2009, AM J MED, V122, P599, DOI 10.1016/j.amjmed.2009.01.022; Atabai K, 2005, MOL BIOL CELL, V16, P5528, DOI 10.1091/mbc.E05-02-0128; Atabai K, 2009, J CLIN INVEST, V119, P3713, DOI 10.1172/JCI40053; Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Bashutski JD, 2010, NEW ENGL J MED, V363, P2396, DOI 10.1056/NEJMoa1005361; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Cho SW, 2014, P NATL ACAD SCI USA, V111, P1545, DOI 10.1073/pnas.1315153111; Cho SW, 2013, J BIOL CHEM, V288, P6814, DOI 10.1074/jbc.M112.393363; Das A, 2016, J IMMUNOL, V196, P5089, DOI 10.4049/jimmunol.1502270; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Ebina K, 2014, OSTEOPOROSIS INT, V25, P2755, DOI 10.1007/s00198-014-2819-x; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Garcia-Carrasco M, 2009, ISR MED ASSOC J, V11, P486; Gordan G S, 1985, Clin Geriatr Med, V1, P95; GOUGH AKS, 1994, LANCET, V344, P23, DOI 10.1016/S0140-6736(94)91049-9; Gravallese EM, 1998, AM J PATHOL, V152, P943; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hu CY, 2009, LUPUS, V18, P676, DOI 10.1177/0961203309103027; Isogai Y, 1996, J BONE MINER RES, V11, P1384; Korns D, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00057; Kudo M, 2013, P NATL ACAD SCI USA, V110, P660, DOI 10.1073/pnas.1216673110; Kuroshima S, 2014, J PERIODONTOL, V85, P24, DOI 10.1902/jop.2013.130094; Kusunoki R, 2012, DIGESTION, V85, P103, DOI 10.1159/000334679; Matsuda A, 2011, MOL MED, V17, P126, DOI 10.2119/molmed.2010.00135; McCauley LK, 2014, J IMMUNOL, V193, P26, DOI 10.4049/jimmunol.1301945; Michalski MN, 2017, PHARMACOL THERAPEUT, V174, P43, DOI 10.1016/j.pharmthera.2017.02.017; Miksa M, 2009, J IMMUNOL, V183, P5983, DOI 10.4049/jimmunol.0802994; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Neutzner M, 2007, CANCER RES, V67, P6777, DOI 10.1158/0008-5472.CAN-07-0165; Novince CM, 2012, J BONE MINER RES, V27, P11, DOI 10.1002/jbmr.508; ODELL WD, 1993, DM-DIS MON, V39, P794; Paganelli M, 2007, INFLAMM BOWEL DIS, V13, P416, DOI 10.1002/ibd.20039; Panopalis Pantelis, 2009, Curr Rheumatol Rep, V11, P177; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Redlich K, 2004, AM J PATHOL, V164, P543, DOI 10.1016/S0002-9440(10)63144-6; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Roldan JF, 2006, J RHEUMATOL, V33, P508; Romas E, 2006, RHEUM DIS CLIN N AM, V32, P759, DOI 10.1016/j.rdc.2006.07.004; Schiller PC, 1999, J BONE MINER RES, V14, P1504, DOI 10.1359/jbmr.1999.14.9.1504; Shirley M, 2017, DRUGS, V77, P1363, DOI 10.1007/s40265-017-0780-7; Sinder BP, 2017, J BONE MINER RES, V32, P2116, DOI 10.1002/jbmr.3196; Sinder BP, 2015, J BONE MINER RES, V30, P2140, DOI 10.1002/jbmr.2735; Sinningen K, 2015, BONE, V76, P107, DOI 10.1016/j.bone.2015.04.003; Soki FN, 2014, J BIOL CHEM, V289, P24560, DOI 10.1074/jbc.M114.571620; Syed Farhan A, 2010, Curr Osteoporos Rep, V8, P235, DOI 10.1007/s11914-010-0035-y; Uchiyama A, 2014, AM J PATHOL, V184, P1981, DOI 10.1016/j.ajpath.2014.03.017; Yoshihara A, 2004, J CLIN PERIODONTOL, V31, P680, DOI 10.1111/j.1600-051X.2004.00548.x	54	10	11	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3730	3741		10.1096/fj.201701238R	http://dx.doi.org/10.1096/fj.201701238R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29475373	Green Submitted, Green Published			2022-12-26	WOS:000435104500021
J	Zhang, JX; Chen, ZH; Chen, DL; Tian, XP; Wang, CY; Zhou, ZW; Gao, Y; Xu, Y; Chen, C; Zheng, ZS; Weng, HW; Ye, S; Kuang, M; Xie, D; Peng, S				Zhang, Jia-Xing; Chen, Zhen-Hua; Chen, Dong-Liang; Tian, Xiao-Peng; Wang, Chen-Yuan; Zhou, Zhi-Wei; Gao, Ying; Xu, Yi; Chen, Cui; Zheng, Zhou-San; Weng, Hui-Wen; Ye, Sheng; Kuang, Ming; Xie, Dan; Peng, Sui			LINC01410-miR-532-NCF2-NF-kappa B feedback loop promotes gastric cancer angiogenesis and metastasis	ONCOGENE			English	Article							COMPETING ENDOGENOUS RNA; NONCODING RNA; EXPRESSION; CERNA; IDENTIFICATION; PROLIFERATION; BIOMARKERS; NETWORKS; INVASION; GENE	Dysregulation of non-coding RNAs, including miRNAs and lncRNAs has been reported to play vital roles in gastric cancer (GC) carcinogenesis, but the mechanism involved is largely unknown. Using the cancer genome atlas (TCGA) data set and bioinformatics analyses, we identified miR-532-5p as a potential tumor suppressor in GC, and found that lncRNA LINC01410 might be a negative regulator of miR-532-5p. We then conducted a series of in vivo and in vitro assays to explore the effect of LINC01410 on miR-532-5p-mediated GC malignancy and the underlying mechanism involved. MiR-532-5p overexpression inhibited GC metastasis and angiogenesis in vitro and in vivo, whereas miR-532-5p silencing had the opposite effect. Further study showed that miR-532-5p attenuated NF-kappa B signaling by directly inhibiting NCF2 expression, while miR-532-5p silencing in GC enhanced NF-kappa B activity. Furthermore, we demonstrated miR-532-5p down-regulation was caused by aberrantly high expression of LINC01410 in GC. Mechanistically, overexpression of LINC01410 promoted GC angiogenesis and metastasis by binding to and suppressing miR-532-5p, which resulted in up-regulation of NCF2 and sustained NF-kappa B pathway activation. Interestingly, NCF2 could in turn increase the promoter activity and expression of LINC01410 via NF-kappa B, thus forming a positive feedback loop that drives the malignant behavior of GC. Finally, high expression of LINC01410, along with low expression of miR-532-5p, was associated with poor survival outcome in GC patients. Our studies uncover a mechanism for constitutive LINC1410-miR-532-5p-NCF2-NF-kappa B feedback loop activation in GC, and consequently, as a potential therapeutic target in GC treatment.	[Zhang, Jia-Xing; Gao, Ying; Xu, Yi; Chen, Cui; Zheng, Zhou-San; Weng, Hui-Wen; Ye, Sheng; Peng, Sui] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Zhang, Jia-Xing; Gao, Ying; Xu, Yi; Chen, Cui; Zheng, Zhou-San; Weng, Hui-Wen; Ye, Sheng; Peng, Sui] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol & Hepatol, Guangzhou, Guangdong, Peoples R China; [Zhang, Jia-Xing; Chen, Dong-Liang; Wang, Chen-Yuan; Xie, Dan] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Chen, Zhen-Hua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Tian, Xiao-Peng] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China; [Zhou, Zhi-Wei] Sun Yat Sen Univ, Dept Gastr & Pancreat Surg, Canc Ctr, Guangzhou, Peoples R China; [Kuang, Ming] Sun Yat Sen Univ, Affiliated Hosp 1, Div Intervent Ultrasound, Dept Med Ultrasound, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Peng, S (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou, Guangdong, Peoples R China.; Peng, S (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol & Hepatol, Guangzhou, Guangdong, Peoples R China.; Xie, D (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China.	xiedan@sysucc.org.cn; pengsui@vip.163.com			National Key R&D Program of China [2017YFC1309001, 2016YFC1302305]; Natural Science Foundation of China [81772514, 81772513, 81401991, 81572359]; Pearl River S&T Nova Program of Guangzhou [201806010005]	National Key R&D Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Pearl River S&T Nova Program of Guangzhou	This work was supported by National Key R&D Program of China (2017YFC1309001, 2016YFC1302305), the Natural Science Foundation of China (Nos. 81772514, 81772513, 81401991, and 81572359), and Pearl River S&T Nova Program of Guangzhou (201806010005).	Adams BD, 2017, J CLIN INVEST, V127, P761, DOI 10.1172/JCI84424; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Chen DL, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0420-1; Guo LL, 2015, WORLD J GASTROENTERO, V21, P11680, DOI 10.3748/wjg.v21.i41.11680; Gupta SC, 2017, INT J CANCER, V140, P1955, DOI 10.1002/ijc.30546; Hao NB, 2017, ONCOTARGET, V8, P81572, DOI 10.18632/oncotarget.19197; Hunt RH, 2015, GUT, V64, P1650, DOI 10.1136/gutjnl-2014-307595; Italiano D, 2012, CELL CYCLE, V11, P4589, DOI 10.4161/cc.22853; Klingenberg M, 2017, J HEPATOL, V67, P603, DOI 10.1016/j.jhep.2017.04.009; Kong PF, 2017, MOL THER, V25, P1027, DOI 10.1016/j.ymthe.2017.01.013; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050702; Lu MH, 2016, ONCOGENE, V35, P3524, DOI 10.1038/onc.2015.413; Muise AM, 2012, GUT, V61, P1028, DOI 10.1136/gutjnl-2011-300078; Nakanishi K, 2016, WIRES RNA, V7, P637, DOI 10.1002/wrna.1356; Osama A, 2016, CANCER BIOMARK, V17, P155, DOI 10.3233/CBM-160626; Roviello G, 2016, GASTRIC CANCER, V19, P31, DOI 10.1007/s10120-015-0537-5; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Seok H, 2018, CELL MOL LIFE SCI, V75, P797, DOI 10.1007/s00018-017-2656-0; Shinohara M, 2010, J BIOL CHEM, V285, P4481, DOI 10.1074/jbc.M109.071779; Song JH, 2012, GASTROENTEROLOGY, V143, P35, DOI 10.1053/j.gastro.2012.05.003; Sun M, 2016, CANCER RES, V76, P6299, DOI 10.1158/0008-5472.CAN-16-0356; Sun TT, 2016, CANCER DISCOV, V6, P784, DOI 10.1158/2159-8290.CD-15-0921; Tan WQ, 2011, J UROLOGY, V186, P2071, DOI 10.1016/j.juro.2011.06.049; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Teng H, 2016, MOL THER, V24, P1806, DOI 10.1038/mt.2016.103; Veneziano D, 2016, HUM MUTAT, V37, P1283, DOI 10.1002/humu.23066; Xu MD, 2017, CLIN CANCER RES, V23, P2071, DOI 10.1158/1078-0432.CCR-16-0742; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yang S, 2016, ONCOTARGET, V7, P85728, DOI 10.18632/oncotarget.13828; Yuan SX, 2016, HEPATOLOGY, V63, P499, DOI 10.1002/hep.27893; Zhang JX, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0586-y; Zhang JX, 2017, CLIN CANCER RES, V23, P298, DOI 10.1158/1078-0432.CCR-16-0414	34	98	103	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	20					2660	2675		10.1038/s41388-018-0162-y	http://dx.doi.org/10.1038/s41388-018-0162-y			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GG2TH	29483646	hybrid, Green Published			2022-12-26	WOS:000432545100004
J	Williams, AH; Wheeler, R; Rateau, L; Malosse, C; Chamot-Rooke, J; Haouz, A; Taha, MK; Boneca, IG				Williams, Allison H.; Wheeler, Richard; Rateau, Lesly; Malosse, Christian; Chamot-Rooke, Julia; Haouz, Ahmed; Taha, Muhamed-Kheir; Boneca, Ivo Gomperts			A step-by-step in crystallo guide to bond cleavage and 1,6-anhydro-sugar product synthesis by a peptidoglycan-degrading lytic transglycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BULGECIN; GONORRHOEAE; BINDING; SLT35; MLTA; MECHANISM; FAMILIES; REVEALS; COMPLEX	Lytic transglycosylases (LTs) are a class of enzymes important for the recycling and metabolism of peptidoglycan (PG). LTs cleave the beta-1,4-glycosidic bond between N-acetylmuramic acid (MurNAc) and GlcNAc in the PG glycan strand, resulting in the concomitant formation of 1,6-anhydro-N-acetylmuramic acid and GlcNAc. No LTs reported to date have utilized chitins as substrates, despite the fact that chitins are GlcNAc polymers linked via beta-1,4-glycosidic bonds, which are the known site of chemical activity for LTs. Here, we demonstrate enzymatically that LtgA, a non-canonical, substrate-permissive LT from Neisseria meningitidis utilizes chitopentaose ((GlcNAc)(5)) as a substrate to produce three newly identified sugars: 1,6-anhydro-chitobiose, 1,6-anhydro-chitotriose, and 1,6-anhydro-chitotetraose. Although LTs have been widely studied, their complex reactions have not previously been visualized in the crystalline state because macromolecular PG is insoluble. Here, we visualized the cleavage of the glycosidic bond and the liberation of GlcNAc-derived residues by LtgA, followed by the synthesis of atypical 1,6-anhydro-GlcNAc derivatives. In addition to the newly identified anhydro-chitin products, we identified trapped intermediates, unpredicted substrate rearrangements, sugar distortions, and a conserved crystallographic water molecule bound to the catalytic glutamate of a high-resolution native LT. This study enabled us to propose a revised alternative mechanism for LtgA that could also be applicable to other LTs. Our work contributes to the understanding of the mechanisms of LTs in bacterial cell wall biology.	[Williams, Allison H.; Wheeler, Richard; Rateau, Lesly; Boneca, Ivo Gomperts] Inst Pasteur, Dept Microbiol, Unite Biol & Genet Paroi Bacterienne, F-75015 Paris, France; [Williams, Allison H.; Wheeler, Richard; Rateau, Lesly; Boneca, Ivo Gomperts] INSERM, F-75015 Paris, France; [Wheeler, Richard] Gustave Roussy Comprehens Canc Ctr, Tumour Immunol & Immunotherapy, F-94805 Villejuif, France; [Malosse, Christian; Chamot-Rooke, Julia] Inst Pasteur, CNRS, USR 2000, Unite Spectrometrie Masse Struct & Proteom, F-75015 Paris, France; [Haouz, Ahmed] Inst Pasteur, Plate Forme Cristallog, CNRS, UMR3528, F-75724 Paris, France; [Taha, Muhamed-Kheir] Inst Pasteur, Dept Infect & Epidemiol, Unite Infect Bacteriennes Invas, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Williams, AH; Boneca, IG (corresponding author), Inst Pasteur, Dept Microbiol, Unite Biol & Genet Paroi Bacterienne, F-75015 Paris, France.; Williams, AH; Boneca, IG (corresponding author), INSERM, F-75015 Paris, France.	awilliam@pasteur.fr; bonecai@pasteur.fr	WHEELER, Richard/AAB-8262-2022; Boneca, Ivo G/H-1677-2014; Chamot-Rooke, Julia/F-3644-2014	WHEELER, Richard/0000-0002-9249-2377; Boneca, Ivo G/0000-0001-8122-509X; Chamot-Rooke, Julia/0000-0002-9427-543X; HAOUZ, Ahmed/0000-0003-1196-1635	EMBO long-term fellowship [ALTF 732-2010]; Institut Carnot-Pasteur Maladies Infectieuses fellowship; ERC starting grant (PGN from SHAPE) [VIR 202283]; Fondation pour la Recherche Medicale (FRM) Grant programme d'urgence [DBF20160635726]; Agence National de la Recherche [ANR-14-CE14-0003]; Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" from the French government's Investissement d'Avenir program [ANR-10-LABX-62-IBEID]	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Institut Carnot-Pasteur Maladies Infectieuses fellowship; ERC starting grant (PGN from SHAPE); Fondation pour la Recherche Medicale (FRM) Grant programme d'urgence; Agence National de la Recherche(French National Research Agency (ANR)); Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" from the French government's Investissement d'Avenir program(French National Research Agency (ANR))	This work was supported by EMBO long-term fellowship ALTF 732-2010 (to A. H. W.), an Institut Carnot-Pasteur Maladies Infectieuses fellowship (to A. H. W.), ERC starting grant (PGN from SHAPE to VIR 202283) (to I. G. B.), Fondation pour la Recherche Medicale (FRM) Grant programme d'urgence (DBF20160635726) (to I. G. B.), Agence National de la Recherche Grant ANR-14-CE14-0003 (to M. K. T.), and Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" Grant ANR-10-LABX-62-IBEID from the French government's Investissement d'Avenir program. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Artola-Recolons C, 2014, ACS CHEM BIOL, V9, P2058, DOI 10.1021/cb500439c; Artola-Recolons C, 2011, BIOCHEMISTRY-US, V50, P2384, DOI 10.1021/bi200085y; Artola-Recolons C, 2011, ACTA CRYSTALLOGR F, V67, P161, DOI 10.1107/S1744309110049171; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Bonis M, 2012, MICROB DRUG RESIST, V18, P230, DOI 10.1089/mdr.2011.0231; Chan YA, 2012, MICROB DRUG RESIST, V18, P271, DOI 10.1089/mdr.2012.0001; Cloud-Hansen KA, 2008, J BACTERIOL, V190, P5989, DOI 10.1128/JB.00506-08; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DIJKSTRA AJ, 1995, FEBS LETT, V366, P115, DOI 10.1016/0014-5793(95)00505-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGEL H, 1992, J BACTERIOL, V174, P6394, DOI 10.1128/JB.174.20.6394-6403.1992; Fibriansah G, 2012, BIOCHEMISTRY-US, V51, P9164, DOI 10.1021/bi300900t; FUKAMIZO T, 1986, ARCH BIOCHEM BIOPHYS, V250, P312, DOI 10.1016/0003-9861(86)90732-0; FUKAMIZO T, 1982, J BIOCHEM-TOKYO, V92, P709, DOI 10.1093/oxfordjournals.jbchem.a133982; Holtje J V, 1996, EXS, V75, P425; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirby AJ, 2001, NAT STRUCT BIOL, V8, P737, DOI 10.1038/nsb0901-737; Kohler PL, 2007, J BACTERIOL, V189, P5421, DOI 10.1128/JB.00531-07; Leung AKW, 2001, BIOCHEMISTRY-US, V40, P5665, DOI 10.1021/bi0028035; Lommatzsch J, 1997, J BACTERIOL, V179, P5465, DOI 10.1128/jb.179.17.5465-5470.1997; Monzingo AF, 1996, NAT STRUCT BIOL, V3, P133, DOI 10.1038/nsb0296-133; Powell AJ, 2006, J MOL BIOL, V359, P122, DOI 10.1016/j.jmb.2006.03.023; Reid CW, 2004, FEBS LETT, V574, P73, DOI 10.1016/j.febslet.2004.08.006; ROMEIS T, 1993, FEMS MICROBIOL LETT, V111, P141; Schaub RE, 2016, MOL MICROBIOL, V102, P865, DOI 10.1111/mmi.13496; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skalweit MJ, 2016, DRUG DES DEV THER, V10, P3013, DOI 10.2147/DDDT.S110193; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TEMPLIN MF, 1992, J BIOL CHEM, V267, P20039; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013; van Asselt EJ, 1999, STRUCT FOLD DES, V7, P1167, DOI 10.1016/S0969-2126(00)80051-9; van Asselt EJ, 1999, FEBS LETT, V458, P429, DOI 10.1016/S0014-5793(99)01198-9; van Asselt EJ, 2000, BIOCHEMISTRY-US, V39, P1924, DOI 10.1021/bi992161p; van Straaten KE, 2007, J BIOL CHEM, V282, P21197, DOI 10.1074/jbc.M701818200; van Straaten KE, 2005, J MOL BIOL, V352, P1068, DOI 10.1016/j.jmb.2005.07.067; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Williams AH, 2017, ANTIBIOTICS-BASEL, V6, DOI 10.3390/antibiotics6010008	43	11	11	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6000	6010		10.1074/jbc.RA117.001095	http://dx.doi.org/10.1074/jbc.RA117.001095			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29483188	Green Published, hybrid			2022-12-26	WOS:000430497300020
J	de Jong, MRW; Visser, L; Huls, G; Diepstra, A; van Vugt, M; Ammatuna, E; van Rijn, RS; Vellenga, E; van den Berg, A; Fehrmann, RSN; van Meerten, T				de Jong, Mathilde R. W.; Visser, Lydia; Huls, Gerwin; Diepstra, Arjan; van Vugt, Marcel; Ammatuna, Emanuele; van Rijn, Rozemarijn S.; Vellenga, Edo; van den Berg, Anke; Fehrmann, Rudolf S. N.; van Meerten, Tom			Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach	PLOS ONE			English	Article							IMPAIR ANTITUMOR-ACTIVITY; MONOCLONAL-ANTIBODY; WEE1 KINASE; RITUXIMAB; RECEPTOR; CHOP; INHIBITORS; EXPRESSION; IBRUTINIB; PATHWAY	Forty percent of patients with diffuse large B-cell lymphoma (DLBCL) show resistant disease to standard chemotherapy (CHOP) in combination with the anti-CD20 monoclonal antibody rituximab (R). Although many new anti-cancer drugs were developed in the last years, it is unclear which of these drugs can be safely combined to improve standard therapy without antagonizing anti-CD20 efficacy. In this study, we aimed to identify rituximab compatible drug-target combinations for DLBCL. For this, we collected gene expression profiles of 1,804 DLBCL patient samples. Subsequently, we performed a guilt-by-association analysis with MS4A1 (CD20) and prioritized the 500 top-ranked CD20-associated gene probes for drug-target interactions. This analysis showed the well-known genes involved in DLBCL pathobiology, but also revealed several genes that are relatively unknown in DLBCL, such as WEE1 and PARP1. To demonstrate potential clinical relevance of these targets, we confirmed high protein expression of WEE1 and PARP1 in patient samples. Using clinically approved WEE1 and PARP1 inhibiting drugs in combination with rituximab, we demonstrated significantly improved DLBCL cell killing, also in rituximab-insensitive cell lines. In conclusion, as exemplified by WEE1 and PARP1, our CD20-based genome-wide analysis can be used as an approach to identify biological relevant drug-targets that are rituximab compatible and may be implemented in phase 1/2 clinical trials to improve DLBCL treatment.	[de Jong, Mathilde R. W.; Huls, Gerwin; Ammatuna, Emanuele; Vellenga, Edo; van Meerten, Tom] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands; [Visser, Lydia; Diepstra, Arjan; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [van Vugt, Marcel; Fehrmann, Rudolf S. N.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [van Rijn, Rozemarijn S.] Med Ctr Leeuwarden, Dept Hematooncol, Leeuwarden, Netherlands	University of Groningen; University of Groningen; University of Groningen; Medical Center Leeuwarden	van Meerten, T (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands.	t.van.meerten@umcg.nl	van den Berg, Anke/H-1718-2011; Fehrmann, Rudolf/E-2551-2011	van den Berg, Anke/0000-0002-8894-2638; Fehrmann, Rudolf/0000-0002-7516-315X; Diepstra, Arjan/0000-0001-9239-1050	Bas Mulder grant from KWF Kankerbestrijding [RUG 2013-5960]; Netherlands Organization for Scientific Research (NWO-VENI grant) [916-16025]; Mandema Stipendium; Bas Mulder grant of KWF Kankerbestrijding [RUG 2014-6727]	Bas Mulder grant from KWF Kankerbestrijding; Netherlands Organization for Scientific Research (NWO-VENI grant)(Netherlands Organization for Scientific Research (NWO)); Mandema Stipendium; Bas Mulder grant of KWF Kankerbestrijding	This research was supported by a Bas Mulder grant from KWF Kankerbestrijding (RUG 2013-5960), and a grant from the Netherlands Organization for Scientific Research (NWO-VENI grant 916-16025) and a Mandema Stipendium (awarded to R.S.N. Fehrmann), and by a Bas Mulder grant of KWF Kankerbestrijding (RUG 2014-6727) and a Mandema Stipendium (awarded to T. van Meerten). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bojarczuk K, 2014, LEUKEMIA, V28, P1163, DOI 10.1038/leu.2014.12; Chanan-Khan A, 2016, LANCET ONCOL, V17, P200, DOI 10.1016/S1470-2045(15)00465-9; Chen JQ, 2013, J PROTEOME RES, V12, P2354, DOI 10.1021/pr400162t; Chila R, 2015, ONCOTARGET, V6, P3394, DOI 10.18632/oncotarget.2583; Cozen W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4856; Da Roit F, 2015, HAEMATOLOGICA, V100, P77, DOI 10.3324/haematol.2014.107011; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; de Miranda NFCC, 2013, J EXP MED, V210, P1729, DOI 10.1084/jem.20122842; Derenzini N, 2015, ONCOTARGET, V6, P6553, DOI 10.18632/oncotarget.2720; Do K, 2015, J CLIN ONCOL, V33, P3409, DOI 10.1200/JCO.2014.60.4009; Engelberts PJ, 2016, J IMMUNOL, V197, P4829, DOI 10.4049/jimmunol.1600811; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Flinn IW, 2016, EUR J CANCER, V54, P11, DOI 10.1016/j.ejca.2015.10.005; Franke A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016596; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Garcia TB, 2017, MOL CANC THER; Gaynor ER, 2001, J CLIN ONCOL, V19, P750, DOI 10.1200/JCO.2001.19.3.750; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Jazirehi AR, 2005, CANCER RES, V65, P264; Johnson NA, 2009, BLOOD, V113, P3773, DOI 10.1182/blood-2008-09-177469; Kheirallah S, 2010, BLOOD, V115, P985, DOI 10.1182/blood-2009-08-237537; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Maddocks K, 2015, BLOOD, V125, P242, DOI 10.1182/blood-2014-08-597914; Maifrede S, 2017, MOL CANCER RES, V15, P967, DOI 10.1158/1541-7786.MCR-16-0468; Matheson CJ, 2016, TRENDS PHARMACOL SCI, V37, P872, DOI 10.1016/j.tips.2016.06.006; Myklebust JH, 2016, BLOOD; Niemann CU, 2013, SEMIN CANCER BIOL, V23, P410, DOI 10.1016/j.semcancer.2013.09.001; OBrien S, 2014, BLOOD, V124, P1994; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pavlasova G, 2016, BLOOD, V128, P1609, DOI 10.1182/blood-2016-04-709519; Polyak MJ, 2008, J BIOL CHEM, V283, P18545, DOI 10.1074/jbc.M800784200; REFF ME, 1994, BLOOD, V83, P435; Restelli V, 2016, BRIT J HAEMATOL, V28, P3360; Satpathy S., 2015, MOL SYST BIOL, V11, P810, DOI [10.15252/msb.20145880, DOI 10.15252/MSB.20145880]; Schmitt A, 2017, CANCER RES, V77, P3040, DOI 10.1158/0008-5472.CAN-16-3398; Sehn LH, 2005, J CLIN ONCOL, V23, P5027, DOI 10.1200/JCO.2005.09.137; Tang J, 2017, P NATL ACAD SCI USA, V114, pE7441, DOI 10.1073/pnas.1705013114; Tangutoori S, 2017, CANCER RES, V77, pB48; Van den Neste E, 2016, BONE MARROW TRANSPL, V51, P51, DOI 10.1038/bmt.2015.213; van Meerten T, 2006, CLIN CANCER RES, V12, P4027, DOI 10.1158/1078-0432.CCR-06-0066; VANIMHOFF GW, 2016, J CLIN ONCOL; Voropaeva EN, 2017, MOL BIOL+, V51, P53, DOI 10.1134/S0026893316060224; Wagner AH, 2016, NUCLEIC ACIDS RES, V44, pD1036, DOI 10.1093/nar/gkv1165; Wang C, 2017, TRANSL ONCOL, V10, P190, DOI 10.1016/j.tranon.2017.01.007; Wang X, 2017, HAEMATOLOGICA; Williamson CT, 2012, EMBO MOL MED, V4, P515, DOI 10.1002/emmm.201200229; Winiarska M, 2014, MABS-AUSTIN, V6, P1300, DOI 10.4161/mabs.32106; Xu-Monette ZY, 2012, BLOOD, V120, P3986, DOI 10.1182/blood-2012-05-433334; Young RM, 2013, NAT REV DRUG DISCOV, V12, P229, DOI 10.1038/nrd3937	53	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193098	10.1371/journal.pone.0193098	http://dx.doi.org/10.1371/journal.pone.0193098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489886	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000054
J	Everink, IHJ; van Haastregt, JCM; Evers, SMAA; Kempen, GIJM; Schols, JMGA				Everink, Irma H. J.; van Haastregt, Jolanda C. M.; Evers, Silvia M. A. A.; Kempen, Gertrudis I. J. M.; Schols, Jos M. G. A.			An economic evaluation of an integrated care pathway in geriatric rehabilitation for older patients with complex health problems	PLOS ONE			English	Article							TRANSITIONS INTERVENTION; HOSPITAL DISCHARGE; COST-EFFECTIVENESS; LIFE	Background Integrated care pathways which cover multiple care settings are increasingly used as a tool to structure care, enhance coordination and improve transitions between care settings. However, little is known about their economic impact. The objective of this study is to determine the cost-effectiveness and cost-utility of an integrated care pathway designed for patients with complex health problems transferring from the hospital, a geriatric rehabilitation facility and primary care. Methods This economic evaluation was performed from a societal perspective alongside a prospective cohort study with two cohorts of patients. The care as usual cohort was included before implementation of the pathway and the care pathway cohort after implementation of the pathway. Both cohorts were measured over nine months, during which intervention costs, healthcare costs, patient and family costs were identified. The outcome measures were dependence in activities of daily living (measured with the KATZ-15) and quality adjusted life years (EQ-5D-3L). Costs and effects were bootstrapped and various sensitivity analyses were performed to assess robustness of the results. Results After nine months, the average societal costs were significantly lower for patients in the care pathway cohort ( 50,791) versus patients in the care as usual cohort ( 62,170; CI = -22,090, -988). Patients in the care pathway cohort had better scores on the KATZ-15 (1.04), indicating cost-effectiveness. No significant differences were found between the two groups on QALY scores (0.01). Conclusions The results of this study indicate that the integrated care pathway is a cost-effective intervention. Therefore, dissemination of the integrated care pathway on a wider scale could be considered. This would provide us the opportunity to confirm the findings of our study in larger economic evaluations. When looking at QALYs, no effects were found. Therefore, it is also recommended to explore if therapy in geriatric rehabilitation could also pay attention to other quality of life-related domains, such as mood and social participation.	[Everink, Irma H. J.; van Haastregt, Jolanda C. M.; Evers, Silvia M. A. A.; Kempen, Gertrudis I. J. M.; Schols, Jos M. G. A.] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Hlth Serv Res, Maastricht, Netherlands; [Everink, Irma H. J.; van Haastregt, Jolanda C. M.; Evers, Silvia M. A. A.; Kempen, Gertrudis I. J. M.; Schols, Jos M. G. A.] Maastricht Univ, Fac Hlth Med & Life Sci, CAPHRI, Maastricht, Netherlands; [Evers, Silvia M. A. A.] Ctr Econ Evaluat, Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Utrecht, Netherlands; [Schols, Jos M. G. A.] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Family Med, Maastricht, Netherlands	Maastricht University; Maastricht University; Trimbos Institute; Maastricht University	Everink, IHJ (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Dept Hlth Serv Res, Maastricht, Netherlands.; Everink, IHJ (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, CAPHRI, Maastricht, Netherlands.	i.everink@maastrichtuniversity.nl	Kempen, Gertrudis I/H-5978-2016; Evers, Silvia/ABG-2128-2020; Evers, Silvia MAA/K-9720-2015; Kempen, Gertrudis/Y-8796-2019	Kempen, Gertrudis I/0000-0002-7053-2198; Evers, Silvia/0000-0003-1026-570X; Evers, Silvia MAA/0000-0003-1026-570X; Kempen, Gertrudis/0000-0002-7053-2198	Dutch National Care for the Elderly Program; Dutch Organization for Health Research and Development (ZonMw) [314070401]	Dutch National Care for the Elderly Program; Dutch Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This study was funded by The Dutch National Care for the Elderly Program and sponsored by The Dutch Organization for Health Research and Development (ZonMw #314070401) to J.M.G.A.S. The funding source had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen D, 2009, INT J EVID-BASED HEA, V7, P61, DOI 10.1111/j.1744-1609.2009.00127.x; [Anonymous], 2015, KOST METH KOST REF E; [Anonymous], 2012, INT J INTEGR CARE; BACHMANN S, 2010, BRIT MED J, V340, pC1718, DOI DOI 10.1136/BMJ.C1718; Boltz M., 2012, EVIDENCE BASED GERIA; Broughton EI, 2011, INT J CARE COORD, V15, P76, DOI 10.1258/jicp.2011.011004; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Courtney M, 2009, J AM GERIATR SOC, V57, P395, DOI 10.1111/j.1532-5415.2009.02138.x; Dautremont JF, 2013, J OTOLARYNGOL-HEAD N, V42, DOI 10.1186/1916-0216-42-59; De Bleser Leentje, 2006, J Nurs Manag, V14, P553, DOI 10.1111/j.1365-2934.2006.00702.x; Deneckere S, 2012, SOC SCI MED, V75, P264, DOI 10.1016/j.socscimed.2012.02.060; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Everink IHJ, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-016-1974-5; Everink Irma Helga Johanna, 2015, Tijdschr Gerontol Geriatr, V46, P104, DOI 10.1007/s12439-015-0125-5; Fields Jane, 2013, Health Manag Technol, V34, P10; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Hendriks MRC, 2013, MED DECIS MAKING, V33, P998, DOI 10.1177/0272989X13482045; Holtzer-Goor KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138225; Husereau D, 2013, INT J TECHNOL ASSESS, V29, P117, DOI 10.1017/S0266462313000160; Institute of Medicine of the National Academies, 2007, PREVENTING MEDICATIO; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Kane RL, 1997, MED CARE, V35, pJS4; Kim S, 2003, J ARTHROPLASTY, V18, P69, DOI 10.1054/arth.2003.50030; Kripalani S, 2007, J HOSP MED, V2, P314, DOI 10.1002/jhm.228; Krummenauer F, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-338; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Lin YK, 2011, J MED SYST, V35, P203, DOI 10.1007/s10916-009-9357-7; Lutomski JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081673; McCloskey R, 2004, J ADV NURS, V46, P186, DOI 10.1111/j.1365-2648.2003.02978.x; Mesteig M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-1; Nolte E, 2014, WHAT IS EVIDENCE EC; Olsson LE, 2009, J ADV NURS, V65, P1626, DOI 10.1111/j.1365-2648.2009.05017.x; Patrick L, 2001, J AM GERIATR SOC, V49, P1471, DOI 10.1046/j.1532-5415.2001.4911239.x; Richardson G, 2004, HEALTH ECON, V13, P1203, DOI 10.1002/hec.901; Rosstad T, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-121; Stange KC, 2009, ANN FAM MED, V7, P100, DOI 10.1370/afm.971; van Asselt ADI, 2009, PHARMACOECONOMICS, V27, P519, DOI 10.2165/00019053-200927060-00007; Van Herck P, 2004, J INTEGRATED CARE PA, V8, P95, DOI DOI 10.1177/147322970400800302; Van Houdt S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-296; Voss R, 2011, ARCH INTERN MED, V171, P1232, DOI 10.1001/archinternmed.2011.278; Wells JL, 2003, ARCH PHYS MED REHAB, V84, P898, DOI 10.1016/S0003-9993(02)04930-4; Zwaap J, 2015, KOSTENEFFECTIVITEIT	43	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191851	10.1371/journal.pone.0191851	http://dx.doi.org/10.1371/journal.pone.0191851			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489820	Green Submitted, gold, Green Published			2022-12-26	WOS:000426276000010
J	Li, JJ; Qu, XC; Tian, J; Zhang, JT; Cheng, JX				Li, Junjie; Qu, Xiaochao; Tian, Jie; Zhang, Jian-Ting; Cheng, Ji-Xin			Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation	PLOS ONE			English	Article							BREAST-CANCER CELLS; DRUG-RESISTANCE; OVEREXPRESSION; METABOLISM; GROWTH	Recent advances have recognized metabolic reprogramming as an underlying mechanism for cancer drug resistance. However, the role of cholesterol metabolism in drug resistance remain elusive. Herein, we report an increased accumulation of cholesteryl ester in gemcitabine-resistant pancreatic ductal adenocarcinoma (PDAC) cells. A potent inhibitor of acylCoA cholesterol acyltransferase-1 (ACAT-1), avasimibe, effectively suppressed proliferation of gemcitabine-resistant PDAC cells. Combination of avasimibe and gemcitabine showed strong synergistic effect in suppressing PDAC cell viability in vitro and tumor growth in vivo. Immunoblotting analysis suggests downregulation of Akt by avasimibe is likely to contribute to the synergism. Collectively, our study demonstrates a new combinational therapeutic strategy to overcome gemcitabine resistance for PDAC treatment.	[Li, Junjie; Cheng, Ji-Xin] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Qu, Xiaochao; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Zhang, Jian-Ting] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Cheng, Ji-Xin] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Cheng, Ji-Xin] Boston Univ, Dept Biomed Engn, Dept Elect & Comp Engn, Boston, MA 02215 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Xidian University; Chinese Academy of Sciences; Institute of Automation, CAS; Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Boston University	Cheng, JX (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.; Cheng, JX (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.; Cheng, JX (corresponding author), Boston Univ, Dept Biomed Engn, Dept Elect & Comp Engn, Boston, MA 02215 USA.	jxcheng@bu.edu	Tian, Jie/H-1190-2011; Li, Junjie/B-1424-2017	Tian, Jie/0000-0003-0498-0432; Li, Junjie/0000-0003-4542-300X; Zhang, Jian-Ting/0000-0002-2803-9914; Cheng, Ji-Xin/0000-0002-5607-6683	DoD Award [W81XWH-14-1-0557]; National Natural Science Foundation of China [81227901, 81530058]	DoD Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by DoD Award W81XWH-14-1-0557 to J-XC and the National Natural Science Foundation of China (grant numbers 81227901 and 81530058) to XQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antalis CJ, 2010, BREAST CANCER RES TR, V122, P661, DOI 10.1007/s10549-009-0594-8; Bandyopadhyay S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179558; Bemlih S, 2010, CANCER BIOL THER, V9, P1025, DOI 10.4161/cbt.9.12.11875; Bivona TG, 2016, NAT MED, V22, P472, DOI 10.1038/nm.4091; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769; Kim MP, 2008, CLIN CANCER RES, V14, P1284, DOI 10.1158/1078-0432.CCR-07-2247; Lee SSY, 2015, ACS NANO, V9, P2420, DOI 10.1021/nn504025a; Li J, 2016, ONCOGENE, V35, P6378, DOI 10.1038/onc.2016.168; Liscovitch M, 2000, TRENDS BIOCHEM SCI, V25, P530, DOI 10.1016/S0968-0004(00)01668-6; Liu HL, 2008, MOL CANCER THER, V7, P263, DOI 10.1158/1535-7163.MCT-07-0445; Liu HL, 2013, J LIPID RES, V54, P776, DOI 10.1194/jlr.M033811; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Lu CW, 2011, AM J PATHOL, V179, P1405, DOI 10.1016/j.ajpath.2011.05.050; Mulas MF, 2011, CELL PROLIFERAT, V44, P360, DOI 10.1111/j.1365-2184.2011.00758.x; Murphy D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-14; Ng SSW, 2001, CLIN CANCER RES, V7, P3269; Paillasse MR, 2009, J LIPID RES, V50, P2203, DOI 10.1194/jlr.M800668-JLR200; Poirot M, 2012, CURR OPIN PHARMACOL, V12, P683, DOI 10.1016/j.coph.2012.09.007; Rahman M, 2015, METABOLITES, V5, P571, DOI 10.3390/metabo5040571; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Silvente-Poirot S, 2014, SCIENCE, V343, P1445, DOI 10.1126/science.1252787; Tadros S, 2017, CANCER RES, V77, P5503, DOI 10.1158/0008-5472.CAN-16-3062; Wu Xi, 2014, Advances in Biological Regulation, V54, P214, DOI 10.1016/j.jbior.2013.09.004; Yang W, 2016, NATURE, V531, P651, DOI 10.1038/nature17412; Yang Youyun, 2011, Int J Biochem Mol Biol, V2, P89; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019; Zahreddine H, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00028; Zhao L, 2017, J IMMUNOTHER, V15; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zhao YH, 2011, CANCER RES, V71, P4585, DOI 10.1158/0008-5472.CAN-11-0127	32	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193318	10.1371/journal.pone.0193318	http://dx.doi.org/10.1371/journal.pone.0193318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489864	gold, Green Published, Green Submitted			2022-12-26	WOS:000426276000065
J	Kumar, S; Knox, RE; Singh, AK; DePauw, RM; Campbell, HL; Isidro-Sanchez, J; Clarke, FR; Pozniak, CJ; N'Daye, A; Meyer, B; Sharpe, A; Ruan, YF; Cuthbert, RD; Somers, D; Fedak, G				Kumar, Sachin; Knox, Ron E.; Singh, Asheesh K.; DePauw, Ron M.; Campbell, Heather L.; Isidro-Sanchez, Julio; Clarke, Fran R.; Pozniak, Curtis J.; N'Daye, Amidou; Meyer, Brad; Sharpe, Andrew; Ruan, Yuefeng; Cuthbert, Richard D.; Somers, Daryl; Fedak, George			High-density genetic mapping of a major QTL for resistance to multiple races of loose smut in a tetraploid wheat cross	PLOS ONE			English	Article							HEXAPLOID BREAD WHEAT; TRITICUM-AESTIVUM; USTILAGO-TRITICI; LINKAGE MAP; CONSENSUS MAP; DURUM; MARKERS; INHERITANCE; INTEGRATION; VIRULENCE	Loose smut, caused by Ustilago tritici (Pers.) Rostr., is a systemic disease of tetraploid durum wheat (Triticum turgidum L.). Loose smut can be economically controlled by growing resistant varieties, making it important to find and deploy new sources of resistance. Blackbird, a variety of T. turgidum L. subsp. carthicum (Nevski) A. Love & D. Love, carries a high level of resistance to loose smut. Blackbird was crossed with the loose smut susceptible durum cultivar Strongfield to produce a doubled haploid (DH) mapping population. The parents and progenies were inoculated with U. tritici races T26, T32 and T33 individually and as a mixture at Swift Current, Canada in 2011 and 2012 and loose smut incidence (LSI) was assessed. Genotyping of the DH population and parents using an Infinium iSelect 90K single nucleotide polymorphism (SNP) array identified 12,952 polymorphic SNPs. The SNPs and 426 SSRs (previously genotyped in the same population) were mapped to 16 linkage groups spanning 3008.4 cM at an average inter-marker space of 0.2 cM in a highdensity genetic map. Composite interval mapping analysis revealed three significant quantitative trait loci (QTL) for loose smut resistance on chromosomes 3A, 6B and 7A. The loose smut resistance QTL on 6B (QUt.spa-6B.2) and 7A (QUt.spa-7A.2) were derived from Blackbird. Strongfield contributed the minor QTL on 3A (QUI.spa-3A.2). The resistance on 6B was a stable major QTL effective against all individual races and the mixture of the three races; it explained up to 74% of the phenotypic variation. This study is the first attempt in durum wheat to identify and map loose smut resistance QTL using a high-density genetic map. The QTL QUt.spa-6B.2 would be an effective source for breeding resistance to multiple races of the loose smut pathogen because it provides near-complete broad resistance to the predominant virulence on the Canadian prairies.	[Kumar, Sachin] Chaudhary Charan Singh Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India; [Knox, Ron E.; Campbell, Heather L.; Clarke, Fran R.; Meyer, Brad; Ruan, Yuefeng; Cuthbert, Richard D.] Agr & Agri Food Canada, Swift Current Res & Dev Ctr, Swift Current, SK, Canada; [Singh, Asheesh K.] Iowa State Univ, 1501 Agron Hall, Ames, IA USA; [DePauw, Ron M.] Adv Wheat Technol, Swift Current, SK, Canada; [Isidro-Sanchez, Julio] Univ Coll Dublin, Sch Agr & Food Sci, Dublin, Ireland; [Pozniak, Curtis J.; N'Daye, Amidou] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [Pozniak, Curtis J.; N'Daye, Amidou] Univ Saskatchewan, Crop Dev Ctr, Saskatoon, SK, Canada; [Sharpe, Andrew] Univ Saskatchewan, Global Inst Food Secur, Saskatoon, SK, Canada; [Somers, Daryl] Vineland Res & Innovat Ctr, Vineland Stn, ON, Canada; [Fedak, George] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada	Chaudhary Charan Singh University; Agriculture & Agri Food Canada; Iowa State University; University College Dublin; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; Agriculture & Agri Food Canada	Kumar, S (corresponding author), Chaudhary Charan Singh Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India.; Knox, RE (corresponding author), Agr & Agri Food Canada, Swift Current Res & Dev Ctr, Swift Current, SK, Canada.	sachinkpsingh@gmail.com; ron.knox@agr.gc.ca	Sanchez, Julio Isidro/L-3174-2015; Kumar, Sachin/AAC-1148-2021	Sanchez, Julio Isidro/0000-0002-9044-3221; Kumar, Sachin/0000-0003-2282-1937; Cuthbert, Richard/0000-0002-1640-4929	Agriculture and Agri-Food Canada; Western Grains Research Foundation; Genome Canada; Agriculture and Agri-Food Canada (AAFC); Western Grains Research Foundation (WGRF); Genome Canada (Canadian Triticum Advancement through Genomics)	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Western Grains Research Foundation; Genome Canada(Genome Canada); Agriculture and Agri-Food Canada (AAFC)(Agriculture & Agri Food Canada); Western Grains Research Foundation (WGRF); Genome Canada (Canadian Triticum Advancement through Genomics)	This work was supported by the Agriculture and Agri-Food Canada (to REK); Western Grains Research Foundation (to REK); Genome Canada (to REK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Malina Poppy, Alison Banman, Theresa Colenutt, Angela Doane and Alana Balliett for their technical help. This study was financially supported by Agriculture and Agri-Food Canada (AAFC), Western Grains Research Foundation (WGRF) and Genome Canada (Canadian Triticum Advancement through Genomics).	Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Avni R, 2014, MOL BREEDING, V34, P1549, DOI 10.1007/s11032-014-0176-2; Blanco A, 1998, THEOR APPL GENET, V97, P721, DOI 10.1007/s001220050948; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; CHURCHILL GA, 1994, GENETICS, V138, P963; Clarke JM, 2009, CAN J PLANT SCI, V89, P505, DOI 10.4141/CJPS08168; Clarke JM, 2005, CAN J PLANT SCI, V85, P901, DOI 10.4141/P04-189; Clarke JM, 2005, CAN J PLANT SCI, V85, P651, DOI 10.4141/P04-119; DEPAUW RM, 1992, CROP SCI, V32, P838, DOI 10.2135/cropsci1992.0011183X003200030069x; DHITAPHICHIT P, 1989, THEOR APPL GENET, V78, P897, DOI 10.1007/BF00266678; Esteras C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-80; Fowler DB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152185; Gadaleta A, 2009, THEOR APPL GENET, V118, P1015, DOI 10.1007/s00122-008-0958-1; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gunderson Kevin L., 2009, V529, P197, DOI 10.1007/978-1-59745-538-1_13; Iehisa JCM, 2014, DNA RES, V21, P555, DOI 10.1093/dnares/dsu020; Kassa MT, 2014, MOL BREEDING, V33, P569, DOI 10.1007/s11032-013-9973-2; Knox RE, 2014, CAN J PLANT PATHOL, V36, P187, DOI 10.1080/07060661.2014.905497; Knox RE, 2002, CAN J PLANT PATHOL, V24, P316; Knox RE, 1999, CAN J PLANT PATHOL, V21, P174, DOI 10.1080/07060669909501209; Knox R, 2012, CABI PLANT PROT SER, P160, DOI 10.1079/9781845938185.0160; Korzun V, 1999, THEOR APPL GENET, V98, P1202, DOI 10.1007/s001220051185; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KRIVCHENKO VI, 1984, GENETIKA+, V20, P1337; Lidon FC, 2014, EMIR J FOOD AGR, V26, P693, DOI 10.9755/ejfa.v26i8.17066; Lin Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0250-2; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; Lotti C, 2000, PLANT BREEDING, V119, P393, DOI 10.1046/j.1439-0523.2000.00526.x; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; Maccaferri M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-873; Mantovani P, 2008, MOL BREEDING, V22, P629, DOI 10.1007/s11032-008-9205-3; Marone D, 2012, THEOR APPL GENET, V125, P1619, DOI 10.1007/s00122-012-1939-y; Martinez-Garcia PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078634; McIntosh R., 2013, CATALOGUE GENE SYMBO; Menzies JG, 2009, CAN J PLANT PATHOL, V31, P265, DOI 10.1080/07060660909507601; Menzies JG, 2003, CAN J PLANT PATHOL, V25, P62, DOI 10.1080/07060660309507050; Menzies JG, 2007, CAN PLANT DIS SURV, V87, P69; NIELSEN J, 1983, PLANT DIS, V67, P860, DOI 10.1094/PD-67-860; NIELSEN J, 1982, CAN J BOT, V60, P1191, DOI 10.1139/b82-148; Peace C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048305; Peleg Z, 2008, THEOR APPL GENET, V117, P103, DOI 10.1007/s00122-008-0756-9; Procunier JD, 1997, GENOME, V40, P176, DOI 10.1139/g97-025; Randhawa HS, 2009, EUPHYTICA, V169, P151, DOI 10.1007/s10681-009-9903-x; Rawlings JO, 1988, APPL REGRESSION ANAL, P250; Russo MA, 2014, MOL BREEDING, V34, P1579, DOI 10.1007/s11032-014-0181-5; SAS, 1999, SAS STAT SOFTW CHANG; Sharma I, 2011, CEREAL RES COMMUN, V39, P376, DOI 10.1556/CRC.39.2011.3.7; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; SHINOHARA M, 1976, Review of Plant Protection Research, V9, P124; Singh AK, 2014, CAN J PLANT SCI, V94, P1289, DOI [10.4141/CJPS-2014-048, 10.4141/cjps-2014-048]; Somers DJ, 2006, GENOME, V49, P1586, DOI 10.1139/G06-127; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Syukov VV, 2015, RUSSIAN J GENET, V5, P55; Thomas PL, 1997, CAN J PLANT PATHOL, V19, P161, DOI 10.1080/07060669709500546; Trebbi D, 2011, THEOR APPL GENET, V123, P555, DOI 10.1007/s00122-011-1607-7; van Poecke RMP, 2013, PLANT BIOTECHNOL J, V11, P809, DOI 10.1111/pbi.12072; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S, 2012, WINDOWS QTL CARTOGRA; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; You FM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-354; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zanke C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00217; Zou ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053541	69	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0192261	10.1371/journal.pone.0192261	http://dx.doi.org/10.1371/journal.pone.0192261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29485999	Green Published, gold, Green Submitted			2022-12-26	WOS:000426242400007
J	Piao, S; Lee, JW; Nagar, H; Jung, SB; Choi, S; Kim, S; Lee, I; Kim, SM; Shin, N; Lee, YR; Lee, SD; Park, JB; Irani, K; Won, M; Hur, GM; Jeon, BH; Kim, DW; Kim, CS				Piao, Shuyu; Lee, Jun Wan; Nagar, Harsha; Jung, Saet-byel; Choi, Sujeong; Kim, Seonhee; Lee, Ikjun; Kim, Sung-min; Shin, Nara; Lee, Yu Ran; Lee, Sang Do; Park, Jin Bong; Irani, Kaikobad; Won, Minho; Hur, Gang Min; Jeon, Byeong Hwa; Kim, Dong Woon; Kim, Cuk-Seong			CR6 interacting factor 1 deficiency promotes endothelial inflammation by SIRT1 downregulation	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; ADHESION MOLECULES; PROGENITOR CELLS; ADIPOSE-TISSUE; MITOCHONDRIA; DYSFUNCTION; INHIBITION; EXPRESSION	Aims CR6 interacting factor 1 (CRIF1) deficiency impairs mitochondrial oxidative phosphorylation complexes, contributing to increased mitochondrial and cellular reactive oxygen species (ROS) production. CRIF1 downregulation has also been revealed to decrease sirtuin 1 (SIRT1) expression and impair vascular function. Inhibition of SIRT1 disturbs oxidative energy metabolism and stimulates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B)-induced inflammation. Therefore, we hypothesized that both CRIF1 deficiency- induced mitochondrial ROS production and SIRT1 reduction play stimulatory roles in vascular inflammation. Methods and results Plasma levels and mRNA expression of proinflammatory cytokines (tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, and IL-6) were markedly elevated in endothelium-specific CRIF1-knockout mice and CRIF1-silenced endothelial cells, respectively. Moreover, CRIF1 deficiency-induced vascular adhesion molecule-1 (VCAM-1) expression was consistently attenuated by the antioxidant N-acetyl-cysteine and NF-kappa B inhibitor (BAY11). We next showed that siRNA-mediated CRIF1 downregulation markedly activated NF-kappa B. SIRT1 overexpression not only rescued CRIF1 deficiency-induced NF-kappa B activation but also decreased inflammatory cytokines (TNF-alpha, IL-1 beta, and IL-6) and VCAM-1 expression levels in endothelial cells. Conclusions These results strongly suggest that CRIF1 deficiency promotes endothelial cell inflammation by increasing VCAM-1 expression, elevating inflammatory cytokines levels, and activating the transcription factor NF-kappa B, all of which were inhibited by SIRT1 overexpression.	[Piao, Shuyu; Nagar, Harsha; Choi, Sujeong; Kim, Seonhee; Lee, Ikjun; Kim, Sung-min; Lee, Yu Ran; Lee, Sang Do; Park, Jin Bong; Jeon, Byeong Hwa; Kim, Cuk-Seong] Chungnam Natl Univ, Sch Med, Dept Physiol & Med Sci, Daejeon, South Korea; [Lee, Jun Wan] Chungnam Natl Univ Hosp, Reg Emergency Ctr, Emergency ICU, Daejeon, South Korea; [Jung, Saet-byel] Chungnam Natl Univ Hosp, Dept Endocrinol, Daejeon, South Korea; [Shin, Nara; Kim, Dong Woon] Chungnam Natl Univ, Sch Med, Dept Anat & Med Sci, Daejeon, South Korea; [Irani, Kaikobad] Univ Iowa, Carver Coll Med, Dept Internal Med, Div Cardiovasc Med, Iowa City, IA USA; [Won, Minho; Hur, Gang Min] Chungnam Natl Univ, Sch Med, Dept Pharmacol, Daejeon, South Korea	Chungnam National University; Chungnam National University; Chungnam National University Hospital; Chungnam National University; Chungnam National University Hospital; Chungnam National University; University of Iowa; Chungnam National University	Kim, CS (corresponding author), Chungnam Natl Univ, Sch Med, Dept Physiol & Med Sci, Daejeon, South Korea.	cskim@cnu.ac.kr	Jeon, Byeong Hwa/D-4160-2012; Kim, Dong Woon/W-8254-2018; Hur, Gang-min/ABF-9263-2021	Jeon, Byeong Hwa/0000-0002-3347-2739; Kim, Dong Woon/0000-0001-7691-1394; Hur, Gang-min/0000-0003-4870-6574; lee, sang do/0000-0003-1778-6575; Nagar, Harsha/0000-0002-2879-0118; Park, Jin Bong/0000-0002-0081-945X; Kim, Seonhee/0000-0001-5374-9259; Won, Minho/0000-0002-5873-5216; Kim, Sungmin/0000-0003-3156-7133; Irani, Kaikobad/0000-0001-9194-7387; Kim, Cuk-Seong/0000-0001-7647-6089	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C-1202-010017]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI17C-1202-010017 to CSK).	Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Breitenstein A, 2011, CARDIOVASC RES, V89, P464, DOI 10.1093/cvr/cvq339; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Davidson SM, 2010, CARDIOVASC RES, V88, P58, DOI 10.1093/cvr/cvq195; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; Elahi MM, 2009, OXID MED CELL LONGEV, V2, P259, DOI 10.4161/oxim.2.5.9441; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gano LB, 2014, AM J PHYSIOL-HEART C, V307, pH1754, DOI 10.1152/ajpheart.00377.2014; GARCIARUIZ C, 1995, MOL PHARMACOL, V48, P825; Gillum MP, 2011, DIABETES, V60, P3235, DOI 10.2337/db11-0616; Hernandez-Aguilera A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/135698; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836; Khan F, 2010, NAT REV RHEUMATOL, V6, P253, DOI 10.1038/nrrheum.2010.44; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Nagar H, 2017, ANTIOXIDANTS REDOX S; Nagar H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098670; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Ryu MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003356; Salminen A, 2008, BIOESSAYS, V30, P939, DOI 10.1002/bies.20799; Savoia C, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/281240; SCHIFFRIN EL, 1992, HYPERTENSION, V19, P1; Tang XQ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00175; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Wan Zan, 2012, Zhonghua Nan Ke Xue, V18, P831; Widlansky ME, 2011, ANTIOXID REDOX SIGN, V15, P1517, DOI 10.1089/ars.2010.3642; Xia F, 2014, J ATHEROSCLER THROMB, V21, P768, DOI 10.5551/jat.23697; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yu E, 2012, CARDIOVASC RES, V95, P173, DOI 10.1093/cvr/cvs111; Zeng WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16013	42	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192693	10.1371/journal.pone.0192693	http://dx.doi.org/10.1371/journal.pone.0192693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474366	Green Published, gold			2022-12-26	WOS:000426049500027
J	Szymczak, M; Kalicinski, P; Kowalewski, G; Broniszczak, D; Markiewicz-Kijewska, M; Ismail, H; Stefanowicz, M; Kowalski, A; Teisseyre, J; Jankowska, I; Patkowski, W				Szymczak, Marek; Kalicinski, Piotr; Kowalewski, Grzegorz; Broniszczak, Dorota; Markiewicz-Kijewska, Malgorzata; Ismail, Hor; Stefanowicz, Marek; Kowalski, Adam; Teisseyre, Joanna; Jankowska, Irena; Patkowski, Waldemar			Acute liver failure in children-Is living donor liver transplantation justified?	PLOS ONE			English	Article							FULMINANT HEPATIC-FAILURE; SINGLE-CENTER EXPERIENCE; OUTCOMES; INFANTS	Objectives Living donor liver transplantation (LDLT) in patients with acute liver failure (ALF) has become an acceptable alternative to transplantation from deceased donors (DDLT). The aim of this study was to analyze outcomes of LDLT in pediatric patients with ALF based on our center's experience. Material and methods We enrolled 63 children (at our institution) with ALF who underwent liver transplantation between 1997 and 2016. Among them 24 (38%) underwent a LDLT and 39 (62%) received a DDLT. Retrospectively analyzed patient clinical data included: time lapse between qualification for transplantation and transplant surgery, graft characteristics, postoperative complications, long-term results post-transplantation, and living donor morbidity. Overall, we have made a comparison of clinical results between LDLT and DDLT groups. Results Follow-up periods ranged from 12 to 182 months (median 109 months) for LDLT patients and 12 to 183 months (median 72 months) for DDLT patients. The median waiting time for a transplant was shorter in LDLT group than in DDLT group. There was not a single case of primary non-function (PNF) in the LDLT group and 20 out of 24 patients (83.3%) had good early graft function; 3 patients (12.5%) in the LDLT group died within 2 months of transplantation but there was no late mortality. In comparison, 4 out of 39 patients (10.2%) had PNF in DDLT group while 20 patients (51.2%) had good early graft function; 8 patients (20.5%) died early within 2 months and 2 patients (5.1%) died late after transplantation. The LDLT group had a shorter cold ischemia time (CIT) of 4 hours in comparison to 9.2 hours in the DDLT group (p< 0.0001). Conclusions LDLT is a lifesaving procedure for pediatric patients with ALF. Our experience showed that it may be performed with very good results, and with very low morbidity and no mortality among living donors when performed by experienced teams following strict procedures.	[Szymczak, Marek; Kalicinski, Piotr; Kowalewski, Grzegorz; Broniszczak, Dorota; Markiewicz-Kijewska, Malgorzata; Ismail, Hor; Stefanowicz, Marek; Kowalski, Adam; Teisseyre, Joanna] Childrens Mem Hlth Inst, Dept Pediat Surg & Organ Transplantat, Warsaw, Poland; [Jankowska, Irena] Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol & Immunol, Warsaw, Poland; [Patkowski, Waldemar] Warsaw Med Univ, Dept Gen Transplant & Liver Surg, Warsaw, Poland	Children's Memorial Health Institute; Children's Memorial Health Institute; Medical University of Warsaw	Szymczak, M; Kowalewski, G (corresponding author), Childrens Mem Hlth Inst, Dept Pediat Surg & Organ Transplantat, Warsaw, Poland.	m.szymczak@ipczd.pl; ranyjulek@gmail.com	Kowalewski, Grzegorz/AAE-4338-2022	Teisseyre, Joanna/0000-0002-3706-9429; Markiewicz-Kijewska, Malgorzata/0000-0003-2664-611X; Patkowski, Waldemar/0000-0002-6238-1967; Szymczak, Marek/0000-0001-6852-8424; Broniszczak-Czyszek, Dorota/0000-0002-4864-6172; Ismail, Hor/0000-0002-3577-4757; Kalicinski, Piotr/0000-0003-0555-2229; Kowalewski, Grzegorz/0000-0001-7183-7711; Jankowska, Irena/0000-0001-6847-9570	Polish Ministry of Science and Higher Education [S153/2017]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The creation of this study was supported by Statutory Grant from The Polish Ministry of Science and Higher Education; award no. S153/2017 to MS.	Baliga P, 2004, LIVER TRANSPLANT, V10, P1364, DOI 10.1002/lt.20252; Bhaduri BR, 1996, SEMIN LIVER DIS, V16, P349, DOI 10.1055/s-2007-1007248; Bhatia V, 2010, INDIAN J PEDIATR, V77, P1288, DOI 10.1007/s12098-010-0167-1; Campsen J, 2008, LIVER TRANSPLANT, V14, P1273, DOI 10.1002/lt.21500; Carius LP, 2009, TRANSPL P, V41, P895, DOI 10.1016/j.transproceed.2009.02.007; Chui AKK, 1997, AUST NZ J SURG, V67, P275, DOI 10.1111/j.1445-2197.1997.tb01962.x; Dhawan A, 2004, PEDIATR TRANSPLANT, V8, P584, DOI 10.1111/j.1399-3046.2004.00292.x; Eacute;boli L, 2017, TRANSPL P, V49, P832, DOI 10.1016/j.transproceed.2017.03.001; El Moghazy WM, 2010, TRANSPL INT, V23, P823, DOI 10.1111/j.1432-2277.2010.01059.x; Emre S, 1999, LIVER TRANSPLANT SUR, V5, P161, DOI 10.1002/lt.500050315; Faraj W, 2010, ANN SURG, V251, P351, DOI 10.1097/SLA.0b013e3181bdfef6; Germani G, 2012, J HEPATOL, V57, P288, DOI 10.1016/j.jhep.2012.03.017; Jain V, 2016, LIVER TRANSPLANT, V22, P1418, DOI 10.1002/lt.24501; Karakayali H, 2007, TRANSPL P, V39, P1157, DOI 10.1016/j.transproceed.2007.02.053; Kato T, 1997, TRANSPLANTATION, V64, P415, DOI 10.1097/00007890-199708150-00007; Kilic M, 2007, TRANSPLANTATION, V84, P475, DOI 10.1097/01.tp.0000276987.55382.e2; Liu CL, 2003, LIVER TRANSPLANT, V9, P1185, DOI 10.1053/jlts.2003.50235; Lutfi R, 2017, J PEDIATR GASTR NUTR, V64, P660, DOI 10.1097/MPG.0000000000001441; Mack CL, 2001, LIVER TRANSPLANT, V7, P890, DOI 10.1053/jlts.2001.27963; MATSUNAMI H, 1992, LANCET, V340, P1411, DOI 10.1016/0140-6736(92)92600-K; Miloh T, 2010, PEDIATR TRANSPLANT, V14, P863, DOI 10.1111/j.1399-3046.2010.01356.x; Miyake Y, 2007, J GASTROENTEROL, V42, P485, DOI 10.1007/s00535-007-2029-9; Nicolette L, 1998, J PEDIATR SURG, V33, P998, DOI 10.1016/S0022-3468(98)90521-8; Noujaim HM, 2002, J PEDIATR SURG, V37, P159, DOI 10.1053/jpsu.2002.30242; Riordan SM, 2000, LIVER TRANSPLANT, V6, P170, DOI 10.1016/S1527-6465(00)80006-4; Sakamoto S, 2008, PEDIATR TRANSPLANT, V12, P167, DOI 10.1111/j.1399-3046.2007.00718.x; Sundaram SS, 2003, LIVER TRANSPLANT, V9, P783, DOI 10.1053/jlts.2003.50104; Szymczak M, 2003, TRANSPL P, V35, P2273, DOI 10.1016/j.transproceed.2003.08.002; Trey C, 1970, Prog Liver Dis, V3, P282; Uribe M, 2008, TRANSPL P, V40, P3253, DOI 10.1016/j.transproceed.2008.03.128; Wu YM, 2004, TRANSPL P, V36, P2226, DOI 10.1016/j.transproceed.2004.08.062; Yamashiki N, 2012, LIVER TRANSPLANT, V18, P1069, DOI 10.1002/lt.23469	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193327	10.1371/journal.pone.0193327	http://dx.doi.org/10.1371/journal.pone.0193327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474400	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500084
J	Decourtye, L; Clemessy, M; Mire, E; Ledent, T; Perin, L; Robinson, IC; Le Bouc, Y; Kappeler, L				Decourtye, Lyvianne; Clemessy, Maud; Mire, Erik; Ledent, Tatiana; Perin, Laurence; Robinson, Iain C.; Le Bouc, Yves; Kappeler, Laurent			Impact of insulin on primary arcuate neurons culture is dependent on early-postnatal nutritional status and neuronal subpopulation	PLOS ONE			English	Article							HYPOTHALAMIC NEURONS; GROWTH-FACTOR; RECEPTOR; RESISTANCE; HEIGHT; LEPTIN; LOCI; MICE	Nutrition plays a critical role in programming and shaping linear growth during early postnatal life through direct action on the development of the neuroendocrine somatotropic (GH/IGF-1) axis. IGF-1 is a key factor in modulating the programming of linear growth during this period. Notably, IGF-1 preferentially stimulates axonal growth of GHRH neurons in the arcuate nucleus of the hypothalamus (Arc), which is crucial for the proliferation of somatotroph progenitors in the pituitary, thus influencing later GH secretory capacity. However, other nutrition-related hormones may also be involved. Among them, insulin shares several structural and functional similarities with IGF-1, as well as downstream signaling effectors. We investigated the role of insulin in the control of Arc axonal growth using an in vitro model of arcuate explants culture and a cell-type specific approach (GHRH-eGFP mice) under both physiological conditions (normally fed pups) and those of dietary restriction (underfed pups). Our data suggest that insulin failed to directly control axonal growth of Arc neurons or influence specific IGF-1-mediated effects on GHRH neurons. Insulin may act on neuronal welfare, which appears to be dependent on neuronal sub-populations and is influenced by the nutritional status of pups in which Arc neurons develop.	[Decourtye, Lyvianne; Clemessy, Maud; Mire, Erik; Ledent, Tatiana; Le Bouc, Yves; Kappeler, Laurent] Sorbonne Univ, INSERM, CRSA, Paris, France; [Perin, Laurence] Sorbonne Univ, Hop Armand Trousseau, AP HP, Paris, France; [Robinson, Iain C.] Natl Inst Med Res, MRC, Div Mol Neuroendocrinol, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; MRC National Institute for Medical Research	Kappeler, L (corresponding author), Sorbonne Univ, INSERM, CRSA, Paris, France.	laurent.kappeler@inserm.fr	Mire, Erik/AAD-3123-2020; Kappeler, Laurent/N-6327-2017	Mire, Erik/0000-0002-6793-0566; Kappeler, Laurent/0000-0001-7971-0838; Ledent, Tatiana/0000-0002-6988-8779; Decourtye Espiard, Lyvianne/0000-0003-2212-1316	Institut National de la Sante et de la Recherche Medicale (INSERM), l'Universite Pierre et Marie Curie (Sorbonne Universites, UPMC Univ Paris 06); Institute of Cardiometabolism and Nutrition (IHU ICAN); Sandoz Biopharmaceuticals France; Premup foundation; French Ministry for Education and Research Training; Societe Francaise d'Endocrinologie et Diabetologie Pediatrique (SFEDP); Sandoz Biopharmaceuticals grant of SFEDP	Institut National de la Sante et de la Recherche Medicale (INSERM), l'Universite Pierre et Marie Curie (Sorbonne Universites, UPMC Univ Paris 06); Institute of Cardiometabolism and Nutrition (IHU ICAN); Sandoz Biopharmaceuticals France; Premup foundation; French Ministry for Education and Research Training; Societe Francaise d'Endocrinologie et Diabetologie Pediatrique (SFEDP); Sandoz Biopharmaceuticals grant of SFEDP	This study was supported by institutional funding from the Institut National de la Sante et de la Recherche Medicale (INSERM), l'Universite Pierre et Marie Curie (Sorbonne Universites, UPMC Univ Paris 06). It benefits from funding from the Institute of Cardiometabolism and Nutrition (IHU ICAN; http://www.ican-institute.org/), Sandoz Biopharmaceuticals France (https://www.sandoz.fr/), and the Premup foundation (https://www.premup.org/fra/accueil). L.D. was supported by a PhD grant from the French Ministry for Education and Research Training and the Societe Francaise d'Endocrinologie et Diabetologie Pediatrique (SFEDP, the Sandoz Biopharmaceuticals grant of SFEDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000035; Balthasar N, 2003, ENDOCRINOLOGY, V144, P2728, DOI 10.1210/en.2003-0006; BARINAGA M, 1985, NATURE, V314, P279, DOI 10.1038/314279a0; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bouyer K, 2008, J NEUROENDOCRINOL, V20, P1278, DOI 10.1111/j.1365-2826.2008.01780.x; Bouyer K, 2013, J NEUROSCI, V33, P840, DOI 10.1523/JNEUROSCI.3215-12.2013; Decourtye L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170083; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; Gouty-Colomer LA, 2010, ENDOCRINOLOGY, V151, P5762, DOI 10.1210/en.2010-0298; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hassouna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051135; Kappeler L, 2009, ENDOCRINOLOGY, V150, P314, DOI 10.1210/en.2008-0981; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; McArthur S, 2011, ENDOCRINOLOGY, V152, P607, DOI 10.1210/en.2010-0798; Mire E, 2008, MOL CELL NEUROSCI, V37, P222, DOI 10.1016/j.mcn.2007.09.009; RECHLER MM, 1985, ANNU REV PHYSIOL, V47, P425; RECIOPINTO E, 1986, J NEUROSCI, V6, P1211; Rhee YH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.295; Salehi A, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-48; Singh B, 2012, J NEUROCHEM, V121, P263, DOI 10.1111/j.1471-4159.2012.07681.x; Solloso A, 2008, J CELL PHYSIOL, V215, P140, DOI 10.1002/jcp.21295; Steculorum SM, 2013, ENDOCRIN METAB CLIN, V42, P149, DOI 10.1016/j.ecl.2012.10.002; Stromberg T, 2006, BLOOD, V107, P669, DOI 10.1182/blood-2005-01-0306; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; UNGER J, 1989, NEUROSCIENCE, V31, P143, DOI 10.1016/0306-4522(89)90036-5; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193196	10.1371/journal.pone.0193196	http://dx.doi.org/10.1371/journal.pone.0193196			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466413	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000425604300095
J	Duan, WL; He, B; Chen, YN; Zou, S; Wang, Y; Nover, D; Chen, W; Yang, GS				Duan, Weili; He, Bin; Chen, Yaning; Zou, Shan; Wang, Yi; Nover, Daniel; Chen, Wen; Yang, Guishan			Identification of long-term trends and seasonality in high-frequency water quality data from the Yangtze River basin, China	PLOS ONE			English	Article							HEAVY-METAL POLLUTION; ORGANIC POLLUTANTS; EUTROPHICATION; REQUIREMENTS; DOWNSTREAM; FRAMEWORK; PATTERNS; IMPACTS; STREAMS; MODEL	Comprehensive understanding of the long-term trends and seasonality of water quality is important for controlling water pollution. This study focuses on spatio-temporal distributions, long-term trends, and seasonality of water quality in the Yangtze River basin using a combination of the seasonal Mann-Kendall test and time-series decomposition. The used weekly water quality data were from 17 environmental stations for the period January 2004 to December 2015. Results show gradual improvement in water quality during this period in the Yangtze River basin and greater improvement in the Uppermost Yangtze River basin. The larger cities, with high GDP and population density, experienced relatively higher pollution levels due to discharge of industrial and household wastewater. There are higher pollution levels in Xiang and Gan River basins, as indicated by higher NH4-N and CODMn concentrations measured at the stations within these basins. Significant trends in water quality were identified for the 2004-2015 period. Operations of the three Gorges Reservoir (TGR) enhanced pH fluctuations and possibly attenuated CODMn, and NH4-N transportation. Finally, seasonal cycles of varying strength were detected for time-series of pollutants in river discharge. Seasonal patterns in pH indicate that maxima appear in winter, and minima in summer, with the opposite true for CODMn. Accurate understanding of long-term trends and seasonality are necessary goals of water quality monitoring system efforts and the analysis methods described here provide essential information for effectively controlling water pollution.	[Duan, Weili; Chen, Yaning; Zou, Shan; Wang, Yi] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China; [Duan, Weili; He, Bin; Chen, Wen; Yang, Guishan] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Key Lab Watershed Geog Sci, Nanjing, Jiangsu, Peoples R China; [Zou, Shan] Hengyang Normal Univ, Hengyang, Peoples R China; [Nover, Daniel] Univ Calif Merced, Dept Engn, Merced, CA USA	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Hengyang Normal University; University of California System; University of California Merced	Duan, WL (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China.; Duan, WL (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, Key Lab Watershed Geog Sci, Nanjing, Jiangsu, Peoples R China.	duan.scut.cn@gmail.com	chen, yaning/AAN-8170-2020; Chen, Yaning/A-2338-2019	Zou, Shan/0000-0003-3896-5679	National Natural Science Foundation of China [41471460, 41501552]; Natural Science Foundation of Jiangsu Province [BK20161612]; Talent Introduction Project of Nanjing Institute of Geography and Limnology, CAS [NIGLAS2015QD09]; "One Hundred Talents Program" of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Talent Introduction Project of Nanjing Institute of Geography and Limnology, CAS; "One Hundred Talents Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was sponsored by the National Natural Science Foundation of China (No. 41471460 and 41501552), the Natural Science Foundation of Jiangsu Province (Grants No BK20161612), the Talent Introduction Project of Nanjing Institute of Geography and Limnology, CAS (NIGLAS2015QD09), and "One Hundred Talents Program" of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was sponsored by the National Natural Science Foundation of China (No. 41471460 and 41501552), the Natural Science Foundation of Jiangsu Province(Grants No BK20161612), the Talent Introduction Project of Nanjing Institute of Geography and Limnology, CAS (NIGLAS2015QD09), and "One Hundred Talents Program" of the Chinese Academy of Sciences. We also wish to acknowledge Dr. C. James Taylor for his help.	Ahlgren P, 2003, J AM SOC INF SCI TEC, V54, P550, DOI 10.1002/asi.10242; Arnold JG, 2012, T ASABE, V55, P1491; Bouza-Deano R, 2008, J HYDROL, V361, P227, DOI 10.1016/j.jhydrol.2008.07.048; Brakebill JW, 2010, J AM WATER RESOUR AS, V46, P757, DOI 10.1111/j.1752-1688.2010.00450.x; Chang H, 2008, WATER RES, V42, P3285, DOI 10.1016/j.watres.2008.04.006; China's Ministry of Environmental Protection, 2016, 2015 STAT ENV REP; China's Ministry of Environmental Protection, 2016, 2015 CHIN ENV B, P2014; Cohn T.A., 2004, TECHNIQUES METHODS; Conley DJ, 2002, ESTUARIES, V25, P848, DOI 10.1007/BF02804910; Ding XW, 2010, J HYDROL, V383, P233, DOI 10.1016/j.jhydrol.2009.12.039; Duan WL, 2015, HYDROL EARTH SYST SC, V19, P1293, DOI 10.5194/hess-19-1293-2015; Duan WL, 2016, NAT HAZARDS, V82, P401, DOI 10.1007/s11069-016-2207-2; Duan WL, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8020133; Gilliom R. J., 1995, DESIGN NATL WATER QU; Haddad M, 2013, CR GEOSCI, V345, P167, DOI 10.1016/j.crte.2013.03.002; Halliday SJ, 2012, SCI TOTAL ENVIRON, V434, P186, DOI 10.1016/j.scitotenv.2011.10.052; He GZ, 2016, ENVIRON DEV, V18, P2, DOI 10.1016/j.envdev.2015.12.003; Hensel DR, 2006, ENVIRON SCI TECHNOL, V40, P4066, DOI 10.1021/es051650b; HIRSCH RM, 1984, WATER RESOUR RES, V20, P727, DOI 10.1029/WR020i006p00727; HIRSCH RM, 1982, WATER RESOUR RES, V18, P107, DOI 10.1029/WR018i001p00107; Hollert H, 2013, ENVIRON SCI POLLUT R, V20, P6904, DOI 10.1007/s11356-013-1943-z; Hurley MA, 1996, ENVIRONMETRICS, V7, P379, DOI 10.1002/(SICI)1099-095X(199607)7:4&lt;379::AID-ENV218&gt;3.0.CO;2-2; Kronvang B, 2005, J HYDROL, V304, P274, DOI 10.1016/j.jhydrol.2004.07.035; Li MT, 2007, ESTUAR COAST SHELF S, V71, P3, DOI 10.1016/j.ecss.2006.08.013; Li XQ, 2015, J GEOCHEM EXPLOR, V153, P30, DOI 10.1016/j.gexplo.2015.02.009; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Liu JY, 2010, J GEOGR SCI, V20, P483, DOI 10.1007/s11442-010-0483-4; Luo PP, 2011, J ENVIRON MONITOR, V13, P2819, DOI 10.1039/c1em10339c; Ma L, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4966-8; MathWorks, 2010, MATLAB VERS 7 10 0 R; Minaudo C, 2015, BIOGEOSCIENCES, V12, P2549, DOI 10.5194/bg-12-2549-2015; Morvan X, 2008, SCI TOTAL ENVIRON, V391, P1, DOI 10.1016/j.scitotenv.2007.10.046; Muller B, 2008, SCI TOTAL ENVIRON, V402, P232, DOI 10.1016/j.scitotenv.2008.04.049; Pedregal DJ, 2007, ENERG CONVERS MANAGE, V48, P1710, DOI 10.1016/j.enconman.2006.11.004; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Qiao Y, 2016, ENVIRON MONIT ASSESS, V188, P1; Rosen MR, 2008, J ENVIRON QUAL, V37, pS190, DOI 10.2134/jeq2008.0049; Schwarz GE., 2006, US GEOLOGICAL SURVEY, V6, P248; Shrestha S, 2008, ENVIRON MODELL SOFTW, V23, P182, DOI 10.1016/j.envsoft.2007.05.006; Taylor CJ, 2007, ENVIRON MODELL SOFTW, V22, P797, DOI 10.1016/j.envsoft.2006.03.002; Venier M, 2012, ENVIRON SCI TECHNOL, V46, P3928, DOI 10.1021/es204527q; Wang BL, 2015, ENVIRON EARTH SCI, V73, P5299, DOI 10.1007/s12665-014-3779-3; Wang JY, 2008, ENVIRON POLLUT, V152, P387, DOI 10.1016/j.envpol.2007.06.050; Wang LX, 2008, J GEOGR SCI, V18, P353, DOI 10.1007/s11442-008-0353-5; Wu B, 2009, J HAZARD MATER, V169, P1093, DOI 10.1016/j.jhazmat.2009.04.065; Xu ZR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109141; Yan WJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003575; Ye C, 2011, J HAZARD MATER, V191, P366, DOI 10.1016/j.jhazmat.2011.04.090; Yin Z.Y., 2005, COMPUT ENVIRON URBAN, V29, P197, DOI DOI 10.1016/J.COMPENVURBSYS.2003.10.001; Young PC, 1999, J FORECASTING, V18, P369, DOI 10.1002/(SICI)1099-131X(199911)18:6<369::AID-FOR748>3.0.CO;2-K; Zeb B. S., 2011, International Journal of Physical Sciences, V6, P7789; Zhang Q, 2009, ENVIRON MONIT ASSESS, V152, P123, DOI 10.1007/s10661-008-0301-y; Zhang Q, 2008, J HYDROL, V353, P215, DOI 10.1016/j.jhydrol.2007.11.023; Zhang XJ, 2010, J HAZARD MATER, V182, P130, DOI 10.1016/j.jhazmat.2010.06.006; Zhang XD, 2011, J WATER RES PLAN MAN, V137, P101, DOI 10.1061/(ASCE)WR.1943-5452.0000096; Zhang Y, 2016, FIELDS I COMMUN, V78, P215, DOI 10.1007/978-1-4939-6568-7_10; Zhang Z, 2010, J ENVIRON MANAGE, V91, P2483, DOI 10.1016/j.jenvman.2010.07.002; Zhao Jian, 2015, Hydrology: Current Research, V6, P211; Zhao J, 2011, J ENVIRON SCI, V23, P1460, DOI 10.1016/S1001-0742(10)60599-2	59	46	47	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0188889	10.1371/journal.pone.0188889	http://dx.doi.org/10.1371/journal.pone.0188889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466354	gold, Green Submitted, Green Published			2022-12-26	WOS:000425604300002
J	McGreevy, PD; Griffiths, MD; Ascione, FR; Wilson, B				McGreevy, Paul D.; Griffiths, Mark D.; Ascione, Frank R.; Wilson, Bethany			Flogging tired horses: Who wants whipping and who would walk away if whipping horses were withheld?	PLOS ONE			English	Article							JOCKEYS; BRITISH	Recent studies have cast doubt on the effectiveness of whipping horses during races and this has led to questions concerning its continuing justification. Furthermore, it has been argued that whipping tired horses in racing is the most televised form of violence to animals. The present study used de-identified data from a recent independent Australian poll (n = 1,533) to characterise the 26% of respondents (113 females and 271 males) who support the whipping of racehorses and the 10% of racing enthusiasts in the sample (44 females and 63 males) who would stop watching races and betting on them if whipping were banned. Logistic regression models examining associations between age, gender, and income level of respondents demonstrated that those who support racehorse whipping are significantly more likely to be male. Among racing enthusiasts who would stop watching races and betting on them if whipping were banned, those in the lowest income bracket were over-represented. The more frequently respondents attended races or gambled on them, the more likely they were to agree that horses should be hit with a whip during the normal course of a race. These findings align with previous studies of violence among men and women but may also be attributed to male support of traditional gambling practices. Globally, racing organisations may consider the findings of the present study helpful in their deliberations on the merits of continuing the practice of whipping tired horses in the name of sport. The study might also provide important data for stakeholders who demand that it continues.	[McGreevy, Paul D.; Wilson, Bethany] Univ Sydney, Sydney Sch Vet Sci, Sydney, NSW, Australia; [Griffiths, Mark D.] Nottingham Trent Univ, Psychol Dept, Int Gaming Res Unit, Nottingham, England; [Ascione, Frank R.] Univ Denver, Grad Sch Social Work, Denver, CO USA	University of Sydney; Nottingham Trent University; University of Denver	McGreevy, PD (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Sydney, NSW, Australia.	paul.mcgreevy@sydney.edu.au	Griffiths, Mark D./AAY-3546-2021	Griffiths, Mark D./0000-0001-8880-6524; McGreevy, Paul/0000-0001-7220-8378	RSPCA Australia	RSPCA Australia	The authors would like to thank RSPCA Australia for supporting publication costs.; The authors would like to thank RSPCA Australia for providing the raw data and for supporting publication costs.	ALBERT A, 1988, J MARRIAGE FAM, V50, P543, DOI 10.2307/352019; Antonacopoulos NMD, 2008, ANTHROZOOS, V21, P139, DOI 10.2752/175303708X305783; Ascione FR, 2009, J SOC ISSUES, V65, P569, DOI 10.1111/j.1540-4560.2009.01614.x; Bergmann I, 2015, PFERDEHEILKUNDE, V31, P490, DOI 10.21836/PEM20150509; British Horseracing Authority, 2011, RESP REG REV US WHIP; Burchfield KB, 2017, CRIME DELINQUENCY; Canale N, 2015, ADDICT BEHAV, V45, P276, DOI 10.1016/j.addbeh.2015.01.035; DEUEL NR, 1988, J EQUINE VET SCI, V8, P240, DOI 10.1016/S0737-0806(88)80016-9; Evans D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015622; Felson RB, 2002, VIOLENCE GENDER REEX; Goodfellow J., 2014, CONVERSATION; Griffiths M. D., 2007, CASINO GAMING INT, V3, P71; Hood J, 2017, ANIMALS, V7, DOI 10.3390/ani7010004; Jones B, 2010, J VET BEHAV, V5, P196, DOI 10.1016/j.jveb.2010.04.001; McGreevy PD, 2007, VET J, V174, P492, DOI 10.1016/j.tvjl.2006.09.008; McGreevy PD, 2013, J VET BEHAV, V8, P395, DOI 10.1016/j.jveb.2013.03.003; McGreevy PD, 2013, J VET BEHAV, V8, P100, DOI 10.1016/j.jveb.2012.04.004; McGreevy PD, 2012, J VET BEHAV, V7, P186, DOI 10.1016/j.jveb.2011.05.001; McGreevy PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033398; McGreevy PD, 2011, J VET BEHAV, V6, P287, DOI 10.1016/j.jveb.2011.02.010; McLean AN, 2010, J VET BEHAV, V5, P203, DOI 10.1016/j.jveb.2010.04.003; Morris T, 2011, GUARDIAN; Pinchbeck GL, 2004, EQUINE VET J, V36, P384, DOI 10.2746/0425164044868387; UEDA Y, 1993, J EQUINE VET SCI, V13, P707, DOI 10.1016/S0737-0806(06)81572-8; Visser EK, 2012, J VET BEHAV, V7, P295, DOI 10.1016/j.jveb.2011.10.007; Wilson B, 2017, PLOS ONE	26	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192843	10.1371/journal.pone.0192843	http://dx.doi.org/10.1371/journal.pone.0192843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	29466458	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000425604300069
J	Ambachew, H; Zheng, MJ; Pappoe, F; Shen, JL; Xu, YH				Ambachew, Henock; Zheng, Meijuan; Pappoe, Faustina; Shen, Jilong; Xu, Yuanhong			Genotyping and sero-virological characterization of hepatitis B virus (HBV) in blood donors, Southern Ethiopia	PLOS ONE			English	Article							GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY; SEROLOGICAL CHARACTERIZATION; VIRAL-HEPATITIS; SUBGENOTYPE A1; GLOBAL BURDEN; MUTATIONS; DISEASE; HISTORY; HBSAG	Hepatitis B virus (HBV) prevalence is highest in Sub-Saharan Africa including Ethiopia. HBV genotypes have distinct geographic distributions and play a role in course of infection and treatment management. However, in Ethiopia there is paucity of information about distribution of HBV genotypes. This study was done to determine genotype, mutation and sero-virological profiles of HBV isolates in Southern Ethiopia. Cross-sectional, laboratory based study was conducted on 103HBsAg sero-positive samples from a total of 2,237 screened blood donors. HBV serological markers and biochemical assays were done. Serum viral load was measured using quantitative real-time PCR. Partial HBV S-gene was amplified with nested PCR and sequenced. Bioinformatics tools were utilized to determine genotypes, serotypes and mutations. Of 103 HBsAg reactive serum samples, 14.6% and 70.9% were sero-positive for HBeAg and HBeAb, respectively. Ninety-eight samples gave detectable viral load with a median of 3.46(2.62-4.82) log IU/ml. HBeAg sero-positive donors carried elevated levels of viral load. Eighty five isolates were successfully amplified, sequenced and genotyped into 58 (68.2%) genotype A (HBV/A) and 27 (31.8%) genotype D (HBV/D). HBV serotypes found were adw2 (74.1%), ayw2 (24.7%), and ayw3 (1.2%). In twenty-four (28.2%) samples mutations in the major hydrophilic region (MHR) were observed. Donors infected with HBV/A had higher viral load and more frequent MHR mutation than HBV/D infected donors. This study illustrated distribution of HBV genotype A and D among blood donors in southern Ethiopia. It also demonstrated occurrence HBV variants that may influence clinical aspects of HBV infection. The study contributes in narrowing the existing gap of HBV molecular study in Ethiopia.	[Ambachew, Henock; Zheng, Meijuan; Xu, Yuanhong] Anhui Med Univ, Affiliated Hosp 1, Dept Clin Lab, Hefei, Anhui, Peoples R China; [Ambachew, Henock; Zheng, Meijuan; Shen, Jilong; Xu, Yuanhong] Anhui Med Univ, Affiliated Hosp 1, Dept Clin Lab Diagnost, Hefei, Anhui, Peoples R China; [Ambachew, Henock] Hawassa Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Hawassa, Ethiopia; [Pappoe, Faustina; Shen, Jilong; Xu, Yuanhong] Anhui Med Univ, Prov Lab Microbiol, Dept Immunol & Parasitol, Hefei, Anhui, Peoples R China; [Pappoe, Faustina; Shen, Jilong; Xu, Yuanhong] Anhui Med Univ, Key Lab Zoonoses Anhui, Hefei, Anhui, Peoples R China; [Pappoe, Faustina] Univ Cape Coast, Coll Hlth & Allied Sci, Sch Med Sci, Dept Microbiol & Immunol, Cape Coast, Ghana	Anhui Medical University; Anhui Medical University; Hawassa University; Anhui Medical University; Anhui Medical University; University of Cape Coast	Xu, YH (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Clin Lab, Hefei, Anhui, Peoples R China.; Xu, YH (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Clin Lab Diagnost, Hefei, Anhui, Peoples R China.; Xu, YH (corresponding author), Anhui Med Univ, Prov Lab Microbiol, Dept Immunol & Parasitol, Hefei, Anhui, Peoples R China.; Xu, YH (corresponding author), Anhui Med Univ, Key Lab Zoonoses Anhui, Hefei, Anhui, Peoples R China.	xyhong1964@163.com		Yuanhong, Xu/0000-0002-1637-3800	National Natural Science Foundation of China [81302525]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, Grant No. 81302525 (YX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe A, 2003, EPIDEMIOL INFECT, V131, P757, DOI 10.1017/S0950268803008574; Aberra H, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2549-8; Asaad AM, 2015, BRAZ J INFECT DIS, V19, P525, DOI 10.1016/j.bjid.2015.03.007; Aslanzadeh J, 2004, ANN CLIN LAB SCI, V34, P389; Ayed K, 2007, J INFECTION, V54, P291, DOI 10.1016/j.jinf.2006.05.013; Barbini L, 2013, INFECT GENET EVOL, V19, P152, DOI 10.1016/j.meegid.2013.07.007; Marugan RB, 2009, WORLD J GASTROENTERO, V15, P423, DOI 10.3748/wjg.15.423; Bell TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045750; Belyhun Y, 2017, ANTIVIR THER, V22, P97, DOI 10.3851/IMP3060; Belyhun Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2090-1; Blum HE, 2016, DIGEST DIS, V34, P293, DOI 10.1159/000444466; Calisti G, 2015, T ROY SOC TROP MED H, V109, P723, DOI 10.1093/trstmh/trv077; Candotti D, 2006, J VIRAL HEPATITIS, V13, P715, DOI 10.1111/j.1365-2893.2006.00741.x; Coleman PF, 2006, EMERG INFECT DIS, V12, P198, DOI 10.3201/eid1203.050038; Echevarria JM, 2006, J MED VIROL, V78, pS36, DOI 10.1002/jmv.20605; Fares MA, 2002, J MOL EVOL, V54, P807, DOI 10.1007/s00239-001-0084-z; Feitelson M A, 2001, ILAR J, V42, P127; Fujiwara K, 2005, WORLD J GASTROENTERO, V11, P6410, DOI 10.3748/wjg.v11.i41.6410; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Grabarczyk P, 2010, J VIRAL HEPATITIS, V17, P444, DOI 10.1111/j.1365-2893.2009.01192.x; Habil FE, 2013, INTERVIROLOGY, V56, P278, DOI 10.1159/000353105; Hadziyannis SJ, 2001, ANTIVIR RES, V52, P91, DOI 10.1016/S0166-3542(01)00173-5; Hasegawa I, 2006, J MED VIROL, V78, P1035, DOI 10.1002/jmv.20659; Hundie GB, 2016, J MED VIROL, V88, P1035, DOI 10.1002/jmv.24437; Kao JH, 2002, J CLIN MICROBIOL, V40, P22, DOI 10.1128/JCM.40.1.22-25.2002; Kimbi GC, 2004, J GEN VIROL, V85, P1211, DOI 10.1099/vir.0.19749-0; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Kwange SO, 2013, VIRUS GENES, V47, P448, DOI 10.1007/s11262-013-0976-1; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183; Madan K, 2009, HEPATOL RES, V39, P157, DOI 10.1111/j.1872-034X.2008.00417.x; Ministry of Health, 2016, NAT STRAT PREV CONTR; Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502; Mwangi J, 2008, INTERVIROLOGY, V51, P417, DOI 10.1159/000205526; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Organization WH, 2015, GUID PREV CAR TREATM; Park SG, 2003, EUR J BIOCHEM, V270, P2929, DOI 10.1046/j.1432-1033.2003.03650.x; Purdy MA, 2007, INTERVIROLOGY, V50, P45, DOI 10.1159/000096312; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Saudy N, 2003, J MED VIROL, V70, P529, DOI 10.1002/jmv.10427; Schultz AK, 2012, NUCLEIC ACIDS RES, V40, pW193, DOI 10.1093/nar/gks414; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shiferaw F, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3459-1; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Suzuki S, 2003, J MED VIROL, V69, P459, DOI 10.1002/jmv.10331; Valsamakis A, 2007, CLIN MICROBIOL REV, V20, P426, DOI 10.1128/CMR.00009-07; Wu CC, 2010, J GEN VIROL, V91, P483, DOI 10.1099/vir.0.012740-0; Yousif M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-328; Yousif M, 2014, INT J INFECT DIS, V29, P125, DOI 10.1016/j.ijid.2014.07.002	55	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0193177	10.1371/journal.pone.0193177	http://dx.doi.org/10.1371/journal.pone.0193177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462187	Green Published, gold, Green Submitted			2022-12-26	WOS:000425554200052
J	He, CL; Feng, ZR; Ren, ZG				He, Chenlong; Feng, Zuren; Ren, Zhigang			A flocking algorithm for multi-agent systems with connectivity preservation under hybrid metric-topological interactions	PLOS ONE			English	Article							COORDINATION; AGENTS	In this paper, we propose a connectivity-preserving flocking algorithm for multi-agent systems in which the neighbor set of each agent is determined by the hybrid metric-topological distance so that the interaction topology can be represented as the range-limited Delaunay graph, which combines the properties of the commonly used disk graph and Delaunay graph. As a result, the proposed flocking algorithm has the following advantages over the existing ones. First, range-limited Delaunay graph is sparser than the disk graph so that the information exchange among agents is reduced significantly. Second, some links irrelevant to the connectivity can be dynamically deleted during the evolution of the system. Thus, the proposed flocking algorithm is more flexible than existing algorithms, where links are not allowed to be disconnected once they are created. Finally, the multi-agent system spontaneously generates a regular quasi-lattice formation without imposing the constraint on the ratio of the sensing range of the agent to the desired distance between two adjacent agents. With the interaction topology induced by the hybrid distance, the proposed flocking algorithm can still be implemented in a distributed manner. We prove that the proposed flocking algorithm can steer the multi-agent system to a stable flocking motion, provided the initial interaction topology of multi-agent systems is connected and the hysteresis in link addition is smaller than a derived upper bound. The correctness and effectiveness of the proposed algorithm are verified by extensive numerical simulations, where the flocking algorithms based on the disk and Delaunay graph are compared.	[He, Chenlong; Feng, Zuren] Xi An Jiao Tong Univ, Syst Engn Inst, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China; [Ren, Zhigang] Xi An Jiao Tong Univ, Autocontrol Res Inst, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	He, CL (corresponding author), Xi An Jiao Tong Univ, Syst Engn Inst, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China.	chenlong.he@stu.xjtu.edu.cn			National Natural Science Foundation of China [61105126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China, Grant No. 61105126 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bialek W, 2014, P NATL ACAD SCI USA, V111, P7212, DOI 10.1073/pnas.1324045111; Bullo F., 2009, APPL MATH SERIES; Cavagna A, 2008, ANIM BEHAV, V76, P237, DOI 10.1016/j.anbehav.2008.02.003; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Cortes J, 2005, ESAIM CONTR OPTIM CA, V11, P691, DOI 10.1051/cocv:2005024; Cortes J, 2004, IEEE T ROBOTIC AUTOM, V20, P243, DOI 10.1109/TRA.2004.824698; Desai JP, 2001, IEEE T ROBOTIC AUTOM, V17, P905, DOI 10.1109/70.976023; Diestel R., 2010, GRADUATE TEXTS MATH, V173; Ginelli F, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.168103; Godsil C., 2001, ALGEBRAIC GRAPH THEO; Gregoire G, 2003, PHYSICA D, V181, P157, DOI 10.1016/S0167-2789(03)00102-7; He C, 2016, P IEEE INT C SYST MA; Jadbabaie A, 2003, IEEE T AUTOMAT CONTR, V48, P988, DOI 10.1109/TAC.2003.812781; Ji M, 2007, IEEE T ROBOT, V23, P693, DOI 10.1109/TRO.2007.900638; Khalil KH, 2002, NONLINEAR SYSTEMS; La HM, 2015, IEEE T SYST MAN CY-S, V45, P1, DOI 10.1109/TSMC.2014.2318282; Lafferriere G, 2005, SYST CONTROL LETT, V54, P899, DOI 10.1016/j.sysconle.2005.02.004; Martin S, 2014, SYST CONTROL LETT, V69, P53, DOI 10.1016/j.sysconle.2014.04.004; Moreau L, 2005, IEEE T AUTOMAT CONTR, V50, P169, DOI 10.1109/TAC.2004.841888; Okabe A., 2000, SPATIAL TESSELLATION, Vsecond, DOI DOI 10.1002/9780470317013; Okubo A., 1986, Advances in Biophysics, V22, P1, DOI 10.1016/0065-227X(86)90003-1; Olfati-Saber R, 2006, IEEE T AUTOMAT CONTR, V51, P401, DOI 10.1109/TAC.2005.864190; Ren W, 2008, IEEE T AUTOMAT CONTR, V53, P1503, DOI 10.1109/TAC.2008.924961; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Shang YL, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-50094-4; Su HS, 2009, INT J CONTROL, V82, P1334, DOI 10.1080/00207170802549578; Tanner HG, 2007, IEEE T AUTOMAT CONTR, V52, P863, DOI 10.1109/TAC.2007.895948; Tanner HG, 2003, 42ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-6, PROCEEDINGS, P2010; Tanner HG, 2003, 42ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-6, PROCEEDINGS, P2016; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Wen G, 2012, IET CONTROL THEORY A, V6, P813, DOI 10.1049/iet-cta.2011.0532; Yang ZQ, 2010, NONLINEAR DYNAM, V60, P255, DOI 10.1007/s11071-009-9593-x; Zavlanos MA, 2008, IEEE T ROBOT, V24, P1416, DOI 10.1109/TRO.2008.2006233; Zavlanos MM, 2007, IEEE DECIS CONTR P, P3196, DOI 10.1109/cdc.2007.4434530	34	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192987	10.1371/journal.pone.0192987	http://dx.doi.org/10.1371/journal.pone.0192987			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462217	gold, Green Published, Green Submitted			2022-12-26	WOS:000425554200040
J	Xiao, SY; Zhang, W; Manley, NR				Xiao, Shiyun; Zhang, Wen; Manley, Nancy R.			Thymic B cell development is controlled by the B potential of progenitors via both hematopoietic-intrinsic and thymic microenvironment-intrinsic regulatory mechanisms	PLOS ONE			English	Article							DELTA-LIKE 4; T-CELL; BONE-MARROW; EPITHELIAL-CELLS; IN-VIVO; NEGATIVE SELECTION; SELF-ANTIGENS; ADULT-MOUSE; STEM-CELLS; PRO-B	Background Hematopoietic stem cells (HSCs) derived from birth through adult possess differing differentiation potential for T or B cell fate in the thymus; neonatal bone marrow (BM) cells also have a higher potential for B cell production in BM compared to adult HSCs. We hypothesized that this hematopoietic-intrinsic B potential might also regulate B cell development in the thymus during ontogeny. Methods Foxn1(lacZ) mutant mice are a model in which down regulation of a thymic epithelial cell (TEC) specific transcription factor beginning one week postnatal causes a dramatic reduction of thymocytes production. In this study, we found that while T cells were decreased, the frequency of thymic B cells was greatly increased in these mutants in the perinatal period. We used this model to characterize the mechanisms in the thymus controlling B cell development. Results Foxn1(lacZ) mutants, T cell committed intrathymic progenitors (DN1a,b) were progressively reduced beginning one week after birth, while thymic B cells peaked at 3-4 weeks with pre-B-II progenitor phenotype, and originated in the thymus. Heterochronic chimeras showed that the capacity for thymic B cell production was due to a combination of higher B potential of neonatal HSCs, combined with a thymic microenvironment deficiency including reduction of DL4 and increase of IL-7 that promoted B cell fate. Conclusion Our findings indicate that the capacity and time course for thymic B-cell production are primarily controlled by the hematopoietic-intrinsic potential for B cells themselves during ontogeny, but that signals from TECs microenvironment also influence the frequency and differentiation potential of B cell development in the thymus.	[Xiao, Shiyun; Zhang, Wen; Manley, Nancy R.] Univ Georgia, Dept Genet, Paul D Coverdell Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Xiao, SY (corresponding author), Univ Georgia, Dept Genet, Paul D Coverdell Ctr, Athens, GA 30602 USA.	shiyun@uga.edu		Xiao, Shiyun/0000-0003-0196-287X	National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) [R01 AI082127]; NIH [R01AI082127]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082127] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grant # R01 AI082127 to NRM from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank E. Richie and A. Singer for critical discussions. We thank J. Nelson in the Center for Tropical and Emerging Global Diseases Flow Cytometry Facility at the University of Georgia for technical support for cell sorting. This work was supported in part by NIH grant R01AI082127 to N.R.M.	Akashi K, 2000, J IMMUNOL, V164, P5221, DOI 10.4049/jimmunol.164.10.5221; Alves NL, 2009, TRENDS IMMUNOL, V30, P468, DOI 10.1016/j.it.2009.07.010; Alves NL, 2009, P NATL ACAD SCI USA, V106, P1512, DOI 10.1073/pnas.0809559106; Arakawa-Hoyt J, 1999, BONE MARROW TRANSPL, V24, P1167, DOI 10.1038/sj.bmt.1702048; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Carsetti R, 2000, J EXP MED, V191, P5, DOI 10.1084/jem.191.1.5; Ceredig R, 2002, INT IMMUNOL, V14, P87, DOI 10.1093/intimm/14.1.87; Ceredig R, 2007, EUR J IMMUNOL, V37, P830, DOI 10.1002/eji.200636728; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; Cuddihy AR, 2009, BLOOD, V113, P2723, DOI 10.1182/blood-2008-06-162040; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Douagi I, 2002, SEMIN IMMUNOL, V14, P361, DOI 10.1016/S1044532302000702; El-Kassar N, 2012, INT IMMUNOL, V24, P661, DOI 10.1093/intimm/dxs067; Ferrero I, 1999, EUR J IMMUNOL, V29, P1598, DOI 10.1002/(SICI)1521-4141(199905)29:05<1598::AID-IMMU1598>3.3.CO;2-F; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; Frommer F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015372; Goldschneider I, 2006, IMMUNOL REV, V209, P58, DOI 10.1111/j.0105-2896.2006.00354.x; GOLDSCHNEIDER I, 1986, J EXP MED, V163, P1, DOI 10.1084/jem.163.1.1; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hashimoto Y, 2002, BLOOD, V100, P3504, DOI 10.1182/blood-2002-03-0733; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kincade PW, 2002, IMMUNOL REV, V187, P116, DOI 10.1034/j.1600-065X.2002.18710.x; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; LEDOUARIN NM, 1975, J EXP MED, V142, P17, DOI 10.1084/jem.142.1.17; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Manley N, 2012, FRONT BIOSCI, V17, P2461; Masuda K, 2005, J IMMUNOL, V174, P2525, DOI 10.4049/jimmunol.174.5.2525; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; McAleer J, 2005, IMMUNOLOGY, V114, P171, DOI 10.1111/j.1365-2567.2004.02101.x; MIYAMAINABA M, 1988, J EXP MED, V168, P811, DOI 10.1084/jem.168.2.811; Mori S, 1997, J IMMUNOL, V158, P4193; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Ohmura K, 1999, J IMMUNOL, V163, P4788; Perera J, 2013, P NATL ACAD SCI USA, V110, P17011, DOI 10.1073/pnas.1313001110; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Prockop SE, 2004, J IMMUNOL, V173, P1604, DOI 10.4049/jimmunol.173.3.1604; Ribeiro AR, 2013, J IMMUNOL, V191, P1200, DOI 10.4049/jimmunol.1203042; ROLINK A, 1993, BLOOD, V81, P2290; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; Rossi MID, 2003, BLOOD, V101, P576, DOI 10.1182/blood-2002-03-0896; SHORTMAN K, 1992, CURR OPIN IMMUNOL, V4, P140, DOI 10.1016/0952-7915(92)90003-W; Swann JB, 2014, CELL REP, V8, P1184, DOI 10.1016/j.celrep.2014.07.017; Williams KM, 2008, BLOOD, V112, P3255, DOI 10.1182/blood-2008-04-153627; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; Xiao SY, 2008, J IMMUNOL, V180, P914, DOI 10.4049/jimmunol.180.2.914; Yamano T, 2015, IMMUNITY, V42, P1048, DOI 10.1016/j.immuni.2015.05.013; Yokota T, 2006, DEVELOPMENT, V133, P2041, DOI 10.1242/dev.02349; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zamisch M, 2005, J IMMUNOL, V174, P60, DOI 10.4049/jimmunol.174.1.60; Zlotoff DA, 2011, BLOOD, V118, P1962, DOI 10.1182/blood-2010-12-324954; Zubkova I, 2005, J IMMUNOL, V175, P2321, DOI 10.4049/jimmunol.175.4.2321; Zuklys S, 2016, NAT IMMUNOL, V17, P1206, DOI 10.1038/ni.3537	60	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0193189	10.1371/journal.pone.0193189	http://dx.doi.org/10.1371/journal.pone.0193189			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462202	gold, Green Submitted, Green Published			2022-12-26	WOS:000425554200055
J	Kukita, Y; Ohkawa, K; Takada, R; Uehara, H; Katayama, K; Kato, K				Kukita, Yoji; Ohkawa, Kazuyoshi; Takada, Ryoji; Uehara, Hiroyuki; Katayama, Kazuhiro; Kato, Kikuya			Selective identification of somatic mutations in pancreatic cancer cells through a combination of next-generation sequencing of plasma DNA using molecular barcodes and a bioinformatic variant filter	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; RARE MUTATIONS	The accuracy of next-generation sequencing (NGS) for detecting tumor-specific mutations in plasma DNA is hindered by errors introduced during PCR/sequencing, base substitutions caused by DNA damage, and pre-existing mutations in normal cells that are present at a low frequency. Here, we performed NGS of genes related to pancreatic cancer (comprising 2.8 kb of genomic DNA) in plasma DNA (average 4.5 ng) using molecular barcodes. The average number of sequenced molecules was 900, and the sequencing depth per molecule was 100 or more. We also developed a bioinformatic variant filter, called CV78, to remove variants that were not considered to be tumor-specific, i.e., those that are either absent or occur at low frequencies in the Catalogue of Somatic Mutations in Cancer database. In a cohort comprising 57 pancreatic cancer patients and 12 healthy individuals, sequencing initially identified variants in 31 (54%) and 5 (42%), respectively, whereas after applying the CV78 filter, 19 (33%) and zero were variant-positive. In a validation cohort consisting of 86 patients with pancreatic cancer and 20 patients with intraductal papillary mucinous neoplasm (IPMN), 62 (72%) with pancreatic cancer patients and 10 (50%) IPMN patients were initially variant positive. After CV78 filtering, these values were reduced to 32 (37%) and 1 (5%), respectively. The variant allele frequency of filtered variants in plasma ranged from 0.25% to 76.1%. Therefore, combining NGS and molecular barcodes with subsequent filtering is likely to eliminate most non-tumor-specific mutations.	[Kukita, Yoji; Kato, Kikuya] Osaka Med Ctr Canc & Cardiovasc Dis, Res Inst, Dept Mol & Med Genet, Osaka, Japan; [Ohkawa, Kazuyoshi; Takada, Ryoji; Uehara, Hiroyuki; Katayama, Kazuhiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan; [Kukita, Yoji; Kato, Kikuya] Nara Inst Sci & Technol, Lab Med Genom, Nara, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases; Nara Institute of Science & Technology	Kato, K (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Res Inst, Dept Mol & Med Genet, Osaka, Japan.; Kato, K (corresponding author), Nara Inst Sci & Technol, Lab Med Genom, Nara, Japan.	kikuya@kato.nifty.jp		Kukita, Yoji/0000-0003-3523-2816; Takada, Ryoji/0000-0002-6568-8091; Kato, Kikuya/0000-0003-1863-6253	Japan Society of Promotion of Science [KAKENHI 16K07157]; JSPS KAKENHI [16K07157]	Japan Society of Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by Japan Society of Promotion of Science (https://www.jsps.go.jp/english/index.html): grant number, KAKENHI 16K07157; recipient, YK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Imamura for helpful discussions. This work was partly supported by JSPS KAKENHI (Grant Number 16K07157).	Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Chen LX, 2017, SCIENCE, V355, P752, DOI 10.1126/science.aai8690; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi SH, 2017, CLIN GASTROENTEROL H, V15, P1509, DOI 10.1016/j.cgh.2017.03.020; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hadano N, 2016, BRIT J CANCER, V115, P59, DOI 10.1038/bjc.2016.175; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krimmel JD, 2016, P NATL ACAD SCI USA, V113, P6005, DOI 10.1073/pnas.1601311113; Kukita Y, 2015, DNA RES, V22, P269, DOI 10.1093/dnares/dsv010; Kukita Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081468; Le Calvez-Kelm F, 2016, ONCOTARGET, V7, P78827, DOI 10.18632/oncotarget.12386; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Takai E, 2015, SCI REP-UK, V5, DOI 10.1038/srep18425; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Xu C, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3425-4	23	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192611	10.1371/journal.pone.0192611	http://dx.doi.org/10.1371/journal.pone.0192611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451897	Green Submitted, gold, Green Published			2022-12-26	WOS:000425369800019
J	Van Bael, S; Watteyne, J; Boonen, K; De Haes, W; Menschaert, G; Ringstad, N; Horvitz, HR; Schoofs, L; Husson, SJ; Temmerman, L				Van Bael, Sven; Watteyne, Jan; Boonen, Kurt; De Haes, Wouter; Menschaert, Gerben; Ringstad, Niels; Horvitz, H. Robert; Schoofs, Liliane; Husson, Steven J.; Temmerman, Liesbet			Mass spectrometric evidence for neuropeptide-amidating enzymes in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXYLATING MONOOXYGENASE; BIOACTIVE PEPTIDES; CONVERTASE-2; PITUITARY; BEHAVIOR; PROTEIN; PROFILE; LACKING; CLONING; DOMAIN	Neuropeptides constitute a vast and functionally diverse family of neurochemical signaling molecules and are widely involved in the regulation of various physiological processes. The nematode Caenorhabditis elegans is well-suited for the study of neuropeptide biochemistry and function, as neuropeptide biosynthesis enzymes are not essential for C. elegans viability. This permits the study of neuropeptide biosynthesis in mutants lacking certain neuropeptide-processing enzymes. Mass spectrometry has been used to study the effects of proprotein convertase and carboxypeptidase mutations on proteolytic processing of neuropeptide precursors and on the peptidome in C. elegans. However, the enzymes required for the last step in the production of many bioactive peptides, the carboxyl-terminal amidation reaction, have not been characterized in this manner. Here, we describe three genes that encode homologs of neuropeptide amidation enzymes in C. elegans and used tandem LC-MS to compare neuropeptides in WT animals with those in newly generated mutants for these putative amidation enzymes. We report that mutants lacking both a functional peptidylglycine alpha-hydroxylating monooxygenase and a peptidylglycine alpha-amidating monooxygenase had a severely altered neuropeptide profile and also a decreased number of offspring. Interestingly, single mutants of the amidation enzymes still expressed some fully processed amidated neuropeptides, indicating the existence of a redundant amidation mechanism in C. elegans. All MS data are available via ProteomeXchange with the identifier PXD008942. In summary, the key steps in neuropeptide processing in C. elegans seem to be executed by redundant enzymes, and loss of these enzymes severely affects brood size, supporting the need of amidated peptides for C. elegans reproduction.	[Van Bael, Sven; Watteyne, Jan; Boonen, Kurt; De Haes, Wouter; Schoofs, Liliane; Temmerman, Liesbet] Univ Leuven, KU Leuven, Dept Biol, Naamsestr 59, B-3000 Leuven, Belgium; [Menschaert, Gerben] Univ Ghent, Dept Math Modelling, Lab Bioinformat & Computat Genom BioBix, B-9000 Ghent, Belgium; [Ringstad, Niels] NYU, Langone Med Ctr, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Dept Cell Biol, New York, NY 10016 USA; [Horvitz, H. Robert] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Husson, Steven J.] Univ Antwerp, Dept Biol, SPHERE Syst Physiol & Ecotoxicol Res, Groenenborgerlaan 171, B-2020 Antwerp, Belgium; [Van Bael, Sven] Agcy Innovat Sci & Technol Flanders IWT, Brussels, Belgium	KU Leuven; Ghent University; New York University; NYU Langone Medical Center; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Antwerp	Van Bael, S; Temmerman, L (corresponding author), Univ Leuven, KU Leuven, Mol & Funct Neurobiol, Naamsestr 59 Box 2465, B-3000 Leuven, Belgium.	sven.vanbael@kuleuven.be; liesbet.temmerman@kuleuven.be	schoofs, liliane/ABD-2943-2020; Schoofs, Liliane/F-2815-2010	Temmerman, Liesbet/0000-0002-1249-3995; Boonen, Kurt/0000-0002-6252-7065; Schoofs, Liliane/0000-0002-1673-432X	KU Leuven Grant [C14/15/049]; FWO Grants [1511512N, G069713N, G052217N]; Belspo Grant [IAP-P7/44]; European Research Council (ERC) Advanced Grant [ERC-2013-ADG-340318]; H Grant [633589]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024663] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	KU Leuven Grant; FWO Grants(FWO); Belspo Grant; European Research Council (ERC) Advanced Grant(European Research Council (ERC)); H Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by KU Leuven Grant C14/15/049, FWO Grants 1511512N, G069713N, and G052217N, and Belspo Grant IAP-P7/44. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Fellows of the Fund for Scientific Research Flanders (FWO Flanders).; Recipient of European Research Council (ERC) Advanced Grant ERC-2013-ADG-340318.; Recipients of H2020 Grant 633589.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; [Anonymous], 2021, LANG ENV STAT COMP; Asada A, 2005, FEBS J, V272, P942, DOI 10.1111/j.1742-4658.2004.04528.x; Atkinson LE, 2010, MOL BIOCHEM PARASIT, V173, P97, DOI 10.1016/j.molbiopara.2010.05.009; Attenborough RMF, 2012, MOL BIOL EVOL, V29, P3095, DOI 10.1093/molbev/mss114; Beets I, 2012, SCIENCE, V338, P543, DOI 10.1126/science.1226860; Chang YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135164; Che FY, 2001, P NATL ACAD SCI USA, V98, P9971, DOI 10.1073/pnas.161542198; Chufan EE, 2009, STRUCTURE, V17, P965, DOI 10.1016/j.str.2009.05.008; Churgin MA, 2017, J NEUROSCI, V37, P7811, DOI [10.1523/JNEUROSCI.2636-16.2017, 10.1523/jneurosci.2636-16.2017]; Czyzyk TA, 2005, DEV BIOL, V287, P301, DOI 10.1016/j.ydbio.2005.09.001; De Haes W, 2015, BBA-PROTEINS PROTEOM, V1854, P812, DOI 10.1016/j.bbapap.2014.12.011; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; EIPPER BA, 1993, PROTEIN SCI, V2, P489; Fan XM, 2000, MOL BRAIN RES, V82, P25, DOI 10.1016/S0169-328X(00)00173-X; Frooninckx Lotte, 2012, Front Endocrinol (Lausanne), V3, P167, DOI 10.3389/fendo.2012.00167; Han M, 2004, J NEUROCHEM, V90, P129, DOI 10.1111/j.1471-4159.2004.02464.x; Hardiman A, 2005, J MOL ENDOCRINOL, V34, P739, DOI 10.1677/jme.1.01812; Hauser F, 1997, BIOCHEM BIOPH RES CO, V241, P509, DOI 10.1006/bbrc.1997.7854; Hobert O., 2013, WORMBOOK 2013; Husson SJ, 2005, BIOCHEM BIOPH RES CO, V335, P76, DOI 10.1016/j.bbrc.2005.07.044; Husson SJ, 2014, EUPA OPEN PROTEOMICS, V3, P280, DOI [10.1016/j.euprot.2014.04.005, DOI 10.1016/J.EUPROT.2014.04.005]; Husson SJ, 2007, FEBS LETT, V581, P4288, DOI 10.1016/j.febslet.2007.08.003; Husson SJ, 2007, J NEUROCHEM, V102, P246, DOI 10.1111/j.1471-4159.2007.04474.x; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Husson SJ, 2010, METHODS MOL BIOL, V615, P29, DOI 10.1007/978-1-60761-535-4_3; Jacob TC, 2003, J NEUROSCI, V23, P2122; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Kolhekar AS, 1997, J NEUROSCI, V17, P1363, DOI 10.1523/jneurosci.17-04-01363.1997; Kumar D, 2016, J MOL ENDOCRINOL, V56, pT63, DOI 10.1530/JME-15-0266; Li C, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00150; Li C, 2010, ADV EXP MED BIOL, V692, P98; Lindemans M, 2009, P NATL ACAD SCI USA, V106, P1642, DOI 10.1073/pnas.0809881106; Mair GR, 2004, FASEB J, V18, P114, DOI 10.1096/fj.03-0429com; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MERKLER DJ, 1994, ENZYME MICROB TECH, V16, P450, DOI 10.1016/0141-0229(94)90014-0; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Pan H, 2006, J NEUROCHEM, V98, P1763, DOI 10.1111/j.1471-4159.2006.04067.x; Peymen K, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00090; Prigge ST, 1997, SCIENCE, V278, P1300, DOI 10.1126/science.278.5341.1300; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Schoofs L, 2017, ANNU REV ENTOMOL, V62, P35, DOI 10.1146/annurev-ento-031616-035500; SONG LX, 1995, J BIOL CHEM, V270, P25007, DOI 10.1074/jbc.270.42.25007; Spijker S, 1999, FASEB J, V13, P735, DOI 10.1096/fasebj.13.6.735; TRENT C, 1983, GENETICS, V104, P619; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Waggoner LF, 2000, GENETICS, V154, P1181	49	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6052	6063		10.1074/jbc.RA117.000731	http://dx.doi.org/10.1074/jbc.RA117.000731			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29487130	Green Published, hybrid			2022-12-26	WOS:000430497300024
J	Chen, Y; Bensing, BA; Seepersaud, R; Mi, W; Liao, MF; Jeffrey, PD; Shajahan, A; Sonon, RN; Azadi, P; Sullam, PM; Rapoport, TA				Chen, Yu; Bensing, Barbara A.; Seepersaud, Ravin; Mi, Wei; Liao, Maofu; Jeffrey, Philip D.; Shajahan, Asif; Sonon, Roberto N.; Azadi, Parastoo; Sullam, Paul M.; Rapoport, Tom A.			Unraveling the sequence of cytosolic reactions in the export of GspB adhesin from Streptococcus gordonii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; glycosylation; adhesin; crystallography; protein export; protein secretion; glycosyltransferase	CARBOHYDRATE-BINDING MODULES; ACCESSORY SEC SYSTEM; SWISS-MODEL; PROTEIN-TRANSLOCATION; CONSERVED DOMAIN; O-GLYCOSYLATION; BIOGENESIS; COMPLEX; SUBSTRATE; FAMILY	Many pathogenic bacteria, including Streptococcus gordonii, possess a pathway for the cellular export of a single serine-rich-repeat protein that mediates the adhesion of bacteria to host cells and the extracellular matrix. This adhesin protein is O-glycosylated by several cytosolic glycosyltransferases and requires three accessory Sec proteins (Asp1-3) for export, but how the adhesin protein is processed for export is not well understood. Here, we report that the S. gordonii adhesin GspB is sequentially O-glycosylated by three enzymes (GtfA/B, Nss, and Gly) that attach N-acetylglucosamine and glucose to Ser/Thr residues. We also found that modified GspB is transferred from the last glycosyltransferase to the Asp1/2/3 complex. Crystal structures revealed that both Asp1 and Asp3 are related to carbohydrate-binding proteins, suggesting that they interact with carbohydrates and bind glycosylated adhesin, a notion that was supported by further analyses. We further observed that Asp1 also has an affinity for phospholipids, which is attenuated by Asp2. In summary, our findings support a model in which the GspB adhesin is sequentially glycosylated by GtfA/B, Nss, and Gly and then transferred to the Asp1/2/3 complex in which Asp1 mediates the interaction of the Asp1/2/3 complex with the lipid bilayer for targeting of matured GspB to the export machinery.	[Chen, Yu; Mi, Wei; Liao, Maofu; Rapoport, Tom A.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Bensing, Barbara A.; Seepersaud, Ravin; Sullam, Paul M.] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA; [Jeffrey, Philip D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Shajahan, Asif; Sonon, Roberto N.; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Rapoport, Tom A.] Harvard Med Sch, Dept Cell Biol, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Princeton University; University System of Georgia; University of Georgia; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Rapoport, TA (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Rapoport, TA (corresponding author), Harvard Med Sch, Dept Cell Biol, Howard Hughes Med Inst, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu	Liao, Maofu/AAD-7333-2021; Shajahan, Asif/J-2941-2019	Liao, Maofu/0000-0002-3481-450X; Shajahan, Asif/0000-0002-4804-1130; Jeffrey, Philip/0000-0002-4351-5341	National Institutes of Health from NIGMS [P41 GM103403]; National Institutes of Health ORIP HEI [S10 RR029205]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586, P41GM103490, P20GM103542, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health ORIP HEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source of the Northeastern Collaborative Access Team (NE-CAT) beamline for help with data collection. NE-CAT is supported by National Institutes of Health Grant P41 GM103403 from NIGMS. The Pilatus 6Mdetector on 24-ID-C beam line is funded by National Institutes of Health ORIP HEI Grant S10 RR029205. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bensing BA, 2014, BBA-MOL CELL RES, V1843, P1674, DOI 10.1016/j.bbamcr.2013.10.019; Bensing BA, 2010, J BACTERIOL, V192, P4223, DOI 10.1128/JB.00373-10; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Booth DS, 2011, JOVE-J VIS EXP, DOI 10.3791/3227; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bu S, 2008, J BACTERIOL, V190, P1256, DOI 10.1128/JB.01078-07; Chen Y, 2016, P NATL ACAD SCI USA, V113, pE1190, DOI 10.1073/pnas.1600494113; Echlin H, 2013, J BACTERIOL, V195, P2166, DOI 10.1128/JB.02255-12; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feltcher ME, 2012, NAT REV MICROBIOL, V10, P779, DOI 10.1038/nrmicro2874; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Iwashkiw JA, 2013, MOL MICROBIOL, V89, P14, DOI 10.1111/mmi.12265; Jiang YL, 2017, J BIOL CHEM, V292, P6213, DOI 10.1074/jbc.M116.770446; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Lee IC, 2014, J BACTERIOL, V196, P1671, DOI 10.1128/JB.01401-13; Li YR, 2014, CURR MICROBIOL, V69, P121, DOI 10.1007/s00284-014-0563-2; Li YR, 2008, MOL MICROBIOL, V70, P1094, DOI 10.1111/j.1365-2958.2008.06456.x; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nagae M, 2014, INT J MOL SCI, V15, P3768, DOI 10.3390/ijms15033768; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Rosch JW, 2007, J BACTERIOL, V189, P801, DOI 10.1128/JB.01549-06; Ru H, 2015, CELL, V163, P1138, DOI 10.1016/j.cell.2015.10.055; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Seepersaud R, 2010, MOL MICROBIOL, V78, P490, DOI 10.1111/j.1365-2958.2010.07346.x; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Takamatsu D, 2004, MOL MICROBIOL, V52, P189, DOI 10.1111/j.1365-2958.2004.03978.x; TROMBE MC, 1979, BIOCHIM BIOPHYS ACTA, V574, P290, DOI 10.1016/0005-2760(79)90010-9; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wu R, 2010, APPL ENVIRON MICROB, V76, P7966, DOI 10.1128/AEM.01434-10; Yen YT, 2013, J BACTERIOL, V195, P682, DOI 10.1128/JB.01742-12; Yen YT, 2011, J BACTERIOL, V193, P3165, DOI 10.1128/JB.00057-11; Zhang H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5339; Zhou MX, 2008, INFECT IMMUN, V76, P5624, DOI 10.1128/IAI.00534-08; Zhou MX, 2012, MOL MICROBIOL, V83, P866, DOI 10.1111/j.1365-2958.2012.07970.x; Zhou MX, 2011, J BACTERIOL, V193, P6560, DOI 10.1128/JB.05668-11; Zhou MX, 2010, J BIOL CHEM, V285, P12140, DOI 10.1074/jbc.M109.066928; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0; Zhu F, 2016, J BIOL CHEM, V291, P27354, DOI 10.1074/jbc.M116.752998; Zhu F, 2015, J BACTERIOL, V197, P510, DOI 10.1128/JB.02267-14; Zhu F, 2011, J BIOL CHEM, V286, P27048, DOI 10.1074/jbc.M110.208629; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmer J, 2009, J MOL BIOL, V394, P606, DOI 10.1016/j.jmb.2009.10.024	55	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5360	5373		10.1074/jbc.RA117.000963	http://dx.doi.org/10.1074/jbc.RA117.000963			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29462788	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000429409300038
J	Stakaityte, G; Nwogu, N; Lippiat, JD; Blair, GE; Poterlowicz, K; Boyne, JR; Macdonald, A; Mankouri, J; Whitehouse, A				Stakaityte, Gabriele; Nwogu, Nnenna; Lippiat, Jonathan D.; Blair, G. Eric; Poterlowicz, Krzysztof; Boyne, James R.; Macdonald, Andrew; Mankouri, Jamel; Whitehouse, Adrian			The cellular chloride channels CLIC1 and CLIC4 contribute to virus-mediated cell motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL T-ANTIGEN; CARCINOMA CELLS; POLYOMAVIRUS; CANCER; EXPRESSION; MIGRATION; INVASION; PATHWAY; TARGETS; PROTEIN	Ion channels regulate many aspects of cell physiology, including cell proliferation, motility, and migration, and aberrant expression and activity of ion channels is associated with various stages of tumor development, with K+ and Cl- channels now being considered the most active during tumorigenesis. Accordingly, emerging in vitro and preclinical studies have revealed that pharmacological manipulation of ion channel activity offers protection against several cancers. Merkel cell polyomavirus (MCPyV) is a major cause of Merkel cell carcinoma (MCC), primarily because of the expression of two early regulatory proteins termed small and large tumor antigens (ST and LT, respectively). Several molecular mechanisms have been attributed to MCPyV-mediated cancer formation but, thus far, no studies have investigated any potential link to cellular ion channels. Here we demonstrate that Cl- channel modulation can reduce MCPyV ST-induced cell motility and invasiveness. Proteomic analysis revealed that MCPyV ST up-regulates two Cl- channels, CLIC1 and CLIC4, which when silenced, inhibit MCPyV ST-induced motility and invasiveness, implicating their function as critical to MCPyV-induced metastatic processes. Consistent with these data, we confirmed that CLIC1 and CLIC4 are up-regulated in primary MCPyV-positive MCC patient samples. We therefore, for the first time, implicate cellular ion channels as a key host cell factor contributing to virus-mediated cellular transformation. Given the intense interest in ion channel modulating drugs for human disease. This highlights CLIC1 and CLIC4 activity as potential targets for MCPyV-induced MCC.	[Stakaityte, Gabriele; Nwogu, Nnenna; Blair, G. Eric; Macdonald, Andrew; Mankouri, Jamel; Whitehouse, Adrian] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Stakaityte, Gabriele; Nwogu, Nnenna; Macdonald, Andrew; Mankouri, Jamel; Whitehouse, Adrian] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Lippiat, Jonathan D.] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; [Poterlowicz, Krzysztof; Boyne, James R.] Univ Bradford, Fac Life Sci, Sch Chem & Biosci, Ctr Skin Sci, Bradford BD7 1DP, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; University of Bradford	Mankouri, J; Whitehouse, A (corresponding author), Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.; Mankouri, J; Whitehouse, A (corresponding author), Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	j.mankouri@leeds.ac.uk; a.whitehouse@leeds.ac.uk	Boyne, James/AAU-6616-2021; Poterlowicz, Krzysztof/AAS-2395-2020; Blair, George Eric/A-5906-2008	Boyne, James/0000-0003-1219-6453; Poterlowicz, Krzysztof/0000-0001-6173-5674; Blair, George Eric/0000-0003-0440-1795; Mankouri, Jamel/0000-0002-4325-3687; `Nwogu, Nnenna/0000-0002-1075-2914; Whitehouse, Adrian/0000-0003-3866-7110; Lippiat, Jonathan/0000-0003-3748-7345	BBSRC DTP Studentship [BB/J014443/1]; Royal Society University Research Fellowship [UF100419]; Kidney Research UK [RP_022_20170302, ST_006_20151127] Funding Source: researchfish	BBSRC DTP Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society University Research Fellowship(Royal Society of London); Kidney Research UK(Kidney Research UK (KRUK))	The work was funded in part by BBSRC DTP Studentship BB/J014443/1 and Royal Society University Research Fellowship UF100419 (to J.M.). The authors declare no conflicts of interest with the contents of this article.	Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Baquero-Perez B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005274; Becker J, 2009, CELL MOL LIFE SCI, V66, P1, DOI 10.1007/s00018-008-8483-6; Berrios C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006020; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fernandez-Salas E, 1999, J BIOL CHEM, V274, P36488, DOI 10.1074/jbc.274.51.36488; Griffiths DA, 2013, J VIROL, V87, P13853, DOI 10.1128/JVI.02159-13; Harms PW, 2013, J INVEST DERMATOL, V133, P936, DOI 10.1038/jid.2012.445; Hodgson NC, 2005, J SURG ONCOL, V89, P1, DOI 10.1002/jso.20167; Houben R, 2013, J INVEST DERMATOL, V133, P2453, DOI 10.1038/jid.2013.169; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Hover S, 2017, J GEN VIROL, V98, P345, DOI 10.1099/jgv.0.000712; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hughes DJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004771; Igloi Z, 2015, J VIROL, V89, P4023, DOI 10.1128/JVI.02946-14; Jackson BR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004098; Jiang L, 2014, BBA-BIOMEMBRANES, V1838, P643, DOI 10.1016/j.bbamem.2013.05.025; Knight LM, 2015, J VIROL, V89, P35, DOI 10.1128/JVI.02317-14; Knips J, 2017, INT J CANCER, V141, P160, DOI 10.1002/ijc.30723; Kwun HJ, 2013, CELL HOST MICROBE, V14, P125, DOI 10.1016/j.chom.2013.06.008; Lang F, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0108; Li XH, 2002, ANNU REV PHYSIOL, V64, P609, DOI 10.1146/annurev.physiol.64.090501.145429; Malik M, 2012, P NATL ACAD SCI USA, V109, P6130, DOI 10.1073/pnas.1201351109; Mao JW, 2013, J CELL PHYSIOL, V228, P991, DOI 10.1002/jcp.24245; McLaughlin-Drubin ME, 2008, BBA-MOL BASIS DIS, V1782, P127, DOI 10.1016/j.bbadis.2007.12.005; Moens U, 2015, VIRUSES-BASEL, V7, P1871, DOI 10.3390/v7041871; Peretti M, 2015, BBA-BIOMEMBRANES, V1848, P2523, DOI 10.1016/j.bbamem.2014.12.012; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Royle J, 2015, VIRUSES-BASEL, V7, P5375, DOI 10.3390/v7102880; Schumann S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.201; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Smith PG, 2001, GENE THER, V8, P1762, DOI 10.1038/sj.gt.3301595; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Stakaityte G, 2018, J VIROL, V92, DOI 10.1128/JVI.00940-17; Stakaityte G, 2014, CANCERS, V6, P1267, DOI 10.3390/cancers6031267; Starrett GJ, 2017, MBIO, V8, DOI 10.1128/mBio.02079-16; Wang P, 2014, WORLD J GASTROENTERO, V20, P2071, DOI 10.3748/wjg.v20.i8.2071; Wheat R, 2014, CANCERS, V6, P1047, DOI 10.3390/cancers6021047; Yao Q, 2009, ONCOL REP, V22, P541, DOI 10.3892/or_00000469; Zhao W, 2015, MOL MED REP, V12, P8041, DOI 10.3892/mmr.2015.4459; Zheng DL, 2012, J CELL BIOCHEM, V113, P1537, DOI 10.1002/jcb.24022	41	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4582	4590		10.1074/jbc.RA117.001343	http://dx.doi.org/10.1074/jbc.RA117.001343			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29462791	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000428204300034
J	Colombo, C; Podlipnik, C; Lo Presti, L; Niikura, M; Bennet, AJ; Bernardi, A				Colombo, Cinzia; Podlipnik, Crtomir; Lo Presti, Leonardo; Niikura, Masahiro; Bennet, Andrew J.; Bernardi, Anna			Design and synthesis of constrained bicyclic molecules as candidate inhibitors of influenza A neuraminidase	PLOS ONE			English	Article							RECEPTOR AGONISTS; CYCLIC ENONES; DRUG DESIGN; IN-VITRO; OSELTAMIVIR; VIRUS; POTENT; ACID; RESISTANCE; ZANAMIVIR	The rise of drug-resistant influenza A virus strains motivates the development of new antiviral drugs, with different structural motifs and substitution. Recently, we explored the use of a bicyclic (bicyclo[3.1.0] hexane) analogue of sialic acid that was designed to mimic the conformation adopted during enzymatic cleavage within the neuraminidase (NA; sialidase) active site. Given that our first series of compounds were at least four orders of magnitude less active than available drugs, we hypothesized that the new carbon skeleton did not elicit the same interactions as the cyclohexene frameworks used previously. Herein, we tried to address this critical point with the aid of molecular modeling and we proposed new structures with different functionalization, such as the introduction of free ammonium and guanidinium groups and ether side chains other than the 3-pentyl side chain, the characteristic side chain in Oseltamivir. A highly simplified synthetic route was developed, starting from the cyclopropanation of cyclopentenone and followed by an aziridination and further functionalization of the five-member ring. This allowed the efficient preparation of a small library of new bicyclic ligands that were characterized by enzyme inhibition assays against influenza A neuraminidases N1, its H274Y mutant, and N2. The results show that none of the new structural variants synthesized, including those containing guanidinium groups rather than free ammonium ions, displayed activity against influenza A neuraminidases at concentrations less than 2 mM. We conclude that the choice and positioning of functional groups on the bicyclo[3.1.0] hexyl system still need to be properly tuned for producing complementary interactions within the catalytic site.	[Colombo, Cinzia; Lo Presti, Leonardo; Bernardi, Anna] Univ Milan, Dipartimento Chim, Milan, Italy; [Colombo, Cinzia; Bennet, Andrew J.] Simon Fraser Univ, Dept Chem, Burnaby, BC, Canada; [Podlipnik, Crtomir] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Niikura, Masahiro] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada	University of Milan; Simon Fraser University; University of Ljubljana; Simon Fraser University	Colombo, C (corresponding author), Univ Milan, Dipartimento Chim, Milan, Italy.; Colombo, C (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC, Canada.	cinzia.colombo@unimi.it	Bernardi, Anna/A-1167-2012; Lo Presti, Leonardo/K-4281-2012; Podlipnik, Crtomir/R-6467-2019; Colombo, Cinzia/I-9376-2016	Bernardi, Anna/0000-0002-1258-2007; Lo Presti, Leonardo/0000-0001-6361-477X; Podlipnik, Crtomir/0000-0002-8429-0273	People Programme of the European Union's Seventh Framework Programme by a Marie Curie Outgoing Fellowship under REA grant [PIOF-GA-2012-327579]; Slovenian Research Agency [P1-0201]	People Programme of the European Union's Seventh Framework Programme by a Marie Curie Outgoing Fellowship under REA grant; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The research leading to these results received funding from the People Programme of the European Union's Seventh Framework Programme by a Marie Curie Outgoing Fellowship to Dr. Cinzia Colombo under REA grant agreement PIOF-GA-2012-327579. Dr. Crtomir Podlipnik acknowledges for support of Slovenian Research Agency via research program P1-0201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, OECHEM TK 2 1 1; [Anonymous], 2016, SCHROD REL 2016 2 SC; [Anonymous], 2014, XPREP; [Anonymous], 2012, **NON-TRADITIONAL**; Babu YS, 2000, J MED CHEM, V43, P3482, DOI 10.1021/jm0002679; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; BOCHE G, 1994, ANGEW CHEM INT EDIT, V33, P115, DOI 10.1002/anie.199401151; Bruker AXS Inc, 2014, SADABS; Chan J, 2012, J AM CHEM SOC, V134, P3748, DOI 10.1021/ja208564y; Chan J, 2011, J AM CHEM SOC, V133, P2989, DOI 10.1021/ja109199p; Chan J, 2010, NAT CHEM BIOL, V6, P405, DOI 10.1038/nchembio.352; Colombo C, 2017, ADV PHYS ORG CHEM, V51, P99, DOI 10.1016/bs.apoc.2017.09.001; De Vincentiis F, 2010, CHEM-ASIAN J, V5, P1652, DOI 10.1002/asia.201000040; Dominguez C, 1997, TETRAHEDRON-ASYMMETR, V8, P511, DOI 10.1016/S0957-4166(97)00001-3; Farren-Dai M, 2017, J ORGANIC CHEM; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gonzalez R, 2005, BIOORGAN MED CHEM, V13, P6556, DOI 10.1016/j.bmc.2005.07.036; Gubareva LV, 2001, ANTIMICROB AGENTS CH, V45, P3403, DOI 10.1128/AAC.45.12.3403-3408.2001; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Menjo Y, 2011, ORG LETT, V13, P5744, DOI 10.1021/ol2023054; Miriyala B, 2004, TETRAHEDRON, V60, P1463, DOI 10.1016/j.tet.2003.12.024; Mohan S, 2010, J MED CHEM, V53, P7377, DOI 10.1021/jm100822f; Mooney CA, 2014, J MED CHEM, V57, P3154, DOI 10.1021/jm401977j; Nakazato A, 2000, J MED CHEM, V43, P4893, DOI 10.1021/jm000346k; Niikura M, 2011, ANTIVIR RES, V90, P160, DOI 10.1016/j.antiviral.2011.03.180; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Raab M, 2011, J MOL MODEL, V17, P1445, DOI 10.1007/s00894-010-0852-z; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wang MZ, 2002, ANTIMICROB AGENTS CH, V46, P3809, DOI 10.1128/AAC.46.12.3809-3816.2002; Wu Y, 2016, J VIROL, V90, P10693, DOI 10.1128/JVI.01703-16; Yang J, 2016, REV MED VIROL, V26, P242, DOI 10.1002/rmv.1879; Yen HL, 2006, J VIROL, V80, P8787, DOI 10.1128/JVI.00477-06; Yeung YY, 2006, J AM CHEM SOC, V128, P6310, DOI 10.1021/ja0616433; Yong YF, 1997, J ORG CHEM, V62, P1540, DOI 10.1021/jo962196k; Zanin M, 2016, CELL HOST MICROBE, V19, P159, DOI 10.1016/j.chom.2016.01.001	42	6	6	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193623	10.1371/journal.pone.0193623	http://dx.doi.org/10.1371/journal.pone.0193623			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489903	gold, Green Published, Green Submitted			2022-12-26	WOS:000426276000097
J	Eshoo, PF; Johnson, A; Duangdala, S; Hansel, T				Eshoo, Paul Frederick; Johnson, Arlyne; Duangdala, Sivilay; Hansel, Troy			Design, monitoring and evaluation of a direct payments approach for an ecotourism strategy to reduce illegal hunting and trade of wildlife in Lao PDR	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; COMMUNITY; POPULATIONS; BENEFITS	Ecotourism as a strategy for achieving biodiversity conservation often results in limited conservation impact relative to its investment and revenue return. In cases where an ecotourism strategy has been used, projects are frequently criticized for not providing sufficient evidence on how the strategy has reduced threats or improved the status of the biodiversity it purports to protect. In Lao PDR, revenue from ecotourism has not been directly linked to or dependent on improvements in biodiversity and there is no evidence that ecotourism enterprises have contributed to conservation. In other developing countries, direct payments through explicit contracts in return for ecosystem services have been proposed as a more cost-effective means for achieving conservation, although further research is needed to evaluate the impact of this approach. To address this need, a new model was tested in the Nam Et-Phou Louey National Protected Area (NPA) in Lao PDR using a direct payments approach to create ecotourism incentives for villagers to increase wildlife populations. Over a four-year period, we monitored along a theory of change to evaluate assumptions about the linkages between intermediate results and biological outcomes. Preliminary results show a negative correlation between ecotourism benefits and hunting infractions in target villages; no increase in hunting sign in the ecotourism sector of the NPA relative to a threefold increase in hunting sign across the NPA's non-tourism sectors; and an overall increase in wildlife sightings. This case provides key lessons on the design of a direct payments approach for an ecotourism strategy, including how to combine threat monitoring and data on wildlife sightings to evaluate strategy effectiveness, on setting rates for wildlife sightings and village fees, and the utility of the approach for protecting very rare species.	[Eshoo, Paul Frederick; Johnson, Arlyne; Duangdala, Sivilay; Hansel, Troy] Wildlife Conservat Soc Lao PDR, Vientiane Lao Pdr, Laos; [Johnson, Arlyne] Fdn Success, Bethesda, MD USA		Eshoo, PF (corresponding author), Wildlife Conservat Soc Lao PDR, Vientiane Lao Pdr, Laos.	pauleshoo@gmail.com	Johnson, Arlyne/AAJ-5005-2021		US Fish and Wildlife Service, Rhino and Tiger Fund [9-G031 (RT-0883)]	US Fish and Wildlife Service, Rhino and Tiger Fund	Funded by US Fish and Wildlife Service, Rhino and Tiger Fund, Grant Agreement No. 9-G031 (RT-0883). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2006, POVERTY DEV BIODIVER, P647; [Anonymous], 2012, S A P I E N S; Baral AN, 2013, THESIS; Berkes F, 2007, P NATL ACAD SCI USA, V104, P15188, DOI 10.1073/pnas.0702098104; Bhula R., 2009, BUSINESS PLAN ECOTOU; Biggs D, 2017, CONSERV BIOL, V31, P5, DOI 10.1111/cobi.12796; Brown Jeff, 2009, Gibbon Journal, V5, P28; Clements T, 2010, ECOL ECON, V69, P1283, DOI 10.1016/j.ecolecon.2009.11.010; Ducourtieux O, 2005, DEV CHANGE, V36, P499, DOI 10.1111/j.0012-155X.2005.00421.x; Epprecht M, 2008, GEOGRAPHICA BERNEN G; Ferraro PJ, 2002, LAND ECON, V78, P339, DOI 10.2307/3146894; Ferraro PJ, 2002, SCIENCE, V298, P1718, DOI 10.1126/science.1078104; Gray TNE, 2017, SCIENCE, V355, P255, DOI 10.1126/science.aal4463; Harrison D., 2007, CURRENT ISSUES TOURI, V10, P194, DOI DOI 10.2167/CIT310.0; Higginbottom K., 2004, WILDLIFE TOURISM IMP; Higginbottom K, 2001, POSITIVE EFFECTS WIL; Johannesen AB, 2005, RESOUR ENERGY ECON, V27, P208, DOI 10.1016/j.reseneeco.2004.10.001; Johnson A, 2006, ANIM CONSERV, V9, P421, DOI 10.1111/j.1469-1795.2006.00049.x; Johnson A., 2012, EVIDENCE BASED CONSE, P73; Johnson A, 2016, BIOL CONSERV, V202, P99, DOI 10.1016/j.biocon.2016.08.018; Keane A, 2011, J APPL ECOL, V48, P1164, DOI 10.1111/j.1365-2664.2011.02034.x; Kill A, 2015, THESIS; Kiss A, 2004, TRENDS ECOL EVOL, V19, P232, DOI 10.1016/j.tree.2004.03.010; Larsen M., 2010, EC ASSESSMENT FUTURE; Lim JE, 2017, THESIS; Lynam AJ, 2006, WILDLIFE PROTECTION; Margoluis R, 2013, ECOL SOC, V18, DOI 10.5751/ES-05610-180322; Milne S, 2009, ORYX, V43, P530, DOI 10.1017/S0030605309990330; Ministry of Economics and Finance and Ministry of Environment Cambodia, 2003, CAMB NAT REP PROT AR, P53; Molina Murillo S. A., 2014, INT J DEV SUSTAINABI, V6, P1287; Moorman RS, 2006, ENVIRON CONSERV, V33, P89, DOI 10.1017/S0376892906002955; Nicholls H, 2004, PLOS BIOL, V2, P1256, DOI 10.1371/journal.pbio.0020310; Niesten E, 2004, INT FOREST REV, V6, P56, DOI 10.1505/ifor.6.1.56.32065; Nooren H., 2001, WILDLIFE TRADE LAOS; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Parsler J., 1997, Tourism and sustainability: principles to practice., P347; Roe D, 2014, ENVIRON EVID, V3, DOI 10.1186/2047-2382-3-6; Salafsky N, 2001, CONSERV BIOL, V15, P1585, DOI 10.1046/j.1523-1739.2001.00220.x; Saypanya S., 2013, CONSERV EVID, V10, P29; Stem CJ, 2003, SOC NATUR RESOUR, V16, P387, DOI 10.1080/08941920309177; Stokes EJ, 2010, INTEGR ZOOL, V5, P363, DOI 10.1111/j.1749-4877.2010.00223.x; Stronza A., 2007, J ECOTOURISM, V6, P210, DOI [DOI 10.2167/JOE177.0, 10.2167/joe177.0]; Swart JAA, 2003, SCIENCE, V299, P1981; Wells M. P., 2004, GETTING BIODIVERSITY, P397	44	18	18	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0186133	10.1371/journal.pone.0186133	http://dx.doi.org/10.1371/journal.pone.0186133			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489821	gold, Green Submitted, Green Published			2022-12-26	WOS:000426276000002
J	Wakelin, S; Tillard, G; van Ham, R; Ballard, R; Farquharson, E; Gerard, E; Geurts, R; Brown, M; Ridgway, H; O'Callaghan, M				Wakelin, Steven; Tillard, Guylene; van Ham, Robert; Ballard, Ross; Farquharson, Elizabeth; Gerard, Emily; Geurts, Rene; Brown, Matthew; Ridgway, Hayley; O'Callaghan, Maureen			High spatial variation in population size and symbiotic performance of Rhizobium leguminosarum bv. trifolii with white clover in New Zealand pasture soils	PLOS ONE			English	Article							NITROGEN-FIXATION; RAINFALL; LEGUMES; CLIMATE	Biological nitrogen fixation through the legume-rhizobia symbiosis is important for sustainable pastoral production. In New Zealand, the most widespread and valuable symbiosis occurs between white clover (Trifolium repens L.) and Rhizobium leguminosarum bv. trifolii (Rlt). As variation in the population size (determined by most probable number assays; MPN) and effectiveness of N-fixation (symbiotic potential; SP) of Rlt in soils may affect white clover performance, the extent in variation in these properties was examined at three different spatial scales: (1) From 26 sites across New Zealand, (2) at farm-wide scale, and (3) within single fields. Overall, Rlt populations ranged from 95 to >1 x 10(8) per g soil, with variation similar at the three spatial scales assessed. For almost all samples, there was no relationship between rhizobia population size and ability of the population to fix N during legume symbiosis (SP). When compared with the commercial inoculant strain, the SP of soils ranged between 14 to 143% efficacy. The N-fixing ability of rhizobia populations varied more between samples collected from within a single hill country field (0.8 ha) than between 26 samples collected from diverse locations across New Zealand. Correlations between SP and calcium and aluminium content were found in all sites, except within a dairy farm field. Given the general lack of association between SP and MPN, and high spatial variability of SP at single field scale, provision of advice for treating legume seed with rhizobia based on field-average MPN counts needs to be carefully considered.	[Wakelin, Steven; Gerard, Emily; Brown, Matthew; O'Callaghan, Maureen] AgResearch Ltd, Lincoln Sci Ctr, Christchurch, New Zealand; [Tillard, Guylene] Inst Natl Super Sci Agron, Dijon, France; [van Ham, Robert; Geurts, Rene] Wageningen Univ, Lab Mol Biol, Wageningen, Netherlands; [Ballard, Ross; Farquharson, Elizabeth] South Australian Res & Dev Inst, Urrbrae, SA, Australia; [Ridgway, Hayley] Lincoln Univ, Fac Agr & Life Sci, Christchurch, New Zealand; [Wakelin, Steven] Scion Res Ltd, Christchurch, New Zealand; [Ridgway, Hayley] Plant & Food Res, Christchurch, New Zealand	AgResearch - New Zealand; Wageningen University & Research; South Australian Research & Development Institute (SARDI); Lincoln University - New Zealand; New Zealand Institute for Plant & Food Research Ltd	Wakelin, S (corresponding author), AgResearch Ltd, Lincoln Sci Ctr, Christchurch, New Zealand.; Wakelin, S (corresponding author), Scion Res Ltd, Christchurch, New Zealand.	Steve.A.Wakelin@scionresearch.com	Wakelin, Steve/C-3170-2011	Wakelin, Steve/0000-0002-1167-8699	P21 programme 'Legumes in challenging environments'; New Zealand Ministry of Business Innovation and Employment (MBIE); DairyNZ within the "Improving forage legume-rhizobia performance" programme [C10X1308]	P21 programme 'Legumes in challenging environments'; New Zealand Ministry of Business Innovation and Employment (MBIE)(New Zealand Ministry of Business, Innovation and Employment (MBIE)); DairyNZ within the "Improving forage legume-rhizobia performance" programme	Work at Whangara was supported by the P21 programme 'Legumes in challenging environments' (SW), and access to the farm was provided by the Whangara B5 group. The wider aspects of this programme are funded by the New Zealand Ministry of Business Innovation and Employment (MBIE) (SW) and DairyNZ within the "Improving forage legume-rhizobia performance" programme (C10X1308) (SW). None of the authors work for commercial enterprises; we are all either university or government funded staff or students.	Abberton M. T., 2006, Aspects of Applied Biology, P81; Annicchiarico P, 2015, CRIT REV PLANT SCI, V34, P327, DOI 10.1080/07352689.2014.898462; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bell NL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01946; Bragg JG, 2015, NEW PHYTOL, V207, P953, DOI 10.1111/nph.13410; BROCKWELL J, 1963, APPL MICROBIOL, V11, P377, DOI 10.1128/AEM.11.5.377-383.1963; Caradus JR, 1996, GRASSLAND RES PRACTI, V6, P1; CARROLL BJ, 1983, Z PFLANZENPHYSIOL, V110, P77, DOI 10.1016/S0044-328X(83)80218-9; Cichota R, 2008, NEW ZEAL J AGR RES, V51, P317, DOI 10.1080/00288230809510463; Deaker R, 2004, SOIL BIOL BIOCHEM, V36, P1275, DOI 10.1016/j.soilbio.2004.04.009; Delestre C, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0110-1; Drew EA, 2012, CROP PASTURE SCI, V63, P467, DOI 10.1071/CP12032; Drew EA, 2011, CROP PASTURE SCI, V62, P903, DOI 10.1071/CP11047; GAUR YD, 1980, NEW ZEAL J AGR RES, V23, P529; Gemell LG, 2005, AUST J EXP AGR, V45, P161, DOI 10.1071/EA03151; Graham P. H., 2008, V7, P23; Greenwood RM, 1965, P NZ GRASSLAND ASS, V26, P95; Hill RJ Laboratories, SOIL TESTS INT; HOGLUND JH, 1979, NEW ZEAL J EXP AGR, V7, P45, DOI 10.1080/03015521.1979.10426162; HURLEY MA, 1983, J APPL BACTERIOL, V55, P159, DOI 10.1111/j.1365-2672.1983.tb02660.x; Ledgard SF, 1999, J AGR SCI-CAMBRIDGE, V132, P215, DOI 10.1017/S002185969800625X; Lowther W. L., 2011, Proceedings of the New Zealand Grassland Association, V73, P93; Rhys G.J., 1981, NZ J EXP AGR, V9, P327; RONSON CW, 1995, GRASSLAND RES PRACTI, V6, P87; Scott R. S., 1977, Proceedings of the New Zealand Grassland Association, V38, P151; Sessitsch A, 2002, CRIT REV PLANT SCI, V21, P323, DOI 10.1080/0735-260291044278; Tait A, 2005, J APPL METEOROL, V44, P1315, DOI 10.1175/JAM2279.1; Tozer KN, 2013, PR N Z GRASSL ASSOC, V75, P215; Unkovich M., 2008, Measuring plant-associated nitrogen fixation in agricultural systems; van Ham R, 2016, APPL SOIL ECOL, V108, P371, DOI 10.1016/j.apsoil.2016.09.016; Wakelin SA, 2016, AUSTRALAS PLANT PATH, V45, P289, DOI 10.1007/s13313-016-0411-x; Wakelin SA, 2013, NEW ZEAL J AGR RES, V56, P248, DOI 10.1080/00288233.2013.822003; Williams W. M., 1987, White clover., P323; WILSON PW, 1947, BACTERIOL REV, V11, P41, DOI 10.1128/MMBR.11.1.41-73.1947; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999	35	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192607	10.1371/journal.pone.0192607	http://dx.doi.org/10.1371/journal.pone.0192607			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489845	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000035
J	Roux-Sibilon, A; Rutge, F; Aptel, F; Attye, A; Guyader, N; Boucart, M; Chiquet, C; Peyrin, C				Roux-Sibilon, Alexia; Rutge, Floriane; Aptel, Florent; Attye, Arnaud; Guyader, Nathalie; Boucart, Muriel; Chiquet, Christophe; Peyrin, Carole			Scene and human face recognition in the central vision of patients with glaucoma	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; EYE-MOVEMENTS; FIELD; PERCEPTION; ORGANIZATION; PERFORMANCE; CONTRAST; FEATURES; DENSITY; SEARCH	Primary open-angle glaucoma (POAG) firstly mainly affects peripheral vision. Current behavioral studies support the idea that visual defects of patients with POAG extend into parts of the central visual field classified as normal by static automated perimetry analysis. This is particularly true for visual tasks involving processes of a higher level than mere detection. The purpose of this study was to assess visual abilities of POAG patients in central vision. Patients were assigned to two groups following a visual field examination (Humphrey 24-2 SITA-Standard test). Patients with both peripheral and central defects and patients with peripheral but no central defect, as well as age-matched controls, participated in the experiment. All participants had to perform two visual tasks where low-contrast stimuli were presented in the central 6 of the visual field. A categorization task of scene images and human face images assessed high-level visual recognition abilities. In contrast, a detection task using the same stimuli assessed low-level visual function. The difference in performance between detection and categorization revealed the cost of high-level visual processing. Compared to controls, patients with a central visual defect showed a deficit in both detection and categorization of all low-contrast images. This is consistent with the abnormal retinal sensitivity as assessed by perimetry. However, the deficit was greater for categorization than detection. Patients without a central defect showed similar performances to the controls concerning the detection and categorization of faces. However, while the detection of scene images was well-maintained, these patients showed a deficit in their categorization. This suggests that the simple loss of peripheral vision could be detrimental to scene recognition, even when the information is displayed in central vision. This study revealed subtle defects in the central visual field of POAG patients that cannot be predicted by static automated perimetry assessment using Humphrey 24-2 SITA-Standard test.	[Roux-Sibilon, Alexia; Peyrin, Carole] Univ Grenoble Alpes, CNRS, LPNC, Grenoble, France; [Rutge, Floriane; Aptel, Florent; Chiquet, Christophe] Univ Hosp, Dept Ophthalmol, Grenoble, France; [Attye, Arnaud; Guyader, Nathalie] Univ Hosp, Dept Neuroradiol & MRI, Grenoble, France; [Guyader, Nathalie] Univ Grenoble Alpes, CNRS, GIPSA Lab, UMR 5210, Grenoble, France; [Boucart, Muriel] Univ Lille, CNRS, SCALab, UMR 9193, Lille, France	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; Universite de Lille	Roux-Sibilon, A (corresponding author), Univ Grenoble Alpes, CNRS, LPNC, Grenoble, France.	alexia.roux-sibilon1@univ-grenoble-alpes.fr	Roux-Sibilon, Alexia/AAL-5540-2020; Attyé, Arnaud/AAM-7762-2020	Attyé, Arnaud/0000-0002-0233-0367; Aptel, Florent/0000-0003-1537-9992	University Grenoble Alpes PhD grant "AGIR-POLE-CSB"; Fondation de France grant "Berthe Fouassier	University Grenoble Alpes PhD grant "AGIR-POLE-CSB"; Fondation de France grant "Berthe Fouassier	ARS was supported by University Grenoble Alpes PhD grant "AGIR-POLE-CSB", https://www.commuraute-univ-greroble-alpes.frfripresentation/annonces/agir-pole-634391htm4-CE3S. FR was supported by Fondation de France grant "Berthe Fouassier, https://www.fondationdefrance.org.fr/fondation/fondation-berthe-fouassier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Boucart M, 2013, INVESTIG OPHTHALMOL; Boucart Muriel, 2016, J Vis, V16, P10, DOI 10.1167/16.2.10; Brown HDH, 2016, OPHTHAL PHYSL OPT, V36, P240, DOI 10.1111/opo.12293; Burton R, 2014, GRAEF ARCH CLIN EXP, V252, P1621, DOI 10.1007/s00417-014-2752-x; Cabeza R, 2000, PSYCHOL SCI, V11, P429, DOI 10.1111/1467-9280.00283; Chen WW, 2013, INVEST OPHTH VIS SCI, V54, P545, DOI 10.1167/iovs.12-9893; Crabb DP, 2016, EYE, V30, P304, DOI 10.1038/eye.2015.244; Crabb DP, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00312; Crabb DP, 2013, OPHTHALMOLOGY, V120, P1120, DOI 10.1016/j.ophtha.2012.11.043; Crabb DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009710; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; Dai H, 2013, HUM BRAIN MAPP, V34, P2455, DOI 10.1002/hbm.22079; Dive S, 2016, J GLAUCOMA, V25, pE889, DOI 10.1097/IJG.0000000000000402; Duncan RO, 2007, PROG RETIN EYE RES, V26, P38, DOI 10.1016/j.preteyeres.2006.10.001; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2005, VIS COGN, V12, P954, DOI 10.1080/13506280444000607; Frezzotti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105931; Gerente VM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126362; Glen FC, 2013, VISION RES, V82, P42, DOI 10.1016/j.visres.2013.02.010; Glen FC, 2012, INVEST OPHTH VIS SCI, V53, P3629, DOI 10.1167/iovs.11-8538; Goffaux V, 2007, J EXP PSYCHOL HUMAN, V33, P995, DOI 10.1037/0096-1523.33.4.995; Grill-Spector K, 2001, VISION RES; Gupta N, 2007, SURV OPHTHALMOL, V52, pS122, DOI 10.1016/j.survophthal.2007.08.006; Guyader N, 2017, VISION RES, V133, P100, DOI 10.1016/j.visres.2016.12.019; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Hawkins AS, 2003, J GLAUCOMA, V12, P134, DOI 10.1097/00061198-200304000-00008; Hood DC, 2013, PROG RETIN EYE RES; Jebara Najate, 2009, Adv Cogn Psychol, V5, P42, DOI 10.2478/v10053-008-0065-5; Kauffmann L, 2015, NEUROIMAGE; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P203, DOI 10.1167/iovs.08-2496; Larson AM, 2009, CONTRIBUTIONS CENTRA; Lenoble Q, VISUAL OBJECT CATEGO; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Li CY, 2012, CURR EYE RES, V37, P794, DOI 10.3109/02713683.2012.683506; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Marechal M, 2014, ACTA OPHTHALMOL, V92, DOI 10.1111/j.1755-3768.2014.T039.x; McKendrick AM, 2005, INVESTIG OPHTHALMOL; McKone E, 2009, PSYCHON B REV, V16, P778, DOI 10.3758/PBR.16.5.778; Nelson P, 1999, BRIT J OPHTHALMOL, V83, P546, DOI 10.1136/bjo.83.5.546; Qing GP, 2010, INVEST OPHTH VIS SCI, V51, P4627, DOI 10.1167/iovs.09-4834; Ramanoel S, 2015, PLOS ONE, V10; Ramulu P, 2009, CURR OPIN OPHTHALMOL, V20, P92, DOI 10.1097/ICU.0b013e32832401a9; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Smith ND, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-45; Smith ND, 2011, OPHTHAL PHYSL OPT, V31, P225, DOI 10.1111/j.1475-1313.2011.00836.x; Tanaka JW, 2014, ATTEN PERCEPT PSYCHO, V76, P1000, DOI 10.3758/s13414-014-0628-0; Weber AJ, 2000, INVEST OPHTH VIS SCI, V41, P1370; Yucel YH, 2001, INVEST OPHTH VIS SCI, V42, P3216	50	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0193465	10.1371/journal.pone.0193465	http://dx.doi.org/10.1371/journal.pone.0193465			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX6NQ	29481572	Green Published, Green Submitted, gold			2022-12-26	WOS:000426202700012
J	Edamatsu, T; Fujieda, A; Itoh, Y				Edamatsu, Takeo; Fujieda, Ayako; Itoh, Yoshiharu			Phenyl sulfate, indoxyl sulfate and p-cresyl sulfate decrease glutathione level to render cells vulnerable to oxidative stress in renal tubular cells	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HYDROGEN-PEROXIDE; UREMIC TOXINS; DAMAGE; INFLAMMATION; INHIBITION; EXPRESSION; BIOMARKERS; INDUCTION; MELLITUS	In chronic kidney disease patients, oxidative stress is generally associated with disease progression and pathogenesis of its comorbidities. Phenyl sulfate is a protein-bound uremic solute, which accumulates in chronic kidney disease patients, but little is known about its nature. Although many reports revealed that protein-bound uremic solutes induce reactive oxygen species production, the effects of these solutes on anti-oxidant level have not been well studied. Therefore, we examined the effects of protein-bound uremic solutes on glutathione levels. As a result, indoxyl sulfate, phenyl sulfate, and p-cresyl sulfate decreased glutathione levels in porcine renal tubular cells. Next we examined whether phenyl sulfate treated cells becomes vulnerable to oxidative stress. In phenyl sulfate-treated cells, hydrogen peroxide induced higher rates of cell death than in control cells. Buthionine sulfoximine, which is known to decrease glutathione level, well mimicked the effect of phenyl sulfate. Finally, we evaluated a mixture of indoxyl sulfate, phenyl sulfate, and p-cresyl sulfate at concentrations comparable to the serum concentrations of hemodialysis patients, and we confirmed its decreasing effect on glutathione level. In conclusion, indoxyl sulfate, phenyl sulfate, and p-cresyl sulfate decrease glutathione levels, rendering the cells vulnerable to oxidative stress.	[Edamatsu, Takeo; Fujieda, Ayako; Itoh, Yoshiharu] Kureha Corp, Pharmaceut & Agrochem Div, Tokyo, Japan		Edamatsu, T (corresponding author), Kureha Corp, Pharmaceut & Agrochem Div, Tokyo, Japan.	edamatsu@kureha.co.jp		Edamatsu, Takeo/0000-0002-1782-2719	Kureha Corporation	Kureha Corporation	This work was supported by Kureha Corporation. Kureha Corporation had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annuk M, 2001, J AM SOC NEPHROL, V12, P2747, DOI 10.1681/ASN.V12122747; [Anonymous], US RENAL DATA SYSTEM, V2; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Boelaert J, 2013, ANAL BIOANAL CHEM, V405, P1937, DOI 10.1007/s00216-012-6636-9; Calderon-Salinas JV, 2011, MOL CELL BIOCHEM, V357, P171, DOI 10.1007/s11010-011-0887-1; Calunga JL, 2005, MEDIAT INFLAMM, P221, DOI 10.1155/MI.2005.221; Del Vecchio L, 2011, SEMIN DIALYSIS, V24, P56, DOI 10.1111/j.1525-139X.2010.00819.x; Dou L, 2007, J THROMB HAEMOST, V5, P1302, DOI 10.1111/j.1538-7836.2007.02540.x; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Edamatsu T, 2014, INT J NEPHROL, V2014, DOI 10.1155/2014/512178; Forman HJ, 2016, ARCH BIOCHEM BIOPHYS, V603, P48, DOI 10.1016/j.abb.2016.05.005; Galli F, 2014, FREE RADICAL RES, V48, P273, DOI 10.3109/10715762.2013.861901; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Gupta S, 2013, J DIABETES COMPLICAT, V27, P548, DOI 10.1016/j.jdiacomp.2013.07.005; Hung SC, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005022; Ito S, 2013, J LEUKOCYTE BIOL, V93, P837, DOI 10.1189/jlb.0112023; Itoh Y, 2012, ANAL BIOANAL CHEM, V403, P1841, DOI 10.1007/s00216-012-5929-3; Kadowaki D, 2012, LIFE SCI, V91, P1304, DOI 10.1016/j.lfs.2012.09.018; Kasimay O, 2009, RENAL FAILURE, V31, P711, DOI 10.3109/08860220903134563; Kikuchi K, 2010, J CHROMATOGR B, V878, P2997, DOI 10.1016/j.jchromb.2010.09.006; Kir HM, 2005, AM J NEPHROL, V25, P441, DOI 10.1159/000087825; Kuczmarski JM, 2014, NEPHROL DIAL TRANSPL, V29, P1514, DOI 10.1093/ndt/gft336; Kumawat Manjulata, 2013, N Am J Med Sci, V5, P213, DOI 10.4103/1947-2714.109193; Laouari D, 2001, AM J PHYSIOL-RENAL, V280, pF636, DOI 10.1152/ajprenal.2001.280.4.F636; Leong SC, 2016, TOXINS, V8, DOI 10.3390/toxins8120358; Massy ZA, 2009, SEMIN DIALYSIS, V22, P405, DOI 10.1111/j.1525-139X.2009.00590.x; Mimic-Oka J, 1999, CLIN NEPHROL, V51, P233; Moh A, 2004, J AM SOC NEPHROL, V15, P1077, DOI 10.1097/01.ASN.0000121841.82093.09; Moningka NC, 2012, NEPHROL DIAL TRANSPL, V27, P913, DOI 10.1093/ndt/gfr449; Motojima M, 2003, KIDNEY INT, V63, P1671, DOI 10.1046/j.1523-1755.2003.00906.x; Muteliefu G, 2009, NEPHROL DIAL TRANSPL, V24, P2051, DOI 10.1093/ndt/gfn757; Owada S, 2001, J ARTIF ORGANS, V4, P8; Santangelo F, 2004, NEPHROL DIAL TRANSPL, V19, P1951, DOI 10.1093/ndt/gfh266; Sato E, 2016, SCI REP-UK, V6, DOI 10.1038/srep36618; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Tucker PS, 2013, BIOMARKERS, V18, P103, DOI 10.3109/1354750X.2012.749302; Vanholder R, 2001, KIDNEY INT, V59, pS266, DOI 10.1046/j.1523-1755.2001.59780266.x; Vanholder R, 2014, J AM SOC NEPHROL, V25, P1897, DOI 10.1681/ASN.2013101062; Watanabe H, 2013, KIDNEY INT, V83, P582, DOI 10.1038/ki.2012.448; Yu M, 2011, CLIN J AM SOC NEPHRO, V6, P30, DOI 10.2215/CJN.05340610	40	33	34	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193342	10.1371/journal.pone.0193342	http://dx.doi.org/10.1371/journal.pone.0193342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474405	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500089
J	Lam, D; Momeni, Z; Theaker, M; Jagadeeshan, S; Yamamoto, Y; Lanowski, JP; Campanucci, VA				Lam, Doris; Momeni, Zeinab; Theaker, Michael; Jagadeeshan, Santosh; Yamamoto, Yasuhiko; Lanowski, Juan P.; Campanucci, Veronica A.			RAGE-dependent potentiation of TRPV1 currents in sensory neurons exposed to high glucose	PLOS ONE			English	Article							PROTEIN-KINASE-C; GLYCATION END-PRODUCTS; DORSAL-ROOT GANGLION; INDUCED OXIDATIVE STRESS; DIABETIC-NEUROPATHY; SYNAPTIC-TRANSMISSION; VANILLOID RECEPTOR; SYMPATHETIC NEURONS; CAPSAICIN RECEPTOR; TYROSINE KINASE	Diabetes mellitus is associated with sensory abnormalities, including exacerbated responses to painful (hyperalgesia) or non-painful (allodynia) stimuli. These abnormalities are symptoms of diabetic peripheral neuropathy (DPN), which is the most common complication that affects approximately 50% of diabetic patients. Yet, the underlying mechanisms linking hyperglycemia and symptoms of DPN remain poorly understood. The transient receptor potential vanilloid 1 (TRPV1) channel plays a central role in such sensory abnormalities and shows elevated expression levels in animal models of diabetes. Here, we investigated the function of TRPV1 channels in sensory neurons cultured from the dorsal root ganglion (DRG) of neonatal mice, under control (5mM) and high glucose (25mM) conditions. After maintaining DRG neurons in high glucose for 1 week, we observed a significant increase in capsaicin (CAP)-evoked currents and CAP-evoked depolarizations, independent of TRPV1 channel expression. These functional changes were largely dependent on the expression of the receptor for Advanced Glycation End-products (RAGE), calcium influx, cytoplasmic ROS accumulation, PKC, and Src kinase activity. Like cultured neurons from neonates, mature neurons from adult mice also displayed a similar potentiation of CAP-evoked currents in the high glucose condition. Taken together, our data demonstrate that under the diabetic condition, DRG neurons are directly affected by elevated levels of glucose, independent of vascular or glial signals, and dependent on RAGE expression. These early cellular and molecular changes to sensory neurons in vitro are potential mechanisms that might contribute to sensory abnormalities that can occur in the very early stages of diabetes.	[Lam, Doris; Momeni, Zeinab; Theaker, Michael; Jagadeeshan, Santosh; Lanowski, Juan P.; Campanucci, Veronica A.] Univ Saskatchewan, Dept Physiol, Coll Med, Saskatoon, SK, Canada; [Yamamoto, Yasuhiko] Kanazawa Univ, Dept Biochem & Mol Vasc Biol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Lam, Doris] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA	University of Saskatchewan; Kanazawa University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Campanucci, VA (corresponding author), Univ Saskatchewan, Dept Physiol, Coll Med, Saskatoon, SK, Canada.	veronica.campanucci@usask.ca	Lam, Doris/AAG-4796-2020; Jagadeeshan, Santosh/AAN-9568-2021	Lam, Doris/0000-0002-3882-9514; Jagadeeshan, Santosh/0000-0002-4285-9281	Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-03958, RGPIN-2010-371702]; Saskatchewan Health Research Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Saskatchewan Health Research Foundation	This study was supported by the Natural Sciences and Engineering Research Council of Canada RGPIN-2015-03958 and RGPIN-2010-371702 to Dr Veronica A. Campanucci; and Saskatchewan Health Research Foundation to Dr Veronica A. Campanucci.	Ahern GP, 2002, J PHYSIOL-LONDON, V545, P441, DOI 10.1113/jphysiol.2002.029561; Baillie LD, 2011, J NEUROSCI METH, V198, P274, DOI 10.1016/j.jneumeth.2011.04.015; Bierhaus A, 2004, J CLIN INVEST, V114, P1741, DOI 10.1172/JCI200418058; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Burkey TH, 2004, METH MOLEC MED, P189; Campanucci V, 2010, NEURON, V66, P827, DOI 10.1016/j.neuron.2010.06.010; Campanucci VA, 2008, J NEUROSCI, V28, P1733, DOI 10.1523/JNEUROSCI.5130-07.2008; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Chandna AR, 2015, EUR J NEUROSCI, V41, P341, DOI 10.1111/ejn.12795; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; de la Hoz CL, 2017, AM J PHYSIOL-ENDOC M, V312, pE407, DOI 10.1152/ajpendo.00444.2016; Deshmukh M, 1996, J CELL BIOL, V135, P1341, DOI 10.1083/jcb.135.5.1341; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; HAMILL OP, 1981, NATURE, V294, P462, DOI 10.1038/294462a0; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hong SS, 2008, J NEUROCHEM, V105, P1212, DOI 10.1111/j.1471-4159.2008.05220.x; Huang TJ, 2002, DIABETOLOGIA, V45, P560, DOI 10.1007/s00125-002-0785-x; Jin XC, 2004, AM J PHYSIOL-CELL PH, V287, pC558, DOI 10.1152/ajpcell.00113.2004; Juranek JK, 2013, BRAIN BEHAV, V3, P701, DOI 10.1002/brb3.176; Kahya MC, 2017, MOL NEUROBIOL, V54, P2345, DOI 10.1007/s12035-016-9727-3; Kamei J, 2001, EUR J PHARMACOL, V422, P83, DOI 10.1016/S0014-2999(01)01059-7; Kang R, 2012, P NATL ACAD SCI USA, V109, P7031, DOI 10.1073/pnas.1113865109; Kasama S, 2007, EUR J NEUROSCI, V25, P2956, DOI 10.1111/j.1460-9568.2007.05584.x; Khan GM, 2002, NEUROSCIENCE, V114, P291, DOI 10.1016/S0306-4522(02)00372-X; Koplas PA, ROLE CALCIUM DESENSI; Li L, 2014, J NEUROSCI, V34, P8246, DOI 10.1523/JNEUROSCI.0278-14.2014; Li XN, 2016, PAIN MED, V17, P803, DOI 10.1093/pm/pnv035; Mousa SA, 2016, PAIN, V157, P910, DOI 10.1097/j.pain.0000000000000459; Myint KM, 2006, DIABETES, V55, P2510, DOI 10.2337/db06-0221; Naruse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027458; Obrosova IG, 2009, BBA-MOL BASIS DIS, V1792, P931, DOI 10.1016/j.bbadis.2008.11.005; Olah Z, 2002, J BIOL CHEM, V277, P35752, DOI 10.1074/jbc.M201551200; Pabbidi RM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-9; Pabbidi RM, 2008, MOL PHARMACOL, V73, P995, DOI 10.1124/mol.107.041707; Palazzo E, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-66; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Radu BM, 2013, CELL MOL NEUROBIOL, V33, P187, DOI 10.1007/s10571-012-9883-6; Rashid MH, 2003, J PHARM EXP THER, V306; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; RUDERMAN NB, 1992, FASEB J, V6, P2905, DOI 10.1096/fasebj.6.11.1644256; Russell JW, 1999, NEUROBIOL DIS, V6, P347, DOI 10.1006/nbdi.1999.0254; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Schmidt RE, 2014, HDB CLIN NEUROLOGY; Sikand P, 2007, J PHYSIOL-LONDON, V581, P631, DOI 10.1113/jphysiol.2006.118620; Spruce MC, 2003, DIABETIC MED, V20, P88, DOI 10.1046/j.1464-5491.2003.00852.x; Sugimoto K, 2008, CURR PHARM DESIGN, V14, P953, DOI 10.2174/138161208784139774; Sugimoto Y, 2013, J PHARMACOL SCI, V123, P256, DOI 10.1254/jphs.13088FP; Szallasi A, 1999, PHARMACOL REV, V51, P159; Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294; Toth C, 2007, CURR MOL MED, V7, P766, DOI 10.2174/156652407783220705; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Vincent AM, 2005, ANTIOXID REDOX SIGN, V7, P1494, DOI 10.1089/ars.2005.7.1494; Vincent AM, 2005, FASEB J, V19, P638, DOI 10.1096/fj.04-2513fje; Vincent AM, 2002, ANN NY ACAD SCI, V959, P368, DOI 10.1111/j.1749-6632.2002.tb02108.x; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; Vinik AI, 2003, SEMIN NEUROL, V23, P365; Wautier JL, 2004, CIRC RES, V95, P233, DOI 10.1161/01.RES.0000137876.28454.64; WOOD JN, 1988, J NEUROSCI, V8, P3208; YAN SD, 1994, J BIOL CHEM, V269, P9889; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	64	16	18	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193312	10.1371/journal.pone.0193312	http://dx.doi.org/10.1371/journal.pone.0193312			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474476	Green Published, gold, Green Submitted			2022-12-26	WOS:000426049500081
J	Niemela, V; Burman, J; Blennow, K; Zetterberg, H; Larsson, A; Sundblom, J				Niemela, Valter; Burman, Joachim; Blennow, Kaj; Zetterberg, Henrik; Larsson, Anders; Sundblom, Jimmy			Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease	PLOS ONE			English	Article							GENE CARRIERS; MICROGLIAL ACTIVATION; NEUROINFLAMMATION; PATHOLOGY; BIOMARKERS; ASTROCYTE; PROTEIN; YKL-40; ONSET; MODEL	Introduction Huntington's disease (HD) is a neurodegenerative disorder, but evidence also suggests neuroinflammation in the pathogenesis. The immune mechanisms involved and the timing of their activation need further clarification. Methods A clinically well-characterized HD cohort and gene negative controls were enrolled. YKL-40 reflecting innate immunity and sCD27, a marker of adaptive immunity, were measured across disease stages. Comparisons were made with markers of neurodegeneration: neurofilament light (NFL), total-tau (T-tau), and phospho-tau (P-tau). Results 52 cross-sectional cerebrospinal fluid samples and 23 follow-up samples were analyzed. sCD27 was elevated in manifest HD and premanifest gene expansion carriers, whereas controls mostly had undetectable levels. YKL-40 showed a trend toward increase in manifest HD. sCD27 correlated with YKL-40 which in turn was closely associated to all included markers of neurodegeneration. YKL-40, NFL, and both forms of tau could all independently predict HD symptoms, but only NFL levels differed between groups after age adjustment. Conclusion Increased sCD27 in premanifest HD is a sign of T cell-mediated neuroinflammation. This finding is novel since other reports almost exclusively have found early involvement of innate immunity. Validation of sCD27 in a larger HD cohort is needed. The role of adaptive immunity in HD needs further clarification, as it may hasten disease progression.	[Niemela, Valter; Burman, Joachim] Uppsala Univ, Dept Neurosci, Neurol, Uppsala, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Molndal, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Larsson, Anders] Uppsala Univ, Dept Med Sci, Clin Chem, Uppsala, Sweden; [Sundblom, Jimmy] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden	Uppsala University; University of Gothenburg; Sahlgrenska University Hospital; University of London; University College London; University of London; University College London; Uppsala University; Uppsala University	Niemela, V (corresponding author), Uppsala Univ, Dept Neurosci, Neurol, Uppsala, Sweden.	valter.niernela@neuro.uu.se	Burman, Joachim/H-7230-2019	Burman, Joachim/0000-0002-7045-1806; Niemela, Valter/0000-0002-2576-9938	Aland Cultural foundation; Selanders stiftelse; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS105509] Funding Source: NIH RePORTER	Aland Cultural foundation; Selanders stiftelse; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Aland Cultural foundation (www.kulturstiftelsen.ax) to JS and Selanders stiftelse (http://www.akademiska.se/sv/Om-Akademiska/Fonder/) to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baake V, 2017, CORTEX, V95, P51, DOI 10.1016/j.cortex.2017.07.017; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Bonneh-Barkay D, 2012, BRAIN PATHOL, V22, P530, DOI 10.1111/j.1750-3639.2011.00550.x; Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Byrne LM, 2016, J HUNTINGTONS DIS, V5, P1, DOI 10.3233/JHD-160196; Byrne LM, 2017, LANCET NEUROLOGY; Constantinescu R, 2011, PARKINSONISM RELAT D, V17, P714, DOI 10.1016/j.parkreldis.2011.06.010; Constantinescu R, 2009, PARKINSONISM RELAT D, V15, P245, DOI 10.1016/j.parkreldis.2008.05.012; Crotti A, 2015, TRENDS IMMUNOL, V36, P364, DOI 10.1016/j.it.2015.04.007; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Komori M, 2015, ANN NEUROL, V78, P3, DOI 10.1002/ana.24408; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McColgan P, 2017, EUROPEAN J NEUROLOGY; Myers RH, 1991, J NEUROPATHOL EXP NE, V50; Niemela V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172762; Paoli RA, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7060067; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Politis M, 2015, NEUROBIOL DIS, V83, P115, DOI 10.1016/j.nbd.2015.08.011; Reilmann R, 2014, MOVEMENT DISORD, V29, P1335, DOI 10.1002/mds.26011; Rodrigues FB, 2016, J NEUROCHEMISTRY; Rodrigues FB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163479; SHOULSON I, 1979, NEUROLOGY, V29, P1, DOI 10.1212/WNL.29.1.1; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Vinther-Jensen T, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000287; Vinther-Jensen T, 2014, PARKINSONISM RELAT D, V20, P1301, DOI 10.1016/j.parkreldis.2014.08.011; Weiss A, 2012, J CLIN INVEST, V122, P3731, DOI 10.1172/JCI64565; Wild EJ, 2015, J CLIN INVEST, V125, P1979, DOI 10.1172/JCI80743; Zetterberg H, 2017, NEUROPATH APPL NEURO, V43, P194, DOI 10.1111/nan.12378	30	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193492	10.1371/journal.pone.0193492	http://dx.doi.org/10.1371/journal.pone.0193492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474427	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500119
J	Salter, I				Salter, Ian			Seasonal variability in the persistence of dissolved environmental DNA (eDNA) in a marine system: The role of microbial nutrient limitation	PLOS ONE			English	Article							BACTERIAL 5-NUCLEOTIDASE ACTIVITY; ORGANIC PHOSPHORUS; EXTRACELLULAR DNA; MEDITERRANEAN SEA; PHOSPHATE-UPTAKE; GROWTH-KINETICS; ATLANTIC-OCEAN; NORTH; PHYTOPLANKTON; DEGRADATION	Environmental DNA (eDNA) can be defined as the DNA pool recovered from an environmental sample that includes both extracellular and intracellular DNA. There has been a significant increase in the number of recent studies that have demonstrated the possibility to detect macroorganisms using eDNA. Despite the enormous potential of eDNA to serve as a biomonitoring and conservation tool in aquatic systems, there remain some important limitations concerning its application. One significant factor is the variable persistence of eDNA over natural environmental gradients, which imposes a critical constraint on the temporal and spatial scales of species detection. In the present study, a radiotracer bioassay approach was used to quantify the kinetic parameters of dissolved eDNA (d-eDNA), a component of extracellular DNA, over an annual cycle in the coastal Northwest Mediterranean. Significant seasonal variability in the biological uptake and turnover of d-eDNA was observed, the latter ranging from several hours to over one month. Maximum uptake rates of d-eDNA occurred in summer during a period of intense phosphate limitation (turnover < 5 hrs). Corresponding increases in bacterial production and uptake of adenosine triphosphate (ATP) demonstrated the microbial utilization of d-eDNA as an organic phosphorus substrate. Higher temperatures during summer may amplify this effect through a general enhancement of microbial metabolism. A partial least squares regression (PLSR) model was able to reproduce the seasonal cycle in d-eDNA persistence and explained 60% of the variance in the observations. Rapid phosphate turnover and low concentrations of bioavailable phosphate, both indicative of phosphate limitation, were the most important parameters in the model. Abiotic factors such as pH, salinity and oxygen exerted minimal influence. The present study demonstrates significant seasonal variability in the persistence of d-eDNA in a natural marine environment that can be linked to the metabolic response of microbial communities to nutrient limitation. Future studies should consider the effect of natural environmental gradients on the seasonal persistence of eDNA, which will be of particular relevance for time-series biomonitoring programs.	[Salter, Ian] UPMC Univ Paris 06, Sorbonne Univ, CNRS, Lab Oceanog Microbienne LOMIC,Observ Oceanol, Banyuls Sur Mer, France; [Salter, Ian] Faroe Marine Res Inst, Torshavn, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Faroe Marine Research Institute (FAMRI)	Salter, I (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, CNRS, Lab Oceanog Microbienne LOMIC,Observ Oceanol, Banyuls Sur Mer, France.; Salter, I (corresponding author), Faroe Marine Res Inst, Torshavn, Denmark.	ian.salter@obs-banyuls.fr	Salter, Ian/AAI-1015-2021	Salter, Ian/0000-0002-4513-0314	LEFE-CYBER; Institut National sciences de l'univers, Les Enveloppes Fluides et l'Environnement, Cycles biogeochimiques, environnement et ressources (INSU-LEFE-CYBER)	LEFE-CYBER; Institut National sciences de l'univers, Les Enveloppes Fluides et l'Environnement, Cycles biogeochimiques, environnement et ressources (INSU-LEFE-CYBER)	This work was carried out as part of the POPPYMED grant, awarded to Ian Salter, by the Institut National sciences de l'univers, Les Enveloppes Fluides et l'Environnement, Cycles biogeochimiques, environnement et ressources (INSU-LEFE-CYBER) (http://www.insu.cnrs.fr/lefe/presentation-cyber).; I thank LEFE-CYBER for financial support of POPPY-MED. I also acknowledge Eric Maria, Cyrielle Tricoire, and Louise Oriol for technical support in collecting samples to contribute towards the SOMLIT coastal observation program and Maria Nielsdottir for proof reading.	ALBANO M, 1987, J BACTERIOL, V169, P3110, DOI 10.1128/jb.169.7.3110-3117.1987; Aminot A., 2007, METHODES ANAL MILIEU; AMMERMAN JW, 1991, LIMNOL OCEANOGR, V36, P1437, DOI 10.4319/lo.1991.36.7.1437; AMMERMAN JW, 1991, LIMNOL OCEANOGR, V36, P1427, DOI 10.4319/lo.1991.36.7.1427; AMMERMAN JW, 1985, SCIENCE, V227, P1338, DOI 10.1126/science.227.4692.1338; Andruszkiewicz EA, 2017, PLOS ONE, V12, P1; [Anonymous], [No title captured]; Aylagas E, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00096; Aylagas E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090529; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bearzi G, 2004, AQUAT CONSERV, V14, P363, DOI 10.1002/aqc.626; Bjorkman K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00189; Boere AC, 2011, ORG GEOCHEM, V42, P1216, DOI 10.1016/j.orggeochem.2011.08.005; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Borin S, 2008, SALINE SYSTEMS, V4; Brum JR, 2005, AQUAT MICROB ECOL, V41, P103, DOI 10.3354/ame041103; Casey JR, 2009, AQUAT MICROB ECOL, V58, P31, DOI 10.3354/ame01348; Chrost R.J., 1990, AQUAT MICROB ECOL, P47; Clark LL, 1999, AM J SCI, V299, P724, DOI 10.2475/ajs.299.7-9.724; COLL M, 2010, PLOS ONE; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Curtin R, 2010, MAR POLICY, V34, P821, DOI 10.1016/j.marpol.2010.01.003; Danovaro R, 1999, PROG OCEANOGR, V44, P287, DOI 10.1016/S0079-6611(99)00030-0; Danovaro R, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00213; DEFLAUN MF, 1987, MAR ECOL PROG SER, V38, P65, DOI 10.3354/meps038065; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Doi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029295; Duhamel S, 2010, LIMNOL OCEANOGR, V55, P1414, DOI 10.4319/lo.2010.55.3.1414; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Fu FX, 2006, EUR J PHYCOL, V41, P15, DOI 10.1080/09670260500505037; Fu FX, 2005, J PHYCOL, V41, P62, DOI 10.1111/j.1529-8817.2005.04063.x; Galand PE, 2015, MOL ECOL, V24, P5785, DOI 10.1111/mec.13347; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Goodwin KD, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00107; Green HC, 2011, ENVIRON MICROBIOL, V13, P3235, DOI 10.1111/j.1462-2920.2011.02549.x; HODGSON CP, 1987, NUCLEIC ACIDS RES, V15, P6295, DOI 10.1093/nar/15.15.6295; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Ignatiades L, 2005, J SEA RES, V54, P51, DOI 10.1016/j.seares.2005.02.010; JIANG SC, 1995, APPL ENVIRON MICROB, V61, P317, DOI 10.1128/AEM.61.1.317-325.1995; Jorgensen NOG, 1996, AQUAT MICROB ECOL, V11, P263, DOI 10.3354/ame011263; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Krom MD, 2005, DEEP-SEA RES PT II, V52, P3090, DOI 10.1016/j.dsr2.2005.08.018; Lacoursiere-Roussel A, 2016, MOL ECOL RESOUR, V16, P1401, DOI 10.1111/1755-0998.12522; Lazzari P, 2016, DEEP-SEA RES PT I, V108, P39, DOI 10.1016/j.dsr.2015.12.006; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Lomas MW, 2014, P NATL ACAD SCI USA, V111, P17540, DOI 10.1073/pnas.1420760111; Lopez-Sandoval DC, 2011, BIOGEOSCIENCES, V8, P815, DOI 10.5194/bg-8-815-2011; Lovdal T, 2008, BIOGEOSCIENCES, V5, P371, DOI 10.5194/bg-5-371-2008; Lovdal T, 2007, LIMNOL OCEANOGR, V52, P1407, DOI 10.4319/lo.2007.52.4.1407; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mather RL, 2008, NAT GEOSCI, V1, P439, DOI 10.1038/ngeo232; Michelou VK, 2011, LIMNOL OCEANOGR, V56, P323, DOI 10.4319/lo.2011.56.1.0323; Moutin T, 2002, J MARINE SYST, V33, P273, DOI 10.1016/S0924-7963(02)00062-3; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; Obernosterer I, 2010, MICROB ECOL, V59, P428, DOI 10.1007/s00248-009-9588-7; Orchard ED, 2010, LIMNOL OCEANOGR, V55, P1390, DOI 10.4319/lo.2010.55.3.1390; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PAUL JH, 1988, APPL ENVIRON MICROB, V54, P718, DOI 10.1128/AEM.54.3.718-727.1988; PAUL JH, 1989, APPL ENVIRON MICROB, V55, P1823, DOI 10.1128/AEM.55.7.1823-1828.1989; PAUL JH, 1988, APPL ENVIRON MICROB, V54, P1682, DOI 10.1128/AEM.54.7.1682-1688.1988; PAUL JH, 1987, APPL ENVIRON MICROB, V53, P170, DOI 10.1128/AEM.53.1.170-179.1987; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Popendorf KJ, 2015, ENVIRON MICROBIOL, V17, P3992, DOI 10.1111/1462-2920.12932; Pujo-Pay M, 2011, BIOGEOSCIENCES, V8, P883, DOI 10.5194/bg-8-883-2011; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; RIGLER FH, 1966, VERH INT VER LIMNOL, V16, P465, DOI DOI 10.1080/03680770.1965.11895717; Sala E, 2004, ECOSYSTEMS, V7, P333, DOI 10.1007/s10021-003-0241-x; SALA E, 2011, PLOS ONE, V6; Sala E, 2012, PLOS ONE, V7; Salter I, 2015, ISME J, V9, P347, DOI 10.1038/ismej.2014.129; Sambrook J, 2001, MOL CLONING LAB J; Sanchez G., 2016, PACKAGE PLSDEPOT TIT; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Sebastian M, 2012, ENVIRON MICROBIOL, V14, P2334, DOI 10.1111/j.1462-2920.2012.02772.x; Sigsgaard EE, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0004; Siuda W, 1998, AQUAT MICROB ECOL, V15, P89, DOI 10.3354/ame015089; Siuda W, 2000, AQUAT MICROB ECOL, V21, P195, DOI 10.3354/ame021195; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Strickland JD, 1972, PRECTICAL HDB SEAWAT; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Talarmin A, 2011, LIMNOL OCEANOGR-METH, V9, P443, DOI 10.4319/lom.2011.9.443; Thingstad TF, 2005, SCIENCE, V309, P1068, DOI 10.1126/science.1112632; THINGSTAD TF, 1993, MAR ECOL PROG SER, V99, P239, DOI 10.3354/meps099239; Thomsen P.F., 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/JOURNAL.PONE.0041732; Thomsen PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165252; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguer P, 1974, MANUEL ANAL SELS NUT; Turner CR, 2014, METHODS ECOL EVOL; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Van Wambeke F, 2002, MICROB ECOL, V43, P119, DOI 10.1007/s00248-001-0038-4; Walters SP, 2009, WATER RES, V43, P4929, DOI 10.1016/j.watres.2009.05.047; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; YENTSCH CS, 1963, DEEP-SEA RES, V10, P221, DOI 10.1016/0011-7471(63)90358-9; Zenetos A, 2012, MEDITERR MAR SCI, V13, P328, DOI 10.12681/mms.327; Zubkov MV, 2007, ENVIRON MICROBIOL, V9, P2079, DOI 10.1111/j.1462-2920.2007.01324.x	102	23	24	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192409	10.1371/journal.pone.0192409	http://dx.doi.org/10.1371/journal.pone.0192409			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474423	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500017
J	Zeiger, JS; Zeiger, RS				Zeiger, Joanna S.; Zeiger, Robert S.			Mental toughness latent profiles in endurance athletes	PLOS ONE			English	Article							GLOBAL SELF-ESTEEM; SPORTS PARTICIPATION; NEED SATISFACTION; CONSTRUCT-VALIDATION; AUTONOMY SUPPORT; EFFECT SIZE; PERFORMANCE; EXERCISE; ACHIEVEMENT; MOTIVATION	Mental toughness in endurance athletes, while an important factor for success, has been scarcely studied. An online survey was used to examine eight mental toughness factors in endurance athletes. The study aim was to determine mental toughness profiles via latent profile analysis in endurance athletes and whether associations exist between the latent profiles and demographics and sports characteristics. Endurance athletes >= 18 years of age were recruited via social media outlets (n = 1245, 53% female). Mental toughness was measured using the Sports Mental Toughness Questionnaire (SMTQ), Psychological Performance Inventory-Alternative (PPI-A), and self-esteem was measured using the Rosenberg Self-Esteem Scale (RSE). A three-class solution emerged, designated as high mental toughness (High MT), moderate mental toughness (Moderate MT) and low mental toughness (Low MT). ANOVA tests showed significant differences between all three classes on all 8 factors derived from the SMTQ, PPI-A and the RSE. There was an increased odds of being in the High MT class compared to the Low MT class for males (OR = 1.99; 95% CI, 1.39, 2.83; P< 0.001), athletes who were over 55 compared to those who were 18 +/- 34 (OR = 2.52; 95% CI, 1.37, 4.62; P< 0.01), high sports satisfaction (OR = 8.17; 95% CI, 5.63, 11.87; P< 0.001), and high division placement (OR = 2.18; 95% CI, 1.46,3.26; P< 0.001). The data showed that mental toughness latent profiles exist in endurance athletes. High MT is associated with demographics and sports characteristics. Mental toughness screening in athletes may help direct practitioners with mental skills training.	[Zeiger, Joanna S.] Race Ready Coaching, Boulder, CO 80307 USA; [Zeiger, Robert S.] Kaiser Permanente Southern Calif Reg, Dept Allergy, San Diego, CA USA; [Zeiger, Robert S.] Kaiser Permanente Southern Calif Reg, Dept Res & Evaluat, Pasadena, CA USA	Kaiser Permanente; Kaiser Permanente	Zeiger, JS (corresponding author), Race Ready Coaching, Boulder, CO 80307 USA.	joannazager@comcast.net		Zeiger, Joanna/0000-0002-2421-2206	Race Ready Coaching	Race Ready Coaching	The funder Race Ready Coaching provided support in the form of salary for author JSZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Adie JW, 2008, MOTIV EMOTION, V32, P189, DOI 10.1007/s11031-008-9095-z; [Anonymous], 2014, US TRIATHLON DEMOGRA; [Anonymous], 2012, MENT HEALTH PHYS ACT, DOI [DOI 10.1016/J.MHPA.2012.02.004, 10.1016/j.mhpa.2012.02.004]; Baumeister RF, 2003, PSYCHOL SCI PUBLIC I, V4; Bowker A, 2006, CAN J BEHAV SCI, V38, P214, DOI 10.1037/cjbs2006009; Brand S, 2014, J ADOLESC HEAL, V54; Carpentier J, 2013, PSYCHOL SPORT EXERC, V14, P423, DOI 10.1016/j.psychsport.2013.01.003; Connaughton D, 2008, J SPORT SCI, V26, P83, DOI 10.1080/02640410701310958; Crust L, 2014, PERS INDIV DIFFER, V69, P87, DOI 10.1016/j.paid.2014.05.016; Crust L, 2013, EUR J SPORT SCI, V13, P215, DOI 10.1080/17461391.2011.635698; Crust L, 2011, PERS INDIV DIFFER, V50, P217, DOI 10.1016/j.paid.2010.09.032; Crust L, 2010, EUR J SPORT SCI, V10, P43, DOI 10.1080/17461390903049972; Crutzen R, 2017, HEALTH PSYCHOL REV, V11, P242, DOI 10.1080/17437199.2015.1124240; Dunn TJ, 2014, BRIT J PSYCHOL, V105, P399, DOI 10.1111/bjop.12046; Faubert J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01154; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Finez L, 2012, J SPORT SCI, V30, P1757, DOI 10.1080/02640414.2012.718089; Gagne M, 2003, J APPL SPORT PSYCHOL, V15, P372, DOI 10.1080/714044203; Galan I, 2014, PREV SCI, V15, P588, DOI 10.1007/s11121-013-0407-5; Gillet N, 2010, PSYCHOL SPORT EXERC, V11, P155, DOI 10.1016/j.psychsport.2009.10.004; Golby J, 2007, PERCEPT MOTOR SKILL, V105, P309, DOI 10.2466/PMS.105.5.309-325; Gucciardi DF, 2008, J APPL SPORT PSYCHOL, V20, P261, DOI 10.1080/10413200801998556; Gucciardi DF, 2017, CURR OPIN PSYCHOL, V16, P17, DOI 10.1016/j.copsyc.2017.03.010; Gucciardi DF, 2015, J PERS, V83, P26, DOI 10.1111/jopy.12079; Gucciardi DF, 2012, J SPORT EXERCISE PSY, V34, P16, DOI 10.1123/jsep.34.1.16; Huang HF, 2012, J ECON PSYCHOL, V33, P776, DOI 10.1016/j.joep.2012.02.007; ISOAHOLA SE, 1989, J LEISURE RES, V21, P32, DOI 10.1080/00222216.1989.11969788; Jones G, 2002, J APPL SPORT PSYCHOL, V14, P205, DOI 10.1080/10413200290103509; Jones G, 2007, SPORT PSYCHOL, V21, P243, DOI 10.1123/tsp.21.2.243; Joseph RP, 2014, QUAL LIFE RES, V23, P661, DOI 10.1007/s11136-013-0492-8; Kaiseler M, 2009, PERS INDIV DIFFER, V47, P728, DOI 10.1016/j.paid.2009.06.012; Kang SM, 2003, PERS SOC PSYCHOL B, V29, P1596, DOI 10.1177/0146167203255986; Killer SC, 2017, J SPORT SCI, V35, P1402, DOI 10.1080/02640414.2015.1085589; Kinnafick FE, 2014, QUAL HEALTH RES, V24, P706, DOI 10.1177/1049732314528811; Koivula N, 2002, PERS INDIV DIFFER, V32, P865, DOI 10.1016/S0191-8869(01)00092-7; Kuan G, 2007, J SPORT SCI MED, V6, P28; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Mahoney JW, 2014, J SPORT EXERCISE PSY, V36, P281, DOI 10.1123/jsep.2013-0260; Martinent G, 2013, J SPORT EXERCISE PSY, V35, P600, DOI 10.1123/jsep.35.6.600; McLachlan GJ, 2003, COMPUT STAT DATA AN, V41, P379, DOI 10.1016/S0167-9473(02)00183-4; Muthen L.K., 2005, MPLUS STAT ANAL LATE; Newland A, 2013, J SPORT HEALTH SCI, V2, P184, DOI 10.1016/j.jshs.2012.09.002; Nicholls AR, 2008, PERS INDIV DIFFER, V44, P1182, DOI 10.1016/j.paid.2007.11.011; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Oberski D, 2016, HUM-COMPUT INT-SPRIN, P275, DOI 10.1007/978-3-319-26633-6_12; Osborne MS, 2014, PSYCHOL WELL-BEING, V4, DOI 10.1186/s13612-014-0018-3; Paradise AW, 2002, J SOC CLIN PSYCHOL, V21, P345, DOI 10.1521/jscp.21.4.345.22598; Pyszczynski T, 2004, PSYCHOL BULL, V130, P435, DOI 10.1037/0033-2909.130.3.435; Reinboth M, 2006, PSYCHOL SPORT EXERC, V7, P269, DOI 10.1016/j.psychsport.2005.06.002; Reis NA, 2015, PSYCHOL SPORT EXERC, V16, P18, DOI 10.1016/j.psychsport.2014.08.011; Rice SM, 2016, SPORTS MED, V46, P1333, DOI 10.1007/s40279-016-0492-2; Roberts GC, 1998, J SPORT SCI, V16, P337, DOI 10.1080/02640419808559362; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; ROSENBERG M, 1995, AM SOCIOL REV, V60, P141, DOI 10.2307/2096350; Rosenberg M, 1965, SCIENCE; Rosenberg MSatas-i & Press, 1965, ROSENBERG SELF ESTEE; Running USA, 2015, RUNN US STAT SPORTS; Sheard M, 2013, MENTAL TOUGHNESS MIN; Sheard M, 2009, PERCEPT MOTOR SKILL, V109, P213, DOI 10.2466/PMS.109.1.213-223; Sheard M, 2009, EUR J PSYCHOL ASSESS, V25, P186, DOI 10.1027/1015-5759.25.3.186; Slattery K, 2015, SPORTS MED, V45, P453, DOI 10.1007/s40279-014-0282-7; SONSTROEM RJ, 1989, MED SCI SPORT EXER, V21, P329; Stamp E, 2015, BRIT ASS SPORT EX SC; Tein JY, 2013, STRUCT EQU MODELING, V20, P640, DOI 10.1080/10705511.2013.824781; Thurston M, 2004, HEALTH PROMOT INT, V19, P379, DOI 10.1093/heapro/dah311; Valmaggia LR, 2013, PSYCHOL MED, V43, P2311, DOI 10.1017/S0033291713000251; Wieser R, 2014, CHIROPR MAN THER, V22, DOI 10.1186/2045-709X-22-17; Wurpts IC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00920	69	27	27	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193071	10.1371/journal.pone.0193071	http://dx.doi.org/10.1371/journal.pone.0193071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX4LV	29474398	gold, Green Published, Green Submitted			2022-12-26	WOS:000426049500054
J	Camara, AS; Horjales, E				Camara, Amanda Souza; Horjales, Eduardo			Computer simulations reveal changes in the conformational space of the transcriptional regulator MosR upon the formation of a disulphide bond and in the collective motions that regulate its DNA-binding affinity	PLOS ONE			English	Article							MOLECULAR-DYNAMICS TRAJECTORIES; CRYSTAL-STRUCTURE; NORMAL-MODE; PROTEINS	M. tuberculosis oxidation sense Regulator (MosR) is a transcriptional regulator from Mycobacterium tuberculosis. It senses the environment oxidation and regulates the expression of a secreted oxidoreductase, thus defending the bacilli against oxidative stress from the phagosome. While most of the members of the Multiple antibiotics resistance Regulator (MarR) family are ligand-responsive, MosR may dissociate from its DNA site upon formation of an intrachain disulphide bond. However, the structure of MosR in its oxidized state is not known, and it is not clear how the formation of this disulphide bond would lead to the conformational changes required for dissociation of the DNA. Nonetheless, MosR presents two crystallographically resolved conformations in its reduced state: bound and unbound to DNA. We managed to simulate MosR unbound to the DNA, both in the presence and in the absence of the disulphide bond. Our results indicate that this disulphide bond precludes the N-terminal residues from adopting a conformation that stands in-between the helix alpha 1 and the DNA binding domain (DBD) from the other chain. Once this conformation is achieved in the reduced state, this DBD detaches from the dimerization domain and becomes more flexible, being able to perform motions with higher amplitude and higher degree of collectivity. Only then, MosR may achieve a conformation where its recognition helices fit into the major grooves of its DNA site. The analysis of the collective motions performed by MosR, during the different situations sampled by the molecular dynamics (MDs), was only possible by the method of filtering harmonic modes with specific frequencies. The frequency of the collective motions performed by the DBD of MosR in the reduced state to achieve a DNA-binding conformation is in the range of 20 to 50 MHz, but it may be associated to more sporadic events since it requires the combination of a suitable conformation of the N-terminal residues.	[Camara, Amanda Souza; Horjales, Eduardo] Univ Sao Paulo, Inst Fis Sao Carlos, Dept Fis & Ciencia Interdisciplinar, Sao Carlos, SP, Brazil	Universidade de Sao Paulo	Horjales, E (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Dept Fis & Ciencia Interdisciplinar, Sao Carlos, SP, Brazil.	horjales@ifsc.usp.br		Horjales, Eduardo/0000-0003-1022-5628	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo, Brazil [2013/26313-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); agencia do Ministerio da Ciencia, Tecnologia, Inovacoes e Comuinicacoes (MCTIC), Brazil	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); agencia do Ministerio da Ciencia, Tecnologia, Inovacoes e Comuinicacoes (MCTIC), Brazil	This work was supported by Fundacao de Apoio a Pesquisa do Estado de Sao Paulo, Brazil -Grant Nr. 2013/26313-5 to E.Horjales; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), agencia do Ministerio da Ciencia, Tecnologia, Inovacoes e Comuinicacoes (MCTIC), Brazil, PhD scholarship to A. S. Camara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; ANSARI A, 1985, P NATL ACAD SCI USA, V82, P5000, DOI 10.1073/pnas.82.15.5000; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bloomfield P., 2004, FOURIER ANAL TIME SE; BrõndÚn CI., 1991, INTRO PROTEIN STRUCT; Brugarolas P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388611; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dauber-Osguthorpe P, 1999, J COMPUT PHYS, V151, P169, DOI 10.1006/jcph.1999.6232; DAUBEROSGUTHORPE P, 1990, BIOCHEMISTRY-US, V29, P8223, DOI 10.1021/bi00488a005; De Simone A, 2006, J PEPT SCI, V12, P740, DOI 10.1002/psc.809; DUNITZ JD, 1988, J PHYS CHEM-US, V92, P856, DOI 10.1021/j100315a002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gajiwala KS, 2000, CURR OPIN STRUCT BIO, V10; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hinsen K., 2005, NORM MODE ANAL THEOR, V1-16; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kalodimos CG, 2002, NAT STRUCT BIOL, V9, P193, DOI 10.1038/nsb763; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Martinez L, 2014, MDANALYSIS; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Press W.H., 1996, NUMERICAL RECIPES FO; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; SESSIONS RB, 1989, J MOL BIOL, V210, P617, DOI 10.1016/0022-2836(89)90136-8; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; WAKSMAN G, 1994, J MOL BIOL, V236, P800, DOI 10.1006/jmbi.1994.1190; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192826	10.1371/journal.pone.0192826	http://dx.doi.org/10.1371/journal.pone.0192826			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470546	Green Published, Green Submitted, gold			2022-12-26	WOS:000425831000020
J	Samsatly, J; Copley, TR; Jabaji, SH				Samsatly, Jamil; Copley, Tanya R.; Jabaji, Suha H.			Antioxidant genes of plants and fungal pathogens are distinctly regulated during disease development in different Rhizoctonia solani pathosystems	PLOS ONE			English	Article							REACTIVE OXYGEN; BOTRYTIS-CINEREA; STACHYBOTRYS-ELEGANS; OXIDATIVE STRESS; VITAMIN-B6 BIOSYNTHESIS; NECROTROPHIC PATHOGENS; SIGNAL-TRANSDUCTION; DEFENSE RESPONSES; RESISTANCE; ARABIDOPSIS	Biotic stress, as a result of plant-pathogen interactions, induces the accumulation of reactive oxygen species in the cells, causing severe oxidative damage to plants and pathogens. To overcome this damage, both the host and pathogen have developed antioxidant systems to quench excess ROS and keep ROS production and scavenging systems under control. Data on ROS-scavenging systems in the necrotrophic plant pathogen Rhizoctonia solani are just emerging. We formerly identified vitamin B6 biosynthetic machinery of R. solani AG3 as a powerful antioxidant exhibiting a high ability to quench ROS, similar to CATALASE (CAT) and GLUTATHIONE S-TRANSFERASE (GST). Here, we provide evidence on the involvement of R. solani vitamin B6 biosynthetic pathway genes; RsolPDX1 (KF620111.1), RsolPDX2 (KF620112.1), and RsolPLR (KJ395592.1) in vitamin B6 de novo biosynthesis by yeast complementation assays. Since gene expression studies focusing on oxidative stress responses of both the plant and the pathogen following R. solani infection are very limited, this study is the first coexpression analysis of genes encoding vitamin B6, CAT and GST in plant and fungal tissues of three pathosystems during interaction of different AG groups of R. solani with their respective hosts. The findings indicate that distinct expression patterns of fungal and host antioxidant genes were correlated in necrotic tissues and their surrounding areas in each of the three R. solani pathosystems: potato sprout-R. solani AG3; soybean hypocotyl-R. solani AG4 and soybean leaves-R. solani AG1-IA interactions. Levels of ROS increased in all types of potato and soybean tissues, and in fungal hyphae following infection of R. solani AGs as determined by non-fluorescence and fluorescence methods using H2DCF-DA and DAB, respectively. Overall, we demonstrate that the co-expression and accumulation of certain plant and pathogen ROS-antioxidant related genes in each pathosystem are highlighted and might be critical during disease development from the plant's point of view, and in pathogenicity and developing of infection structures from the fungal point of view.	[Samsatly, Jamil; Copley, Tanya R.; Jabaji, Suha H.] McGill Univ, Plant Sci Dept, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada	McGill University	Jabaji, SH (corresponding author), McGill Univ, Plant Sci Dept, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada.	suha.jabaji@mcgill.ca	Jabaji, Suha/D-2479-2016	Jabaji, Suha/0000-0002-7232-9994	Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-04805]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Discovery grant RGPIN-2016-04805 to S. Jabaji, provided by the Natural Sciences and Engineering Research Council of Canada, http://www.nserc-crsng.gc.ca/index_eng.asp.; The authors thank D. Donnelley and K. Sabbally and for providing certified seed potatoes of Russet Burbank. We also acknowledge the J.-B Charron for the use of Zeiss SteREO Discovery. V20 microscope. Financial support, through a Discovery grant (RGPIN-2016-04805) to S. Jabaji, was provided by the Natural Sciences and Engineering research Council of Canada.	Able AJ, 2003, PROTOPLASMA, V221, P137, DOI 10.1007/s00709-002-0064-1; Aliferis KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111930; Aliferis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042576; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Asselbergh B, 2007, PLANT PHYSIOL, V144, P1863, DOI 10.1104/pp.107.099226; Barna B, 2012, PLANT PHYSIOL BIOCH, V59, P37, DOI 10.1016/j.plaphy.2012.01.014; Benabdellah K, 2009, NEW PHYTOL, V184, P682, DOI 10.1111/j.1469-8137.2009.02978.x; Breitenbach M, 2015, BIOMOLECULES, V5, P318, DOI 10.3390/biom5020318; Buskila Y, 2011, PHYTOPATHOLOGY, V101, P436, DOI 10.1094/PHYTO-09-10-0251; Chamoun R, 2015, MOL GENET GENOMICS, V290, P877, DOI 10.1007/s00438-014-0962-x; Chamoun R, 2013, CURR GENET, V59, P43, DOI 10.1007/s00294-012-0386-2; Chamoun R, 2011, MYCOLOGIA, V103, P483, DOI 10.3852/10-235; Chung KR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/635431; Ciampi MB, 2008, PHYTOPATHOLOGY, V98, P932, DOI 10.1094/PHYTO-98-8-0932; Conrath U, 2009, ADV BOT RES, V51, P361, DOI 10.1016/S0065-2296(09)51009-9; Copley TR, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1020-8; Denslow SA, 2005, PHYSIOL MOL PLANT P, V66, P244, DOI 10.1016/j.pmpp.2005.09.004; Fenille RC, 2002, EUR J PLANT PATHOL, V108, P783, DOI 10.1023/A:1020811019189; Floryszak-Wieczorek J, 2007, NEW PHYTOL, V175, P718, DOI 10.1111/j.1469-8137.2007.02142.x; Foley RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152548; Foley RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056814; Gengenbacher M, 2006, J BIOL CHEM, V281, P3633, DOI 10.1074/jbc.M508696200; Gkarmiri K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1758-z; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Garcia VG, 2006, SPAN J AGRIC RES, V4, P55; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Johanson A, 1998, FEMS MICROBIOL LETT, V162, P289, DOI 10.1111/j.1574-6968.1998.tb13011.x; Keijer J, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P149; Keshavarz-Tohid V, 2016, J PLANT PHYSIOL, V199, P29, DOI 10.1016/j.jplph.2016.05.005; Laluk K., 2010, Arabidopsis Book, V8, pe0136, DOI 10.1199/tab.0136; Lehtonen MJ, 2008, PHYTOPATHOLOGY, V98, P1190, DOI 10.1094/PHYTO-98-11-1190; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; MINET M, 1992, PLANT J, V2, P417; Moccand C, 2014, J BIOL CHEM, V289, P8203, DOI 10.1074/jbc.M113.540526; Mooney S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/389723; Mooney S, 2009, MOLECULES, V14, P329, DOI 10.3390/molecules14010329; Morissette DC, 2008, CURR GENET, V53, P67, DOI 10.1007/s00294-007-0166-6; Mylona PV, 2010, REACTIVE OXYGEN SPEC, P101, DOI DOI 10.1201/9781439854082-7; Nikraftar F, 2013, PHYSIOL MOL PLANT P, V81, P74, DOI 10.1016/j.pmpp.2012.11.004; Pietrowska E, 2015, PROTOPLASMA, V252, P307, DOI 10.1007/s00709-014-0680-6; Pogany M, 2009, PLANT PHYSIOL, V151, P1459, DOI 10.1104/pp.109.141994; Raschke M, 2011, PLANT J, V66, P414, DOI 10.1111/j.1365-313X.2011.04499.x; Rodriguez-Navarro S, 2002, YEAST, V19, P1261, DOI 10.1002/yea.916; Samsatly J, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01429; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Sneh B., 2013, RHIZOCTONIA SPECIES; Stetina KC, 2006, PLANT DIS, V90, P39, DOI 10.1094/PD-90-0039; Taheri P, 2011, J PLANT PHYSIOL, V168, P1114, DOI 10.1016/j.jplph.2011.01.001; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tsror L, 2010, J PHYTOPATHOL, V158, P649, DOI 10.1111/j.1439-0434.2010.01671.x; Unger C, 2005, J PHYTOPATHOL, V153, P15, DOI 10.1111/j.1439-0434.2004.00922.x; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Vanderschuren H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00143; Wagner S, 2006, PLANT CELL, V18, P1722, DOI 10.1105/tpc.105.036269; Zhang Y., 2014, INT J ANTENN PROPAG, V2014, P6, DOI DOI 10.3390/SU6084910; Zhang YF, 2014, MOL PLANT MICROBE IN, V27, P688, DOI 10.1094/MPMI-01-14-0020-R; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	61	22	23	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192682	10.1371/journal.pone.0192682	http://dx.doi.org/10.1371/journal.pone.0192682			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466404	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300066
J	Vreeman, RC; Ayaya, SO; Musick, BS; Yiannoutsos, CT; Cohen, CR; Nash, D; Wabwire, D; Wools-Kaloustian, K; Wiehe, SE				Vreeman, Rachel C.; Ayaya, Samuel O.; Musick, Beverly S.; Yiannoutsos, Constantin T.; Cohen, Craig R.; Nash, Denis; Wabwire, Deo; Wools-Kaloustian, Kara; Wiehe, Sarah E.			Adherence to antiretroviral therapy in a clinical cohort of HIV-infected children in East Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; HIV-1-INFECTED CHILDREN; REPORTED ADHERENCE; DRUG-RESISTANCE; UNITED-KINGDOM; WESTERN KENYA; MORTALITY; UGANDA; AIDS	Objective To describe antiretroviral therapy (ART) adherence and associated factors for a large HIV-infected pediatric cohort followed by sites of the East Africa International Epidemiologic Databases to Evaluate AIDS (IeDEA) consortium. Methods This study utilized prospectively collected clinical data from HIV-infected children less than 13 years of age who initiated ART within 4 clinical care programs (with 26 clinical sites) in Kenya, Uganda, and Tanzania and were followed for up to 6 years. Programs used one of 3 adherence measures, including 7-day quantitative recall, 7-day categorical recall, and clinician pill assessments. We fit a hierarchical, three-level, logistic-regression model to examine adherence, with observations nested within patient, and patients within the 26 sites providing pediatric HIV data to this analysis. Results In East Africa, 3,304 children, 52.0% male, were enrolled in care and were subsequently observed for a median of 92 weeks (inter-quartile range [IQR] 50.3-145.0 weeks). Median age at ART initiation was 5.5 years ([IQR] 3.0-8.5 years). "Good" adherence, as reported by each clinic's measures, was extremely high, remaining on average above 90% throughout all years of follow-up. Longer time on ART was associated with higher adherence (adjusted Odds Ratio-aOR-per log-transformed week on ART: 1.095, 95% Confidence Interval-CI-[1.052-1.150].) Patients enrolled in higher-volume programs exhibited higher rates of clinician- assessed adherence (aOR per log-500 patients: 1.174, 95% CI [1.108-1.245]). Significant site-level variability in reported adherence was observed (0.28), with even higher variability among patients (0.71). In a sub-analysis, being an orphan at the start of ART was strongly associated with lower ART adherence rates (aOR: 0.919, 95% CI [0.864-0.976]). Conclusions Self-reported adherence remained high over a median of 1.8 years in HIV care, but varied according to patient-level and site-level factors. Consistent adherence monitoring with validated measures and attention to vulnerable groups is recommended.	[Vreeman, Rachel C.; Musick, Beverly S.; Yiannoutsos, Constantin T.; Wools-Kaloustian, Kara; Wiehe, Sarah E.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Vreeman, Rachel C.; Wools-Kaloustian, Kara; Wiehe, Sarah E.] Regenstrief Inst Inc, Indianapolis, IN 46202 USA; [Vreeman, Rachel C.; Ayaya, Samuel O.; Musick, Beverly S.; Wools-Kaloustian, Kara; Wiehe, Sarah E.] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Vreeman, Rachel C.; Ayaya, Samuel O.] Moi Univ, Sch Med, Coll Hlth Sci, Eldoret, Kenya; [Yiannoutsos, Constantin T.] RM Fairbanks Sch Publ Hlth, Indianapolis, IN USA; [Cohen, Craig R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Nash, Denis] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Wabwire, Deo] Makerere Univ Johns Hopkins Univ Res Collaborat, Kampala, Uganda	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Moi University; University of California System; University of California San Francisco; City University of New York (CUNY) System; Makerere University	Vreeman, RC (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.; Vreeman, RC (corresponding author), Regenstrief Inst Inc, Indianapolis, IN 46202 USA.; Vreeman, RC (corresponding author), Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya.; Vreeman, RC (corresponding author), Moi Univ, Sch Med, Coll Hlth Sci, Eldoret, Kenya.	rvreeman@iu.edu	Nash, Denis/AFI-7485-2022; Wiehe, Sarah/ABH-4578-2020	Wiehe, Sarah/0000-0002-8148-0848; Nash, Denis/0000-0002-3280-5386; Vreeman, Rachel/0000-0001-5460-8204	National Institute for Mental Health (NIH) [5K23MH087225-03]; National Institute of Allergy and Infectious Disease (NIH) [U01 AI069911]; President's Emergency Plan for AIDS Relief (PEPFAR) through USAID [AID-623-A-12-0001]; United States Agency for International Development (USAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069911, U01AI096299] Funding Source: NIH RePORTER	National Institute for Mental Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Disease (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); President's Emergency Plan for AIDS Relief (PEPFAR) through USAID(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by a career development award to Dr. Vreeman from the National Institute for Mental Health (NIH) (grant number 5K23MH087225-03), and the East Africa IeDEA Consortium is supported by National Institute of Allergy and Infectious Disease (NIH) (grant number U01 AI069911). This research was also supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through USAID under the terms of Cooperative Agreement No. AID-623-A-12-0001, which is made possible through joint support of the United States Agency for International Development (USAID). The funders had no role in study design, interpretation of results, or decision to publish.; These data were collected by a large number of committed of clinicians and staff providing HIV care across East Africa; their diligence and hard work are much appreciated. The IeDEA consortium is funded by the National Institute of Allergy and Infectious Disease (U01 AI069911). Dr. Vreeman's work was also supported by the National Institute of Mental Health (5K23MH087225- 03). This research was also supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through USAID under the terms of Cooperative Agreement No. AID-623-A-12- 0001, which is made possible through joint support of the United States Agency for International Development (USAID). The funders had no role in study design, interpretation of results, or decision to publish.	Bangsberg David R, 2007, Curr HIV/AIDS Rep, V4, P65, DOI 10.1007/s11904-007-0010-0; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bhattacharya M, 2011, ANN TROP PAEDIATR, V31, P331, DOI 10.1179/1465328111Y.0000000031; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Biressaw S, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-132; Boyd MA, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000279707.01557.b2; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Doerholt K, 2006, PEDIATR INFECT DIS J, V25, P420, DOI 10.1097/01.inf.0000214994.44346.d3; Eby J, 2015, PHARMACOEPIDEM DR S, V24, P1313, DOI 10.1002/pds.3887; Egger M, 2011, INT J EPIDEMIOLOGY; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Elise A, 2005, JAIDS-J ACQ IMM DEF, V40, P498, DOI 10.1097/01.qai.0000168180.76405.5f; Gavin Patrick J, 2002, Paediatr Drugs, V4, P581; Gibb DM, 2003, BMJ-BRIT MED J, V327, P1019, DOI 10.1136/bmj.327.7422.1019; Gibb DM, 2003, PEDIATR INFECT DIS J, V22, P56, DOI 10.1097/00006454-200301000-00015; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Gross R, 2015, AIDS CARE, V27, P322, DOI 10.1080/09540121.2014.969676; Group: WMGRS, 2006, WHO CHILD GROWTH STA; Haberer Jessica, 2009, Curr HIV/AIDS Rep, V6, P194, DOI 10.1007/s11904-009-0026-8; Haberer JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036737; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Johnson LF, 2012, PEDIATR INFECT DIS J, V31, P474, DOI 10.1097/INF.0b013e3182456ba2; Kabue MM, 2008, AIDS PATIENT CARE ST, V22, P245, DOI 10.1089/apc.2007.0049; Kulzer JL, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-8; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Little K, 2007, CURR HIV RES, V5, P139, DOI 10.2174/157016207780077002; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Mghamba FW, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-95; Mukhtar-Yola Mariya, 2006, Afr J AIDS Res, V5, P141, DOI 10.2989/16085900609490374; Mullen J, 2002, J MED VIROL, V68, P299, DOI 10.1002/jmv.10203; Muller AD, 2008, PEDIAT INFECT DIS J; Myer L, 2005, REPROD HEALTH MATTER, V13, P136, DOI 10.1016/S0968-8080(05)25185-6; Nabukeera-Barungi N, 2007, ANN TROP PAEDIATR, V27, P123, DOI 10.1179/146532807X192499; Nabukeera-Barungi N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1265-5; Nassali M, 2009, AIDS CARE, V21, P1124, DOI 10.1080/09540120802707467; Nsheha AH, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.238.2280; Nyandiko WM, 2006, JAIDS-J ACQ IMM DEF, V43, P418, DOI 10.1097/01.qai.0000243122.52282.89; Olds PK, 2015, AIDS CARE, V27, P327, DOI 10.1080/09540121.2014.983452; Polisset J, 2009, AIDS BEHAV, V13, P23, DOI 10.1007/s10461-008-9437-6; Remien RH, 2007, AIDS BEHAV, V11, P663, DOI 10.1007/s10461-006-9201-8; San-Andres FJ, 2003, CLIN INFECT DIS, V36, P1177, DOI 10.1086/374358; Simoni JM, 2007, PEDIATRICS, V119, pE1371, DOI 10.1542/peds.2006-1232; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Tam LW, 2008, J ACQUIR IMMUNE DEFI; The State of the World's Children 2009, 2009, STAT WORLDS CHILDR 2; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNICEF, 2012, ORPH; Van Dyke RB, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e61; Vreeman RC, 2008, JAIDS-J ACQ IMM DEF, V49, P163, DOI 10.1097/QAI.0b013e318183a996; Vreeman RC, 2008, PEDIATR INFECT DIS J, V27, P686, DOI 10.1097/INF.0b013e31816dd325; Vreeman Rachel C, 2014, J Int AIDS Soc, V17, P19227, DOI 10.7448/IAS.17.1.19227; Vreeman RC, 2015, AIDS BEHAV, V19, P626, DOI 10.1007/s10461-015-0998-x; Walker AS, 2008, AIDS BEHAV; World Health Organization, 2006, PROGR GLOB ACC HIV A; Yoder RB, 2011, J ACQUIRED IMMUNE DE	57	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0191848	10.1371/journal.pone.0191848	http://dx.doi.org/10.1371/journal.pone.0191848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	29466385	gold, Green Published			2022-12-26	WOS:000425604300018
J	Fuller-Jackson, JP; Clarke, IJ; Rao, A; Henry, BA				Fuller-Jackson, John-Paul; Clarke, Iain J.; Rao, Alexandra; Henry, Belinda A.			Exercise counteracts the homeostatic decrease in thermogenesis caused by caloric restriction in sheep	FASEB JOURNAL			English	Article						brown adipose tissue; diet; physical activity; hypothalamic appetite-regulating peptides	BROWN ADIPOSE-TISSUE; REDUCED BODY-WEIGHT; ENERGY-EXPENDITURE; ADAPTIVE THERMOGENESIS; SKELETAL-MUSCLE; MELANOCORTIN-4 RECEPTOR; UNCOUPLING PROTEIN-3; OVARIECTOMIZED EWES; PHYSICAL-ACTIVITY; OREXIN-A	Caloric restriction causes a homeostatic reduction in thermogenesis. We aimed to determine whether exercise could counteract this. We studied four groups of normal-weight ewes (n = 5), including control sedentary fed ad libitum, exercise fed ad libitum (30 min/d, 5 d/wk), diet-restricted (70% of ad libitum food intake), and combined diet and exercise. Temperature probes implanted in sternal and retroperitoneal adipose tissue and skeletal muscle measured thermogenesis. After the 4-wk intervention, hypothalami were collected for in situ hybridization, and fat and muscle biopsies were collected for real-time PCR and Western blotting. Combined diet and exercise reduced adiposity (P < 0.05). Caloric restriction alone reduced overnight temperatures in sternal and retroperitoneal fat (P < 0.05), which was counteracted by exercise (P < 0.05). Exercise did not induce expression of cellular markers of browning in adipose tissue. There was no effect of diet or exercise on skeletal muscle thermogenesis. Combined diet and exercise increased the expression of neuropeptide Y and agouti-related protein in the hypothalamic arcuate nucleus (P < 0.05), consistent with reduced adiposity. Gene expressions of key hypothalamic appetite-regulating peptides were not associated with altered thermogenesis. We demonstrate that exercise counteracts the inhibitory effect of caloric restriction to restore thermogenesis in adipose tissue of sheep.Fuller-Jackson, J.-P., Clarke, I. J., Rao, A., Henry, B. A. Exercise counteracts the homeostatic decrease in thermogenesis caused by caloric restriction in sheep.	[Fuller-Jackson, John-Paul; Clarke, Iain J.; Rao, Alexandra; Henry, Belinda A.] Monash Univ, Dept Physiol, Monash Biomed Discovery Inst, Clayton, Vic, Australia	Monash University	Henry, BA (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Metab Diabet & Obes Program, Dept Physiol, 26 Innovat Walk,Bldg 13 F,Wellington Rd, Clayton, Vic 3800, Australia.	belinda.henry@monash.edu		Clarke, Iain/0000-0002-6613-2757; Fuller-Jackson, John-Paul/0000-0002-2997-1340				Anderson EJP, 2016, J MOL ENDOCRINOL, V56, pT157, DOI 10.1530/JME-16-0014; Arruda AP, 2007, BBA-BIOMEMBRANES, V1768, P1498, DOI 10.1016/j.bbamem.2007.03.016; Backholer K, 2010, NEUROENDOCRINOLOGY, V91, P27, DOI 10.1159/000260060; BALLOR DL, 1988, AM J CLIN NUTR, V47, P19, DOI 10.1093/ajcn/47.1.19; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; BOCKING AD, 1986, J DEV PHYSIOL, V8, P237; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cakir I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008322; Calbet JAL, 2015, SCAND J MED SCI SPOR, V25, P223, DOI 10.1111/sms.12194; Camps SGJA, 2015, METABOLISM, V64, P1284, DOI 10.1016/j.metabol.2015.06.016; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Germano CMR, 2008, HORM METAB RES, V40, P842, DOI 10.1055/s-0028-1086024; Goele K, 2009, OBESITY FACTS, V2, P105, DOI 10.1159/000210369; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Harper ME, 2002, DIABETES, V51, P2459, DOI 10.2337/diabetes.51.8.2459; Henry BA, 2015, J ANIM SCI, V93, P2083, DOI 10.2527/jas.2014-8764; Henry BA, 2001, BRAIN RES, V918, P40, DOI 10.1016/S0006-8993(01)02918-3; Henry BA, 2000, ENDOCRINOLOGY, V141, P1506, DOI 10.1210/en.141.4.1506; Henry BA, 2017, ENDOCRINOLOGY, V158, P2212, DOI 10.1210/en.2017-00081; Henry BA, 2011, ENDOCRINOLOGY, V152, P2609, DOI 10.1210/en.2011-0143; Hewagalamulage SD, 2015, J NEUROENDOCRINOL, V27, P44, DOI 10.1111/jne.12233; Hewagalamulage SD, 2016, ENDOCRINOLOGY, V157, P3540, DOI 10.1210/en.2016-1287; HIRATA K, 1981, JPN J PHYSIOL, V31, P657; Johns DJ, 2014, J ACAD NUTR DIET, V114, P1557, DOI 10.1016/j.jand.2014.07.005; KAHN CR, 1976, J CELL BIOL, V70, P261, DOI 10.1083/jcb.70.2.261; KEKOW J, 1988, DIABETES, V37, P321, DOI 10.2337/diabetes.37.3.321; Kissileff HR, 2012, AM J CLIN NUTR, V95, P309, DOI 10.3945/ajcn.111.012385; Kiwaki K, 2004, AM J PHYSIOL-ENDOC M, V286, pE551, DOI 10.1152/ajpendo.00126.2003; Kotz CM, 2006, NEUROSCIENCE, V142, P29, DOI 10.1016/j.neuroscience.2006.05.028; Kotz CM, 2002, REGUL PEPTIDES, V104, P27, DOI 10.1016/S0167-0115(01)00346-9; LEHMAN MN, 1986, J COMP NEUROL, V244, P19, DOI 10.1002/cne.902440103; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; LEWIS DE, 1993, AM J PHYSIOL, V264, pE279, DOI 10.1152/ajpendo.1993.264.2.E279; Loh K, 2015, TRENDS ENDOCRIN MET, V26, P125, DOI 10.1016/j.tem.2015.01.003; MacLean PS, 2009, AM J PHYSIOL-REG I, V297, pR793, DOI 10.1152/ajpregu.00192.2009; Motiani P, 2017, DIABETES OBES METAB, V19, P1379, DOI 10.1111/dom.12947; Muller MJ, 2015, AM J CLIN NUTR, V102, P807, DOI 10.3945/ajcn.115.109173; Nixon Joshua P, 2012, Handb Exp Pharmacol, P77, DOI 10.1007/978-3-642-24716-3_4; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Novak CM, 2006, AM J PHYSIOL-ENDOC M, V290, pE396, DOI 10.1152/ajpendo.00293.2005; Oldfield BJ, 2002, NEUROSCIENCE, V110, P515, DOI 10.1016/S0306-4522(01)00555-3; Overton JM, 2004, PHYSIOL BEHAV, V81, P749, DOI 10.1016/j.physbeh.2004.04.025; Rogers NH, 2016, ENDOCRINOLOGY, V157, P1430, DOI 10.1210/en.2015-1745; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Rosenbaum M, 2016, OBESITY, V24, P1620, DOI 10.1002/oby.21559; ROTHWELL NJ, 1984, BIOSCIENCE REP, V4, P351, DOI 10.1007/BF01140499; Scharhag-Rosenberger F, 2014, MED SCI SPORT EXER, V46, P1736, DOI 10.1249/MSS.0000000000000286; Song CK, 2008, AM J PHYSIOL-REG I, V295, pR417, DOI 10.1152/ajpregu.00174.2008; THOMAS GB, 1991, ENDOCRINOLOGY, V128, P1151, DOI 10.1210/endo-128-2-1151; Trexler E. T., 2017, J NAT SCI, V3, pe335; Tupone D, 2011, J NEUROSCI, V31, P15944, DOI 10.1523/JNEUROSCI.3909-11.2011; Valle A, 2005, AM J PHYSIOL-ENDOC M, V289, pE15, DOI 10.1152/ajpendo.00553.2004; Verty ANA, 2010, ENDOCRINOLOGY, V151, P4236, DOI 10.1210/en.2009-1235; Vosselman MJ, 2015, INT J OBESITY, V39, P1696, DOI 10.1038/ijo.2015.130; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu MV, 2014, J BIOL CHEM, V289, P34129, DOI 10.1074/jbc.M114.591008; YOSHIOKA K, 1989, ENDOCRINOL JAPON, V36, P403; Yu YH, 2009, BEHAV BRAIN RES, V205, P50, DOI 10.1016/j.bbr.2009.07.003	61	2	2	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3859	3869		10.1096/fj.201701504R	http://dx.doi.org/10.1096/fj.201701504R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29455575				2022-12-26	WOS:000435104500031
J	Garcia-Guerrero, AE; Camacho-Villasana, Y; Zamudio-Ochoa, A; Winge, DR; Perez-Martinez, X				Garcia-Guerrero, Aldo E.; Camacho-Villasana, Yolanda; Zamudio-Ochoa, Angelica; Winge, Dennis R.; Perez-Martinez, Xochitl			Cbp3 and Cbp6 are dispensable for synthesis regulation of cytochrome b in yeast mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MITOCHONDRIA; COENZYME QH2-CYTOCHROME-C REDUCTASE; RIESKE FE/S PROTEIN; MESSENGER-RNA; NUCLEAR GENE; BC(1) COMPLEX; MEMBRANE SYSTEM; TRANSLATIONAL ACTIVATION; EXPRESSION; COX1	Cytochrome b (Cytb) is the only mitochondrial encoded subunit from the bc(1) complex. Cbp3 and Cbp6 are chaperones necessary for translation of the COB mRNA and Cytb hemylation. Here we demonstrate that their role in translation is dispensable in some laboratory strains, whereas their role in Cytb hemylation seems to be universally conserved. BY4742 yeast requires Cbp3 and Cbp6 for efficient COB mRNA translation, whereas the D273-10b strain synthesizes Cytb at wildtype levels in the absence of Cbp3 and Cbp6. Steady-state levels of Cytb are close to wildtype in mutant D273-10b cells, and Cytb forms non-functional, supercomplex-like species with cytochrome c oxidase, in which at least core 1, cytochrome c(1), and Rieske iron-sulfur subunits are present. We demonstrated that Cbp3 interacts with the mitochondrial ribosome and with the COB mRNA in both BY4742 and D273-10b strains. The polymorphism( s) causing the differential function of Cbp3, Cbp6, and the assembly feedback regulation of Cytb synthesis is of nuclear origin rather than mitochondrial, and Smt1, a COB mRNA-binding protein, does not seem to be involved in the observed differential phenotype. Our results indicate that the essential role of Cbp3 and Cbp6 is to assist Cytb hemylation and demonstrate that in the absence of heme b, Cytb can form non-functional supercomplexes with cytochrome c oxidase. Our observations support that an additional protein or proteins are involved in Cytb synthesis in some yeast strains.	[Garcia-Guerrero, Aldo E.; Camacho-Villasana, Yolanda; Zamudio-Ochoa, Angelica; Perez-Martinez, Xochitl] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Circuito Exterior S-N Ciudad Univ, Mexico City 04510, DF, Mexico; [Winge, Dennis R.] Univ Utah, Dept Med & Biochem, Hlth Sci Ctr, Salt Lake City, UT 84132 USA; [Zamudio-Ochoa, Angelica] Rowan Univ, Sch Osteopath Med, Dept Cell Biol, 2 Med Ctr Dr, Stratford, NJ 08084 USA	Universidad Nacional Autonoma de Mexico; Utah System of Higher Education; University of Utah; Rowan University; Rowan University School of Osteopathic Medicine	Perez-Martinez, X (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Circuito Exterior S-N Ciudad Univ, Mexico City 04510, DF, Mexico.	xperez@ifc.unam.mx	Zamudio-Ochoa, Angelica/AAC-3684-2020	Zamudio-Ochoa, Angelica/0000-0002-6347-5789	Consejo Nacional de Ciencia y Tecnologia [47514, 255917]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico [IN204414, IN209217]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK110858] Funding Source: NIH RePORTER	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Consejo Nacional de Ciencia y Tecnologia Grant 47514 (to X.P.-M.) and Fellowship 255917 (to A.E. G.-G.) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico Grants IN204414 and IN209217 (to X.P.-M.). The authors declare that they have no conflicts of interest with the contents of this article.	Atkinson A, 2011, MOL CELL BIOL, V31, P3988, DOI 10.1128/MCB.05673-11; Atkinson A, 2010, J BIOL CHEM, V285, P19450, DOI 10.1074/jbc.M110.109793; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Bestwick M, 2010, MOL CELL BIOL, V30, P172, DOI 10.1128/MCB.00869-09; Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2; Brachmann CB, 1998, YEAST, V14, P115; BRANDT U, 1994, J BIOL CHEM, V269, P12947; Burke D., 2000, METHODS YEAST GENETI, P39; Conte A, 2015, BBA-MOL CELL RES, V1853, P987, DOI 10.1016/j.bbamcr.2015.02.006; COSTANZO MC, 1988, P NATL ACAD SCI USA, V85, P2677, DOI 10.1073/pnas.85.8.2677; CRIVELLONE MD, 1988, J BIOL CHEM, V263, P14323; Cui TZ, 2014, J BIOL CHEM, V289, P6133, DOI 10.1074/jbc.M113.523688; Cui TZ, 2012, MOL CELL BIOL, V32, P4400, DOI 10.1128/MCB.00441-12; DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513; DIECKMANN CL, 1984, J BIOL CHEM, V259, P4722; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; Garcia-Villegas R, 2017, J BIOL CHEM, V292, P10912, DOI 10.1074/jbc.M116.773077; Gruschke S, 2012, J CELL BIOL, V199, P137, DOI 10.1083/jcb.201206040; Gruschke S, 2011, J CELL BIOL, V193, P1101, DOI 10.1083/jcb.201103132; Guthrie C., 2002, GUIDE YEAST GENETICS, P23; Hildenbeutel M, 2014, J CELL BIOL, V205, P511, DOI 10.1083/jcb.201401009; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Islas-Osuna MA, 2002, J BIOL CHEM, V277, P37987, DOI 10.1074/jbc.M206132200; Kehrein K, 2015, ONCOTARGET, V6, P16806, DOI 10.18632/oncotarget.4783; Kim HJ, 2012, BBA-MOL CELL RES, V1823, P1604, DOI 10.1016/j.bbamcr.2012.04.008; Krause-Buchholz U, 2004, CURR GENET, V46, P20, DOI 10.1007/s00294-004-0503-y; Kuhl I, 2012, MITOCHONDRION, V12, P381, DOI 10.1016/j.mito.2012.02.002; LABOUESSE M, 1984, EUR J BIOCHEM, V144, P85, DOI 10.1111/j.1432-1033.1984.tb08434.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Ostojic J, 2016, NUCLEIC ACIDS RES, V44, P5785, DOI 10.1093/nar/gkw490; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Rak M, 2016, MOL BIOL CELL, V27, P919, DOI 10.1091/mbc.E15-09-0642; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; Ralser M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120093; RODEL G, 1986, CURR GENET, V11, P41, DOI 10.1007/BF00389424; RODEL G, 1986, CURR GENET, V11, P47, DOI 10.1007/BF00389425; SCHAGGER H, 1988, ANAL BIOCHEM, V173, P201, DOI 10.1016/0003-2697(88)90179-0; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SHERMAN F, 1963, GENETICS, V48, P375; Shingu-Vazquez M, 2010, J BIOL CHEM, V285, P34382, DOI 10.1074/jbc.M110.161976; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Su CH, 2014, MOL BIOL CELL, V25, P965, DOI [10.1091/mbc.E13-0-0575, 10.1091/mbc.E13-10-0575]; Wegener N, 2011, MOL CELL, V44, P191, DOI 10.1016/j.molcel.2011.07.036; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WU M, 1989, J BIOL CHEM, V264, P11122; Young MJ, 2008, YEAST, V25, P903, DOI 10.1002/yea.1644; Zamudio-Ochoa A, 2014, RNA BIOL, V11, P953, DOI 10.4161/rna.29780; Zara V, 2004, EUR J BIOCHEM, V271, P1209, DOI 10.1111/j.1432-1033.2004.04024.x; Zara V, 2009, BBA-MOL CELL RES, V1793, P89, DOI 10.1016/j.bbamcr.2008.04.011; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	58	4	4	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5585	5599		10.1074/jbc.RA117.000547	http://dx.doi.org/10.1074/jbc.RA117.000547			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475949	Green Published, hybrid			2022-12-26	WOS:000430044100020
J	Xu, YC; Lin, JX; Cui, T; Srinivas, S; Feng, YJ				Xu, Yongchang; Lin, Jingxia; Cui, Tao; Srinivas, Swaminath; Feng, Youjun			Mechanistic insights into transferable polymyxin resistance among gut bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED COLISTIN-RESISTANCE; ESCHERICHIA-COLI; PHOSPHOETHANOLAMINE TRANSFERASE; LIPID-A; CARBAPENEM-RESISTANT; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; GENE; IDENTIFICATION	Polymyxins such as colistin are antibiotics used as a final line of defense in the management of infections with multidrug-resistant Gram-negative bacteria. Although natural resistance to polymyxins is rare, the discovery of a mobilized colistin resistance gene (mcr-1) in gut bacteria has raised significant concern. As an intramembrane enzyme, MCR-1 catalyzes the transfer of phosphoethanolamine (PEA) to the 1 (or 4')-phosphate group of the lipid A moiety of lipopolysaccharide, thereby conferring colistin resistance. However, the structural and biochemical mechanisms used by this integral membrane enzyme remain poorly understood. Here, we report the modeled structure of the full-length MCR-1 membrane protein. Together with molecular docking, our structural and functional dissection of the complex of MCR-1 with its phosphatidylethanolamine (PE) substrate suggested the presence of a 12 residue-containing cavity for substrate entry, which is critical for both enzymatic activity and its resultant phenotypic resistance to colistin. More importantly, two periplasm-facing helices (PH2 and PH2') of the trans-membrane domain were essential for MCR-1 activity. MALDI-TOF MS and thin-layer chromatography assays provide both in vivo and in vitro evidence that MCR-1 catalyzes the transfer of PEA from the PE donor substrate to its recipient substrate lipid A. Also, the chemical modification of lipid A species was detected in clinical species of bacteria carrying mcr-1. Our results provide mechanistic insights into transferable MCR-1 polymyxin resistance, raising the prospect of rational design of small molecules that reverse bacterial polymyxin resistance, as a last-resort clinical option to combat pathogens with carbapenem resistance.	[Xu, Yongchang; Lin, Jingxia; Feng, Youjun] Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou 310058, Zhejiang, Peoples R China; [Feng, Youjun] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Cui, Tao] Northwestern Polytech Univ, Sch Life Sci, Xian 710072, Shaanxi, Peoples R China; [Srinivas, Swaminath] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	Zhejiang University; Zhejiang University; Northwestern Polytechnical University; University of Illinois System; University of Illinois Urbana-Champaign	Feng, YJ (corresponding author), Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou 310058, Zhejiang, Peoples R China.	fengyj@zju.edu.cn	Srinivas, Swaminath/AAK-7213-2021	Srinivas, Swaminath/0000-0002-7210-5122	National Key RAMP;D Program of China [2017YFD0500202]; National Key Basic Research Program of China [2016YFC1200100]; National Natural Science Foundation of China [31570027, 81772142]; Fundamental Research Funds for the Central Universities [3102016QD022]	National Key RAMP;D Program of China; National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Key R&D Program of China Grant 2017YFD0500202 (to Y.F.), National Key Basic Research Program of China Grant 2016YFC1200100 (to Y.F.), National Natural Science Foundation of China Grants 31570027 and 81772142 (to Y.F.), and Fundamental Research Funds for the Central Universities Grant 3102016QD022 (to T.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen WJ, 2015, J COMPUT CHEM, V36, P1132, DOI 10.1002/jcc.23905; Alves AL, 2017, COSMETICS-BASEL, V4, P39, DOI [DOI 10.3390/COSMETICS4040039, 10.3390/cosmetics4040039]; Anandan A, 2017, P NATL ACAD SCI USA, V114, P2218, DOI 10.1073/pnas.1612927114; Baron S, 2016, INT J ANTIMICROB AG, V48, P583, DOI 10.1016/j.ijantimicag.2016.06.023; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Borowiak M, 2017, J ANTIMICROB CHEMOTH, V72, P3317, DOI 10.1093/jac/dkx327; Carattoli A, 2017, EUROSURVEILLANCE, V22, P18, DOI 10.2807/1560-7917.ES.2017.22.31.30589; CAROFF M, 1988, CARBOHYD RES, V175, P273, DOI 10.1016/0008-6215(88)84149-1; CDC, 2013, ANTIBIOTIC RESISTANC; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; Delgado-Blas JF, 2016, ANTIMICROB AGENTS CH, V60, P6356, DOI 10.1128/AAC.01319-16; Di Pilato V, 2016, ANTIMICROB AGENTS CH, V60, P5612, DOI 10.1128/AAC.01075-16; Du H, 2016, LANCET INFECT DIS, V16, P287, DOI 10.1016/S1473-3099(16)00056-6; El Garch F, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2016.08.033; El Hamidi A, 2005, J LIPID RES, V46, P1773, DOI 10.1194/jlr.D500014-JLR200; Feng YJ, 2015, MICROBIOLOGYOPEN, V4, P644, DOI 10.1002/mbo3.270; Feng YJ, 2013, J BACTERIOL, V195, P3451, DOI 10.1128/JB.00378-13; Feng YJ, 2011, MOL MICROBIOL, V80, P195, DOI 10.1111/j.1365-2958.2011.07564.x; Gao RS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005957; Gao RS, 2016, SCI CHINA LIFE SCI, V59, P732, DOI 10.1007/s11427-016-5070-1; Gros M, 2013, J CHROMATOGR A, V1292, P173, DOI 10.1016/j.chroma.2012.12.072; Haenni M, 2016, ANTIMICROB AGENTS CH, V60, P6433, DOI 10.1128/AAC.01147-16; Hankins JV, 2012, P NATL ACAD SCI USA, V109, P8722, DOI 10.1073/pnas.1201313109; Hasman H, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.49.30085; Hinchliffe P, 2017, SCI REP-UK, V7, DOI 10.1038/srep39392; Hu ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep38793; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Laxminarayan R, 2016, LANCET, V388, P218, DOI 10.1016/S0140-6736(16)31079-0; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Li RC, 2017, J ANTIMICROB CHEMOTH, V72, P393, DOI 10.1093/jac/dkw411; Li W., 2015, NUCLEIC ACIDS RES, V43, pW58, DOI DOI 10.1093/nar/gkv316; Li ZC, 2016, SCI CHINA LIFE SCI, V59, P971, DOI 10.1007/s11427-016-5111-9; Liu L., 2017, ATMOS CHEM PHYS DISC, V2017, P1, DOI DOI 10.1002/EJLT.201500463; Liu Y., 2017, MATH PROBLEMS ENG, V2017, P1, DOI DOI 10.1111/0DI.12660.[; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Loeschner K, 2015, ANAL BIOANAL CHEM, V407, P4541, DOI 10.1007/s00216-015-8631-4; Lu X, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.02632-16, 10.1128/AAC.02632-16]; Ma GX, 2016, SCI REP-UK, V6, DOI 10.1038/srep39540; Monte DF, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02718-16; Paterson DL, 2016, LANCET INFECT DIS, V16, P132, DOI 10.1016/S1473-3099(15)00463-6; Petrou VI, 2016, SCIENCE, V351, P608, DOI 10.1126/science.aad1172; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poirel L, 2017, J ANTIMICROB CHEMOTH, V72, P2947, DOI 10.1093/jac/dkx225; Poirel L, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.00127-17, 10.1128/AAC.00127-17]; Powl AM, 2010, P NATL ACAD SCI USA, V107, P14064, DOI 10.1073/pnas.1001793107; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Roer L, 2017, EURO SURVEILL, V22; Schwarz S, 2016, J ANTIMICROB CHEMOTH, V71, P2066, DOI 10.1093/jac/dkw274; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Stec B, 2000, J MOL BIOL, V299, P1303, DOI 10.1006/jmbi.2000.3799; Stojanoski V, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0303-0; Sun J, 2017, MBIO, V8, DOI 10.1128/mBio.00625-17; Sun J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.176, 10.1038/nmicrobiol.2016.176]; Tijet N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180347; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Wang QJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00361-17; Wang QJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0288-0; Wanty C, 2013, J MOL BIOL, V425, P3389, DOI 10.1016/j.jmb.2013.06.029; Wei PC, 2018, FASEB J, V32, P1085, DOI 10.1096/fj.201700705R; World Health Organization, 2014, ANT RES GLOB REP SUR; Xavier BB, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.27.30280; Yang YQ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01204-16, 10.1128/AAC.01204-16]; Yao X, 2016, LANCET INFECT DIS, V16, P288, DOI 10.1016/S1473-3099(16)00057-8; Ye HY, 2016, MBIO, V7, DOI 10.1128/mBio.00177-16; Yin WJ, 2017, MBIO, V8, DOI 10.1128/mBio.00543-17; Zhai YF, 2002, J MOL MICROB BIOTECH, V4, P69; Zhang HM, 2016, SCI BULL, V61, P875, DOI 10.1007/s11434-016-1086-y; Zhang XF, 2016, EMERG INFECT DIS, V22, P1679, DOI 10.3201/eid2209.160464; Zhao FF, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02229-16; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200	76	36	41	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4350	4365		10.1074/jbc.RA117.000924	http://dx.doi.org/10.1074/jbc.RA117.000924			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29462787	Green Published, hybrid			2022-12-26	WOS:000428204300009
J	Bernard, L; Eljezi, T; Clauson, H; Lambert, C; Bouattour, Y; Chennell, P; Pereira, B; Sautou, V				Bernard, Lise; Eljezi, Teuta; Clauson, Helene; Lambert, Celine; Bouattour, Yassine; Chennell, Philip; Pereira, Bruno; Sautou, Valerie		ARMED Study Grp	Effects of flow rate on the migration of different plasticizers from PVC infusion medical devices	PLOS ONE			English	Article							PHTHALATE	Infusion medical devices (MDs) used in hospitals are often made of plasticized polyvinylchloride (PVC). These plasticizers may leach out into infused solutions during clinical practice, especially during risk-situations, e.g multiple infusions in Intensive Care Units and thus may enter into contact with the patients. The migrability of the plasticizers is dependent of several clinical parameters such as temperature, contact time, nature of the simulant, etc... However, no data is available about the influence of the flow rate at which drug solutions are administrated. In this study, we evaluated the impact of different flow rates on the release of the different plasticizers during an infusion procedure in order to assess if they could expose the patients to more toxic amounts of plasticizers. Migration assays with different PVC infusion sets and extension lines were performed with different flow rates that are used in clinical practice during 1h, 2h, 4h, 8h and 24h, using a lipophilic drug simulant. From a clinical point of view, the results showed that, regardless of the plasticizer, the faster the flow rate, the higher the infused volume and the higher the quantities of plasticizers released, both from infusion sets and extension lines, leading to higher patient exposure. However, physically, there was no significant difference of the migration kinetics linked to the flow rate for a same medical device, reflecting complex interactions between the PVC matrix and the simulant. The migration was especially dependent on the nature and the composition of the medical device.	[Bernard, Lise; Eljezi, Teuta; Chennell, Philip; Sautou, Valerie] Univ Clermont Auvergne, CHU Clermont Ferrand, CNRS, SIGMA Clermont,ICCF, Clermont Ferrand, France; [Clauson, Helene; Bouattour, Yassine] CHU Clermont Ferrand, Serv Pharm, Clermont Ferrand, France; [Lambert, Celine; Pereira, Bruno] CHU Clermont Ferrand, Direct Rech Clin & Innovat, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand	Bernard, L (corresponding author), Univ Clermont Auvergne, CHU Clermont Ferrand, CNRS, SIGMA Clermont,ICCF, Clermont Ferrand, France.	l_bernard@chu-clermontferrand.fr	Chennell, Philip/I-6457-2019; Bouattour, Yassine/AAA-5569-2021	Chennell, Philip/0000-0001-8086-7517; Bouattour, Yassine/0000-0002-6937-1796; SAUTOU, Valerie/0000-0002-3944-3752	French Medicine Agency (ANSM, Agence Nationale de Securite du Medicament et des Produits de Sante)	French Medicine Agency (ANSM, Agence Nationale de Securite du Medicament et des Produits de Sante)	This study is a part of the project ARMED (Assessment and risk management of medical devices in plasticized polyvinyl chloride) which has received the financial support of the French Medicine Agency (ANSM, Agence Nationale de Securite du Medicament et des Produits de Sante). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; "This study is a part of the project ARMED (Assessment and risk management of medical devices in plasticized polyvinyl chloride) which has received the financial support of the French Medicine Agency (ANSM, Agence Nationale de Securite du Medicament et des Produits de Sante)"	Al Salloum H, 2017, MAT SCI ENG C-MATER, V75, P317, DOI 10.1016/j.msec.2017.02.057; Al Salloum H, 2016, MAT SCI ENG C-MATER, V61, P56, DOI 10.1016/j.msec.2015.12.008; Bagel-Boithias S, 2005, AM J HEALTH-SYST PH, V62, P182, DOI 10.1093/ajhp/62.2.182; Bernard L, 2015, INT J PHARMACEUT, V494, P136, DOI 10.1016/j.ijpharm.2015.08.033; Bernard L, 2015, INT J PHARMACEUT, V485, P341, DOI 10.1016/j.ijpharm.2015.03.030; Bernard L, 2014, TALANTA, V129, P39, DOI 10.1016/j.talanta.2014.04.069; Bernardini L. G., 2015, ANAL BIOANAL CHEM, P1; Bourdeaux D, 2016, J PHARMACEUT BIOMED, V118, P206, DOI 10.1016/j.jpba.2015.10.034; David RM, 2015, TOXICOL LETT, V238, P100, DOI 10.1016/j.toxlet.2015.07.013; National Industry Chemicals Notification and Assessment Scheme (NICNAS), 2012, EX170STD1259 NICNAS; Rose RJ, 2012, ANAESTHESIA, V67, P514, DOI 10.1111/j.1365-2044.2011.07006.x; The Danish Environmental Protection Agency, 2014, 1557 DAN ENV PROT AG	12	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192369	10.1371/journal.pone.0192369	http://dx.doi.org/10.1371/journal.pone.0192369			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474357	Green Published, gold, Green Submitted			2022-12-26	WOS:000426049500016
J	Fowler, EK; Mohorianu, I; Smith, DT; Dalmay, T; Chapman, T				Fowler, Emily K.; Mohorianu, Irina; Smith, Damian T.; Dalmay, Tamas; Chapman, Tracey			Small RNA populations revealed by blocking rRNA fragments in Drosophila melanogaster reproductive tissues	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MICRORNAS; SEQUENCES; PROFILE; MIRNAS; LOCI	RNA interference (RNAi) is a complex and highly conserved regulatory mechanism mediated via small RNAs (sRNAs). Recent technical advances in high throughput sequencing have enabled an increasingly detailed analysis of sRNA abundances and profiles in specific body parts and tissues. This enables investigations of the localized roles of microRNAs (miRNAs) and small interfering RNAs (siRNAs). However, variation in the proportions of non-coding RNAs in the samples being compared can hinder these analyses. Specific tissues may vary significantly in the proportions of fragments of longer non-coding RNAs (such as ribosomal RNA or transfer RNA) present, potentially reflecting tissue-specific differences in biological functions. For example, in Drosophila, some tissues contain a highly abundant 30nt rRNA fragment (the 2S rRNA) as well as abundant 5' and 3' terminal rRNA fragments. These can pose difficulties for the construction of sRNA libraries as they can swamp the sequencing space and obscure sRNA abundances. Here we addressed this problem and present a modified "rRNA blocking" protocol for the construction of high-definition (HD) adapter sRNA libraries, in D. melanogaster reproductive tissues. The results showed that 2S rRNAs targeted by blocking oligos were reduced from > 80% to < 0.01% total reads. In addition, the use of multiple rRNA blocking oligos to bind the most abundant rRNA fragments allowed us to reveal the underlying sRNA populations at increased resolution. Sideby-side comparisons of sequencing libraries of blocked and non-blocked samples revealed that rRNA blocking did not change the miRNA populations present, but instead enhanced their abundances. We suggest that this rRNA blocking procedure offers the potential to improve the in-depth analysis of differentially expressed sRNAs within and across different tissues.	[Fowler, Emily K.; Mohorianu, Irina; Smith, Damian T.; Dalmay, Tamas; Chapman, Tracey] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich, Norfolk, England; [Mohorianu, Irina] Univ East Anglia, Sch Comp Sci, Norwich Res Pk, Norwich, Norfolk, England	University of East Anglia; University of East Anglia	Chapman, T (corresponding author), Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich, Norfolk, England.	tracey.chapman@uea.ac.uk	Mohorianu, Irina/J-2549-2019; Chapman, Tracey/E-5100-2011; Dalmay, Tamas/E-1377-2011	Mohorianu, Irina/0000-0003-4863-761X; Dalmay, Tamas/0000-0003-1492-5429	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H008047/1, BB/L003139/1]; Natural Environment Research Council (NERC) [NE/J024244/1]; BBSRC [BB/H008047/1, BB/L003139/1] Funding Source: UKRI; NERC [NE/R000891/1, NE/J024244/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L003139/1, BB/H008047/1] Funding Source: researchfish; Natural Environment Research Council [NE/R000891/1, NE/J024244/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/H008047/1; BB/L003139/1) and Natural Environment Research Council (NERC) (NE/J024244/1) for funding (research grants to TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beckers M, 2017, RNA, V23, P823, DOI 10.1261/rna.059360.116; Blenkiron C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122203; Campbell JD, 2015, RNA, V21, P164, DOI 10.1261/rna.046060.114; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176458; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; Fonseca NA, 2012, BIOINFORMAT BTS, V605; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Johnson BR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-586; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; Lopez-Gomollon S, 2012, PLANTA, V236, P1875, DOI 10.1007/s00425-012-1734-7; Marco A, 2015, G3-GENES GENOM GENET, V5, P2199, DOI 10.1534/g3.115.019497; Mohorianu I, 2013, RNA BIOL, V10, P1221, DOI 10.4161/rna.25538; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Ozkan S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3773-8; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; SCHMIDT T, 1985, INSECT BIOCHEM, V15, P391, DOI 10.1016/0020-1790(85)90031-9; Sorefan Karim, 2012, Silence, V3, P4, DOI 10.1186/1758-907X-3-4; Stage DE, 2007, GENOME RES, V17, P1888, DOI 10.1101/gr.6376807; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150933; Wei H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071068; Wen JY, 2014, GENOME RES, V24, P1236, DOI 10.1101/gr.161554.113; Wickersheim ML, 2013, BIOTECHNIQUES, V55, P271, DOI 10.2144/000114102; Xu P, 2015, METHODS NEXT GEN SEQ, V2, P1; Zywicki M, 2012, NUCLEIC ACIDS RES, V40, P4013, DOI 10.1093/nar/gks020	33	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0191966	10.1371/journal.pone.0191966	http://dx.doi.org/10.1371/journal.pone.0191966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474379	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000426049500013
J	Huang, KX; Luo, XZ; Zheng, Z				Huang, Kuixian; Luo, Xingzhang; Zheng, Zheng			Application of a combined approach including contamination indexes, geographic information system and multivariate statistical models in levels, distribution and sources study of metals in soils in Northern China	PLOS ONE			English	Article							POSITIVE MATRIX FACTORIZATION; POLYCYCLIC AROMATIC-HYDROCARBONS; HEALTH-RISK ASSESSMENT; SOURCE APPORTIONMENT; PARTICULATE MATTER; HEAVY-METALS; URBAN SOILS; SOURCE IDENTIFICATION; AGRICULTURAL SOILS; TRACE-METALS	The purpose of this study is to recognize the contamination characteristics of trace metals in soils and apportion their potential sources in Northern China to provide a scientific basis for basic of soil environment management and pollution control. The data set of metals for 12 elements in surface soil samples was collected. The enrichment factor and geoaccumulation index were used to identify the general geochemical characteristics of trace metals in soils. The UNMIX and positive matrix factorizations (PMF) models were comparatively applied to apportion their potential sources. Furthermore, geostatistical tools were used to study the spatial distribution of pollution characteristics and to identify the affected regions of sources that were derived from apportionment models. The soils were contaminated by Cd, Hg, Pb and Zn to varying degree. Industrial activities, agricultural activities and natural sources were identified as the potential sources determining the contents of trace metals in soils with contributions of 24.8% +/- 24.9%, 33.3% +/- 37.2% and 38.0% +/- 41.8%, respectively. The slightly different results obtained from UNMIX and PMF might be caused by the estimations of uncertainty and different algorithms within the models.	[Huang, Kuixian; Luo, Xingzhang; Zheng, Zheng] Fudan Univ, Dept Environm Sci & Engn, Shanghai, Peoples R China	Fudan University	Zheng, Z (corresponding author), Fudan Univ, Dept Environm Sci & Engn, Shanghai, Peoples R China.	zzhenghj@fudan.edu.cn						Byrne BM, 2005, J PERS ASSESS, V85, P17, DOI 10.1207/s15327752jpa8501_02; Carr R, 2008, ENVIRON GEOCHEM HLTH, V30, P45, DOI 10.1007/s10653-007-9106-0; CEPA (Chinese Environmental Protection Administration), 1995, GB156181995 CEPA CME; Chabukdhara M, 2012, CHEMOSPHERE, V87, P945, DOI 10.1016/j.chemosphere.2012.01.055; Chen SC, 2006, SCI TOTAL ENVIRON, V366, P112, DOI 10.1016/j.scitotenv.2005.08.047; Chueinta W, 2000, ATMOS ENVIRON, V34, P3319, DOI 10.1016/S1352-2310(99)00433-1; CNEMC (China National Environmental Monitoring Centre), 1990, US; Davidson CM, 2006, ANAL CHIM ACTA, V565, P63, DOI 10.1016/j.aca.2006.02.014; Facchinelli A, 2001, ENVIRON POLLUT, V114, P313, DOI 10.1016/S0269-7491(00)00243-8; Franco C, 2006, GEODERMA, V136, P852, DOI 10.1016/j.geoderma.2006.06.012; Han LF, 2017, ECOTOX ENVIRON SAFE, V144, P321, DOI 10.1016/j.ecoenv.2017.06.021; Henry RC, 1999, CHEMOMETR INTELL LAB, V48, P91, DOI 10.1016/S0169-7439(99)00015-5; Henry RC, 2003, CHEMOMETR INTELL LAB, V65, P179, DOI 10.1016/S0169-7439(02)00108-9; Jiang YX, 2017, CHEMOSPHERE, V168, P1658, DOI 10.1016/j.chemosphere.2016.11.088; Kim M, 2007, ATMOS ENVIRON, V41, P9231, DOI 10.1016/j.atmosenv.2007.07.061; Lambert R, 2007, SCI TOTAL ENVIRON, V378, P293, DOI 10.1016/j.scitotenv.2007.02.008; Lee E, 1999, ATMOS ENVIRON, V33, P3201, DOI 10.1016/S1352-2310(99)00113-2; Li XD, 2001, APPL GEOCHEM, V16, P1361, DOI 10.1016/S0883-2927(01)00045-2; Loska K, 1997, WATER AIR SOIL POLL, V93, P347, DOI 10.1023/A:1022121615949; Loska K, 2003, POL J ENVIRON STUD, V12, P187; Luo L, 2009, J ENVIRON MANAGE, V90, P2524, DOI 10.1016/j.jenvman.2009.01.011; Luo XS, 2012, SCI TOTAL ENVIRON, V421, P17, DOI 10.1016/j.scitotenv.2011.04.020; Maas S, 2010, ENVIRON POLLUT, V158, P2294, DOI 10.1016/j.envpol.2010.02.001; Meng WQ, 2016, AGR WATER MANAGE, V171, P153, DOI 10.1016/j.agwat.2016.03.013; Mico C, 2006, CHEMOSPHERE, V65, P863, DOI 10.1016/j.chemosphere.2006.03.016; Ministry of Environmental Protection and Ministry of Land and Resource of the People's Republic of China (MEP and MLR), 2014, B NAT SOIL POLL STAT; Muller G.M.M.G.M.G.M.G.P., 1969, GEOJOURNAL, V2, P108, DOI DOI 10.1055/S-2007-1023171; Nziguheba G, 2008, SCI TOTAL ENVIRON, V390, P53, DOI 10.1016/j.scitotenv.2007.09.031; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Parra S, 2014, CHEMOMETR INTELL LAB, V138, P127, DOI 10.1016/j.chemolab.2014.08.003; Pekey H, 2004, MAR POLLUT BULL, V49, P809, DOI 10.1016/j.marpolbul.2004.06.029; Qiao M, 2011, ENVIRON MONIT ASSESS, V172, P353, DOI 10.1007/s10661-010-1339-1; Ramadan Z, 2003, CHEMOMETR INTELL LAB, V66, P15, DOI 10.1016/S0169-7439(02)00160-0; Reff A, 2007, J AIR WASTE MANAGE, V57, P146, DOI 10.1080/10473289.2007.10465319; SCC (State Council of the People's Republic of China), 2016, NAT SOIL POLL PREV T; SEPAC, 2004, 1662004 SEPAC HJT; Shi RG, 2010, B ENVIRON CONTAM TOX, V85, P287, DOI 10.1007/s00128-010-0070-5; Soonthornnonda P, 2008, WATER RES, V42, P1989, DOI 10.1016/j.watres.2007.11.034; Streets DG, 2005, ATMOS ENVIRON, V39, P7789, DOI 10.1016/j.atmosenv.2005.08.029; Sutherland RA, 2000, ENVIRON GEOL, V39, P611, DOI 10.1007/s002540050473; Taiwo AM, 2014, ATMOS ENVIRON, V97, P109, DOI 10.1016/j.atmosenv.2014.07.051; Tao S, 2004, SCI TOTAL ENVIRON, V320, P11, DOI 10.1016/S0048-9697(03)00453-4; THURSTON GD, 1985, ATMOS ENVIRON, V19, P9, DOI 10.1016/0004-6981(85)90132-5; Tianjin environmental protection bureau, 2016, WORK PLAN SOIL POLL; TMBS (Tianjin Municipal Bureau of Statistics), 2014, TIANJ STAT YB; Vaccaro S, 2007, CHEMOSPHERE, V69, P1055, DOI 10.1016/j.chemosphere.2007.04.032; VROM, 2000, CIRC TARG VAL INT VA; Wang XL, 2005, SCI TOTAL ENVIRON, V350, P28, DOI 10.1016/j.scitotenv.2004.09.044; Wang YC, 2012, J ENVIRON SCI, V24, P690, DOI 10.1016/S1001-0742(11)60833-4; Wu Chao, 2016, Transactions of the Chinese Society of Agricultural Engineering, V32, P207, DOI 10.11975/j.issn.1002-6819.2016.18.028; Wu GH, 2010, B ENVIRON CONTAM TOX, V84, P336, DOI 10.1007/s00128-010-9939-6; Xu FX, 2009, NEW RUR CONSTR ENV P; Xue JL, 2014, ENVIRON SCI POLLUT R, V21, P7698, DOI 10.1007/s11356-014-2726-x; Zhang CB, 2008, ENVIRON POLLUT, V151, P470, DOI 10.1016/j.envpol.2007.04.017; Zhang J, 2002, ESTUAR COAST SHELF S, V54, P1051, DOI 10.1006/ecss.2001.0879; Zhang Y, 2012, WATER RES, V46, P3065, DOI 10.1016/j.watres.2012.03.006; Zhao L, 2014, SCI TOTAL ENVIRON, V468, P654, DOI 10.1016/j.scitotenv.2013.08.094; Zheng TH, 2014, J SOIL SEDIMENT, V14, P110, DOI 10.1007/s11368-013-0753-8; Zhi YY, 2016, J SOIL SEDIMENT, V16, P467, DOI 10.1007/s11368-015-1263-7; Zuo Q, 2007, ENVIRON POLLUT, V147, P303, DOI 10.1016/j.envpol.2006.05.029	60	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0190906	10.1371/journal.pone.0190906	http://dx.doi.org/10.1371/journal.pone.0190906			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474412	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500004
J	Tveit, RL; Lehmann, S; Bjorvatn, B				Tveit, Ragnhild L.; Lehmann, Sverre; Bjorvatn, Bjorn			Prevalence of several somatic diseases depends on the presence and severity of obstructive sleep apnea	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; HEART HEALTH; METABOLIC SYNDROME; HYPERTENSION; ASSOCIATION; POPULATION; HYPOPNEA; MEN; POLYGRAPHY; SYMPTOMS	Study objectives The objective was to investigate the prevalence of heart attack, angina pectoris, stroke, hypertension, diabetes mellitus, chronic obstructive pulmonary disease, asthma and obesity in relation to the presence and severity of obstructive sleep apnea. Methods The sample consisted of 1887 patients, with mean age of 48.6 years (range 16-83 years), referred to a university hospital on suspicion of obstructive sleep apnea. The patients filled out a questionnaire asking whether they were previously diagnosed with the comorbidities in interest. Obstructive sleep apnea was diagnosed and categorized based on a standard respiratory polygraphic sleep study using a type 3 portable monitor. The patients' weight, height and blood pressure were measured during the consultations. Results In total, 37.9% were categorized as not having obstructive sleep apnea (Apnea-hypopnea index < 5), 29.6% mild obstructive sleep apnea (Apnea-hypopnea index 5-14.9), 17.3% moderate obstructive sleep apnea (Apnea-hypopnea index 15-29.9), and 15.2% severe obstructive sleep apnea (Apnea-hypopnea index >= 30). The prevalence of heart attack, angina pectoris, hypertension, measured systolic blood pressure >= 140 mmHg, measured diastolic blood pressure >= 90 mmHg, diabetes mellitus and obesity (body mass index >= 30) were higher with greater obstructive sleep apnea severity. Logistic and linear regression analyses showed that these comorbidities were positively associated with obstructive sleep apnea severity. This was not the case for stroke, chronic obstructive pulmonary disease and asthma. After adjustment for sex, age, alcohol and smoking in the logistic regression analyses, hypertension, measured systolic blood pressure >= 140 mmHg, measured diastolic blood pressure >= 90 mmHg and obesity remained positively associated with obstructive sleep apnea severity. Conclusions A higher prevalence of heart attack, angina pectoris, hypertension, diabetes mellitus, and obesity was seen with greater obstructive sleep apnea severity. Obesity and hypertension, conditions easy to clinically assess, appear as the most central comorbidities with greater obstructive sleep apnea severity.	[Tveit, Ragnhild L.; Bjorvatn, Bjorn] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Lehmann, Sverre; Bjorvatn, Bjorn] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, Bergen, Norway; [Lehmann, Sverre] Univ Bergen, Dept Clin Sci, Sect Thorac Med, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Tveit, RL (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	rag1991@hotmail.com						Agusti A, 2011, EUR RESPIR REV, V20, P183, DOI 10.1183/09059180.00004311; Arnardottir ES, 2016, EUR RESPIR J, V47, P194, DOI 10.1183/13993003.01148-2015; Attal P, 2010, J CLIN ENDOCR METAB, V95, P483, DOI 10.1210/jc.2009-1912; Bista Sabin R, 2012, Dent Clin North Am, V56, P373, DOI 10.1016/j.cden.2012.01.002; Bjorvatn B, 2015, SLEEP BREATH, V19, P1387, DOI 10.1007/s11325-015-1155-5; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Cepeda-Valery B, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0535-y; Franklin KA, 2015, J THORAC DIS, V7, P1311, DOI 10.3978/j.issn.2072-1439.2015.06.11; Franklin KA, 2013, EUR RESPIR J, V41, P610, DOI 10.1183/09031936.00212711; Fredheim JM, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-84; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Greenberg-Dotan S, 2014, SLEEP BREATH, V18, P69, DOI 10.1007/s11325-013-0850-3; Haentjens P, 2007, ARCH INTERN MED, V167, P757, DOI 10.1001/archinte.167.8.757; Hermann DM, 2009, NEUROLOGY, V73, P1313, DOI 10.1212/WNL.0b013e3181bd137c; Hrubos-Strom H, 2011, J SLEEP RES, V20, P162, DOI 10.1111/j.1365-2869.2010.00861.x; Jonassen TM, 2016, CLIN RESPIR IN PRESS; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kapur Vishesh, 2002, Sleep Breath, V6, P49, DOI 10.1007/s11325-002-0049-5; Kweon SS, 2013, CIRC J, V77, P734, DOI 10.1253/circj.CJ-12-0613; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marin JM, 2010, AM J RESP CRIT CARE, V182, P325, DOI 10.1164/rccm.200912-1869OC; Masa JF, 2011, AM J RESP CRIT CARE, V184, P964, DOI 10.1164/rccm.201103-0428OC; Nerfeldt P, 2014, SLEEP BREATH, V18, P297, DOI 10.1007/s11325-013-0884-6; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; O'Connor GT, 2009, AM J RESP CRIT CARE, V179, P1159, DOI 10.1164/rccm.200712-1809OC; Peker Y, 2002, AM J RESP CRIT CARE, V166, P159, DOI 10.1164/rccm.2105124; Peppard PE, 2007, J CLIN SLEEP MED, V3, P265; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Pratt-Ubunama MN, 2007, CHEST, V131, P453, DOI 10.1378/chest.06-1442; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Sanders MH, 2003, AM J RESP CRIT CARE, V167, P7, DOI 10.1164/rccm.2203046; Steveling EH, 2014, RESPIRATION, V88, P451, DOI 10.1159/000368615; WETTER DW, 1994, ARCH INTERN MED, V154, P2219, DOI 10.1001/archinte.154.19.2219; World Health Organization,, 2015, OB OV; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	35	19	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192671	10.1371/journal.pone.0192671	http://dx.doi.org/10.1371/journal.pone.0192671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474482	Green Published, gold			2022-12-26	WOS:000426049500026
J	Gao, TG; Zhang, TJ; Guo, H; Hu, YT; Shang, JG; Zhang, YL				Gao, Tanguang; Zhang, Tingjun; Guo, Hong; Hu, Yuantao; Shang, Jianguo; Zhang, Yulan			Impacts of the active layer on runoff in an upland permafrost basin, northern Tibetan Plateau	PLOS ONE			English	Article							BOREAL CATCHMENT UNDERLAIN; HEIHE RIVER-BASIN; FLOW; MOUNTAIN; THAW; THICKNESS; REGION; CARBON	The paucity of studies on permafrost runoff generation processes, especially in mountain permafrost, constrains the understanding of permafrost hydrology and prediction of hydrological responses to permafrost degradation. This study investigated runoff generation processes, in addition to the contribution of summer thaw depth, soil temperature, soil moisture, and precipitation to streamflow in a small upland permafrost basin in the northern Tibetan Plateau. Results indicated that the thawing period and the duration of the zero-curtain were longer in permafrost of the northern Tibetan Plateau than in the Arctic. Limited snowmelt delayed the initiation of surface runoff in the peat permafrost in the study area. The runoff displayed intermittent generation, with the duration of most runoff events lasting less than 24 h. Precipitation without runoff generation was generally correlated with lower soil moisture conditions. Combined analysis suggested runoff generation in this region was controlled by soil temperature, thaw depth, precipitation frequency and amount, and antecedent soil moisture. This study serves as an important baseline to evaluate future environmental changes on the Tibetan Plateau.	[Gao, Tanguang; Zhang, Tingjun; Hu, Yuantao; Shang, Jianguo] Lanzhou Univ, Coll Earth & Environm Sci, Minist Educ, Key Lab Western Chinas Environm Syst, Lanzhou, Gansu, Peoples R China; [Guo, Hong] Univ Arkansas, Fayetteville, AR 72701 USA; [Zhang, Yulan] Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, State Key Lab Cryospher Sci, Lanzhou, Gansu, Peoples R China	Lanzhou University; University of Arkansas System; University of Arkansas Fayetteville; Chinese Academy of Sciences	Zhang, TJ (corresponding author), Lanzhou Univ, Coll Earth & Environm Sci, Minist Educ, Key Lab Western Chinas Environm Syst, Lanzhou, Gansu, Peoples R China.; Zhang, YL (corresponding author), Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, State Key Lab Cryospher Sci, Lanzhou, Gansu, Peoples R China.	tjzhang@lzu.edu.cn; yulan.zhang@lzb.ac.cn	Gao, Tanguang/ABG-7175-2021; ZHANG, TINGJUN/AAX-3662-2020	Gao, Tanguang/0000-0002-3050-5590; ZHANG, Tingjun/0000-0001-6974-9501	National Natural Science Foundation of China [91325202, 41501063, 41421061]; Fundamental Research Funds for the Central Universities [lzujbky-2017-40]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the National Natural Science Foundation of China (91325202; 41501063, 41421061), and Fundamental Research Funds for the Central Universities (lzujbky-2017-40).	Abbott BW, 2015, BIOGEOSCIENCES, V12, P3725, DOI 10.5194/bg-12-3725-2015; Bi YB, 2015, REMOTE SENS-BASEL, V7, P6741, DOI 10.3390/rs70606741; Bosson E, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016429; Carey SK, 2001, J HYDROL, V253, P110, DOI 10.1016/S0022-1694(01)00478-4; Cheng GD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000631; Cheng GD, 2014, NATL SCI REV, V1, P413, DOI 10.1093/nsr/nwu017; Connon RF, 2014, HYDROL PROCESS, V28, P4163, DOI 10.1002/hyp.10206; Evans SG, 2015, WATER RESOUR RES, V51, P9564, DOI 10.1002/2015WR017732; Frauenfeld OW, 2007, INT J CLIMATOL, V27, P47, DOI 10.1002/joc.1372; Gao TG, 2016, COLD REG SCI TECHNOL, V126, P36, DOI 10.1016/j.coldregions.2016.03.007; Gao TG, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-5196-7; Hinkel KM, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000927; HINZMAN LD, 1991, COLD REG SCI TECHNOL, V19, P95, DOI 10.1016/0165-232X(91)90001-W; Hu YR, 2011, HYDROL PROCESS, V25, P3399, DOI 10.1002/hyp.8069; Johansson E, 2015, EARTH SYST SCI DATA, V7, P93, DOI 10.5194/essd-7-93-2015; Johansson E, 2015, J HYDROL, V527, P688, DOI 10.1016/j.jhydrol.2015.05.026; Jones JB, 2010, CAN J FOREST RES, V40, P1210, DOI 10.1139/X10-047; Koch JC, 2013, HYDROGEOL J, V21, P93, DOI 10.1007/s10040-012-0934-3; Koch JC, 2014, WATER RESOUR RES, V50, P8141, DOI 10.1002/2014WR015586; Li R, 2012, CHINESE SCI BULL, V57, P4609, DOI 10.1007/s11434-012-5323-8; Liu GS, 2012, WATER SCI TECH-W SUP, V12, P352, DOI 10.2166/ws.2012.003; Liu JS, 2011, QUATERN INT, V244, P178, DOI 10.1016/j.quaint.2010.12.018; Mu CC, 2015, ARCT ANTARCT ALP RES, V47, P203, DOI 10.1657/AAAR00C-13-095; Nelson FE, 2004, PERMAFROST PERIGLAC, V15, P99, DOI 10.1002/ppp.488; Niu L, 2011, SCI CHINA EARTH SCI, V54, P615, DOI 10.1007/s11430-010-4073-1; OUTCALT SI, 1990, WATER RESOUR RES, V26, P1509, DOI 10.1029/90WR00139; Qin J, 2017, WATER-SUI, V9, DOI 10.3390/w9090666; Quinton WL, 2013, HYDROGEOL J, V21, P201, DOI 10.1007/s10040-012-0935-2; Rogger M, 2017, WATER RESOUR RES, V53, P1288, DOI 10.1002/2016WR019341; Shiklomanov N. I., 2012, PROC 10 INT C PERMAF, V1, P377; Streletskiy DA, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/9/095003; Tromp-van Meerveld HJ, 2006, WATER RESOUR RES, V42, DOI [10.1029/2004WR003778, 10.1029/2004WR003800]; Walvoord MA, 2016, VADOSE ZONE J, V15, DOI 10.2136/vzj2016.01.0010; Wang GX, 2009, J HYDROL, V375, P438, DOI 10.1016/j.jhydrol.2009.06.046; Wang JY, 2008, ECOHYDROLOGY PROCESS; [王庆峰 Wang Qingfeng], 2013, [冰川冻土, Journal of Glaciology and Geocryology], V35, P19; Wright N, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006880; Wu QB, 2015, GLOBAL PLANET CHANGE, V124, P149, DOI 10.1016/j.gloplacha.2014.09.002; Wu QB, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012974; Yang DQ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024057; [张明礼 Zhang Mingli], 2016, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V30, P159; Zhang TJ, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005642; Zhang TJ., 2005, INFLUENCE SEASONAL S, V43; Zhou Y.W., 2000, PERMAFROST IN CHINA; Zhou YC, 2013, SCI CHINA EARTH SCI, V56, P311, DOI 10.1007/s11430-012-4498-9	45	9	10	6	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192591	10.1371/journal.pone.0192591	http://dx.doi.org/10.1371/journal.pone.0192591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470510	gold, Green Published, Green Submitted			2022-12-26	WOS:000425831000014
J	Sim, HJ; Kim, SH; Myung, KJ; Kwon, T; Lee, HS; Park, TJ				Sim, Hyo Jung; Kim, Sang-Hyun; Myung, Kyung-Jae; Kwon, Taejoon; Lee, Hyun-Shik; Park, Tae Joo			Xenopus: An alternative model system for identifying muco-active agents	PLOS ONE			English	Article							PROTEIN-KINASE-C; MUCOCILIARY EPIDERMIS; MULTICILIATED CELLS; GOBLET CELLS; SECRETION; CA2+	The airway epithelium in human plays a central role as the first line of defense against environmental contaminants. Most respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and respiratory infections, disturb normal muco-ciliary functions by stimulating the hypersecretion of mucus. Several muco-active agents have been used to treat hypersecretion symptoms in patients. Current muco-active reagents control mucus secretion by modulating either airway inflammation, cholinergic parasympathetic nerve activities or by reducing the viscosity by cleaving crosslinking in mucin and digesting DNAs in mucus. However, none of the current medication regulates mucus secretion by directly targeting airway goblet cells. The major hurdle for screening potential muco-active agents that directly affect the goblet cells, is the unavailability of in vivo model systems suitable for high-throughput screening. In this study, we developed a high-throughput in vivo model system for identifying muco-active reagents using Xenopus laevis embryos. We tested mucus secretion under various conditions and developed a screening strategy to identify potential muco-regulators. Using this novel screening technique, we identified narasin as a potential muco-regulator. Narasin treatment of developing Xenopus embryos significantly reduced mucus secretion. Furthermore, the human lung epithelial cell line, Calu-3, responded similarly to narasin treatment, validating our technique for discovering muco-active reagents.	[Sim, Hyo Jung; Myung, Kyung-Jae; Kwon, Taejoon; Park, Tae Joo] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea; [Kim, Sang-Hyun] Kyungpook Natl Univ, Sch Med, Dept Pharmacol, CMRI, Daegu, South Korea; [Myung, Kyung-Jae; Park, Tae Joo] Inst Basic Sci, Ctr Genom Integr, Ulsan, South Korea; [Lee, Hyun-Shik] Kyungpook Natl Univ, Coll Nat Sci, Daegu, South Korea	Ulsan National Institute of Science & Technology (UNIST); Kyungpook National University; Institute for Basic Science - Korea (IBS); Kyungpook National University	Park, TJ (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea.; Park, TJ (corresponding author), Inst Basic Sci, Ctr Genom Integr, Ulsan, South Korea.; Lee, HS (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Daegu, South Korea.	leeh@knu.ac.kr; parktj@unist.ac.kr	Park, Tae Joo/G-1460-2011; Kwon, Taejoon/S-3835-2016; Kwon, Taejoon/AAR-9814-2020	Park, Tae Joo/0000-0003-3176-177X; Kwon, Taejoon/0000-0002-9794-6112; Lee, Hyun-Shik/0000-0002-3837-9867	Korean National Research Foundation [2015R1D1A1A02061763, NRF-2015R1A2A1A10053265, IBS-R022-D1]; UNIST [1.140034.01]	Korean National Research Foundation(National Research Foundation of Korea); UNIST	This study was supported by grants from the Korean National Research Foundation (2015R1D1A1A02061763 to TJP and NRF-2015R1A2A1A10053265to HSL), IBS-R022-D1 to KJM, and the research fund from UNIST (1.140034.01 to TJP).	Abdullah LH, 1997, AM J PHYSIOL-LUNG C, V273, pL201, DOI 10.1152/ajplung.1997.273.1.L201; Abdullah LH, 2012, METHODS MOL BIOL, V842, P259, DOI 10.1007/978-1-61779-513-8_16; Balsamo R, 2010, EUR RESPIR REV, V19, P127, DOI 10.1183/09059180.00003510; Brooks ER, 2014, CURR BIOL, V24, pR973, DOI 10.1016/j.cub.2014.08.047; Dartt DA, 2000, EXP EYE RES, V71, P619, DOI 10.1006/exer.2000.0915; Dubaissi E, 2014, DEVELOPMENT, V141, P1514, DOI 10.1242/dev.102426; Dubaissi E, 2011, DIS MODEL MECH, V4, P179, DOI 10.1242/dmm.006494; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Kreda SM, 2007, J PHYSIOL-LONDON, V584, P245, DOI 10.1113/jphysiol.2007.139840; Lang TG, 2016, MOL BIOL EVOL, V33, P1921, DOI 10.1093/molbev/msw066; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rogers DF, 2007, RESP CARE, V52, P1134; Walentek P, 2014, DEVELOPMENT, V141, P1526, DOI 10.1242/dev.102343; Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604; Yoon MJ, 2013, CARCINOGENESIS, V34, P1918, DOI 10.1093/carcin/bgt137	17	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193310	10.1371/journal.pone.0193310	http://dx.doi.org/10.1371/journal.pone.0193310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470529	Green Submitted, Green Published, gold			2022-12-26	WOS:000425831000047
J	Park, HJ; Lee, CW; Kim, D; Do, H; Han, SJ; Kim, JE; Koo, BH; Lee, JH; Yim, JH				Park, Ha Ju; Lee, Chang Woo; Kim, Dockyu; Do, Hackwon; Han, Se Jong; Kim, Jung Eun; Koo, Bon-Hun; Lee, Jun Hyuck; Yim, Joung Han			Crystal structure of a cold-active protease (Pro21717) from the psychrophilic bacterium, Pseudoalteromonas arctica PAMC 21717, at 1.4 angstrom resolution: Structural adaptations to cold and functional analysis of a laundry detergent enzyme	PLOS ONE			English	Article							SERINE ALKALINE PROTEASE; BACILLUS-MOJAVENSIS; ESCHERICHIA-COLI; IN-VITRO; PURIFICATION; SUBTILISIN; CLONING; TOOLS	Enzymes isolated from organisms found in cold habitats generally exhibit higher catalytic activity at low temperatures than their mesophilic homologs and are therefore known as cold-active enzymes. Cold-active proteases are very useful in a variety of biotechnological applications, particularly as active ingredients in laundry and dishwashing detergents, where they provide strong protein-degrading activity in cold water. We identified a cold-active protease (Pro21717) from a psychrophilic bacterium, Pseudoalteromonas arctica PAMC 21717, and determined the crystal structure of its catalytic domain (CD) at a resolution of 1.4 angstrom. The Pro21717-CD structure shows a conserved subtilisin-like fold with a typical catalytic triad (Asp185, His244, and Ser425) and contains four calcium ions and three disulfide bonds. Interestingly, we observed an unexpected electron density at the substrate-binding site from a co-purified peptide. Although the sequence of this peptide is unknown, analysis of the peptide-complexed structure nonetheless provides some indication of the substrate recognition and binding mode of Pro21717. Moreover, various parameters, including a wide substrate pocket size, an abundant active-site loop content, and a flexible structure provide potential explanations for the cold-adapted properties of Pro21717. In conclusion, this is first structural characterization of a cold-adapted subtilisin-like protease, and these findings provide a structural and functional basis for industrial applications of Pro21717 as a cold-active laundry or dishwashing detergent enzyme.	[Park, Ha Ju; Kim, Dockyu; Han, Se Jong; Kim, Jung Eun; Yim, Joung Han] Korea Polar Res Inst, Div Polar Life Sci, Incheon, South Korea; [Lee, Chang Woo; Do, Hackwon; Lee, Jun Hyuck] Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea; [Lee, Chang Woo; Han, Se Jong; Lee, Jun Hyuck] Univ Sci & Technol, Dept Polar Sci, Incheon, South Korea; [Kim, Jung Eun] Sungkyunkwan Univ, Grad Sch, Dept Pharm, Suwon, South Korea; [Koo, Bon-Hun] Aniscien Co Ltd, Jeonju, South Korea	Korea Polar Research Institute (KOPRI); Korea Polar Research Institute (KOPRI); Sungkyunkwan University (SKKU)	Yim, JH (corresponding author), Korea Polar Res Inst, Div Polar Life Sci, Incheon, South Korea.; Lee, JH (corresponding author), Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea.; Lee, JH (corresponding author), Univ Sci & Technol, Dept Polar Sci, Incheon, South Korea.	junhyucklee@kopri.re.kr; jhyim@kopri.re.kr		HAN, Se Jong/0000-0001-9576-2179; , Hackwon/0000-0001-7663-2010	Polar Genomics 101 Project: Genome Analysis of Polar Organisms and Establishment of Application Platform - Korea Polar Research Institute [PE18080]; KOPRI project [PE17100]; KOPRI; Aniscien Co., Ltd.	Polar Genomics 101 Project: Genome Analysis of Polar Organisms and Establishment of Application Platform - Korea Polar Research Institute(Korea Polar Research Institute of Marine Research Placement (KOPRI)); KOPRI project(Korea Polar Research Institute of Marine Research Placement (KOPRI)); KOPRI(Korea Polar Research Institute of Marine Research Placement (KOPRI)); Aniscien Co., Ltd.	This work was supported by the Polar Genomics 101 Project: Genome Analysis of Polar Organisms and Establishment of Application Platform (grant number PE18080) funded by the Korea Polar Research Institute. In addition, this work was performed with the support of another KOPRI project (grant number PE17100). The funder, KOPRI, provided support in the form of salaries for authors [HJP, CWL, DK, HD, SJH, JEK, JHL and JHY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company, Aniscien Co., Ltd., provided support in the form of salaries for author [B-HK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; We thank the staff at the BL7A beamline of Pohang Accelerator Laboratory (PAL) (Pohang, Korea) for their kind help with data collection. Preliminary X-ray diffraction analyses were performed at the X-ray facility of Korea Basic Science Institute (KBSI) (Ochang, Korea). This work was supported by the Polar Genomics 101 Project: Genome Analysis of Polar Organisms and Establishment of Application Platform (grant number PE18080) funded by the Korea Polar Research Institute. In addition, this work was performed with the support of another KOPRI project (grant number PE17100). There are no conflicts of interest to declare.	Beg QK, 2003, ENZYME MICROB TECH, V32, P294, DOI 10.1016/S0141-0229(02)00293-4; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blow DM, 1997, TRENDS BIOCHEM SCI, V22, P405, DOI 10.1016/S0968-0004(97)01115-8; BODE W, 1986, EMBO J, V5, P813, DOI 10.1002/j.1460-2075.1986.tb04286.x; Chen XL, 2007, MICROBIOL-SGM, V153, P2116, DOI 10.1099/mic.0.2007/006056-0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong DH, 2005, ACTA CRYSTALLOGR F, V61, P308, DOI 10.1107/S1744309105004082; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Georlette D, 2004, FEMS MICROBIOL REV, V28, P25, DOI 10.1016/j.femsre.2003.07.003; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Haddar A, 2009, BIORESOURCE TECHNOL, V100, P3366, DOI 10.1016/j.biortech.2009.01.061; Han SJ, 2016, PREP BIOCHEM BIOTECH, V46, P328, DOI 10.1080/10826068.2015.1031390; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huston AL, 2004, APPL ENVIRON MICROB, V70, P3321, DOI 10.1128/AEM.70.6.3321-3328.2004; Jaouadi B, 2008, BIOCHIMIE, V90, P1291, DOI 10.1016/j.biochi.2008.03.004; Kennan RM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001210; Kim Dockyu, 2010, [Korean Journal of Microbiology, 미생물학회지], V46, P73; Kulakova L, 1999, APPL ENVIRON MICROB, V65, P611; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maurer KH, 2004, CURR OPIN BIOTECH, V15, P330, DOI 10.1016/j.copbio.2004.06.005; Maynes JT, 2005, ACTA CRYSTALLOGR D, V61, P580, DOI 10.1107/S0907444905004889; ODonohue MJ, 1996, J BIOL CHEM, V271, P26477, DOI 10.1074/jbc.271.43.26477; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEEK K, 1993, APPL ENVIRON MICROB, V59, P1168, DOI 10.1128/AEM.59.4.1168-1175.1993; RIESENBERG D, 1991, J BIOTECHNOL, V20, P17, DOI 10.1016/0168-1656(91)90032-Q; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Smith CA, 1999, J MOL BIOL, V294, P1027, DOI 10.1006/jmbi.1999.3291; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang QF, 2005, BIOTECHNOL LETT, V27, P1195, DOI 10.1007/s10529-005-0016-x; Xu GuoYing, 2011, Advances in Polar Science, V22, P124, DOI 10.3724/SP.J.1085.2011.00124; Yan BQ, 2009, EXTREMOPHILES, V13, P725, DOI 10.1007/s00792-009-0263-1	34	10	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0191740	10.1371/journal.pone.0191740	http://dx.doi.org/10.1371/journal.pone.0191740			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466378	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300015
J	Frye, V; Wilton, L; Hirshfield, S; Chiasson, MA; Lucy, D; Usher, D; McCrossin, J; Greene, E; Koblin, B				Frye, Victoria; Wilton, Leo; Hirshfield, Sabina; Chiasson, Mary Ann; Lucy, Debbie; Usher, DaShawn; McCrossin, Jermaine; Greene, Emily; Koblin, Beryl		All About Me Study Team	Preferences for HIV test characteristics among young, Black Men Who Have Sex With Men (MSM) and transgender women: Implications for consistent HIV testing	PLOS ONE			English	Article							AFRICAN-AMERICAN MEN; PREEXPOSURE PROPHYLAXIS; SURVEILLANCE SYSTEM; SOCIAL SUPPORT; UNITED-STATES; LATINO MEN; US CITIES; PREVENTION; CARE; COMMUNITY	Background Promoting consistent HIV testing is critical among young, Black Men Who Have Sex With Men (MSM) and transgender women who are overrepresented among new HIV cases in the United States. New HIV test options are available, including mobile unit testing, one-minute testing, at home or self-testing and couples HIV testing and counseling (CHTC). In the context of these newer options, the objective of this study was to explore whether and how preferences for specific characteristics of the tests acted as barriers to and/or facilitators of testing in general and consistent testing specifically among young Black MSM and transgender women aged 16 to 29. Methods We conducted 30 qualitative, semi-structured, in-depth interviews with young, Black, gay, bisexual or MSM and transgender women in the New York City metropolitan area to identify preferences for specific HIV tests and aspects of HIV testing options. Participants were primarily recruited from online and mobile sites, followed by community-based, face-to-face recruitment strategies to specifically reach younger participants. Thematic coding was utilized to analyze the qualitative data based on a grounded theoretical approach. Results We identified how past experiences, perceived test characteristics (e.g., accuracy, cost, etc.) and beliefs about the "fit" between the individual, and the test relate to preferred testing methods and consistent testing. Three major themes emerged as important to preferences for HIV testing methods: the perceived accuracy of the test method, venue characteristics, and lack of knowledge or experience with the newer testing options, including self-testing and CHTC. Conclusions These findings suggest that increasing awareness of and access to newer HIV testing options (e.g., free or reduced price on home or self-tests or CHTC available at all testing venues) is critical if these new options are to facilitate increased levels of consistent testing among young, Black MSM and transgender women. Addressing perceptions of test accuracy and supporting front line staff in creating welcoming and safe testing environments may be key intervention targets. Connecting young Black MSM and transgender women to the best test option, given preferences for specific characteristics, may support more and more consistent HIV testing.	[Frye, Victoria] CUNY, Sch Med, Sophie Davis Sch Biomed Educ, Dept Community Hlth & Social Med, New York, NY 10031 USA; [Frye, Victoria; Greene, Emily] New York Blood Ctr, Lab Social & Behav Sci, New York, NY 10021 USA; [Wilton, Leo] SUNY Binghamton, Coll Community & Publ Affairs, Dept Human Dev, Binghamton, NY 13902 USA; [Wilton, Leo] Univ Johannesburg, Fac Humanities, Johannesburg, South Africa; [Hirshfield, Sabina; Chiasson, Mary Ann] Publ Hlth Solut, Div Res & Evaluat, New York, NY USA; [Lucy, Debbie; Usher, DaShawn; McCrossin, Jermaine; Koblin, Beryl] New York Blood Ctr, Lab Infect Dis Prevent, Project ACHIEVE, New York, NY 10021 USA; [Greene, Emily] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	City University of New York (CUNY) System; Sophie Davis School of Biomedical Education; New York Blood Center; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Johannesburg; New York Blood Center; Columbia University	Wilton, L (corresponding author), SUNY Binghamton, Coll Community & Publ Affairs, Dept Human Dev, Binghamton, NY 13902 USA.; Wilton, L (corresponding author), Univ Johannesburg, Fac Humanities, Johannesburg, South Africa.	lwilton@binghamton.edu	Hirshfield, Sabina/AAE-4412-2021	Hirshfield, Sabina/0000-0002-2649-469X; Frye, Victoria/0000-0003-3239-7201; Greene, Emily/0000-0001-6321-7088	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD078595]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development under Grant #R01HD078595 (PI: B. Koblin). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PCG, CONCISE OVERVIEW BAR; Arnold EA, 2009, J GAY LESBIAN SOC SE, V21, P171, DOI 10.1080/10538720902772006; Behler RL, 2017, AIDS BEHAV; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2016, HIV SURVEILLANCE SPE, V15, P1; Centers for Disease Control and Prevention, 2012, HIV SURVEILLANCE REP, V22, P1; Clark H, 2017, AIDS BEHAV, V21, P2774, DOI 10.1007/s10461-016-1656-7; Cooley LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104162; Corbin J, 1998, BASICS QUALITATIVE R; Cummiskey J., 2008, Morbidity and Mortality Weekly Report, V57, P660; Eaton LA, 2017, PREV SCI; Eaton LA, 2015, AM J PUBLIC HEALTH, V105, pE75, DOI 10.2105/AJPH.2014.302322; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Frye V, 2015, AIDS PATIENT CARE ST, V29, P617, DOI 10.1089/apc.2015.0100; Garofalo R, 2006, J ADOLESCENT HEALTH, V38, P230, DOI 10.1016/j.jadohealth.2005.03.023; Garofalo R, 2014, PEDIATR ANN, V43, P227, DOI 10.3928/00904481-20140522-06; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P621, DOI 10.1089/apc.2013.0245; Graham LF, 2014, INT J TRANSGENDERISM, V15, P100, DOI 10.1080/15532739.2014.937042; Gray KM, 2014, JAIDS-J ACQ IMM DEF, V65, P129, DOI 10.1097/QAI.0000000000000028; Halkitis PN, 2011, ANN BEHAV MED, V42, P361, DOI 10.1007/s12160-011-9299-4; Hall HI, 2017, JMIR PUBLIC HLTH SUR, V3, P38; Hightow-Weidman LB, 2015, HEALTH EDUC BEHAV, V42, P493, DOI 10.1177/1090198114562043; Hoots BE, 2016, CLIN INFECT DIS, V63, P672, DOI 10.1093/cid/ciw367; Hussen SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075382; Irvin R, 2014, AIDS BEHAV, V18, P1272, DOI 10.1007/s10461-014-0734-y; Johnson AS, 2014, JAMA-J AM MED ASSOC, V312, P432, DOI 10.1001/jama.2014.8534; Klarkowski D, 2014, EXPERT REV ANTI-INFE, V12, P49, DOI 10.1586/14787210.2014.866516; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Lelutiu-Weinberger C, 2016, JAIDS-J ACQ IMM DEF, V73, P547, DOI 10.1097/QAI.0000000000001140; Lemos D, 2015, J GAY LESBIAN SOC SE, V27, P64, DOI 10.1080/10538720.2015.988837; Levy ME, 2014, AIDS BEHAV, V18, P972, DOI 10.1007/s10461-014-0719-x; Mannheimer SB, 2014, JAIDS-J ACQ IMM DEF, V67, P438, DOI 10.1097/QAI.0000000000000334; Mashburn AJ, 2004, J COMMUNITY PSYCHOL, V32, P45, DOI 10.1002/jcop.10080; Maulsby C, 2014, AIDS BEHAV, V18, P10, DOI 10.1007/s10461-013-0476-2; Mayer KH, 2014, AM J PUBLIC HEALTH, V104, P976, DOI 10.2105/AJPH.2014.301876; McCree DH, 2013, AM J PUBLIC HEALTH, V103, P1851, DOI 10.2105/AJPH.2013.301260; Metsch LR, 2013, JAMA-J AM MED ASSOC, V310, P1701, DOI 10.1001/jama.2013.280034; Metsch LR, 2012, AM J PUBLIC HEALTH, V102, P1160, DOI 10.2105/AJPH.2011.300460; Millett GA, 2011, JAIDS-J ACQ IMM DEF, V58, P64, DOI 10.1097/QAI.0b013e31822542ad; Mimiaga MJ, 2016, AIDS PATIENT CARE ST, V30, P484, DOI 10.1089/apc.2016.0123; Morgan E, 2017, PUBLIC HEALTH REP, V132, P48, DOI 10.1177/0033354916679988; Morris E, 2016, J SCHOOL HEALTH, V86, P888, DOI 10.1111/josh.12457; Nemoto T, 2015, LGBT HEALTH, V2, P235, DOI 10.1089/lgbt.2014.0046; New York City Department of Health and Mental Hygiene, 2016, HIV PEOPL ID TRANSG; New York City Department of Health and Mental Hygiene, 2015, HIV SURV ANN REP 201; Patton, 2014, QUALITATIVE RES EVAL; Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581; Peng P, 2017, AIDS BEHAV; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Sanchez T, 2010, AIDS BEHAV, V14, P351, DOI 10.1007/s10461-009-9610-6; Santos GM, 2013, JAIDS-J ACQ IMM DEF, V63, pE167, DOI 10.1097/QAI.0b013e318294de80; Scott HM, 2014, AIDS BEHAV, V18, P913, DOI 10.1007/s10461-013-0608-8; Smith DK, 2015, SEX TRANSM DIS, V42, P88, DOI 10.1097/OLQ.0000000000000238; St Lawrence JS, 2015, AIDS EDUC PREV, V27, P195, DOI 10.1521/aeap.2015.27.3.195; Stekler J, 2007, ANN INTERN MED, V147, P147, DOI 10.7326/0003-4819-147-2-200707170-00022; Stephenson R, 2011, AIDS BEHAV, V15, pS80, DOI 10.1007/s10461-011-9893-2; Wilton L, 2009, AIDS BEHAV, V13, P532, DOI 10.1007/s10461-009-9529-y; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1	58	29	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192936	10.1371/journal.pone.0192936	http://dx.doi.org/10.1371/journal.pone.0192936			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8CI	29462156	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200036
J	Lichtenberg, E; Olson, LJ				Lichtenberg, Erik; Olson, Lars J.			The fruit and vegetable import pathway for potential invasive pest arrivals	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; PROPAGULE PRESSURE; GLOBAL TRADE; RISK; BORDER; POLICY	The expansion of international trade in commodities increases the risk of alien species invasions. Invaders are difficult to detect on introduction, so prevention remains the preferred strategy for managing the threat of invasions. Propagule pressure has been shown to be a good predictor of invasion risk. Most studies to date, however, link potential invasive species arrivals with indirect measures of propagule pressure such as aggregate trade volumes. This paper estimates propagule pressure using data that measure actual arrivals. Specifically, it uses inspection data that covers almost all U.S. fruit and vegetable imports from 2005-2014 to estimate a logit model of the probability of potential invasive species arrival and expected propagule frequencies for 2,240 commodity/country of origin combinations. Clear patterns in the geographic origin and commodity pathways for potential pests are identified. The average probability of arrival is low, approximately 0.03, but is two to ten times higher for some commodities, most notably herbs. We identify commodities with a high number of expected arrivals due to either a large volume of trade, high interception rates, or a combination of both. Seven of the top ten countries of origin for propagule frequency are from the Western Hemisphere and further trade liberalization within the Western Hemisphere is likely to heighten challenges to enforcement of US phytosanitary standards. Patterns in the data can help identify the commodities and countries of origin in greatest need of technical assistance and guide targeting of surveillance for the pathways of greatest phytosanitary concern.	[Lichtenberg, Erik; Olson, Lars J.] Univ Maryland, Dept Agr & Resource Econ, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Lichtenberg, E (corresponding author), Univ Maryland, Dept Agr & Resource Econ, College Pk, MD 20742 USA.	elichten@umd.edu	Lichtenberg, Erik/C-3195-2014	Lichtenberg, Erik/0000-0003-0619-6254	USDA/ERS PREISM [58-7000-8-0143]; National Socio-Environmental Synthesis Center (SESYNC) from the National Science Foundation [DBI-1052875]; Direct For Biological Sciences [1052875] Funding Source: National Science Foundation	USDA/ERS PREISM; National Socio-Environmental Synthesis Center (SESYNC) from the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by USDA/ERS PREISM Cooperative Agreement 58-7000-8-0143 (to Erik Lichtenberg, Lars J Olson) and by the National Socio-Environmental Synthesis Center (SESYNC) under funding received from the National Science Foundation DBI-1052875 (to Lars J Olson).	[Anonymous], 1993, OTAF565; APHIS, 2013, 201327132 FR APHIS; Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Banks NC, 2015, ECOL LETT, V18, P188, DOI 10.1111/ele.12397; Bradley BA, 2012, FRONT ECOL ENVIRON, V10, P20, DOI 10.1890/110145; Brockerhoff EG, 2014, ECOLOGY, V95, P594, DOI 10.1890/13-0465.1; Broda C, 2006, Q J ECON, V121, P541, DOI 10.1162/qjec.2006.121.2.541; Brooks N., 2009, FAU1258 US DEP AGR; Ferrier P., 2014, 168 US DEP AGR; Gao YL, 2017, ANNU REV ENTOMOL, V62, P165, DOI 10.1146/annurev-ento-031616-035425; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Keller RP, 2007, P NATL ACAD SCI USA, V104, P203, DOI 10.1073/pnas.0605787104; Leung B, 2004, ECOLOGY, V85, P1651, DOI 10.1890/02-0571; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Liebhold AM, 2012, FRONT ECOL ENVIRON, V10, P135, DOI 10.1890/110198; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; National Research Council, 2002, PRED INV NON PLANTS; Normile D, 2004, SCIENCE, V306, P968, DOI 10.1126/science.306.5698.968; Paini D. R., 2016, P NATL ACAD SCI; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Smith C.S., 1999, Biological Invasions, V1, P89, DOI 10.1023/A:1010091918466; Springborn M, 2011, ECOL ECON, V70, P2145, DOI 10.1016/j.ecolecon.2011.06.016; Springborn MR, 2016, J ECON BEHAV ORGAN, V132, P98, DOI 10.1016/j.jebo.2016.03.011; Turbelin AJ, 2017, GLOBAL ECOL BIOGEOGR, V26, P78, DOI 10.1111/geb.12517; Venette RC, 2002, ANNU REV ENTOMOL, V47, P143, DOI 10.1146/annurev.ento.47.091201.145147; Wonham MJ, 2013, ECOL APPL, V23, P1691, DOI 10.1890/12-1985.1	31	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192280	10.1371/journal.pone.0192280	http://dx.doi.org/10.1371/journal.pone.0192280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451910	Green Published, gold, Green Submitted			2022-12-26	WOS:000425369800009
J	Perera, VR; Lapek, JD; Newton, GL; Gonzalez, DJ; Pogliano, K				Perera, Varahenage R.; Lapek, John D., Jr.; Newton, Gerald L.; Gonzalez, David J.; Pogliano, Kit			Identification of the S-transferase like superfamily bacillithiol transferases encoded by Bacillus subtilis	PLOS ONE			English	Article							QUANTITATIVE PROTEOMIC ANALYSIS; GLUTATHIONE TRANSFERASES; GENOME SEQUENCES; BIOSYNTHESIS; MYCOTHIOL; PROTEINS; DETOXIFICATION; SPORULATION; METABOLISM; BIOCONTROL	Bacillithiol is a low molecular weight thiol found in Firmicutes that is analogous to glutathione, which is absent in these bacteria. Bacillithiol transferases catalyze the transfer of bacillithiol to various substrates. The S-transferase-like (STL) superfamily contains over 30,000 putative members, including bacillithiol transferases. Proteins in this family are extremely divergent and are related by structural rather than sequence similarity, leaving it unclear if all share the same biochemical activity. Bacillus subtilis encodes eight predicted STL superfamily members, only one of which has been shown to be a bacillithiol transferase. Here we find that the seven remaining proteins show varying levels of metal dependent bacillithiol transferase activity. We have renamed the eight enzymes BstA-H. Mass spectrometry and gene expression studies revealed that all of the enzymes are produced to varying levels during growth and sporulation, with BstB and BstE being the most abundant and BstF and BstH being the least abundant. Interestingly, several bacillithiol transferases are induced in the mother cell during sporulation. A strain lacking all eight bacillithiol transferases showed normal growth in the presence of stressors that adversely affect growth of bacillithiol-deficient strains, such as paraquat and CdCl2. Thus, the STL bacillithiol transferases represent a new group of proteins that play currently unknown, but potentially significant roles in bacillithiol-dependent reactions. We conclude that these enzymes are highly divergent, perhaps to cope with an equally diverse array of endogenous or exogenous toxic metabolites and oxidants.	[Perera, Varahenage R.; Newton, Gerald L.; Pogliano, Kit] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA; [Lapek, John D., Jr.; Gonzalez, David J.] Univ Calif San Diego, Sch Med, Dept Pharmacol & Pharm, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Pogliano, K (corresponding author), Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA.	kpogliano@ucsd.edu			National Institutes of Health [AI113295]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant number AI113295 to Kit Pogliano.	Alcaraz LD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-332; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Becker EC, 2007, MOL MICROBIOL, V66, P1066, DOI 10.1111/j.1365-2958.2007.05992.x; Chen Y, 2013, ENVIRON MICROBIOL, V15, P848, DOI 10.1111/j.1462-2920.2012.02860.x; Chi BK, 2013, ANTIOXID REDOX SIGN, V18, P1273, DOI 10.1089/ars.2012.4686; Chi BK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009506; Coles BF, 2003, BIOFACTORS, V17, P115, DOI 10.1002/biof.5520170112; Dickson JM, 2013, BIOSCI REP, V33; Earl AM, 2012, J BACTERIOL, V194, P2378, DOI 10.1128/JB.05675-11; Edwards A, 2016, METHODS MOL BIOL, V1394, P1, DOI 10.1007/978-1-4939-3341-9_1; Eichenberger P, 2003, J MOL BIOL, V327, P945, DOI 10.1016/S0022-2836(03)00205-5; Eklund BI, 2002, ANAL BIOCHEM, V309, P102, DOI 10.1016/S0003-2697(02)00258-0; Eliuk S, 2015, ANNU REV ANAL CHEM, V8, P61, DOI 10.1146/annurev-anchem-071114-040325; Fahey RC, 2013, BBA-GEN SUBJECTS, V1830, P3182, DOI 10.1016/j.bbagen.2012.10.006; Fang Z, 2015, MICROBIOLOGYOPEN, V4, P616, DOI 10.1002/mbo3.267; Fang Z, 2013, BIOCHEM J, V454, P239, DOI 10.1042/BJ20130415; Feng J, 2006, J BIOL CHEM, V281, P10778, DOI 10.1074/jbc.M513192200; Feng XX, 2014, CHEM BIOL, V21, P1557, DOI 10.1016/j.chembiol.2014.08.018; Gaballa A, 2013, ANTIOXID REDOX SIGNA; Gaballa A, 2014, ANTIOXID REDOX SIGN, V21, P357, DOI 10.1089/ars.2013.5327; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goncharenko KV, 2015, ANGEW CHEM INT EDIT, V54, P2821, DOI 10.1002/anie.201410045; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Harwood CR, 1990, MOL BIOL METHODS BAC, pxxxv; He PQ, 2011, J INORG BIOCHEM, V105, P1259, DOI 10.1016/j.jinorgbio.2011.06.006; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Hendrickson EL, 2006, ANALYST, V131, P1335, DOI 10.1039/b610957h; Hernick M, 2013, EXPERT REV ANTI-INFE, V11, P49, DOI [10.1586/ERI.12.152, 10.1586/eri.12.152]; Klaus A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062497; Ma Z, 2014, MOL MICROBIOL; Mannervik B, 2012, J BIOL CHEM, V287, P6072, DOI 10.1074/jbc.X112.342675; Mazzetti AP, 2015, NEUROCHEM INT, V82, P10, DOI 10.1016/j.neuint.2015.01.008; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Newton GL, 2012, MICROBIOL-SGM, V158, P1117, DOI 10.1099/mic.0.055715-0; Newton GL, 2011, BIOCHEMISTRY-US, V50, P10751, DOI 10.1021/bi201460j; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton GL, 2002, ARCH MICROBIOL, V178, P388, DOI 10.1007/s00203-002-0469-4; Nonejuie P, 2016, J ANTIBIOT, V69, P353, DOI 10.1038/ja.2015.116; Ojkic N, 2016, ELIFE, V5, DOI 10.7554/eLife.18657; PALVA I, 1982, GENE, V19, P81, DOI 10.1016/0378-1119(82)90191-3; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Perera VR, 2014, BBA-GEN SUBJECTS, V1840, P2851, DOI 10.1016/j.bbagen.2014.05.001; Perez-Garcia A, 2011, CURR OPIN BIOTECH, V22, P187, DOI 10.1016/j.copbio.2010.12.003; Pivato M, 2014, ARCH BIOCHEM BIOPHYS, V560, P83, DOI 10.1016/j.abb.2014.07.018; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Posada AC, 2014, INFECT IMMUN, V82, P316, DOI 10.1128/IAI.01074-13; Rajan SS, 2004, BIOCHEMISTRY-US, V43, P15472, DOI 10.1021/bi048665r; Rajkarnikar A, 2013, BIOCHEM BIOPH RES CO, V436, P128, DOI 10.1016/j.bbrc.2013.04.027; Roberts AA, 2013, BIOCHEM J, V451, P69, DOI 10.1042/BJ20121541; Rosario-Cruz Z, 2015, MOL MICROBIOL, V98, P218, DOI 10.1111/mmi.13115; RUGER HJ, 1979, INT J SYST BACTERIOL, V29, P196, DOI 10.1099/00207713-29-3-196; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Shi M, 2009, AM J PATHOL, V175, P54, DOI 10.2353/ajpath.2009.081019; Shin JY, 2015, ELIFE, V4, DOI 10.7554/eLife.06474; SIMONEN M, 1993, MICROBIOL REV, V57, P109, DOI 10.1128/MMBR.57.1.109-137.1993; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Tolonen AC, 2014, JOVE-J VIS EXP, DOI 10.3791/51416; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Vuilleumier S, 1997, J BACTERIOL, V179, P1431, DOI 10.1128/jb.179.5.1431-1441.1997; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Yoon JH, 2010, INT J SYST EVOL MICR, V60, P15, DOI 10.1099/ijs.0.008318-0; Zhao QF, 2015, NATURE, V518, P115, DOI 10.1038/nature14137; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r	72	4	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192977	10.1371/journal.pone.0192977	http://dx.doi.org/10.1371/journal.pone.0192977			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW5PR	29451913	Green Published, gold, Green Submitted			2022-12-26	WOS:000425369800031
J	Roudnicky, F; Yoon, SY; Poghosyan, S; Schwager, S; Poyet, C; Vella, G; Bachmann, SB; Karaman, S; Shin, JW; Otto, VI; Detmar, M				Roudnicky, Filip; Yoon, Sun Young; Poghosyan, Susanna; Schwager, Simon; Poyet, Cedric; Vella, Giorgia; Bachmann, Samia B.; Karaman, Sinem; Shin, Jay W.; Otto, Vivianne I.; Detmar, Michael			Alternative transcription of a shorter, non-anti-angiogenic thrombospondin-2 variant in cancer-associated blood vessels	ONCOGENE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; INVASIVE BLADDER-CANCER; TUMOR-GROWTH; VEGF-A; ENDOGENOUS INHIBITOR; EXPRESSION DATA; TYPE-1 REPEATS; MICE; IDENTIFICATION; SKIN	Thrombospondin-2 (TSP2) is an anti-angiogenic matricellular protein that inhibits tumor growth and angiogenesis. Tumor-associated blood vascular endothelial cells (BECs) were isolated from human invasive bladder cancers and from matched normal bladder tissue by immuno-laser capture microdissection. Exon expression profiling analyses revealed a particularly high expression of a short TSP2 transcript containing only the last 9 (3') exons of the full-length TSP2 transcript. Using 5' and 3' RACE (rapid amplification of cDNA ends) and Sanger sequencing, we confirmed the existence of the shorter transcript of TSP2 (sTSP2) and determined its sequence which completely lacked the anti-angiogenic thrombospondin type 1 repeats domain. The largest open reading frame predicted within the transcript comprises 209 amino acids and matches almost completely the C-terminal lectin domain of full-length TSP2. We produced recombinant sTSP2 and found that unlike the full-length TSP2, sTSP2 did not inhibit vascular endothelial growth factor-A-induced proliferation of cultured human BECs, but in contrast when combined with TSP2 blocked the inhibitory effects of TSP2 on BEC proliferation. In vivo studies with stably transfected A431 squamous cell carcinoma cells revealed that full-length TSP2, but not sTSP2, inhibited tumor growth and angiogenesis. This study reveals that the transcriptional program of tumor stromal cells can change to transcribe a new version of an endogenous angiogenesis inhibitor that has lost its anti-angiogenic activity.	[Roudnicky, Filip; Yoon, Sun Young; Poghosyan, Susanna; Schwager, Simon; Vella, Giorgia; Bachmann, Samia B.; Karaman, Sinem; Otto, Vivianne I.; Detmar, Michael] ETH, Inst Pharmaceut Sci, Zurich, Switzerland; [Poyet, Cedric] Univ Zurich Hosp, Dept Urol, Zurich, Switzerland; [Shin, Jay W.] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; RIKEN	Detmar, M (corresponding author), ETH, Inst Pharmaceut Sci, Zurich, Switzerland.	michael.detmar@pharma.ethz.ch	Karaman, Sinem/C-4428-2017	Karaman, Sinem/0000-0002-0719-1773; Roudnicky, Filip/0000-0001-7156-2383; Otto, Vivianne/0000-0002-1157-0186	Swiss National Science Foundation [310030B_147087]; Advanced European Research Council Grant LYVICAM; Krebsliga Schweiz; Krebsliga Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Advanced European Research Council Grant LYVICAM; Krebsliga Schweiz; Krebsliga Zurich	This work was supported by Swiss National Science Foundation grant 310030B_147087, Advanced European Research Council Grant LYVICAM, Krebsliga Schweiz and Krebsliga Zurich (to MD).	Armstrong LC, 2002, MOL BIOL CELL, V13, P1893, DOI 10.1091/mbc.E01-09-0066; Balar AV, 2013, J CLIN ONCOL, V31, P724, DOI 10.1200/JCO.2012.42.5215; Bengtsson M, 2008, AROMA AFFYMETRIX GEN; Borgia B, 2010, CANCER RES, V70, P309, DOI 10.1158/0008-5472.CAN-09-2939; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carnemolla B, 2002, BLOOD, V99, P1659, DOI 10.1182/blood.V99.5.1659; Castronovo V, 2006, MOL CELL PROTEOMICS, V5, P2083, DOI 10.1074/mcp.M600164-MCP200; Cline MS, 2005, BIOINFORMATICS, V21, pI107, DOI 10.1093/bioinformatics/bti1010; Dawson DW, 1999, MOL PHARMACOL, V55, P332, DOI 10.1124/mol.55.2.332; DETMAR M, 1990, J INVEST DERMATOL, V95, pS219, DOI 10.1111/1523-1747.ep12875807; Detmar M, 2000, J DERMATOL SCI, V24, pS78, DOI 10.1016/S0923-1811(00)00145-6; Dieterich LC, 2012, J PATHOL, V228, P378, DOI 10.1002/path.4072; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Francois P, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3246; Freeman LA, 2013, METHODS MOL BIOL, V1027, P3, DOI 10.1007/978-1-60327-369-5_1; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hanahan D, 1996, EUR J CANCER, V32A, P2386, DOI 10.1016/S0959-8049(96)00401-7; Hawighorst T, 2001, EMBO J, V20, P2631, DOI 10.1093/emboj/20.11.2631; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Huwiler KG, 2002, BIOCHEMISTRY-US, V41, P14329, DOI 10.1021/bi026463u; Iruela-Arispe ML, 1999, CIRCULATION, V100, P1423, DOI 10.1161/01.CIR.100.13.1423; Kunstfeld R, 2014, J DERMATOL SCI, V74, P106, DOI 10.1016/j.jdermsci.2014.01.002; Kyriakides TR, 1999, J INVEST DERMATOL, V113, P782, DOI 10.1046/j.1523-1747.1999.00755.x; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449; Laajala E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r77; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Noh YH, 2003, J INVEST DERMATOL, V121, P1536, DOI 10.1046/j.1523-1747.2003.12643.x; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Panetti TS, 1997, J LAB CLIN MED, V129, P208, DOI 10.1016/S0022-2143(97)90141-4; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; Ren B, 2009, CANCER RES, V69, P3856, DOI 10.1158/0008-5472.CAN-08-2940; Rodrigo-Domingo M, 2014, BRIEF BIOINFORM, V15, P519, DOI 10.1093/bib/bbt011; Roudnicky F, 2017, J PATHOL, V242, P193, DOI 10.1002/path.4892; Roudnicky F, 2013, CANCER RES, V73, P1097, DOI 10.1158/0008-5472.CAN-12-1855; Rybak JN, 2007, CANCER RES, V67, P10948, DOI 10.1158/0008-5472.CAN-07-1436; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Srinivasan K, 2005, METHODS, V37, P345, DOI 10.1016/j.ymeth.2005.09.007; Streit M, 1999, AM J PATHOL, V155, P441, DOI 10.1016/S0002-9440(10)65140-1; Streit M, 1999, P NATL ACAD SCI USA, V96, P14888, DOI 10.1073/pnas.96.26.14888; Streit M, 2002, CANCER RES, V62, P2004; Sun JF, 2009, AM J PHYSIOL-HEART C, V296, pH1344, DOI 10.1152/ajpheart.01246.2008; VOGEL T, 1993, J CELL BIOCHEM, V53, P74, DOI 10.1002/jcb.240530109; VOLPERT OV, 1995, BIOCHEM BIOPH RES CO, V217, P326, DOI 10.1006/bbrc.1995.2780; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wiemann S, 2001, GENOME RES, V11, P422, DOI 10.1101/gr.GR1547R; Yang XP, 2016, CELL, V164, P805, DOI 10.1016/j.cell.2016.01.029; Yee KO, 2004, AM J PATHOL, V165, P541, DOI 10.1016/S0002-9440(10)63319-6	60	17	17	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2018	37	19					2573	2585		10.1038/s41388-018-0129-z	http://dx.doi.org/10.1038/s41388-018-0129-z			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GF3RN	29467494	Green Published, hybrid			2022-12-26	WOS:000431873400009
J	Li, MS; Cowley, EA; El Hiani, Y; Linsdell, P				Li, Man-Song; Cowley, Elizabeth A.; El Hiani, Yassine; Linsdell, Paul			Functional organization of cytoplasmic portals controlling access to the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; POSITIVE CHARGES; ABC TRANSPORTER; BINDING-SITE; ATP-BINDING; ARCHITECTURE; VESTIBULE; LOCATION; SEGMENT; PATHWAY	The cystic fibrosis transmembrane conductance regulator (CFTR) is a Cl- channel that apparently has evolved from an ancestral active transporter. Key to the CFTR's switch from pump to channel function may have been the appearance of one or more "lateral portals." Such portals connect the cytoplasm to the transmembrane channel pore, allowing a continuous pathway for the electrodiffusional movement of Cl- ions. However, these portals remain the least well-characterized part of the Cl- transport pathway; even the number of functional portals is uncertain, and if multiple portals do exist, their relative functional contributions are unknown. Here, we used patch-clamp recording to identify the contributions of positively charged amino acid side chains located in CFTR's cytoplasmic transmembrane extensions to portal function. Mutagenesis-mediated neutralization of several charged side chains reduced single-channel Cl- conductance. However, these same mutations differentially affected channel blockade by cytoplasmic suramin and Pt(NO2)(4)(2-) anions. We considered and tested several models by which the contribution of these positively charged side chains to one or more independent or non-independent portals to the pore could affect Cl- conductance and interactions with blockers. Overall, our results suggest the existence of a single portal that is lined by several positively charged side chains that interact electrostatically with both Cl- and blocking anions. We further propose that mutations at other sites indirectly alter the function of this single portal. Comparison of our functional results with recent structural information on CFTR completes our picture of the overall molecular architecture of the Cl- permeation pathway.	[Li, Man-Song; Cowley, Elizabeth A.; El Hiani, Yassine; Linsdell, Paul] Dalhousie Univ, Dept Physiol & Biophys, POB 15000, Halifax, NS B3H 4R2, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, POB 15000, Halifax, NS B3H 4R2, Canada.	paul.linsdell@dal.ca		El Hiani, Yassine/0000-0002-1251-5066; Linsdell, Paul/0000-0001-6257-6273; Cowley, Elizabeth/0000-0002-5839-5549	Cystic Fibrosis Canada	Cystic Fibrosis Canada	This work was supported by Cystic Fibrosis Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Callebaut I, 2017, CELL MOL LIFE SCI, V74, P3, DOI 10.1007/s00018-016-2385-9; Corradi V, 2015, J BIOL CHEM, V290, P22891, DOI 10.1074/jbc.M115.665125; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; El Hiani Y, 2016, CELL MOL LIFE SCI, V73, P1917, DOI 10.1007/s00018-015-2113-x; El Hiani Y, 2015, J BIOL CHEM, V290, P15855, DOI 10.1074/jbc.M115.656181; El Hiani Y, 2012, BIOPHYS J, V103, P1719, DOI 10.1016/j.bpj.2012.09.020; El Hiani Y, 2010, J BIOL CHEM, V285, P32126, DOI 10.1074/jbc.M110.113332; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Ge N, 2004, J BIOL CHEM, V279, P55283, DOI 10.1074/jbc.M411935200; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; Linsdell Paul, 2017, Adv Exp Med Biol, V925, P13, DOI 10.1007/5584_2016_33; Linsdell P, 2017, CELL MOL LIFE SCI, V74, P67, DOI 10.1007/s00018-016-2389-5; Linsdell P, 2016, BBA-BIOMEMBRANES, V1858, P740, DOI 10.1016/j.bbamem.2016.01.009; Linsdell P, 2015, BBA-BIOMEMBRANES, V1848, P1573, DOI 10.1016/j.bbamem.2015.04.004; Linsdell P, 2014, PFLUG ARCH EUR J PHY, V466, P2243, DOI 10.1007/s00424-014-1501-7; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Mornon JP, 2015, CELL MOL LIFE SCI, V72, P1377, DOI 10.1007/s00018-014-1749-2; Negoda A, 2017, BBA-BIOMEMBRANES, V1859, P1049, DOI 10.1016/j.bbamem.2017.02.014; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; St Aubin CN, 2007, MOL PHARMACOL, V71, P1360, DOI 10.1124/mol.106.031732; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Zhang JY, 2015, BIOCHEMISTRY-US, V54, P3839, DOI 10.1021/acs.biochem.5b00427; Zhang Z, 2017, CELL, V170, P483, DOI 10.1016/j.cell.2017.06.041; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zhou JJ, 2007, J MEMBRANE BIOL, V216, P129, DOI 10.1007/s00232-007-9056-6; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327	28	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5649	5658		10.1074/jbc.RA117.001373	http://dx.doi.org/10.1074/jbc.RA117.001373			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475947	hybrid, Green Published			2022-12-26	WOS:000430044100025
J	Freeman, SL; Martel, A; Devos, JM; Basran, J; Raven, EL; Roberts, GCK				Freeman, Samuel L.; Martel, Anne; Devos, Juliette M.; Basran, Jaswir; Raven, Emma L.; Roberts, Gordon C. K.			Solution structure of the cytochrome P450 reductase-cytochrome c complex determined by neutron scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neutron scattering; protein-protein interaction; cytochrome P450; cytochrome c; electron transfer; protein structure; cytochrome P450 reductase; SANS; transient complex; solution structure; protein structural dynamics	SMALL-ANGLE SCATTERING; NITRIC-OXIDE SYNTHASE; FMN-BINDING DOMAIN; ELECTRON-TRANSFER; P450 OXIDOREDUCTASE; COENZYME BINDING; 3-DIMENSIONAL STRUCTURE; DIFLAVIN REDUCTASES; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE	Electron transfer in all living organisms critically relies on formation of complexes between the proteins involved. The function of these complexes requires specificity of the interaction to allow for selective electron transfer but also a fast turnover of the complex, and they are therefore often transient in nature, making them challenging to study. Here, using small-angle neutron scattering with contrast matching with deuterated protein, we report the solution structure of the electron transfer complex between cytochrome P450 reductase (CPR) and its electron transfer partner cytochrome c. This is the first reported solution structure of a complex between CPR and an electron transfer partner. The structure shows that the interprotein interface includes residues from both the FMN- and FAD-binding domains of CPR. In addition, the FMN is close to the heme of cytochrome c but distant from the FAD, indicating that domain movement is required between the electron transfer steps in the catalytic cycle of CPR. In summary, our results reveal key details of the CPR catalytic mechanism, including interactions of two domains of the reductase with cytochrome c and motions of these domains relative to one another. These findings shed light on interprotein electron transfer in this system and illustrate a powerful approach for studying solution structures of protein-protein complexes.	[Freeman, Samuel L.; Basran, Jaswir; Raven, Emma L.] Univ Leicester, Dept Chem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 7RH, Leics, England; [Basran, Jaswir; Roberts, Gordon C. K.] Univ Leicester, Dept Mol & Cell Biol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 7RH, Leics, England; [Freeman, Samuel L.; Basran, Jaswir; Raven, Emma L.; Roberts, Gordon C. K.] Univ Leicester, Leicester Inst Struct & Chem Biol, Leicester LE1 7RH, Leics, England; [Freeman, Samuel L.; Martel, Anne; Devos, Juliette M.] Inst Laue Langevin, 71 Ave Martyrs, F-38042 Grenoble, France	University of Leicester; University of Leicester; University of Leicester; Institut Laue-Langevin (ILL)	Raven, EL (corresponding author), Univ Leicester, Dept Chem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 7RH, Leics, England.; Roberts, GCK (corresponding author), Univ Leicester, Dept Mol & Cell Biol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 7RH, Leics, England.	emma.raven@le.ac.uk; gcr@le.ac.uk		Martel, Anne/0000-0002-1232-8519; Freeman, Samuel/0000-0002-1467-5282	Institut Laue-Langevin; University of Leicester; Engineering and Physical Sciences Research Council	Institut Laue-Langevin; University of Leicester; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by a studentship from the Institut Laue-Langevin, the University of Leicester, and the Engineering and Physical Sciences Research Council (through a doctoral training account). The authors declare that they have no conflicts of interest with the contents of this article.	Ahuja S, 2013, J BIOL CHEM, V288, P22080, DOI 10.1074/jbc.M112.448225; Aigrain L, 2012, INT J MOL SCI, V13, P15012, DOI 10.3390/ijms131115012; Bashir Q, 2011, FEBS J, V278, P1391, DOI 10.1111/j.1742-4658.2011.08062.x; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; DAVYDOV DR, 1992, ARCH BIOCHEM BIOPHYS, V297, P304, DOI 10.1016/0003-9861(92)90677-O; Deep S, 2005, BIOCHEMISTRY-US, V44, P10654, DOI 10.1021/bi050482x; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Dunne O, 2017, EUR BIOPHYS J BIOPHY, V46, P425, DOI 10.1007/s00249-016-1186-2; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Farooq Y, 2010, BIOCHEM J, V432, P485, DOI 10.1042/BJ20100744; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Freeman SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09840-8; Grunau A, 2006, BIOCHEMISTRY-US, V45, P1421, DOI 10.1021/bi052115r; Gutierrez A, 2002, BIOCHEMISTRY-US, V41, P4626, DOI 10.1021/bi0159433; Haertlein M, 2016, METHOD ENZYMOL, V566, P113, DOI 10.1016/bs.mie.2015.11.001; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Haque MM, 2014, FEBS J, V281, P5325, DOI 10.1111/febs.13073; Haque MM, 2012, J BIOL CHEM, V287, P30105, DOI 10.1074/jbc.M112.339697; Hay S, 2010, J AM CHEM SOC, V132, P9738, DOI 10.1021/ja1016206; Hedison TM, 2015, FEBS J, V282, P4357, DOI 10.1111/febs.13501; Hiruma Y, 2013, J MOL BIOL, V425, P4353, DOI 10.1016/j.jmb.2013.07.006; HORECKER BL, 1950, J BIOL CHEM, V183, P593; Huang R, 2015, J BIOL CHEM, V290, P4843, DOI 10.1074/jbc.M114.582700; Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022; Iyanagi T, 2012, ARCH BIOCHEM BIOPHYS, V528, P72, DOI 10.1016/j.abb.2012.09.002; JACROT B, 1976, PHILOS T ROY SOC B, V276, P109, DOI 10.1098/rstb.1976.0101; Jang HH, 2010, BBA-PROTEINS PROTEOM, V1804, P1285, DOI 10.1016/j.bbapap.2010.02.003; Jenner M, 2011, ANGEW CHEM INT EDIT, V50, P8291, DOI 10.1002/anie.201101077; Kline SR, 2006, J APPL CRYSTALLOGR, V39, P895, DOI 10.1107/S0021889806035059; Konarev PV, 2016, J APPL CRYSTALLOGR, V49, P953, DOI 10.1107/S1600576716005793; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Makris TM., 2005, CYTOCHROME P450, P149; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; NISIMOTO Y, 1986, J BIOL CHEM, V261, P14232; Panjkovich A, 2016, BIOINFORMATICS, V32, P2062, DOI 10.1093/bioinformatics/btw071; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Riddick DS, 2013, DRUG METAB DISPOS, V41, P12, DOI 10.1124/dmd.112.048991; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Schilder J, 2013, CURR OPIN STRUC BIOL, V23, P911, DOI 10.1016/j.sbi.2013.07.009; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; STUHRMANN HB, 1974, J APPL CRYSTALLOGR, V7, P173, DOI 10.1107/S0021889874009071; Sugishima M, 2014, P NATL ACAD SCI USA, V111, P2524, DOI 10.1073/pnas.1322034111; Svergun D., 2013, SMALL ANGLE XRAY NEU, P65; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; TAMBURINI PP, 1986, MOL PHARMACOL, V30, P178; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; Volkov AN, 2015, ACCOUNTS CHEM RES, V48, P3036, DOI 10.1021/acs.accounts.5b00343; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Waskell L., 2015, CYTOCHROME P450 STRU, P33, DOI [DOI 10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6_9]; Wolthers KR, 2007, BIOCHEMISTRY-US, V46, P11833, DOI 10.1021/bi701209p; Worrall JAR, 2002, BIOCHEMISTRY-US, V41, P11721, DOI 10.1021/bi026296y; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; Zhao Q, 1999, PROTEIN SCI, V8, P298	59	13	13	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5210	5219		10.1074/jbc.RA118.001941	http://dx.doi.org/10.1074/jbc.RA118.001941			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29475945	Green Published, hybrid			2022-12-26	WOS:000429409300025
J	Houtman, CJ; Maligaspe, E; Hunt, CG; Fernandez-Fueyo, E; Martinez, AT; Hammel, KE				Houtman, Carl J.; Maligaspe, Eranda; Hunt, Christopher G.; Fernandez-Fueyo, Elena; Martinez, Angel T.; Hammel, Kenneth E.			Fungal lignin peroxidase does not produce the veratryl alcohol cation radical as a diffusible ligninolytic oxidant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE-ROT FUNGUS; PHANEROCHAETE-CHRYSOSPORIUM; CERIPORIOPSIS-SUBVERMISPORA; HORSERADISH-PEROXIDASE; MANGANESE PEROXIDASE; COMPARATIVE GENOMICS; HYDROGEN-PEROXIDE; STEADY-STATE; COMPOUND-II; OXIDATION	Peroxidases are considered essential agents of lignin degradation by white-rot basidiomycetes. However, low-molecular-weight oxidants likely have a primary role in lignin breakdown because many of these fungi delignify wood before its porosity has sufficiently increased for enzymes to infiltrate. It has been proposed that lignin peroxidases (LPs, EC 1.11.1.14) fulfill this role by oxidizing the secreted fungal metabolite veratryl alcohol (VA) to its aryl cation radical (VA(+center dot)), releasing it to act as a one-electron lignin oxidant within woody plant cell walls. Here, we attached the fluorescent oxidant sensor BODIPY 581/591 throughout beads with a nominal porosity of 6 kDa and assessed whether peroxidase-generated aryl cation radical systems could oxidize the beads. As positive control, we used the 1,2,4,5-tetra-methoxybenzene (TMB) cation radical, generated from TMB by horseradish peroxidase. This control oxidized the beads to depths that increased with the amount of oxidant supplied, ultimately resulting in completely oxidized beads. A reaction-diffusion computer model yielded oxidation profiles that were within the 95% confidence intervals for the data. By contrast, bead oxidation caused by VA and the LPA isozyme of Phanerochaete chrysosporium was confined to a shallow shell of LP-accessible volume at the bead surface, regardless of how much oxidant was supplied. This finding contrasted with the modeling results, which showed that if the LP/VA system were to release VA(+center dot), it would oxidize the bead interiors. We conclude that LPA releases insignificant quantities of VA(+center dot) and that a different mechanism produces small ligninolytic oxidants during white rot.	[Houtman, Carl J.; Maligaspe, Eranda; Hunt, Christopher G.; Hammel, Kenneth E.] US Forest Serv, Madison, WI 53726 USA; [Fernandez-Fueyo, Elena; Martinez, Angel T.] CSIC, Ctr Invest Biol, Madrid, Spain; [Hammel, Kenneth E.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Maligaspe, Eranda] St Johns Univ, Dept Chem, Queens, NY 11439 USA; [Fernandez-Fueyo, Elena] Delft Univ Technol, Dept Biotechnol, NL-2628 CD Delft, Netherlands	United States Department of Agriculture (USDA); United States Forest Service; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Wisconsin System; University of Wisconsin Madison; Saint John's University; Delft University of Technology	Hammel, KE (corresponding author), US Forest Serv, Madison, WI 53726 USA.	kehammel@wisc.edu	Hunt, Christopher G/D-6339-2011; Hammel, Kenneth E/G-1890-2011	Hunt, Christopher G/0000-0002-4799-7085; Hammel, Kenneth E/0000-0002-2935-5847; Houtman, Carl/0000-0001-8139-6673	United States Department of Energy, Office of Biological and Environmental Research [DE-SC0006929]	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was supported by United States Department of Energy, Office of Biological and Environmental Research Grant DE-SC0006929 (to K. E. H., C. J. H., and C. G H.). The authors declare that they have no conflicts of interest with the contents of this article.	Acebes S, 2017, J PHYS CHEM B, V121, P3946, DOI 10.1021/acs.jpcb.7b00835; Baciocchi E, 2002, BIOCHEM BIOPH RES CO, V293, P832, DOI 10.1016/S0006-291X(02)00306-6; Bietti M, 1998, J PHYS CHEM A, V102, P7337, DOI 10.1021/jp9812482; BLANCHETTE RA, 1992, HOLZFORSCHUNG, V46, P109, DOI 10.1515/hfsg.1992.46.2.109; Blanchette RA, 1997, J BIOTECHNOL, V53, P203, DOI 10.1016/S0168-1656(97)01674-X; BONO JJ, 1990, EUR J BIOCHEM, V192, P189, DOI 10.1111/j.1432-1033.1990.tb19213.x; Branchi B, 2005, ORG BIOMOL CHEM, V3, P2604, DOI 10.1039/b504199f; CAI DY, 1992, J BIOL CHEM, V267, P11149; Camarero S, 1999, J BIOL CHEM, V274, P10324, DOI 10.1074/jbc.274.15.10324; CANDEIAS LP, 1995, J BIOL CHEM, V270, P16745, DOI 10.1074/jbc.270.28.16745; Cussler E. L, 2009, DIFFUSION MASS TRANS; DEJONG E, 1994, FEMS MICROBIOL REV, V13, P153, DOI 10.1016/0168-6445(94)90078-7; DIMONIE MV, 1982, EUR POLYM J, V18, P639, DOI 10.1016/0014-3057(82)90043-X; DOLMAN D, 1975, CAN J BIOCHEM CELL B, V53, P495, DOI 10.1139/o75-069; Doyle WA, 1996, BIOCHEM J, V315, P15, DOI 10.1042/bj3150015; Drummen GPC, 2004, FREE RADICAL BIO MED, V36, P1635, DOI 10.1016/j.freeradbiomed.2004.03.014; FARRELL RL, 1989, ENZYME MICROB TECH, V11, P322, DOI 10.1016/0141-0229(89)90014-8; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Filley TR, 2002, ORG GEOCHEM, V33, P111, DOI 10.1016/S0146-6380(01)00144-9; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; FORNEY LJ, 1982, J BIOL CHEM, V257, P1455; GOEZ M, 1991, BER BUNSEN PHYS CHEM, V95, P1179, DOI 10.1002/bbpc.19910951004; GOODWIN DC, 1995, BIOCHEMISTRY-US, V34, P5060, DOI 10.1021/bi00015a017; GORREBEECK C, 1991, RECL TRAV CHIM PAY B, V110, P231; Guyer JE, 2009, COMPUT SCI ENG, V11, P6, DOI 10.1109/MCSE.2009.52; HAMMEL KE, 1986, P NATL ACAD SCI USA, V83, P3708, DOI 10.1073/pnas.83.11.3708; HAMMEL KE, 1993, J BIOL CHEM, V268, P12274; HAMMEL KE, 1985, J BIOL CHEM, V260, P8348; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; HARVEY PJ, 1986, FEBS LETT, V195, P242, DOI 10.1016/0014-5793(86)80168-5; HARVEY PJ, 1989, BIOCHIM BIOPHYS ACTA, V994, P59, DOI 10.1016/0167-4838(89)90062-9; Hilden L, 2000, FEBS LETT, V477, P79, DOI 10.1016/S0014-5793(00)01757-9; Hunt CG, 2013, ENVIRON MICROBIOL, V15, P956, DOI 10.1111/1462-2920.12039; INMAN JK, 1969, BIOCHEMISTRY-US, V8, P4074, DOI 10.1021/bi00838a026; KERSTEN PJ, 1990, BIOCHEM J, V268, P475, DOI 10.1042/bj2680475; Khindaria A, 1995, BIOCHEMISTRY-US, V34, P16860, DOI 10.1021/bi00051a037; Khindaria A, 1996, BIOCHEMISTRY-US, V35, P6418, DOI 10.1021/bi9601666; KHINDARIA A, 1995, BIOCHEMISTRY-US, V34, P6020, DOI 10.1021/bi00018a003; KIRK TK, 1986, BIOCHEM J, V236, P279, DOI 10.1042/bj2360279; KODURI RS, 1995, J BIOL CHEM, V270, P22254, DOI 10.1074/jbc.270.38.22254; Koduri RS, 1996, ARCH BIOCHEM BIOPHYS, V326, P261, DOI 10.1006/abbi.1996.0074; Korripally P, 2015, APPL ENVIRON MICROB, V81, P7802, DOI 10.1128/AEM.02064-15; KREMER SM, 1992, EUR J BIOCHEM, V205, P133, DOI 10.1111/j.1432-1033.1992.tb16760.x; Lakowicz J.R., 2006, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; Mester T, 1998, J BIOL CHEM, V273, P15412, DOI 10.1074/jbc.273.25.15412; Nagy LG, 2016, MOL BIOL EVOL, V33, P959, DOI 10.1093/molbev/msv337; Niesner R, 2000, J CHEM ENG DATA, V45, P1121, DOI 10.1021/je0000569; PASZCZYNSKI A, 1986, ARCH BIOCHEM BIOPHYS, V244, P750, DOI 10.1016/0003-9861(86)90644-2; Recabarren R, 2016, THEOR CHEM ACC, V135, DOI 10.1007/s00214-016-1828-6; Saez-Jimenez V, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0615-x; Saez-Jimenez V, 2015, J BIOL CHEM, V290, P23201, DOI 10.1074/jbc.M115.665919; Stone J.E., 1968, CELLUL CHEM TECHNOL, V2, P343; Tien M, 1997, J BIOL CHEM, V272, P8912; TIEN M, 1988, METHOD ENZYMOL, V161, P238; TIEN M, 1986, J BIOL CHEM, V261, P1687; Urano Y, 1996, J CHEM SOC PERK T 2, P1169, DOI 10.1039/p29960001169; VANSTROEBIEZEN SAM, 1993, ANAL CHIM ACTA, V273, P553, DOI 10.1016/0003-2670(93)80202-V	58	18	19	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4702	4712		10.1074/jbc.RA117.001153	http://dx.doi.org/10.1074/jbc.RA117.001153			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29462790	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000428848300013
J	Dittbrenner, BJ; Pollock, MM; Schilling, JW; Olden, JD; Lawler, JJ; Torgersen, CE				Dittbrenner, Benjamin J.; Pollock, Michael M.; Schilling, Jason W.; Olden, Julian D.; Lawler, Joshua J.; Torgersen, Christian E.			Modeling intrinsic potential for beaver (Castor canadensis) habitat to inform restoration and climate change adaptation	PLOS ONE			English	Article							POPULATION; WASHINGTON; MANAGEMENT; SCIENCE; STREAMS; TOOL; DAM	Through their dam-building activities and subsequent water storage, beaver have the potential to restore riparian ecosystems and offset some of the predicted effects of climate change by modulating streamflow. Thus, it is not surprising that reintroducing beaver to watersheds from which they have been extirpated is an often-used restoration and climate-adaptation strategy. Identifying sites for reintroduction, however, requires detailed information about habitat factors-information that is not often available at broad spatial scales. Here we explore the potential for beaver relocation throughout the Snohomish River Basin in Washington, USA with a model that identifies some of the basic building blocks of beaver habitat suitability and does so by relying solely on remotely sensed data. More specifically, we developed a generalized intrinsic potential model that draws on remotely sensed measures of stream gradient, stream width, and valley width to identify where beaver could become established if suitable vegetation were to be present. Thus, the model serves as a preliminary screening tool that can be applied over relatively large extents. We applied the model to 5,019 stream km and assessed the ability of the model to correctly predict beaver habitat by surveying for beavers in 352 stream reaches. To further assess the potential for relocation, we assessed land ownership, use, and land cover in the landscape surrounding stream reaches with varying levels of intrinsic potential. Model results showed that 33% of streams had moderate or high intrinsic potential for beaver habitat. We found that no site that was classified as having low intrinsic potential had any sign of beavers and that beaver were absent from nearly three quarters of potentially suitable sites, indicating that there are factors preventing the local population from occupying these areas. Of the riparian areas around streams with high intrinsic potential for beaver, 38% are on public lands and 17% are on large tracts of privately-owned timber land. Thus, although there are a large number of areas that could be suitable for relocation and restoration using beavers, current land use patterns may substantially limit feasibility in these areas.	[Dittbrenner, Benjamin J.; Lawler, Joshua J.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Pollock, Michael M.] NOAA, Northwest Fisheries Sci Ctr, Seattle, WA USA; [Schilling, Jason W.] Tulalip Tribes Nat Resources, Tulalip, WA USA; [Olden, Julian D.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Torgersen, Christian E.] Univ Washington, US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Cascadia Field Stn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle	Dittbrenner, BJ (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	castor@uw.edu	Olden, Julian D/A-8535-2010	Dittbrenner, Benjamin/0000-0001-7980-5597; Olden, Julian/0000-0003-2143-1187	U.S Environmental Protection Agency's FY Noncompetitive Tribal Projects for Restoration and Protection of Puget Sound, Federal [PA-00J322-01]; Conservation, Research and Education Opportunities International's CREOi award	U.S Environmental Protection Agency's FY Noncompetitive Tribal Projects for Restoration and Protection of Puget Sound, Federal; Conservation, Research and Education Opportunities International's CREOi award	This research was funded by the U.S Environmental Protection Agency's FY 2011 Noncompetitive Tribal Projects for Restoration and Protection of Puget Sound, Federal Grant Number PA-00J322-01, to JWS & BJD; and Conservation, Research and Education Opportunities Internationals 2015 CREOi award to BJD. http://blogs.nwifc.org/psp/2015/02/final-progress-report-deliverables-22/ http://creoi.org/the-skykomish-beaver-project-building-educational-opportunities-for-aspiring-ecologists-2/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AW., 1982, FWSOBS82; Anderson J. T., 2014, P 4 INT C FUTURE ENV; [Anonymous], 2014, GEN TECHNICAL REPORT; Barnes DM, 1997, J WILDLIFE MANAGE, V61, P1371, DOI 10.2307/3802140; Bartz KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124415; Beechie T, 2014, WATER RESOUR RES, V50, P39, DOI 10.1002/2013WR013629; Benda L, 2007, FOREST SCI, V53, P206; Burnett K., 2003, AQUATIC PROTECTED AR, P144; Castro J., 2015, BEAVER RESTORATION G; Cowardin LM., 2005, WATER ENCY; Cox Daniel R., 2009, Transactions of the Illinois State Academy of Science, V102, P55; Davies JR, 2007, J AM WATER RESOUR AS, V43, P414, DOI 10.1111/j.1752-1688.2007.00032.x; Elsner MM, 2010, CLIMATIC CHANGE, V102, P225, DOI 10.1007/s10584-010-9855-0; Gibson PP, 2014, AQUAT CONSERV, V24, P391, DOI 10.1002/aqc.2432; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; HOWARD RJ, 1985, J WILDLIFE MANAGE, V49, P19, DOI 10.2307/3801833; Janzen K, 2011, CAN WATER RESOUR J, V36, P331, DOI 10.4296/cwrj3604846; JENKINS S H, 1979, Mammalian Species, P1, DOI 10.2307/3503787; JENKINS SH, 1975, OECOLOGIA, V21, P157, DOI 10.1007/BF00345558; JOHNSTON CA, 1990, ECOLOGY, V71, P1617, DOI 10.2307/1938297; Johnston CA, 1986, BOUNDARY DYNAMICS AQ, V57, P47; Kemp PS, 2012, FISH FISH, V13, P158, DOI 10.1111/j.1467-2979.2011.00421.x; Law A, 2016, FRESHWATER BIOL, V61, P486, DOI 10.1111/fwb.12721; Macfarlane WW, 2015, GEOMORPHOLOGY; Mackie Richard, 1997, TRADING MOUNTAINS BR; MCCOMB WC, 1990, GREAT BASIN NAT, V50, P273; Mote P, 2008, HYDROL EARTH SYST SC, V12, P193, DOI 10.5194/hess-12-193-2008; Naiman RJ, 1999, HYDROBIOLOGIA, V410, P79, DOI 10.1023/A:1003768102188; Parker H, 2014, WILDLIFE BIOL, V20, P267, DOI 10.2981/wlb.00040; Perkins TE, 2000, THESIS; Petro V.M., 2013, THESIS; Pollock MM, 2014, BIOSCIENCE, V64, P279, DOI 10.1093/biosci/biu036; Pollock MM, 2004, N AM J FISH MANAGE, V24, P749, DOI 10.1577/M03-156.1; Pollock MM, 2003, AM FISH S S, V37, P213; Pollock MM, 1994, LINKING SPECIES ECOS, P117; Raymond CL, 2013, SUSTAINABILITY-BASEL, V5, P136, DOI 10.3390/su5010136; Retzer J., 1956, USDA TECHNICAL B; Robinson S, 2007, ARCTIC, V60, P430; Scheuerell MD, 2006, CAN J FISH AQUAT SCI, V63, P1596, DOI 10.1139/F06-056; Snodgrass JW, 1997, J APPL ECOL, V34, P1043, DOI 10.2307/2405293; Snodgrass JW, 1998, ECOLOGY, V79, P928, DOI 10.2307/176590; Snohomish Basin Salmon Recovery Forum, 2005, SNOH RIV BAS SALM CO; Snyder R V., 1970, MT BAKER NATL FOREST; Stavros EN, 2014, INT J WILDLAND FIRE, V23, P899, DOI 10.1071/WF13169; Stevens CE, 2007, BIOL CONSERV, V134, P1, DOI 10.1016/j.biocon.2006.07.017; Suzuki N, 1998, NORTHWEST SCI, V72, P102; Westbrook CJ, 2011, RIVER RES APPL, V27, DOI 10.1002/rra.1359; Whitfield CJ, 2015, AMBIO, V44, P7, DOI 10.1007/s13280-014-0575-y; Wright JP, 2002, OECOLOGIA, V132, P96, DOI 10.1007/s00442-002-0929-1	49	30	30	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192538	10.1371/journal.pone.0192538	http://dx.doi.org/10.1371/journal.pone.0192538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489853	Green Published, Green Submitted, gold			2022-12-26	WOS:000426276000030
J	Soeters, HM; Koivogui, L; de Beer, L; Johnson, CY; Diaby, D; Ouedraogo, A; Toure, F; Bangoura, FO; Chang, MA; Chea, N; Dotson, EM; Finlay, A; Fitter, D; Hamel, MJ; Hazim, C; Larzelere, M; Park, BJ; Rowe, AK; Thompson-Paul, AM; Twyman, A; Barry, M; Ntaw, G; Diallo, AO				Soeters, Heidi M.; Koivogui, Lamine; de Beer, Lindsey; Johnson, Candice Y.; Diaby, Dianka; Ouedraogo, Abdoulaye; Toure, Fatoumata; Bangoura, Fode Ousmane; Chang, Michelle A.; Chea, Nora; Dotson, Ellen M.; Finlay, Alyssa; Fitter, David; Hamel, Mary J.; Hazim, Carmen; Larzelere, Maribeth; Park, Benjamin J.; Rowe, Alexander K.; Thompson-Paul, Angela M.; Twyman, Anthony; Barry, Moumie; Ntaw, Godlove; Diallo, Alpha Oumar			Infection prevention and control training and capacity building during the Ebola epidemic in Guinea	PLOS ONE			English	Article							HEALTH-CARE WORKERS; VIRUS DISEASE; LIBERIA	Background During the 2014-2016 Ebola epidemic in West Africa, a key epidemiological feature was disease transmission within healthcare facilities, indicating a need for infection prevention and control (IPC) training and support. Methods IPC training was provided to frontline healthcare workers (HCW) in healthcare facilities that were not Ebola treatment units, as well as to IPC trainers and IPC supervisors placed in healthcare facilities. Trainings included both didactic and hands-on components, and were assessed using pre-tests, post-tests and practical evaluations. We calculated median percent increase in knowledge. Results From October December 2014, 20 IPC courses trained 1,625 Guineans: 1,521 HCW, 55 IPC trainers, and 49 IPC supervisors. Median test scores increased 40% (interquartile range [IQR]: 19-86%) among HCW, 15% (IQR: 8-33%) among IPC trainers, and 21% (IQR: 15-30%) among IPC supervisors (all P<0.0001) to post-test scores of 83%, 93%, and 93%, respectively. Conclusions IPC training resulted in clear improvements in knowledge and was feasible in a public health emergency setting. This method of IPC training addressed a high demand among HCW. Valuable lessons were learned to facilitate expansion of IPC training to other prefectures; this model may be considered when responding to other large outbreaks.	[Soeters, Heidi M.; de Beer, Lindsey; Johnson, Candice Y.; Chang, Michelle A.; Chea, Nora; Dotson, Ellen M.; Finlay, Alyssa; Fitter, David; Hamel, Mary J.; Hazim, Carmen; Larzelere, Maribeth; Park, Benjamin J.; Rowe, Alexander K.; Thompson-Paul, Angela M.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Koivogui, Lamine] Inst Natl Sante Publ, Conakry, Guinea; [Diaby, Dianka; Ntaw, Godlove] Catholic Relief Serv, Conakry, Guinea; [Ouedraogo, Abdoulaye; Bangoura, Fode Ousmane; Twyman, Anthony] WHO, Conakry, Guinea; [Toure, Fatoumata] Hop Natl Donka, Conakry, Guinea; [Barry, Moumie; Diallo, Alpha Oumar] Guinea Minist Hlth & Publ Hyg, Conakry, Guinea	Centers for Disease Control & Prevention - USA; World Health Organization	Soeters, HM (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	HMSoeters@cdc.gov	Soeters, Heidi/H-3271-2019; Thompson-Paul, Angela/N-7067-2016	Soeters, Heidi/0000-0002-9415-9340; Thompson-Paul, Angela/0000-0003-1186-9150; Hazim, Carmen/0000-0002-6024-9815; Johnson, Candice/0000-0002-2544-3110	United States Agency for International Development; CDC Foundation; Rio Tinto Group	United States Agency for International Development(United States Agency for International Development (USAID)); CDC Foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Rio Tinto Group	IPC trainings were supported by the United States Agency for International Development, CDC Foundation, and Rio Tinto Group. CDC staff were provided in kind during the response. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper C, 2016, BMC MED, V14, DOI 10.1186/s12916-015-0548-4; Grinnell M, 2015, MMWR-MORBID MORTAL W, V64, P1083, DOI 10.15585/mmwr.mm6438a6; Kilmarx PH, 2014, MMWR-MORBID MORTAL W, V63, P1168; Matanock A, 2014, MMWR-MORBID MORTAL W, V63, P1077; WHO, 2016, EB RESP ROADM SIT RE; World Health Organization, 2015, EB RESP ROADM SIT RE	6	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193291	10.1371/journal.pone.0193291	http://dx.doi.org/10.1371/journal.pone.0193291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489885	Green Submitted, Green Published, gold			2022-12-26	WOS:000426276000062
J	Ishihara, K; Taniguchi, H				Ishihara, Kengo; Taniguchi, Hirokazu			Fat(max) as an index of aerobic exercise performance in mice during uphill running	PLOS ONE			English	Article							MAXIMAL FAT-OXIDATION; MAMMALIAN RESPIRATORY SYSTEM; ANAEROBIC THRESHOLD; SUBSTRATE OXIDATION; WIDE-RANGE; CAPACITY; RATES; INTENSITIES; CROSSOVER; DESIGN	Endurance exercise performance has been used as a representative index in experimental animal models in the field of health sciences, exercise physiology, comparative physiology, food function or nutritional physiology. The objective of the present study was to evaluate the effectiveness of Fat(max) (the exercise intensity that elicits maximal fat oxidation) as an additional index of endurance exercise performance that can be measured during running at submaximal exercise intensity in mice. We measured both Fat(max) and V-o2 peak of trained ICR mice that voluntary exercised for 8 weeks and compared them with a sedentary group of mice at multiple inclinations of 20, 30, 40, and 50 degrees on a treadmill. The Vo(2) at Fat(max) of the training group was significantly higher than that of the sedentary group at inclinations of 30 and 40 degrees (P < 0.001). The running speed at Fat(max) of the training group was significantly higher than that of the sedentary group at inclinations of 20, 30, and 40 degrees (P < 0.05). Blood lactate levels sharply increased in the sedentary group (7.33 +/- 2.58 mM) compared to the training group (3.13 +/- 1.00 mM, P < 0.01) when running speeds exceeded the Fat(max) of sedentary mice. Vo(2) at Fat(max) significantly correlated to Vo(2 peak), running time to fatigue, and lactic acid level during running (P < 0.05) although the reproducibility of Vol peak was higher than that of Vo(2) at Fat(max). In conclusion, Fat(max)), can be used as a functional assessment of the endurance exercise performance of mice during submaximal exercise intensity.	[Ishihara, Kengo; Taniguchi, Hirokazu] Ryukoku Univ, Fac Agr, Shiga, Japan	Ryukoku University	Ishihara, K (corresponding author), Ryukoku Univ, Fac Agr, Shiga, Japan.	kengo@agr.ryukoku.ac.jp	Ishihara, Kengo/J-7913-2019	Ishihara, Kengo/0000-0001-9374-5033	Sugiyama Sangyo Kagaku Institute [2015]	Sugiyama Sangyo Kagaku Institute	This research was supported by Sugiyama Sangyo Kagaku Institute (Grant No. 2015 to KI) (http://www.sugiyama-c-i-I.or.jp/kenkyu.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten J, 2004, INT J SPORTS MED, V25, P32, DOI 10.1055/s-2003-45231; Achten J, 2003, INT J SPORTS MED, V24, P603, DOI 10.1055/s-2003-43265; Achten J, 2003, METABOLISM, V52, P747, DOI 10.1016/S0026-0495(03)00068-4; Achten J, 2002, MED SCI SPORT EXER, V34, P92, DOI 10.1097/00005768-200201000-00015; ASTRAND PO, 1976, PROG CARDIOVASC DIS, V19, P51, DOI 10.1016/0033-0620(76)90008-6; Ayachi M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00372; Chappell MA, 2007, PHYSIOL BIOCHEM ZOOL, V80, P652, DOI 10.1086/521202; Conner JD, 2014, JOVE-J VIS EXP, V90; Costa JM, 2015, AMINO ACIDS, V47, P745, DOI 10.1007/s00726-014-1903-z; Croci I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097930; DAVIS JA, 1976, J APPL PHYSIOL, V41, P544, DOI 10.1152/jappl.1976.41.4.544; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Gmada N, 2012, DIABETES METAB, V38, P40, DOI 10.1016/j.diabet.2011.07.004; Hoydal MA, 2007, EUR J CARDIOV PREV R, V14, P753, DOI 10.1097/HJR.0b013e3281eacef1; Kemi OJ, 2002, J APPL PHYSIOL, V93, P1301, DOI 10.1152/japplphysiol.00231.2002; Knab AM, 2009, PHYSIOL BEHAV, V98, P433, DOI 10.1016/j.physbeh.2009.07.006; Kurauti MA, 2016, J ENDOCRINOL, V229, P221, DOI 10.1530/JOE-15-0483; LECHNER AJ, 1978, RESP PHYSIOL, V34, P29, DOI 10.1016/0034-5687(78)90047-6; Lima-Silva AE, 2010, J SPORT SCI MED, V9, P31; Meyer T, 2009, SCAND J MED SCI SPOR, V19, P213, DOI 10.1111/j.1600-0838.2008.00775.x; Michallet AS, 2008, DIABETES METAB, V34, P514, DOI 10.1016/j.diabet.2008.04.004; Mille-Hamard L, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-29; Perez-Martin A, 2001, DIABETES METAB, V27, P466; Petrosino JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148010; Rami M, 2014, JENTASHAPIR J HLTH R, V5, P53; Rezende EL, 2006, J EXP BIOL, V209, P115, DOI 10.1242/jeb.01883; Rezende EL, 2006, PHYSIOL BIOCHEM ZOOL, V79, P83, DOI 10.1086/498187; SEEHERMAN HJ, 1981, RESP PHYSIOL, V44, P11, DOI 10.1016/0034-5687(81)90074-8; Silveira RD, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0115-1; TAYLOR CR, 1981, RESP PHYSIOL, V44, P25, DOI 10.1016/0034-5687(81)90075-X; WASSERMAN K, 1987, CIRCULATION, V76, P29; Wasserman K, 1990, CIRCULATION S2, V81, P1114	32	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193470	10.1371/journal.pone.0193470	http://dx.doi.org/10.1371/journal.pone.0193470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474428	gold, Green Submitted, Green Published			2022-12-26	WOS:000426049500114
J	Karlsson, E; Shin, JH; Westman, G; Eriksson, LA; Olsson, L; Mapell, V				Karlsson, Emma; Shin, Jae Ho; Westman, Gunnar; Eriksson, Leif A.; Olsson, Lisbeth; Mapell, Valeria			In silico and in vitro studies of the reduction of unsaturated alpha,beta bonds of trans-2-hexenedioic acid and 6-amino-trans-2-hexenoic acid - Important steps towards biobased production of adipic acid	PLOS ONE			English	Article							OLD YELLOW ENZYME; HIGH-LEVEL CONVERSION; L-LYSINE; ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; LIGAND-BINDING; BIOSYNTHESIS; PATHWAY; AMINOTRANSFERASE; PURIFICATION	The biobased production of adipic acid, a precursor in the production of nylon, is of great interest in order to replace the current petrochemical production route. Glucose-rich lignocellulosic raw materials have high potential to replace the petrochemical raw material. A number of metabolic pathways have been proposed for the microbial conversion of glucose to adipic acid, but achieved yields and titers remain to be improved before industrial applications are feasible. One proposed pathway starts with lysine, an essential metabolite industrially produced from glucose by microorganisms. However, the drawback of this pathway is that several reactions are involved where there is no known efficient enzyme. By changing the order of the enzymatic reactions, we were able to identify an alternative pathway with one unknown enzyme less compared to the original pathway. One of the reactions lacking known enzymes is the reduction of the unsaturated a,6 bond of 6-amino-trans-2-hexenoic acid and trans-2-hexenedioic acid. To identify the necessary enzymes, we selected N-ethylmaleimide reductase from Escherichia coli and Old Yellow Enzyme 1 from Saccharomyces pastorianus. Despite successful in silico docking studies, where both target substrates could fit in the enzyme pockets, and hydrogen bonds with catalytic residues of both enzymes were predicted, no in vitro activity was observed. We hypothesize that the lack of activity is due to a difference in electron withdrawing potential between the naturally reduced aldehyde and the carboxylate groups of our target substrates. Suggestions for protein engineering to induce the reactions are discussed, as well as the advantages and disadvantages of the two metabolic pathways from lysine. We have highlighted bottlenecks associated with the lysine pathways, and proposed ways of addressing them.	[Karlsson, Emma; Shin, Jae Ho; Olsson, Lisbeth; Mapell, Valeria] Chalmers Univ Technol, Div Ind Biotechnol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Westman, Gunnar] Dept Chem & Chem Engn, Div Chem & Biochem, Gothenburg, Sweden; [Eriksson, Leif A.] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	Chalmers University of Technology; University of Gothenburg	Olsson, L (corresponding author), Chalmers Univ Technol, Div Ind Biotechnol, Dept Biol & Biol Engn, Gothenburg, Sweden.	lisbeth.olsson@chalmers.se	Westman, Gunnar/D-4499-2015; Mapelli, Valeria/E-4434-2014; shin, Jaeho/K-6792-2013; Eriksson, Leif A/D-1226-2012	Mapelli, Valeria/0000-0001-8724-3221; shin, Jaeho/0000-0002-5874-9765; Eriksson, Leif A/0000-0001-5654-3109	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) [2013-78]; Swedish Research Council (VR) [20143914]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Swedish Research Council (VR)(Swedish Research Council)	The study was funded by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) under the strategic programme of "Research for Transition to a Bio-based Economy and within the collaborative project BioBuF (Project no. 2013-78) www.biobuf.se. The Swedish National Infrastructure for Computing (SNIC) is acknowledged for providing computing time. L.A.E. acknowledges the Swedish Research Council (VR) for funding (no. 20143914).	Babu T, 2015, PROCESS BIOCHEM, V50, P2066, DOI 10.1016/j.procbio.2015.09.018; Becker J, 2012, CURR OPIN BIOTECH, V23, P631, DOI 10.1016/j.copbio.2011.11.012; Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003; Brenna E, 2015, J MOL CATAL B-ENZYM, V114, P77, DOI 10.1016/j.molcatb.2014.12.011; Brenna E, 2013, ORG BIOMOL CHEM, V11, P2988, DOI 10.1039/c3ob40076j; Burgard A. P., 2016, US patent, Patent No. [9,382,556 B2, 9382556, 9,382,556]; Deng Y, 2015, J APPL MICROBIOL, V119, P1057, DOI 10.1111/jam.12905; Fisher Scientific Inc T, DET AM AC CELL CULT; Forsythe RG, 1997, COMPUT APPL BIOSCI, V13, P537; FOX KM, 1994, STRUCTURE, V2, P1089, DOI 10.1016/S0969-2126(94)00111-1; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; GOUGH JA, 1983, J MOL BIOL, V166, P1, DOI 10.1016/S0022-2836(83)80047-3; HAMMER T, 1991, J BASIC MICROB, V31, P43, DOI 10.1002/jobm.3620310109; HAMMER T, 1992, J BASIC MICROB, V32, P21, DOI 10.1002/jobm.3620320106; Hansson T, 1998, J COMPUT AID MOL DES, V12, P27, DOI 10.1023/A:1007930623000; HERMES JD, 1985, BIOCHEMISTRY-US, V24, P2959, DOI 10.1021/bi00333a023; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Joo JC, 2017, CHEM SCI, V8, P1406, DOI 10.1039/c6sc02842j; Kallscheuer N, 2016, APPL MICROBIOL BIOT, P1; Kind S, 2014, METAB ENG, V25, P113, DOI 10.1016/j.ymben.2014.05.007; Kind S, 2010, METAB ENG, V12, P341, DOI 10.1016/j.ymben.2010.03.005; KINZEL JJ, 1983, J BACTERIOL, V155, P417, DOI 10.1128/JB.155.1.417-419.1983; KISS RD, 1992, BIOTECHNOL BIOENG, V39, P565, DOI 10.1002/bit.260390512; Kohli RM, 1998, J BIOL CHEM, V273, P32763, DOI 10.1074/jbc.273.49.32763; KUNO S, 1985, BIOL CHEM H-S, V366, P463, DOI 10.1515/bchm3.1985.366.1.463; Li Z., 2016, SCI REP, V6; Liu HB, 2013, RSC ADV, V3, P1666, DOI 10.1039/c2ra22374k; Lonsdale R, 2015, J AM CHEM SOC, V137, P14733, DOI 10.1021/jacs.5b08687; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Marx A, 1997, BIOTECHNOL BIOENG, V56, P168, DOI 10.1002/(SICI)1097-0290(19971020)56:2<168::AID-BIT6>3.0.CO;2-N; MAVROVOUNIOTIS ML, 1991, J BIOL CHEM, V266, P14440; Mimitsuka T, 2007, BIOSCI BIOTECH BIOCH, V71, P2130, DOI 10.1271/bbb.60699; Miura K, 1997, BIOL PHARM BULL, V20, P110; Moritz B, 2002, METAB ENG, V4, P295, DOI 10.1006/mben.2002.0233; Oh YH, 2015, J IND MICROBIOL BIOT, V42, P1481, DOI 10.1007/s10295-015-1678-6; Padhi SK, 2009, J AM CHEM SOC, V131, P3271, DOI 10.1021/ja8081389; Park SJ, 2014, BIOTECHNOL J, V9, P1322, DOI 10.1002/biot.201400156; Parthasarathy A, 2011, BIOCHEMISTRY-US, V50, P3540, DOI 10.1021/bi1020056; Pesic M, 2017, CHEMISTRYSELECT, V2, P3866, DOI 10.1002/slct.201700724; Pompeu YA, 2013, ACS CATAL, V3, P2376, DOI 10.1021/cs400622e; Raemakers-Franken P. C., 2009, U.S. Patent, Patent No. [7491520 (B2), 7491520, US7491520 B2]; Rohles CM, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0553-0; SCHMIDT H, 1988, FEMS MICROBIOL LETT, V49, P203; Shin JH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0566-8; Simon H, 1998, STUD NAT PROD CHEM, V20, P817; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Stueckler C, 2010, DALTON T, V39, P8472, DOI 10.1039/c002971h; Swiderska MA, 2007, THESIS; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; TISCHER W, 1979, EUR J BIOCHEM, V97, P103, DOI 10.1111/j.1432-1033.1979.tb13090.x; Toogood HS, 2011, CHEMBIOCHEM, V12, P738, DOI 10.1002/cbic.201000662; Turk SCHJ, 2016, ACS SYNTH BIOL, V5, P65, DOI 10.1021/acssynbio.5b00129; VAZ ADN, 1995, BIOCHEMISTRY-US, V34, P4246, DOI 10.1021/bi00013a014; Walton AZ, 2013, HDB FLAVOPROTEINS, V2; Warburg O, 1932, NATURWISSENSCHAFTEN, V20, P980, DOI 10.1007/BF01504728; WILLIAMS A, 2000, NEW DIR ORG, P1; Williams RE, 2002, MICROBIOL-SGM, V148, P1607, DOI 10.1099/00221287-148-6-1607; Williams RE, 2004, APPL ENVIRON MICROB, V70, P3566, DOI 10.1128/AEM.70.6.3566-3574.2004; Winkler CK, 2012, J BIOTECHNOL, V162, P381, DOI 10.1016/j.jbiotec.2012.03.023; Yu JL, 2014, BIOTECHNOL BIOENG, V111, P2580, DOI 10.1002/bit.25293	62	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193503	10.1371/journal.pone.0193503	http://dx.doi.org/10.1371/journal.pone.0193503			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474495	gold, Green Published, Green Submitted			2022-12-26	WOS:000426049500122
J	Sivarajah, S; Smith, SM; Thomas, SC				Sivarajah, Sivajanani; Smith, Sandy M.; Thomas, Sean C.			Tree cover and species composition effects on academic performance of primary school students	PLOS ONE			English	Article							NATURAL-ENVIRONMENT; BUILT ENVIRONMENT; ACHIEVEMENT; RESTORATION; EXPOSURE; ANXIETY	Human exposure to green space and vegetation is widely recognized to result in physical and mental health benefits; however, to date, the specific effects of tree cover, diversity, and species composition on student academic performance have not been investigated. We compiled standardized performance scores in Grades 3 and 6 for the collective student body in 387 schools across the Toronto District School Board (TDSB), and examined variation in relation to tree cover, tree diversity, and tree species composition based on comprehensive inventories of trees on school properties combined with aerial-photo-based assessments of tree cover. Analyses accounted for variation due to socioeconomic factors using the learning opportunity index (LOI), a regional composite index of external challenges to learning that incorporates income and other factors, such as students with English as a second language. As expected, LOI had the greatest influence on student academic performance; however, the proportion of tree cover, as distinct from other types of "green space" such as grass, was found to be a significant positive predictor of student performance, accounting for 13% of the variance explained in a statistical model predicting mean student performance assessments. The effects of tree cover and species composition were most pronounced in schools that showed the highest level of external challenges, suggesting the importance of urban forestry investments in these schools.	[Sivarajah, Sivajanani; Smith, Sandy M.; Thomas, Sean C.] Univ Toronto, Fac Forestry, Toronto, ON, Canada	University of Toronto	Sivarajah, S (corresponding author), Univ Toronto, Fac Forestry, Toronto, ON, Canada.	sivalanani.sivarajah@mail.utoronto.ca	Sivarajah, Janani/AAN-8663-2020; THOMAS, Sean C./B-6089-2008	Sivarajah, Janani/0000-0002-0530-4615; THOMAS, Sean C./0000-0002-0686-2483	NSERC; Toronto District School Board, Sustainability Office; Toronto District School Board (TDSB); Toronto District School Board; Canadian Natural Sciences and Engineering Research Council	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Toronto District School Board, Sustainability Office; Toronto District School Board (TDSB); Toronto District School Board; Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Sean C. Thomas and Sandy M. Smith were supported by individual NSERC Discovery grants (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/index_eng.asp). Toronto District School Board, Sustainability Office offered additional financial support (http://www.tdsb.on.ca/).; The authors gratefully acknowledge funding from the Toronto District School Board (TDSB) and support of staff from the Sustainability Office of the TDSB (in particular Richard Christie, Bruce Day, and Gail Bornstein). Thanks also to Professors W.A. Kenney and D.Puric-Mladenovic for allowing the use of their NeighbourWoods data and the Education Quality and Accountability (EQAO) Office for the student body standardized test scores for each school, and M. Lukas Seehausen and Susan Frye for providing helpful comments on an early version of the manuscript. This research was funded by the Toronto District School Board, and grants from the Canadian Natural Sciences and Engineering Research Council.	Altschul I., 2012, J SOC SOC WORK RES, V3, P13, DOI [10.5243/jsswr.2012.2, 10.5243/jsswr, DOI 10.5243/JSSWR.2012.2]; [Anonymous], 1989, EXPERIENCE NATURE; Ashcraft MH, 2001, J EXP PSYCHOL GEN, V130, P224, DOI 10.1037/0096-3445.130.2.224; Caro D.H., 2009, CANADIAN J ED, V32, P558; Chambers EA, 2004, GENDER EDUC, V16, P327, DOI 10.1080/09540250042000251470; City of Toronto, WELLB TOR; City of Toronto, FOR LAND COV PARKS R; Cummins SK, 2001, PEDIATR CLIN N AM, V48, P1241, DOI 10.1016/S0031-3955(05)70372-2; Dyment JE, 2008, HEALTH EDUC RES, V23, P952, DOI 10.1093/her/cym059; Eamon MK, 2005, J YOUTH ADOLESCENCE, V34, P163, DOI 10.1007/s10964-005-3214-x; Fjortoft I., 2004, CHILD YOUTH ENV, V14, P21, DOI [DOI 10.7721/CHILYOUTENVI.14.2.0021, 10.7721/chilyoutenvi.14.2.0021]; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; Hansmann Ralf, 2007, Urban Forestry & Urban Greening, V6, P213, DOI 10.1016/j.ufug.2007.08.004; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; HARTIG T, 1991, ENVIRON BEHAV, V23, P3, DOI 10.1177/0013916591231001; Herrington S, 1998, LANDSCAPE URBAN PLAN, V42, P191, DOI 10.1016/S0169-2046(98)00087-5; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Maas J, 2008, ENVIRON PLANN, V41, P1763; Magurran A.E., 2013, ECOLOGICAL DIVERSITY; Matsuoka RH, 2010, LANDSCAPE URBAN PLAN, V97, P273, DOI 10.1016/j.landurbplan.2010.06.011; McCoy LP, 2005, J EDUC RES, V98, P131, DOI 10.3200/JOER.98.3.131-135; Mitchell R, 2008, LANCET, V372, P1655, DOI 10.1016/S0140-6736(08)61689-X; Nowak David J., 2006, Urban Forestry & Urban Greening, V4, P115, DOI 10.1016/j.ufug.2006.01.007; Park BJ, 2011, LANDSCAPE URBAN PLAN, V102, P24, DOI 10.1016/j.landurbplan.2011.03.005; Pretty J, 2005, INT J ENVIRON HEAL R, V15, P319, DOI 10.1080/09603120500155963; RICHARDSON FC, 1972, J COUNS PSYCHOL, V19, P551, DOI 10.1037/h0033456; Takano T, 2002, J EPIDEMIOL COMMUN H, V56, P913, DOI 10.1136/jech.56.12.913; Taylor AF, 2001, ENVIRON BEHAV, V33, P54, DOI 10.1177/00139160121972864; Toronto District School Board, LEARN OPP IND EL; Tranter P.J., 2004, CHILD GEOGR, V2, P131, DOI [10.1080/1473328032000168813, DOI 10.1080/1473328032000168813]; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; Villeneuve PJ, 2012, ENVIRON RES, V115, P51, DOI 10.1016/j.envres.2012.03.003; Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548	33	42	43	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193254	10.1371/journal.pone.0193254	http://dx.doi.org/10.1371/journal.pone.0193254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX4LV	29474503	gold, Green Published, Green Submitted			2022-12-26	WOS:000426049500071
J	Rigalli, JP; Reichel, M; Reuter, T; Tocchetti, GN; Dyckhoff, G; Herold-Mende, C; Theile, D; Weiss, J				Rigalli, Juan Pablo; Reichel, Matthias; Reuter, Tasmin; Tocchetti, Guillermo Nicolas; Dyckhoff, Gerhard; Herold-Mende, Christel; Theile, Dirk; Weiss, Johanna			The pregnane X receptor (PXR) and the nuclear receptor corepressor 2 (NCoR2) modulate cell growth in head and neck squamous cell carcinoma	PLOS ONE			English	Article							COLON-CANCER CELLS; BREAST-CANCER; FUNCTIONAL INTERACTION; MULTIDRUG-RESISTANCE; XENOBIOTIC RECEPTOR; TUMOR RECURRENCE; EXPRESSION; SMRT; TUMORIGENICITY; PROLIFERATION	Head and neck squamous cell carcinoma (HNSCC) is the sixth most frequent cancer worldwide. The pregnane X receptor (PXR) is a nuclear receptor regulating several target genes associated with cancer malignancy. We here demonstrated a significant effect of PXR on HNSCC cell growth, as evidenced in PXR knock-down experiments. PXR transcriptional activity is more importantly regulated by the presence of coactivators and corepressors than by PXR protein expression. To date, there is scarce information on the regulation of PXR in HNSCC and on its role in the pathogenesis of this disease. Coactivator and corepressor expression was screened through qRT-PCR in 8 HNSCC cell lines and correlated to PXR activity, determined by using a reporter gene assay. All cell lines considerably expressed all the cofactors assessed. PXR activity negatively correlated with nuclear receptor corepressor 2 (NCoR2) expression, indicating a major role of this corepressor in PXR modulation and suggesting its potential as a surrogate for PXR activity in HNSCC. To test the association of NCoR2 with the malignant phenotype, a subset of three cell lines was transfected with an over-expression plasmid for this corepressor. Subsequently, cell growth and chemoresistance assays were performed. To elucidate the mechanisms underlying NCoR2 effects on cell growth, caspase 3/7 activity and protein levels of cleaved caspase 3 and PARP were evaluated. In HNO97 cells, NCoR2 over-expression decreased cell growth, chemoresistance and increased cleaved caspase 3 levels, caspase activity and cleaved PARP levels. On the contrary, in HNO124 and HNO210 cells, NCoR2 over-expression increased cell growth, drug resistance and decreased cleaved caspase 3 levels, caspase activity and cleaved PARP levels. In conclusion, we demonstrated a role of PXR and NCoR2 in the modulation of cell growth in HNSCC. This may contribute to a better understanding of the highly variable HNSCC therapeutic response.	[Rigalli, Juan Pablo; Reichel, Matthias; Reuter, Tasmin; Tocchetti, Guillermo Nicolas; Theile, Dirk; Weiss, Johanna] Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany; [Tocchetti, Guillermo Nicolas] Inst Expt Physiol IFISE CONICET, Rosario, Santa Fe, Argentina; [Dyckhoff, Gerhard; Herold-Mende, Christel] Heidelberg Univ, Dept Otorhinolaryngol Head & Neck Surg, Mol Cell Biol Grp, Heidelberg, Germany; [Herold-Mende, Christel] Heidelberg Univ, Div Neurosurg Res, Dept Neurosurg, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Weiss, J (corresponding author), Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany.	johanna.weiss@med.uni-heidelberg.de	Rigalli, Juan Pablo/E-2099-2018	Rigalli, Juan Pablo/0000-0003-4168-9396; Tocchetti, Guillermo Nicolas/0000-0003-3884-0980	German Research Foundation (DFG) [RI2673/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by the German Research Foundation (DFG), Grant RI2673/1-1 to J.P.R. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoulnik IU, 2006, CANCER RES, V66, P10594, DOI 10.1158/0008-5472.CAN-06-1023; Akutsu Y, 2011, ANN SURG ONCOL, V18, P2946, DOI 10.1245/s10434-011-1645-z; Belandia B, 2000, J BIOL CHEM, V275, P30801, DOI 10.1074/jbc.C000484200; Blackmore JK, 2014, ENDOCRINOLOGY, V155, P3251, DOI 10.1210/en.2014-1002; D'Alterio C, 2012, CURR CANCER DRUG TAR, V12, P693, DOI 10.2174/156800912801784820; di Masi A, 2009, MOL ASPECTS MED, V30, P297, DOI 10.1016/j.mam.2009.04.002; Fleming FJ, 2004, J CLIN PATHOL, V57, P1069, DOI 10.1136/jcp.2004.016733; Gao YN, 2014, INT J CLIN EXP PATHO, V7, P760; Green AR, 2008, BREAST CANCER RES TR, V110, P427, DOI 10.1007/s10549-007-9737-y; Huh JW, 2013, J SURG ONCOL, V108, P374, DOI 10.1002/jso.23405; Johnson DR, 2006, MOL PHARMACOL, V69, P99, DOI 10.1124/mol.105.013375; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Leon X, 2016, EUR ARCH OTO-RHINO-L, V273, P4525, DOI 10.1007/s00405-016-4144-9; Li CW, 2009, MOL PHARMACOL, V75, P363, DOI 10.1124/mol.108.047845; Mani S, 2005, CLIN CANCER RES, V11, P6359, DOI 10.1158/1078-0432.CCR-05-0252; Martinez-Iglesias OA, 2016, P NATL ACAD SCI USA, V113, pE328, DOI 10.1073/pnas.1520469113; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Ninck S, 2003, INT J CANCER, V106, P34, DOI 10.1002/ijc.11188; Niu YD, 2014, CANCER LETT, V347, P88, DOI 10.1016/j.canlet.2014.01.026; Ouyang N, 2010, BRIT J CANCER, V102, P1753, DOI 10.1038/sj.bjc.6605677; Rigalli JP, 2013, CANCER CHEMOTH PHARM, V71, P1335, DOI 10.1007/s00280-013-2133-x; Pondugula SR, 2013, CANCER LETT, V328, P1, DOI 10.1016/j.canlet.2012.08.030; Rigalli JP, 2016, CANCER LETT, V376, P165, DOI 10.1016/j.canlet.2016.03.040; Robbins D, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.23; Rotte A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075405; Rovito D, 2016, ONCOTARGET, V7, P65109, DOI 10.18632/oncotarget.11371; Sharma D, 2013, BIOCHEM PHARMACOL, V85, P1700, DOI 10.1016/j.bcp.2013.04.002; Smith CL, 2012, BREAST CANCER RES TR, V136, P253, DOI 10.1007/s10549-012-2262-7; Song L, 2005, CANCER RES, V65, P4554, DOI 10.1158/0008-5472.CAN-04-4108; Song XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140011; Takezawa T, 2012, DRUG METAB PHARMACOK, V27, P430, DOI 10.2133/dmpk.DMPK-11-RG-126; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Van Tubergen EA, 2013, CLIN CANCER RES, V19, P1169, DOI 10.1158/1078-0432.CCR-12-2927; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HW, 2011, J CLIN INVEST, V121, P3220, DOI 10.1172/JCI41514; Xiao LY, 2017, PHARMACOL RES, V119, P443, DOI 10.1016/j.phrs.2017.03.004; Yang CC, 2016, ORAL ONCOL, V56, P54, DOI 10.1016/j.oraloncology.2016.03.010; Zhou J, 2008, MOL ENDOCRINOL, V22, P868, DOI 10.1210/me.2007-0197; Zucchini N, 2005, BBA-MOL CELL RES, V1745, P48, DOI 10.1016/j.bbamcr.2005.02.005	39	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193242	10.1371/journal.pone.0193242	http://dx.doi.org/10.1371/journal.pone.0193242			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470550	Green Published, gold, Green Submitted			2022-12-26	WOS:000425831000044
J	Mattos, VF; Currency, LSC; Carvalho, MA; Schneider, MC				Mattos, Viviane Fagundes; Carvalho Currency, Leonardo Sousa; Carvalho, Marcos Andre; Schneider, Marielle Cristina			Insights into the origin of the high variability of multivalent-meiotic associations in holocentric chromosomes of Tityus (Archaeotityus) scorpions	PLOS ONE			English	Article							CYTOGENETIC ANALYSIS; ACHIASMATIC MEIOSIS; SEX-CHROMOSOMES; BUTHIDAE; KARYOTYPE; HETEROCHROMATIN; COMPLEX; RDNA; HETEROZYGOSITY; TRANSLOCATIONS	Scorpions represent an intriguing group of animals characterized by a high incidence of heterozygous chromosomal rearrangements. In this work, we examined six species of Tityus (Archaeotityus) from Brazilian fauna with a particular focus on elucidating the rearrangements responsible for the intraspecific variability of diploid number and the presence of long chromosomal chains in meiosis. To access any interpopulation diversity, we also studied individuals from four species representing distinct localities. Most species demonstrated intraspecific polymorphism in diploid number (2n = 19 and 2n = 20 in T. clathratus, T. mattogrossensis, and T. pusillus, 2n = 16, 2n = 17 and 2n = 18 in T. paraguayensis, and 2n = 16 and 2n = 24 in T. silvestris) and multi-chromosomal associations during meiosis I, which differed even among individuals with the same chromosome number. In some species, the heterozygous rearrangements were not fixed, resulting such as in Tityus clathatrus, in 11 different chromosomal configurations recognized within a same population. Based on meiotic chromosome behaviour, we suggested that independent rearrangements (fusion/fission and reciprocal translocations), occurring in different combinations, originated the multi-chromosomal chains. To evaluate the effects of these chromosome chains on meiotic segregation, we applied the chi-square test in metaphase II cells. The non-significant occurrence of aneuploid nuclei indicated that non-disjunction was negligible in specimens bearing heterozygous rearrangements. Finally, based on our analysis of many chromosome characteristics, e.g., holocentricity, achiasmate meiosis, endopolyploidy, ability to segregate heterosynaptic or unsynapsed chromosomes, (TTAGG) n sequence located in terminal regions of rearranged chromosomes, we suggest that the maintenance of multi-chromosomal associations may be evolutionarily advantageous for these species.	[Mattos, Viviane Fagundes] Univ Estadual Paulista, UNESP, Dept Biol, Sao Paulo, Brazil; [Carvalho Currency, Leonardo Sousa] Univ Fed Piaui, UFPI, Campus Almicar Ferreira Sobral Floriano, Piaui, Brazil; [Carvalho, Marcos Andre] Univ Fed Mato Grosso, Dept Biol & Zool, Cuiaba, Mato Grosso, Brazil; [Schneider, Marielle Cristina] Univ Fed Sao Paulo, UNIFESP, Dept Ecol & Biol Evolut, Sao Paulo, Brazil; [Carvalho Currency, Leonardo Sousa] Univ Fed Minas Gerais, Posgrad Zool, Belo Horizonte, MG, Brazil	Universidade Estadual Paulista; Universidade Federal do Piaui; Universidade Federal de Mato Grosso; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Minas Gerais	Schneider, MC (corresponding author), Univ Fed Sao Paulo, UNIFESP, Dept Ecol & Biol Evolut, Sao Paulo, Brazil.	marielle.unifesp@gmail.com		Schneider, Marielle/0000-0002-2888-6355	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2011/21643-1, 2013/11840-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors would like to thank Dr. Douglas Araujo from Universidade Federal de Mato Grosso do Sul for collecting some of the Tityus paraguayensis specimens, Jairo A. Moreno from Universidade de Sao Paulo for confirming the identification of the analyzed scorpions, and Dr. Vitor Lemes Landeiro from Universidade Federal de Mato Grosso for helping in statistical analysis. Collecting permits were granted by the Instituto Brasileiro de Meio Ambiente e Recursos Naturais Renovaveis (IBAMA) and the Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBIO) (25471-1; 40014-2). The authors are also grateful to the rangers of Floresta Nacional dos Palmares (23561-1), Parque Nacional Cavernas do Peruacu (48224-1) and Parque Nacional Chapada dos Guimardes (41383-2) for their help during the field work. This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (process numbers 2011/21643-1; 2013/11840-0).	Burt DW, 2002, ENCY LIFE SCI; Cao ZJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3602; Carvalho KA, 2009, CYTOGENET GENOME RES, V126, P359, DOI 10.1159/000264179; CHINNAPPA CC, 1979, CHROMOSOMA, V71, P227, DOI 10.1007/BF00292825; Cook LG, 2000, GENOME, V43, P255, DOI 10.1139/gen-43-2-255; Dernburg AF, 2001, J CELL BIOL, V153, pF33, DOI 10.1083/jcb.153.6.F33; DIEZ M, 1993, HEREDITY, V70, P231, DOI 10.1038/hdy.1993.34; Emanuel BS, 2007, NAT REV GENET, V8, P869, DOI 10.1038/nrg2136; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; FREITAS TRO, 1997, BRAZ J GENET, V20, P1; Gazoni T, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-109; Gokhman VE, 2017, COMP CYTOGENET, V11, P97, DOI 10.3897/CompCytogen.v11i1.10872; Gomes FP, 2017, CURSO ESTATISTICA EX; Gross MC, 2009, HEREDITY, V102, P435, DOI 10.1038/hdy.2009.3; Gruetzner F, 2006, CHROMOSOMA, V115, P75, DOI 10.1007/s00412-005-0034-4; Heckmann S, 2011, CYTOGENET GENOME RES, V134, P220, DOI 10.1159/000327713; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Jankowska M, 2015, CHROMOSOMA, V124, P519, DOI 10.1007/s00412-015-0524-y; JOHN B, 1964, HEREDITY, V19, P147, DOI 10.1038/hdy.1964.12; JOHN B., 1958, HEREDITY, V12, P185, DOI 10.1038/hdy.1958.23; King M., 1993, SPECIES EVOLUTION; Larson A., 1984, Chromosomes Today, V8, P215; Lee C, 2005, NAT GENET, V37, P660, DOI 10.1038/ng0705-660; Lourenco LB, 2000, GENET MOL BIOL, V23, P131, DOI 10.1590/S1415-47572000000100024; LOURENCO W R, 1979, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V1, P95; Lourenco W.R., 1982, Revista Nordestina de Biologia, V5, P35; LOURENCO W R, 1984, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V6, P349; Lourenco Wilson R., 1992, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V14, P473; Lourenco Wilson R., 2006, Boletin de la S.E.A., P117; Lourenco WR, 2002, SCORPIONS OF BRAZIL; Lourenco WR, 2012, B SOC ENTOMOLOGICA A, P277; Lourenco WR, 1984, B MUS NATL HIST NAT, V6, P349; Luceno M, 1996, CARYOLOGIA, V49, P301, DOI 10.1080/00087114.1996.10797374; Manterola M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000625; Ortiz AM, 2011, PLANT SYST EVOL, V292, P73, DOI 10.1007/s00606-010-0397-8; MARTINS VG, 1995, GENOME, V38, P958, DOI 10.1139/g95-126; Mattos VF, 2014, ZOOL SCI, V31, P603, DOI 10.2108/zs140005; Mattos VF, 2013, CHROMOSOME RES, V21, P121, DOI 10.1007/s10577-013-9342-3; Melters DP, 2012, CHROMOSOME RES, V20, P579, DOI 10.1007/s10577-012-9292-1; Moraes AP, 2017, PLANT BIOLOGY, V19, P298, DOI 10.1111/plb.12527; Murray BG, 2001, ANN BOT-LONDON, V87, P83, DOI 10.1006/anbo.2000.1307; Nagaki K, 2005, PLANT CELL, V17, P1886, DOI 10.1105/tpc.105.032961; Nunn GB, 1996, J MOL EVOL, V42, P211, DOI 10.1007/BF02198847; Ojanguren-Affilastro AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181337; Ojanguren-Affilastro AA, 2017, MOL PHYLOGENET EVOL, V110, P39, DOI 10.1016/j.ympev.2017.02.018; Olmo E, 2005, GENETICA, V125, P185, DOI 10.1007/s10709-005-8008-2; Paresque Roberta, 2004, Boletim do Museu de Biologia Mello Leitao, V17, P5; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Pisa S. de T., 1950, Cienc Cult, V2, P202; Piza S., 1955, Arquivos do Museu Nacional Rio de Janeiro, V42, P611; Piza S.de., 1949, Scient Genet Torino, V3, P147; PIZA S. de T, 1957, CANADIAN ENT, V89, P565; Piza S. de T., 1943, Revista de Agricultura Sao Paulo, V18, P249; Piza S. de T. Jr., 1940, Revista de Biologia e Hygiene Sao Paolo, V10, P143; Piza S.T., 1950, CIENCIA CULTURA, V2, P57; Piza S.T., 1948, REV AGR, V23, P181; Piza ST, 1947, AN ESC SUP AGR LUIZ, V62, P177; Piza ST, 1947, ESC SUP AGR LUIZ QUE, V62, p169 ; Piza ST, 1947, ESC SUPER AGR LUIZ Q, V62, P183, DOI [10.1590/S0071-12761947000100008, DOI 10.1590/S0071-12761947000100008]; Pliskova J, 2016, ANN ZOOL, V66, P467, DOI 10.3161/00034541ANZ2016.66.3.011; Poletto AB, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-50; REED KM, 1992, CYTOGENET CELL GENET, V61, P40, DOI 10.1159/000133366; REIG OA, 1969, CHROMOSOMA, V28, P211, DOI 10.1007/BF00331531; Rein J.O, 2017, SCORPION FILES; de Almeida BRR, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0494-6; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Sadilek D, 2015, BIOL J LINN SOC, V115, P69, DOI 10.1111/bij.12488; Schneider M. C., 2017, SCORPION CYTOGENETIC; Schneider MC, 2014, CYTOGENET GENOME RES, V144, P341, DOI 10.1159/000375388; Schneider MC, 2010, J HERED, V101, P491, DOI 10.1093/jhered/esq004; Schneider MC, 2009, J HERED, V100, P545, DOI 10.1093/jhered/esp023; Schneider MC, 2009, CHROMOSOME RES, V17, P883, DOI 10.1007/s10577-009-9076-4; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; Schwager EE, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0399-x; Adilardi RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164427; Adilardi RS, 2015, GENETICA, V143, P393, DOI 10.1007/s10709-015-9838-1; Adilardi RS, 2014, COMP CYTOGENET, V8, P81, DOI 10.3897/CompCytogen.v8i2.6461; SHANAHAN CM, 1990, GENOME, V33, P914, DOI 10.1139/g90-138; SHANAHAN CM, 1989, GENOME, V32, P882, DOI 10.1139/g89-525; SHARMA G. P., 1959, RES BULL PANJAB UNIV SCI, V10, P197; Sharma Geeta, 2003, Cytologia (Tokyo), V68, P115, DOI 10.1508/cytologia.68.115; Sharma PP, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0661; Sharp HE, 2007, J EVOLUTION BIOL, V20, P2427, DOI 10.1111/j.1420-9101.2007.01395.x; Siqueira S, 2004, GENET MOL BIOL, V27, P363, DOI 10.1590/S1415-47572004000300010; Soltis DE, 2007, TAXON, V56, P13, DOI 10.2307/25065732; TAKAHASHI CS, 1976, RADIAT RES, V67, P371, DOI 10.2307/3574425; Vitkova M, 2005, CHROMOSOME RES, V13, P145, DOI 10.1007/s10577-005-7721-0; White MJD, 1978, SYST ZOOL, V27, p478 	90	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192070	10.1371/journal.pone.0192070	http://dx.doi.org/10.1371/journal.pone.0192070			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466400	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300027
J	Proverbio, AM; De Benedetto, F; Ferrari, MV; Ferrarini, G				Proverbio, Alice Mado; De Benedetto, Francesco; Ferrari, Maria Vittoria; Ferrarini, Giorgia			When listening to rain sounds boosts arithmetic ability	PLOS ONE			English	Article							BACKGROUND MUSIC; INDIVIDUAL-DIFFERENCES; STRESS RECOVERY; PERFORMANCE; NOISE; EXTROVERTS; COGNITION; EXTRAVERSION; INTROVERTS; EXPOSURE	Studies in the literature have provided conflicting evidence about the effects of background noise or music on concurrent cognitive tasks. Some studies have shown a detrimental effect, while others have shown a beneficial effect of background auditory stimuli. The aim of this study was to investigate the influence of agitating, happy or touching music, as opposed to environmental sounds or silence, on the ability of non-musician subjects to perform arithmetic operations. Fifty university students (25 women and 25 men, 25 introverts and 25 extroverts) volunteered for the study. The participants were administered 180 easy or difficult arithmetic operations (division, multiplication, subtraction and addition) while listening to heavy rain sounds, silence or classical music. Silence was detrimental when participants were faced with difficult arithmetic operations, as it was associated with significantly worse accuracy and slower RTs than music or rain sound conditions. This finding suggests that the benefit of background stimulation was not music-specific but possibly due to an enhanced cerebral alertness level induced by the auditory stimulation. Introverts were always faster than extroverts in solving mathematical problems, except when the latter performed calculations accompanied by the sound of heavy rain, a condition that made them as fast as introverts. While the background auditory stimuli had no effect on the arithmetic ability of either group in the easy condition, it strongly affected extroverts in the difficult condition, with RTs being faster during agitating or joyful music as well as rain sounds, compared to the silent condition. For introverts, agitating music was associated with faster response times than the silent condition. This group difference may be explained on the basis of the notion that introverts have a generally higher arousal level compared to extroverts and would therefore benefit less from the background auditory stimuli.	[Proverbio, Alice Mado; De Benedetto, Francesco; Ferrari, Maria Vittoria; Ferrarini, Giorgia] Univ Milano Bicocca, Neuromi Ctr Neurosci, Dept Psychol, Milan, Italy	University of Milano-Bicocca	Proverbio, AM (corresponding author), Univ Milano Bicocca, Neuromi Ctr Neurosci, Dept Psychol, Milan, Italy.	mado.proverbio@unimib.it	DE BENEDETTO, FRANCESCO/AAX-6641-2021	DE BENEDETTO, FRANCESCO/0000-0001-8582-0064; Proverbio, Alice Mado/0000-0002-5138-1523				Alvarsson JJ, 2010, INT J ENV RES PUB HE, V7, P1036, DOI 10.3390/ijerph7031036; Angel LA, 2010, PERCEPT MOTOR SKILL, V110, P1059, DOI 10.2466/04.11.22.PMS.110.C.1059-1064; Avila C, 2012, PSYCHOL MUSIC, V40, P84, DOI 10.1177/0305735611422672; Baijot S, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0095-y; Banerjee A, 2016, PHYSICA A, V444, P110, DOI 10.1016/j.physa.2015.10.030; Beh HC, 1999, ERGONOMICS, V42, P1087, DOI 10.1080/001401399185153; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Bloor AJ, 2009, EMOT BEHAV DIFFIC, V14, P261, DOI 10.1080/13632750903303070; Bottiroli S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00284; BREBNER J, 1974, J RES PERS, V8, P263, DOI 10.1016/0092-6566(74)90037-3; Brebner J., 1990, STIMULUS RESPONSE CO, P241; Cassidy G., 2007, PSYCHOL MUSIC, V35, P517, DOI [10.1177/0305735607076444, DOI 10.1177/0305735607076444]; Chabris CF, 1999, NATURE, V400, P826, DOI 10.1038/23608; Chemin B, 2014, PSYCHOL SCI, V25, P2147, DOI 10.1177/0956797614551161; Chen SF, 2013, BIOL PSYCHOL, V94, P297, DOI 10.1016/j.biopsycho.2013.07.005; Cheng L, 2016, HEARING RES, V333, P93, DOI 10.1016/j.heares.2016.01.001; Cheng L, 2011, PHYSIOL BEHAV, V104, P981, DOI 10.1016/j.physbeh.2011.06.018; Dalton Brian H., 2007, Occupational Ergonomics, V7, P143; Daly I, 2014, IEEE ENG MED BIO, P4595, DOI 10.1109/EMBC.2014.6944647; DAVIES DR, 1973, BRIT J PSYCHOL, V64, P383, DOI 10.1111/j.2044-8295.1973.tb01364.x; Doucet C, 1997, PERS INDIV DIFFER, V23, P775, DOI 10.1016/S0191-8869(97)00104-9; El Haj M, 2012, EDUC GERONTOL, V38, P30, DOI 10.1080/03601277.2010.515897; Eysenck H.J., 1967, BIOL BASIS PERSONALI; EYSENCK HJ, 1990, J PERS, V58, P245, DOI 10.1111/j.1467-6494.1990.tb00915.x; Eysenck HJ., 1965, MANUAL EYSENCK PERSO, V1st ed; Ferreri L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00779; Furnham A, 1999, EUR J PERSONALITY, V13, P27, DOI 10.1002/(SICI)1099-0984(199901/02)13:1<27::AID-PER318>3.0.CO;2-R; Hallam S, 2002, EDUC STUD, V28, P111, DOI 10.1080/03055690220124551; Hallam S., 1998, BRIT J SPEC EDUC, V25, P88, DOI [10.1111/1467-8527.t01-1-00063, DOI 10.1111/1467-8527.T01-1-00063]; Hallam S., 2009, OXFORD HDB MUSIC PSY, P471; Hetland L, 2000, J AESTHET EDUC, V34, P105, DOI 10.2307/3333640; Iwanaga M, 2002, PERCEPT MOTOR SKILL, V94, P1251, DOI 10.2466/PMS.94.3.1251-1258; Kampfe J, 2011, PSYCHOL MUSIC, V39, P424, DOI 10.1177/0305735610376261; Kahneman D., 1973, ATTENTION EFFORT; Kallinen K, 2002, COMPUT HUM BEHAV, V18, P537, DOI 10.1016/S0747-5632(02)00005-5; Kang HJ, 2014, PSYCHOL MUSIC, V42, P728, DOI 10.1177/0305735613485152; Liu BL, 2012, NEUROSCI LETT, V518, P80, DOI 10.1016/j.neulet.2012.04.055; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; MILLER LK, 1989, J MUSIC THER, V26, P42, DOI 10.1093/jmt/26.1.42; Miskovic D, 2008, SURG ENDOSC, V22, P2416, DOI 10.1007/s00464-008-0040-8; Mistry H., 2015, J APPL PSYCHOL SOCIA, V1, P1; Moreno R, 2000, J EDUC PSYCHOL, V92, P117, DOI 10.1037//0022-0663.92.1.117; Nozaradan S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0393; Oakes S, 2006, APPL COGNITIVE PSYCH, V20, P505, DOI 10.1002/acp.1199; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARENTE JA, 1976, PERCEPT MOTOR SKILL, V43, P337, DOI 10.2466/pms.1976.43.1.337; Pietschnig J, 2010, INTELLIGENCE, V38, P314, DOI 10.1016/j.intell.2010.03.001; Proverbio AM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01646; Proverbio CAAM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15219; Rammsayer T, 2004, BIOL PSYCHOL, V66, P35, DOI 10.1016/j.biopsycho.2003.08.003; RAUSCHER FH, 1993, NATURE, V365, P611, DOI 10.1038/365611a0; Ribeiro FS, 2017, RES DEV DISABIL, V62, P26, DOI 10.1016/j.ridd.2016.11.008; Rogenmoser L, 2016, SOC COGN AFFECT NEUR, V11, P1428, DOI 10.1093/scan/nsw048; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; Schellenberg EG, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P499, DOI 10.1016/B978-0-12-381460-9.00012-2; Schmithorst VJ, 2004, NEUROSCI LETT, V354, P193, DOI 10.1016/j.neulet.2003.10.037; Soderlund GBW, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-55; Stahl J, 2004, BRAIN COGNITION, V56, P293, DOI 10.1016/j.bandc.2004.07.004; Stansfeld SA, 2005, LANCET, V365, P1942, DOI 10.1016/S0140-6736(05)66660-3; STELMACK RM, 1985, J RES PERS, V19, P416, DOI 10.1016/0092-6566(85)90009-1; STELMACK RM, 1993, J PERS SOC PSYCHOL, V65, P399, DOI 10.1037/0022-3514.65.2.399; STELMACK RM, 1977, PSYCHOPHYSIOLOGY, V14, P368, DOI 10.1111/j.1469-8986.1977.tb02966.x; STELMACK RM, 1990, J PERS, V58, P293, DOI 10.1111/j.1467-6494.1990.tb00917.x; Thompson W. F., 2011, PSYCHOL MUSIC, V39, P1, DOI 10.1177/0305735611400173; Thompson WF, 2001, PSYCHOL SCI, V12, P248, DOI 10.1111/1467-9280.00345; Tierney A, 2015, J COGNITIVE NEUROSCI, V27, P400, DOI 10.1162/jocn_a_00704; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; van der Zwaag MD, 2012, ERGONOMICS, V55, P12, DOI 10.1080/00140139.2011.638403; Verrusio W, 2015, CONSCIOUS COGN, V35, P150, DOI 10.1016/j.concog.2015.05.005; WOLF RH, 1972, PERCEPT MOTOR SKILL, V35, P928, DOI 10.2466/pms.1972.35.3.928; Woo Ee Wen, 2005, Tohoku Psychologica Folia, V64, P68	71	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192296	10.1371/journal.pone.0192296	http://dx.doi.org/10.1371/journal.pone.0192296			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	29466472	Green Submitted, Green Published, gold			2022-12-26	WOS:000425604300043
J	de Oliveira, SM; de Almeida, REM; Ciampitti, IA; Pierozan, C; Lago, BC; Trivelin, PCO; Favarin, JL				de Oliveira, Silas Maciel; Munhoz de Almeida, Rodrigo Estevam; Ciampitti, Ignacio A.; Pierozan Junior, Clovis; Lago, Bruno Cocco; Ocheuze Trivelin, Paulo Cesar; Favarin, Jose Laercio			Understanding N timing in corn yield and fertilizer N recovery: An insight from an isotopic labeled-N determination	PLOS ONE			English	Article							NITROGEN-USE EFFICIENCY; ZEA-MAYS L.; MICROBIAL BIOMASS; AMMONIUM-SULFATE; WINTER-WHEAT; MAIZE; FATE; MANAGEMENT; TILLAGE; NITRATE	Early fertilizer nitrogen (N) application on cover crops or their residues during the off-season is a practice adopted in Brazil subtropical conditions under no-tillage corn (Zea mays L.) systems. However, the effect of early N application on yield, plant N content, and N recovery efficiency (NRE) for corn is not yet well documented. Five fertilizer N timings in an oat-corn system were evaluated in two studies utilizing an isotopic-labeled N determination, 15 N isotope. The N fertilization timings were: (i) oat tillering, (ii) 15 days before corn planting time, over the oat residues, (iii) at corn planting time, (iv) in-season at the three-leaf growth stage (V3), and (v) in-season split application at V3 and six-leaf (V6) growth stages. Based on the statistical analysis, the N fertilization timings were separated into three groups: 1) N-OATS, designated to N applied at oat; 2) N-PLANT, referred to pre-plant and planting N applications; and 3) N-CORN, designated to in-season corn N applications. Corn yield was not affected by the N fertilization timing. However, the N-CORN N fertilization timings enhanced NRE by 17% and 35% and final N recovery system (plant plus soil) by 16% and 24% all relative to N-OATS and N-PLANT groups, respectively. Overall, N-OATS resulted in the largest N derived from fertilizer (NDFF) amount in the deeper soil layer, in overall a delta of 10 kg N ha(-1) relative to the rest of the groups. Notwithstanding corn yield was not affected, early N fertilization under subtropical conditions is not a viable option since NRE was diminished and the non-recovery N increased relative to the in-season N applications.	[de Oliveira, Silas Maciel; Pierozan Junior, Clovis; Lago, Bruno Cocco; Favarin, Jose Laercio] Univ Sao Paulo, Luiz Queiroz Coll Agr, Dept Crop Sci, Piracicaba, SP, Brazil; [Munhoz de Almeida, Rodrigo Estevam] Brazilian Corp Agr Res Fishery & Aquiculture, Palmas, Tocantins, Brazil; [Ciampitti, Ignacio A.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Pierozan Junior, Clovis] Parana Fed Inst Educ Sci & Technol, Palmas, Parana, Brazil; [Ocheuze Trivelin, Paulo Cesar] Univ Sao Paulo, Ctr Nucl Energy Agr, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Kansas State University; Instituto Federal do Parana; Universidade de Sao Paulo	de Oliveira, SM (corresponding author), Univ Sao Paulo, Luiz Queiroz Coll Agr, Dept Crop Sci, Piracicaba, SP, Brazil.; Ciampitti, IA (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.	silasmaciel@usp.br; ciampitti@ksu.edu	Lago, Bruno Cocco/ABE-4251-2020; Pierozan Junior, Clovis/E-4596-2018; de Almeida, Rodrigo Estevam Munhoz/AAX-3551-2020; Trivelin, Paulo Cesar Ocheuze/D-7605-2012; de Oliveira, Silas Maciel/AAE-5415-2022	Pierozan Junior, Clovis/0000-0002-0308-3572; de Almeida, Rodrigo Estevam Munhoz/0000-0002-3675-1661; Trivelin, Paulo Cesar Ocheuze/0000-0001-6191-9748; de Oliveira, Silas Maciel/0000-0002-1162-2994; Ciampitti, Ignacio/0000-0001-9619-5129; LAGO, BRUNO/0000-0002-9625-4974	Agrisus Foundation [1081/12]; Sao Paulo Research Foundation [2012/24226-5]	Agrisus Foundation; Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research study was supported by Agrisus Foundation (1081/12) and the Sao Paulo Research Foundation (2012/24226-5) (SMO). This is contribution no. 18-074-J from the Kansas Agricultural Experiment Station (IAC) and (8881.134205/2016-01) the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES) (SMO).	Amado T, 2003, REV BRAS CIENC SOLO, V27; Cambouris AN, 2016, CAN J SOIL SCI, V96, P386, DOI 10.1139/cjss-2015-0134; Cantarella H, 1997, B TECNICO, V2, P43; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Ceretta Carlos Alberto, 2002, Sci. agric. (Piracicaba, Braz.), V59, P549, DOI 10.1590/S0103-90162002000300021; Chen YL, 2015, EUR J AGRON, V62, P79, DOI 10.1016/j.eja.2014.09.008; Christianson LE, 2015, J ENVIRON QUAL, V44, P1852, DOI 10.2134/jeq2015.03.0170; Ciampitti IA, 2013, AGRON J, V105, P783, DOI 10.2134/agronj2012.0467; Ciampitti IA, 2012, FIELD CROP RES, V133, P48, DOI 10.1016/j.fcr.2012.03.008; Couto-Vazquez A, 2016, SOIL TILL RES, V161, P10, DOI 10.1016/j.still.2016.02.011; Dawson JC, 2008, FIELD CROP RES, V107, P89, DOI 10.1016/j.fcr.2008.01.001; Dinnes DL, 2002, AGRON J, V94, P153, DOI 10.2134/agronj2002.0153; Dobermann A., 2005, IFA INT WORKSH ENH E, V1, P28; Dourado Neto D, 2010, SOIL SCI SOC AM J, V74, P139, DOI 10.2136/sssaj2009.0192; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Geisseler D, 2010, SOIL BIOL BIOCHEM, V42, P2058, DOI 10.1016/j.soilbio.2010.08.021; Girotto E, 2013, NUTR CYCL AGROECOSYS, V95, P115, DOI 10.1007/s10705-013-9552-2; Hancock JM, 2011, PLANT SOIL, V348, P139, DOI 10.1007/s11104-011-0917-5; He P, 2013, J PLANT NUTR, V36, P1258, DOI 10.1080/01904167.2013.784982; Institute S, 2009, SAS SYST WIND; Jayasundara S, 2007, NUTR CYCL AGROECOSYS, V79, P141, DOI 10.1007/s10705-007-9103-9; Kumar M, 2016, AGR WATER MANAGE, V163, P263, DOI 10.1016/j.agwat.2015.10.002; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Lange A, 2008, PESQUI AGROPECU BRAS, V43, P123, DOI 10.1590/S0100-204X2008000100016; Lehrsch GA, 2016, NUTR CYCL AGROECOSYS, V104, P125, DOI 10.1007/s10705-015-9755-9; LIANG BC, 1994, CAN J SOIL SCI, V74, P235, DOI 10.4141/cjss94-032; Lyons SE, 2017, AGRON J, V109, P795, DOI 10.2134/agronj2016.10.0620; Martinez-Mena M, 2013, EUR J AGRON, V49, P149, DOI 10.1016/j.eja.2013.04.006; MEAD AD, 1993, PSYCHOL BULL, V114, P449, DOI 10.1037/0033-2909.114.3.449; Mohammed YA, 2013, J PLANT NUTR, V36, P749, DOI 10.1080/01904167.2012.754039; Ning P, 2013, FIELD CROP RES, V144, P19, DOI 10.1016/j.fcr.2013.01.020; Pittelkow CM, 2017, J ENV QUAL; Randall GW, 2003, J ENVIRON QUAL, V32, P1764, DOI 10.2134/jeq2003.1764; REDDY GB, 1993, SOIL SCI SOC AM J, V57, P111, DOI 10.2136/sssaj1993.03615995005700010021x; Rimski-Korsakov H, 2012, NUTR CYCL AGROECOSYS, V93, P253, DOI 10.1007/s10705-012-9513-1; Rimski-Korsakov H, 2009, J PLANT NUTR, V32, P565, DOI 10.1080/01904160802714961; Ritchie SW, 1989, SPECIAL REPORT, V80, P21; Roberts TL, 2016, AGRON J, V108, P2123, DOI 10.2134/agronj2016.02.0092; Cabezas WARL, 2007, REV BRAS CIENC SOLO, V31, P739, DOI 10.1590/S0100-06832007000400015; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Rutkowska A, 2016, PLANT SOIL ENVIRON, V62, P367, DOI 10.17221/185/2016-PSE; Shipitalo MJ, 2013, SOIL SCI SOC AM J, V77, P1329, DOI 10.2136/sssaj2013.01.0045; Stevens WB, 2005, AGRON J, V97, P1046, DOI 10.2134/agronj2003.0313; Sugihara S, 2010, SOIL SCI PLANT NUTR, V56, P105, DOI 10.1111/j.1747-0765.2009.00428.x; Team RC, 2016, LANG ENV STAT COMP; Vetsch JA, 2004, AGRON J, V96, P502, DOI 10.2134/agronj2004.0502; Walsh O, 2012, J PLANT NUTR, V35, P538, DOI 10.1080/01904167.2012.644373; Wang SJ, 2016, NUTR CYCL AGROECOSYS, V105, P129, DOI 10.1007/s10705-016-9780-3; Wietholter DPS, 2004, CIENC RUR, V34; WUEST SB, 1992, AGRON J, V84, P682, DOI 10.2134/agronj1992.00021962008400040028x; Zuber SM, 2016, SOIL BIOL BIOCHEM, V97, P176, DOI 10.1016/j.soilbio.2016.03.011	52	22	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192776	10.1371/journal.pone.0192776	http://dx.doi.org/10.1371/journal.pone.0192776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462178	Green Published, gold			2022-12-26	WOS:000425554200026
J	Min, S; Song, EAC; Oyelakin, A; Gluck, C; Smalley, K; Romano, RA				Min, Sangwon; Song, Eun-Ah Christine; Oyelakin, Akinsola; Gluck, Christian; Smalley, Kirsten; Romano, Rose-Anne			Functional characterization and genomic studies of a novel murine submandibular gland epithelial cell line	PLOS ONE			English	Article							SALIVARY-GLAND; MYOEPITHELIAL CELLS; PLEOMORPHIC ADENOMAS; EXPRESSION; GENE; BASAL; P63; DIFFERENTIATION; PROLIFERATION; REGULATOR	A better understanding of the normal and diseased biology of salivary glands (SG) has been hampered, in part, due to difficulties in cultivating and maintaining salivary epithelial cells. Towards this end, we have generated a mouse salivary gland epithelial cell (mSGc) culture system that is well-suited for the molecular characterization of SG cells and their differentiation program. We demonstrate that mSGc can be maintained for multiple passages without a loss of proliferation potential, readily form 3D-spheroids and importantly express a panel of well-established salivary gland epithelial cell markers. Moreover, mSGc 3D-spheroids also exhibit functional maturation as evident by robust agonist-induced intracellular calcium signaling. Finally, transcriptomic characterization of mSGc by RNA-seq and hierarchical clustering analysis with adult organ RNA-seq datasets reveal that mSGc retain most of the molecular attributes of adult mouse salivary gland. This well-characterized mouse salivary gland cell line will fill a critical void in the field by offering a valuable resource to examine various mechanistic aspects of mouse salivary gland biology.	[Min, Sangwon; Song, Eun-Ah Christine; Oyelakin, Akinsola; Romano, Rose-Anne] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14260 USA; [Gluck, Christian; Smalley, Kirsten; Romano, Rose-Anne] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Romano, RA (corresponding author), SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14260 USA.; Romano, RA (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14260 USA.	rromano2@buffalo.edu	Gluck, Christian/HHC-5073-2022	Oyelakin, Akinsola/0000-0003-0607-6631	National Institute of Dental and Craniofacial Research/National Institutes of Health [DE025889, DE023526]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE023526] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institute of Dental and Craniofacial Research/National Institutes of Health DE025889 (RAR), DE023526.	Akiba T, 2002, J BIOCHEM, V132, P621, DOI 10.1093/oxfordjournals.jbchem.a003265; Ambudkar IS, 2012, CURR MED CHEM, V19, P5774; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Baker OJ, 2010, TISSUE ENG PART C-ME, V16, P1135, DOI 10.1089/ten.TEC.2009.0438; Bilal H, 2003, J HISTOCHEM CYTOCHEM, V51, P133, DOI 10.1177/002215540305100201; David R, 2008, TISSUE ENG PT A, V14, P331, DOI 10.1089/tea.2007.0122; Debnath I, 2008, GENES IMMUN, V9, P706, DOI 10.1038/gene.2008.70; DRAEGER A, 1991, APMIS, V99, P405, DOI 10.1111/j.1699-0463.1991.tb05169.x; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Gervais EM, 2016, ORGANOGENESIS, V12, P194, DOI 10.1080/15476278.2016.1252887; Gluck C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3228-7; Hammond NL, 2012, J INVEST DERMATOL, V132, P1543, DOI 10.1038/jid.2012.27; HE XJ, 1989, GEN PHARMACOL, V20, P175, DOI 10.1016/0306-3623(89)90011-6; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; Ihrler S, 2002, VIRCHOWS ARCH, V440, P519, DOI 10.1007/s004280100537; Ikeura K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147407; Silvestre FJ, 2009, MED ORAL PATOL ORAL, V14, pE8; Jucker M, 1996, NEUROSCIENCE, V71, P1153, DOI 10.1016/0306-4522(95)00496-3; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1187, DOI 10.1016/j.ijrobp.2004.12.051; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Li FL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/956107; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matsuzaki T, 2012, ACTA HISTOCHEM CYTOC, V45, P251, DOI 10.1267/ahc.12018; McCall AD, 2013, TISSUE ENG PT A, V19, P2215, DOI [10.1089/ten.TEA.2012.0674, 10.1089/ten.tea.2012.0674]; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nanduri LSY, 2014, STEM CELL REP, V3, P957, DOI 10.1016/j.stemcr.2014.09.015; Nanduri LSY, 2013, RADIOTHER ONCOL, V108, P458, DOI 10.1016/j.radonc.2013.05.020; Nelson DA, 2013, BIOL OPEN, V2, P439, DOI 10.1242/bio.20134309; Nordgarden H, 2001, ORAL DIS, V7, P226, DOI 10.1034/j.1601-0825.2001.70405.x; Ogawa Y, 2000, VIRCHOWS ARCH, V437, P58, DOI 10.1007/s004280000186; Oksvold MP, 2014, CLIN THER, V36, P847, DOI 10.1016/j.clinthera.2014.05.010; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Parikh N, 2008, ARCH ORAL BIOL, V53, P1091, DOI 10.1016/j.archoralbio.2008.07.002; Phelps RG, 1998, MOL MED, V4, P356, DOI 10.1007/BF03401742; Pringle S, 2016, STEM CELLS, V34, P640, DOI 10.1002/stem.2278; Pringle S, 2011, JOVE-J VIS EXP, DOI 10.3791/2484; Quissell D O, 1997, In Vitro Cell Dev Biol Anim, V33, P164; Quissell DO, 1998, IN VITRO CELL DEV-AN, V34, P58; Rizzo JM, 2016, CELL DEATH DIFFER, V23, P1073, DOI 10.1038/cdd.2015.162; Rogus-Pulia NM, 2011, DYSPHAGIA, V26, P295, DOI 10.1007/s00455-010-9311-3; Romano RA, 2007, J INVEST DERMATOL, V127, P1175, DOI 10.1038/sj.jid.5700652; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623; Runkel F, 2006, J MOL HISTOL, V37, P353, DOI 10.1007/s10735-006-9063-4; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimomura Y, 2008, DEVELOPMENT, V135, P743, DOI 10.1242/dev.006718; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; Volponi AA, 2013, J DENT RES, V92, P329, DOI 10.1177/0022034513481041; Xie YS, 2012, J INVEST DERMATOL, V132, P547, DOI 10.1038/jid.2011.381; YANAGAWA T, 1986, VIRCHOWS ARCH B, V51, P187, DOI 10.1007/BF02899028	55	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192775	10.1371/journal.pone.0192775	http://dx.doi.org/10.1371/journal.pone.0192775			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462154	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200025
J	Tian, SQ; Ohta, A; Horiuchi, H; Fukuda, R				Tian, Siqi; Ohta, Akinori; Horiuchi, Hiroyuki; Fukuda, Ryouichi			Oxysterol-binding protein homologs mediate sterol transport from the endoplasmic reticulum to mitochondria in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; PHOSPHATIDYLSERINE TRANSPORT; ER-MITOCHONDRIA; CONTACT SITES; CHOLESTEROL; GOLGI; MOVEMENT; METABOLISM; PURIFICATION; MECHANISM	Sterols are present in eukaryotic membranes and significantly affect membrane fluidity, permeability, and microdomain formation. They are synthesized in the endoplasmic reticulum (ER) and transported to other organelles and the plasma membrane. Sterols play important roles in the biogenesis and maintenance of mitochondrial membranes. However, the mechanisms underlying ER-to-mitochondrion sterol transport remain to be identified. Here, using purified yeast membrane fractions enriched in ER and mitochondria, we show that the oxysterol-binding protein homologs encoded by the OSH genes in the yeast Saccharomyces cerevisiae mediate sterol transport from the ER to mitochondria. Combined depletion of all seven Osh proteins impaired sterol transport from the ER to mitochondria in vitro; however, sterol transport was recovered at different levels upon adding one of the Osh proteins. Of note, the sterol content in the mitochondrial fraction was significantly decreased in vivo after Osh4 inactivation in a genetic background in which all the other OSH genes were deleted. We also found that Osh5-Osh7 bind cholesterol in vitro. We propose a model in which Osh proteins share a common function to transport sterols between membranes, with varying contributions by these proteins, depending on the target membranes. In summary, we have developed an in vitro system to examine intracellular sterol transport and provide evidence for involvement of Osh proteins in sterol transport from the ER to mitochondria in yeast.	[Tian, Siqi; Horiuchi, Hiroyuki; Fukuda, Ryouichi] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan; [Ohta, Akinori] Chubu Univ, Coll Biosci & Biotechnol, Dept Biol Chem, 1200 Matsumoto Cho, Kasugai, Aichi 4878501, Japan	University of Tokyo; Chubu University	Fukuda, R (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	afukuda@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science KAKENHI [17688005, 20580072, 16J00457]; Asahi Group Foundation; Public Foundation of Elizabeth Arnold-Fuji	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Asahi Group Foundation; Public Foundation of Elizabeth Arnold-Fuji	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 17688005, 20580072, and 16J00457; a grant from Asahi Group Foundation; and a grant from the Public Foundation of Elizabeth Arnold-Fuji. The authors declare that they have no conflicts of interest with the contents of this article.	Alfaro G, 2011, TRAFFIC, V12, P1521, DOI 10.1111/j.1600-0854.2011.01265.x; Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Beh CT, 2001, GENETICS, V157, P1117; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bowden K, 2008, J BIOL CHEM, V283, P18210, DOI 10.1074/jbc.M800918200; BUCKLEY JT, 1982, J BIOL CHEM, V257, P3320; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Deng L, 2010, BBA-MOL CELL BIOL L, V1801, P635, DOI 10.1016/j.bbalip.2010.02.008; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Galmes R, 2016, EMBO REP, V17, P800, DOI 10.15252/embr.201541108; Gatta AT, 2015, ELIFE, V4, DOI 10.7554/eLife.07253; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Kajiwara K, 2014, J CELL SCI, V127, P376, DOI 10.1242/jcs.132001; Kentala H, 2016, INT REV CEL MOL BIO, V321, P299, DOI 10.1016/bs.ircmb.2015.09.006; Kobayashi S, 2014, BBA-MOL CELL BIOL L, V1841, P1264, DOI 10.1016/j.bbalip.2014.05.003; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969; Leventis R, 2001, BIOPHYS J, V81, P2257, DOI 10.1016/S0006-3495(01)75873-0; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Martin LA, 2016, J BIOENERG BIOMEMBR, V48, P137, DOI 10.1007/s10863-014-9592-6; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Mesmin B, 2013, CELL MOL LIFE SCI, V70, P3405, DOI 10.1007/s00018-012-1247-3; Motohashi K, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0162-8; Mousley CJ, 2012, CELL, V148, P702, DOI 10.1016/j.cell.2011.12.026; Murley A, 2015, J CELL BIOL, V209, P539, DOI 10.1083/jcb.201502033; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Romeo GR, 2008, J BIOL CHEM, V283, P9595, DOI 10.1074/jbc.M710092200; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Soffientini U, 2016, CLIN SCI, V130, P1843, DOI 10.1042/CS20160339; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Tavassoli S, 2013, EMBO REP, V14, P434, DOI 10.1038/embor.2013.36; Tian SQ, 2015, BIOSCI BIOTECH BIOCH, V79, P1608, DOI 10.1080/09168451.2015.1058702; TOKUNAGA M, 1992, J BIOL CHEM, V267, P17553; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; URBANI L, 1990, J BIOL CHEM, V265, P1919; Venkateswarlu K, 1998, J BIOL CHEM, V273, P4492, DOI 10.1074/jbc.273.8.4492; Vipond R, 1998, INFECT IMMUN, V66, P1990, DOI 10.1128/IAI.66.5.1990-1998.1998; von Filseck JM, 2015, SCIENCE, V349, P432, DOI 10.1126/science.aab1346; von Filseck JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7671; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	63	21	22	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5636	5648		10.1074/jbc.RA117.000596	http://dx.doi.org/10.1074/jbc.RA117.000596			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29487131	hybrid, Green Published			2022-12-26	WOS:000430044100024
J	Baarbe, JK; Yielder, P; Haavik, H; Holmes, MWR; Murphy, BA				Baarbe, Julianne K.; Yielder, Paul; Haavik, Heidi; Holmes, Michael W. R.; Murphy, Bernadette Ann			Subclinical recurrent neck pain and its treatment impacts motor training-induced plasticity of the cerebellum and motor cortex	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; CERVICAL-SPINE; SHORT-TERM; POSITION; RANGE; MANIPULATION; MOTION; PROPRIOCEPTION; CONNECTIVITY	The cerebellum processes pain inputs and is important for motor learning. Yet, how the cerebellum interacts with the motor cortex in individuals with recurrent pain is not clear. Functional connectivity between the cerebellum and motor cortex can be measured by a twin coil transcranial magnetic stimulation technique in which stimulation is applied to the cerebellum prior to stimulation over the motor cortex, which inhibits motor evoked potentials (MEPs) produced by motor cortex stimulation alone, called cerebellar inhibition (CBI). Healthy individuals without pain have been shown to demonstrate reduced CBI following motor acquisition. We hypothesized that CBI would not reduce to the same extent in those with mild recurrent neck pain following the same motor acquisition task. We further hypothesized that a common treatment for neck pain (spinal manipulation) would restore reduced CBI following motor acquisition. Motor acquisition involved typing an eight-letter sequence of the letters Z,P,D,F with the right index finger. Twenty-seven neck pain participants received spinal manipulation (14 participants, 18-27 years) or sham control (13 participants, 19-24 years). Twelve healthy controls (20-27 years) also participated. Participants had CBI measured; they completed manipulation or sham control followed by motor acquisition; and then had CBI re-measured. Following motor acquisition, neck pain sham controls remained inhibited (58 +/- 33% of test MEP) vs. healthy controls who disinhibited (98 +/- 49% of test MEP, P<0.001), while the spinal manipulation group facilitated (146 +/- 95% of test MEP, P<0.001). Greater inhibition in neck pain sham vs. healthy control groups suggests that neck pain may change cerebellar-motor cortex interaction. The change to facilitation suggests that spinal manipulation may reverse inhibitory effects of neck pain.	[Baarbe, Julianne K.] Univ Hlth Network, Krembil Res Inst, Div Neurol, Toronto, ON, Canada; [Baarbe, Julianne K.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Yielder, Paul; Murphy, Bernadette Ann] Univ Ontario, Inst Technol, Fac Hlth Sci, Oshawa, ON, Canada; [Yielder, Paul] Deakin Univ, Sch Med, Fac Hlth, Waurn Ponds, Vic, Australia; [Haavik, Heidi] Ctr Chiropract Res, New Zealand Coll Chiropract, Auckland, New Zealand; [Holmes, Michael W. R.] Brock Univ, Dept Kinesiol, Fac Appl Hlth Sci, St Catharines, ON, Canada	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Ontario Tech University; Deakin University; Brock University	Murphy, BA (corresponding author), Univ Ontario, Inst Technol, Fac Hlth Sci, Oshawa, ON, Canada.	Bernadette.Murphy@uoit.ca	Haavik, Heidi/AAG-1084-2021; Holmes, Mike/AAA-9582-2019	Haavik, Heidi/0000-0001-7182-2085; Holmes, Mike/0000-0002-1918-1695; Murphy, Bernadette/0000-0001-9832-5740	Australian Spinal Research Foundation [LG 2013-22]; Natural Sciences and Engineering Research Council of Canada Discovery Grants; Canada Foundation for Innovation - John R Evans Leaders Fund; Canadian Institutes of Health Research - Frederick Banting and Charles Best Canada Graduate Scholarships; Ontario Graduate Scholarships; University of Ontario Institute of Technology	Australian Spinal Research Foundation; Natural Sciences and Engineering Research Council of Canada Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation - John R Evans Leaders Fund(Canada Foundation for Innovation); Canadian Institutes of Health Research - Frederick Banting and Charles Best Canada Graduate Scholarships(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarships(Ontario Graduate Scholarship); University of Ontario Institute of Technology	The authors received funding from the Australian Spinal Research Foundation (LG 2013-22) (BM, MH, HH), Natural Sciences and Engineering Research Council of Canada Discovery Grants (BM), and Canada Foundation for Innovation - John R Evans Leaders Fund (BM). Graduate student funding was provided through Canadian Institutes of Health Research - Frederick Banting and Charles Best Canada Graduate Scholarships (JKB), Ontario Graduate Scholarships (JKB), and University of Ontario Institute of Technology (JKB). Other than funding from these agencies, the authors have no competing interests to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Baarbe J, 2014, J NEUROPHYSIOL, V111, P715, DOI 10.1152/jn.00661.2013; Bank PJM, 2013, EUR J PAIN, V17, P145, DOI 10.1002/j.1532-2149.2012.00186.x; Barr MS, 2013, J NEUROIMMUNE PHARM, V8, P535, DOI 10.1007/s11481-012-9383-y; Borsook D, 2007, PAIN, V132, P8, DOI 10.1016/j.pain.2007.09.006; Borsook D, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-27; Boudreau S, 2007, PAIN, V132, P169, DOI 10.1016/j.pain.2007.07.019; Canadian Chiropractic Association, 2005, J Can Chiropr Assoc, V49, P158; Cao DY, 2013, J MANIP PHYSIOL THER, V36, P68, DOI 10.1016/j.jmpt.2013.01.004; Caumo W, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00357; Coombes SA, 2016, PAIN, V157, P117, DOI 10.1097/j.pain.0000000000000337; Coronado RA, 2012, J ELECTROMYOGR KINES, V22, P752, DOI 10.1016/j.jelekin.2011.12.013; Daligadu J, 2013, J MANIP PHYSIOL THER, V36, P10; Daskalakis ZJ, 2004, J PHYSIOL-LONDON, V557, P689, DOI 10.1113/jphysiol.2003.059808; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Fisher KM, 2009, CLIN NEUROPHYSIOL, V120, P2109, DOI 10.1016/j.clinph.2009.08.021; Gay CW, 2014, J MANIP PHYSIOL THER, V37, P614, DOI 10.1016/j.jmpt.2014.09.001; Guerraz M, 2011, ACTA PSYCHOL, V136, P390, DOI 10.1016/j.actpsy.2011.01.004; Guzman J, 2008, SPINE, V33, pS14, DOI 10.1097/BRS.0b013e3181643efb; Haavik H, 2011, J MANIP PHYSIOL THER, V34, P88, DOI 10.1016/j.jmpt.2010.12.009; Haavik-Taylor H., 2007, CHIROPR J AUST, V37, P106, DOI DOI 10.3316/INFORMIT.234919797047272; Huang X, 2017, MOL PSYCHIATR, V22, P1274, DOI 10.1038/mp.2017.143; HUBKA MJ, 1994, J MANIP PHYSIOL THER, V17, P591; JULL G, 1988, MED J AUSTRALIA, V148, P233, DOI 10.5694/j.1326-5377.1988.tb99431.x; Knox JJ, 2005, EXP BRAIN RES, V165, P107, DOI 10.1007/s00221-005-2293-y; Knox J, 2006, BEHAV NEUROSCI, V120, P1211, DOI 10.1037/0735-7044.120.6.1211; Kristjansson E, 2003, CLIN REHABIL, V17, P768, DOI 10.1191/0269215503cr676oa; Lee HJ, 2005, SPINE, V30, pE60, DOI 10.1097/01.brs.0000152160.28052.a2; Lee HJ, 2004, SPINE, V29, P33, DOI 10.1097/01.BRS.0000103944.10408.BA; Lee HY, 2008, MANUAL THER, V13, P419, DOI 10.1016/j.math.2007.04.001; Magstim, 2002, MAGST BIST SYST OP M; Manto M, 2007, CEREBELLUM, V6, P3, DOI 10.1080/14734220701234690; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Manzoni D, 2007, CEREBELLUM, V6, P24, DOI 10.1080/14734220601132135; Martin PG, 2009, J NEUROPHYSIOL, V102, P606, DOI 10.1152/jn.91348.2008; Mhalla A, 2010, PAIN, V149, P495, DOI 10.1016/j.pain.2010.03.009; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Niazi IK, 2015, EXP BRAIN RES, V233, P1165, DOI 10.1007/s00221-014-4193-5; Noda Y, 2015, PSYCHOL MED, V45, P3411, DOI 10.1017/S0033291715001609; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulus I, 2008, J REHABIL MED, V40, P426, DOI 10.2340/16501977-0189; Pelletier R, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0480-y; Penhune VB, 2002, J NEUROSCI, V22, P1397, DOI 10.1523/JNEUROSCI.22-04-01397.2002; Pinto AD, 2001, EXP BRAIN RES, V140, P505, DOI 10.1007/s002210100862; Popa LS, 2013, CEREBELLUM, V12, P331, DOI 10.1007/s12311-013-0452-4; RHEALT W, 1992, Journal of Orthopaedic and Sports Physical Therapy, V15, P147; Rossi S, 2003, CLIN NEUROPHYSIOL, V114, P1351, DOI 10.1016/S1388-2457(03)00073-7; Ruscheweyh R, 2014, PAIN, V155, P1303, DOI 10.1016/j.pain.2014.04.006; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Shen Y, 2017, BIOL PSYCHIAT, V81, pE49, DOI 10.1016/j.biopsych.2016.06.013; Shen Y, 2016, BIOL PSYCHIAT, V80, pE13, DOI 10.1016/j.biopsych.2016.02.006; Sjolander P, 2008, MANUAL THER, V13, P122, DOI 10.1016/j.math.2006.10.002; Taylor HH, 2008, J MANIP PHYSIOL THER, V31, P115, DOI 10.1016/j.jmpt.2007.12.011; UGAWA Y, 1995, ANN NEUROL, V37, P703, DOI 10.1002/ana.410370603; Uthaikhup S, 2012, ARCH GERONTOL GERIAT, V55, P667, DOI 10.1016/j.archger.2012.01.013; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Waberski TD, 2008, NEUROSCI LETT, V435, P137, DOI 10.1016/j.neulet.2008.02.020; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; YOUDAS JW, 1992, PHYS THER, V72, P770, DOI 10.1093/ptj/72.11.770; Zabihhosseinian M, 2015, CLIN BIOMECH, V30, P397, DOI 10.1016/j.clinbiomech.2015.03.020	62	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193413	10.1371/journal.pone.0193413	http://dx.doi.org/10.1371/journal.pone.0193413			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489878	gold, Green Published, Green Submitted			2022-12-26	WOS:000426276000073
J	Zhan, Y; Marchand, CH; Maes, A; Mauries, A; Sun, Y; Dhaliwal, JS; Uniacke, J; Arragain, S; Jiang, H; Gold, ND; Martin, VJJ; Lemaire, SD; Zerges, W				Zhan, Yu; Marchand, Christophe H.; Maes, Alexandre; Mauries, Adeline; Sun, Yi; Dhaliwal, James S.; Uniacke, James; Arragain, Simon; Jiang, Heng; Gold, Nicholas D.; Martin, Vincent J. J.; Lemaire, Stephane D.; Zerges, William			Pyrenoid functions revealed by proteomics in Chlamydomonas reinhardtii	PLOS ONE			English	Article							IMMUNOLOGICAL COMPARISONS; CONCENTRATING MECHANISM; CHLOROPLAST RIBOSOME; SMALL-SUBUNIT; GREEN-ALGAE; PROTEIN; RNA; RUBISCO; MUTANTS; IDENTIFICATION	Organelles are intracellular compartments which are themselves compartmentalized. Biogenic and metabolic processes are localized to specialized domains or microcompartments to enhance their efficiency and suppress deleterious side reactions. An example of intra-organellar compartmentalization is the pyrenoid in the chloroplasts of algae and hornworts. This microcompartment enhances the photosynthetic CO2-fixing activity of the Calvin-Benson cycle enzyme Rubisco, suppresses an energetically wasteful oxygenase activity of Rubisco, and mitigates limiting CO2 availability in aquatic environments. Hence, the pyrenoid is functionally analogous to the carboxysomes in cyanobacteria. However, a comprehensive analysis of pyrenoid functions based on its protein composition is lacking. Here we report a proteomic characterization of the pyrenoid in the green alga Chlamydomonas reinhardtii. Pyrenoid-enriched fractions were analyzed by quantitative mass spectrometry. Contaminant proteins were identified by parallel analyses of pyrenoid-deficient mutants. This pyrenoid proteome contains 190 proteins, many of which function in processes that are known or proposed to occur in pyrenoids: e.g. the carbon concentrating mechanism, starch metabolism or RNA metabolism and translation. Using radioisotope pulse labeling experiments, we show that pyrenoid-associated ribosomes could be engaged in the localized synthesis of the large subunit of Rubisco. New pyrenoid functions are supported by proteins in tetrapyrrole and chlorophyll synthesis, carotenoid metabolism or amino acid metabolism. Hence, our results support the long-standing hypothesis that the pyrenoid is a hub for metabolism. The 81 proteins of unknown function reveal candidates for new participants in these processes. Our results provide biochemical evidence of pyrenoid functions and a resource for future research on pyrenoids and their use to enhance agricultural plant productivity. Data are available via ProteomeXchange with identifier PXD004509.	[Zhan, Yu; Sun, Yi; Dhaliwal, James S.; Uniacke, James; Arragain, Simon; Jiang, Heng; Gold, Nicholas D.; Martin, Vincent J. J.; Zerges, William] Concordia Univ, Dept Biol, Montreal, PQ, Canada; [Zhan, Yu; Sun, Yi; Dhaliwal, James S.; Uniacke, James; Arragain, Simon; Jiang, Heng; Gold, Nicholas D.; Martin, Vincent J. J.; Zerges, William] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada; [Marchand, Christophe H.; Maes, Alexandre; Mauries, Adeline; Lemaire, Stephane D.] Sorbonne Univ, UPMC Univ Paris 06, CNRS,Inst Biol Physicochim, UMR8226,Lab Biol Mol & Cellulaire Eucaryotes, 13 Rue Pierre & Marie Curie, Paris, France; [Uniacke, James] Univ Guelph, Dept Mol & Cellular Biol, Sci Complex, Guelph, ON, Canada; [Arragain, Simon] Univ Calif Davis, Chem Dept, Davis, CA 95616 USA	Concordia University - Canada; Concordia University - Canada; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Guelph; University of California System; University of California Davis	Zerges, W (corresponding author), Concordia Univ, Dept Biol, Montreal, PQ, Canada.; Zerges, W (corresponding author), Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada.; Lemaire, SD (corresponding author), Sorbonne Univ, UPMC Univ Paris 06, CNRS,Inst Biol Physicochim, UMR8226,Lab Biol Mol & Cellulaire Eucaryotes, 13 Rue Pierre & Marie Curie, Paris, France.	stephane.lemaire@ibpc.fr; william.zerges@concordia.ca	Lemaire, Stéphane D/A-3530-2008; Arragain, Simon/AAA-6356-2019; MARCHAND, Christophe H/B-5854-2008	Lemaire, Stéphane D/0000-0001-6442-0547; Arragain, Simon/0000-0002-6500-0066; MARCHAND, Christophe H/0000-0002-0729-3841; Maes, Alexandre/0000-0002-7966-1340; Dhaliwal, James/0000-0001-8851-7562; Sun, Yi/0000-0002-2366-7153	Natural Sciences and Engineering Research Council of Canada [217566]; L'Agence Nationale de la Recherche (France) [ANR-12-BSV5-0019 REDPR02, ANR-LABX-011, ANR-11-EQPX-0008]; CYNTHIOL [12-BSV6-011]; Foundation pour la Recherche Medicale [DBI20141231801]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); L'Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); CYNTHIOL; Foundation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by 217566 from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca.) (WZ); ANR-12-BSV5-0019 REDPR02, ANR-LABX-011, and ANR-11-EQPX-0008 from L'Agence Nationale de la Recherche (France) (http://www.agence-nationale-recherche.fr/en/) and CYNTHIOL, 12-BSV6-011 (SDL); and DBI20141231801 Foundation pour la Recherche Medicale (https://www.frm.org/) (A Maes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball S.G., 2009, CHLAMYDOMONAS SOURCE, P1; Bienvenut WV, 2011, PROTEOMICS, V11, P1734, DOI 10.1002/pmic.201000634; Bollenbach TJ, 2009, PLANT MOL BIOL, V69, P541, DOI 10.1007/s11103-008-9436-z; DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991; Engel BD, 2015, ELIFE, V4, DOI 10.7554/eLife.04889; Eriksson M, 1996, P NATL ACAD SCI USA, V93, P12031, DOI 10.1073/pnas.93.21.12031; Fang W, 2012, PLANT CELL, V24, P1876, DOI 10.1105/tpc.112.097949; FLEMING GH, 1987, MOL GEN GENET, V206, P226, DOI 10.1007/BF00333578; Foyer CH, 2009, ANNU REV PLANT BIOL, V60, P455, DOI 10.1146/annurev.arplant.043008.091948; Genkov T, 2010, J BIOL CHEM, V285, P19833, DOI 10.1074/jbc.M110.124230; GOLDBERG I, 1970, Journal of Cell Biology, V44, P572, DOI 10.1083/jcb.44.3.572; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Hayakawa H, 2001, BIOCHEMISTRY-US, V40, P9977, DOI 10.1021/bi010595q; Hippler M, 2001, PLANT J, V28, P595, DOI 10.1046/j.1365-313X.2001.01175.x; Joyard J, 2010, PROG LIPID RES, V49, P128, DOI 10.1016/j.plipres.2009.10.003; Jungnick N, 2014, PHOTOSYNTH RES, V121, P159, DOI 10.1007/s11120-014-0004-x; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; KERBY NW, 1978, PLANTA, V142, P91, DOI 10.1007/BF00385125; Kerfeld CA, 2016, CURR OPIN PLANT BIOL, V31, P66, DOI 10.1016/j.pbi.2016.03.009; KUCHITSU K, 1988, PROTOPLASMA, V144, P17, DOI 10.1007/BF01320276; Leister D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00255; Long BM, 2005, CAN J BOT, V83, P746, DOI 10.1139/B05-058; Lundquist PK, 2012, PLANT PHYSIOL, V158, P1172, DOI 10.1104/pp.111.193144; Mackinder LCM, 2016, P NATL ACAD SCI USA, V113, P5958, DOI 10.1073/pnas.1522866113; Mason CB, 2006, NAT PROTOC, V1, P2227, DOI 10.1038/nprot.2006.348; MCKAY RML, 1991, CAN J BOT, V69, P1040, DOI 10.1139/b91-134; Meyer MT, 2012, P NATL ACAD SCI USA, V109, P19474, DOI 10.1073/pnas.1210993109; MIYAMURA S, 1991, PROTOPLASMA, V161, P192, DOI 10.1007/BF01322731; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; OKADA M, 1991, CAN J BOT, V69, P1053, DOI 10.1139/b91-135; Phinney BS, 2005, J PROTEOME RES, V4, P497, DOI 10.1021/pr049791k; Ramazanov ZRM, 1994, PLANTA, V195, P7; RANDOLPHANDERSON BL, 1989, J MOL EVOL, V29, P68, DOI 10.1007/BF02106183; Rawat M, 1996, PLANTA, V198, P263; RIS H, 1962, J CELL BIOL, V13, P383, DOI 10.1083/jcb.13.3.383; Sambrook J., 2001, MOL CLONING LAB MANU; Satagopan S, 2004, J BIOL CHEM, V279, P14240, DOI 10.1074/jbc.M313215200; Schottkowski M, 2012, P NATL ACAD SCI USA, V109, P19286, DOI 10.1073/pnas.1209860109; Shukla M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051913; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Syeda R, 2015, ELIFE, V4, DOI 10.7554/eLife.07369; Tardif M, 2012, MOL BIOL EVOL, V29, P3625, DOI 10.1093/molbev/mss178; Terashima M, 2010, MOL CELL PROTEOMICS, V9, P1514, DOI 10.1074/mcp.M900421-MCP200; Tirumani S, 2014, PLANT MOL BIOL, V85, P277, DOI 10.1007/s11103-014-0183-z; Uniacke J, 2008, J CELL BIOL, V182, P641, DOI 10.1083/jcb.200805125; Uniacke J, 2007, PLANT CELL, V19, P3640, DOI 10.1105/tpc.107.054882; Uniacke J, 2011, METHODS MOL BIOL, V714, P15, DOI 10.1007/978-1-61779-005-8_2; Uniacke J, 2009, P NATL ACAD SCI USA, V106, P1439, DOI 10.1073/pnas.0811268106; Wang YJ, 2015, PLANT J, V82, P429, DOI 10.1111/tpj.12829; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wu JH, 2008, BIOCHEM BIOPH RES CO, V372, P288, DOI 10.1016/j.bbrc.2008.05.058; Wu JH, 2009, BIOCHEMISTRY-US, V48, P2012, DOI 10.1021/bi801752p; Yamaguchi K, 2003, J BIOL CHEM, V278, P33774, DOI 10.1074/jbc.M301934200; Yamaguchi K, 2002, PLANT CELL, V14, P2957, DOI 10.1105/tpc.004341; Yang JJ, 1997, J BIOL CHEM, V272, P12874, DOI 10.1074/jbc.272.19.12874; Zhan Y, 2015, J CELL SCI, V128, P4210, DOI 10.1242/jcs.175232	56	28	30	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0185039	10.1371/journal.pone.0185039	http://dx.doi.org/10.1371/journal.pone.0185039			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481573	Green Published, gold			2022-12-26	WOS:000426202700001
J	Bennett, SD; Lowther, SA; Chingoli, F; Chilima, B; Kabuluzi, S; Ayers, TL; Warne, TA; Mintz, E				Bennett, Sarah D.; Lowther, Sara A.; Chingoli, Felix; Chilima, Benson; Kabuluzi, Storn; Ayers, Tracy L.; Warne, Thomas A.; Mintz, Eric			Assessment of water, sanitation and hygiene interventions in response to an outbreak of typhoid fever in Neno District, Malawi	PLOS ONE			English	Article							DIARRHEA PREVENTION; BACTEREMIA; CHILDREN; BURDEN; ADULTS	On May 2, 2009 an outbreak of typhoid fever began in rural villages along the Malawi Mozambique border resulting in 748 illnesses and 44 deaths by September 2010. Despite numerous interventions, including distribution of WaterGuard (WG) for in-home water treatment and education on its use, cases of typhoid fever continued. To inform response activities during the ongoing Typhoid outbreak information on knowledge, attitudes, and practices surrounding typhoid fever, safe water, and hygiene were necessary to plan future outbreak interventions. In September 2010, a survey was administered to female heads in randomly selected households in 17 villages in Neno District, Malawi. Stored household drinking water was tested for free chlorine residual (FCR) levels using the N,N diethyl-p-phenylene diamine colorimetric method (HACH Company, Loveland, CO, USA). Attendance at community-wide educational meetings was reported by 56% of household respondents. Respondents reported that typhoid fever is caused by poor hygiene (77%), drinking unsafe water (49%), and consuming unsafe food (25%), and that treating drinking water can prevent it (68%). WaterGuard, a chlorination solution for drinking water treatment, was observed in 112 (56%) households, among which 34% reported treating drinking water. FCR levels were adequate (FCR >= 0.2 mg/L) in 29 (76%) of the 38 households who reported treatment of stored water and had stored water available for testing and an observed bottle of WaterGuard in the home. Soap was observed in 154 (77%) households, among which 51% reported using soap for hand washing. Educational interventions did not reach almost one-half of target households and knowledge remains low. Despite distribution and promotion of WaterGuard and soap during the outbreak response, usage was low. Future interventions should focus on improving water, sanitation and hygiene knowledge, practices, and infrastructure. Typhoid vaccination should be considered.	[Bennett, Sarah D.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Bennett, Sarah D.; Ayers, Tracy L.; Mintz, Eric] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA; [Lowther, Sara A.] Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA USA; [Chingoli, Felix] Neno Dist Hlth Off, Neno, Malawi; [Chilima, Benson; Kabuluzi, Storn] Minist Hlth, Community Hlth Serv Unit, Lilongwe, Malawi; [Warne, Thomas A.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Lilongwe, Malawi	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Bennett, SD (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.; Bennett, SD (corresponding author), Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA.	iyk3@cdc.gov		Ayers, Tracy/0000-0003-4140-3263	Division of Global Disease Detection and Emergency Response, CGH; Division of Global Disease Detection and Emergency Response, CDC	Division of Global Disease Detection and Emergency Response, CGH; Division of Global Disease Detection and Emergency Response, CDC	The investigation was funded by the Division of Global Disease Detection and Emergency Response, CGH, CDC.	Archibald LK, 2000, J INFECT DIS, V181, P1414, DOI 10.1086/315367; Blum LS, 2014, AM J TROP MED HYG, V91, P729, DOI 10.4269/ajtmh.14-0067; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; Clarke K, 2012, AM SOC TROP MED HYG; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Fiebelkorn AP, 2012, SOC SCI MED, V75, P622, DOI 10.1016/j.socscimed.2012.02.011; Figueroa ME, 2010, CTR PUBLICATION HCI; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Imanishi M, 2014, AM J TROP MED HYG, V90, P945, DOI 10.4269/ajtmh.13-0497; Luby SP, 2006, TROP MED INT HEALTH, V11, P479, DOI 10.1111/j.1365-3156.2006.01592.x; Luby SP, 2004, AM J TROP MED HYG, V71, P420, DOI 10.4269/ajtmh.2004.71.420; Luby SP, 2008, AM J TROP MED HYG, V78, P382, DOI 10.4269/ajtmh.2008.78.382; Lutterloh E, 2012, CLIN INFECT DIS, V54, P1100, DOI 10.1093/cid/cis012; Makutsa P, 2001, AM J PUBLIC HEALTH, V91, P1571, DOI 10.2105/AJPH.91.10.1571; Mintz E, 2008, CONTROL COMMUNICABLE, P664; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; Muyembe-Tamfum JJ, 2009, TRAVEL MED INFECT DI, V7, P40, DOI 10.1016/j.tmaid.2008.12.006; Neil KP, 2012, CLIN INFECT DIS, V54, P1091, DOI 10.1093/cid/cis025; Nelson C., 2012, CONTROLLING TYPHOID; Neno District Health Officer, 2010, TYPH FEV OUTBR REP; Organization WH, 2003, BACKGR DOC DIAGN TRE, V15, P460; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Reller ME, 2003, AM J TROP MED HYG, V69, P411, DOI 10.4269/ajtmh.2003.69.411; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Slayton RB, 2013, HUM VACC IMMUNOTHER, V9, P903, DOI 10.4161/hv.23007; Thevos A K, 2000, Educ Health (Abingdon), V13, P366; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; Walters MS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002726; Were V., 2012, INT J POPUL RES, V2012, P1, DOI [10.1155/2012/470598, DOI 10.1155/2012/470598]; WHO, 2008, GUID DRINK WAT QUAL; WHO Regional Office for Africa, 2012, OUTBREAK B, V2, P12; WHO/UNICEF Joint Monitoring Programme, 2012, PROGR DRINK WAT SAN; WHO-WORLD HEALTH ORGANIZATION, 2012, REP AD HOC CONS TYPH	36	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193348	10.1371/journal.pone.0193348	http://dx.doi.org/10.1371/journal.pone.0193348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474394	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500091
J	Dong, B; Peng, Y; Wang, ZQ; Adegbija, O; Hui, J; Ma, J; Ma, YH				Dong, Bin; Peng, Yang; Wang, Zhiqiang; Adegbija, Odewumi; Hui, Jie; Ma, Jun; Ma, Ying-Hua			Joint association between body fat and its distribution with all-cause mortality: A data linkage cohort study based on NHANES (1988-2011)	PLOS ONE			English	Article							MASS INDEX; PHYSICAL-ACTIVITY; RISK; CIRCUMFERENCE; ADIPOSITY; NUTRITION	Objective Although obesity is recognized as an important risk of mortality, how the amount and distribution of body fat affect mortality risk is unclear. Furthermore, whether fat distribution confers any additional risk of mortality in addition to fat amount is not understood. Methods This data linkage cohort study included 16415 participants (8554 females) aged 18 to 89 years from National Health and Nutrition Examination Survey III (1988-1994) and its linked mortality data (31 December 2011). Cox proportional hazard models and parametric survival models were used to estimate the association between body fat percentage (BF%), based on bioelectrical impedance analysis, and waist-hip ratio (WHR) with mortality. Results A total of 4999 deaths occurred during 19-year follow-up. A U-shaped association between BF% and mortality was found in both sexes, with the adjusted hazard ratios for other groups between 1.02 (95% confidence interval: 0.89, 1.18) and 2.10 (1.47, 3.01) when BF% groups of 25-30% in males and 30-35% in females were used as references. A non-linear relationship between WHR and mortality was detected in males, with the adjusted hazard ratios among other groups ranging from 1.05 (0.94, 1.18) to 1.52 (1.15, 2.00) compared with the WHR category of 0.95-1.0. However in females, the death risk constantly increased across the WHR spectrum. Joint impact of BF% and WHR suggested males with BF% of 25-30% and WHR of 0.95-1.0 and females with BF% of 30-35% and WHR <0.9 were associated with the lowest mortality risk and longest survival age compared with their counterparts in other categories. Conclusions This study supported the use of body fat distribution in addition to fat amount in assessing the risk of all-cause mortality.	[Dong, Bin; Ma, Jun; Ma, Ying-Hua] Peking Univ, Sch Publ Hlth, Hlth Sci Ctr, Beijing, Peoples R China; [Peng, Yang; Wang, Zhiqiang; Adegbija, Odewumi] Univ Queensland, Sch Med, Ctr Chron Dis, Herston, Qld, Australia; [Hui, Jie] Inst Urban Indigenous Hlth, Brisbane, Qld, Australia	Peking University; University of Queensland	Ma, YH (corresponding author), Peking Univ, Sch Publ Hlth, Hlth Sci Ctr, Beijing, Peoples R China.	yinghuama@bjmu.edu.cn	Adegbija, Odewumi/N-1434-2019; Peng, Yang/J-8980-2016	Peng, Yang/0000-0002-9119-5506; Adegbija, Odewumi/0000-0001-6517-3795; Hu, Jie/0000-0003-2940-6525	National Health and Medical Research Council [APP1042343]; University of Queensland International Scholarship [44078179]; Excellent Talents Fund Program of Peking University Health Science Center [BMU2017YJ002]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland International Scholarship; Excellent Talents Fund Program of Peking University Health Science Center	This study was funded by the National Health and Medical Research Council (APP1042343), University of Queensland International Scholarship (44078179) and the Excellent Talents Fund Program of Peking University Health Science Center (BMU2017YJ002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2016, JAMA-J AM MED ASSOC, V315, P1989, DOI 10.1001/jama.2016.4666; Allison DB, 2002, INT J OBESITY, V26, P410, DOI 10.1038/sj.ijo.0801925; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Andersen SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138429; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2716; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Chen Y, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5446; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chumlea WC, 2002, INT J OBESITY, V26, P1596, DOI 10.1038/sj.ijo.0802167; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; National Clinical Guideline Centre (UK), 2014, OB ID ASS MAN OV WEI; Parker ED, 2009, AM J EPIDEMIOL, V169, P837, DOI 10.1093/aje/kwn395; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Reis JP, 2009, OBESITY, V17, P1232, DOI 10.1038/oby.2008.664; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; World Health Organization, 1995, PHYS STAT US INT ANT; Yerrakalva D, 2015, OBESITY, V23, P1944, DOI 10.1002/oby.21181; Zong G, 2016, OBESITY IN PRESS	23	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193368	10.1371/journal.pone.0193368	http://dx.doi.org/10.1371/journal.pone.0193368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474498	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500096
J	Niles, MT; Salerno, JD				Niles, Meredith T.; Salerno, Jonathan D.			A cross-country analysis of climate shocks and smallholder food insecurity	PLOS ONE			English	Article							SECURITY; ADAPTATION; DIVERSIFICATION; STRATEGIES; NICARAGUA; DYNAMICS; OPTIONS; AFRICA	Future climate changes will affect smallholder farmers in the developing world, posing threats to household food security. Nevertheless, there remains limited comparable evidence across multiple countries and regions regarding the global extent of climate shocks affecting smallholder food security. We examine data from 5,299 household surveys across 15 countries in Latin America, Africa and South Asia to assess the extent of climate shocks and their association with food insecurity, as well as what strategies may help buffer against climate shocks. We find that 71% of households reported experiencing a climate shock in the previous five years. Fifty-four percent reported experiencing food insecurity during one or more months annually. A multilevel statistical model estimated factors correlated with food insecurity as well as factors correlated with food insecurity among households that had experienced a climate shock. Households that reported experiencing a climate shock were 1.73 times more likely to be food insecure. As well, larger and poorer households were associated with higher odds of food insecurity while using pesticides, keeping large livestock, and being more educated are associated with lower odds of food insecurity. Among households that had experienced a climate shock, additional factors are correlated with lower odds of food insecurity when compared to otherwise similar households: use of fertilizers, pesticides, veterinary medicines, large livestock, and household assets. Together, these results demonstrate the extent of existing climate shocks affecting smallholder farmers and how interventions may potentially support adaptation and reduce food insecurity.	[Niles, Meredith T.] Univ Vermont, Dept Nutr & Food Sci, Food Syst Program, Burlington, VT 05405 USA; [Salerno, Jonathan D.] Univ Colorado, Sustainabil Energy & Environm Complex, Environm Studies Program, Boulder, CO 80309 USA; [Salerno, Jonathan D.] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA	University of Vermont; University of Colorado System; University of Colorado Boulder; University of California System; University of California Davis	Niles, MT (corresponding author), Univ Vermont, Dept Nutr & Food Sci, Food Syst Program, Burlington, VT 05405 USA.	mtniles@uvm.edu		Niles, Meredith/0000-0002-8323-1351	Giorgio Ruffolo post-doctoral fellowship program in sustainability science at Harvard University; Italian Ministry for the Environment, Land and Sea; Giorgio Ruffolo post-doctoral fellowship program in sustainability science at Harvard University through the Italian Ministry for the Environment, Land and Sea	Giorgio Ruffolo post-doctoral fellowship program in sustainability science at Harvard University; Italian Ministry for the Environment, Land and Sea; Giorgio Ruffolo post-doctoral fellowship program in sustainability science at Harvard University through the Italian Ministry for the Environment, Land and Sea	MTN was funded as sustainability science fellow by the Giorgio Ruffolo post-doctoral fellowship program in sustainability science at Harvard University. This program is funded by the Italian Ministry for the Environment, Land and Sea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been graciously supported by the Giorgio Ruffolo post-doctoral fellowship program in sustainability science at Harvard University (where Meredith Niles was a post-doctoral fellow) made possible through the Italian Ministry for the Environment, Land and Sea. We thank Lini Wollenberg, Laura Cramer, Wiebke Forche, Todd Rosenstock, and Mark Grote for their helpful comments and feedback throughout the process.	Adger WN, 2005, GLOBAL ENVIRON CHANG, V15, P77, DOI [10.1016/j.gloenvcha.2004.12.005, 10.1016/j.gloenvcha.2005.03.001]; Anderson MB., 2000, PACTS NATURAL DISAST; Asseng S, 2013, NAT CLIM CHANGE, V3, P827, DOI [10.1038/nclimate1916, 10.1038/NCLIMATE1916]; Bacon CM, 2014, GLOBAL ENVIRON CHANG, V25, P133, DOI 10.1016/j.gloenvcha.2014.02.005; Barrett CB, 2001, FOOD POLICY, V26, P315, DOI 10.1016/S0306-9192(01)00014-8; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Bene C., 2015, IMPACT CLIMATE RELAT; Bhatta GD, 2017, ENVIRON DEV SUSTAIN, V19, P497, DOI 10.1007/s10668-015-9743-x; Block S, 2001, FOOD POLICY, V26, P333, DOI 10.1016/S0306-9192(01)00015-X; Brown ME., 2015, CLIMATE CHANGE GLOBA; Brown ME, 2008, SCIENCE, V319, P580, DOI 10.1126/science.1154102; Bryan E, 2009, ENVIRON SCI POLICY, V12, P413, DOI 10.1016/j.envsci.2008.11.002; CCAFS, 2016, CCAFS HOUS BAS SURV; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; Coughlan de Perez E, 2014, MANAGING RISK EXTREM; Coumou D, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034018; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Davidson D, 2016, NAT CLIM CHANGE, V6, P433, DOI 10.1038/nclimate3007; de Leeuw J, 2009, J STAT SOFTW, V31, P1; De Muro P., 2007, ED RURAL PEOPLE FOOD; Evans DBG, 2016, ENVIRON RES LETT, V11; FAO IFAD UNICEF WFP & WHO, 2017, STAT FOOD SEC NUTR W; Food and Agriculture Organization (FAO), 2011, WORLD LIV 2011 LIV F, DOI DOI 10.1080/; Forch W., 2014, AGR FOOD SECUR, V3, P1, DOI [DOI 10.1186/2048-7010-3-13, 10.1186/2048-7010-3-13]; Gelman A., 2007, DATA ANAL USING REGR; Gifi A., 1990, NONLINEAR MULTIVARIA; Global Research Alliance, 2014, RED GREENH GAS EM LI; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Grace D., 2015, CCAFS WORKING PAPER; Guillemaud T., 2016, SUSTAIN AGR REV, V19, P35, DOI [10.1007/978-3-319-26777-7_2, DOI 10.1007/978-3-319-26777-7_2]; Hanke H, WORLD DEV; Harris K., 2015, AFRICAN STUD Q, V15, P13; Hertel TW, 2010, APPL ECON PERSPECT P, V32, P355, DOI 10.1093/aepp/ppq016; Hertel TW, 2014, ENERG ECON, V46, P562, DOI 10.1016/j.eneco.2014.04.014; Khan ZR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0284; Koster JM, 2013, HUM ECOL, V41, P221, DOI 10.1007/s10745-012-9549-5; Kristjanson P, 2012, FOOD SECUR, V4, P381, DOI 10.1007/s12571-012-0194-z; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lobell DB, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015012; Mehar M, 2016, J RURAL STUD, V44, P123, DOI 10.1016/j.jrurstud.2016.01.001; Nelson G.C, 2010, FOOD SECURITY FARMIN; Ng'ang'a SK, 2016, AGR SYST, V146, P44, DOI 10.1016/j.agsy.2016.04.004; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Salerno J, BIOSCIENCE; Sanchez PA, 2005, SCIENCE, V307, P357, DOI 10.1126/science.1109057; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Silvestri S, 2012, REG ENVIRON CHANGE, V12, P791, DOI 10.1007/s10113-012-0293-6; Sweet TM, 2017, J EDUC BEHAV STAT, V42, P107, DOI 10.3102/1076998616659752; Tai APK, 2014, NAT CLIM CHANGE, V4, P817, DOI [10.1038/nclimate2317, 10.1038/NCLIMATE2317]; Tanner T, 2015, NAT CLIM CHANGE, V5, P23, DOI 10.1038/NCLIMATE2431; UN, 2015, SUSTAINABLE DEV GOAL; UNEP UNCTAD, 2008, ORG AGR FOOD SECURIT; United Nations Development Program, HUMAN DEV REPORT, P71; United Nations Food and Agriculture Organization, 2008, CLIM CHANG FOOD SEC; Vermeulen S., 2016, EC ADVANTAGE ASSESSI; Vermeulen SJ, 2012, ENVIRON SCI POLICY, V15, P136, DOI 10.1016/j.envsci.2011.09.003; Vermeulen SJ, 2012, ANNU REV ENV RESOUR, V37, P195, DOI 10.1146/annurev-environ-020411-130608; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wood SA, 2014, GLOBAL ENVIRON CHANG, V25, P163, DOI 10.1016/j.gloenvcha.2013.12.011	62	35	35	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192928	10.1371/journal.pone.0192928	http://dx.doi.org/10.1371/journal.pone.0192928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX4LV	29474383	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500048
J	Sandlin, RD; Wong, KHK; Tessier, SN; Swel, A; Bookstaver, LD; Ahearn, BE; Maheswaran, S; Haber, DA; Stott, SL; Toner, M				Sandlin, Rebecca D.; Wong, Keith H. K.; Tessier, Shannon N.; Swel, Anisa; Bookstaver, Lauren D.; Ahearn, Bennett E.; Maheswaran, Shyamala; Haber, Daniel A.; Stott, Shannon L.; Toner, Mehmet			Ultra-fast vitrification of patient-derived circulating tumor cell lines	PLOS ONE			English	Article							LUNG-CANCER; PERSONALIZED MEDICINE; BLOOD; CRYOPRESERVATION	Emerging technologies have enabled the isolation and characterization of rare circulating tumor cells (CTCs) from the blood of metastatic cancer patients. CTCs represent a non-invasive opportunity to gain information regarding the primary tumor and recent reports suggest CTCs have value as an indicator of disease status. CTCs are fragile and difficult to expand in vitro, so typically molecular characterization must be performed immediately following isolation. To ease experimental timelines and enable biobanking, cryopreservation methods are needed. However, extensive cellular heterogeneity and the rarity of CTCs complicates the optimization of cryopreservation methods based upon cell type, necessitating a standardized protocol. Here, we optimized a previously reported vitrification protocol to preserve patient-derived CTC cell lines using highly conductive silica microcapillaries to achieve ultra-fast cooling rates with low cryoprotectant concentrations. Using this vitrification protocol, five CTC cell lines were cooled to cryogenic temperatures. Thawed CTCs exhibited high cell viability and expanded under in vitro cell culture conditions. EpCAM biomarker expression was maintained for each CTC cell line. One CTC cell line was selected for molecular characterization, revealing that RNA integrity was maintained after storage. A qPCR panel showed no significant difference in thawed CTCs compared to fresh controls. The data presented here suggests vitrification may enable the standardization of cryopreservation methods for CTCs.	[Sandlin, Rebecca D.; Wong, Keith H. K.; Tessier, Shannon N.; Swel, Anisa; Bookstaver, Lauren D.; Ahearn, Bennett E.; Stott, Shannon L.; Toner, Mehmet] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Engn Med, BioMEMS Resource Ctr, Boston, MA 02115 USA; [Sandlin, Rebecca D.; Wong, Keith H. K.; Tessier, Shannon N.; Swel, Anisa; Bookstaver, Lauren D.; Ahearn, Bennett E.; Maheswaran, Shyamala; Toner, Mehmet] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02115 USA; [Maheswaran, Shyamala] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA; [Haber, Daniel A.] Harvard Med Sch, Massachusetts MA Gen Hosp, Canc Ctr, Boston, MA USA; [Haber, Daniel A.] Harvard Med Sch, Massachusetts MA Gen Hosp, Dept Med, Boston, MA USA; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Stott, Shannon L.] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Dept Med, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital	Toner, M (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Engn Med, BioMEMS Resource Ctr, Boston, MA 02115 USA.; Toner, M (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02115 USA.	mtoner@hms.harvard.edu	Stott, Shannon L./AAC-5311-2019	Tessier, Shannon/0000-0003-2373-232X	US National Institutes of Health (NIH) P41 Grant [EB002503]; NIH National Institute of Biomedical Imaging and Bioengineering [EB012493]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA129933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB012493] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) P41 Grant; NIH National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the US National Institutes of Health (NIH) P41 Grant (EB002503; M. T.; https://www.nih.gov), NIH National Institute of Biomedical Imaging and Bioengineering (EB012493; M.T.; https://www.nibib.nih.gov) and the Howard Hughes Medical Institute (D. A. H.; http://www.hhmi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Baker M, 2012, NATURE, V486, P141, DOI 10.1038/486141a; Barbazan J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040476; Bulfoni M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101775; Fahy GM, 2004, CRYOBIOLOGY, V48, P22, DOI 10.1016/j.cryobiol.2003.11.004; Girotti MR, 2016, CANCER DISCOV, V6, P286, DOI 10.1158/2159-8290.CD-15-1336; Gleghorn JP, 2010, LAB CHIP, V10, P27, DOI 10.1039/b917959c; Harouaka R, 2014, PHARMACOL THERAPEUT, V141, P209, DOI 10.1016/j.pharmthera.2013.10.004; Heo YS, 2015, TECHNOLOGY, V3, P64, DOI 10.1142/S2339547815500053; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Hou HW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01259; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Hunt CJ, 2006, CRYOLETTERS, V27, P73; Karabacak NM, 2014, NAT PROTOC, V9, P694, DOI 10.1038/nprot.2014.044; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Liu AG, 2015, ADV EXP MED BIOL, V864, P55, DOI 10.1007/978-3-319-20579-3_5; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Risco R, 2007, CRYOBIOLOGY, V55, P222, DOI 10.1016/j.cryobiol.2007.08.006; Stacey GN, 2008, NAT PROTOC, V3, P1981, DOI 10.1038/nprot.2008.190; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Warkiani ME, 2016, NAT PROTOC, V11, P134, DOI 10.1038/nprot.2016.003; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533	26	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192734	10.1371/journal.pone.0192734	http://dx.doi.org/10.1371/journal.pone.0192734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474365	Green Published, gold			2022-12-26	WOS:000426049500035
J	White, M; Freistaedter, A; Jones, GJB; Zervos, E; Roper, RL				White, Michael; Freistaedter, Andrew; Jones, Gwendolyn J. B.; Zervos, Emmanuel; Roper, Rachel L.			Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer	PLOS ONE			English	Article							REGULATORY T-CELLS; SMALLPOX VACCINE; TUMOR-GROWTH; PHASE-I; VIRUS; IDENTIFICATION; EXPRESSION; MODEL; IMMUNOTHERAPY; ESTABLISHMENT	Pancreatic cancer is the 5th leading cause of cancer deaths, and there are no effective treatments. We developed a poxvirus platform vaccine with improved immunogenicity and inserted the mesothelin gene to create an anti-mesothelin cancer vaccine. Mesothelin expression is mostly restricted to tumors in adult mammals and thus may be a good target for cancer treatment. We show here that the modified vaccinia virus Ankara (MVA) virus expressing mesothelin and the enhanced MVA virus missing the immunosuppressive A35 gene and expressing mesothelin were both safe in mice and were able to induce IFN-gamma secreting T cells in response to mesothelin expressing tumor cells. In addition, the MVA virus has oncolytic properties in vitro as it can replicate in and kill Panc02 pancreatic adenocarcinoma cell line tumor cells, even though it is unable to replicate in most mammalian cells. Deletion of the A35 gene in MVA improved T cell responses as expected. However, we were unable to demonstrate inhibition of Panc02 tumor growth in immunocompetent mice with pre-vaccination of mice, boosts, or even intratumoral injections of the recombinant viruses. Vaccine efficacy may be limited by shedding of mesothelin from tumor cells thus creating a protective screen from the immune system.	[White, Michael; Zervos, Emmanuel] East Carolina Univ, Brody Sch Med, Dept Surg, Greenville, NC USA; [Freistaedter, Andrew; Jones, Gwendolyn J. B.; Roper, Rachel L.] East Carolina Univ, Brody Sch Med, Dept Microbiol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Roper, RL (corresponding author), East Carolina Univ, Brody Sch Med, Dept Microbiol, Greenville, NC 27858 USA.	roperr@ecu.edu	Roper, Rachel/A-7935-2013	Roper, Rachel/0000-0001-6971-7745	Leo Jenkins Cancer Center at East Carolina University; Lineberger Comprehensive Cancer Center	Leo Jenkins Cancer Center at East Carolina University; Lineberger Comprehensive Cancer Center	The authors wish to acknowledge the financial support of the Leo Jenkins Cancer Center at East Carolina University and the Lineberger Comprehensive Cancer Center (RR and EZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2001, CLIN CANCER RES, V7, P3862; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Bera TK, 2000, MOL CELL BIOL, V20, P2902, DOI 10.1128/MCB.20.8.2902-2906.2000; Bisht H, 2004, P NATL ACAD SCI USA, V101, P6641, DOI 10.1073/pnas.0401939101; Campbell CT, 2013, CLIN CANCER RES, V19, P1290, DOI 10.1158/1078-0432.CCR-12-2478; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Chang CL, 2007, GENE THER, V14, P1189, DOI 10.1038/sj.gt.3302974; Chard LS, 2015, CLIN CANCER RES, V21, P405, DOI 10.1158/1078-0432.CCR-14-0464; Chowdhury PS, 1999, J IMMUNOL METHODS, V231, P83, DOI 10.1016/S0022-1759(99)00142-8; Collignon A, 2015, ONCOTARGET, V6, P23462, DOI 10.18632/oncotarget.4359; Cordes LM, 2016, CURR OPIN ONCOL, V28, P232, DOI 10.1097/CCO.0000000000000281; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Fleischauer C, 2015, J GEN VIROL, V96, P2806, DOI 10.1099/vir.0.000202; Gilbert SC, 2013, VACCINE, V31, P4241, DOI 10.1016/j.vaccine.2013.03.020; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Group USCSW, 2015, US CANC STAT 2008 20; Guzman E, 2012, J VIROL, V86, P5452, DOI 10.1128/JVI.00264-12; Hagiwara Y, 2008, CANCER SCI, V99, P666, DOI 10.1111/j.1349-7006.2008.00731.x; Hassan R, 2005, APPL IMMUNOHISTO M M, V13, P243, DOI 10.1097/01.pai.00000141545.36485.d6; Hassan R, 2007, CLIN CANCER RES, V13, P5144, DOI 10.1158/1078-0432.CCR-07-0869; Hassan R, 2016, J CLIN ONCOL, V34, P4171, DOI 10.1200/JCO.2016.68.3672; Hatch GJ, 2013, J VIROL, V87, P7805, DOI 10.1128/JVI.03481-12; Hersperger AR, 2014, J VIROL, V88, P9472, DOI 10.1128/JVI.01464-14; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Hui EP, 2013, CANCER RES, V73, P1676, DOI 10.1158/0008-5472.CAN-12-2448; Imamura O, 2008, CANCER LETT, V268, P278, DOI 10.1016/j.canlet.2008.04.002; Jacobs C, 2011, INT J CANCER, V128, P897, DOI 10.1002/ijc.25399; Jones GJB, 2014, VACCINE, V32, P3977, DOI 10.1016/j.vaccine.2014.05.018; Kim M, 2015, J MICROBIOL, V53, P209, DOI 10.1007/s12275-015-5041-4; Leao IC, 2008, CTS-CLIN TRANSL SCI, V1, P228, DOI 10.1111/j.1752-8062.2008.00070.x; Li M, 2008, MOL CANCER THER, V7, P286, DOI 10.1158/1535-7163.MCT-07-0483; Madan RA, 2016, METHOD MOL BIOL, V1403, P755; Nakaishi M, 2007, CANCER SCI, V98, P659, DOI 10.1111/j.1349-7006.2007.00438.x; Nesslinger NJ, 2010, CLIN CANCER RES, V16, P4046, DOI 10.1158/1078-0432.CCR-10-0948; Odunsi K, 2012, P NATL ACAD SCI USA, V109, P5797, DOI 10.1073/pnas.1117208109; Parviainen S, 2015, INT J CANCER, V136, P1065, DOI 10.1002/ijc.29068; Rehm KE, 2009, IMMUNOL; Rehm KE, 2011, VACCINE, V29, P3276, DOI 10.1016/j.vaccine.2011.02.023; Rehm KE, 2010, VIROLOGY, V397, P176, DOI 10.1016/j.virol.2009.11.008; Rehm KE, 2010, J VIROL, V84, P418, DOI 10.1128/JVI.01802-09; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roper RL, 2017, METHODS MOL BIOL, V1581, P121, DOI 10.1007/978-1-4939-6869-5_7; Roper Rachel L, 2012, Methods Mol Biol, V890, P259, DOI 10.1007/978-1-61779-876-4_15; Roper Rachel L, 2004, Methods Mol Biol, V269, P113; Roper RL, 2006, J VIROL, V80, P306, DOI 10.1128/JVI.80.1.306-313.2006; Sanchez-Sampedro L, 2015, VIRUSES-BASEL, V7, P1726, DOI 10.3390/v7041726; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Thomas AM, 2004, J EXP MED, V200, P297, DOI 10.1084/jem.20031435; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Villena-Vargas J, 2012, ANN CARDIOTHORAC SUR, V1, P466, DOI 10.3978/j.issn.2225-319X.2012.10.03; Weltzin R, 2003, NAT MED, V9, P1125, DOI 10.1038/nm916; Yokokawa J, 2005, CLIN CANCER RES, V11, P6342, DOI 10.1158/1078-0432.CCR-05-0596; Zervos E, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0314-2; Zhang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09928	54	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193131	10.1371/journal.pone.0193131	http://dx.doi.org/10.1371/journal.pone.0193131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474384	Green Published, Green Submitted, gold			2022-12-26	WOS:000426049500057
J	Bishop, PJ; Graham, DF; Lamas, LP; Hutchinson, JR; Rubenson, J; Hancock, JA; Wilson, RS; Hocknull, SA; Barrett, RS; Lloyd, DG; Clemente, CJ				Bishop, P. J.; Graham, D. F.; Lamas, L. P.; Hutchinson, J. R.; Rubenson, J.; Hancock, J. A.; Wilson, R. S.; Hocknull, S. A.; Barrett, R. S.; Lloyd, D. G.; Clemente, C. J.			The influence of speed and size on avian terrestrial locomotor biomechanics: Predicting locomotion in extinct theropod dinosaurs	PLOS ONE			English	Article							GROUND REACTION FORCES; CENTER-OF-MASS; INCREASED ROTATIONAL INERTIA; EXTANT BIRDS NEORNITHES; BIPEDAL RUNNING ABILITY; HIND-LIMB FUNCTION; QUAIL COTURNIX; HUMAN WALKING; SENSITIVITY-ANALYSIS; TURNING PERFORMANCE	How extinct, non-avian theropod dinosaurs moved is a subject of considerable interest and controversy. A better understanding of non-avian theropod locomotion can be achieved by better understanding terrestrial locomotor biomechanics in their modern descendants, birds. Despite much research on the subject, avian terrestrial locomotion remains little explored in regards to how kinematic and kinetic factors vary together with speed and body size. Here, terrestrial locomotion was investigated in twelve species of ground-dwelling bird, spanning a 1,780-fold range in body mass, across almost their entire speed range. Particular attention was devoted to the ground reaction force (GRF), the force that the feet exert upon the ground. Comparable data for the only other extant obligate, striding biped, humans, were also collected and studied. In birds, all kinematic and kinetic parameters examined changed continuously with increasing speed, while in humans all but one of those same parameters changed abruptly at the walk-run transition. This result supports previous studies that show birds to have a highly continuous locomotor repertoire compared to humans, where discrete 'walking' and 'running' gaits are not easily distinguished based on kinematic patterns alone. The influences of speed and body size on kinematic and kinetic factors in birds are developed into a set of predictive relationships that may be applied to extinct, non-avian theropods. The resulting predictive model is able to explain 79-93% of the observed variation in kinematics and 69-83% of the observed variation in GRFs, and also performs well in extrapolation tests. However, this study also found that the location of the whole-body centre of mass may exert an important influence on the nature of the GRF, and hence some caution is warranted, in lieu of further investigation.	[Bishop, P. J.; Hocknull, S. A.] Queensland Museum, Geosci Program, Brisbane, Qld, Australia; [Bishop, P. J.; Graham, D. F.; Hocknull, S. A.; Barrett, R. S.; Lloyd, D. G.] Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld, Australia; [Bishop, P. J.; Graham, D. F.; Hocknull, S. A.; Barrett, R. S.; Lloyd, D. G.] Menzies Hlth Inst Queensland, Innovat Hlth Technol, Gold Coast, Qld, Australia; [Lamas, L. P.; Hutchinson, J. R.] Royal Vet Coll, Dept Comparat Biomed Sci, Struct & Motion Lab, Hatfield, Herts, England; [Lamas, L. P.] Univ Lisbon, Fac Med Vet, Lisbon, Portugal; [Rubenson, J.] Penn State Univ, Dept Kinesiol, Biomech Lab, University Pk, PA 16802 USA; [Rubenson, J.; Lloyd, D. G.] Univ Western Australia, Sch Human Sci, Crawley, Australia; [Hancock, J. A.] Mary Baldwin Univ, Murphy Deming Coll Hlth Sci, Staunton, VA USA; [Wilson, R. S.; Clemente, C. J.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Clemente, C. J.] Univ Sunshine Coast, Sch Sci & Engn, Maroochydore, Qld, Australia	Queensland Museum; Griffith University; Menzies Health Institute Queensland; University of London; University of London Royal Veterinary College; Universidade de Lisboa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Western Australia; University of Queensland; University of the Sunshine Coast	Bishop, PJ (corresponding author), Queensland Museum, Geosci Program, Brisbane, Qld, Australia.; Bishop, PJ (corresponding author), Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld, Australia.; Bishop, PJ (corresponding author), Menzies Hlth Inst Queensland, Innovat Hlth Technol, Gold Coast, Qld, Australia.	peter.bishop@qm.qld.gov.au	Hutchinson, John/AAH-1593-2020; Clemente, Christofer/I-7649-2016; Lloyd, David Gavin/AAH-6066-2020	Clemente, Christofer/0000-0001-8174-3890; Lloyd, David Gavin/0000-0002-0824-9682; Lamas, Luis/0000-0003-1668-0314; Hocknull, Scott/0000-0003-4157-8434; Wilson, Robbie/0000-0002-0116-5427; Rubenson, Jonas/0000-0003-2854-1776; Barrett, Rod/0000-0002-1784-1629; Hutchinson, John/0000-0002-6767-7038	Australian Government Research Training Program Scholarship; International Society of Biomechanics Matching Dissertation Grant; Australian Research Council DECRA Fellowship [DE120101503]; Australian Research Council Future Fellowship [FT150100492]	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); International Society of Biomechanics Matching Dissertation Grant; Australian Research Council DECRA Fellowship(Australian Research Council); Australian Research Council Future Fellowship(Australian Research Council)	This research was supported by an Australian Government Research Training Program Scholarship (to P.J.B.), an International Society of Biomechanics Matching Dissertation Grant (to P.J.B.; https://isbweb.org/), an Australian Research Council DECRA Fellowship (DE120101503, to C.J.C.; www.arc.gov.au) and an Australian Research Council Future Fellowship (FT150100492, to R.S.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourachid A, 2000, IBIS, V142, P538, DOI 10.1111/j.1474-919X.2000.tb04455.x; Abourachid A, 2011, ZOOLOGY, V114, P360, DOI 10.1016/j.zool.2011.07.002; Ahn AN, 2004, J EXP BIOL, V207, P399, DOI 10.1242/jeb.00761; Alexander R. McN., 1977, P168; ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; ALEXANDER RM, 1978, J ZOOL, V185, P27, DOI 10.1111/j.1469-7998.1978.tb03311.x; ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; ALEXANDER RM, 1983, J ZOOL, V201, P363; ALEXANDER RM, 1980, J BIOMECH, V13, P383, DOI 10.1016/0021-9290(80)90019-6; ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Allen V, 2013, NATURE, V497, P104, DOI 10.1038/nature12059; Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; Aminiaghdam S, 2017, J EXP BIOL, V220, P478, DOI 10.1242/jeb.148312; Andrada E, 2015, SCI REP-UK, V5, DOI 10.1038/srep13636; Andrada E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1405; Andrada E, 2013, J EXP BIOL, V216, P3906, DOI 10.1242/jeb.085399; Andrada E, 2013, J THEOR BIOL, V335, P97, DOI 10.1016/j.jtbi.2013.06.031; Bakker RT., 1986, DINOSAUR HERESIES; Bates KT, 2012, PALEOBIOLOGY, V38, P486, DOI 10.1666/10004.1; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2004, J APPL PHYSIOL, V97, P2266, DOI 10.1152/japplphysiol.00003.2004; BIEWENER AA, 1990, SCIENCE, V250, P1097, DOI 10.1126/science.2251499; Birn-Jeffery AV, 2014, J EXP BIOL, V217, P3786, DOI 10.1242/jeb.102640; Bishop PJ, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0276; Blanco RE, 2005, P ROY SOC B-BIOL SCI, V272, P1769, DOI 10.1098/rspb.2005.3133; Blanco RE, 2001, ACTA PALAEONTOL POL, V46, P193; BLICKHAN R, 1992, P75; Blob RW, 2001, J EXP BIOL, V204, P1099; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Breit GA, 1997, MED SCI SPORT EXER, V29, P540, DOI 10.1097/00005768-199704000-00017; Campione NE, 2014, METHODS ECOL EVOL, V5, P913, DOI 10.1111/2041-210X.12226; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Carrano MT, 1998, PALEOBIOLOGY, V24, P450, DOI 10.1017/S0094837300020108; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; Carrier DR, 2001, J EXP BIOL, V204, P3917; CAVAGNA GA, 1975, J APPL PHYSIOL, V39, P174, DOI 10.1152/jappl.1975.39.1.174; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; CAVANAGH PR, 1980, J BIOMECH, V13, P397, DOI 10.1016/0021-9290(80)90033-0; Chiappe L. M., 2002, MESOZOIC BIRDS HEADS; CLARK J, 1975, J ZOOL, V176, P87; Clark KP, 2014, J EXP BIOL, V217, P2037, DOI 10.1242/jeb.099523; Clemente CJ, J ZOOLOGY IN PRESS; Cracraft J, 1971, B AM MUS NAT HIST, V4, P171; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Gatesy SM, 1999, J MORPHOL, V240, P127, DOI 10.1002/(SICI)1097-4687(199905)240:2<127::AID-JMOR4>3.0.CO;2-Q; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; Gatesy SM, 1999, J MORPHOL, V240, P115, DOI 10.1002/(SICI)1097-4687(199905)240:2<115::AID-JMOR3>3.0.CO;2-Y; GATESY SM, 1991, J MORPHOL, V209, P83, DOI 10.1002/jmor.1052090107; Gatesy SM, 1997, J VERTEBR PALEONTOL, V17, P308, DOI 10.1080/02724634.1997.10010977; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; GATESY SM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P219; Gatesy SM, 2009, J VERTEBR PALEONTOL, V29, P535, DOI 10.1671/039.029.0213; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Giarmatzis G, 2015, J BONE MINER RES, V30, P1431, DOI 10.1002/jbmr.2483; Goetz JE, 2008, J BIOMECH, V41, P770, DOI 10.1016/j.jbiomech.2007.11.022; Grossi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088458; HAMILL J, 1983, HUM MOVEMENT SCI, V2, P47, DOI 10.1016/0167-9457(83)90005-2; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hancock JA, 2007, IBIS, V149, P605, DOI 10.1111/j.1474-919X.2007.00688.x; Hancock JA, 2014, IBIS, V156, P198, DOI 10.1111/ibi.12115; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; HEGLUND NC, 1982, J EXP BIOL, V97, P41; Henderson Donald M., 2003, Ichnos, V10, P99, DOI 10.1080/10420940390257914; HRELJAC A, 1995, J BIOMECH, V28, P669, DOI 10.1016/0021-9290(94)00120-S; Hubel TY, 2015, J EXP BIOL, V218, P2830, DOI 10.1242/jeb.122135; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Hutchinson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026037; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P123, DOI 10.1006/zjls.2000.0254; Hutchinson JR, 2004, J MORPHOL, V262, P441, DOI 10.1002/jmor.10240; Hutchinson JR, 2004, J MORPHOL, V262, P421, DOI 10.1002/jmor.10241; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P169, DOI 10.1006/zjls.2000.0267; Hutchinson JR, 2000, PALEOBIOLOGY, V26, P734, DOI 10.1666/0094-8373(2000)026<0734:AAATEO>2.0.CO;2; Keller TS, 1996, CLIN BIOMECH, V11, P253, DOI 10.1016/0268-0033(95)00068-2; Kilbourne BM, 2016, J EXP BIOL, V219, P1405, DOI 10.1242/jeb.124081; Kluitenberg B, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-235; Kram R, 1998, J APPL PHYSIOL, V85, P764, DOI 10.1152/jappl.1998.85.2.764; Lamas LP, 2015, MUSCULOSKELETAL BIOM; Lee DV, 2001, J EXP BIOL, V204, P3927; Main RP, 2007, J EXP BIOL, V210, P2676, DOI 10.1242/jeb.004580; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Muir GD, 1996, J PHYSIOL-LONDON, V493, P589, DOI 10.1113/jphysiol.1996.sp021406; MUNRO CF, 1987, J BIOMECH, V20, P147, DOI 10.1016/0021-9290(87)90306-X; Naish D, 2012, COMPLETE DINOSAUR, P379; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; Nudds RL, 2011, P ROY SOC B-BIOL SCI, V278, P2654, DOI 10.1098/rspb.2010.2742; Nyakatura JA, 2012, J EXP ZOOL PART A, V317A, P580, DOI 10.1002/jez.1750; Ogihara N, 2007, J HUM EVOL, V53, P302, DOI 10.1016/j.jhevol.2007.04.004; Orme D., 2015, CAPER COMP ANAL PHYL; OSTROM JH, 1976, BIOL J LINN SOC, V8, P91, DOI 10.1111/j.1095-8312.1976.tb00244.x; Paul G., 1988, PREDATORY DINOSAURS; Paul G.S., 2008, TYRANNOSAURUS REX, P307; Paul Gregory S., 2000, Gaia (Lisboa), V15, P257; R Core Team, 2012, R LANG ENV STAT COMP; Reilly SM, 2000, J MORPHOL, V243, P173, DOI 10.1002/(SICI)1097-4687(200002)243:2<173::AID-JMOR6>3.3.CO;2-5; Riley PO, 2008, MED SCI SPORT EXER, V40, P1093, DOI 10.1249/MSS.0b013e3181677530; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Roberts TJ, 2002, J EXP BIOL, V205, P1485; Roberts TJ, 1998, J EXP BIOL, V201, P2753; Rode C, 2016, J EXP BIOL, V219, P485, DOI 10.1242/jeb.127910; Rose KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep24292; Rubenson J, 2004, P ROY SOC B-BIOL SCI, V271, P1091, DOI 10.1098/rspb.2004.2702; Rubenson J, 2007, J EXP BIOL, V210, P2548, DOI 10.1242/jeb.02792; Rubenson J, 2011, J R SOC INTERFACE, V8, P740, DOI 10.1098/rsif.2010.0466; Rubenson J, 2009, J APPL PHYSIOL, V106, P1618, DOI 10.1152/japplphysiol.91115.2008; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; SELLERS WI, 2017, PEERJ, V5, DOI DOI 10.7717/PEERJ.3420; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Smith NC, 2010, J EXP BIOL, V213, P1347, DOI 10.1242/jeb.020271; Stoessel A, 2012, J EXP BIOL, V215, P4055, DOI 10.1242/jeb.070458; Thavarajah NK, 2016, SCI REP-UK, V6, DOI 10.1038/srep36512; Thulborn T., 1990, DINOSAUR TRACKS; Turner AH, 2012, B AM MUS NAT HIST, P5; Usherwood JR, 2008, J EXP BIOL, V211, P3744, DOI 10.1242/jeb.023416; Usherwood JR, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0414; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Watson RR, 2011, P ROY SOC B-BIOL SCI, V278, P2040, DOI 10.1098/rspb.2010.2022; Weishampel DB., 2004, DINOSAURIA; Winter D., 2009, BIOMECHANICS MOTOR C, V4th	125	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192172	10.1371/journal.pone.0192172	http://dx.doi.org/10.1371/journal.pone.0192172			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466362	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000425604300032
J	Levitt-Barmats, Y; Shenkar, N				Levitt-Barmats, Ya'arit; Shenkar, Noa			Observations on the symbiotic relationship between the caridean shrimp Odontonia sibogae (Bruce, 1972) and its ascidian host Herdmania momus (Savigny, 1816)	PLOS ONE			English	Article							RED-SEA; PONTONIINAE CRUSTACEA; CARIBBEAN SEA; SELECTION; DECAPODA; PALAEMONIDAE; ENVIRONMENTS; REPRODUCTION; RECRUITMENT; ANEMONES	Symbiotic relationships between shrimps and other invertebrates are a very common phenomenon in tropical environments. Although the caridean shrimp-ascidian association has been known for many years, the nature of this relationship is still unclear. The current study investigated the association between the caridean shrimp Odontonia sibogae (Bruce, 1972) and solitary ascidians. A combination of field work conducted along the Red Sea coast of Israel and laboratory experiments, conducted during 2015-2016, revealed a clear preference of the shrimps for the ascidian species Herdmania momus (Savigny, 1816), with a low survival ability of the shrimp outside their host's body. The shrimps usually inhabit their host as pairs of male and female or pair of females, but never as pairs of males. Out of the 53 studied females, 51% were observed to bear between 156-1,146 embryos, throughout the course of the year. As these ascidian hosts are known to create large aggregates, we suggest that males may possibly wander among the ascidians occupied by females in order to increase their reproductive success. To date, this is the first study to record the shrimp Dactylonia ascidicola (Borradaile, 1898) inhabiting the ascidian H. momus; and the first study to investigate in depth the ascidian-shrimp association in the Red Sea. It thus provides a platform for future research into the physiological and behavioral adaptations required for such a unique association.	[Levitt-Barmats, Ya'arit; Shenkar, Noa] Tel Aviv Univ, Sch Zool, George S Wise Fac Life Sci, Tel Aviv, Israel; [Levitt-Barmats, Ya'arit; Shenkar, Noa] Tel Aviv Univ, Israel Natl Ctr Biodivers Studies, Steinhardt Museum Nat Hist, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Levitt-Barmats, Y; Shenkar, N (corresponding author), Tel Aviv Univ, Sch Zool, George S Wise Fac Life Sci, Tel Aviv, Israel.; Levitt-Barmats, Y; Shenkar, N (corresponding author), Tel Aviv Univ, Israel Natl Ctr Biodivers Studies, Steinhardt Museum Nat Hist, Tel Aviv, Israel.	yaaritle@post.tau.ac.il; shenkarn@post.tau.ac.il	Levitt-Barmats, Ya'arit/AFL-7219-2022	Levitt-Barmats, Ya'arit/0000-0001-7596-7257	Steinhardt Museum of Natural History, Israel National Center for Biodiversity Studies, Tel Aviv University; Inter-University Institute for Marine Sciences in Eilat; Israeli Taxonomy Initiative fellowship; Caroline von Humboldt award; Marie Curie CIG grant [321547]	Steinhardt Museum of Natural History, Israel National Center for Biodiversity Studies, Tel Aviv University; Inter-University Institute for Marine Sciences in Eilat; Israeli Taxonomy Initiative fellowship; Caroline von Humboldt award; Marie Curie CIG grant	This research could not have been finished without the support and help of the Steinhardt Museum of Natural History, Israel National Center for Biodiversity Studies, Tel Aviv University. We are also grateful to the Inter-University Institute for Marine Sciences in Eilat for their hospitality and support, and to Kiflawi M. and Mass T. labs for the use of their facilities; Dr. I. Scharf and M. Novosolov for their valuable comments and advices; T. Sheler, T. Shlesinger, O. Bronstein and O. Ben-Zvi for technical help; and N. Paz for editorial assistance. The authors are grateful to the reviewers for their constructive comments.; This work was supported by the Israeli Taxonomy Initiative fellowship for YLB, http://taxonomy.tau.ac.il/eng; the Caroline von Humboldt award for NS, https://www.exzellenz.hu-berlin.de/en/funding/young-researchers/the-caroline-von-humboldt-grant-programme; the FP7 Marie Curie CIG grant (321547) for NS, https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/fp7/calls/fp7-people-2013-cig.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeza JA, 2011, J EXP MAR BIOL ECOL, V407, P41, DOI 10.1016/j.jembe.2011.07.011; Baeza JA, 2013, J ZOOL, V289, P172, DOI 10.1111/j.1469-7998.2012.00974.x; Baeza J.A., 2015, LIFESTYLES FEEDING B, V2, P163; Baeza JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121120; Baeza JA, 2007, REPROD SOCIAL BEHAV, P245; Bauer R. T., 2004, REMARKABLE SHRIMPS A, V7; BAUER RT, 1992, INVERTEBR REPROD DEV, V22, P193, DOI 10.1080/07924259.1992.9672272; BAUER RT, 1989, J EXP MAR BIOL ECOL, V127, P175, DOI 10.1016/0022-0981(89)90183-4; Brokovich E, 2006, ECOL INDIC, V6, P494, DOI 10.1016/j.ecolind.2005.07.002; BRUCE A J, 1976, Micronesica, V12, P83; Bruce A. J., 1983, ZOOLOGISCHE VERHANDE, V205, P1; Bruce AJ, 1969, MAR BIOL ASS INDIA, V11, P115; Castro P., 1969, THESIS; Chaparro OR, 2001, J EXP MAR BIOL ECOL, V266, P97, DOI 10.1016/S0022-0981(01)00336-7; De Grave S, 2001, J BIOGEOGR, V28, P1239, DOI 10.1046/j.1365-2699.2001.00633.x; DiBattista JD, 2016, J BIOGEOGR, V43, P423, DOI 10.1111/jbi.12649; Duris Z., 2017, MAR BIODIVERS, P1; Fautin DG, 1995, MAR ECOL PROG SER, V129, P77, DOI 10.3354/meps129077; Fransen CHJM, 2006, ZOOSYSTEMA, V28, P713; Fransen CHJM, 2002, ZOOLOGISCHE VERHANDE; Gewing MT, 2014, BIOINVASIONS REC, V3, P77, DOI 10.3391/bir.2014.3.2.04; GHERARDI F, 1991, Tropical Zoology, V4, P107; GOREN M, 1993, ISR J ZOOL, V39, P293; Grippa GB, 1996, ATTI SOC ITALIANA SC, V135, P401; Guo CC, 1996, J EXP MAR BIOL ECOL, V202, P165, DOI 10.1016/0022-0981(96)00020-2; Hariri KI., 2000, STATUS LIVING MARINE; Harmelin-Vivien M.L., 1989, Ecological Studies, V69, P21; Holthuis L. B., 1951, Occ Pap Hancock Found, VNo. 11, P1; Hurt C, 2013, MOL ECOL, V22, P4532, DOI 10.1111/mec.12398; KNOWLTON N, 1980, EVOLUTION, V34, P161, DOI 10.1111/j.1558-5646.1980.tb04802.x; KNOWLTON N, 1985, B MAR SCI, V37, P893; Koplovitz G, 2016, MANAG BIOL INVASION, V7, P43, DOI 10.3391/mbi.2016.7.1.06; Leung TLF, 2008, VIE MILIEU, V58, P107; LIMBAUGH CONRAD, 1961, BULL MAR SCI GULF AND CARIBBEAN, V11, P237; Limviriyakul P, 2016, J EXP MAR BIOL ECOL, V485, P24, DOI 10.1016/j.jembe.2016.08.001; Olliff ERR, 2013, CRUSTACEANA, V86, P564, DOI 10.1163/15685403-00003192; Rius M, 2012, MAR POLLUT BULL, V64, P2060, DOI 10.1016/j.marpolbul.2012.06.029; Ross MD, 1983, BIOL CRUSTACEA, P163; Ruppert EE, 2004, INVERTEBRATE ZOOLOGY; Shenkar N, 2008, BIOL INVASIONS, V10, P1431, DOI 10.1007/s10530-008-9217-2; Spiridonov V.A., 1999, Zoologische Mededelingen (Leiden), V73, P63; Thiel M, 2001, SYMBIOSIS, V30, P163; Van Tassell James L., 1994, Cybium, V18, P117; Vannini M, 2000, TROP ZOOL, V13, P251, DOI 10.1080/03946975.2000.10531136; Vine P., 1986, RED SEA INVERTEBRATE; WESTINGA E, 1981, MAR BIOL, V62, P139, DOI 10.1007/BF00388176; Wirtz P, 1997, J ZOOL, V242, P799, DOI 10.1111/j.1469-7998.1997.tb05827.x	47	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192045	10.1371/journal.pone.0192045	http://dx.doi.org/10.1371/journal.pone.0192045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466373	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300025
J	Mayer, VE; Nepel, M; Blatrix, R; Oberhauser, FB; Fiedler, K; Schonenberger, J; Voglmayr, H				Mayer, Veronika E.; Nepel, Maximilian; Blatrix, Rumsais; Oberhauser, Felix B.; Fiedler, Konrad; Schoenenberger, Juerg; Voglmayr, Hermann			Transmission of fungal partners to incipient Cecropia-tree ant colonies	PLOS ONE			English	Article							BLACK FUNGI; AZTECA ANTS; HOST-PLANT; CHAETOTHYRIALES; AGRICULTURE; ASSOCIATION; HYMENOPTERA; FORMICIDAE; MUTUALISM; NITROGEN	Ascomycete fungi in the nests of ants inhabiting plants (= myrmecophytes) are very often cultivated by the ants in small patches and used as food source. Where these fungi come from is not known yet. Two scenarios of fungus recruitment are possible: (1) random infection through spores or hyphal fragments from the environment, or (2) transmission from mother to daughter colonies by the foundress queen. It is also not known at which stage of the colony life cycle fungiculture is initiated, and whether the-symbiont fungi serve as food for the ant queen. To clarify these questions, we investigated four Azteca ant species inhabiting three different Cecropia species (C. insignis, C. obtusifolia, and C. peltata). We analysed an rRNA gene fragment from 52 fungal patches produced by founding queens and compared them with those from established Azteca colonies (n = 54). The infrabuccal pockets of winged queens were dissected to investigate whether young queens carry fungi from their mother colony. Additionally, N-15 labelling experiments were done to verify whether the queen feeds on the patches until she is nourished by her first worker offspring. We infer from the results that the fungi cultivated in hollow plant structures are transferred from the parental colony of the young queen. First, fungal genotypes/OTU diversity was not significantly different between foundress queen patches and established colonies, and second, hyphal parts were discovered in the infrabuccal pockets of female alates. We could show that fungiculture already starts before queens lay their eggs, and that the queens do not feed on fungal patch material but feed it to the larvae. Our findings suggest that fungiculture may be crucial for successful colony founding of arboreal ants in the tropics.	[Mayer, Veronika E.; Nepel, Maximilian; Fiedler, Konrad; Schoenenberger, Juerg; Voglmayr, Hermann] Univ Vienna, Dept Bot & Biodivers Res, Rennweg 14, Vienna, Austria; [Nepel, Maximilian] Univ Vienna, Dept Microbiol & Ecosyst Sci, Althanstr 14, Vienna, Austria; [Blatrix, Rumsais] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, Paris, France; [Oberhauser, Felix B.] Univ Regensburg, Dept Zool, Univ Str 31, Regensburg, Germany	University of Vienna; University of Vienna; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Regensburg	Mayer, VE (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Rennweg 14, Vienna, Austria.	veronika.mayer@univie.ac.at	Voglmayr, Hermann/B-1484-2013; Fiedler, Konrad/H-8788-2019; Schönenberger, Jürg/D-3413-2014; Schönenberger, Jürg/AAE-6479-2020	Voglmayr, Hermann/0000-0001-7666-993X; Fiedler, Konrad/0000-0002-4789-3753; Schönenberger, Jürg/0000-0001-6791-2731; Schönenberger, Jürg/0000-0001-6791-2731; Nepel, Maximilian/0000-0001-7049-0613; Blatrix, Rumsais/0000-0003-1662-7791; Mayer, Veronika E./0000-0001-6662-8237; Oberhauser, Felix Benjamin/0000-0002-9278-2497	Verein zur Forderung der Tropenstation La Gam ba; Faculty of Life Sciences	Verein zur Forderung der Tropenstation La Gam ba; Faculty of Life Sciences	The study was supported by the Verein zur Forderung der Tropenstation La Gam ba (to M.N.) and by the Faculty of Life Sciences.	Arenas A, 2016, J EXP BIOL, V219, P2490, DOI 10.1242/jeb.139568; Badali H, 2008, STUD MYCOL, P175, DOI 10.3114/sim.2008.61.18; Bailey IW, 1924, BOT GAZ, V77, P32, DOI 10.1086/333279; Bischof S, 2013, PLANT CELL, V25, P1400, DOI 10.1105/tpc.113.109793; Blatrix R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068101; Blatrix R, 2012, P ROY SOC B-BIOL SCI, V279, P3940, DOI 10.1098/rspb.2012.1403; Chomnunti P, 2012, FUNGAL DIVERS, V56, P63, DOI 10.1007/s13225-012-0197-2; Cook D, 2013, J AGR FOOD CHEM, V61, P3797, DOI 10.1021/jf4008423; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; De Hoog GS, 2000, MED MYCOL, V38, P243, DOI 10.1080/mmy.38.s1.243.250; Defossez E, 2011, P ROY SOC B-BIOL SCI, V278, P1419, DOI 10.1098/rspb.2010.1884; Defossez E, 2009, NEW PHYTOL, V182, P942, DOI 10.1111/j.1469-8137.2009.02793.x; Dejean A, 2005, NATURE, V434, P973, DOI 10.1038/434973a; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esquivel A, 2012, NEMATROPICA, V42, P163; Fernandez-Marin H, 2006, P ROY SOC B-BIOL SCI, V273, P1689, DOI 10.1098/rspb.2006.3492; FIALA B, 1990, INSECT SOC, V37, P212, DOI 10.1007/BF02224049; Gegenbauer C, 2012, ANN BOT-LONDON, V110, P757, DOI 10.1093/aob/mcs140; Gutierrez-Valencia J, 2017, MOL PHYLOGENET EVOL, V111, P196, DOI 10.1016/j.ympev.2017.04.009; HALL T., 2013, BIOEDIT VERSION 7 2; Hammer O., PAST PALEONTOLOGICAL; Hata H, 2006, BIOL LETT-UK, V2, P593, DOI 10.1098/rsbl.2006.0528; Holldobler B., 1990, pi; Ihering H., 1907, ENGLERS BOT JB, V39, P666; Ihering H. Von, 1898, Zoologischer Anzeiger, P238; JANZEN DH, 1969, ECOLOGY, V50, P147, DOI 10.2307/1934677; JANZEN DH, 1972, ECOLOGY, V53, P885, DOI 10.2307/1934304; KELLER L, 1989, OECOLOGIA, V80, P236, DOI 10.1007/BF00380157; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kokolo B, 2016, SYMBIOSIS, V69, P169, DOI 10.1007/s13199-016-0402-2; Kuhn KM, 2014, INSECT SOC, V61, P239, DOI 10.1007/s00040-014-0348-4; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Longino J, 2007, ANTS COSTA RICA; LONGINO JT, 1989, BIOTROPICA, V21, P126, DOI 10.2307/2388703; LONGINO JT, 1991, ANT - PLANT INTERACTIONS, P271; Marti HE, 2015, INSECT SOC, V62, P357, DOI 10.1007/s00040-015-0413-7; Mayer VE, 2017, INSECT SOC, P1; Mayer VE, 2009, P ROY SOC B-BIOL SCI, V276, P3265, DOI 10.1098/rspb.2009.0768; Moog J, 2005, INSECT SOC, V52, P169, DOI 10.1007/s00040-005-0791-3; Moog J., 2009, ASS PANT ANT CLADOMY; Morath Shannon U., 2012, Fungal Biology Reviews, V26, P73, DOI 10.1016/j.fbr.2012.07.001; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Muller F., 1876, JENAISCHE Z MED NATU, V10, P281; Nepel M, 2016, FUNGAL ECOL, V23, P131, DOI 10.1016/j.funeco.2016.07.007; Nepel M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112756; Nishi AH, 2008, SOCIOBIOLOGY, V52, P367; Valverde JP, 2011, SYMBIOSIS, V55, P47, DOI 10.1007/s13199-011-0146-y; Pauli JN, 2014, P R SOC LOND B, V281; Pearson HHW., 1902, BOT J LINN SOC, V35, P375, DOI [10.1111/j.1095-8339.1902.tb00599.x, DOI 10.1111/J.1095-8339.1902.TB00599.X]; Ponnudurai R, 2017, ISME J, V11, P463, DOI 10.1038/ismej.2016.124; QUINLAN RJ, 1978, INSECT SOC, V25, P237, DOI 10.1007/BF02224744; Reblova M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163396; Ruiz-Gonzalez MX, 2011, BIOL LETTERS, V7, P475, DOI 10.1098/rsbl.2010.0920; Sagers CL, 2000, OECOLOGIA, V123, P582, DOI 10.1007/PL00008863; Sanchez A, 2016, INSECT SOC, V63, P155, DOI 10.1007/s00040-015-0450-2; Schlick-Steiner BC, 2008, P NATL ACAD SCI USA, V105, P940, DOI 10.1073/pnas.0708320105; Schremmer F., 1984, ZOOLO JB ABT SYST GE, V3, P385; SCHUPP EW, 1986, OECOLOGIA, V70, P379, DOI 10.1007/BF00379500; Selbmann L, 2015, CURR GENET, V61, P335, DOI 10.1007/s00294-014-0457-7; Silliman BR, 2003, P NATL ACAD SCI USA, V100, P15643, DOI 10.1073/pnas.2535227100; Thurber AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026243; Vasse M., 2017, P R SOC LOND B, V284; Voglmayr H, 2011, FUNGAL BIOL-UK, V115, P1077, DOI 10.1016/j.funbio.2010.11.006; Wheeler DE, 1996, INSECT SOC, V43, P297, DOI 10.1007/BF01242930; Wheeler W.M., 1920, T AM PHIL SOC, V22, P235; Wheeler WM, 1942, B MUS COMP ZOOL HARV, V90, P1; Wiernasz DC, 2003, EVOLUTION, V57, P2179, DOI 10.1111/j.0014-3820.2003.tb00396.x; Yumoto T, 1999, ECOL RES, V14, P393, DOI 10.1046/j.1440-1703.1999.00307.x; Zupancic J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148166	69	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192207	10.1371/journal.pone.0192207	http://dx.doi.org/10.1371/journal.pone.0192207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466381	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300038
J	Munoz-Alia, MA; Muller, CP; Russell, SJ				Munoz-Alia, Miguel Angel; Muller, Claude P.; Russell, Stephen J.			Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses	PLOS ONE			English	Article							PERSISTENT MEASLES VIRUSES; EPITHELIAL-CELL RECEPTOR; CANINE-DISTEMPER VIRUS; ANTIBODIES; FUSION; SSPE; CD46; INFECTION; EPITOPES; IMMUNE	Subacute sclerosing panencephalitis (SSPE) is a progressive, lethal complication of measles caused by particular mutants of measles virus (MeV) that persist in the brain despite high levels of neutralizing antibodies. We addressed the hypothesis that antigenic drift is involved in the pathogenetic mechanism of SSPE by analyzing antigenic alterations in the MeV envelope hemagglutinin protein (MeV-H) found in patients with SSPE in relation to major circulating MeV genotypes. To this aim, we obtained cDNA for the MeV-H gene from tissue taken at brain autopsy from 3 deceased persons with SSPE who had short (3 +/- 4 months, SMa79), average (3.5 years, SMa84), and long (18 years, SMa94) disease courses. Recombinant MeVs with a substituted MeV-H gene were generated by a reverse genetic system. Virus neutralization assays with a panel of anti-MeV-H murine monoclonal antibodies (mAbs) or vaccine-immunized mouse anti-MeV-H polyclonal sera were performed to determine the antigenic relatedness. Functional and receptor-binding analysis of the SSPE MeV-H showed activity in a SLAM/nectin-4 +/- dependent manner. Similar to our panel of wild-type viruses, our SSPE viruses showed an altered antigenic profile. Genotypes A, G3, and F (SSPE case SMa79) were the exception, with an intact antigenic structure. Genotypes D7 and F (SSPE SMa79) showed enhanced neutralization by mAbs targeting antigenic site IIa. Genotypes H1 and the recently reported D4.2 were the most antigenically altered genotypes. Epitope mapping of neutralizing mAbs BH015 and BH130 reveal a new antigenic site on MeV-H, which we designated F for its intermediate position between previously defined antigenic sites Ia and Ib. We conclude that SSPE-causing viruses show similar antigenic properties to currently circulating MeV genotypes. The absence of a direct correlation between antigenic changes and predisposition of a certain genotype to cause SSPE does not lend support to the proposed antigenic drift as a pathogenetic mechanism in SSPE.	[Munoz-Alia, Miguel Angel; Russell, Stephen J.] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Muller, Claude P.] Luxembourg Inst Hlth, Dept Infect & Immun, Esch Sur Alzette, Luxembourg; [Muller, Claude P.] Lab Natl Sante, Dudelange, Luxembourg; [Russell, Stephen J.] Mayo Clin, Div Hematol, Rochester, MN USA	Mayo Clinic; Luxembourg Institute of Health; Mayo Clinic	Munoz-Alia, MA (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	alia.miguel@mayo.edu	Muñoz-Alía, Miguel Angel/W-1774-2019	Muñoz-Alía, Miguel Angel/0000-0002-6217-9451; Russell, Stephen/0000-0002-0799-6432	Mayo Clinic; NCI Cancer Center [5P30 CA15083-43C1]	Mayo Clinic; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by Al and Mary Agnes McQuinn and Mayo Clinic. Mayo Clinic Medical Genome Facility-Proteomics Core is supported by the NCI Cancer Center Support Grant 5P30 CA15083-43C1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Munoz-Alia MA, 2017, VIRUS RES, V236, P30, DOI 10.1016/j.virusres.2017.04.018; Munoz-Alia MA, 2015, VIRUS RES, V196, P122, DOI 10.1016/j.virusres.2014.11.015; BACZKO K, 1993, VIROLOGY, V197, P188, DOI 10.1006/viro.1993.1579; Bode CA, 2009, ORG BIOMOL CHEM, V7, P3391, DOI 10.1039/b907395g; Breton CA, 2015, MOL THER-ONCOLYTICS, V2, DOI 10.1038/mto.2015.12; Carabana Escudero J., 1998, THESIS; CARTER MJ, 1983, PROG BRAIN RES, V59, P163; CATTANEO R, 1989, VIROLOGY, V173, P415, DOI 10.1016/0042-6822(89)90554-0; CATTANEO R, 1993, J VIROL, V67, P1493, DOI 10.1128/JVI.67.3.1493-1502.1993; Cernescu C, 1985, Virologie, V36, P155; Cernescu C, 1982, Virologie, V33, P189; de Witte L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000049; del Valle JR, 2007, J VIROL, V81, P10597, DOI 10.1128/JVI.00923-07; Delpeut S., 2017, J VIROL, V91; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; El Mubarak HS, 2007, J GEN VIROL, V88, P2028, DOI 10.1099/vir.0.82804-0; Ertl O.T., 2003, THESIS; Fernandez-Munoz R, 2011, NONFLAVIVIRUS ENCEPH; FERNANDEZMUNOZ R, 1992, J GEN VIROL, V73, P2195, DOI 10.1099/0022-1317-73-9-2195; Finsterbusch T, 2009, J GEN VIROL, V90, P2739, DOI 10.1099/vir.0.013524-0; Fournier P, 1997, J GEN VIROL, V78, P1295, DOI 10.1099/0022-1317-78-6-1295; Griffin D. E., 2013, FIELDS VIROLOGY, P1042; Griffin DE, 2012, FEMS MICROBIOL REV, V36, P649, DOI 10.1111/j.1574-6976.2012.00330.x; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hasegawa K, 2007, J VIROL, V81, P13149, DOI 10.1128/JVI.01415-07; HU AH, 1994, J GEN VIROL, V75, P1043, DOI 10.1099/0022-1317-75-5-1043; HU AZ, 1993, VIROLOGY, V192, P351, DOI 10.1006/viro.1993.1042; Ishida H, 2004, MICROBIOL IMMUNOL, V48, P277, DOI 10.1111/j.1348-0421.2004.tb03524.x; Jin L, 2002, J NEUROVIROL, V8, P335, DOI 10.1080/13550280290100752; Kimura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11648; KOBUNE F, 1990, J VIROL, V64, P700, DOI 10.1128/JVI.64.2.700-705.1990; Kweder H, 2014, ADV VIROL, V2014, DOI 10.1155/2014/205617; Laksono BM, 2016, VIRUSES, V28, P8; Lech PJ, 2014, VIROLOGY, V454, P237, DOI 10.1016/j.virol.2014.01.027; Lech PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052306; Leonard VHJ, 2008, J CLIN INVEST, V118, P2448, DOI 10.1172/JCI35454; Liu YP, 2014, J VIROL, V88, P2195, DOI 10.1128/JVI.02628-13; Ludlow M, 2013, J GEN VIROL, V94, P1933, DOI 10.1099/vir.0.054650-0; Masse N, 2004, J VIROL, V78, P9051, DOI 10.1128/JVI.78.17.9051-9063.2004; Mateo M, 2014, J VIROL, V88, P14161, DOI 10.1128/JVI.02379-14; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; Moraga Llop F, 2008, CLINICA DIAGNOSTICO, P63; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Munoz-Alfa MA, 2017, J VIROL, V91, DOI 10.1128/JVI.00209-17; Munoz-Alia MA, 2009, 10 SPAN NAT C VIR SA; Munoz-Alia MA, 2013, 15 INT C NEG STRAND; Nakamura T, 2004, NAT BIOTECHNOL, V22, P331, DOI 10.1038/nbt942; Nakashima M, 2013, J BIOL CHEM, V288, P8085, DOI 10.1074/jbc.M112.427609; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Navaratnarajah CK, 2008, J BIOL CHEM, V283, P11763, DOI 10.1074/jbc.M800896200; Navaratnarajah CK, 2016, J VIROL, V90, P68, DOI 10.1128/JVI.02253-15; Ndifon W, 2009, P NATL ACAD SCI USA, V106, P8701, DOI 10.1073/pnas.0903427106; Nicasio M, 2012, VIRUSES-BASEL, V4, P1731, DOI 10.3390/v4091731; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Parks CL, 1999, J VIROL, V73, P3560, DOI 10.1128/JVI.73.5.3560-3566.1999; PAYNE FE, 1973, J INFECT DIS, V127, P505, DOI 10.1093/infdis/127.5.505; Pratakpiriya W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00375-6; Pratakpiriya W, 2012, J VIROL, V86, P10207, DOI 10.1128/JVI.00824-12; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Rima BK, 1997, J GEN VIROL, V78, P97, DOI 10.1099/0022-1317-78-1-97; RIMA BK, 1995, J GEN VIROL, V76, P1173, DOI 10.1099/0022-1317-76-5-1173; ROTA JS, 1992, VIROLOGY, V188, P135, DOI 10.1016/0042-6822(92)90742-8; Rota PA, 2009, CURR TOP MICROBIOL, V330, P129; Santibanez S, 2005, J GEN VIROL, V86, P365, DOI 10.1099/vir.0.80467-0; Seki F, 2011, J VIROL, V85, P11871, DOI 10.1128/JVI.05067-11; Shingai M, 2003, J GEN VIROL, V84, P2133, DOI 10.1099/vir.0.19091-0; Shirogane Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2252; Tahara M, 2013, J VIROL, V87, P666, DOI 10.1128/JVI.02033-12; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Toth AM, 2009, J VIROL, V83, P961, DOI 10.1128/JVI.01669-08; TOURTELLOTTE WW, 1968, NEUROLOGY, V18, P117, DOI 10.1212/WNL.18.1_Part_2.117; Verrier F, 2001, J VIROL, V75, P9177, DOI 10.1128/JVI.75.19.9177-9186.2001; von Messling V, 2001, J VIROL, V75, P6418, DOI 10.1128/JVI.75.14.6418-6427.2001; Wendorf K, 2016, OPEN FORUM INFECT DI, V3, P916; Woelk CH, 2002, J GEN VIROL, V83, P1419, DOI 10.1099/0022-1317-83-6-1419; Woelk CH, 2001, J GEN VIROL, V82, P2463, DOI 10.1099/0022-1317-82-10-2463; Young VA, 2009, CURR TOP MICROBIOL, V330, P3; Zhang P, 2007, P NATL ACAD SCI USA, V104, P8449, DOI 10.1073/pnas.0703039104; Zhong L, 2009, BIOCHEM BIOPH RES CO, V390, P1056, DOI 10.1016/j.bbrc.2009.10.115; Ziegler D, 1996, J GEN VIROL, V77, P2479, DOI 10.1099/0022-1317-77-10-2479	81	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192245	10.1371/journal.pone.0192245	http://dx.doi.org/10.1371/journal.pone.0192245			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466428	Green Submitted, gold, Green Published			2022-12-26	WOS:000425604300041
J	Tchernookova, BK; Heer, C; Young, M; Swygart, D; Kaufman, R; Gongwer, M; Shepherd, L; Caringal, H; Jacoby, J; Kreitzer, MA; Malchow, RP				Tchernookova, Boriana K.; Heer, Chad; Young, Marin; Swygart, David; Kaufman, Ryan; Gongwer, Michael; Shepherd, Lexi; Caringal, Hannah; Jacoby, Jason; Kreitzer, Matthew A.; Malchow, Robert Paul			Activation of retinal glial (Muller) cells by extracellular ATP induces pronounced increases in extracellular H plus flux	PLOS ONE			English	Article							SODIUM-BICARBONATE COTRANSPORT; HORIZONTAL CELLS; MODULATION; FEEDBACK; PHOTORECEPTORS; INHIBITION; PROTONS; TRANSMISSION; ORGANIZATION; ASTROCYTES	Small alterations in extracellular acidity are potentially important modulators of neuronal signaling within the vertebrate retina. Here we report a novel extracellular acidification mechanism mediated by glial cells in the retina. Using self-referencing H+-selective micro-electrodes to measure extracellular H+ fluxes, we show that activation of retinal Mu Euller (glial) cells of the tiger salamander by micromolar concentrations of extracellular ATP induces a pronounced extracellular H+ flux independent of bicarbonate transport. ADP, UTP and the non-hydrolyzable analog ATP gamma s at micromolar concentrations were also potent stimulators of extracellular H+ fluxes, but adenosine was not. The extracellular H+ fluxes induced by ATP were mimicked by the P2Y1 agonist MRS 2365 and were significantly reduced by the P2 receptor blockers suramin and PPADS, suggesting activation of P2Y receptors. Bath-applied ATP induced an intracellular rise in calcium in Mu Euller cells; both the calcium rise and the extracellular H+ fluxes were significantly attenuated when calcium re-loading into the endoplasmic reticulum was inhibited by thapsigargin and when the PLC-IP3 signaling pathway was disrupted with 2-APB and U73122. The anion transport inhibitor DIDS also markedly reduced the ATP-induced increase in H+ flux while SITS had no effect. ATP-induced H+ fluxes were also observed from Mu Euller cells isolated from human, rat, monkey, skate and lamprey retinae, suggesting a highly evolutionarily conserved mechanism of potential general importance. Extracellular ATP also induced significant increases in extracellular H+ flux at the level of both the outer and inner plexiform layers in retinal slices of tiger salamander which was significantly reduced by suramin and PPADS. We suggest that the novel H+ flux mediated by ATP-activation of Mu Euller cells and of other glia as well may be a key mechanism modulating neuronal signaling in the vertebrate retina and throughout the brain.	[Tchernookova, Boriana K.; Jacoby, Jason; Malchow, Robert Paul] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Heer, Chad; Young, Marin; Swygart, David; Kaufman, Ryan; Gongwer, Michael; Shepherd, Lexi; Caringal, Hannah; Kreitzer, Matthew A.] Indiana Wesleyan Univ, Dept Biol, Marion, IN USA; [Malchow, Robert Paul] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tchernookova, BK; Malchow, RP (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.; Malchow, RP (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL USA.	btcher2@uic.edu; paulmalc@uic.edu		Kreitzer, Matthew/0000-0002-2836-8590	National Science Foundation [0924372, 0924383, 1359230, 1557820, 1557725]; Sigma Xi; Scientific Research Society; Laura and Arthur Colwin Summer Fellowship from the Marine Biological Laboratory; LAS Award for Faculty in the Natural Sciences from the University of Illinois at Chicago; Division Of Integrative Organismal Systems [1557725] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Sigma Xi; Scientific Research Society; Laura and Arthur Colwin Summer Fellowship from the Marine Biological Laboratory; LAS Award for Faculty in the Natural Sciences from the University of Illinois at Chicago; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants 0924372, 0924383, 1359230,1557820, and 1557725, a Grants in Aid Award from Sigma Xi, the Scientific Research Society, a Laura and Arthur Colwin Summer Fellowship from the Marine Biological Laboratory, a gift from the estate of Mr. John C. Hangensick, and an LAS Award for Faculty in the Natural Sciences from the University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Science Foundation Grants 0924372, 0924383, 1359230, 1557820, and 1557725, a Grants in Aid Award from Sigma Xi, the Scientific Research Society, a Laura and Arthur Colwin Summer Fellowship from the Marine Biological Laboratory, an LAS Award for Faculty in the Natural Sciences from the University of Illinois at Chicago, and a gift from the estate of Mr. John C. Hagensick. We thank Ms. Hannah Parsons of Indiana Wesleyan University for help collecting data, Mr. Russell English of the University of California at Berkeley for help with formatting of the manuscript, and Ms. Katherine Sheetz for help proof-reading the manuscript.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; BARNES S, 1993, P NATL ACAD SCI USA, V90, P10081, DOI 10.1073/pnas.90.21.10081; BARNES S, 1991, J NEUROSCI, V11, P4015; Bazargani N, 2016, NAT NEUROSCI, V19, P182, DOI 10.1038/nn.4201; Breton S, 1998, AM J PHYSIOL-CELL PH, V275, pC1134, DOI 10.1152/ajpcell.1998.275.4.C1134; Burnstock G, 2012, PURINERGIC SIGNALING, DOI 10.1007/978-3-642-28863-0; Cadetti L, 2006, J NEUROPHYSIOL, V95, P1992, DOI 10.1152/jn.01042.2005; CEVC G, 1990, BIOCHIM BIOPHYS ACTA, V1031, P311, DOI 10.1016/0304-4157(90)90015-5; Dallerac G, 2016, PROG NEUROBIOL, V144, P48, DOI 10.1016/j.pneurobio.2016.01.003; del Puerto A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00197; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Grewer C, 2005, J MEMBRANE BIOL, V203, P1, DOI 10.1007/s00232-004-0731-6; Harada K, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00499; Hirasawa H, 2003, J GEN PHYSIOL, V122, P657, DOI 10.1085/jgp.200308863; Hirasawa H, 2012, J PHYSIOL SCI, V62, P359, DOI 10.1007/s12576-012-0220-0; Jacoby J, 2014, J NEUROPHYSIOL, V111, P1056, DOI 10.1152/jn.00768.2013; Jacoby J, 2012, J NEUROPHYSIOL, V107, P868, DOI 10.1152/jn.00878.2011; Keirstead SA, 1997, GLIA, V21, P194, DOI 10.1002/(SICI)1098-1136(199710)21:2<194::AID-GLIA3>3.3.CO;2-7; KLEINSCHMIDT J, 1991, ANN NY ACAD SCI, V635, P468, DOI 10.1111/j.1749-6632.1991.tb36529.x; Kramer RH, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002322; Kreitzer MA, 2007, J GEN PHYSIOL, V130, P169, DOI 10.1085/jgp.200709737; Kreitzer MA, 2017, J NEUROPHYSIOL, V118, P3132, DOI 10.1152/jn.00409.2017; Kreitzer MA, 2012, EUR J NEUROSCI, V36, P3040, DOI 10.1111/j.1460-9568.2012.08226.x; KUHTREIBER WM, 1990, J CELL BIOL, V110, P1565, DOI 10.1083/jcb.110.5.1565; Mamedova LK, 2004, BIOCHEM PHARMACOL, V67, P1763, DOI 10.1016/j.bcp.2004.01.011; MCLAUGHLIN S, 1981, J GEN PHYSIOL, V77, P445, DOI 10.1085/jgp.77.4.445; MCLAUGHLIN SG, 1971, J GEN PHYSIOL, V58, P667, DOI 10.1085/jgp.58.6.667; Molina AJA, 2004, J PHYSIOL-LONDON, V560, P639, DOI 10.1113/jphysiol.2004.065425; Newman EA, 1999, GLIA, V26, P302, DOI 10.1002/(SICI)1098-1136(199906)26:4<302::AID-GLIA4>3.0.CO;2-A; Newman EA, 2004, GLIA, V47, P268, DOI 10.1002/glia.20030; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; NEWMAN EA, 1984, NATURE, V309, P155, DOI 10.1038/309155a0; NEWMAN EA, 1991, J NEUROSCI, V11, P3972; Newman EA, 1996, J NEUROSCI, V16, P159; Newman EA, 1998, J NEUROSCI, V18, P4022; Newman EA, 2004, NEURON GLIA BIOL, V1, P245, DOI 10.1017/S1740925X0500013X; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Petrelli F, 2016, CURR OPIN PHARMACOL, V26, P138, DOI 10.1016/j.coph.2015.11.010; SAKAI HM, 1986, J COMP NEUROL, V245, P107, DOI 10.1002/cne.902450108; Smith PJS, 1999, MICROSC RES TECHNIQ, V46, P398, DOI 10.1002/(SICI)1097-0029(19990915)46:6<398::AID-JEMT8>3.0.CO;2-H; Smith PJS, 2001, AM J PHYSIOL-CELL PH, V280, pC1, DOI 10.1152/ajpcell.2001.280.1.C1; Somieski P, 2001, PFLUG ARCH EUR J PHY, V442, P142, DOI 10.1007/s004240000505; Thoreson WB, 2008, J NEUROSCI, V28, P5691, DOI 10.1523/JNEUROSCI.0403-08.2008; Thoreson WB, 2012, PROG RETIN EYE RES, V31, P407, DOI 10.1016/j.preteyeres.2012.04.003; Van Hook MJ, 2013, JOVE-J VIS EXP, P1; Vessey JP, 2005, J NEUROSCI, V25, P4108, DOI 10.1523/JNEUROSCI.5253-04.2005; Vroman R, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001864; Wang TM, 2014, NAT NEUROSCI, V17, P262, DOI 10.1038/nn.3627; Warren TJ, 2016, J NEUROSCI, V36, P10075, DOI 10.1523/JNEUROSCI.1090-16.2016; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; ZHANG PP, 2016, SCI REP UK, V6	51	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0190893	10.1371/journal.pone.0190893	http://dx.doi.org/10.1371/journal.pone.0190893			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466379	Green Submitted, Green Published, gold			2022-12-26	WOS:000425604300004
J	Velez, G; Machlab, DA; Tang, PH; Sun, Y; Tsang, SH; Bassuk, AG; Mahajan, VB				Velez, Gabriel; Machlab, Daniel A.; Tang, Peter H.; Sun, Yang; Tsang, Stephen H.; Bassuk, Alexander G.; Mahajan, Vinit B.			Proteomic analysis of the human retina reveals region-specific susceptibilities to metabolic-and oxidative stress-related diseases	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; VASCULAR INJURY; GENE; MUTATION; CELL; PATHOPHYSIOLOGY; DEGENERATION; EXPRESSION; GLAUCOMA; EBSELEN	Differences in regional protein expression within the human retina may explain molecular predisposition of specific regions to ophthalmic diseases like age-related macular degeneration, cystoid macular edema, retinitis pigmentosa, and diabetic retinopathy. To quantify protein levels in the human retina and identify patterns of differentially-expressed proteins, we collected foveomacular, juxta-macular, and peripheral retina punch biopsies from healthy donor eyes and analyzed protein content by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Protein expression was analyzed with 1-way ANOVA, gene ontology, pathway representation, and network analysis. We identified a mean of 1,974 proteins in the foveomacular retina, 1,999 in the juxta-macular retina, and 1,779 in the peripheral retina. Six hundred ninety-seven differentially-expressed proteins included those unique to and abundant in each anatomic region. Proteins with higher expression in each region include: heat-shock protein 90-alpha (HSP90AA1), and pyruvate kinase (PKM) in the foveomacular retina; vimentin (VIM) and fructose-bisphosphate aldolase C (ALDOC); and guanine nucleotide-binding protein subunit beta-1 (GNB1) and guanine nucleotide-binding protein subunit alpha-1 (GNAT1) in the peripheral retina. Pathway analysis identified downstream mediators of the integrin signaling pathway to be highly represented in the foveomacular region (P = 6.48 e-06). Metabolic pathways were differentially expressed among all retinal regions. Gene ontology analysis showed that proteins related to antioxidant activity were higher in the juxta-macular and the peripheral retina, but present in lower amounts in the foveomacular retina. Our proteomic analysis suggests that certain retinal regions are susceptible to different forms of metabolic and oxidative stress. The findings give mechanistic insight into retina function, reveal important molecular processes, and prioritize new pathways for therapeutic targeting.	[Velez, Gabriel; Machlab, Daniel A.; Tang, Peter H.; Mahajan, Vinit B.] Stanford Univ, Om Lab, Palo Alto, CA 94304 USA; [Velez, Gabriel; Tang, Peter H.; Sun, Yang; Mahajan, Vinit B.] Stanford Univ, Byers Eye Inst, Dept Ophthalmol, Palo Alto, CA 94304 USA; [Velez, Gabriel] Univ Iowa, Med Scientist Training Program, Iowa City, IA USA; [Tang, Peter H.; Sun, Yang; Mahajan, Vinit B.] Palo Alto Vet Adm, Palo Alto, CA 94304 USA; [Tsang, Stephen H.] Columbia Univ, Jonas Childrens Vis Care, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, Bernard & Shirlee Brown Glaucoma Lab, Columbia Stem Cell Initiat,Inst Human Nutr, New York, NY 10027 USA; [Tsang, Stephen H.] Columbia Univ, Dept Pathol, Bernard & Shirlee Brown Glaucoma Lab, Columbia Stem Cell Initiat,Inst Human Nutr, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Dept Cell Biol, Bernard & Shirlee Brown Glaucoma Lab, Columbia Stem Cell Initiat,Inst Human Nutr, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY USA; [Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA	Stanford University; Stanford University; University of Iowa; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; University of Iowa	Mahajan, VB (corresponding author), Stanford Univ, Om Lab, Palo Alto, CA 94304 USA.; Mahajan, VB (corresponding author), Stanford Univ, Byers Eye Inst, Dept Ophthalmol, Palo Alto, CA 94304 USA.; Mahajan, VB (corresponding author), Palo Alto Vet Adm, Palo Alto, CA 94304 USA.	vinit.mahajan@stanford.edu		Bassuk, Alexander/0000-0002-4067-2157; Mahajan, Vinit/0000-0003-1886-1741; Velez, Gabriel/0000-0003-0819-5933	NIH [R01EY026682, R01EY024665, R01EY025225, R01EY024698, R21AG050437, F30EYE027986, T32GM007337, K08-EY022058, R01-EY025295]; Doris Duke Charitable Foundation [2013103]; Research to Prevent Blindness; National Institutes of Health [R01EY024698, R21AG050437, 5P30EY019007, R01EY018213]; National Cancer Institute Core [5P30CA013696]; Research to Prevent Blindness (RPB) Physician-Scientist Award, unrestricted funds from RPB, New York, NY, USA; Tistou and Charlotte Kerstan Foundation, New York State [C029572]; Foundation Fighting Blindness New York Regional Research Center Grant [C-NY05-0705-0312]; Joel Hoffman Fund; Professor Gertrude Rothschild Stem Cell Foundation; Gebroe Family Foundation; VA merit [CX001298]; Ziegler Foundation for the Blind; Lowe syndrome association; Alcon Research Institute; NATIONAL EYE INSTITUTE [R01EY025295, K08EY022058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; Veterans Affairs [I01CX001481] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Research to Prevent Blindness (RPB) Physician-Scientist Award, unrestricted funds from RPB, New York, NY, USA; Tistou and Charlotte Kerstan Foundation, New York State; Foundation Fighting Blindness New York Regional Research Center Grant; Joel Hoffman Fund; Professor Gertrude Rothschild Stem Cell Foundation; Gebroe Family Foundation; VA merit(US Department of Veterans Affairs); Ziegler Foundation for the Blind; Lowe syndrome association; Alcon Research Institute(Novartis); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	VBM and AGB are supported by NIH grants [R01EY026682, R01EY024665, R01EY025225, R01EY024698 and R21AG050437; https://www.nih.gov], The Doris Duke Charitable Foundation [grant# 2013103; http://www.ddcf.org], and Research to Prevent Blindness [https://www.rpbusa.org/rpb]. GV is supported by NIH [F30EYE027986 and T32GM007337; https://www.nih.gov]. The Barbara & Donald Jonas Laboratory of Regenerative Medicine and Bernard & Shirlee Brown Glaucoma Laboratory are supported by the National Institutes of Health [5P30EY019007, R01EY018213, R01EY024698, R21AG050437; https://www.nih.gov], National Cancer Institute Core [5P30CA013696], the Research to Prevent Blindness (RPB) Physician-Scientist Award, unrestricted funds from RPB [https://www.rpbusa.org], New York, NY, USA. SHT is a member of the RD-CURE Consortium and is supported by the Tistou and Charlotte Kerstan Foundation [http://www.kerstanstiftung.org], New York State [C029572], the Foundation Fighting Blindness New York Regional Research Center Grant [C-NY05-0705-0312; http://www.blindness.org], the Joel Hoffman Fund, the Professor Gertrude Rothschild Stem Cell Foundation, and the Gebroe Family Foundation. YS is supported by NIH grant [K08-EY022058, R01-EY025295; https://www.nih.gov], VA merit CX001298 [https://www.va.gov], Ziegler Foundation for the Blind [http://emzfoundation.com], Lowe syndrome association [http://lowesyndrome.org], and Alcon Research Institute [www.myalcon.com/research-development/alcon-research-institute/].; VBM and AGB are supported by NIH grants [R01EY026682, R01EY024665, R01EY025225, R01EY024698, R21AG050437], The Doris Duke Charitable Foundation Grant #2013103, and Research to Prevent Blindness (RPB), New York, NY. GV is supported by NIH grants [F30EYE027986 and T32GM007337]. The Barbara & Donald Jonas Laboratory of Regenerative Medicine and Bernard & Shirlee Brown Glaucoma Laboratory are supported by the National Institute of Health [5P30EY019007, R01EY018213, R01EY024698, R21AG050437], National Cancer Institute Core [5P30CA013696], the Research to Prevent Blindness (RPB) Physician-Scientist Award, unrestricted funds from RPB, New York, NY, USA. SHT is a member of the RD-CURE Consortium and is supported by the Tistou and Charlotte Kerstan Foundation, the Schneeweiss Stem Cell Fund, New York State [C029572], the Foundation Fighting Blindness New York Regional Research Center Grant [C-NY05-0705-0312], the Joel Hoffman Fund, the Professor Gertrude Rothschild Stem Cell Foundation, and the Gebroe Family Foundation. YS is supported by NIH grants [K08EY022058 and R01EY025295] and the U.S. Department of Veterans Affairs Grant CX001298.	Bareil C, 2001, HUM GENET, V108, P328, DOI 10.1007/s004390100496; Bjornson RD, 2008, J PROTEOME RES, V7, P293, DOI 10.1021/pr0701198; Coppey LJ, 2001, BRIT J PHARMACOL, V134, P21, DOI 10.1038/sj.bjp.0704216; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; Duh EJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93751; Duncan JL, 2011, INVEST OPHTH VIS SCI, V52, P9614, DOI 10.1167/iovs.11-8600; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Gabryel B, 2006, PHARMACOL REP, V58, P381; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Giordano CR, 2015, INVEST OPHTH VIS SCI, V56, P3095, DOI 10.1167/iovs.14-16194; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730; HAYDEN DW, 1992, J VET DIAGN INVEST, V4, P209, DOI 10.1177/104063879200400222; Hipp S, 2015, ACTA OPHTHALMOL, V93, pE281, DOI 10.1111/aos.12573; Hoang QQ, 2014, P NATL ACAD SCI USA, V111, P2402, DOI 10.1073/pnas.1324284111; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Jung CW, 2001, NEUROSCI LETT, V304, P157, DOI 10.1016/S0304-3940(01)01784-0; Kang DH, 2013, CIRCULATION, V128, P834, DOI 10.1161/CIRCULATIONAHA.113.001725; La Spada AR, 2011, NEUROBIOLOGY HUNTING; Li MY, 2014, HUM MOL GENET, V23, P4001, DOI 10.1093/hmg/ddu114; Liebmann JM, 2017, NEW ENGL J MED, V376, P2079, DOI 10.1056/NEJMcibr1702486; Lin JB, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.3; Lu L, 2006, J CELL PHYSIOL, V206, P119, DOI 10.1002/jcp.20439; Mahajan VB, 2014, PROTEOM CLIN APPL, V8, P204, DOI 10.1002/prca.201300062; Malukiewicz-Wisniewska Grazyna, 2005, Klin Oczna, V107, P70; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; McFadden SL, 2003, TOXICOL APPL PHARM, V186, P46, DOI 10.1016/S0041-008X(02)00017-0; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Morimura H, 1999, NAT GENET, V23, P393, DOI 10.1038/70496; Nita Malgorzata, 2016, Oxid Med Cell Longev, V2016, P3164734, DOI 10.1155/2016/3164734; Punzo C, 2012, J BIOL CHEM, V287, P1642, DOI 10.1074/jbc.R111.304428; Rong YQ, 1999, P NATL ACAD SCI USA, V96, P9897, DOI 10.1073/pnas.96.17.9897; Skeie JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127567; Skeie JM, 2014, JAMA OPHTHALMOL, V132, P1271, DOI 10.1001/jamaophthalmol.2014.2065; Skeie JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082140; Sorrentino FS, 2016, EYE, V30, P1542, DOI 10.1038/eye.2016.197; Sun LL, 2013, RAPID COMMUN MASS SP, V27, P157, DOI 10.1002/rcm.6437; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tan SM, 2015, EXP EYE RES, V136, P1, DOI 10.1016/j.exer.2015.04.015; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; Tokarz P, 2013, BIOGERONTOLOGY, V14, P461, DOI 10.1007/s10522-013-9463-2; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsai CY, 2017, EYE LOND; Velez G, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.97818; Velez Gabriel, 2017, Am J Ophthalmol Case Rep, V5, P107, DOI 10.1016/j.ajoc.2016.12.023; Velez G, 2016, JAMA OPHTHALMOL, V134, P444, DOI 10.1001/jamaophthalmol.2015.5934; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wang R, 2012, NAT BIOTECHNOL, V30, P135, DOI 10.1038/nbt.2112; Williams PA, 2017, SCIENCE, V355, P756, DOI 10.1126/science.aal0092; Wolfensberger TJ, 2017, DEV OPHTHALMOL, V58, P74, DOI 10.1159/000455275; Xu JY, 2014, BBA-MOL BASIS DIS, V1842, P2106, DOI 10.1016/j.bbadis.2014.07.008; Yen CY, 2009, MOL CELL PROTEOMICS, V8, P857, DOI 10.1074/mcp.M800384-MCP200; Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680; Zhang PB, 2015, PROTEOMICS, V15, P836, DOI 10.1002/pmic.201400397	57	26	27	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193250	10.1371/journal.pone.0193250	http://dx.doi.org/10.1371/journal.pone.0193250			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466423	gold, Green Published, Green Submitted			2022-12-26	WOS:000425604300103
J	Zhang, WQ; Li, Z; Fang, H; Zhang, MC; Duan, LS				Zhang, Weiqiang; Li, Zhi; Fang, Hui; Zhang, Mingcai; Duan, Liusheng			Analysis of the genetic basis of plant height-related traits in response to ethylene by QTL mapping in maize (Zea mays L.)	PLOS ONE			English	Article							UP RNA GENE; GROWTH-REGULATORS; INTERNODE ELONGATION; MOLECULAR MARKERS; INBRED LINES; GRAIN-YIELD; EAR HEIGHT; MAJOR QTL; GIBBERELLIN; RICE	Ethylene (ET) is critical importance in the growth, development, and stress responses of plants. Plant hormonal stress responses have been extensively studied, however, the role of ET in plant growth, especially plant height (PH) remains unclear. Understanding the genetic control for PH in response to ET will provide insights into the regulation of maize development. To clarify the genetic basis of PH-related traits of maize in response to ET, we mapped QTLs for PH, ear height (EH), and internode length above the uppermost ear (ILAU) in two recombinant inbred line (RIL) populations of Zea mays after ET treatment and in an untreated control (CK) group. Sixty QTLs for the three traits were identified. Twenty-two QTLs were simultaneously detected under both ET treatment and untreated control, and five QTLs were detected at two geographic locations under ET treatment only. Individual QTL can be explained 3.87-17.71% of the phenotypic variance. One QTL (q2PH9-1, q1PH9, q1EH9/q1ILAU9-1, q2ILAU9, and q2EH9) for the measured traits (PH, EH, ILAU) was consistent across both populations. Two QTLs (q2PH2-5, q2ILAU2-2, q1PH2-2, and q1ILAU2-2; q1PH8-1, q1EH8-1, q2PH8-1) were identified for up to two traits in both locations and populations under both ET treatment and untreated control. These consistent and stable regions are important QTLs of potential hot spots for PH, ear height (EH), and internode length above the uppermost ear (ILAU) response to ET in maize; therefore, QTL fine-mapping and putative candidate genes validation should enable the cloning of PH, EH, and ILAU related genes to ET response. These results will be valuable for further fine-mapping and quantitative trait nucleotides (QTNs) determination, and elucidate the underlying molecular mechanisms of ET responses in maize.	[Zhang, Weiqiang; Zhang, Mingcai; Duan, Liusheng] China Agr Univ, Engn Res Ctr Plant Growth Regulator, State Key Lab Plant Physiol & Biochem, Minist Educ,Coll Agron & Biotechnol, Beijing, Peoples R China; [Li, Zhi; Fang, Hui] China Agr Univ, Coll Agron & Biotechnol, Natl Maize Improvement Ctr China, Beijing, Peoples R China	China Agricultural University; China Agricultural University	Duan, LS (corresponding author), China Agr Univ, Engn Res Ctr Plant Growth Regulator, State Key Lab Plant Physiol & Biochem, Minist Educ,Coll Agron & Biotechnol, Beijing, Peoples R China.	duanlsh@cau.edu.cn	zhang, weiqiang/U-7999-2017	zhang, weiqiang/0000-0003-3127-6205; Duan, Liusheng/0000-0003-0323-9378	China National Science Fund for Distinguished Young Scholars [31425017]	China National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by The China National Science Fund for Distinguished Young Scholars (Grant 31425017 to L.D.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by The China National Science Fund for Distinguished Young Scholars (Grant 31425017 to L.D.). The authors are grateful to Professor Xiaohong Yang, China Agricultural University, who developed the populations and contributed materials, and to Professor Yanhui Chen and Lixia Ku, Henan Agricultural University, for helpful advice and critical review of the manuscript.	Abeles FB, 2012, ETHYLENE IN PLANT BI; Andersen JR, 2005, THEOR APPL GENET, V111, P206, DOI 10.1007/s00122-005-1996-6; [Anonymous], 2014, THESIS; Bai W, 2009, PLANT BREEDING; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen GS, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-015-0421-3; CLARK RV, 1977, CAN J PLANT SCI, V57, P31, DOI 10.4141/cjps77-005; COHEN E, 1987, PLANT PHYSIOL, V84, P282, DOI 10.1104/pp.84.2.282; Dugardeyn Jasper, 2008, V10, P199, DOI 10.1007/7089_2007_151; Fukao T, 2008, PLANT SCI, V175, P43, DOI 10.1016/j.plantsci.2007.12.002; Gonzalo M, 2010, HEREDITY, V104, P583, DOI 10.1038/hdy.2009.140; Guo SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119095; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Han ZP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092535; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; HOFFMANNBENNING S, 1992, PLANT PHYSIOL, V99, P1156, DOI 10.1104/pp.99.3.1156; Jiang FK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037040; Kant S, 2009, PLANT PHYSIOL, V151, P691, DOI 10.1104/pp.109.143875; KIEBER JJ, 1993, TRENDS GENET, V9, P356, DOI 10.1016/0168-9525(93)90041-F; Ku L, 2015, MOL GENET GENOMICS, P1; Ku LX, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0483-x; Lee DH, 2014, J PLANT BIOL, V57, P106, DOI 10.1007/s12374-013-0528-1; Li JH, 2012, J EXP BOT, V63, P6407, DOI 10.1093/jxb/ers295; Li Z. Z., 2015, SCI REPORTS, V5; Lima MDA, 2006, MOL BREEDING, V17, P227, DOI 10.1007/s11032-005-5679-4; Lubberstedt T, 1997, CROP SCI, V37, P921, DOI 10.2135/cropsci1997.0011183X003700030037x; Lv HK, 2014, PLANT MOL BIOL, V84, P243, DOI 10.1007/s11103-013-0129-x; Ma BO, 2010, CHINESE SCI BULL, V55, P2204, DOI 10.1007/s11434-010-3192-2; Mao CZ, 2006, PLANT MOL BIOL, V61, P141, DOI 10.1007/s11103-005-6184-1; Marlay S., 2011, EXTERNAL PUBLICATION; Martin DN, 1999, PLANT PHYSIOL, V121, P775, DOI 10.1104/pp.121.3.775; Merchante C, 2013, CURR OPIN PLANT BIOL, V16, P554, DOI 10.1016/j.pbi.2013.08.001; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; NORBERG OS, 1988, AGRON J, V80, P768, DOI 10.2134/agronj1988.00021962008000050015x; Osman KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079305; Pan QC, 2016, NEW PHYTOL, V210, P1083, DOI 10.1111/nph.13810; Park JE, 2007, PLANT SCI, V172, P150, DOI 10.1016/j.plantsci.2006.08.005; Peiffer JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067066; Prioul JL, 1999, J EXP BOT, V50, P1281, DOI 10.1093/jexbot/50.337.1281; Qi WW, 2011, PLANT PHYSIOL, V157, P216, DOI 10.1104/pp.111.179945; Raihan MS, 2016, THEOR APPL GENET, P1; Rajala A, 2004, AGR FOOD SCI, V13, P186, DOI 10.2137/1239099041838058; Rajala A, 2002, AGR FOOD SCI FINLAND, V11, P233, DOI 10.23986/afsci.5721; Rajala A, 2002, PLANT GROWTH REGUL, V38, P51, DOI 10.1023/A:1020924307455; Riechmann JL, 1998, BIOL CHEM, V379, P633; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sari-Gorla M, 1999, THEOR APPL GENET, V99, P289, DOI 10.1007/s001220051234; Schaller GE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-9; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Shekoofa A., 2008, Journal of Agronomy, V7, P41; Sibov ST, 2003, HEREDITAS, V139, P107, DOI 10.1111/j.1601-5223.2003.01667.x; Stepanova AN, 2009, CURR OPIN PLANT BIOL, V12, P548, DOI 10.1016/j.pbi.2009.07.009; Tang JH, 2007, EUPHYTICA, V155, P117, DOI 10.1007/s10681-006-9312-3; Tang ZX, 2013, MOL BREEDING, V31, P1, DOI 10.1007/s11032-012-9762-3; Teng F, 2013, PLANT J, V73, P405, DOI 10.1111/tpj.12038; TOUZET P, 1995, THEOR APPL GENET, V91, P200, DOI 10.1007/BF00220878; Van Der Straeten D, 2001, PLANT PHYSIOL, V125, P955, DOI 10.1104/pp.125.2.955; Wang Q, 2013, J EXP BOT, V64, P4863, DOI 10.1093/jxb/ert272; Wang S, 2007, WINDOWS QTL CARTOGRA, V2, P5; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Wei X, 2011, THESIS, P14; Weyers JDB, 2001, NEW PHYTOL, V152, P375, DOI 10.1046/j.0028-646X.2001.00281.x; Xu ML, 2014, Patent Application, Patent No. [14/ 546,401, 14546401]; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yang TB, 2000, J BIOL CHEM, V275, P3137, DOI 10.1074/jbc.275.5.3137; Yang Xiao-Jun, 2008, Yichuan, V30, P1477, DOI 10.3724/SP.J.1005.2008.01477; Ye DL, 2015, J AGR SCI, P1; Zhang Q, 2014, FIELD CROP RES, V164, P82, DOI 10.1016/j.fcr.2014.06.006; Zhang WQ, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2438-1; Zhang XB, 2013, PLANT MOL BIOL REP, V31, P594, DOI 10.1007/s11105-012-0526-3; Zhang Y, 2010, AGR SCI CHINA, V9, P1400, DOI 10.1016/S1671-2927(09)60231-5; Zhuang J, 2010, PLANT GROWTH REGUL, V62, P51, DOI 10.1007/s10725-010-9484-7	73	6	7	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193072	10.1371/journal.pone.0193072	http://dx.doi.org/10.1371/journal.pone.0193072			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466465	Green Submitted, Green Published, gold			2022-12-26	WOS:000425604300083
J	Huang, WC; Lee, IK; Chen, YC; Tsai, CY; Liu, JW				Huang, Wen-Chi; Lee, Ing-Kit; Chen, Yi-Chun; Tsai, Ching-Yen; Liu, Jien-Wei			Characteristics and predictors for gastrointestinal hemorrhage among adult patients with dengue virus infection: Emphasizing the impact of existing comorbid disease(s)	PLOS ONE			English	Article							FEVER; PREVENTION; GUIDELINES; RISK; CARE	Background Gastrointestinal (GI) bleeding is a leading cause of death in dengue. This study aims to identify predictors for GI bleeding in adult dengue patients, emphasizing the impact of existing comorbid disease(s). Methods Of 1300 adults with dengue virus infection, 175 (mean age, 56.5 +/- 13.7 years) patients with GI bleeding and 1,125 (mean age, 49.2 +/- 15.6 years) without GI bleeding (controls) were retrospectively analyzed. Results Among 175 patients with GI bleeding, dengue hemorrhagic fever was found in 119 (68%) patients; the median duration from onset dengue illness to GI bleeding was 5 days. Gastric ulcer, erythematous gastritis, duodenal ulcer, erosive gastritis, and hemorrhagic gastritis were found in 52.3%, 33.3%, 28.6%, 28.6%, and 14.3% of 42 patients with GI bleeding who had undergone endoscopic examination, respectively. Overall, nine of the 175 patients with GI bleeding died, giving an in-hospital mortality rate of 5.1%. Multivariate analysis showed age >= 60 years (cases vs. controls: 48% vs. 28.3%) (odds ratio [OR]: 1.663, 95% confidence interval [ CI]: 1.128-2.453), end stage renal disease with additional comorbidities (cases vs. controls: 1.7% vs. 0.2%) (OR: 9.405, 95% CI: 1.4-63.198), previous stroke with additional comorbidities (cases vs. controls: 7.4% vs. 0.6%) (OR: 9.772, 95% CI: 3.302-28.918), gum bleeding (cases vs. controls: 27.4% vs. 11.5%) (OR: 1.732, 95% CI: 1.1-2.727), petechiae (cases vs. controls: 56.6% vs. 29.1%) (OR: 2.109, 95% CI: 1.411-3.153), and platelet count < 50x10(9) cells/L (cases vs. controls: 53.1% vs. 25.8%) (OR: 3.419, 95% CI: 2.103-5.558) were independent predictors of GI bleeding in patients with dengue virus infection. Conclusions Our study is the first to disclose that end stage renal disease and previous stroke, with additional comorbidities, were strongly significant associated with the risk of GI bleeding in patients with dengue virus infection. Identification of these risk factors can be incorporated into the patient assessment and management protocol of dengue virus infection to reduce its mortality.	[Huang, Wen-Chi; Lee, Ing-Kit; Chen, Yi-Chun; Tsai, Ching-Yen; Liu, Jien-Wei] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Lee, Ing-Kit; Liu, Jien-Wei] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Lee, IK (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan.; Lee, IK (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	leee@cgmh.org.tw			Ministry of Science and Technology, Taiwan [105-2314-B-182A-112]; Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan [CMRPG8E0691]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan	This study was supported by a grant (document no. 105-2314-B-182A-112 to IKL) from the Ministry of Science and Technology, Taiwan and by a grant (no. CMRPG8E0691 to IKL) from Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson N, 2000, AM FAM PHYSICIAN, V62, P2053; Basílio-de-Oliveira C.A., 2005, Braz J Infect Dis, V9, P341, DOI 10.1590/S1413-86702005000400012; Bhaskar E, 2015, J INFECT DEV COUNTR, V9, P105, DOI 10.3855/jidc.5031; Chamnanchanunt S, 2012, SE ASIAN J TROP MED, V43, P890; Coleman CI, 2012, INT J CLIN PRACT, V66, P53, DOI 10.1111/j.1742-1241.2011.02809.x; Darlington A, 2011, THROMB HAEMOSTASIS, V106, P67, DOI 10.1160/TH10-12-0785; Fariz-Safhan MN, 2014, TROP BIOMED, V31, P270; Kalman RS, 2015, SEMIN DIALYSIS, V28, P68, DOI 10.1111/sdi.12301; Kaw D, 2006, SEMIN DIALYSIS, V19, P317, DOI 10.1111/j.1525-139X.2006.00179.x; Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149; Lee IK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154772; Lee IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001532; Lye DC, 2017, LANCET, V389, P1611, DOI 10.1016/S0140-6736(17)30269-6; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012; Rockey DC, 2005, GASTROENTEROL CLIN N, V34, P581, DOI 10.1016/j.gtc.2005.08.002; Rowe EK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002777; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Sam SS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002194; Shu PY, 2009, CLIN VACCINE IMMUNOL, V16, P589, DOI 10.1128/CVI.00475-08; Shu PY, 2003, J CLIN MICROBIOL, V41, P2408, DOI 10.1128/JCM.41.6.2408-2416.2003; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; SUMARMO, 1983, B WORLD HEALTH ORGAN, V61, P693; Tomashek KM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001614; The TD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001679; TSAI CJ, 1991, AM J GASTROENTEROL, V86, P33; WHO, 1997, DENG HAEM FEV DIAGN; WIJDICKS EFM, 1994, STROKE, V25, P2146, DOI 10.1161/01.STR.25.11.2146; Wong JGX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148579; World Health Organization, 2009, DENGUE GUIDELINES DI; Zusman RM, 1999, CLIN CARDIOL, V22, P559, DOI 10.1002/clc.4960220905	31	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192919	10.1371/journal.pone.0192919	http://dx.doi.org/10.1371/journal.pone.0192919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462169	Green Published, gold, Green Submitted			2022-12-26	WOS:000425554200033
J	Moore, AF; Cassone, VM; Alloway, KD; Bartell, PA				Moore, Ashli F.; Cassone, Vincent M.; Alloway, Kevin D.; Bartell, Paul A.			The premammillary nucleus of the hypothalamus is not necessary for photoperiodic timekeeping in female turkeys (Meleagris gallopavo)	PLOS ONE			English	Article							DOPAMINE-MELATONIN NEURONS; DEPENDENT LIGHT INDUCTION; DEEP-BRAIN PHOTORECEPTORS; SEASONAL REPRODUCTION; GONADAL DEVELOPMENT; AVIAN HYPOTHALAMUS; JAPANESE-QUAIL; BIRDS; EXPRESSION; PHOTOREFRACTORINESS	In birds, seasonal reproduction is regulated by day length, with long days in the spring activating the hypothalamic-pituitary-gonadal axis and reproductive behaviors. The photoreceptors mediating this process remain unknown, but recently, the premammillary nucleus (PMM) of the hypothalamus has been implicated as the site of photoperiodic signaling in turkeys. We performed electrolytic lesions of the PMM to elucidate its role in the photoactivation and maintenance of egg production in female turkeys. Our results show that ablation of the PMM does not alter the normal lay cycle. No differences were found between lesioned birds and sham controls in the latency to lay following photostimulation, nor in subsequent egg production over a period of 29 weeks. No differences in the incidence of gonadal regression were found, indicating that the PMM is not essential for the termination of breeding. We conclude that any role of the PMM in photoperiodic regulation, if it exists, is redundant with other components of the system.	[Moore, Ashli F.; Cassone, Vincent M.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Alloway, Kevin D.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA USA; [Bartell, Paul A.] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA	University of Kentucky; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bartell, PA (corresponding author), Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA.	pab43@psu.edu	Cassone, Vincent/AAD-5191-2022		National Institute of Food and Agriculture, U.S. Department of Agriculture [2014-67012-21608]	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2014-67012-21608 to AFM, https://nifa.usda.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Michael Hulet for husbandry protocols, Dr. Jared Smith for valuable advice on neurosurgical techniques, and Dr. Chad Dechow for statistical advice. We also thank undergraduate researchers Elana Keller and Eric Salevsky for surgical assistance, Graham Gorgas for help designing and constructing trap nests, and Jun Yi for assistance with histological processing. Turkey poults were generously provided by Aviagen Turkeys. This work was supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2014-67012-21608.	[Anonymous], 2011, NICHOLAS 500 SEASONA, P24901; BITTMAN EL, 1991, AM J PHYSIOL, V260, pR90, DOI 10.1152/ajpregu.1991.260.1.R90; Cassone VM, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P829; Chaurasia SS, 2005, J NEUROCHEM, V92, P158, DOI 10.1111/j.1471-4159.2004.02874.x; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; El Halawani ME, 2009, GEN COMP ENDOCR, V163, P123, DOI 10.1016/j.ygcen.2008.11.030; Garcia-Fernandez JM, 2015, FRONT NEUROENDOCRIN, V37, P13, DOI 10.1016/j.yfrne.2014.11.001; Goldman BD, 2001, J BIOL RHYTHM, V16, P283, DOI 10.1177/074873001129001980; Halford S, 2009, CURR BIOL, V19, P1396, DOI 10.1016/j.cub.2009.06.066; Hazlerigg D, 2008, CURR BIOL, V18, pR795, DOI 10.1016/j.cub.2008.07.040; Johnson AL, 2000, STURKIES AVIAN PHYSL, P583; Kang SW, 2007, NEUROSCIENCE, V150, P223, DOI 10.1016/j.neuroscience.2007.08.031; Kang SW, 2010, NEUROSCIENCE, V170, P200, DOI 10.1016/j.neuroscience.2010.06.082; Kang SW, 2006, GEN COMP ENDOCR, V146, P91, DOI 10.1016/j.ygcen.2005.10.017; Kosonsiriluk S, 2016, NEUROENDOCRINOLOGY, V103, P678, DOI 10.1159/000442206; Kosonsiriluk S, 2013, GEN COMP ENDOCR, V190, P149, DOI 10.1016/j.ygcen.2013.02.015; Kuenzel WJ, 2015, POULTRY SCI, V94, P786, DOI [10.3382/ps.2014-04370, 10.3382/ps.2014-4370]; Kuenzel WJ, 2000, POULTRY SCI, V79, P1679, DOI 10.1093/ps/79.11.1679; Leclerc B, 2010, J NEUROENDOCRINOL, V22, P119, DOI 10.1111/j.1365-2826.2009.01942.x; Lewis PD, 1998, WORLD POULTRY SCI J, V54, P119, DOI 10.1079/WPS19980009; MacDougall-Shackleton SA, 2009, INTEGR COMP BIOL, V49, P580, DOI 10.1093/icb/icp048; MENAKER M, 1970, P NATL ACAD SCI USA, V67, P320, DOI 10.1073/pnas.67.1.320; Moore RY, 1996, BEHAV BRAIN RES, V73, P125; Nakane Y, 2014, CURR BIOL, V24, pR596, DOI 10.1016/j.cub.2014.05.038; Nakane Y, 2010, CELL TISSUE RES, V342, P341, DOI 10.1007/s00441-010-1073-6; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Nishiwaki-Ohkawa T, 2016, J ENDOCRINOL, V229, pR117, DOI 10.1530/JOE-16-0066; Proudman JA, 2002, POULTRY SCI, V81, P1218, DOI 10.1093/ps/81.8.1218; Rathinam T, 2005, BRAIN RES BULL, V64, P455, DOI 10.1016/j.brainresbull.2004.10.003; Sharp PJ, 2005, ANN NY ACAD SCI, V1040, P189, DOI 10.1196/annals.1327.024; SIOPES TD, 1974, POULTRY SCI, V53, P2035, DOI 10.3382/ps.0532035; Siopes TD, 2001, POULTRY SCI, V80, P95, DOI 10.1093/ps/80.1.95; Stevenson TJ, 2013, GEN COMP ENDOCR, V190, P81, DOI 10.1016/j.ygcen.2013.04.011; Thayananuphat A, 2007, J NEUROENDOCRINOL, V19, P407, DOI 10.1111/j.1365-2826.2007.01544.x; Thayananuphat A, 2007, J NEUROENDOCRINOL, V19, P399, DOI 10.1111/j.1365-2826.2007.01545.x; Yamamura T, 2004, ENDOCRINOLOGY, V145, P4264, DOI 10.1210/en.2004-0366; Yasuo S, 2005, ENDOCRINOLOGY, V146, P2551, DOI 10.1210/en.2005-0057; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117; Yoshimura T, 2010, ANIM SCI J, V81, P403, DOI 10.1111/j.1740-0929.2010.00777.x	39	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0190274	10.1371/journal.pone.0190274	http://dx.doi.org/10.1371/journal.pone.0190274			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462137	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200004
J	Banjara, S; Mao, JH; Ryan, TM; Caria, S; Kvansakul, M				Banjara, Suresh; Mao, Jiahao; Ryan, Timothy M.; Caria, Sofia; Kvansakul, Marc			Grouper iridovirus GIV66 is a Bcl-2 protein that inhibits apoptosis by exclusively sequestering Bim	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; STRUCTURAL BIOLOGY; PEPTIDE COMPLEX; VIRUS; BAX; HOMOLOG; CONSERVATION; BIOMOLECULES; PUBLICATION; ACTIVATION	Programmed cell death or apoptosis is a critical mechanism for the controlled removal of damaged or infected cells, and proteins of the Bcl-2 family are important arbiters of this process. Viruses have been shown to encode functional and structural homologs of Bcl-2 to counter premature host-cell apoptosis and ensure viral proliferation or survival. Grouper iridovirus (GIV) is a large DNA virus belonging to the Iridoviridae family and harbors GIV66, a putative Bcl-2-like protein and mitochondrially localized apoptosis inhibitor. However, the molecular and structural basis of GIV66-mediated apoptosis inhibition is currently not understood. To gain insight into GIV66's mechanism of action, we systematically evaluated its ability to bind peptides spanning the BH3 domain of pro-apoptotic Bcl-2 family members. Our results revealed that GIV66 harbors an unusually high level of specificity for pro-apoptotic Bcl-2 and displays affinity only for Bcl-2-like 11 (Bcl2L11 or Bim). Using crystal structures of both apo-GIV66 and GIV66 bound to the BH3 domain from Bim, we unexpectedly found that GIV66 forms dimers via an interface that results in occluded access to the canonical Bcl-2 ligand-binding groove, which breaks apart upon Bim binding. This observation suggests that GIV66 dimerization may affect GIV66's ability to bind host pro-death Bcl-2 proteins and enables highly targeted virus-directed suppression of host apoptosis signaling. Our findings provide a mechanistic understanding for the potent anti-apoptotic activity of GIV66 by identifying it as the first single-specificity, pro-survival Bcl-2 protein and identifying a pivotal role of Bim in GIV-mediated inhibition of apoptosis.	[Banjara, Suresh; Mao, Jiahao; Caria, Sofia; Kvansakul, Marc] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Ryan, Timothy M.] Australian Synchrotron, SAXS WAXS, 800 Blackburn Rd, Clayton, Vic 3168, Australia	La Trobe University	Kvansakul, M (corresponding author), La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia.	m.kvansakul@latrobe.edu.au	Kvansakul, Marc/AAF-2453-2019	Kvansakul, Marc/0000-0003-2639-2498; Caria, Sofia/0000-0001-7289-2093; Banjara, Suresh/0000-0002-2123-8101	Australian Research Council Fellowship [FT130101349]; La Trobe University scholarship	Australian Research Council Fellowship(Australian Research Council); La Trobe University scholarship	This work was supported in whole or part by Australian Research Council Fellowship FT130101349 (to M.K.) and a La Trobe University scholarship (to S.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anasir MI, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100305; Anasir MI, 2017, J BIOL CHEM, V292, P9010, DOI 10.1074/jbc.M116.768879; Banadyga L, 2011, J VIROL, V85, P1922, DOI 10.1128/JVI.01959-10; Banjara S, 2017, J VIROL, V91, DOI 10.1128/JVI.02228-16; Bellows DS, 2002, J VIROL, V76, P2469, DOI 10.1128/JVI.76.5.2469-2479.2002; Brouwer JM, 2014, MOL CELL, V55, P938, DOI 10.1016/j.molcel.2014.07.016; Burton DR, 2015, ACTA CRYSTALLOGR D, V71, P1593, DOI 10.1107/S1399004715009402; Campbell S, 2014, J VIROL, V88, P8667, DOI 10.1128/JVI.01092-14; Caria S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.469; Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; CHIOU SK, 1994, J VIROL, V68, P6553, DOI 10.1128/JVI.68.10.6553-6566.1994; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Desbien AL, 2009, P NATL ACAD SCI USA, V106, P5663, DOI 10.1073/pnas.0901036106; Eimon PM, 2014, METHOD ENZYMOL, V544, P395, DOI 10.1016/B978-0-12-417158-9.00016-9; Eimon PM, 2010, APOPTOSIS, V15, P331, DOI 10.1007/s10495-009-0432-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fairlie WD, 2006, CELL DEATH DIFFER, V13, P426, DOI 10.1038/sj.cdd.4401762; Fuchs Y, 2015, NAT REV MOL CELL BIO, V16, P329, DOI 10.1038/nrm3999; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jette CA, 2008, CELL DEATH DIFFER, V15, P1063, DOI 10.1038/cdd.2008.42; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Kirby N, 2016, ACTA CRYSTALLOGR D, V72, P1254, DOI 10.1107/S2059798316017174; Kirby NM, 2014, CURR OPIN STRUC BIOL, V28, P41, DOI 10.1016/j.sbi.2014.07.007; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Kvansakul M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.436; KVANSAKUL M, 2017, VIRUSES-BASEL, V9, DOI DOI 10.3390/V9100290; Kvansakul M, 2007, MOL CELL, V25, P933, DOI 10.1016/j.molcel.2007.02.004; Kvansakul M, 2016, METHODS MOL BIOL, V1491, P213, DOI 10.1007/978-1-4939-3581-9_16; Kvansakul M, 2015, APOPTOSIS, V20, P136, DOI 10.1007/s10495-014-1051-7; Kvansakul M, 2014, METHOD ENZYMOL, V544, P49, DOI 10.1016/B978-0-12-417158-9.00003-0; Kvansakul M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001236; Lin PW, 2008, APOPTOSIS, V13, P165, DOI 10.1007/s10495-007-0152-y; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Luna-Vargas MPA, 2016, FEBS J, V283, P2676, DOI 10.1111/febs.13624; Marshall B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.52; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Muppidi A, 2012, J AM CHEM SOC, V134, P14734, DOI 10.1021/ja306864v; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Okamoto T, 2012, J VIROL, V86, P11501, DOI 10.1128/JVI.01115-12; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rautureau GJP, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.178; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Shamas-Din A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008714; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Trewhella J, 2017, ACTA CRYSTALLOGR D, V73, P710, DOI 10.1107/S2059798317011597; Tsai CT, 2005, J VIROL, V79, P2010, DOI 10.1128/JVI.79.4.2010-2023.2005; van Regenmortel M. H. V., 2000, VIRUS TAXONOMY CLASS; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Westphal D, 2007, J VIROL, V81, P7178, DOI 10.1128/JVI.00404-07; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002	67	24	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5464	5477		10.1074/jbc.RA117.000591	http://dx.doi.org/10.1074/jbc.RA117.000591			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29483196	Green Published, hybrid			2022-12-26	WOS:000430044100011
J	Adil, M; Lee, K; Zaid, HM; Latiff, NRA; Alnarabiji, MS				Adil, Muhammad; Lee, Keanchuan; Zaid, Hasnah Mohd; Latiff, Noor Rasyada Ahmad; Alnarabiji, Mohamad Sahban			Experimental study on electromagnetic-assisted ZnO nanofluid flooding for enhanced oil recovery (EOR)	PLOS ONE			English	Article							NANOPARTICLES; SANDSTONE	Recently, nano-EOR has emerged as a new frontier for improved and enhanced oil recovery (IOR & EOR). Despite their benefits, the nanoparticles tend to agglomerate at reservoir conditions which cause their detachment from the oil/water interface, and are consequently retained rather than transported through a porous medium. Dielectric nanoparticles including ZnO have been proposed to be a good replacement for EOR due to their high melting point and thermal properties. But more importantly, these particles can be polarized under electromagnetic (EM) irradiation, which provides an innovative smart Nano-EOR process denoted as EM-Assisted Nano-EOR. In this study, parameters involved in the oil recovery mechanism under EM waves, such as reducing mobility ratio, lowering interfacial tensions (IFT) and altering wettability were investigated. Two-phase displacement experiments were performed in sandpacks under the water-wet condition at 95 degrees C, with permeability in the range of 265-300 mD. A crude oil from Tapis oil field was employed; while ZnO nanofluids of two different particle sizes (55.7 and 117.1 nm) were prepared using 0.1 wt. % nanoparticles that dispersed into brine (3 wt. % NaCl) along with SDBS as a dispersant. In each flooding scheme, three injection sequential scenarios have been conducted: (i) brine flooding as a secondary process, (ii) surfactant/nano/EM-assisted nano flooding, and (iii) second brine flooding to flush nanoparticles. Compare with surfactant flooding (2% original oil in place/OOIP) as tertiary recovery, nano flooding almost reaches 8.5-10.2% of OOIP. On the other hand, EM-assisted nano flooding provides an incremental oil recovery of approximately 9-10.4% of OOIP. By evaluating the contact angle and interfacial tension, it was established that the degree of IFT reduction plays a governing role in the oil displacement mechanism via nano-EOR, compare to mobility ratio. These results reveal a promising way to employ water-based ZnO nanofluid for enhanced oil recovery purposes at a relatively high reservoir temperature.	[Adil, Muhammad; Lee, Keanchuan; Zaid, Hasnah Mohd; Latiff, Noor Rasyada Ahmad] Univ Teknol PETRONAS, Dept Fundamental & Appl Sci, Tronoh, Perak, Malaysia; [Alnarabiji, Mohamad Sahban] Univ Teknol PETRONAS, Dept Chem Engn, Tronoh, Perak, Malaysia	Universiti Teknologi Petronas; Universiti Teknologi Petronas	Lee, K (corresponding author), Univ Teknol PETRONAS, Dept Fundamental & Appl Sci, Tronoh, Perak, Malaysia.	lee.kc@utp.edu.my	Alnarabiji, Mohamad/AAH-6736-2019; Muhammad, Adil/AAH-9333-2020	Muhammad, Adil/0000-0001-8269-2984	Universiti Teknologi PETRONAS [YUTP 0153AA-E17]; Universiti Teknologi PETRONAS	Universiti Teknologi PETRONAS; Universiti Teknologi PETRONAS	The corresponding author, Lee Kean Chuan, received a funding from Universiti Teknologi PETRONAS under the grant YUTP 0153AA-E17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Universiti Teknologi PETRONAS for funding the research.	Abu El Ela M, 2012, OIL GAS J, V110, P84; Adil M, 2016, AIP C P, V1787; Adil M, 2016, ENERG FUEL, V30, P6169, DOI 10.1021/acs.energyfuels.6b01116; Adil M, 2015, AIP CONF PROC, V1669, DOI 10.1063/1.4919154; Ahmed T, 2010, RESERVOIR ENGINEERING HANDBOOK, 4TH EDITION, P733; Al-Mjeni R., 2010, OILFIELD REV, V22, P16; [Anonymous], 2012, AB DHAB INT PETR C E; Carcoana A., 1992, APPL ENHANCED OIL RE, P135; Chang H.L., 2006, J PET TECHNOL, V58, P84, DOI [10.2118/89175-JPT, DOI 10.2118/89175-JPT]; CHATZIS I, 1984, SOC PETROL ENG J, V24, P555, DOI 10.2118/10114-PA; Craig F.F, 1980, MONOGR SER SOC PET E, V3; Cui MM, 2013, SCIENCE, V342, P460, DOI 10.1126/science.1242852; Donaldson EC., 1985, ENHANCED OIL RECOVER; Ehtesabi H, 2014, ENERG FUEL, V28, P423, DOI 10.1021/ef401338c; Green D.W., 1998, ENHANCED OIL RECOVER; GUPTA SP, 1979, SOC PETROL ENG J, V19, P116, DOI 10.2118/7063-PA; Hendraningrat L, 2014, UNLOCKING POTENTIAL; Hendraningrat L, 2013, SPE RESERVOIR CHARAC; Hendraningrat L, 2013, J PETROL SCI ENG, V111, P128, DOI 10.1016/j.petrol.2013.07.003; Latimer N., 2011, 2011 NAT POSTGR C, P1; Li X, 2010, SPE W REG M; Manousaki E, 2004, WATER RES, V38, P3751, DOI 10.1016/j.watres.2004.06.002; Miranda C., 2012, SOC PETR ENG SPE INT, V2012; Moore T., 1955, 30 ANN FALL M PETR B; Morrow N. R., 1990, J PETROL TECHNOL, V42, P1; Morrow NR., 1987, REV EFFECTS INITIAL; Ogolo N.A., 2012, SPE SAUD AR SECT TEC; Pwaga S., 2010, COMP STUDY DIFFERENT; Roustaei A., 2013, EGYPT J PET, V22, P427, DOI [DOI 10.1016/J.EJPE.2013.06.010, 10.1016/j.ejpe.2013.06.010]; Shandrygin AN, 2008, SPE ANN TECHN C EXH; Tang GQ, 1997, SPE RESERVOIR ENG, V12, P269, DOI 10.2118/36680-PA; Torsater O, 2012, SPE KUW INT PETR C E; Vargo J., 1999, SPE ROCK MOUNT REG M; Viksund B.G., 1998, P 1998 INT S SOC COR; Wu Y., 2009, EXPT STUDY POLYM ENH; Zaid HM, 2017, INT J NANOTECHNOL, V14, P284, DOI 10.1504/IJNT.2017.082478; Zaid HM, 2016, AIP C P, V1787; Zhang TT, 2015, SPE J, V20, P667, DOI 10.2118/166346-PA	38	45	46	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193518	10.1371/journal.pone.0193518	http://dx.doi.org/10.1371/journal.pone.0193518			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489897	Green Published, gold, Green Submitted			2022-12-26	WOS:000426276000084
J	Buijs, RVC; Leemans, EL; Greuter, M; Tielliu, IFJ; Zeebregts, CJ; Willems, TP				Buijs, Ruben V. C.; Leemans, Eva L.; Greuter, Marcel; Tielliu, Ignace F. J.; Zeebregts, Clark J.; Willems, Tineke P.			Quantification of abdominal aortic calcification: Inherent measurement errors in current computed tomography imaging	PLOS ONE			English	Article							CORONARY-ARTERY CALCIUM; CARDIOVASCULAR EVENTS; CT; ATHEROSCLEROSIS; REPRODUCIBILITY; RECONSTRUCTION; PREDICTOR; RATES	Objective Quantification software for coronary calcification is often used to measure abdominal aortic calcification on computed tomography (CT) images. However, there is no evidence substantiating the reliability and accuracy of these tools in this setting. Differences in coronary and abdominal CT acquisition and presence of intravascular contrast may affect the results of these tools. Therefore, this study investigates the effects of CT acquisition parameters and iodine contrast on automated quantification of aortic calcium on CT. Methods Calcium scores, provided in volume and mass, were assessed by automated calcium quantification software on CT scans. First, differences in calcium scores between the abdominal and coronary CT scanning protocols were assessed by imaging a thorax phantom containing calcifications of 9 metrical variations. Second, aortic calcification was quantified in 50 unenhanced and contrast-enhanced clinical abdominal CT scans at a calcification threshold of 299 Hounsfield Units (HU). Also, the lowest possible HU threshold for calcifications was calculated per individual patient and compared to a 130 HU threshold between contrast enhanced and unenhanced CT images, respectively. Results No significant differences in volume and mass scores between the abdominal and the coronary CT protocol were found. However, volume and mass of all calcifications were overestimated compared to the physical volume and mass (volume range: 0-649%; mass range: 0-2619%). In comparing unenhanced versus contrast-enhanced CT images showed significant volume differences for both thresholds, as well as for mass differences for the 130 vs patient-specific threshold (230 +/- 22.6 HU). Conclusion Calcification scoring on CT angiography tends to grossly overestimate volume and mass suggesting a low accuracy and reliability. These are reduced further by interference of intravascular contrast. Future studies applying calcium quantification tools on CT angiography imaging should acknowledge these issues and apply corrective measures to ensure the validity of their outcomes.	[Buijs, Ruben V. C.; Tielliu, Ignace F. J.; Zeebregts, Clark J.] Univ Groningen, Univ Med Ctr Groningen, Div Vasc Surg, Dept Surg, Groningen, Netherlands; [Leemans, Eva L.] Acad Med Ctr, Dept Biomech Engn & Phys, Amsterdam, Netherlands; [Leemans, Eva L.] Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Greuter, Marcel; Willems, Tineke P.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen	Zeebregts, CJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Vasc Surg, Dept Surg, Groningen, Netherlands.	czeebregts@hotmail.com	Greuter, Marcel J W/B-4363-2013	Greuter, Marcel J W/0000-0001-5721-9159; Leemans, Eva/0000-0002-3640-9938				3Mensio structural heart, 2017, 3MENSIO STRUCT HEART; Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Criqui MH, 2014, ARTERIOSCL THROM VAS, V34, P1574, DOI 10.1161/ATVBAHA.114.303268; Doherty TM, 2004, ENDOCR REV, V25, P629, DOI 10.1210/er.2003-0015; Golestani R, 2010, ANN MED, V42, P539, DOI 10.3109/07853890.2010.515604; Goncalves FB, 2012, HEART, V98, P988, DOI 10.1136/heartjnl-2011-301464; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Groen JM, 2007, INVEST RADIOL, V42, P848, DOI 10.1097/RLI.0b013e318154c549; Komen N, 2011, ACTA RADIOL, V52, P943, DOI 10.1258/ar.2011.110189; Komen N, 2011, AM J SURG, V201, P759, DOI 10.1016/j.amjsurg.2010.01.033; McCollough CH, 2007, RADIOLOGY, V243, P527, DOI 10.1148/radiol.2432050808; Pallant J., 2005, SPSS SURVIVAL MANUAL, V2; Parikh NI, 2008, AM J CARDIOL, V102, P440, DOI 10.1016/j.amjcard.2008.04.007; Rolf A, 2013, INT J CARDIOVAS IMAG, V29, P1819, DOI 10.1007/s10554-013-0258-y; Saremi A, 2010, DIABETES CARE, V33, P2642, DOI 10.2337/dc10-1388; Stortecky S, 2014, EUROINTERVENTION, V10, P339, DOI 10.4244/EIJV10I3A59; VanWagner LB, 2014, ATHEROSCLEROSIS, V235, P599, DOI 10.1016/j.atherosclerosis.2014.05.962; Weininger M, 2012, RADIOLOGY, V265, P70, DOI 10.1148/radiol.12112532	19	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193419	10.1371/journal.pone.0193419	http://dx.doi.org/10.1371/journal.pone.0193419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489868	Green Submitted, gold, Green Published			2022-12-26	WOS:000426276000074
J	Choe, EK; Kang, HY; Lee, Y; Choi, SH; Kim, HJ; Kim, JS				Choe, Eun Kyung; Kang, Hae Yeon; Lee, Young; Choi, Seung Ho; Kim, Hee Joung; Kim, Joo Sung			The longitudinal association between changes in lung function and changes in abdominal visceral obesity in Korean non-smokers	PLOS ONE			English	Article							EXAMINATION SURVEY KNHANES; ADIPOSE-TISSUE; PULMONARY-FUNCTION; METABOLIC SYNDROME; SYSTEMIC INFLAMMATION; COMPUTED-TOMOGRAPHY; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; BODY-COMPOSITION; NATIONAL-HEALTH	Obesity, particularly abdominal obesity, might be related to decreased lung function. We aimed to investigate whether obesity indices are associated with forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) in asymptomatic non-smokers through a longitudinal cohort study. The clinical records of 1,145 subjects (428 males, mean age 52.3 years) who underwent a comprehensive health evaluation, including spirometry and abdominal fat computed tomography, at least twice between 2007 and 2014 were retrospectively reviewed and analysed. The mean follow-up period was 1,105 days (over 3.0 years). The baseline total adipose tissue (TAT) and visceral adipose tissue (VAT) were inversely associated with both FEV1 and FVC (P < 0.05). The longitudinal study found that increasing TAT and VAT were significantly related to decreasing FEV1 and FVC, whereas decreasing TAT and VAT were related to increasing FEV1 and FVC in both males and females (P < 0.05). The strength and consistency of these associations were clearer in males than in females. However, no significant relationship was found between changes in subcutaneous adipose tissue and changes in lung function. In Korean non-smokers, longitudinal changes in abdominal visceral fat were found to be inversely related to changes in lung function over a mean period of three years. These results suggest that decreasing abdominal visceral obesity could increase lung function despite ageing.	[Choe, Eun Kyung] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Healthcare Res Inst, Dept Surg, Seoul, South Korea; [Kang, Hae Yeon; Choi, Seung Ho; Kim, Joo Sung] Seoul Natl Univ Hosp, Healthcare Res Inst, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea; [Lee, Young] Vet Med Res Inst, Vet Hlth Serv, Med Ctr, Seoul, South Korea; [Kim, Hee Joung] Konkuk Univ, Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Joo Sung] Seoul Natl Univ, Coll Med, Dept Internal Med, Liver Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Konkuk University; Konkuk University Medical Center; Seoul National University (SNU)	Kang, HY (corresponding author), Seoul Natl Univ Hosp, Healthcare Res Inst, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea.	joybell77@hanmail.net		Kang, Hae Yeon/0000-0003-3965-7539				BJORNTORP P, 1991, INT J OBESITY, V15, P67; Bosy-Westphal A, 2010, J NUTR, V140, P954, DOI 10.3945/jn.109.118737; Cartier A, 2009, AM J CLIN NUTR, V89, P1307, DOI 10.3945/ajcn.2008.27030; Chen Y, 2002, AM J EPIDEMIOL, V155, P191, DOI 10.1093/aje/155.3.191; Chen Y, 2007, AM J CLIN NUTR, V85, P35, DOI 10.1093/ajcn/85.1.35; Chen Y, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-32; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Choi SH, 2015, ATHEROSCLEROSIS, V242, P515, DOI 10.1016/j.atherosclerosis.2015.08.004; Chung SJ, 2008, GUT, V57, P1360, DOI 10.1136/gut.2007.147090; ENZI G, 1986, AM J CLIN NUTR, V44, P739, DOI 10.1093/ajcn/44.6.739; Faber DR, 2010, ATHEROSCLEROSIS, V212, P274, DOI 10.1016/j.atherosclerosis.2010.04.029; Fenger RV, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-208; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Gurka MJ, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003609; Jeon YK, 2015, OSTEOPOROSIS INT, V26, P2423, DOI 10.1007/s00198-015-3152-8; John BJ, 2006, ALIMENT PHARM THER, V23, P1511, DOI 10.1111/j.1365-2036.2006.02915.x; Kang HT, 2013, ARCH GERONTOL GERIAT, V57, P54, DOI 10.1016/j.archger.2013.02.004; Kuhn C, 2000, AM J RESP CELL MOL, V22, P289, DOI 10.1165/ajrcmb.22.3.3690; Lafontan M, 2008, DIABETES METAB, V34, P317, DOI 10.1016/j.diabet.2008.04.001; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Lim SY, 2010, J KOREAN MED SCI, V25, P1480, DOI 10.3346/jkms.2010.25.10.1480; Melo LC, 2014, EINSTEIN-SAO PAULO, V12, P120, DOI 10.1590/S1679-45082014RW2691; Neveu WA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-28; Ochs-Balcom HM, 2006, CHEST, V129, P853, DOI 10.1378/chest.129.4.853; Park SK, 2016, CIRC J, V80, P2489, DOI 10.1253/circj.CJ-16-0625; Park YS, 2011, J KOREAN MED SCI, V26, P771, DOI 10.3346/jkms.2011.26.6.771; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; RAY CS, 1983, AM REV RESPIR DIS, V128, P501, DOI 10.1164/arrd.1983.128.3.501; Rossi A, 2008, INT J OBESITY, V32, P1423, DOI 10.1038/ijo.2008.103; RUBINSTEIN I, 1990, ANN INTERN MED, V112, P828, DOI 10.7326/0003-4819-112-11-828; Samaras K, 2010, OBESITY, V18, P884, DOI 10.1038/oby.2009.443; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; SURATT PM, 1984, J APPL PHYSIOL, V57, P403, DOI 10.1152/jappl.1984.57.2.403; Sutherland TJT, 2008, EUR RESPIR J, V32, P85, DOI 10.1183/09031936.00112407; Thijs W, 2014, RESP MED, V108, P351, DOI 10.1016/j.rmed.2013.10.003; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	39	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193516	10.1371/journal.pone.0193516	http://dx.doi.org/10.1371/journal.pone.0193516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474424	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500123
J	Saanchez, L; Beltran, E; de Stefani, A; Guo, LT; Shea, A; Shelton, GD; De Risio, L; Burmeister, LM				Sanchez, Lluis; Beltran, Elsa; de Stefani, Alberta; Guo, Ling T.; Shea, Anita; Shelton, G. Diane; De Risio, Luisa; Burmeister, Louise M.			Clinical and genetic characterisation of dystrophin-deficient muscular dystrophy in a family of Miniature Poodle dogs	PLOS ONE			English	Article							ANIMAL-MODELS; DUCHENNE; CANINE; DELETION; DMD; MECHANISMS; EXPRESSION; PATHOGENESIS; CARRIERS; HOMOLOG	Four full-sibling intact male Miniature Poodles were evaluated at 4-19 months of age. One was clinically normal and three were affected. All affected dogs were reluctant to exercise and had generalised muscle atrophy, a stiff gait and a markedly elevated serum creatine kinase activity. Two affected dogs also showed poor development, learning difficulties and episodes of abnormal behaviour. In these two dogs, investigations into forebrain structural and metabolic diseases were unremarkable; electromyography demonstrated fibrillation potentials and complex repetitive discharges in the infraspinatus, supraspinatus and epaxial muscles. Histopathological, immunohistochemical and immunoblotting analyses of muscle biopsies were consistent with dystrophin-deficient muscular dystrophy. DNA samples were obtained from all four full-sibling male Poodles, a healthy female littermate and the dam, which was clinically normal. Whole genome sequencing of one affected dog revealed a >5 Mb deletion on the X chromosome, encompassing the entire DMD gene. The exact deletion breakpoints could not be experimentally ascertained, but we confirmed that this region was deleted in all affected males, but not in the unaffected dogs. Quantitative polymerase chain reaction confirmed all three affected males were hemizygous for the mutant X chromosome, while the wildtype chromosome was observed in the unaffected male littermate. The female littermate and the dam were both heterozygous for the mutant chromosome. Forty-four Miniature Poodles from the general population were screened for the mutation and were homozygous for the wildtype chromosome. The finding represents a naturally-occurring mutation causing dystrophin-deficient muscular dystrophy in the dog.	[Sanchez, Lluis; Beltran, Elsa; de Stefani, Alberta; Shea, Anita; De Risio, Luisa] Anim Hlth Trust, Ctr Small Anim Studies, Neurol Neurosurg Serv, Newmarket, Suffolk, England; [Guo, Ling T.; Shelton, G. Diane] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Burmeister, Louise M.] Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket, Suffolk, England	Animal Health Trust; University of California System; University of California San Diego; Animal Health Trust	Saanchez, L (corresponding author), Anim Hlth Trust, Ctr Small Anim Studies, Neurol Neurosurg Serv, Newmarket, Suffolk, England.	lluis.sanchez@aht.org.uk	De Risio, Luisa/ABB-3561-2020	De Risio, Luisa/0000-0001-9005-4165; Burmeister, Louise/0000-0002-6551-055X; BELTRAN, ELSA/0000-0002-0807-7817	Animal Health Trust; Kennel Club Charitable Trust	Animal Health Trust; Kennel Club Charitable Trust	The work was supported by the Animal Health Trust and the Kennel Club Charitable Trust. The funders provided support in the form of salaries for authors LS, EB, AdS, AS and LDR (Animal Health Trust) and LMB (Kennel Club Charitable Trust). The Kennel Club Genetics Centre at the Animal Health Trust is maintained by funding from the Kennel Club Charitable Trust (https://kccharitabletrust.org.uk/). One of the authors is currently employed by a commercial company, Dick White Referrals, but this affiliation did not play a role in the study as the author (AdS) was based at the Animal Health Trust at the time of their contribution to this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Anil G, 2010, RADIOL CLIN N AM, V48, P497, DOI 10.1016/j.rcl.2010.02.016; Atencia-Fernandez S, 2015, ANIM GENET, V46, P175, DOI 10.1111/age.12266; Baltzer WI, 2007, J AM ANIM HOSP ASSOC, V43, P227, DOI 10.5326/0430227; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Bushby K., 2005, CURRENT PAEDIAT, V15, P292, DOI [DOI 10.1016/J.CUPE.2005.04.001, 10.1016/j.cupe.2005.04.001, 10.1016/j.cupe.2005.04.001.4D]; CARPENTER JL, 1989, AM J PATHOL, V135, P909; CASKEY CT, 1980, CLIN GENET, V18, P329; COLE DEC, 1994, CLIN CHEM, V40, P2099; Collins CA, 2003, INT J EXP PATHOL, V84, P165, DOI 10.1046/j.1365-2613.2003.00354.x; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; Daoud F, 2009, HUM MOL GENET, V18, P3779, DOI 10.1093/hmg/ddp320; Dubowitz V., 2013, MUSCLE BIOPSY PRACTI; El Nemer W, 2000, EUR J IMMUNOGENET, V27, P29; FRANCKE U, 1985, AM J HUM GENET, V37, P250; Goldstein JA, 2010, J GEN PHYSIOL, V136, P29, DOI 10.1085/jgp.201010436; Guo LT, 2010, NEUROMUSCULAR DISORD, V20, P820, DOI 10.1016/j.nmd.2010.07.278; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoogerwaard EM, 1999, LANCET, V353, P2116, DOI 10.1016/S0140-6736(98)10028-4; Hoogerwaard EM, 1999, NEUROMUSCULAR DISORD, V9, P347, DOI 10.1016/S0960-8966(99)00018-8; Jenkins Christopher A, 2015, Canine Genet Epidemiol, V2, P7, DOI 10.1186/s40575-015-0019-4; Klymiuk N, 2013, HUM MOL GENET, V22, P4368, DOI 10.1093/hmg/ddt287; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Kornegay JN, 2003, NEUROMUSCULAR DISORD, V13, P493, DOI 10.1016/S0960-8966(03)00025-7; Kornegay JN, 2012, MAMM GENOME, V23, P85, DOI 10.1007/s00335-011-9382-y; Larcher T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110371; Le Guiner C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16105; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Nakamura K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05635; Nghiem PP, 2017, MAMM GENOME, V28, P106, DOI 10.1007/s00335-016-9675-2; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; Olby NJ, 2011, JAVMA-J AM VET MED A, V238, P207, DOI 10.2460/javma.238.2.207; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; Pouwels S, 2014, OSTEOPOROSIS INT, V25, P509, DOI 10.1007/s00198-013-2442-2; Ricotti V, 2016, DEV MED CHILD NEUROL, V58, P77, DOI 10.1111/dmcn.12922; Rozen S, 2000, Methods Mol Biol, V132, P365; Schatzberg SJ, 1998, MUSCLE NERVE, V21, P991, DOI 10.1002/(SICI)1097-4598(199808)21:8<991::AID-MUS2>3.3.CO;2-S; Schatzberg SJ, 1999, NEUROMUSCULAR DISORD, V9, P289, DOI 10.1016/S0960-8966(99)00011-5; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Shelton GD, 2009, NEUROMUSCULAR DISORD, V19, P800, DOI 10.1016/j.nmd.2009.09.006; Shelton GD, 2005, NEUROMUSCULAR DISORD, V15, P127, DOI 10.1016/j.nmd.2004.10.019; Shelton GD, 2002, VET CLIN N AM-SMALL, V32, P103, DOI 10.1016/S0195-5616(03)00081-0; Shelton GD, 2001, J VET INTERN MED, V15, P240, DOI 10.1892/0891-6640(2001)015&lt;0240:MDIFD&gt;2.3.CO;2; Smith BF, 2011, LAB INVEST, V91, P216, DOI 10.1038/labinvest.2010.146; VALENTINE BA, 1992, AM J MED GENET, V42, P352, DOI 10.1002/ajmg.1320420320; VanBelzen DJ, 2017, MOL THER-METH CLIN D, V4, P62, DOI 10.1016/j.omtm.2016.12.001; Walmsley GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008647; Wetterman CA, 2000, J AM VET MED ASSOC, V216, P878, DOI 10.2460/javma.2000.216.878; Winand N, 1994, MOL CHARACTERIZATION; WINNARD AV, 1995, AM J HUM GENET, V56, P158	55	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193372	10.1371/journal.pone.0193372	http://dx.doi.org/10.1371/journal.pone.0193372			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474464	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000426049500098
J	Aguilar-Ortiz, S; Salgado-Pineda, P; Marco-Pallares, J; Pascual, JC; Vega, D; Soler, J; Brunel, C; Martin-Blanco, A; Soto, A; Ribas, J; Maristany, T; Sarro, S; Salvador, R; Rodriguez-Fornells, A; Pomarol-Clotet, E; McKenna, PJ				Aguilar-Ortiz, Salvatore; Salgado-Pineda, Pilar; Marco-Pallares, Josep; Pascual, Juan C.; Vega, Daniel; Soler, Joaquim; Brunel, Cristina; Martin-Blanco, Ana; Soto, Angel; Ribas, Joan; Maristany, Teresa; Sarro, Salvador; Salvador, Raymond; Rodriguez-Fornells, Antoni; Pomarol-Clotet, Edith; McKenna, Peter J.			Abnormalities in gray matter volume in patients with borderline personality disorder and their relation to lifetime depression: A VBM study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; STRUCTURAL BRAIN ABNORMALITIES; AXIS-I COMORBIDITY; BIPOLAR DISORDER; FOLLOW-UP; METAANALYSIS; SCHIZOPHRENIA; INFERENCE; AMYGDALA; SIZE	Background Structural imaging studies of borderline personality disorder (BPD) have found regions of reduced cortical volume, but these have varied considerably across studies. Reduced hippocampus and amygdala volume have also been a regular finding in studies using conventional volumetric measurement. How far comorbid major depression, which is common in BPD and can also affect in brain structure, influences the findings is not clear. Methods Seventy-six women with BPD and 76 matched controls were examined using whole-brain voxel-based morphometry (VBM). The hippocampus and amygdala were also measured, using both conventional volume measurement and VBM within a mask restricted to these two subcortical structures. Lifetime history of major depression was assessed using structured psychiatric interview. Results At a threshold of p = 0.05 corrected, the BPD patients showed clusters of volume reduction in the dorsolateral prefrontal cortex bilaterally and in the pregenual/subgenual medial frontal cortex. There was no evidence of volume reductions in the hippocampus or amygdala, either on conventional volumetry or using VBM masked to these regions. Instead there was evidence of right-sided enlargement of these structures. No significant structural differences were found between patients with and without lifetime major depression. Conclusions According to this study, BPD is characterized by a restricted pattern of cortical volume reduction involving the dorsolateral frontal cortex and the medial frontal cortex, both areas of potential relevance for the clinical features of the disorder. Previous findings concerning reduced hippocampus and amygdala volume in the disorder are not supported. Brain structural findings in BPD do not appear to be explainable on the basis of history of associated lifetime major depression.	[Aguilar-Ortiz, Salvatore; Salgado-Pineda, Pilar; Brunel, Cristina; Sarro, Salvador; Salvador, Raymond; Pomarol-Clotet, Edith; McKenna, Peter J.] FIDMAG Germanes Hosp Res Fdn, Barcelona, Spain; [Aguilar-Ortiz, Salvatore; Brunel, Cristina] Benito Menni Ctr Assistencial Salut Mental, Barcelona, Spain; [Aguilar-Ortiz, Salvatore] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, PhD Programme, Psiquiatria, Barcelona, Spain; [Salgado-Pineda, Pilar; Pascual, Juan C.; Soler, Joaquim; Sarro, Salvador; Salvador, Raymond; Pomarol-Clotet, Edith; McKenna, Peter J.] CIBERSAM, Barcelona, Spain; [Marco-Pallares, Josep; Rodriguez-Fornells, Antoni] Univ Barcelona, Bellvitge Hosp, Fac Psychol, Barcelona, Spain; [Pascual, Juan C.; Soler, Joaquim; Martin-Blanco, Ana] Hosp Santa Creu & Sant Pau, Dept Psychiat, Barcelona, Spain; [Vega, Daniel; Soto, Angel; Ribas, Joan] Consorci Sanitari Anoia, Serv Psiquiatria & Salut Mental, Igualada, Spain; [Maristany, Teresa] Hosp St Joan de Deu, Esplugues De Llobregrat, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital of Santa Creu i Sant Pau	Pomarol-Clotet, E (corresponding author), FIDMAG Germanes Hosp Res Fdn, Barcelona, Spain.; Pomarol-Clotet, E (corresponding author), CIBERSAM, Barcelona, Spain.	epomarol-clotet@fidmag.com	Marco-Pallares, Josep/GNH-1787-2022; Marco-Pallares, Josep/C-1256-2008; Vendrell, Pere/B-4392-2011; vega, daniel/AAB-7859-2019; Pascual, Juan C./M-2559-2014; Sarro, Salvador/E-7806-2010	Marco-Pallares, Josep/0000-0001-9175-1480; Marco-Pallares, Josep/0000-0001-9175-1480; Vendrell, Pere/0000-0001-8918-5440; Pascual, Juan C./0000-0001-8039-9346; Soler, Joaquim/0000-0001-8077-3641; Sarro, Salvador/0000-0003-1835-2189; Vega, Daniel/0000-0002-5621-8987; Pomarol-Clotet, Edith/0000-0002-8159-8563; Salvador, Raymond/0000-0001-5557-1562; Salgado-Pineda, Pilar/0000-0001-7720-0885	Catalonian Government [2014SGR1573]; foundation La Fundacio A La Marato A de TV3 [2009-092410]; Miguel Servet Research Contract grants from the Plan Nacional de I+D+i [CP10/00596, CP13/00018]; Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion; European Regional Development Fund (FEDER)	Catalonian Government; foundation La Fundacio A La Marato A de TV3; Miguel Servet Research Contract grants from the Plan Nacional de I+D+i; Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion(Instituto de Salud Carlos III); European Regional Development Fund (FEDER)(European Commission)	This work was supported by the Catalonian Government (2014SGR1573), the foundation La Fundacio A La Marato A de TV3 (2009-092410) and two Miguel Servet Research Contract grants (CP10/00596 to EP-C and CP13/00018 to RS) from the Plan Nacional de I+D+i and co-funded by the Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion and the European Regional Development Fund (FEDER).; This work was supported by the Catalonian Government (2014SGR1573), the foundation La Fundacio La Marato de TV3 (2009-092410) and two Miguel Servet Research Contract grants (CP10/00596 to EP-C and CP13/00018 to RS) from the Plan Nacional de I+D+i and co-funded by the Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion and the European Regional Development Fund (FEDER).	Andersson M, 2007, TR07JA2 FMRIB; Arnone D, 2012, EUR NEUROPSYCHOPHARM, V22, P1, DOI 10.1016/j.euroneuro.2011.05.003; Arnone D, 2009, BRIT J PSYCHIAT, V195, P194, DOI 10.1192/bjp.bp.108.059717; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baker STE, 2013, NEUROSCI BIOBEHAV R, V37, P1713, DOI 10.1016/j.neubiorev.2013.06.015; Barrachina J, ACTAS ESPANOLAS PSIQ, V32, P293; Benjamini Y, 2001, ANN STAT, V29, P1165; Bohus M, 2009, PSYCHOPATHOLOGY, V42, P32, DOI 10.1159/000173701; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Bora E, 2010, BIOL PSYCHIAT, V67, P1097, DOI 10.1016/j.biopsych.2010.01.020; Brambilla P, 2004, PSYCHIAT RES-NEUROIM, V131, P125, DOI 10.1016/j.pscychresns.2004.04.003; Coccaro EF, 2011, BIOL PSYCHIAT, V69, P1153, DOI 10.1016/j.biopsych.2011.02.032; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; First M.B., 1999, ENTREVISTA 150 NICA; Frias A, 2015, PSYCHOPATHOLOGY, V48, P1, DOI 10.1159/000363145; GARCIA MV, 1995, ACTAS LUSO-ESP NEUR, V23, P178; GOMEZBENEYTO M, 1994, J PERS DISORD, V8, P104, DOI 10.1521/pedi.1994.8.2.104; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; GUNDERSON JG, 1987, J CLIN PSYCHIAT, V48, P5; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Hazlett EA, 2005, BIOL PSYCHIAT, V58, P614, DOI 10.1016/j.biopsych.2005.04.029; Hibar DP, 2016, MOL PSYCHIAT; Irle E, 2005, BIOL PSYCHIAT, V57, P173, DOI 10.1016/j.biopsych.2004.10.004; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Koenigsberg HW, 1999, DEPRESS ANXIETY, V10, P158, DOI 10.1002/(SICI)1520-6394(1999)10:4<158::AID-DA4>3.0.CO;2-B; Labudda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083677; Leichsenring F, 2011, LANCET, V377, P74, DOI 10.1016/S0140-6736(10)61422-5; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Lis E, 2007, J PSYCHIATR NEUROSCI, V32, P162; Lyoo IK, 1998, J AFFECT DISORDERS, V50, P235, DOI 10.1016/S0165-0327(98)00104-9; Niedtfeld I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065824; Nunes PM, 2009, J PERS DISORD, V23, P333, DOI 10.1521/pedi.2009.23.4.333; OBrien LM, HARV REV PSYCHIAT, V14, P141; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pearse LJ, 2014, J NERV MENT DIS, V202, P368, DOI 10.1097/NMD.0000000000000132; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Ruocco AC, 2005, PSYCHIAT RES, V137, P191, DOI 10.1016/j.psychres.2005.07.004; Ruocco AC, 2012, PSYCHIAT RES-NEUROIM, V201, P245, DOI 10.1016/j.pscychresns.2012.02.012; Sacher J, 2013, MAGN RESON IMAGING, V31, P366, DOI 10.1016/j.mri.2012.06.007; Sala M, 2011, J AFFECT DISORDERS, V131, P417, DOI 10.1016/j.jad.2010.11.036; Schulte T, 2012, ALCOHOL CLIN EXP RES, V36, P2017, DOI 10.1111/j.1530-0277.2012.01831.x; Schulze L, 2016, BIOL PSYCHIAT, V79, P97, DOI 10.1016/j.biopsych.2015.03.027; Sebastian A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00698; Selvaraj S, 2012, BIPOLAR DISORD, V14, P135, DOI 10.1111/j.1399-5618.2012.01000.x; Slotema CW, 2012, PSYCHOL MED, V42, P1873, DOI 10.1017/S0033291712000165; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Soler J, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-139; Soloff P, 2008, PSYCHIAT RES-NEUROIM, V164, P223, DOI 10.1016/j.pscychresns.2008.02.003; Soloff PH, 2012, J PSYCHIATR RES, V46, P516, DOI 10.1016/j.jpsychires.2012.01.003; Wingenfeld K, 2010, PSYCHONEUROENDOCRINO, V35, P154, DOI 10.1016/j.psyneuen.2009.09.014; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zanarini MC, 2013, AM J PSYCHIAT, V170, P671, DOI 10.1176/appi.ajp.2013.13010055; Zanarini MC, 2004, AM J PSYCHIAT, V161, P2108, DOI 10.1176/appi.ajp.161.11.2108; Zanarini MC, 1998, AM J PSYCHIAT, V155, P1733, DOI 10.1176/ajp.155.12.1733; Zetzsche T, 2006, BIOL PSYCHIAT, V60, P302, DOI 10.1016/j.biopsych.2005.11.020; Zimmerman Mark, 2013, Dialogues Clin Neurosci, V15, P155	60	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0191946	10.1371/journal.pone.0191946	http://dx.doi.org/10.1371/journal.pone.0191946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	29466364	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300021
J	El Moussawi, L; Chakkour, M; Kreydiyyeh, SI				El Moussawi, Layla; Chakkour, Mohamed; Kreydiyyeh, Sawsan I.			Epinephrine modulates Na+/K+ ATPase activity in Caco-2 cells via Src, p38MAPK, ERK and PGE2	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; IRRITABLE-BOWEL-SYNDROME; NF-KAPPA-B; K+-ATPASE; NA+,K+-ATPASE ACTIVITY; CROSS-TALK; P38 MAPK; CARDIAC MYOCYTES; KINASE-ACTIVITY; ACTIVATION	Epinephrine, a key stress hormone, is known to affect ion transport in the colon. Stress has been associated with alterations in colonic functions leading to changes in water movements manifested as diarrhea or constipation. Colonic water movement is driven by the Na+-gradient created by the Na+/K+-ATPase. Whether epinephrine acts via an effect on the Na+/K+-ATPase hasn't been studied before. The aim of this work was to investigate the effect of epinephrine on the Na+/K+-ATPase and to elucidate the signaling pathway involved using CaCo-2 cells as a model. The activity of the Na+/K+-ATPase was assayed by measuring the amount of inorganic phosphate released in presence and absence of ouabain, a specific inhibitor of the enzyme. Epinephrine, added for 20 minutes, decreased the activity of the Na+/K+-ATPase by around 50%. This effect was found to be mediated by alpha 2 adrenergic receptors as it was fully abolished in the presence of yohimbine an alpha 2-blocker, but persisted in presence of other adrenergic antagonists. Furthermore, treatment with Rp-cAMP, a PKA inhibitor, mimicked epinephrine's negative effect and didn't result in any additional inhibition when both were added simultaneously. Treatment with indomethacin, PP2, SB202190, and PD98059, respective inhibitors of COX enzymes, Src, p38MAPK, and ERK completely abrogated the effect of epinephrine. The effect of epinephrine did not appear also in presence of inhibitors of all four different types of PGE2 receptors. Western blot analysis revealed an epinephrine-induced increase in the phosphorylation of p38 MAPK and ERK that disappeared in presence of respectively PP2 and SB2020190. In addition, an inhibitory effect, similar to that of epinephrine's, was observed upon incubation with PGE2. It was concluded that epinephrine inhibits the Na+/K+-ATPase by the sequential activation of alpha 2 adrenergic receptors, Src, p38MAPK, and ERK leading to PGE2 release.	[El Moussawi, Layla; Chakkour, Mohamed; Kreydiyyeh, Sawsan I.] Amer Univ Beirut, Dept Biol, Fac Arts & Sci, Beirut, Lebanon	American University of Beirut	Kreydiyyeh, SI (corresponding author), Amer Univ Beirut, Dept Biol, Fac Arts & Sci, Beirut, Lebanon.	Sawkreyd@aub.edu.lb			University Research Board; University Research Board at the American University of Beirut	University Research Board; University Research Board at the American University of Beirut	This work was supported by the University Research Board.; This work was funded by the University Research Board at the American University of Beirut. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen H, 2003, J BIOL CHEM, V278, P17170, DOI 10.1074/jbc.M211426200; ADAMVIZI V, 1979, J NEURAL TRANSM, V46, P59, DOI 10.1007/BF01243429; Averbeck B, 2001, NEUROREPORT, V12, P2097, DOI 10.1097/00001756-200107200-00011; BERTORELLO AM, 1991, P NATL ACAD SCI USA, V88, P11359, DOI 10.1073/pnas.88.24.11359; Bhatia V, 2005, J GASTROEN HEPATOL, V20, P332, DOI 10.1111/j.1440-1746.2004.03508.x; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; BOUSCAREL B, 1985, EUR J PHARMACOL, V107, P223, DOI 10.1016/0014-2999(85)90062-7; Chae HJ, 2004, IMMUNOPHARM IMMUNOT, V26, P75, DOI 10.1081/IPH-120029946; CHARNEY AN, 1975, J CLIN INVEST, V56, P653, DOI 10.1172/JCI108135; CHARNEY AN, 1976, J CLIN INVEST, V57, P1590, DOI 10.1172/JCI108429; CHEN YH, 1994, J BIOL CHEM, V269, P27372; Cimen B, 2004, MOL CELL BIOCHEM, V259, P53, DOI 10.1023/B:MCBI.0000021344.64317.a2; Cornelius F, 1996, FEBS LETT, V380, P277, DOI 10.1016/0014-5793(96)00032-4; DICAMPO V, 1990, FEBS LETT, V274, P96, DOI 10.1016/0014-5793(90)81338-O; ERICKSONLAMY KA, 1992, INVEST OPHTH VIS SCI, V33, P2672; ESMANN M, 1988, METHOD ENZYMOL, V156, P105; EVERHART JE, 1991, GASTROENTEROLOGY, V100, P998, DOI 10.1016/0016-5085(91)90275-P; Feleder C, 2004, AM J PHYSIOL-REG I, V286, pR1156, DOI 10.1152/ajpregu.00486.2003; FESCHENKO MS, 1995, J BIOL CHEM, V270, P14072, DOI 10.1074/jbc.270.23.14072; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; HAWK CT, 1993, AM J PHYSIOL, V265, pF449, DOI 10.1152/ajprenal.1993.265.3.F449; Irtegun S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071035; ISHIDA M, 1995, CIRC RES, V77, P1053, DOI 10.1161/01.RES.77.6.1053; James JH, 1999, AM J PHYSIOL-ENDOC M, V277, pE176, DOI 10.1152/ajpendo.1999.277.1.E176; Jin XH, 1998, AM J PHYSIOL-REG I, V275, pR515, DOI 10.1152/ajpregu.1998.275.2.R515; Kemeny M, 2003, CURRENT DIRECTIONS P, V12, P1599; Kreydiyyeh SI, 2007, PROSTAG OTH LIPID M, V83, P295, DOI 10.1016/j.prostaglandins.2007.02.003; Kreydiyyeh SI, 2004, PFLUG ARCH EUR J PHY, V448, P231, DOI 10.1007/s00424-004-1242-0; Kreydiyyeh SI, 2000, LIFE SCI, V67, P1275, DOI 10.1016/S0024-3205(00)00717-7; Lane SM, 1998, AM J RESP CRIT CARE, V158, P760, DOI 10.1164/ajrccm.158.3.9802031; Lee C, 2017, J NEUROGASTROENTEROL, V23, P349, DOI 10.5056/jnm16220; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; MINTOROVITCH J, 1994, J CEREBR BLOOD F MET, V14, P332, DOI 10.1038/jcbfm.1994.40; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; NATHANSON JA, 1995, NEURON, V14, P781, DOI 10.1016/0896-6273(95)90222-8; OHTOMO Y, 1994, KIDNEY INT, V45, P1606, DOI 10.1038/ki.1994.211; Oliveira MS, 2009, J NEUROCHEM, V109, P416, DOI 10.1111/j.1471-4159.2009.05961.x; Pechkovsky DV, 2008, J BIOL CHEM, V283, P12898, DOI 10.1074/jbc.M708226200; Perez-Vizcaino F, 1999, AM J PHYSIOL-HEART C, V276, pH651, DOI 10.1152/ajpheart.1999.276.2.H651; Rouch AJ, 2000, AM J PHYSIOL-RENAL, V279, pF294, DOI 10.1152/ajprenal.2000.279.2.F294; Seven I, 2005, MOL CELL BIOCHEM, V271, P107, DOI 10.1007/s11010-005-5616-1; Shih C, 2004, IMMUNOPHARMACOLOGY I, V618, P70; SIMONSON MS, 1993, J BIOL CHEM, V268, P9347; Singh RP, 1999, J BIOL CHEM, V274, P19593, DOI 10.1074/jbc.274.28.19593; Skayian Y, 2006, LIFE SCI, V80, P173, DOI 10.1016/j.lfs.2006.08.037; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Thobe BM, 2006, AM J PHYSIOL-CELL PH, V291, pC476, DOI 10.1152/ajpcell.00076.2006; Xia Q, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.69	50	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193139	10.1371/journal.pone.0193139	http://dx.doi.org/10.1371/journal.pone.0193139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466417	Green Submitted, gold, Green Published			2022-12-26	WOS:000425604300089
J	Newman, LP; Bhat, N; Fleming, JA; Neuzil, KM				Newman, Laura P.; Bhat, Niranjan; Fleming, Jessica A.; Neuzil, Kathleen M.			Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016	PLOS ONE			English	Article							DOSE DISTRIBUTION; EPIDEMIOLOGY	By analyzing publicly available surveillance data from 2011-2016, we produced country-specific estimates of seasonal influenza activity for 118 countries in the six World Health Organization regions. Overall, the average country influenza activity period was 4.7 months. Our analysis characterized 100 countries (85%) with one influenza peak season, 13 (11%) with two influenza peak seasons, and five (4%) with year-round influenza activity. Surveillance data were limited for many countries. These data provide national estimates of influenza activity, which may guide planning for influenza vaccination implementation, program timing and duration, and policy development.	[Newman, Laura P.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Bhat, Niranjan; Fleming, Jessica A.; Neuzil, Kathleen M.] PATH, Ctr Vaccine Innovat & Access, Seattle, WA USA; [Neuzil, Kathleen M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA	University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Baltimore	Newman, LP (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	lpnewman@uw.edu			Bill and Melinda Gates Foundation [OPP1084288]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was financially supported by grant OPP1084288 from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P67, DOI 10.1111/j.1750-2659.2010.00183.x; Andrus JK, 2007, PUBLIC HEALTH REP, V122, P811; [Anonymous], 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.1.009, 10.5365/WPSAR.2013.4.1.009]; [Anonymous], 2015, WHO EXP GROUP M SEAS; [Anonymous], J INFECT DIS S1; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Caini S, 2017, SPATIOTEMPORAL CHARA; Chadha MS, 2015, DYNAMICS INFLUENZA S, P1; Chen JF, 2014, SE ASIAN J TROP MED, V45, P319; Clerc Y, 1980, Arch Inst Pasteur Madagascar, V47, P101; CLERC Y, 1981, Archives de l'Institut Pasteur de Madagascar, V48, P223; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dalhatu IT, 2012, J INFECT DIS S1, V206, P2009; de Mello WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005095; Debellut F, 2017, FORECASTING DEMAND M; Emukule GO, 2016, INFLUENZA ACTIVITY K, P2007; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003; Katz MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098615; Koul PA, 2014, EMERG INFECT DIS, V20, P1723, DOI 10.3201/eid2010.140431; Lambach P, 2015, VACCINE, V33, P6493, DOI 10.1016/j.vaccine.2015.08.037; Lutwama JJ, 2012, J INFECT DIS, V206, pS87, DOI 10.1093/infdis/jis578; McLean KA, 2016, VACCINE, P8; Mmbaga VM, 2012, J INFECT DIS S1, V206, p[2008, 2008]; Moura FEA, 2010, CURR OPIN INFECT DIS, V23, P415, DOI 10.1097/QCO.0b013e32833cc955; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; Nyatanyi T, 2012, J INFECT DIS S1, V206, P2008; Paget J, 2007, EUROPE, V7, P2004; Palache A, 2015, VACCINE, V33, P5598, DOI 10.1016/j.vaccine.2015.08.082; Palache A, 2014, VACCINE, V32, P6369, DOI 10.1016/j.vaccine.2014.07.012; Ravaoarinoro M, 1982, Arch Inst Pasteur Madagascar, V49, P85; Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412; Samaan G, 2013, REV EVIDENCE SUPPORT, V8; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tay EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077244; Western Pacific Region Global Influenza Surveillance, 2012, PLOS ONE, V7, P2006; WHO, 2013, GLOB EP SURV STAND I; World Health Organization, 2011, MAN LAB DIAGN VIR SU; World Health Organization, 2012, VACC INFL; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552	43	37	38	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193263	10.1371/journal.pone.0193263	http://dx.doi.org/10.1371/journal.pone.0193263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466459	Green Submitted, Green Published, gold			2022-12-26	WOS:000425604300105
J	Brand, RF; Rostal, MK; Kemp, A; Anyamba, A; Zwiegers, H; Van Huyssteen, CW; Karesh, WB; Paweska, JT				Brand, Robert F.; Rostal, Melinda K.; Kemp, Alan; Anyamba, Assaf; Zwiegers, Herman; Van Huyssteen, Cornelius W.; Karesh, William B.; Paweska, Janusz T.			A phytosociological analysis and description of wetland vegetation and ecological factors associated with locations of high mortality for the 2010-11 Rift Valley fever outbreak in South Africa	PLOS ONE			English	Article							VIRUS; SEROPREVALENCE; CIRCULATION; PREDICTION; PROVINCE; VECTORS; HISTORY; KENYA	Rift Valley fever (RVF) is endemic in Africa and parts of the Middle East. It is an emerging zoonotic disease threat to veterinary and public health. Outbreaks of the disease have severe socio-economic impacts. RVF virus emergence is closely associated with specific endorheic wetlands that are utilized by the virus' mosquito vectors. Limited botanical vegetation surveys had been published with regard to RVF virus (RVFV) ecology. We report on a phytosociological classification, analysis and description of wetland vegetation and related abiotic parameters to elucidate factors possibly associated with the 2010-2011 RVFV disease outbreak in South Africa. The study sites were located in the western Free State and adjacent Northern Cape covering an area of similar to 40,000 km(2) with wetlands associated with high RVF mortality rates in livestock. Other study sites included areas where no RVF activity was reported during the 2010-11 RVF outbreak. A total of 129 plots (30 m(2)) were selected where a visible difference could be seen in the wetland and upland vegetation. The Braun-Blanquet method was used for plant sampling. Classification was done using modified Two-Way Indicator Species Analysis. The vegetation analysis resulted in the identification of eight plant communities, seven sub-communities and two variants. Indirect ordination was carried out using CANOCO to investigate the relationship between species and wetland ecology. The study also identified 5 categories of wetlands including anthropogenic wetlands. Locations of reported RVF cases overlapped sites characterized by high clay-content soils and specific wetland vegetation. These findings indicate ecological and environmental parameters that represent preferred breeding habitat for RVFV competent mosquito vectors.	[Brand, Robert F.] Cuyahoga Cty Board Hlth, Parma, OH USA; [Brand, Robert F.] Univ Free State, Dept Bot, Bloemfontein, South Africa; [Rostal, Melinda K.; Karesh, William B.] EcoHlth Alliance, New York, NY USA; [Kemp, Alan; Paweska, Janusz T.] Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa; [Anyamba, Assaf] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA; [Anyamba, Assaf] Univ Space Res Assoc, Greenbelt, MD USA; [Zwiegers, Herman] ExecuVet Bloemfontein, Bloemfontein, Free State, South Africa; [Van Huyssteen, Cornelius W.] Univ Free State, Soil & Crop & Climate Sci Dept, Bloemfontein, Free State, South Africa	University of the Free State; EcoHealth Alliance; National Institute for Communicable Diseases (NICD); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universities Space Research Association (USRA); University of the Free State	Brand, RF (corresponding author), Cuyahoga Cty Board Hlth, Parma, OH USA.; Brand, RF (corresponding author), Univ Free State, Dept Bot, Bloemfontein, South Africa.; Rostal, MK (corresponding author), EcoHlth Alliance, New York, NY USA.	robertbrand22@gmail.com; rostal@ecohealthalliance.org	Karesh, William/AAU-9084-2020	Karesh, William/0000-0001-6042-2860; Anyamba, Assaf/0000-0003-0932-9585; Brand, Robert/0000-0002-9790-3120; Rostal, Melinda/0000-0002-6563-5280; /0000-0002-2051-467X	Defense Threat Reduction Agency [HDTRA1-14-1-0029]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Defense Threat Reduction Agency, Grant Number: HDTRA1-14-1-0029, DTRA URL: http://www.dtra.mil/. The only funding that was used or contributed to this study was provided via a grant by DTRA. The funding agency, DTRA, did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. The specific roles of authors are articulated in the author contributions section.	[Anonymous], 2017, UNPUBLISHED RFV YEAR; Anyamba A, 2010, AM J TROP MED HYG, V83, P43, DOI 10.4269/ajtmh.2010.09-0289; Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; Archer BN, 2013, EMERG INFECT DIS, V19, P1918, DOI 10.3201/eid1912.121527; Arum SO, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1601-7; BARNARD BJH, 1977, J S AFR VET ASSOC, V48, P45; Bezuidenhout H., 1995, KOEDOE, V38, P2; Brand RF, 2013, S AFR J BOT, V88, P223, DOI 10.1016/j.sajb.2013.07.011; Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE G, DOI 10.1007/978-3-7091-8110-2; Britch S.C., 2007, EMERG INFECT DIS, V13, P1; Brown LR, 2013, KOEDOE, V55, DOI 10.4102/koedoe.v55i1.1103; Buckner EA, 2011, J VECTOR ECOL, V36, P269, DOI 10.1111/j.1948-7134.2011.00167.x; Catuneanu O, 2005, J AFR EARTH SCI, V43, P211, DOI 10.1016/j.jafrearsci.2005.07.007; Cetre-Sossah C, 2012, EMERG INFECT DIS, V18, P972, DOI 10.3201/eid1806.111165; Collins NB, 2009, THESIS; Collins NB, 2014, VEGCAP PROGRAM CAPTU; Collins NB., 2005, WETLANDS BASICS SOME; Cronk J, 2001, WETLAND PLANTS BIOL; Dingaan M. N. V., 2002, Navorsinge van die Nasionale Museum Bloemfontein, V18, P33; El Vilaly AE, 2013, PROG PHYS GEOG, V37, P259, DOI 10.1177/0309133313478315; Evans A, 2008, EPIDEMIOL INFECT, V136, P1261, DOI 10.1017/S0950268807009806; Fafetine J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002065; GAUCH HG, 1982, ECOLOGY, V63, P1643, DOI 10.2307/1940105; Gauch Jr HG, 1982, MULTIVARIATE ANAL CO; Gear J, 1951, S AFR MED J, P909; Geldenhuys J.N, 1982, S AFRICAN J WILDLIFE, V12; Germishuizen G., 2006, 41 SABONET; GOUDIE AS, 1991, PROG PHYS GEOG, V15, P221, DOI 10.1177/030913339101500301; Heinrich N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001557; Hill M.O., 1979, TWINSPAN FORTRAN PRO; Holmes PJ, 2008, HOLOCENE, V18, P1193, DOI 10.1177/0959683608095577; Jupp PG, 1998, J AM MOSQUITO CONTR, V14, P40; Keddy PA, 2004, Q REV BIOL, V79, P55, DOI 10.1086/381509; Kent M., 1992, VEGETATION DESCRIPTI; LaBeaud AD, 2011, AM J TROP MED HYG, V84, P641, DOI 10.4269/ajtmh.2011.10-0187; Legendre P., 1998, NUMERICAL ECOLOGY; LEPS J, 1992, J VEG SCI, V3, P119, DOI 10.2307/3236006; LINTHICUM KJ, 1984, MOSQ NEWS, V44, P228; Marshall TR, 1987, ORIGIN PANS W ORANGE; McIntosh B. M., 1981, Rift Valley fever. Proceedings of a Workshop on Rift Valley fever, Herzlia, Israel, March 18-21, 1980., P92; Mdlulwa Z, 2015, THESIS; Miller M, 2011, J ZOO WILDLIFE MED, V42, P29, DOI 10.1638/2009-0176.1; Mucina L., 2006, VEGETATION S AFRICA; Mueller-Dombois D., 1974, AIMS METHODS VEGETAT; Murithi RM, 2011, EPIDEMIOL INFECT, V139, P372, DOI 10.1017/S0950268810001020; Novella NS, 2013, J APPL METEOROL CLIM, V52, P588, DOI 10.1175/JAMC-D-11-0238.1; NYAGAH K, 1995, SEDIMENT GEOL, V96, P43, DOI 10.1016/0037-0738(94)00126-F; PEDGLEY DE, 1983, PHILOS T R SOC B, V302, P463, DOI 10.1098/rstb.1983.0068; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Pienaar Nicolaas J., 2013, Onderstepoort j. vet. res., V80, P1; Podani J, 2006, J VEG SCI, V17, P113, DOI 10.1111/j.1654-1103.2006.tb02429.x; Pourrut X, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000763; Romoser WS, 2011, RES REP TROP MED, V2, P121, DOI 10.2147/RRTM.S13947; RSA OIE Rift Valley fever Virus, 2010, 17 RSA; SELLERS RF, 1980, J HYG-CAMBRIDGE, V85, P65, DOI 10.1017/S0022172400027108; SELLERS RF, 1982, VET REC, V110, P73, DOI 10.1136/vr.110.4.73; Sheldon, 1996, SELECTED GUIDELINES; Sindato C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005002; Tichy L, 2006, USERS MANUAL J VEG S; Tiner R.W., 1999, WETLAND INDICATORS G; Verdonschot PFM, 2014, LIMNOLOGICA, V45, P69, DOI 10.1016/j.limno.2013.11.002; WEIHER E, 1995, OIKOS, V73, P323, DOI 10.2307/3545956; Westhoff V., 1973, CLASSIFICATION PLANT, V5, P617, DOI [10.1007/978-94-010-2701-4_20, DOI 10.1007/978-94-009-9183-5_9]; Whitaker R. H., 1980, CLASSIFICATION PLANT; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023	65	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0191585	10.1371/journal.pone.0191585	http://dx.doi.org/10.1371/journal.pone.0191585			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462214	Green Submitted, gold, Green Published			2022-12-26	WOS:000425554200009
J	Lewis, AR; Young, RP; Gibbons, JM; Jones, JPG				Lewis, Amy R.; Young, Richard P.; Gibbons, James M.; Jones, Julia P. G.			To what extent do potential conservation donors value community-aspects of conservation projects in low income countries?	PLOS ONE			English	Article							NATURAL-RESOURCE MANAGEMENT; BIODIVERSITY CONSERVATION; ECOSYSTEM SERVICES; POVERTY ALLEVIATION; CHOICE EXPERIMENTS; PREFERENCE; VALUATION; COSTS; EXPERIENCES; PAYMENTS	There is a major gap in funding required for conservation, especially in low income countries. Given the significant contribution of taxpayers in industrialized countries to funding conservation overseas, and donations from membership organisation, understanding the preferences of ordinary people in a high income country for different attributes of conservation projects is valuable for future marketing of conservation. We conducted a discrete choice experiment with visitors to a UK zoo, while simultaneously conducting a revealed preference study through a real donation campaign on the same sample. Respondents showed the highest willingness to pay for projects that have local community involvement in management (95% confidence interval 9.82 pound to 15.83) pound, and for improvement in threatened species populations (2.97 pound - 13.87) pound. Both of these were significantly larger than the willingness to pay for projects involving provision of alternative livelihoods, or improving the condition of conservation sites. Results of the simultaneous donation campaign showed that respondents were very willing to donate the suggested 1 pound or above donation (88% made a donation, n = 1798); there was no effect of which of the two campaigns they were exposed to (threatened species management or community involvement in management). The small number of people who did not make a donation had a higher stated willingness to pay within the choice experiment, which may suggest hypothetical bias. Conservationists increasingly argue that conservation should include local communities in management (for both pragmatic and moral reasons). It is heartening that potential conservation donors seem to agree.	[Lewis, Amy R.; Gibbons, James M.; Jones, Julia P. G.] Bangor Univ, Sch Environm Nat Resources & Geog, Gwynedd, Wales; [Young, Richard P.] Durrell Wildlife Conservat Trust, Jersey, Channel Islands, England; [Young, Richard P.] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England	Bangor University; Imperial College London	Lewis, AR (corresponding author), Bangor Univ, Sch Environm Nat Resources & Geog, Gwynedd, Wales.	amy.spike.lewis@gmail.com	Jones, Julia P G/ABD-5629-2021	Jones, Julia P G/0000-0002-5199-3335; Lewis, Amy/0000-0001-5682-4541; Young, Richard/0000-0002-6515-6343; Gibbons, James/0000-0002-0083-9872	Leverhulme Trust [RPG-2014-056]	Leverhulme Trust(Leverhulme Trust)	This research was funded by the Leverhulme Trust, grant code: RPG-2014-056 (www.leverhulme.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Amulen DR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172820; Ancrenaz M, 2007, PLOS BIOL, V5, P2443, DOI 10.1371/journal.pbio.0050289; Andrianandrasana HT, 2005, BIODIVERS CONSERV; Arana JE, 2013, J TRAVEL RES, V52, P82, DOI 10.1177/0047287512457260; Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Bare M, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125010; Birol E, 2006, ECOL ECON, V60, P145, DOI 10.1016/j.ecolecon.2006.06.002; Boissiere M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176897; Booth JE, 2009, BIOL CONSERV, V142, P3196, DOI 10.1016/j.biocon.2009.07.024; Brimont L, 2015, ECOSYST SERV, V14, P113, DOI 10.1016/j.ecoser.2015.04.003; Brouwer R, 2000, ECOL ECON, V32, P137, DOI 10.1016/S0921-8009(99)00070-1; Carlsson F, 2001, J ENVIRON ECON MANAG, V41, P179, DOI 10.1006/jeem.2000.1138; Christie M, 2012, ECOL ECON, V83, P67, DOI 10.1016/j.ecolecon.2012.08.012; Desbureaux S., 2016, IMPACT PROTECTED ARE; Di Minin E, 2013, ANIM CONSERV, V16, P249, DOI 10.1111/j.1469-1795.2012.00595.x; Dolch Rainer, 2015, Madagascar Conservation & Development, V10, P21; DWP, 2013, STATISTICS; Dyer J, 2014, J ENVIRON MANAGE, V137, P137, DOI 10.1016/j.jenvman.2013.11.057; Earle S., 2016, THESIS; Fisher B, 2007, ECOL ECON, V62, P93, DOI 10.1016/j.ecolecon.2006.05.020; Fisher JA, 2014, ECOSYST SERV, V7, P34, DOI 10.1016/j.ecoser.2013.08.002; Gardner CJ, 2011, ORYX, V45, P336, DOI 10.1017/S0030605310001808; Gardner CJ, 2013, J APPL ECOL, V50, P1289, DOI 10.1111/1365-2664.12164; Hanley N, 2003, ANIM CONSERV, V6, P123, DOI 10.1017/S1367943003003160; Hanley N, 2001, J ECON SURV, V15, P435, DOI 10.1111/1467-6419.00145; Hanley N, 1998, ENVIRON RESOUR ECON, V11, P413, DOI 10.1023/A:1008287310583; Hartung C, 2010, P 4 ACM IEEE INT C I, DOI [DOI 10.1145/2369220.2369236, 10.1145/2369220.2369236]; Hein L, 2013, CURR OPIN ENV SUST, V5, P87, DOI 10.1016/j.cosust.2012.12.004; Hensher DA, 2003, TRANSPORTATION, V30, P133, DOI 10.1023/A:1022558715350; Hensher DA, 2010, TRANSPORT RES B-METH, V44, P735, DOI 10.1016/j.trb.2009.12.012; Hirsch PD, 2011, CONSERV BIOL, V25, P259, DOI 10.1111/j.1523-1739.2010.01608.x; Hughes R, 2001, INTEGRATING CONSERVA, V3; Johansson-Stenman O, 2012, J ECON BEHAV ORGAN, V84, P879, DOI 10.1016/j.jebo.2012.10.006; Kellert SR, 2000, SOC NATUR RESOUR, V13, P705, DOI 10.1080/089419200750035575; Kenter JO, 2011, GLOBAL ENVIRON CHANG, V21, P505, DOI 10.1016/j.gloenvcha.2011.01.001; Li C, 2015, P NATL ACAD SCI USA, V112, P7396, DOI 10.1073/pnas.1406486112; List JA, 2001, ENVIRON RESOUR ECON, V20, P241, DOI 10.1023/A:1012791822804; Markova-Nenova N, 2017, FOREST POLICY ECON, V80, P71, DOI 10.1016/j.forpol.2017.02.005; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Morkbak MR, 2010, ENVIRON RESOUR ECON, V45, P537, DOI 10.1007/s10640-009-9327-z; Morse-Jones S, 2012, ECOL ECON, V78, P9, DOI 10.1016/j.ecolecon.2011.11.002; Murphy JJ, 2005, ENVIRON RESOUR ECON, V30, P313, DOI 10.1007/s10640-004-3332-z; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pascual U, 2014, BIOSCIENCE, V64, P1027, DOI 10.1093/biosci/biu146; Peters H, 2009, OCEAN COAST MANAGE, V52, P219, DOI 10.1016/j.ocecoaman.2008.12.001; Pollini J, 2014, EARTH CONSERV DEV, P172; Rabearivony Jeanneney, 2010, Madagascar Conservation & Development, V5, P35; Rakotonarivo OS, 2016, J ENVIRON MANAGE, V183, P98, DOI 10.1016/j.jenvman.2016.08.032; Rakotonarivo OS, 2016, IMPROVING CHOICE EXP; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Rasolofoson R.A., 2016, CONSERV LETT, V2, P1, DOI [10.1111/conl.12272, DOI 10.1111/CONL.12272]; Roe D, 2011, GATEKEEPER, V150, P28; Salafsky N, 2000, WORLD DEV, V28, P1421, DOI 10.1016/S0305-750X(00)00031-0; Sarrias M, 2015, TITLE MULTINOMIAL LO; Scales IR, 2014, EARTH CONSERV DEV, P1; Taylor LO, 2010, ENVIRON RESOUR ECON, V47, P197, DOI 10.1007/s10640-010-9371-8; Waeber PO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161115; Whitworth AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029839; Zander KK, 2014, CONSERV SOC, V12, P27, DOI 10.4103/0972-4923.132126	60	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2018	13	2							e0192935	10.1371/journal.pone.0192935	http://dx.doi.org/10.1371/journal.pone.0192935			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW5PR	29451923	Green Submitted, gold, Green Published			2022-12-26	WOS:000425369800026
J	Bryant, JD; Sweeney, SR; Sentandreu, E; Shin, M; Ipas, H; Xhemalce, B; Momb, J; Tiziani, S; Appling, DR				Bryant, Joshua D.; Sweeney, Shannon R.; Sentandreu, Enrique; Shin, Minhye; Ipas, Helene; Xhemalce, Blerta; Momb, Jessica; Tiziani, Stefano; Appling, Dean R.			Deletion of the neural tube defect-associated gene Mthfd1l disrupts one-carbon and central energy metabolism in mouse embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSURE DEFECTS; MURINE EMBRYOS; FOLATE; MICE; SERINE; CYCLE; SUPPRESSION; DATABASE; HUMANS; UNITS	One-carbon (1C) metabolism is a universal folate-dependent pathway essential for de novo purine and thymidylate synthesis, amino acid interconversion, universal methyl-donor production, and regeneration of redox cofactors. Homozygous deletion of the 1C pathway gene Mthfd1l encoding methylenetetrahydrofolate dehydrogenase (NADP(+)-dependent) 1-like, which catalyzes mitochondrial formate production from 10-formyltetrahydrofolate, results in 100% penetrant embryonic neural tube defects (NTDs), underscoring the central role of mitochondrially derived formate in embryonic development and providing a mechanistic link between folate and NTDs. However, the specific metabolic processes that are perturbed by Mthfd1l deletion are not known. Here, we performed untargeted metabolomics on whole Mthfd1l-null and wildtype mouse embryos in combination with isotope tracer analysis in mouse embryonic fibroblast (MEF) cell lines to identify Mthfd1l deletion-induced disruptions in 1C metabolism, glycolysis, and the TCA cycle. We found that maternal formate supplementation largely corrects these disruptions in Mthfd1l-null embryos. Serine tracer experiments revealed that Mthfd1l-null MEFs have altered methionine synthesis, indicating that Mthfd1l deletion impairs the methyl cycle. Supplementation of Mthfd1l-null MEFs with formate, hypoxanthine, or combined hypoxanthine and thymidine restored their growth to wildtype levels. Thymidine addition alone was ineffective, suggesting a purine synthesis defect in Mthfd1l-null MEFs. Tracer experiments also revealed lower proportions of labeled hypoxanthine and inosine monophosphate in Mthfd1l-null than in wildtype MEFs, suggesting that Mthfd1l deletion results in increased reliance on the purine salvage pathway. These results indicate that disruptions of mitochondrial 1C metabolism have wide-ranging consequences for many metabolic processes, including those that may not directly interact with 1C metabolism.	[Bryant, Joshua D.; Shin, Minhye; Ipas, Helene; Xhemalce, Blerta; Momb, Jessica; Appling, Dean R.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Sweeney, Shannon R.; Sentandreu, Enrique; Tiziani, Stefano] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Sweeney, Shannon R.; Sentandreu, Enrique; Tiziani, Stefano] Univ Texas Austin, Dell Pediat Res Inst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Appling, DR (corresponding author), Univ Texas Austin, 100 East 24th St,Stop A5000, Austin, TX 78712 USA.	dappling@austin.utexas.edu	Sentandreu, Enrique/ABH-4264-2020; Sentandreu, Enrique/L-8684-2013	Sentandreu, Enrique/0000-0002-4157-580X; Xhemalce, Blerta/0000-0002-0517-9607	National Institutes of Health, NCI Grant [P30 CA54174]; University of Texas Health Science Center at San Antonio (UTHSCSA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD074428, R01HD083809] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER	National Institutes of Health, NCI Grant; University of Texas Health Science Center at San Antonio (UTHSCSA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Sergey Krupenko for the generous gift of the antibodies against ALDH1L2. Support for the NMR facility was provided by the University of Texas Health Science Center at San Antonio (UTHSCSA) and National Institutes of Health, NCI Grant P30 CA54174 (CTRC at UTHSCSA).	Akimova D, 2017, BIRTH DEFECTS RES, V109, P106, DOI 10.1002/bdra.23583; Au KS, 2017, AM J MED GENET A, V173, P3042, DOI 10.1002/ajmg.a.38478; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; BARLOWE C K, 1988, Biofactors, V1, P171; Beaudin AE, 2011, AM J CLIN NUTR, V93, P789, DOI 10.3945/ajcn.110.002766; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Crider KS, 2011, NUTRIENTS, V3, P370, DOI 10.3390/nu3030370; Davis SR, 2004, AM J PHYSIOL-ENDOC M, V286, pE272, DOI 10.1152/ajpendo.00351.2003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016; Dunlevy LPE, 2006, BIRTH DEFECTS RES A, V76, P544, DOI 10.1002/bdra.20286; GARCIAMARTINEZ LF, 1993, BIOCHEMISTRY-US, V32, P4671, DOI 10.1021/bi00068a027; Gunther UL, 2000, J MAGN RESON, V145, P201, DOI 10.1006/jmre.2000.2071; Hansler A, 2014, BIRTH DEFECTS RES A, V100, P623, DOI 10.1002/bdra.23272; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Hunter ES, 1995, TERATOLOGY, V52, P317, DOI 10.1002/tera.1420520602; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Krupenko NI, 2010, J BIOL CHEM, V285, P23054, DOI 10.1074/jbc.M110.128843; Leung KY, 2017, CELL REP, V21, P1795, DOI 10.1016/j.celrep.2017.10.072; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lodi A, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0024-z; Lu XY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03108-x; Ludwig C, 2012, METABOLOMICS, V8, P8, DOI 10.1007/s11306-011-0347-7; Ludwig C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-366; MATSUDA M, 1990, TERATOLOGY, V41, P147, DOI 10.1002/tera.1420410204; Michalska A.E., 2007, CURR PROTOC STEM CEL; Miyazawa H, 2017, DEVELOPMENT, V144, P63, DOI 10.1242/dev.138545; Momb J, 2013, P NATL ACAD SCI USA, V110, P549, DOI 10.1073/pnas.1211199110; Narisawa A, 2012, HUM MOL GENET, V21, P1496, DOI 10.1093/hmg/ddr585; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Prasannan P, 2009, ARCH BIOCHEM BIOPHYS, V481, P86, DOI 10.1016/j.abb.2008.10.028; Strickland KC, 2011, CHEM-BIOL INTERACT, V191, P129, DOI 10.1016/j.cbi.2011.01.008; Sudiwala S, 2016, BIOCHIMIE, V126, P63, DOI 10.1016/j.biochi.2016.02.010; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Tiziani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082859; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Xia J, 2011, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi1410s34, DOI 10.1002/0471250953.BI1410S34]; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xu L, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0114-x	41	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5821	5833		10.1074/jbc.RA118.002180	http://dx.doi.org/10.1074/jbc.RA118.002180			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29483189	Green Published, hybrid			2022-12-26	WOS:000430497300007
J	Huehn, A; Cao, WX; Elam, WA; Liu, XQ; De La Cruz, EM; Sindelar, CV				Huehn, Andrew; Cao, Wenxiang; Elam, W. Austin; Liu, Xueqi; De La Cruz, Enrique M.; Sindelar, Charles V.			The actin filament twist changes abruptly at boundaries between bare and cofilin-decorated segments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; ADF/COFILIN FAMILY; HELICAL FILAMENTS; DYNAMICS; RECONSTRUCTION; RESOLUTION; MECHANISM; KINETICS; BINDING; STATE	Cofilin/ADF proteins are actin-remodeling proteins, essential for actin disassembly in various cellular processes, including cell division, intracellular transport, and motility. Cofilins bind actin filaments cooperatively and sever them preferentially at boundaries between bare and cofilin-decorated (cofilactin) segments. The cooperative binding to actin has been proposed to originate from conformational changes that propagate allosterically from clusters of bound cofilin to bare actin segments. Estimates of the lengths over which these cooperative conformational changes propagate vary dramatically, ranging from 2 to > 100 subunits. Here, we present a general, structure-based method for detecting from cryo-EM micrographs small variations in filament geometry (i.e. twist) with single-subunit precision. How these variations correlate with regulatory protein occupancy reveals how far allosteric, conformational changes propagate along filaments. We used this method to determine the effects of cofilin on the actin filament twist. Our results indicate that cofilin-induced changes in filament twist propagate only 1-2 subunits from the boundary into the bare actin segment, independently of the boundary polarity (i.e. irrespective of whether or not the bare actin segment flanks the pointed or barbed-end side of the boundary) and the pyrene fluorophore labeling of actin. These observations indicate that the filament twist changes abruptly at boundaries between bare and cofilin-decorated segments, thereby constraining mechanistic models of cooperative actin filament interactions and severing by cofilin. The methods presented here extend the capability of cryo-EM to analyze biologically relevant deviations from helical symmetry in actin as well as other classes of linear polymers.	[Huehn, Andrew; Cao, Wenxiang; Elam, W. Austin; Liu, Xueqi; De La Cruz, Enrique M.; Sindelar, Charles V.] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA; [Elam, W. Austin] C4 Therapeut, 675 W Kendall St, Cambridge, MA 02142 USA	Yale University	De La Cruz, EM; Sindelar, CV (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	enrique.delacruz@yale.edu; charles.sindelar@yale.edu			National Institutes of Health R01 Grant [GM097348, GM110533001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110530, R01GM097348, T32GM008283] Funding Source: NIH RePORTER	National Institutes of Health R01 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R01 Grants GM097348 (to E. M. D. L. C.) and GM110533001 (to C. V. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bobkov AA, 2006, J MOL BIOL, V356, P325, DOI 10.1016/j.jmb.2005.11.072; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; DE LA CRUZ EM, 1995, BIOCHEMISTRY-US, V34, P5452, DOI 10.1021/bi00016a016; De La Cruz EM, 2015, J BIOL CHEM, V290, P17137, DOI 10.1074/jbc.R115.636472; De La Cruz EM, 2010, BIOPHYS J, V98, P1893, DOI 10.1016/j.bpj.2010.01.023; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; Dedova IV, 2004, BIOPHYS CHEM, V110, P119, DOI 10.1016/j.bpc.2004.01.009; Egelman EH, 2010, METHOD ENZYMOL, V482, P167, DOI 10.1016/S0076-6879(10)82006-3; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Elam WA, 2017, J BIOL CHEM, V292, P19565, DOI 10.1074/jbc.M117.808378; Elam WA, 2013, BIOCHEM BIOPH RES CO, V438, P728, DOI 10.1016/j.bbrc.2013.07.109; Elam WA, 2013, FEBS LETT, V587, P1215, DOI 10.1016/j.febslet.2013.01.062; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2015, STRUCTURE, V23, P173, DOI 10.1016/j.str.2014.11.006; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Gressin L, 2015, CURR BIOL, V25, P1437, DOI 10.1016/j.cub.2015.04.011; Hayakawa K, 2014, P NATL ACAD SCI USA, V111, P9810, DOI 10.1073/pnas.1321451111; He SD, 2017, J STRUCT BIOL, V198, P163, DOI 10.1016/j.jsb.2017.02.003; Kanellos G, 2016, J CELL SCI, V129, P3211, DOI 10.1242/jcs.187849; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Mentes A, 2018, P NATL ACAD SCI USA, V115, P1292, DOI 10.1073/pnas.1718316115; Ngo KX, 2015, ELIFE, V4, DOI 10.7554/eLife.04806; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfaendtner J, 2010, P NATL ACAD SCI USA, V107, P7299, DOI 10.1073/pnas.0911675107; Prochniewicz E, 2005, J MOL BIOL, V353, P990, DOI 10.1016/j.jmb.2005.09.021; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schramm AC, 2017, BIOPHYS J, V112, P2624, DOI 10.1016/j.bpj.2017.05.016; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wioland H, 2017, CURR BIOL, V27, P1956, DOI 10.1016/j.cub.2017.05.048; Yu JY, 2017, ELIFE, V6, P1, DOI 10.7554/eLife.27621; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	41	30	31	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5377	5383		10.1074/jbc.AC118.001843	http://dx.doi.org/10.1074/jbc.AC118.001843			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29463680	hybrid, Green Published			2022-12-26	WOS:000430044100001
J	Stec, D; Arakawa, K; Michalczyk, L				Stec, Daniel; Arakawa, Kazuharu; Michalczyk, Lukasz			An integrative description of Macrobiotus shonaicus sp nov (Tardigrada: Macrobiotidae) from Japan with notes on its phylogenetic position within the hufelandi group	PLOS ONE			English	Article							RAMAZZOTTIUS-SUBANOMALUS BISEROV; EUTARDIGRADA MACROBIOTIDAE; ANNOTATED ZOOGEOGRAPHY; PHYLUM TARDIGRADA; DNA; VARIABILITY; REVISION; AMERICA; MAFFT	Tardigrade research in Japan dates back over 100 years, and to date, 167 species of this ecdysozoan phylum have been reported from the country. Of these species, the Macrobiotus hufelandi complex has been represented only by the nominal taxon of this group, Macrobiotus hufelandi. In this article, a new species of the hufelandi group from Japan, Macrobiotus shonaicus sp. nov., is described using integrative taxonomy. In addition to the detailed morphological and morphometric data, obtained using phase contrast light microscopy (PCM) and scanning electron microscopy (SEM), we provide DNA sequences of four molecular markers (both nuclear and mitochondrial). The new species belongs to the persimilis subgroup and is most similar to M. anemone from USA, M. naskreckii from Mozambique, and M. patagonicus from Argentina, but it can be easily distinguished from these species by the presence of thin flexible filaments on terminal discs of the egg process. By the latter character, the new species is most similar to M. paulinae and M. polypiformis, but it can be easily distinguished from them by having a solid egg surface between egg processes (i.e., without pores or reticulum). A phylogenetic analysis of available DNA sequences of the COI marker for the hufelandi group revealed that the new species clusters with the two other species that exhibit filaments on egg process discs (M. paulinae and M. polypiformis) and with two species that have entire egg processes modified into filaments (M. kristenseni and M. scoticus). All five species form a clade distinct from all other sequenced species of the hufelandi group with typical mushroom-or inverted goblet-shaped egg processes, which may suggest that the ancestor of the five species with atypical egg processes had a mutation allowing derivations from the mushroom or inverted chalice-like shape of egg processes.	[Stec, Daniel; Michalczyk, Lukasz] Jagiellonian Univ, Inst Zool & Biomed Res, Gronostajowa 9, Krakow, Poland; [Arakawa, Kazuharu] Keio Univ, Inst Adv Biosci, Mizukami 246-2, Tsuruoka, Yamagata, Japan	Jagiellonian University; Keio University	Arakawa, K (corresponding author), Keio Univ, Inst Adv Biosci, Mizukami 246-2, Tsuruoka, Yamagata, Japan.	gaou@sfc.keio.ac.jp	Stec, Daniel/AAL-3532-2020; Michalczyk, Lukasz/D-1362-2009	Michalczyk, Lukasz/0000-0002-2912-4870; Stec, Daniel/0000-0001-6876-0717; Arakawa, Kazuharu/0000-0002-2893-4919	Polish National Science Centre [2016/22/E/NZ8/00417]; KAKENHI from the Japan Society for the Promotion of Science (JSPS) [17H03620]; Yamagata Prefectural Government; Tsuruoka City, Japan	Polish National Science Centre; KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yamagata Prefectural Government; Tsuruoka City, Japan	We thank Nozomi Abe and Naoko Ishii for technical support in tardigrade culturing. The study was supported by the Sonata Bis program of the Polish National Science Centre (grant no. 2016/22/E/NZ8/00417 to LM), by a KAKENHI Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS) (grant no. 17H03620 to KA), and partly by research funds from the Yamagata Prefectural Government and Tsuruoka City, Japan (to KA). The Chlorella vulgaris used to feed the tardigrades was provided courtesy of Chlorella Industry Co. LTD.; This work was supported by the Sonata Bis programme of the Polish National Science Centre (grant no. 2016/22/E/NZ8/00417 to LM): study design, data collection and analysis, decision to publish and preparation of the manuscript; KAKENHI Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS) (grant no. 17H03620 to KA): data collection; Yamagata Prefectural Government and Tsuruoka City, Japan (to KA): data collection.	[Anonymous], 2014, TRACER V1 6; [Anonymous], 1834, MACROBIOTUS HUFELAND; Arakawa K, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.63; Bakowski M, 2016, ANN ZOOL, V66, P155, DOI 10.3161/00034541ANZ2016.66.2.001; BERTOLANI R, 1993, ZOOL SCR, V22, P127, DOI 10.1111/j.1463-6409.1993.tb00347.x; Bertolani R., 2011, Zoologiya Bespozvonochnykh, V8, P23; Bertolani R, 2014, MOL PHYLOGENET EVOL, V76, P110, DOI 10.1016/j.ympev.2014.03.006; Bertolani Roberto, 2011, Zootaxa, V2997, P19; BINDA M G, 1972, Bollettino delle Sedute della Accademia Gioenia di Scienze Naturali in Catania, V11, P47; Binda M.G., 1986, Animalia (Catania), V11, P85; BISEROV VI, 1990, ZOOL ZH, V69, P5; Casquet J, 2012, MOL ECOL RESOUR, V12, P136, DOI 10.1111/j.1755-0998.2011.03073.x; Cesari M, 2011, ZOOTAXA, P42; Cesari M, 2009, MOL ECOL RESOUR, V9, P699, DOI 10.1111/j.1755-0998.2009.02538.x; Ciobanu DA, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.429.7755; Cuenot L., 1932, Faune de France Paris, V24, P1; Degma P, 2009, ACTUAL CHECKLIST TAR; Doyere LMF, 1840, ANN SCI NATURELLES 2, V14, P269; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontoura P, 2017, ZOOTAXA, V4263, P450, DOI 10.11646/zootaxa.4263.3.2; Giribet G, 1996, MOL BIOL EVOL, V13, P76, DOI 10.1093/oxfordjournals.molbev.a025573; Guidetti R, 2005, ZOOL SCR, V34, P235, DOI 10.1111/j.1463-6409.2005.00193.x; Guidetti R, 2013, J NAT HIST, V47, P2409, DOI 10.1080/00222933.2013.800610; Guil N, 2012, CLADISTICS, V28, P21, DOI 10.1111/j.1096-0031.2011.00364.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hinton JA, 2016, GA J SCI, V74, pa14; Iijima I., 1889, TXB ZOOLOGY; Kaczmarek L, 2017, ZOOTAXA, V4363, P101, DOI 10.11646/zootaxa.4363.1.4; Kaczmarek L, 2016, ZOOTAXA, V4203, P1, DOI 10.11646/zootaxa.4203.1.1; Kaczmarek Lukasz, 2004, Genus (Wroclaw), V15, P141; Kaczmarek L, 2015, ZOOTAXA, V3923, P1, DOI 10.11646/zootaxa.3923.1.1; Kaczmarek L, 2014, ZOOTAXA, V3790, P357, DOI 10.11646/zootaxa.3790.2.5; Kaczmarek Lukasz, 2009, Acta Zoologica Cracoviensia Ser B-Invertebrata, V52B, P87, DOI 10.3409/azc.52b_1-2.87-99; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kosztyla P, 2016, ZOOL J LINN SOC-LOND, V178, P765, DOI 10.1111/zoj.12409; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Marley NJ, 2011, ZOOTAXA, P51, DOI 10.11646/zootaxa.2819.1.2; MAUCCI W, 1988, Revista Chilena de Entomologia, V16, P5; Mcinnes SJ, 2017, ZOOTAXA, V4284, P1, DOI 10.11646/zootaxa.4284.1.1; Meyer HA, 2014, SOUTHEAST NAT, V13, P117, DOI DOI 10.1656/058.013.S511; Meyer HA, 2017, P BIOL SOC WASH, V130, P98, DOI 10.2988/16-00009; Michalczyk L, 2003, ZOOTAXA, V331, P1, DOI DOI 10.11646/ZOOTAXA.331.1.1; Michalczyk L, 2012, ZOOTAXA, P1; Michalczyk L, 2013, J LIMNOL, V72, P175, DOI 10.4081/jlimnol.2013.s1.e22; Mironov Sergey V., 2012, Zootaxa, V3253, P54; Morek W, 2016, ZOOL J LINN SOC-LOND, V178, P785, DOI 10.1111/zoj.12457; Morek W, 2016, CONTRIB ZOOL, V85, P173, DOI 10.1163/18759866-08502003; Murray J., 1907, T ROY SOC EDINBURGH, V45, P669, DOI DOI 10.1017/S0080456800011789; Murray J., 1911, P ROY IRISH ACAD, V31, P1, DOI DOI 10.5962/BHL.TITLE.64352; Nelson DR, 2015, ECOLOGY AND GENERAL BIOLOGY, VOL I: THORP AND COVICH'S FRESHWATER INVERTEBRATES, 4TH EDITION, P347, DOI 10.1016/B978-0-12-385026-3.00017-6; Pilato G., 1981, Animalia (Catania), V8, P51; Pilato G., 1983, ANIMALIA, V10, P262; Pilato Giovanni, 2003, Zootaxa, V258, P1; Plate L., 1888, ZOOLOGISCHE JB, V3, P487, DOI DOI 10.5962/BHL.PART.1265; Richters F., 1926, HDB ZOOLOGIE, V3, P58, DOI 10.5852/ejt.2017.327; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossi G, 2009, ZOOTAXA, P21, DOI 10.11646/zootaxa.2095.1.3; Roszkowska M, 2017, EUR J TAXON, V327, P1, DOI 10.5852/ejt.2017.327; Schill RO, 2010, ORG DIVERS EVOL, V10, P287, DOI 10.1007/s13127-010-0025-z; SCHUSTER RO, 1980, T AM MICROSC SOC, V99, P284, DOI 10.2307/3226004; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stec D, SYSTEMATICS BIODIVER; Stec D, 2017, ANN ZOOL, V67, P181, DOI 10.3161/00034541ANZ2017.67.2.001; Stec D, 2017, ZOOTAXA, V4300, P403, DOI 10.11646/zootaxa.4300.3.4; Stec D, 2016, ZOOTAXA, V4208, P176, DOI 10.11646/zootaxa.4208.2.5; Stec D, 2016, ZOOL J LINN SOC-LOND, V178, P776, DOI 10.1111/zoj.12404; Stec D, 2015, ZOOTAXA, V4052, P501, DOI 10.11646/zootaxa.4052.5.1; Suzuki AC, 2017, DIVERS COMMON ANIM, P267, DOI 10.1007/978-4-431-56432-4_10; Thulin G, 1928, HEREDITAS, V11, P207, DOI 10.1111/j.1601-5223.1928.tb02488.x; Welnicz W, 2011, J ZOOL SYST EVOL RES, V49, P34, DOI 10.1111/j.1439-0469.2010.00595.x; Yoshida Y, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002266; Zeller C., 2010, THESIS	76	29	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192210	10.1371/journal.pone.0192210	http://dx.doi.org/10.1371/journal.pone.0192210			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489835	gold, Green Published, Green Submitted			2022-12-26	WOS:000426276000020
J	Gracia, ES; de Bekker, C; Hanks, EM; Hughes, DP				Gracia, Emilia Sola; de Bekker, Charissa; Hanks, Ephraim M.; Hughes, David P.			Within the fortress: A specialized parasite is not discriminated against in a social insect society	PLOS ONE			English	Article							SICK ANTS; EVOLUTION; BEHAVIOR	Social insect colonies function cohesively due, in part, to altruistic behaviors performed towards related individuals. These colonies can be affected by parasites in two distinct ways, either at the level of the individual or the entire colony. As such, colonies of social insects can experience conflict with infected individuals reducing the cohesiveness that typifies them. Parasites of social insects therefore offer us a framework to study conflicts within social insect colonies in addition to the traditionally viewed conflicts afforded by groups of low genetic relatedness due to multiple mating for example. In our study, we use the behavior manipulating fungal pathogen, Ophiocordyceps kimflemingiae (= unilateralis) and its host, Camponotus castaneus, to ask if colony members are able to detect infected individuals. Such detection would be optimal for the colony since infected workers die near foraging trails where the fungus develops its external structures and releases spores that infect other colony members. To determine if C. castaneus workers can detect these future threats, we used continuous -time point observations coupled with longer continuous observations to discern any discrimination towards infected individuals. After observing 1,240 hours of video footage we found that infected individuals are not removed from the colony and continuously received food during the course of fungal infection. We also calculated the distances between workers and the nest entrance in a total of 35,691 data points to find infected workers spent more time near the entrance of the nest. Taken together, these results suggest healthy individuals do not detect the parasite inside their nestmates. The colony's inability to detect infected individuals allows O. kimflemingiae to develop within the colony, while receiving food and protection from natural enemies, which could damage or kill its ant host before the parasite has completed its development.	[Gracia, Emilia Sola] Penn State Univ, Huck Inst Life Sci, Ecol Program, University Pk, PA 16802 USA; [Gracia, Emilia Sola; Hanks, Ephraim M.; Hughes, David P.] Penn State Univ, Ctr Infect Dis Dynam, Huck Inst Life Sci, University Pk, PA 16802 USA; [Gracia, Emilia Sola; Hughes, David P.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Gracia, Emilia Sola; Hughes, David P.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [de Bekker, Charissa] Univ Cent Florida, Dept Stat, Orlando, FL 32816 USA; [Hanks, Ephraim M.] Penn State Univ, Dept Stat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University System of Florida; University of Central Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gracia, ES (corresponding author), Penn State Univ, Huck Inst Life Sci, Ecol Program, University Pk, PA 16802 USA.; Gracia, ES; Hughes, DP (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, Huck Inst Life Sci, University Pk, PA 16802 USA.; Gracia, ES; Hughes, DP (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.; Gracia, ES; Hughes, DP (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	exs399@psu.edu; dph14@psu.edu		Sola-Gracia, Emilia/0000-0001-9566-8895; de Bekker, Charissa/0000-0002-7325-172X	National Science Foundation Graduate Research Fellowship [DGE1255832]; Marie Curie Actions International Outgoing Fellowship [IOF 299501]; NSF as part of the joint NSF-NIH-USDA [NIH-NSF-USDA, USDA-NSF-NIH] Ecology and Evolution of Infectious Diseases program (DPH/EMH) [1414296]; NSF [IOS-1558062]	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Marie Curie Actions International Outgoing Fellowship; NSF as part of the joint NSF-NIH-USDA [NIH-NSF-USDA, USDA-NSF-NIH] Ecology and Evolution of Infectious Diseases program (DPH/EMH); NSF(National Science Foundation (NSF))	Emilia Sold Gracia was supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE1255832. Charissa de Bekker was supported by a Marie Curie Actions International Outgoing Fellowship [IOF 299501]. This work was funded by NSF grant 1414296 as part of the joint NSF-NIH-USDA [NIH-NSF-USDA, USDA-NSF-NIH] Ecology and Evolution of Infectious Diseases program (DPH/EMH) and NSF grants IOS-1558062 (DPH).	Andersen SB, 2009, AM NAT, V174, P424, DOI 10.1086/603640; Araujo JPM, 2016, ADV GENET, V94, P1, DOI 10.1016/bs.adgen.2016.01.001; Araujo JP, FUNGAL COMMUNITY ITS, P359; Aubert A, 2008, BRAIN BEHAV IMMUN, V22, P833, DOI 10.1016/j.bbi.2008.01.010; Baracchi D, 2012, J INSECT PHYSIOL, V58, P1589, DOI 10.1016/j.jinsphys.2012.09.014; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beros S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1473; Bos N, 2012, J EVOLUTION BIOL, V25, P342, DOI 10.1111/j.1420-9101.2011.02425.x; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Bourke Andrew F.G., 1995, pi; Chapuisat M, 2010, CURR BIOL, V20, pR104, DOI 10.1016/j.cub.2009.12.037; de Bekker C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1812-x; de Bekker C, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0166-3; De Souza DJ, 2008, J INSECT PHYSIOL, V54, P828, DOI 10.1016/j.jinsphys.2008.03.001; Fujii JK, 1975, EGYPTIAN ACAD J BIOL; Hamilton C, 2011, BIOL LETTERS, V7, P89, DOI 10.1098/rsbl.2010.0466; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Holldobler B., 1990, pi; Hughes DP, 2016, ADV GENET, V94, P437, DOI 10.1016/bs.adgen.2016.01.004; Hughes D. P, STUDIES MYC IN PRESS; Hughes David P., 2011, BMC Ecology, V11, P13, DOI 10.1186/1472-6785-11-13; Hughes DP, 2009, ECOL ENTOMOL, V34, P214, DOI 10.1111/j.1365-2311.2008.01066.x; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Leclerc JB, 2017, ANIM BEHAV, V129, P133, DOI 10.1016/j.anbehav.2017.05.002; Leclerc JB, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1394-8; Lenth R, 2016, COMPREHENSIVE R ARCH; Loreto RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103516; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Myles TG, 2002, SOCIOBIOLOGY, V40, P243; Pontoppidan MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004835; Qiu HL, 2016, J INVERTEBR PATHOL, V138, P24, DOI 10.1016/j.jip.2016.05.005; Quevillon LE, 2015, SCI REP-UK, V5, DOI 10.1038/srep13393; R Core Team, 2021, R LANGUAGE ENV STAT; Scharf I, 2012, AM NAT, V180, P671, DOI 10.1086/667894; Schmid-Hempel P., 1998, Parasites in social insects.; SendovaFranks AB, 1995, ANIM BEHAV, V50, P1683, DOI 10.1016/0003-3472(95)80021-2; Van PELT ARNOLD, 1958, JOUR TENNESSEE ACAD SCI, V33, P120	39	14	15	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193536	10.1371/journal.pone.0193536	http://dx.doi.org/10.1371/journal.pone.0193536			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474472	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500126
J	Schurmann, M; Shepheard, N; Frese, N; Geishendorf, K; Sudhoff, H; Golzhauser, A; Ruckert, U; Kaltschmidt, C; Kaltschmidt, B; Thomas, A				Schuermann, Matthias; Shepheard, Norman; Frese, Natalie; Geishendorf, Kevin; Sudhoff, Holger; Goelzhaeuser, Armin; Rueckert, Ulrich; Kaltschmidt, Christian; Kaltschmidt, Barbara; Thomas, Andy			Technical feasibility study for production of tailored multielectrode arrays and patterning of arranged neuronal networks	PLOS ONE			English	Article							PLANAR MICROELECTRODE ARRAYS; POLY-L-LYSINE; EXTRACELLULAR RECORDINGS; DISSOCIATED NEURONS; SOFT LITHOGRAPHY; CULTURED NEURONS; CELLS; TITANIUM; ADHESION; SURFACE	In this manuscript, we first reveal a simple ultra violet laser lithographic method to design and produce plain tailored multielectrode arrays. Secondly, we use the same lithographic setup for surface patterning to enable controlled attachment of primary neuronal cells and help neurite guidance. For multielectrode array production, we used flat borosilicate glass directly structured with the laser lithography system. The multi layered electrode system consists of a layer of titanium coated with a layer of di-titanium nitride. Finally, these electrodes are covered with silicon nitride for insulation. The quality of the custom made multielectrode arrays was investigated by light microscopy, electron microscopy and X-ray diffraction. The performance was verified by the detection of action potentials of primary neurons. The electrical noise of the custom-made MEA was equal to commercially available multielectrode arrays. Additionally, we demonstrated that structured coating with poly lysine, obtained with the aid of the same lithographic system, could be used to attach and guide neurons to designed structures. The process of neuron attachment and neurite guidance was investigated by light microscopy and charged particle microscopy. Importantly, the utilization of the same lithographic system for MEA fabrication and poly lysine structuring will make it easy to align the architecture of the neuronal network to the arrangement of the MEA electrode.. In future studies, this will lead to multielectrode arrays, which are able to specifically attach neuronal cell bodies to their chemically defined electrodes and guide their neurites, gaining a controlled connectivity in the neuronal network. This type of multielectrode array would be able to precisely assign a signal to a certain neuron resulting in an efficient way for analyzing the maturation of the neuronal connectivity in small neuronal networks.	[Schuermann, Matthias; Kaltschmidt, Christian; Kaltschmidt, Barbara] Bielefeld Univ, Cell Biol, Bielefeld, Germany; [Schuermann, Matthias; Sudhoff, Holger] Klinikum Bielefeld, Dept Otolaryngol Head & Neck Surg, Bielefeld, Germany; [Shepheard, Norman; Thomas, Andy] Bielefeld Univ, Ctr Spinelect Mat & Devices, Phys Dept, Bielefeld, Germany; [Shepheard, Norman; Rueckert, Ulrich] Bielefeld Univ, Cognit Interact Technol Ctr Excellence, Cognitron & Sensor Syst, Bielefeld, Germany; [Frese, Natalie; Goelzhaeuser, Armin] Bielefeld Univ, Phys Dept, Phys Supramol Syst & Surfaces, Bielefeld, Germany; [Geishendorf, Kevin; Thomas, Andy] Leibniz Inst Solid State & Mat Res Dresden IFW Dr, Inst Metall Mat, Dresden, Germany; [Kaltschmidt, Barbara] Bielefeld Univ, Mol Neurobiol, Bielefeld, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld; University of Bielefeld; Leibniz Institute for Solid State & Materials Research Dresden; University of Bielefeld	Schurmann, M (corresponding author), Bielefeld Univ, Cell Biol, Bielefeld, Germany.; Schurmann, M (corresponding author), Klinikum Bielefeld, Dept Otolaryngol Head & Neck Surg, Bielefeld, Germany.; Thomas, A (corresponding author), Bielefeld Univ, Ctr Spinelect Mat & Devices, Phys Dept, Bielefeld, Germany.; Thomas, A (corresponding author), Leibniz Inst Solid State & Mat Res Dresden IFW Dr, Inst Metall Mat, Dresden, Germany.	matthias.schuermann@klinikumbielefeld.de; a.thomas@ifw-dresden.de	Sudhoff, Holger/AAV-9741-2020; Gölzhäuser, Armin/N-3998-2019; Thomas, Andy/C-7210-2008	Sudhoff, Holger/0000-0002-9274-5645; Gölzhäuser, Armin/0000-0002-0838-9028; Thomas, Andy/0000-0001-8594-9060	Ministry of Innovation, Science and Research (MIWF) of North Rhine-Westphalia; Cluster of Excellence Cognitive Interaction Technology 'CITEC' at Bielefeld University - German Research Foundation (DFG) [EXC 277]; DFG; Bielefeld University	Ministry of Innovation, Science and Research (MIWF) of North Rhine-Westphalia; Cluster of Excellence Cognitive Interaction Technology 'CITEC' at Bielefeld University - German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Bielefeld University	This work was supported by the Ministry of Innovation, Science and Research (MIWF) of North Rhine-Westphalia with an independent researcher grant and by the Cluster of Excellence Cognitive Interaction Technology 'CITEC' (EXC 277) at Bielefeld University, which is funded by the German Research Foundation (DFG; http://www.dfg.de/). The authors received this funding were (UR, NS).; We acknowledge support for the Article Processing Charge by the DFG and the Open Access Publication Fund of Bielefeld University.	Becchetti A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00063; Berdondini L, 2002, MICR MED BIOL 2 ANN; Boehler MD, 2012, J NEUROSCI METH, V203, P344, DOI 10.1016/j.jneumeth.2011.09.020; Buitenweg J, 2003, IEEE T BIO-MED ENG, V50, P501, DOI 10.1109/TBME.2003.809486; Buitenweg JR, 2002, IEEE T BIO-MED ENG, V49, P1580, DOI 10.1109/TBME.2002.805555; COREY JM, 1991, J NEUROSCI RES, V30, P300, DOI 10.1002/jnr.490300204; Downes JH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002522; Erickson J, 2008, J NEUROSCI METH, V175, P1, DOI 10.1016/j.jneumeth.2008.07.023; Eversmann B, 2003, IEEE J SOLID-ST CIRC, V38, P2306, DOI 10.1109/JSSC.2003.819174; Hiromoto S, 2004, BIOMATERIALS, V25, P979, DOI 10.1016/S0142-9612(03)00620-3; James CD, 2000, IEEE T BIO-MED ENG, V47, P17, DOI 10.1109/10.817614; James CD, 2004, IEEE T BIO-MED ENG, V51, P1640, DOI 10.1109/TBME.2004.827252; Janders M, 1996, ENG MED BIOL SOC 199; Jewett KA, 2015, EUR J NEUROSCI, V42, P2078, DOI 10.1111/ejn.12968; Jones IL, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00360; Jun SB, 2007, J NEUROSCI METH, V160, P317, DOI 10.1016/j.jneumeth.2006.09.009; Jungblut M, 2009, BIOMED MICRODEVICES, V11, P1269, DOI 10.1007/s10544-009-9346-0; Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9; Kim YH, 2011, J NEUROSCI METH, V202, P38, DOI 10.1016/j.jneumeth.2011.08.036; Kleczkowska P, 2015, NEUROTOX RES, V28, P352, DOI 10.1007/s12640-015-9553-9; KLEINFELD D, 1988, J NEUROSCI, V8, P4098; Klenke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065280; Kurishita Y, 2010, J AM CHEM SOC, V132, P13290, DOI 10.1021/ja103615z; Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8; LETOURNEAU PC, 1975, DEV BIOL, V44, P77, DOI 10.1016/0012-1606(75)90378-4; Maccione A, 2015, BRAIN RES BULL, V119, P118, DOI 10.1016/j.brainresbull.2015.07.008; Marconi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034648; Muller J, 2015, LAB CHIP, V15, P2767, DOI 10.1039/c5lc00133a; Muthmann JO, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00028; Nam Y, 2004, IEEE T BIO-MED ENG, V51, P158, DOI 10.1109/TBME.2003.820336; Nam Y, 2006, BIOSENS BIOELECTRON, V22, P589, DOI 10.1016/j.bios.2006.01.027; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Pershin YV, 2010, NEURAL NETWORKS, V23, P881, DOI 10.1016/j.neunet.2010.05.001; Reinhard K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106148; Ruardij TG, 2000, IEEE T BIO-MED ENG, V47, P1593, DOI 10.1109/10.887940; RUEGG UT, 1984, NEUROSCI LETT, V49, P319, DOI 10.1016/0304-3940(84)90309-4; Ryynanen T, 2011, MICROMACHINES-BASEL, V2, P394, DOI 10.3390/mi2040394; Samhaber R, 2016, J NEUROSCI METH, V257, P194, DOI 10.1016/j.jneumeth.2015.09.022; Schurmann M, 2015, SMALL, V11, P5781, DOI 10.1002/smll.201501540; Singec I, 2015, BIOL OPEN, V4, P1222, DOI 10.1242/bio.012096; Stephens CL, 2012, EXP NEUROL, V234, P20, DOI 10.1016/j.expneurol.2011.12.009; Stett A, 2003, ANAL BIOANAL CHEM, V377, P486, DOI 10.1007/s00216-003-2149-x; THOMAS CA, 1972, EXP CELL RES, V74, P61, DOI 10.1016/0014-4827(72)90481-8; Urban PL, 2010, LAB CHIP, V10, P3206, DOI 10.1039/c0lc00211a; Withers GS, 2006, J NEUROBIOL, V66, P1183, DOI 10.1002/neu.20298; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540	47	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192647	10.1371/journal.pone.0192647	http://dx.doi.org/10.1371/journal.pone.0192647			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474358	gold, Green Published, Green Submitted			2022-12-26	WOS:000426049500025
J	Wu, CY; Wang, Q; He, LR; Yang, EH; Zeng, XF				Wu, Chanyuan; Wang, Qian; He, Linrong; Yang, Enhao; Zeng, Xiaofeng			Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: A retrospective case-control study	PLOS ONE			English	Article							IDIOPATHIC INFLAMMATORY MYOPATHIES; INTERSTITIAL LUNG-DISEASE; PREDICTIVE FACTORS; PROGNOSTIC-FACTORS; CARDIAC INVOLVEMENT; SHORT-TERM; FOLLOW-UP; SURVIVAL; CANCER; COHORT	BACKGROUND Polymyositis and dermatomyositis (PM/DM) are systemic autoimmune diseases with multiple organ involvements that manifest as muscular and cutaneous disorders, interstitial lung disease (ILD) and malignancies. However, information concerning the outcomes and associated factors for PM/DM patients who are hospitalized is limited. METHODS We retrospectively reviewed the medical charts of PM/DM patients admitted to a Chinese tertiary referral hospital (Peking Union Medical College Hospital, PUMCH) from 2008 to 2014. The deceased group included 63 patients who had "deceased discharge" status or were confirmed to have died within two weeks of hospital discharge. The demographic data, clinical manifestations, and direct causes of death were analyzed retrospectively. Medical records for 126 age- and sex-matched PM/DM patients were selected as controls from 982 inpatients successively admitted to the same center during the same period. In addition to the comparison of clinical manifestations between the two groups, binary logistic regression was conducted to explore the risk factors related to PM/DM mortality. RESULTS Over the past 6 years at PUMCH, the in-hospital mortality rate of PM/DM patients was 4.58%. The male gender and the elder patients had a high risk of death (P = 0.031 and P = 0.001 respectively). The three most frequent causes of death for PM/DM patients were pulmonary infection (35%), ILD exacerbation (21%) or both conditions (25%). Pulmonary infection (P<0.001, OR = 5.63, 95% CI, 2.37-13.36), pneumomediastinum (P = 0.041, OR = 11.02, 95%CI, 1.10-110.54), Gottron's papules (P = 0.010, OR = 3.24, 95%CI, 1.32-7.97), and elevated erythrocyte sedimentation rate (ESR) (P = 0.005, OR = 9.9, 95%CI 2.0-49.0) were independent risk factors for in-hospital mortality of PM/DM patients. CONCLUSION: PM/DM patients continue to display high in-hospital mortality. Pulmonary infection is the strongest predictor of poor prognosis in PM/DM patients, followed by pneumomediastinum, Gottron's papules, and elevated ESR.	[Wu, Chanyuan; Wang, Qian; Yang, Enhao; Zeng, Xiaofeng] Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Rheumatol, Beijing, Peoples R China; [Wu, Chanyuan; Wang, Qian; Yang, Enhao; Zeng, Xiaofeng] Chinese Acad Med Sci, Beijing, Peoples R China; [He, Linrong] China Japan Friendship Hosp, Dept Rheumatol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; China-Japan Friendship Hospital	Zeng, XF (corresponding author), Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Rheumatol, Beijing, Peoples R China.; Zeng, XF (corresponding author), Chinese Acad Med Sci, Beijing, Peoples R China.	zengxfpurne@163.com	Zeng, Xiao/ABG-5938-2021	He, Linrong/0000-0002-9044-9340	National Science Foundation of China [81601430]; Natural Science Foundation of China [81471615]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China, Grant number:81601430, URL: http://www.nsfc.gov.cn/, to CYW and the Natural Science Foundation of China, Grant number:81471615, URL: http://www.nsfc.gov.cn/, to QW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airio A, 2006, CLIN RHEUMATOL, V25, P234, DOI 10.1007/s10067-005-1164-z; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Chen D, 2014, CLIN EXP RHEUMATOL, V32, P615; Dimachkie MM, 2014, NEUROL CLIN, V32, P595, DOI 10.1016/j.ncl.2014.04.007; Dobloug GC, 2015, SEMIN ARTHRITIS RHEU, V45, P301, DOI 10.1016/j.semarthrit.2015.06.005; Erlacher P, 2001, CLIN CHIM ACTA, V306, P27, DOI 10.1016/S0009-8981(01)00392-8; Fiorentino D, 2011, J AM ACAD DERMATOL, V65, P25, DOI 10.1016/j.jaad.2010.09.016; Hill CL, 2001, LANCET, V357, P96, DOI 10.1016/S0140-6736(00)03540-6; Huber AM, 2014, ARTHRIT CARE RES, V66, P732, DOI 10.1002/acr.22212; Hughes M, 2015, ANN RHEUM DIS, V74, P795, DOI 10.1136/annrheumdis-2014-206812; Limaye V, 2012, INTERN MED J, V42, P191, DOI 10.1111/j.1445-5994.2010.02406.x; Linos E, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4135; Marie I, 2001, J RHEUMATOL, V28, P2230; Marie I, 2011, ARTHRITIS RHEUM-US, V63, P3439, DOI 10.1002/art.30513; Marie I, 2011, SEMIN ARTHRITIS RHEU, V41, P48, DOI 10.1016/j.semarthrit.2010.08.003; Miro O, 1999, MED CLIN-BARCELONA, V112, P521; Murabayashi K, 1991, Ryumachi, V31, P391; Murray SG, 2015, ARTHRIT CARE RES, V67, P673, DOI 10.1002/acr.22501; Peng JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154441; Rojas-Serrano J, 2015, CLIN RHEUMATOL, V34, P1563, DOI 10.1007/s10067-015-3023-x; Schiopu E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3704; SIGURGEIRSSON B, 1992, NEW ENGL J MED, V326, P363, DOI 10.1056/NEJM199202063260602; Stockton D, 2001, BRIT J CANCER, V85, P41, DOI 10.1054/bjoc.2001.1699; Taborda AL, 2014, CLIN EXP RHEUMATOL, V32, P188; Wang Pei-zhen, 2008, Zhonghua Jiehe He Huxi Zazhi, V31, P417; Woo JH, 2013, MOD RHEUMATOL, V23, P503, DOI 10.1007/s10165-012-0673-2; Yamasaki Y, 2011, J RHEUMATOL, V38, P1636, DOI 10.3899/jrheum.101002; Yu KH, 2011, CLIN RHEUMATOL, V30, P1595, DOI 10.1007/s10067-011-1840-0; Zhang L, 2012, CLIN CARDIOL, V35, P686, DOI 10.1002/clc.22026	29	25	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192491	10.1371/journal.pone.0192491	http://dx.doi.org/10.1371/journal.pone.0192491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474373	Green Submitted, Green Published, gold			2022-12-26	WOS:000426049500022
J	Etinger, A; Kumar; Ackley, W; Soiefer, L; Chun, J; Singh, P; Grossman, E; Matalon, A; Holzman, RS; Meijers, B; Lowenstein, J				Etinger, Aleksey; Kumar; Ackley, William; Soiefer, Leland; Chun, Jonathan; Singh, Prabjhot; Grossman, Eric; Matalon, Albert; Holzman, Robert S.; Meijers, Bjorn; Lowenstein, Jerome			The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes	PLOS ONE			English	Article							P-CRESYL SULFATE; RESIDUAL RENAL-FUNCTION; INDOXYL SULFATE; PROTEIN-BINDING; CLEARANCE; MORTALITY; DIALYSIS; TOXINS	Background There is growing evidence that the accumulation of protein-bound uremic retention solutes, such as indoxyl sulfate, p-cresyl sulfate and kynurenic acid, play a role in the accelerated cardiovascular disease seen in patients undergoing chronic hemodialysis. Protein-binding, presumably to albumin, renders these solutes poor-dialyzable. We previously observed that the free fraction of indoxyl sulfate was markedly reduced at the end of hemodialysis. We hypothesized that solute binding might be pH-dependent and attributed the changes in free solute concentration to the higher serum pH observed at the end of standard hemodialysis with dialysis buffer bicarbonate concentration greater than 35 mmol/L. We observed that acidification of uremic plasma to pH 6 in vitro greatly increased the proportion of freeIS. Methods We tested our hypothesis by reducing the dialysate bicarbonate buffer concentration to 25 mmol/L for the initial half of the hemodialysis treatment ("isohydric dialysis"). Eight stable hemodialysis patients underwent" isohydric dialysis" for 90 minutes and then were switched to standard buffer (bicarbonate = 37mmol/L). A second dialysis, 2 days later, employed standard buffer throughout. Results We found a clearcut separation of blood pH and bicarbonate concentrations after 90 minutes of "isohydric dialysis" (pH = 7.37, bicarbonate = 22.4 mmol/L) and standard dialysis (pH = 7.49, bicarbonate = 29.0 mmol/L). Binding affinity varied widely among the 10 uremic retention solutes analyzed. Kynurenic acid (0.05 free), p-cresyl sulfate (0.12 free) and indoxyl sulfate (0.13 free) demonstrated the greatest degree of binding. Three solutes (indoxyl glucuronide, p-cresyl glucuronide, and phenyl glucuronide) were virtually unbound. Analysis of free and bound concentrations of uremic retention solutes confirmed our prediction that binding of solute is affected by pH. However, in a mixed models analysis, we found that the reduction in total uremic solute concentration during dialysis accounted for a greater proportion of the variation in free concentration, presumably an effect of saturation binding to albumin, than did the relatively small change in pH produced by isohydric dialysis. The effect of pH on binding appeared to be restricted to those solutes most highly protein-bound. The solutes most tightly bound exhibited the lowest dialyzer clearances. An increase in dialyzer clearance during isohydric and standard dialyses was statistically significant only for kynurenic acid. Conclusion These findings provide evidence that the binding of uremic retention solutes is influenced by pH. The effect of reducing buffer bicarbonate concentration ("isohydric dialysis:"), though significant, was small but may be taken to suggest that further modification of dialysis technique that would expose blood to a greater decrease in pH would lead to a greater increase the free fraction of solute and enhance the efficacy of hemodialysis in the removal of highly protein-bound uremic retention solutes.	[Etinger, Aleksey; Kumar; Ackley, William; Soiefer, Leland; Chun, Jonathan; Singh, Prabjhot; Grossman, Eric; Matalon, Albert; Holzman, Robert S.; Lowenstein, Jerome] NYU, Sch Med, New York, NY 10003 USA; [Meijers, Bjorn] Univ Hosp Leuven, Dept Nephrol, Leuven, Belgium; [Meijers, Bjorn] Dept Immunol & Microbiol, Leuven, Belgium	New York University; KU Leuven; University Hospital Leuven	Lowenstein, J (corresponding author), NYU, Sch Med, New York, NY 10003 USA.	jerome.lowenstein@nyumc.org		Lowenstein, Jerome/0000-0002-2090-2015; Chun, Jonathan/0000-0002-0720-7173; , aleksey/0000-0002-2427-5186	Nephrology Division of NYU Langone Medical Center	Nephrology Division of NYU Langone Medical Center	Supported by discretionary funds in Nephrology Division of NYU Langone Medical Center	Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bohringer F, 2015, ASAIO J, V61, P55, DOI 10.1097/MAT.0000000000000166; Chun J, 2015, CHANGES PH HEMODIALY; de Loor H, 2016, ANAL CHIM ACTA, V936, P149, DOI 10.1016/j.aca.2016.06.057; Eloot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076838; Evenepoel P, 2017, KIDNEY INT, V92, P1323, DOI 10.1016/j.kint.2017.06.029; Jhawar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118703; Kochansky CJ, 2008, MOL PHARM, V5, P438, DOI 10.1021/mp800004s; Krieter DH, 2017, ACTA PHYSIOL, V219, P510, DOI 10.1111/apha.12730; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Lowenstein J, 2017, KIDNEY INT, V91, P561, DOI 10.1016/j.kint.2016.09.052; Lowenstein J, 2011, FASEB J, V25, P1781, DOI 10.1096/fj.11-0602ufm; Meijers BKI, 2008, AM J KIDNEY DIS, V51, P839, DOI 10.1053/j.ajkd.2007.12.035; Meijers B, 2014, SEMIN NEPHROL, V34, P228, DOI 10.1016/j.semnephrol.2014.02.012; Meijers BKI, 2011, NEPHROL DIAL TRANSPL, V26, P759, DOI 10.1093/ndt/gfq818; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Melamed ML, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-134; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nazzal L, 2017, NEPHROL DIAL TRANSPL, V32, P1809, DOI 10.1093/ndt/gfx029; Poesen R, 2013, CLIN J AM SOC NEPHRO, V8, P1508, DOI 10.2215/CJN.00300113; R Core Team, 2021, R LANGUAGE ENV STAT; Rhee EP, 2013, J AM SOC NEPHROL, V24, P1330, DOI 10.1681/ASN.2012101006; Rhee EP, 2010, J AM SOC NEPHROL, V21, P1041, DOI 10.1681/ASN.2009111132; Sam Ramin, 2006, Hemodial Int, V10, P15, DOI 10.1111/j.1542-4758.2006.01170.x; SCRIBNER BH, 1960, T AM SOC ART INT ORG, V6, P114; Shafi T, 2017, KIDNEY INT, V92, P1484, DOI 10.1016/j.kint.2017.05.012; Shafi T, 2016, KIDNEY INT, V89, P1099, DOI 10.1016/j.kint.2015.10.011; Smith WW, 1938, J BIOL CHEM, V124, P107; Sombolos KI, 2005, ARTIF ORGANS, V29, P892, DOI 10.1111/j.1525-1594.2005.00126.x; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Termorshuizen, 2001, AM J KIDNEY DIS, V38, P85; U S Renal Data System, US RENAL DATA SYSTEM; Uwai Y, 2012, PHARMACOL RES, V65, P254, DOI 10.1016/j.phrs.2011.11.003; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Watanabe H, 2012, DRUG METAB DISPOS, V40, P1423, DOI 10.1124/dmd.112.045617; Wu IW, 2012, NEPHROL DIAL TRANSPL, V27, P1169, DOI 10.1093/ndt/gfr453	38	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0192770	10.1371/journal.pone.0192770	http://dx.doi.org/10.1371/journal.pone.0192770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	29470534	Green Published, gold, Green Submitted			2022-12-26	WOS:000425831000018
J	Brocklehurst, S; Watson, M; Carr, IM; Out, S; Heidmann, I; Meyer, P				Brocklehurst, Samuel; Watson, Michael; Carr, Ian M.; Out, Suzan; Heidmann, Iris; Meyer, Peter			Induction of epigenetic variation in Arabidopsis by over-expression of DNA METHYLTRANSFERASE1 (MET1)	PLOS ONE			English	Article							DNA METHYLATION; GENE; METHYLTRANSFERASES; TRANSCRIPTION; TRANSPOSONS; MAINTENANCE; MUTANTS; HDA6	Epigenetic marks such as DNA methylation and histone modification can vary among plant accessions creating epi-alleles with different levels of expression competence. Mutations in epigenetic pathway functions are powerful tools to induce epigenetic variation. As an alternative approach, we investigated the potential of over-expressing an epigenetic function, using DNA METHYLTRANSFERASE1 (MET1) for proof-of-concept. In Arabidopsis thaliana, MET1 controls maintenance of cytosine methylation at symmetrical CG positions. At some loci, which contain dense DNA methylation in CG-and non-CG context, loss of MET1 causes joint loss of all cytosines methylation marks. We find that over-expression of both catalytically active and inactive versions of MET1 stochastically generates new epi-alleles at loci encoding transposable elements, non-coding RNAs and proteins, which results for most loci in an increase in expression. Individual transformants share some common phenotypes and genes with altered gene expression. Altered expression states can be transmitted to the next generation, which does not require the continuous presence of the MET1 transgene. Long-term stability and epigenetic features differ for individual loci. Our data show that overexpression of MET1, and potentially of other genes encoding epigenetic factors, offers an alternative strategy to identify epigenetic target genes and to create novel epi-alleles.	[Brocklehurst, Samuel; Watson, Michael; Meyer, Peter] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England; [Carr, Ian M.] Univ Leeds, Sch Med, Inst Biomed & Clin Sci LIBACS, Leeds, W Yorkshire, England; [Out, Suzan; Heidmann, Iris] Enza Zaden Res & Dev BV, Enkhuizen, Netherlands	University of Leeds; University of Leeds	Meyer, P (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	p.meyer@leeds.ac.uk	Heidmann, Iris/AAL-1293-2021	Meyer, Peter/0000-0001-5177-0353	BBSRC CASE studentship [BB/K011669/1]; BBSRC CASE studentship; Biotechnology and Biological Sciences Research Council [1361758] Funding Source: researchfish	BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SB was funded by a BBSRC CASE studentship (http://www.bbsrc.ac.uk/) BB/K011669/1.r SB was supported by a BBSRC CASE studentship.	Baev V, 2010, PLANT PHYSIOL BIOCH, V48, P393, DOI 10.1016/j.plaphy.2010.03.013; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Catoni M, 2017, EMBO J, V36, P617, DOI 10.15252/embj.201695602; CLARKADAMS CD, 1988, GENE DEV, V2, P150, DOI 10.1101/gad.2.2.150; CLARKADAMS CD, 1987, MOL CELL BIOL, V7, P679, DOI 10.1128/MCB.7.2.679; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cowan RK, 2005, MOL BIOL EVOL, V22, P2084, DOI 10.1093/molbev/msi202; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durut N, 2014, PLANT CELL, V26, P1330, DOI 10.1105/tpc.114.123893; Elgin SCR, 2013, COLD SPRING HARBOR P, V5; Finnegan EJ, 1998, P NATL ACAD SCI USA, V95, P5824, DOI 10.1073/pnas.95.10.5824; Finnegan EJ, 2002, CURR OPIN PLANT BIOL, V5, P101, DOI 10.1016/S1369-5266(02)00233-9; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Johannes F, 2011, GENETICS, V188, P215, DOI 10.1534/genetics.111.127118; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kankel MW, 2003, GENETICS, V163, P1109; Kato M, 2004, GENETICS, V168, P961, DOI 10.1534/genetics.104.029637; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Kovarik A, 1997, THEOR APPL GENET, V95, P301, DOI 10.1007/s001220050563; Law JA, 2010, CURR BIOL, V20, P951, DOI 10.1016/j.cub.2010.03.062; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Liu XC, 2012, PLANT PHYSIOL, V158, P119, DOI 10.1104/pp.111.184275; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Mirouze M, 2012, P NATL ACAD SCI USA, V109, P5880, DOI 10.1073/pnas.1120841109; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Naydenov M, 2015, PLANT PHYSIOL BIOCH, V87, P102, DOI 10.1016/j.plaphy.2014.12.022; O'Malley R C, 2012, Cold Spring Harb Symp Quant Biol, V77, P135, DOI 10.1101/sqb.2012.77.014571; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Rangwala SH, 2007, GENETICS, V176, P151, DOI 10.1534/genetics.107.071092; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Silveira AB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003437; Singh A, 2008, PLANT J, V56, P814, DOI 10.1111/j.1365-313X.2008.03640.x; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Subramanian J, 2005, GENETICS, V171, P427, DOI 10.1534/genetics.105.042861; To TK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002055; To TK, 2011, BIOCHEM BIOPH RES CO, V406, P414, DOI 10.1016/j.bbrc.2011.02.058; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Virdi KS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7386; Watson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105338; Weigel D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-249; Wu K, 2008, J EXP BOT, V59, P225, DOI 10.1093/jxb/erm300; Yao YL, 2012, PLANT CELL REP, V31, P1549, DOI 10.1007/s00299-012-1269-1; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zubko E, 2012, PLANT J, V71, P1029, DOI 10.1111/j.1365-313X.2012.05051.x	61	10	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192170	10.1371/journal.pone.0192170	http://dx.doi.org/10.1371/journal.pone.0192170			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466369	Green Published, gold, Green Submitted			2022-12-26	WOS:000425604300031
J	Giles, LV; Tebbutt, SJ; Carlsten, C; Koehle, MS				Giles, Luisa V.; Tebbutt, Scott J.; Carlsten, Christopher; Koehle, Michael S.			The effect of low and high-intensity cycling in diesel exhaust on flow-mediated dilation, circulating NOx, endothelin-1 and blood pressure	PLOS ONE			English	Article							ULTRAFINE PARTICLE DEPOSITION; NITRIC-OXIDE; AIR-POLLUTION; VASCULAR FUNCTION; DYSFUNCTION; INHALATION; EXPOSURE; EXERCISE; HUMANS; IMPAIRMENT	Introduction Exposure to air pollution impairs aspects of endothelial function such as flow-mediated dilation (FMD). Outdoor exercisers are frequently exposed to air pollution, but how exercising in air pollution affects endothelial function and how these effects are modified by exercise intensity are poorly understood. Objectives Therefore, the purpose of this study was to determine the effects of low-intensity and high-intensity cycling with diesel exhaust (DE) exposure on FMD, blood pressure, plasma nitrite and nitrate (NOx) and endothelin-1. Methods Eighteen males performed 30-minute trials of low or high-intensity cycling (30% and 60% of power at VO2peak) or a resting control condition. For each subject, each trial was performed once while breathing filtered air (FA) and once while breathing DE (300ug/m(3) of PM2.5, six trials in total). Preceding exposure, immediately post-exposure, 1 hour and 2 hours post-exposure, FMD, blood pressure and plasma endothelin-1 and NOx concentrations were measured. Data were analyzed using repeated-measures ANOVA and linear mixed model. Results Following exercise in DE, plasma NOx significantly increased and was significantly greater than FA (p<0.05). Two hours following DE exposure, endothelin-1 was significantly less than FA (p = 0.037) but exercise intensity did not modify this response. DE exposure did not affect FMD or blood pressure. Conclusion Our results suggest that exercising in DE did not adversely affect plasma NOX, endothelin-1, FMD and blood pressure. Therefore, recommendations for healthy individuals to moderate or avoid exercise during bouts of high pollution appear to have no acute protective effect.	[Giles, Luisa V.; Koehle, Michael S.] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada; [Tebbutt, Scott J.; Carlsten, Christopher] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Tebbutt, Scott J.; Carlsten, Christopher] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Tebbutt, Scott J.; Carlsten, Christopher] St Pauls Hosp, Vancouver, BC, Canada; [Carlsten, Christopher] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Koehle, Michael S.] Univ British Columbia, Div Sports Med, Vancouver, BC, Canada; [Giles, Luisa V.] Douglas Coll, Sports Sci Dept, New Westminster, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia	Giles, LV (corresponding author), Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada.; Giles, LV (corresponding author), Douglas Coll, Sports Sci Dept, New Westminster, BC, Canada.	gilesl@douglascollege.ca	Koehle, Michael/C-7850-2013	Koehle, Michael/0000-0001-7026-8422	Canadian Academy of Sport and Exercise Medicine [15R44931]; Health Canada [15R66575]; Fraser Basin Council BC Clean Air Research Fund (BC CLEAR) [15R44554]; Natural Science and Engineering Research Council (NSERC) [15R65329]	Canadian Academy of Sport and Exercise Medicine; Health Canada; Fraser Basin Council BC Clean Air Research Fund (BC CLEAR); Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Academy of Sport and Exercise Medicine: http://casem-acmse.org/ 15R44931 to MSK; Health Canada: http://www.hc-sc.gc.ca/index-eng.php 15R66575 to MSK; Fraser Basin Council BC Clean Air Research Fund (BC CLEAR): http://www.fraserbasin.bc.ca/ 15R44554 to MSK; Natural Science and Engineering Research Council (NSERC): http://www.nserc-crsng.gc.ca/index_eng.asp 15R65329 to MSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, EPA600890057F NAT CT; Atkinson G, 2013, ATHEROSCLEROSIS, V226, P425, DOI 10.1016/j.atherosclerosis.2012.11.027; Birger N, 2011, INHAL TOXICOL, V23, P219, DOI 10.3109/08958378.2011.562256; Brauner EV, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-13; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; BUGA GM, 1993, CIRC RES, V73, P808, DOI 10.1161/01.RES.73.5.808; Cannon RO, 2001, J CLIN INVEST, V108, P279, DOI 10.1172/JCI12761; Chalupa DC, 2004, ENVIRON HEALTH PERSP, V112, P879, DOI 10.1289/ehp.6851; Cherng TW, 2009, AM J PHYSIOL-REG I, V297, pR640, DOI 10.1152/ajpregu.90899.2008; Cutrufello PT, 2011, INHAL TOXICOL, V23, P658, DOI 10.3109/08958378.2011.604106; Daigle CC, 2003, INHAL TOXICOL, V15, P539, DOI 10.1080/08958370304468; de Geus B, 2007, BRIT J SPORT MED, V41, P8, DOI 10.1136/bjsm.2006.027615; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; DeSouza CA, 2000, CIRCULATION, V102, P1351, DOI 10.1161/01.CIR.102.12.1351; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Giles LV, 2014, MED SCI SPORT EXER, V46, P1999, DOI 10.1249/MSS.0000000000000309; Giles LV, 2014, SPORTS MED, V44, P223, DOI 10.1007/s40279-013-0108-z; Gokce N, 2002, AM J CARDIOL, V90, P124, DOI 10.1016/S0002-9149(02)02433-5; GOODMAN C, 1985, EUR J APPL PHYSIOL O, V54, P436, DOI 10.1007/BF02337191; Hansen CS, 2007, TOXICOL APPL PHARM, V219, P24, DOI 10.1016/j.taap.2006.10.032; HAYNES WG, 1994, LANCET, V344, P852, DOI 10.1016/S0140-6736(94)92827-4; Knuckles TL, 2008, TOXICOL APPL PHARM, V230, P346, DOI 10.1016/j.taap.2008.03.010; Knuckles TL, 2011, J TOXICOL ENV HEAL A, V74, P828, DOI 10.1080/15287394.2011.570225; Langrish JP, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004309; Langrish JP, 2009, HYPERTENSION, V54, P910, DOI 10.1161/HYPERTENSIONAHA.109.135947; Mills NL, 2011, EUR HEART J, V32, P2660, DOI 10.1093/eurheartj/ehr195; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Neunteufl T, 2000, J AM COLL CARDIOL, V35, P277, DOI 10.1016/S0735-1097(99)00542-2; Nurkiewicz TR, 2009, TOXICOL SCI, V110, P191, DOI 10.1093/toxsci/kfp051; Patrician PA, 2002, RES NURS HEALTH, V25, P76, DOI 10.1002/nur.10015; Peretz A, 2008, ENVIRON HEALTH PERSP, V116, P937, DOI 10.1289/ehp.11027; Peretz Alon, 2007, BMC Cardiovasc Disord, V7, P11, DOI 10.1186/1471-2261-7-11; Rakhit RD, 2001, HEART, V86, P368, DOI 10.1136/heart.86.4.368; Rundell KW, 2007, INHAL TOXICOL, V19, P133, DOI 10.1080/08958370601051727; Rundell KW, 2010, INHAL TOXICOL; SAGAI M, 1993, FREE RADICAL BIO MED, V14, P37, DOI 10.1016/0891-5849(93)90507-Q; Sun QH, 2008, ARTERIOSCL THROM VAS, V28, P1760, DOI 10.1161/ATVBAHA.108.166967; Thijssen DHJ, 2008, AM J PHYSIOL-HEART C, V295, pH1594, DOI 10.1152/ajpheart.00669.2008; Toborek M, 1999, BASIC RES CARDIOL, V94, P295, DOI 10.1007/s003950050156; VITA JA, 1989, J AM COLL CARDIOL, V14, P1193, DOI 10.1016/0735-1097(89)90416-6; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wauters A, 2012, ACTA CARDIOLOGICA; Wauters A, 2013, HYPERTENSION, V62, P352, DOI 10.1161/HYPERTENSIONAHA.111.00991; Weinberger B, 2001, TOXICOL SCI, V59, P5, DOI 10.1093/toxsci/59.1.5; West BW., 2015, LINEAR MIXED MODELS, V2; Wilcox CS, 2003, ACTA PHYSIOL SCAND, V179, P217, DOI 10.1046/j.0001-6772.2003.01205.x; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009	47	23	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192419	10.1371/journal.pone.0192419	http://dx.doi.org/10.1371/journal.pone.0192419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466393	Green Submitted, gold, Green Published			2022-12-26	WOS:000425604300057
J	Huang, XD; Zhao, W; Zhang, LX; Yang, XJ; Wang, LH; Chen, YS; Wang, JH; Zhang, C; Wu, GL				Huang, XuDong; Zhao, Wei; Zhang, LiXia; Yang, XinJun; Wang, LiHui; Chen, YunShuang; Wang, JingHua; Zhang, Chao; Wu, GuangLi			The role of complement activation in rhabdomyolysis-induced acute kidney injury	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ISCHEMIA-REPERFUSION INJURY; ACUTE-RENAL-FAILURE; ALTERNATIVE PATHWAY; SKELETAL-MUSCLE; EPITHELIAL-CELLS; C5A; DYSFUNCTION; C3A; DEFICIENCY	Rhabdomyolysis (RM) may cause kidney damage and results primarily in acute kidney injury (AKI). Complement is implicated in the pathogenesis of renal diseases and ischemia-reperfusion injury (IRI), but the role of complement, especially its activation pathway(s) and its effect in RM-induced AKI, is not clear. This study established a rat model of AKI induced by RM via intramuscular treatment with glycerol. Cobra venom factor (CVF) was administered via tail vein injection to deplete complement 12 h prior to intramuscular injection of glycerol. We found that the complement components, including complement 3 (C3), C1q, MBL-A, factor B(fB), C5a, C5b-9, and CD59, were significantly increased in rat kidneys after intramuscular glycerol administration. However, the levels of serum BUN and Cr, renal tubular injury scores, and the number of TUNEL-positive cells decreased significantly in the CVF+AKI group. These results suggest that complement plays an important role in RM-induced AKI and that complement depletion may improve renal function and decrease renal tissue damage by reducing the inflammatory response and apoptosis.	[Huang, XuDong; Wu, GuangLi] Chinese Peoples Liberat Army Gen Hosp, Dept Nephrol, Beijing, Peoples R China; [Huang, XuDong; Zhao, Wei; Zhang, LiXia; Yang, XinJun; Wang, LiHui; Chen, YunShuang; Wang, JingHua; Zhang, Chao; Wu, GuangLi] Bethune Int Peace Hosp, Dept Nephrol, Shijiazhuang, Hebei, Peoples R China	Chinese People's Liberation Army General Hospital	Wu, GL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Nephrol, Beijing, Peoples R China.; Wu, GL (corresponding author), Bethune Int Peace Hosp, Dept Nephrol, Shijiazhuang, Hebei, Peoples R China.	wugl@medmail.com.cn			Fund of the Chinese PLA 12th Five-Year Plan for Medical Sciences [CWS12J061, CBJ14J013]; Chinese PLA Medical Science and Technology Youth Development Project [16QNP072]	Fund of the Chinese PLA 12th Five-Year Plan for Medical Sciences; Chinese PLA Medical Science and Technology Youth Development Project	This study was supported by grants from the Fund of the Chinese PLA 12th Five-Year Plan for Medical Sciences (CWS12J061, CBJ14J013) and the Chinese PLA Medical Science and Technology Youth Development Project (16QNP072). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegretti AP, 2012, CELL IMMUNOL, V277, P1, DOI 10.1016/j.cellimm.2012.06.008; Anaraki PK, 2014, STEM CELLS DEV, V23, P352, DOI 10.1089/scd.2013.0318; Belliere J, 2015, J AM SOC NEPHROL, V26, P1363, DOI 10.1681/ASN.2014040320; Braig D, 2014, INT IMMUNOL, V26, P467, DOI 10.1093/intimm/dxu056; Burdo TH, J CLIN CELL IMMUNOL; Casiraghi F, 2017, AM J TRANSPLANT, V17, P2312, DOI 10.1111/ajt.14262; Cataland SR, 2014, BLOOD, V123, P3733, DOI 10.1182/blood-2013-12-547067; Chan RK, 2006, J IMMUNOL, V177, P8080, DOI 10.4049/jimmunol.177.11.8080; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Danobeitia JS, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-16; De Vries B, 2003, TRANSPLANTATION, V75, P375, DOI 10.1097/01.TP.0000044455.05584.2A; Ding Y.C., 2012, MATH PROBL ENG, V2012, P1, DOI DOI 10.1155/2012/509420; Farrar CA, 2006, FASEB J, V20, P217, DOI 10.1096/fj.05-4747com; Fernandez WG, 2000, ACAD EMERG MED, V7, P575; Flierl MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002560; Gou SJ, 2013, KIDNEY INT, V83, P129, DOI 10.1038/ki.2012.313; Harhausen D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-15; Holt SG, 2001, INTENS CARE MED, V27, P803, DOI 10.1007/s001340100878; Hu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.274; Janelle V, 2014, CANCER IMMUNOL RES, V2, P200, DOI 10.1158/2326-6066.CIR-13-0173; Kacani L, 2001, J IMMUNOL, V166, P3410, DOI 10.4049/jimmunol.166.5.3410; Khan FY, 2009, NETH J MED, V67, P272; Lane R, 2003, BMJ-BRIT MED J, V327, P115, DOI 10.1136/bmj.327.7407.115; Lane T, 2014, CIRC RES, V114, P672, DOI 10.1161/CIRCRESAHA.114.302770; Lee M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087316; Lesher AM, 2013, J AM SOC NEPHROL, V24, P53, DOI 10.1681/ASN.2012060570; Li HY, 2014, J BIOL CHEM, V289, P14283, DOI 10.1074/jbc.M114.555318; Li K, 2012, IMMUNOBIOLOGY, V217, P65, DOI 10.1016/j.imbio.2011.07.033; Lueck K, 2011, EYE, V25, P1074, DOI 10.1038/eye.2011.109; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Michels M, 2015, BRAIN BEHAV IMMUN, V43, P54, DOI 10.1016/j.bbi.2014.07.002; Mihlan M, 2011, FASEB J, V25, P4198, DOI 10.1096/fj.11-186460; Miwa T, 2013, J IMMUNOL, V190, P3552, DOI 10.4049/jimmunol.1202275; Naesens M, 2009, J AM SOC NEPHROL, V20, P1839, DOI 10.1681/ASN.2008111145; NATH KA, 1985, J CLIN INVEST, V76, P667, DOI 10.1172/JCI112020; Otteby KE, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4410; PAPADIMITRIOU JC, 1991, J IMMUNOL, V147, P212; Park P, 2001, J AM SOC NEPHROL, V12, P1383, DOI 10.1681/ASN.V1271383; Peake PW, 2002, NEPHROL DIAL TRANSPL, V17, P745, DOI 10.1093/ndt/17.5.745; Peng Q, 2012, J AM SOC NEPHROL, V23, P1474, DOI 10.1681/ASN.2011111072; Pepys MB, 2012, J IMMUNOL METHODS, V384, P92, DOI 10.1016/j.jim.2012.07.013; Plotnikov EY, 2009, BBA-MOL BASIS DIS, V1792, P796, DOI 10.1016/j.bbadis.2009.06.005; Sauret JM, 2002, AM FAM PHYSICIAN, V65, P907; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Spiller OB, 2000, CLIN EXP IMMUNOL, V121, P234, DOI 10.1046/j.1365-2249.2000.01305.x; Suresh R, 2016, J CELL SCI, V129, P1928, DOI 10.1242/jcs.179291; Tang S, 1999, J IMMUNOL, V162, P4336; Tang WX, 2013, ARTIF ORGANS, V37, P390, DOI 10.1111/j.1525-1594.2012.01574.x; Thiele JR, 2014, CIRCULATION, V130, P35, DOI 10.1161/CIRCULATIONAHA.113.007124; Thurman JM, 2003, J IMMUNOL, V170, P1517, DOI 10.4049/jimmunol.170.3.1517; Thurman JM, 2007, J IMMUNOL, V178, P1819, DOI 10.4049/jimmunol.178.3.1819; Vernon KA, 2012, ADV CHRONIC KIDNEY D, V19, P84, DOI 10.1053/j.ackd.2012.02.015; Vogel CW, 2010, TOXICON, V56, P1198, DOI 10.1016/j.toxicon.2010.04.007; WARD MM, 1988, ARCH INTERN MED, V148, P1553, DOI 10.1001/archinte.148.7.1553; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343; Yang C, 2014, J NEUROIMMUNOL, V267, P16, DOI 10.1016/j.jneuroim.2013.11.007; Yang CW, 2003, FASEB J, V17, P1754, DOI 10.1096/fj.02-1191fje; Zhang J, 2014, FASEB J, V28, P1511, DOI 10.1096/fj.13-242693; Zhang YZ, 2012, CLIN J AM SOC NEPHRO, V7, P265, DOI 10.2215/CJN.07900811; Zhao W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151158; Zou L, 2013, J IMMUNOL, V191, P5625, DOI 10.4049/jimmunol.1301903	61	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192361	10.1371/journal.pone.0192361	http://dx.doi.org/10.1371/journal.pone.0192361			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8RO	29466390	gold, Green Published, Green Submitted			2022-12-26	WOS:000425604300052
J	Perez-Perez, B; Cristobal-Narvaez, P; Sheinbaum, T; Kwapil, TR; Ballesp, S; Pena, E; de Castro-Catala, M; Riba, MD; Rosa, A; Barrantes-Vidal, N				Perez-Perez, Beatriz; Cristobal-Narvaez, Paula; Sheinbaum, Tamara; Kwapil, Thomas R.; Ballesp, Sergi; Pena, Elionora; de Castro-Catala, Marta; Riba, Maria Dolors; Rosa, Araceli; Barrantes-Vidal, Neus			Interaction between FKBP5 variability and recent life events in the anxiety spectrum: Evidence for the differential susceptibility model	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; GENE-ENVIRONMENT INTERACTIONS; CHILDHOOD TRAUMA; EPIGENETIC MODIFICATION; DEPRESSIVE-DISORDERS; SOCIAL PHOBIA; RISK; NEUROTICISM; SCHIZOPHRENIA; EXTROVERSION	Background Gene-environment interaction (GxE) research has highlighted the importance of investigating the FK506 binding protein 51 (FKBP5) gene as a sensitivity gene. However, previous GxE studies with FKBP5 have not measured the full environmental spectrum or applied statistical tests to discern whether the GxE interaction fits better with the differential-susceptibility or diathesis-stress hypotheses. This study examined whether single nucleotide polymorphisms (SNPs) on FKBP5 gene moderate the association of positive and negative recent life events (LEs) with depressive symptoms, state-anxiety, neuroticism, and social anxiety traits. Methods A total of 86 nonclinical young adults were administered psychological measures and were genotyped for five FKBP5 SNPs (rs3800373, rs9296158, rs1360780, rs9470080 and rs4713916). Results Regression analyses indicated significant GxE interactions for social anxiety and neuroticism. The interactions predicting neuroticism fit different models for different SNPs, although the overall effect indicated by the haplotype was consistent with the differential-susceptibility hypothesis: the risk-haplotype group presented higher neuroticism in the presence of more negative LEs and lower neuroticism in the presence of more positive LEs. The GxE interactions for social anxiety were consistent with the diathesis-stress model. The lack of significance in the for-better side for social anxiety might be related to the fact that it mapped onto low extraversion, which is associated with a lower permeability to positive experiences. Discussion Findings underscore the importance of testing the differential-susceptibility model in relation to FKBP5 to adequately characterize its role in healthy and pathological developmental processes.	[Perez-Perez, Beatriz; Sheinbaum, Tamara; Ballesp, Sergi; Barrantes-Vidal, Neus] UAB, Dept Psicol Clin & Salut, Barcelona, Spain; [Cristobal-Narvaez, Paula] Fundacio St Joan de Deu, Parc Sanitari St Joan de Deu, Res Innovat & Teaching Unit, Barcelona, Spain; [Cristobal-Narvaez, Paula; Rosa, Araceli; Barrantes-Vidal, Neus] Inst Salud Carlos III, Ctr Biomed Res Network Mental Hlth CIBERSAM, Madrid, Spain; [Kwapil, Thomas R.] Univ Illinois, Dept Psychol, Champaign, IL USA; [Pena, Elionora; de Castro-Catala, Marta; Rosa, Araceli] Univ Barcelona, Seccio Zool & Antropol Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Spain; [Pena, Elionora; de Castro-Catala, Marta; Rosa, Araceli] IBUB, Barcelona, Spain; [Riba, Maria Dolors] UAB, Dept Psicobiol & Metodol Ciencies Salut, Barcelona, Spain; [Barrantes-Vidal, Neus] St Pere Claver Fundacio Sanitaria, Barcelona, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; University of Illinois System; University of Illinois Urbana-Champaign; University of Barcelona; University of Barcelona; Autonomous University of Barcelona	Barrantes-Vidal, N (corresponding author), UAB, Dept Psicol Clin & Salut, Barcelona, Spain.; Barrantes-Vidal, N (corresponding author), Inst Salud Carlos III, Ctr Biomed Res Network Mental Hlth CIBERSAM, Madrid, Spain.; Barrantes-Vidal, N (corresponding author), St Pere Claver Fundacio Sanitaria, Barcelona, Spain.	neus.barrantes@uab.cat	de Castro-Catala, Marta/E-2246-2019; Kwapil, Thomas/I-3163-2019; Cristóbal-Narváez, Paula/AFU-7048-2022; Rosa, Araceli/Q-2099-2016; Cristóbal-Narváez, Paula/K-3265-2017; Barrantes-Vidal, Neus/A-9578-2013; Peña, Elionora/ABH-7588-2020; Sheinbaum, Tamara/A-8008-2016	de Castro-Catala, Marta/0000-0002-5550-4885; Cristóbal-Narváez, Paula/0000-0001-8184-6347; Rosa, Araceli/0000-0001-6935-3785; Cristóbal-Narváez, Paula/0000-0001-8184-6347; Barrantes-Vidal, Neus/0000-0002-8671-1238; Peña, Elionora/0000-0001-5003-5453; Sheinbaum, Tamara/0000-0002-2268-7697; Perez-Perez, Beatriz/0000-0001-7563-9042	Spanish Ministerio de Economia y Competitividad [P512011-30321-C02-01, P512011-30321-C02-02, PSI2014-54009-R, PSI2014-56303-REDT]; Fundacio La Marato de TV3 [091110]; Comissionat per a Universitats i Recerca of the Generalitat de Catalunya [2014SGR1070, 2014SGR1636]; Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia Award	Spanish Ministerio de Economia y Competitividad(Spanish Government); Fundacio La Marato de TV3; Comissionat per a Universitats i Recerca of the Generalitat de Catalunya(Generalitat de Catalunya); Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia Award(ICREA)	This work was supported by the Spanish Ministerio de Economia y Competitividad (Plan Nacional de I+D P512011-30321-C02-01 and C02-02; PSI2014-54009-R; Red de Excelencia PSI2014-56303-REDT, PROMOSAM: Investigacion en Procesos, Mecanismos y Tratamientos Psicologicos para Ia Promocion de Ia Salud Mental), Fundacio La Marato de TV3 (091110) and Comissionat per a Universitats i Recerca of the Generalitat de Catalunya (2014SGR1070 and 2014SGR1636). Neus Barrantes-Vidal is supported by the Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia Award.	Appel K, 2011, NEUROPSYCHOPHARMACOL, V36, P1982, DOI 10.1038/npp.2011.81; Barrantes-Vidal N, 2013, SCHIZOPHR RES, V145, P50, DOI 10.1016/j.schres.2013.01.007; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Beck & Steer, 2011, MANUAL BECK DEPRESSI; Belsky J, 2007, CURR DIR PSYCHOL SCI, V16, P300, DOI 10.1111/j.1467-8721.2007.00525.x; Belsky J, 2013, DEV PSYCHOPATHOL, V25, P1243, DOI 10.1017/S095457941300059X; Belsky J, 2014, WORLD PSYCHIATRY, V13, P87, DOI 10.1002/wps.20092; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Bevilacqua L, 2012, ARCH GEN PSYCHIAT, V69, P62, DOI 10.1001/archgenpsychiatry.2011.152; Bienvenu OJ, 2007, AM J PSYCHIAT, V164, P1714, DOI 10.1176/appi.ajp.2007.06101667; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Collip D, 2013, BRIT J PSYCHIAT, V202, P261, DOI 10.1192/bjp.bp.112.115972; Costa P. T., 1999, INVENTARIO PERSONALI; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Cristobal-Narvaez P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158809; Daskalakis NP, 2015, SCHIZOPHRENIA BULL, V41, P323, DOI 10.1093/schbul/sbu189; Del Giudice M, 2017, DEV PSYCHOPATHOL, V29, P1267, DOI 10.1017/S0954579416001292; Eichhammer P, 2005, MOL PSYCHIATR, V10, P520, DOI 10.1038/sj.mp.4001658; Fani N, 2013, JAMA PSYCHIAT, V70, P392, DOI 10.1001/2013.jamapsychiatry.210; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; Jeronimus BF, 2013, PSYCHOL MED, V43, P2403, DOI 10.1017/S0033291713000159; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Klengel T, 2015, NEUROPSYCHOPHARMACOL, V40, P244, DOI 10.1038/npp.2014.208; Klengel T, 2013, EPIGENOMICS-UK, V5, P109, DOI [10.2217/epi.13.11, 10.2217/EPI.13.11]; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; O'Keefe DJ, 2003, HUM COMMUN RES, V29, P431, DOI 10.1111/j.1468-2958.2003.tb00846.x; Ogle CM, 2014, J PERS, V82, P93, DOI 10.1111/jopy.12037; Pangallo A, 2015, PSYCHOL ASSESSMENT, V27, P1, DOI 10.1037/pas0000024; Piqueras JA, 2012, BEHAV PSYCHOL, V20, P505; Pluess M, 2015, CHILD DEV PERSPECT, V9, P138, DOI 10.1111/cdep.12120; Pluess M, 2010, PROG NEURO-PSYCHOPH, V34, P1070, DOI 10.1016/j.pnpbp.2010.05.028; Roisman GI, 2012, DEV PSYCHOPATHOL, V24, P389, DOI 10.1017/S0954579412000065; Roy A, 2012, J PSYCHIATR RES, V46, P72, DOI 10.1016/j.jpsychires.2011.09.009; Roy A, 2010, NEUROPSYCHOPHARMACOL, V35, P1674, DOI 10.1038/npp.2009.236; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Sarubin N, 2015, PERS INDIV DIFFER, V82, P193, DOI 10.1016/j.paid.2015.03.028; Scheuer S, 2016, J PSYCHIATR RES, V72, P30, DOI 10.1016/j.jpsychires.2015.10.009; Shibuya N, 2010, NEUROSCI LETT, V485, P194, DOI 10.1016/j.neulet.2010.09.010; StataCorp, 2011, STAT STAT SOFTW REL; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; van IJzendoorn MH, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.73; van Ijzendoorn MH, 2015, DEV PSYCHOPATHOL, V27, P151, DOI 10.1017/S0954579414001369; VanZomeren-Dohm AA, 2015, PSYCHONEUROENDOCRINO, V51, P426, DOI 10.1016/j.psyneuen.2014.10.003; White MG, 2012, GENES BRAIN BEHAV, V11, P869, DOI 10.1111/j.1601-183X.2012.00837.x; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; Zannas AS, 2014, GENES BRAIN BEHAV, V13, P25, DOI 10.1111/gbb.12104; Zannas AS, 2016, NEUROPSYCHOPHARMACOL, V41, P261, DOI 10.1038/npp.2015.235; Zimmermann P, 2011, AM J PSYCHIAT, V168, P1107, DOI 10.1176/appi.ajp.2011.10111577; Zuckerman M., 1999, VULNERABILITY PSYCHO	52	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0193044	10.1371/journal.pone.0193044	http://dx.doi.org/10.1371/journal.pone.0193044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	29466454	Green Published, Green Submitted, gold			2022-12-26	WOS:000425604300080
J	Acikalin, MY; Watson, KK; Fitzsimons, GJ; Platt, ML				Acikalin, M. Yavuz; Watson, Karli K.; Fitzsimons, Gavan J.; Platt, Michael L.			Rhesus macaques form preferences for brand logos through sex and social status based advertising	PLOS ONE			English	Article							DECISION-MAKING; EVOLUTIONARY PSYCHOLOGY; CONSUMER-BEHAVIOR; MONKEYS; ATTENTION; SIGNALS; CORTEX; DRINKING; ANTERIOR; HUMANS	Like humans, monkeys value information about sex and status, inviting the hypothesis that our susceptibility to these factors in advertising arises from shared, ancestral biological mechanisms that prioritize social information. To test this idea, we asked whether rhesus macaques (Macaca mulatta) show choice behavior that is similar to humans in response to sex and social status in advertising. Our results show that monkeys form preferences for brand logos repeatedly paired with images of macaque genitals and high status monkeys. Moreover, monkeys sustain preferences for these brand logos even though choosing them provided no tangible rewards, a finding that cannot be explained by a decision mechanism operating solely on material outcomes. Together, our results endorse the hypothesis that the power of sex and status in advertising emerges from the spontaneous engagement of shared, ancestral neural circuits that prioritize information useful for navigating the social environment. Finally, our results show that simple associative conditioning is sufficient to explain the formation of preferences for brand logos paired with sexual or status-based images.	[Acikalin, M. Yavuz] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; [Watson, Karli K.] Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA; [Fitzsimons, Gavan J.] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Platt, Michael L.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Platt, Michael L.] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Platt, Michael L.] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA	Stanford University; University of Colorado System; University of Colorado Boulder; Duke University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Acikalin, MY (corresponding author), Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.	mya@stanford.edu		Acikalin, Mehmet Yavuz/0000-0003-0081-3629	NIH [R03MH066259, R01MH071817, R01MH086712]; Esther and Joseph Klingenstein Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Esther and Joseph Klingenstein Foundation(Klingenstein Philanthropies)	The authors wish to acknowledge support from NIH grants R03MH066259, R01MH071817 and R01MH086712 and the Esther and Joseph Klingenstein Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps MAJ, 2016, NEURON, V90, P692, DOI 10.1016/j.neuron.2016.04.018; Archer J, 1996, AM PSYCHOL, V51, P909, DOI 10.1037/0003-066X.51.9.909; BAKER MJ, 1977, J MARKETING RES, V14, P538, DOI 10.2307/3151194; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Belch M.A., 1982, ACR N AM ADV, V9, P424; BERNSTEIN IS, 1966, BEHAVIOUR, V26, P91, DOI 10.1163/156853966X00038; Bray S, 2007, J NEUROPHYSIOL, V97, P3036, DOI 10.1152/jn.01211.2006; Chang SWC, 2013, P NATL ACAD SCI USA, V110, P10387, DOI 10.1073/pnas.1301213110; Chang SWC, 2013, NAT NEUROSCI, V16, P243, DOI 10.1038/nn.3287; Choi SM, 2005, J ADVERTISING, V34, P85, DOI 10.1080/00913367.2005.10639190; Cosmides L., 2000, HDB EMOTIONS, V2, P91, DOI DOI 10.31887/DCNS.2000.2.2/ASSCHACHTER; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Deaner RO, 2003, CURR BIOL, V13, P1609, DOI 10.1016/j.cub.2003.08.025; Eagly AH, 1997, AM PSYCHOL, V52, P1380, DOI 10.1037/0003-066X.52.12.1380.b; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; Griskevicius V, 2013, J CONSUM PSYCHOL, V23, P372, DOI 10.1016/j.jcps.2013.03.003; Hayden BY, 2007, P R SOC B, V274, P1751, DOI 10.1098/rspb.2007.0368; HONG JW, 1995, PSYCHOL MARKET, V12, P53, DOI 10.1002/mar.4220120105; Ivanic AS, 2011, PSYCHOL SCI, V22, P1557, DOI 10.1177/0956797611419519; JANISZEWSKI C, 1993, J CONSUM RES, V20, P171, DOI 10.1086/209342; Keltner D., 2013, EVOLUTION SOCIAL PSY, P115; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; MADDISON S, 1980, J COMP PHYSIOL PSYCH, V94, P365, DOI 10.1037/h0077664; Maestripieri D, 2009, PHYSIOL BEHAV, V96, P613, DOI 10.1016/j.physbeh.2008.12.016; MASSERMAN JH, 1964, AM J PSYCHIAT, V121, P584, DOI 10.1176/ajp.121.6.584; McCormack K, 2009, HORM BEHAV, V55, P538, DOI 10.1016/j.yhbeh.2009.01.009; Morwitz VG, 2014, J CONSUM PSYCHOL, V24, P572, DOI 10.1016/j.jcps.2014.01.004; Pearson JM, 2014, NEURON, V82, P950, DOI 10.1016/j.neuron.2014.04.037; Petty R.E., 1986, ADV EXPT SOCIAL PSYC, V19, P123, DOI [10.1016/S0065-2601(08)60214-2, DOI 10.1016/S0065-2601(08)60214-2, https://doi.org/10.1016/S0065-2601(08)60214-2]; Prescott MJ, 2010, J NEUROSCI METH, V193, P167, DOI 10.1016/j.jneumeth.2010.09.003; Reichert T, 2002, ANN REV SEX RES, V13, P241; Reichert T, 2001, J ADVERTISING, V30, P13, DOI 10.1080/00913367.2001.10673628; Rucker DD, 2012, J CONSUM PSYCHOL, V22, P352, DOI 10.1016/j.jcps.2011.06.001; Saad G, 2000, PSYCHOL MARKET, V17, P1005, DOI 10.1002/1520-6793(200012)17:12<1005::AID-MAR1>3.3.CO;2-8; Saad G, 2007, EVOLUTIONARY BASES C, P59; Santos LR, 2015, ANNU REV PSYCHOL, V66, P321, DOI 10.1146/annurev-psych-010814-015310; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Taylor CR, 2006, J ADVERTISING, V35, P21, DOI 10.2753/JOA0091-3367350402; Tremblay S, 2017, TRENDS COGN SCI, V21, P265, DOI 10.1016/j.tics.2017.01.007; Utevsky AV, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001941; Watson KK, 2012, CURR BIOL, V22, P2268, DOI 10.1016/j.cub.2012.10.016; Watson KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004156; WOOD RJ, 1980, J COMP PHYSIOL PSYCH, V94, P1135, DOI 10.1037/h0077745	43	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0193055	10.1371/journal.pone.0193055	http://dx.doi.org/10.1371/journal.pone.0193055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8CI	29462189	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200046
J	Gonzalez-Medina, E; Castillo-Guerrero, JA; Herzka, SZ; Fernandez, G				Gonzalez-Medina, Erick; Alfredo Castillo-Guerrero, Jose; Zinah Herzka, Sharon; Fernandez, Guillermo			High quality diet improves lipid metabolic profile and breeding performance in the blue-footed booby, a long-lived seabird	PLOS ONE			English	Article							MURRELET BRACHYRAMPHUS-MARMORATUS; STABLE-ISOTOPE ANALYSIS; BODY-MASS CHANGES; GULL-BILLED TERN; FOOD AVAILABILITY; REPRODUCTIVE-PERFORMANCE; MARBLED MURRELET; MATERNAL INVESTMENT; PLASMA METABOLITES; THREATENED SEABIRD	Understanding the role of diet in the physiological condition of adults during reproduction and hence its effect on reproductive performance is fundamental to understand reproductive strategies in long-lived animals. In birds, little is known about the influence of the quality of food consumed at the beginning of the reproductive period and its short-term effects on reproductive performance. To assess the role of diet in the physiological condition of female blue-footed booby, Sula nebouxii (BFBO), during reproduction we evaluated whether individual differences in diet (assessed by using delta C-13 and delta N-15 values of whole blood from female birds and muscle tissue of the principal prey species) prior to egg laying and during incubation influenced their lipid metabolic profile (measured as triglyceride levels and C:N ratio) and their reproductive performance (defined by laying date, clutch size and hatching success). Females with higher delta N-15 values in their blood during the courtship and incubation periods had a higher lipid metabolic profile, earlier laying date, greater clutch size (2-3 eggs) and higher hatching success. Females that laid earlier and more eggs (2-3 eggs) consumed more Pacific anchoveta (Cetengraulis mysticetus) and Pacific thread herring (Opisthonema libertate) than did other females. These two prey species also had high amounts of lipids (C:N ratio) and caloric content (Kcal/g fresh weight). The quality of food consumed by females at the beginning of reproduction affected their physiological condition, as well as their short-term reproductive performance. Our work emphasizes the importance of determining the influence of food quality during reproduction to understand the reproductive decisions and consequences in long-lived animals.	[Gonzalez-Medina, Erick] Univ Nacl Autonoma Mexico, Posgrad Ciencias Mar & Limnol, Mexico City, DF, Mexico; [Alfredo Castillo-Guerrero, Jose] Univ Guadalajara, Ctr Univ Costa Sur, CONACYT, Dept Estudios El Desarrollo Sustentable Zona Cost, Municipio De Cihuatlan, Jalisco, Mexico; [Zinah Herzka, Sharon] CICESE, Dept Oceanog Biol, Ensenada, Baja California, Mexico; [Fernandez, Guillermo] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Mazatlan, Mazatlan, Mexico; [Gonzalez-Medina, Erick] Univ Extremadura, Conservat Biol Res Grp, Area Zool, Badajoz, Spain	Universidad Nacional Autonoma de Mexico; Universidad de Guadalajara; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Nacional Autonoma de Mexico; Universidad de Extremadura	Gonzalez-Medina, E (corresponding author), Univ Nacl Autonoma Mexico, Posgrad Ciencias Mar & Limnol, Mexico City, DF, Mexico.; Fernandez, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Mazatlan, Mazatlan, Mexico.; Gonzalez-Medina, E (corresponding author), Univ Extremadura, Conservat Biol Res Grp, Area Zool, Badajoz, Spain.	gmedinaerick@gmail.com; gfernandez@ola.icmyl.unam.mx	Herzka, Sharon Z./E-1507-2015; Fernandez, Guillermo/B-7534-2008; González-Medina, Erick/ABG-9046-2020	Herzka, Sharon Z./0000-0001-7091-7656; Fernandez, Guillermo/0000-0002-8478-5575; González-Medina, Erick/0000-0002-9748-8641	Fondo Mexicano para Ia Conservacion de Ia Naturaleza A.C. [PIE-2012-A-P-C-IGSI-12-12]; CONACYT [1010/176/2012]; Sonoran Joint Venture, Pronatura Mexico A.G; National Council of Science and Technology (CONACYT) [201218, 473980]	Fondo Mexicano para Ia Conservacion de Ia Naturaleza A.C.; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Sonoran Joint Venture, Pronatura Mexico A.G; National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding for this work was provided by Fondo Mexicano para Ia Conservacion de Ia Naturaleza A.C. (PIE-2012-A-P-C-IGSI-12-12), CONACYT (No. 1010/176/2012), Sonoran Joint Venture, Pronatura Mexico A.G. E.G.M. was supported by a PhD and postdoctoral fellowship provided by The National Council of Science and Technology (CONACYT; #201218, #473980 respectively).	Albano N, 2011, ARDEA, V99, P93, DOI 10.5253/078.099.0111; Castillo-Guerrero JA, 2011, J ORNITHOL, V152, P269, DOI 10.1007/s10336-010-0575-z; Alonso-Alvarez C, 2002, WATERBIRDS, V25, P253, DOI 10.1675/1524-4695(2002)025[0253:CIPBAB]2.0.CO;2; Ancona S, 2012, MAR ECOL PROG SER, V462, P261, DOI 10.3354/meps09851; Ancona S, 2011, J ANIM ECOL, V80, P799, DOI 10.1111/j.1365-2656.2011.01821.x; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Becker BH, 2007, MAR ECOL PROG SER, V329, P267, DOI 10.3354/meps329267; Bonnet X, 2001, OIKOS, V92, P297, DOI 10.1034/j.1600-0706.2001.920212.x; Bykov V. P., 1983, MARINE FISHES CHEM C; Castro-Gonzalez MI, 1998, REV BIOL TROP, V46, P249; Cerasale DJ, 2006, AUK, V123, P836, DOI 10.1642/0004-8038(2006)123[836:DEOPOB]2.0.CO;2; CHASTEL O, 1995, ECOLOGY, V76, P2240, DOI 10.2307/1941698; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Crawford RJM, 2008, AFR J MAR SCI, V30, P185, DOI 10.2989/AJMS.2008.30.1.19.469; Crossin GT, 2013, GEN COMP ENDOCR, V193, P112, DOI 10.1016/j.ygcen.2013.07.011; Dentressangle F, 2008, BEHAV ECOL SOCIOBIOL, V62, P1899, DOI 10.1007/s00265-008-0620-6; DRENT RH, 1980, ARDEA, V68, P225; Du WG, 2006, OIKOS, V112, P363, DOI 10.1111/j.0030-1299.2006.13552.x; Engilis A, 1998, WILSON BULL, V110, P332; Forero MG, 2002, MAR ECOL PROG SER, V234, P289, DOI 10.3354/meps234289; Gasparini J, 2007, J EVOLUTION BIOL, V20, P874, DOI 10.1111/j.1420-9101.2007.01315.x; Gilmour ME, 2015, AUK, V132, P191, DOI 10.1642/AUK-14-21.1; Grindstaff JL, 2005, J ANIM ECOL, V74, P1051, DOI 10.1111/j.1365-2656.2005.01002.x; Harris M, 2004, BIRD STUDY, V51, P31; Hayes Jack P., 2001, P8, DOI 10.1017/CBO9780511551741.003; Hernandez M, 2018, SCI TOTAL ENVIRON, V624, P713, DOI 10.1016/j.scitotenv.2017.12.150; Hernandez-Aguilar S.B., 2012, THESIS CTR INTERDISC; HLEAP JOSÉ IGOR, 2010, Rev.Bio.Agro, V8, P57; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hoy SR, 2016, J ANIM ECOL, V85, P892, DOI 10.1111/1365-2656.12517; HOYT DF, 1979, AUK, V96, P73; Janssen Michael H., 2009, Marine Ornithology, V37, P33; Jenni Lukas, 2001, Avian Science, V1, P55; Jenni-Eiermann S, 2002, ZOOLOGY, V105, P239, DOI 10.1078/0944-2006-00066; JENNIEIERMANN S, 1994, AUK, V111, P888, DOI 10.2307/4088821; Karell P, 2008, FUNCT ECOL, V22, P682, DOI 10.1111/j.1365-2435.2008.01425.x; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Korpimaki E, 1998, OIKOS, V83, P259, DOI 10.2307/3546837; Lanctot RB, 2003, HORM BEHAV, V43, P489, DOI 10.1016/S0018-506X(03)00030-8; Lerma-Lizarraga M, 2014, THESIS; Limmer B, 2007, BEHAV ECOL SOCIOBIOL, V61, P1885, DOI 10.1007/s00265-007-0429-8; Margalida A, 2007, J ORNITHOL, V148, P309, DOI 10.1007/s10336-007-0133-5; Margalida A, 2014, ECOL APPL, V24, P436, DOI 10.1890/13-0414.1; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Monaghan P, 1996, P ROY SOC B-BIOL SCI, V263, P1183, DOI 10.1098/rspb.1996.0173; Moody AT, 2012, J ORNITHOL, V153, P1067, DOI 10.1007/s10336-012-0836-0; Nager RG, 2006, ARDEA, V94, P323; Navarro J, 2008, J EXP MAR BIOL ECOL, V358, P14, DOI 10.1016/j.jembe.2008.01.005; Nelson JB, 2005, THE PELECANIFORMS; Norris DR, 2007, J APPL ECOL, V44, P875, DOI 10.1111/j.1365-2664.2007.01329.x; Osorio-Beristain M, 1998, BEHAV ECOL SOCIOBIOL, V43, P307, DOI 10.1007/s002650050496; PARNELL A, 2008, STABLE ISOTOPE ANAL; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pena-Alvarez B., 2009, THESIS; Penniman T.M., 1990, P218; PERDECK AC, 1992, J ANIM ECOL, V61, P13, DOI 10.2307/5504; Piatt JF, 1996, EXX VALD OIL SPILL S, P712; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Quillfeldt P, 2004, POLAR BIOL, V27, P168, DOI 10.1007/s00300-003-0572-2; R Development Core Team, 2007, R LANG ENV STAT COMP; Ramirez-Pinilla MP, 2006, HERPETOL MONOGR, V20, P194, DOI 10.1655/0733-1347(2007)20[194:PTONDG]2.0.CO;2; Robinson S, 2005, IBIS, V147, P483, DOI 10.1111/j.1474-919x.2005.00431.x; Romano MD, 2006, WATERBIRDS, V29, P407, DOI 10.1675/1524-4695(2006)29[407:TTJHOM]2.0.CO;2; ROWE L, 1994, AM NAT, V143, P698, DOI 10.1086/285627; Sandell MI, 2007, J AVIAN BIOL, V38, P284, DOI 10.1111/j.2007.0908-8857.03640.x; Seaman DA, 2005, J EXP BIOL, V208, P761, DOI 10.1242/jeb.01451; Selman RG, 1996, P ROY SOC B-BIOL SCI, V263, P1585, DOI 10.1098/rspb.1996.0232; Smith I., 2011, OTAGO ARCHAEOLOGICAL; Smith SB, 2007, CONDOR, V109, P48, DOI 10.1650/0010-5422(2007)109[48:EODCOP]2.0.CO;2; Smith SB, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov036; Sorensen MC, 2009, J ANIM ECOL, V78, P460, DOI 10.1111/j.1365-2656.2008.01492.x; StatSoft Inc., 2011, STAT DAT AN SOFTW SY; Stauss C, 2012, MAR ECOL PROG SER, V457, P151, DOI 10.3354/meps09734; SYDEMAN WJ, 1991, J ANIM ECOL, V60, P135, DOI 10.2307/5450; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Vanderkist BA, 2000, FUNCT ECOL, V14, P758, DOI 10.1046/j.1365-2435.2000.00475.x; Villegas A, 2013, J ORNITHOL, V154, P431, DOI 10.1007/s10336-012-0907-2; Walsberg G.E., 1983, P135, DOI 10.1017/CBO9780511759994.007; Wang Y, 2017, ZOOL RES, V38, P81, DOI 10.24272/j.issn.2095-8137.2017.011; Wanless S, 2005, MAR ECOL PROG SER, V294, P1, DOI 10.3354/meps294001; Warner DA, 2014, PHYSIOL BIOCHEM ZOOL, V87, P276, DOI 10.1086/674454; White TCR, 2008, BIOL REV, V83, P227, DOI 10.1111/j.1469-185X.2008.00041.x; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; Williams TD, 1999, AUK, V116, P994, DOI 10.2307/4089679; Yerkes T, 2008, J WILDLIFE MANAGE, V72, P715, DOI 10.2193/2007-115	88	9	9	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0193136	10.1371/journal.pone.0193136	http://dx.doi.org/10.1371/journal.pone.0193136			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462199	Green Published, gold, Green Submitted			2022-12-26	WOS:000425554200050
J	Konishi, T; Takahashi, Y				Konishi, Tomokazu; Takahashi, Yoko			Lipoproteins comprise at least 10 different classes in rats, each of which contains a unique set of proteins as the primary component	PLOS ONE			English	Article							PLASMA-LIPOPROTEINS; LIPID-LEVELS; DENSITY; CHOLESTEROL; SIZE; EXPRESSION; SUBCLASSES; BINDING; SYSTEM; GENE	Although lipoproteins are conventionally separated into a few classes using density gradient centrifugation, there may be a much higher number of physical classes that differ in origin or phase. Comprehensive knowledge of the classes of lipoproteins is rather limited, which hinders both the study of their functions and the identification of the primary causes of related diseases. This study aims to determine the number of classes of lipoproteins that can be practically distinguishable and identify the differences between them. We separated rat serum samples by gel filtration. The elution was continuously monitored for triglyceride (TG), cholesterol, and protein, and fractionated for further SDS-PAGE and immunological detection of apoprotein A-I (ApoA1) and apoprotein B (ApoB). The elution patterns were analyzed using a parsimonious method, i.e., the estimation of the least number of classes. Ten classes were recognized that contained different amounts of TG and cholesterol, as well as a unique protein content. Each of the classes contained much more protein than that observed previously, especially in low-density lipoproteins (LDL) classes. In particular, two major antiproteases formed complexes with specific classes of LDL; because these classes exclusively carry cholesterol and antiproteases, they may lead to the progression of atheroma by supplying materials that enlarge fatty streaks and protecting thrombi from enzymatic digestion. The separated classes may have specific biological functions. The attribution of protein species to certain classes will help understand the functions. A distinction among lipoprotein classes may provide important information in the field of vascular pathology.	[Konishi, Tomokazu] Akita Prefectural Univ, Grad Sch Bioresource Sci, Akita, Japan; [Takahashi, Yoko] Natl Agr & Food Res Org NARO, Food Res Inst, Div Food Funct Res, Tsukuba, Ibaraki, Japan	Akita Prefectural University; National Agriculture & Food Research Organization - Japan	Konishi, T (corresponding author), Akita Prefectural Univ, Grad Sch Bioresource Sci, Akita, Japan.	konishi@akita-pu.ac.jp	Konishi, Tomokazu/K-8067-2012	Konishi, Tomokazu/0000-0003-4826-6265				ANDERSEN GR, 1995, J BIOL CHEM, V270, P25133, DOI 10.1074/jbc.270.42.25133; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arai H, 2014, J ATHEROSCLER THROMB, V21, P79; BACHORIK PS, 1995, CLIN CHEM, V41, P1414; Badimon L, 2012, EUR HEART J-ACUTE CA, V1, P60, DOI 10.1177/2048872612441582; Banbula A, 2005, J BIOCHEM, V138, P527, DOI 10.1093/jb/mvi162; Berg JM, 2006, BIOCHEMISTRY; Chang CT, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/164846; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; Civeira F, 2014, J AM COLL CARDIOL, V63, P1228, DOI 10.1016/j.jacc.2013.11.054; Conn EC., 1987, OUTLINES BIOCH; ELOVSON J, 1988, J LIPID RES, V29, P1461; ENGHILD JJ, 1989, J BIOL CHEM, V264, P11428; Goff Jr DC, 2013, J AM COLL CARDIOL, V11, P5, DOI DOI 10.1016/J.JACC.2013.11.005; Gordon SM, 2010, J PROTEOME RES, V9, P5239, DOI 10.1021/pr100520x; GREEVE J, 1993, J LIPID RES, V34, P1367; Hogarth CA, 2003, COMP BIOCHEM PHYS B, V135, P219, DOI 10.1016/S1096-4959(03)00046-0; Krimbou L, 2001, J BIOL CHEM, V276, P33241, DOI 10.1074/jbc.M100326200; Kunding AH, 2008, BIOPHYS J, V95, P1176, DOI 10.1529/biophysj.108.128819; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; LEHMANN R, 1993, EUR J CLIN CHEM CLIN, V31, P633; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Ma CD, 2015, NATURE, V517, P347, DOI 10.1038/nature14018; Niimi Shingo, 2011, Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku, P55; Okazaki M, 2005, ARTERIOSCL THROM VAS, V25, P578, DOI 10.1161/01.ATV.0000155017.60171.88; Okazaki M, 2016, J OLEO SCI, V65, P265, DOI 10.5650/jos.ess16020; OSCHRY Y, 1982, J LIPID RES, V23, P1099; Porsgaard T, 2005, LIPIDS, V40, P273, DOI 10.1007/s11745-005-1382-4; Quillin ML, 2000, ACTA CRYSTALLOGR D, V56, P791, DOI 10.1107/S090744490000679X; Ramasamy I, 2014, CLIN CHEM LAB MED, V52, P1695, DOI 10.1515/cclm-2013-0358; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Rosenson RS, 2011, CLIN CHEM, V57, P392, DOI 10.1373/clinchem.2010.155333; Scheffer PG, 1997, CLIN CHEM, V43, P1904; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SPECTOR AA, 1975, J LIPID RES, V16, P165; Stahlman M, 2008, J LIPID RES, V49, P481, DOI 10.1194/jlr.D700025-JLR200; Suto A, 2013, J VET MED SCI, V75, P1471, DOI 10.1292/jvms.13-0098; Takahashi Y, 2011, J AGR FOOD CHEM, V59, P8976, DOI 10.1021/jf201403u; Tcholakova S, 2006, ADV COLLOID INTERFAC, V123, P259, DOI 10.1016/j.cis.2006.05.021; Voet D., 2005, BIOCHEMISTRY-US; von Zychlinski A., 2015, TRANSLATIONAL PROTEO, V7, P30, DOI [10.1016/j.trprot.2014.12.001, DOI 10.1016/J.TRPROT.2014.12.001]; von Zychlinski A, 2014, J PROTEOMICS, V106, P181, DOI 10.1016/j.jprot.2014.04.030; Watanabe J, 2012, ARTHRITIS RHEUM-US, V64, P1828, DOI 10.1002/art.34363; Wu ZP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209130	47	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2018	13	2							e0192955	10.1371/journal.pone.0192955	http://dx.doi.org/10.1371/journal.pone.0192955			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8CI	29462161	Green Published, Green Submitted, gold			2022-12-26	WOS:000425554200037
J	Escate, R; Mata, P; Cepeda, JM; Padro, T; Badimon, L				Escate, Rafael; Mata, Pedro; Cepeda, Jose Maria; Padro, Teresa; Badimon, Lina			miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemia	FASEB JOURNAL			English	Article						LDL cholesterol; microRNAs; innate immunity; inflammatory markers; age	MICRORNAS; ATHEROSCLEROSIS; INFLAMMATION; LDL; LIPOPROTEINS; CELLS; CHOLESTEROL; PROTEIN; ACTIVATION; MECHANISMS	Familial hypercholesterolemia (FH) conveys a high risk of premature atherosclerosis as a result of lifelong exposure to high LDL cholesterol levels that are not fully reduced by standard-of-care lipid-lowering treatment. Inflammatory mediators have played a role in the progression of atherosclerotic lesions. Here, we investigated whether innate immunity cells in patients with FH have a specific proinflammatory phenotype that is distinct from that of cells in normal participants. To this end, miR-505-3p-a microRNA related to chronic inflammation-and its target genes were investigated in monocyte-derived macrophages (MACs) of patients with FH(FH-MACs) and non-FH controls (co-MACs). On the basis of the profiler PCR array analysis of agomiR-505-3p-transfected MACs, we identified the chemokine receptors, CCR3, CCR4, and CXCR1, as genes that are regulated by miR-505-3p via the transcription factor, RUNX1. miR-505-3p was significantly down-regulated, whereas CCR3, CCR4, CXCR, and RUNX1 were increased in FH-MAC compared with co-MAC, with the increase being more evident in the proinflammatory M1-like FH-MAC. Chemokine receptor levels were unrelated to LDL plasma levels at entry, but correlated with age in patients with FH, not in controls. In summary, we demonstrate for first time to our knowledge that MACs from FH-MACs have an inflammatory phenotype that is characterized by the up-regulation of CCR3, CCR4, and CXCR1 under the control of miR-505-3p. These results suggest a chronic inflammatory condition in FH innate immunity cells that is not reverted by standard lipid-lowering treatment.	[Escate, Rafael; Padro, Teresa; Badimon, Lina] Hosp Santa Creu & Sant Pau, Catalan Inst Cardiovasc Sci ICCC, St Pau Biomed Res Inst IIB St Pau, Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Barcelona, Spain; [Mata, Pedro] Fdn Hipercolesterolemia Familiar, Madrid, Spain; [Cepeda, Jose Maria] Hosp Vega Baja, Dept Internal Med, Orihuela, Spain; [Badimon, Lina] Univ Autonoma Barcelona, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona	Padro, T (corresponding author), Cardiovasc Sci Inst ICCC, Cardiovasc Res Ctr, St Antoni Maria Claret 167, Barcelona 08025, Spain.	tpadro@csic-iccc.org	Escate, Rafael/D-3271-2016; BADIMON, LINA/S-2950-2019; Badimon, Lina/O-4711-2014	Escate, Rafael/0000-0002-8448-7244; Badimon, Lina/0000-0002-9162-2459	Fundacion Jesus Serra; Fundacion de Investigacion Cardiovascular, Barcelona; Institute of Health Carlos III (ISCIII) [FIS PI16/01915, TerCel-RD/12/0019/0026]; Institute of Health Carlos III (ISCIII) [Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV)] [CB16/11/00411]; Spanish Ministry of Economy and Competitiveness [SAF2016-76819-R]; European Regional Development Fund (FEDER) "Una Manera de Hacer Europa"; Department of Economy and Knowledge of the Government of Catalonia [2014SGR1303]; Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya	Fundacion Jesus Serra; Fundacion de Investigacion Cardiovascular, Barcelona; Institute of Health Carlos III (ISCIII); Institute of Health Carlos III (ISCIII) [Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV)]; Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (FEDER) "Una Manera de Hacer Europa"; Department of Economy and Knowledge of the Government of Catalonia; Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya	The authors acknowledge Dr. Esther Pena for help in confocal microscopy analysis, and Montse Gomez-Pardo (both from Catalan Institute of Cardiovascular Sciences) for technical assistance during the study. The authors are indebted to the patients for their valuable contribution and willingness to participate. The authors also thank Fundacion Jesus Serra and Fundacion de Investigacion Cardiovascular, Barcelona, for their continuous support. This work was supported by the Institute of Health Carlos III (ISCIII) [FIS PI16/01915 (to T.P.); TerCel-RD/12/0019/0026 and Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV) CB16/11/00411 (to L.B.)], the Spanish Ministry of Economy and Competitiveness [SAF2016-76819-R (to L.B.)], the European Regional Development Fund (FEDER) "Una Manera de Hacer Europa," the Secretary of University and Research, Department of Economy and Knowledge of the Government of Catalonia (2014SGR1303), and Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya. The authors declare no conflicts of interest.	Alonso R, 2008, ATHEROSCLEROSIS, V200, P315, DOI 10.1016/j.atherosclerosis.2007.12.024; Andreou L, 2015, TRENDS MOL MED, V21, P307, DOI 10.1016/j.molmed.2015.02.003; Antonopoulos AS, 2012, CURR PHARM DESIGN, V18, P1519; Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Badimon L, 2006, CURR MOL MED, V6, P439, DOI 10.2174/156652406778018725; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bekkering S, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0645-3; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; Buttari B, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/257543; CLARKSON SB, 1988, J EXP MED, V167, P408, DOI 10.1084/jem.167.2.408; El Messal M, 2006, CLIN CHIM ACTA, V366, P185, DOI 10.1016/j.cca.2005.09.027; Escate R, 2016, ATHEROSCLEROSIS, V246, P177, DOI 10.1016/j.atherosclerosis.2016.01.002; Escate R, 2017, J CELL MOL MED, V21, P487, DOI 10.1111/jcmm.12993; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Greaves DR, 2001, ARTERIOSCL THROM VAS, V21, P923, DOI 10.1161/01.ATV.21.6.923; GUYTON JR, 1991, J LIPID RES, V32, P953; Haley KJ, 2000, CIRCULATION, V102, P2185; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hartmann P, 2015, CELL MOL LIFE SCI, V72, P3253, DOI 10.1007/s00018-015-1925-z; Hasan D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-222; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Holven KB, 2003, EUR HEART J, V24, P1756, DOI 10.1016/S0195-668X(03)00467-6; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Leonard DA, 2011, CORONARY ARTERY DIS, V22, P491, DOI 10.1097/MCA.0b013e32834b67e2; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Li XF, 2014, CIRCULATION, V129, P1244, DOI 10.1161/CIRCULATIONAHA.113.006840; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Liu Y, 1997, ARTERIOSCL THROM VAS, V17, P317, DOI 10.1161/01.ATV.17.2.317; Llorente-Cortes V, 2002, ARTERIOSCL THROM VAS, V22, P387, DOI 10.1161/hq0302.105367; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; Mata N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-94; Mozas Pilar, 2004, Hum Mutat, V24, P187, DOI 10.1002/humu.9264; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Ninomiya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066086; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Raghuwanshi SK, 2012, J IMMUNOL, V189, P2824, DOI 10.4049/jimmunol.1201114; Raisch J, 2013, WORLD J GASTROENTERO, V19, P2985, DOI 10.3748/wjg.v19.i20.2985; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2014, LANCET, V384, P607, DOI 10.1016/S0140-6736(14)61009-6; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Rousselle A, 2013, J CLIN INVEST, V123, P1343, DOI 10.1172/JCI66580; Suades R, 2014, THROMB HAEMOSTASIS, V111, P111, DOI 10.1160/TH13-07-0612; van Wijk DF, 2014, J AM COLL CARDIOL, V64, P1418, DOI 10.1016/j.jacc.2014.01.088; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Vogt A, 2015, APPL CLIN GENET, V8, P27, DOI 10.2147/TACG.S44315; Weber C, 2011, J CLIN INVEST, V121, P2898, DOI 10.1172/JCI44925; Wierzbicki Anthony S, 2008, BMJ, V337, pa1095, DOI 10.1136/bmj.a1095; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450; Yang Y, 2015, CELL PHYSIOL BIOCHEM, V36, P1371, DOI 10.1159/000430303; Zernecke A, 2012, THROMB HAEMOSTASIS, V107, P626, DOI 10.1160/TH11-08-0603	51	24	25	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					601	612		10.1096/fj.201700476RR	http://dx.doi.org/10.1096/fj.201700476RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	32172543				2022-12-26	WOS:000425146900007
